<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6249703\results\search\country\results.xml">
   <result pre="already providing integrated services for injecting drug users. For example," exact="Germany" post="launched a strategy that integrates care for HIV, hepatitis"/>
   <result pre="care and treatment services for all. Testing for hepatitis in" exact="Ukraine" post="A girl receives the hepatitis B vaccine at a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6445942\results\search\country\results.xml">
   <result pre="Since then, seasonal waves have occurred every other year in" exact="the United States," post="the largest occurring in 2018 (Fig.Â 1) (6â€&quot;8)). Because"/>
   <result pre="then, seasonal waves have occurred every other year in the" exact="United States," post="the largest occurring in 2018 (Fig.Â 1) (6â€&quot;8)). Because"/>
   <result pre="to be recognized in 1840, with larger epidemics documented in" exact="Sweden" post="in 1881 and in the United States in 1894."/>
   <result pre="with larger epidemics documented in Sweden in 1881 and in" exact="the United States" post="in 1894. Early, widespread epidemics came to be referred"/>
   <result pre="larger epidemics documented in Sweden in 1881 and in the" exact="United States" post="in 1894. Early, widespread epidemics came to be referred"/>
   <result pre="2014 to 2015, large AFM epidemics began to appear across" exact="the United States" post="and globally (Fig.Â 1); again, such outbreaks typically occurred"/>
   <result pre="to 2015, large AFM epidemics began to appear across the" exact="United States" post="and globally (Fig.Â 1); again, such outbreaks typically occurred"/>
   <result pre="at the same times: beginning in 2014, AFM epidemics in" exact="the United States" post="have recurred in 2-year cycles of increasing magnitude, usually"/>
   <result pre="the same times: beginning in 2014, AFM epidemics in the" exact="United States" post="have recurred in 2-year cycles of increasing magnitude, usually"/>
   <result pre="other regions of the world, but historically less so in" exact="the United States." post="Could we be entering some kind of new epidemic"/>
   <result pre="regions of the world, but historically less so in the" exact="United States." post="Could we be entering some kind of new epidemic"/>
   <result pre="illness associated with a nationwide outbreak of enterovirus D68 in" exact="the USA" post="(2014): a descriptive epidemiological investigation. Lancet Respir Med3:879â€&quot;887. doi:10.1016/S2213-2600(15)00335-5.26482320"/>
   <result pre="SakthivelSK, SchmidDS, SewardJF, TongS, ObersteMS, PallanschM, FeikinD2016Acute flaccid myelitis in" exact="the United States," post="August-December 2014: results of nationwide surveillance. Clin Infect Dis63:737â€&quot;745."/>
   <result pre="SchmidDS, SewardJF, TongS, ObersteMS, PallanschM, FeikinD2016Acute flaccid myelitis in the" exact="United States," post="August-December 2014: results of nationwide surveillance. Clin Infect Dis63:737â€&quot;745."/>
   <result pre="enterovirus D68 strain associated with acute flaccid myelitis cases in" exact="the USA" post="(2012â€&quot;14): a retrospective cohort study. Lancet Infect Dis15:671â€&quot;682. doi:10.1016/S1473-3099(15)70093-9.25837569"/>
   <result pre="interclade recombination of enterovirus D68 during the 2014 outbreak in" exact="the United States." post="J Virol90:1997â€&quot;2007. doi:10.1128/JVI.02418-15.26656685 30.GongY-N, YangS-L, ShihS-R, HuangYC, ChangPY, HuangCG,"/>
   <result pre="recombination of enterovirus D68 during the 2014 outbreak in the" exact="United States." post="J Virol90:1997â€&quot;2007. doi:10.1128/JVI.02418-15.26656685 30.GongY-N, YangS-L, ShihS-R, HuangYC, ChangPY, HuangCG,"/>
   <result pre="Rev34:507â€&quot;510. doi:10.1093/ptj/34.10.507.13204195 37.NeumannDA2004Historical perspectiveâ€&quot;polio: its impact on the people of" exact="the United States" post="and the emerging profession of physical therapy. J Orthop"/>
   <result pre="doi:10.1093/ptj/34.10.507.13204195 37.NeumannDA2004Historical perspectiveâ€&quot;polio: its impact on the people of the" exact="United States" post="and the emerging profession of physical therapy. J Orthop"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6711314\results\search\country\results.xml">
   <result pre="and human viral origins, and likely originated in swine in" exact="Mexico" post="[10,28]. (a) Barriers to viral emergence While spillovers by"/>
   <result pre="canine influenza virus in shelters and its molecular epidemiology in" exact="the United States." post="J. Virol.84, 12 636â€&quot;12 645. (10.1128/JVI.01350-10) 24PuryearWBet al.2016Prevalence of"/>
   <result pre="influenza virus in shelters and its molecular epidemiology in the" exact="United States." post="J. Virol.84, 12 636â€&quot;12 645. (10.1128/JVI.01350-10) 24PuryearWBet al.2016Prevalence of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6745427\results\search\country\results.xml">
   <result pre=": bold;} span.year {font-family : courier ; font-style : italic;}" exact="Oman" post="Med JOman Med JOMJOman Medical Journal1999-768X2070-5204OMJ OMJ-D-17-00118 doi: 10.5001/omj.2019.73"/>
   <result pre="Biochemistry and Molecular Biology Unit, Public Health Pests Laboratory, Jeddah," exact="Saudi Arabia;" post="Pesticides and Bait Unit, Public Health Pests Laboratory, Jeddah,"/>
   <result pre="Arabia; Pesticides and Bait Unit, Public Health Pests Laboratory, Jeddah," exact="Saudi Arabia." post="E-mail: tambo071@gmail.com ppub: 2019-9345391396received: 2017-7-04accepted: 2018-10-24(C) Oman Medical Specialty"/>
   <result pre="Laboratory, Jeddah, Saudi Arabia. E-mail: tambo071@gmail.com ppub: 2019-9345391396received: 2017-7-04accepted: 2018-10-24(C)" exact="Oman" post="Medical Specialty Board, 2019This is an open-access article distributed"/>
   <result pre="biological control preparedness and resilience approaches, and innovations implementation in" exact="Saudi Arabia" post="and GCC for the purpose of controlling the threat"/>
   <result pre="Keywords: Mosquito Vectors Aedes Zika Virus Arboviruses Dengue Information Dissemination" exact="Saudi Arabia" post="Introduction With people in Saudi Arabia increasingly living in"/>
   <result pre="Arboviruses Dengue Information Dissemination Saudi Arabia Introduction With people in" exact="Saudi Arabia" post="increasingly living in urban and semi-urban areas, the country"/>
   <result pre="confirmed cases of dengue fever were documented in 2016 in" exact="Saudi Arabia" post="alone,2 and dengue infection remains a major public health"/>
   <result pre="public health concern in the Western and South-western areas of" exact="Saudi Arabia" post="and Yemen. Most cases are related to predominant dengue"/>
   <result pre="the proliferation of the incriminated disease vector (Aedes mosquito species)." exact="Saudi Arabia" post="recorded 6000 cases of dengue fever in 2015, and"/>
   <result pre="and phylogenetic of DENV 1-4 and other arboviral diseases in" exact="Saudi Arabia," post="Yemen, and other Middle Eastern countries is crucial for"/>
   <result pre="and sandflies, which pose a significant public health threat in" exact="Saudi Arabia." post="Improving community behavioral communication change approaches Fostering practical approaches"/>
   <result pre="are needed to enhance community social mobilization and communication in" exact="Saudi Arabia," post="Oman, Yemen, UAE, Qatar, and Kuwait regarding the threat"/>
   <result pre="and communication in Saudi Arabia, Oman, Yemen, UAE, Qatar, and" exact="Kuwait" post="regarding the threat of dengue, Zika, and other arboviral"/>
   <result pre="in dengue and other arboviral diseases control and elimination in" exact="Saudi Arabia" post="and Gulf Cooperation Council. Consolidating innovative and integrated biological"/>
   <result pre="circulating Aedes-linked dengue and arboviral diseases threats and pandemics in" exact="Saudi Arabia," post="the GCC, and worldwide. Strengthening governmental/private research and development"/>
   <result pre="threat and epidemics innovations in control and eventual elimination in" exact="Saudi Arabia" post="and its neighbor countries. Likewise, increasing monitoring and evaluation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6749704\results\search\country\results.xml">
   <result pre="75%, such as Fiji, Indonesia, Iran, Italy, Malaysia, Mexico, and" exact="Pakistan" post="[9]), it is unlikely that even three monthly testing"/>
   <result pre="specific examples are presented for Australia, Brazil, China, Egypt, and" exact="the USA" post="in Additional fileÂ 1: Appendix B. In order to"/>
   <result pre="study examples are presented for Australia, Brazil, China, Egypt, and" exact="the USA" post="in Additional fileÂ 1: Appendix Bâ€&quot;Figure S5-S9. Uncertainty bounds"/>
   <result pre="country [26]. For example, the Centre for Disease Control in" exact="the USA" post="prices adult vaccines for hepatitis B at US$30.81; human"/>
   <result pre="antiviral PWID People who inject drugs RNA Ribonucleic acid US$" exact="United States" post="dollar WHO World Health Organization Publisherâ€™s Note Springer Nature"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6820696\results\search\country\results.xml">
   <result pre="globe remains quite variable: Western and Central Europe and North" exact="America" post="are approaching global targets; Latin America and Eastern and"/>
   <result pre="Central Europe and North America are approaching global targets; Latin" exact="America" post="and Eastern and Southern Africa show high levels of"/>
   <result pre="Population-based HIV Impact Assessments (PHIA) study in Zimbabwe, Malawi, and" exact="Zambia" post="conducted by Columbia's ICAP group, 30% of people living"/>
   <result pre="of gay men and other MSM knew of theirs.3 In" exact="the United States," post="the Centers for Disease Control and Prevention (CDC) estimated"/>
   <result pre="gay men and other MSM knew of theirs.3 In the" exact="United States," post="the Centers for Disease Control and Prevention (CDC) estimated"/>
   <result pre="still account for a majority of new HIV infections in" exact="the United States," post="about 20% of blacks, 21% of Hispanic/Latino, and 13%"/>
   <result pre="account for a majority of new HIV infections in the" exact="United States," post="about 20% of blacks, 21% of Hispanic/Latino, and 13%"/>
   <result pre="with variations by country, race/ethnicity, sex/gender, and age.10 In the" exact="United Kingdom," post="for example, about 43% of people aged 15 years"/>
   <result pre="Asia, and 23% in Western and Central Europe and North" exact="America" post="were diagnosed with CD4 counts below the AIDS-defining limit"/>
   <result pre="can contribute substantially to transmission of new HIV infections. In" exact="the United States," post="for example, it is estimated that persons unaware of"/>
   <result pre="contribute substantially to transmission of new HIV infections. In the" exact="United States," post="for example, it is estimated that persons unaware of"/>
   <result pre="to access HIV care and treatment services. For example, in" exact="South Africa," post="although approximately 68% of gay men and other MSM"/>
   <result pre="Central Africa (9% decline), Western and Central Europe and North" exact="America" post="(9% decline), the Caribbean (5% decline), and the Middle"/>
   <result pre="Africa (4% decline). Trends over the same period in Latin" exact="America" post="were stable, and in Eastern Europe and Central Asia,"/>
   <result pre="this gender difference has not changed in many years. In" exact="the United States," post="a country with similarly high access to ART, although"/>
   <result pre="gender difference has not changed in many years. In the" exact="United States," post="a country with similarly high access to ART, although"/>
   <result pre="locales and population groups, such as gay men in the" exact="United Kingdom," post="increased uptake of PrEP alongside increased uptake of treatment"/>
   <result pre="be having a significant effect on HIV incidence. In the" exact="United Kingdom" post="overall, new HIV diagnoses fell by 17% between 2016"/>
   <result pre="as we do for the testing and treatment cascade. In" exact="the United States," post="characteristics of PrEP users are not reflective of trends"/>
   <result pre="we do for the testing and treatment cascade. In the" exact="United States," post="characteristics of PrEP users are not reflective of trends"/>
   <result pre="in the HIV Epidemic: PHIA Findings from Zimbabwe, Malawi, and" exact="Zambia" post="[O-10:114LB]. Presented at: Conference on Retroviruses and Opportunistic Infections"/>
   <result pre="2018. 18.collab: Centers for Disease Control and Prevention. HIV in" exact="the United States." post="Fact Sheet. 2018 Available at: https://www.cdc.gov/hiv/pdf/statistics/overview/cdc-hiv-us-ataglance.pdf. Accessed November 15,"/>
   <result pre="18.collab: Centers for Disease Control and Prevention. HIV in the" exact="United States." post="Fact Sheet. 2018 Available at: https://www.cdc.gov/hiv/pdf/statistics/overview/cdc-hiv-us-ataglance.pdf. Accessed November 15,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6832525\results\search\country\results.xml">
   <result pre="transmission to humans, facilitating subsequent eradication from Europe and North" exact="America" post="[1,2,3,4]. However, today, YFV remains prevalent in tropical regions"/>
   <result pre="YFV remains prevalent in tropical regions of Africa and South" exact="America" post="[4,5], with over 900 million people currently living in"/>
   <result pre="health, which has been starkly illustrated by recent outbreaks in" exact="Angola" post="in 2015â€&quot;2016 [1,12,13] and Brazil in 2016â€&quot;2017 [14,15,16], and"/>
   <result pre="illustrated by recent outbreaks in Angola in 2015â€&quot;2016 [1,12,13] and" exact="Brazil" post="in 2016â€&quot;2017 [14,15,16], and associated imports into non-endemic regions"/>
   <result pre="between 25% and 50% and is correspondingly higher in South" exact="America" post="compared to Africa [31]. Mortality rates may depend on"/>
   <result pre="the large populations in tropical Africa and Central and South" exact="America" post="at risk of potentially catastrophic epidemics, today, treatment options"/>
   <result pre="[53] was able to neutralize divergent YFV strains (YFV-17D and" exact="Angola" post="lineage) [54,56]. The mAb 5A recognizes a conserved region"/>
   <result pre="reduction of YFV cases was observed globally [181]. However, when" exact="Angola" post="was hit by urban outbreak which spread to neighboring"/>
   <result pre="outbreak which spread to neighboring countries, including in the Democratic" exact="Republic of" post="the Congoâ€™s capital Kinshasa, the epidemic created an urgent"/>
   <result pre="[182,183,184]. Furthermore, an unusually large outbreak of the disease in" exact="Brazil" post="in early 2017, including areas that previously were not"/>
   <result pre="and SAL II), the East African lineage (EAL) and the" exact="Angola" post="lineage (AL). In agreement with a previous phylogenetic analysis"/>
   <result pre="the causative agent of an outbreak of VHF in Northern" exact="Uganda" post="in 2010 [227], validating the diagnostic utility of NGS"/>
   <result pre="outbreak [228] and the Lassa fever virus (LASV) outbreak in" exact="Nigeria" post="in 2018 [229]. This technology has multiple advantages for"/>
   <result pre="absent. However, import of YFV from the Angolan outbreak to" exact="China" post="was recorded for the first time in 2016 [15,232]."/>
   <result pre="related to each other and possessed limited divergence from the" exact="Angola" post="1971 strain (three amino acid substitutions) despite a 45-year"/>
   <result pre="for YFV were detected in ten forest mammal species from" exact="French Guiana," post="including members of the divergent orders Rodentia and Carnivora,"/>
   <result pre="human and vector population density [3,5,6]. The 2015â€&quot;2016 outbreak in" exact="Angola" post="is considered an urban outbreak, with human mobility and"/>
   <result pre="to YFV infection. The expansion of the 2016â€&quot;2017 outbreak in" exact="Brazil" post="to an area not previously considered endemic for YFV"/>
   <result pre="outbreaks were previously common [2,3,4,6]. Vector control programs in South" exact="America" post="all but eradicated Ae. aegypti by the 1960s [4],"/>
   <result pre="a dominant lethal gene (RIDL). In trials performed on the" exact="Cayman Islands," post="engineered male Ae. aegypti RIDL mosquitos (strain OX513A) carrying"/>
   <result pre="continuing outbreaks of VHF in tropical regions. Recent epidemics in" exact="Angola" post="and Brazil serve to underline that the threat from"/>
   <result pre="of VHF in tropical regions. Recent epidemics in Angola and" exact="Brazil" post="serve to underline that the threat from this re-emerging"/>
   <result pre="Infect. Dis.2016221854185510.3201/eid2210.16081827536787 13.KraemerM.U.G.FariaN.R.ReinerR.C.GoldingN.NikolayB.StasseS.JohanssonM.A.SaljeH.FayeO.WintG.R.W.et al.Spread of yellow fever virus outbreak in" exact="Angola" post="and the Democratic Republic of the Congo 2015â€&quot;16: A"/>
   <result pre="al.Spread of yellow fever virus outbreak in Angola and the" exact="Democratic Republic of the Congo" post="2015â€&quot;16: A modelling studyLancet Infect. Dis.20171733033810.1016/S1473-3099(16)30513-828017559 14.PaulesC.I.FauciA.S.Yellow Feverâ€&quot;Once Again"/>
   <result pre="of yellow fever virus outbreak in Angola and the Democratic" exact="Republic of" post="the Congo 2015â€&quot;16: A modelling studyLancet Infect. Dis.20171733033810.1016/S1473-3099(16)30513-828017559 14.PaulesC.I.FauciA.S.Yellow"/>
   <result pre="virus outbreak in Angola and the Democratic Republic of the" exact="Congo" post="2015â€&quot;16: A modelling studyLancet Infect. Dis.20171733033810.1016/S1473-3099(16)30513-828017559 14.PaulesC.I.FauciA.S.Yellow Feverâ€&quot;Once Again"/>
   <result pre="Rev. Vaccines2015141479149210.1586/14760584.2015.108343026366673 182.OtshudiemaJ.O.NdakalaN.G.MawandaE.-T.K.TshapendaG.P.KimfutaJ.M.NsibuL.-R.N.GueyeA.S.DeeJ.PhilenR.M.GieseC.et al.Yellow Fever Outbreak - Kongo Central Province," exact="Democratic Republic of the Congo," post="August 2016MMWR Morb. Mortal. Wkly. Rep.20176633533810.15585/mmwr.mm6612a528358796 183.VanniceK.Wilder-SmithA.HombachJ.Fractional-Dose Yellow Fever"/>
   <result pre="Vaccines2015141479149210.1586/14760584.2015.108343026366673 182.OtshudiemaJ.O.NdakalaN.G.MawandaE.-T.K.TshapendaG.P.KimfutaJ.M.NsibuL.-R.N.GueyeA.S.DeeJ.PhilenR.M.GieseC.et al.Yellow Fever Outbreak - Kongo Central Province, Democratic" exact="Republic of" post="the Congo, August 2016MMWR Morb. Mortal. Wkly. Rep.20176633533810.15585/mmwr.mm6612a528358796 183.VanniceK.Wilder-SmithA.HombachJ.Fractional-Dose"/>
   <result pre="Vaccinationâ€&quot;Advancing the Evidence BaseN. Engl. J. Med.201837960360510.1056/NEJMp180343329995585 184.BarrettA.D.T.Yellow Fever in" exact="Angola" post="and Beyond--The Problem of Vaccine Supply and DemandN. Engl."/>
   <result pre="Ebola surveillanceNature201653022823210.1038/nature1699626840485 229.KafetzopoulouL.E.PullanS.T.LemeyP.SuchardM.A.EhichioyaD.U.PahlmannM.ThielebeinA.HinzmannJ.OestereichL.WozniakD.M.et al.Metagenomic sequencing at the epicenter of the" exact="Nigeria" post="2018 Lassa fever outbreakScience2019363747710.1126/science.aau934330606844 230.JainM.OlsenH.E.PatenB.AkesonM.The Oxford Nanopore MinION: Delivery"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6857389\results\search\country\results.xml">
   <result pre="threat PathakVineet K.1MohanM1[1], Department of Community and Family Medicine, All" exact="India" post="Institute of Medical Sciences, Raipur, Chhattisgarh, India Address for"/>
   <result pre="Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh," exact="India" post="Address for correspondence: Dr. Vineet K. Pathak, Department of"/>
   <result pre="Vineet K. Pathak, Department of Community and Family Medicine, All" exact="India" post="Institute of Medical Sciences, Raipur - 492 099, Chhattisgarh,"/>
   <result pre="factors responsible for resurgence, surveillance and the treatment options available." exact="India" post="being hyperendemic, national level comprehensive studies to estimate the"/>
   <result pre="now been recorded in several European countries[4] and in 2014," exact="Japan" post="reported its first outbreak of the disease in 70"/>
   <result pre="to practice of primary healthcare. Realizing the importance Government of" exact="India" post="has named 16th May 2019 â€œNational Dengue day.â€� The"/>
   <result pre="The very first report of existence of dengue fever in" exact="India" post="was way back in 1946.[8] Notable epidemics are one"/>
   <result pre="1946.[8] Notable epidemics are one in the eastern Coast of" exact="India" post="(1963-64),[9] Delhi (1967),[9] and Kanpur (1968).[10] The southern part"/>
   <result pre="dengue and now it has also established its roots in" exact="India" post="where it is becoming hyperendemic in our population. National"/>
   <result pre="comprehensive studies to estimate the true burden of dengue in" exact="India" post="and its geographical mapping are not sufficient. Through integrated"/>
   <result pre="Dis2015215172025695200 6National Dengue Day 2019 | National Health Portal of" exact="India" post="[Internet]cited 2019 Sep 18Available from: https://www.nhp.gov.in/national-dengue-day-2019_pg 7GublerDJEpidemic dengue/dengue hemorrhagic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6883514\results\search\country\results.xml">
   <result pre="Meningitis gone viral: description of the echovirus wave 2013 in" exact="Germany" post="GrafJonas1HartmannChristian J.23LehmannHelmar C.4OttoCarolin5AdamsOrtwin6KarenfortMichael7SchneiderChristian4RuprechtKlemens5BosseHans Martin7DiedrichSabine8BÃ¶ttcherSindy8SchnitzlerAlfons3HartungHans-Peter1AktasOrhan1http://orcid.org/0000-0001-7987-658XAlbrechtPhilippphil.albrecht@gmail.com1[1], 0000 0000 8922 7789grid.14778.3dDepartment of"/>
   <result pre="of echovirus 30 [7]. EV meningitis epidemics in Shandong (Peopleâ€™s" exact="Republic of" post="China, 2014 [8]) and Finland (2009 and 2010 [9])"/>
   <result pre="epidemics in Shandong (Peopleâ€™s Republic of China, 2014 [8]) and" exact="Finland" post="(2009 and 2010 [9]) and the clinical pattern of"/>
   <result pre="clinical pattern of viral central nervous system (CNS) infections in" exact="Italy" post="[10] have previously been characterized: EV-positive patients presented with"/>
   <result pre="fluid (CSF) and clinical features of EV-positive meningitis patients in" exact="Germany" post="[14] and the differences in adult and pediatric EV-positive"/>
   <result pre="the differences in adult and pediatric EV-positive meningitis patients in" exact="Switzerland" post="[15] have already been analyzed, but there is still"/>
   <result pre="which accurately fits to previous data of Shandong [8] and" exact="Finland" post="[9] (Finland 2009 15â€‰years 8â€‰months, Finland 2010 17â€‰years 6â€‰months,"/>
   <result pre="of Shandong [8] and Finland [9] (Finland 2009 15â€‰years 8â€‰months," exact="Finland" post="2010 17â€‰years 6â€‰months, Shandong 2014 children within 15â€‰years of"/>
   <result pre="the National Enterovirussurveillance (EVSurv) all pediatric and neurological hospitals in" exact="Germany" post="are offered free-of-charge enterovirus diagnostics in patients with suspected"/>
   <result pre="paralysis. This health care concept is also well established in" exact="the US" post="and led to a concise description of the disease"/>
   <result pre="work. References References 1.HasbunRRosenthalNBalada-LlasatJMet al.Epidemiology of meningitis and encephalitis in" exact="the United States," post="2011-2014Clin Infect Dis20176535936310.1093/cid/cix31928419350 2.WrightWFPintoCNPalisocKet al.Viral (aseptic) meningitis: a reviewJ"/>
   <result pre="References References 1.HasbunRRosenthalNBalada-LlasatJMet al.Epidemiology of meningitis and encephalitis in the" exact="United States," post="2011-2014Clin Infect Dis20176535936310.1093/cid/cix31928419350 2.WrightWFPintoCNPalisocKet al.Viral (aseptic) meningitis: a reviewJ"/>
   <result pre="meningitis in adultsClin Infect Dis19982789689810.1086/5171629798053 26.KhetsurianiNQuirozESHolmanRCet al.Viral meningitis-associated hospitalizations in" exact="the United States," post="1988-1999Neuroepidemiology20032234535210.1159/00007292414557685 27.ChangL-YHuangL-MGauSS-Fet al.Neurodevelopment and cognition in children after enterovirus"/>
   <result pre="in adultsClin Infect Dis19982789689810.1086/5171629798053 26.KhetsurianiNQuirozESHolmanRCet al.Viral meningitis-associated hospitalizations in the" exact="United States," post="1988-1999Neuroepidemiology20032234535210.1159/00007292414557685 27.ChangL-YHuangL-MGauSS-Fet al.Neurodevelopment and cognition in children after enterovirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6893414\results\search\country\results.xml">
   <result pre="initially isolated from a sentinel rhesus monkey in Zika forest," exact="Uganda" post="in 1947 [1,2], and had been perceived as a"/>
   <result pre="due to outbreaks in varying places, such as Yap Island," exact="French Polynesia," post="and Micronesia [3,4]. Thus, ZIKV has been recognized as"/>
   <result pre="in varying places, such as Yap Island, French Polynesia, and" exact="Micronesia" post="[3,4]. Thus, ZIKV has been recognized as an emerging"/>
   <result pre="More recently, unexpected outbreaks of ZIKV infection have occurred in" exact="Brazil" post="and rapidly spread from South America to Central-American and"/>
   <result pre="infection have occurred in Brazil and rapidly spread from South" exact="America" post="to Central-American and Asian countries, involving millions of residents"/>
   <result pre="to be associated with Guillainâ€&quot;BarrÃ© syndrome in the epidemics of" exact="French Polynesia," post="and further damage caused by ZIKV, including severe congenital"/>
   <result pre="SZ01 was originally isolated from a patient who returned from" exact="Samoa" post="[24]. Both FLR, isolated from the blood of a"/>
   <result pre="Both FLR, isolated from the blood of a human in" exact="Colombia" post="[25], and MR766, isolated from a sentinel monkey in"/>
   <result pre="Colombia [25], and MR766, isolated from a sentinel monkey in" exact="Uganda" post="in 1947 [1], were obtained from ATCC. YFV strain"/>
   <result pre="and prepared as previously described [26]. DENV II strain New" exact="Guinea" post="C was kindly provided by Zhigang Song at Shanghai"/>
   <result pre="(passage 4â€&quot;6) and FLR (passage 4â€&quot;6), DENV II strain New" exact="Guinea" post="C (passage 5â€&quot;7), and YFV strain 17D (passage 5â€&quot;7)"/>
   <result pre="against ZIKV (SZ01, FLR, and MR766) and DENV II New" exact="Guinea" post="C and YFV 17D, Ery-Est and Ery were serially"/>
   <result pre="Acknowledgments This work was supported by the National Megaprojects of" exact="China" post="for Major Infectious Diseases (2018ZX10301403 to L.L.), the National"/>
   <result pre="Diseases (2018ZX10301403 to L.L.), the National Natural Science Foundation of" exact="China" post="(81661128041, 81672019, and 81822045 to L.L.), grants from the"/>
   <result pre="Clinical Center (2016-27 to L.L. and KY-GW-2017-17 to P.Z.), and" exact="China" post="Postdoctoral Science Foundation (2018M640341 and 2019T120302 to S.X.). Supplementary"/>
   <result pre="characterization of the Asian lineage Zika virus imported to ChinaSci." exact="China" post="Life Sci.20165942843010.1007/s11427-016-5043-426993654 25.LahonA.AryaR.P.KneubehlA.R.VogtM.B.Dailey GarnesN.J.Rico-HesseR.Characterization of a Zika Virus Isolate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6896946\results\search\country\results.xml">
   <result pre="UniversityGeelong, VICAustralia Edited by: Elisa Vicenzi, San Raffaele Hospital (IRCCS)," exact="Italy" post="Reviewed by: Davide Angeletti, University of Gothenburg, Sweden *Correspondence:"/>
   <result pre="Hospital (IRCCS), Italy Reviewed by: Davide Angeletti, University of Gothenburg," exact="Sweden" post="*Correspondence: Ralph A. Tripp ratripp@uga.edu This article was submitted"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6913311\results\search\country\results.xml">
   <result pre="that is used clinically for treatment of various diseases in" exact="Japan" post="and other East Asian countries. We evaluated the effects"/>
   <result pre="medicine originated in ancient Chinese medicine and was introduced into" exact="Japan" post="in the fifth or sixth century. In the seventeenth"/>
   <result pre="pharmacies or prescribed by physicians, are currently being used in" exact="Japan" post="and other East Asian countries. Maoto is often prescribed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6943894\results\search\country\results.xml">
   <result pre="evolution, we analyzed the NP gene of H3N2 viruses in" exact="Taiwan" post="and 14,220 NP sequences collected from Influenza Research Database."/>
   <result pre="on viral replication properties. Results The NP genetic analysis by" exact="Taiwan" post="and global sequences showed similar evolution pattern that the"/>
   <result pre="Viral replication Viral translation Funding http://dx.doi.org/10.13039/501100004663Ministry of Science and Technology," exact="Taiwan" post="Funding National Health Research Institutes, Taiwan Background Influenza A"/>
   <result pre="of Science and Technology, Taiwan Funding National Health Research Institutes," exact="Taiwan" post="Background Influenza A viruses are common respiratory infectious pathogens"/>
   <result pre="epidemiology curve showed that the H3N2 subtype continuously circulated in" exact="Taiwan" post="and caused epidemics throughout the years (AdditionalÂ fileÂ 1)."/>
   <result pre="performed using MEGA 7. NP genes from 79 randomly selected" exact="Taiwan" post="clinical isolates, 14 reference strains, as well as the"/>
   <result pre="phylogenetic tree and showed similar time distribution among clades as" exact="Taiwan" post="isolates. When comparing protein variations, the backbone of NP"/>
   <result pre="pâ€‰ Discussion Through the analysis of NP gene evolution in" exact="Taiwan" post="and globally, we observed that the protein sequence backbone"/>
   <result pre="in the 2006â€&quot;2007 influenza virus season, NP-450S appeared temporarily in" exact="Taiwan" post="(Additional file 2). The excess morbidity of H3N2 was"/>
   <result pre="protein of H3N2 viruses. NP substitutions of 79 randomly chosen" exact="Taiwan" post="H3N2 isolates from 1999 to 2017, WHO recommended vaccine"/>
   <result pre="StatesJAMA200328917918610.1001/jama.289.2.17912517228 18.JianJWChenGWLaiCTHsuLCChenPJKuoSHWuHSShihSRGenetic and epidemiological analysis of influenza virus epidemics in" exact="Taiwan" post="during 2003 to 2006J Clin Microbiol2008461426143410.1128/JCM.01560-0718256223 19.LinJHChiuSCChengJCChangHWHsiaoKLLinYCWuHSLiuHFMolecular epidemiology and"/>
   <result pre="and molecular evolution of influenza A virus nucleoprotein genes in" exact="Taiwan" post="between 1979 and 2009PLoS One20116e2345410.1371/journal.pone.002345421858124 26.LiaoCMChangSYChenSCChioCPInfluenza-associated morbidity in subtropical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6954140\results\search\country\results.xml">
   <result pre="drugs remains a challenge to ending the HIV epidemic in" exact="the United States." post="The first legal syringe services program (SSP) in Florida"/>
   <result pre="remains a challenge to ending the HIV epidemic in the" exact="United States." post="The first legal syringe services program (SSP) in Florida"/>
   <result pre="serious public health epidemics as has been the case in" exact="the United States" post="[1, 2]. Additionally, challenges in linkage to care, retention"/>
   <result pre="public health epidemics as has been the case in the" exact="United States" post="[1, 2]. Additionally, challenges in linkage to care, retention"/>
   <result pre="that less than half of PWID living with HIV in" exact="the US" post="are virally suppressed [3, 4]. Further, as homelessness and"/>
   <result pre="the highest rate of HIV diagnoses per 100,000 (42.9) in" exact="the US," post="with over 3.5 times the national rate (11.8) in"/>
   <result pre="prophylaxis for HIV infection in injecting drug users in Bangkok," exact="Thailand" post="(the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6958409\results\search\country\results.xml">
   <result pre="which is a cap-dependent endonuclease inhibitor, have been approved in" exact="Japan" post="and the US [23], with pimodivir, a PB2 inhibitor,"/>
   <result pre="a cap-dependent endonuclease inhibitor, have been approved in Japan and" exact="the US" post="[23], with pimodivir, a PB2 inhibitor, having pre-approval access"/>
   <result pre="then further tested in mice and is now approved in" exact="Japan" post="for treatment of influenza infection [62]. 2.2.2. Immortalized Lung"/>
   <result pre="manuscript. Funding Studies in David Engelberg are supported by the" exact="Israel" post="Science Foundation (grant #1463/18). Lina Lim and David Engelberg"/>
   <result pre="#1463/18). Lina Lim and David Engelberg are supported by the" exact="Singapore" post="National Research Foundation under its HUJ-NUS partnership program at"/>
   <result pre="NS1 proteins from different influenza virus subtypes expressed in yeastSci." exact="China" post="Ser. C Life Sci.20095254555010.1007/s11427-009-0072-x19557332 147.NemeroffM.E.QianX.-Y.KrugR.M.The Influenza Virus NS1 Protein"/>
   <result pre="influenza A and B viruses and affects the virus replicationSci." exact="China" post="Life Sci.2010531098110510.1007/s11427-010-4048-721104370 182.MaH.KienF.ManiÃ¨reM.ZhangY.LagardeN.TseK.S.PoonL.L.M.NalB.Human Annexin A6 Interacts with Influenza A"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6958466\results\search\country\results.xml">
   <result pre="1947 from a rhesus monkey in the Zika forest of" exact="Uganda" post="[1]. In 1952, the virus was detected in humans."/>
   <result pre="major outbreak of ZIKV infection was reported from the Yap" exact="Island" post="in the Federated States of Micronesia in 2007. The"/>
   <result pre="ZIKV infection was reported from the Yap Island in the" exact="Federated States of Micronesia" post="in 2007. The World Health Organization (WHO) report [1]"/>
   <result pre="reported from the Yap Island in the Federated States of" exact="Micronesia" post="in 2007. The World Health Organization (WHO) report [1]"/>
   <result pre="three cases of ZIKV infection in humans in Oyo state," exact="Nigeria" post="[2]. In 1979, Fagbami [3] observed that 40% of"/>
   <result pre="the isolation of the virus from A. aegypti mosquitoes in" exact="Malaysia" post="in 1966 [4,5]. After 11 years of this observation,"/>
   <result pre="human infections in Asia were discovered in central Java of" exact="Indonesia" post="in patients having fever, malaise, stomach ache, anorexia, and"/>
   <result pre="and West African soldiers were brought into combat in the" exact="Burma" post="Campaign from January 1942 to July 1945. Specifically, the"/>
   <result pre="West African countries such as Kenya, Uganda, Nyasaland, Tanganyika, and" exact="Rhodesia" post="(Burma Star Associationâ€&quot;The 11th East African Division). During those"/>
   <result pre="ZIKV during 2007 to 2017, respectively. On 2 March 2015" exact="Brazil" post="notified WHO of reports of an illness characterized by"/>
   <result pre="port cities around the entire Mediterranean. It probably originated in" exact="Ethiopia" post="and came through rodents in ships carrying grain to"/>
   <result pre="pandemic has eased considerably after the sudden eruption in South" exact="America" post="in 2015â€&quot;16 except for sporadic infections around the globe"/>
   <result pre="for sporadic infections around the globe such as in Ahmedabad," exact="India" post="in 2017 [67]. However, this quiescence should not be"/>
   <result pre="the Zika virus genomic sequences in Africa, Asia, and South" exact="America" post="from selected hosts, all of same length (10272 nt)"/>
   <result pre="separation between the three groups, less so between Asia and" exact="America" post="than between Africa and Asia as also seen quantitatively"/>
   <result pre="that the Africa samples are older than Asia and South" exact="America" post="ones. Further details are available in [81]. An alternative"/>
   <result pre="a series of recent outbreaks in South America, particularly in" exact="Brazil" post="before the 2016 Olympic games, it became a serious"/>
   <result pre="declared the Ebolavirus disease (EVD, or Ebola) outbreak in the" exact="Democratic Republic of the Congo" post="(DRC) a Public Health Emergency of International Concern (PHEIC)"/>
   <result pre="the Ebolavirus disease (EVD, or Ebola) outbreak in the Democratic" exact="Republic of" post="the Congo (DRC) a Public Health Emergency of International"/>
   <result pre="(EVD, or Ebola) outbreak in the Democratic Republic of the" exact="Congo" post="(DRC) a Public Health Emergency of International Concern (PHEIC)"/>
   <result pre="of the basic reproduction number of Zika virus infection during" exact="Colombia" post="epidemic, 2015â€&quot;2016Trav. Med. Infect. Dis.20161427427610.1016/j.tmaid.2016.03.01627060613 32.MlakarJ.KorvaM.TulN.PopovicM.Poljsak-PriteljM.MrazJ.KolencJ.RusK.R.VipotnikT.V.VodusekV.F.et al.Zika virus associated"/>
   <result pre="Sci. India193624955 84.LednickyJ.Beau De RocharsV.M.El BadryM.LoebJ.TelismaT.ChavannesS.AnilisG.CellaE.CiccozziM.RashidM.et al.Zika Virus Outbreak in" exact="Haiti" post="in 2014: Molecular and Clinical DataPLoS Negl. Trop. Dis.201610e000468710.1371/journal.pntd.000468727111294"/>
   <result pre="chemicals using graph-theoretic indicesDiscr. Appl. Math.198819174410.1016/0166-218X(88)90004-2 175.Ebola in the Democratic" exact="Republic of" post="the Congo: Health Emergency UpdateAvailable online: https://www.who.int/emergencies/diseases/ebola/drc-2019(accessed on 1"/>
   <result pre="South America, respectively. Magenta represents overlap between Asia and South" exact="America" post="and orange between Africa and Asia. pharmaceuticals-12-00157-t001_Table 1Table 1"/>
   <result pre="africanus: Aedes africanus; ZIKV: Zika virus. Year Country Remarks 1947" exact="Uganda" post="First isolation and identification of ZIKV. Found in rhesus"/>
   <result pre="Found in rhesus monkey, R766, caged in Zika forest. 1948" exact="Uganda" post="Detected in A. africanus mosquitoes. Found in Zika forest."/>
   <result pre="Detected in A. africanus mosquitoes. Found in Zika forest. 1951" exact="Nigeria" post="First instance of ZIKV antibodies in human blood, found"/>
   <result pre="1952 Uganda, Tanganyika First human cases of ZIKV infection detected." exact="India" post="ZIKV antibodies found in human blood. 1953 Malaya, North"/>
   <result pre="ZIKV antibodies found in human blood. 1953 Malaya, North Borneo," exact="Philippines" post="ZIKV antibodies found in residents. Nigeria ZIKV infection detected"/>
   <result pre="1953 Malaya, North Borneo, Philippines ZIKV antibodies found in residents." exact="Nigeria" post="ZIKV infection detected in three persons. 1954 Egypt, Vietnam"/>
   <result pre="residents. Nigeria ZIKV infection detected in three persons. 1954 Egypt," exact="Vietnam" post="ZIKV antibodies found in few residents. 1955 Nigeria ZIKV"/>
   <result pre="1954 Egypt, Vietnam ZIKV antibodies found in few residents. 1955" exact="Nigeria" post="ZIKV antibodies found in human blood. 1957 Mozambique ZIKV"/>
   <result pre="residents. 1955 Nigeria ZIKV antibodies found in human blood. 1957" exact="Mozambique" post="ZIKV antibodies found in human blood. 1958 Uganda Two"/>
   <result pre="blood. 1957 Mozambique ZIKV antibodies found in human blood. 1958" exact="Uganda" post="Two strains of ZIKV found in A. aegypti mosquitoes"/>
   <result pre="ZIKV found in A. aegypti mosquitoes in Zika forest. 1960" exact="Angola" post="ZIKV antibodies found in indigenous residents. 1961â€&quot;1962 Central African"/>
   <result pre="forest. 1960 Angola ZIKV antibodies found in indigenous residents. 1961â€&quot;1962" exact="Central African Republic" post="ZIKV antibodies found in human blood. 1961â€&quot;1964 Ethiopia ZIKV"/>
   <result pre="Central African Republic ZIKV antibodies found in human blood. 1961â€&quot;1964" exact="Ethiopia" post="ZIKV antibodies found in human blood. 1962 Senegal ZIKV"/>
   <result pre="blood. 1961â€&quot;1964 Ethiopia ZIKV antibodies found in human blood. 1962" exact="Senegal" post="ZIKV antibodies found in human blood. 1963â€&quot;1964 Central African"/>
   <result pre="blood. 1962 Senegal ZIKV antibodies found in human blood. 1963â€&quot;1964" exact="Central African Republic," post="Burkina-Faso ZIKV antibodies found in human blood. 1963â€&quot;1965 Ivory"/>
   <result pre="African Republic, Burkina-Faso ZIKV antibodies found in human blood. 1963â€&quot;1965" exact="Ivory Coast" post="ZIKV antibodies found in human blood. 1964 Uganda First"/>
   <result pre="1963â€&quot;1965 Ivory Coast ZIKV antibodies found in human blood. 1964" exact="Uganda" post="First confirmation that ZIKV causes human disease.Clinical features reported."/>
   <result pre="First confirmation that ZIKV causes human disease.Clinical features reported. 1964â€&quot;1965" exact="Guinea-Bissau" post="ZIKV antibodies found in human blood. 1964â€&quot;1966 Togo, Cameroon"/>
   <result pre="1964â€&quot;1965 Guinea-Bissau ZIKV antibodies found in human blood. 1964â€&quot;1966 Togo," exact="Cameroon" post="ZIKV antibodies found in human blood. 1965 Niger ZIKV"/>
   <result pre="1964â€&quot;1966 Togo, Cameroon ZIKV antibodies found in human blood. 1965" exact="Niger" post="ZIKV antibodies found in human blood. 1965â€&quot;1967 Nigeria ZIKV"/>
   <result pre="blood. 1965 Niger ZIKV antibodies found in human blood. 1965â€&quot;1967" exact="Nigeria" post="ZIKV antibodies found in human blood. 1967 Benin, Gabon,"/>
   <result pre="Nigeria ZIKV antibodies found in human blood. 1967 Benin, Gabon," exact="Liberia" post="ZIKV antibodies found in human blood. 1966â€&quot;1967 Uganda, Kenya,"/>
   <result pre="ZIKV antibodies found in human blood. 1966â€&quot;1967 Uganda, Kenya, Somalia," exact="Morocco" post="ZIKV antibodies found in human blood. 1967â€&quot;1969 Uganda ZIKV"/>
   <result pre="Kenya, Somalia, Morocco ZIKV antibodies found in human blood. 1967â€&quot;1969" exact="Uganda" post="ZIKV antibodies found in human blood. 1968 Kenya ZIKV"/>
   <result pre="blood. 1967â€&quot;1969 Uganda ZIKV antibodies found in human blood. 1968" exact="Kenya" post="ZIKV antibodies found in human blood. 1969â€&quot;1972 Nigeria ZIKV"/>
   <result pre="blood. 1968 Kenya ZIKV antibodies found in human blood. 1969â€&quot;1972" exact="Nigeria" post="ZIKV antibodies found in human blood. 1969 Malaysia ZIKV"/>
   <result pre="blood. 1969â€&quot;1972 Nigeria ZIKV antibodies found in human blood. 1969" exact="Malaysia" post="ZIKV found in A. aegypti mosquitoes. 1969â€&quot;1983 Indonesia, Malaysia,"/>
   <result pre="Malaysia ZIKV found in A. aegypti mosquitoes. 1969â€&quot;1983 Indonesia, Malaysia," exact="Pakistan" post="ZIKV found in mosquitoes.Sporadic human infections. 1970 Nigeria ZIKV"/>
   <result pre="Indonesia, Malaysia, Pakistan ZIKV found in mosquitoes.Sporadic human infections. 1970" exact="Nigeria" post="ZIKV antibodies found in human blood. 1971â€&quot;1972 Angola ZIKV"/>
   <result pre="infections. 1970 Nigeria ZIKV antibodies found in human blood. 1971â€&quot;1972" exact="Angola" post="ZIKV antibodies found in human blood. 1972,1975, 1988,1990 Senegal"/>
   <result pre="1971â€&quot;1972 Angola ZIKV antibodies found in human blood. 1972,1975, 1988,1990" exact="Senegal" post="ZIKV antibodies found in human blood. 1979 Central African"/>
   <result pre="1972,1975, 1988,1990 Senegal ZIKV antibodies found in human blood. 1979" exact="Central African Republic" post="ZIKV antibodies found in human blood. 1980 Nigeria ZIKV"/>
   <result pre="Central African Republic ZIKV antibodies found in human blood. 1980" exact="Nigeria" post="ZIKV antibodies found in human blood. 1984 Uganda ZIKV"/>
   <result pre="blood. 1980 Nigeria ZIKV antibodies found in human blood. 1984" exact="Uganda" post="ZIKV antibodies found in human blood. 1996â€&quot;1997 Malaysia ZIKV"/>
   <result pre="blood. 1984 Uganda ZIKV antibodies found in human blood. 1996â€&quot;1997" exact="Malaysia" post="ZIKV antibodies found in human blood. 1999 Ivory Coast"/>
   <result pre="blood. 1996â€&quot;1997 Malaysia ZIKV antibodies found in human blood. 1999" exact="Ivory Coast" post="ZIKV antibodies found in human blood. pharmaceuticals-12-00157-t003_Table 3Table 3"/>
   <result pre="Data summarized from [18,19]. Year Country Remarks 2007 Yap Island," exact="Micronesia" post="First outbreak reported in humans. 2008 Senegal First reported"/>
   <result pre="2007 Yap Island, Micronesia First outbreak reported in humans. 2008" exact="Senegal" post="First reported case of traveler infected in Senegal returning"/>
   <result pre="humans. 2008 Senegal First reported case of traveler infected in" exact="Senegal" post="returning to home country and passing infection through sexual"/>
   <result pre="to home country and passing infection through sexual contact. 2010" exact="Cameroon" post="ZIKV antibodies found in human blood. 2010â€&quot;2015 Cambodia, Indonesia,"/>
   <result pre="found in human blood. 2010â€&quot;2015 Cambodia, Indonesia, Malaysia, Philippines, Thailand," exact="Maldives" post="Mosquito transmission of ZIKV in these countries to travelers"/>
   <result pre="who then carried the infection to their home countries. 2011â€&quot;2014" exact="French Polynesia" post="Second reported outbreak of ZIKV infections. Connection with microcephaly"/>
   <result pre="Tahiti ZIKV isolated from patientâ€™s semen showing sexual transmissibility. 2014" exact="Zambia" post="ZIKV antibodies found in human blood. 2015 April/May Brazil,"/>
   <result pre="human blood. 2015 April/May Brazil, Bahia state National Reference Laboratory," exact="Brazil" post="confirmed, by PCR, ZIKV infections, for the first time"/>
   <result pre="infections, for the first time in the Americas. 2015 July" exact="Brazil" post="Zika cases confirmed by laboratory tests in 12 states."/>
   <result pre="infections detected primarily in the Bahia region. 2015 October South" exact="America" post="Colombia, Republic of Cabo Verde report confirmed cases of"/>
   <result pre="primarily in the Bahia region. 2015 October South America Colombia," exact="Republic of" post="Cabo Verde report confirmed cases of ZIKV infections.Brazil reported"/>
   <result pre="the Bahia region. 2015 October South America Colombia, Republic of" exact="Cabo Verde" post="report confirmed cases of ZIKV infections.Brazil reported unusual increase"/>
   <result pre="of cases of neonatal microcephaly. 2015 November Central and South" exact="America" post="Brazil reported 141 suspected cases of microcephaly and declared"/>
   <result pre="cases of neonatal microcephaly. 2015 November Central and South America" exact="Brazil" post="reported 141 suspected cases of microcephaly and declared a"/>
   <result pre="cases of microcephaly and declared a national public health emergency." exact="Brazil" post="reported detection of ZIKV in amniotic fluid of fetuses"/>
   <result pre="in amniotic fluid of fetuses with confirmed microcephaly. Suriname, Panama," exact="El Salvador," post="Guatemala, and Paraguay confirmed cases of ZIKV infection. The"/>
   <result pre="fetuses with confirmed microcephaly. Suriname, Panama, El Salvador, Guatemala, and" exact="Paraguay" post="confirmed cases of ZIKV infection. The Pan American Health"/>
   <result pre="Health Organization and WHO issued an epidemiological alert. 2015 November" exact="Mexico" post="Three cases of ZIKV infection confirmed by PCR. 2015"/>
   <result pre="Three cases of ZIKV infection confirmed by PCR. 2015 November" exact="French Polynesia" post="Retrospective analysis reveals unusually large number of central nervous"/>
   <result pre="fetuses and infants in 2014â€&quot;2015. 2015 December Central and South" exact="America" post="Honduras, French Guiana, and Martinique reported confirmed cases of"/>
   <result pre="infants in 2014â€&quot;2015. 2015 December Central and South America Honduras," exact="French Guiana," post="and Martinique reported confirmed cases of ZIKV infections. 2015"/>
   <result pre="2015 December Central and South America Honduras, French Guiana, and" exact="Martinique" post="reported confirmed cases of ZIKV infections. 2015 December Puerto"/>
   <result pre="and Martinique reported confirmed cases of ZIKV infections. 2015 December" exact="Puerto Rico" post="First confirmed case of Zika infection reported. 2016 Maldives"/>
   <result pre="Puerto Rico First confirmed case of Zika infection reported. 2016" exact="Maldives" post="Finnish national working in Maldivestested positive for Zika after"/>
   <result pre="positive for Zika after return to Finland. 2016 January Americas" exact="Guyana" post="reported the first PCR-confirmed case of locally acquired Zika"/>
   <result pre="PCR-confirmed case of locally acquired Zika infection.Ecuador, Bolivia, Barbados, Haiti," exact="Dominican Republic," post="Nicaragua, Curacao and Jamaica reported the first confirmed cases"/>
   <result pre="locally acquired Zika infection.Ecuador, Bolivia, Barbados, Haiti, Dominican Republic, Nicaragua," exact="Curacao" post="and Jamaica reported the first confirmed cases of Zika"/>
   <result pre="Zika infection.Ecuador, Bolivia, Barbados, Haiti, Dominican Republic, Nicaragua, Curacao and" exact="Jamaica" post="reported the first confirmed cases of Zika infections.First case"/>
   <result pre="first confirmed cases of Zika infections.First case of Zika in" exact="St. Martin" post="reported. 2016 January US Virgin Islands First confirmed case"/>
   <result pre="infections.First case of Zika in St. Martin reported. 2016 January" exact="US Virgin Islands" post="First confirmed case of Zika in St. Croix reported."/>
   <result pre="case of Zika in St. Martin reported. 2016 January US" exact="Virgin Islands" post="First confirmed case of Zika in St. Croix reported."/>
   <result pre="2016 February Americas First confirmed case of ZIKV infection in" exact="Chile" post="reported.First case of sexually transmitted Zika infection in Texas,"/>
   <result pre="infection in Texas, USA reported. 2016 Various countries Angola, Antigua," exact="British Virgin Islands," post="Trinidad and Tobago, Guadulope, Fiji, Marshall Islands, Papua New"/>
   <result pre="in Texas, USA reported. 2016 Various countries Angola, Antigua, British" exact="Virgin Islands," post="Trinidad and Tobago, Guadulope, Fiji, Marshall Islands, Papua New"/>
   <result pre="USA reported. 2016 Various countries Angola, Antigua, British Virgin Islands," exact="Trinidad and Tobago," post="Guadulope, Fiji, Marshall Islands, Papua New Guinea, and other"/>
   <result pre="Angola, Antigua, British Virgin Islands, Trinidad and Tobago, Guadulope, Fiji," exact="Marshall Islands," post="Papua New Guinea, and other countries report first cases"/>
   <result pre="British Virgin Islands, Trinidad and Tobago, Guadulope, Fiji, Marshall Islands," exact="Papua New Guinea," post="and other countries report first cases of ZIKV infections."/>
   <result pre="and other countries report first cases of ZIKV infections. 2016" exact="Singapore" post="ZIKV infection reported. 2016/2017 India Three cases of ZIKV"/>
   <result pre="cases of ZIKV infections. 2016 Singapore ZIKV infection reported. 2016/2017" exact="India" post="Three cases of ZIKV infection reported in Ahmedabad. 2017"/>
   <result pre="India Three cases of ZIKV infection reported in Ahmedabad. 2017" exact="Singapore" post="Several cases of locally transmitted ZIKV confirmed. pharmaceuticals-12-00157-t004_Table 4Table"/>
   <result pre="A. taylori Asia 106 89.08 3.95 âˆ’11.63% Homo sapiens South" exact="America" post="103 85.92 3.31 âˆ’4.55% Homo sapiens pharmaceuticals-12-00157-t005_Table 5Table 5"/>
   <result pre="d Locus ID Year Country Host Africa 83.1238 KF268949 1980" exact="Central African Republic" post="Aedes opok 226.8671 KF383115 1968 Central African Republic Aedes"/>
   <result pre="KF268949 1980 Central African Republic Aedes opok 226.8671 KF383115 1968" exact="Central African Republic" post="Aedes africanus 187.0571 KF383116 1968 Senegal Aedes luteocephalus 204.2905"/>
   <result pre="KF383115 1968 Central African Republic Aedes africanus 187.0571 KF383116 1968" exact="Senegal" post="Aedes luteocephalus 204.2905 KF383118 2001 Senegal Aedes dalzieli Asia"/>
   <result pre="africanus 187.0571 KF383116 1968 Senegal Aedes luteocephalus 204.2905 KF383118 2001" exact="Senegal" post="Aedes dalzieli Asia 219.0294 KY241697 2016 Singapore Homo sapiens"/>
   <result pre="204.2905 KF383118 2001 Senegal Aedes dalzieli Asia 219.0294 KY241697 2016" exact="Singapore" post="Homo sapiens 258.6828 KY241700 2016 Singapore Homo sapiens 224.1343"/>
   <result pre="Asia 219.0294 KY241697 2016 Singapore Homo sapiens 258.6828 KY241700 2016" exact="Singapore" post="Homo sapiens 224.1343 KY241704 2016 Singapore Homo sapiens 286.1132"/>
   <result pre="sapiens 258.6828 KY241700 2016 Singapore Homo sapiens 224.1343 KY241704 2016" exact="Singapore" post="Homo sapiens 286.1132 KY241766 2016 Singapore Homo sapiens 261.6707"/>
   <result pre="sapiens 224.1343 KY241704 2016 Singapore Homo sapiens 286.1132 KY241766 2016" exact="Singapore" post="Homo sapiens 261.6707 MK238035 2018 India Homo sapiens 261.6707"/>
   <result pre="sapiens 286.1132 KY241766 2016 Singapore Homo sapiens 261.6707 MK238035 2018" exact="India" post="Homo sapiens 261.6707 MK238038 2018 India Homo sapiens South"/>
   <result pre="sapiens 261.6707 MK238035 2018 India Homo sapiens 261.6707 MK238038 2018" exact="India" post="Homo sapiens South America 220.3336 KY559005 2018 Brazil Homo"/>
   <result pre="India Homo sapiens 261.6707 MK238038 2018 India Homo sapiens South" exact="America" post="220.3336 KY559005 2018 Brazil Homo sapiens 261.9161 KY559027 2018"/>
   <result pre="MK238038 2018 India Homo sapiens South America 220.3336 KY559005 2018" exact="Brazil" post="Homo sapiens 261.9161 KY559027 2018 Brazil Homo sapiens 242.1343"/>
   <result pre="America 220.3336 KY559005 2018 Brazil Homo sapiens 261.9161 KY559027 2018" exact="Brazil" post="Homo sapiens 242.1343 KY785427 2018 Brazil Homo sapiens 264.0801"/>
   <result pre="sapiens 261.9161 KY559027 2018 Brazil Homo sapiens 242.1343 KY785427 2018" exact="Brazil" post="Homo sapiens 264.0801 KY785429 2018 Brazil Homo sapiens 185.0375"/>
   <result pre="sapiens 242.1343 KY785427 2018 Brazil Homo sapiens 264.0801 KY785429 2018" exact="Brazil" post="Homo sapiens 185.0375 KY785433 2018 Brazil Homo sapiens 283.8677"/>
   <result pre="sapiens 264.0801 KY785429 2018 Brazil Homo sapiens 185.0375 KY785433 2018" exact="Brazil" post="Homo sapiens 283.8677 KY785456 2018 Brazil Homo sapiens 294.1674"/>
   <result pre="sapiens 185.0375 KY785433 2018 Brazil Homo sapiens 283.8677 KY785456 2018" exact="Brazil" post="Homo sapiens 294.1674 MH882537 2018 Brazil Homo sapiens pharmaceuticals-12-00157-t006_Table"/>
   <result pre="sapiens 283.8677 KY785456 2018 Brazil Homo sapiens 294.1674 MH882537 2018" exact="Brazil" post="Homo sapiens pharmaceuticals-12-00157-t006_Table 6Table 6 Anti-ZIKV compounds having the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6968813\results\search\country\results.xml">
   <result pre="infection has been detected in 70% of patients with TB." exact="South Africa" post="(177,000) has reported the highest number of incident TB"/>
   <result pre="highest number of incident TB cases among PLHIV, followed by" exact="India" post="(92,000) and Mozambique (58,000). Also, in 2018 0.25 million"/>
   <result pre="incident TB cases among PLHIV, followed by India (92,000) and" exact="Mozambique" post="(58,000). Also, in 2018 0.25 million (16.8%) of a"/>
   <result pre="was a lower association for DR-TB infection in PLHIV from" exact="the US." post="Additional information on overlapping risk factors for coinfection, including"/>
   <result pre="an emerging HIV epidemic. Detailed analysis of surveillance data from" exact="Kazakhstan" post="showed no change in the proportion of TB patients"/>
   <result pre="for MDR-TB and HIV coinfection. These are Angola, China, the" exact="Democratic Republic of the Congo," post="Ethiopia, India, Indonesia, Kenya, Mozambique, Myanmar, Nigeria, Papua New"/>
   <result pre="MDR-TB and HIV coinfection. These are Angola, China, the Democratic" exact="Republic of" post="the Congo, Ethiopia, India, Indonesia, Kenya, Mozambique, Myanmar, Nigeria,"/>
   <result pre="of the Congo, Ethiopia, India, Indonesia, Kenya, Mozambique, Myanmar, Nigeria," exact="Papua New Guinea," post="South Africa, Thailand, and Zimbabwe. A few studies have"/>
   <result pre="Ethiopia, India, Indonesia, Kenya, Mozambique, Myanmar, Nigeria, Papua New Guinea," exact="South Africa," post="Thailand, and Zimbabwe. A few studies have estimated the"/>
   <result pre="trends and transmission patterns were analyzed in a study from" exact="the US" post="with restriction fragmentâ€&quot;length polymorphism among TB patients and clustering"/>
   <result pre="M/XDR-TB occurred in Tugela Ferry of the KwaZulu-Natal region in" exact="South Africa" post="in an HIV-positive population, characterized by a high mortality"/>
   <result pre="including next-generation sequencing.40â€&quot;42 Studies from other cities, such as Tomsk," exact="Russia" post="and Shanghai, China, also reported similar findings.43,44 A study"/>
   <result pre="Shanghai, China, also reported similar findings.43,44 A study from Mumbai," exact="India" post="reported an alarmingly high burden of MDR-TB, MDR-TB with"/>
   <result pre="guidance in clinical interpretation of sequencing data. A study from" exact="China" post="reported that the Beijing strain was the most frequently"/>
   <result pre="protocol for establishing rapid diagnosis by detecting R resistance.56 Only" exact="Ethiopia" post="and South Africa have been able to scale up"/>
   <result pre="establishing rapid diagnosis by detecting R resistance.56 Only Ethiopia and" exact="South Africa" post="have been able to scale up GeneXpert MTB/RIF in"/>
   <result pre="among HIV-positive and HIV-negative patients eligible for retreatment regimen in" exact="Togo" post="using GeneXpert MTB/RIF. New Microbe New Infect. 2015;8:24â€&quot;27. doi:10.1016/j.nmni.2015.09.001"/>
   <result pre="co-infected with tuberculosis and HIV in a rural area of" exact="South Africa." post="Lancet. 2006;368(9547):1575â€&quot;1580. doi:10.1016/S0140-6736(06)69573-117084757 27.ShahNS, WrightA, BaiGH, et al. Worldwide"/>
   <result pre="BrustJC, et al. Transmission of extensively drug resistant tuberculosis in" exact="South Africa." post="N Engl J Med. 2017;376(3):243â€&quot;253. doi:10.1056/NEJMoa160454428099825 42.CohenKA, AbeelT, Manson"/>
   <result pre="and cure rates with concurrent treatment for MDR-TB/HIV co-infection in" exact="South Africa." post="Clin Infect Dis. 2018;66(8):1246â€&quot;1253. doi:10.1093/cid/cix112529293906 83.ShinSS, ModongoC, BoydR, et"/>
   <result pre="and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal," exact="South Africa," post="2000â€&quot;2003. Int J Tuberc Lung Dis. 2010;14(4):413â€&quot;419.20202298 86.DanielsJF, KhogaliM,"/>
   <result pre="risk factors and impact in an antiretroviral treatment service in" exact="South Africa." post="AIDS. 2007;21(3):335â€&quot;341. doi:10.1097/QAD.0b013e328011efac17255740 96.NavasE, MartÃ­n-DÃ¡vilaP, MorenoL, et al. Paradoxical"/>
   <result pre="doi:10.1016/S1473-3099(10)70026-820334848 98.HorsburghCRJr.Priorities for the treatment of latent tuberculosis infection in" exact="the United States." post="N Engl J Med. 2004;350(20):2060â€&quot;2067. doi:10.1056/NEJMsa03166715141044 99.DurovniB, SaraceniV, MoultonLH,"/>
   <result pre="98.HorsburghCRJr.Priorities for the treatment of latent tuberculosis infection in the" exact="United States." post="N Engl J Med. 2004;350(20):2060â€&quot;2067. doi:10.1056/NEJMsa03166715141044 99.DurovniB, SaraceniV, MoultonLH,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6977312\results\search\country\results.xml">
   <result pre="among sheep on a farm in the Rift Valley of" exact="Kenya" post="[1]. The virus infects also humans through inoculation after"/>
   <result pre="to extend to other parts of Asia, Europe [13] and" exact="United States" post="[14, 15]. Such an introduction would cause significant losses"/>
   <result pre="in 2000 [18], around 22% in East Africa, West Africa," exact="South Africa" post="and Madagascar from 2006 to 2010 [16], and 28%"/>
   <result pre="around 22% in East Africa, West Africa, South Africa and" exact="Madagascar" post="from 2006 to 2010 [16], and 28% in Tanzania"/>
   <result pre="and Madagascar from 2006 to 2010 [16], and 28% in" exact="Tanzania" post="in 2007 [19]. In 2019 RVFV emerged in Mayotte,"/>
   <result pre="has extended outside the African continent to Indian Ocean Islands:" exact="Madagascar" post="[26], Comoros, and Mayotte [27â€&quot;29], and has reached the"/>
   <result pre="African continent to Indian Ocean Islands: Madagascar [26], Comoros, and" exact="Mayotte" post="[27â€&quot;29], and has reached the Arabian Peninsula in 2000â€&quot;2001,"/>
   <result pre="a total estimated 200,000 human infections and 250 deaths in" exact="Saudi Arabia" post="and Yemen. During the twenty-first century, outbreaks also occurred"/>
   <result pre="also occurred in Egypt, Kenya, Somalia, Tanzania, Sudan, Madagascar, the" exact="Republic of" post="South Africa, Namibia, Mauritania, Uganda, Niger, and Mayotte (Fig.Â"/>
   <result pre="in Egypt, Kenya, Somalia, Tanzania, Sudan, Madagascar, the Republic of" exact="South Africa," post="Namibia, Mauritania, Uganda, Niger, and Mayotte (Fig.Â 2), with"/>
   <result pre="the Republic of South Africa, Namibia, Mauritania, Uganda, Niger, and" exact="Mayotte" post="(Fig.Â 2), with fatal cases (TableÂ 1). Recently, RVFV"/>
   <result pre="with fatal cases (TableÂ 1). Recently, RVFV has circulated in" exact="Mayotte" post="from November 2018 to August 2019 [30, 31]. Moreover,"/>
   <result pre="cases Cumulated reported cases Deaths confirmed Cumulated confirmed deaths 2000â€&quot;2001" exact="Saudi Arabia," post="Yemen 886 886 123 123 2006â€&quot;2007 Kenya 700 1586"/>
   <result pre="reported cases Deaths confirmed Cumulated confirmed deaths 2000â€&quot;2001 Saudi Arabia," exact="Yemen" post="886 886 123 123 2006â€&quot;2007 Kenya 700 1586 158"/>
   <result pre="deaths 2000â€&quot;2001 Saudi Arabia, Yemen 886 886 123 123 2006â€&quot;2007" exact="Kenya" post="700 1586 158 281 2006â€&quot;2007 Somalia 114 1700 51"/>
   <result pre="886 123 123 2006â€&quot;2007 Kenya 700 1586 158 281 2006â€&quot;2007" exact="Somalia" post="114 1700 51 332 2006â€&quot;2007 Tanzania 264 1964 109"/>
   <result pre="1586 158 281 2006â€&quot;2007 Somalia 114 1700 51 332 2006â€&quot;2007" exact="Tanzania" post="264 1964 109 441 2007â€&quot;2008 Sudan 747 2711 230"/>
   <result pre="1700 51 332 2006â€&quot;2007 Tanzania 264 1964 109 441 2007â€&quot;2008" exact="Sudan" post="747 2711 230 671 2008â€&quot;2009 Madagascar 712 3423 26"/>
   <result pre="1964 109 441 2007â€&quot;2008 Sudan 747 2711 230 671 2008â€&quot;2009" exact="Madagascar" post="712 3423 26 697 2009â€&quot;2011 South Africa and Namibia"/>
   <result pre="2711 230 671 2008â€&quot;2009 Madagascar 712 3423 26 697 2009â€&quot;2011" exact="South Africa" post="and Namibia &amp;gt;â€‰250 3673 26 723 2010 Mauritania 63"/>
   <result pre="2008â€&quot;2009 Madagascar 712 3423 26 697 2009â€&quot;2011 South Africa and" exact="Namibia" post="&amp;gt;â€‰250 3673 26 723 2010 Mauritania 63 3736 13"/>
   <result pre="2009â€&quot;2011 South Africa and Namibia &amp;gt;â€‰250 3673 26 723 2010" exact="Mauritania" post="63 3736 13 736 2012 Mauritania 41 3777 18"/>
   <result pre="3673 26 723 2010 Mauritania 63 3736 13 736 2012" exact="Mauritania" post="41 3777 18 754 2013â€&quot;2014 Mauritania and Senegal 11"/>
   <result pre="3736 13 736 2012 Mauritania 41 3777 18 754 2013â€&quot;2014" exact="Mauritania" post="and Senegal 11 3788 0 754 2015 Mauritania 31"/>
   <result pre="736 2012 Mauritania 41 3777 18 754 2013â€&quot;2014 Mauritania and" exact="Senegal" post="11 3788 0 754 2015 Mauritania 31 3819 8"/>
   <result pre="754 2013â€&quot;2014 Mauritania and Senegal 11 3788 0 754 2015" exact="Mauritania" post="31 3819 8 762 2016â€&quot;2018 Uganda 16 3835 7"/>
   <result pre="3788 0 754 2015 Mauritania 31 3819 8 762 2016â€&quot;2018" exact="Uganda" post="16 3835 7 769 2016 Niger 348 4183 33"/>
   <result pre="3819 8 762 2016â€&quot;2018 Uganda 16 3835 7 769 2016" exact="Niger" post="348 4183 33 802 2018 Kenya 26 4209 6"/>
   <result pre="3835 7 769 2016 Niger 348 4183 33 802 2018" exact="Kenya" post="26 4209 6 808 2019 Mayotte 143 4352 0"/>
   <result pre="4183 33 802 2018 Kenya 26 4209 6 808 2019" exact="Mayotte" post="143 4352 0 808 2019â€&quot;â€¦a Sudana 365a 4717 11a"/>
   <result pre="humans by Laughlin et al. during the major outbreak in" exact="Egypt" post="in 1977, it is considered that less than 5%"/>
   <result pre="mortality, varied from one to another outbreak. For example, in" exact="South Africa" post="in 1975 [44] and in Tanzania in 2007 [19]"/>
   <result pre="For example, in South Africa in 1975 [44] and in" exact="Tanzania" post="in 2007 [19] most of RVF severe cases presented"/>
   <result pre="encephalopathy (respectively 71% and 89%), whereas hemorrhagic manifestations predominated in" exact="Mauritania" post="in 2015 (81%) [45] and Madagascar in 2008 (88%)"/>
   <result pre="hemorrhagic manifestations predominated in Mauritania in 2015 (81%) [45] and" exact="Madagascar" post="in 2008 (88%) [46]. In Saudi Arabia in 2000,"/>
   <result pre="2015 (81%) [45] and Madagascar in 2008 (88%) [46]. In" exact="Saudi Arabia" post="in 2000, hepatic insufficiency (75%) and renal failures (41%)"/>
   <result pre="status was associated with a 75% case fatality rate in" exact="Tanzania" post="in 2007 [19]. Schistosomal liver co-involvement and bacterial or"/>
   <result pre="as a result of gastrointestinal bleeding and hepatic encephalitis in" exact="Mayotte" post="[28], and 4/31 (13%) severe cases described during the"/>
   <result pre="and 4/31 (13%) severe cases described during the epidemic in" exact="Mauritania" post="in 2015 had chronic hepatitis B [61], suggesting that"/>
   <result pre="[40, 47]. A population-based survey during the 2007 outbreak in" exact="Kenya" post="even reported 26% of hemorrhagic RVF disease with a"/>
   <result pre="coma [17, 35, 44, 70â€&quot;73]. In a human outbreak in" exact="Mauritania" post="in 1989, up to 5% of observed infections had"/>
   <result pre="be as high as 50% in this form [40]. From" exact="Mauritania" post="in 1989, clear a cellular CSF were documented in"/>
   <result pre="for chronic myeloid leukemia with acute RVFV encephalitis acquired in" exact="Saudi Arabia," post="CSF was documented predominantly with polynuclear leukocytes. Magnetic resonance"/>
   <result pre="oliguria were also reported with a bad prognosis [62]. In" exact="Mauritania" post="in 2015, creatininemia was meanly more than fourfold upper"/>
   <result pre="fourfold upper the reference range in severe cases [61]. In" exact="Saudi Arabia" post="in 2000, renal impairment concerned up to 60% of"/>
   <result pre="manifestations has been estimated to 1% during epidemic outbreaks in" exact="Egypt" post="in 1977, and up to 15% both in patients"/>
   <result pre="and severe RVF disease during the 2000 outbreak in southwest" exact="Saudi Arabia" post="[84]. Unilateral or bilateral symptoms generally occur 5 to"/>
   <result pre="as those with normal deliveries [91]. A retrospective study in" exact="Egypt" post="in 1980 found no increase in the risk of"/>
   <result pre="was briefly mentioned that ribavirin was used without efficacy in" exact="Saudi Arabia" post="[101]. Evidence suggests ribavirin efficacy in animal models [102,"/>
   <result pre="of suspected severe RVF cases during the major epidemic in" exact="Saudi Arabia" post="in 2000 [42], the updated guidelines for health workers"/>
   <result pre="the draft. TL was the French military physicians deployed in" exact="Mayotte" post="who was at the origin of this work. GD"/>
   <result pre="the French National Reference center for Arboviruses, confirmed cases in" exact="Mayotte" post="and helped in the discussion and the draft for"/>
   <result pre="diagnostics and preventionVet Res2010416110.1051/vetres/201003321188836 9.TongCJavelleEGrardGDiaALacrosseCFouriÃ©Tet al.Tracking Rift Valley fever: from" exact="Mali" post="to Europe and other countries, 2016Eurosurveillance.201924180021310.2807/1560-7917.ES.2019.24.8.1800213 10.ChevalierVRelevance of Rift"/>
   <result pre="11.LiuJSunYShiWTanSPanYCuiSet al.The first imported case of Rift Valley fever in" exact="China" post="reveals a genetic reassortment of different viral lineagesEmerg Microbes"/>
   <result pre="Biomed.20166972772910.1016/j.apjtb.2016.07.013 13.LumleySHernÃ¡ndez-TrianaLMHortonDLFernÃ¡ndez de MarcoMDMMedlockJMHewsonRet al.Competence of mosquitoes native to the" exact="United Kingdom" post="to support replication and transmission of Rift Valley fever"/>
   <result pre="Trop Med Hyg19797363063310.1016/0035-9203(79)90006-3575446 18.AhmadKMore deaths from Rift Valley fever in" exact="Saudi Arabia" post="and YemenLancet2000356142210.1016/S0140-6736(05)74068-X11052595 19.MohamedMMoshaFMghambaJZakiSRShiehW-JPaweskaJet al.Epidemiologic and clinical aspects of a"/>
   <result pre="for Disease Control (CDC). Update: Outbreak of Rift Valley Fever" exact="Saudi Arabia," post="August-November 2000. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4943a3.htm. Accessed 29 June 2019. 43.KahlonSSPetersCJLeducJMuchiriEMMuiruriSNjengaMKet al.Severe"/>
   <result pre="Rift Valley fever, Part I: acute febrile and hemorrhagic-like diseasesJ" exact="Egypt" post="Public Health Assoc197853181182572398 64.AdamFJouanARiouOPhilippeBCoulibalyIBerliozBet al.Development of a clinical and"/>
   <result pre="Valley fever. Part 2: Ophthalmologic and central nervous system complicationsJ" exact="Egypt" post="Public Health Assoc.197853183184572399 74.HanecheFLeparc-GoffartISimonFHentzienMMartinez-PourcherVCaumesEet al.Rift Valley fever in kidney"/>
   <result pre="74.HanecheFLeparc-GoffartISimonFHentzienMMartinez-PourcherVCaumesEet al.Rift Valley fever in kidney transplant recipient returning from" exact="Mali" post="with viral RNA detected in semen up to four"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6993835\results\search\country\results.xml">
   <result pre="article are: Anirban Basu, National Brain Research Centre, Manesar, Haryana," exact="India" post="No competing interests were disclosed. Jayantee Kalita, Department of"/>
   <result pre="Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow," exact="India" post="No competing interests were disclosed. Encephalitis is an important"/>
   <result pre="uniform definitions and study populations. Worldwide the prevalence varies. In" exact="the US," post="there were 73 hospitalizations due to encephalitis per 100,000"/>
   <result pre="this region in 2005 13, after which the Government of" exact="India" post="imported the Chinese live attenuated vaccine (SA-14-14-2 strain), which"/>
   <result pre="of their insect vectors. For example, arboviral encephalitides prevalent in" exact="the US" post="include Western equine, eastern equine, Californian, and St. Louis"/>
   <result pre="sex predilection 4. West Nile encephalitis virus was introduced in" exact="the US" post="in the 1990s and the illness is endemic there"/>
   <result pre="RM, Stanton BF, St Geme JW, Schor NF (Eds.). Elsevier" exact="India" post="First South asiaEdn,2016;2946â€&quot;7. Reference Source 2KhetsurianiNHolmanRCAndersonLJ: Burden of encephalitis-associated"/>
   <result pre="South asiaEdn,2016;2946â€&quot;7. Reference Source 2KhetsurianiNHolmanRCAndersonLJ: Burden of encephalitis-associated hospitalizations in" exact="the United States," post="1988-1997.Clin Infect Dis.2002;35(2):175â€&quot;82. 10.1086/34130112087524 3ShuklaBAguileraEASalazarLet al.: Aseptic meningitis in"/>
   <result pre="asiaEdn,2016;2946â€&quot;7. Reference Source 2KhetsurianiNHolmanRCAndersonLJ: Burden of encephalitis-associated hospitalizations in the" exact="United States," post="1988-1997.Clin Infect Dis.2002;35(2):175â€&quot;82. 10.1086/34130112087524 3ShuklaBAguileraEASalazarLet al.: Aseptic meningitis in"/>
   <result pre="Recommendation 4GeorgeBPSchneiderEBVenkatesanAet al.: Encephalitis hospitalization rates and inpatient mortality in" exact="the United States," post="2000-2010.PLoS One.2014;9(9):e104169. 10.1371/journal.pone.010416925192177 5ParpiaASLiYChenCet al.: Encephalitis, Ontario, Canada, 2002-2013.Emerg"/>
   <result pre="4GeorgeBPSchneiderEBVenkatesanAet al.: Encephalitis hospitalization rates and inpatient mortality in the" exact="United States," post="2000-2010.PLoS One.2014;9(9):e104169. 10.1371/journal.pone.010416925192177 5ParpiaASLiYChenCet al.: Encephalitis, Ontario, Canada, 2002-2013.Emerg"/>
   <result pre="Recommendation 14JainPSinghAKKhanDNet al.: Trend of Japanese encephalitis in Uttar Pradesh," exact="India" post="from 2011 to 2013.Epidemiol Infect.2016;144(2):363â€&quot;70. 10.1017/S095026881500092826112391 15MeenaJKKhandelwalSGuptaPet al.: Scrub"/>
   <result pre="24JainPPrakashSKhanDNet al.: Aetiology of acute encephalitis syndrome in Uttar Pradesh," exact="India" post="from 2014 to 2016.J Vector Borne Dis.2017;54(4):311â€&quot;6. 10.4103/0972-9062.22583529460860 25EsserHJMÃ¶glingRCletonNBet"/>
   <result pre="RM, Stanton BF, St Geme JW, Schor NF (Eds). Elsevier" exact="India" post="First South Asia Edn,2016;1572â€&quot;8. Reference Source 57de MirandaPBlumMR: Pharmacokinetics"/>
   <result pre="al.: Role of oral Minocycline in acute encephalitis syndrome in" exact="India" post="- a randomized controlled trial.BMC Infect Dis2016;16: 67. 10.1186/s12879-016-1385-626847071"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7001263\results\search\country\results.xml">
   <result pre="block in the control of HIV and viral hepatitis in" exact="Tanzania" post="KawambwaRahim H.Kawambwa7@gmail.com1http://orcid.org/0000-0003-3726-2816MajigoMtebe V.mmajigo@gmail.com1MohamedAhmed A.Ahmedabade@yahoo.com2MateeMecky I.mateemecky@yahoo.com1[1], 0000 0001 1481 7466grid.25867.3eDepartment"/>
   <result pre="made available in this article, unless otherwise stated. Abstract Background" exact="Tanzania" post="has witnessed a significant decrease in the prevalence of"/>
   <result pre="HIV Hepatitis B virus Hepatitis C virus Dar es Salaam" exact="Tanzania" post="Background Tanzania has reported a steady fall in the"/>
   <result pre="B virus Hepatitis C virus Dar es Salaam Tanzania Background" exact="Tanzania" post="has reported a steady fall in the prevalence of"/>
   <result pre="June and September 2017 in Dar-es-salaam, the largest city in" exact="Tanzania" post="with an estimated population of around 6 million inhabitants."/>
   <result pre="HIV, HBV, HCV, and co-infections among 219 PWID in Dar-es-salaam," exact="Tanzania" post="Infection Frequency positive Seropositive 95% CI of seropositive HIV"/>
   <result pre="findings are also higher compared with the previous report from" exact="Tanzania" post="[6], possibly indicating an increase of infection with these"/>
   <result pre="certainly limited the impact of the initiatives undertaken by the" exact="Tanzania" post="AIDS control program, including the outreach services. We recommend"/>
   <result pre="needle sharing practice, supporting findings of previous studies conducted in" exact="Tanzania" post="[14, 16, 20], and disputing a common belief in"/>
   <result pre="References 1.collab: NACPHIV/AIDS and sexually transmitted infection suiveillance report 24," exact="Tanzania" post="Maninlans 2013â€&quot;20142014 2.collab: NBSTanzania HIV Impact Survey (THIS) 2016/17"/>
   <result pre="drug use in six African countries: Egypt, Kenya, Mauritius, Nigeria," exact="South Africa" post="and Tanzania. Drugs: education, prevention and policyDrugs2006132121137 14.McCurdySAWilliamsMLKilonzoGPRossMWLeshabariMTHeroin and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7004624\results\search\country\results.xml">
   <result pre="10.1097/CM9.000000000000064700009 : Review Articles Human immunodeficiency virus prevention strategies in" exact="China" post="WuZun-You12ScottSarah Robbins1 ChenLi-Min[1], [2], Correspondence to: Dr. Zun-You Wu,"/>
   <result pre="Control and Prevention, 155 Changbai Road, Changping District, Beijing 102206," exact="China" post="E-Mail: wuzy@263.net ppub: 2020-2-2epub: 2020-2-21333318325received: 2019-8-09(C) , 2020This is"/>
   <result pre="HIV epidemic. Keywords Human immunodeficiency virus infection Epidemic Prevention strategies" exact="China" post="Introduction The epidemic of human immunodeficiency virus (HIV) infection"/>
   <result pre="infection has changed remarkably around the world and domestically in" exact="China" post="over the past three decades, with a reduction in"/>
   <result pre="an appropriate assessment of their feasibility to be adopted in" exact="China" post="as national strategies. General Prevention Measures All prevention strategies"/>
   <result pre="status has been shown to help increase safer sexual practices.[15]" exact="China" post="adopted VCT as a part of its national HIV"/>
   <result pre="of HIV among former commercial plasma donors in the mid-1990s,[18â€&quot;20]" exact="China" post="has made significant improvements in ensuring a safe blood"/>
   <result pre="inject drugs With the first initial cases of HIV in" exact="China" post="among injection drug users, strategies to control the spread"/>
   <result pre="route of HIV transmission in China. However, the lessons from" exact="the US" post="and UK[24,25] warn us that these strategies must be"/>
   <result pre="why HIV continues to spread via sexual transmission. Since 2004," exact="China" post="has promoted condom use in female sex workers and"/>
   <result pre="have been recognized as a major public health threat in" exact="China" post="since they re-emerged in the early 1980s.[31] Importantly, HIV"/>
   <result pre="a key component of China's national HIV/AIDS strategy. In 2005," exact="China" post="started its first PMTCT program in eight cities throughout"/>
   <result pre="to reducing the transmission of HIV worldwide. Observational studies in" exact="China" post="have also observed that treatment as prevention can significantly"/>
   <result pre="treatment as prevention policies among sero-discordant couples was adopted in" exact="China" post="in 2011, and have since significantly reduced HIV transmission,"/>
   <result pre="treatment has resulted in reduced new transmission of HIV infections.[45]" exact="China" post="too has adopted these targets as a part of"/>
   <result pre="carried out in 2015 found that 68% of PLWH in" exact="China" post="were diagnosed, 67% among those diagnosed were receiving ART,"/>
   <result pre="and diagnosis, along with immediate initiation of ART, could help" exact="China" post="achieve the 90-90-90 targets. New social media Social media"/>
   <result pre="Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis," exact="China" post="has pilot-tested male circumcision among MSM. Unfortunately, the acceptability"/>
   <result pre="of HIV transmission through anal sex. Microbicide development research in" exact="China" post="was launched in 2008 under the National 11th Five-Year"/>
   <result pre="National 11th Five-Year Plan on HIV. Thus far, studies in" exact="China" post="have been focused on pre-clinical development, addressing the mechanism"/>
   <result pre="has shown positive results.[76] The RV 144 trial performed in" exact="Thailand" post="found that the HIV infection rate was 31.2% lower"/>
   <result pre="transmission in urban cities in China. As the population of" exact="China" post="is quite large, a tiny change in HIV incidence"/>
   <result pre="stop the epidemic. Cases in African countries or parts of" exact="China" post="have demonstrated that implementation of combined interventions can achieve"/>
   <result pre="1:26â€&quot;32. 10.1016/S2414-6447(19)30057-0 9.collab: National Center for AIDS/STD Control and Prevention," exact="China" post="CDC. Annual Report of China National HIV/STD/HCV Comprehensive Prevention"/>
   <result pre="for AIDS/STD Control and Prevention, China CDC. Annual Report of" exact="China" post="National HIV/STD/HCV Comprehensive Prevention and Treatment Programs in 2018."/>
   <result pre="in 2018. Beijing: National Center for AIDS/STD Control and Prevention," exact="China" post="CDC; 2019. 10.WuZCharacteristics of HIV sexually transmission and challenges"/>
   <result pre="HIV sexually transmission and challenges for controlling the epidemic in" exact="China" post="(in Chinese). Chin J Epidemiol2018; 39:707â€&quot;709. doi: 10.3760/cma.j.issn.0254-6450.2018.06.002. 11.WuZSunXSullivanSGDetelsRPublic"/>
   <result pre="28.HughesAJSaxtonPJThirty years of condom-based HIV prevention by gay men in" exact="New Zealand." post="N Z Med J2015; 128:19â€&quot;30. 29.collab: National Center for"/>
   <result pre="J2015; 128:19â€&quot;30. 29.collab: National Center for AIDS/STD Control and Prevention," exact="China" post="CDC. China National HIV/Syphilis/HCV Surveillance Report in 2015. Beijing:"/>
   <result pre="29.collab: National Center for AIDS/STD Control and Prevention, China CDC." exact="China" post="National HIV/Syphilis/HCV Surveillance Report in 2015. Beijing: National Center"/>
   <result pre="in 2015. Beijing: National Center for AIDS/STD Control and Prevention," exact="China" post="CDC; 2015. 30.LiuHSuYZhuLXingJWuJWangNEffectiveness of ART and condom use for"/>
   <result pre="with decline in risk of HIV acquisition in rural KwaZulu-Natal," exact="South Africa." post="Science2013; 339:966â€&quot;971. doi: 10.1126/science.1228160.23430656 43.UNAIDS. 90-90-90 an ambitious treatment"/>
   <result pre="prophylaxis for HIV infection in injecting drug users in Bangkok," exact="Thailand" post="(the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase"/>
   <result pre="Academic Conference of National Center for AIDS/STD Control and Prevention," exact="China" post="CDC. Beijing, 2018 62.KarrisMYBeekmannSEMehtaSRAndersonCMPolgreenPMAre we prepped for preexposure prophylaxis"/>
   <result pre="(PrEP)? Provider opinions on the real-world use of PrEP in" exact="the United States" post="and Canada. Clin Infect Dis2014; 58:704â€&quot;712. doi: 10.1093/cid/cit796.24319083 63.LiuCDingYNingZGaoMLiuXWongFYet"/>
   <result pre="Provider opinions on the real-world use of PrEP in the" exact="United States" post="and Canada. Clin Infect Dis2014; 58:704â€&quot;712. doi: 10.1093/cid/cit796.24319083 63.LiuCDingYNingZGaoMLiuXWongFYet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7019949\results\search\country\results.xml">
   <result pre="of measles in developed countries, including the Americas, Europe, and" exact="Australia" post="found that 100% of measles cases were imported or"/>
   <result pre="with movement of individuals between rural and urban areas in" exact="Sierra Leone," post="Guinea, and Liberia [14]. This led the international community"/>
   <result pre="between rural and urban areas in Sierra Leone, Guinea, and" exact="Liberia" post="[14]. This led the international community to restrict air"/>
   <result pre="with this, between November 10, 2014, and July 12, 2015," exact="the US" post="Centers for Disease Control and Prevention (CDC) made 2374"/>
   <result pre="and rate of infectious diseases among different populations [23,24]. In" exact="the United States," post="efforts focused on prevention of disease transmission and dissemination"/>
   <result pre="rate of infectious diseases among different populations [23,24]. In the" exact="United States," post="efforts focused on prevention of disease transmission and dissemination"/>
   <result pre="found that viral introductions into KwaZulu-Natal, a rural region in" exact="South Africa," post="were a major driver of the ongoing epidemic, accounting"/>
   <result pre="HIV epidemics. Expanding to international travel, a study conducted in" exact="France" post="assessed the frequency of travel-related illnesses among residents of"/>
   <result pre="France assessed the frequency of travel-related illnesses among residents of" exact="France" post="who had returned from abroad with an infectious disease"/>
   <result pre="is much more likely to have been acquired outside of" exact="the US" post="and other western nations, these likely represent easily identified"/>
   <result pre="associated with international travel in the region of the Americas," exact="Australia" post="and Europe, 2001â€&quot;2013: A systematic reviewTravel Med. Infect. Dis.201513101810.1016/j.tmaid.2014.10.02225468523"/>
   <result pre="Border RegionEBioMedicine201521456146310.1016/j.ebiom.2015.07.02426629540 29.AibekovaL.FoleyB.HortelanoG.RaeesM.AbdraimovS.ToichuevR.AliS.Molecular epidemiology of HIV-1 subtype A in former" exact="Soviet Union" post="countriesPLoS ONE201813e019189110.1371/journal.pone.019189129389951 30.CastleyA.SawleshwarkarS.VarmaR.HerringB.ThapaK.DwyerD.ChiboD.NguyenN.HawkeK.RatcliffR.et al.A national study of the molecular"/>
   <result pre="al.A national study of the molecular epidemiology of HIV-1 in" exact="Australia" post="2005â€&quot;2012PLoS ONE201712e017060110.1371/journal.pone.017060128489920 31.ChaillonA.Avila-RiosS.WertheimJ.O.DennisA.Garcia-MoralesC.Tapia-TrejoD.Mejia-VillatoroC.PascaleJ.M.Porras-CortesG.Quant-DuranC.J.et al.Identification of major routes of HIV"/>
   <result pre="Dynamics of a Novel HIV-1 Subtype G Clade Circulating in" exact="Cape Verde" post="and PortugalPLoS ONE201510e012738410.1371/journal.pone.012738425993094 33.LeroyH.ArvieuxC.BiziragusenyukaJ.ChapplainJ.M.GuiguenC.MicheletC.TattevinP.A retrospective study of 230 consecutive"/>
   <result pre="Dis.2015611462146810.1093/cid/civ52626129754 47.WangY.LiangY.FengY.WangB.LiY.WuZ.ZhangJ.BalochZ.ZhangA.M.LiuL.et al.HIV-1 prevalence and subtype/recombinant distribution among travelers entering" exact="China" post="from Vietnam at the HeKou port in the Yunnan"/>
   <result pre="al.HIV-1 prevalence and subtype/recombinant distribution among travelers entering China from" exact="Vietnam" post="at the HeKou port in the Yunnan province, China,"/>
   <result pre="Analyze the distribution of HIV-1 subtype A in thirteen former" exact="Soviet Union" post="countries HIV-1 subtype A clusters are intermixed Intermixed clusters"/>
   <result pre="(2017) [30] Determine HIV-1 subtype distribution and phylogenetic structure in" exact="Australia" post="between 2005 and 2012 HIV-1 epidemic in Australia is"/>
   <result pre="structure in Australia between 2005 and 2012 HIV-1 epidemic in" exact="Australia" post="is characterized by an increasing prevalence of non-B subtype"/>
   <result pre="various Mesoamerican countries, but analyses indicate that Central and Southern" exact="Mexico" post="and Belize were significant sources of HIV transmission throughout"/>
   <result pre="countries, but analyses indicate that Central and Southern Mexico and" exact="Belize" post="were significant sources of HIV transmission throughout MesoamericaEvidence of"/>
   <result pre="of HIV transmission throughout MesoamericaEvidence of significant viral migration within" exact="Mexico" post="Human migration or travel is assumed to be the"/>
   <result pre="routes of the HIV-1 subtype G clades present throughout Angola," exact="Cape Verde," post="and Portugal HIV-1 subtype G likely originated in Central"/>
   <result pre="HIV-1 subtype G clades present throughout Angola, Cape Verde, and" exact="Portugal" post="HIV-1 subtype G likely originated in Central Africa and"/>
   <result pre="later The local dissemination of HIV-1 subtype G infections in" exact="Cape Verde" post="and Portugal are shaped by historical and ongoing movement"/>
   <result pre="dissemination of HIV-1 subtype G infections in Cape Verde and" exact="Portugal" post="are shaped by historical and ongoing movement of human"/>
   <result pre="by historical and ongoing movement of human populations between Angola," exact="Cape Verde," post="and Portugal Leroy (2008) [33] To assess the frequency"/>
   <result pre="ongoing movement of human populations between Angola, Cape Verde, and" exact="Portugal" post="Leroy (2008) [33] To assess the frequency of travel-related"/>
   <result pre="illnesses among ill-returned travelers in one infectious diseases department in" exact="France" post="Of the 265 diagnoses made in travelers who returned"/>
   <result pre="sequence variability among travel-associated cases with reported infection outside of" exact="Poland" post="and trace the country of origin where infected was"/>
   <result pre="they traveled to Results show genetic variations in HIV within" exact="Lebanon" post="and the discovery of new HIV-subtypes which indicate extreme"/>
   <result pre="new HIV-subtypes which indicate extreme heterogeneity of HIV subtypes in" exact="Lebanon" post="Rasmussen (2018) [40] Quantify the contribution of local viral"/>
   <result pre="infection acquired in Africa and among African communities in the" exact="United Kingdom" post="African-acquired HIV infections diagnosed in the United Kingdom by"/>
   <result pre="in the United Kingdom African-acquired HIV infections diagnosed in the" exact="United Kingdom" post="by 2001 make up about 21% of all reported"/>
   <result pre="the possibility of locating evidence for ongoing non-B transmission in" exact="Switzerland" post="by identifying possible transmission pairs Migration has a greater"/>
   <result pre="non-B subtype HIV-1A fraction of all non-B infections diagnosed in" exact="Switzerland" post="could be prevented by local interventionsTo contain HIV dissemination,"/>
   <result pre="contain HIV dissemination, awareness should be raised among immigrants and" exact="Swiss" post="individuals with partners from countries where HIV is endemic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7020194\results\search\country\results.xml">
   <result pre="SingaporeSingaporeSingapore Edited by: Randall Glenn Worth, The University of Toledo," exact="United States" post="Reviewed by: Kazuyuki Tsujino, National Hospital Organization Osaka Toneyama"/>
   <result pre="Toneyama Medical Center, Toyonaka, Japan; Reinoud Gosens, University of Groningen," exact="Netherlands" post="*Correspondence: Thai Tran, tran_thai@nuhs.edu.sg; phstt@nus.edu.sg This article was submitted"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7029158\results\search\country\results.xml">
   <result pre="Mathematics and Information Science, Shaanxi Normal University, Xiâ€™an, 710119, Peopleâ€™s" exact="Republic of" post="China. sytang@snnu.edu.cn **Corresponding author. School of Mathematics and Statistics,"/>
   <result pre="of Mathematics and Statistics, Xiâ€™an Jiaotong University, Xiâ€™an, 710049, Peopleâ€™s" exact="Republic of" post="China. yxiao@mail.xjtu.edu.cn ***Corresponding author. The Interdisplinary Research Center for"/>
   <result pre="Mathematics and Life Sciences, Xiâ€™an Jiaotong University, Xiâ€™an, 710049, Peopleâ€™s" exact="Republic of" post="China. wujh@yorku.ca pmc-release: 2020-2-2ppub: 2020epub: 2020-2-25248255received: 2020-2-2rev-recd: 2020-2-8accepted: 2020-2-9(C)"/>
   <result pre="â€œMiddle East Respiratory Syndromeâ€� (MERS) virus in 2012 in the" exact="Kingdom of Saudi Arabia" post="and in 2015 in South Korea (Gralinski &amp;amp; Menachery,"/>
   <result pre="Respiratory Syndromeâ€� (MERS) virus in 2012 in the Kingdom of" exact="Saudi Arabia" post="and in 2015 in South Korea (Gralinski &amp;amp; Menachery,"/>
   <result pre="in the Kingdom of Saudi Arabia and in 2015 in" exact="South Korea" post="(Gralinski &amp;amp; Menachery, 2020). Currently, there exist no vaccines"/>
   <result pre="started since December 29th, 2019 in Wuhan, Hubei province, Peopleâ€™s" exact="Republic of" post="China, and has progressively expanded to various parts of"/>
   <result pre="of China, and has progressively expanded to various parts of" exact="China" post="and has reached as well other countries, including Japan,"/>
   <result pre="China and has reached as well other countries, including Japan," exact="South Korea," post="Thailand, Vietnam, Malaysia, Singapore, Nepal, Cambodia, the Philippines, Russia,"/>
   <result pre="including Japan, South Korea, Thailand, Vietnam, Malaysia, Singapore, Nepal, Cambodia," exact="the Philippines," post="Russia, the United Arab Emirates, Australia, Canada, the United"/>
   <result pre="Korea, Thailand, Vietnam, Malaysia, Singapore, Nepal, Cambodia, the Philippines, Russia," exact="the United Arab Emirates," post="Australia, Canada, the United States of America and Europe"/>
   <result pre="Thailand, Vietnam, Malaysia, Singapore, Nepal, Cambodia, the Philippines, Russia, the" exact="United Arab Emirates," post="Australia, Canada, the United States of America and Europe"/>
   <result pre="Cambodia, the Philippines, Russia, the United Arab Emirates, Australia, Canada," exact="the United States" post="of America and Europe (France, Germany, Italy, UK, Finland"/>
   <result pre="the Philippines, Russia, the United Arab Emirates, Australia, Canada, the" exact="United States of America" post="and Europe (France, Germany, Italy, UK, Finland and Sweden)."/>
   <result pre="the United Arab Emirates, Australia, Canada, the United States of" exact="America" post="and Europe (France, Germany, Italy, UK, Finland and Sweden)."/>
   <result pre="United States of America and Europe (France, Germany, Italy, UK," exact="Finland" post="and Sweden). So far, the new virus has infected"/>
   <result pre="least 636 of them (National Health Commission of the Peopleâ€™s" exact="Republic of" post="China, 2020). While considerable progress has been achieved with"/>
   <result pre="infection. Following this announcement, many other cities and provinces of" exact="China" post="decided to enforce similar measures. In the meantime, many"/>
   <result pre="2019-nCov cases from the National Health Commission of the Peopleâ€™s" exact="Republic of" post="China (National Health Commission of the Peopleâ€™s Republic of"/>
   <result pre="from the National Health Commission of the Peopleâ€™s Republic of" exact="China" post="(National Health Commission of the Peopleâ€™s Republic of China,"/>
   <result pre="Peopleâ€™s Republic of China (National Health Commission of the Peopleâ€™s" exact="Republic of" post="China, 2020). The data information includes the cumulative confirmed"/>
   <result pre="reported daily by the National Health Commission of the Peopleâ€™s" exact="Republic of" post="China. Parameter estimation process Under the gradually enhanced control"/>
   <result pre="research was funded by the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(grant numbers: 11631012 (YX, ST), 61772017(ST)), and by the"/>
   <result pre="China (grant numbers: 11631012 (YX, ST), 61772017(ST)), and by the" exact="Canada" post="Research Chair Program (grant number: 230720 (JW) and the"/>
   <result pre="(JW) and the 10.13039/501100000038Natural Sciences and Engineering Research Council of" exact="Canada" post="(Grant number:105588-2011 (JW). Declaration of competing interest None. References"/>
   <result pre="ChinaSocial Science Research Network202010.2139/ssrn.3524675 National Health Commission of the Peopleâ€™s" exact="Republic of" post="ChinaAvailable at:http://www.nhc.gov.cn/2020 PellB.KuangY.ViboudC.ChowellG.Using phenomenological models for forecasting the 2015"/>
   <result pre="the joint support by the 10.13039/501100004519Tianyuan Mathematical Center in Northwest" exact="China" post=", the 10.13039/501100000020Fields Institute for Research in Mathematical Sciences"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7054940\results\search\country\results.xml">
   <result pre="(WHO). As on February 4, 2020, 425 deaths reported in" exact="China" post="only and one death outside China (Philippines). In a"/>
   <result pre="425 deaths reported in China only and one death outside" exact="China" post="(Philippines). In a short span of time, the virus"/>
   <result pre="were identified in the horseshoe bats (non-caged) in 2005 from" exact="Hong Kong" post="(Lau et al. 2005). Since then, bats are considered"/>
   <result pre="on February 4, 2020, 425 deaths have been reported in" exact="China" post="only (World Health Organization 2020b). Further, the spread of"/>
   <result pre="emerged and was named 2019-nCoV. As on February 4th 2020," exact="China" post="has confirmed 20471 cases with 425 deaths and 2788"/>
   <result pre="As of now, around 15 complete 2019-nCoV genome sequences (10" exact="China" post="and 5 USA) have been reported. To note, a"/>
   <result pre="In the whole genome phylogenetic analysis, the 2019-nCoV strains from" exact="China" post="and the USA clustered in a monophyletic clade (Figure"/>
   <result pre="whole genome phylogenetic analysis, the 2019-nCoV strains from China and" exact="the USA" post="clustered in a monophyletic clade (Figure 3). The nearest"/>
   <result pre="(Figure 3). The nearest neighbors of the 2019-nCoV isolates from" exact="China" post="and USA were two Bat_SARS-like coronaviruses (Bat-SL-CoVZC45, Accession no."/>
   <result pre="the complete genome sequences between current outbreaks 2019-nCoV isolates from" exact="China" post="and the USA ranges 99.8 to 100% on the"/>
   <result pre="genome sequences between current outbreaks 2019-nCoV isolates from China and" exact="the USA" post="ranges 99.8 to 100% on the nucleotide level indicating"/>
   <result pre="animal origin. The solid-black circles are for nCoV isolates from" exact="China" post="and solid-black squares are for the isolates from the"/>
   <result pre="from China and solid-black squares are for the isolates from" exact="the USA." post="4.2. Analysis targeting the spike (S)-gene of CoVs We"/>
   <result pre="coronavirus, bat_coronaviruses. The solid-black circles are for nCoV isolates from" exact="China" post="and the USA. Additionally, for S-gene, per cent similarity"/>
   <result pre="The solid-black circles are for nCoV isolates from China and" exact="the USA." post="Additionally, for S-gene, per cent similarity range pattern was"/>
   <result pre="evaluated in amino acid based index where 2019-nCoV isolates from" exact="China" post="and USA were 100% identical. The range varied between"/>
   <result pre="(World Health Organization 2020a). The live-animal markets such as in" exact="China" post="could provide chances to animal CoVs to get transmitted"/>
   <result pre="of time. Since its origin from Wuhan, Hubei province of" exact="China" post="in the first week of December 2019, it has"/>
   <result pre="week of December 2019, it has claimed 425 lives in" exact="China" post="and infected 20630 in 24 countries including China. Additionally,"/>
   <result pre="are emerging in different countries and three confirmed cases from" exact="India" post="also emerged till compilation of this paper, February 4th,"/>
   <result pre="4th, 2020. As of now deaths were reported only from" exact="China" post="but now causality in Philippines reported for the first"/>
   <result pre="deaths were reported only from China but now causality in" exact="Philippines" post="reported for the first time outside China. The nCoV"/>
   <result pre="developing better diagnostics and effective vaccines. A report emerged from" exact="China" post="where the scientists claimed successful isolation of the 2019-nCoV"/>
   <result pre="al.2014Middle East respiratory syndrome coronavirus infection in dromedary camels in" exact="Saudi Arabia." post="MBio. 5(2):e00884â€&quot;00814. doi:10.1128/mBio.00884-1424570370 ChengVC, WongS-C, ToKK, HoP, YuenK-Y2020Preparedness and"/>
   <result pre="relative of human Middle East respiratory syndrome coronavirus in bat," exact="South Africa." post="Emerg Infect Dis. 19(10):1697â€&quot;1699. doi:10.3201/eid1910.13094624050621 JiangS, HeY, LiuS2005SARS vaccine"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N Engl J Med. 367(19):1814â€&quot;1820.23075143 ZhouP, YangX-L, WangX-G, HuB,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7057477\results\search\country\results.xml">
   <result pre="on the western hemisphere, though it was initially reported from" exact="Uganda" post="in 1940s [1, 2]. Transmission of ZIKV is related"/>
   <result pre="a sentinel rhesus macaque placed in the Zika Forest of" exact="Uganda" post="[4, 5]. ZIKV stayed relatively silent for almost 70Â"/>
   <result pre="years and all of a sudden emerged all over the" exact="America" post="after Pacific Islands to Brazil [6]. Recently it was"/>
   <result pre="sudden emerged all over the America after Pacific Islands to" exact="Brazil" post="[6]. Recently it was identified that the ZIKV strain"/>
   <result pre="the ZIKV strain found in the Americas had escalated to" exact="Angola" post="and was linked with a cluster of microcephaly [7â€&quot;9]."/>
   <result pre="since it emerged in the Pacific Ocean [19] and South" exact="America" post="[20, 21]. The 2015â€&quot;16 epidemic occurred in the America"/>
   <result pre="South America [20, 21]. The 2015â€&quot;16 epidemic occurred in the" exact="America" post="was due to strain of the Asian lineage generally"/>
   <result pre="of the north African continent, Vietnam, Malaysia, Indonesia, Philippines, India," exact="Thailand" post="and Pakistan (Fig.Â 1) [11, 24]. The first human"/>
   <result pre="north African continent, Vietnam, Malaysia, Indonesia, Philippines, India, Thailand and" exact="Pakistan" post="(Fig.Â 1) [11, 24]. The first human case was"/>
   <result pre="1) [11, 24]. The first human case was detected in" exact="Uganda" post="in 1952 during a study indicating the presence of"/>
   <result pre="when outbreak of ZIKV infection in humans occurred in Yap," exact="Federated States of Micronesia," post="in the Pacific region [26]. In French Polynesia the"/>
   <result pre="Federated States of Micronesia, in the Pacific region [26]. In" exact="French Polynesia" post="the largest epidemic of ZIKV occurred during 2013 to"/>
   <result pre="of ZIKV occurred during 2013 to 2014 and extended to" exact="New Caledonia," post="Cook Islands, Vanuatu, Easter Island, Solomon Islands and other"/>
   <result pre="occurred during 2013 to 2014 and extended to New Caledonia," exact="Cook Islands," post="Vanuatu, Easter Island, Solomon Islands and other Pacific Islands"/>
   <result pre="and extended to New Caledonia, Cook Islands, Vanuatu, Easter Island," exact="Solomon Islands" post="and other Pacific Islands [5]. ZIKV transmission is known"/>
   <result pre="not explicit to ZIKV infection, especially in prevalent areas. In" exact="French Polynesia" post="serious neurological complications with Guillainâ€&quot;BarrÃ© syndrome was increased to"/>
   <result pre="the main vector responsible for dissemination of lymphatic filariasis in" exact="French Polynesia." post="After the epidemic in French Polynesia these species of"/>
   <result pre="of lymphatic filariasis in French Polynesia. After the epidemic in" exact="French Polynesia" post="these species of mosquitoes were collected and tested for"/>
   <result pre="(stregomyia) hensilliÂ identifiedÂ as the probable principal vector that cause" exact="Micronesia" post="outbreak [38]. Later on, in 2013, the ZIKV spread"/>
   <result pre="[38]. Later on, in 2013, the ZIKV spread out to" exact="French Polynesia," post="with consequent extent to Oceanian islands (New Caledonia, Cook"/>
   <result pre="Guillainâ€&quot;BarrÃ© syndrome and cases of other neurologic manifestations appears in" exact="Brazil" post="and French Polynesia throughout ZIKV epidemics, even though it"/>
   <result pre="and cases of other neurologic manifestations appears in Brazil and" exact="French Polynesia" post="throughout ZIKV epidemics, even though it is self-limiting [50,"/>
   <result pre="self-limiting [50, 51]. A report from Ministry of Health of" exact="Brazil" post="indicates that there is a possible relation between fetal"/>
   <result pre="central nervous system malformation and microcephaly have been stated by" exact="Brazil" post="comprising 120 deaths in between 22nd October 2015 and"/>
   <result pre="2016; however, only 163 cases of microcephaly were recorded in" exact="Brazil" post="per year on average from 2001 to 2014. Of"/>
   <result pre="characterized by progressive muscular weakness [55]. Outbreak of ZIKV in" exact="French Polynesia" post="fourÂ years ago added it to the viruses that"/>
   <result pre="were reported in 2014. 62% of GBS cases reported in" exact="Brazil" post="had a history of signs and symptoms associated to"/>
   <result pre="this viral infection. 220 cases of GBS are reported in" exact="Colombia" post="while 136 in El Salvador including 5 deaths in"/>
   <result pre="cases of GBS are reported in Colombia while 136 in" exact="El Salvador" post="including 5 deaths in the time period from December"/>
   <result pre="in MalaysiaAm J Trop Med Hyg19691841141510.4269/ajtmh.1969.18.4114976739 14.GrardGCaronMMomboIMNkogheDOndoSMJiolleDet al.Zika virus in" exact="Gabon" post="(Central Africa)â€&quot;2007: a new threat from Aedes albopictus?PLoS Negl"/>
   <result pre="Microbiol Infect201420O595O59610.1111/1469-0691.1270724909208 41.Lourenco-de-OliveiraRRuaAVVezzaniDWillatGVazeilleMMoussonLet al.Aedes aegypti from temperate regions of South" exact="America" post="are highly competent to transmit dengue virusBMC Infect Dis20131361010.1186/1471-2334-13-61024373423"/>
   <result pre="BrazilEmerg Microbes Infect.20176e6910.1038/emi.2017.5928790458 46.BesnardMLastÃ¨reSTeissierACao-LormeauVMussoDEvidence of perinatal transmission of Zika virus," exact="French Polynesia," post="December 2013 and February 2014Euro Surveill2014192075110.2807/1560-7917.ES2014.19.13.2075124721538 47.ProMED-mail. 23 December"/>
   <result pre="Disease Prevention and Control. Rapid risk assessment: ZIKV infection outbreak," exact="Brazil" post="and the Pacific region. 25 May 2015. http://ecdc.europa.eu/en/publications/Publications/rapidrisk-assessment-Zika%20virus-south-america-Brazil-2015.pdf. 55.PithadiaABKakadiaNGuillainâ€&quot;BarrÃ©"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7061886\results\search\country\results.xml">
   <result pre="EVD was first recognised when two large outbreaks occurred in" exact="South Sudan" post="and the Democratic Republic of Congo (DRC) in 1976.2"/>
   <result pre="was first recognised when two large outbreaks occurred in South" exact="Sudan" post="and the Democratic Republic of Congo (DRC) in 1976.2"/>
   <result pre="when two large outbreaks occurred in South Sudan and the" exact="Democratic Republic of Congo" post="(DRC) in 1976.2 3 Thereafter, EVD outbreaks have been"/>
   <result pre="two large outbreaks occurred in South Sudan and the Democratic" exact="Republic of" post="Congo (DRC) in 1976.2 3 Thereafter, EVD outbreaks have"/>
   <result pre="outbreaks occurred in South Sudan and the Democratic Republic of" exact="Congo" post="(DRC) in 1976.2 3 Thereafter, EVD outbreaks have been"/>
   <result pre="EVD outbreaks have been reported in 1994 and 1995 in" exact="Uganda" post="and the DRC, respectively.4 Frequent large outbreaks have since"/>
   <result pre="have since been reported from Gabon, DRC, Uganda, Guinea, Liberia," exact="Sierra Leone" post="and Nigeria.1 5â€&quot;7 Isolated EVD outbreaks have been reported"/>
   <result pre="and Nigeria.1 5â€&quot;7 Isolated EVD outbreaks have been reported in" exact="South Africa," post="USA, UK and Italy.8 There has been an increase"/>
   <result pre="species of the genus Ebolavirus have been identified. They include" exact="Zaire" post="ebolavirus (ZEBOV), Bundibugyo ebolavirus (BEBOV), Sudan ebolavirus (SEBOV), Reston"/>
   <result pre="been identified. They include Zaire ebolavirus (ZEBOV), Bundibugyo ebolavirus (BEBOV)," exact="Sudan" post="ebolavirus (SEBOV), Reston ebolavirus and CÃ´te d'Ivoire ebolavirus. Most"/>
   <result pre="of the equator.9 African tropical rainforests, for example, the Western" exact="Congo" post="swamp forests and the MinkebÃ© forest in Gabon, have"/>
   <result pre="11 countries in Africa. The affected countries include the DRC," exact="South Sudan," post="Uganda, Mali, Nigeria, Sierra Leone, Guinea, Liberia, South Africa,"/>
   <result pre="affected countries include the DRC, South Sudan, Uganda, Mali, Nigeria," exact="Sierra Leone," post="Guinea, Liberia, South Africa, Gabon and CÃ´te dâ€™Ivoire (figure"/>
   <result pre="DRC, South Sudan, Uganda, Mali, Nigeria, Sierra Leone, Guinea, Liberia," exact="South Africa," post="Gabon and CÃ´te dâ€™Ivoire (figure 2). Figure 2 Map"/>
   <result pre="Sudan, Uganda, Mali, Nigeria, Sierra Leone, Guinea, Liberia, South Africa," exact="Gabon" post="and CÃ´te dâ€™Ivoire (figure 2). Figure 2 Map showing"/>
   <result pre="and widespread EVD outbreak was observed in West Africa (Guinea," exact="Sierra Leone" post="and Liberia) and DRC.14 20 21 Table 1 EVD"/>
   <result pre="affected countries Year Country Virus Cases Deaths CFR (%)* 1976" exact="Democratic Republic of Congo" post="EBOV 318 280 88 1976 South Sudan SUDV 284"/>
   <result pre="countries Year Country Virus Cases Deaths CFR (%)* 1976 Democratic" exact="Republic of" post="Congo EBOV 318 280 88 1976 South Sudan SUDV"/>
   <result pre="Country Virus Cases Deaths CFR (%)* 1976 Democratic Republic of" exact="Congo" post="EBOV 318 280 88 1976 South Sudan SUDV 284"/>
   <result pre="1976 Democratic Republic of Congo EBOV 318 280 88 1976" exact="South Sudan" post="SUDV 284 151 53 1977 Democratic Republic of Congo"/>
   <result pre="Democratic Republic of Congo EBOV 318 280 88 1976 South" exact="Sudan" post="SUDV 284 151 53 1977 Democratic Republic of Congo"/>
   <result pre="280 88 1976 South Sudan SUDV 284 151 53 1977" exact="Democratic Republic of Congo" post="EBOV 1 1 100 1979 South Sudan SUDV 34"/>
   <result pre="88 1976 South Sudan SUDV 284 151 53 1977 Democratic" exact="Republic of" post="Congo EBOV 1 1 100 1979 South Sudan SUDV"/>
   <result pre="South Sudan SUDV 284 151 53 1977 Democratic Republic of" exact="Congo" post="EBOV 1 1 100 1979 South Sudan SUDV 34"/>
   <result pre="1977 Democratic Republic of Congo EBOV 1 1 100 1979" exact="South Sudan" post="SUDV 34 22 65 1994 Gabon EBOV 52 31"/>
   <result pre="Democratic Republic of Congo EBOV 1 1 100 1979 South" exact="Sudan" post="SUDV 34 22 65 1994 Gabon EBOV 52 31"/>
   <result pre="1 100 1979 South Sudan SUDV 34 22 65 1994" exact="Gabon" post="EBOV 52 31 60 1994 CÃ´te dâ€™Ivoire TAFV 1"/>
   <result pre="31 60 1994 CÃ´te dâ€™Ivoire TAFV 1 0 0 1995" exact="Democratic Republic of Congo" post="EBOV 315 250 79 1996 Gabon EBOV 37 21"/>
   <result pre="60 1994 CÃ´te dâ€™Ivoire TAFV 1 0 0 1995 Democratic" exact="Republic of" post="Congo EBOV 315 250 79 1996 Gabon EBOV 37"/>
   <result pre="CÃ´te dâ€™Ivoire TAFV 1 0 0 1995 Democratic Republic of" exact="Congo" post="EBOV 315 250 79 1996 Gabon EBOV 37 21"/>
   <result pre="1995 Democratic Republic of Congo EBOV 315 250 79 1996" exact="Gabon" post="EBOV 37 21 57 1996â€&quot;1997 Gabon EBOV 60 45"/>
   <result pre="315 250 79 1996 Gabon EBOV 37 21 57 1996â€&quot;1997" exact="Gabon" post="EBOV 60 45 75 1996 South Africa EBOV 2"/>
   <result pre="37 21 57 1996â€&quot;1997 Gabon EBOV 60 45 75 1996" exact="South Africa" post="EBOV 2 1 50 2000â€&quot;2001 Uganda SUDV 425 224"/>
   <result pre="45 75 1996 South Africa EBOV 2 1 50 2000â€&quot;2001" exact="Uganda" post="SUDV 425 224 53 2001â€&quot;2002 Gabon EBOV 65 53"/>
   <result pre="2 1 50 2000â€&quot;2001 Uganda SUDV 425 224 53 2001â€&quot;2002" exact="Gabon" post="EBOV 65 53 82 2001â€&quot;2002 Republic of Congo EBOV"/>
   <result pre="425 224 53 2001â€&quot;2002 Gabon EBOV 65 53 82 2001â€&quot;2002" exact="Republic of" post="Congo EBOV 57 43 75 2002â€&quot;2003 Republic of Congo"/>
   <result pre="53 2001â€&quot;2002 Gabon EBOV 65 53 82 2001â€&quot;2002 Republic of" exact="Congo" post="EBOV 57 43 75 2002â€&quot;2003 Republic of Congo EBOV"/>
   <result pre="82 2001â€&quot;2002 Republic of Congo EBOV 57 43 75 2002â€&quot;2003" exact="Republic of" post="Congo EBOV 143 128 89 2003 Republic of Congo"/>
   <result pre="Republic of Congo EBOV 57 43 75 2002â€&quot;2003 Republic of" exact="Congo" post="EBOV 143 128 89 2003 Republic of Congo EBOV"/>
   <result pre="75 2002â€&quot;2003 Republic of Congo EBOV 143 128 89 2003" exact="Republic of" post="Congo EBOV 35 29 83 2004 South Sudan SUDV"/>
   <result pre="Republic of Congo EBOV 143 128 89 2003 Republic of" exact="Congo" post="EBOV 35 29 83 2004 South Sudan SUDV 17"/>
   <result pre="89 2003 Republic of Congo EBOV 35 29 83 2004" exact="South Sudan" post="SUDV 17 7 41 2005 Republic of Congo EBOV"/>
   <result pre="2003 Republic of Congo EBOV 35 29 83 2004 South" exact="Sudan" post="SUDV 17 7 41 2005 Republic of Congo EBOV"/>
   <result pre="29 83 2004 South Sudan SUDV 17 7 41 2005" exact="Republic of" post="Congo EBOV 12 10 83 2007 Democratic Republic of"/>
   <result pre="2004 South Sudan SUDV 17 7 41 2005 Republic of" exact="Congo" post="EBOV 12 10 83 2007 Democratic Republic of Congo"/>
   <result pre="41 2005 Republic of Congo EBOV 12 10 83 2007" exact="Democratic Republic of Congo" post="EBOV 264 187 71 2007â€&quot;2008 Uganda BDBV 149 37"/>
   <result pre="2005 Republic of Congo EBOV 12 10 83 2007 Democratic" exact="Republic of" post="Congo EBOV 264 187 71 2007â€&quot;2008 Uganda BDBV 149"/>
   <result pre="of Congo EBOV 12 10 83 2007 Democratic Republic of" exact="Congo" post="EBOV 264 187 71 2007â€&quot;2008 Uganda BDBV 149 37"/>
   <result pre="2007 Democratic Republic of Congo EBOV 264 187 71 2007â€&quot;2008" exact="Uganda" post="BDBV 149 37 25 2008â€&quot;2009 Democratic Republic of Congo"/>
   <result pre="264 187 71 2007â€&quot;2008 Uganda BDBV 149 37 25 2008â€&quot;2009" exact="Democratic Republic of Congo" post="EBOV 32 15 47 2011 Uganda SUDV 1 1"/>
   <result pre="187 71 2007â€&quot;2008 Uganda BDBV 149 37 25 2008â€&quot;2009 Democratic" exact="Republic of" post="Congo EBOV 32 15 47 2011 Uganda SUDV 1"/>
   <result pre="2007â€&quot;2008 Uganda BDBV 149 37 25 2008â€&quot;2009 Democratic Republic of" exact="Congo" post="EBOV 32 15 47 2011 Uganda SUDV 1 1"/>
   <result pre="2008â€&quot;2009 Democratic Republic of Congo EBOV 32 15 47 2011" exact="Uganda" post="SUDV 1 1 100 2012 Uganda SUDV 11 4"/>
   <result pre="32 15 47 2011 Uganda SUDV 1 1 100 2012" exact="Uganda" post="SUDV 11 4 36 2012 Democratic Republic of Congo"/>
   <result pre="1 1 100 2012 Uganda SUDV 11 4 36 2012" exact="Democratic Republic of Congo" post="Bundibugyo 36 13 36 2012 Uganda SUDV 6 3"/>
   <result pre="1 100 2012 Uganda SUDV 11 4 36 2012 Democratic" exact="Republic of" post="Congo Bundibugyo 36 13 36 2012 Uganda SUDV 6"/>
   <result pre="2012 Uganda SUDV 11 4 36 2012 Democratic Republic of" exact="Congo" post="Bundibugyo 36 13 36 2012 Uganda SUDV 6 3"/>
   <result pre="2012 Democratic Republic of Congo Bundibugyo 36 13 36 2012" exact="Uganda" post="SUDV 6 3 50 2014 Democratic Republic of Congo"/>
   <result pre="36 13 36 2012 Uganda SUDV 6 3 50 2014" exact="Democratic Republic of Congo" post="EBOV 69 49 71 2014 Guinea EBOV 3814 2544"/>
   <result pre="13 36 2012 Uganda SUDV 6 3 50 2014 Democratic" exact="Republic of" post="Congo EBOV 69 49 71 2014 Guinea EBOV 3814"/>
   <result pre="2012 Uganda SUDV 6 3 50 2014 Democratic Republic of" exact="Congo" post="EBOV 69 49 71 2014 Guinea EBOV 3814 2544"/>
   <result pre="2014 Democratic Republic of Congo EBOV 69 49 71 2014" exact="Guinea" post="EBOV 3814 2544 67 2014 Liberia EBOV 10â€‰678 4810"/>
   <result pre="69 49 71 2014 Guinea EBOV 3814 2544 67 2014" exact="Liberia" post="EBOV 10â€‰678 4810 45 2014 Sierra Leone EBOV 14â€‰124"/>
   <result pre="3814 2544 67 2014 Liberia EBOV 10â€‰678 4810 45 2014" exact="Sierra Leone" post="EBOV 14â€‰124 3659 26 2014 Nigeria EBOV 20 8"/>
   <result pre="4810 45 2014 Sierra Leone EBOV 14â€‰124 3659 26 2014" exact="Nigeria" post="EBOV 20 8 40 2014 Mali EBOV 8 6"/>
   <result pre="14â€‰124 3659 26 2014 Nigeria EBOV 20 8 40 2014" exact="Mali" post="EBOV 8 6 75 2017 Democratic Republic of Congo"/>
   <result pre="20 8 40 2014 Mali EBOV 8 6 75 2017" exact="Democratic Republic of Congo" post="EBOV 8 4 50 2018 Democratic Republic of Congo"/>
   <result pre="8 40 2014 Mali EBOV 8 6 75 2017 Democratic" exact="Republic of" post="Congo EBOV 8 4 50 2018 Democratic Republic of"/>
   <result pre="2014 Mali EBOV 8 6 75 2017 Democratic Republic of" exact="Congo" post="EBOV 8 4 50 2018 Democratic Republic of Congo"/>
   <result pre="2017 Democratic Republic of Congo EBOV 8 4 50 2018" exact="Democratic Republic of Congo" post="EBOV 54 33 61 2018â€&quot;2019 Democratic Republic of Congo"/>
   <result pre="Democratic Republic of Congo EBOV 8 4 50 2018 Democratic" exact="Republic of" post="Congo EBOV 54 33 61 2018â€&quot;2019 Democratic Republic of"/>
   <result pre="of Congo EBOV 8 4 50 2018 Democratic Republic of" exact="Congo" post="EBOV 54 33 61 2018â€&quot;2019 Democratic Republic of Congo"/>
   <result pre="2018 Democratic Republic of Congo EBOV 54 33 61 2018â€&quot;2019" exact="Democratic Republic of Congo" post="EBOV 3220 2150 67 2019 Uganda EBOV 4 4"/>
   <result pre="Democratic Republic of Congo EBOV 54 33 61 2018â€&quot;2019 Democratic" exact="Republic of" post="Congo EBOV 3220 2150 67 2019 Uganda EBOV 4"/>
   <result pre="of Congo EBOV 54 33 61 2018â€&quot;2019 Democratic Republic of" exact="Congo" post="EBOV 3220 2150 67 2019 Uganda EBOV 4 4"/>
   <result pre="2018â€&quot;2019 Democratic Republic of Congo EBOV 3220 2150 67 2019" exact="Uganda" post="EBOV 4 4 100 Total 34â€‰356 14â€‰823 Source: WHO,"/>
   <result pre="fatality rate; EBOV, Ebola virus; EVD, Ebola virus disease; SUDV," exact="Sudan" post="Ebola virus; TAFV, TaÃ¯ Forest ebolavirus. Context of EVD"/>
   <result pre="ecosystems due to deforestation, which displaces bats. The part of" exact="Guinea" post="where the West African EVD outbreak of 2014â€&quot;2016 started"/>
   <result pre="of 2014â€&quot;2016 started has been largely deforested. Moreover, wars in" exact="Liberia" post="and Sierra Leone and corruption in Guinea caused poverty,"/>
   <result pre="started has been largely deforested. Moreover, wars in Liberia and" exact="Sierra Leone" post="and corruption in Guinea caused poverty, leading people to"/>
   <result pre="Moreover, wars in Liberia and Sierra Leone and corruption in" exact="Guinea" post="caused poverty, leading people to migrate for work and"/>
   <result pre="World Health Organ1978;56:271â€&quot;93.307456 3collab: World Health OrganisationEbola virus disease: the" exact="Democratic Republic of the Congo." post="External situation report2019;b:52. 4OkwareSI, OmaswaFG, ZarambaS, et al.An outbreak"/>
   <result pre="Health Organ1978;56:271â€&quot;93.307456 3collab: World Health OrganisationEbola virus disease: the Democratic" exact="Republic of" post="the Congo. External situation report2019;b:52. 4OkwareSI, OmaswaFG, ZarambaS, et"/>
   <result pre="in Uganda. PLoS Pathog2008;4:e100021210.1371/journal.ppat.100021219023410 6BaizeS, PannetierD, OestereichL, et al.Emergence of" exact="Zaire" post="Ebola virus disease in guinea. N Engl J Med2014;371:1418â€&quot;25.10.1056/NEJMoa140450524738640"/>
   <result pre="Med2014;371:1418â€&quot;25.10.1056/NEJMoa140450524738640 7MagangaGD, KapetshiJ, BerthetN, et al.Ebola virus disease in the" exact="Democratic Republic of Congo." post="N Engl J Med2014;371:2083â€&quot;91.10.1056/NEJMoa141109925317743 8AurelieKK, GuyMM, BonaNF, et al.A"/>
   <result pre="7MagangaGD, KapetshiJ, BerthetN, et al.Ebola virus disease in the Democratic" exact="Republic of" post="Congo. N Engl J Med2014;371:2083â€&quot;91.10.1056/NEJMoa141109925317743 8AurelieKK, GuyMM, BonaNF, et"/>
   <result pre="et al.Genetic diversity and evolutionary dynamics of Ebola virus in" exact="Sierra Leone." post="Nature2015;524:93â€&quot;6.10.1038/nature1449025970247 20CarrollSA, TownerJS, SealyTK, et al.Molecular evolution of viruses"/>
   <result pre="MakialaS, et al.2017 outbreak of Ebola virus disease in northern" exact="Democratic Republic of Congo." post="J Infect Dis2019:jiz10710.1093/infdis/jiz107 31LiuW, LiZ, DuY, et al.Ebola virus"/>
   <result pre="et al.2017 outbreak of Ebola virus disease in northern Democratic" exact="Republic of" post="Congo. J Infect Dis2019:jiz10710.1093/infdis/jiz107 31LiuW, LiZ, DuY, et al.Ebola"/>
   <result pre="the Ebola outbreak on health systems and population health in" exact="Sierra Leone." post="J Publ Health2016;38:673â€&quot;8. 47PinzonJE, WilsonJM, TuckerCJ, et al.Trigger events:"/>
   <result pre="al.Rapid assessment of Ebola infection prevention and control needs-six districts," exact="Sierra Leone." post="MMWR Morb Mortal Wkly Rep2014;63:1172â€&quot;4.25503922 56collab: World Health OrganizationInfection"/>
   <result pre="Med2014;371:1177â€&quot;80.10.1056/NEJMp140990325140858 60WilkinsonA, FairheadJComparison of social resistance to Ebola response in" exact="Sierra Leone" post="and guinea suggests explanations lie in political configurations not"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7064018\results\search\country\results.xml">
   <result pre="samples from a cluster of patients with pneumonia in Wuhan," exact="China" post="[11]. The disease caused by SARS-CoV-2 is named Coronavirus"/>
   <result pre="who died of pneumonia at the Al-Fakieh hospital in Jeddah," exact="Saudi Arabia." post="MERS-CoV. A retrospective study then linked MERS-CoV to a"/>
   <result pre="linked MERS-CoV to a hospital outbreak in April, 2012, in" exact="Jordan" post="[13]. Dromedaries and camels are implicated as the zoonotic"/>
   <result pre="in all continents, the majority of which were reported by" exact="Saudi Arabia" post="(2106 cases, 780 deaths) [15]. CLINICAL CHARACTERISTICS OF HUMAN"/>
   <result pre="virus (up to 61,000 lethal infections per year only in" exact="the US" post="according to the Centers for Disease Control and Prevention,"/>
   <result pre="non-SARS coronaviruses. Country Number of cases investigated Percentage positive Reference" exact="Brazil" post="775 7.6% [65] Brazil (slums) 282 21.2% [66] Hong"/>
   <result pre="of cases investigated Percentage positive Reference Brazil 775 7.6% [65]" exact="Brazil" post="(slums) 282 21.2% [66] Hong Kong, China 4181 2.1%"/>
   <result pre="Reference Brazil 775 7.6% [65] Brazil (slums) 282 21.2% [66]" exact="Hong Kong," post="China 4181 2.1% [67] Ghana 593 13.7% [68] Guangzou,"/>
   <result pre="775 7.6% [65] Brazil (slums) 282 21.2% [66] Hong Kong," exact="China" post="4181 2.1% [67] Ghana 593 13.7% [68] Guangzou, China"/>
   <result pre="(slums) 282 21.2% [66] Hong Kong, China 4181 2.1% [67]" exact="Ghana" post="593 13.7% [68] Guangzou, China 13,048 2.3% [69] Guangzou,"/>
   <result pre="Kong, China 4181 2.1% [67] Ghana 593 13.7% [68] Guangzou," exact="China" post="13,048 2.3% [69] Guangzou, China 11,399 4.3% [70] Kenya"/>
   <result pre="Ghana 593 13.7% [68] Guangzou, China 13,048 2.3% [69] Guangzou," exact="China" post="11,399 4.3% [70] Kenya 417 8.4% [71] Kenya 5,573"/>
   <result pre="Guangzou, China 13,048 2.3% [69] Guangzou, China 11,399 4.3% [70]" exact="Kenya" post="417 8.4% [71] Kenya 5,573 10.1% [72] South Africa"/>
   <result pre="[69] Guangzou, China 11,399 4.3% [70] Kenya 417 8.4% [71]" exact="Kenya" post="5,573 10.1% [72] South Africa 620 without TB 10.5%"/>
   <result pre="4.3% [70] Kenya 417 8.4% [71] Kenya 5,573 10.1% [72]" exact="South Africa" post="620 without TB 10.5% [73] 214 with TB 8%"/>
   <result pre="Africa 620 without TB 10.5% [73] 214 with TB 8%" exact="South Africa" post="860 4.8% [74] South Africa 1,026 15% [75] USA"/>
   <result pre="[73] 214 with TB 8% South Africa 860 4.8% [74]" exact="South Africa" post="1,026 15% [75] USA 854,575 4,6% [76] TB: tuberculosis."/>
   <result pre="paralysis of Wuhan, the entire Hubei province, vast areas of" exact="China" post="followed by entire regions in South Korea and Northern"/>
   <result pre="province, vast areas of China followed by entire regions in" exact="South Korea" post="and Northern Italy during January/February 2020. In these few"/>
   <result pre="China followed by entire regions in South Korea and Northern" exact="Italy" post="during January/February 2020. In these few weeks, there have"/>
   <result pre="contact with a MERS-CoV-infected subject is close. Several reports from" exact="Saudi Arabia" post="describe transmission of silent or subclinical secondary infections after"/>
   <result pre="unexpected rise in the numbers of COVID-19 cases in northern" exact="Italy" post="and South Korea in the third week of February"/>
   <result pre="in the numbers of COVID-19 cases in northern Italy and" exact="South Korea" post="in the third week of February 2020, indicated the"/>
   <result pre="people have tested positive SARS-CoV-2 and towns in north of" exact="Italy" post="were quarantined [30]. Preliminary information from Italy suggests that"/>
   <result pre="in north of Italy were quarantined [30]. Preliminary information from" exact="Italy" post="suggests that a large proportion of the primary clusters"/>
   <result pre="building is on quarantine). Similarly, the current COVID-19 spreading in" exact="South Korea" post="has been largely fostered by several hospital outbreaks, the"/>
   <result pre="months of the current outbreak, COVID-19 has spread rapidly throughout" exact="China" post="and caused varying degrees of illness [19]. Several studies"/>
   <result pre="infections. The discrepancy between the severity of cases observed in" exact="China" post="and those outside China could be a result of"/>
   <result pre="the severity of cases observed in China and those outside" exact="China" post="could be a result of prior exposure community circulation"/>
   <result pre="2020 Project Oncobiome; Fondation Carrefour; High-end Foreign Expert Program in" exact="China" post="(GDW20171100085), Institut National du Cancer (INCa); Inserm (HTE); Institut"/>
   <result pre="Engl J Med2014371982883510.1056/nejmoa140585825162889 23HuiDSPerlman S and ZumlaASpread of MERS to" exact="South Korea" post="and China.Lancet Respir Med20153750951010.1016/s2213-2600(15)00238-626050550 24collab: WHO.Coronavirus disease (COVID-19) outbreak.Available"/>
   <result pre="and PerlmanSMiddle East respiratory syndrome.Lancet20153869997995100710.1016/S0140-6736(15)60454-826049252 30DayMCovid-19: surge in cases in" exact="Italy" post="and South Korea makes pandemic look more likely.BMJ2020368m75110.1136/bmj.m75132098875 31collab:"/>
   <result pre="East respiratory syndrome.Lancet20153869997995100710.1016/S0140-6736(15)60454-826049252 30DayMCovid-19: surge in cases in Italy and" exact="South Korea" post="makes pandemic look more likely.BMJ2020368m75110.1136/bmj.m75132098875 31collab: ReutersSouth Korea reports"/>
   <result pre="433, with over 1,000 at new outbreak site feeling ill.The" exact="Japan" post="Times.2020Available at https://www.japantimes.co.jp/news/2020/02/22/asia-pacific/covid-19-south-korea/#.XlbglGhKg_E [Accessed: 29.02.2020] 32GagneurAValletSTalbotPJLegrand-QuillienMCPicardBPayan C and SizunJOutbreaks"/>
   <result pre="detected among patients hospitalised with severe acute respiratory illness in" exact="South Africa," post="2012 to 2013.Health Sci Rep201818e5910.1002/hsr2.5930623094 75NunesMCKuschnerZRabedeZMadimabeRVan NiekerkNMoloiJKuwandaLRossenJWKlugmanKPAdrian PV and"/>
   <result pre="African children.PLoS One201492e8644810.1371/journal.pone.008644824498274 76KillerbyMEBiggsHMHaynesADahlRMMustaquimDGerber SI and WatsonJTHuman coronavirus circulation in" exact="the United States" post="2014-2017.J Clin Virol2018101525610.1016/j.jcv.2018.01.01929427907 Abbreviations: ACE â€&quot; angiotensin converting enzyme;"/>
   <result pre="children.PLoS One201492e8644810.1371/journal.pone.008644824498274 76KillerbyMEBiggsHMHaynesADahlRMMustaquimDGerber SI and WatsonJTHuman coronavirus circulation in the" exact="United States" post="2014-2017.J Clin Virol2018101525610.1016/j.jcv.2018.01.01929427907 Abbreviations: ACE â€&quot; angiotensin converting enzyme;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7073332\results\search\country\results.xml">
   <result pre="C virus, HDV hepatitis delta virus, EBOV Ebola viruses, ZEBOV-GP" exact="Zaire" post="Ebola virus glycoprotein, HIV human immunodeficiency virus, EBV Epstein-Barr"/>
   <result pre="proven to have moderate activity in inhibiting the entry of" exact="Zaire" post="Ebola virus glycoprotein and human immunodeficiency virus (ZEBOV-GP/HIV)18. Altogether,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7089181\results\search\country\results.xml">
   <result pre="in 2013â€&quot;2014, followed by a more recent one in the" exact="Republic of" post="Congo with 1891 fatalities [37], has attracted extensive media"/>
   <result pre="followed by a more recent one in the Republic of" exact="Congo" post="with 1891 fatalities [37], has attracted extensive media attention."/>
   <result pre="countries were revaccinated in the early 2000s for fear that" exact="Iraq" post="might have weaponized smallpox virus (which it had not,"/>
   <result pre="drug effective against orthopoxviruses, tecovirimat, has recently been approved by" exact="the United States" post="Federal Drug Administration [55]. Smallpox as an exclusively human"/>
   <result pre="effective against orthopoxviruses, tecovirimat, has recently been approved by the" exact="United States" post="Federal Drug Administration [55]. Smallpox as an exclusively human"/>
   <result pre="biological warfare agent by British and American forces in North" exact="America" post="[36], and remains on the top of the list"/>
   <result pre="stocks are officially kept in only two designated laboratories in" exact="Russia" post="and the US. Monkeypox virus (BSL-3), a zoonotic agent"/>
   <result pre="officially kept in only two designated laboratories in Russia and" exact="the US." post="Monkeypox virus (BSL-3), a zoonotic agent causing sequelae similar"/>
   <result pre="smallpox but less fatal, is endemic in central Africa (Democratic" exact="Republic of" post="Congo; DRC); recent introductions to the UK were travel-related."/>
   <result pre="OPV infections was cidofovir, a bisphosphonate developed at REGA, in" exact="Belgium" post="[31, 35]) and FDA approved against human cytomegalovirus (HCMV)."/>
   <result pre="[55, 104, 118, 146]. Tecovirimat (TPOXXÂ®) is currently stockpiled in" exact="the US" post="and production for similar stockpiles in Europe is planned."/>
   <result pre="decade mainly in South-East Asia and in South America, Central" exact="America" post="and the Caribbean, globally amounting to millions of cases."/>
   <result pre="cases. Autochthonous cases of Chikungunya fever have been reported in" exact="Italy" post="[93]. Viremia with rashes and fever usually lead to"/>
   <result pre="rates over 30%. Recently a person-to-person transmission of Lassavirus in" exact="Germany" post="[148] and an outbreak in Nigeria raised public health"/>
   <result pre="transmission of Lassavirus in Germany [148] and an outbreak in" exact="Nigeria" post="raised public health concerns. Arenaviruses are enveloped viruses incorporating"/>
   <result pre="years or older [80, 110]. Favipiravir developed and approved in" exact="Japan" post="specifically for treatment of influenza virus infections, and its"/>
   <result pre="viruses, in the genus Henipavirus, are considered zoonotic agents in" exact="Australia" post="(horses) and South-East Asia (pigs), respectively. Both viruses may"/>
   <result pre="17.BugertJJWelzelTMZeierMDaraiGHantavirus infection-haemorrhagic fever in the Balkansâ€&quot;potential nephrological hazards in the" exact="Kosovo" post="warNephrol Dial Transpl1999141843184410.1093/ndt/14.8.1843 18.Bullard-FeibelmanKMGoveroJZhuZSalazarVVeselinovicMDiamondMSGeissBJThe FDA-approved drug sofosbuvir inhibits Zika"/>
   <result pre="the British Empire in North America2005NormanUniversity of Oklahoma Press 37.DyerOEscalating" exact="Congo" post="Ebola epidemic passes 2000 cases amid violence and suspicionBMJ2019365l406210.1136/bmj.l406231167752"/>
   <result pre="delayed brincidofovir treatment against a lethal rabbitpox virus challenge in" exact="New Zealand" post="White rabbitsAntivir Res201714327828610.1016/j.antiviral.2017.04.00228392420 57.GubarevaLVBesselaarTGDanielsRSFryAGregoryVHuangWHurtACJorqueraPALackenbyALeangS-KLoJPereyaslovDRebelo-de-AndradeHSiqueiraMMTakashitaEOdagiriTWangDZhangWMeijerAGlobal update on the susceptibility of"/>
   <result pre="in a measles encephalitis modelAntivir Res20098126126610.1016/j.antiviral.2008.12.00619133295 70.JohnsonSHenschkeNMaayanNMillsIBuckleyBSKakourouAMarshallRRibavirin for treating Crimean" exact="Congo" post="haemorrhagic feverCochrane Database Syst Rev201810.1002/14651858.CD012713.pub230362116 71.JonssonCBHooperJMertzGTreatment of hantavirus pulmonary"/>
   <result pre="of renal and pulmonary syndrome in a region of northeast" exact="Germany" post="where Tula hantavirus circulatesJ Clin Microbiol200341104894489710.1128/jcm.41.10.4894-4897.200314532254 77.KobanRNeumannMDaugsABlochONitscheALanghammerSEllerbrokHA novel three-dimensional"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7090748\results\search\country\results.xml">
   <result pre="Ebola in western Africa, Zika in South America, H7N9 in" exact="China" post="and many Asian countries, and H1N1 influenza worldwide. In"/>
   <result pre="syndrome (SARS) coronavirus (SARS-CoV) emerged in November 2002 in Guangdong," exact="China" post="and caused globally 8098 human infections with 774 deaths"/>
   <result pre="East respiratory syndrome (MERS) coronavirus (MERS-CoV) emerged in 2012 in" exact="Saudi Arabia" post="and caused 2494 infections with 858 associated deaths (34.4%)"/>
   <result pre="in other 16 countries (National Health Commission of the Peopleâ€™s" exact="Republic of" post="China 2020; WHO 2020c). Since the emerging viruses are"/>
   <result pre="16 countries (National Health Commission of the Peopleâ€™s Republic of" exact="China" post="2020; WHO 2020c). Since the emerging viruses are previously"/>
   <result pre="virus, human immunodeficiency virus, dengue virus, West Nile virus, Crimean" exact="Congo" post="hemorrhagic fever virus, and hepatitis A virus (GarcÃ­a-Serradilla et"/>
   <result pre="and timely as the 2019-nCoV is currently spreading rapidly in" exact="China" post="and causing severe respiratory diseases and deaths of many"/>
   <result pre="The author was supported by the Natural Science Foundation of" exact="China" post="(Grant #81620108020), Shenzhen Science and Technology Program (Grant No."/>
   <result pre="Pneumo-, and ParamyxovirusesSci Rep201774339510.1038/srep4339528262699 National Health Commission of the Peopleâ€™s" exact="Republic of" post="China (2020) http://www.nhc.gov.cn/xcs/yqfkdt/202001/e71bd2e7a0824ca69f87bbf1bef2a3c9.shtml RainsfordKDParkeALClifford-RashotteMKeanWFTherapy and pharmacological properties of hydroxychloroquine"/>
   <result pre="ParamyxovirusesSci Rep201774339510.1038/srep4339528262699 National Health Commission of the Peopleâ€™s Republic of" exact="China" post="(2020) http://www.nhc.gov.cn/xcs/yqfkdt/202001/e71bd2e7a0824ca69f87bbf1bef2a3c9.shtml RainsfordKDParkeALClifford-RashotteMKeanWFTherapy and pharmacological properties of hydroxychloroquine and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7090771\results\search\country\results.xml">
   <result pre="2019 novel coronavirus infection in children: expertsâ€™ consensus statement ShenKunlingkunlingshen1717@163.com1YangYonghongyyh628628@sina.com2WangTianyou3ZhaoDongchizhao_wh2004@hotmail.com4JiangYi5JinRunming6ZhengYuejie7XuBaoping1XieZhengde2LinLikai8ShangYunxiao9LuXiaoxia10ShuSainan11BaiYan6DengJikui12LuMin13YeLeping14WangXuefeng15WangYongyan16GaoLiwei1collab:" exact="China" post="National Clinical Research Center for Respiratory Diseasescollab: National Center"/>
   <result pre="Medical Associationcollab: Chinese Medical Doctor Association Committee on Respirology Pediatricscollab:" exact="China" post="Medicine Education Association Committee on Pediatricscollab: Chinese Research Hospital"/>
   <result pre="on Pediatricscollab: Chinese Non-government Medical Institutions Association Committee on Pediatricscollab:" exact="China" post="Association of Traditional Chinese Medicine, Committee on Childrenâ€™s Health"/>
   <result pre="Traditional Chinese Medicine, Committee on Childrenâ€™s Health and Medicine Researchcollab:" exact="China" post="News of Drug Information Association, Committee on Childrenâ€™s Safety"/>
   <result pre="grid.412467.20000 0004 1806 3501Department of Pediatric Respiratory, Shengjing Hospital of" exact="China" post="Medical University, [10], grid.33199.310000 0004 0368 7223Department of Respiratory"/>
   <result pre="grid.410318.f0000 0004 0632 3409Institute of Basic Research in Clinical Medicine," exact="China" post="Academy of Chinese Medical Sciences, epub: 2020-2-219received: 2020-1-29accepted: 2020-1-30(C)"/>
   <result pre="from 1Â month to 17Â years had been reported in" exact="China" post="[1]. Coronavirus (CoV) belongs to the Coronaviridae family, Nidovirales"/>
   <result pre="and development of anti-virus vaccines has been carried out in" exact="China" post="at present. Publisher's Note Springer Nature remains neutral with"/>
   <result pre="this consensus statement. References References 1.National Health Commission of Peopleâ€™s" exact="Republic of" post="China. https://www.nhc.gov.cn/xcs/yqfkdt/202001/a53e6df293cc4ff0b5a16ddf7b6b2b31.shtml. Access 20 Jan 2020. 2.ZhuNZhangDWangWLiXYangBSongJet al.A novel"/>
   <result pre="China, 2019N Engl J Med.202010.1056/NEJMoa200101731978945 3.National Health Commission of Peopleâ€™s" exact="Republic of" post="China. Diagnosis and treatment of pneumonia caused by novel"/>
   <result pre="syndrome coronavirus in childrenSaudi Med J20153648448610.15537/smj.2015.4.1024325828287 12.National Health Commission of" exact="People's Republic of China." post="Code for the diagnosis and treatment of community-acquired pneumonia"/>
   <result pre="coronavirus in childrenSaudi Med J20153648448610.15537/smj.2015.4.1024325828287 12.National Health Commission of People's" exact="Republic of" post="China. Code for the diagnosis and treatment of community-acquired"/>
   <result pre="Commissioncollab: National Health and Family Planningcollab: Commission of The Peopleâ€™s" exact="Republic of" post="Chinacollab: Pediatric Section of Chinese Medical Association Respiratory Groupcollab:"/>
   <result pre="excipient in SD ratsInt J Pediatr201946692697 23.National Health Commission of" exact="People's Republic of China." post="Guidelines on the diagnosis and treatment of hand, foot"/>
   <result pre="in SD ratsInt J Pediatr201946692697 23.National Health Commission of People's" exact="Republic of" post="China. Guidelines on the diagnosis and treatment of hand,"/>
   <result pre="the treatment of SARS: initial virological and clinical findingsThorax20045925225610.1136/thorax.2003.01265814985565 30.AbbVie" exact="Deutschland" post="GmbH &amp;amp; Co.KG. Lopinar veletonavir tablet specification. https://www.jianke.com/product/79823.html.Â Access"/>
   <result pre="Effect of ArbidolePharm J Chin PLA200420274276 32.National Health Commission of" exact="People's Republic of China." post="Influenza diagnosis and treatment protocol (revised edition 2019). https://wenku.baidu.com/view/00f0d41d2079168884868762caaedd3383c4b57f.html."/>
   <result pre="of ArbidolePharm J Chin PLA200420274276 32.National Health Commission of People's" exact="Republic of" post="China. Influenza diagnosis and treatment protocol (revised edition 2019)."/>
   <result pre="Communities. https://www.cdc.gov/coronavirus/2019-ncov/guidance-prevent-spread-chinese.html. Access 20 Jan 2020. 35.National Health Commission of" exact="People's Republic of China." post="Guidelines for transmission and prevention of novel coronaviruses. https://www.nhc.gov.cn/xcs/kpzs/202001/9e73060017d744aeafff8834fc0389f4.shtml."/>
   <result pre="https://www.cdc.gov/coronavirus/2019-ncov/guidance-prevent-spread-chinese.html. Access 20 Jan 2020. 35.National Health Commission of People's" exact="Republic of" post="China. Guidelines for transmission and prevention of novel coronaviruses."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7091034\results\search\country\results.xml">
   <result pre="50 million people â€&quot; the Spanish influenza pandemic of 1918." exact="India" post="was the focal point of this pandemic in terms"/>
   <result pre="8% of the population at that time). The epidemic in" exact="India" post="originated in Bombay in September 1918 where the troops"/>
   <result pre="peak season had just begun [5]. Influenza surveillance studies from" exact="India" post="have identified three major patterns of influenza circulation: Srinagar"/>
   <result pre="and Vellore situated in the South west. Whereas rest of" exact="India" post="has peak activity coinciding with the rains (Juneâ€&quot;October) with"/>
   <result pre="2019. 6.ChadhaMSPotdarVASahaSet al.Dynamics of influenza seasonality at sub-regional levels in" exact="India" post="and implications for vaccination timingPLoS One201510e012412210.1371/journal.pone.012412225938466 7.BridgesCBKuehnertMJHallCBTransmission of influenza:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7091691\results\search\country\results.xml">
   <result pre="phosphate in more than ten hospitals across several provinces in" exact="China" post="has shown that it alleviates the symptoms for most"/>
   <result pre="recently been approved. The rich tradition of herbal medicine in" exact="China" post="is also being deployed against COVID-19. In the newest"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7093024\results\search\country\results.xml">
   <result pre="ChicagoChicago, ILUnited States Edited by: Chunfu Zheng, Fujian Medical University," exact="China" post="Reviewed by: Qi Wang, Harbin Veterinary Research Institute (CAAS),"/>
   <result pre="Research Institute (CAAS), China; Jun Wang, The University of Arizona," exact="United States" post="*Correspondence: Lijun Rong, Lijun@uic.edu Qinghua Cui, cuiqinghua1122@163.com â€ These"/>
   <result pre="Province (Grant No. 2017CXGC1309); (3) Shandong Provincial Natural Science Foundation," exact="China" post="(Grant No. ZR2019MH078); (4) Project for function implementation of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7098069\results\search\country\results.xml">
   <result pre="advanced into human clinical trials to treat COVID-19 in both" exact="China" post="and the U.S., was reported to improve patient outcomes"/>
   <result pre="high morbidity and mortality. The outbreak of SARS in southern" exact="China" post="between November 2002 and July 2003 eventually resulted in"/>
   <result pre="a mortality rate of 9%, while MERS, first identified in" exact="Saudi Arabia" post="in 2012, has caused a total of 2519 laboratory-confirmed"/>
   <result pre="PillaiS. K. (2020) First case of 2019 novel coronavirus in" exact="the United States." post="N. Engl. J. Med.10.1056/NEJMoa2001191. AshburnT. T.; ThorK. B. (2004)"/>
   <result pre="K. (2020) First case of 2019 novel coronavirus in the" exact="United States." post="N. Engl. J. Med.10.1056/NEJMoa2001191. AshburnT. T.; ThorK. B. (2004)"/>
   <result pre="and its complex with an inhibitor. Proc. Natl. Acad. Sci." exact="U. S." post="A.100, 13190â€&quot;13195. 10.1073/pnas.1835675100.14585926 ChouK.-C.; WeiD.-Q.; ZhongW.-Z. (2003) Binding mechanism"/>
   <result pre="for public health preparedness for mass gatherings at the 2016" exact="Brazil" post="Olympic Games. Int. J. Infect. Dis.44, 11â€&quot;5. 10.1016/j.ijid.2016.02.001.26854199 Cao-LormeauV.-M.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7099677\results\search\country\results.xml">
   <result pre="Research Center for Eco-Environmental Sciences, Chinese Academy of SciencesChina[â€¡], The" exact="Hong Kong" post="Polytechnic UniversityHong Kong[Â§], Hangzhou Institute for Advanced Study, UCASChina[âˆ¥],"/>
   <result pre="By March 15, 2020, infected cases had reached 81â€¯048 in" exact="China" post="and a total of 72â€¯600 cases outside China have"/>
   <result pre="81â€¯048 in China and a total of 72â€¯600 cases outside" exact="China" post="have been reported to the WHO from 146 countries"/>
   <result pre="contaminated faulty sewage system in a high-rise housing estate in" exact="Hong Kong" post="in 2003 was linked to the SARS outbreak of"/>
   <result pre="is already compromised. The high levels of PM pollution in" exact="China" post="may increase the susceptibility of the population to more"/>
   <result pre="ZhengB. J.; NgW. L.; LaiR. W.; GuanY.; YuenK. Y.; GroupH." exact="U. S." post="S.Clinical progression and viral load in a community outbreak"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7101493\results\search\country\results.xml">
   <result pre="limited to subgroups of the population. Countries such as the" exact="United Kingdom," post="Georgia and Egypt are well on their way to"/>
   <result pre="subgroups of the population. Countries such as the United Kingdom," exact="Georgia" post="and Egypt are well on their way to reaching"/>
   <result pre="the population. Countries such as the United Kingdom, Georgia and" exact="Egypt" post="are well on their way to reaching the WHO"/>
   <result pre="References REFERENCES 1Norwegian Institute of Public Health. Tuberculosis (TB) in" exact="Norway" post="- fact sheet. Available: https://www.fhi.no/en/id/infectious-diseases/TB/tuberculosis-tb-in-norwayâ€&quot;fact-sh/. Accessed: 20 November 2019."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102556\results\search\country\results.xml">
   <result pre="novel coronavirus responsible for a pneumonia outbreak originating in Wuhan," exact="China" post="YuFeiaDuLanyingbOjciusDavid M.cPanChungenchungenp@163.comdâˆ—JiangShiboshibojiang@fudan.edu.cnbeâˆ—âˆ—[a], [b], [c], [d], [e], âˆ—Corresponding author. Haid"/>
   <result pre="coronavirus causing a pneumonia outbreak in Wuhan City in central" exact="China" post="was denoted as 2019-nCoV by the World Health Organization"/>
   <result pre="confirmed cases of 2019-nCoV infection, including 26 deaths, reported in" exact="China" post="and other countries. Therefore, combating this new virus and"/>
   <result pre="of viral pneumonia caused by an unknown pathogen in Wuhan," exact="China" post="[1]. Subsequently, the unknown pathogen was identified as a"/>
   <result pre="in the original epidemic area, Wuhan, and other cities in" exact="China" post="and in foreign countries. More seriously, 15 healthcare workers"/>
   <result pre="to be further developed promptly in clinical trials in both" exact="China" post="and the United State through the continuous collaborations among"/>
   <result pre="in blood donors and slaughterhouse workers in Jeddah and Makkah," exact="Saudi Arabia," post="fall 2012JÂ Infect Dis209201424324624218504 5ReuskenC.MouH.GodekeG.J.van der HoekL.MeyerB.MullerM.A.Specific serology for"/>
   <result pre="Immunol17620066085609216670317 53ZengL.P.GeX.Y.PengC.TaiW.JiangS.DuL.Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronavirusesSci" exact="China" post="Life Sci6020171399140229134417 54ChenW.H.DuL.ChagS.M.MaC.TricocheN.TaoX.Yeast-expressed recombinant protein of the receptor-binding domain"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102570\results\search\country\results.xml">
   <result pre="trials of treatments for seasonal influenza have been performed in" exact="Japan" post="and US, and favipiravir was approved as a treatment"/>
   <result pre="as a treatment for novel or re-emerging influenza viruses in" exact="Japan" post="in 2014. Favipiravir is considered for administration to patients"/>
   <result pre="al., 2016). Since children died of avian influenza A(H5N1) in" exact="Hong Kong" post="in 1997 (Ku &amp;amp; Chan, 1999), concern regarding novel"/>
   <result pre="has been used to treat patients with severe influenza in" exact="China" post="(Cao, 2018; Wang et al., 2019). Although each novel"/>
   <result pre="trials of treatments for seasonal influenza have been performed in" exact="Japan" post="and the US, and favipiravir was approved as a"/>
   <result pre="treatments for seasonal influenza have been performed in Japan and" exact="the US," post="and favipiravir was approved as a treatment for novel"/>
   <result pre="as a treatment for novel or re-emerging influenza viruses in" exact="Japan" post="in 2014. However, favipiravir (AviganÂ®) is only considered for"/>
   <result pre="been performed to assess its efficacy in treating SFTS in" exact="Japan" post="(Yasukawa, 2016) and as a combination therapy with oseltamivir"/>
   <result pre="therapy with oseltamivir to treat patients with severe influenza in" exact="China" post="(Cao, 2018; Wang et al., 2019). In addition to"/>
   <result pre="possessing an NA H275Y substitution spread globally, 12.3% (142/1155) in" exact="the US" post="(Dharan et al., 2009), 64% in South Africa, Oceania"/>
   <result pre="(142/1155) in the US (Dharan et al., 2009), 64% in" exact="South Africa," post="Oceania and SE Asia (Hurt et al., 2009), and"/>
   <result pre="have elapsed since an avian influenza case was reported in" exact="Hong Kong" post="in 1997, and a decade has elapsed since the"/>
   <result pre="treating patients with severe influenza in combination with oseltamivir in" exact="China" post="(Cao, 2018; Wang et al., 2019). Favipiravir and oseltamivir"/>
   <result pre="day for 9Â days, and the approved favipiravir dose in" exact="Japan" post="is 1600Â mg twice a day on day 1"/>
   <result pre="model (Smither et al., 2014). An Ebola study conducted in" exact="Guinea" post="included 126 patients, and 111 were analyzed and compared"/>
   <result pre="significant (Sissoko et al., 2016). An Ebola study conducted in" exact="Sierra Leone" post="included 39 favipiravir-treated patients and 85 historical control patients."/>
   <result pre="clinical recovery compared to oseltamivir monotherapy in severe influenza in" exact="China" post="(Cao, 2018; Wang et al., 2019). 5.4 The dose"/>
   <result pre="mg package insert). The approved favipiravir dose for influenza in" exact="Japan" post="is 1600Â mg twice a day on day 1"/>
   <result pre="al., 2013). Since children died of avian influenza A(H5N1) in" exact="Hong Kong" post="in 1997 (Ku &amp;amp; Chan, 1999), concern has been"/>
   <result pre="Novartis, and research funding from Maruho Co., Ltd., MSD, and" exact="Japan" post="Blood Products Organization; all payments were sent to the"/>
   <result pre="Favipiravir (T-705)-Sierra Leone, 2014Clinical Infectious Diseases6320161288129427553371 BakerL.Bat rabies outbreak in" exact="Peru" post="claims one, but others survive: Mass vaccination campaign underwayhttps://rabiesalliance.org/resource/bat-rabies-outbreak-peru-claims-one-others-survive-mass-vaccination-campaign-underway2017"/>
   <result pre="among RNA virusesProceedings of the National Academy of Sciences of" exact="the United States" post="of America901993417141758387212 ElionG.B.Mechanism of action and selectivity of acyclovirThe"/>
   <result pre="RNA virusesProceedings of the National Academy of Sciences of the" exact="United States" post="of America901993417141758387212 ElionG.B.Mechanism of action and selectivity of acyclovirThe"/>
   <result pre="a broad spectrum inhibitor of viral RNA polymeraseProceedings of the" exact="Japan" post="Academy. Series B, Physical and Biological Sciences932017449463 FurutaY.TakahashiK.FukudaY.KunoM.KamiyamaT.KozakiK. â€¦ShirakiK.In"/>
   <result pre="favipiravir in influenzaProceedings of the National Academy of Sciences of" exact="the United States" post="of America1152018116131161830352857 GowenB.B.JuelichT.L.SefingE.J.BraselT.SmithJ.K.ZhangL. â€¦FreibergA.N.Favipiravir (T-705) inhibits Junin virus infection"/>
   <result pre="in influenzaProceedings of the National Academy of Sciences of the" exact="United States" post="of America1152018116131161830352857 GowenB.B.JuelichT.L.SefingE.J.BraselT.SmithJ.K.ZhangL. â€¦FreibergA.N.Favipiravir (T-705) inhibits Junin virus infection"/>
   <result pre="(T-705) inhibits Junin virus infection and reduces mortality in a" exact="Guinea" post="pig model of argentine hemorrhagic feverPLoS Neglected Tropical Diseases72013e2614"/>
   <result pre="influenza A virusesProceedings of the National Academy of Sciences of" exact="the United States" post="of America107201088288720080770 KuA.S.ChanL.T.The first case of H5N1 avian influenza"/>
   <result pre="A virusesProceedings of the National Academy of Sciences of the" exact="United States" post="of America107201088288720080770 KuA.S.ChanL.T.The first case of H5N1 avian influenza"/>
   <result pre="Lassa feverClinical Infectious Diseases65201785585929017278 RenaultP.JosseranL.PierreV.Chikungunya-related fatality rates, Mauritius, India, and" exact="Reunion" post="IslandEmerging Infectious Diseases1420081327 Rocha-PereiraJ.JochmansD.DallmeierK.LeyssenP.NascimentoM.S.NeytsJ.Favipiravir (T-705) inhibits in vitro norovirus"/>
   <result pre="syndromeAntimicrobial Agents and Chemotherapy5720134673468023856782 SafronetzD.RosenkeK.WestoverJ.B.MartellaroC.OkumuraA.FurutaY. â€¦GowenB.B.The broad-spectrum antiviral favipiravir protects" exact="Guinea" post="pigs from lethal Lassa virus infection post-disease onsetScientific Reports520151477526456301"/>
   <result pre="the Ministry of Education, Culture, Sports, Science and Technology of" exact="Japan" post="and joint research project with Toyama Chemical Co., Ltd."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102576\results\search\country\results.xml">
   <result pre="technology, as well as international cooperation. This experience will provide" exact="China" post="and other countries with valuable lessons for quickly coordinating"/>
   <result pre="infectious disease was reported in November 2002, in Guangdong Province," exact="China" post="[4]. While the source of the virus was not"/>
   <result pre="On February 21, 2003, an infected Guangdong doctor travelled to" exact="Hong Kong," post="leading to spread of the virus globally [5]. Not"/>
   <result pre="World Health Organization (WHO) received reports of cases from Guangdong," exact="Hong Kong," post="and Hanoi, was a global alert on the disease"/>
   <result pre="Respiratory Syndrome caused by MERS-CoV in 2012. It occurred in" exact="Saudi Arabia" post="and spread to other countries including the United States,"/>
   <result pre="occurred in Saudi Arabia and spread to other countries including" exact="the United States," post="England, France, and South Korea. The mortality rate was"/>
   <result pre="in Saudi Arabia and spread to other countries including the" exact="United States," post="England, France, and South Korea. The mortality rate was"/>
   <result pre="to other countries including the United States, England, France, and" exact="South Korea." post="The mortality rate was as high as 34.4%. As"/>
   <result pre="of coronavirus, which is highly homologous to bat coronavirus, hit" exact="China" post="again [16,17]. At the end of December, some hospitals"/>
   <result pre="of unexplained pneumonia in those with a history of South" exact="China" post="seafood market exposure [18,19]. In December 31 the pneumonia"/>
   <result pre="human society. How do we learn from the experience of" exact="China" post="and the international community in responding to the outbreak?"/>
   <result pre="January 30, 2020, the cumulative number of 2019-nCoV cases in" exact="China" post="had exceeded the total number of previous SARS cases"/>
   <result pre="and treatment of patients have become the biggest challenges that" exact="China" post="and the international community need to face. It is"/>
   <result pre="China, except for the death of a pneumonia patient in" exact="the Philippines" post="[32] (as of February 9, 2020). Since 2019-nCOV has"/>
   <result pre="except for the death of a pneumonia patient in the" exact="Philippines" post="[32] (as of February 9, 2020). Since 2019-nCOV has"/>
   <result pre="24, considering the rapid increase in the number of cases," exact="China" post="began to build several temporary hospitals, including â€œHuoshenshanâ€� and"/>
   <result pre="staff nationwide to assist Hubei Province [27]. Back in 2003," exact="China" post="built the Xiaotangshan Temporary Hospital in 6 days [36],"/>
   <result pre="far slower than for 2019-nCoV. Similarly, in the current epidemic," exact="China" post="implemented main domestic response measures before WHOâ€™s announcement of"/>
   <result pre="government can carry out precise measures. At the same time," exact="China" post="Unicom formed a joint big data team of more"/>
   <result pre="In summary, in the 2019-nCoV epidemic, the overall response of" exact="China" post="and the international community is faster than it was"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102582\results\search\country\results.xml">
   <result pre="1099 patients with laboratory-confirmed COVID-19 from 552 hospitals in mainland" exact="China" post="[3]. Considering that the number of unreported and unconfirmed"/>
   <result pre="which is similar to that of severe seasonal influenza [4]." exact="India" post="has 39confirmed cases till 10th March, 2020 and contact"/>
   <result pre="in 42.3% of 26 fatalities due to COVID-19 in Wuhan," exact="China" post="[8]. In a study in 140 patients with COVID-19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102591\results\search\country\results.xml">
   <result pre="of the new coronavirus infections COVID-19 in December 2019 in" exact="China" post="has quickly become a global health emergency. Given the"/>
   <result pre="acute respiratory coronavirus 2 syndrome) developed from Wuhan Province in" exact="China" post="[1]. Phylogenetic analysis demonstrated that this is a different"/>
   <result pre="demonstrated by an analysis conducted in 16,242 RA patients from" exact="the US" post="CORRONA registry that each 0.6 unit increase in Disease"/>
   <result pre="both RA and cytokine release syndrome) has been approved in" exact="China" post="and is currently ongoing in patients with COVID-19 pneumonia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7105126\results\search\country\results.xml">
   <result pre="of data of patients attended at certain public institutions in" exact="Spain" post="is limited by the Data Protection Law (Ley de"/>
   <result pre="sex [8] and some type of violence [9]. WWID in" exact="the US" post="face high levels of stigma, punishing drug laws, increasing"/>
   <result pre="severe substance abuse in a harm reduction setting in Madrid," exact="Spain" post="[15,29], we found our findings very relevant. Fourth, an"/>
   <result pre="et al.Estimating the number of persons who inject drugs in" exact="the United States" post="by meta-analysis to calculate national rates of HIV and"/>
   <result pre="al.Estimating the number of persons who inject drugs in the" exact="United States" post="by meta-analysis to calculate national rates of HIV and"/>
   <result pre="women who inject drugs: accessing health and prevention services in" exact="Puerto Rico." post="Puerto Rico health sciences journal. 2018;37(2):88â€&quot;97. 29905919 25GilbertL, Jiwatramâ€�NegronT,"/>
   <result pre="inject drugs: accessing health and prevention services in Puerto Rico." exact="Puerto Rico" post="health sciences journal. 2018;37(2):88â€&quot;97. 29905919 25GilbertL, Jiwatramâ€�NegronT, NikitinD, RychkovaO,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7106608\results\search\country\results.xml">
   <result pre="baseline, suggesting that interventions to improve uptake of ART in" exact="Vietnam" post="are essential for achieving UNAIDS 90â€&quot;90-90 goals in people"/>
   <result pre="the HIV care continuum. Keywords HIV care continuum Opioid use" exact="Vietnam" post="Anti-retroviral medication HIV viral suppression Funding http://dx.doi.org/10.13039/100000026National Institute on"/>
   <result pre="and OUD over the past 15â€‰years [7]. Beginning in 2005," exact="Vietnam" post="began providing antiretroviral therapy through the U.S. Presidentâ€™s Emergency"/>
   <result pre="to address injection drug use are multifaceted. For several decades," exact="Vietnam" post="has used compulsory drug detention centers (known as 06"/>
   <result pre="as 06 centers) to curb substance use [9]. In 2008," exact="Vietnam" post="began to shift from this model, building clinics to"/>
   <result pre="Over the past several years, changes in external aid challenged" exact="Vietnam" post="to identify how to continue to provide HIV and"/>
   <result pre="in 2016 found most people with HIV and OUD in" exact="Vietnam" post="prefer integrated treatment, where they can receive both MMT"/>
   <result pre="that increase transmission risk [12â€&quot;14]. Over the last several years," exact="Vietnam" post="has successfully piloted clinics that provide both HIV and"/>
   <result pre="explored what individual characteristics may contribute to viral suppression in" exact="Vietnam" post="regardless of opioid use. Several studies demonstrate that comorbid"/>
   <result pre="antibody were associated with virologic failure on HIV treatment in" exact="Vietnam" post="[17]. Social isolation, high perceived stigma, and multiple daily"/>
   <result pre="have also been associated with suboptimal HIV virologic suppression in" exact="Vietnam" post="[18]. The primary objective of this analysis was to"/>
   <result pre="sent to the National Hospital for Tropical Diseases in Hanoi," exact="Vietnam" post="for HIV-1 PCR testing using Abbott m2000rt RealTime HIV-1"/>
   <result pre="the UNAIDS goal of 90% with HIV viral suppression in" exact="Vietnam" post="hinges on increasing the proportion of people receiving ART."/>
   <result pre="to all persons living with HIV, regardless of drug use." exact="Vietnam" post="is working to identify ways to help support people"/>
   <result pre="results have not been reported in Vietnam; however, research in" exact="China" post="[29] and South Africa [30] has shown that marriage"/>
   <result pre="been reported in Vietnam; however, research in China [29] and" exact="South Africa" post="[30] has shown that marriage may be positively associated"/>
   <result pre="This association has not, to our knowledge, been explored in" exact="Vietnam" post="to date. Authors working in China suggest that subpopulations"/>
   <result pre="knowledge, been explored in Vietnam to date. Authors working in" exact="China" post="suggest that subpopulations of patients with depression may have"/>
   <result pre="This warrants further investigation, particularly as a recent study in" exact="Vietnam" post="showed that one-fifth of patients living with HIV who"/>
   <result pre="disorder who account for the majority of HIV infections in" exact="Vietnam" post="[3]. Further research regarding the potential role of strong"/>
   <result pre="role of strong social supports and ART self-management practices in" exact="Vietnam" post="may suggest ways to improve HIV viral suppression among"/>
   <result pre="connections that are a pillar of Vietnamese culture. Studies in" exact="Italy" post="[39] and Russia [40] suggest that marriage was associated"/>
   <result pre="a pillar of Vietnamese culture. Studies in Italy [39] and" exact="Russia" post="[40] suggest that marriage was associated with viral suppression"/>
   <result pre="the social support from these relationships. Studies primarily conducted in" exact="the United States" post="have demonstrated the negative association between co-occurring methamphetamine use"/>
   <result pre="social support from these relationships. Studies primarily conducted in the" exact="United States" post="have demonstrated the negative association between co-occurring methamphetamine use"/>
   <result pre="a structural intervention to increase access to OUD treatment in" exact="Vietnam" post="and will assessed prospectively. Third, Vietnam is a middle-income"/>
   <result pre="to OUD treatment in Vietnam and will assessed prospectively. Third," exact="Vietnam" post="is a middle-income country that has devoted substantial national"/>
   <result pre="and consent of the OHSU Institutional Review Board and the" exact="Vietnam" post="Ministry of Health Research Ethics Committee. Ethics approval and"/>
   <result pre="was approved by the OHSU Institutional Review Board and the" exact="Vietnam" post="Ministry of Health Research Ethics Committee. Participants provided written"/>
   <result pre="approving the National Strategy on HIV/AIDS prevention and control in" exact="Viet Nam" post="till 2010 with a vision to 2020, S.R.o. Vietnam,"/>
   <result pre="33.VellozaJet al.Depression and ART initiation among HIV Serodiscordant couples in" exact="Kenya" post="and UgandaAIDS Behav20172182509251810.1007/s10461-017-1829-z28634661 34.SudfeldCRet al.Depression at antiretroviral therapy initiation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7108526\results\search\country\results.xml">
   <result pre="due to the novel type of coronavirus (2019-nCoV) appeared in" exact="China" post="highlights the high zoonotic potential of coronaviruses and the"/>
   <result pre="with 638 deaths (ECDC 2020a). The virus moved also outside" exact="China" post="and human cases were detected in other Countries of"/>
   <result pre="Asia (221), and in different continents, such as Europe (31)," exact="America" post="(19) and Oceania (15) (ECDC 2020b). The epidemiological data"/>
   <result pre="obtained from familiar outbreaks and confirmed cases reported outside of" exact="China" post="supported the human to human transmission (Chan etÂ al.2020;"/>
   <result pre="2020 Identification of the novel coronavirus (2019-nCoV) 9 Jan 2020" exact="China" post="CDC reported that the 2019-nCoV had been detected as"/>
   <result pre="available 13 Jan 2020 First case of infection outside of" exact="China" post="(1 imported case in Thailand) 21 Jan 2020 Chinese"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N Engl J Med. 2012;367:1814â€&quot;20.23075143 ZhouP, YangXL, WangXGet al..A"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7110270\results\search\country\results.xml">
   <result pre="(SARS-CoV-2) which can be deadly was first identified in Wuhan," exact="China" post="in December 2019 (Cheng and Shan 2020; Wu P"/>
   <result pre="of around 82,098 confirmed cases and 3298 deaths in mainland" exact="China" post="(http://2019ncov.chinacdc.cn/2019-nCoV/), and Most new coronavirus cases are now outside"/>
   <result pre="They modeled the epidemic curve of SARS-CoV-2 cases, in mainland" exact="China" post="from December 1, 2019 to January 24, 2020 through"/>
   <result pre="April of 2020, and local epidemics across cities in mainland" exact="China" post="would lag by 1â€&quot;2Â weeks. A 50% reduction in"/>
   <result pre="cases (cCFR), while using data from confirmed cases outside mainland" exact="China" post="and a right-censored likelihood to model the number of"/>
   <result pre="not high compared to the 17% CFR of SARS in" exact="Hong Kong" post="(Donnelly et al.2003; Ghani et al.2005) and 20% CFR"/>
   <result pre="al.2003; Ghani et al.2005) and 20% CFR of MERS in" exact="South Korea" post="(Mizumoto et al.2015), the 5%â€&quot;8% risk of death is"/>
   <result pre="the epidemiology of influenza A (H1N1) v virus infection in" exact="Thailand" post="from early outbreak data, June-July 2009Eurosurveillance2009141929210.2807/ese.14.31.19292-en19660247 DonnellyCAGhaniACLeungGMHedleyAJFraserCRileySAbu-RaddadLJHoL-MThachT-QChauPEpidemiological determinants of"/>
   <result pre="(MERS) death during the course of the outbreak in the" exact="Republic of" post="Korea, 2015Int J Infect Dis2015397910.1016/j.ijid.2015.08.00526275845 MorganOHow decision makers can"/>
   <result pre="Zhuge C, Hong L (2020) Epidemic analysis of COVID-19 in" exact="China" post="by dynamical modeling. arXiv preprint arXiv:200206563 PetukhovaTOjkicDMcEwenBDeardonRPoljakZAssessment of autoregressive"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci2020631431564034 Zhang Z, Wu Q, Zhang T (2020)"/>
   <result pre="in a data-limited situation: the Zika virus (ZIKV) outbreaks in" exact="Brazil" post="from 2015 to 2016 as an exampleParasit Vectors20191234410.1186/s13071-019-3602-931300061 ZhaoSMusaSSLinQRanJYangGWangWLouYYangLGaoDHeDEstimating"/>
   <result pre="ZhaoSMusaSSLinQRanJYangGWangWLouYYangLGaoDHeDEstimating the unreported number of novel coronavirus (2019-nCoV) cases in" exact="China" post="in the first half of January 2020: a data-driven"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7111068\results\search\country\results.xml">
   <result pre="recombination events. W. Tan and colleagues, who now constitute the" exact="China" post="Novel Coronavirus Investigating and Research Team, described subsequently the"/>
   <result pre="easy sampling and virus diagnostics, 90% of hospitalized patients from" exact="Hongkong" post="were positive for PCR virus detection in selfâ€�collected saliva"/>
   <result pre="the first patient was reported on the West Coast of" exact="the United States." post="The patient developed respiratory symptoms after a family visit"/>
   <result pre="first patient was reported on the West Coast of the" exact="United States." post="The patient developed respiratory symptoms after a family visit"/>
   <result pre="(Vetter et al., 2020). On January 24, two citizens of" exact="Germany" post="developed symptoms and became 2019â€�nCoVâ€�positive after meeting a Chinese"/>
   <result pre="800 infected subjects from Wuhan travelled to international destinations, with" exact="Thailand" post="and Japan leading the list. Public health measures must"/>
   <result pre="subjects from Wuhan travelled to international destinations, with Thailand and" exact="Japan" post="leading the list. Public health measures must therefore also"/>
   <result pre="et al., 2020). Risk of transmission to Africa and South" exact="America" post="is, however, by some epidemiologists considered to be low"/>
   <result pre="The viral pneumonia patients were treated with arbidol, approved in" exact="Russia" post="and China for influenza treatment. When the diagnosis of"/>
   <result pre="pneumonia patients were treated with arbidol, approved in Russia and" exact="China" post="for influenza treatment. When the diagnosis of the novel"/>
   <result pre="is still ongoing. Numerous clinical trials have been registered in" exact="China" post="to test different compounds or combinations of compounds against"/>
   <result pre="is food, eaten when ill is medicineâ€™) such that in" exact="China" post="pangolin products, for example are reputed to help against"/>
   <result pre="the lockdown of Wuhan and of particular small cities in" exact="Italy" post="and Germany. WHO has declared the novel coronavirus epidemic"/>
   <result pre="et al (2020) First Case of 2019 Novel Coronavirus in" exact="the United States." post="N Engl J Med [Epub ahead of print]. 10.1056/NEJMoa2001191"/>
   <result pre="al (2020) First Case of 2019 Novel Coronavirus in the" exact="United States." post="N Engl J Med [Epub ahead of print]. 10.1056/NEJMoa2001191"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7113379\results\search\country\results.xml">
   <result pre="nCoV infected patients linked to viral loads and lung injurySci" exact="China" post="Life Sci20206336437410.1007/s11427-020-1643-832048163 5.Emerg Infect Ids2020266 6.DentEMorleyJECruz-JentoftAJet al.Physical frailty: ICFSR"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7117553\results\search\country\results.xml">
   <result pre="Resource Center, as of theÂ 27th of March 2020, in" exact="Italy" post="alone 80,589 patients had been diagnosed with COVID-19, and"/>
   <result pre="diagnosed with COVID-19, and 8,215 fatalities had occurred. Doctors in" exact="Italy" post="have been forced to face excruciating decisions about which"/>
   <result pre="biologic therapies for rheumatoid arthritisSemin. Arthritis Rheum.20103932734619117595 2.RosenbaumLFacing COVID-19 in" exact="Italy" post="â€&quot; ethics, logistics, and therapeutics on the epidemicâ€™s front"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7117787\results\search\country\results.xml">
   <result pre="MedAAEMArchives of Academic Emergency Medicine2645-4904Shahid Beheshti University of Medical SciencesTehran," exact="Iran" post="e41 : Review Article Epidemiological and Clinical Aspects of"/>
   <result pre="the previous epidemics, initial hotspots of diseases were Middle East," exact="Saudi Arabia" post="(MERS) and China and animal to human, and then"/>
   <result pre="hotspots of diseases were Middle East, Saudi Arabia (MERS) and" exact="China" post="and animal to human, and then human to human"/>
   <result pre="countries (1,2). For COVID-19, as suggested by epidemiological evidence in" exact="China" post="(at the time of writing this paper), this outbreak"/>
   <result pre="to human transmission immediately, and swept through most regions in" exact="China" post="even faster than the previous pandemics (3). Recent epidemics"/>
   <result pre="of viral respiratory diseases in the world have started from" exact="China" post="(except for MERS that originated in Saudi Arabia), and"/>
   <result pre="are several possible reasons for this. From an economic perspective," exact="China" post="has emerged as one of the leading countries in"/>
   <result pre="virus would spread to other parts of the world (4)." exact="China" post="has already acknowledged the possibility of a new virus"/>
   <result pre="international institutions regarding delayed provision and sharing of data by" exact="China" post="government, this country has started extensive collaborations with international"/>
   <result pre="of cases through coordinating with Johns Hopkins University (5). Moreover," exact="China" post="scaled up public health measures and quarantined many cities,"/>
   <result pre="of the disease to other parts of the world. Although," exact="China" post="has been struggling with tough conditions in the previous"/>
   <result pre="Coronavirus epidemic is progressively increasing in three countries, including Italy," exact="South Korea," post="and Iran. The shared string that links these three"/>
   <result pre="infection in healthy people (9). Evidence of a study in" exact="Singapore" post="revealed higher loads of virus in confirmed cases of"/>
   <result pre="reported to be 6.4 days (15,16), while another study in" exact="China" post="reported longer incubation times up to 24 days (13)."/>
   <result pre="and the index value based on data calculated in Wuhan," exact="China" post="was 2.2 (95% CI, 1.4 to 3.9) (17) and"/>
   <result pre="reports on a family in one of the provinces of" exact="China" post="show that all six-members of a family, aged 10-66"/>
   <result pre="of 20 February, there were 18264 (24%) recovered cases in" exact="China" post="and recovery and mortality rates of the disease among"/>
   <result pre="on six infants (45-days to one-year) infected with COVID-19 in" exact="China" post="indicated mild symptoms of the disease in this age"/>
   <result pre="of the disease (26). However, findings from a study in" exact="Singapore" post="shows that infected patients with no history of underlying"/>
   <result pre="10% and 34%, respectively (18). Results of a study in" exact="China" post="revealed the overall case fatality rate of 2.3% for"/>
   <result pre="a few deaths are reported in this age group in" exact="China" post="and Iran. Availability of and access to healthcare facilities"/>
   <result pre="as criteria of discharge from hospital or quarantine center in" exact="China" post="(35). However, recent studies reported several cases of COVID-19"/>
   <result pre="have been reported in RT-PCR test (10,38); hence, hospitals in" exact="China" post="have considered additional antibody test (negative IgM and positive"/>
   <result pre="Germany. Furthermore, three targets in N gene are considered in" exact="the US" post="protocol (40). RT-PCR is an expensive test and no"/>
   <result pre="such as Chest CT. However, results of recent studies in" exact="China" post="demonstrate low specificity for this diagnostic approach (41). As"/>
   <result pre="(mostly fever) and all people with a travel history to" exact="China" post="or visiting Chinese travelers or citizens it the previous"/>
   <result pre="authorities are actively looking for cases in all provinces of" exact="China" post="and efforts for finding additional cases inside and outside"/>
   <result pre="started in medical institutions. The Department of Disease Control in" exact="Thailand" post="scaled up the Emergency Operations Center to Level 3"/>
   <result pre="Contact tracing and other epidemiological investigation are ongoing in the" exact="Republic of" post="Korea to prevent the spread of the disease. The"/>
   <result pre="Screening of passengers on direct and indirect flights from Wuhan" exact="China" post="to the 3 main ports of entry in the"/>
   <result pre="Wuhan China to the 3 main ports of entry in" exact="the United States" post="has begun and will expand to Atlanta and Chicago"/>
   <result pre="China to the 3 main ports of entry in the" exact="United States" post="has begun and will expand to Atlanta and Chicago"/>
   <result pre="prevent traveling to mainland china and flights to and from" exact="China" post="were temporarily suspended. Passengers and US citizens with a"/>
   <result pre="Passengers and US citizens with a history of traveling to" exact="China" post="during the previous month were encouraged to stay home"/>
   <result pre="of medical staff and nurses were voluntarily deployed to Wuhan," exact="China" post="(60). According to primary reports from China and Singapre,"/>
   <result pre="deployed to Wuhan, China (60). According to primary reports from" exact="China" post="and Singapre, working with protective equipment for a long"/>
   <result pre="technically supporting this study. Ethical approval was granted by the" exact="Iran" post="National Committee for ethics in Biomedical Research, Tehran, Iran"/>
   <result pre="the Iran National Committee for ethics in Biomedical Research, Tehran," exact="Iran" post="(IR.SBMU.RETECH.REC.1398.874). Conflict of interest The authors declare that they"/>
   <result pre="of an outbreak of 2019 novel coronavirus diseases (COVID-19) in" exact="China" post="Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7118644\results\search\country\results.xml">
   <result pre="were formally collected during a clinical trial conducted in the" exact="Democratic Republic of Congo" post="that randomized 175 patients to be treated with remdesivir"/>
   <result pre="formally collected during a clinical trial conducted in the Democratic" exact="Republic of" post="Congo that randomized 175 patients to be treated with"/>
   <result pre="during a clinical trial conducted in the Democratic Republic of" exact="Congo" post="that randomized 175 patients to be treated with remdesivir"/>
   <result pre="The NIH-sponsored clinical trial, ongoing in the U.S. and the" exact="Republic of" post="Korea, is a double-blinded, placebo-controlled trial in which patients"/>
   <result pre="Two double-blinded placebo-controlled trials are also recruiting in Hubei Province," exact="China" post="[44,45]. One targets hospitalized patients with mild-to-moderate COVID-19 [44],"/>
   <result pre="of the clinical trials currently underway in the U.S. and" exact="China" post="will provide crucial information about whether remdesivir represents a"/>
   <result pre="the rhesus macaque model of MERS-CoV infectionProc. Natl. Acad. Sci." exact="U. S." post="A.2020 19MartyA.M.JonesM.K.The novel coronavirus (SARS-CoV-2) is a one health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7126217\results\search\country\results.xml">
   <result pre="and Drug Control, No.2, Tiantan Xili, Dongcheng District, Beijing, 10050," exact="PR China." post="masc@nifdc.org.cn âˆ—âˆ—Corresponding author. National Institutes for Food and Drug"/>
   <result pre="and Drug Control, No.2, Tiantan Xili, Dongcheng District, Beijing, 10050," exact="PR China." post="wyljoe@126.com pmc-release: 2020-1-1ppub: 2020-4-4epub: 2020-1-1251112550112550received: 2019-8-27rev-recd: 2019-10-24accepted: 2020-1-4(C) Elsevier"/>
   <result pre="competing interest None. References References Chinese Pharmacopoeia CommissionPharmacopoeia of People's" exact="Republic of" post="China2015China Medical Science PressBeijing CorreiaV.SantosL.A.GiriaM.Almeida-SantosM.M.Rebelo-de-AndradeH.Influenza A(H1N1)pdm09 resistance and cross-decreased"/>
   <result pre="work was supported by the National Natural Science Foundation of" exact="China" post="(grant No. 81303194) and the Academic Leader Foundation of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7127009\results\search\country\results.xml">
   <result pre="The Coronavirus-associated disease, that was first identified in 2019 in" exact="China" post="(CoViD-19), is a pandemic caused by a bat-derived beta-coronavirus,"/>
   <result pre="homology with SARS and MERS-CoV, responsible for past outbreaks in" exact="China" post="and in Middle East. SARS-CoV2 spread from China where"/>
   <result pre="outbreaks in China and in Middle East. SARS-CoV2 spread from" exact="China" post="where the first infections were described in December 2019"/>
   <result pre="It was first reported in late December 2019 in Wuhan," exact="China" post="and the disease was officially named CoViD-19 by the"/>
   <result pre="many countries worldwide with a significant rate of infection in" exact="Italy" post="that currently accounts for more than 110,000 infected cases"/>
   <result pre="the Middle East Respiratory Syndrome (MERS)-CoV responsible for infections in" exact="Saudi Arabia" post="in 2012, respectively. Both these viruses had intermediate hosts"/>
   <result pre="hydroxychloroquine in CoViD-19 patients. Hydroxychloroquine is thus being used in" exact="Italy" post="for the treatment of CoViD-19 patients despite the absence"/>
   <result pre="uncomplicated SARS or MERS infection [10,11]. Recent preliminary data from" exact="China" post="reported high plasma levels of cytokines including IL-6, related"/>
   <result pre="single dose of tocilizumab was used in 21 patients in" exact="China" post="suffering from severe respiratory syndrome during CoViD-19 infection, at"/>
   <result pre="current measures. From the epidemiology of SARS-CoV and SARS-CoV2 in" exact="China" post="we have learned how fundamental are measures such as"/>
   <result pre="of a CoViD-19 infection. Furthermore, an international registry supported by" exact="America" post="College of Rheumatology, European League Against Rheumatism and other"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7129715\results\search\country\results.xml">
   <result pre="pyrogenic cytokine and, and a trial involving 21 patients in" exact="China" post="[6] found that tocilizumab (an IL-6 receptor antagonist) quickly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7134984\results\search\country\results.xml">
   <result pre="disasters may directly cause or exacerbate such epidemics, as in" exact="Haiti" post="following the January 2010 earthquake. Hemorrhagic fever viruses have"/>
   <result pre="In February 2003, 300 people in the Guangdong Province of" exact="China" post="were reported as suffering from a novel and severe"/>
   <result pre="previously known to be infected with SARS, subsequently traveled to" exact="Hong Kong," post="leading to infection of several other visitors to the"/>
   <result pre="airplane, spreading the virus to Vietnam, Singapore, Ireland, Canada, and" exact="the United States." post="The bulk of SARS cases occurred in eastern Asia,"/>
   <result pre="spreading the virus to Vietnam, Singapore, Ireland, Canada, and the" exact="United States." post="The bulk of SARS cases occurred in eastern Asia,"/>
   <result pre="were identified in Europe, 29 cases and no deaths in" exact="the United States," post="and 251 total cases with 43 deaths in Canada."/>
   <result pre="identified in Europe, 29 cases and no deaths in the" exact="United States," post="and 251 total cases with 43 deaths in Canada."/>
   <result pre="A (H1N1) pandemic. The first cases emerged in the southwestern" exact="United States" post="and Mexico in early 2009.12 By late April 2009,"/>
   <result pre="The first cases emerged in the southwestern United States and" exact="Mexico" post="in early 2009.12 By late April 2009, reported cases"/>
   <result pre="April 2009, reported cases of A(H1N1) had spread across North" exact="America" post="and worldwide. By August 2010, when the pandemic had"/>
   <result pre="was documented among children, young adults, and pregnant women.13 In" exact="Mexico" post="City alone, 58 of 899 patients (6.5%) with influenza"/>
   <result pre="the ICU. Even in higher-resource settings, ICU capacity was strained." exact="Australia" post="and New Zealand reported an 8-fold increase in influenza"/>
   <result pre="Even in higher-resource settings, ICU capacity was strained. Australia and" exact="New Zealand" post="reported an 8-fold increase in influenza incidence during the"/>
   <result pre="United States.14 In a cohort study of all ICUs in" exact="Australia" post="and New Zealand from June through August 2009, 5.2%"/>
   <result pre="In a cohort study of all ICUs in Australia and" exact="New Zealand" post="from June through August 2009, 5.2% of ICU bed-days"/>
   <result pre="Ninety-day mortality in this cohort was 17.3%, less than in" exact="Mexico" post="City, but still substantial despite the increased resources that"/>
   <result pre="the Ministries of Health in the West African nations of" exact="Guinea" post="and Liberia reported outbreaks of Ebola virus disease (EVD)"/>
   <result pre="of Health in the West African nations of Guinea and" exact="Liberia" post="reported outbreaks of Ebola virus disease (EVD) that rapidly"/>
   <result pre="EVD epidemic affected over 28,000 persons in Guinea, Liberia, and" exact="Sierra Leone," post="in addition to smaller case numbers in Nigeria, Mali,"/>
   <result pre="with EVD received treatment outside of Africa, including 11 in" exact="the United States" post="and 16 in Europe.16 Of these 27 patients, the"/>
   <result pre="EVD received treatment outside of Africa, including 11 in the" exact="United States" post="and 16 in Europe.16 Of these 27 patients, the"/>
   <result pre="low numbers of cases permitted an intensity of care in" exact="the United States" post="and Europe that may not be feasible in a"/>
   <result pre="numbers of cases permitted an intensity of care in the" exact="United States" post="and Europe that may not be feasible in a"/>
   <result pre="being depleted rapidly. Per Joint Commission requirements, accredited hospitals in" exact="the United States" post="are required to plan for 96Â hours of autonomous"/>
   <result pre="depleted rapidly. Per Joint Commission requirements, accredited hospitals in the" exact="United States" post="are required to plan for 96Â hours of autonomous"/>
   <result pre="approximately 62,000 full-feature ventilators (20 ventilators per 100,000 residents) in" exact="the United States." post="An influenza pandemic with a 30% attack rate and"/>
   <result pre="62,000 full-feature ventilators (20 ventilators per 100,000 residents) in the" exact="United States." post="An influenza pandemic with a 30% attack rate and"/>
   <result pre="hypoxemic respiratory failure. Given ongoing issues with drug shortages in" exact="the United States" post="and elsewhere for commonly used agents, planning must also"/>
   <result pre="respiratory failure. Given ongoing issues with drug shortages in the" exact="United States" post="and elsewhere for commonly used agents, planning must also"/>
   <result pre="were 56 Centers for Disease Control and Prevention-designated ETUs in" exact="the United States," post="not of all which have maintained their capabilities since"/>
   <result pre="56 Centers for Disease Control and Prevention-designated ETUs in the" exact="United States," post="not of all which have maintained their capabilities since"/>
   <result pre="capacity.41 Because the total number of designated ETU beds in" exact="the United States" post="is less than 100, it would take relatively few"/>
   <result pre="Because the total number of designated ETU beds in the" exact="United States" post="is less than 100, it would take relatively few"/>
   <result pre="Infect Dis12201268769522738893 14InvestigatorsA.I.WebbS.A.PettilaV.Critical care services and 2009 H1N1 influenza in" exact="Australia" post="and New ZealandNÂ Engl J Med36120091925193419815860 15KumarA.ZarychanskiR.PintoR.Critically ill patients"/>
   <result pre="critical illnessCrit Care20201621727468829 17UyekiT.M.MehtaA.K.DaveyR.T.Jr.Clinical management of Ebola virus disease in" exact="the United States" post="and EuropeNÂ Engl J Med374201663664626886522 18SellT.K.BoddieC.McGintyE.E.Media messages and perception"/>
   <result pre="illnessCrit Care20201621727468829 17UyekiT.M.MehtaA.K.DaveyR.T.Jr.Clinical management of Ebola virus disease in the" exact="United States" post="and EuropeNÂ Engl J Med374201663664626886522 18SellT.K.BoddieC.McGintyE.E.Media messages and perception"/>
   <result pre="21OchiS.TsubokuraM.KatoS.Hospital staff shortage after the 2011 triple disaster in Fukushima," exact="Japan" post="- an earthquake, tsunamis, and nuclear power plant accident:"/>
   <result pre="Health Prep6201232832923241461 25MeltzerM.I.PatelA.AjaoA.Estimates of the demand for mechanical ventilation in" exact="the United States" post="during an influenza pandemicClin Infect Dis60Suppl 12015S52S5725878301 26RubinsonL.VaughnF.NelsonS.Mechanical ventilators"/>
   <result pre="Prep6201232832923241461 25MeltzerM.I.PatelA.AjaoA.Estimates of the demand for mechanical ventilation in the" exact="United States" post="during an influenza pandemicClin Infect Dis60Suppl 12015S52S5725878301 26RubinsonL.VaughnF.NelsonS.Mechanical ventilators"/>
   <result pre="under this title is not available for any work of" exact="the United States" post="Government.â€� Title 17Â U.SÂ C. Â§101 defines a US"/>
   <result pre="this title is not available for any work of the" exact="United States" post="Government.â€� Title 17Â U.SÂ C. Â§101 defines a US"/>
   <result pre="work prepared by a military service member or employee of" exact="the US" post="Government as part of that personâ€™s official duties. The"/>
   <result pre="the Departments of the Navy, the Department of Defense, nor" exact="the US" post="Government."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138017\results\search\country\results.xml">
   <result pre="affected city, Wuhan, and related regions in Hubei province of" exact="China" post="have reported 13â€ˆ522 confirmed patients (66Â·16% of total cases)"/>
   <result pre="in 23 other countries beyond China, including Japan, Thailand, Singapore," exact="South Korea," post="Australia, the USA, Malaysia, and Germany. Because of the"/>
   <result pre="countries beyond China, including Japan, Thailand, Singapore, South Korea, Australia," exact="the USA," post="Malaysia, and Germany. Because of the seriousness of this"/>
   <result pre="emergency of international concern on Jan 30, 2020, followed by" exact="the USA" post="announcing a public health emergency on Jan 31, 2020."/>
   <result pre="protective equipment, and charitable funds from inside and outside of" exact="China" post="are transported to the epidemic area to support the"/>
   <result pre="protect the healthy population against viral infection not only in" exact="China" post="but also in the rest of the world. China"/>
   <result pre="in China but also in the rest of the world." exact="China" post="also faces other challenges, including asymptomatic carriers with 2019-nCoV"/>
   <result pre="areas of Hubei province. First-line medical staff and scientists in" exact="China" post="have had a leading role in fighting the outbreak"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci2020published online Jan 21.10.1007/s11427-020-1637-5 6LetkoMCMunsterVFunctional assessment of cell"/>
   <result pre="2020http://www.xinhuanet.com/english/2020-02/03/c_138752003.htm 19collab: Ministry of Science and Technology of the People's" exact="Republic of" post="ChinaEmergency scientific programs on prevention and control of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138145\results\search\country\results.xml">
   <result pre="of a new heart disease. The National Health Commission of" exact="China" post="reported that often the first contact of patients with"/>
   <result pre="non-specific complications of infection. Studies during the flu epidemic in" exact="the USA" post="and clinical practice show that inflammation due to flu"/>
   <result pre="References References 1MunsterV.J.KoopmansM.van DoremalenN.van RielD.de WitE.A novel coronavirus emerging in" exact="China" post="â€&quot; key questions for impact assessmentN. Engl. J. Med.38282020"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138156\results\search\country\results.xml">
   <result pre="than using the wisdom of the crowd. Not surprising, with" exact="Italy" post="being one of the epicentres of the COVID-19 epidemic,"/>
   <result pre="a result, several exploratory trials are currently being undertaken in" exact="China" post="and elsewhere using immunosuppressants to try and dampen the"/>
   <result pre="Study GroupNatalizumab for active Crohn's diseaseN. Engl. J. Med.3482003243212510039 GuanW.-J.NiZ.-Y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.LiuL.ShanH.LeiC.-L.HuiD.S.C.DuB.LiL.-J.ZengG.YuenK.-Y.ChenR.-C.TangC.-L.WangT.ChenP.-Y.XiangJ.LiS.-Y.WangJ.-L.LiangZ.-J.PengY.-X.WeiL.LiuY.HuY.-H.PengP.WangJ.-M.LiuJ.-Y.ChenZ.LiG.ZhengZ.-J.QiuS.-Q.LuoJ.YeC.-J.ZhuS.-Y.ZhongN.-S.collab:" exact="China" post="Medical Treatment Expert Group for Covid-19Clinical characteristics of coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138334\results\search\country\results.xml">
   <result pre="in overdoses and death. At least 2 million persons in" exact="the United States" post="have OUD, and more than 10 million misuse opioids;"/>
   <result pre="overdoses and death. At least 2 million persons in the" exact="United States" post="have OUD, and more than 10 million misuse opioids;"/>
   <result pre="and cardiomyopathy (6), and its use has markedly increased in" exact="the United States;" post="clinicians should be alert to the possibility of increased"/>
   <result pre="cardiomyopathy (6), and its use has markedly increased in the" exact="United States;" post="clinicians should be alert to the possibility of increased"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138382\results\search\country\results.xml">
   <result pre="a human coronavirus causing the COVID-19 disease. It emerged in" exact="China" post="in December 2019 and rapidly propagated in numerous countries,"/>
   <result pre="and lopinavir/ritonavir is currently investigated in a clinical trial in" exact="Saudi Arabia" post="(Arabi et al., 2018). This is to our knowledge"/>
   <result pre="of COVID-19. The administration by vapor inhalation currently performed in" exact="China" post="offers the advantage of targeting specifically the respiratory tract;"/>
   <result pre="trials. Publications of data about IFN-based COVID-19 treatment performed in" exact="China" post="in early 2020, expected in a near future, should"/>
   <result pre="Principal Investigator: Florence Ader. Scientific coordinator: Yazdan Yazdanpanah. Chief methodologist:" exact="France" post="Mentre. Infectious diseases specialists: FranÃ§ois-Xavier Lescure, Nathan Peiffer-Smadja. Intensivists:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7144238\results\search\country\results.xml">
   <result pre="Unit, Guangzhou Women and Childrenâ€™s Medical Center, Guangzhou Medical UniversityPeopleâ€™s" exact="Republic of" post="China[b], Unit of Respiratory Infection and Immunity, CAS Key"/>
   <result pre="&amp;amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of SciencesPeopleâ€™s" exact="Republic of" post="China[c], Department of Respiratory Medicine, Peking Union Medical College"/>
   <result pre="Peking Union Medical College Hospital, Chinese Academy of Medical SciencesPeopleâ€™s" exact="Republic of" post="China CONTACT Xiao Su xsu@ips.ac.cnUnit of Respiratory Infection and"/>
   <result pre="Medical College Hospital, Chinese Academy of Medical SciencesPeopleâ€™s Republic of" exact="China" post="CONTACT Xiao Su xsu@ips.ac.cnUnit of Respiratory Infection and Immunity,"/>
   <result pre="Institut Pasteur of Shanghai, Chinese Academy of Sciences, 200031, Shanghai," exact="China" post="Yiyu Yang yangyy65@yahoo.comThe Joint Center for Infection and Immunity,"/>
   <result pre="Women and Children's Medical Center, Guangzhou Medical University, 510623, Guangzhou," exact="China" post="collection: 2020epub: 2020-3-391691706received: 2019-10-28rev-recd: 2020-3-06accepted: 2020-3-09(C) The Author(s), 2020This"/>
   <result pre="Foundation of China10.13039/50110000180981900010817300019194230581970075 the Strategic Leading Project (B) of CASXDPB0303" exact="China" post="Postdoctoral Science Foundation10.13039/5011000028582018M630935 Innovative Research Team of High-level Local"/>
   <result pre="is supported by grants from National Natural Science Foundation of" exact="China" post="(81900010; 81730001; 91942305; 81970075), the Strategic Leading Project (B)"/>
   <result pre="91942305; 81970075), the Strategic Leading Project (B) of CAS XDPB0303," exact="China" post="Postdoctoral Science Foundation (2018M630935), and Innovative Research Team of"/>
   <result pre="not consistent. Several influenza antiviral drugs have been approved by" exact="the US" post="Food and Drug Administration (FDA); oseltamivir, zanamivir, amantadine and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7144333\results\search\country\results.xml">
   <result pre="scrambling to respond to the expanding spread of disease in" exact="the United States" post="and elsewhere around the world. At a time when"/>
   <result pre="to respond to the expanding spread of disease in the" exact="United States" post="and elsewhere around the world. At a time when"/>
   <result pre="contribution to fighting the global spread of HIV. In 2003" exact="the United States" post="government implemented PEPFAR, the largest global health program devoted"/>
   <result pre="to fighting the global spread of HIV. In 2003 the" exact="United States" post="government implemented PEPFAR, the largest global health program devoted"/>
   <result pre="or curative treatment. Our national progress has been such that" exact="the United States" post="has now set a goal to reduce new HIV"/>
   <result pre="curative treatment. Our national progress has been such that the" exact="United States" post="has now set a goal to reduce new HIV"/>
   <result pre="be able to realistically visualize the end of AIDS in" exact="the United States" post="without the continued public investment in systems that are"/>
   <result pre="able to realistically visualize the end of AIDS in the" exact="United States" post="without the continued public investment in systems that are"/>
   <result pre="when they work in partnership with public health agencies. In" exact="the United States" post="and across the world, NGOs have been a critical"/>
   <result pre="they work in partnership with public health agencies. In the" exact="United States" post="and across the world, NGOs have been a critical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7144545\results\search\country\results.xml">
   <result pre="pandemic. Abstract From January 2020, coronavirus disease (COVID-19) originated in" exact="China" post="has spread around the world. The disease is caused"/>
   <result pre="with COVID-19 pneumonia and elevated IL-6 has been conducted in" exact="China" post="with promising results (ChiCTR2000029765). Based on these results, a"/>
   <result pre="clinical trial enrolling 330 patients globally has been announced in" exact="the US" post="(https://www.roche.com/media/releases/med-cor-2020-03-19.htm). In addition, other strategies have been attempted to"/>
   <result pre="with severe COVID-19 have been treated with CytoSorb in China," exact="Italy" post="and Germany (https://cytosorb-therapy.com/en/covid-19). However, data on the effectiveness of"/>
   <result pre="COVID-19 have been treated with CytoSorb in China, Italy and" exact="Germany" post="(https://cytosorb-therapy.com/en/covid-19). However, data on the effectiveness of this approach"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7146687\results\search\country\results.xml">
   <result pre="fatality rates reported in men compared with women in China," exact="South Korea," post="and Italy3 to date are attributed to sex-specific biological"/>
   <result pre="and people on low incomes in many countries including in" exact="the USA," post="may also be deemed non-essential and diverted to respond"/>
   <result pre="grave concern. The PLGHA expanded the Global Gag Rule (the" exact="Mexico" post="City policy), which blocks US global health assistance to"/>
   <result pre="miscarriages associated with the 1918 influenza pandemic: the Scandinavian and" exact="United States" post="experiencesJ Infect Dis20420111157116421917887 13collab: American Public Health AssociationPreventing and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7147535\results\search\country\results.xml">
   <result pre="in Wuhan, Hubei Province, China. On 9 January, 2020, the" exact="China" post="Center for Disease Control and Prevention reported a novel"/>
   <result pre="with COVID-19. Baricitinib, a Janus kinase 1/2 inhibitor submitted to" exact="the US" post="Food and Drug Administration and the European Medicines Agency"/>
   <result pre="et al. Features, evaluation and treatment coronavirus (COVID-19). StatPearls. Treasure" exact="Island" post="(FL): StatPearls Publishing. 2020. https://www.ncbi.nlm.nih.gov/books/NBK554776/. Accessed 1 Apr 2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7151436\results\search\country\results.xml">
   <result pre="experience in managing coronavirus outbreaks. As of March 25, 2020," exact="Singapore" post="has hospitalized 631 COVID-19 cases confirmed by real-time reverse"/>
   <result pre="was an imported patient who was ill before coming to" exact="Singapore" post="and admitted to the intensive care unit (ICU) upon"/>
   <result pre="and admitted to the intensive care unit (ICU) upon arrival.14" exact="Singapore" post="was taken by surprise during the 2003 SARS epidemic,"/>
   <result pre="Clinical virology The largest report to date on COVID-19 from" exact="China" post="revealed 1% asymptomatic of 72,134 cases. Of the 44,672"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7154513\results\search\country\results.xml">
   <result pre="Control and prevention of the disease is especially difficult in" exact="China" post="and elsewhere if there are infected individuals with no"/>
   <result pre="of preparedness future-proof. Comparisons to SARS Kwok YungYuen University of" exact="Hong Kong" post="Many SARS-related coronaviruses are widely prevalent in bats. It"/>
   <result pre="recent emergence of SARS-CoV-2 and its rapid, continuing spread across" exact="China" post="and movement around the world raise many scientific and"/>
   <result pre="of SARS-CoV-2 exists there, due to close economic relations with" exact="China" post="and intensive air traffic between regions. With scarce screening"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7155909\results\search\country\results.xml">
   <result pre="that much of the viral transmission that has occurred in" exact="the United States" post="has been undiagnosed, where two cases reported 6 weeks"/>
   <result pre="much of the viral transmission that has occurred in the" exact="United States" post="has been undiagnosed, where two cases reported 6 weeks"/>
   <result pre="ARDS from other causes. U.S., European Union, and recently released" exact="United Kingdom" post="ARDS guidelines strongly recommend the use of low tidal"/>
   <result pre="the U.S./European Union guidelines or less than 6â€‰ml/kg in the" exact="United Kingdom" post="guidelines, to maintain plateau pressures less than 30â€‰cm H20),"/>
   <result pre="30â€‰cm H20), with permissive hypercapnia.77,78 The U.S., European Union, and" exact="United Kingdom" post="guidelines also strongly recommend the use of prone positioning"/>
   <result pre="than 12â€‰h per day in patients with severe (moderate-severe in" exact="United Kingdom" post="guidelines) ARDS, and this recommendation is echoed in the"/>
   <result pre="Health Organization guidelines for the management of COVID-19 echo the" exact="United Kingdom" post="ARDS guidelines in recommending a conservative fluid management strategy"/>
   <result pre="evidence of tissue hypoperfusion.49,78 While both the U.S./European Union and" exact="United Kingdom" post="ARDS guidelines weakly recommend the use of higher PEEP"/>
   <result pre="of higher PEEP in moderate to severe ARDS and the" exact="United Kingdom" post="guidelines weakly recommend the use of neuromuscular blockade by"/>
   <result pre="guide effectiveness of the use of extracorporeal membrane oxygenation. The" exact="United Kingdom" post="ARDS guidelines weakly recommend consideration of extracorporeal membrane oxygenation"/>
   <result pre="in severe and moderate cases of COVID-19 are underway in" exact="China" post="(trial Nos. NCT04252664 and NCT04257656). Remdesivir is also the"/>
   <result pre="the views of the U.S. Department of Veterans Affairs or" exact="the United States" post="Government. Competing Interests Dr. Greenland reports the following financial"/>
   <result pre="views of the U.S. Department of Veterans Affairs or the" exact="United States" post="Government. Competing Interests Dr. Greenland reports the following financial"/>
   <result pre="Veterans Affairs or the United States Government. Competing Interests Dr." exact="Greenland" post="reports the following financial relationships, which are not related"/>
   <result pre="The other authors declare no competing interests. References References 1.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWcollab:" exact="China" post="Novel Coronavirus I, Research T: A novel coronavirus from"/>
   <result pre="in Wuhan, China: A descriptive study.Lancet2020; 395:507â€&quot;13. DOI: 10.1016/S0140-6736(20)30211-732007143 23.GuanWJNiZYHuYLiangWHOuCQHeJXLiuLShanHLeiCLHuiDSCDuBLiLJZengGYuenKYChenRCTangCLWangTChenPYXiangJLiSYWangJLLiangZJPengYXWeiLLiuYHuYHPengPWangJMLiuJYChenZLiGZhengZJQiuSQLuoJYeCJZhuSYZhongNScollab:" exact="China" post="Medical Treatment Expert Group for C: Clinical characteristics of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7156260\results\search\country\results.xml">
   <result pre="MedAAEMArchives of Academic Emergency Medicine2645-4904Shahid Beheshti University of Medical SciencesTehran," exact="Iran" post="e45 : Review Article Antiviral therapy in management of"/>
   <result pre="articles were conducted in China, one article was conducted in" exact="South Korea" post="and one study was performed in Singapore. Only one"/>
   <result pre="Combination Main findings Randomized clinical trial Cao et al; 2020;" exact="China" post="(10) 199 58 (50 to 68) 120 Severe COVID-19"/>
   <result pre="lopinavirâ€&quot;ritonavir treated and standard care groups. Case-series Chen N; 2020;" exact="China" post="(11) 99 21 to 82 67 COVID-19 patients Oseltamivir"/>
   <result pre="Yes Recovery rate: 31%; Mortality rate: 11% Chen Q; 2020;" exact="China" post="(12) 9 14 to 56 5 Symptomatic COVID-19 Lopinavir/"/>
   <result pre="hospital stay was 9 to 20 days. Guan W; 2020;" exact="China" post="(13) 1099 47.0 (IQR: 35.0â€&quot;58.0) 637 Non-severe and severe"/>
   <result pre="admission and need for ventilator or death Hu Z; 2020;" exact="China" post="(15) 24 5 to 95 8 Asymptomatic COVID-19 infection"/>
   <result pre="mortality, no ICU admission, no severe complication Huang C; 2020;" exact="China" post="(16) 41 49 (IQR 41Â·0â€&quot;58Â·0) 30 Symptomatic COVID-19 Oseltamivir"/>
   <result pre="6 patients died 28 patients were discharged Liu K; 2020;" exact="China" post="(19) 137 20 to 83 61 Severe COVID-19 Not"/>
   <result pre="Yes 16 patients died during the study. Liu L; 2020;" exact="China" post="(20) 51 16 to 68 32 Discharged COVID-19 patients"/>
   <result pre="stay was 9-13 days. 1 patient died. Qin X; 2020;" exact="China" post="(21) 89 23 to 86 45 All COVID-19 patients"/>
   <result pre="patients were discharged and 1 patient died. Shang J; 2020;" exact="China" post="(22) 416 49 (IQR: 36-61) 194 Survived and dead"/>
   <result pre="(5.6% in non-treated vs. 12.9 treated; p=0.288) Wang D; 2020;" exact="China" post="(23) 138 22 to 92 75 ICU and Non-ICU"/>
   <result pre="and 36 patients were admitted to ICU. Wu J; 2020;" exact="China" post="(25) 80 46.10 Â± 15.42 39 All severity ranges"/>
   <result pre="discharged and 59 patients remained in hospital. Xu X; 2020;" exact="China" post="(26) 62 41 (IQR: 32-52) 35 Symptomatic COVID-19 Lopinavir/ritonavirArbidolLopinavir/ritonavir"/>
   <result pre="was discharged. Other patients remained in hospital Yang W; 2020;" exact="China" post="(27) 149 45.11 Â± 13.35 81 All COVID-19 patients"/>
   <result pre="were discharged and 76 remained in hospital. Young BE; 2020;" exact="Singapore" post="(28) 18 31 to 73 9 Symptomatic COVID-19 Lopinavir/ritonavir"/>
   <result pre="patients experienced side effects of antiviral therapy Zhang G; 2020;" exact="China" post="(29) 221 20 to 96 108 Non-severe and severe"/>
   <result pre="improved after administration of ECMO and IMV Zhou Z; 2020;" exact="China" post="(31) 10 29 to 68 8 Confirmed COVID-19 patients"/>
   <result pre="and 4 patients were discharged Case reports Han X; 2020;" exact="China" post="(14) 1 23 1 Diabetic patient with COVID-19 Oseltamivir/"/>
   <result pre="was discharged from hospital after 15 days Li W; 2020;" exact="China" post="(17) 5 10 months to 6 years 4 Children"/>
   <result pre="change the outcome or length of stay Lim J; 2020;" exact="South Korea" post="(18) 1 54 1 Symptomatic COVID-19 patient Lopinavir/ritonavir 1"/>
   <result pre="process or a result of anti-viral therapy Wang Z; 2020;" exact="China" post="(24) 4 19 to 63 3 COVID-19 patients Lopinavir/ritonavir"/>
   <result pre="recovered and 2 patients remained in hospital Zhang Z; 2020;" exact="China" post="(30) 2 38 1 Symptomatic COVID-19 patients oseltamivir and"/>
   <result pre="one clinical trial protocol commissioned by a research team in" exact="Saudi Arabia" post="existed. This study, named as the MIRACLE trial, was"/>
   <result pre="5ChenXChughtaiAADydaAMacIntyreCRComparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in" exact="Saudi Arabia" post="and South Korea Emerging microbes &amp;amp; infections20176116 6Alavi-MoghaddamMA Novel"/>
   <result pre="Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and" exact="South Korea" post="Emerging microbes &amp;amp; infections20176116 6Alavi-MoghaddamMA Novel Coronavirus (COVID-19) Outbreak"/>
   <result pre="virology2020[In press] 13GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical Characteristics of Coronavirus Disease 2019 in" exact="China" post="The New England journal of medicine2020 14HanXFanYWanYLShiHA Diabetic Patient"/>
   <result pre="infections with COVID-19 screened among close contacts in Nanjing, ChinaScience" exact="China" post="Life Sciences20201631564034 16HuangCWangYLiXRenLZhaoJHuYet al.Clinical features of patients infected with"/>
   <result pre="features of patients infected with 2019 novel coronavirus in Wuhan," exact="China" post="The Lancet202039510223497506 17LiWCuiHLiKFangYLiSChest computed tomography in children with COVID-19"/>
   <result pre="of 51 patients discharged from hospital with COVID-19 in Chongqing," exact="China" post="medRxiv2020[In press] 21QinXQiuSYuanYZongYTuoZLiJet al.Clinical Characteristics and Treatment of Patients"/>
   <result pre="Characteristics and Treatment of Patients Infected with COVID-19 in Shishou," exact="China" post="Lancet Respiratory Medicine2020Pre-Print. Available at SSRN: https://ssrn.com/abstract=3541147 22ShangJDuRLuQWuJXuSKeZet al.The"/>
   <result pre="138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan," exact="China" post="Jama20203231110619 24WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases"/>
   <result pre="novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang," exact="China" post="The Journal of infection2020[In press] 28YoungBEOngSWXKalimuddinSLowJGTanSYLohJet al.Epidemiologic Features and"/>
   <result pre="Features and Clinical Course of Patients Infected With SARS-CoV-2 in" exact="Singapore" post="Jama2020[In press] 29ZhangGHuCLuoLFangFChenYLiJet al.Clinical features and outcomes of 221"/>
   <result pre="features and outcomes of 221 patients with COVID-19 in Wuhan," exact="China" post="medRxiv2020:Pre-Print. Available at MedRxiv: https://www.medrxiv.org/content/10.1101/2020.03.02.20030452v1 30ZhangZLiXZhangWShiZLZhengZWangTClinical Features and Treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7158580\results\search\country\results.xml">
   <result pre="targets. For example, find a traditional biologics license application via" exact="the US" post="Food and Drug Administration. Given a satisfactory risk-benefit profile,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7160820\results\search\country\results.xml">
   <result pre="to distribute kits. Yale-funded researchers are partnering with collaborators in" exact="Puerto Rico" post="to learn how best to ramp up home HIV-testing,"/>
   <result pre="funded through the End the HIV Epidemic: A Plan for" exact="America" post="Initiative [19] includes inspiring work to reach African-Americas in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7162280\results\search\country\results.xml">
   <result pre="a reminder to the last cholera outbreak in 1982 in" exact="Germany" post="(photo taken by A. Tarnok). At that time, Hamburg"/>
   <result pre="albeit â€œonlyâ€� persisting in the resourceâ€�poor settings of Africa and" exact="Haiti" post="4, regions with limited access to clean water. I"/>
   <result pre="and fake). Most evident for everyone is panic buying, in" exact="China" post="but also in Europe. Yesterday (March 2), I went"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7162395\results\search\country\results.xml">
   <result pre="Sciences for Children and Adults, via Campi 287, 41125 Modena," exact="Italy" post="Email: andrea.cossarizza@unimore.it â€ Sara De Biasi is a Marylou"/>
   <result pre="origin were described in the city of Wuhan, Hubei province," exact="China" post="1. One month later, different laboratories, first in China"/>
   <result pre="province, China 1. One month later, different laboratories, first in" exact="China" post="and then in different countries, were able to demonstrate"/>
   <result pre="epidemics have spread all over Asia and presented itself in" exact="the United States" post="(Snohomish County, Washington) on January 19 5 and in"/>
   <result pre="have spread all over Asia and presented itself in the" exact="United States" post="(Snohomish County, Washington) on January 19 5 and in"/>
   <result pre="States (Snohomish County, Washington) on January 19 5 and in" exact="Germany" post="on January 24 6, arriving from China through different"/>
   <result pre="5 and in Germany on January 24 6, arriving from" exact="China" post="through different routes. Italy, where a higher number of"/>
   <result pre="20. Thus, in reality, the high rate of infection in" exact="Italy" post="soon after the identification of the first case only"/>
   <result pre="Unfortunately, in several countries, such as Germany, France, UK, and" exact="United States," post="very few tests have been conducted at the beginning"/>
   <result pre="that, in 2012, was first described in a man in" exact="Saudi Arabia" post="10. MERS has been found in 27 countries and"/>
   <result pre="continuous support. References References 1collab: WHO , Novel coronavirus â€�" exact="China" post="Jan 12, 2020https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ 2LuR, ZhaoX, LiJ, NiuP, YangB, WuH,"/>
   <result pre="features of patients infected with 2019 novel coronavirus in Wuhan." exact="China" post="Lancet2020;395(10223):497â€&quot;506.31986264 4LiQ, GuanX, WuP, WangX, ZhouL, TongY, RenR, LeungKSM,"/>
   <result pre="TuralA, et al. First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med2020;382:929â€&quot;936. 10.1056/NEJMoa2001191.32004427 6RotheC, SchunkM, SothmannP, BretzelG,"/>
   <result pre="et al. First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med2020;382:929â€&quot;936. 10.1056/NEJMoa2001191.32004427 6RotheC, SchunkM, SothmannP, BretzelG,"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N Engl J Med2012;367(19):1814â€&quot;1820.23075143 11https://www.who.int/emergencies/mers-cov/en/ 12DongE, DuH, GardnerL. An"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7162773\results\search\country\results.xml">
   <result pre="âˆ—âˆ—Dr Jinlyu Sun, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing," exact="China" post="100730; Tel.: +86-18611382050. sunjinlv@pumch.cn #Dr Taijiao Jiang, No. 9,"/>
   <result pre="Tel.: +86-13366191184. taijiao@ibms.pumc.edu.cn ##Dr Guogang Xu, 28 Fuxing Road, Beijing," exact="China" post="100853; Tel.: +86-010-66876407. guogang_xu@qq.com â€¡These authors contributed equally to"/>
   <result pre="have led to a near disappearance of new cases in" exact="China" post="included rapid sequencing of the virus to establish testing"/>
   <result pre="China. To stop transmission of the virus and save lives," exact="China" post="adopted strategies and tactics that included a nationwide directive"/>
   <result pre="including 212 of 233 (91.0%) countries and international conveyances. The" exact="United States" post="(560,402 cases), Spain (166,831 cases), Italy (156,363 cases), Germany"/>
   <result pre="(91.0%) countries and international conveyances. The United States (560,402 cases)," exact="Spain" post="(166,831 cases), Italy (156,363 cases), Germany (127,854 cases), and"/>
   <result pre="international conveyances. The United States (560,402 cases), Spain (166,831 cases)," exact="Italy" post="(156,363 cases), Germany (127,854 cases), and Iran (71,686 cases)"/>
   <result pre="United States (560,402 cases), Spain (166,831 cases), Italy (156,363 cases)," exact="Germany" post="(127,854 cases), and Iran (71,686 cases) are among the"/>
   <result pre="Spain (166,831 cases), Italy (156,363 cases), Germany (127,854 cases), and" exact="Iran" post="(71,686 cases) are among the hardest hit, but cases"/>
   <result pre="epidemic curves and major intervention measures that were implemented in" exact="China" post="are shown in FigureÂ 1 . Here is a"/>
   <result pre="COVID-19 epidemiology curves and major intervention measures implemented in China." exact="China" post="CDC, Chinese Center for Disease Control and Prevention; NHC,"/>
   <result pre="Commission; WHO, World Health Organization. Data from the NHC, excluding" exact="Hong Kong" post="and Macau Special Administrative Regions and Taiwan. On December"/>
   <result pre="Health Organization. Data from the NHC, excluding Hong Kong and" exact="Macau" post="Special Administrative Regions and Taiwan. On December 31, 2019,"/>
   <result pre="of the National Institute of Viral Disease Control and Prevention.13" exact="China" post="informed the WHO. On January 10, 2020, the whole"/>
   <result pre="Several rapid and sensitive detection tests were developed by the" exact="China" post="CDC. On January 16, 2020, the National Health Commission"/>
   <result pre="Chinese guidance were more widely used in clinical practice in" exact="China" post="owing to its simplicity. According to the Chinese guidelines,20,89"/>
   <result pre="or lung transplant patients. ECMO has rarely been used in" exact="China" post="owing to limited resources.1,23 Moreover, there are no published"/>
   <result pre="specific information. â€¡The number of clinical trials of COVID-19 in" exact="China" post="as of April 3, 2020. Data from http://www.chictr.org.cn/. Xu"/>
   <result pre="However, the results of a clinical trial of lopinavir/ritonavir in" exact="China" post="showed no clear benefit beyond standard care in hospitalized"/>
   <result pre="approved for treatment of influenza on February 15, 2020, in" exact="China" post="and is being studied in COVID-19 clinical trials. The"/>
   <result pre="efficiently,40,44 and several clinical trials have been quickly conducted in" exact="China" post="to evaluate the efficacy and safety of chloroquine and"/>
   <result pre="modulators The results of laboratory findings of COVID-19 patients in" exact="China" post="showed an increase in plasma inflammatory cytokine levels, especially"/>
   <result pre="Queensland University in Australia, the National Institutes of Health in" exact="the United States," post="and the pharmaceutical companies Inovio and Moderna. On January"/>
   <result pre="University in Australia, the National Institutes of Health in the" exact="United States," post="and the pharmaceutical companies Inovio and Moderna. On January"/>
   <result pre="strain of SARS-CoV-2 was successfully isolated from patientsâ€™ samples in" exact="China" post="to provide the basis for vaccine development.69 On February"/>
   <result pre="Notice of COVID-19 â€¢Enforcement laws including â€œLaw of the Peopleâ€™s" exact="Republic of" post="China on the prevention and treatment of infectious diseases,â€�"/>
   <result pre="COVID-19 â€¢Enforcement laws including â€œLaw of the Peopleâ€™s Republic of" exact="China" post="on the prevention and treatment of infectious diseases,â€� â€œSurveillance"/>
   <result pre="and regions. We compare the epidemiologic characteristics among China, Italy," exact="South Korea," post="and the United States in FigureÂ 3 . The"/>
   <result pre="compare the epidemiologic characteristics among China, Italy, South Korea, and" exact="the United States" post="in FigureÂ 3 . The data from China show"/>
   <result pre="the epidemiologic characteristics among China, Italy, South Korea, and the" exact="United States" post="in FigureÂ 3 . The data from China show"/>
   <result pre="the United States in FigureÂ 3 . The data from" exact="China" post="show that the daily number of infected patients has"/>
   <result pre="are a steady daily number of imported cases. Similarly, in" exact="South Korea," post="the strategy that worked also included early testing, tracking,"/>
   <result pre="included early testing, tracking, and isolation. Unfortunately, lessons learned in" exact="China" post="have not been universally adopted, and the numbers of"/>
   <result pre="of SARS-CoV-2. Right, daily numbers of increasing cases. Data for" exact="China" post="were obtained from the National Health Commission of China,"/>
   <result pre="obtained from the National Health Commission of China, which excluded" exact="Hong Kong" post="and Macau Special Administrative Regions and Taiwan. Data for"/>
   <result pre="National Health Commission of China, which excluded Hong Kong and" exact="Macau" post="Special Administrative Regions and Taiwan. Data for the remaining"/>
   <result pre="obtained from the World Health Organisation. The lessons learned in" exact="China" post="and South Korea are that in these times of"/>
   <result pre="the World Health Organisation. The lessons learned in China and" exact="South Korea" post="are that in these times of crises, the earlier"/>
   <result pre="the earlier the intervention from a societal perspective the better." exact="China" post="had implemented an electronic monitoring system for infectious disease"/>
   <result pre="significant to evaluate the number and distribution of cases in" exact="China" post="as a basis for aggressive testing, tracking, and quarantining."/>
   <result pre="with continued closure of nonessential businesses. Conclusion The experience in" exact="China" post="is unique in that it was the first country"/>
   <result pre="to implement drastic measures to combat COVID-19. The strategy in" exact="China" post="was early testing, diligent tracking, and strict isolation of"/>
   <result pre="Even with this, there were more than 80,000 cases in" exact="China" post="and more than 3000 deaths. All countries, even China,"/>
   <result pre="China, can learn from this. Although the drastic measures that" exact="China" post="implemented appear for now to have stopped the viral"/>
   <result pre="part by the 10.13039/501100005089Beijing Municipal Natural Science Foundation General Program," exact="China" post="(7192197), CAMS Innovation Fund for Medical Sciences, China (2016-I2M-1-003),"/>
   <result pre="General Program, China (7192197), CAMS Innovation Fund for Medical Sciences," exact="China" post="(2016-I2M-1-003), the 10.13039/501100001809National Natural Science Foundation of China (31671371"/>
   <result pre="Medical Sciences, China (2016-I2M-1-003), the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(31671371 and 81700490), the Central Public-Interest Scientific Institution Basal"/>
   <result pre="and 81700490), the Central Public-Interest Scientific Institution Basal Research Fund," exact="China" post="(2016ZX310195, 2017PT31026, and 2018PT31016), and the Epidemic Research Project"/>
   <result pre="Research Project of Guangzhou Regenerative Medicine and Health Guangdong Laboratory," exact="China" post="(2020GZR110406001). Disclosures The authors have no conflicts of interest"/>
   <result pre="arm meta-analysis. [e-pub before print]. J Med Virol 10.1002/jmv.25735. 3collab:" exact="China" post="Centers for Disease ControlChina-WHO new coronavirus pneumonia (COVID-19) joint"/>
   <result pre="the 2019-nCoV epidemic?Lancet395202039139332035533 10collab: National Health Commission of the People's" exact="Republic of" post="China[New coronavirus pneumonia prevention and control program (seventh trial"/>
   <result pre="novel coronavirus genome identified in a cluster of pneumonia casesâ€&quot;Wuhan," exact="China" post="2019-2020China CDC Wkly220206162 14collab: The Joint Prevention and Control"/>
   <result pre="incubation period of COVID-19 infectionEClinicalMedicine202010033132292899 20National Health Commission of the" exact="People's Republic of China." post="Diagnosis and treatment protocol for novel coronavirus pneumonia (trial"/>
   <result pre="period of COVID-19 infectionEClinicalMedicine202010033132292899 20National Health Commission of the People's" exact="Republic of" post="China. Diagnosis and treatment protocol for novel coronavirus pneumonia"/>
   <result pre="Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan," exact="China" post="[e-pub before print]. Allergy, doi:10.1111/all.14238. 26ZhouF.YuT.DuR.Clinical course and risk"/>
   <result pre="drugs to treat coronavirus disease 2019 (COVID-19)Drug Discov Ther142020586032147628 43collab:" exact="China" post="National Health CommissionPress conference of the Joint Prevention and"/>
   <result pre="in patients with severe COVID-19 pneumonia: single-center experience from Wuhan," exact="China" post="[preprint]medRxiv202003.06.20032342 54ZhouW.LiuY.TianD.al. Potential benefits of precise corticosteroids therapy for"/>
   <result pre="32 recovered patients donate plasma to others with coronavirus infection." exact="China" post="Daily 2020 Feb 16. Available at: https://www.chinadaily.com.cn/a/202002/16/WS5e48cbf6a310128217277d72.html. Accessed February"/>
   <result pre="associated with clinical outcomes in 323 COVID-19 patients in Wuhan," exact="China" post="[e-pub before print]Clin Infect Dis202010.1093/cid/ciaa539 69Wu Z, McGoogan JM."/>
   <result pre="before print]. JAMA, doi:10.1001/jama.2020.2648. 70First vaccine clinical trials begin in" exact="the United States." post="March 17, 2020Available at:https://www.nature.com/articles/d41586-020-00154-wAccessed March 17, 2020 71China has"/>
   <result pre="print]. JAMA, doi:10.1001/jama.2020.2648. 70First vaccine clinical trials begin in the" exact="United States." post="March 17, 2020Available at:https://www.nature.com/articles/d41586-020-00154-wAccessed March 17, 2020 71China has"/>
   <result pre="treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adult in" exact="China" post="(2018 edition)Chin J Tuberc Respir Dis42018255280 79collab: Chinese Society"/>
   <result pre="during the first 50 days of the COVID-19 epidemic in" exact="China" post="[preprint]medRxiv202001.30.20019844 87collab: China National Health CommissionCovid-19 prevention and control"/>
   <result pre="50 days of the COVID-19 epidemic in China [preprint]medRxiv202001.30.20019844 87collab:" exact="China" post="National Health CommissionCovid-19 prevention and control schemeAvailable at:http://www.nhc.gov.cn/xcs/zhengcwj/202003/4856d5b0458141fa9f376853224d41d7.shtmlAccessed March"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7164851\results\search\country\results.xml">
   <result pre="evidence-based drug policy. The emerging opioid overdose crisis in North" exact="America" post="is addressed in two articles. Irvine and colleagues provide"/>
   <result pre="models for considering the epidemic of opioid use disorder in" exact="the US," post="and interventions to tackle the epidemic (Group,Â 2020). Together,"/>
   <result pre="important role at reaching the WHO incidence target in Montreal," exact="Canada" post="(GodinÂ etÂ al., 2020). Indeed, due to frequent incarceration"/>
   <result pre="required to achieve HCV elimination in LMIC settings. In 2019," exact="Mexico" post="became the first country in Latin America to commit"/>
   <result pre="settings. In 2019, Mexico became the first country in Latin" exact="America" post="to commit to HCV elimination, with the study by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7166105\results\search\country\results.xml">
   <result pre="arthroplasty, suffer from chronic pain and dysfunction. At this time," exact="the United States" post="Surgeon General has recommended suspending elective procedures (including hip"/>
   <result pre="suffer from chronic pain and dysfunction. At this time, the" exact="United States" post="Surgeon General has recommended suspending elective procedures (including hip"/>
   <result pre="the nation have followed suit. In addition, the President of" exact="the United States" post="has declared a national state of emergency for the"/>
   <result pre="nation have followed suit. In addition, the President of the" exact="United States" post="has declared a national state of emergency for the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7167217\results\search\country\results.xml">
   <result pre="China, was first reported to the WHO Country Office in" exact="China" post="on 31 December 2019.Â This study aims to report"/>
   <result pre="since being connected with severe acute respiratory syndrome (SARS) in" exact="China" post="in 2002 and 2003 with mortality rates of 10%"/>
   <result pre="syndrome coronavirus (MERS-CoV), emerged in Middle Eastern countries such as" exact="Saudi Arabia" post="with a 37% mortality rate (Yin and Wunderink 2018;"/>
   <result pre="of of unknown etiologic origin emerged in Wuhan, Hubei province," exact="China" post="(Zhu et al. 2020). This problem has been the"/>
   <result pre="al. 2020). The increase in the number of cases in" exact="China" post="and internationally has indicated a second transmission from human"/>
   <result pre="2010) Regions Places reporting cases Confirmed cases Deaths Comments Asia" exact="China" post="79,968 2873 Including 66,907 cases from Hubei Povince Asia"/>
   <result pre="China 79,968 2873 Including 66,907 cases from Hubei Povince Asia" exact="Republic of" post="Korea 3600 18 Asia Iran 593 43 Asia Japan"/>
   <result pre="from Hubei Povince Asia Republic of Korea 3600 18 Asia" exact="Iran" post="593 43 Asia Japan 239 5 Asia Singapore 102"/>
   <result pre="Republic of Korea 3600 18 Asia Iran 593 43 Asia" exact="Japan" post="239 5 Asia Singapore 102 0 Asia Kuwait 45"/>
   <result pre="18 Asia Iran 593 43 Asia Japan 239 5 Asia" exact="Singapore" post="102 0 Asia Kuwait 45 0 Asia Thailand 42"/>
   <result pre="43 Asia Japan 239 5 Asia Singapore 102 0 Asia" exact="Kuwait" post="45 0 Asia Thailand 42 0 Asia Bahrain 41"/>
   <result pre="5 Asia Singapore 102 0 Asia Kuwait 45 0 Asia" exact="Thailand" post="42 0 Asia Bahrain 41 0 Asia Taiwan 40"/>
   <result pre="0 Asia Kuwait 45 0 Asia Thailand 42 0 Asia" exact="Bahrain" post="41 0 Asia Taiwan 40 0 Asia Malaysia 25"/>
   <result pre="0 Asia Thailand 42 0 Asia Bahrain 41 0 Asia" exact="Taiwan" post="40 0 Asia Malaysia 25 0 Asia United Arab"/>
   <result pre="0 Asia Bahrain 41 0 Asia Taiwan 40 0 Asia" exact="Malaysia" post="25 0 Asia United Arab Emirates 21 0 Asia"/>
   <result pre="0 Asia Taiwan 40 0 Asia Malaysia 25 0 Asia" exact="United Arab Emirates" post="21 0 Asia Vietnam 16 0 Asia Iraq 13"/>
   <result pre="Taiwan 40 0 Asia Malaysia 25 0 Asia United Arab" exact="Emirates" post="21 0 Asia Vietnam 16 0 Asia Iraq 13"/>
   <result pre="Malaysia 25 0 Asia United Arab Emirates 21 0 Asia" exact="Vietnam" post="16 0 Asia Iraq 13 0 Asia Israel 7"/>
   <result pre="United Arab Emirates 21 0 Asia Vietnam 16 0 Asia" exact="Iraq" post="13 0 Asia Israel 7 0 Asia Oman 6"/>
   <result pre="0 Asia Vietnam 16 0 Asia Iraq 13 0 Asia" exact="Israel" post="7 0 Asia Oman 6 0 Asia Lebanon 4"/>
   <result pre="0 Asia Iraq 13 0 Asia Israel 7 0 Asia" exact="Oman" post="6 0 Asia Lebanon 4 0 Asia Pakistan 4"/>
   <result pre="0 Asia Israel 7 0 Asia Oman 6 0 Asia" exact="Lebanon" post="4 0 Asia Pakistan 4 0 Asia India 3"/>
   <result pre="0 Asia Oman 6 0 Asia Lebanon 4 0 Asia" exact="Pakistan" post="4 0 Asia India 3 0 Asia Philippines 3"/>
   <result pre="0 Asia Lebanon 4 0 Asia Pakistan 4 0 Asia" exact="India" post="3 0 Asia Philippines 3 1 Asia Sri Lanka"/>
   <result pre="0 Asia Pakistan 4 0 Asia India 3 0 Asia" exact="Philippines" post="3 1 Asia Sri Lanka 1 0 Asia Afghanistan"/>
   <result pre="0 Asia India 3 0 Asia Philippines 3 1 Asia" exact="Sri Lanka" post="1 0 Asia Afghanistan 1 0 Asia Qatar 1"/>
   <result pre="Asia India 3 0 Asia Philippines 3 1 Asia Sri" exact="Lanka" post="1 0 Asia Afghanistan 1 0 Asia Qatar 1"/>
   <result pre="Asia Philippines 3 1 Asia Sri Lanka 1 0 Asia" exact="Afghanistan" post="1 0 Asia Qatar 1 0 Asia Nepal 1"/>
   <result pre="Asia Sri Lanka 1 0 Asia Afghanistan 1 0 Asia" exact="Qatar" post="1 0 Asia Nepal 1 0 Asia Cambodia 1"/>
   <result pre="0 Asia Afghanistan 1 0 Asia Qatar 1 0 Asia" exact="Nepal" post="1 0 Asia Cambodia 1 0 Europe Italy 1128"/>
   <result pre="0 Asia Qatar 1 0 Asia Nepal 1 0 Asia" exact="Cambodia" post="1 0 Europe Italy 1128 29 Europe Germany 111"/>
   <result pre="0 Asia Nepal 1 0 Asia Cambodia 1 0 Europe" exact="Italy" post="1128 29 Europe Germany 111 0 Europe France 100"/>
   <result pre="0 Asia Cambodia 1 0 Europe Italy 1128 29 Europe" exact="Germany" post="111 0 Europe France 100 2 Europe Spain 66"/>
   <result pre="0 Europe Italy 1128 29 Europe Germany 111 0 Europe" exact="France" post="100 2 Europe Spain 66 0 Europe UK 23"/>
   <result pre="29 Europe Germany 111 0 Europe France 100 2 Europe" exact="Spain" post="66 0 Europe UK 23 0 Europe Switzerland 18"/>
   <result pre="2 Europe Spain 66 0 Europe UK 23 0 Europe" exact="Switzerland" post="18 0 Europe Norway 15 0 Europe Sweden 13"/>
   <result pre="0 Europe UK 23 0 Europe Switzerland 18 0 Europe" exact="Norway" post="15 0 Europe Sweden 13 0 Europe Austria 10"/>
   <result pre="0 Europe Switzerland 18 0 Europe Norway 15 0 Europe" exact="Sweden" post="13 0 Europe Austria 10 0 Europe Greece 7"/>
   <result pre="0 Europe Norway 15 0 Europe Sweden 13 0 Europe" exact="Austria" post="10 0 Europe Greece 7 0 Europe The Netherlands"/>
   <result pre="0 Europe Sweden 13 0 Europe Austria 10 0 Europe" exact="Greece" post="7 0 Europe The Netherlands 7 0 Europe Croatia"/>
   <result pre="Europe Austria 10 0 Europe Greece 7 0 Europe The" exact="Netherlands" post="7 0 Europe Croatia 5 0 Europe Finland 3"/>
   <result pre="Europe Greece 7 0 Europe The Netherlands 7 0 Europe" exact="Croatia" post="5 0 Europe Finland 3 0 Europe Georgia 3"/>
   <result pre="Europe The Netherlands 7 0 Europe Croatia 5 0 Europe" exact="Finland" post="3 0 Europe Georgia 3 0 Europe Denmark 3"/>
   <result pre="0 Europe Croatia 5 0 Europe Finland 3 0 Europe" exact="Georgia" post="3 0 Europe Denmark 3 0 Europe Romania 3"/>
   <result pre="0 Europe Finland 3 0 Europe Georgia 3 0 Europe" exact="Denmark" post="3 0 Europe Romania 3 0 Europe Russia 2"/>
   <result pre="0 Europe Georgia 3 0 Europe Denmark 3 0 Europe" exact="Romania" post="3 0 Europe Russia 2 0 Europe Monaco 1"/>
   <result pre="0 Europe Denmark 3 0 Europe Romania 3 0 Europe" exact="Russia" post="2 0 Europe Monaco 1 0 Europe Azerbaijan 1"/>
   <result pre="0 Europe Romania 3 0 Europe Russia 2 0 Europe" exact="Monaco" post="1 0 Europe Azerbaijan 1 0 Europe North Macedonia"/>
   <result pre="0 Europe Russia 2 0 Europe Monaco 1 0 Europe" exact="Azerbaijan" post="1 0 Europe North Macedonia 1 0 Europe Ireland"/>
   <result pre="0 Europe Monaco 1 0 Europe Azerbaijan 1 0 Europe" exact="North Macedonia" post="1 0 Europe Ireland 1 0 Europe Estonia 1"/>
   <result pre="Europe Monaco 1 0 Europe Azerbaijan 1 0 Europe North" exact="Macedonia" post="1 0 Europe Ireland 1 0 Europe Estonia 1"/>
   <result pre="Europe Azerbaijan 1 0 Europe North Macedonia 1 0 Europe" exact="Ireland" post="1 0 Europe Estonia 1 0 Europe Iceland 1"/>
   <result pre="Europe North Macedonia 1 0 Europe Ireland 1 0 Europe" exact="Estonia" post="1 0 Europe Iceland 1 0 Europe Lithuania 1"/>
   <result pre="0 Europe Ireland 1 0 Europe Estonia 1 0 Europe" exact="Iceland" post="1 0 Europe Lithuania 1 0 Europe Armenia 1"/>
   <result pre="0 Europe Estonia 1 0 Europe Iceland 1 0 Europe" exact="Lithuania" post="1 0 Europe Armenia 1 0 Europe Belarus 1"/>
   <result pre="0 Europe Iceland 1 0 Europe Lithuania 1 0 Europe" exact="Armenia" post="1 0 Europe Belarus 1 0 Europe Luxembourg 1"/>
   <result pre="0 Europe Lithuania 1 0 Europe Armenia 1 0 Europe" exact="Belarus" post="1 0 Europe Luxembourg 1 0 Europe Belgium 1"/>
   <result pre="0 Europe Armenia 1 0 Europe Belarus 1 0 Europe" exact="Luxembourg" post="1 0 Europe Belgium 1 0 Europe San Marino"/>
   <result pre="0 Europe Belarus 1 0 Europe Luxembourg 1 0 Europe" exact="Belgium" post="1 0 Europe San Marino 1 0 Other Cases"/>
   <result pre="0 Europe Luxembourg 1 0 Europe Belgium 1 0 Europe" exact="San Marino" post="1 0 Other Cases on an international conveyance, Japan"/>
   <result pre="San Marino 1 0 Other Cases on an international conveyance," exact="Japan" post="705 6 America USA 69 1 America Canada 20"/>
   <result pre="0 Other Cases on an international conveyance, Japan 705 6" exact="America" post="USA 69 1 America Canada 20 0 America Mexico"/>
   <result pre="an international conveyance, Japan 705 6 America USA 69 1" exact="America" post="Canada 20 0 America Mexico 4 0 America Brazil"/>
   <result pre="international conveyance, Japan 705 6 America USA 69 1 America" exact="Canada" post="20 0 America Mexico 4 0 America Brazil 2"/>
   <result pre="705 6 America USA 69 1 America Canada 20 0" exact="America" post="Mexico 4 0 America Brazil 2 0 America Ecuador"/>
   <result pre="6 America USA 69 1 America Canada 20 0 America" exact="Mexico" post="4 0 America Brazil 2 0 America Ecuador 1"/>
   <result pre="69 1 America Canada 20 0 America Mexico 4 0" exact="America" post="Brazil 2 0 America Ecuador 1 0 Oceania Australia"/>
   <result pre="1 America Canada 20 0 America Mexico 4 0 America" exact="Brazil" post="2 0 America Ecuador 1 0 Oceania Australia 26"/>
   <result pre="20 0 America Mexico 4 0 America Brazil 2 0" exact="America" post="Ecuador 1 0 Oceania Australia 26 1 Oceania New"/>
   <result pre="0 America Mexico 4 0 America Brazil 2 0 America" exact="Ecuador" post="1 0 Oceania Australia 26 1 Oceania New Zealand"/>
   <result pre="0 America Brazil 2 0 America Ecuador 1 0 Oceania" exact="Australia" post="26 1 Oceania New Zealand 1 0 Africa Egypt"/>
   <result pre="0 America Ecuador 1 0 Oceania Australia 26 1 Oceania" exact="New Zealand" post="1 0 Africa Egypt 1 0 Africa Nigeria 1"/>
   <result pre="Oceania Australia 26 1 Oceania New Zealand 1 0 Africa" exact="Egypt" post="1 0 Africa Nigeria 1 0 Africa Algeria 1"/>
   <result pre="Oceania New Zealand 1 0 Africa Egypt 1 0 Africa" exact="Nigeria" post="1 0 Africa Algeria 1 0 Total 87,137 2979"/>
   <result pre="0 Africa Egypt 1 0 Africa Nigeria 1 0 Africa" exact="Algeria" post="1 0 Total 87,137 2979 COVID-19 from SARS to"/>
   <result pre="2979 COVID-19 from SARS to MERS SARS-CoV, which originated in" exact="China" post="and then spread to other parts of the world"/>
   <result pre="template for full-length (+) RNA genomes (Cui et al. 2019;" exact="Jordan" post="et al. 2018). During transcription, a subset of 7â€&quot;9"/>
   <result pre="proteins, are produced by discontinuous transcription (Cui et al. 2019;" exact="Jordan" post="et al. 2018). Viral nucleocapsids are combined from genomic"/>
   <result pre="SARS epidemic and COVID-19 occurred during the Spring Festival in" exact="China" post="(SFC), the country's most famous traditional festival, during which"/>
   <result pre="and case reports have also started from other provinces in" exact="China" post="(Luk et al. 2019). The first non-Chinese case of"/>
   <result pre="provinces, and then to the Asian continent, was reported from" exact="Thailand" post="on January 13, 2020 (World Health Organization, 2019-nCoV Situation"/>
   <result pre="patient reported being a Chinese tourist who had traveled to" exact="Thailand" post="and had no epidemiologic connection with the marketplace (Li"/>
   <result pre="et al. 2020a). Other evidence from overseas countries such as" exact="the USA" post="(Holshue et al. 2020) and France has continued to"/>
   <result pre="countries such as the USA (Holshue et al. 2020) and" exact="France" post="has continued to be reported (Stoecklin et al. 2020)."/>
   <result pre="This virus disseminated to the Midle Eastern region; for example," exact="Iran" post="was a region with potential to develop a major"/>
   <result pre="the isolation of SARS-CoV from a patient with pneumonia in" exact="China" post="(Ksiazek et al. 2003). As in other respiratory infection"/>
   <result pre="al. 2018). According to a human MERS-CoV case report from" exact="South Korea," post="use of the combination of lopinavir/ritonavir (LPV/RTV) (anti-HIV drugs),"/>
   <result pre="drug, remdesivir, was used in the first case reported in" exact="the USA," post="and it seemed successful; however, more cases are needed"/>
   <result pre="et al (2020) First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med 382(10):929â€&quot;936 HuangCWangYLiXRenLZhaoJHuYet al.Clinical features of"/>
   <result pre="al (2020) First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med 382(10):929â€&quot;936 HuangCWangYLiXRenLZhaoJHuYet al.Clinical features of"/>
   <result pre="et al2020NatureA new coronavirus associated with human respiratory disease in" exact="China" post="Wu C, Liu Y, Yang Y, Zhang P, Zhong"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7169409\results\search\country\results.xml">
   <result pre="in 2001 after isolation from dozens of young children in" exact="the Netherlands" post="[1]. Soon after its initial identification, HMPV was found"/>
   <result pre="2001 after isolation from dozens of young children in the" exact="Netherlands" post="[1]. Soon after its initial identification, HMPV was found"/>
   <result pre="respiratory illnesses [30]. A study by Edwards et al. in" exact="the United States" post="estimated that HMPV was responsible for annual hospitalization rates"/>
   <result pre="illnesses [30]. A study by Edwards et al. in the" exact="United States" post="estimated that HMPV was responsible for annual hospitalization rates"/>
   <result pre="five [33]. In a study by Davis et al. in" exact="the United States," post="hospitalizations were highest for children under the age of"/>
   <result pre="[33]. In a study by Davis et al. in the" exact="United States," post="hospitalizations were highest for children under the age of"/>
   <result pre="and 6% required mechanical ventilation. In a recent study in" exact="Norway" post="described by Moe et al. [29,40], up to 10%"/>
   <result pre="metapneumovirus: A systematic analysisLancet Glob. Health20197e1031e104510.1016/S2214-109X(19)30264-531303294 25.HaynesA.K.FowlkesA.L.SchneiderE.MutucJ.D.ArmstrongG.L.GerberS.I.Human Metapneumovirus Circulation in" exact="the United States," post="2008 to 2014Pediatrics201613710.1542/peds.2015-292727244790 26.NoordeenF.PitchaiF.N.N.KudagammanaS.T.RafeekR.A.M.A mini outbreak of human metapneumovirus"/>
   <result pre="A systematic analysisLancet Glob. Health20197e1031e104510.1016/S2214-109X(19)30264-531303294 25.HaynesA.K.FowlkesA.L.SchneiderE.MutucJ.D.ArmstrongG.L.GerberS.I.Human Metapneumovirus Circulation in the" exact="United States," post="2008 to 2014Pediatrics201613710.1542/peds.2015-292727244790 26.NoordeenF.PitchaiF.N.N.KudagammanaS.T.RafeekR.A.M.A mini outbreak of human metapneumovirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7169770\results\search\country\results.xml">
   <result pre="2019; previously 2019â€�nCoV), epiâ€�centred in Hubei Province of the Peopleâ€™s" exact="Republic of" post="China, has spread to many other countries. On 30."/>
   <result pre="1 and other forums. As of midst of February 2020," exact="China" post="bears the large burden of morbidity and mortality, whereas"/>
   <result pre="the incidence in other Asian countries, in Europe and North" exact="America" post="remains low so far. Coronaviruses are enveloped, positive singleâ€�stranded"/>
   <result pre="vulnerable region certainly is Africa, due to dense traffic between" exact="China" post="and Africa. Very few African countries have sufficient and"/>
   <result pre="has identified 13 topâ€�priority countries (Algeria, Angola, Cote dâ€™Ivoire, the" exact="Democratic Republic of the Congo," post="Ethiopia, Ghana, Kenya, Mauritius, Nigeria, South Africa, Tanzania, Uganda,"/>
   <result pre="identified 13 topâ€�priority countries (Algeria, Angola, Cote dâ€™Ivoire, the Democratic" exact="Republic of" post="the Congo, Ethiopia, Ghana, Kenya, Mauritius, Nigeria, South Africa,"/>
   <result pre="Democratic Republic of the Congo, Ethiopia, Ghana, Kenya, Mauritius, Nigeria," exact="South Africa," post="Tanzania, Uganda, Zambia) which either maintain direct links to"/>
   <result pre="Africa, Tanzania, Uganda, Zambia) which either maintain direct links to" exact="China" post="or a high volume of travel to China. Recent"/>
   <result pre="10.1016/S0140-6736(20)30304-4 14HolshueML, DeBoltC, FirstLindquist S et al. Novel Coronavirus in" exact="the United States." post="N Engl J Med2019. 15WangM, CaoR, ZhangL et al."/>
   <result pre="14HolshueML, DeBoltC, FirstLindquist S et al. Novel Coronavirus in the" exact="United States." post="N Engl J Med2019. 15WangM, CaoR, ZhangL et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7171518\results\search\country\results.xml">
   <result pre="wet animal and seafood wholesale market in Wuhan, Hubei Province," exact="China" post="[1,2]. Early studies predicted the onset of a possible"/>
   <result pre="571 COVID-19 infection cases were reported in 25 provinces of" exact="China" post="[7]. Upto 22 January 2020 China National Health Commission"/>
   <result pre="in 25 provinces of China [7]. Upto 22 January 2020" exact="China" post="National Health Commission reported the details of first 17"/>
   <result pre="infection cases were confirmed along with 56 deaths in mainland" exact="China" post="[8]. Another report of 24th January 2020, estimated 5502"/>
   <result pre="report of 24th January 2020, estimated 5502 COVID-19 infections in" exact="China" post="[9,10]. The first COVID-19 infection case was reported on"/>
   <result pre="in USA mounted to 311,635 surpassing the infected cases of" exact="Italy" post="(124,632) and China (81,669). Out of these 288,356 cases"/>
   <result pre="to 311,635 surpassing the infected cases of Italy (124,632) and" exact="China" post="(81,669). Out of these 288,356 cases are active and"/>
   <result pre="authorities concluded that 31,161 people had contracted the infection in" exact="China" post="as of 7 February 2019, and that more than"/>
   <result pre="On 5th April 2020, total number of infected cases in" exact="Italy" post="has reached to 124,632 out of which 20,996 have"/>
   <result pre="cases (https://www.worldometers.info/coronavirus/). Currently total number of corona virus cases in" exact="India" post="reported so far 3374. So far there are 77"/>
   <result pre="to a local seafood market (â€œwet marketâ€�) in Wuhan City" exact="China" post="on 29 December 2019 [12]. The research is under"/>
   <result pre="out the source of the COVID-19 outbreak CDC researchers of" exact="China" post="collected 585 environmental samples from Huanan Seafood Market in"/>
   <result pre="COVID-19 varies widely between countries ranging from 0.2 % in" exact="Germany" post="to 7.7 % in Italy. It may not be"/>
   <result pre="significant. As we look towards the trajectory in case of" exact="Iran" post="on 24th of February 2020 it had 2 confirmed"/>
   <result pre="convalescent plasma therapy was also tested by doctors in Shanghai" exact="China" post="and in USA as well in which blood plasma"/>
   <result pre="to prevent and control the spread of the COVID-19. In" exact="China" post="the National Health Commission issued national guidelines on the"/>
   <result pre="[71]. In addition to papers published in scientific journals, the" exact="China" post="CDC has provided guidelines to raise awareness among the"/>
   <result pre="J Clin Invest2020e1320910.1111/eci.13209 11HolshueM.L.DeBoltC.S.LindquistK.H.LofyJ.First case of 2019 novel coronavirus in" exact="the United States," post="NEngl J Med202010.1056/NEJMoa2001191 12LiQ.GuanX.WuP.WangX.ZhouL.Early transmission dynamics in wuhan, China,"/>
   <result pre="Clin Invest2020e1320910.1111/eci.13209 11HolshueM.L.DeBoltC.S.LindquistK.H.LofyJ.First case of 2019 novel coronavirus in the" exact="United States," post="NEngl J Med202010.1056/NEJMoa2001191 12LiQ.GuanX.WuP.WangX.ZhouL.Early transmission dynamics in wuhan, China,"/>
   <result pre="for Disease Control and Prevention585 environmental samples from the south" exact="China" post="seafood market in wuhan, Hubei province, China2020http://www.chinacdc.cn/yw_9324/202001/t20200127_211469.html 30LuH.TangC.W.TangY.Outbreak of"/>
   <result pre="transmissionSci Chin Life Sci202010.1007/s11427-020-1637-5 33collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="ChinaPrevent guideline of 2019-nCoVhttp://www.nhc.gov.cn/xcs/yqfkdt/202001/bc661e49b5bc487dba182f5c49ac445b.shtml2020 34JaimesJ.A.MilletJ.K.StoutA.E.AndreN.M.WhittakerG.R.AÂ tale of two viruses:"/>
   <result pre="Union Med Coll Hosp2020http://kns.cnki.net/kcms/detail/11.5882.r.20200130.1430.002.html 39collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="ChinaPneumonia diagnosis and treatment of 2019-nCoV infection from Chinese"/>
   <result pre="coronavirus vaccine stimulates neutralising and protective antibody responsesVaccine245200665266116214268 60CheungE.China coronavirus:" exact="Hong Kong" post="researchers have already developed vaccine but need time to"/>
   <result pre="vaccine but need time to test it, expert reveals: south" exact="China" post="morning post[cited 2020 29 January]; Available from:https://www.scmp.com/news/hongkong/health-environment/article/3047956/chinacoronavirus-hong-kong-researchers-have2020 61Xinhua. China"/>
   <result pre="south China morning post[cited 2020 29 January]; Available from:https://www.scmp.com/news/hongkong/health-environment/article/3047956/chinacoronavirus-hong-kong-researchers-have2020 61Xinhua." exact="China" post="fast-tracks novel coronavirus vaccine development xinhua[cited 202 29 January];"/>
   <result pre="6 March]; Available from:http://www.cloverbiopharma.com/index.php?m=content&amp;amp;c=index&amp;amp;a=show&amp;amp;catid=11&amp;amp;id=402019 64collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="ChinaPneumonia infected with novel coronavirus is included in the"/>
   <result pre="legal infectious diseaseshttp://www.nhc.gov.cn/jkj/s7915/202001/e4e2d5e6 f01147e0a8df3f6701d49f33.shtml2020 65collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="ChinaNotice on printing and distributing the technical guide for"/>
   <result pre="medical institutions1st ed.2020http://www.nhc.gov.cn/yzygj/s7659/202001/b91fdab7c304431eb082d6784 7d27e14.shtml 66collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="ChinaNotice on printing and distributing the work plan for"/>
   <result pre="in the near futureAccessedhttp://www.nhc.gov.cn/tigs/s7848/202001/808bbf75e5ce415aa19f74c78ddc653f.shtml2020 67collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="ChinaNotice on further prevention and control of pneumonia caused"/>
   <result pre="nCoV outbreak (Interim guidance)2020WHO/nCov/IPC_Masks/2020 72collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="ChinaGuidelines for public protection against novel coronavirus infectionhttp://www.nhc.gov.cn/jkj/s7915/202001/bc661e49b5bc487dba182f5c49ac445b.shtml2020 73GretebeckL.M.SubbaraoK.Animal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7171523\results\search\country\results.xml">
   <result pre="a coronavirus? What is COVID-19? Covid-19 disease, which appeared in" exact="China" post="in late 2019, is caused by SARS-CoV-2, a virus"/>
   <result pre="the coronavirus? According to WHO, after an epidemic outbreak in" exact="China" post="in January-February, the epidemic situation has changed globally since"/>
   <result pre="since 23rd February, 2020. With the intensification of outbreaks in" exact="South Korea," post="Japan, and Singapore, and the appearance of new outbreaks"/>
   <result pre="Japan, and Singapore, and the appearance of new outbreaks in" exact="Iran" post="and Italy. In these countries, we are witnessing community"/>
   <result pre="European Union are now affected by COVID-19 [1], especially Italy," exact="Spain" post="and France. On 16th March 2020, the WHO counted"/>
   <result pre="March 2020, the WHO counted almost as many cases in" exact="China" post="as outside of China: 165Â 515 confirmed cases worldwide,"/>
   <result pre="China: 165Â 515 confirmed cases worldwide, including 81Â 077 in" exact="China" post="and 86Â 438 outside China (in 143 different countries)."/>
   <result pre="worldwide, including 81Â 077 in China and 86Â 438 outside" exact="China" post="(in 143 different countries). And 3218 deaths in China"/>
   <result pre="outside China (in 143 different countries). And 3218 deaths in" exact="China" post="and 3388 outside China [3]. WHO has therefore called"/>
   <result pre="different countries). And 3218 deaths in China and 3388 outside" exact="China" post="[3]. WHO has therefore called these countries to act"/>
   <result pre="can make a difference [4]. Indeed, on 31st March 2020" exact="Italy" post="became at the top of the world ranking of"/>
   <result pre="due to Covid-19, followed by Spain, but is just behind" exact="the United States" post="in terms of cases tested positive for the virus."/>
   <result pre="to Covid-19, followed by Spain, but is just behind the" exact="United States" post="in terms of cases tested positive for the virus."/>
   <result pre="measures much more precociously than Europe [5]. In the Maghreb," exact="the States" post="take early measures going from the simple prudence to"/>
   <result pre="and hydroxychloroquine) for the treatment of COVID-19 disease. According to" exact="the US" post="Centers for Disease Control and Prevention, hydroxychloroquine and chloroquine"/>
   <result pre="in human lung [16]. Tested in China, and partially in" exact="France" post="and the United States, chloroquine, an antimalarial substance, is"/>
   <result pre="lung [16]. Tested in China, and partially in France and" exact="the United States," post="chloroquine, an antimalarial substance, is carefully administered in Switzerland"/>
   <result pre="[16]. Tested in China, and partially in France and the" exact="United States," post="chloroquine, an antimalarial substance, is carefully administered in Switzerland"/>
   <result pre="United States, chloroquine, an antimalarial substance, is carefully administered in" exact="Switzerland" post="as a treatment against the Covid-19 pandemic. The clinical"/>
   <result pre="on Tuesday, 245th March, 2020 with very restricted conditions. The" exact="United States" post="has also approved the use of chloroquine, which has"/>
   <result pre="like to thank University Sultan Moulay Slimane of Beni Mellal," exact="Morocco" post="for supporting this work."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7174922\results\search\country\results.xml">
   <result pre="its amino acid composition emerged on February 20th, 2020 in" exact="Italy" post="(Lombardy). Viruses with RdRp mutation have a median of"/>
   <result pre="human pathogen Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in" exact="China" post="and its rapid national and international spread poses a"/>
   <result pre="reported that mortality rate is three times higher out of" exact="China" post="(15.2% [95% CI 12.5â€&quot;17.9] out of China, compared to"/>
   <result pre="patients all around the world (i.e. China, USA, Canada, Australia," exact="United Kingdom," post="Germany, France, Japan, Italy, Switzerland, Singapore, Luxembourg, Netherlands, Spain,"/>
   <result pre="France, Japan, Italy, Switzerland, Singapore, Luxembourg, Netherlands, Spain, Portugal, Sweden," exact="Czech Republic," post="Thailand, India, Cambodia, Hong Kong, Finland, Singapore, and Ireland)"/>
   <result pre="Luxembourg, Netherlands, Spain, Portugal, Sweden, Czech Republic, Thailand, India, Cambodia," exact="Hong Kong," post="Finland, Singapore, and Ireland) taking into particular consideration those"/>
   <result pre="alignment, comparing WSM sequence to sequences isolated from patients, whereas" exact="Swiss" post="Model and Ez-mol were used for protein modeling. The"/>
   <result pre="our dataset into 4 geographic areas: Asia, Oceania, Europe, North" exact="America" post="(Fig.Â 1). Within each area we performed alignment analysis"/>
   <result pre="located in each one of the European states (Spain, Portugal," exact="United Kingdom," post="Netherlands, Italy, Germany, Switzerland, France, Luxemburg, Sweden, Finland, Denmark"/>
   <result pre="United Kingdom, Netherlands, Italy, Germany, Switzerland, France, Luxemburg, Sweden, Finland," exact="Denmark" post="and Belgium). Finally, the North America group contains genomes"/>
   <result pre="France, Luxemburg, Sweden, Finland, Denmark and Belgium). Finally, the North" exact="America" post="group contains genomes from US and Canadian patients. Fig.Â"/>
   <result pre="4 geographic areas: Asia (nâ€‰=â€‰71), Oceania (nâ€‰=â€‰15), Europe (nâ€‰=â€‰101), North" exact="America" post="(nâ€‰=â€‰33). The mutation frequency was estimated for each of"/>
   <result pre="It is also possible to observe that Europe and North" exact="America" post="show a differential pattern of mutations: mutation 14408 (red),"/>
   <result pre="(purple) and 17746 (light blue) are present mostly in North" exact="America" post="We evaluated the distribution of SARS-CoV-2 mutations through different"/>
   <result pre="noted that the viral strains found in Europe and North" exact="America" post="are derived from the L-â€œstrainâ€� originated in Asia [23]."/>
   <result pre="March 1stâ€&quot;13th, a different cluster of mutations emerged in North" exact="America" post="Moreover, a different pattern of hotspot mutations is clearly"/>
   <result pre="2020, when the outbreak of positive cases was reported in" exact="the US" post="and Canada. In this group, three novel mutations (17746,"/>
   <result pre="P to L) is observed for the first time in" exact="Italy" post="(Lombardy) on February 20th, 2020, when a dramatic increase"/>
   <result pre="genomes with mutation in position 14408 (RdRp) (nâ€‰=â€‰53, 4 North" exact="America" post="and 49 European), and group 2 without RdRp mutation"/>
   <result pre="genomes with mutation in position 14408 (RdRp) (nâ€‰=â€‰53, 4 North" exact="America" post="and 49 European), and group 2 without RdRp mutation"/>
   <result pre="14408 and 23403) and 3 other different mutations in North" exact="America" post="(in positions 17746, 17857 and 18060). So far, these"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7174982\results\search\country\results.xml">
   <result pre="et al., 2020), which spread from a single city in" exact="China" post="to the entire country within 30Â days (Wu and"/>
   <result pre="case of Covid-19 was a student who returned from Wuhan," exact="China" post="on 30th January 2020 (Sahasranaman and Kumar, 2020). By"/>
   <result pre="improved and systematized by Arabian physicians. It was introduced into" exact="India" post="during the 11thâ€&quot;13th century in the Mughal period (Subbarayappa,"/>
   <result pre="and is derived from the Yunan, the ancient name of" exact="Greece" post="(Husain et al., 2010). Unani medicine flourished to its"/>
   <result pre="an endangered species in many parts of the world, including" exact="India" post="(Bhat, 2016). Information about these drugs is presented in"/>
   <result pre="also speculation that close to two-thirds of Covid-19 cases from" exact="China" post="may have gone undetected (Menkir et al., 2020). Going"/>
   <result pre="Zanzibar copal (Hymenaea verrucosa Gaertn.) as incense at Unguja Ukuu," exact="Tanzania" post="in the 7-8th century CE: chemical insights into trade"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7179500\results\search\country\results.xml">
   <result pre="of patients with respiratory failure. During the Ebola outbreak in" exact="Sierra Leone" post="in 2016, a decrease in the number of women"/>
   <result pre="obvious disparities between income and the provision of healthcare in" exact="Sierra Leone" post="and the high-income world, this highlights that the battle"/>
   <result pre="of vertical transmission of severe acute respiratory syndrome coronavirus 2," exact="China" post="[published online ahead of print, 2020 Jun 17]Emerg Infect"/>
   <result pre="42Faculty of Intensive Care Medicine ICS, Association of Anaesthetist of" exact="Great Britain" post="and Ireland, Royal College of Anaesthetists. COVID-19 Airway Management"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7180007\results\search\country\results.xml">
   <result pre="mental health counseling during the COVID-19 epidemic in Wuhan, Hubei," exact="China" post="(from the collection of Suliman Khan, used with permission)."/>
   <result pre="coronavirus 2 (SARS-CoV-2) caused a deadly pneumonia outbreak in Wuhan," exact="China" post="[1,2]. It is thought to be the continuation of"/>
   <result pre="acute respiratory syndrome (SARS) in Middle East (2009) and Guangdong," exact="China" post="(2002-03), respectively [3-6]. The COVID-19 infection, soon after its"/>
   <result pre="its emergence not only caused a number of deaths in" exact="China" post="but rapidly spread to other countries as well [7]."/>
   <result pre="as gloves, masks, and headcovers during the massive lockdown in" exact="China" post="may induce further stress in the general population. To"/>
   <result pre="cooperate. It has been generally observed in several cities of" exact="China" post="that foreigners (mostly students) find ways to flee. It"/>
   <result pre="and psychiatric symptoms followed by the 2019-nCoV outbreak in Wuhan," exact="China" post="(S24,S25). Exposure based therapy may also be useful in"/>
   <result pre="of continued viral outbreaks around the world and specifically in" exact="China" post="that affects millions of people, it is imperative to"/>
   <result pre="operating grant support from the National Natural Science Foundation of" exact="China" post="(grants no: 81870942, 81471174 and 81520108011), National Key Research"/>
   <result pre="81471174 and 81520108011), National Key Research and Development Program of" exact="China" post="(grant no: 2018YFC1312200), and Innovation Scientists and Technicians Troop"/>
   <result pre="Scientists and Technicians Troop Constructions Projects of Henan Province of" exact="China" post="(for MX). Authorship contribution: SK is the leading author"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February 2003.Lancet. 2003;362:1353-8. 10.1016/S0140-6736(03)14630-214585636 5BawazirAAl-MazrooEJradiHAhmedABadriMMERS-CoV infection: Mind"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7180238\results\search\country\results.xml">
   <result pre="of Respiratory Medicine, Second Affiliated Hospital of Zhengzhou University, Zhengzhou," exact="China" post="KraftColleen SuzanneEditor[], Address correspondence to Suliman Khan, Suliman.khan18@mails.ucas.ac.cn, or"/>
   <result pre="Hospital of Zhengzhou University khanSuliman National Natural Science Foundation of" exact="China" post="(NSFC)https://doi.org/10.13039/501100001809 8147117481520108011XueMengzhou fig-count: table-count: equation-count: ref-count: page-count: word-count: INTRODUCTION"/>
   <result pre="the outbreak of severe acute respiratory syndrome (SARS) in Guangdong," exact="China" post="in 2002 and 2003 (2, 3). SARS was determined"/>
   <result pre="high rate of transmission to other people occurred in Guangdong," exact="China" post="(32), followed by subsequent outbreaks in Hong Kong. In"/>
   <result pre="occurred in Guangdong, China (32), followed by subsequent outbreaks in" exact="Hong Kong." post="In Hong Kong, a total of 138 people contracted"/>
   <result pre="China (32), followed by subsequent outbreaks in Hong Kong. In" exact="Hong Kong," post="a total of 138 people contracted the infection within"/>
   <result pre="infected by MERS-CoV developed severe pneumonia and died in Jeddah," exact="Saudi Arabia" post="(1, 33). Analysis of cluster of nosocomial cases in"/>
   <result pre="Arabia (1, 33). Analysis of cluster of nosocomial cases in" exact="Jordan" post="during April 2012 confirmed that MERS-CoV caused the outbreak"/>
   <result pre="several cases were reported in more than 37 countries, including" exact="the USA," post="Japan, Iran, and South Korea (38). The infection rapidly"/>
   <result pre="more than 37 countries, including the USA, Japan, Iran, and" exact="South Korea" post="(38). The infection rapidly spread across the globe from"/>
   <result pre="COVID-19 caused 77,262 confirmed cases and 2,595 deaths inside mainland" exact="China" post="alone (38). Through February 24, WHO had reported 8"/>
   <result pre="due to SARS-CoV-2 infection. (38). The spread of SARS-CoV-2 in" exact="Iran" post="poses a higher risk of pandemics in the Middle"/>
   <result pre="(39). Moreover, the R0 for MERS ranged from 0.45 in" exact="Saudi Arabia" post="to 8.1 in South Korea (36). Considering the lower"/>
   <result pre="MERS ranged from 0.45 in Saudi Arabia to 8.1 in" exact="South Korea" post="(36). Considering the lower R0 value, the rapid increase"/>
   <result pre="health authorities, including those in China, Germany, Thailand, Japan, and" exact="the United States" post="(WHO, COVID-19, technical guidance, Feb 12, 2020). These tests"/>
   <result pre="authorities, including those in China, Germany, Thailand, Japan, and the" exact="United States" post="(WHO, COVID-19, technical guidance, Feb 12, 2020). These tests"/>
   <result pre="spillovers to humans during the outbreak of 2002 in Guangdong," exact="China" post="(3). Similarly, MERS-CoV became epidemic after a series of"/>
   <result pre="have originated in bats and have been introduced to Wuhan," exact="China" post="through an unknown intermediate. Until now, no effective clinical"/>
   <result pre="operating grant support from the National Natural Science Foundation of" exact="China" post="(grant numbers 81870942, 81471174 and 81520108011), National Key Research"/>
   <result pre="81471174 and 81520108011), National Key Research and Development Program of" exact="China" post="(grant number 2018YFC1312200), and Innovation Scientists and Technicians Troop"/>
   <result pre="Scientists and Technicians Troop Constructions Projects of Henan Province of" exact="China" post="(for M.X.). We declare no conflicts of interest. References"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003. Lancet362:1353â€&quot;1358. doi:10.1016/S0140-6736(03)14630-2.14585636 4.BawazirA, Al-MazrooE, JradiH,"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N Engl J Med367:1814â€&quot;1820. doi:10.1056/NEJMoa1211721.23075143 6.KhanS, NabiG, HanG, SiddiqueR,"/>
   <result pre="LipkinWI2014Middle East respiratory syndrome coronavirus infection in dromedary camels in" exact="Saudi Arabia." post="mBio5:e00884-14-e00814. doi:10.1128/mBio.00884-14. 15.SarrisJ, KavanaghDJ2009Kava and St. Johnâ€™s Wort: current"/>
   <result pre="relative of human Middle East respiratory syndrome coronavirus in bat," exact="South Africa." post="Emerg Infect Dis19:1697â€&quot;1699. doi:10.3201/eid1910.130946.24050621 17.HuangC, WangY, LiX, RenL, ZhaoJ,"/>
   <result pre="origin and transmission of Middle East respiratory syndrome coronavirus in" exact="the UAE." post="Zoonoses Public Health65:322â€&quot;333. doi:10.1111/zph.12435.29239118 26.ChuDKW, HuiKPY, PereraRAPM, MiguelE, NiemeyerD,"/>
   <result pre="early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou," exact="PR China." post="J Med Microbiol52:715â€&quot;720. doi:10.1099/jmm.0.05320-0.12867568 33.de GrootRJ, BakerSC, BaricRS, BrownCS,"/>
   <result pre="ZhanF, MaX, WangD, XuW, WuG, GaoGF, TanW, collab: for the" exact="China" post="Novel Coronavirus Investigating and Research Team. 2020A novel coronavirus"/>
   <result pre="Case Investigation Team. 2020First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med382:929â€&quot;936. doi:10.1056/NEJMoa2001191.32004427 46.ChanJFW, LauSKP, ToKKW, ChengVCC,"/>
   <result pre="Investigation Team. 2020First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med382:929â€&quot;936. doi:10.1056/NEJMoa2001191.32004427 46.ChanJFW, LauSKP, ToKKW, ChengVCC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7180381\results\search\country\results.xml">
   <result pre="neonatal malformations associated with Zika virus (ZIKV) infection in Latin" exact="America" post="{5}, the yellow fever (YFV) epidemics in Angola and"/>
   <result pre="in Latin America {5}, the yellow fever (YFV) epidemics in" exact="Angola" post="and Brazil with importation to China [6], the ever-expanding"/>
   <result pre="America {5}, the yellow fever (YFV) epidemics in Angola and" exact="Brazil" post="with importation to China [6], the ever-expanding West Nile"/>
   <result pre="fever (YFV) epidemics in Angola and Brazil with importation to" exact="China" post="[6], the ever-expanding West Nile virus (WNV) epidemic in"/>
   <result pre="time in 1999, rapidly spreading from the east coast of" exact="the USA" post="to the rest of the country and to Canada"/>
   <result pre="the USA to the rest of the country and to" exact="Canada" post="before invading the Caribbean, Central and South America [7]."/>
   <result pre="and to Canada before invading the Caribbean, Central and South" exact="America" post="[7]. In 2002, 14,000 cases of WNV encephalitis in"/>
   <result pre="in horses and 4,000 cases in humans were reported in" exact="the USA." post="WNV is now enzootic in the region. Dr Joao"/>
   <result pre="The mosquito is widely prevalent in the tropics including tropical" exact="America" post="and most countries in subsaharan Africa. In 2007â€&quot;2010 yellow"/>
   <result pre="infecting many travelers. Cases of yellow fever were exported from" exact="Brazil" post="to Europe, Peru and the USA. The virus continued"/>
   <result pre="Cases of yellow fever were exported from Brazil to Europe," exact="Peru" post="and the USA. The virus continued to spread in"/>
   <result pre="yellow fever were exported from Brazil to Europe, Peru and" exact="the USA." post="The virus continued to spread in 2017â€&quot;18 into the"/>
   <result pre="first half of 2018. In Africa, yellow fever spread from" exact="Angola" post="to the Democratic Republic of Congo in 2016â€&quot;17, and"/>
   <result pre="2018. In Africa, yellow fever spread from Angola to the" exact="Democratic Republic of Congo" post="in 2016â€&quot;17, and emerged in Nigeria and Uganda in"/>
   <result pre="In Africa, yellow fever spread from Angola to the Democratic" exact="Republic of" post="Congo in 2016â€&quot;17, and emerged in Nigeria and Uganda"/>
   <result pre="yellow fever spread from Angola to the Democratic Republic of" exact="Congo" post="in 2016â€&quot;17, and emerged in Nigeria and Uganda in"/>
   <result pre="the Democratic Republic of Congo in 2016â€&quot;17, and emerged in" exact="Nigeria" post="and Uganda in 2018 [16]. More dramatically, 11 cases"/>
   <result pre="Republic of Congo in 2016â€&quot;17, and emerged in Nigeria and" exact="Uganda" post="in 2018 [16]. More dramatically, 11 cases were imported"/>
   <result pre="in 2018 [16]. More dramatically, 11 cases were imported from" exact="Angola" post="to China, which is the first time in history"/>
   <result pre="Dr Rome Buathong (Bureau of Epidemiology, Dept of Disease Contrtol," exact="Thailand" post="Ministry of Public Health) reminded the audience that until"/>
   <result pre="detected until May 2013, when a Canadian traveler returning from" exact="Thailand" post="was diagnosed with the disease. A ZIKV surveillance program"/>
   <result pre="of 1698 confirmed cases of ZIKV infection was recorded in" exact="Thailand" post="during this two year period. The age groups most"/>
   <result pre="the South Pacific and South America, with a focus on" exact="Brazil" post="where major clinical outcomes in pregnant women were common."/>
   <result pre="ZIKV infection and microcephaly was reported in 2015 in Recife," exact="Brazil" post="where three women infected with ZIKV during their pregnancy"/>
   <result pre="in babies born to ZIKV-infected mothers, had been observed in" exact="French Polynesia" post="as early as 2014. As reported by Dr Patricia"/>
   <result pre="Polynesia as early as 2014. As reported by Dr Patricia" exact="Brasil" post="(Oswaldo Cruz Foundation, Rio do Janeiro), a prospective cohort"/>
   <result pre="Brazil) talked of the interplay between various flaviviruses. Given that" exact="Brazil" post="is hyperendemic for arboviruses, there was concern that previous"/>
   <result pre="and DENV Ab negative persons. Thus, the epidemiological evidence in" exact="Brazil" post="did not support the hypothesis that previous exposure to"/>
   <result pre="microcephaly. The mutation was also found in ZIKV strains from" exact="French Polynesia," post="where numerous cases of microcephaly have been recorded, but"/>
   <result pre="the World Mosquito Program to eliminate dengue. A trial in" exact="Australia" post="has demonstrated that, shortly after release of Wolbachia-infected Aedes"/>
   <result pre="DENV was stopped [25]. Similar trials are being conducted in" exact="Viet Nam," post="Indonesia and Brazil. The fear that Wolbachia infection of"/>
   <result pre="stopped [25]. Similar trials are being conducted in Viet Nam," exact="Indonesia" post="and Brazil. The fear that Wolbachia infection of Ae"/>
   <result pre="Vaccines 5.1 Yellow fever Dr Joao Bosco Siqueira reported that" exact="Brazil" post="had suffered from a shortage of yellow fever vaccine."/>
   <result pre="undergone large-scale Phase 3 clinical trials in Asia and Latin" exact="America" post="[13], [14], demonstrating increasing efficacy with age and higher"/>
   <result pre="been introduced into public immunization programs in endemic areas of" exact="the Philippines" post="and Brazil. The vaccine showed high efficacy and good"/>
   <result pre="introduced into public immunization programs in endemic areas of the" exact="Philippines" post="and Brazil. The vaccine showed high efficacy and good"/>
   <result pre="are currently in Phase 3 clinical trials: TDV, developed by" exact="the US" post="CDC and manufactured by Takeda, and TV003/005, developed by"/>
   <result pre="US CDC and manufactured by Takeda, and TV003/005, developed by" exact="the US" post="NIH. TDV is a tetravalent live attenuated chimeric vaccine"/>
   <result pre="is undergoing Phase 3 trials in Brazil, Columbia, Nicaragua, Panama," exact="Sri Lanka" post="and Thailand. Preliminary phase 3 data show the vaccine"/>
   <result pre="undergoing Phase 3 trials in Brazil, Columbia, Nicaragua, Panama, Sri" exact="Lanka" post="and Thailand. Preliminary phase 3 data show the vaccine"/>
   <result pre="E genes and is presently entering Phase IIb trials in" exact="the USA," post="Brazil, and several countries in Latin America (Puerto Rico,"/>
   <result pre="trials in the USA, Brazil, and several countries in Latin" exact="America" post="(Puerto Rico, Mexico, Panama, Peru, Columbia..); a purified inactivated"/>
   <result pre="were 10 fold more reported cases of DENV infection in" exact="Brazil" post="than during the preceding year, leading to 600 deaths;"/>
   <result pre="and more than 1400 deaths from dengue were reported in" exact="the Philippines!" post="An estimated 390 million dengue infections occur annually [9]."/>
   <result pre="age turns out to be very low (only 10% in" exact="Singapore" post="for example)? The dramatic emergence and spread of epidemic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7182166\results\search\country\results.xml">
   <result pre="The previous incidence of the SARS-CoV outbreak, which started in" exact="China" post="in the year 2002 and lasted until July 2003,"/>
   <result pre="spread across the world, affecting 24 countries that included Cambodia," exact="Hong Kong," post="Singapore, Hanoi, Canada, and others, recording 8,437 SARS cases"/>
   <result pre="later called COVID-19 in February 2020. The WHOÂ and the" exact="China" post="Bureau had announced the discovery of a new coronavirus"/>
   <result pre="Respir Crit Care MedCarlosWGDela CruzCSCaoBPasnickSJamilS02012020 36A novel coronavirus emerging in" exact="China" post="- key questions for impact assessmentN Engl J MedMunsterVJKoopmansMvan"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7184357\results\search\country\results.xml">
   <result pre="novel coronavirus, was first identified in the Hubei province of" exact="China" post="in December 2019 and has now spread worldwide. The"/>
   <result pre="of trade names, commercial products, or organizations imply endorsement by" exact="the US" post="government. Financial support. This work was supported by the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7185310\results\search\country\results.xml">
   <result pre="of Health, the Department of Health and Human Services, or" exact="the United States" post="government. Author Disclosure Statement No competing financial interests exist."/>
   <result pre="Health, the Department of Health and Human Services, or the" exact="United States" post="government. Author Disclosure Statement No competing financial interests exist."/>
   <result pre="influenza virus vaccine: prospects and challenges. Annu Rev Med2013;64:189â€&quot;20223327522 27." exact="United States of America," post="Presidential Executive Order on Modernizing Influenza Vaccines in the"/>
   <result pre="of America, Presidential Executive Order on Modernizing Influenza Vaccines in" exact="the United States" post="to Promote National Security and Public Health, September 19,"/>
   <result pre="America, Presidential Executive Order on Modernizing Influenza Vaccines in the" exact="United States" post="to Promote National Security and Public Health, September 19,"/>
   <result pre="and LaverWDetermination of the number of nonoverlapping antigenic areas on" exact="Hong Kong" post="(H3N2) influenza virus hemagglutinin with monoclonal antibodies and the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7186945\results\search\country\results.xml">
   <result pre="in critical illness. The early reports of 25% encephalopathy from" exact="China" post="are likely a gross underestimation, which we know occurs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7187878\results\search\country\results.xml">
   <result pre="adulthoodProc Nutr Soc752201611512410.1017/S002966511600007026934951 29WangW.LuJ.GuW.ZhangY.LiuJ.NingG.Care for diabetes with COVID-19: advice from" exact="China" post="[published online ahead of print, 2020 Apr 13]J Diabetes202010.1111/1753-0407.13036"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7189021\results\search\country\results.xml">
   <result pre="(WHO) declaration of COVID-19 as a global pandemic. Abstract Background" exact="China" post="has been fighting the epidemic of pneumonia-like diseases first"/>
   <result pre="have helped to bring the situation under control. Keywords Wuhan" exact="China" post="COVID-19 Outbreak Chloroquine Hydroxychloroquine Introduction Several cases of unknown"/>
   <result pre="pneumonia have been confirmed and registered in Wuhan, Hubei Province," exact="China" post="since December 8, 2019 (Huang et al. 2020). Most"/>
   <result pre="a group of previously isolated SARS-like coronaviruses from bats in" exact="China" post="(Wu et al. 2020). Possible transmissions After the first"/>
   <result pre="drug take over? There are no medications specifically licensed by" exact="the US" post="Food and Drug Administration (FDA) for the treatment of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7189412\results\search\country\results.xml">
   <result pre="with the Huanan wholesale seafood market in Wuhan, Hubei province," exact="China" post="(Huang etÂ al., 2020). Next-generation sequencing analysis from bronchoalveolar"/>
   <result pre="cases of COVID-19 across 177 countries/regions, with 30,300 fatalities. China," exact="Italy" post="and Spain have been the most affected countries with"/>
   <result pre="COVID-19 across 177 countries/regions, with 30,300 fatalities. China, Italy and" exact="Spain" post="have been the most affected countries with combined fatalities"/>
   <result pre="Amera thanks the College of Natural Science, Wollo University, Dessie," exact="Ethiopia" post="for the sponsorship. The authors also thank to Supercomputing"/>
   <result pre="Severe outcomes among patients with coronavirus disease 2019 (COVID-19) â€&quot;" exact="United States," post="February 12â€&quot;March 16, 2020. ChenH., WeiP., HuangC., TanL., LiuY.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7190301\results\search\country\results.xml">
   <result pre="was shown for SARS, with a 2004 study done in" exact="Hong Kong" post="showing earlier discharge from hospital and lower mortality in"/>
   <result pre="now needed to provide clinical evidence. Three trials initiated by" exact="the US" post="National COVID-19 Convalescent Plasma Project are currently being evaluated"/>
   <result pre="also planned or underway in China, Colombia, Iran, Mexico, and" exact="the Netherlands." post="The success of convalescent plasma therapy hinges on the"/>
   <result pre="can only be used to treat a few patients. In" exact="the USA," post="the Red Crossâ€&quot;in collaboration with the FDAâ€&quot;has published a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7190393\results\search\country\results.xml">
   <result pre="identified in Wuhan, the capital city of Hubei province in" exact="China" post="[6]. The pathogen has since been identified as a"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci202063345746010.1007/s11427-020-1637-532009228 15.GralinskiLEMenacheryVDReturn of the coronavirus: 2019-nCoVViruses.202010.3390/v1202013531991541 16.RotheCSchunkMSothmannPBretzelGFroeschlGWallrauchCet al.Transmission"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7190742\results\search\country\results.xml">
   <result pre="And HIV URFS Identified Amongst People Who Inject Drugs In" exact="India" post="RodgersMary A.mary.rodgers@abbott.com1GomathiSelvamurthi2VallariAna1SaravananShanmugam2LucasGregory M.3MehtaShruti4SolomonSunil S.234ClohertyGavin A.1[1], 0000 0004 0366 7505grid.417574.4Abbott"/>
   <result pre="of HIV and HCV are significantly higher amongst PWID in" exact="India" post="compared to the general population, the strains circulating within"/>
   <result pre="HIV/HCV prevalence study conducted amongst PWID across five cities in" exact="India" post="in 2016â€&quot;2017, a total of Nâ€‰=â€‰498 HCV and Nâ€‰=â€‰755"/>
   <result pre="to be endemic after its discovery amongst Indian immigrants to" exact="Canada" post="from the Punjab region12. Previous HCV diversity studies have"/>
   <result pre="contrast to HCV diversity studies, previous HIV diversity studies in" exact="India" post="have been small in scale (13â€&quot;130 participants), limited to"/>
   <result pre="region21â€&quot;28. The predominant strain of HIV in all regions of" exact="India" post="is subtype C21â€&quot;28. However, URFs are frequent (32.73%) and"/>
   <result pre="analysis: Amritsar and Delhi in North India, Kanpur in Central" exact="India" post="and Imphal and Aizawl in Northeastern India. Samples were"/>
   <result pre="city revealed that unique strains predominated in different regions of" exact="India" post="(Fig.Â 3). In the Northeastern city of Imphal, genotypes"/>
   <result pre="the study site where they were identified. The map of" exact="India" post="was obtained from https://d-maps.com/carte.php?num_car=4183&amp;amp;lang=en. Unlike the diversity encountered within"/>
   <result pre="considerably higher in PWID (2.4â€&quot;64.9%)30 than in non-PWID populations in" exact="India" post="(0.22â€&quot;0.88%)45,46, it remains possible that the strains in the"/>
   <result pre="this study suggests that INSTI-based regimens could be successful in" exact="India" post="as a first-line HIV treatment option. With DAA cures"/>
   <result pre="support the hypothesis that new strains have been imported to" exact="India" post="via the Golden Triangle and Golden Crescent opium trade"/>
   <result pre="Southeast Asia (CRF01_AE), East Asia (subtype B and URFs), and" exact="Pakistan" post="(subtype A)6,56 (TableÂ 2). Although HCV samples were not"/>
   <result pre="6 strains identified in the North and Northeastern sites in" exact="India" post="are more prevalent in East Asia57. An important purpose"/>
   <result pre="purpose of this study was to characterize viral diversity in" exact="India" post="towards the ultimate goal of using diverse viral strains"/>
   <result pre="Giroir, B. P. Ending the HIV Epidemic: A Plan for" exact="the United States." post="Jama, 10.1001/jama.2019.1343 (2019). 6.HemelaarJet al.Global and regional molecular epidemiology"/>
   <result pre="B. P. Ending the HIV Epidemic: A Plan for the" exact="United States." post="Jama, 10.1001/jama.2019.1343 (2019). 6.HemelaarJet al.Global and regional molecular epidemiology"/>
   <result pre="assignment web resourceHepatology20145931832710.1002/hep.2674424115039 15.AmjeshRNairASSugunanVSDiversity of Hepatitis C virus in Southern" exact="India" post="Based on 5â€™UTR SequenceIndian J Virol20122334935310.1007/s13337-012-0103-224293823 16.BarmanBBoraKLynrahKGLyngdohWVJamilMHepatitis C virus"/>
   <result pre="and adolescents May 2013. (2013). 45.Organization), N. N. A. C." exact="India" post="HIV Estimation 2017 report. Annual Report NACO 2016-2017, 339-407"/>
   <result pre="Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the" exact="Democratic Republic of the Congo." post="Journal of virology91, 10.1128/JVI.01841-16 (2017). 54.Crime), U. U. N."/>
   <result pre="Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic" exact="Republic of" post="the Congo. Journal of virology91, 10.1128/JVI.01841-16 (2017). 54.Crime), U."/>
   <result pre="al.A systematic review of hepatitis C virus epidemiology in Asia," exact="Australia" post="and EgyptLiver Int201131Suppl 2618010.1111/j.1478-3231.2011.02540.x21651703"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7191286\results\search\country\results.xml">
   <result pre="2020, 6 weeks after it had first been reported from" exact="China" post="as a new respiratory virus [1]. By then 118,000"/>
   <result pre="in the general population, ranges for example from 8.0 in" exact="Germany" post="to 20.4 in the USA, 41.9 in the UK,"/>
   <result pre="ranges for example from 8.0 in Germany to 20.4 in" exact="the USA," post="41.9 in the UK, 47.8 in Italy, 54.0 in"/>
   <result pre="USA, 41.9 in the UK, 47.8 in Italy, 54.0 in" exact="Spain" post="and 67.7 in Belgium [4]. However, these figures may"/>
   <result pre="UK, 47.8 in Italy, 54.0 in Spain and 67.7 in" exact="Belgium" post="[4]. However, these figures may reflect considerable underestimates of"/>
   <result pre="temporary hospitals in the UK, to new hospital building in" exact="China" post="and field hospitals, e.g. in Central Park in New"/>
   <result pre="revealed under-reporting to international public health authorities of mortality in" exact="China" post="â€&quot; at least 50% higher than initially reported [9]."/>
   <result pre="their products can treat or prevent COVID-19 [10]. To date" exact="South Korea," post="which has a stringent detect, test, isolate, treat and"/>
   <result pre="in containing COVID-19. In the 14 days to 4th May," exact="South Korea" post="reported 2.5 new cases of COVID-19/million population compared for"/>
   <result pre="2.5 new cases of COVID-19/million population compared for example with" exact="the USA" post="which, in the same period, reported 1229 new cases"/>
   <result pre="pandemic a total of 4.9 COVID-19 attributable deaths/million population in" exact="South Korea," post="compared with 204.4 COVID-19 attributable deaths/million population in the"/>
   <result pre="South Korea, compared with 204.4 COVID-19 attributable deaths/million population in" exact="the USA" post="[2]. The European Union (EU) is showing its capacity"/>
   <result pre="the European Medicines Agency, is working with other regulators, including" exact="the US" post="Food and Drugs Administration, to support research and development"/>
   <result pre="US President George W Bush launched an unsuccessful call at" exact="the US" post="National Institutes of Health for a three-part approach, involving"/>
   <result pre="factor in their models for the UK [7] and in" exact="the USA" post="there have been armed demonstrators in the streets in"/>
   <result pre="significant rise in incidence of the disease, for example in" exact="Singapore" post="and Japan, with reports also of significant COVID-19 resurgence"/>
   <result pre="and Japan, with reports also of significant COVID-19 resurgence in" exact="China" post="[2]. It remains to be seen how well the"/>
   <result pre="journal. During 2014 he was a physician and pharmacologist in" exact="Rwanda" post="within the US AID and US CDC Human Resources"/>
   <result pre="2014 he was a physician and pharmacologist in Rwanda within" exact="the US" post="AID and US CDC Human Resources for Health Program."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194560\results\search\country\results.xml">
   <result pre="College of Veterinary Medicine, King Faisal University, Al-hofuf, 31982, Al-ahsa," exact="Saudi Arabia." post="mkandeel@kfu.edu.sa pmc-release: 2020-4-4ppub: 2020-6-6epub: 2020-4-4251117627117627received: 2020-2-25rev-recd: 2020-3-27accepted: 2020-3-30(C) Elsevier"/>
   <result pre="severe and highly contagious viral disease was evolved in Wuhan," exact="China" post="[1]. The causative agent was detected to be a"/>
   <result pre="Middle East Respiratory Syndrome Coronavirus (MERS CoV) was diagnosed in" exact="Saudi Arabia" post="[4]. Soon after the emergence of SARS and MERS"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci." exact="China" post="Life Sci.20201431564034 2PeirisJ.LaiS.PoonL.GuanY.YamL.LimW.Coronavirus as a possible cause of severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194707\results\search\country\results.xml">
   <result pre="caused by a novel strain of coronavirus was detected in" exact="China" post="in December 2019, and declared a public health emergency"/>
   <result pre="Methods This descriptive cross-sectional online survey study was conducted in" exact="Jordan" post="during the COVID-19 outbreak (from 15 to 30 March"/>
   <result pre="media. Keywords Coronavirus Pandemics Pharmacists Faculty of pharmacy Pharmaceutical association" exact="Jordan" post="Introduction According to the Centres for Disease Control and"/>
   <result pre="of 2019, the novel COVID-19 has disseminated rapidly, starting with" exact="China" post="then spreading to many countries around the world in"/>
   <result pre="such as the Guaranteed Mask Supply Scheme.10 Another study from" exact="China" post="acknowledged that community pharmacy management teams shall support different"/>
   <result pre="designated telephone lines in addition to providing patient education.13 From" exact="the United Arab Emirates" post="(UAE), it was stated that pharmacists can also play"/>
   <result pre="telephone lines in addition to providing patient education.13 From the" exact="United Arab Emirates" post="(UAE), it was stated that pharmacists can also play"/>
   <result pre="in addition to providing patient education.13 From the United Arab" exact="Emirates" post="(UAE), it was stated that pharmacists can also play"/>
   <result pre="a descriptive cross-sectional online survey. This study was conducted in" exact="Jordan" post="during the Coronavirus outbreak (from 15 to 30 March"/>
   <result pre="is quite surprising as hydroxychloroquine has been regulated by the" exact="Jordan" post="Food and Drug Administration and is not allowed to"/>
   <result pre="half of the graduates from the private educational institutions in" exact="Jordan" post="are international students, who travel back to their countries"/>
   <result pre="their countries once they graduate; international students who remain in" exact="Jordan" post="are not able to practice as pharmacists. Representing a"/>
   <result pre="services in Jordan. This model initiated in the nineties in" exact="the United States" post="of America (USA) with pharmacy chains being initial adopters,"/>
   <result pre="in Jordan. This model initiated in the nineties in the" exact="United States of America" post="(USA) with pharmacy chains being initial adopters, though now"/>
   <result pre="model initiated in the nineties in the United States of" exact="America" post="(USA) with pharmacy chains being initial adopters, though now"/>
   <result pre="1/4/2020 2WHO. Coronavirus. World health organizationAvailable at:https://www.who.int/emergencies/diseases/novel-coronavirus-2019Accessed on 22/3/2020 3collab:" exact="United States" post="Centers for disease control and prevention CoronavirusCOVID-19)-Situation summaryAvailable at:https://www.cdc.gov/coronavirus/2019-ncov/index.htmlAccessed"/>
   <result pre="guidance for providing pharmaceutical care services during COVID-19 pandemic: a" exact="China" post="perspectiveRes Soc Adm Pharm202010.1016/j.sapharm.2020.03.012 13AmarilesP.Ledezma-MoralesM.Salazar-OspinaA.How to link patients with"/>
   <result pre="of T lymphocytesSci Rep6120163947927995987 39ManolakisP.G.SkeltonJ.B.Pharmacists' contributions to primary care in" exact="the United States" post="collaborating to address unmet patient care needs: the emerging"/>
   <result pre="T lymphocytesSci Rep6120163947927995987 39ManolakisP.G.SkeltonJ.B.Pharmacists' contributions to primary care in the" exact="United States" post="collaborating to address unmet patient care needs: the emerging"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194797\results\search\country\results.xml">
   <result pre="unknown etiology was detected in Wuhan City, Hubei Province of" exact="China" post="and reported to China Country Office of The World"/>
   <result pre="in Wuhan City, Hubei Province of China and reported to" exact="China" post="Country Office of The World Health Organization (WHO) on"/>
   <result pre="(WHO) on December 31, 2019. The National Health Commission of" exact="China" post="reported that the outbreak is associated with exposures in"/>
   <result pre="Public Health Thailand, the Ministry of Health, Labour and Welfare," exact="Japan" post="and Republic of Korea reported their first imported case"/>
   <result pre="Thailand, the Ministry of Health, Labour and Welfare, Japan and" exact="Republic of" post="Korea reported their first imported case of lab-confirmed 2019-nCoV"/>
   <result pre="MERS-CoV [15,18,23,24,31]. TableÂ 1 Feature SARS-CoV-2 SARS-CoV-1 MERS-CoV Origin Wuhan," exact="China" post="Guangdong, China Jeddah, Saudi Arab Asymptomatic viral load High"/>
   <result pre="TableÂ 1 Feature SARS-CoV-2 SARS-CoV-1 MERS-CoV Origin Wuhan, China Guangdong," exact="China" post="Jeddah, Saudi Arab Asymptomatic viral load High Less Less"/>
   <result pre="origin of a new human coronavirus: there and back againSci" exact="China" post="Life Sci2020 7Li WS.Z.YuM.RenW.SmithC.EpsteinJ.H.Bats are natural reservoirs of SARS-like"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes Metabol Syndr: Clin Res Rev142020241e246"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194918\results\search\country\results.xml">
   <result pre="global pandemic created by the Coronavirus SARS-CoV-2, started in Wuhan," exact="China" post="in December 2019, has generated panic, both in term"/>
   <result pre="as SARS-CoV-2 and 2019-nCoV emerged in the city of Wuhan," exact="China" post="in December 2019. Soon after it started spreading quickly"/>
   <result pre="spreading quickly and reached other cities in China, Japan, and" exact="South Korea." post="As this paper goes to press there are more"/>
   <result pre="press release, the last patient suffering from Ebola virus in" exact="Democratic Republic of Congo" post="has been released from the hospital. Lopinavir/Ritonavir and interferon"/>
   <result pre="release, the last patient suffering from Ebola virus in Democratic" exact="Republic of" post="Congo has been released from the hospital. Lopinavir/Ritonavir and"/>
   <result pre="last patient suffering from Ebola virus in Democratic Republic of" exact="Congo" post="has been released from the hospital. Lopinavir/Ritonavir and interferon"/>
   <result pre="drug to treat MERS-CoV [6], [7]. In another study in" exact="South Korea," post="Lopinavir/Ritonavir (Kaletra, Abbvie) was administered to patients suffering from"/>
   <result pre="commonly used drug, the National Health Commission of the Peopleâ€™s" exact="Republic of" post="China has recommended these drugs to be included in"/>
   <result pre="drug, the National Health Commission of the Peopleâ€™s Republic of" exact="China" post="has recommended these drugs to be included in the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194968\results\search\country\results.xml">
   <result pre="sub-Saharan Africa has reported relatively few cases: several thousand in" exact="South Africa" post="and just tens or hundreds in other countries. However,"/>
   <result pre="be one solution to make the most of limited resources." exact="South Africa" post="acted rapidly by imposing a lockdown, banning the sale"/>
   <result pre="housing with limited access to sanitation. To help reduce transmission," exact="Kenya" post="has banned public gatherings, made the wearing of masks"/>
   <result pre="been a topic of interest in recent years: in Kenya," exact="South Africa," post="and elsewhere, provision of 3 month or even 6"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7195043\results\search\country\results.xml">
   <result pre="novel coronavirus (COVID-19)Int J Surg2020 Feb 26 10ChenS.YangJ.YangW.WangC.BÃ¤rnighausenT.COVID-19 control in" exact="China" post="during mass population movements at New YearLancet202010.1016/S0140-6736(20)30421-9 11BobdeyS.RayS.Going viralâ€&quot;COVID-19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7195149\results\search\country\results.xml">
   <result pre="off the coast of Japan, they were heading home to" exact="the US." post="Fourteen had tested positive for covid-19. On arrival, one"/>
   <result pre="under investigation, many of which have already been approved by" exact="the US" post="Food and Drug Administration for treating other conditions, which"/>
   <result pre="harming us too. To address both these issues, in 2010," exact="the US" post="National Institute of Allergy and Infectious Diseases (NIAID) began"/>
   <result pre="a large-scale clinical trial during an Ebola outbreak in the" exact="Democratic Republic of the Congo." post="When this showed that remdesivir didn't prevent deaths as"/>
   <result pre="large-scale clinical trial during an Ebola outbreak in the Democratic" exact="Republic of" post="the Congo. When this showed that remdesivir didn't prevent"/>
   <result pre="large clinical trials evaluating remdesivir are getting under way in" exact="the US" post="and these, combined with trials in China, should give"/>
   <result pre="led by researchers at the Wuhan Institute of Virology in" exact="China" post="showed that they demonstrate some antiviral activity in human"/>
   <result pre="people have reportedly been treated this way for covid-19 in" exact="China" post="already, but the findings haven't yet been published. Arturo"/>
   <result pre="patients experience symptoms of a cytokine storm shortly before death," exact="Swiss" post="pharmaceutical giant Roche began investigating whether its rheumatoid arthritis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196187\results\search\country\results.xml">
   <result pre="and therapeutic approaches IyerMahalaxmi1JayaramayyaKaavya1SubramaniamMohana Devi2LeeSoo Bin3DayemAhmed Abdal3ChoSsang-Goo3VellingiriBalachandar4*[1], India[2], India[3], Korea[4]," exact="India" post="*Corresponding author. Tel: +91-422-2422514, +91-422-2422222; Fax: +91-422-2422387; E-mail: geneticbala@buc.edu.in,"/>
   <result pre="the development of vaccines and drugs against COVID-19. In the" exact="Republic of" post="Korea, since the first confirmed case of SARS-CoV-2 on"/>
   <result pre="rapidly taking the necessary steps to minimize the infection. The" exact="Republic of" post="Korea has implemented several measures to effectively flatten the"/>
   <result pre="Kerala. As per WHOâ€™s report on April 21, 2020, in" exact="India" post="18,601 were confirmed cases, 3252 had recovered, and 590"/>
   <result pre="to conquer this deadly infection of COVID-19. The government of" exact="India" post="has announced the call for research projects from its"/>
   <result pre="The ICMR has recommended the use of RT-PCR probes from" exact="the USA" post="that are distributed to laboratories in the country. In"/>
   <result pre="the use of hydroxychloroquine for high-risk COVID-19 cases (32). In" exact="China" post="and France, small studies provide some indications of possible"/>
   <result pre="Remdesivir Recruiting 1. Hoag Memorial Hospital Presbyterian Newport Beach, California," exact="United States" post="2. Stanford Hospital, Stanford, California, United States 3. Providence"/>
   <result pre="Newport Beach, California, United States 2. Stanford Hospital, Stanford, California," exact="United States" post="3. Providence Regional Medical left Everett, Everett, Washington, United"/>
   <result pre="United States 3. Providence Regional Medical left Everett, Everett, Washington," exact="United States" post="Fingolimod in COVID-19 Fingolimod 0.5 mg Recruiting Wan-Jin Chen"/>
   <result pre="Fingolimod in COVID-19 Fingolimod 0.5 mg Recruiting Wan-Jin Chen Fuzhou," exact="China" post="The Clinical Study of Carrimycin on Treatment Patients With"/>
   <result pre="province hospital of integrated Chinese &amp;amp; Western Medicine Wuhan, Hubei," exact="China" post="2. Yichang first people's Hospital Yichang, Hubei, China 3."/>
   <result pre="Wuhan, Hubei, China 2. Yichang first people's Hospital Yichang, Hubei," exact="China" post="3. Renmin Hospital of Wuhan UniversityWuhan, China Evaluation of"/>
   <result pre="Hospital Yichang, Hubei, China 3. Renmin Hospital of Wuhan UniversityWuhan," exact="China" post="Evaluation of the Efficacy and Safety of Sarilumab in"/>
   <result pre="COVID-19 Sarilumab Recruiting Regeneron Study Site New York, New York," exact="United States" post="Mild/Moderate 2019-nCoV Remdesivir RCT Remdesivir Recruiting Jin Yin-tan hospital"/>
   <result pre="Remdesivir RCT Remdesivir Recruiting Jin Yin-tan hospital Wu Han, Hubei," exact="China" post="Adaptive COVID-19 Treatment Trial Remdesivir Recruiting 1. National Institutes"/>
   <result pre="and Infectious Diseases Laboratory of Immunoregulation, Clinical Research SectionBethesda, Maryland," exact="United States" post="2. University of Nebraska Medical left - Infectious DiseasesOmaha,"/>
   <result pre="2. University of Nebraska Medical left - Infectious DiseasesOmaha, Nebraska," exact="United States" post="3. University of Texas Medical Branch - Division of"/>
   <result pre="of Texas Medical Branch - Division of Infectious DiseaseGalveston, Texas," exact="United States" post="4. Providence Sacred Heart Medical leftSpokane, Washington, United States"/>
   <result pre="Texas, United States 4. Providence Sacred Heart Medical leftSpokane, Washington," exact="United States" post="Ongoing Clinical Trials for the Management of the COVID-19"/>
   <result pre="Pandemic Thymosin; suramin; conventional treatment + adalimumab Not yet recruiting" exact="China" post="Severe 2019-nCoV Remdesivir RCT Remdesivir Recruiting Bin Cao; Beijing,"/>
   <result pre="Severe 2019-nCoV Remdesivir RCT Remdesivir Recruiting Bin Cao; Beijing, Beijing," exact="China" post="Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome"/>
   <result pre="Washington Health Research Institute - Vaccines and Infectious DiseasesSeattle, Washington," exact="United States" post="Study to Evaluate the Safety and Antiviral Activity of"/>
   <result pre="(COVID-19) Remdesivir Recruiting 1. Hoag Memorial Hospital PresbyterianNewport Beach, California," exact="United States" post="2. Stanford Hospital, Stanford, California, United States 3. Providence"/>
   <result pre="PresbyterianNewport Beach, California, United States 2. Stanford Hospital, Stanford, California," exact="United States" post="3. Providence Regional Medical left Everett, Everett, Washington, United"/>
   <result pre="United States 3. Providence Regional Medical left Everett, Everett, Washington," exact="United States" post="Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment"/>
   <result pre="IFN-beta Combination for nCoV Treatment 1. Lopinavir/ritonavir Recruiting University of" exact="Hong Kong," post="Queen Mary Hospital 2. Ribavirin Hong Kong, Hong Kong"/>
   <result pre="Recruiting University of Hong Kong, Queen Mary Hospital 2. Ribavirin" exact="Hong Kong," post="Hong Kong 3. Interferon Beta-1B Efficacy of Chloroquine and"/>
   <result pre="of Hong Kong, Queen Mary Hospital 2. Ribavirin Hong Kong," exact="Hong Kong" post="3. Interferon Beta-1B Efficacy of Chloroquine and Lopinavir/ Ritonavir"/>
   <result pre="Failure Methylprednisolone Recruiting Medical ICU,Peking Union Medical College HospitalBeijing, Beijing," exact="China" post="The efficacy and safety of carrimycin treatment in patients"/>
   <result pre="citrate Recruiting Department and Institute of Infectious Disease, Wuhan, Hubei," exact="China" post="A study for the efficacy of hydroxychloroquine for mild"/>
   <result pre="Randomized Control Trial Oral Not yet recruiting Subsai Kongsaengdao, Bangkok," exact="Thailand" post="Randomized Controlled Trial of Losartan for Patients With COVID-19"/>
   <result pre="Losartan Not yet recruiting Hennepin County Medical left, Minneapolis, Minnesota," exact="United States" post="M Health Fairview University of Minnesota Medical left, Minneapolis,"/>
   <result pre="M Health Fairview University of Minnesota Medical left, Minneapolis, Minnesota," exact="United States" post="University of Minnesota, Minneapolis, Minnesota, United States Chloroquine Prevention"/>
   <result pre="left, Minneapolis, Minnesota, United States University of Minnesota, Minneapolis, Minnesota," exact="United States" post="Chloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare"/>
   <result pre="Tocilizumab Recruiting Anhui Medical University Affiliated First Hospital, Hefei, Anhui," exact="China" post="Guiqiang Wang, Beijing, Beijing, China Peking University First Hospital,"/>
   <result pre="Affiliated First Hospital, Hefei, Anhui, China Guiqiang Wang, Beijing, Beijing," exact="China" post="Peking University First Hospital, Beijing, Beijing, China Trial of"/>
   <result pre="Wang, Beijing, Beijing, China Peking University First Hospital, Beijing, Beijing," exact="China" post="Trial of Treatments for COVID-19 in Hospitalized Adults 1."/>
   <result pre="Losartan Not yet recruiting Hennepin County Medical left, Minneapolis, Minnesota," exact="United States" post="M Health Fairview University of Minnesota Medical left, Minneapolis,"/>
   <result pre="M Health Fairview University of Minnesota Medical left, Minneapolis, Minnesota," exact="United States" post="University of Minnesota, Minneapolis, Minnesota, United States Comparison of"/>
   <result pre="left, Minneapolis, Minnesota, United States University of Minnesota, Minneapolis, Minnesota," exact="United States" post="Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients with Mild"/>
   <result pre="Medical left, University of Ulsan College of Medicine, Seoul, Korea," exact="Republic of" post="Korea Evaluation of Ganovo (Danoprevir) Combined with Ritonavir in"/>
   <result pre="ritonavir +/-Interferon Recruiting The Ninth Hospital of Nanchang Nanchang, Jiangxi," exact="China" post="Eculizumab (Soliris) in Covid-19 Infected Patients Eculizumab Initiated -"/>
   <result pre="Prophylaxis for SARS-Coronavirus-2 Hydroxychloroquine Recruiting University of Minnesota, Minneapolis, Minnesota," exact="United States" post="The efficacy and safety of pirfenidone capsules in the"/>
   <result pre="138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan," exact="China" post="Oseltamivir Recruiting Zhongnan Hospital of Wuhan University in Wuhan,"/>
   <result pre="China Oseltamivir Recruiting Zhongnan Hospital of Wuhan University in Wuhan," exact="China" post="Expanded Access Remdesivir (RDV; GS-5734TM) Remdesivir Initiated - The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196535\results\search\country\results.xml">
   <result pre="Traditional Chinese Medicine Prescriptions (Peng, 1996) and Pharmacopoeia of the" exact="People's Republic of China" post="(Pharmacopoeia Commission China, 2015) were used to screened the"/>
   <result pre="Chinese Medicine Prescriptions (Peng, 1996) and Pharmacopoeia of the People's" exact="Republic of" post="China (Pharmacopoeia Commission China, 2015) were used to screened"/>
   <result pre="Prescriptions (Peng, 1996) and Pharmacopoeia of the People's Republic of" exact="China" post="(Pharmacopoeia Commission China, 2015) were used to screened the"/>
   <result pre="data were standardized on the basis of Pharmacopoeia of the" exact="People's Republic of China" post="(Peng, 1996) and the Chinese Materia Medica (Zhu, 1998)."/>
   <result pre="were standardized on the basis of Pharmacopoeia of the People's" exact="Republic of" post="China (Peng, 1996) and the Chinese Materia Medica (Zhu,"/>
   <result pre="on the basis of Pharmacopoeia of the People's Republic of" exact="China" post="(Peng, 1996) and the Chinese Materia Medica (Zhu, 1998)."/>
   <result pre="a CM prescription recommended by the National Health Commission of" exact="China" post="for the treatment of COVID-19, which was optimized by"/>
   <result pre="care workers during the severe acute respiratory syndrome epidemic in" exact="Hong Kong" post="to prevent severe acute respiratoryJ. Alternat. Complement. Med.1120054955 LiX.CaiY.P.TuS.Y.WuY.T.LiL.J.Treatment"/>
   <result pre="Medical Publishing HouseBeijing collab: Pharmacopoeia Commission ChinaPharmacopoeia of the People's" exact="Republic of" post="China2015Chemical Industry PressBeijing QiuJ.When the east meets the west:"/>
   <result pre="1 Acknowledgements The authors thank the 10.13039/501100001809Natural Science Foundation of" exact="China" post="(NSFC) for their financial support, this work was supported"/>
   <result pre="supported by the 10.13039/501100012166National Key Research and Development Program of" exact="China" post="(2017YFC1702703), the 10.13039/501100001809National Natural Science Foundation of China (Nos."/>
   <result pre="Program of China (2017YFC1702703), the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(Nos. 41806191; 81473369), and the Key R &amp;amp; D"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196844\results\search\country\results.xml">
   <result pre="Klinische Pharmakologie und Toxikologie CharitÃ©â€&quot;UniversitÃ¤tsmedizin Berlin Luisenstr. 7, 10117 Berlin," exact="Germany" post="ralf.stahlmann@charite.de ppub: 2020-3epub: 2020-3-3pmc-release: 2020-3-311713213219received: 2020-3-4accepted: 2020-3-13 Background With"/>
   <result pre="standard supportive treatment. The virus SARS-CoV-2, first isolated in Wuhan," exact="China" post="and the pathogen responsible for COVID-19, is spreading rapidly"/>
   <result pre="syndrome (MERS) hit the headlines. MERS was first diagnosed in" exact="Saudi Arabia" post="in 2012 and was fatal in around one in"/>
   <result pre="(figure). Camostat, an inhibitor of this protease, is licensed in" exact="Japan" post="for treatment of chronic pancreatitis (4), but no clinical"/>
   <result pre="such as oseltamivir, darunavir, and umifenovir, which was developed in" exact="Russia" post="for the treatment of influenza (table 1). In view"/>
   <result pre="patients with worsening clinical symptoms received this medication in a" exact="Singapore" post="hospital. Improvement was seen in three patients, but not"/>
   <result pre="of the treatment of a 35-year-old man with COVID-19 in" exact="the USA" post="was published on 5 March 2020 (14). This was"/>
   <result pre="2, 0.5 g on day 3 2900 Lihir Medical Center" exact="Spain" post="(Catalonia)Department of Health, Generalitat de Catalunya July 2020 Hydroxychloroquine"/>
   <result pre="daily for 5 days 30 Shanghai Public Health Clinical Center" exact="China" post="August 2020 Remdesivir Placebo-controlled double-blind trial (1:1 randomization)Participants: Moderately"/>
   <result pre="in 308 patients with mild symptoms. 453 Capital Medical UniversityPeking" exact="China" post="April 2020 Remdesivir Open trial, comparison with standard treatmentParticipants:"/>
   <result pre="2 Ã— 500 mg/day for 2 weeks 400 Tongji Hospital" exact="China" post="July 2020 Thalidomide Placebo-controlled double-blind trialParticipants: Patients with PCR-confirmed"/>
   <result pre="14 days 100 Second Affiliated Hospital of Wenzhou Medical University" exact="China" post="June 2020 rh-ACE2 Pilot study, open designParticipants: Patients with"/>
   <result pre="standard treatment 24 First Affiliated Hospital of Guangzhou Medical University" exact="China" post="April 2020 *1 Altogether, &amp;gt;80 trials have been registered"/>
   <result pre="viral RNA-dependent RNA polymerase, licensed for treatment of influenza in" exact="Japan" post="62 Penciclovir Nucleoside analog, guanosine derivative, inhibits viral DNA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196923\results\search\country\results.xml">
   <result pre="above 130,000 around the world. Infected people in Europe and" exact="America" post="correspond about 40% and 30% of the total reported"/>
   <result pre="Spike ACE2 receptor antiviral drugs COVID-19 Funding National Science Centre," exact="Poland" post="This work was supported by the National Science Centre,"/>
   <result pre="countries, Europe, North America, Asia, Middle East, Africa, and Latin" exact="America" post="(Coronavirus COVID-19 Global Cases by the Center for Systems"/>
   <result pre="help to Ebola patients during the 2019 outbreak in the" exact="Democratic Republic of the Congo." post="A coronavirus research at the university of Iowa suggested"/>
   <result pre="to Ebola patients during the 2019 outbreak in the Democratic" exact="Republic of" post="the Congo. A coronavirus research at the university of"/>
   <result pre="PillaiS. K. (2020). First case of 2019 novel coronavirus in" exact="the United States." post="New England Journal of Medicine, 382(10), 929â€&quot;936. 10.1056/NEJMoa200119132004427 HuangC.,"/>
   <result pre="K. (2020). First case of 2019 novel coronavirus in the" exact="United States." post="New England Journal of Medicine, 382(10), 929â€&quot;936. 10.1056/NEJMoa200119132004427 HuangC.,"/>
   <result pre="Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of" exact="China" post="International Exchange and Promotive Association for Medical and Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7197577\results\search\country\results.xml">
   <result pre="22.JainS, KamimotoL, BramleyAMet al..Hospitalized patients with 2009 H1N1 influenza in" exact="the United States," post="April-June 2009. N Engl J Med. 2009;361(20):1935-1944.19815859 23.TokuhiraN, ShimeN,"/>
   <result pre="KamimotoL, BramleyAMet al..Hospitalized patients with 2009 H1N1 influenza in the" exact="United States," post="April-June 2009. N Engl J Med. 2009;361(20):1935-1944.19815859 23.TokuhiraN, ShimeN,"/>
   <result pre="TasherD, GlikmanDet al..Hospitalization of children with influenza A(H1N1) virus in" exact="Israel" post="during the 2009 outbreak in Israel: a multicenter survey."/>
   <result pre="East respiratory syndrome coronavirus infection in the Makkah region of" exact="Saudi Arabia," post="March to June 2014. Ann Saudi Med. 2015;35(3):203-209.26409794 36.SaadM,"/>
   <result pre="Middle East respiratory syndrome coronavirus infection: a single-center experience in" exact="Saudi Arabia." post="Int J Infect Dis. 2014;29(6):301-306.25303830 37.ArabiYM, Al-OmariA, MandourahYet al..Critically"/>
   <result pre="presentation and outcomes of Middle East respiratory syndrome in the" exact="Republic of" post="Korea. Infect Chemother. 2016;48(2):118-126.27433382 39.AssiriA, Al-TawfiqJA, Al-RabeeahAAet al..Epidemiological, demographic,"/>
   <result pre="factors in 267 patients with severe acute respiratory syndrome in" exact="Hong Kong." post="Ann Intern Med. 2003;139(9):715-723.14597455 43.TsaiLK, HsiehST, ChangYCNeurological manifestations in"/>
   <result pre="and clinical characteristics of 28 cases of coronavirus disease in" exact="South Korea." post="Osong Public Health Res Perspect. 2020;11(1):8-14.32149037 61.HuangC, WangY, LiXet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7198433\results\search\country\results.xml">
   <result pre="presentation greatly resembling SARS-CoV [[1], [2], [3]]. COVID-19 started in" exact="China" post="but now is present in many different countries with"/>
   <result pre="different countries with the highest number of cases in US," exact="Italy" post="and Spain among others. To better understand this new"/>
   <result pre="with the highest number of cases in US, Italy and" exact="Spain" post="among others. To better understand this new global epidemic"/>
   <result pre="on COVID-19 in sewage in Europe was reported recently in" exact="the Netherlands," post="by RIVM National Institute for Public Health and the"/>
   <result pre="weeks later COVID-19 virus was detected in sewage waters from" exact="Australia" post="[6] and Paris, France [7]. Detection of SARS-CoV-2 is"/>
   <result pre="was detected in sewage waters from Australia [6] and Paris," exact="France" post="[7]. Detection of SARS-CoV-2 is generally carried out with"/>
   <result pre="therapies were reported and are being used in trials in" exact="the US," post="France and Spain. 2 Meteorology and air quality influence"/>
   <result pre="reported and are being used in trials in the US," exact="France" post="and Spain. 2 Meteorology and air quality influence Zhou"/>
   <result pre="studies were performed in this regard in the North of" exact="Italy" post="this year [11,12]. Results reported in both studies go"/>
   <result pre="with poor air quality like some in the North of" exact="Italy" post="increased probability of COVID-19 infections are mainly due to"/>
   <result pre="to human-to-human. The other selected paper also from North of" exact="Italy" post="indicates that Lombardy and Emilia Romagna are some of"/>
   <result pre="death cases taken from 66 administrative regions in Italy, Spain," exact="France" post="and Germany [14]. Results show that out of the"/>
   <result pre="taken from 66 administrative regions in Italy, Spain, France and" exact="Germany" post="[14]. Results show that out of the 4443 fatality"/>
   <result pre="3487 (78 %) were in five regions located in North" exact="Italy" post="and central Spain. Additionally, the same five regions show"/>
   <result pre="correlation may not be applicable to other countries such as" exact="Taiwan" post="that although exhibits high NO2 levels does not follow"/>
   <result pre="the pollen, that starts in spring. A recent paper from" exact="the Netherlands" post="is not on COVID-19 but flu and collects data"/>
   <result pre="pollen, that starts in spring. A recent paper from the" exact="Netherlands" post="is not on COVID-19 but flu and collects data"/>
   <result pre="public health. The first data detecting COVID-19 in sewage from" exact="the Netherlands" post="[5], Australia [6] and Paris, France [7] supports this"/>
   <result pre="health. The first data detecting COVID-19 in sewage from the" exact="Netherlands" post="[5], Australia [6] and Paris, France [7] supports this"/>
   <result pre="first data detecting COVID-19 in sewage from the Netherlands [5]," exact="Australia" post="[6] and Paris, France [7] supports this idea of"/>
   <result pre="in sewage from the Netherlands [5], Australia [6] and Paris," exact="France" post="[7] supports this idea of using WBE to reveal"/>
   <result pre="performed on indoor air quality at the largest hospital in" exact="Iran" post="[24]. The air of patient rooms with confirmed COVID-19"/>
   <result pre="[27]. Disinfection procedures applied to hospitals indoor facilities developed in" exact="China" post="used mainly chlorine [28]. For the contaminated areas, disinfection"/>
   <result pre="anti-inflammatory [3,[29], [30], [31]]. There are also publications, mainly from" exact="China" post="and India [3], who recommended traditional medicinal plants to"/>
   <result pre="[30], [31]]. There are also publications, mainly from China and" exact="India" post="[3], who recommended traditional medicinal plants to treat COVID-19."/>
   <result pre="anti-malaria drug hydroxychloroquine is used in clinical trials in Marseille," exact="France" post="and some parts of US. Important information needs to"/>
   <result pre="the submission of the revised version of this Opinion Paper" exact="the US" post="National Institute of Allergy and Infectious Disease (NIAID) did"/>
   <result pre="certainly more important and need to be in place. In" exact="Spain" post="up till now 15 % of the people infected"/>
   <result pre="from Coronavirus disease (COVID19) pandemic â€&quot; case study from the" exact="Republic of" post="IrelandSci. Total Environ.725202013853232304970 26LaiaA.C.K.NunayonaS.S.TanbT.F.LicW.S.A pilot study on the disinfection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7199720\results\search\country\results.xml">
   <result pre="suffering. Importantly, there are also academically skilled TCM experts in" exact="China" post="who have rich clinical experiences and can properly treat"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7199731\results\search\country\results.xml">
   <result pre="drug discoveryBr. J. Pharmacol.16220111239124921091654 130HuangH.-J.YuH.W.ChenC.-Y.HsuC.-H.ChenH.-Y.LeeK.-J.Current developments of computer-aided drug designJ." exact="Taiwan" post="Inst. Chem. Eng.412010623635 131KapetanovicI.Computer-aided drug discovery and development (CADDD):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7200052\results\search\country\results.xml">
   <result pre="identified in several cases of acute respiratory syndrome in Wuhan," exact="China" post="in December 2019. On March 11 2020, WHO declared"/>
   <result pre="coronavirus identified in patients with acute respiratory syndrome in Wuhan," exact="China" post="in December 2019 [1, 2]. Since then, the SARS-CoV-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202545\results\search\country\results.xml">
   <result pre="Age distribution of the infected and diseased patients in Mainland" exact="China" post="through February 11, 2020. The figures are adopted and"/>
   <result pre="According to the online period life tables put out by" exact="the US" post="Social Security Administration [18], the annual chance of death"/>
   <result pre="to 14.8% by the age 89. According to estimates by" exact="the US" post="Centers for Disease Control [19], approximately 5,945,690 individuals older"/>
   <result pre="to a SARS-CoV-2 vaccine, most of them taking place in" exact="China" post="[30]. Broadly speaking, the success of a vaccine partly"/>
   <result pre="Symptomatic treatments According to the recent COVID-19 treatment guidelines in" exact="China" post="[43], symptomatic treatment for COVID-19 patients is recommended for"/>
   <result pre="are variable, we share a common concern that outside of" exact="China" post="there may be an insufficient number of beds for"/>
   <result pre="Control. Estimated Influenza Illnesses, Medical visits, Hospitalizations, and Deaths in" exact="the United States" post="â€&quot; 2017â€&quot;2018 influenza season.https://www.cdc.gov/flu/about/burden/2017-2018.htm 20GuanW, NiZ, HuY, LiangW, OuC,"/>
   <result pre="Estimated Influenza Illnesses, Medical visits, Hospitalizations, and Deaths in the" exact="United States" post="â€&quot; 2017â€&quot;2018 influenza season.https://www.cdc.gov/flu/about/burden/2017-2018.htm 20GuanW, NiZ, HuY, LiangW, OuC,"/>
   <result pre="LeiC, HuiDSC, DuB, LiL, ZengG, et al., collab: for the" exact="China" post="Medical Treatment Expert Group for Covid-19*. Clinical Characteristics of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202626\results\search\country\results.xml">
   <result pre="Reaction : People and Places : Geographical Locations : Asia:" exact="Japan" post=": Research and Analysis Methods : Mathematical and Statistical"/>
   <result pre="of rapid test results seems to be much higher in" exact="Japan" post="than in other countries, because approximately 90% of influenza"/>
   <result pre="though over 20 million cases of infection were reported in" exact="Japan" post="during the 2009 H1N1pdm pandemic, only 198 deaths were"/>
   <result pre="of influenza based on clinical symptoms alone is difficult. In" exact="the US," post="antiviral treatment was infrequently prescribed for outpatients with influenza"/>
   <result pre="Public Health noted that the reliability of rapid tests in" exact="Japan" post="seems to be higher than that in other countries,"/>
   <result pre="and specificity of an RIDT that is widely used in" exact="Japan" post="(ImunoAce Flu, TAUNS, Shizuoka, Japan), and to demonstrate its"/>
   <result pre="adult patients (Table 1). The performance of RIDTs used in" exact="Japan" post="might be higher than those reported in the meta-analysis"/>
   <result pre="The Clinical Practice Guidelines by the Infectious Diseases Society of" exact="America" post="(IDSA) emphasize that clinicians should collect upper respiratory tract"/>
   <result pre="important factor related to the high sensitivity of RIDTs in" exact="Japan" post="was the measure used to collect samples for RIDTs."/>
   <result pre="[9]. The manuals for the other RIDT kits used in" exact="Japan" post="report their sensitivity (88%â€&quot;100%) and specificity (94%â€&quot;100%) [19]. The"/>
   <result pre="A/H1N1pdm09 virus (40â€&quot;69%) in the H1N1 pandemic of 2009 in" exact="the US" post="[24]. The IDSA guidelines recommend that clinicians use rapid"/>
   <result pre="rapid molecular assays [9] [25]. Similarly, in a report from" exact="Japan" post="[25], sensitivity and specificity of an RIDT, QUICKNAVI (Otsuka"/>
   <result pre="of Health, Labour and Welfare. Countermeasures for influenza epidemic of" exact="Japan" post="(in Japanese) 2019 [https://www.mhlw.go.jp/bunya/kenkou/influenza/. 4HaydenFG, SugayaN, HirotsuN, LeeN, de"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202804\results\search\country\results.xml">
   <result pre="in Western countries and, in particular, in the elderly. In" exact="Spain" post="and Italy, one of the countries that should theoretically"/>
   <result pre="of the Mediterranean diet and current food consumption patterns in" exact="Spain" post="from a nutritional and water perspectiveSci Total Environ66420191020102930769304 9GrossoG.MarventanoS.GiorgianniG.RacitiT.GalvanoF.MistrettaA.Mediterranean"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202810\results\search\country\results.xml">
   <result pre="propelled various treatment modalities that have not been approved by" exact="the US" post="Food and Drug Administration (FDA) to prevent or cure"/>
   <result pre="to both their own health and the public's health. In" exact="the United States," post="there has been controversy over discussions about injecting disinfectants"/>
   <result pre="both their own health and the public's health. In the" exact="United States," post="there has been controversy over discussions about injecting disinfectants"/>
   <result pre="and treat SARS-CoV-2 infection. For example, it is common in" exact="China" post="to use of herbal plants to fight the virus"/>
   <result pre="and temporal associations with COVID-19 - National Poison Data System," exact="United States," post="January 1, 2020â€&quot;March 31, 2020 [Internet]Ctr Dis Control Prev2020[cited"/>
   <result pre="Drug Metab12102011989996[R]21892916 15SardarizadehS.Coronavirus: misinformation and false medical advice spreads in" exact="Iran" post="[Internet][cited 2020Apr26]. Available fromhttps://www.bbc.com/news/world-middle-east-516775302020[BBC News. BBC] 16Risk communication: EPI-WIN"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202902\results\search\country\results.xml">
   <result pre="its use. The pandemic of SARS-CoV-2 which began in Wuhan," exact="China" post="from December 2019, has spread rapidly around the world."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7203261\results\search\country\results.xml">
   <result pre="novel coronavirus SARS-CoV-2, was observed for the first time in" exact="China" post="and then spread worldwide becoming pandemic. Currently, there is"/>
   <result pre="drug, recently involved in four phase III clinical trials in" exact="China" post="and United States [25], has a broad spectrum of"/>
   <result pre="involved in four phase III clinical trials in China and" exact="United States" post="[25], has a broad spectrum of antiviral activities against"/>
   <result pre="transmembrane serine protease (TMPRSS2) inhibitors like camostat mesilate, approved in" exact="Japan" post="for the treatment of pancreatic inflammation [10]. This drug"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7203543\results\search\country\results.xml">
   <result pre="During the COVID-19 Pandemic Among People Living with HIV in" exact="China" post="SunShufangshufang_sun@brown.edu12HouJianhua3ChenYaokai4LuYanqiu4BrownLarry12OperarioDon5[1], grid.240588.30000 0001 0557 9478Department of Psychiatry, Rhode Island"/>
   <result pre="in China SunShufangshufang_sun@brown.edu12HouJianhua3ChenYaokai4LuYanqiu4BrownLarry12OperarioDon5[1], grid.240588.30000 0001 0557 9478Department of Psychiatry, Rhode" exact="Island" post="Hospital, [2], grid.40263.330000 0004 1936 9094Department of Psychiatry and"/>
   <result pre="to note that prior to the COVID-19 outbreak, PLWH in" exact="China" post="were already affected by high levels of HIV stigma"/>
   <result pre="bias. In a recent report of a northeastern clinic in" exact="China" post="that synthesized patientsâ€™ data in the past ten years,"/>
   <result pre="by authorsâ€™ observations and clinical experience in HIV care in" exact="China" post="as well as preliminary findings from a recent survey"/>
   <result pre="findings from a recent survey we conducted among PLWH in" exact="China" post="(in February and March 2020, full report in writing)."/>
   <result pre="challenges during the COVID-19 outbreak experienced by PLWH in the" exact="China" post="context, including (1) linkage to care and access to"/>
   <result pre="Due to the city-level centralized management of infectious diseases in" exact="China" post="(e.g., PLWH are often assigned to certain hospitals designated"/>
   <result pre="strict quarantine enforcement and transportation lockdown in many regions across" exact="China" post="beginning in late January 2020 may have caused massive"/>
   <result pre="medical resources, departments of infectious diseases in many hospitals in" exact="China" post="were designated for COVID-19 and suspended on taking new"/>
   <result pre="we conducted a survey with PLWH from 25 provinces in" exact="China" post="(Nâ€‰=â€‰703) to capture HIV care and mental health challenges"/>
   <result pre="concerns related to medication disruption, hospitals and HIV clinics in" exact="China" post="have developed protocols to mail antiretroviral drugs to PLWH"/>
   <result pre="(i.e., Chinese lunar new year), the most important holiday in" exact="China" post="in which people travel to their hometowns to gather"/>
   <result pre="the COVID-19 outbreak. In our survey with 703 PLWH in" exact="China" post="(data collected in Februaryâ€&quot;March 2020), 60.8% reported depression, 49.8%"/>
   <result pre="suppression, and HIV transmission risk. Conclusion and Implications Lessons from" exact="China" post="may inform HIV care for PLWH globally during the"/>
   <result pre="dual epidemics of COVID-19 and HIV, the healthcare system in" exact="China" post="may need to adopt more flexibility, allocate resources successfully,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7206941\results\search\country\results.xml">
   <result pre="have qualified epidemiological and technical information, through scientific reports from" exact="China" post="and other countries that have been published in the"/>
   <result pre="The authorities announce the expansion of intensive care services in" exact="Brazil" post="to face the pandemic. Qualified personnel may not be"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7207128\results\search\country\results.xml">
   <result pre="antigenic insult which maintains cytokines release [11]. Interestingly, data from" exact="China" post="suggests the viral load is higher in patients with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7207154\results\search\country\results.xml">
   <result pre="globally in Charles Nicolle (1866â€&quot;1936), professor at the CollÃ¨ge de" exact="France" post="and director of the Institut Pasteur in Tunis, wrote"/>
   <result pre="reported in the countries of the intertropical zones, reaching Southern" exact="America" post="and Africa where containment will be difficult to achieve."/>
   <result pre="periods of exponential spread as is currently the case in" exact="the USA," post="France, Spain, or Italy. Not necessarily because the disease"/>
   <result pre="it during the epidemic of the Asian flu in the" exact="United Kingdom" post="in 1957. For a week to ten days, the"/>
   <result pre="Italy, Spain, France, UK and as we now see in" exact="the USA." post="Confinement and isolation at home have therefore been decided"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7207156\results\search\country\results.xml">
   <result pre="12: e12317 EMM: Following Italy, many other European countries and" exact="the USA" post="are implementing various degrees of quarantine/social distancing to slow"/>
   <result pre="other countries to escape the dramatic escalation we see in" exact="Italy" post="or the USA? GÃ©rard Krause (GK): We are looking"/>
   <result pre="to escape the dramatic escalation we see in Italy or" exact="the USA?" post="GÃ©rard Krause (GK): We are looking into a situation"/>
   <result pre="report a lower rate of increase in cases (in particular" exact="Taiwan" post="and Hong Kong) or decreasing numbers (Mainland China, Korea)."/>
   <result pre="countries were a lot better prepared to deal with outbreaks." exact="Hong Kong" post="in particular has had longâ€�standing preparedness with epidemics. China"/>
   <result pre="Hong Kong in particular has had longâ€�standing preparedness with epidemics." exact="China" post="implemented aggressive quarantine measures relatively early on. Korea quickly"/>
   <result pre="quickly responded by conducting massive testing and quarantining infected people." exact="Taiwan" post="also responded quickly and systematically to implement rapid testing"/>
   <result pre="in internal and tropical medicine, hospital hygiene and epidemiology in" exact="Germany" post="and the USA. Between 2000 and 2013, he was"/>
   <result pre="and tropical medicine, hospital hygiene and epidemiology in Germany and" exact="the USA." post="Between 2000 and 2013, he was unit head and"/>
   <result pre="1 trial for the mRNA vaccine has already begun in" exact="the USA." post="Since no vaccines have been tested even in animal"/>
   <result pre="a second infection wave in Wuhan, in the rest of" exact="China" post="or elsewhere once the first peak has passed? Recent"/>
   <result pre="Why do we see a low fatality rate in Singapore," exact="Hong Kong," post="Japan and South Korea despite high infection levels compared"/>
   <result pre="we see a low fatality rate in Singapore, Hong Kong," exact="Japan" post="and South Korea despite high infection levels compared to"/>
   <result pre="a low fatality rate in Singapore, Hong Kong, Japan and" exact="South Korea" post="despite high infection levels compared to higher death rates"/>
   <result pre="high infection levels compared to higher death rates in Italy," exact="Spain" post="or the USA? GK: Those are different stages in"/>
   <result pre="levels compared to higher death rates in Italy, Spain or" exact="the USA?" post="GK: Those are different stages in different countries and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7211516\results\search\country\results.xml">
   <result pre="in Coronavirus Disease 2019 https://orcid.org/0000-0001-8749-6018GasparyanArmen Yuri1https://orcid.org/0000-0002-5035-7396MisraDurga Prasanna2https://orcid.org/0000-0003-2511-6918YessirkepovMarlen3https://orcid.org/0000-0002-4188-8486ZimbaOlena4[1], UK[2], India[3], [4]," exact="Ukraine" post="Address for Correspondence: Armen Yuri Gasparyan, MD. Departments of"/>
   <result pre="the virus and 234,279 related deaths.1 The USA, Italy, UK," exact="Spain" post="and France are now the five countries with the"/>
   <result pre="and 234,279 related deaths.1 The USA, Italy, UK, Spain and" exact="France" post="are now the five countries with the highest death"/>
   <result pre="with antivirals (lopinavir/ritonavir) and methylprednisolone in severe COVID-19 in Wuhan," exact="China" post="demonstrated elevation of lymphocyte counts, decrease of inflammatory markers,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7211730\results\search\country\results.xml">
   <result pre="in COVID-19 outbreak in Italy, Spain, Iran, Turkey, USA and" exact="United Kingdom" post="appears to have a close correlation to probably inadequate"/>
   <result pre="Oronavirus (COVID-19) [Updated 2020 Apr 6]. in: StatPearls [Internet]. Treasure" exact="Island" post="(FL): StatPearls Publishing2020Available from:https://www.ncbi.nlm.nih.gov/books/NBK554776/ CavaC.BertoliG.CastiglioniI.In silico discovery of candidate"/>
   <result pre="risk of non-Hodgkin lymphoid malignancies in agricultural cohorts from France," exact="Norway" post="and the USA: a pooled analysis from the AGRICOH"/>
   <result pre="MinotS.BrysonA.ChehoudC.WuG.D.LewisJ.D.BushmanF.D.Rapid evolution of the human gut viromeProc. Natl. Acad. Sci." exact="U. S." post="A.110302013124501245510.1073/pnas.130083311023836644 ModiS.R.LeeH.H.SpinaC.S.CollinsJ.J.Antibiotic treatment expands the resistance reservoir and ecological"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7212074\results\search\country\results.xml">
   <result pre="MedAAEMArchives of Academic Emergency Medicine2645-4904Shahid Beheshti University of Medical SciencesTehran," exact="Iran" post="aaem-8-e51 : Review Article Management of Pemphigus in COVID-19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7212248\results\search\country\results.xml">
   <result pre="pandemic or the transitional phase, and clinical epidemiological data from" exact="China" post="can prove to be a guiding light for the"/>
   <result pre="be postponed safely?Urol Oncol2017354150.e9150.e1510.1016/j.urolonc.2016.11.010 20.KhoranaAATullioKElsonPPennellNAGrobmyerSRKaladyMFRaymondDAbrahamJKleinEAWalshRMMonteleoneEEWeiWHobbsBBolwellBJTime to initial cancer treatment in" exact="the United States" post="and association with survival over time: an observational studyPLoS"/>
   <result pre="postponed safely?Urol Oncol2017354150.e9150.e1510.1016/j.urolonc.2016.11.010 20.KhoranaAATullioKElsonPPennellNAGrobmyerSRKaladyMFRaymondDAbrahamJKleinEAWalshRMMonteleoneEEWeiWHobbsBBolwellBJTime to initial cancer treatment in the" exact="United States" post="and association with survival over time: an observational studyPLoS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7212283\results\search\country\results.xml">
   <result pre="to the above study, another study of 1099 patients from" exact="China" post="showed that the most common symptoms on admission were"/>
   <result pre="there has not been a study of COVID-19 patients in" exact="the United States" post="that reports on gastrointestinal symptoms. In a case series"/>
   <result pre="has not been a study of COVID-19 patients in the" exact="United States" post="that reports on gastrointestinal symptoms. In a case series"/>
   <result pre="not proven. In addition, the first case of COVID-19 in" exact="the United States" post="presented with a 2-day history of nausea and vomiting"/>
   <result pre="proven. In addition, the first case of COVID-19 in the" exact="United States" post="presented with a 2-day history of nausea and vomiting"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7213034\results\search\country\results.xml">
   <result pre="CoV (2014-16).[2] An acute respiratory illness broke out in Wuhan," exact="China" post="in December 2019. A novel virus belonging to the"/>
   <result pre="to be bat and Malayan pangolin species extensively used in" exact="China" post="for medicinal purposes are also involved in the transmission"/>
   <result pre="interference oligonucleotides therapies (RNAi) like siRNA (small interfering RNA) and" exact="India" post="based electroporated DNA vaccine are all in the race.[31]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7213617\results\search\country\results.xml">
   <result pre="of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing 400036," exact="China" post="E-Mail: yaokaichen@hotmail.com ppub: 2020-5-5epub: 2020-5-5133911321134received: 2020-2-06(C) , 2020This is"/>
   <result pre="On February 5, 2020, the National Health Commission of the" exact="People's Republic of China" post="and the National Administration of Traditional Chinese Medicine issued"/>
   <result pre="February 5, 2020, the National Health Commission of the People's" exact="Republic of" post="China and the National Administration of Traditional Chinese Medicine"/>
   <result pre="2020, the National Health Commission of the People's Republic of" exact="China" post="and the National Administration of Traditional Chinese Medicine issued"/>
   <result pre="2020;133:1132â€&quot;1134. doi: 10.1097/CM9.0000000000000790 References References 1.National Health Commission of the" exact="People's Republic of China." post="Guidelines for Diagnosis and Treatment of Novel Coronavirus Pneumonia"/>
   <result pre="doi: 10.1097/CM9.0000000000000790 References References 1.National Health Commission of the People's" exact="Republic of" post="China. Guidelines for Diagnosis and Treatment of Novel Coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7214230\results\search\country\results.xml">
   <result pre="serious epidemics [19]. In November 2002, SARS emerged in southern" exact="China" post="and the first case was recorded in Foshan city,"/>
   <result pre="from bats/civet cats [6]. Ten years later, MERS emerged in" exact="Saudi Arabia" post="and spread to about 27 different countries resulting in"/>
   <result pre="was initially isolated from stallholders who worked at the South" exact="China" post="seafood market in Wuhan City, Hubei Province, China [9,"/>
   <result pre="the South China seafood market in Wuhan City, Hubei Province," exact="China" post="[9, 10, 20]. This market illegally sells wild animals"/>
   <result pre="distribution The verified COVID-19 occurred at Wuhan City, Hubei Province," exact="China" post="but then the outbreak has rapidly evolved affecting other"/>
   <result pre="different countries and regions of Asia, Australia, Europe, and North" exact="America" post="[9]. Zoonotic nature of the COVID-19 COVID-19 is a"/>
   <result pre="Now the outbreak has rapidly evolved affecting other parts of" exact="China" post="(Fig.Â 1). The COVID-19 also occurred in different parts"/>
   <result pre="countries with a total of 780 confirmed cases [18]. Whereas" exact="Japan" post="reporting the highest number of cases. Therefore, keeping in"/>
   <result pre="an outbreak of the COVID-19 in different geographical regions of" exact="China" post="Most importantly, Pakistan is still safe from the outbreak"/>
   <result pre="the COVID-19 in different geographical regions of China Most importantly," exact="Pakistan" post="is still safe from the outbreak of this deadly"/>
   <result pre="safe from the outbreak of this deadly COVID-19. However, if" exact="Pakistan" post="will not take the precautionary measures on an urgent"/>
   <result pre="Chines Government have been extraordinary and were seeing the effects." exact="China" post="has completely locked down several cities, threatened quarantined violators"/>
   <result pre="severe acute respiratory syndromeN Engl J Med2003348201967197610.1056/NEJMoa03074712690091 4.FanYZhaoKShiZLZhouPBat Coronaviruses in" exact="China" post="Viruses201911321010.3390/v11030210 5.GalanteOAvniYSFuchsLFersterOAAlmogYCoronavirus NL63-induced adult respiratory distress syndromeAm J Respir"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7214343\results\search\country\results.xml">
   <result pre="represented 20%. Fifty-six percent of the reported cases were in" exact="Egypt" post="[8]. COVID-19 and liver transplantation: Based on previous observations"/>
   <result pre="On the other hand, reports during an influenza outbreak in" exact="Germany" post="in winter 2017/2018 showed increased organ failure scores of"/>
   <result pre="DDLT, and this type is the most widely used in" exact="the USA" post="and Europe [19]. The other type is LDLT, and"/>
   <result pre="only option available for patients living in some countries like" exact="Egypt" post="as cadaveric organ transplant is still banned there, and"/>
   <result pre="applied in one of the major centers of LTX in" exact="Portugal" post="is to test new liver transplant cases with PCR"/>
   <result pre="COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of" exact="India" post="(LTSI)Hepatol Int202010.1007/s12072-020-10041-1 33HuangC.WangY.LiX.Clinical features of patients infected with 2019"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7214347\results\search\country\results.xml">
   <result pre="epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in" exact="Italy" post="GentileSandroaMambroAndreabStrolloFelicefelix.strollo@gmail.comcâ�Ž[a], [b], [c], â�ŽCorresponding author at: Elle-Di and San"/>
   <result pre="long as the COVID-19 resource centre remains active. Keywords COVID-19" exact="Italy" post="Diabetes mellitus Comorbidities Chronically ill patients Between the end"/>
   <result pre="quarantine which guaranteed the outbreak switch-off in about two months." exact="Italy" post="recorded its first COVID-19 pandemic event on January 31,"/>
   <result pre="event on January 31, 2020, when two tourists coming from" exact="China" post="were found to be virus-positive in Rome [4]. On"/>
   <result pre="Fig. 3 depict the evolution pattern of the epidemic in" exact="Italy" post="throughout April 18, 2020 showing some slight positive signals,"/>
   <result pre="long-lasting trend. Fig. 1 Overall trend of the epidemic in" exact="Italy" post="as of April 18, 2020 with respect to progressive"/>
   <result pre="in the North (quite turbulent) and in the Center-South of" exact="Italy" post="(much slower) and now, when freezing the official picture"/>
   <result pre="clear difference? Despite discrepancies in timing, modality and rule severity," exact="China" post="and Italy adopted similar containment procedures, yet the spread"/>
   <result pre="Despite discrepancies in timing, modality and rule severity, China and" exact="Italy" post="adopted similar containment procedures, yet the spread of contagion"/>
   <result pre="of contagion was much faster in Northern than in Southern" exact="Italy" post="(almost invariably comparable to Lazio). It is quite evident"/>
   <result pre="prevalence estimates, since the very beginning of the epidemic in" exact="China" post="[15]. Table 3 Absolute and relative prevalence of most"/>
   <result pre="shows that death rate was significantly higher in infected Northern" exact="Italy" post="inhabitants than in their Southern counterpart (i.e. 17.2% vs"/>
   <result pre="https://www.iss.it/coronavirus) [12]. Fig. 5 Territorial differences in SARS-CoV-2 infection within" exact="Italy" post="as of April 16, 2020 (Source: Data from the"/>
   <result pre="more frequent among people living in the southern regions of" exact="Italy" post="[48]. The latter, however, display a slightly higher phenolic"/>
   <result pre="supported by a non-conditioning special grant of NYX startup, Naples," exact="Italy" post="Authorship: All authors meet the International Committee of Medical"/>
   <result pre="confirmed Covid-19 case traced back to November 17, inÂ South" exact="China" post="Morning Post, 13 marzo 2020Â https://www.scmp.com/news/china/society/article/3074991/coronavirus-chinas-first-confirmed-covid-19-case-traced-back. 2Coronavirus, il primo"/>
   <result pre="Res Clin Pract162202010813710.1016/j.diabres.2020.10813732259611 16ISS, Characteristics of SARS-CoV-2 patients dying in" exact="Italy" post="Report based on available data on April 16, 2020,"/>
   <result pre="16, 2020, https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_16_april_2020.pdf 17ESA. Coronavirus: nitrogen dioxide emissions fall in" exact="Italy" post="http://www.esa.int/Space_in_Member_States/Italy/Coronavirus_calano_in_Italia_le_emissioni_di_diossido_di_azoto 18Position paper. Relazione circa lâ€™effetto dellâ€™inquinamento da particolato"/>
   <result pre="Superiore di SanitÃ . Characteristics of SARS-CoV-2 patients dying in" exact="Italy" post="Report based on available data on April 20th, 2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7215132\results\search\country\results.xml">
   <result pre="as in various Universities in Latin America, Japan, China, Italy," exact="Spain" post="and other countries. He is the author of more"/>
   <result pre="is a Permanent Lecturer on Sustainable Rural Development in Latin" exact="America" post="at the University of California, Berkeley. She also teaches"/>
   <result pre="also teaches in various universities in Colombia, Brazil, Nicaragua, Argentina," exact="Spain" post="and Italy. She served as the president of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7215134\results\search\country\results.xml">
   <result pre="identified in several cases of acute respiratory syndrome in Wuhan," exact="China" post="in December 2019 [1, 2]. The transmission pathways of"/>
   <result pre="the 10-day treatment group (https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19). However, a trial conducted in" exact="China" post="showed Remdesivir did not improve patientsâ€™ condition nor reduced"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7216567\results\search\country\results.xml">
   <result pre="the British Eire Association of Vitreoretinal Surgeons (BEAVRS) and the" exact="United Kingdom" post="&amp;amp; Ireland Society of Cataract &amp;amp; Refractive Surgeons [UKISCRS]"/>
   <result pre="Association of Vitreoretinal Surgeons (BEAVRS) and the United Kingdom &amp;amp;" exact="Ireland" post="Society of Cataract &amp;amp; Refractive Surgeons [UKISCRS] have issued"/>
   <result pre="in ophthalmology during the novel coronavirus outbreak: an experience from" exact="Hong Kong." post="Graefes Arch Clin Exp Ophthalmol. 2020. 10.1007/s00417-020-04641-8. 22.Dawn Sim"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7216760\results\search\country\results.xml">
   <result pre="addressed. With over 1.3 million positive cases of COVID-19 in" exact="the US" post="based solely on the results of RNA molecular tests,"/>
   <result pre="targets for current drug repurposing efforts. Camostat mesylate, approved in" exact="Japan" post="for treatment of pancreatic inflammation, has been shown to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7217781\results\search\country\results.xml">
   <result pre="Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) that originated from Wuhan," exact="China" post="in late 2019. It was classified as a global"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7217786\results\search\country\results.xml">
   <result pre="treatment of the Ebola virus infection [110]. Health authorities in" exact="China" post="have initiated clinical trials at multiple places in Hubei"/>
   <result pre="trial. National Institute of Allergy and Infectious Diseases (NIAID) in" exact="the US" post="are conducting phase II trial. The French National Institute"/>
   <result pre="well as the Chinese medicine formulate were also recommended by" exact="China" post="for treatment of COVID-19 [116]. Currently, for clinical treatment"/>
   <result pre="and transcription [129,130]. It has been approved for listing in" exact="Japan" post="[131,132]. With this in mind, it is quite urgent"/>
   <result pre="genes, was developed by Shenzhen Geno-Immune Medical Institute (SGIMI) in" exact="China" post="and used for injection of people along with activated"/>
   <result pre="were approved for clinical trial as well, developed by the" exact="China" post="National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development"/>
   <result pre="(NCT04336410); Bifidobacterium probiotic carrying S protein gene by Symvivo in" exact="Canada" post="(NCT04334980); adenovirus vaccine vector carrying S protein in UK"/>
   <result pre="coronavirus disease 2019 and influenza A: a report from IranArch" exact="Iran" post="Med23202023924332271596 5WuX.CaiY.HuangX.YuX.ZhaoL.WangF.Co-infection with SARS-CoV-2 and influenza A virus in"/>
   <result pre="63LeungG.M.HedleyA.J.HoL.M.ChauP.WongI.O.ThachT.Q.The epidemiology of severe acute respiratory syndrome in the 2003" exact="Hong Kong" post="epidemic: an analysis of all 1755 patientsAnn Intern Med141200466267315520422"/>
   <result pre="fatal case of Middle East respiratory syndrome coronavirus infection in" exact="the United Arab Emirates," post="April 2014Am J Pathol186201665265826857507 91NichollsJ.M.PoonL.L.LeeK.C.NgW.F.LaiS.T.LeungC.Y.Lung pathology of fatal severe"/>
   <result pre="case of Middle East respiratory syndrome coronavirus infection in the" exact="United Arab Emirates," post="April 2014Am J Pathol186201665265826857507 91NichollsJ.M.PoonL.L.LeeK.C.NgW.F.LaiS.T.LeungC.Y.Lung pathology of fatal severe"/>
   <result pre="vaccines: recommendations of the advisory committee on immunization practices -" exact="United States," post="2017-18 influenza seasonMMWR Recomm Rep (Morb Mortal Wkly Rep)662017120"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7218355\results\search\country\results.xml">
   <result pre="[8], [9], [10], Alan DL Sihoe, Department of Surgery, Gleneagles" exact="Hong Kong" post="Hospital, Nam Fung Path, Wong Chuk Hang, Hong Kong"/>
   <result pre="Gleneagles Hong Kong Hospital, Nam Fung Path, Wong Chuk Hang," exact="Hong Kong" post="SAR, China. Email: asihoe@gmail.com epub: 2020-5-5ppub: 2020-6285243249(C) SAGE Publications,"/>
   <result pre="everywhere in tailoring their own responses to the COVID-19 challenge." exact="Hong Kong," post="China Hong Kong has largely avoided a massive surge"/>
   <result pre="tailoring their own responses to the COVID-19 challenge. Hong Kong," exact="China Hong Kong" post="has largely avoided a massive surge in the incidence"/>
   <result pre="their own responses to the COVID-19 challenge. Hong Kong, China" exact="Hong Kong" post="has largely avoided a massive surge in the incidence"/>
   <result pre="of people that normally travel daily between it and mainland" exact="China" post="where the virus outbreak was first reported. This is"/>
   <result pre="is probably due to a combination of two factors.5 First," exact="Hong Kong" post="was the epicentre of the 2003 SARS outbreak, and"/>
   <result pre="situation in Wuhan in January 2020, the vast majority of" exact="Hong Kong" post="people spontaneously began rigorous mask-wearing, personal hygiene, and social"/>
   <result pre="8, before a single case had even been confirmed in" exact="Hong Kong," post="the new â€œsevere respiratory disease associated with a novel"/>
   <result pre="January 25, when there were only 5 confirmed cases in" exact="Hong Kong," post="the Hospital Authority activated its emergency response level, suspending"/>
   <result pre="focused on the COVID-19 response. The private healthcare sector in" exact="Hong Kong" post="is relatively large and robust, and private hospitals quickly"/>
   <result pre="of normal service, including elective surgery. Cardiothoracic surgery services in" exact="Hong Kong" post="during the COVID-19 outbreak have been affected to a"/>
   <result pre="controlled, the ward and intensive care unit bed situation in" exact="Hong Kong" post="has not been excessively strained and has not compromised"/>
   <result pre="recent uptick in the number of COVID-19 cases due to" exact="Hong Kong" post="citizens returning from abroad and a mini-outbreak from those"/>
   <result pre="provision of cardiothoracic surgery services may yet come under review." exact="India" post="India saw its first cases on January 30, 2020,"/>
   <result pre="of cardiothoracic surgery services may yet come under review. India" exact="India" post="saw its first cases on January 30, 2020, originating"/>
   <result pre="to healthcare and testing. The infection rate of COVID-19 in" exact="India" post="is reported to be 1.7%, significantly lower than in"/>
   <result pre="suspended and international incoming and outgoing flights have been suspended." exact="Japan" post="After a patient in Japan was first diagnosed with"/>
   <result pre="outgoing flights have been suspended. Japan After a patient in" exact="Japan" post="was first diagnosed with COVID-19 infection on January 15,"/>
   <result pre="January 22, 2020. The first death of a patient in" exact="Japan" post="was confirmed on February 13. In the early phase,"/>
   <result pre="to continue the surgery required during this difficult period. Shanghai," exact="China" post="As of April 2020, the situation in Shanghai has"/>
   <result pre="over 300, most of them coming from other places in" exact="China" post="or from other countries. With merely 3 deaths so"/>
   <result pre="was suspended in most general hospitals when the situation in" exact="China" post="was critical in late January and early February. Invasive"/>
   <result pre="is safe, as long as enough precautions have been taken.10" exact="Singapore" post="Singapore confirmed its first COVID-19 infection on January 23,"/>
   <result pre="safe, as long as enough precautions have been taken.10 Singapore" exact="Singapore" post="confirmed its first COVID-19 infection on January 23, 2020."/>
   <result pre="About a week later, a 47-year-old woman who travelled to" exact="China" post="was confirmed to have coronavirus. At the time of"/>
   <result pre="was confirmed to have coronavirus. At the time of writing," exact="Singapore" post="had reported a total of 1375 confirmed COVID-19 cases"/>
   <result pre="outbreaks like this, including customized intensive care. This has helped" exact="Singapore" post="to concentrate all infected cases in one hospital so"/>
   <result pre="and pandemics cannot be overemphasized. In a paper published by" exact="Singapore" post="researchers in the Lancet on March 2020, the median"/>
   <result pre="dangerous then SARS. This phenomenon is clearly being experienced in" exact="Singapore" post="with a second wave of infections. Hence, a month"/>
   <result pre="mid-April 2020. Hopefully, this will be the last wave and" exact="Singapore" post="can get back to normal 3 months down the"/>
   <result pre="can get back to normal 3 months down the line." exact="South Korea" post="In South Korea, SARS-CoV-2 was detected and confirmed as"/>
   <result pre="to normal 3 months down the line. South Korea In" exact="South Korea," post="SARS-CoV-2 was detected and confirmed as COVID-19 for the"/>
   <result pre="should be shared to minimize casualties in this global crisis." exact="Taiwan" post="From the lesson learned from the SARS outbreak in"/>
   <result pre="From the lesson learned from the SARS outbreak in 2003," exact="Taiwan" post="started its prevention program the first moment that person-to-person"/>
   <result pre="surgical masks, N95 masks, and negative-pressure control rooms by the" exact="Taiwan" post="Center for Disease Control, to ensure their availability for"/>
   <result pre="numbers in all surgical departments, medical and surgical practice in" exact="Taiwan" post="remains unchanged for all patients without risk of COVID-19"/>
   <result pre="wave of new cases due to overseas citizens returning to" exact="Taiwan" post="was observed in March, although there was subsequently a"/>
   <result pre="there was subsequently a continuous decrease in reported new cases." exact="Thailand" post="Thailand has been the number one destination for Chinese"/>
   <result pre="was subsequently a continuous decrease in reported new cases. Thailand" exact="Thailand" post="has been the number one destination for Chinese tourists"/>
   <result pre="Chinese tourists for decades. When COVID-19 started to spread widely," exact="Thailand" post="was probably the most at-risk region (except for Hong"/>
   <result pre="widely, Thailand was probably the most at-risk region (except for" exact="Hong Kong" post="and Macao). The first COVID-19 case detected in Thailand"/>
   <result pre="Hong Kong and Macao). The first COVID-19 case detected in" exact="Thailand" post="was in a Chinese tourist. The spread first started"/>
   <result pre="first started amongst people who had contact with foreigners. However," exact="Thailand" post="currently ranks sixth in the world among countries with"/>
   <result pre="on cancer patients. The total number of confirmed cases in" exact="Thailand" post="at the time of writing was around 2200, with"/>
   <result pre="postoperative measures) whilst providing a safe environment for surgical teams." exact="Turkey" post="The last deadly infectious outbreak in Istanbul, Turkey was"/>
   <result pre="surgical teams. Turkey The last deadly infectious outbreak in Istanbul," exact="Turkey" post="was a cholera epidemic in 1970.13 Nationwide vaccination and"/>
   <result pre="As the reported number of new cases and mortalities in" exact="Turkey" post="continued to increase, although at a slower rate, as"/>
   <result pre="Lancet Respir Med2020 Apr 9. pii: S2213-2600(20)30170-3. 5SihoeADL. COVID-19: the" exact="Hong Kong" post="perspective. The Society of Thoracic Surgeons: In the news"/>
   <result pre="125: 2345â€&quot;51.15189961 8HuiDS.Severe acute respiratory syndrome (SARS): lessons learnt in" exact="Hong Kong." post="J Thorac Dis2013; 5: S122.23977432 9LumALauC. Coronavirus: Hong Kong"/>
   <result pre="in Hong Kong. J Thorac Dis2013; 5: S122.23977432 9LumALauC. Coronavirus:" exact="Hong Kong" post="may have to impose strict lockdown with people told"/>
   <result pre="adviser says, amid warnings of third wave of infections. South" exact="China" post="Morning Post. 5 Apr 2020 [Cited 5 April 2020]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7219724\results\search\country\results.xml">
   <result pre="Health care organization and Economics. Academy of Medical Sciences of" exact="Bosnia and Herzegovina," post="Sarajevo, Bosnia and Herzegovina. izetmasic@gmail.com. ORCID ID: http//www.orcid.org/000-0002-9080-5456. ppub:"/>
   <result pre="Economics. Academy of Medical Sciences of Bosnia and Herzegovina, Sarajevo," exact="Bosnia and Herzegovina." post="izetmasic@gmail.com. ORCID ID: http//www.orcid.org/000-0002-9080-5456. ppub: 2020-33217176received: 2020-3-20accepted: 2020-4-03(C) ,"/>
   <result pre="and there have been instances of COVID-19 community spread in" exact="the United States." post="COVID-19 spreads by contact with respiratory droplets that spread"/>
   <result pre="there have been instances of COVID-19 community spread in the" exact="United States." post="COVID-19 spreads by contact with respiratory droplets that spread"/>
   <result pre="but sold all distribution rights to the European Community and" exact="the US" post="in 1986 to Pfizer (14). Some pharmacologists believe that"/>
   <result pre="in the local plant Stephania cephalantha) has been used in" exact="Japan" post="since almost 70 years ago for a number of"/>
   <result pre="from these books have been passed on for centuries in" exact="Bosnia and Herzegovina" post="by attars, scholars and qualified persons, most of them"/>
   <result pre="to higest (national) level. Decision makers in healthcare sector of" exact="Bosnia and Herzegovina" post="are â€žseparatedâ€œ and very much influenced on the same"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7219859\results\search\country\results.xml">
   <result pre="1%) specifically designed for pregnant women (three registries, two from" exact="Italy" post="and one from the United States, designed to determine"/>
   <result pre="pregnant women (three registries, two from Italy and one from" exact="the United States," post="designed to determine the clinical characteristics of COVID-19 infection"/>
   <result pre="women (three registries, two from Italy and one from the" exact="United States," post="designed to determine the clinical characteristics of COVID-19 infection"/>
   <result pre="characteristics of COVID-19 infection in pregnancy and a survey from" exact="Turkey" post="to evaluate physical activity and sleep). Of the 588"/>
   <result pre="on the ClincalTrials.gov website, 376 (64%) were interventional (22% in" exact="the United States" post="and 16% in China) and involved agents such as"/>
   <result pre="the ClincalTrials.gov website, 376 (64%) were interventional (22% in the" exact="United States" post="and 16% in China) and involved agents such as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7220586\results\search\country\results.xml">
   <result pre="in patients with COVID-19. A meta-analysis of eight trials in" exact="China" post="showed that diabetes was present in 8% of 46,248"/>
   <result pre="[2] has been reported. Further, meta-analysis of nine studies from" exact="China" post="(nâ€‰=â€‰1936) showed a significant correlation between severity of COVID-19"/>
   <result pre="study in 1122 patients with COVID-19 in 88 centres across" exact="the USA" post="found diabetes to be associated with more than fourfold"/>
   <result pre="an interesting postulation that widespread use of DPP4 inhibitors in" exact="India" post="and many other countries might be protecting individuals with"/>
   <result pre="COVID-19. The clinical evidence is inconclusive. While one study in" exact="China" post="did not find any association of ACE inhibitor use"/>
   <result pre="and ARBs in another study [29, 30]. One study in" exact="the USA" post="did not find any significant difference in mortality in"/>
   <result pre="1128 patients hospitalised with COVID-19 in nine hospitals in Hubei," exact="China" post="showed significantly reduced all-cause mortality with the use of"/>
   <result pre="on glycaemia: Chloroquine has also been licensed for use in" exact="India" post="for patients with type 2 diabetes. Although the efficacy"/>
   <result pre="brought out in an excellent study in healthy people in" exact="China" post="at the time when there was a huge burden"/>
   <result pre="events. A prediction model of the effect of lockdown in" exact="India" post="on blood glucose showed a 3.6% increase in HbA1c"/>
   <result pre="been shown to improve glycaemia. Telemedicine guidelines for physicians in" exact="India" post="have been published [42]. Patients need to be educated"/>
   <result pre="variations in severity of COVI19 in patients with diabetes? In" exact="the United States," post="the disease has caused disproportionately more fatalities in Blacks"/>
   <result pre="in severity of COVI19 in patients with diabetes? In the" exact="United States," post="the disease has caused disproportionately more fatalities in Blacks"/>
   <result pre="Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in" exact="the United States." post="J Diabetes Sci Technol. 2020. 10.1177/1932296820924469. 6.CareyIMCritchleyJADeWildeSHarrisTHoskingFJCookDGGlycemic control and"/>
   <result pre="characteristics and clinical outcomes of COVID-19 patients hospitalized in the" exact="United States." post="J Diabetes Sci Technol. 2020. 10.1177/1932296820924469. 6.CareyIMCritchleyJADeWildeSHarrisTHoskingFJCookDGGlycemic control and"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes Metab Syndr202014241610.1016/j.dsx.2020.03.01132247211 39.YangJKLinSSJiXJGuoLMBinding of SARS"/>
   <result pre="work: health, distress and life satisfaction of working adults in" exact="China" post="one monthinto the COVID-19 outbreakPsychiatry Res202028811295810.1016/j.psychres.2020.11295832283450 41.GhosalSSinhaBMajumderMMisraAEstimation of effects"/>
   <result pre="multivariate regression analysisDiabetes Metab Syndr2020143192310.1016/j.dsx.2020.03.01432298984 42.GhoshAGuptaRMisraATelemedicine for diabetes care in" exact="India" post="during COVID19 pandemic and national lockdown period: guidelines for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7221333\results\search\country\results.xml">
   <result pre="bold;} span.year {font-family : courier ; font-style : italic;} Sci" exact="China" post="Life SciSci China Life SciScience China. Life Sciences1674-73051869-1889Science China"/>
   <result pre=": courier ; font-style : italic;} Sci China Life SciSci" exact="China" post="Life SciScience China. Life Sciences1674-73051869-1889Science China PressBeijing pmcid: 72213331669"/>
   <result pre="Sci China Life SciSci China Life SciScience China. Life Sciences1674-73051869-1889Science" exact="China" post="PressBeijing pmcid: 72213331669 doi: 10.1007/s11427-020-1669-x : Insight Cell membrane-derived"/>
   <result pre="supported by the Major State Basic Research Development Program of" exact="China" post="(2017YFA0205201), the National Natural Science Foundation of China (81901876,"/>
   <result pre="Program of China (2017YFA0205201), the National Natural Science Foundation of" exact="China" post="(81901876, 81422023 and U1705281), the Fundamental Research Funds for"/>
   <result pre="and the Program for New Century Excellent Talents in University," exact="China" post="(NCET-13-0502). Compliance and ethics The author(s) declare that they"/>
   <result pre="nanostructuresTrends Biotech20123032333010.1016/j.tibtech.2012.03.002 ChenSLiangXJNanobiotechnology and nanomedicine: small change brings big differenceSci" exact="China" post="Life Sci20186137137210.1007/s11427-018-9293-229675552 DehainiDFangRHZhangLBiomimetic strategies for targeted nanoparticle deliveryBioeng Translational"/>
   <result pre="Translational Med20161304610.1002/btm2.10004 GuoHCaiCWangBZhuoFJiangRWangNLiBZhangWZhuYFanYet al.Novel hepacivirus in Asian house shrew, ChinaSci" exact="China" post="Life Sci20196270170410.1007/s11427-018-9435-730701456 HolmesECDudasGRambautAAndersenKGThe evolution of Ebola virus: Insights from"/>
   <result pre="arthritis therapyJ Control Release202032030431310.1016/j.jconrel.2020.01.05432004586 WangJWangYWangRZhangSLiuXLiangXJTargeted nanoparticles for precise cancer therapySci" exact="China" post="Life Sci2019621392139510.1007/s11427-019-9824-031555962 WeiXZhangGRanDKrishnanNFangRHGaoWSpectorS AZhangLT-cell-mimicking nanoparticles can neutralize HIV infectivityAdv"/>
   <result pre="precision theranostics for perihilar cholangiocar-cinomaBiomater Sci202081575157910.1039/C9BM02088H32096499 ZhangYYuJQiangLGuZNanomedicine for obesity treatmentSci" exact="China" post="Life Sci20186137337910.1007/s11427-017-9257-129623548"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7222554\results\search\country\results.xml">
   <result pre="2003 and influenza A subtype H1N1 from 2010. Most recently," exact="Saudi Arabia" post="was initially infected by Middle East coronavirus respiratory syndrome"/>
   <result pre="when the first case of the disease was recorded in" exact="the USA" post="and not imported from China. This review highlights the"/>
   <result pre="and other CoVs. On 7 January 2020, the authorities in" exact="China" post="declared the isolation of the new CoV type [12]."/>
   <result pre="in China. At the time of writing this review, Although" exact="China" post="declared that it is free of new cases, but"/>
   <result pre="A surge in the reported cases in Europe (Italy, France," exact="Spain" post="and UK) and the USA had been reported [15]."/>
   <result pre="reported cases in Europe (Italy, France, Spain and UK) and" exact="the USA" post="had been reported [15]. This review is intended to"/>
   <result pre="qRT-PCR; ELISA technique Samples obtained from 40-SARS hospitalized patients in" exact="Hong Kong" post="Â [37] SARS-CoV Enhanced RT-fluorescent PCR Samples obtained from"/>
   <result pre="Enhanced RT-fluorescent PCR Samples obtained from 80-SARS hospitalized patients in" exact="Hong Kong" post="Â [38] SARS-CoV Quantitative, RT and, nested PCR Samples"/>
   <result pre="and, nested PCR Samples obtained from 46-SARS hospitalized patients from" exact="Taiwan" post="Â [39] SARS-CoV Western blot assay with N195 protein"/>
   <result pre="diseases Â [40] SARS-CoV RT-PCR 274 clinical sera collected from" exact="Hong Kong" post="Â [41] Detection of genetic material (PCR) Just as"/>
   <result pre="consumer RT-PCR kits was carried out [38,43]. The University of" exact="Hong Kong" post="used two monoplex assays that were reactive Sarbecovirus (SARS-CoV-2,"/>
   <result pre="species, human). The clinical trials released were conducted mostly in" exact="the USA," post="but one on SARS in China [51â€&quot;53]. Both SARS"/>
   <result pre="conducted mostly in the USA, but one on SARS in" exact="China" post="[51â€&quot;53]. Both SARS and MERS vaccine candidates have been"/>
   <result pre="adopted at the moment in the standard clinical practices of" exact="China" post="for SARS-CoV-2 infection [27]. However, the validity of using"/>
   <result pre="For example, a retrospective study from Jinyintan Hospital in Wuhan," exact="China" post="showed that antibiotics were given to 70 patients (71%)."/>
   <result pre="now part of the recommendations of the People's RepÃºblica of" exact="China" post="National Health Commission (NHC) for the study of SARS-CoV-2-induced"/>
   <result pre="clinical studies are intensively conducted throughout the world, especially in" exact="China" post="and USA. For example, molecular modeling studies are using"/>
   <result pre="investigating RDV at Clinicaltrials.gov and being conducted in USA and" exact="China" post="(NCT04292899, NCT04292730, NCT04252664, NCT04257656, NCT04280705, NCT04315948 and NCT04302766). The"/>
   <result pre="dose [87]. An NIH-supported clinical trial is being conducted in" exact="the USA." post="RDV will be provided to patients as a loading"/>
   <result pre="efficacy of RBV for SARS-CoV-2 infection at the University of" exact="Hong Kong," post="Queen Mary Hospital. In the study, RBV (400Â mg"/>
   <result pre="22 March, several active clinical trials are currently conducted in" exact="China" post="according to the Chinese Clinical Trial Registry to test"/>
   <result pre="reversing respiratory dysfunction in those patients. A retrospective study from" exact="China" post="hospitals demonstrated the benefits of tocilizumab in addition to"/>
   <result pre="h [115]. Another clinical study (NCT04315480) has been conducted in" exact="Italy" post="is investigating the early administration of single-dose injection of"/>
   <result pre="ChiCTR2000029386 is a randomized clinical trial currently being conducted in" exact="China" post="on 48 patients and methylprednisolone to be administrated to"/>
   <result pre="and intensive care unit length [127]. A recent study from" exact="Italy" post="is suggesting a synergistic effect of combining hydroxychloroquine with"/>
   <result pre="treatment of COVID-19 by the National Health Commission of the" exact="People's Republic of China" post="[145]. Results have shown that the symptoms of COVID-19"/>
   <result pre="of COVID-19 by the National Health Commission of the People's" exact="Republic of" post="China [145]. Results have shown that the symptoms of"/>
   <result pre="by the National Health Commission of the People's Republic of" exact="China" post="[145]. Results have shown that the symptoms of COVID-19"/>
   <result pre=", DiNapoli RFeatures, evaluation and treatment coronavirus (COVID-19). StatPearls, Treasure" exact="Island" post="(FL) (2020). 4.ChenWH , StrychU , HotezPJ , BottazziMEThe"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N. Engl. J. Med.367(19), 1814â€&quot;1820 (2012). 23075143 â€¢ Stepping"/>
   <result pre="of MERS-CoV: a novel human coronavirus, ahead of Hajj pilgrimage." exact="Iran" post="Red. Crescent. Med. J.18(11), e23874 (2016).28191331 37.LauSK , CheX-Y"/>
   <result pre="DeboltC , LindquistSet al.First case of 2019 novel coronavirus in" exact="the United States." post="N. Engl. J. Med.382(10), 929â€&quot;936 (2020).32004427 75.ChenN , ZhouM"/>
   <result pre=", LindquistSet al.First case of 2019 novel coronavirus in the" exact="United States." post="N. Engl. J. Med.382(10), 929â€&quot;936 (2020).32004427 75.ChenN , ZhouM"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7224629\results\search\country\results.xml">
   <result pre="be calculable in economic returns. The National Health Policy of" exact="India" post="(2017) articulates increasing investment in health to 2.5 per"/>
   <result pre="safety of interventions under the NPPP. In a country like" exact="India" post="where health is a State subject, the NPPP needs"/>
   <result pre="be encouraged and facilitated. This will strengthen public health in" exact="India" post="through access to the vast, modern and easily accessible"/>
   <result pre="a comprehensive risk communication strategy that addresses context-specific needs of" exact="India" post="with diversity in sociocultural norms, educational status, languages, faiths"/>
   <result pre="of academic and research institutions and the pharmaceutical industry in" exact="India" post="has to be harnessed for the promotion of R&amp;amp;D"/>
   <result pre="the corona virus disease 2019 epidemicWorld J Clin Cases20208652732149049 15collab:" exact="India" post="Today TechWhatsApp and MyGov launch official coronavirus and COVID-19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7227507\results\search\country\results.xml">
   <result pre="small-molecule drug entities, the universe of those already approved in" exact="the US" post="- for multitudes of different medical conditions - might"/>
   <result pre="Antigen tests for SARS-CoV-2 have only begun commercialization, marked by" exact="the US" post="FDA's emergency use authorization for the first antigen test"/>
   <result pre="Covid-19 serological test (for use in clinical laboratories) issued by" exact="the US" post="FDA (https://www.fda.gov/media/136622/download); unknown is when any serological test will"/>
   <result pre="is when any serological test will receive full approval in" exact="the US," post="where validation for specificity and sensitivity are critical. Antibody"/>
   <result pre="asymptomatic Covid-19 has been done in very few countries -" exact="Iceland" post="being one example [11]. A major limitation is inherent"/>
   <result pre="8FIND. COVID-19Diagnostics Resource Centre. Foundation for Innovative New Diagnostics. Geneva" exact="Switzerland" post="2020https://www.finddx.org/covid-19/ 9GeraciJ.HawillB.Candidate Drug, Dupilumab, To Mitigate COVID-19 Patients With"/>
   <result pre="11Iceland Minister of HealthLarge scale testing of general population in" exact="Iceland" post="underway15 March 2020https://www.government.is/news/article/2020/03/15/Large-scale-testing-of- general-population-in-Iceland-underway/ 12JordanB.U.S. biologics and biosimilars need"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7228272\results\search\country\results.xml">
   <result pre="world. More than 80Â 000 cases have been reported in" exact="China" post="and epidemics have grown in other countries.1 However, minimal"/>
   <result pre="DISCUSSION More recently, the rate of new cases outside of" exact="China" post="has outpaced than inside of China, which can be"/>
   <result pre="a city of Hubei Province in China.2 The epidemic in" exact="China" post="peaked between late January and late February 2020. The"/>
   <result pre="(Novo Nordisk). References REFERENCES 1collab: National Health Commission of the" exact="People's Republic of China" post=". March 24: daily briefing on novel coronavirus cases"/>
   <result pre="Nordisk). References REFERENCES 1collab: National Health Commission of the People's" exact="Republic of" post="China . March 24: daily briefing on novel coronavirus"/>
   <result pre="REFERENCES 1collab: National Health Commission of the People's Republic of" exact="China" post=". March 24: daily briefing on novel coronavirus cases"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7228359\results\search\country\results.xml">
   <result pre="coronavirus SARSâ€�CoVâ€�2, which emerged in late December 2019 in Wuhan," exact="China" post="(World Health Organization, 2019), has surpassed the combined death"/>
   <result pre="receptor Mas. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 100(14), 8258â€&quot;8263.12829792 Smyth, L. J., CaÃ±adasâ€�Garre, M.,"/>
   <result pre="Mas. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="100(14), 8258â€&quot;8263.12829792 Smyth, L. J., CaÃ±adasâ€�Garre, M., Cappa, R."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7228735\results\search\country\results.xml">
   <result pre="care unit (ICU) beds. When the COVID-19 pandemic spread to" exact="Italy" post="and Spain, ICUs had a massive influx of patients"/>
   <result pre="outbreak in 2003, with super-spreading events occurring throughout hospitals in" exact="Hong Kong," post="China, and Canada.2 Reports of infections related to aerosol-generating"/>
   <result pre="SARS-CoV-2. Of the published cases of tracheostomies done in Singapore," exact="Hong Kong," post="and Canada during the SARS outbreak, hospitals used enhanced"/>
   <result pre="published cases of tracheostomies done in Singapore, Hong Kong, and" exact="Canada" post="during the SARS outbreak, hospitals used enhanced PPE measures"/>
   <result pre="early and current experience with the COVID-19 outbreak in Wuhan," exact="China" post="and surrounding regions. Contributors BAM, MJB, and SJW contributed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7229764\results\search\country\results.xml">
   <result pre="(SARS) outbreak caused by the coronavirus SARS-CoV-1 occurred in mainland" exact="China" post="in 2002, the World Health Organization (WHO) has recommended"/>
   <result pre="2.1 Data We obtained the data of COVID-19 cases in" exact="China" post="from January 23rd to March 29th 2020 from the"/>
   <result pre="29th 2020 from the National Health Commission of the Peopleâ€™s" exact="Republic of" post="ChinaÂ [10]. The data information includes the cumulative number"/>
   <result pre="susceptible to COVID-19. Fig. 1 The data of COVID-19 in" exact="China" post="from January to March 2020. (A) The cumulative number"/>
   <result pre="Benefits of getting vaccinated against influenza The COVID-19 outbreak in" exact="China" post="coincided partially with flu season, and it was difficult"/>
   <result pre="impact of vaccination against influenza on the COVID-19 epidemics in" exact="China" post="in terms of the final size and the peak"/>
   <result pre="through the postpandemic periodScience14202010.1126/science.abb5793 2LeungK.WuJ.T.LiuD.LeungG.M.First-wave COVID-19 transmissibility and severity in" exact="China" post="outside Hubei after control measures, and second-wave scenario planning:"/>
   <result pre="model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan," exact="China" post="with individual reaction and governmental actionInt. J. Infect. Dis.202010.1016/j.ijid.2020.02.058"/>
   <result pre="communityCochrane Database Syst. Rev.52018CD00518810.1002/14651858 10National Health Commission of the Peopleâ€™s" exact="Republic of" post="China2020http://www.nhc.gov.cn/xcs/yqfkdt/gzbd_index.shtml. (Accessed 5 April 2020) 11TangB.WangX.LiQ.BragazziN.L.TangS.Y.XiaoY.N.WuJ.H.Estimation of the transmission"/>
   <result pre="YX was supported by the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(NSFC, 11631012), JW was supported by the Canadian Institute"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7229974\results\search\country\results.xml">
   <result pre="has been associated with an epidemic initially focused in Wuhan," exact="China" post="[1]. From there, SARS-CoV-2 has spread quickly throughout China,"/>
   <result pre="clear that this fearsome infection could not be confined to" exact="China" post="only, but soon it spread to neighboring Asian countries"/>
   <result pre="WHO declared the rapidly spreading coronavirus outbreak a pandemic and" exact="Italy" post="is currently the country with the highest number of"/>
   <result pre="the successful use of convalescent plasma in COVID-19 patients in" exact="China" post="and considering the efficacy of this treatment in previous"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7230338\results\search\country\results.xml">
   <result pre="113Â°30â€²E), or in countries near to the Equator such as" exact="Malaysia" post="(Kuala Lampur, 3Â°8â€²N 101Â°41â€²E). The novel Beta-CoV responsible for"/>
   <result pre="the vulnerability of this population (Figure 1D). Counterintuitively, even in" exact="India" post="(which is a developing country relatively close to Wuhan)"/>
   <result pre="a variable percentage of malaria patients out of global cases:" exact="Nigeria" post="(25%), the Democratic Republic of the Congo (12%), Uganda"/>
   <result pre="of malaria patients out of global cases: Nigeria (25%), the" exact="Democratic Republic of the Congo" post="(12%), Uganda (5%), Ivory Coast (4%), Mozambique (4%), and"/>
   <result pre="malaria patients out of global cases: Nigeria (25%), the Democratic" exact="Republic of" post="the Congo (12%), Uganda (5%), Ivory Coast (4%), Mozambique"/>
   <result pre="of global cases: Nigeria (25%), the Democratic Republic of the" exact="Congo" post="(12%), Uganda (5%), Ivory Coast (4%), Mozambique (4%), and"/>
   <result pre="cases: Nigeria (25%), the Democratic Republic of the Congo (12%)," exact="Uganda" post="(5%), Ivory Coast (4%), Mozambique (4%), and Niger (4%).By"/>
   <result pre="(25%), the Democratic Republic of the Congo (12%), Uganda (5%)," exact="Ivory Coast" post="(4%), Mozambique (4%), and Niger (4%).By adding Ethiopia, South"/>
   <result pre="Republic of the Congo (12%), Uganda (5%), Ivory Coast (4%)," exact="Mozambique" post="(4%), and Niger (4%).By adding Ethiopia, South Africa, and"/>
   <result pre="Congo (12%), Uganda (5%), Ivory Coast (4%), Mozambique (4%), and" exact="Niger" post="(4%).By adding Ethiopia, South Africa, and India, the number"/>
   <result pre="Ivory Coast (4%), Mozambique (4%), and Niger (4%).By adding Ethiopia," exact="South Africa," post="and India, the number of deaths and cases associated"/>
   <result pre="cases of COVID-19 and 1243 deaths have been reported in" exact="the United States" post="of America (~327 million of people) (Figure 1D, WHO"/>
   <result pre="of COVID-19 and 1243 deaths have been reported in the" exact="United States of America" post="(~327 million of people) (Figure 1D, WHO data source)."/>
   <result pre="1243 deaths have been reported in the United States of" exact="America" post="(~327 million of people) (Figure 1D, WHO data source)."/>
   <result pre="potentially explains the heterogeneous diffusion of COVID-19 among countries (e.g.," exact="Nigeria" post="in comparison with South Africa) or within them (e.g.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7230702\results\search\country\results.xml">
   <result pre="grows wild in shallow waters along the Pacific coast of" exact="Japan" post="(Kii Peninsula, Kyushu, and Nansei Islands), Korean Peninsula, and"/>
   <result pre="Grant-in-Aid for Scientific Research (C) (Grant Number 16K08633) from the" exact="Japan" post="Society for the Promotion of Science and an industryâ€&quot;academia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7231470\results\search\country\results.xml">
   <result pre="italic;} Zool ResZool ResZRZoological Research2095-8137Science Press16 Donghuangchenggen Beijie, Beijing 100717," exact="China" post="pmcid: 7231470 pmid: 32314559zr-41-3-213 doi: 10.24272/j.issn.2095-8137.2020.031 : Commentary Zoonotic"/>
   <result pre="epidemic was first characterized in a man with pneumonia in" exact="Saudi Arabia" post="in 2012 (Zaki et al., 2012), in which sporadic"/>
   <result pre="sequences phylogenetically related to MERS-CoV in bats (Nycteris sp.) in" exact="Ghana" post="and Europe (Pipistrellus sp.) (Annan et al., 2013). In"/>
   <result pre="MERS-CoV specific antibodies in dromedary camels (Camelus dromedarius) from Egypt," exact="Oman" post="and other locations in the Middle East, but that"/>
   <result pre="Malayan pangolins are found in nature throughout Southeast Asia (including" exact="Laos" post="PDR, Cambodia, Thailand, Myanmar, Vietnam, and Indonesia), but not"/>
   <result pre="pangolins are illegally smuggled in live from Southeast Asia to" exact="China" post="to be sold in live animal markets or as"/>
   <result pre="animal markets, including civets, raccoon dogs, and ferret badgers, and" exact="the USA" post="instituted a trade embargo on civet cats (https://www.cdc.gov/sars/about/civet-embargo.html). After"/>
   <result pre="Drosten C, Drexler JFHuman betacoronavirus 2c EMC/2012-related viruses in bats," exact="Ghana" post="and EuropeEmerging Infectious Diseases201319345645910.3201/eid1903.12150323622767 3Assiri A, Al-Tawfiq JA, Al-Rabeeah"/>
   <result pre="Chinese horseshoe batsProceedings of the National Academy of Sciences of" exact="the United States" post="of America200510239140401404510.1073/pnas.050673510216169905 22Li Q, Guan XH, Wu P, Wang"/>
   <result pre="horseshoe batsProceedings of the National Academy of Sciences of the" exact="United States" post="of America200510239140401404510.1073/pnas.050673510216169905 22Li Q, Guan XH, Wu P, Wang"/>
   <result pre="civet and humanProceedings of the National Academy of Sciences of" exact="the United States" post="of America200510272430243510.1073/pnas.040960810215695582 47Stadler K, Masignani V, Eickmann M, Becker"/>
   <result pre="and humanProceedings of the National Academy of Sciences of the" exact="United States" post="of America200510272430243510.1073/pnas.040960810215695582 47Stadler K, Masignani V, Eickmann M, Becker"/>
   <result pre="DY, Xu WB, Wu GZ, Gao GF, Tan WJ, The" exact="China" post="Novel Coronavirus Investigating and Research TeamA novel coronavirus from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7232149\results\search\country\results.xml">
   <result pre="children of primary school age (5â€&quot;8 years) [10]. Data for" exact="the United States" post="for each epidemic season from 200 to 2011 (excluding"/>
   <result pre="of primary school age (5â€&quot;8 years) [10]. Data for the" exact="United States" post="for each epidemic season from 200 to 2011 (excluding"/>
   <result pre="that was isolated from a human in 2017 in Novosibirsk," exact="Russia" post="and belongs to B/Victoria lineage. Three of seven mice"/>
   <result pre="sequences, available in the GISAID database, isolated from residents of" exact="Russia" post="and Kazakhstan, as well as vaccine and reference strains"/>
   <result pre="well as strains from the neighboring Altai Republic and the" exact="Republic of" post="Kazakhstan. At the same time, all of them are"/>
   <result pre="human population in the Novosibirsk region, Altai Republic, and the" exact="Republic of" post="Kazakhstan (Table S1). Thus, strain B/2017 is a typical"/>
   <result pre="in the Novosibirsk region, Altai Republic, and the Republic of" exact="Kazakhstan" post="(Table S1). Thus, strain B/2017 is a typical genetic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7232622\results\search\country\results.xml">
   <result pre="higher in sub-Saharan Africa, South and Southeast Asia, and South" exact="America" post="and the Caribbean than in Europe.36 A similar analysis"/>
   <result pre="HIV-negative adults with tuberculosis from seven high-burden countries (CÃ´te d'Ivoire," exact="Democratic Republic of the Congo," post="Kenya, Nigeria, South Africa, Peru and Thailand). Molecular or"/>
   <result pre="adults with tuberculosis from seven high-burden countries (CÃ´te d'Ivoire, Democratic" exact="Republic of" post="the Congo, Kenya, Nigeria, South Africa, Peru and Thailand)."/>
   <result pre="countries (CÃ´te d'Ivoire, Democratic Republic of the Congo, Kenya, Nigeria," exact="South Africa," post="Peru and Thailand). Molecular or phenotypic drug susceptibility testing"/>
   <result pre="d'Ivoire, Democratic Republic of the Congo, Kenya, Nigeria, South Africa," exact="Peru" post="and Thailand). Molecular or phenotypic drug susceptibility testing was"/>
   <result pre="in order to meet the UNAIDS 90-90-90 targets. In 2011," exact="Malawi" post="was one of the first countries to implement such"/>
   <result pre="Allâ€™ policy adoption in six countries (Burundi, Kenya, Malawi, Rwanda," exact="Uganda" post="and Zambia).60 They showed a strong and sustained effect"/>
   <result pre="International Epidemiology Databases to Evaluate AIDS (IeDEA) is supported by" exact="the US" post="National Institutes of Health's National Institute of Allergy and"/>
   <result pre="supported by special project funding (Grant No. 174281) from the" exact="Swiss" post="National Science Foundation. Map disclaimer: The depiction of boundaries"/>
   <result pre="al.Mortality in patients with HIV-1 infection starting antiretroviral therapy in" exact="South Africa," post="Europe, or North America: a collaborative analysis of prospective"/>
   <result pre="hepatitis C virus infection in human immunodeficiency virus clinics in" exact="Zambia" post="and Mozambique. Open Forum Infect Dis2016;3:ofw049. 10.1093/ofid/ofw04927047986 49JaquetA, WandelerG,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7233228\results\search\country\results.xml">
   <result pre="King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh," exact="Saudi Arabia." post="hajjar@kfshrc.edu.sa pmc-release: 2020-5-5ppub: 2020-6epub: 2020-5-5726163(C) King Faisal Specialist Hospital"/>
   <result pre="2020-5-5726163(C) King Faisal Specialist Hospital &amp;amp; Research Centre (General Organization)," exact="Saudi Arabia," post="2020This is an open access article under the CC"/>
   <result pre="The virus was first recognized in the city of Wuhan," exact="China" post="in December 2019 [3] and has swept the globe"/>
   <result pre="number of cases and the wide geographical spread outside of" exact="China" post="[4]. At the time of the announcement, the WHO"/>
   <result pre="that less than 1% of the 72,314 cases reported in" exact="China" post="were in children under the age of 10 years,"/>
   <result pre="years) [6]. Data from around 150,000 laboratory-confirmed COVID-19 cases in" exact="the United States" post="indicate that 2,572 (1.7%) cases were among children under"/>
   <result pre="[6]. Data from around 150,000 laboratory-confirmed COVID-19 cases in the" exact="United States" post="indicate that 2,572 (1.7%) cases were among children under"/>
   <result pre="panel of pediatric infectious disease physicians and pharmacists from North" exact="America" post="has recommended Remdesivir as a preferred antiviral agent followed"/>
   <result pre="in epidemics of influenza A in a local community in" exact="Japan" post="during two consecutive seasons with A (H3N2) as a"/>
   <result pre="of King Faisal Specialist Hospital &amp;amp; Research Centre (General Organization)," exact="Saudi Arabia." post=""/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7233243\results\search\country\results.xml">
   <result pre="of Human Immunodeficiency Virus 1 Genomic RNAProc. Natl. Acad. Sci." exact="U. S." post="A.9081993339333978475087 64Piekna-PrzybylskaD.SharmaG.BambaraR.A.Mechanism of HIV-1 RNA Dimerization in the Central"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235275\results\search\country\results.xml">
   <result pre="of Medical Biochemistry, Korle-Bu, College of Health Sciences, University of" exact="Ghana" post="Medical SchoolAccraGhana[], 4Diagnosis and Treatment of HIV Infection Unit,"/>
   <result pre="PuthisastraPhnom PenhCambodia Edited by: Alexander Rodriguez-Palacios, Case Western Reserve University," exact="United States" post="Reviewed by: Alfonso J. Rodriguez-Morales, Technological University of Pereira,"/>
   <result pre="States Reviewed by: Alfonso J. Rodriguez-Morales, Technological University of Pereira," exact="Colombia" post="*Correspondence: Sandro Vento ventosandro@yahoo.it; svento@puthisastra.edu.kh This article was submitted"/>
   <result pre="(6); the fact that COVID-19 is reducing the capacity of" exact="the United States" post="health system to address effectively HIV prevention and care,"/>
   <result pre="the fact that COVID-19 is reducing the capacity of the" exact="United States" post="health system to address effectively HIV prevention and care,"/>
   <result pre="area with the highest number of new HIV diagnoses in" exact="the United States" post="(8); lessons learnt from dealing with the HIV pandemic"/>
   <result pre="with the highest number of new HIV diagnoses in the" exact="United States" post="(8); lessons learnt from dealing with the HIV pandemic"/>
   <result pre="COVID-19 pneumonia (14). Five HIV-coinfected patients have been reported from" exact="Spain" post="(15). Four patients were on ARVs, and had CD4"/>
   <result pre="were given darunavir/cobicistat. Three HIV-coinfected cases have been reported from" exact="Italy" post="(16). A 62-year-old man with undetectable viral load and"/>
   <result pre="but also in individuals with undetectable HIV-RNA (22). In urban" exact="South Africa," post="the death rate for influenza-associated severe acute respiratory illness"/>
   <result pre="a higher death rate in HIV-infected patients. Preliminary data from" exact="China" post="indicate that patients with moderate or severe COVID-19 have"/>
   <result pre="the disease (over 25% of TB deaths worldwide) (27). In" exact="South Africa," post="tuberculosis coinfection is associated with greater mortality in subjects"/>
   <result pre="for COVID-19 Among HIV/AIDS Patients in Two Districts of Wuhan," exact="China" post="(3/4/2020). Available online at: SSRN: https://ssrn.com/abstract=3550029 (accessed April 29,"/>
   <result pre="al.. Mortality amongst patients with influenza-associated severe acute respiratory illness," exact="South Africa," post="2009-2013. PLoS ONE. (2015) 10:e0118884. 10.1371/journal.pone.011888425786103 24.ChenGWuDGuoWCaoYHuangDWangHet al.Clinical and"/>
   <result pre="individuals aged â‰¥15 years hospitalized with severe respiratory illness in" exact="South Africa," post="2010-2016. Open Forum Infect Dis. (2019) 6:ofz020. 10.1093/ofid/ofz02030906797 29.BernardEKreisBLe"/>
   <result pre="and deterred health care seeking during the SARS epidemic in" exact="Hong Kong." post="Am J Public Health. (2005) 95:933â€&quot;4. 10.2105/AJPH.2004.04676315914811"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235449\results\search\country\results.xml">
   <result pre="Science, Technology and Research (A*STAR), Immunos, BiopolisSingaporeSingapore[], 2National University of" exact="Singapore" post="Graduate School for Integrative Sciences and Engineering, National University"/>
   <result pre="Kingdom Edited by: Aurelio Cafaro, Istituto Superiore di SanitÃ (ISS)," exact="Italy" post="Reviewed by: Pierre Roques, CEA Saclay, France; Adam Taylor,"/>
   <result pre="by: Pierre Roques, CEA Saclay, France; Adam Taylor, Griffith University," exact="Australia" post="*Correspondence: Lisa F. P. Ng lisa_ng@immunol.a-star.edu.sg This article was"/>
   <result pre="Unit, Department of Cell Biology and Infection, Institute Pasteur, Paris," exact="France" post="Fok-Moon Lum, Department of Neurology, Stanford University School of"/>
   <result pre="Department of Neurology, Stanford University School of Medicine, Stanford, CA," exact="United States" post="epub: 2020-5-5collection: 202011894received: 2019-12-18accepted: 2020-4-17(C) Chan, Teo, Torres-Ruesta, Hartimath,"/>
   <result pre="first discovered in 1959, during a large outbreak in northern" exact="Uganda" post="that affected more that 2 million people (2, 3)."/>
   <result pre="re-emerged with two outbreaks in 1996 and 2003 in southern-central" exact="Uganda" post="and Ivory Coast, respectively, affecting thousands of people (1,"/>
   <result pre="two outbreaks in 1996 and 2003 in southern-central Uganda and" exact="Ivory Coast," post="respectively, affecting thousands of people (1, 4â€&quot;6). Antibody-based serological"/>
   <result pre="serological studies revealed high proportions of previously unreported alphavirus-seropositive coastal" exact="Kenya" post="and Uganda populations, particularly to ONNV and closely-related CHIKV"/>
   <result pre="revealed high proportions of previously unreported alphavirus-seropositive coastal Kenya and" exact="Uganda" post="populations, particularly to ONNV and closely-related CHIKV (4, 9,"/>
   <result pre="WT ONNV isolate (IMTSSA/5163) was isolated from a patient in" exact="Chad" post="in 2004 (kindly provided by Marc Grandadam from UnitÃ©"/>
   <result pre="Resource Center (BRC) of Agency for Science, Technology, and Research," exact="Singapore" post="(A*STAR). Experimental procedures involving mice were approved by the"/>
   <result pre="and the National Advisory Committee for Laboratory Animal Research of" exact="Singapore" post="(NACLAR). Virus Infection and Disease Evaluation Mice were inoculated"/>
   <result pre="Authority (AVA) National Advisory Committee for Laboratory Animal Research of" exact="Singapore" post="(NACLAR). Author Contributions LN and LR supervised the study."/>
   <result pre="conflict of interest. The authors would like to thank the" exact="Singapore" post="Immunology Network (SIgN) mouse core for support in animal"/>
   <result pre="A*STAR Graduate Scholarship (AGS). AT-R was supported by the A*STAR" exact="Singapore" post="International Graduate Award (SINGA) scholarship. Flow cytometry platform is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235487\results\search\country\results.xml">
   <result pre="Science and Technology2017SHZDZX01 National Key Research and Development Program of" exact="China" post="10.13039/501100012166 2017ZX10203205â€�006â€�002 Ministry of Education â€� Singapore 10.13039/501100001459 Tier"/>
   <result pre="Development Program of China 10.13039/501100012166 2017ZX10203205â€�006â€�002 Ministry of Education â€�" exact="Singapore" post="10.13039/501100001459 Tier 1 FRC National Medical Research Council 10.13039/501100001349"/>
   <result pre="Medical Research Council 10.13039/501100001349 MOHâ€�OFLCG18Mayâ€�0003 National Natural Science Foundation of" exact="China" post="10.13039/501100001809 81871448 fig-count: table-count: page-count: word-count: 1 Introduction The"/>
   <result pre="this problem, â‰ˆ80% of the malaria parasites in parts of" exact="Thailand" post="and Vietnam were resistant to artemisinin and piperaquine, and"/>
   <result pre="â‰ˆ80% of the malaria parasites in parts of Thailand and" exact="Vietnam" post="were resistant to artemisinin and piperaquine, and that the"/>
   <result pre="and Technology (2017SHZDZX01), National Key Research and Development Program of" exact="China" post="(2017ZX10203205â€�006â€�002) and National Natural Science Foundation of China (81871448)."/>
   <result pre="Program of China (2017ZX10203205â€�006â€�002) and National Natural Science Foundation of" exact="China" post="(81871448). D.H. gratefully acknowledges the Office of the President,"/>
   <result pre="President of Research and Technology at the National University of" exact="Singapore" post="for supporting this study. The authors also gratefully acknowledge"/>
   <result pre="a Ministry of Education (MOE) Tier 1 FRC grant and" exact="Singapore" post="Ministry of Health's National Medical Research Council under its"/>
   <result pre="P.Niu, F.Zhan, X.Ma, D.Wang, W.Xu, G.Wu, G. F.Gao, W.Tan, collab:" exact="China" post="Novel Coronavirus Investigating and Research Team , N. Engl."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235633\results\search\country\results.xml">
   <result pre="trials has been conducted in more than 10 hospitals in" exact="China" post="to assess the efficacy of chloroquine to treat COVID-19"/>
   <result pre="less efficacious in a clinical trial conducted in the Democratic" exact="Republic of" post="Congo.15 In cell culture, remdesivir has broad-spectrum antiviral activity"/>
   <result pre="clinical studies worldwide: two studies in China, and studies in" exact="the United States," post="Singapore and South Korea. Results of these trials are"/>
   <result pre="studies worldwide: two studies in China, and studies in the" exact="United States," post="Singapore and South Korea. Results of these trials are"/>
   <result pre="two studies in China, and studies in the United States," exact="Singapore" post="and South Korea. Results of these trials are not"/>
   <result pre="in China, and studies in the United States, Singapore and" exact="South Korea." post="Results of these trials are not available yet. Lopinavirâ€&quot;ritonavir"/>
   <result pre="Another molecule that is being evaluated in COVID-19 patients in" exact="China" post="is favipiravir. Favipiravir (T-705) is an antiviral drug that"/>
   <result pre="an antiviral drug that has been approved in 2014 in" exact="Japan" post="to treat pandemic influenza virus infections. It acts as"/>
   <result pre="with activity against influenza virus infection that is approved in" exact="Russia" post="and China.31 The primary outcome of this study was"/>
   <result pre="profile in macrophage activation syndrome (MAS).2 A retrospective analysis in" exact="China" post="indicated IL-6 and ferritin as predictors for COVID-19-related mortality,"/>
   <result pre="the true benefit of this therapy. Based on these results," exact="China" post="updated its treatment guidelines and approved the use of"/>
   <result pre="respiratory failure will be evaluated in a clinical study in" exact="Belgium" post="(SARPAC trial). Leukine will be administered in a nebulised"/>
   <result pre="References 1collab: World Health Organization. Report of the WHO â€&quot;" exact="China" post="Joint Mission on Coronavirus Disease 2019 (COVID-19) Geneva: WHO,"/>
   <result pre="1â€&quot;14.31911583 18HolshueMLDeBoltCLindquistS, et al.First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med2020; 382: 929â€&quot;936.32004427 19LiGDe ClercqE.Therapeutic options"/>
   <result pre="18HolshueMLDeBoltCLindquistS, et al.First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med2020; 382: 929â€&quot;936.32004427 19LiGDe ClercqE.Therapeutic options"/>
   <result pre="respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study." exact="Hong Kong" post="Med J2003; 9: 399â€&quot;406.14660806 24SpanakisNTsiodrasSHaagmansBL, et al.Virological and serological"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236586\results\search\country\results.xml">
   <result pre="and COVID-19 disease were first identified in Wuhan, Hubei province," exact="China" post="at the end of 2019. This virus has spread"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236639\results\search\country\results.xml">
   <result pre="0004 1936 9094Division of Cardiothoracic Surgery, Department of Surgery, Rhode" exact="Island" post="Hospital, Alpert Medical School of Brown University, [24], grid.134563.60000"/>
   <result pre="The present outbreak of COVID-19, initially observed in the Peopleâ€™s" exact="Republic of" post="Chinaâ€™s Hubei Province, has pandemically spread to every country"/>
   <result pre="on reports of exponentially increasing cases of COVID-19 observed in" exact="China" post="and subsequently in other locations throughout the world [10]."/>
   <result pre="just 1Â month after the first officially reported case from" exact="China" post="[11]. Scientists, infectious disease experts and most governments around"/>
   <result pre="ebola outbreak in a healthworkers base camp, Port Loko District," exact="Sierra Leone," post="March 2015Int J Infect Dis.201645216 66.Parmet WE, Sinha MS."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236853\results\search\country\results.xml">
   <result pre="associated with a high mortality [1â€&quot;3]. Epidemics in Wuhan in" exact="China" post="and Lombardy in Italy have been devastating, and SARS-CoV-2"/>
   <result pre="mortality [1â€&quot;3]. Epidemics in Wuhan in China and Lombardy in" exact="Italy" post="have been devastating, and SARS-CoV-2 has developed into a"/>
   <result pre="infected patients linked to viral loads and lung injury. Sci" exact="China" post="Life Sci2020; 63:364â€&quot;374.32048163 6EslerMEslerDCan angiotensin receptor-blocking drugs perhaps be"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236857\results\search\country\results.xml">
   <result pre="and Prisons. New England Journal of Medicine2020. 6.KaebleDCowhigMCorrectional populations in" exact="the United States," post="2016. Ncj2016; 251211. 7.ErlyanaEFisherDGReynoldsGLEmergency room use after being released"/>
   <result pre="Prisons. New England Journal of Medicine2020. 6.KaebleDCowhigMCorrectional populations in the" exact="United States," post="2016. Ncj2016; 251211. 7.ErlyanaEFisherDGReynoldsGLEmergency room use after being released"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236962\results\search\country\results.xml">
   <result pre="equine encephalitis virus: the problem is not over for tropical" exact="America" post="GuzmÃ¡n-TerÃ¡nCamilo1CalderÃ³n-RangelAlfonso2Rodriguez-MoralesAlfonso34MattarSalimmattarsalim@hotmail.com2[1], grid.441929.30000 0004 0486 6602Instituto de Investigaciones BiolÃ³gicas del"/>
   <result pre="of the host. VEEV and other similar equine encephalitis in" exact="America" post="In addition to VEEV, Eastern equine encephalitis (EEEV), Western"/>
   <result pre="As a result of vaccination, in some countries such as" exact="the United States," post="there are no longer periodically severe epidemics of EEEV"/>
   <result pre="a result of vaccination, in some countries such as the" exact="United States," post="there are no longer periodically severe epidemics of EEEV"/>
   <result pre="observed. The VEEV continues to present epidemic outbreaks in South" exact="America" post="in equine and human populations [3, 4]. Fig.Â 1"/>
   <result pre="Sindbis virus (SINV) [5]. It circulates in North and South" exact="America" post="among especially passerine birds and Culex tarsalis mosquitoes its"/>
   <result pre="outbreaks that covered western North America, extending northward into Saskatchewan," exact="Canada" post="[7], the epizootic reached the east side of the"/>
   <result pre="past four decades [10], the last human case in North" exact="America" post="occurred in 1994, and the virus has not been"/>
   <result pre="in mosquito pools since 2008. The WEEV was isolated in" exact="Argentina" post="in 2009. Subsequently, an outbreak in Uruguay resulted in"/>
   <result pre="was isolated in Argentina in 2009. Subsequently, an outbreak in" exact="Uruguay" post="resulted in a fatal human case [11] (Fig.Â 1)."/>
   <result pre="American variant is found in areas of Central and South" exact="America" post="and along the coast of the Gulf of Mexico."/>
   <result pre="be grouped into two variants. The variant found in North" exact="America" post="is more pathogenic than the variant of Central and"/>
   <result pre="significant differences in ecology and pathogenesis, the isolations of South" exact="America" post="from EEEV were recently classified as a distinct species"/>
   <result pre="were only three reported cases of EEEV in humans in" exact="Brazil" post="and Trinidad. Unlike the epidemiological profile in South America,"/>
   <result pre="the disease was described as a â€œmad plagueâ€� in South" exact="America" post="in the 1920s [14]. The VEEV was isolated in"/>
   <result pre="and outbreaks have been reported in Venezuela, Colombia, Ecuador, Panama," exact="Costa Rica," post="Nicaragua Guatemala, Honduras, Salvador, Panama, Mexico and the United"/>
   <result pre="have been reported in Venezuela, Colombia, Ecuador, Panama, Costa Rica," exact="Nicaragua" post="Guatemala, Honduras, Salvador, Panama, Mexico and the United States"/>
   <result pre="Colombia, Ecuador, Panama, Costa Rica, Nicaragua Guatemala, Honduras, Salvador, Panama," exact="Mexico" post="and the United States [1]. The VEEV has enzootic"/>
   <result pre="Panama, Costa Rica, Nicaragua Guatemala, Honduras, Salvador, Panama, Mexico and" exact="the United States" post="[1]. The VEEV has enzootic and epizootic serotypes. Within"/>
   <result pre="Costa Rica, Nicaragua Guatemala, Honduras, Salvador, Panama, Mexico and the" exact="United States" post="[1]. The VEEV has enzootic and epizootic serotypes. Within"/>
   <result pre="caused by VEEV is an emerging infectious disease in Latin" exact="America" post="[1, 18]. Outbreaks have been documented for decades in"/>
   <result pre="or tens of thousands of cases per year throughout Latin" exact="America" post="[19] (Fig.Â 2). Fig.Â 2 Time evolution of the"/>
   <result pre="so far only in Brazil; Subtype (V) Cabassou. Isolated in" exact="French Guiana" post="mosquitoes; Subtype (VI). AG8O-663. Isolated in mosquitoes from Argentina"/>
   <result pre="far only in Brazil; Subtype (V) Cabassou. Isolated in French" exact="Guiana" post="mosquitoes; Subtype (VI). AG8O-663. Isolated in mosquitoes from Argentina"/>
   <result pre="French Guiana mosquitoes; Subtype (VI). AG8O-663. Isolated in mosquitoes from" exact="Argentina" post="[18, 20] (TableÂ 1). TableÂ 1 Subtypes and serotypes"/>
   <result pre="by the insect, Oeciacus vicarius, to birds in western North" exact="America" post="[28]. Enzootic cycles have also been inferred for the"/>
   <result pre="[29]. VEEV in bats of America. In 1970 in Oxaca," exact="Mexico" post="was found a vampire bat D. rotundus infected with"/>
   <result pre="serve as an alternative host for virus maintenance [15]. In" exact="Trinidad and Tobago," post="a seroprevalence study was carried out against antibodies selected"/>
   <result pre="in Valle del Cauca, Colombia, in 1935 and dispersed to" exact="Venezuela" post="the following year. In 1943 the outbreak reached Trinidad"/>
   <result pre="reached Trinidad (TableÂ 2) [36]. Additional epizootics were reported in" exact="Peru" post="from 1942 to 1946 [25, 37]. One of the"/>
   <result pre="of which 20 were fatal, this outbreak then expanded to" exact="Venezuela" post="where 23,283 human cases were presented including 960 neurological"/>
   <result pre="humans in the Americas, 1935â€&quot;2011 Year Country Equines Humans 1935" exact="Colombia" post="Unknown â€&quot; 1935â€&quot;1943 Colombia Unknown â€&quot; 1935â€&quot;1943 Venezuela Unknown"/>
   <result pre="1935â€&quot;2011 Year Country Equines Humans 1935 Colombia Unknown â€&quot; 1935â€&quot;1943" exact="Colombia" post="Unknown â€&quot; 1935â€&quot;1943 Venezuela Unknown â€&quot; 1942â€&quot;1946 Peru Unknown"/>
   <result pre="Humans 1935 Colombia Unknown â€&quot; 1935â€&quot;1943 Colombia Unknown â€&quot; 1935â€&quot;1943" exact="Venezuela" post="Unknown â€&quot; 1942â€&quot;1946 Peru Unknown â€&quot; 1943 Trinidad Unknown"/>
   <result pre="â€&quot; 1935â€&quot;1943 Colombia Unknown â€&quot; 1935â€&quot;1943 Venezuela Unknown â€&quot; 1942â€&quot;1946" exact="Peru" post="Unknown â€&quot; 1943 Trinidad Unknown â€&quot; 1962 Colombia Unknown"/>
   <result pre="â€&quot; 1942â€&quot;1946 Peru Unknown â€&quot; 1943 Trinidad Unknown â€&quot; 1962" exact="Colombia" post="Unknown 3000 1962 Venezuela Unknown 23,283 1967â€&quot;1968 Colombia Unknown"/>
   <result pre="â€&quot; 1943 Trinidad Unknown â€&quot; 1962 Colombia Unknown 3000 1962" exact="Venezuela" post="Unknown 23,283 1967â€&quot;1968 Colombia Unknown Unknown 1967â€&quot;1968 Venezuela Unknown"/>
   <result pre="â€&quot; 1962 Colombia Unknown 3000 1962 Venezuela Unknown 23,283 1967â€&quot;1968" exact="Colombia" post="Unknown Unknown 1967â€&quot;1968 Venezuela Unknown Unknown 1969 Ecuador 20,000"/>
   <result pre="3000 1962 Venezuela Unknown 23,283 1967â€&quot;1968 Colombia Unknown Unknown 1967â€&quot;1968" exact="Venezuela" post="Unknown Unknown 1969 Ecuador 20,000 31,000 1969 El Salvador"/>
   <result pre="23,283 1967â€&quot;1968 Colombia Unknown Unknown 1967â€&quot;1968 Venezuela Unknown Unknown 1969" exact="Ecuador" post="20,000 31,000 1969 El Salvador Unknown Unknown 1969 Guatemala"/>
   <result pre="Unknown 1967â€&quot;1968 Venezuela Unknown Unknown 1969 Ecuador 20,000 31,000 1969" exact="El Salvador" post="Unknown Unknown 1969 Guatemala Unknown Unknown 1969 Mexico 50,000"/>
   <result pre="1969 Ecuador 20,000 31,000 1969 El Salvador Unknown Unknown 1969" exact="Guatemala" post="Unknown Unknown 1969 Mexico 50,000 Unknown 1969 Other CA"/>
   <result pre="1969 El Salvador Unknown Unknown 1969 Guatemala Unknown Unknown 1969" exact="Mexico" post="50,000 Unknown 1969 Other CA countries Unknown Unknown 1971"/>
   <result pre="Other CA countries Unknown Unknown 1971 USA 2000 110 1972" exact="Mexico" post="Unknown â€&quot; 1992 Venezuela Unknown Unknown 1993 Venezuela Unknown"/>
   <result pre="Unknown 1971 USA 2000 110 1972 Mexico Unknown â€&quot; 1992" exact="Venezuela" post="Unknown Unknown 1993 Venezuela Unknown Unknown 1993 Mexico Unknown"/>
   <result pre="110 1972 Mexico Unknown â€&quot; 1992 Venezuela Unknown Unknown 1993" exact="Venezuela" post="Unknown Unknown 1993 Mexico Unknown â€&quot; 1995 Venezuela 4000"/>
   <result pre="â€&quot; 1992 Venezuela Unknown Unknown 1993 Venezuela Unknown Unknown 1993" exact="Mexico" post="Unknown â€&quot; 1995 Venezuela 4000 100,000 Colombia 1996 Mexico"/>
   <result pre="Unknown 1993 Venezuela Unknown Unknown 1993 Mexico Unknown â€&quot; 1995" exact="Venezuela" post="4000 100,000 Colombia 1996 Mexico Unknown â€&quot; 1998 Colombia"/>
   <result pre="Unknown Unknown 1993 Mexico Unknown â€&quot; 1995 Venezuela 4000 100,000" exact="Colombia" post="1996 Mexico Unknown â€&quot; 1998 Colombia Unknown 250 2011"/>
   <result pre="1993 Mexico Unknown â€&quot; 1995 Venezuela 4000 100,000 Colombia 1996" exact="Mexico" post="Unknown â€&quot; 1998 Colombia Unknown 250 2011 Colombia 4"/>
   <result pre="1995 Venezuela 4000 100,000 Colombia 1996 Mexico Unknown â€&quot; 1998" exact="Colombia" post="Unknown 250 2011 Colombia 4 foci â€&quot; 2011 Venezuela"/>
   <result pre="Colombia 1996 Mexico Unknown â€&quot; 1998 Colombia Unknown 250 2011" exact="Colombia" post="4 foci â€&quot; 2011 Venezuela 3 foci â€&quot; During"/>
   <result pre="1998 Colombia Unknown 250 2011 Colombia 4 foci â€&quot; 2011" exact="Venezuela" post="3 foci â€&quot; During 1967 and 1968, epizootics occurred"/>
   <result pre="2). At the end of 1969, epizootics were reported in" exact="El Salvador" post="and Guatemala; these outbreaks eventually spread to most of"/>
   <result pre="and Guatemala; these outbreaks eventually spread to most of Central" exact="America" post="and Mexico [38â€&quot;40]. During this outbreak, about 50,000 horses"/>
   <result pre="these outbreaks eventually spread to most of Central America and" exact="Mexico" post="[38â€&quot;40]. During this outbreak, about 50,000 horses died, in"/>
   <result pre="about 52,000 human cases, of which 93 were fatal in" exact="Mexico" post="[41, 42]. Initially, the deaths of horses in Mexico"/>
   <result pre="in Mexico [41, 42]. Initially, the deaths of horses in" exact="Mexico" post="were reported in the state of Chiapas, this outbreak"/>
   <result pre="in Venezuela, followed by additional outbreaks in 1993 in both" exact="Venezuela" post="and Mexico [40] (Fig.Â 2; TableÂ 2). In 1995,"/>
   <result pre="followed by additional outbreaks in 1993 in both Venezuela and" exact="Mexico" post="[40] (Fig.Â 2; TableÂ 2). In 1995, both Venezuela"/>
   <result pre="and Mexico [40] (Fig.Â 2; TableÂ 2). In 1995, both" exact="Venezuela" post="and Colombia reported outbreaks [44] involving some 100,000 human"/>
   <result pre="[40] (Fig.Â 2; TableÂ 2). In 1995, both Venezuela and" exact="Colombia" post="reported outbreaks [44] involving some 100,000 human cases, of"/>
   <result pre="with this outbreak. Small equine epizootics were also reported in" exact="Mexico" post="in 1993 and 1996 [40] (Fig.Â 2; TableÂ 2)."/>
   <result pre="conclusion, Venezuelan equine encephalitis is a persistent zoonosis in Latin" exact="America" post="through long periods of apparent epidemiological silence. Rodents can"/>
   <result pre="Las encephalitis equinas en la salud pÃºblica. Universidad Nacional de" exact="Colombia" post="Press. Facultad de Medicina Veterinaria y de Zootecnia. 2005;"/>
   <result pre="equine encephalomyelitis: surveys of human illness during an epizootic in" exact="Guatemala" post="and El SalvadorAm J Epidemiol19719321301365101138 40.ObersteMSWeaverSCWattsDMSmithJFIdentification and genetic analysis"/>
   <result pre="ColombiaAm J Trop Med Hyg.195982 Pt 117518913637316 49.Sanmartin-BarberiCGrootHOsorno-MesaEHuman epidemic in" exact="Colombia" post="caused by the Venezuelan equine encephalomyelitis virusAm J Trop"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7237358\results\search\country\results.xml">
   <result pre="used for treating malaria; Artemisia annua (sweet wormwood) native to" exact="China" post="and Cinchona officinalis (Cinchona tree) native to South America"/>
   <result pre="to China and Cinchona officinalis (Cinchona tree) native to South" exact="America" post="are the most well known (Mohammadi etÂ al., 2020)"/>
   <result pre="detoxifying decoction (LCDD) widely used in treating COVID-19 patients in" exact="China" post="was developed based on four formulae described in the"/>
   <result pre="of Cinchona tree bark was rediscovered by Spanish settlers in" exact="Peru" post="in the mid-17th century. In the following years, Cinchona"/>
   <result pre="investigation for other indications (www.ClinicalTrials.gov). A preliminary clinical study in" exact="France" post="recently showed promising results of chloroquine and hydroxychloroquine in"/>
   <result pre="Joint Prevention and Control Mechanism of the State Council of" exact="China" post="on April 17, the initial trial indicated that LCDD"/>
   <result pre="viral infection-induced cytokine storm. Unfortunately, the success of LCDD in" exact="China" post="cannot be easily transferred to other countries for several"/>
   <result pre="TCM infrastructure and the general cultural acceptance of TCM in" exact="China" post="are lacking outside China. Hence, there is no mechanism"/>
   <result pre="treating COVID-19 as an investigational therapy or complementary medicine in" exact="the United States" post="for example. Second, although the US Food and Drug"/>
   <result pre="COVID-19 as an investigational therapy or complementary medicine in the" exact="United States" post="for example. Second, although the US Food and Drug"/>
   <result pre="complementary medicine in the United States for example. Second, although" exact="the US" post="Food and Drug Administration (FDA) has a route for"/>
   <result pre="seem to value science enough, despite its purported importance. In" exact="the United States," post="for example, the total federal budget for major science"/>
   <result pre="to value science enough, despite its purported importance. In the" exact="United States," post="for example, the total federal budget for major science"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7237904\results\search\country\results.xml">
   <result pre="studies in the region. For instance, two remdesivir trials in" exact="China" post="(Clinical Trial Numberi: NCT04252664 and NCT04257656) were halted due"/>
   <result pre="The work was supported by the 10.13039/501100002338Ministry of Education of" exact="China" post="for an Innovative Research Team in University grant (No."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7237932\results\search\country\results.xml">
   <result pre="other treatments were available. A placebo-controlled RCT of remdesivir in" exact="China" post="failed to demonstrate a statistically significant clinical benefit in"/>
   <result pre="the drug has been approved for treatment of COVID-19 in" exact="the US" post="(Beigel et al., 2020). Immunomodulators may ameliorate severe COVID-19"/>
   <result pre="illness caused by SARS-CoV-2, a zoonotic coronavirus that emerged in" exact="China" post="in 2019 and has rapidly spread around the world"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7238163\results\search\country\results.xml">
   <result pre="Short History of Yellow Fever: Once Upon a Time in" exact="America" post="The yellow fever virus circulates in African forests from"/>
   <result pre="the recently introduced Zika virus. It is thought that the" exact="Brazil" post="2016-18 yellow fever outbreak was almost entirely due to"/>
   <result pre="Interestingly, endemic yellow fever has never been reported in Asia," exact="Madagascar" post="or other Indian Ocean islands, for reasons that are"/>
   <result pre="In both its native range Asia and recently invaded South" exact="America" post="and Africa, Ae. albopictus has retained its ancestral capacity"/>
   <result pre="the West Nile virus in several temperate cities, particularly in" exact="the USA" post="[50]. The optimistic view, but not very realistic, is"/>
   <result pre="a sylvan cycle of yellow fever in Central and South" exact="America" post="500 years ago, new viruses may appear in transmission"/>
   <result pre="change [56]. Indeed, this virus has already been found in" exact="Haiti" post="[57] in Cx. quinquefasciatus, a human-biting mosquito recorded in"/>
   <result pre="of re-emergence of urban transmission of yellow fever virus in" exact="Brazil" post="facilitated by competent Aedes populationsSci. Rep.20177484810.1038/s41598-017-05186-328687779 24.Moreira-SotoA.TorresM.C.Lima de MendonÃ§aM.C.Mares-GuiaM.A.Dos"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7238722\results\search\country\results.xml">
   <result pre="Abstract Summary According to the World Health Organization (WHO) the" exact="China" post="office was first notified of cases of atypical pneumonia"/>
   <result pre="pandemic of aÂ coronavirus. It started in Guangdong Province in" exact="China" post="in 2002 [2]. Severe atypical cases of pneumonia emerged"/>
   <result pre="severe disease. In 2012, the MERS coronavirus was discovered in" exact="Saudi Arabia," post="isolated from the sputum of aÂ man who died"/>
   <result pre="aÂ single patient caused an outbreak of 186 cases in" exact="South Korea," post="while aÂ more recent case identified in an emergency"/>
   <result pre="to spread. A retrospective study suggested travelling by train in" exact="China" post="yielded the highest proportion of imported cases to new"/>
   <result pre="patients during the convalescent period. Additionally, the first person in" exact="the USA" post="with coronavirus infection shed the virus in loose stool"/>
   <result pre="surface areas after potential contamination, one group of researchers in" exact="China" post="reported that previous research on SARS and MERS suggested"/>
   <result pre="reported on clinical presentation and characteristics of early cases in" exact="China" post="and 1 of the latest publications studied the first"/>
   <result pre="increasing number of pediatric cases are now being reported from" exact="China" post="[11]. The adult patients in the Wuhan study had"/>
   <result pre="were still hospitalized [12]. Discharge criteria suggested by pediatricians in" exact="China" post="include children with aÂ normal body temperature for at"/>
   <result pre="14 days can be advised [11]. A retrospective study from" exact="China" post="analyzed chest CT scans from 21 symptomatic patients with"/>
   <result pre="mild or moderate progression of disease [14]. Other clinicians in" exact="China" post="also studied chest CT scans and confirmed typical multilobar"/>
   <result pre="Recommendations to prevent nosocomial spread AÂ recent manuscript out of" exact="Canada" post="provided an extensive review of measures designed to prevent"/>
   <result pre="preferably be administered by metered dose inhalers [20]. Pediatricians in" exact="China" post="have also provided recommendations for personal protective gear [11]."/>
   <result pre="no evidence it will be effective against COVID-19. Pediatricians in" exact="China" post="have suggested nebulized interferon be considered in infected children"/>
   <result pre="is no data to support itsâ€™ use and publications from" exact="Canada" post="advise against routine nebulizer use, noting the potential for"/>
   <result pre="between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in" exact="China" post="from 2019 to 2020: A data driven correlation reportTravel"/>
   <result pre="reportTravel Med Infect Dis202010.1016/j.tmaid.2020.10156832425697 8.QunLXuhuaGPengWet al.Early transmission dynamics in Wuhan," exact="China" post="of novel corona-infected pneumoniaN Engl J Med202010.1056/NEJMoa2001316 9.RouthCShunkMSothmannPTransmission of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7238951\results\search\country\results.xml">
   <result pre="positioned venues for detecting HCV infection among these persons. The" exact="United States" post="has witnessed an unprecedented opioid overdose epidemic since 2013"/>
   <result pre="inject drugs (5,6,9,10). Although three quarters of HCV infections in" exact="the United States" post="are among persons born during 1945â€&quot;1965, this study demonstrates"/>
   <result pre="drugs (5,6,9,10). Although three quarters of HCV infections in the" exact="United States" post="are among persons born during 1945â€&quot;1965, this study demonstrates"/>
   <result pre="virus infections among young nonurban persons who inject drugs in" exact="the United States," post="2006â€&quot;2012.Clin Infect Dis2014;59:1411â€&quot;9. 10.1093/cid/ciu64325114031 4. Van HandelMM, RoseCE, HalliseyEJ,"/>
   <result pre="infections among young nonurban persons who inject drugs in the" exact="United States," post="2006â€&quot;2012.Clin Infect Dis2014;59:1411â€&quot;9. 10.1093/cid/ciu64325114031 4. Van HandelMM, RoseCE, HalliseyEJ,"/>
   <result pre="BairdJR, LiuT, TaylorLE. HCV among The Miriam Hospital and Rhode" exact="Island" post="Hospital adult ED patients.R I Med J (2013)2014;97:35â€&quot;9.24983020 10."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7239338\results\search\country\results.xml">
   <result pre="Ebolavirus. Four highly pathogenic species have been identified in humans:" exact="Zaire" post="ebolavirus, Sudan ebolavirus, TaÃ¯ Forest ebolavirus, and Bundibugyo ebolavirus.14Zaire"/>
   <result pre="highly pathogenic species have been identified in humans: Zaire ebolavirus," exact="Sudan" post="ebolavirus, TaÃ¯ Forest ebolavirus, and Bundibugyo ebolavirus.14Zaire ebolavirus is"/>
   <result pre="specie of the 2013â€&quot;2016 West Africa outbreak and the current" exact="Democratic Republic of Congo" post="outbreak, responsible of &amp;gt;Â 95% of the reported fatality"/>
   <result pre="of the 2013â€&quot;2016 West Africa outbreak and the current Democratic" exact="Republic of" post="Congo outbreak, responsible of &amp;gt;Â 95% of the reported"/>
   <result pre="2013â€&quot;2016 West Africa outbreak and the current Democratic Republic of" exact="Congo" post="outbreak, responsible of &amp;gt;Â 95% of the reported fatality"/>
   <result pre="since its discovery in 1976. Spread over Guinea, Liberia, and" exact="Sierra Leone," post="28,616 cases of patients with EVD have been reported,"/>
   <result pre="candidates was favipiravir (Tâ€�705), an RNA polymerase inhibitor approved in" exact="Japan" post="for the treatment of noncomplicated influenza infections and in"/>
   <result pre="treatment of noncomplicated influenza infections and in clinical development in" exact="the United States." post="Favipiravir is an oral drug with a fast absorption"/>
   <result pre="of noncomplicated influenza infections and in clinical development in the" exact="United States." post="Favipiravir is an oral drug with a fast absorption"/>
   <result pre="an open multicenter nonrandomized clinical trial that took place in" exact="Guinea" post="from December 2014 to April 2015.37 JIKI was the"/>
   <result pre="brincidofovir, and convalescent plasma were implemented in Gunea, Liberia, and" exact="Sierra Leone" post="during the 2013â€&quot;2016 outbreak, yet none of them could"/>
   <result pre="with 10 to 1,000 focus forming units with Ebola virus" exact="Gabon" post="2001 strain, belonging to Zaire ebolavirus species. Viral load"/>
   <result pre="forming units with Ebola virus Gabon 2001 strain, belonging to" exact="Zaire" post="ebolavirus species. Viral load was detectable in most animals"/>
   <result pre="Accordingly, a first experiment was designed where cynomolgus macaques from" exact="Mauritius" post="Island were infected 2Â days after the initiation of"/>
   <result pre="a first experiment was designed where cynomolgus macaques from Mauritius" exact="Island" post="were infected 2Â days after the initiation of treatment"/>
   <result pre="drug halfâ€�maximal effective concentration for various emerging viruses. CCHFV, Crimea" exact="Congo" post="haemorrhagic fever virus; EBOV, Ebola virus; JUNV, Junin virus;"/>
   <result pre="150 or 180Â mg/kg were conducted in cynomolgus macaques from" exact="Mauritius" post="Island using the same design (i.e., with treatment starting"/>
   <result pre="or 180Â mg/kg were conducted in cynomolgus macaques from Mauritius" exact="Island" post="using the same design (i.e., with treatment starting 2Â"/>
   <result pre="exposed people. The promising vesicular stomatitis virusâ€�based vaccine used in" exact="Guinea" post="provided high level protection after a 10â€�day delay, but"/>
   <result pre="prophylaxis or postexposure setting. During the last Marburg outbreak in" exact="Uganda" post="in October 2017, favipiravir was considered for such a"/>
   <result pre="Research Program on Emerging and Reâ€�emerging Infectious Diseases of the" exact="Japan" post="Agency for Medical Research and Development (AMED). Conflict of"/>
   <result pre="of Interest As Editorâ€�inâ€�Chief for CPT: Pharmacometrics &amp;amp; Systems Pharmacology," exact="France" post="MentrÃ© was not involved in the review or decision"/>
   <result pre="J.S.et alClinical illness and outcomes in patients with Ebola in" exact="Sierra Leone." post="N. Engl. J. Med.371, 2092â€&quot;2100 (2014).25353969 18Olejnik, J., Ryabchikova,"/>
   <result pre="Pathol.12, 387â€&quot;418 (2017).27959626 20Towner, J.S.et alGeneration of eGFP expressing recombinant" exact="Zaire" post="ebolavirus for analysis of early pathogenesis events and highâ€�throughput"/>
   <result pre="Becquart, P., Padilla, C., Baize, S. &amp;amp; Leroy, E.M.Human fatal" exact="Zaire" post="Ebola virus infection is associated with an aberrant innate"/>
   <result pre="virus RNA in semen for six months after returning from" exact="Haiti" post="to Italy, January 2016. Eurosurveillance21, (2016). 84Osuna, C.E. &amp;amp;"/>
   <result pre="rVSVâ€�vectored vaccine expressing Ebola surface glycoprotein: interim results from the" exact="Guinea" post="ring vaccination clusterâ€�randomised trial. Lancet386, 857â€&quot;866 (2015).26248676 91Marzi, A.et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7239775\results\search\country\results.xml">
   <result pre="COVID-19 patients has started in different countries (among which are" exact="the USA" post="[7], Italy [8] and the Netherlands [9]) and others"/>
   <result pre="started in different countries (among which are the USA [7]," exact="Italy" post="[8] and the Netherlands [9]) and others will follow"/>
   <result pre="countries (among which are the USA [7], Italy [8] and" exact="the Netherlands" post="[9]) and others will follow in the very next"/>
   <result pre="(among which are the USA [7], Italy [8] and the" exact="Netherlands" post="[9]) and others will follow in the very next"/>
   <result pre="present phase of this pandemic, we are aware that in" exact="Italy" post="(as well as in the rest of the world)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7241406\results\search\country\results.xml">
   <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci63202045746032009228 38Zhao, Y., Zhao, Z., Wang, Y., Zhou,"/>
   <result pre="isolation from ocular secretions of a patient with COVID-19 in" exact="Italy" post="with prolonged viral RNA detectionAnn Intern Med2020 Apr 17M20M1176"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7242729\results\search\country\results.xml">
   <result pre="by: Zisis Kozlakidis, International Agency for Research on Cancer (IARC)," exact="France" post="Reviewed by: Irene Crespo, University of LeÃ³n, Spain; Abdul"/>
   <result pre="Al-Bari, University of Rajshahi, Bangladesh; Javier GonzÃ¡lez-Gallego, University of LeÃ³n," exact="Spain" post="*Correspondence: Russel J. Reiter reiter@uthscsa.edu Alberto Dominguez-Rodriguez adrvdg@hotmail.com This"/>
   <result pre="the past 20 years, two coronavirus epidemics that originated in" exact="China" post="caused large-scale pandemics that involved over 20 countries leading"/>
   <result pre="few randomized trials initiated in China, and more recently in" exact="the US" post="(46). In the 2014 Ebola outbreak, a randomized clinical"/>
   <result pre="latest human coronavirus threat. Viruses. (2018) 10:E93. 10.3390/v1002009329495250 2.FlahaultA. Has" exact="China" post="faced only a herald wave of SARS-CoV-2?Lancet. (2020) 395:947."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7242884\results\search\country\results.xml">
   <result pre="and affordable following discovery. Even in wealthy countries such as" exact="the United States," post="many COVID-19 patients have struggled with the cost of"/>
   <result pre="affordable following discovery. Even in wealthy countries such as the" exact="United States," post="many COVID-19 patients have struggled with the cost of"/>
   <result pre="from patentability in order to ensure drug prices were affordable." exact="India" post="and Brazil, for example, had previously only allowed for"/>
   <result pre="Brazil, Ecuador, Ghana, Indonesia, Malaysia, Mozambique, Thailand, Rwanda, Zambia, and" exact="Zimbabwe" post="each issued compulsory licenses for one or more antiretroviral"/>
   <result pre="While most countries issued licenses for a specific patented drug," exact="Ghana" post="and Zimbabwe issued categorical compulsory licenses on all antiretroviral"/>
   <result pre="countries issued licenses for a specific patented drug, Ghana and" exact="Zimbabwe" post="issued categorical compulsory licenses on all antiretroviral drugs [7]."/>
   <result pre="decreasing the price of antiretroviral drugs in the mid-2000s were" exact="Thailand" post="and Brazil. Both countries provided free antiretroviral treatments to"/>
   <result pre="government to import generic versions of the antiretroviral drugs from" exact="India" post="at a significantly lowered cost â€&quot; generic efavirenz at"/>
   <result pre="PPPY and generic lopinavir/ritonavir at US$676 PPPY [8]. Like Thailand," exact="Brazil" post="issued a compulsory license for efavirenz in 2007. Merck"/>
   <result pre="license for efavirenz in 2007. Merck initially offered efavirenz to" exact="Brazil" post="at the price of US$760 PPPY. By issuing a"/>
   <result pre="of US$760 PPPY. By issuing a compulsory license for efavirenz," exact="Brazil" post="was able to generically import efavirenz at US$170 per"/>
   <result pre="generically import efavirenz at US$170 per patient/y. However, unlike Thailand," exact="Brazil" post="did not issue a compulsory license for lopinavir/ritonavir. In"/>
   <result pre="license, Abbott Laboratories eventually lowered the price of lopinavir/ritonavir in" exact="Brazil" post="from US$3241 PPPY to a price of US$1380 PPPY"/>
   <result pre="version [8]. Notably, the discounted price of Abbottâ€™s lopinavir/ritonavir in" exact="Brazil" post="was still more than twice the price of the"/>
   <result pre="more than twice the price of the generic lopinavir/ritonavir that" exact="Thailand" post="acquired through compulsory licensing and importing from India. Photo:"/>
   <result pre="as part of their COVID-19 response. On March 24, 2020," exact="Israel" post="issued a compulsory license to import generic versions of"/>
   <result pre="drug could be a possible treatment for COVID-19 patients. Unlike" exact="Thailand" post="and Brazil, Israel did not issue the license due"/>
   <result pre="a possible treatment for COVID-19 patients. Unlike Thailand and Brazil," exact="Israel" post="did not issue the license due to the drugâ€™s"/>
   <result pre="not issue the license due to the drugâ€™s pricing. Instead," exact="Israel" post="issued the compulsory license and turned to generic alternatives"/>
   <result pre="issued the compulsory license and turned to generic alternatives from" exact="India" post="because AbbVie was unable to provide sufficient supplies of"/>
   <result pre="their COVID-19 response. In March, legislatures in Canada, Chile, and" exact="Ecuador" post="laid the legal groundwork for the issuance of compulsory"/>
   <result pre="technologies [13]. Similarly, a Committee of the National Assembly in" exact="Ecuador" post="has passed a resolution requiring the Ecuadorian President and"/>
   <result pre="Health. The Projected Economic Impact of the COVID-19 Pandemic on" exact="the US" post="Healthcare System. New York: FAIR Health, Inc.; 2020. 2World"/>
   <result pre="Access to Antiretroviral Therapy in the Less-Developed World: Lessons from" exact="Brazil" post="and Thailand.AIDS. 2007;21Suppl 4:S21-9. 10.1097/01.aids.0000279703.78685.a617620749 9HarrisDTRIPS after fifteen years:"/>
   <result pre="civil movement and political leadership.Global Health. 2011;7:32. 10.1186/1744-8603-7-3221910864 11Kass D." exact="Israel" post="Defies AbbVie IP To Import Generic Drugs For COVID-19."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7242950\results\search\country\results.xml">
   <result pre="the use of chloroquine in coronavirus-19 infection was conducted in" exact="China" post="and was published on 4th February. It analyzed the"/>
   <result pre="per patient. However, a recent randomized clinical trial published in" exact="China" post="examining the efficacy and safety of the administration of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7243793\results\search\country\results.xml">
   <result pre="RNA viral infectionsAntiviral Res.8220099510219428599 39ZhangY.F.Potential coronavirus drug approved for marketing." exact="China" post="Daily, February 17, 2020https://www.chinadaily.com.cn/2020 40WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and chloroquine effectively inhibit"/>
   <result pre="(2R01GM097082-05), the European Lead Factory (IMI) (grant agreement 115489), the" exact="Qatar" post="National Research Foundation (NPRP6-065-3-012), Cofunds Alert (grant agreement 665250),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7246053\results\search\country\results.xml">
   <result pre="of COVID-19 in our region compared with the rest of" exact="the United States" post="and the world; 2) the mode of transmission of"/>
   <result pre="COVID-19 in our region compared with the rest of the" exact="United States" post="and the world; 2) the mode of transmission of"/>
   <result pre="al11 and available at: https://coronavirus.jhu.edu/map.html). Since the first case in" exact="the United States" post="was reported on January 20, 2020, COVID-19 has spread"/>
   <result pre="and available at: https://coronavirus.jhu.edu/map.html). Since the first case in the" exact="United States" post="was reported on January 20, 2020, COVID-19 has spread"/>
   <result pre="6 million cases and 350,000 deaths in the world, with" exact="the United States" post="accounting for 1.8 million cases and greater than 100,000"/>
   <result pre="million cases and 350,000 deaths in the world, with the" exact="United States" post="accounting for 1.8 million cases and greater than 100,000"/>
   <result pre="major deadly diseases. Geneva: World Health Organization;Â 2018. Studies from" exact="China" post="and early reports from other regions showed that the"/>
   <result pre="(12Â of 98) and 7% (9 of 128), respectively.32 In" exact="the United States," post="from February 12, to April 9, 2020, of the"/>
   <result pre="of 98) and 7% (9 of 128), respectively.32 In the" exact="United States," post="from February 12, to April 9, 2020, of the"/>
   <result pre="PVP-I products.42 In a recent inÂ vivo study in the" exact="United Kingdom," post="Eggers etÂ al44 tested the use of a 0.5%"/>
   <result pre="of raw materials in the pharmaceutical industry originate from outside" exact="the United States" post="can be problematic. This will be especially true if"/>
   <result pre="raw materials in the pharmaceutical industry originate from outside the" exact="United States" post="can be problematic. This will be especially true if"/>
   <result pre="before incorporating them into the mainstream. Several undergraduate faculty across" exact="the United States" post="have developed problem-based learning tools and simulation models for"/>
   <result pre="incorporating them into the mainstream. Several undergraduate faculty across the" exact="United States" post="have developed problem-based learning tools and simulation models for"/>
   <result pre="of print]. Head Neckhttps://doi.org/10.1002/hed.26193accessed April 29, 2020 8PrameshC.S.BadweR.A.Cancer management in" exact="India" post="during COVID-19N Engl J Med3822020e6132343498 9AndersonR.M.HeesterbeekH.KlinkenbergD.HollingsworthT.D.How will country-based mitigation"/>
   <result pre="head and neck oncologic and microvascular surgery practice patterns across" exact="the United States" post="during the SARS-CoV-2 (COVID19) pandemic[e-pub ahead of print]. Head"/>
   <result pre="and neck oncologic and microvascular surgery practice patterns across the" exact="United States" post="during the SARS-CoV-2 (COVID19) pandemic[e-pub ahead of print]. Head"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7246824\results\search\country\results.xml">
   <result pre="of Hubei, located in the southern part of the Peopleâ€™s" exact="Republic of" post="China [1]. The novel virus was initially termed as"/>
   <result pre="located in the southern part of the Peopleâ€™s Republic of" exact="China" post="[1]. The novel virus was initially termed as â€œ2019"/>
   <result pre="have been indicated as putative key reservoirs of coronavirus in" exact="China" post="[5]. From a genomic standpoint, the SARS-CoV-2 shares approximately"/>
   <result pre="risk of contracting MERS infection during the MERS outbreak in" exact="South Korea" post="in May-June of 2015. Buzz conveying negative feelings was"/>
   <result pre="anti-viral effects [24], whereas another start-up, Insilico Medicine, located in" exact="Hong Kong," post="has reported to have found six new drugs that"/>
   <result pre="located in Chongqing, in the southwestern part of the Peopleâ€™s" exact="Republic of" post="China, to monitor the flow of people during the"/>
   <result pre="Nations Habitat III on housing and sustainable urban development in" exact="Ecuador" post="(the â€œNew Urban Agendaâ€�). It is becoming more and"/>
   <result pre="events. In recent years, several cities and communities in Spain," exact="New Zealand," post="United States, United Kingdom, Canada and United Arab Emirates"/>
   <result pre="recent years, several cities and communities in Spain, New Zealand," exact="United States," post="United Kingdom, Canada and United Arab Emirates have launched"/>
   <result pre="several cities and communities in Spain, New Zealand, United States," exact="United Kingdom," post="Canada and United Arab Emirates have launched initiatives and"/>
   <result pre="and communities in Spain, New Zealand, United States, United Kingdom," exact="Canada" post="and United Arab Emirates have launched initiatives and challenges"/>
   <result pre="in Spain, New Zealand, United States, United Kingdom, Canada and" exact="United Arab Emirates" post="have launched initiatives and challenges with the aim of"/>
   <result pre="New Zealand, United States, United Kingdom, Canada and United Arab" exact="Emirates" post="have launched initiatives and challenges with the aim of"/>
   <result pre="among the major factors of the success of the Peopleâ€™s" exact="Republic of" post="China in the efforts of containing COVID-19. Further research"/>
   <result pre="major factors of the success of the Peopleâ€™s Republic of" exact="China" post="in the efforts of containing COVID-19. Further research is"/>
   <result pre="(COVID-19) rapid research program. J.W. is partially supported by the" exact="Canada" post="Research Chair Program (grant number: 230720), by the Natural"/>
   <result pre="230720), by the Natural Sciences and Engineering Research Council of" exact="Canada" post="(Grant number: 105588-2011), and the Canadian Institute of Health"/>
   <result pre="and AI prediction of the epidemics trend of COVID-19 in" exact="China" post="under public health interventionsJ. Thorac. Dis.20201216517410.21037/jtd.2020.02.6432274081 18.SongJ.SongT.M.SeoD.C.JinD.L.KimJ.S.Social Big Data"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7247743\results\search\country\results.xml">
   <result pre="not occur in previous epidemics (1). Initially the response from" exact="China" post="and elsewhere was for scientists to look at compounds"/>
   <result pre="chloroquine has also been identified by several groups (in China," exact="South Korea" post="and the USA, (4â€&quot;7) to have micromolar activity against"/>
   <result pre="been identified by several groups (in China, South Korea and" exact="the USA," post="(4â€&quot;7) to have micromolar activity against SARS-CoV-2 in vitro"/>
   <result pre="HIV (23). Miramistin is approved as broad-spectrum anti-infective agent in" exact="Russia" post="(24), but it does not appear to have been"/>
   <result pre="targets capsid and is lysosomotropic No, but is approved in" exact="Russia" post="Antiseptic The current COVID-19 pandemic is sweeping the globe"/>
   <result pre="affiliations. ACKNOWLEDGMENTS AND DISCLOSURES This work has been reviewed at" exact="the US" post="EPA and has been approved for publication. The views"/>
   <result pre="and do not necessarily represent the views or policies of" exact="the United States" post="Environment Protection Agency. Reference to commercial products or services"/>
   <result pre="do not necessarily represent the views or policies of the" exact="United States" post="Environment Protection Agency. Reference to commercial products or services"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7249458\results\search\country\results.xml">
   <result pre="billion market, with 21 companies selling tissue engineeringâ€&quot;based products in" exact="the United States" post="alone as of 2017.12 In the current setting of"/>
   <result pre="market, with 21 companies selling tissue engineeringâ€&quot;based products in the" exact="United States" post="alone as of 2017.12 In the current setting of"/>
   <result pre="D-dimer, erythrocyte sedimentation rate, C-reactive protein, and absolute lymphopenia.20 In" exact="the United States," post="the most widely available diagnostic test is polymerase chain"/>
   <result pre="erythrocyte sedimentation rate, C-reactive protein, and absolute lymphopenia.20 In the" exact="United States," post="the most widely available diagnostic test is polymerase chain"/>
   <result pre="MelchiorriA.J., and MikosA.G.An overview of the tissue engineering market in" exact="the United States" post="from 2011 to 2018. Tissue Eng Part A25,1, 201930027831"/>
   <result pre="and MikosA.G.An overview of the tissue engineering market in the" exact="United States" post="from 2011 to 2018. Tissue Eng Part A25,1, 201930027831"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7249615\results\search\country\results.xml">
   <result pre="is currently only approved for treatment of chronic pancreatitis in" exact="Japan" post="[27]. Very little data are available on the drugâ€™s"/>
   <result pre="Camostat mesilate is currently undergoing Phase 1/2 trial testing in" exact="the USA" post="for chronic pancreatitis [28]. If deemed safe, it could"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7250076\results\search\country\results.xml">
   <result pre="[b], [c], [d], [e], [f], â�ŽCorresponding author at: FAO ECTAD" exact="Tanzania" post="&amp;amp; Department of Veterinary Tropical Diseases, University of Pretoria,"/>
   <result pre="Tanzania &amp;amp; Department of Veterinary Tropical Diseases, University of Pretoria," exact="South Africa." post="Folorunso.fasina@fao.org pmc-release: 2020-5-5ppub: 2020-7epub: 2020-5-596519523received: 2020-3-28rev-recd: 2020-5-11accepted: 2020-5-13(C) ,"/>
   <result pre="would quarantine used vehicles and/or equipment. As currently demonstrated in" exact="South Korea," post="this proposal is feasible, less disruptive and, potentially, more"/>
   <result pre="in U.S. https://www.cdc.gov/media/releases/2020/s0226-Covid-19-spread.html [Accessed 29 February 2020]. ChenS.YangJ.YangW.WangC.BÃ¤rnighausenT.COVID-19 control in" exact="China" post="during mass population movements at New YearLancet39510226202076476610.1016/S0140-6736(20)30421-932105609 China prisons"/>
   <result pre="control in China during mass population movements at New YearLancet39510226202076476610.1016/S0140-6736(20)30421-932105609" exact="China" post="prisons report 500 cases, as virus spreads in South"/>
   <result pre="YearLancet39510226202076476610.1016/S0140-6736(20)30421-932105609 China prisons report 500 cases, as virus spreads in" exact="South Korea" post="â€&quot; as it happened2020The Guardian 6:40pm: Japan says 79"/>
   <result pre="spreads in South Korea â€&quot; as it happened2020The Guardian 6:40pm:" exact="Japan" post="says 79 more people have tested positive for coronavirus"/>
   <result pre="patients recovered from COVID-19JAMA202010.1001/jama.2020.2783 LauderdaleT.-L.McDonaldL.C.ShiauY.-R.ChenP.-C.WangH.-Y.LaiJ.-F.The status of antimicrobial resistance in" exact="Taiwan" post="among gram-negative pathogens: the Taiwan Surveillance of Antimicrobial Resistance"/>
   <result pre="status of antimicrobial resistance in Taiwan among gram-negative pathogens: the" exact="Taiwan" post="Surveillance of Antimicrobial Resistance (TSAR) program, 2000Diagn Microbiol Infect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7250111\results\search\country\results.xml">
   <result pre="of Medicine, University of Colombo, 25 Kynsey Road, Colombo 08," exact="Sri Lanka." post="pmc-release: 2020-5-5ppub: 2020-8epub: 2020-5-5268979987received: 2020-4-8rev-recd: 2020-5-5accepted: 2020-5-16(C) European Society"/>
   <result pre="size calculation or randomization not given Paton etÂ al., 2012," exact="United Kingdom" post="[20] Randomized, double-blind, placebo-controlled trial HIV-infected asymptomatic patients, not"/>
   <result pre="well tolerated despite more flu-like episodes Paton etÂ al., 2002," exact="Singapore" post="[24] Non-controlled prospective study HIV-infected patients with a viral"/>
   <result pre="patients with two severe adverse events Piconi etÂ al., 2011," exact="Italy" post="[23] Non-controlled prospective study HIV-infected, adult, immunological non-responders (CD4+"/>
   <result pre="to reduce immune activation in HIV Engchanil etÂ al., 2006," exact="Thailand" post="[19] Prospective, randomized open-label clinical trial HIV-infected children (&amp;lt;14Â"/>
   <result pre="reduce immune activation in HIV HCV Helal etÂ al., 2016," exact="Egypt" post="[27] Randomized, prospective, single-blind, controlled study Patients with chronic"/>
   <result pre="additional adverse events due to HCQ Peymani etÂ al., 2016," exact="Iran" post="[26] Randomized, triple-blind, placebo-controlled pilot trial Patients with HCV"/>
   <result pre="RNA noted after stopping CQ Dengue Tricou etÂ al., 2010," exact="Vietnam" post="[28] Randomized, double-blind, placebo-controlled trial Patients with clinically suspected"/>
   <result pre="group had significantly more adverse events Borges etÂ al., 2013," exact="Brazil" post="[29] Randomized double-blind study Patients with clinically suspected dengue,"/>
   <result pre="upon ceasing the regimen Chikungunya De Lamballerie etÂ al. French" exact="Reunion" post="Islands 2008 [30] Randomized, double-blind, placebo-controlled trial Patients with"/>
   <result pre="(none assessed HCQ). A double-blind RCT (nÂ =Â 307) in" exact="Vietnam" post="administered CQ 1500 mg over 3Â days (dosage regimen"/>
   <result pre="in acute chikungunya infection. This double-blind RCT, conducted in French" exact="Reunion" post="Islands in 2006, enrolled 54 adult patients with virologically"/>
   <result pre="Chinese studies, and an expert consensus from Guangdong Province of" exact="China" post="(abstract in English) recommends using CQ 500 mg (presumably"/>
   <result pre="between the two groups. A non-randomized controlled trial from Marseille," exact="France" post="(full-paper reviewed) enrolled 26 patients with virologically confirmed COVID-19"/>
   <result pre="patients who received azithromycin. Results of two more RCTs from" exact="China" post="on using HCQ in COVID-19 are available as preprints"/>
   <result pre="RCTs on using CQ for COVID-19. The first study from" exact="China" post="randomized 22 virologically confirmed COVID-19 patients to receive either"/>
   <result pre="management protocols across all centres. The other two studies from" exact="China" post="(available as preprints) mentioned in the results section also"/>
   <result pre="of a randomized clinical trialmedRxiv2020202003.22.20040758 39MagagnoliJ.NarendranS.PereiraF.CummingsT.HardinJ.W.SuttonS.S.Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covid-19medRxiv2020202004.16.20065920 40HuangM.TangT.PangP.LiM.MaR.LuJ.Treating COVID-19 with chloroquineJÂ Mol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7250768\results\search\country\results.xml">
   <result pre="more than 1,95,000 deaths globally (as on 25th April 2020)." exact="India" post="recorded its first case on 30th January 2020 and"/>
   <result pre="been an upsurge of cases, and as on 25th April," exact="India" post="has recorded more than 25,000 cases and more than"/>
   <result pre="mechanisms (Fig.Â 1), significantly increasing the morbidity and mortality.3 Because" exact="India" post="is the world capital of DM, HTN,Â and CVD,"/>
   <result pre="counterparts.14 Interestingly, the CVDs report of the year 2018 from" exact="China" post="reveals the prevalence of HTN and DM to be"/>
   <result pre="35.5%, 30%, 24.5%, and 9.6%, respectively.16 Finally, preliminary data from" exact="the United States" post="involving 7162 patients with COVID-19 revealed the presence of"/>
   <result pre="30%, 24.5%, and 9.6%, respectively.16 Finally, preliminary data from the" exact="United States" post="involving 7162 patients with COVID-19 revealed the presence of"/>
   <result pre="ng/L; 95% confidence interval [CI]: 6.8â€&quot;44.5Â ng/L).22 Initial reports from" exact="China" post="indicated that there are two patterns of myocardial injury"/>
   <result pre="underlying health conditions among patients with coronavirus disease 2019 â€&quot;" exact="United States," post="february 12â€&quot;march 28, 2020MMWR Morb Mortal Wkly Rep69202038238632240123 18lhogbaniT.Acute"/>
   <result pre="21]. Circulation, 10.1161/CIRCULATIONAHA.120.047523 35MetzlerB.SiostrzonekP.BinderR.K.BauerA.ReinstadlerS.J.Decline of acute coronary syndrome admissions in" exact="Austria" post="since the outbreak of COVID-19: the pandemic response causes"/>
   <result pre="disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in" exact="Hong Kong," post="ChinaCirc Cardiovasc Qual Outcomes132020e00663110.1161/CIRCOUTCOMES.120.006631 37MahmudE.DauermanH.L.WeltF.G.Management of Acute Myocardial Infarction"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7251044\results\search\country\results.xml">
   <result pre="emergency by the World Health Organization. This condition began in" exact="China" post="in December 2019, was exported by international travellers and"/>
   <result pre="pandemic, even in areas of high HIV prevalence such as" exact="Thailand" post="[16]. In fact, antiretroviral therapy used by HIV positive"/>
   <result pre="European countries have 29 beds per 100,000 population, 35 in" exact="the USA" post="and 5 or less in many LMIC countries), PPE"/>
   <result pre="physicians per 10,000 population in Africa and parts of South" exact="America" post="compared with 21.5 in North Americas and 32.1 in"/>
   <result pre="associated with essential hypertension, are described in Africa and South" exact="America" post="[29, 30]. Although very recent work has shown no"/>
   <result pre="healthcare providers. Images and video clips in the press from" exact="Italy" post="and New York showing make-shift emergency rooms, beds on"/>
   <result pre="JW, Sutton SS, Ambati J. Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covid-19. medRxiv 2020.04.16.20065920. 10.1101/2020.04.16.20065920 8.Lu CC,"/>
   <result pre="12.CohenCMoyesJTempiaSGroomMWalazaSPretoriusMet al.Severe influenza-associated respiratory infection in high HIV prevalence setting," exact="South Africa," post="2009â€&quot;2011Emerg Infect Dis201319111766177410.3201/eid1911.13054624209781 13.LinJCNicholKLExcess mortality due to pneumonia or"/>
   <result pre="HIV-infected and uninfected children and adults in 2 provinces of" exact="South Africa," post="2012â€&quot;2014J Infect Dis201821881228123710.1093/infdis/jiy31029800425 15.WalazaSCohenCNanooACohenALMcAnerneyJvon MollendorfCet al.Excess mortality associated with"/>
   <result pre="MollendorfCet al.Excess mortality associated with influenza among tuberculosis deaths in" exact="South Africa," post="1999â€&quot;2009PLoS One2015106e012917310.1371/journal.pone.012917326076197 16.Joob B, Wiwanitkit V (2020) SARS-CoV-2 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7251277\results\search\country\results.xml">
   <result pre="Istanbul: Sequencing findings from the epicenter of the pandemic in" exact="Turkey" post="KaracanIlker12â€ AkgunTugba Kizilboga1â€ AgaogluN. Bugra13IrvemArzu4AlkurtGizem1YildizJale1KoseBetsi1OzelA. Serra5AltunalL. Nilsun5CanNisan Denizce6DemirkolYasemin Kendir17AydinMehtap5DoganOzlem"/>
   <result pre="under a Creative Commons Attribution-NonCommercial 4.0 International License Abstract OBJECTIVE:" exact="Turkey" post="is one of the latest countries that COVID-19 disease"/>
   <result pre="with implications for the origin of a spread first through" exact="China" post="to Europe then to Istanbul. CONCLUSION: Here, we report"/>
   <result pre="mutational or recombination events. The first case of COVID-19 in" exact="Turkey" post="was reported on 11 March 2020, much later than"/>
   <result pre="countries. As of April 1, the Ministry of Health of" exact="Turkey" post="announced that COVID-19 had reached all over Turkey, exhibiting"/>
   <result pre="highest spread in Istanbul. The first full-length SARS-CoV-2 genome in" exact="Turkey" post="was isolated from a patient in Kayseri province and"/>
   <result pre="in the COVID-19 Guide of the Ministry of Health of" exact="Turkey" post="[27]. Therefore, thorax computed tomography (CT), in line with"/>
   <result pre="Belgium, Netherlands, and Latvia, whereas COV-13 was clustered with Sweden," exact="Belgium" post="and Wales isolates (Figure 3). FIGURE 2 Inferred phylogeny"/>
   <result pre="As of May 2020, more than 3,500 patients died in" exact="Turkey" post="due to COVID-19, and most of the reported patients"/>
   <result pre="Since the first and most of the current cases in" exact="Turkey" post="are located in Istanbul, the characterization of virus samples"/>
   <result pre="found to be closely clustered within samples isolated mostly in" exact="Belgium" post="(Figure 3). This close relationship with Belgium isolates gives"/>
   <result pre="isolated mostly in Belgium (Figure 3). This close relationship with" exact="Belgium" post="isolates gives clues of early viral entry, at least"/>
   <result pre="Financial Disclosure: This work was supported by Health Institutes of" exact="Turkey" post="(TUSEB) (Grant No: 2020TK02-8686/8799) Authorship Contributions: Concept â€&quot; IK,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252029\results\search\country\results.xml">
   <result pre="with severe COVID-19 and in a phase II study in" exact="Italy" post="approved by the Italian Agency of Pharmaceutics. Siltuximab (SylvantTM)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252082\results\search\country\results.xml">
   <result pre="coronavirus disease (COVID-19) after it was initially reported in Wuhan," exact="China" post="in late December 2019. COVID-19 is caused by severe"/>
   <result pre="are currently underway, including in Australia, China, Japan, Europe and" exact="the USA" post="to test the effectiveness of various drugs previously approved"/>
   <result pre="hospitalised COVID-19 patients (nÂ =Â 323) in Tianyou Hospital, Wuhan," exact="China" post="from 8 January to 20 February 2020, and reported"/>
   <result pre="on hospitalised COVID-19 patients (nÂ =Â 298) in Guangdong Province," exact="China" post="between January 11, 2020 to February 11, 2020 reported"/>
   <result pre="already been initiated across the globe38 and early findings from" exact="China" post="reported good prognosis for patients who received hydroxychloroquine sulfate"/>
   <result pre="routine care of hospitalised COVID-19 patients (nÂ =Â 181) in" exact="France" post="compared the efficacy of standard care alone (nÂ =Â"/>
   <result pre="hydroxychloroquine alone.36 â€¢A pilot uncontrolled non-comparative observational study in Marseille," exact="France" post="investigated the efficacy of hydroxychloroquine with azithromycin in mild"/>
   <result pre="it does not recommend against the use of ibuprofen. â€¢Similarly," exact="the US" post="FDA issued a statement on March 19 that all"/>
   <result pre="production capacities of world's two largest producers of medical supplies," exact="China" post="and India, following lockdown. After hydroxychloroquine was claimed effective"/>
   <result pre="system as a case in point. The Pharmaceutical Society of" exact="Australia" post="(PSA) and The Pharmacy Guild of Australia have developed"/>
   <result pre="Pharmaceutical Society of Australia (PSA) and The Pharmacy Guild of" exact="Australia" post="have developed valuable practical resources that can be used"/>
   <result pre="by the TGA in liaison with the Pharmacy Guild of" exact="Australia" post="and the PSA. Again, pharmacists are on the front"/>
   <result pre="implemented by the Department of Health. The Pharmacy Guild of" exact="Australia" post="and the PSA in liaison with health authorities have"/>
   <result pre="the COVID-19 outbreak. Stewards for seasonal influenza vaccination Given that" exact="Australia" post="is entering the influenza season, health authorities are urging"/>
   <result pre="risk of doubling-up of seasonal influenza and COVID-19. Pharmacists in" exact="Australia" post="are well placed with appropriate background knowledge and training"/>
   <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci" exact="China" post="Life Sci6332020 Mar36437432048163 50American College of CardiologyHFSA/ACC/AHA statement addresses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252421\results\search\country\results.xml">
   <result pre="symptoms [3]. The characteristics from the COVID-19 outbreak reported from" exact="China" post="[3] provided important lessons with respect to cardiovascular involvements"/>
   <result pre="mortality in retrospective clinical series of COVID-19 patients hospitalized in" exact="China" post="[7], indicating potential serious bystander effects on other organs,"/>
   <result pre="[12] displaying the prevalence of co-morbidities in COVID-19 patients in" exact="Germany" post="disclosed that in all classes of disease severity more"/>
   <result pre="Asia with a surprisingly low fatality rate. 14th April 2020" exact="South Africa" post="had 2272 infections with 27 deaths despite a detailed"/>
   <result pre="decades lower than in higher income countries. For example in" exact="Uganda" post="the life expectancy at birth for males and females"/>
   <result pre="older than 60Â years. This age pyramid influences the current" exact="Uganda" post="cardiovascular health challenges which does include hypertension and coronary"/>
   <result pre="low-to-middle income countries but also some high-income countries such as" exact="Japan" post="having a universal BCG vaccination policy in newborns. BCG"/>
   <result pre="high number of people living with HIV/AIDS on anti-retroviral therapy." exact="South Africa" post="has a population of 57 million withâ€‰&amp;gt;â€‰12% being HIV-infected."/>
   <result pre="most prevalent risk factor in cardiovascular disease, in particular in" exact="China" post="[44]. In several early trials of COVID-19 populations, hypertension"/>
   <result pre="approximately 30â€&quot;40% in the overall population of diseased individuals in" exact="China" post="[7, 45, 46] and Italy [47]. In those patients,"/>
   <result pre="population of diseased individuals in China [7, 45, 46] and" exact="Italy" post="[47]. In those patients, who have complications or even"/>
   <result pre="anti-hypertensive drugs combined [50]. However, adequate blood pressure control in" exact="China" post="in the age group, where COVID-19 is most prevalent,"/>
   <result pre="cardiac surgery in the developing worldJ Thorac Cardiovasc Surg20181562206220930082076 15.LwabiPNamuyongaJLubegaSOketchoMMwambuTSebattaEOkelloEOmaginoJSliwaKThe" exact="Uganda" post="Heart AssociationEur Heart J2019402396239731539909 16.SliwaKNtusiNBattling cardiovascular diseases in a"/>
   <result pre="enzyme 2 in human pulmonary arterial hypertensionEur Respir J201810.1183/13993003.02638-201729903860 44.YangZJLiuJGeJPChenLZhaoZGYangWYcollab:" exact="China" post="National Diabetes and Metabolic Disorders Study GroupPrevalence of cardiovascular"/>
   <result pre="cardiovascular disease risk factor in the Chinese population: the 2007â€&quot;2008" exact="China" post="National Diabetes and Metabolic Disorders StudyEur Heart J20123321322021719451 45.WangDHuBHuCZhuFLiuXZhangJWangBXiangHChengZXiongYZhaoYLiYWangXPengZClinical"/>
   <result pre="SARS-CoV-2 admitted to ICUs of the Lombardy region, ItalyJAMA202010.1001/jama.2020.539432250385 48.WangZChenZZhangLWangXHaoGZhangZShaoLTianYDongYZhengCWangJZhuMWeintraubWSGaoRcollab:" exact="China" post="Hypertension Survey InvestigatorsStatus of hypertension in China: Results from"/>
   <result pre="Hypertension Survey InvestigatorsStatus of hypertension in China: Results from the" exact="China" post="hypertension survey, 2012â€&quot;2015Circulation20181372344235629449338 49.LiuLScollab: Writing Group of 2010 Chinese"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7254006\results\search\country\results.xml">
   <result pre="Microbiology, Li Ka Shing Faculty of Medicine, The University of" exact="Hong Kong," post="Pokfulam, Hong Kong Special Administrative Region. jfwchan@hku.hkkyyuen@hku.hk 1Co-first authors."/>
   <result pre="Shing Faculty of Medicine, The University of Hong Kong, Pokfulam," exact="Hong Kong" post="Special Administrative Region. jfwchan@hku.hkkyyuen@hku.hk 1Co-first authors. pmc-release: 2020-5-5ppub: 2020-9epub:"/>
   <result pre="the nasopharyngeal aspirate specimen of a laboratory-confirmed COVID-19 patient in" exact="Hong Kong" post="[17]. MERS-CoV EMC/2012 strain (GenBank accession number: NC_019843.3) was"/>
   <result pre="3 facility at the Department of Microbiology, The University of" exact="Hong Kong," post="as previously described [19,20]. The FDA-approved drug library (Cat#"/>
   <result pre="Competing Interest JFWC has received travel grants from Pfizer Corporation" exact="Hong Kong" post="and Astellas Pharma Hong Kong Corporation Limited, and was"/>
   <result pre="travel grants from Pfizer Corporation Hong Kong and Astellas Pharma" exact="Hong Kong" post="Corporation Limited, and was an invited speaker for Gilead"/>
   <result pre="Corporation Limited, and was an invited speaker for Gilead Sciences" exact="Hong Kong" post="Limited and Luminex Corporation. The other authors declared no"/>
   <result pre="SARS-CoV-2 infection and virus load in fecal samples from the" exact="Hong Kong" post="cohort and systematic review and meta-analysisGastroenterology202010.1053/j.gastro.2020.03.065pii: S0016-5085(20)30448-0. [Epub ahead"/>
   <result pre="Therapeutics), 10.13039/501100003452Innovation and Technology Commission , The Government of the" exact="Hong Kong" post="Special Administrative Region of the Peopleâ€™s Republic of China;"/>
   <result pre="of the Hong Kong Special Administrative Region of the Peopleâ€™s" exact="Republic of" post="China; the National Program on Key Research Project of"/>
   <result pre="of China; the National Program on Key Research Project of" exact="China" post="(grant no. 2020YFA0707500 and 2020YFA0707504); the Theme-Based Research Scheme"/>
   <result pre="the Theme-Based Research Scheme (T11/707/15) of the Research Grants Council," exact="Hong Kong" post="Special Administrative Region; and the High Level-Hospital Program, Health"/>
   <result pre="of Richard Yu and Carol Yu, the Shaw Foundation of" exact="Hong Kong," post="Michael Seak-Kan Tong, May Tam Mak Mei Yin, Respiratory"/>
   <result pre="Chan Yin Chuen Memorial Charitable Foundation, Marina Man-Wai Lee, the" exact="Hong Kong" post="Hainan Commercial Association South China Microbiology Research Fund, the"/>
   <result pre="Marina Man-Wai Lee, the Hong Kong Hainan Commercial Association South" exact="China" post="Microbiology Research Fund, the Jessie &amp;amp; George Ho Charitable"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7255246\results\search\country\results.xml">
   <result pre="lower the effective reproduction number. This is the rationale for" exact="the US" post="national initiative, â€œEnding the HIV Epidemic: A Plan for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7255394\results\search\country\results.xml">
   <result pre="and Europe PMC, consistent with existing copyright protections.pcc-21-e576.pdf Abstract Objectives:" exact="Spain" post="has been one of the countries most severely affected"/>
   <result pre="health emergency and pandemic by the World Health Organization (1)." exact="Spain" post="is one of the most severely affected countries by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256352\results\search\country\results.xml">
   <result pre="UniversityIran[b], Department of Mechanical and Industrial Engineering, College of Engineering," exact="Qatar" post="UniversityQatar[c], Biomedical Research Center, Qatar UniversityQatar[d], Department of Microbiology,"/>
   <result pre="Industrial Engineering, College of Engineering, Qatar UniversityQatar[c], Biomedical Research Center," exact="Qatar" post="UniversityQatar[d], Department of Microbiology, Faculty of Pharmaceutical Sciences, Tehran"/>
   <result pre="is classified as enveloped viruses (Mackie, 2003). SARS-CoV-2 originating in" exact="China" post="and the city of Wuhan is believed to be"/>
   <result pre="cases have been reported in other countries such as Thailand," exact="South Korea," post="Japan, Taiwan, Australia, and the United States, and even"/>
   <result pre="countries such as Thailand, South Korea, Japan, Taiwan, Australia, and" exact="the United States," post="and even more recently in Iran (Velavan &amp;amp; Meyer,"/>
   <result pre="such as Thailand, South Korea, Japan, Taiwan, Australia, and the" exact="United States," post="and even more recently in Iran (Velavan &amp;amp; Meyer,"/>
   <result pre="Australia, and the United States, and even more recently in" exact="Iran" post="(Velavan &amp;amp; Meyer, 2020; Zhu etÂ al., 2020). The"/>
   <result pre="Ref. (Guo etÂ al., 2020). Although a recent research in" exact="China" post="suggests bat as the potential source of the virus,"/>
   <result pre="presentation and outcomes of Middle East respiratory syndrome in the" exact="Republic of" post="Korea. Infection &amp;amp; Chemotherapy, 48(2), 118â€&quot;126. 10.3947/ic.2016.48.2.11827433382 CuiH., ZhangC.,"/>
   <result pre="MERS-CoV infection. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 117(12), 6771â€&quot;6776. 10.1073/pnas.192208311732054787 DongE., DuH., &amp;amp; GardnerL."/>
   <result pre="infection. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="117(12), 6771â€&quot;6776. 10.1073/pnas.192208311732054787 DongE., DuH., &amp;amp; GardnerL. (2020). An"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256451\results\search\country\results.xml">
   <result pre="SciencesPontypoolUnited Kingdom Edited by: Kian Fan Chung, Imperial College London," exact="United Kingdom" post="Reviewed by: Koshika Yadava, University of Oxford, United Kingdom;"/>
   <result pre="London, United Kingdom Reviewed by: Koshika Yadava, University of Oxford," exact="United Kingdom;" post="Yong-hua Gao, First Affiliated Hospital of Zhengzhou University, China"/>
   <result pre="United Kingdom; Yong-hua Gao, First Affiliated Hospital of Zhengzhou University," exact="China" post="*Correspondence: Eugenie R. Lumbers eugenie.lumbers@newcastle.edu.au This article was submitted"/>
   <result pre="is SARS-CoV-2 which causes COVID-19. It was first recognized in" exact="China" post="in December 2019 and is now sweeping the world."/>
   <result pre="of print].32215613 7.collab: American Heart AssociationThe Heart Failure Society of" exact="America" post="The American College of Cardiology. Patients Taking ACE-i and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256510\results\search\country\results.xml">
   <result pre="at the end of 2019, the National Health Commission of" exact="China" post="released more details about the epidemic in early 2020"/>
   <result pre="thought that the Hunan seafood market in Wuhan city in" exact="China" post="was the origin of the outbreak. Although it had"/>
   <result pre="Although it had been proposed that the COVID-19 patients in" exact="China" post="might have utilized infected animals as a foodstuff, or"/>
   <result pre="recent investigations have suggested that pangolins that were smuggled from" exact="Malaysia" post="to China, along with other possible intermediate hosts like"/>
   <result pre="five percent among tens of thousands of confirmed patients in" exact="China" post="[30]. The spread of SARS-CoV-2 from asymptomatic individuals (or"/>
   <result pre="SARS-CoV-2 had not been able to spread quickly in southern" exact="China" post="[49]. Although the above-mentioned reports suggest a relationship between"/>
   <result pre="A study in six departments of a hospital in Wuhan," exact="China" post="demonstrated that the use of N95 masks, disinfectants, and"/>
   <result pre="trials Identifier Status country Tocilizumab inÂ COVID-19Â Pneumonia NCT04317092 Recruiting" exact="Italy" post="Evaluation of the Efficacy and Safety of Sarilumab in"/>
   <result pre="Safety of Sarilumab in Hospitalized Patients WithÂ COVID-19 NCT04315298 Recruiting" exact="United States" post="A Pilot Study of Sildenafil inÂ COVID-19 NCT04304313 Recruiting"/>
   <result pre="States A Pilot Study of Sildenafil inÂ COVID-19 NCT04304313 Recruiting" exact="China" post="ACE Inhibitors, Angiotensin II Type-I Receptor Blockers, and Severity"/>
   <result pre="Blockers, and Severity of COVID-19 (CODIV-ACE) NCT04318418 Not yet recruiting" exact="Italy" post="Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as"/>
   <result pre="Cases and Chemoprophylaxis of Contacts as Prevention (HCQ4COV19) NCT04304053 Recruiting" exact="Spain" post="The Use PUL-042 Inhalation Solution to Prevent COVID-19 in"/>
   <result pre="Sarilumab Trial - CORIMUNO-19 - SARI NCT04324073 Not yet recruiting" exact="France" post="Hydroxychloroquine Versus Placebo in Patients Presenting COVID-19 Infection and"/>
   <result pre="of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 NCT04323527 Recruiting" exact="Brazil" post="Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for"/>
   <result pre="2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection NCT04283461 Recruiting" exact="United States" post="Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) NCT04322682 Recruiting Canada Tocilizumab"/>
   <result pre="Recruiting United States Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) NCT04322682 Recruiting" exact="Canada" post="Tocilizumab for SARS-CoV2 Severe Pneumonitis NCT04315480 Not yet recruiting"/>
   <result pre="Canada Tocilizumab for SARS-CoV2 Severe Pneumonitis NCT04315480 Not yet recruiting" exact="Italy" post="Efficacy and Safety of Darunavir and Cobicistat for Treatment"/>
   <result pre="Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV NCT04252274 Recruiting" exact="China" post="Treatment and Prevention of Traditional Chinese Medicines (TCMs) on"/>
   <result pre="of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection NCT04251871 Recruiting" exact="China" post="COVIDL1: A Study to Investigate the Efficacy of Tradipitant"/>
   <result pre="Inhalation in Severe Acute Respiratory Syndrome in COVID-19 NCT04306393 Recruiting" exact="United States" post="Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult"/>
   <result pre="Bacterial and Viral Lung (COVID-19) Infections NCT03331445 Active, not recruiting" exact="Canada" post="NK Cells Treatment for Novel Coronavirus Pneumonia NCT04280224 Recruiting"/>
   <result pre="Canada NK Cells Treatment for Novel Coronavirus Pneumonia NCT04280224 Recruiting" exact="China" post="Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir"/>
   <result pre="recruiting Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 NCT04308668 Recruiting" exact="United States" post="STOP PIV - Phase III DAS181 Lower Tract PIV"/>
   <result pre="DAS181 Lower Tract PIV Infection in Immunocompromised Subjects NCT03808922 Recruiting" exact="United States" post="Norwegian Coronavirus Disease 2019 Study NCT04316377 Not yet recruiting"/>
   <result pre="yet recruiting Lessening Organ Dysfunction With VITamin C NCT03680274 Recruiting" exact="Canada" post="Glucocorticoid Therapy for Novel CoronavirusCritically Ill Patients With Severe"/>
   <result pre="CoronavirusCritically Ill Patients With Severe Acute Respiratory Failure NCT04244591 Recruiting" exact="China" post="Convalescent Plasma to Limit Coronavirus Associated Complications NCT04325672 Not"/>
   <result pre="Plasma to Limit Coronavirus Associated Complications NCT04325672 Not yet recruiting" exact="United States" post="Vitamin C Infusion for the Treatment of Severe 2019-nCoV"/>
   <result pre="for the Treatment of Severe 2019-nCoV Infected Pneumonia NCT04264533 Recruiting" exact="China" post="Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory"/>
   <result pre="RoActemra iv, RoActemra sc, Kevzara sc NCT04322773 Not yet recruiting" exact="Denmark" post="Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in"/>
   <result pre="Associated With Azythromycin in SARS-Cov-2 Virus NCT04322123 Not yet recruiting" exact="Brazil" post="Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild"/>
   <result pre="(GS-5734â&quot;¢) in Participants With Severe Coronavirus Disease (COVID-19) NCT04292899 Recruiting" exact="United States" post="NestCellÂ® Mesenchymal Stem Cell to Treat Patients With Severe"/>
   <result pre="or Critically Severe Patients With COVID-19 Pneumonia-RCT (BEST-RCT) NCT04305106 Recruiting" exact="China" post="The Efficacy and Safety of Thalidomide in the Adjuvant"/>
   <result pre="of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells NCT04313322 Recruiting" exact="Jordan" post="Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)"/>
   <result pre="in the Treatment of COVID-19 (TT-NPC) NCT04308317 Enrolling by invitation" exact="China" post="Fingolimod in COVID-19 NCT04280588 Recruiting China CD24Fc as a"/>
   <result pre="NCT04308317 Enrolling by invitation China Fingolimod in COVID-19 NCT04280588 Recruiting" exact="China" post="CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment (SAC-COVID)v"/>
   <result pre="Non-antiviral Immunomodulator in COVID-19 Treatment (SAC-COVID)v NCT04317040 Not yet recruiting" exact="United States" post="Treatment With Mesenchymal Stem Cells for Severe Corona Virus"/>
   <result pre="Stem Cells for Severe Corona Virus Disease 2019(COVID-19) NCT04288102 Recruiting" exact="China" post="The Clinical Study of Carrimycin on Treatment Patients With"/>
   <result pre="recruiting Efficacy and Safety of Corticosteroids in COVID-19(Methylprednisolone) NCT04273321 Recruiting" exact="China" post="Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) NCT04318444"/>
   <result pre="Exposure Prophylaxis for Coronavirus Disease (COVID-19) NCT04318444 Not yet recruiting" exact="United States" post="Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19"/>
   <result pre="recruiting Safety and Immunity of Covid-19 aAPC Vaccine NCT04299724 Recruiting" exact="China" post="Immunity and Safety of Covid-19 Synthetic Minigene Vaccine NCT04276896"/>
   <result pre="Immunity and Safety of Covid-19 Synthetic Minigene Vaccine NCT04276896 Recruiting" exact="China" post="A Phase I Clinical Trial in 18â€&quot;60 Adults (APICTH)(vaccine)"/>
   <result pre="Phase I Clinical Trial in 18â€&quot;60 Adults (APICTH)(vaccine) NCT04313127 Recruiting" exact="China" post="Favipiravir Combined With Tocilizumab in the Treatment of Corona"/>
   <result pre="in the Treatment of Corona Virus Disease 2019 NCT04310228 Recruiting" exact="China" post="Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp"/>
   <result pre="and Mild Novel Coronavirus Pneumonia (COVID-19) NCT04273763 Enrolling by invitation" exact="China" post="Yinhu Qingwen Decoction for the Treatment of Mild /"/>
   <result pre="Treatment of Mild / Common CoVID-19 NCT04278963 Active, not recruiting" exact="China" post="Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquine"/>
   <result pre="COVID19: A Randomized Control Trial (THDMS-COVID19) NCT04303299 Not yet recruiting" exact="Thailand" post="The Effect of T89 on Improving Oxygen Saturation and"/>
   <result pre="of Cytokine Release Syndrome (CRS) in COVID-19 (TACOS) NCT04306705 Recruiting" exact="China" post="Mild/Moderate 2019-nCoV Remdesivir RCT NCT04252664 Recruiting China Losartan for"/>
   <result pre="(TACOS) NCT04306705 Recruiting China Mild/Moderate 2019-nCoV Remdesivir RCT NCT04252664 Recruiting" exact="China" post="Losartan for Patients With COVID-19 Requiring Hospitalization NCT04312009 Not"/>
   <result pre="for Patients With COVID-19 Requiring Hospitalization NCT04312009 Not yet recruiting" exact="United States" post="Trial of Treatments for COVID-19 in Hospitalized Adults (DisCoVeRy)Drug:"/>
   <result pre="Patients With COVID-19 Not Requiring Hospitalization NCT04311177 Not yet recruiting" exact="United States" post="Study of Human Umbilical Cord Mesenchymal Stem Cells in"/>
   <result pre="Treatment of Novel Coronavirus Severe Pneumonia NCT04273646 Not yet recruiting" exact="China" post="Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With"/>
   <result pre="for Pneumonia Patients Infected With 2019 Novel Coronavirus NCT04252118 Recruiting" exact="China" post="The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV"/>
   <result pre="in the 2019-nCoV PneumoniaDrug: Abidol hydrochloride, Oseltamivir, Lopinavir/ritonavir NCT04255017 recruiting" exact="China" post="A Prospective/Retrospective, Randomized Controlled Clinical Study of Interferon Atomization"/>
   <result pre="Abidol hydrochloride, Abidol Hydrochloride combined with Interferon atomization NCT04254874 recruiting" exact="China" post="Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia"/>
   <result pre="Severe or Critical Patients With COVID-19 Pneumonia (BEST-CP) NCT04275414 recruiting" exact="China" post="A Randomized, Open, Controlled Clinical Study to Evaluate the"/>
   <result pre="Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia NCT04261270 recruiting" exact="China" post="Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress (COVID-AIV)"/>
   <result pre="COVID-19 Associated Acute Respiratory Distress (COVID-AIV) NCT04311697 Not yet recruiting" exact="Israel" post="The Efficacy of Different Hormone Doses in 2019-nCoV Severe"/>
   <result pre="Different Hormone Doses in 2019-nCoV Severe PneumoniaDrug: Methylprednisolone NCT04263402 recruiting" exact="China" post="Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (NoCovid)"/>
   <result pre="Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (NoCovid) NCT04305457 Recruiting" exact="United States" post="Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label,"/>
   <result pre="Infected by COVID-19: an Open-label, Pilot Study. (BARI-COVID) NCT04320277 Recruiting" exact="Italy" post="Adaptive COVID-19 Treatment Trial (ACTT)Drug: Remdesivir NCT04280705 Recruiting United"/>
   <result pre="Recruiting Italy Adaptive COVID-19 Treatment Trial (ACTT)Drug: Remdesivir NCT04280705 Recruiting" exact="United States" post="Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With"/>
   <result pre="N-acetylcysteineÂ +Â Fuzheng Huayu Tablet, N-acetylcysteineÂ +Â Placebo NCT04279197 Recruiting" exact="China" post="NO Prevention of COVID-19 for Healthcare ProvidersDrug: Inhaled nitric"/>
   <result pre="PatientsDrug: Immunoglobulin of cured patients, Î³-Globulin NCT04264858 Not yet recruiting" exact="China" post="Efficacy and Safety of IFN-Î±2Î² in the Treatment of"/>
   <result pre="StaffDrug: recombinant human Interferon Alpha-1b, thymosin alpha 1 NCT04320238 Recruiting" exact="China" post="Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19"/>
   <result pre="Inactivated Convalescent Plasma in the Treatment of COVID-19 NCT04292340 Recruiting" exact="China" post="Clinical Study of Arbidol Hydrochloride Tablets in the Treatment"/>
   <result pre="of Novel Coronavirus InfectionDrug: GanovoÂ +Â ritonavir+/-Interferon nebulization NCT04291729 Completed" exact="China" post="Eculizumab (Soliris) in Covid-19 Infected Patients NCT04288713 Available Severe"/>
   <result pre="Infected Patients NCT04288713 Available Severe 2019-nCoV Remdesivir RCT NCT04257656 Recruiting" exact="China" post="nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome"/>
   <result pre="Inhalation in Severe Acute Respiratory Syndrome in COVID-19 NCT04306393 Recruiting" exact="United States" post="Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel"/>
   <result pre="Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(CoV) Pneumonia NCT04269525 Recruiting" exact="China" post="Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir"/>
   <result pre="for the Treatment of Severe 2019-nCoV Infected Pneumonia NCT04264533 Recruiting" exact="China" post="Expanded Access Remdesivir (RDV; GS-5734â&quot;¢) NCT04302766 Available Xiyanping Injection"/>
   <result pre="of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection NCT04283461 recruiting" exact="United States" post="Tocilizumab for SARS-CoV2 Severe Pneumonitis NCT04315480 Not yet recruiting"/>
   <result pre="States Tocilizumab for SARS-CoV2 Severe Pneumonitis NCT04315480 Not yet recruiting" exact="Italy" post="Efficacy and Safety of Darunavir and Cobicistat for Treatment"/>
   <result pre="Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV NCT04252274 recruiting" exact="China" post="Efficacy and Safety of Hydroxychloroquine for Treatment of Pneumonia"/>
   <result pre="for Treatment of Pneumonia Caused by 2019-nCoV (HC-nCoV) NCT04261517 Completed" exact="China" post="Treatment and Prevention of Traditional Chinese Medicines (TCMs) on"/>
   <result pre="therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) NCT04251871 recruiting" exact="China" post="Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to"/>
   <result pre="Meplazumab for Injection to Treat With 2019-nCoV Pneumonia NCT04275245 recruiting" exact="China" post="Stem Cell Educator Therapy Treat the Viral Inflammation Caused"/>
   <result pre="recruiting NK Cells Treatment for Novel Coronavirus Pneumonia NCT04280224 Recruiting" exact="China" post="Glucocorticoid Therapy for Novel CoronavirusCritically Ill Patients With Severe"/>
   <result pre="Patients With Severe Acute Respiratory FailureDrug: methylprednisolone therapy NCT04244591 Recruiting" exact="China" post="Norwegian Coronavirus Disease 2019 StudyDrug: Hydroxychloroquine Sulfate NCT04316377 Not"/>
   <result pre="Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment NCT04276688 Recruiting" exact="China" post="Post-exposure Prophylaxis for SARS-Coronavirus-2 Drug: Hydroxychloroquine NCT04308668 Recruiting United"/>
   <result pre="Recruiting China Post-exposure Prophylaxis for SARS-Coronavirus-2 Drug: Hydroxychloroquine NCT04308668 Recruiting" exact="United States" post="A Pilot Clinical Study on Inhalation of Mesenchymal Stem"/>
   <result pre="(2019-nCoV), December 2019 to January 2020. Eurosurveillance. 2020;25(4). 5Parry J." exact="China" post="coronavirus: cases surge as official admits human to human"/>
   <result pre="domesticated animals to SARSâ€&quot;coronavirus 2Science2020 46STRAITSTIMES T. Second dog in" exact="Hong Kong" post="tests positive for coronavirus 2020 MAR 20 [Available from:"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospitalJ. Antimicrob. Chemother.565200591992216183666 138Mair-JenkinsJ.Saavedra-CamposM.BaillieJ.K.ClearyP.KhawF.-M.LimW.S.The effectiveness of convalescent plasma and"/>
   <result pre="al. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="European Journal of Clinical Microbiology and Infectious Diseases. 2005;24(1):44-6."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256539\results\search\country\results.xml">
   <result pre="the New York City areaJAMA32320202020522059 3LivingstonE.BucherK.Coronavirus disease 2019 (COVID-19) in" exact="Italy" post="[published online ahead of print March 17, 2020]JAMAhttps://doi.org/10.1001/jama.2020.4344 4RobinsonD.P.LorenzoM.E.JianW.KleinS.L.Elevated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7261908\results\search\country\results.xml">
   <result pre="NYUnited States Edited by: Nejat Duzgunes, University of the Pacific," exact="United States" post="Reviewed by: Doina Atanasiu, University of Pennsylvania, United States;"/>
   <result pre="Pacific, United States Reviewed by: Doina Atanasiu, University of Pennsylvania," exact="United States;" post="Konstantin Kousoulas, Louisiana State University, United States *Correspondence: Shibo"/>
   <result pre="University of Pennsylvania, United States; Konstantin Kousoulas, Louisiana State University," exact="United States" post="*Correspondence: Shibo Jiang, shibojiang@fudan.edu.cn Lu Lu, lul@fudan.edu.cn â€ ORCID:"/>
   <result pre="HIV infection, zidovudine, was approved for clinical use in 1987," exact="the United States" post="FDA has approved &amp;gt;80 antiviral drugs so far. They"/>
   <result pre="infection, zidovudine, was approved for clinical use in 1987, the" exact="United States" post="FDA has approved &amp;gt;80 antiviral drugs so far. They"/>
   <result pre="2011). More than 40 anti-HIV drugs have been approved by" exact="the United States" post="FDA, most of which are reverse transcriptase inhibitors (RTIs,"/>
   <result pre="More than 40 anti-HIV drugs have been approved by the" exact="United States" post="FDA, most of which are reverse transcriptase inhibitors (RTIs,"/>
   <result pre="inhibit viral replication in cells, was approved by Japanese and" exact="United States" post="FDA and proved effective against infection by influenza virus"/>
   <result pre="study was supported by grants from the National Mega-Projects of" exact="China" post="for Major Infectious Diseases (2018ZX10301403 to LL) and the"/>
   <result pre="(2018ZX10301403 to LL) and the National Natural Science Foundation of" exact="China" post="(81661128041, 81672019, and 81822045 to LL, 81630090 to SJ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7262150\results\search\country\results.xml">
   <result pre="Middle East respiratory syndrome coronavirus NHC National Health Commission of" exact="China" post="OR odds ratio RBBB right bundle branch block SARS"/>
   <result pre="of arrhythmic events.17 These concepts were strengthened by a nationwide" exact="Denmark" post="studied, which showed a strong relationship between yearly influenza"/>
   <result pre="arrhythmic syndrome. Corroborating this concern, the National Health Commission of" exact="China" post="(NHC) reported that among SARSâ€�CoVâ€�2 infection confirmed cases, cardiovascular"/>
   <result pre="Middle East respiratory syndrome coronavirus infection: a singleâ€�center experience in" exact="Saudi Arabia." post="Int J Infect Dis. 2014;29:301â€�306.25303830 14Alâ€�AbdallatMM, PayneDC, AlqasrawiS, et"/>
   <result pre="al. A major outbreak of severe acute respiratory syndrome in" exact="Hong Kong." post="N Engl J Med. 2003;348:1986â€�1994.12682352 40BoothCM, MatukasLM, TomlinsonGA, et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7262202\results\search\country\results.xml">
   <result pre="treatment. Lung cancer has the highest morbidity and mortality in" exact="China" post="and the world. Most patients with lung cancer are"/>
   <result pre="novel coronavirus diseases (COVIDâ€�19) has spread rapidly and widely in" exact="China" post="and several other countries in less than two months."/>
   <result pre="than two months. Faced with the gravity of the epidemic," exact="China" post="has incorporated COVIDâ€�19 into the statutory Class B infectious"/>
   <result pre="300â€&quot;2. 10.1016/S2215-0366(20)30073-0.32085840 32LiuS, YangL, ZhangCet alOnline mental health services in" exact="China" post="during the COVIDâ€�19 outbreak. Lancet Psychiatry2020; 7: e17â€&quot;8. 10.1016/S2215-0366(20)30077-8.32085841"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7263255\results\search\country\results.xml">
   <result pre="(SARS) caused by SARS-CoV (Î²-CoV) emerged in Guangdong province of" exact="China" post="in 2002â€&quot;2003, and Middle East respiratory syndrome (MERS) caused"/>
   <result pre="East respiratory syndrome (MERS) caused by MERS-CoV (Î²-CoV) emerged in" exact="Saudi Arabia" post="in 2012. Both these CoVs were of bat origin"/>
   <result pre="selling dead seafood animals and trading of live animals. As" exact="China" post="had a quick surveillance system after the SARS outbreak,"/>
   <result pre="be an epidemic, initially spreading to other countries like Thailand," exact="South Korea," post="and Japan as there was massive Chinese migration due"/>
   <result pre="initially spreading to other countries like Thailand, South Korea, and" exact="Japan" post="as there was massive Chinese migration due to Chinese"/>
   <result pre="countries evacuated their respective citizens from Wuhan and travelers from" exact="China" post="and other affected countries were kept under quarantine/isolation for"/>
   <result pre="reduced in China, with a drastic increase in countries like" exact="the USA" post="with 6.44 lacs cases, Spain and Italy with almost"/>
   <result pre="increase in countries like the USA with 6.44 lacs cases," exact="Spain" post="and Italy with almost 1.8 and 1.6 lacs cases"/>
   <result pre="countries like the USA with 6.44 lacs cases, Spain and" exact="Italy" post="with almost 1.8 and 1.6 lacs cases each. Most"/>
   <result pre="form of viral pneumonia called COVID-19 that originated in Wuhan," exact="China" post="and was avowed a pandemic by WHO on 11th"/>
   <result pre="Phylogenetic origin Source/intermediate source Receptor Mortality rate Ro SARS-CoV-2 Wuhan," exact="China" post="Class I, Cluster IIa Bats/unknown ACE-2 2.3% 2â€&quot;2.5 SARS-CoV"/>
   <result pre="Bats/ palm civets or dromedary camels ACE-2 9.5% 1.7â€&quot;1.9 MERS-CoV" exact="Saudi Arabia" post="Class II Bats/ palm civets or dromedary camels DDP4"/>
   <result pre="ChiCTR2000029898, ChiCTR2000029899, ChiCTR2000029935 and ChiCTR2000029939) were immediately carried out in" exact="China" post="for the safety and efficacy of CQ and hydroxychloroquine"/>
   <result pre="repurposing of antiretroviral drug which have been previously approved by" exact="United States" post="Food and Drug Administration (FDA) is really helpful in"/>
   <result pre="(ARB) or Umifenovir is an antiviral drug currently approved in" exact="China" post="and Russia for the prophylaxis treatment of respiratory viral"/>
   <result pre="Umifenovir is an antiviral drug currently approved in China and" exact="Russia" post="for the prophylaxis treatment of respiratory viral infections and"/>
   <result pre="therapy alone or in combination therapy to treat COVID-19. Currently," exact="China" post="is conducting various studies to evaluate the potential of"/>
   <result pre="of ARB as a treatment option. A study conducted in" exact="China" post="reveals that ARB effectively inhibits SARS-CoV-2 infection at low"/>
   <result pre="Î¼M in vitro. The National Health Commission (NHC) of the" exact="People's Republic of China" post="has included ARB in the latest version of the"/>
   <result pre="in vitro. The National Health Commission (NHC) of the People's" exact="Republic of" post="China has included ARB in the latest version of"/>
   <result pre="The National Health Commission (NHC) of the People's Republic of" exact="China" post="has included ARB in the latest version of the"/>
   <result pre="open study has been initiated by Jieming QU, Rujin Hospital," exact="China" post="to observe the safety and efficacy of ARB in"/>
   <result pre="its action against RNA viruses. It was however approved in" exact="Japan" post="and France and not in other countries for a"/>
   <result pre="against RNA viruses. It was however approved in Japan and" exact="France" post="and not in other countries for a few indications"/>
   <result pre="(DRV) is a second-generation protease inhibitor against HIV-1. Scientists in" exact="China" post="declared on 4 February 2020 that DRV prevented in"/>
   <result pre="Oseltamivir with or without antibiotics and corticosteroids is reported in" exact="China" post="[116]. Oseltamivir is also used in clinical trials with"/>
   <result pre="are the possible adverse effects of tetracyclines. Nantes University Hospital," exact="France" post="has been given approval to start a double blinded,"/>
   <result pre="as weak [177]. Indeed, a study was performed in Wuhan" exact="China" post="identifying clinical outcomes of patients infected with COVID-19 (NÂ"/>
   <result pre="effective therapeutic alternative for severe COVID-19 infections. A group from" exact="China" post="administered a single 200Â ml dose of CP to"/>
   <result pre="inactivated virus vaccines and live attenuated vaccines (Serum Institute of" exact="India" post="with Codagenix). Johnson &amp;amp; Johnson is working on an"/>
   <result pre="Israel, Wroclaw Medical University, Poland, Oxford University Clinical Research Unit," exact="Vietnam" post="NCT04333628, NCT04331600, NCT04328493 2 Hydroxychloroquine 3, 3, 2, 2,"/>
   <result pre="COVID-19 disease Dr. Michael Hill, University of Calgary, Canada, Germany," exact="United States," post="Baylor University Medical Center, United States, California, Rambam Health"/>
   <result pre="of Calgary, Canada, Germany, United States, Baylor University Medical Center," exact="United States," post="California, Rambam Health Care Campus NCT04329611, NCT04340544, NCT04329923, NCT04333225,"/>
   <result pre="route Anti-Malarial/Anti-Infective Combination to treat COVID-19 patients HonorHealth Research Institute," exact="United States" post="NCT04339426 6 Lopinavir/ritonavir 2 Oral route Antiretroviral, to treat"/>
   <result pre="route Antiretroviral, to treat COVID-19 patients Sunnybrook Health Sciences Centre," exact="Canada" post="NCT04330690 7 Lopinavir/ritonavir vs Hydroxychloroquine sulfate 2 Oral route"/>
   <result pre="S.C injection To treat moderate to severe COVID-19 Lisa Barrett," exact="Canada" post="NCT04321993 9 Remdesivir, Lopinavir/ritonavir, interferon Î²-1A, and hydroxychloroquine 3"/>
   <result pre="treat COVID-19 patients National Institute of Health and Medical Research," exact="France" post="NCT04315948 10 Hydroxychloroquine, Oseltamivir, Azithromycin 3 Oral route To"/>
   <result pre="Azithromycin 3 Oral route To treat COVID-19 patients Shehnoor Azhar," exact="Pakistan" post="NCT04338698 11 Hydroxychloroquine and Nitazoxanide 2, 3 Oral route"/>
   <result pre="Oral route To treat COVID-19 patients Intermountain Health Care, Inc.," exact="United States," post="Intermountain Medical Center, United States NCT04329832, NCT04334382 13 1."/>
   <result pre="patients Intermountain Health Care, Inc., United States, Intermountain Medical Center," exact="United States" post="NCT04329832, NCT04334382 13 1. Lopinavir/ritonavir,2. Ribavirin and3. Interferon beta-1b"/>
   <result pre="3 S.C injection To treat COVID-19 patients The University of" exact="Hong Kong," post="Hong Kong NCT04276688 14 Clevudine 2 Oral route Antiviral,"/>
   <result pre="injection To treat COVID-19 patients The University of Hong Kong," exact="Hong Kong" post="NCT04276688 14 Clevudine 2 Oral route Antiviral, to evaluate"/>
   <result pre="to treat patients with COVID-19 pneumonia Jieming QU, Ruijin Hospital," exact="China" post="NCT04260594 16 Isotretinoin 3 Oral route Retinoid, to evaluate"/>
   <result pre="to evaluate the safety and efficacy in COVID-19 Tanta University," exact="Egypt" post="NCT04361422 17 Ivermectin and Nitazoxanide 2, 3 Oral route"/>
   <result pre="safety and efficacy of the combination in COVID-19 Tanta University," exact="Egypt" post="NCT04360356 18 Recombinant human Interferon Î±1Î² 1 Nebulization To"/>
   <result pre="Interferon Î±1Î² 1 Nebulization To treat COVID-19 patients Tongji Hospital," exact="China" post="NCT04293887 19 1.Bromhexine hydrochloride, 2.Arbidol hydrochloride and 3. Recombinant"/>
   <result pre="with COVID-19 pneumonia Second Affiliated Hospital of Wenzhou Medical University," exact="China" post="NCT04273763 20 Deferoxamine 1 &amp;amp; 2 Intravenous infusion Iron"/>
   <result pre="the Severity of COVID-19 Manifestations Kermanshah University of Medical Sciences," exact="Iran" post="NCT04333550 21 Dexamethasone 4 I.V Steroid, to treat patients"/>
   <result pre="patients with ARDS caused by COVID-19 Dr. Negrin University Hospital," exact="Spain" post="NCT04325061 22 Piclidenoson 2 Oral route A3 adenosine receptor"/>
   <result pre="A3 adenosine receptor agonist, to treat COVID-19 patients Can-Fite BioPharma," exact="Israel" post="NCT04333472 23 Favipiravir 3 Oral route Antiviral, to evaluate"/>
   <result pre="to evaluate safety and efficacy in COVID-19 patients Giuliano Rizzardini," exact="Italy" post="NCT04336904 24 Huaier Granule 2 &amp;amp; 3 Oral route"/>
   <result pre="&amp;amp; 3 Oral route Adjuvant treatment of COVID-19 Tongji Hospital," exact="China" post="NCT04291053 25 Tranexamic acid 2 Oral route Antifibrinolytics, to"/>
   <result pre="its effect on COVID-19 The University of Alabama at Birmingham," exact="United States" post="NCT04338126 26 BLD-2660 2 Oral route Antiviral small molecule,"/>
   <result pre="Oral route Antiviral small molecule, to treat COVID-19 Blade Therapeutics," exact="United States" post="NCT04334460 27 Sildenafil citrate 3 Oral route Phosphodiesterase inhibitor,"/>
   <result pre="Oral route Phosphodiesterase inhibitor, to treat COVID-19 patients Tongji Hospital," exact="China" post="NCT04304313 28 Losartan 1 Oral route Angiotensin receptor blocker,"/>
   <result pre="respiratory failure due to COVID-19 University of Kansas Medical Center," exact="United States" post="NCT04335123 29 Telmisartan 2 Oral route Angiotensin receptor blocker,"/>
   <result pre="evaluate the efficacy in COVID-19 patients Laboratorio Elea Phoenix S.A.," exact="Argentina" post="NCT04355936 30 Atorvastatin 2 Oral route Statin, to assess"/>
   <result pre="efficacy of drug to prevent cytokine storm Johns Hopkins University," exact="United States" post="NCT04365257 32 Chlorpromazine 3 Oral route Antipsychotics, to repurpose"/>
   <result pre="repurpose the drug for COVID-19 treatment Centre Hospitalier St Anne," exact="France" post="NCT04366739 33 Lenalidomide 4 Oral route Antiangiogenic agent, to"/>
   <result pre="to treat mild to moderate COVID-19 patients Getafe University Hospital," exact="Spain" post="NCT04361643 34 FT516 - induced pluripotent stem cell 1"/>
   <result pre="of cells in patients with COVID-19 Pneumonia Cell Therapy Network," exact="Spain" post="NCT04361942 36 Human Mesenchymal Stem Cells 1 &amp;amp; 2"/>
   <result pre="factor and to treat patients with COVID-19 pneumonia Puren Hospital," exact="China" post="NCT04339660 37 Anti-SARS-CoV-2 convalescent plasma 2 I.V infusion To"/>
   <result pre="safety and efficacy Medical College of Wisconsin, Hackensack Meridian Health," exact="United States," post="Joakim Dillner, Sweden NCT04354831, NCT04343755, NCT04390178, NCT04384497 38 Anti-SARS-CoV-2"/>
   <result pre="College of Wisconsin, Hackensack Meridian Health, United States, Joakim Dillner," exact="Sweden" post="NCT04354831, NCT04343755, NCT04390178, NCT04384497 38 Anti-SARS-CoV-2 convalescent plasma 3"/>
   <result pre="Service, France,National Institute of Medical Sciences and Nutrition Salvador Zubiran," exact="United Mexican States" post="NCT04372979, NCT04388410 39 Hyperimmune plasma with standard therapy 2"/>
   <result pre="evaluate safety and efficacy in COVID-19 patients University of Catanzaro," exact="Italy" post="NCT04385043 40 bac-TRL-Spike 1 Oral route To prevent COVID-19"/>
   <result pre="Oral route To prevent COVID-19 in Healthy adults Symvivo Corporation," exact="Canada" post="NCT04334980 41 IFX-1 with Best supportive care 2 &amp;amp;"/>
   <result pre="&amp;amp; 3 I.V C5a antibody, to treat pneumonia. InflaRx GmbH," exact="Netherlands" post="NCT04333420 42 Acalabrutinib with Best supportive care 2 Oral"/>
   <result pre="tyrosine kinase inhibitor, To evaluate safety, efficacy and pharmacokinetics AstraZeneca," exact="United States" post="NCT04380688, NCT04346199 43 Baricitinib 2 &amp;amp; 3 I.V Janus"/>
   <result pre="I.V Janus Kinase inhibitor, to treat COVID-19 University of Colorado," exact="United States" post="NCT04340232 44 Tocilizumab 2 I.V injection Immunosuppressive, to treat"/>
   <result pre="COVID-19 pneumonia National Cancer Institute, Naples, University Hospital Inselspital, Berne," exact="Switzerland" post="NCT04317092, NCT04335071 45 Canakinumab 3 I.V infusion Anti-human-IL-1Î² monoclonal"/>
   <result pre="efficacy in COVID-19 patients with cytokine release syndrome Novartis Pharmaceuticals," exact="United States" post="NCT04362813 46 Ruxolitinib 2 â€&quot; Kinase inhibitor, to treat"/>
   <result pre="inflammation in patients with stage II/III COVID-19 Dr. Andreas Hochhaus," exact="Germany" post="NCT04338958 47 Ruxolitinib 3 Oral route To evaluate safety"/>
   <result pre="and efficacy in COVID-19 patients with Cytokine storm Novartis Pharmaceuticals," exact="United Kingdom" post="NCT04362137 48 BCG vaccine 3 Intracutaneous injection To reduce"/>
   <result pre="Absenteeism in COVID-19 UMC Utrecht, Netherlands, Murdoch Children Research Institute," exact="Australia" post="NCT04328441, NCT04327206 49 Artificial Antigen Presenting Cell (aAPC) Vaccine"/>
   <result pre="1 S.C injection To treat COVID-19 Shenzhen Geno-Immune Medical Institute," exact="China" post="NCT04299724 50 ChAdOx1 nCoV-19 Vaccine 1 &amp;amp; 2 I.M"/>
   <result pre="1 &amp;amp; 2 I.M To treat COVID-19 University of Oxford," exact="United Kingdom" post="NCT04324606 8 Recent advancement and future perspective Considerable progress"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003Lancet36220031353135810.1016/S0140-6736(03)14630-214585636 7HuangC.WangY.LiX.RenL.ZhaoJ.HuY.ZhangL.FanG.XuJ.GuX.ChengZ.YuT.XiaJ.WeiY.WuW.XieX.YinW.LiH.LiuM.XiaoY.GaoH.GuoL.XieJ.WangG.JiangR.GaoZ.JinQ.WangJ.CaoB.Clinical features of patients infected"/>
   <result pre="20Severe outcomes among patients with coronavirus disease 2019 (COVID-19) â€&quot;" exact="United States," post="February 12â€&quot;March 16, 2020 | MMWR, (n.d.). https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm (accessed"/>
   <result pre="insights into the structure of the coronavirionProc. Natl. Acad. Sci." exact="U. S." post="A.106200958258710.1073/pnas.080527010619124777 26TsengY.-T.ChangC.-H.WangS.-M.HuangK.-J.WangC.-T.Identifying SARS-CoV membrane protein amino acid residues linked"/>
   <result pre="integrates processive RNA polymerase and exonuclease activitiesProc. Natl. Acad. Sci." exact="U. S." post="A.1112014E3900E390910.1073/pnas.132370511125197083 51HsuJ.T.-A.KuoC.-J.HsiehH.-P.WangY.-C.HuangK.-K.LinC.P.-C.HuangP.-F.ChenX.LiangP.-H.Evaluation of metal-conjugated compounds as inhibitors of 3CL"/>
   <result pre="Biol. Sci.1620201724173110.7150/ijbs.4549832226290 56CascellaM.RajnikM.CuomoA.DulebohnS.C.Di NapoliR.Features, evaluation and treatment coronavirus (COVID-19)StatPearls2020StatPearls PublishingTreasure" exact="Island" post="(FL)http://www.ncbi.nlm.nih.gov/books/NBK554776/ 57LiG.ClercqE.D.Therapeutic options for the 2019 novel coronavirus (2019-nCoV)Nat."/>
   <result pre="fusion inhibition by the antiviral drug ArbidolProc. Natl. Acad. Sci." exact="U. S." post="A.114201720621410.1073/pnas.161702011428003465 100ZengL.-Y.YangJ.LiuS.Investigational hemagglutinin-targeted influenza virus inhibitorsExpert Opin. Investig. Drugs262017637310.1080/13543784.2017.1269170"/>
   <result pre="University Novel Coronavirus Management and Research TeamEvidence-Based Medicine Chapter of" exact="China" post="International Exchange and Promotive Association for Medical and Health"/>
   <result pre="treatment of severe COVID-19 patients with tocilizumabProc. Natl. Acad. Sci." exact="U. S." post="A.1172020109701097510.1073/pnas.200561511732350134 164RuanQ.YangK.WangW.JiangL.SongJ.Clinical predictors of mortality due to COVID-19 based"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes &amp;amp; Metabolic Syndrome: Clinical Research"/>
   <result pre="Environ.725202013827710.1016/j.scitotenv.2020.13827732278175 Acknowledgement The authors acknowledge European Molecular Biology Organization (EMBO)," exact="Germany" post="for providing EMBO Short-term Fellowship to Dr. Abhjeet Pandey."/>
   <result pre="thankful to i) Manipal Academy of Higher Education (MAHE), Manipal," exact="India" post="(for Postdoctoral Fellowship to Dr Abhijeet Pandey and Dr"/>
   <result pre="Delhi (for Senior Research Fellowship to Divya Gopalan) and All" exact="India" post="Council for Technical Education (AICTE), Government of India, New"/>
   <result pre="to Manipal and Manipal College of Pharmaceutical Sciences, MAHE, Manipal," exact="India" post="for providing necessary facilities."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264504\results\search\country\results.xml">
   <result pre="in nonâ€�pregnant adults. A World Health Organization (WHO) report from" exact="China" post="states that only 1% of the described cases in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264535\results\search\country\results.xml">
   <result pre="of a dreaded novel viral coronavirus (SARSâ€�CoVâ€�2) disease threat in" exact="China" post="and spreading all over the globe. World Health Organization"/>
   <result pre="16th March 2020 in Beijing Ditan Hospital, Capital Medical University," exact="China" post="(http://www.bjdth.com/html/1/151/163/3665.html). It is very important to note that the"/>
   <result pre="COVIDâ€�19. 6 ROUTE OF TRANSMISSION The epidemiological investigation in Wuhan," exact="China" post="has identified the outbreak which was associated with Huanan"/>
   <result pre="award from the University Grants Commission, New Delhi, Government of" exact="India" post="(DSKPDF Schemeâ€�No.F.4â€�2/2006 (BSR)/BL/17â€�18/0234). References REFERENCES 1MukherjeeS. Emerging infectious diseases:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264541\results\search\country\results.xml">
   <result pre="It has already been used for SARSâ€�Covâ€�2. Some countries, including" exact="China" post="and India, have approved its use in symptomatic infected"/>
   <result pre="BruceH, et al. First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med.2020;382:929â€&quot;36. 10.1056/NEJMoa200119132004427 9Adaptive COVIDâ€�19 treatment trial"/>
   <result pre="et al. First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med.2020;382:929â€&quot;36. 10.1056/NEJMoa200119132004427 9Adaptive COVIDâ€�19 treatment trial"/>
   <result pre="national study of HIV in pregnancy and childhood in the" exact="United Kingdom" post="and Ireland. BMC Infect Dis2015;16:1â€&quot;11. 32SinclairSM, JonesJK, MillerRK, GreeneMF,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264596\results\search\country\results.xml">
   <result pre="strategy for containing the epidemic and has been successful in" exact="South Korea" post="and China, where it was stringently employed. In the"/>
   <result pre="We realized as a result of our current experience that" exact="China" post="is currently the major producer of the world's medical"/>
   <result pre="of our medications. A collaborative relationship with health authorities in" exact="China" post="will be crucial to our ability to cope with"/>
   <result pre="evidence for HQ efficacy comes from several conflicting reports from" exact="China" post="and an article in the International Journal of Antimicrobial"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264656\results\search\country\results.xml">
   <result pre="cluster of pneumonia (COVIDâ€�19) cases have been found in Wuhan" exact="China" post="in late December, 2019, and subsequently, a novel coronavirus"/>
   <result pre="prevention and control COVIDâ€�19. Funding National Natural Science Foundation of" exact="China" post="10.13039/501100001809 81521001, 81870182 National Key Basic Research Programme2016YFC1301204, 2020YFC1316701"/>
   <result pre="000 and they are American, Spain, Italy, Germany, France, The" exact="United Kingdom," post="China, Iran and Turkey in a descending order. The"/>
   <result pre="are American, Spain, Italy, Germany, France, The United Kingdom, China," exact="Iran" post="and Turkey in a descending order. The number of"/>
   <result pre="Spain, Italy, Germany, France, The United Kingdom, China, Iran and" exact="Turkey" post="in a descending order. The number of confirmed cases"/>
   <result pre="and 24.7Â days (22.9â€�28.1), respectively. The case fatality ratio in" exact="China" post="was 1.38% (1.23â€�1.53), with substantially higher ratios in older"/>
   <result pre="international cases stratified by age were consistent with those from" exact="China" post="(4.5% [1.8â€�11.1] in those aged â‰¥60Â years [nÂ =Â"/>
   <result pre="around April 2020 and local epidemic across cities in mainland" exact="China" post="would lag by 1â€�2Â weeks in a study.5 In"/>
   <result pre="the epidemic peak would be on 17 February 2020 in" exact="China" post="and an obvious rise could occur from 25 to"/>
   <result pre="in various global databases according to the data of the" exact="China" post="National Center for Bioinformation 2019 Novel Coronavirus Resource (2019â€�nCoVR)"/>
   <result pre="of virus submitted by different regions. In the world, China," exact="United Kingdom" post="and United States have uploaded 569, 3521 and 2022"/>
   <result pre="by different regions. In the world, China, United Kingdom and" exact="United States" post="have uploaded 569, 3521 and 2022 virus sequences, respectively"/>
   <result pre="understand the interaction of SARSâ€�CoVâ€�2 and ACE2 receptor, scientists from" exact="the United States" post="and China separately analysed the cryoâ€�electronic microscope (cryoâ€�EM) structures"/>
   <result pre="the interaction of SARSâ€�CoVâ€�2 and ACE2 receptor, scientists from the" exact="United States" post="and China separately analysed the cryoâ€�electronic microscope (cryoâ€�EM) structures"/>
   <result pre="SARSâ€�CoVâ€�2 and ACE2 receptor, scientists from the United States and" exact="China" post="separately analysed the cryoâ€�electronic microscope (cryoâ€�EM) structures of SARSâ€�CoVâ€�2"/>
   <result pre="â€˜Diagnosis and Treatment Guideline of the Novel Coronavirus Pneumoniaâ€™ of" exact="China" post="proposed to use fluorescentâ€�tagged probe based realâ€�time RTâ€�PCR to"/>
   <result pre="Treatment Guideline of COVIDâ€�19 from version 2 to 7 in" exact="China" post="Description Ver 7 (Mar 4) Ver 6 (Feb 18)"/>
   <result pre="Treatment Guideline of the Novel Coronavirus Pneumonia (Version 7)â€™ of" exact="China" post="(TableÂ 1). According to a recent study, an increase"/>
   <result pre="al 2020 Clinical case study Cure a COVIDâ€�19 patient in" exact="the United States" post="by intravenous injection Wang et al 2020 In vitro"/>
   <result pre="2020 Clinical case study Cure a COVIDâ€�19 patient in the" exact="United States" post="by intravenous injection Wang et al 2020 In vitro"/>
   <result pre="stage.76, 77 A recent study reported two COVIDâ€�19 cases in" exact="South Korea" post="and found that they did not have a significant"/>
   <result pre="treatment, has been used to cure a COVIDâ€�19 patient in" exact="the United States" post="by intravenous injection in January 2020.42 A recent in"/>
   <result pre="has been used to cure a COVIDâ€�19 patient in the" exact="United States" post="by intravenous injection in January 2020.42 A recent in"/>
   <result pre="far, the main affected areas have from the original outbreak" exact="China" post="to outside regions, especially American and Europe. Fortunately, we"/>
   <result pre="work was supported by the National Natural Science Foundation of" exact="China" post="(81521001, 81870182) and the National Key Basic Research Programme"/>
   <result pre="of its spike protein for risk of human transmission. Sci" exact="China" post="Life Sci. 2020;63(3):457â€�460.32009228 37WrappD, WangN, CorbettKS, et al. Cryoâ€�EM"/>
   <result pre="LindquistS, et al. First Case of 2019 Novel Coronavirus in" exact="the United States." post="N Engl J Med. 2020;382(10):929â€�936.32004427 43FanC, LiK, DingY, LuWL,"/>
   <result pre="et al. First Case of 2019 Novel Coronavirus in the" exact="United States." post="N Engl J Med. 2020;382(10):929â€�936.32004427 43FanC, LiK, DingY, LuWL,"/>
   <result pre="respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study." exact="Hong Kong" post="Med J. 2003;9(6):399â€�406.14660806 77ChanKW, WongVT, TangSCW, COVIDâ€�19: An update"/>
   <result pre="al. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur J Clin Microbiol Infect Dis. 2005;24(1):44â€�46.15616839 96HungIF, ToKK,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264879\results\search\country\results.xml">
   <result pre="The Novel Coronavirus â€&quot; Latest Findings The Novel Coronavirus: from" exact="China" post="to a pandemic BrÃ¼ssow BrÃ¼ssowHarald1haraldbruessow@yahoo.com[1], Department of BiosystemsLaboratory of"/>
   <result pre="of Wuhan followed by a now contained extension to mainland" exact="China" post="has now spread to all continents as a major"/>
   <result pre="as a major pandemic with current hotspots in Europe and" exact="the USA." post="This minireview is an update of an earlier report"/>
   <result pre="continents and hotspots of infection have developed in Europe and" exact="the USA" post="that outnumber the original focus of infection in China,"/>
   <result pre="million confirmed cases were counted (April 19: 2.3 million). Numerically," exact="the USA" post="leads the field with 466â€™000 cases, followed by Spain"/>
   <result pre="the USA leads the field with 466â€™000 cases, followed by" exact="Spain" post="(153k; kÂ =Â 1000), Italy (143k), France (118k) and"/>
   <result pre="with 466â€™000 cases, followed by Spain (153k; kÂ =Â 1000)," exact="Italy" post="(143k), France (118k) and Germany (118k), all reporting more"/>
   <result pre="cases, followed by Spain (153k; kÂ =Â 1000), Italy (143k)," exact="France" post="(118k) and Germany (118k), all reporting more cases than"/>
   <result pre="Spain (153k; kÂ =Â 1000), Italy (143k), France (118k) and" exact="Germany" post="(118k), all reporting more cases than China (83k). Then"/>
   <result pre="France (118k) and Germany (118k), all reporting more cases than" exact="China" post="(83k). Then comes UK and Iran (65k each), Turkey"/>
   <result pre="reporting more cases than China (83k). Then comes UK and" exact="Iran" post="(65k each), Turkey (42k), and even small countries are"/>
   <result pre="than China (83k). Then comes UK and Iran (65k each)," exact="Turkey" post="(42k), and even small countries are reporting high numbers"/>
   <result pre="and even small countries are reporting high numbers (Belgium and" exact="Switzerland" post="with 24k each). The death toll is, with 96â€™000"/>
   <result pre="toll is, with 96â€™000 COVIDâ€�19 victims (April 19: 161â€™000), substantial;" exact="Italy" post="and Spain, with 18k and 15k deaths, have had"/>
   <result pre="15k deaths, have had a disproportionately large share, followed by" exact="France" post="and the UK. At the moment New York City"/>
   <result pre="preparedness (Horton, 2020). By early March, 3300 healthcare workers in" exact="China" post="were infected, and 22 died. An Italian survey showed"/>
   <result pre="can only be partially replaced (e.g. by veterinary doctors in" exact="France" post="offering to help out, and by the recruitment of"/>
   <result pre="and protecting hospitals from patient overflow (Chen et al., 2020d)." exact="Italy" post="became a hotspot of the COVIDâ€�19 epidemic in Europe,"/>
   <result pre="and domicile virus testing (Spina et al., 2020). Telemedicine In" exact="the United States," post="29% of the physicians are older than 55Â years."/>
   <result pre="domicile virus testing (Spina et al., 2020). Telemedicine In the" exact="United States," post="29% of the physicians are older than 55Â years."/>
   <result pre="death rates Very different CFR are reported for different countries:" exact="Italy" post="7.7, Iran and Spain 5.7, China 4.0, France and"/>
   <result pre="Very different CFR are reported for different countries: Italy 7.7," exact="Iran" post="and Spain 5.7, China 4.0, France and USA 2.4,"/>
   <result pre="CFR are reported for different countries: Italy 7.7, Iran and" exact="Spain" post="5.7, China 4.0, France and USA 2.4, South Korea"/>
   <result pre="reported for different countries: Italy 7.7, Iran and Spain 5.7," exact="China" post="4.0, France and USA 2.4, South Korea 0.9, Switzerland"/>
   <result pre="different countries: Italy 7.7, Iran and Spain 5.7, China 4.0," exact="France" post="and USA 2.4, South Korea 0.9, Switzerland 0.6, Germany"/>
   <result pre="Iran and Spain 5.7, China 4.0, France and USA 2.4," exact="South Korea" post="0.9, Switzerland 0.6, Germany 0.2% (status of March 16)."/>
   <result pre="5.7, China 4.0, France and USA 2.4, South Korea 0.9," exact="Switzerland" post="0.6, Germany 0.2% (status of March 16). These differences"/>
   <result pre="4.0, France and USA 2.4, South Korea 0.9, Switzerland 0.6," exact="Germany" post="0.2% (status of March 16). These differences must be"/>
   <result pre="these rates (Lazzarini and Putoto, 2020). The high CFR in" exact="Italy" post="might result from a combination of several factors. One"/>
   <result pre="animal model for dengue fever (Guastalegname and Vallone, 2020). Epidemiology" exact="China" post="Of the 70â€™000 cases reported by Feb 17 in"/>
   <result pre="in the other provinces of China. The epidemic in mainland" exact="China" post="was a mixture of case importation, which was dominant"/>
   <result pre="phase. Due to public health measures, the epidemic in mainland" exact="China" post="was selfâ€�sustained for only 3Â weeks, with basic reproduction"/>
   <result pre="By March 18, no local transmitted cases were reported in" exact="China" post="(asymptomatic infections were not registered). Restaurants, shops, schools and"/>
   <result pre="fever patients to prevent secondary flares of the epidemic in" exact="China" post="by imported infections (Normile, 2020). Mathematical models Without control"/>
   <result pre="(school closure, case and contact isolation, travel restrictions) in mainland" exact="China" post="could have reduced this number to 200Â 000 cases."/>
   <result pre="lesser toll of an estimated 30Â 000 cases in mainland" exact="China" post="by Feb. 19 (Tian et al., 2020). Indeed, the"/>
   <result pre="showed that until Feb 10, the early epidemic in mainland" exact="China" post="was well predicted according to the volume of infected"/>
   <result pre="and public health counterâ€�measures determined the epidemic course in mainland" exact="China" post="(Kraemer et al., 2020). According to a model from"/>
   <result pre="intervention 280â€™000 cases of infected persons would be expected in" exact="Singapore" post="after 80Â days, assuming a low R value (RÂ"/>
   <result pre="public lockdown (Adam, 2020). Superâ€�spreaders From three infection clusters in" exact="Singapore" post="(a tourist group, a business meeting and a church"/>
   <result pre="Wuhan. A 90% travel reduction delayed virus transmission to mainland" exact="China" post="by 1Â week, but did not cause case reduction"/>
   <result pre="importation into Africa was tenâ€�fold lower than into Europe. Egypt," exact="Algeria" post="and South Africa were highâ€�risk countries. When calculating a"/>
   <result pre="Africa was tenâ€�fold lower than into Europe. Egypt, Algeria and" exact="South Africa" post="were highâ€�risk countries. When calculating a preparedness and vulnerability"/>
   <result pre="vulnerability index, an epidemic would have the greatest impact on" exact="Nigeria" post="(Gilbert et al., 2020). The first infections occurred in"/>
   <result pre="by a group of 30 tourists from Wuhan visiting Italy," exact="Switzerland" post="and France. Five of them developed mild disease during"/>
   <result pre="programs and quarantine measures, the most effective single measure in" exact="China" post="was the prolongation of the holidays to two weeks"/>
   <result pre="with the host family (Chen et al., 2020c). In contrast," exact="Iran" post="allowed pilgrimage to Qom and experienced a large regional"/>
   <result pre="clinical samples of COVIDâ€�19 patients from Asia, Australia, Europe and" exact="America" post="showed nearly identical RNA sequences (Kim et al., 2020)."/>
   <result pre="sequence closely related to that of a Chinese tourist to" exact="Italy" post="while a patient from Lombardy was most closely related"/>
   <result pre="isolated in Munich, suggestive of multiple introduction of SARSâ€�CoVâ€�2 into" exact="Italy" post="(Giovanetti et al., 2020). RNA sequencing of lung washes"/>
   <result pre="an earlier viral clearance (Liu et al., 2020). Patients from" exact="Hong Kong" post="were followed for viral load in selfâ€�collected saliva. Titres"/>
   <result pre="did not accumulate mutations (To et al., 2020). Patients from" exact="Singapore" post="with mild disease demonstrated a median duration of virus"/>
   <result pre="planning exit strategies from lockdown situations. All COVIDâ€�19 patients from" exact="Hong Kong" post="developed ELISA IgG antibodies against the spike protein, which"/>
   <result pre="E. P. (2020) Impact of school closures for COVIDâ€�19 on" exact="the US" post="healthâ€�care workforce and net mortality: a modelling study. Lancet"/>
   <result pre="W., Wang, C., and BÃ¤rnighausen, T. (2020c) COVIDâ€�19 control in" exact="China" post="during mass population movements at New Year. Lancet395: 764â€&quot;766.32105609"/>
   <result pre="(2020) COVIDâ€�19: preparing for superspreader potential among Umrah pilgrims to" exact="Saudi Arabia." post="Lancet395: e48.32113506 Ebrahim, S.H., Ahmed, Q.A., Gozzer, E., Schlagenhauf,"/>
   <result pre="transmission of severe acute respiratory syndrome coronavirus 2 (SARSâ€�CoVâ€�2) in" exact="the USA." post="Lancet395: 1137â€&quot;1144.32178768 Gilbert, M., Pullano, G., Pinotti, F., Valdano,"/>
   <result pre="of print]. 10.1016/j.cell.2020.04.004 Normile, D. (2020) As normalcy returns, can" exact="China" post="keep COVIDâ€�19 at bay?Science368: 18â€&quot;19.32241931 Olsen, S.J., Chen, M.Y.,"/>
   <result pre="Chowell, G. (2020) Transmission potential and severity of COVIDâ€�19 in" exact="South Korea." post="Int J Infect Dis93: 339â€&quot;344.32198088 Spina, S., Marrazzo, F.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264920\results\search\country\results.xml">
   <result pre="2020, a case of novel coronavirus was confirmed in Wuhan," exact="China" post="[4]. Within a short period of time, the number"/>
   <result pre="70 countries and infected more than 60 million people in" exact="the United States" post="alone [13]. As of May 27, 2020, SARS-CoV-2 had"/>
   <result pre="countries and infected more than 60 million people in the" exact="United States" post="alone [13]. As of May 27, 2020, SARS-CoV-2 had"/>
   <result pre="ancestor type, A and C mainly exist in Europe and" exact="the United States," post="while B mainly exists in east Asia, providing a"/>
   <result pre="type, A and C mainly exist in Europe and the" exact="United States," post="while B mainly exists in east Asia, providing a"/>
   <result pre="future animal management [57]. After the outbreak, many regions in" exact="China" post="have introduced relevant laws and regulations, and some animals"/>
   <result pre="[81]. At present, SARS-CoV-2 nucleic acid detection kit approved by" exact="China" post="national medical products adminstration mainly uses real-time fluorescence quantitative"/>
   <result pre="cell infection in vitro [89]. The first SARS-CoV-2 patient in" exact="the United States" post="showed a marked improvement in symptoms after being treated"/>
   <result pre="infection in vitro [89]. The first SARS-CoV-2 patient in the" exact="United States" post="showed a marked improvement in symptoms after being treated"/>
   <result pre="neutralize the virus [105]. In addition, some medical teams in" exact="China" post="are using plasma from infected patients and traditional Chinese"/>
   <result pre="and may erupt repeatedly each winter [117]. In this outbreak," exact="China" post="performed very well and actively supported other countries to"/>
   <result pre="the epidemic. Thousands of people are diagnosed every day in" exact="the United States," post="Italy, Russia and other countries. As the currently has"/>
   <result pre="epidemic. Thousands of people are diagnosed every day in the" exact="United States," post="Italy, Russia and other countries. As the currently has"/>
   <result pre="people are diagnosed every day in the United States, Italy," exact="Russia" post="and other countries. As the currently has the largest"/>
   <result pre="other countries. As the currently has the largest number of" exact="the United States," post="confirmed its domestic unemployment increased, many small and medium-sized"/>
   <result pre="countries. As the currently has the largest number of the" exact="United States," post="confirmed its domestic unemployment increased, many small and medium-sized"/>
   <result pre="supply of medical resources, cost huge financial resources and forced" exact="the United States" post="to increase the printing of dollars. This has also"/>
   <result pre="of medical resources, cost huge financial resources and forced the" exact="United States" post="to increase the printing of dollars. This has also"/>
   <result pre="supported by grants from The National Natural Science Foundation of" exact="China" post="(no.81271920, no.81672099 and no.81871720), Key Disciplines of Jiangsu Science"/>
   <result pre="monitoring of persons exposed to patients with confirmed COVID-19 -" exact="United States," post="January-February 2020. MMWR Morb Mortal Wkly Rep. 2020;69:245â€&quot;46. 47.Patel"/>
   <result pre="Interim Clinical Guidance for the 2019 Novel coronavirus outbreak -" exact="United States," post="December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly"/>
   <result pre="of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in" exact="Hong Kong." post="Infect Control Hosp Epidemiol. 2020:41(5):493â€&quot;98. 59.Ong SWX, Tan YK,"/>
   <result pre="10.1093/infdis/jiaa211. 109.TobÃ­asAEvaluation of the lockdowns for the SARS-CoV-2 epidemic in" exact="Italy" post="and Spain after one month follow upSci Total Environ202072513853910.1016/j.scitotenv.2020.13853932304973"/>
   <result pre="of the lockdowns for the SARS-CoV-2 epidemic in Italy and" exact="Spain" post="after one month follow upSci Total Environ202072513853910.1016/j.scitotenv.2020.13853932304973 110.TobÃ­asACarnereroCRecheCMassaguÃ©JViaMMinguillÃ³nMCAlastueyAQuerolXChanges in"/>
   <result pre="Care Costs And Resource Use Associated With COVID-19 In The" exact="United States." post="Health Aff (Millwood). 2020. 10.1377/hlthaff.2020.00426."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266420\results\search\country\results.xml">
   <result pre="of Nursing and Public Health, University of KwaZulu-Natal (UKZN), Durban," exact="South Africa," post="epub: 2020-6-613(C) , This article is made available via"/>
   <result pre="prior to quarantine regulations [3]. Similarly, reports of IPV in" exact="France" post="have increased by 30% since March 17th, 2020 and"/>
   <result pre="17th, 2020 and by 25% since March 20th, 2020 in" exact="Argentina" post="[1]. In the United States, which as of June"/>
   <result pre="by 25% since March 20th, 2020 in Argentina [1]. In" exact="the United States," post="which as of June 1st has the largest COVID-19"/>
   <result pre="25% since March 20th, 2020 in Argentina [1]. In the" exact="United States," post="which as of June 1st has the largest COVID-19"/>
   <result pre="some form of gender-based violence in their lifetime [10]. In" exact="the US," post="estimates suggest that the lifetime prevalence of IPV among"/>
   <result pre="Mental Health and Safety of Women Living with HIV in" exact="South Africa." post="AIDS Behav. Apr 29 2020. 10.OrzaLBewleySChungCet al.â€œViolence Enough alreadyâ€�:"/>
   <result pre="25.JewkesRMorrellRGender and sexuality: emerging perspectives from the heterosexual epidemic in" exact="South Africa" post="and implications for HIV risk and preventionJ Int AIDS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266578\results\search\country\results.xml">
   <result pre="CoV infection called as COVID-19 originated in Wuhan, Hubei Province," exact="China" post="in December 2019 [1]. The causative agent for this"/>
   <result pre="coronavirus include severe acute respiratory syndrome (SARS), which originated in" exact="China" post="in 2002 [3] and the ongoing Middle East respiratory"/>
   <result pre="rate (CFR) of COVID-19 was highest in Italy, Spain, and" exact="France" post="where severe Vit D deficiency (mean 25OHD concentration &amp;lt;"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003Lancet36220031353135814585636 4AssiriA.McGeerA.PerlT.M.Hospital outbreak of Middle East"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266583\results\search\country\results.xml">
   <result pre="has affected people's lives globally, since first observed in Wuhan," exact="China" post="in the last days of 2019 [1,2]. The main"/>
   <result pre="54Teixeira da SilvaJ.A.Convalescent plasma: A possible treatment of COVID-19 in" exact="India" post="[published online ahead of print, 2020 Apr 15]Med J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266750\results\search\country\results.xml">
   <result pre="COVID-19 prevention services to homeless people who use drugs in" exact="Iran" post="DeilamizadeAbbasaMoghanibashi-MansouriehAmirbâ�Ž[a], [b], â�ŽCorresponding author. pmc-release: 2020-6-6epub: 2020-6-6102806(C) Elsevier B.V.,"/>
   <result pre="for as long as the COVID-19 resource centre remains active." exact="Iran" post="was among the first countries struck by the COVID-19"/>
   <result pre="and clients in harm reduction centres. Non-governmental organizations (NGOs) in" exact="Iran" post="are key partners in implementing harm reduction programmes, operating"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266814\results\search\country\results.xml">
   <result pre="Medicine, Li Ka Shing Faculty of Medicine, The University of" exact="Hong Kong," post="epub: 2020-6-6pmc-release: 2020-6-6collection: 2020574received: 2020-1-30rev-recd: 2020-4-14accepted: 2020-4-14(C) , Open"/>
   <result pre="from the buffy coats of healthy donor samples from the" exact="Hong Kong" post="Red Cross by Ficoll-Hypaque (Pharmacia, Sweden) gradient centrifugation. The"/>
   <result pre="part by the General Research Fund, Research Grants Council of" exact="Hong Kong" post="(17115015, 17121214, 17126317, 17122519); Theme-based Research Scheme from the"/>
   <result pre="Theme-based Research Scheme from the Research Grants Council of the" exact="Hong Kong" post="SAR, China (Project No. T11-705/14N); Chinese National Natural Science"/>
   <result pre="from the Research Grants Council of the Hong Kong SAR," exact="China" post="(Project No. T11-705/14N); Chinese National Natural Science Foundation of"/>
   <result pre="China (Project No. T11-705/14N); Chinese National Natural Science Foundation of" exact="China" post="(31570898); and Natural Science Foundation of Guangdong Province, China"/>
   <result pre="of China (31570898); and Natural Science Foundation of Guangdong Province," exact="China" post="(2016A030313112). Competing interests The authors declare no competing interests."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267113\results\search\country\results.xml">
   <result pre="still scarce and limited to data from China, Spain, Italy," exact="United States of America," post="Germany, France, The United Kingdom, and other international registries."/>
   <result pre="China, Spain, Italy, United States of America, Germany, France, The" exact="United Kingdom," post="and other international registries. This will be a problem"/>
   <result pre="load Severe adverse events &amp;amp; treatment complications Duan et al6" exact="China" post="23 January 2020 to 19 February 2020 10, 6â€‰M:4â€‰F,"/>
   <result pre="effects, Evanescent facial red spot (nâ€‰=â€‰1) Chenguang Shen et al7" exact="China" post="20 January 2020Â to 25 March 2020 5, Age"/>
   <result pre="12 d No severe adverse effects Bin Zhang et al8" exact="China" post="16 February 2020 to 15 March 2020 69â€‰y/F, HTN"/>
   <result pre="43th d) No adverse reactions Jin Young Ahn et al9" exact="South Korea" post="22 February 2020 to 6 March 2020 71â€‰y/M 500â€‰mL"/>
   <result pre="20.51 (5th d) â€�36.33 (9th d) Mingxiang Ye et al10" exact="China" post="11 February 2020Â toÂ 18 March 2020 69/M 600â€‰mL"/>
   <result pre="al. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur J Clin Microbiol Infect Dis. 2005;24(1):44â€�46.15616839 17SyalK. COVIDâ€�19:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267115\results\search\country\results.xml">
   <result pre="aerosolised virus from medical equipment and procedures including endoscopy.32 In" exact="China" post="healthcare workers made up 3.5% of COVIDâ€�19 patients and"/>
   <result pre="China healthcare workers made up 3.5% of COVIDâ€�19 patients and" exact="Italy" post="have reported that 20% of its responding healthcare work"/>
   <result pre="mortality.104, 105, 106 Results from a recent human trial in" exact="China" post="did not demonstrate a statistically significant improvement in time"/>
   <result pre="controls, chloroquine had a superior effect in 100 patients in" exact="China" post="infected with COVIDâ€�19 in terms of a reduction in"/>
   <result pre="and delay in viral clearance.109 Chloroquine is not accessible in" exact="Australia" post="and it has been suggested that hydroxychloroquine could be"/>
   <result pre="COVIDâ€�19 has been reported.112 It is currently being tested in" exact="Japan" post="and has no significant drug interactions. In a recent"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267122\results\search\country\results.xml">
   <result pre="of Science and Technology 10.13039/501100010803 Ministry of Human Resource Development," exact="India" post="10.13039/501100004541 fig-count: table-count: page-count: word-count: RafiqD, BatoolA, BazazMA. Three"/>
   <result pre="Ministry of Science and Technology; Ministry of Human Resource Development," exact="India" post="List of Abbreviations ACE2 Angiotensin Converting Enzyme II ARDS"/>
   <result pre="2019 was centered in Wuhan, Hubei Province of the People's" exact="Republic of" post="China.1, 2, 3, 4, 5 It was initially named"/>
   <result pre="children Unclear 20â€�50 million &amp;gt;2% 1918â€�1919 Asian flu Children Southern" exact="China" post="1â€�4 million 0.1%â€�0.2% 1957â€�1958 Hongkong flu All age groups"/>
   <result pre="1918â€�1919 Asian flu Children Southern China 1â€�4 million 0.1%â€�0.2% 1957â€�1958" exact="Hongkong" post="flu All age groups Southern China 1â€�4 million 0.1%â€�0.2%"/>
   <result pre="1â€�4 million 0.1%â€�0.2% 1957â€�1958 Hongkong flu All age groups Southern" exact="China" post="1â€�4 million 0.1%â€�0.2% 1968â€�1969 Serious acute respiratory syndrome (SARS)"/>
   <result pre="0.1%â€�0.2% 1968â€�1969 Serious acute respiratory syndrome (SARS) Middleâ€�aged adults (45â€�65)" exact="China" post="774 &amp;lt;10% 2002â€�2003 Swine flu Children, young adults and"/>
   <result pre="&amp;lt;10% 2002â€�2003 Swine flu Children, young adults and pregnant women" exact="Mexico" post="18â€‰000 &amp;lt;0.025% 2009â€�2010 Middle east respiratory syndrome (MERS) Elderly"/>
   <result pre="(60+) Middle East 861 &amp;gt;30% 2012 COVIDâ€�19 All age groups" exact="China" post="36â€‰000 and continuing &amp;gt;2% 2019â€�2020 SARSâ€�CoVâ€�2019 has rapidly transmitted"/>
   <result pre="combating viral spread helped increase the number of cases outside" exact="China" post="to about 13â€�fold in 2â€‰weeks. This lead the WHO"/>
   <result pre="nasal cannula, tracheostomy, and bronchoscopy). On the other hand, The" exact="United States" post="CDC first recommended the use of airborne precautions for"/>
   <result pre="used for one of the earliest patients of COVIDâ€�19 in" exact="the United States" post="on the basis of â€œcompassionate useâ€�.32, 33 4.3 Favipiravir"/>
   <result pre="for one of the earliest patients of COVIDâ€�19 in the" exact="United States" post="on the basis of â€œcompassionate useâ€�.32, 33 4.3 Favipiravir"/>
   <result pre="Beijing, China, in 2003 and (Ro = 3.5â€�6.7) in Jeddah," exact="Kingdom of Saudi Arabia," post="in 2014. Later an updated estimation risk has been"/>
   <result pre="in 2003 and (Ro = 3.5â€�6.7) in Jeddah, Kingdom of" exact="Saudi Arabia," post="in 2014. Later an updated estimation risk has been"/>
   <result pre="taken from the 1918 influenza pandemic that emerged in London," exact="United Kingdom." post="The study involved simulating three different cases: i) a"/>
   <result pre="high reproductive number at the beginning of the outbreak in" exact="China" post="with the maximum peak in midâ€�January 2020. However, with"/>
   <result pre="China, COVIDâ€�19 has gone global. Infections are escalating in Europe," exact="United States," post="Iran, South Korea, and elsewhere, with authorities instigating increasingly"/>
   <result pre="gone global. Infections are escalating in Europe, United States, Iran," exact="South Korea," post="and elsewhere, with authorities instigating increasingly restrictive actions to"/>
   <result pre="instigating increasingly restrictive actions to contain the virus. Europe and" exact="Japan" post="are already in recession territory given their high reliance"/>
   <result pre="As per OECD, the countries that are deeply interconnected to" exact="China" post="are the ones that will forecast the largest downward"/>
   <result pre="that will forecast the largest downward growth revisions particularly Japan," exact="South Korea," post="and Australia. Largeâ€�scale quarantines, socialâ€�distancing measures, and travel restriction"/>
   <result pre="favor of A.B from Department of Biotechnology (DBT), Govt. of" exact="India" post="is duly acknowledged. References REFERENCES 1GorbalenyaAE, BakerSC, BaricRS, et"/>
   <result pre="Estimating the Unreported Number of Novel Coronavirus (2019â€�nCoV) Cases in" exact="China" post="in the First Half of January 2020: a dataâ€�driven"/>
   <result pre="D., Zhuge, C., &amp;amp; Hong, L.Epidemic analysis of COVIDâ€�19 in" exact="China" post="by dynamical modeling. pp. 1â€&quot;18. http://arxiv.org/abs/2002.06563 62ZhangS, DiaoMY, YuW,"/>
   <result pre="model for the coronavirus disease 2019 (COVIDâ€�19) outbreak in Wuhan," exact="China" post="with individual reaction and governmental action. Int J Infect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267399\results\search\country\results.xml">
   <result pre="Natural Science Foundation 10.13039/501100003995 1708085QH207 National Natural Science Foundation of" exact="China" post="10.13039/501100001809 8180360281970584 fig-count: table-count: page-count: word-count: ZhouH, FangY, XuT,"/>
   <result pre="the ability to infect humans. Subsequently, it spread rapidly throughout" exact="China" post="and caused outbreaks in many other countries, including Japan,"/>
   <result pre="China and caused outbreaks in many other countries, including Japan," exact="South Korea," post="Italy, and the United States (Zhu et al., 2020)."/>
   <result pre="in many other countries, including Japan, South Korea, Italy, and" exact="the United States" post="(Zhu et al., 2020). On January 31, 2020, the"/>
   <result pre="many other countries, including Japan, South Korea, Italy, and the" exact="United States" post="(Zhu et al., 2020). On January 31, 2020, the"/>
   <result pre="causing outbreaks of SARSâ€�like clinical symptoms in Wuhan city of" exact="China" post="and was officially designated SARSâ€�CoVâ€�2 by the WHO. SARSâ€�CoVâ€�2"/>
   <result pre="(Inoue, 2020). As these two drugs have been prescribed in" exact="Japan" post="for many years and have adequate clinical data with"/>
   <result pre="expected treatment effect in a patient infected with SARSâ€�CoVâ€�2 in" exact="the United States" post="attracted much attention (Holshue et al., 2020). Currently, remdesivir"/>
   <result pre="treatment effect in a patient infected with SARSâ€�CoVâ€�2 in the" exact="United States" post="attracted much attention (Holshue et al., 2020). Currently, remdesivir"/>
   <result pre="(such as ChiCTR2000029539, ChiCTR2000029603, and ChiCTR2000029759) have been approved in" exact="China" post="to test the effectiveness of HIV protease inhibitors such"/>
   <result pre="by experts of the Academy of Military Medical Sciences of" exact="China" post="and was approved for clinical trials (Zhang, 2020b). The"/>
   <result pre="statistics, a total of 60,107 patients infected with SARSâ€�CoVâ€�2 in" exact="China" post="were treated with TCM by February 17, 2020. A"/>
   <result pre="SARSâ€�CoVâ€�2. 4 CONCLUDING REMARKS Although the outbreak of SARSâ€�CoVâ€�2 in" exact="China" post="was contained by the joint efforts of the government,"/>
   <result pre="medical staff, outbreaks in other countries and regions outside of" exact="China" post="have become increasingly severe and uncontrollable. By April 9,"/>
   <result pre="work was supported by the National Natural Science Foundation of" exact="China" post="(No. 81803602 and 81970584), the Anhui Provincial Natural Science"/>
   <result pre="camelid nanobodies. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 110(15), E1371â€&quot;E1379. 10.1073/pnas.130133611023530214 Dong, L., Hu, S.,"/>
   <result pre="nanobodies. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="110(15), E1371â€&quot;E1379. 10.1073/pnas.130133611023530214 Dong, L., Hu, S., &amp;amp; Gao,"/>
   <result pre="broad spectrum inhibitor of viral RNA polymerase. Proceedings of the" exact="Japan" post="Academy. Series B, Physical and Biological Sciences, 93(7), 449â€&quot;463."/>
   <result pre="S. K. (2020). First case of 2019 novel coronavirus in" exact="the United States." post="The New England Journal of Medicine, 382(10), 929â€&quot;936. 10.1056/NEJMoa200119132004427"/>
   <result pre="K. (2020). First case of 2019 novel coronavirus in the" exact="United States." post="The New England Journal of Medicine, 382(10), 929â€&quot;936. 10.1056/NEJMoa200119132004427"/>
   <result pre="convalescent plasma in 2 patients with Ebola virus disease in" exact="the United States." post="Clinical Infectious Diseases, 61(4), 496â€&quot;502. 10.1093/cid/civ33425904375 Kruse, R. L."/>
   <result pre="plasma in 2 patients with Ebola virus disease in the" exact="United States." post="Clinical Infectious Diseases, 61(4), 496â€&quot;502. 10.1093/cid/civ33425904375 Kruse, R. L."/>
   <result pre="ligase RCHY1. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 113(35), E5192â€&quot;E5201. 10.1073/pnas.160343511327519799 Masters, P. S. (2006)."/>
   <result pre="RCHY1. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="113(35), E5192â€&quot;E5201. 10.1073/pnas.160343511327519799 Masters, P. S. (2006). The molecular"/>
   <result pre="human coronavirus. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 101(27), 10012â€&quot;10017. 10.1073/pnas.040359610115226499 Xia, S., Liu, M.,"/>
   <result pre="coronavirus. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="101(27), 10012â€&quot;10017. 10.1073/pnas.040359610115226499 Xia, S., Liu, M., Wang, C.,"/>
   <result pre="Molecular Immunology, 11, 1â€&quot;3. 10.1038/s41423-020-0374-2 collab: Xinhua Daily . (2020)." exact="China" post="optimizes treatment for COVIDâ€�19. Retrieved from http://english.www.gov.cn/news/topnews/202003/07/content_WS5e62fff1c6d0c201c2cbdb82.html Xu, X.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267548\results\search\country\results.xml">
   <result pre="Disorders; National Clinical Research Center for Child Health, and Disorders;" exact="China" post="International Science and Technology Cooperation Base of Child Development"/>
   <result pre="Ministry of Education Key Laboratory of Child Development and Disorders," exact="China" post="International Science and Technology Cooperation base of Child Development"/>
   <result pre="have been confirmed in other countries and regions outside China." exact="Italy" post="is the worst affected country in Europe. So far,"/>
   <result pre="stay (p=0.001) and lower mortality (p=0.049) than control group. Wong21" exact="Hong Kong" post="Medical Journal 15â€‰days after symptom onset 200â€‰mL Unknown CP"/>
   <result pre="al. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur J Clin Microbiol Infect Dis2005;24:44â€�6.15616839 6SooYO, ChengY, WongR,"/>
   <result pre="outcome of mechanically ventilated patients with 2009 H1N1 influenza in" exact="Bosnia and Herzegovina" post="and Serbia: impact of newly established multidisciplinary intensive care"/>
   <result pre="al. Feasibility of using convalescent plasma immunotherapy for MERSâ€�CoV infection," exact="Saudi Arabia." post="Emerg Infect Dis2016;22:1554â€�61.27532807 19collab: World Health Organization . Use"/>
   <result pre="al. Treatment of severe acute respiratory syndrome with convalescent plasma." exact="Hong Kong" post="Med J2003;9:199â€�201.12777656 22WuX, GaoH, WuH, et al. Successful treatment"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospital. J Antimicrob Chemother2005;56:919â€�22.16183666 24LukeTC, KilbaneEM, JacksonJL, et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267562\results\search\country\results.xml">
   <result pre="Institute of Bioâ€�Science and Technology, 1266, Tamuraâ€�cho, Nagahama, Shiga, 526â€�0829," exact="Japan" post="Tel: +81 749 64 811 Email: t_shirai@nagahama-i-bio.ac.jp epub: 2020-5-510.1002/1873-3468.13806received:"/>
   <result pre="coronavirus COVIDâ€�19 crude drug drug repurposing homology modeling SARSâ€�CoV Funding" exact="Japan" post="Agency for Medical Research and Development 10.13039/100009619 fig-count: table-count:"/>
   <result pre="respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study." exact="Hong Kong" post="Med J9, 399â€&quot;406.14660806 15ChuCM, ChengVC, HungIF, WongMM, ChanKH, ChanKS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267883\results\search\country\results.xml">
   <result pre="Europeans 1793â€&quot;1798 American plague âˆ¼25,000 Yellow fever, which terrorized colonial" exact="America" post="1832 2nd cholera pandemic in Paris 18,402 Spread from"/>
   <result pre="America 1832 2nd cholera pandemic in Paris 18,402 Spread from" exact="India" post="to Europe/Western Hemisphere 1918 Spanish influenza âˆ¼50 million Led"/>
   <result pre="the â€œBlack Deathâ€� followed trade routes from what is now" exact="Mongolia" post="and China, across Asia, and into Europe (1347 to"/>
   <result pre="(1347 to 1348). Likewise, cholera spread along travel routes from" exact="India" post="to Europe in 1831 to 1833, 1845, 1866, and"/>
   <result pre="was undoubtedly a human-caused pandemic (2). In its earliest days," exact="the United States" post="was struck by recurring deadly epidemics along the Eastern"/>
   <result pre="undoubtedly a human-caused pandemic (2). In its earliest days, the" exact="United States" post="was struck by recurring deadly epidemics along the Eastern"/>
   <result pre="countryside to avoid the plague raging in the city. That" exact="China" post="has been able to achieve at least short-term regional"/>
   <result pre="potential of public health police power. Some other countries/jurisdictions, e.g.," exact="Hong Kong," post="Singapore, and South Korea, have controlled early COVID-19 waves"/>
   <result pre="police power. Some other countries/jurisdictions, e.g., Hong Kong, Singapore, and" exact="South Korea," post="have controlled early COVID-19 waves as well. Anecdotal evidence"/>
   <result pre="doi:10.1038/s41467-017-00923-8.29066781 14.MarkelH2004When germs travel: six major epidemics that have invaded" exact="America" post="since 1900 and the fears they have unleashed. Pantheon"/>
   <result pre="KolokotronisS-O, HynesWH, DeSalleR, BallSJ, DaszakP, MacPheeRDE, GreenwoodAD2008Historical mammal extinction on" exact="Christmas Island" post="(Indian Ocean) correlates with introduced infectious disease. PLoS One3:e3602."/>
   <result pre="HynesWH, DeSalleR, BallSJ, DaszakP, MacPheeRDE, GreenwoodAD2008Historical mammal extinction on Christmas" exact="Island" post="(Indian Ocean) correlates with introduced infectious disease. PLoS One3:e3602."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7269097\results\search\country\results.xml">
   <result pre="T.J.L. would like to thank Alexa Harnagel, Brock Nelson and" exact="Jordan" post="Hosfelt for initial literature research. Abbreviations ACE2 angiotensin-converting enzyme"/>
   <result pre="protease/deubiquitinase inhibitors blocks SARS virus replication. Proc. Natl. Acad. Sci." exact="U. S." post="A.2008, 105 (42), 16119â€&quot;24. 10.1073/pnas.0805240105.18852458 WrappD.; WangN.; CorbettK. S.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7269098\results\search\country\results.xml">
   <result pre="with the universal use of PPE has been effective in" exact="Taiwan" post="and Austria, at least so far, although face masks"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7269525\results\search\country\results.xml">
   <result pre="Americas in the 16th century. The arrival of Europeans in" exact="America" post="was considered as the first globalization event where the"/>
   <result pre="families and caused a socioeconomic disruption in Guinea, Liberia, and" exact="Sierra Leone." post="The outbreak of COVID-19 provides strong evidence that urbanization"/>
   <result pre="et al.9 reported on the progression of COVID-19 cases in" exact="Brazil" post="and previous experiences with other health emergencies that constituted"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7269953\results\search\country\results.xml">
   <result pre="no finally verified data and no antiviral drugs licensed by" exact="the US" post="Food and Drug Administration and European Medicines Agency for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270404\results\search\country\results.xml">
   <result pre="(CRSA)ParisFrance Edited by: Gennady Bocharov, Institute of Numerical Mathematics (RAS)," exact="Russia" post="Reviewed by: FranÃ§ois J. M. A. Meurens, Agroalimentaire et"/>
   <result pre="de l'alimentation de Nantes-Atlantique, France; Simon H. Bridge, Northumbria University," exact="United Kingdom" post="*Correspondence: Jean-Michel Sallenave jean-michel.sallenave@inserm.fr This article was submitted to"/>
   <result pre="from an initial pan-European endeavor (â€œDiscoveryâ€�), now conducted largely in" exact="France" post="because of enrollment difficulties, are eagerly awaited. This drug"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270517\results\search\country\results.xml">
   <result pre="COVID-19. Gupta et al. performed a survey among rheumatologists in" exact="India" post="to assess the attitudes of physicians while initiating anti-rheumatic"/>
   <result pre="Lau AC, Lai FY, Shung E, Chan J, Wong V," exact="Hong Kong" post="Hospital Authority SCGCorticosteroid treatment of severe acute respiratory syndrome"/>
   <result pre="WC, Hu HC, Lin CY, Chao WC, Sheu CC, for" exact="Taiwan" post="Severe Influenza Research Consortium IImpact of corticosteroid treatment on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270651\results\search\country\results.xml">
   <result pre="research proposals dealing with many aspects of coronavirus by the" exact="Swiss" post="National Science Foundation (http://www.snf.ch/en/funding/programmes/coronavirus/Pages/default.aspx). Future calls for proposals focused"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270733\results\search\country\results.xml">
   <result pre="classified as patient 1, was asymptomatic when coming back from" exact="Germany" post="to Codogno, his hometown, from where the infection exponentially"/>
   <result pre="4, Fig. 5 ). Fig. 2 Numbers of COVID-19 in" exact="Italy" post="as of March 26, 2020. (*) positive to virus"/>
   <result pre="Fig. 4 Trend of the COVID-19 epidemic in Italy. Source:" exact="Italia" post="Tutto Bene, modified (last updated, March 26, 2020).https://www.italiatuttobene.it/ (accessed"/>
   <result pre="despite the risk to be re-infected by new entries into" exact="China" post="being still pending and requiring strict health monitoring procedures"/>
   <result pre="few days mostly, yet not only, in worst affected Northern" exact="Italy" post="regions. Tensile structures were also erected close to main"/>
   <result pre="Fortunately, all this triggered international solidarity, first of all from" exact="China" post="- in terms of expert physicians and tons of"/>
   <result pre="and tons of medical supplies for our ICUs, followed Cuba," exact="Russia" post="and other countries. Scientific research has also been working"/>
   <result pre="report of 1099 selected patients with laboratory-confirmed disease throughout Mainland" exact="China" post="during the first 2Â months of the current outbreak"/>
   <result pre="important lessons from the coronavirus disease 2019 (COVID-19) outbreak in" exact="China" post="summary of a report of 72 314 cases from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270858\results\search\country\results.xml">
   <result pre="affected community settings. Although no case has been documented in" exact="Saudi Arabia," post="there is a great risk of sudden emergence of"/>
   <result pre="Keywords Emerging Nipah Ebola and Zika virus Outbreaks Surveillance Hajj" exact="Saudi Arabia" post="Abbreviations WHO, World Health Organization PHEIC, Public Health Emergency"/>
   <result pre="antimicrobial resistance been reported in most endemics countries worldwide including" exact="Saudi Arabia" post="[1], [2]. Ample and sustained investment in research and"/>
   <result pre="threats pilgrims and citizenry protection, diseases prevention and control in" exact="Saudi Arabia" post="and worldwide [1], [2]. Early recognition and infectious case"/>
   <result pre="guidelines and countermeasures amongst perennial pilgrims and local populations in" exact="Saudi Arabia." post="Nipah virus (NiV) outbreak The ongoing re-emerging Nipah virus"/>
   <result pre="laboratory confirmed cases, and over 25 suspected cases in Kerala," exact="India" post="[4]. Nipah virus causes severe disease in both humans"/>
   <result pre="1998 outbreak among pig farmers from Kampung Sungai Nipah in" exact="Malaysia" post="and spread to Singapore with more than 100 deaths"/>
   <result pre="farmers from Kampung Sungai Nipah in Malaysia and spread to" exact="Singapore" post="with more than 100 deaths and nearly 300 human"/>
   <result pre="outbreaks in 2001 and 2007 outbreaks claimed 50 lives in" exact="India" post="alone, whereas Bangladesh has borne the brunt of Nipah"/>
   <result pre="and 2007 outbreaks claimed 50 lives in India alone, whereas" exact="Bangladesh" post="has borne the brunt of Nipah viral disease in"/>
   <result pre="[5], [12]. So far, no case has been reported in" exact="Saudi Arabia," post="although some studies have revealed the presence of trace"/>
   <result pre="[10], [11], but still no documented local case nationwide in" exact="Saudi Arabia." post="Zika virus outbreak Zika virus infection has emerged as"/>
   <result pre="Muslims from 183 nations annually to perform pilgrimage in Mecca," exact="Saudi Arabia" post="[3]. The broad geographical range of the vector and"/>
   <result pre="[1]. The first reports of human disease were described in" exact="Uganda" post="and Tanzania during an outbreak in 1952 [1], [3],"/>
   <result pre="first reports of human disease were described in Uganda and" exact="Tanzania" post="during an outbreak in 1952 [1], [3], [13]. On"/>
   <result pre="responsible for the ongoing outbreaks in the Caribbean and South" exact="America" post="following the initial outbreak in Brazil [2]. The primary"/>
   <result pre="the Caribbean and South America following the initial outbreak in" exact="Brazil" post="[2]. The primary route of human ZIKV transmission is"/>
   <result pre="not yet been documented in highly endemic Aedes settings in" exact="Saudi Arabia," post="Africa and elsewhere and requires urgent investigations [19], [20]."/>
   <result pre="revealed the presence or circulation of flavivirus linked diseases in" exact="Saudi Arabia." post="ZIKV infection during pregnancy can cause a set of"/>
   <result pre="virus outbreak in Ituri, Kivu and Bikoro communities in North-West," exact="DR Congo" post="has led to the declaration of national health emergency"/>
   <result pre="outbreak in Ituri, Kivu and Bikoro communities in North-West, DR" exact="Congo" post="has led to the declaration of national health emergency"/>
   <result pre="response to the 2014 West Africa Ebola outbreak crisis (Guinea," exact="Sierra Leone" post="and Liberia) led to more than 11, 325 deaths"/>
   <result pre="huge natural resources mining and exploitation documented over decades in" exact="DR Congo;" post="This remains a regional and global public health and"/>
   <result pre="resilient logistics in frontline are urgent needed, in supporting the" exact="DR Congo" post="Ministry of Health and related intersectorial stakeholders, to closely"/>
   <result pre="logistics in frontline are urgent needed, in supporting the DR" exact="Congo" post="Ministry of Health and related intersectorial stakeholders, to closely"/>
   <result pre="out in prevention and containment of further spread [28]. In" exact="Saudi Arabia," post="there has not reported case of imported and local"/>
   <result pre="case of recent emerging diseases threat has been reported in" exact="Saudi Arabia," post="rapid and coordinated leadership for resource mobilization and financing"/>
   <result pre="management of infants with possible congenital Zika virus infection â€&quot;" exact="United States," post="August 2016MMWR Morb Mortal Wkly Rep65201687087827559830 27World Health Organization"/>
   <result pre="Wkly Rep65201687087827559830 27World Health Organization (WHO)New Ebola outbreak declared in" exact="Democratic Republic of the Congo." post="8 May 2018News Release2018http://www.who.int/news-room/detail/08-05-2018-new-ebola-outbreak-declared-in-democratic-republic-of-the-congo [accessed 10th May 2018]. 28TamboE.ChenghoC.F.UgwuC.E.WurieI.JonhsonJ.K.NgogangJ.Y.Rebuilding"/>
   <result pre="Rep65201687087827559830 27World Health Organization (WHO)New Ebola outbreak declared in Democratic" exact="Republic of" post="the Congo. 8 May 2018News Release2018http://www.who.int/news-room/detail/08-05-2018-new-ebola-outbreak-declared-in-democratic-republic-of-the-congo [accessed 10th May"/>
   <result pre="Dis Poverty6120177128486978 29World Health Organization (WHO)Ebola virus disease â€&quot; Democratic" exact="Republic of" post="the Congo2017http://www.who.int/csr/don/13-may-2017-ebola-drc/en/ [accessed on 18th May 2017] 30AlmutairiK.M.AlodhayaniA.A.MoussaM.AboshaiqahA.E.TumalaR.B.VinluanJ.M.Ebola outbreak"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7271460\results\search\country\results.xml">
   <result pre="and HIV/hepatitis C co-infections among people who inject drugs in" exact="Mozambique" post="http://orcid.org/0000-0001-8901-2240SemÃ¡ BaltazarCynthiacynthiasema@yahoo.comcynthia.baltazar@ins.gov.mz12BootheMakini23KelloggTimothy3RicardoPaulino1SathaneIsabel4FazitoErika5RaymondHenry F.36TemmermanMarleen27LuchtersStanley28910[1], grid.419229.5Instituto Nacional de SaÃºde (INS), [2],"/>
   <result pre="drugs HIV Hepatitis B Hepatitis C Co-infections Respondent driven sampling" exact="Mozambique" post="Funding http://dx.doi.org/10.13039/100009054U.S. Presidentâ€™s Emergency Plan for AIDS Relief 5U2GPS002829"/>
   <result pre="fibrosis, and malignancy [2, 9â€&quot;11]. The BBS among PWID in" exact="Mozambique" post="estimated HBV prevalence at 32.1 and 36.4%, and HCV"/>
   <result pre="Data about HBV and HCV among the general population in" exact="Mozambique" post="is limited to a few studies in the southern"/>
   <result pre="the highest burden of HIV among key population groups in" exact="Mozambique" post="and yet there continues to be lack of integrated"/>
   <result pre="was to evaluate HIV/HBV and HIV/HCV co-infections among PWID in" exact="Mozambique" post="and to assess associated risk factors. The findings from"/>
   <result pre="lack of integrated services for HIV and viral hepatitis. Since" exact="Mozambique" post="has one of the highest HIV prevalence rates in"/>
   <result pre="Board of the University of California at San Francisco (13â€&quot;10,699);" exact="the US" post="Centers for Disease Control and Prevention (CDC) determined the"/>
   <result pre="is higher than that among other population groups in the" exact="Mozambique" post="where there was an estimated 4.9% of youths HIV"/>
   <result pre="drug use, global harm reduction service coverage remains insufficient [36]." exact="Mozambique" post="does not have integrated harm reduction programs and policies"/>
   <result pre="affiliations. The study team acknowledges the immense contributions of all" exact="Mozambique" post="BBS Technical Working Group, and all others that have"/>
   <result pre="through the U.S. Centers for Disease Control and Prevention (CDC)" exact="Mozambique" post="Country Office under the terms of Cooperative Agreement Number"/>
   <result pre="are fully available at the Data Management Unit of the" exact="Mozambique" post="National Institute of Health (INS) data repository for researchers"/>
   <result pre="https://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/legaldocument/wcms_172584.pdf.Â Accessed 28 Feb 2020. 6.MISAU, INS. Final report: the" exact="Mozambique" post="integrated biological and behavioral survey among people who inject"/>
   <result pre="Infect Dis2017217 9.Bagheri AmiriFMostafaviEMirzazadehAHIV, HBV and HCV Coinfection prevalence in" exact="Iran" post="- a systematic review and meta-analysisPLoS One20163111(3) 10.Ray SaraswatiLSarnaASebastianMPSharmaVMadanIThiorIet"/>
   <result pre="the integrated biological and behavioral survey among female sex workers," exact="Mozambique" post="2011â€&quot;2012. Maputo: 2013.Â Available from: https://ins.gov.mz/sites/default/files/2019-11/IBBS-FSW-Final-Report.pdf.Â Accessed 28 Feb"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7273044\results\search\country\results.xml">
   <result pre="of lopinavir plus ritonavir on adult patients with COVIDâ€�19 in" exact="China" post="showed that concomitant use of these drugs had no"/>
   <result pre="in bedside coronaviruses was that with the IFNâ€�Î²1b used in" exact="Saudi Arabia" post="to treat MERSâ€�CoV all patients using this drug combination"/>
   <result pre="Zhang et al.,Â 2020). 3 CONCLUSION 2019â€�nCoV outbreak from Wuhan," exact="China" post="offered a respiratory viral pandemic that currently there are"/>
   <result pre="broad spectrum inhibitor of viral RNA polymerase. Proceedings of the" exact="Japan" post="Academy, Series B Physical and Biological Sciences, 93(7), 449â€&quot;463."/>
   <result pre="Journal of Pathology: A Journal of the Pathological Society of" exact="Great Britain" post="and Ireland, 203(2), 631â€&quot;637. Henry, S. D., Metselaar, H."/>
   <result pre="MERSâ€�CoV infection. roceedings of the National Academy of Sciences of" exact="the United States" post="of America, 117(12), 6771â€&quot;6776. Wrapp, D., Wang, N., Corbett,"/>
   <result pre="infection. roceedings of the National Academy of Sciences of the" exact="United States of America," post="117(12), 6771â€&quot;6776. Wrapp, D., Wang, N., Corbett, K. S.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7276770\results\search\country\results.xml">
   <result pre="Molecular Sciences, Polytechnic Marche University, Via Conca 71, 60020, Ancona," exact="Italy" post="Email: federico.diotallevi@hotmail.it epub: 2020-5-510.1111/jdv.16646(C) , This article is being"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7277397\results\search\country\results.xml">
   <result pre="outbreak caused by the Î²-coronavirus SARS-CoV originated in Guangdong in" exact="China" post="[21]. During the 2002â€&quot;2003 epidemic, approximately 8098 cases were"/>
   <result pre="causing a series of highly pathogenic respiratory tract infections in" exact="Saudi Arabia" post="and other Middle East countries [29]. Despite fears, the"/>
   <result pre="(SARS-CoV-2) was first detected in the city of Wuhan in" exact="China" post="in December 2019 [38,39]. It was thought to have"/>
   <result pre="of COVID-19 with intravenous administration of remdesivir took place in" exact="the US," post="leading to improvement in the patientâ€™s condition with a"/>
   <result pre="against several DNA and RNA viruses, has been approved in" exact="Russia" post="and China for prevention and treatment of influenza [100]."/>
   <result pre="DNA and RNA viruses, has been approved in Russia and" exact="China" post="for prevention and treatment of influenza [100]. Antiviral effect"/>
   <result pre="of disease in COVID-19 patients in the Hubei province in" exact="China" post="compared to other regions of the world [162]. Recently,"/>
   <result pre="use in 53 hospitalized COVID-19 patientsâ€&quot;of which, 22 were in" exact="the US," post="22 in Europe or Canada and 9 in Japan"/>
   <result pre="which, 22 were in the US, 22 in Europe or" exact="Canada" post="and 9 in Japan [169]. Thirty-six of the 53"/>
   <result pre="the US, 22 in Europe or Canada and 9 in" exact="Japan" post="[169]. Thirty-six of the 53 patients (68%) showed clinical"/>
   <result pre="patients were subjected to a clinical trial for remdesivir in" exact="China" post="[170]. Of the 237 patients enrolled in the study,"/>
   <result pre="and conducting trials at 180 sites in China, France, Germany," exact="Hong Kong," post="Italy, Japan, Korea, the Netherlands Singapore, Spain, Sweden, Switzerland,"/>
   <result pre="sites in China, France, Germany, Hong Kong, Italy, Japan, Korea," exact="the Netherlands" post="Singapore, Spain, Sweden, Switzerland, Taiwan, the United Kingdom and"/>
   <result pre="in China, France, Germany, Hong Kong, Italy, Japan, Korea, the" exact="Netherlands" post="Singapore, Spain, Sweden, Switzerland, Taiwan, the United Kingdom and"/>
   <result pre="Japan, Korea, the Netherlands Singapore, Spain, Sweden, Switzerland, Taiwan, the" exact="United Kingdom" post="and the United States. In the second SIMPLE trial,"/>
   <result pre="Netherlands Singapore, Spain, Sweden, Switzerland, Taiwan, the United Kingdom and" exact="the United States." post="In the second SIMPLE trial, the safety and efficacy"/>
   <result pre="Singapore, Spain, Sweden, Switzerland, Taiwan, the United Kingdom and the" exact="United States." post="In the second SIMPLE trial, the safety and efficacy"/>
   <result pre="Arbidol against Coronavirus Infection (ELACOI) single-blind randomized controlled trial in" exact="China" post="included 44 patients with mild or moderate clinical status"/>
   <result pre="strainsVirology2005337859210.1016/j.virol.2005.04.01015914223 33.MeyerB.MullerM.A.CormanV.M.ReuskenC.B.RitzD.GodekeG.J.LattweinE.KalliesS.SiemensA.van BeekJ.et al.Antibodies against MERS coronavirus in dromedary camels," exact="United Arab Emirates," post="2003 and 2013Emerg. Infect. Dis.20142055255910.3201/eid2004.13174624655412 34.EckerleI.CormanV.M.MullerM.A.LenkM.UlrichR.G.DrostenC.Replicative Capacity of MERS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278221\results\search\country\results.xml">
   <result pre="pmcid: 72782212603 doi: 10.1038/s41419-020-2603-0 : Review Article COVID-19 infection: the" exact="China" post="and Italy perspectives http://orcid.org/0000-0002-3850-4875ChenJun1http://orcid.org/0000-0002-8308-5534LuHongzhou1http://orcid.org/0000-0001-9428-5972MelinoGerry2BocciaStefania34http://orcid.org/0000-0003-2919-1296PiacentiniMauro25RicciardiWalter34http://orcid.org/0000-0002-2571-9367WangYing6http://orcid.org/0000-0001-9716-2126ShiYufangyufangshi@sibs.ac.cn67ZhuTongyutyzhu@shphc.org.cn1[1], 0000 0004 1770 0943grid.470110.3Shanghai Public"/>
   <result pre="doi: 10.1038/s41419-020-2603-0 : Review Article COVID-19 infection: the China and" exact="Italy" post="perspectives http://orcid.org/0000-0002-3850-4875ChenJun1http://orcid.org/0000-0002-8308-5534LuHongzhou1http://orcid.org/0000-0001-9428-5972MelinoGerry2BocciaStefania34http://orcid.org/0000-0003-2919-1296PiacentiniMauro25RicciardiWalter34http://orcid.org/0000-0002-2571-9367WangYing6http://orcid.org/0000-0001-9716-2126ShiYufangyufangshi@sibs.ac.cn67ZhuTongyutyzhu@shphc.org.cn1[1], 0000 0004 1770 0943grid.470110.3Shanghai Public Health Clinical"/>
   <result pre="spread globally, especially in most parts of Europe, Iran, and" exact="the United States." post="Here, we update the recent understanding in clinical characteristics,"/>
   <result pre="globally, especially in most parts of Europe, Iran, and the" exact="United States." post="Here, we update the recent understanding in clinical characteristics,"/>
   <result pre="diagnosis strategies, as well as clinical management of COVID-19 in" exact="China" post="as compared to Italy, with the purpose to integrate"/>
   <result pre="as compared to Italy, with the purpose to integrate the" exact="China" post="experience with the global efforts to outline references for"/>
   <result pre="Respiratory tract diseases Facts The Covid-19 pandemic exploded first in" exact="China" post="and subsequently in Italy. We therefore compared these two"/>
   <result pre="of data of the pandemic, with a special attention to" exact="China" post="and Italy. With the great efforts mostly based on"/>
   <result pre="With the great efforts mostly based on strict containment measures," exact="China" post="has successfully emerged out of the first wave of"/>
   <result pre="Spain, Germany, and, just weeks later, UK. In this context," exact="Italy" post="is one of the first and hardest hit country"/>
   <result pre="on a worldwide scale (a), source Worldmeter (www.worldmeters.info), and on" exact="Italy" post="(b), modified with permission from PNAS USA, 2020. 10.1073/pnas.2004978117."/>
   <result pre="of cases (a) and deaths (b) in China, European, and" exact="the United States." post="Distributions of the cases (c). The inset in panel"/>
   <result pre="cases (a) and deaths (b) in China, European, and the" exact="United States." post="Distributions of the cases (c). The inset in panel"/>
   <result pre="The inset in panel a reports the new cases in" exact="Italy" post="as to 10 May, showing a drastic reduction on"/>
   <result pre="laboratory confirmed cases of COVID-19 in the Italy, China, and" exact="the USA," post="as of 10 May 2020. The SARS-CoV-2 virus is"/>
   <result pre="COVID-19 in China. We decided to compare the data of" exact="China" post="and Italy because these were the first two countries"/>
   <result pre="China. We decided to compare the data of China and" exact="Italy" post="because these were the first two countries hit by"/>
   <result pre="adults15. Table 1 compares the major characteristics of COVID-19 in" exact="China" post="versus Italy. Patients in Italy were more older compared"/>
   <result pre="major characteristics of COVID-19 in China versus Italy. Patients in" exact="Italy" post="were more older compared to patients in China, with"/>
   <result pre="comorbidities. Therefore, the proportions of severe and critical patients in" exact="Italy" post="were higher than that in China, partially leading to"/>
   <result pre="aerosol droplets. This is an important issue, considering that in" exact="Italy" post="alone, over 170 doctors have died so far! As"/>
   <result pre="fast-track approval from the National Medical Products Administration (NMPA). In" exact="the USA," post="only one serological test has been approved by the"/>
   <result pre="recent study by Ai et al.36 involved 1014 patients in" exact="China" post="reported that the sensitivity of toracic CT in suggesting"/>
   <result pre="was 97%. In the early February, 2020, some experts in" exact="China" post="suggested CT as one of the best clinical diagnostic"/>
   <result pre="the standard of care39. However, more recently, another study from" exact="France" post="showed that HCQ was effective against SARS-CoV-2, especially when"/>
   <result pre="improvement50. More recently, a randomized, controlled study conducted in Wuhan," exact="China" post="also failed to identify beneficial effect of LPV/r beyond"/>
   <result pre="was found to reduce viral load when given early56. In" exact="the USA," post="the first COVID-19 patient was treated with intravenous remdesivir"/>
   <result pre="In fact, despite the fact that in Italy, Spain, and" exact="Germany" post="the increase in number of new SARS-CoV-2 infections has"/>
   <result pre="Statement reported the daily incidence of new covid-19 infections in" exact="Germany" post="(a blue dots and line) followed by a statistical"/>
   <result pre="fail to be implemented. The read frequency of cases in" exact="South Korea" post="(b), despite full implementation, shows that sporatic new infections"/>
   <result pre="endemic cases88. Conclusion and way forward After several monthsâ€™ lockdown," exact="China" post="is now reopening, facing the risk of second wave"/>
   <result pre="confirmed and suspected cases quarantine. We learnt from countries like" exact="South Korea" post="and Singapore that such approaches can be feasible, even"/>
   <result pre="cases quarantine. We learnt from countries like South Korea and" exact="Singapore" post="that such approaches can be feasible, even in absence"/>
   <result pre="supported by grants from the National Key R&amp;amp;D Program of" exact="China" post="(2018YFA0107500), the Scientific Innovation Project of the Chinese Academy"/>
   <result pre="Funding on COVID-19 Infection, the National Natural Science Foundation of" exact="China" post="(81530043, 81861138015, 31771641, and 81571612), PANDORA-ID-NET (to G.I.), the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278987\results\search\country\results.xml">
   <result pre="A pneumonia of unknown cause was detected in Wuhan, Peopleâ€™s" exact="Republic of" post="China and first reported to the World Health Organization"/>
   <result pre="of unknown cause was detected in Wuhan, Peopleâ€™s Republic of" exact="China" post="and first reported to the World Health Organization (WHO)"/>
   <result pre="following a large spread outside China, with epidemic foci in" exact="South Korea" post="and Japan and a massive outbreak in Italy, the"/>
   <result pre="spread outside China, with epidemic foci in South Korea and" exact="Japan" post="and a massive outbreak in Italy, the WHO declared"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278991\results\search\country\results.xml">
   <result pre="city of Wuhan, China. Rapidly, it became an epidemic in" exact="China" post="and has now spread throughout the world reaching pandemic"/>
   <result pre="will die compared with 2.8% of men, and data from" exact="Hong Kong" post="hospitals state that 32% of male and 15% of"/>
   <result pre="[178], our region, Emilia Romagna, is the second area of" exact="Italy" post="for absolute number of SARS-CoV-2 infections (26,487 confirmed cases/4,452,638"/>
   <result pre="close to the most critical hot-spot of the infection in" exact="Italy" post="[region Lombardia (0.83%); Lodi (1.43%), Codogno area (red zone)]"/>
   <result pre="Study supported by â€œLocal Research grantsâ€� from University of Ferrara," exact="Italy" post="(FIR and FAR to D.G. and V.T.). Conflicts of"/>
   <result pre="recognition of and innate antiviral responses to Seoul virus in" exact="Norway" post="ratsBrain Behav. Immun.20082250351610.1016/j.bbi.2007.10.00518053684 29.RobinsonD.P.HallO.J.NillesT.L.BreamJ.H.KleinS.L.17beta-estradiol protects females against influenza by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7279248\results\search\country\results.xml">
   <result pre="Î²-CoVs are SARS-CoV, responsible for the 2003 epidemic started in" exact="China" post="(that caused 8000 infections and 800 deaths i.e., a"/>
   <result pre="which was responsible for the 2012 epidemic that began in" exact="Saudi Arabia" post="(causing 2400 infections and 800 deaths i.e., a 35%"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci." exact="China" post="Life Sci.20206345746010.1007/s11427-020-1637-532009228 34.WanY.ShangJ.GrahamR.BaricR.S.LiF.Receptor Recognition by the Novel Coronavirus from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7279901\results\search\country\results.xml">
   <result pre="caused by SARS-CoV-2, first appeared in December 2019 in Wuhan," exact="China" post="and has since rapidly spread around the world. On"/>
   <result pre="China: the mystery and the miracleJ Med Virol20209240140231950516 2ZhuNZhangDWangWLiXYangBSongJet al.collab:" exact="China" post="Novel Coronavirus Investigating and Research TeamA novel coronavirus from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7280142\results\search\country\results.xml">
   <result pre="of the adults hospitalized for COVID-19 with underlying conditions in" exact="the USA," post="74.8% had chronic renal disease. Evidence synthesis Evidence is"/>
   <result pre="of the adults hospitalized for COVID-19 with underlying conditions in" exact="the USA," post="74.8% had chronic renal disease. 3 Evidence synthesis 3.1"/>
   <result pre="address some of these needs, several hospitals and clinics in" exact="the USA" post="have adopted a telehealth care delivery approach; however, such"/>
   <result pre="of the adults hospitalized for COVID-19 with underlying conditions in" exact="the USA," post="74.8% had chronic renal disease, but patients with chronic"/>
   <result pre="COVID-19 spread in hemodialysis (HD) centers [34], [35], [36]. In" exact="the USA" post="specifically, 0.5 million individuals receive dialysis treatment and constitute"/>
   <result pre="or die of acute renal failure [33]. Several studies in" exact="China" post="have tracked the development of AKI once admitted for"/>
   <result pre="frame [6], [25]. One study of 1099 cases from mainland" exact="China" post="showed that six (0.5%) COVID-19 patients developed AKI [5]."/>
   <result pre="evaluating the risk factors of developing severe COVID-19 infections. In" exact="the USA," post="nearly 60 000 individuals had RCC in 2018, although"/>
   <result pre="medicine. Recently, RCC-based liquid biopsy was validated and approved by" exact="the US" post="FDA for the prognosis and diagnosis of the disease"/>
   <result pre="was effective in the treatment of a COVID-19 patient in" exact="the USA" post="[75], [78]. Further research efforts focus on drugs that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7280997\results\search\country\results.xml">
   <result pre="[16,19,20]. Nine years later, a strain of CoV evolved in" exact="Saudi Arabia" post="to cause the Middle East Respiratory Syndrome Coronavirus (MERS-CoV),"/>
   <result pre="Transmembrane protease, serine 2 (TMPRSS2) inhibitor Interfering with viral entry" exact="Japan" post="approved [46] Favipiravir Nucleoside analog Binds to the viral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7281209\results\search\country\results.xml">
   <result pre="Animals Female BALB/c mice (5 weeks old) were obtained from" exact="Japan" post="SLC (Shizuoka, Japan). All animal experiments were conducted in"/>
   <result pre="were frozen in Tissue-Tek optimal cutting temperature compound (Sakura Finetek" exact="Japan" post="Co., Ltd., Tokyo, Japan). Cryosections (7 Î¼m) were cut"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7281404\results\search\country\results.xml">
   <result pre="infection that causes COVID-19, and it first appeared in Wuhan," exact="China" post="in December 2019 and spread rapidly all over the"/>
   <result pre="that have implemented massive screening for the whole population, like" exact="South Korea," post="the overall case fatality may be less than 1%,"/>
   <result pre="well as post-influenza complications (only in a few countries including" exact="Russia" post="and China), [37]. Overall, umifenovir has a broad variety"/>
   <result pre="in late phases [61]. According to the guidelines implemented in" exact="China" post="for COVID-19 infection, IFNÎ± is to be administered by"/>
   <result pre="C5b-9 or membrane attack complex (MAC) from subsequent formation. In" exact="the United States," post="eculizumab is approved for treating paroxysmal nocturnal hemoglobinuria and"/>
   <result pre="or membrane attack complex (MAC) from subsequent formation. In the" exact="United States," post="eculizumab is approved for treating paroxysmal nocturnal hemoglobinuria and"/>
   <result pre="Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment published by" exact="China" post="National Health Commission on 4 March 2020 included tocilizumab"/>
   <result pre="dangerous lung inflammation in 21 patients with severe COVID-19 in" exact="China" post="[91]. However, Health Canada notified healthcare providers that severe"/>
   <result pre="21 patients with severe COVID-19 in China [91]. However, Health" exact="Canada" post="notified healthcare providers that severe cases of drug-induced liver"/>
   <result pre="with COVID-19, most notably in a recent single-arm study in" exact="China" post="with tocilizumab in critically ill COVID-19 patients [94]. Currently,"/>
   <result pre="of 500 milligrams twice daily for ten days [109]. In" exact="the United States," post="the FDA endorsed an emergency use authorization to permit"/>
   <result pre="500 milligrams twice daily for ten days [109]. In the" exact="United States," post="the FDA endorsed an emergency use authorization to permit"/>
   <result pre="been used for the treatment of chronic pancreatitis patients in" exact="Japan" post="[141]. Therefore, camostat mesylate could also be of benefit"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7283245\results\search\country\results.xml">
   <result pre="of patients affected with pneumonia of unknown cause in Wuhan," exact="China" post="in December 2019, led to the identification, isolation and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7284144\results\search\country\results.xml">
   <result pre="Jiao Tong University, 800 Dongchuan Road, Minhang District, Shanghai 200240," exact="China" post="collection: 2020epub: 2020-6-6111received: 2020-4-28accepted: 2020-5-06(C) Informa UK Limited, trading"/>
   <result pre="interactions molecular dynamics Funding Ministry of Science and Technology of" exact="China" post="Science and Technology Commission of Shanghai Municipality Natural Science"/>
   <result pre="and Technology of China, the National Natural Science Foundation of" exact="China" post="(Contract no. 61832019, 61503244), the Science and Technology Commission"/>
   <result pre="an inhibitor. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 100(23), 13190â€&quot;13195. 10.1073/pnas.183567510014585926 ZhangL., &amp;amp; LiuY. (2020)."/>
   <result pre="inhibitor. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="100(23), 13190â€&quot;13195. 10.1073/pnas.183567510014585926 ZhangL., &amp;amp; LiuY. (2020). Potential interventions"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7284148\results\search\country\results.xml">
   <result pre="Genetics, Department of Zoology, Aligarh Muslim University, Aligarh, 202002, UP," exact="India" post="collection: 2020epub: 2020-6-618received: 2020-4-22rev-recd: 2020-5-17accepted: 2020-5-17(C) Informa UK Limited,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7284455\results\search\country\results.xml">
   <result pre="severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan," exact="China" post="and rapidly spread worldwide, with a vast majority of"/>
   <result pre="and left-sided headache for 4â€‰days. He had just returned from" exact="Spain" post="the day before admission. On examination his lungs were"/>
   <result pre="middle east respiratory syndrome coronavirus infection: a single-center experience in" exact="Saudi Arabia." post="Int J Infect Dis2014; 29: 301â€&quot;306.25303830 19KimJEHeoJHKimHO, et al.Neurological"/>
   <result pre="of print 3132020 DOI: 10.1161/STROKEAHA.120.030023. 51BersanoAPantoniLOn being a neurologist in" exact="Italy" post="at the time of the COVID-19 outbreak. [published online"/>
   <result pre="al.Risk factors for pneumonia among patients with Parkinsonâ€™s disease: a" exact="Taiwan" post="nationwide population-based study. Neuropsychiatr Dis Treat2016; 12: 1037â€&quot;1046.27175081 62collab:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7286219\results\search\country\results.xml">
   <result pre="support this workÂ (Smith 2020). Pharmaceutical and biotechnology companies in" exact="China" post="have also stepped up to the development of vaccines"/>
   <result pre="been approved for phase I or II clinical trial in" exact="China" post="at the end of April of 2020. Several biotechnology"/>
   <result pre="the 2019-nCoV spike in the prefusion conformationScience20203671260126310.1126/science.abb250732075877 Xinhua net (2020)" exact="China" post="fast-tracks novel coronavirus vaccine development. http://www.xinhuanet.com/english/2020-01/28/c_138739562.htm. Accessed 20 Mar"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7286259\results\search\country\results.xml">
   <result pre="known as SARS coronaviruses (SARS-CoV) which infected 8422 people in" exact="China" post="and Hong Kong and caused 916 deaths with a"/>
   <result pre="SARS coronaviruses (SARS-CoV) which infected 8422 people in China and" exact="Hong Kong" post="and caused 916 deaths with a mortality rate of"/>
   <result pre="2012, almost a decade later, another bat-originated virus emerged in" exact="Saudi Arabia" post="and the transmission to humans was via dromedary camels."/>
   <result pre="(COVID-19). The outbreak was first reported in Wuhan, Hubei province," exact="China" post="in December 2019 (Wang et al., 2020). The intermediary"/>
   <result pre="#RG-1438-015. J. Lee thanks to 10.13039/501100002462Chungnam National University , Daejeon," exact="Republic of" post="Korea for the funding support. The authors thank the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7287466\results\search\country\results.xml">
   <result pre="[15], [25]. Populationally (Table1 ), during the SARS-CoV outbreak in" exact="China" post="2002â€&quot;2003 about 8096 cases were affected, approximately 90% of"/>
   <result pre="Print. 10WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan," exact="China" post="Geneva2020 [updated 9 January 202014 January 2020]. Available from:"/>
   <result pre="a descriptive studyLancet39510223202050751332007143 26CarterJohn B.SaundersVenetia A.Virology: principles and applications2013WileyHoboken, New" exact="Jersey" post="27Siegel JD, Rhinehart E, Jackson M, Chiarello L, and"/>
   <result pre="Pneumonia cases possibly associated with a novel coronavirus in Wuhan," exact="China" post="â€&quot; 9 January 2020. ECDC: Stockholm; 2020 (accessed Jan"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7287479\results\search\country\results.xml">
   <result pre="cases, and 103 deaths among inmates and correctional staff in" exact="the United States" post="(US) (Wallace, Hagan, &amp;amp; Curran, 2020), and over 56,000"/>
   <result pre="and 103 deaths among inmates and correctional staff in the" exact="United States" post="(US) (Wallace, Hagan, &amp;amp; Curran, 2020), and over 56,000"/>
   <result pre="cases and 987 deaths, globally (JusticeÂ Project Pakistan,Â 2020). In" exact="the US," post="jails and prisons are responsible for a large proportion"/>
   <result pre="water. Over a quarter of criminal justice involved populations in" exact="the US" post="are charged with a drug offense (Rabuy,Â 2016), and"/>
   <result pre="offense (Rabuy,Â 2016), and it is estimated that 65% of" exact="the US" post="prison population has a substance use disorder (â€œBehind Bars"/>
   <result pre="the number of people incarcerated (PrisonÂ Policy Initiative,Â 2020). In" exact="the US," post="all but four states have suspended or reduced medical"/>
   <result pre="temporary release of inmates, with approximately 35% of inmates in" exact="Iran" post="and 31% in Turkey on furlough (Pakes, 2020). The"/>
   <result pre="with approximately 35% of inmates in Iran and 31% in" exact="Turkey" post="on furlough (Pakes, 2020). The risk of COVID-19 does"/>
   <result pre="to trigger a fourth wave of opioid overdose deaths in" exact="the US." post="Nearly half of all harm reduction programs in the"/>
   <result pre="the US. Nearly half of all harm reduction programs in" exact="the US" post="report reduced services due to staff shortages and lack"/>
   <result pre="Project2020Retrieved from https://www.themarshallproject.org/2020/04/03/a-new-tactic-to-fight-coronavirus-send-the-homeless-from-jails-to-hotels WallaceMHaganLCurranKGCOVID-19 in Correctional and Detention Facilities â€&quot;" exact="United States," post="Februaryâ€&quot;April 2020MMWR Morb Mortal Wkly Rep69202058759010.15585/mmwr.mm6919e1externalicon32407300 WangZ.TangK.Combating COVID-19: Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7288766\results\search\country\results.xml">
   <result pre="are licensed under the identical terms. In the past decade," exact="India" post="has witnessed several outbreaks/epidemics (such as H1N1, H5N1, avian"/>
   <result pre="Zika and Nipah) which were successfully tackled with appropriate research1." exact="India" post="with its 1.3 billion population residing in densely populated"/>
   <result pre="Permission can be sought from the Drugs Controller General of" exact="India" post="(DCGI) for restricted use of combination drugs which are"/>
   <result pre="bioequivalence studies, bioavailability studies and ECs. Clinical Trials Registry of" exact="India" post="(CTRI) It is a public database to improve accountability"/>
   <result pre="to register all clinical trials on Clinical Trials Registry of" exact="India" post="(CTRI) Platform run by the National Institute of Medical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7289747\results\search\country\results.xml">
   <result pre="detected from the city of Wuhan in Hubei province in" exact="China" post="[1,2]. Reports say that most of the original cases"/>
   <result pre="contact with a local animal and seafood market of Wuhan," exact="China" post="[3,4]. Further, the detailed sequence analysis of the sample"/>
   <result pre="in phase I clinical trial at University Medical Center Hamburg-Eppendorf," exact="Germany" post="[98]. Studies involving relatively conserved N protein expressing MVA"/>
   <result pre="Journal of Pathology: A Journal of the Pathological Society of" exact="Great Britain" post="and Ireland20632005251259 20HeY.LiJ.DuL.YanX.HuG.ZhouY.JiangS.Identification and characterization of novel neutralizing epitopes"/>
   <result pre="in Chinese horseshoe batsProc. Natl. Acad. Sci.1033920051404014045 29BaizeS.PannetierD.OestereichL.RiegerT.KoivoguiL.MagassoubaN.F.SoropoguiB.SowM.S.KeÃ¯taS.De ClerckH.TiffanyA.Emergence of" exact="Zaire" post="Ebola virus disease in GuineaN. Engl. J. Med.3711520141418142524738640 30RiskiH.HoviT.Coronavirus"/>
   <result pre="gene expression by promoting host mRNA degradationProc. Natl. Acad. Sci." exact="U. S." post="A.103342006128851289016912115 114ItoN.MosselE.C.NarayananK.PopovV.L.HuangC.InoueT.PetersC.J.MakinoS.Severe acute respiratory syndrome coronavirus 3a protein is"/>
   <result pre="the Department of Zoology, Kumaun University SSJ Campus, Almora (Uttarakhand)," exact="India" post="and DST-FIST (Department of Science &amp;amp; Technology, India) grant"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7290442\results\search\country\results.xml">
   <result pre="COVID-19 laboratory confirmed cases is ~6.9% ranging from ~0.1% in" exact="Singapore" post="to ~16.3% in Belgium [4]. Whilst it is difficult"/>
   <result pre="is ~6.9% ranging from ~0.1% in Singapore to ~16.3% in" exact="Belgium" post="[4]. Whilst it is difficult to compare case fatality"/>
   <result pre="systems within each country. Clinical characteristics of SARS-CoV-2 patients from" exact="China" post="[5,6], South Korea [7], and the United States [8]"/>
   <result pre="each country. Clinical characteristics of SARS-CoV-2 patients from China [5,6]," exact="South Korea" post="[7], and the United States [8] have recently been"/>
   <result pre="of SARS-CoV-2 patients from China [5,6], South Korea [7], and" exact="the United States" post="[8] have recently been reported with fever, dry cough,"/>
   <result pre="SARS-CoV-2 patients from China [5,6], South Korea [7], and the" exact="United States" post="[8] have recently been reported with fever, dry cough,"/>
   <result pre="By combining both sequencing and RNA modification data, scientists in" exact="South Korea" post="have identified 41 potential RNA modification sites that could"/>
   <result pre="shortly [59]. Another vaccine that has entered clinical trials in" exact="China" post="has been developed by CanSino Biologics (Tianjin, China), the"/>
   <result pre="COVID-19 treatment with some success [73,74]. However, new data from" exact="China" post="cast doubt on the beneficial effect in seriously ill"/>
   <result pre="RNA-dependent RNA polymerase inhibitor developed by Fujifilm Toyama Chemical in" exact="Japan" post="that is safe and has been effective in other"/>
   <result pre="has been approved by the National Medical Products Administration of" exact="China" post="as the first anti-COVID-19 drug in the country [66]."/>
   <result pre="effect against the SARS-CoV-2 [83]. A multicenter clinical trial in" exact="China" post="has reported efficacy with amelioration of exacerbation of pneumonia"/>
   <result pre="agent during CRS observed in severely ill COVID-19 patients in" exact="China" post="and Italy with promising results [98,99]. COVID-19 patients treated"/>
   <result pre="CRS observed in severely ill COVID-19 patients in China and" exact="Italy" post="with promising results [98,99]. COVID-19 patients treated with Tocilizumab"/>
   <result pre="with promising results [98,99]. COVID-19 patients treated with Tocilizumab in" exact="China" post="showed marked improvement indicating that Tocilizumab potentially could be"/>
   <result pre="administration of tocilizumab in a COVID-19 patient with pneumonia in" exact="Italy" post="showed favorable changes of CT findings within 14 days"/>
   <result pre="SARS-CoV outbreak and informed the response to this pandemic in" exact="Hong Kong," post="Singapore, and Taiwan, for example. Genomic characterization will have"/>
   <result pre="for infectious diseases, flagged unusual infection related activity in Wuhan," exact="China" post="and reported the spread nine days before WHO officially"/>
   <result pre="genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in" exact="Italy" post="in January and February 2020: Additional clues on multiple"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7290740\results\search\country\results.xml">
   <result pre="collection at Wuhan Institute of Virology, Chinese Academy of Sciences," exact="China" post="and amplified from 10-day-old chicken embryos. The virus titers"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291183\results\search\country\results.xml">
   <result pre="virus. The sequence analysis of its RNA made available by" exact="China" post="in the public database showed that it is a"/>
   <result pre="this rate to increase to 5.8%. On the other hand," exact="South Korea" post="registered a death rate of 1% or less, while"/>
   <result pre="rate of 1% or less, while the death rate in" exact="Italy" post="seems to be, for now, several folds higher (Rosenbaum"/>
   <result pre="vaccine development to combat COVID-19. Current therapeutic options Till date," exact="the US" post="Food and Drug Administration (FDA) has approved an antiviral"/>
   <result pre="2015). A team of virologists led by SS Vasan from" exact="Australia" post="has already shown that these animals are susceptible to"/>
   <result pre="huge pressure to meet these demands. However, recent results from" exact="China" post="have shown that hACE2 mice do support SARS-CoV-2 infection"/>
   <result pre="a lack of disease model for coronavirus. CanSino Biologics from" exact="China" post="has also developed a replication-defective adenovirus expressing Spike protein"/>
   <result pre="led to deaths in humans with far less dosages in" exact="Great Britain." post="In another instance, to treat human autoimmune disease, a"/>
   <result pre="personal memoirRevista Cubana de Medicina Tropical20025417117915846943 HouserKVBroadbentAJGretebeckLVogelLLamirandeEWSuttonTBockKWMinaiMet al.Enhanced inflammation in" exact="New Zealand" post="white rabbits when MERS-CoV reinfection occurs in the absence"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291249\results\search\country\results.xml">
   <result pre="burden of influenza has been estimated at $11.2 billion in" exact="the United States" post="alone [174], and 294,000â€&quot;518,000 deaths are caused by flu-related"/>
   <result pre="of influenza has been estimated at $11.2 billion in the" exact="United States" post="alone [174], and 294,000â€&quot;518,000 deaths are caused by flu-related"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291320\results\search\country\results.xml">
   <result pre="severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan," exact="China" post="with further worldwide transmission to a pandemic outbreak. An"/>
   <result pre="similar to SARS-CoV [27,28]. According to the retrospective study from" exact="China" post="including 191 patients with COVID-19, the median time from"/>
   <result pre="storms in critically ill patients [8]. Large case series from" exact="China" post="including 72,314 patients with COVID-19 have indicated that the"/>
   <result pre="[32]. Recent investigation has demonstrated a higher mortality rate in" exact="Italy" post="(7.2%) than in China (2.3%), which could be due"/>
   <result pre="demonstrated a higher mortality rate in Italy (7.2%) than in" exact="China" post="(2.3%), which could be due to the older age"/>
   <result pre="which could be due to the older age distribution in" exact="Italy" post="relative to that in China [33]. Importantly, 3.8% of"/>
   <result pre="the older age distribution in Italy relative to that in" exact="China" post="[33]. Importantly, 3.8% of the whole cohort were health"/>
   <result pre="severe or critical [32]. Lately, increasing numbers of reports from" exact="the United States" post="(U.S.) have linked obesity to more severe COVID-19 illness"/>
   <result pre="or critical [32]. Lately, increasing numbers of reports from the" exact="United States" post="(U.S.) have linked obesity to more severe COVID-19 illness"/>
   <result pre="[33]. The high proportion of older patients with COVID-19 in" exact="Italy" post="(patients 70 years or older; 37.6% in Italy vs."/>
   <result pre="COVID-19 in Italy (patients 70 years or older; 37.6% in" exact="Italy" post="vs. 11.9% in China) was considered the main determinant"/>
   <result pre="previously referenced analysis of 44,672 confirmed COVID-19 cases from Wuhan," exact="China" post="were noted in patients with CVD (10.5%), DM (7.3%),"/>
   <result pre="by CT, indicating cardiac inflammation [55]. An early report from" exact="China" post="demonstrated that the late increase of hs-cTnI in nonsurvivors"/>
   <result pre="[7]. Moreover, the first description of critically ill patients from" exact="the United States" post="indicated that 33% of the ICU patients developed cardiomyopathy"/>
   <result pre="Moreover, the first description of critically ill patients from the" exact="United States" post="indicated that 33% of the ICU patients developed cardiomyopathy"/>
   <result pre="only one retrospective registry cohort of 25 COVID-19 patients in" exact="China" post="with CT pulmonary angiography suggested a high rate of"/>
   <result pre="required for virus/cell fusion [104]. A small single-arm study from" exact="France" post="has tested the effect of hydroxychloroquine (an analogue of"/>
   <result pre="into host cells [17]. This drug is clinically available in" exact="Japan" post="and is a promising agent to be further tested."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291595\results\search\country\results.xml">
   <result pre="has spread to approximately 184 regions and countries including Japan," exact="South Korea" post="and the USA, Africa, Europe and Australia [2]. As"/>
   <result pre="approximately 184 regions and countries including Japan, South Korea and" exact="the USA," post="Africa, Europe and Australia [2]. As of April 7,"/>
   <result pre="including Japan, South Korea and the USA, Africa, Europe and" exact="Australia" post="[2]. As of April 7, the total number of"/>
   <result pre="type of coronavirus was identified in Wuhan Hubei Province in" exact="China" post="[17]. The full genome of the novel coronavirus was"/>
   <result pre="and the Centers for Disease Control and Prevention (CDC) of" exact="America" post="[8]. It was named severe acute respiratory syndrome coronavirus"/>
   <result pre="virus SARS-CoV-2 was first reported to be from the South" exact="China" post="seafood market [17]. However, subsequent studies have shown that"/>
   <result pre="China, Japan, Korea, Italy, etc. 29 countries, including China, Vietnam," exact="Singapore" post="and Canada &amp;gt;27 countries, mainly in Saudi Arabia, South"/>
   <result pre="Korea, Italy, etc. 29 countries, including China, Vietnam, Singapore and" exact="Canada" post="&amp;gt;27 countries, mainly in Saudi Arabia, South Korea, Jordan"/>
   <result pre="including China, Vietnam, Singapore and Canada &amp;gt;27 countries, mainly in" exact="Saudi Arabia," post="South Korea, Jordan and Qatar [81] Natural reservoir Not"/>
   <result pre="Vietnam, Singapore and Canada &amp;gt;27 countries, mainly in Saudi Arabia," exact="South Korea," post="Jordan and Qatar [81] Natural reservoir Not identified Bat"/>
   <result pre="and Canada &amp;gt;27 countries, mainly in Saudi Arabia, South Korea," exact="Jordan" post="and Qatar [81] Natural reservoir Not identified Bat Bat"/>
   <result pre="&amp;gt;27 countries, mainly in Saudi Arabia, South Korea, Jordan and" exact="Qatar" post="[81] Natural reservoir Not identified Bat Bat [81] Receptor"/>
   <result pre="3%, a number closer to the official national statistics of" exact="China" post="(2.01%) [51]. These differences in mortality rates are possibly"/>
   <result pre="effective pan-CoV therapy. The first case of SARS-CoV-2 infection in" exact="the USA" post="was successfully treated with RDA. Moreover, a randomized, double-blind,"/>
   <result pre="influenza and has been widely used to inhibit COVID-19 in" exact="China" post="[45,70]. Other neuraminidase inhibitors, zanamivir and peramivir, are also"/>
   <result pre="the treatment of influenza and other respiratory viral infections in" exact="Russia" post="and China [72,73]. Blaising and coauthors consider ARB to"/>
   <result pre="of influenza and other respiratory viral infections in Russia and" exact="China" post="[72,73]. Blaising and coauthors consider ARB to be a"/>
   <result pre="storms. Tocilizumab (TCZ) has been used to treat COVID-19 in" exact="China" post="and Italy. TCZ was recommended for COVID-19 patients to"/>
   <result pre="&amp;amp; G). The COVID-19 outbreak poses a serious challenge to" exact="China" post="and the whole world; it has profoundly affected public"/>
   <result pre="of 2019 coronavirus disease (COVID-19 (A, B &amp;amp;Â C) in" exact="China" post="by province/region as of 7 April 2020. (D, E"/>
   <result pre="Certainly, vigorous measures to prevent contagion have been taken in" exact="China" post="and other countries. To prevent the spread of infection,"/>
   <result pre="H), and the number of recovered patients was 77,468 in" exact="China" post="(FigureÂ 3B). Therefore, we are confident that the outbreak"/>
   <result pre="Executive summary Coronavirus disease 2019 (COVID-19) was first reported in" exact="China" post="and currently poses a serious challenge worldwide. The pneumonia"/>
   <result pre="The research was supported by National Natural Science Foundation of" exact="China" post="(no. 81970738 and no.Â 81600157) and Key Research and"/>
   <result pre="al.Estimating the unreported number of novel coronavirus (2019-nCoV) cases in" exact="China" post="in the first half of January 2020: a data-driven"/>
   <result pre="(2016).27012512 12.KillerbyME , BiggsHM , HaynesAet al.Human coronavirus circulation in" exact="the United States" post="2014â€&quot;2017. J. Clin. Virol.101, 52â€&quot;56 (2018).29427907 13.WeversBA , VanDer"/>
   <result pre="12.KillerbyME , BiggsHM , HaynesAet al.Human coronavirus circulation in the" exact="United States" post="2014â€&quot;2017. J. Clin. Virol.101, 52â€&quot;56 (2018).29427907 13.WeversBA , VanDer"/>
   <result pre="of its spike protein for risk of human transmission. Sci." exact="China" post="Life Sci.63(3), 457â€&quot;460 (2020).32009228 36.MousavizadehL , GhasemiSGenotype and phenotype"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291979\results\search\country\results.xml">
   <result pre="ever. Frost later became the first â€œProfessor of epidemiologyâ€� in" exact="the United States." post="I am not aware of documents establishing the connection"/>
   <result pre="Frost later became the first â€œProfessor of epidemiologyâ€� in the" exact="United States." post="I am not aware of documents establishing the connection"/>
   <result pre="to a wave of smallpox inoculation, at least in the" exact="United Kingdom." post="In his 1747 nonrandomized trial on board, a naval"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7293492\results\search\country\results.xml">
   <result pre="and when governments with advanced health systems such as Australia," exact="New Zealand," post="South Korea, Hong Kong, Taiwan, and Singapore have already"/>
   <result pre="governments with advanced health systems such as Australia, New Zealand," exact="South Korea," post="Hong Kong, Taiwan, and Singapore have already flattened their"/>
   <result pre="advanced health systems such as Australia, New Zealand, South Korea," exact="Hong Kong," post="Taiwan, and Singapore have already flattened their curves. This"/>
   <result pre="as Australia, New Zealand, South Korea, Hong Kong, Taiwan, and" exact="Singapore" post="have already flattened their curves. This may point to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7293728\results\search\country\results.xml">
   <result pre="on mortality related to influenza between 1976 and 1999 in" exact="the USA," post="the highest mortality was associated with H3N2, followed by"/>
   <result pre="to be higher than that to H3N2 or H1N1 in" exact="China" post="[3]. Furthermore, influenza B virus caused more complications, including"/>
   <result pre="have been used historically for treatment of influenza-like illness in" exact="China" post="[13]. When a randomized, double-blind, positive-controlled clinical trial of"/>
   <result pre="Health, Li Ka Shing Faculty of Medicine, the University of" exact="Hong Kong," post="Hong Kong Special Administrative Region). All the viruses were"/>
   <result pre="Ka Shing Faculty of Medicine, the University of Hong Kong," exact="Hong Kong" post="Special Administrative Region). All the viruses were cultured in"/>
   <result pre="Pharmaceutical Co., Ltd. (Shijiazhuang, China), National Natural Science Foundation of" exact="China" post="(NSFC-FDCT-81661168012), Guangdong Science and Technology Department (2013B051000085), Engineering Technology"/>
   <result pre="B lineage circulation and hospitalization rates in a subtropical city," exact="Hong Kong," post="2000â€&quot;2010Clinical Infectious Diseases201256567768423074315 2ThompsonW. W.MooreM. R.WeintraubE.et al.Estimating influenza-associated deaths"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7293882\results\search\country\results.xml">
   <result pre="of trends of new cases within our reference regions of" exact="Italy" post="and New York. Florida began its upward trend a"/>
   <result pre="us as a practice. The maximum number of cases in" exact="Italy" post="was 6557 and the maximum number of cases in"/>
   <result pre="and low viral impact, relative to highly affected areas like" exact="Italy" post="and New York, a reversal of stay at home"/>
   <result pre="in areas of the high incidence of COVID-19, especially in" exact="Italy" post="and New York. For example, in Papa Giovanni XXIII"/>
   <result pre="to aid triage and management during the COVID-19 pandemic. Affiliation:" exact="Italy" post="submitting corresponding author: post-acceptance corresponding author 12.NasproRDa PozzoLFUrology in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7294848\results\search\country\results.xml">
   <result pre="Slobodan Paessler, The University of Texas Medical Branch at Galveston," exact="United States" post="Reviewed by: Maria Teresa Sanchez-Aparicio, Icahn School of Medicine"/>
   <result pre="Maria Teresa Sanchez-Aparicio, Icahn School of Medicine at Mount Sinai," exact="United States;" post="Ricardo Soto-Rifo, University of Chile, Chile *Correspondence: Lobelia Samavati"/>
   <result pre="at Mount Sinai, United States; Ricardo Soto-Rifo, University of Chile," exact="Chile" post="*Correspondence: Lobelia Samavati ay6003@wayne.edu Bruce D. Uhal bduhal@gmail.com This"/>
   <result pre="late 2019, the SARS-CoV-2 outbreak was first reported in Wuhan," exact="China" post="that later led to a true crisis worldwide (Huang"/>
   <result pre="dysfunction (Lu et al., 2020). Mortality related to SARS-CoV-2 in" exact="China" post="as reported by the WHO is about 3.4% (Guo"/>
   <result pre="indicate that a significant portion of SARS-CoV-2 related hospitalization in" exact="the USA" post="are below the age of 50 years. Given the"/>
   <result pre="metabolic diseases, including obesity, hypertension, cardiovascular diseases and diabetes in" exact="the US" post="population (Moore et al., 2017), this infection may cause"/>
   <result pre="MagagnoliJ.NarendranS.PereiraF.CummingsT.HardinJ. W.SuttonS. S.et al. (2020). Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covid-19. medRxiv. 10.1101/2020.04.16.20065920 MalhotraA.KangB. P.CheungS.OpawumiD.MeggsL. G."/>
   <result pre="Peer reviewed: metabolic syndrome prevalence by race/ethnicity and sex in" exact="the United States," post="National Health and Nutrition Examination Survey, 1988â€&quot;2012. Prev. Chronic"/>
   <result pre="reviewed: metabolic syndrome prevalence by race/ethnicity and sex in the" exact="United States," post="National Health and Nutrition Examination Survey, 1988â€&quot;2012. Prev. Chronic"/>
   <result pre="(2020). Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in" exact="Italy" post="and China. J. Infect. Dev. Ctries14, 125â€&quot;128. 10.3855/jidc.1260032146445 RajV."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7294857\results\search\country\results.xml">
   <result pre="Patients also show elevated C-reactive protein levels [16]. Researchers from" exact="China" post="studied the effect of infection on pregnant women suffering"/>
   <result pre="World Health Organizationhttps://apps.who.int/iris/handle/10665/331785 2Features, Evaluation and Treatment Coronavirus (COVID-19)CascellaMRajnikMCuomoADulebohnSCDi NapoliRTreasure" exact="Island" post="(FL): StatPearls Publishing; LLCStatPearls2020https://www.ncbi.nlm.nih.gov/books/NBK554776/ 3Clinical course and risk factors"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7295489\results\search\country\results.xml">
   <result pre="palm civet cats (Fig. 2) in the Guangdong province of" exact="China" post="and about 8422 infected cases with 916 deaths were"/>
   <result pre="2012, a bat origin virus MERS-CoV epidemic was emerged in" exact="Saudi Arabia" post="through the dromedary camels (Fig. 2) and caused 858"/>
   <result pre="diagnosed with concentrated pneumonia with an unknown etiology in Wuhan," exact="China" post="(Bogoch et al., 2020; Hui et al., 2019; Lu"/>
   <result pre="SARS-CoV-2 causing human pneumonia, was first detailed in Wuhan, Central" exact="China" post="(Paola et al., 2020). Coronaviruses are naturally hosted and"/>
   <result pre="the option of Favipiravir and Remdesivir which were trialed by" exact="China" post="and Japan but further studies are required (Fu et"/>
   <result pre="of Favipiravir and Remdesivir which were trialed by China and" exact="Japan" post="but further studies are required (Fu et al., 2020;"/>
   <result pre="the rhesus macaque model of MERS-CoV infectionProc. Natl. Acad. Sci." exact="U. S." post="A.1171220206771677610.1073/pnas.192208311732054787 DingY.WangH.ShenH.LiZ.GengJ.HanH.CaiJ.LiX.KangW.WengD.The clinical pathology of severe acute respiratory syndrome"/>
   <result pre="fatal case of Middle East respiratory syndrome coronavirus infection in" exact="the United Arab Emirates," post="April 2014Am. J. Pathol.1863201665265826857507 OzaslanMehmetSafdarMuhamadHalil KilicI.KhailanyRozhgar A.Practical measures to"/>
   <result pre="case of Middle East respiratory syndrome coronavirus infection in the" exact="United Arab Emirates," post="April 2014Am. J. Pathol.1863201665265826857507 OzaslanMehmetSafdarMuhamadHalil KilicI.KhailanyRozhgar A.Practical measures to"/>
   <result pre="genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in" exact="Italy" post="in January and February 2020: additional clues on multiple"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7295552\results\search\country\results.xml">
   <result pre="that a total of 1,787,680 people were COVID-19 positive in" exact="the USA," post="and there were totally 104,396 individuals lost their lives"/>
   <result pre="direct relationship of NSAID use and severe COVID-19. WHO and" exact="the United States" post="National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel"/>
   <result pre="relationship of NSAID use and severe COVID-19. WHO and the" exact="United States" post="National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel"/>
   <result pre="in 88.7% of the COVID-19 patients in a study in" exact="China" post="[13]. Acetaminophen is the recommended antipyretic in COVID-19. It"/>
   <result pre="[29]. Pros and cons Favipiravir is not available commercially in" exact="the USA." post="The safety and efficacy of the drug is not"/>
   <result pre="55]. Pros and cons During the 2005 SARS outbreak in" exact="Hong Kong," post="Cheng et al [56], have published the most extensive"/>
   <result pre="to guide treatment decisions at this point. Case series from" exact="Italy" post="by Monti et al [70] looked at the clinical"/>
   <result pre="lung injury. On the contrary, another single-center case series from" exact="Spain" post="by Fernandez-Ruiz et al [74] described their preliminary experience"/>
   <result pre="for most of them apart from the clinical trial from" exact="Hong Kong" post="which published results recently. A phase 2 clinical trial"/>
   <result pre="86 patients for 14 days for treatment of COVID-19 in" exact="Hong Kong." post="The treatment group took all the above medications while"/>
   <result pre="For example, currently, all routine surgical procedures are postponed across" exact="the US" post="healthcare systems. However, the availability of such testing capacity"/>
   <result pre="strategy. After several weeks of strict lockdown, many states in" exact="the USA" post="no longer has stay-at-home orders, testing capacity improved significantly"/>
   <result pre="as has been suggested possible from preliminary data available from" exact="South Korea" post="and Japan with similar approach. Unfortunately, the influence of"/>
   <result pre="suggested possible from preliminary data available from South Korea and" exact="Japan" post="with similar approach. Unfortunately, the influence of â€œlock-down fatigueâ€�"/>
   <result pre="from the American Heart Association, the Heart Failure Society of" exact="America" post="and the American College of Cardiology. Patients taking ACE-i"/>
   <result pre="to hydroxychloroquine-azithromycin treatment for COVID-19Cardiology2020 27MagagnoliJNarendranSPereiraFCummingsTHardinJWSuttonSSAmbatiJOutcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covid-19medRxiv202010.1101/2020.04.16.20065920 28Food and Drug Administration. https://www.fda.gov/media/137564/download"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7296089\results\search\country\results.xml">
   <result pre="Jean Struelens, European Centre for Disease Prevention and Control (ECDC)," exact="Sweden" post="*Correspondence: Ville Peltola ville.peltola@utu.fi This article was submitted to"/>
   <result pre="detect the onset of RSV season in different parts of" exact="Japan" post="with various climate conditions. Another interesting study on RSV"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7296288\results\search\country\results.xml">
   <result pre="have not been any new antifungals approved for use in" exact="the USA" post="since our last review in 2017. Some strains of"/>
   <result pre="Table 2 Select new FDA-approved antibiotics on the market in" exact="the USA" post="since year 2017 Google Scholar and Medscape Search [25â€&quot;27]"/>
   <result pre="new FDA-approved anti-tuberculosis drugs and antivirals on the market in" exact="the USA" post="since year 2017 Drug class Names and notes Indications"/>
   <result pre="agents appeared, used again in some European countries, China, and" exact="South Korea" post="[23] Ramoplanin Clostridium difficile Not absorbed from oral administration"/>
   <result pre="administration Minocycline MRSA Mecillinam [32] MDR Enterobacteriaceae Not available in" exact="the USA" post="Tetracyclines, Î²-lactams, microcyclics Neuroprotection in Parkinsonâ€™s disease [33] Exploring"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7296524\results\search\country\results.xml">
   <result pre="SARS-COV-2, lead to coronavirus disease 2019 (COVID-19). COVID-19 burst in" exact="China" post="and rapidly spread worldwide. Italy was the first European"/>
   <result pre="2019 (COVID-19). COVID-19 burst in China and rapidly spread worldwide." exact="Italy" post="was the first European country to be interested in"/>
   <result pre="affect childhood and adolescence scarcely, as very recently demonstrated in" exact="Italy" post="[88]. However, allergic and immunodeficient children and adolescents need"/>
   <result pre="Induc Dis2020182010.18332/tid/11932432206052 12.Guan WJ, Ni ZY, Hu Y, et al." exact="China" post="Medical Treatment Expert Group for Covid-19. Clinical Characteristics of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7297930\results\search\country\results.xml">
   <result pre="Kung University, [6], grid.412717.60000 0004 0532 2914Department of Biotechnology, Southern" exact="Taiwan" post="University of Science and Technology, epub: 2020-6-6110accepted: 2020-6-8(C) ,"/>
   <result pre="23]. In the first randomized and open-label trial conducted in" exact="China" post="among 199 COVID-19 patients treated with ritonavir/lopinavir, no differences"/>
   <result pre="recruited to evaluate the efficacy of favipiravir plus interferon-Î± in" exact="China" post="(ChiCTR2000029600) [33]. Based on the anticipated synergistic effect of"/>
   <result pre="pneumonia [53, 54]. A small open-label non-randomized clinical trial in" exact="France" post="demonstrated a positive effect of HCQ in combination with"/>
   <result pre="HCQ in combination with azithromycin [5]. Upon this finding, although" exact="the US" post="FDA issued an Emergency Use Authorization for hydroxychloroquine in"/>
   <result pre="SARS-CoV-2. Reducing viral copy numbers in SARS-CoV-2; Under debates between" exact="China" post="and France? Anti-malaria. Treatment of rheumatoid arthritis, lupus, and"/>
   <result pre="H, et al. First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med. 2020;382(10):929â€&quot;36. 12.Grein J, Ohmagari N,"/>
   <result pre="et al. First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med. 2020;382(10):929â€&quot;36. 12.Grein J, Ohmagari N,"/>
   <result pre="drugs that may act on the novel coronavirus (2019-nCoV), Wuhan," exact="China" post="through a drug-target interaction deep learning model. bioRxiv. 2020."/>
   <result pre="scabies treatment on the prevalence of head lice in Atoifi" exact="Solomon Islands." post="PLoS Negl Trop Dis. 2018;12(9):e0006825. 43.Beach MJ, Streit TG,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7297931\results\search\country\results.xml">
   <result pre="peculiar reasons, children and infants have generally been spared in" exact="Hong Kong," post="China until recently, when returning students from affected cities"/>
   <result pre="children and infants have generally been spared in Hong Kong," exact="China" post="until recently, when returning students from affected cities with"/>
   <result pre="there have been 111 confirmed pediatric cases of COVID-19 in" exact="Hong Kong," post="China consisting of 62 males and 49 females, aged"/>
   <result pre="been 111 confirmed pediatric cases of COVID-19 in Hong Kong," exact="China" post="consisting of 62 males and 49 females, aged between"/>
   <result pre="local imported cases were travelers returning from the UK and" exact="the USA" post="[1]. With over 1064 confirmed cases and four deaths,"/>
   <result pre="adult population at approximately 0.4% and even higher (3.7%) in" exact="the US" post="[1, 5, 6]. Table 1 Comparison of COVID-19 cases"/>
   <result pre="cases in the 0â€&quot;19Â years old of different cities/countriesa Variables" exact="Hong Kong," post="China [1] Mainland China [2] Singapore[3] Korea [4] USA"/>
   <result pre="the 0â€&quot;19Â years old of different cities/countriesa Variables Hong Kong," exact="China" post="[1] Mainland China [2] Singapore[3] Korea [4] USA [5,"/>
   <result pre="old of different cities/countriesa Variables Hong Kong, China [1] Mainland" exact="China" post="[2] Singapore[3] Korea [4] USA [5, 6] Italy [7]"/>
   <result pre="[1] Mainland China [2] Singapore[3] Korea [4] USA [5, 6]" exact="Italy" post="[7] United Kingdom[8] Spain[9] Total COVID-19 cases in the"/>
   <result pre="dInclude patientsâ€‰ Reports of children with confirmed COVID-19 in mainland" exact="China" post="have described mild cold-likeâ€‰ with/without â€‰gastrointestinal symptoms and suggest"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7298161\results\search\country\results.xml">
   <result pre="Review Article Overview of therapeutic drug research for COVID-19 in" exact="China" post="LiHeng12YangLi1LiuFei-fei12MaXin-na3HePei-lan1TangWei1TongXian-kunxktong@simm.ac.cn1ZuoJian-pingjpzuo@simm.ac.cn123[1], 0000000119573309grid.9227.eLaboratory of Immunopharmacology, Shanghai Institute of MateriaMedica, Chinese"/>
   <result pre="SARS-CoV-2 as of April 22. In response to this epidemic," exact="China" post="has issued seven trial versions of diagnosis and treatment"/>
   <result pre="a new type of unexplained pneumoniaÂ appeared in the South" exact="China" post="Seafood Wholesale Market in Wuhan, Hubei Province, but its"/>
   <result pre="and MERS-CoV [1]. After the alert of this new pathogen," exact="China" post="quickly took measures to completely block off Hubei Province"/>
   <result pre="in Fig. 2. Overview of COVID-19 drug-related clinical trials in" exact="China" post="Due to the sudden emergence of SARS-CoV-2, no specific"/>
   <result pre="such a short period of time, we can see that" exact="China" post="has responded to the epidemic in a timely manner"/>
   <result pre="twice a day [13]. Lopinavir/ritonavir Lopinavir was first approved in" exact="the United States" post="in 2000 for the treatment of HIV infection [20]."/>
   <result pre="a day [13]. Lopinavir/ritonavir Lopinavir was first approved in the" exact="United States" post="in 2000 for the treatment of HIV infection [20]."/>
   <result pre="A and B viruses, and it was first approved in" exact="Russia" post="[43]. It can inhibit the adhesion of viruses to"/>
   <result pre="inhibit RNA-dependent polymerase [52] and was approved for marketing in" exact="Japan" post="in 2014. It is used for antiviral treatment of"/>
   <result pre="EC50 of 0.77â€‰Î¼M [39]. Recently, the first COVID-19 patient in" exact="the United States" post="was treated with remdesivir on the 7th day of"/>
   <result pre="of 0.77â€‰Î¼M [39]. Recently, the first COVID-19 patient in the" exact="United States" post="was treated with remdesivir on the 7th day of"/>
   <result pre="Reports announced that up to 90% of COVID-19 patients in" exact="China" post="have been given Chinese patent medicine or TCM prescriptions."/>
   <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci2020634576032009228 2.ZhangNWangLDengXLiangRSuMHeCet al.Recent advances in the detection of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7299651\results\search\country\results.xml">
   <result pre="HistoryErasmus University Rotterdam Erasmus School of History, Culture and CommunicationRotterdamThe" exact="Netherlands" post="Correspondence to Dr Daniel R Curtis, History, Erasmus University"/>
   <result pre="Program for University Prominent Young and Middle-aged Teachers and Presidents," exact="China" post="Fundamental Research Funds for the Central Universities 30919013302 http://dx.doi.org/10.13039/501100003246Nederlandse"/>
   <result pre="recent survey evidence taken from the 2014â€&quot;2015 Ebola outbreak in" exact="Liberia" post="showed that respondents who expressed low trust in the"/>
   <result pre="seen in the victimisation of Chinese people in Chinatowns in" exact="the USA" post="during the Third Plague Pandemic outbreaks,27 and has manifested"/>
   <result pre="The film begins on â€˜day 2â€™ of the outbreak in" exact="Hong Kong" post="and then proceeds to show the spread of the"/>
   <result pre="is then sold by farmers to a chef in a" exact="Macau" post="casino. The failure to wash his hands while handling"/>
   <result pre="the viewer is taken from various locationsâ€&quot;Chicago and Minneapolis in" exact="the USA," post="where Beth travelled back to from Hong Kong, as"/>
   <result pre="Minneapolis in the USA, where Beth travelled back to from" exact="Hong Kong," post="as well as scenes of the infection unfolding in"/>
   <result pre="as well as scenes of the infection unfolding in London," exact="Hong Kong," post="Macau, and other parts of China such as Guangdong."/>
   <result pre="unfolding in London, Hong Kong, Macau, and other parts of" exact="China" post="such as Guangdong. As a global outbreak we are"/>
   <result pre="coincidence that the roots of the disease are seen in" exact="Macau" post="and Hong Kong, and the explanatory scene of how"/>
   <result pre="the roots of the disease are seen in Macau and" exact="Hong Kong," post="and the explanatory scene of how the disease unfolded"/>
   <result pre="same could be said of the WHO epidemiologist sent to" exact="Hong Kong" post="to find the origins of the MEV-1 pathogen. Although"/>
   <result pre="University Prominent Young and Middle-aged Teachers and Presidents, China; and" exact="the Netherlands" post="Organisation for Scientific Research (NWO) Vidi (grant no 016.Vidi.185.046)."/>
   <result pre="Prominent Young and Middle-aged Teachers and Presidents, China; and the" exact="Netherlands" post="Organisation for Scientific Research (NWO) Vidi (grant no 016.Vidi.185.046)."/>
   <result pre="Colonizing the Body: State Medicine and Epidemic Disease in Nineteenth-Century" exact="India" post="(Berkeley, CA: University of California Press). 3. Dwight Conquergood"/>
   <result pre="46, no. 2: 148. 4. Anon (2019b), â€œEbola: Attackers Kill" exact="DR Congo" post="Journalist Shining Light on Virus,â€� BBC News, November 3,"/>
   <result pre="no. 2: 148. 4. Anon (2019b), â€œEbola: Attackers Kill DR" exact="Congo" post="Journalist Shining Light on Virus,â€� BBC News, November 3,"/>
   <result pre="Fairhead (2017), â€œComparison of Social Resistance to Ebola Response in" exact="Sierra Leone" post="and Guinea Suggests Explanations Lie in Political Configurations Not"/>
   <result pre="of Social Resistance to Ebola Response in Sierra Leone and" exact="Guinea" post="Suggests Explanations Lie in Political Configurations Not Culture,â€� Critical"/>
   <result pre="â€œManufacturing Consent?: Media Messages in the Mobilization Against HIV/AIDS in" exact="India" post="and Lessons for Health Communication,â€� Health Communication 29, no."/>
   <result pre="and the Politics of Provisions from Early Modern Europe and" exact="China" post="to the Food Crisis of 2008,â€� The Journal of"/>
   <result pre="Nature567, no. 7749 (2019a), 433.10.1038/d41586-019-00892-630914813 collab: Anon â€œEbola: Attackers Kill" exact="DR Congo" post="Journalist Shining Light on Virus.â€� BBC News, 2019bhttps://www.bbc.com/news/world-africa-50283286. collab:"/>
   <result pre="no. 7749 (2019a), 433.10.1038/d41586-019-00892-630914813 collab: Anon â€œEbola: Attackers Kill DR" exact="Congo" post="Journalist Shining Light on Virus.â€� BBC News, 2019bhttps://www.bbc.com/news/world-africa-50283286. collab:"/>
   <result pre="and the Politics of Provisions from Early Modern Europe and" exact="China" post="to the Food Crisis of 2008.â€� The Journal of"/>
   <result pre="â€œManufacturing Consent?: Media Messages in the Mobilization against HIV/AIDS in" exact="India" post="and Lessons for Health Communication.â€� Health Communication29, no. 3"/>
   <result pre="and FairheadJames â€œComparison of Social Resistance to Ebola Response in" exact="Sierra Leone" post="and Guinea Suggests Explanations Lie in Political Configurations Not"/>
   <result pre="of Social Resistance to Ebola Response in Sierra Leone and" exact="Guinea" post="Suggests Explanations Lie in Political Configurations Not Culture.â€� Critical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7300441\results\search\country\results.xml">
   <result pre="MERSâ€�CoV infection. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 117(12), 6771â€&quot;6776. 10.1073/pnas.192208311732054787 Xu, Y., Jia, Z.,"/>
   <result pre="infection. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="117(12), 6771â€&quot;6776. 10.1073/pnas.192208311732054787 Xu, Y., Jia, Z., Zhou, L.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7300636\results\search\country\results.xml">
   <result pre="another public health crisis, the opioid epidemic, rages on throughout" exact="the United States" post="[2, 3]. In other parts of the world, the"/>
   <result pre="public health crisis, the opioid epidemic, rages on throughout the" exact="United States" post="[2, 3]. In other parts of the world, the"/>
   <result pre="and opioids has remained relatively stable; however, in Eastern Europe," exact="Russia" post="and Central Asia opiate use has increased [4]. In"/>
   <result pre="homelessness and frequent interaction with criminal justice systems [9]. In" exact="the United States" post="alone, approximately four million people experiencing homelessness cycle in"/>
   <result pre="and frequent interaction with criminal justice systems [9]. In the" exact="United States" post="alone, approximately four million people experiencing homelessness cycle in"/>
   <result pre="opioids due to closings of chemical manufacturing plants in Wuhan," exact="China" post="[13]. Rising nationalism evidenced by policies banning pharmaceutical and"/>
   <result pre="banning pharmaceutical and PPE exports, such as those instituted by" exact="the United States" post="and India [14], and border closings, such as those"/>
   <result pre="pharmaceutical and PPE exports, such as those instituted by the" exact="United States" post="and India [14], and border closings, such as those"/>
   <result pre="exports, such as those instituted by the United States and" exact="India" post="[14], and border closings, such as those implemented in"/>
   <result pre="[14], and border closings, such as those implemented in South" exact="America" post="[15], may decrease the availability of certain drugs, including"/>
   <result pre="social distancing needs of the single adult homeless population in" exact="the United States" post="on a given day during the COVIDâ€�19 pandemic [18]."/>
   <result pre="distancing needs of the single adult homeless population in the" exact="United States" post="on a given day during the COVIDâ€�19 pandemic [18]."/>
   <result pre="and naloxone has saved tens of thousands of lives in" exact="the United States" post="alone [21]; however, access to these harm reduction services"/>
   <result pre="naloxone has saved tens of thousands of lives in the" exact="United States" post="alone [21]; however, access to these harm reduction services"/>
   <result pre="makers in nations with high rates of opioid use, including" exact="Russia" post="and other Eastern European and Central Asian countries where"/>
   <result pre="MeringofM, et al. Two independent HIV epidemics in saint Petersburg," exact="Russia" post="revealed by molecular epidemiology. AIDS Res Hum Retroviruses. 2015;31(6):608â€&quot;14.25417740"/>
   <result pre="13LinthicumK. Coronavirus chokes the drug trade â€&quot; from Wuhan, through" exact="Mexico" post="and onto U.S. streets Los Angeles Times. 2020 [cited"/>
   <result pre="policy research.2020 [cited 2020 June 15]. Available from: https://voxeu.org/content/covidâ€�19â€�andâ€�tradeâ€�policyâ€�whyâ€�turningâ€�inwardâ€�wonâ€�tâ€�work 15GriffinO." exact="Colombia" post="to close borders to prevent spread of coronavirus. Reuters."/>
   <result pre="JarlaisDC. The Impact of COVIDâ€�19 on syringe services programs in" exact="the United States." post="AIDS Behav. 2020;1â€�3.30903450 17BlackM. How COVIDâ€�19 Is impacting people"/>
   <result pre="The Impact of COVIDâ€�19 on syringe services programs in the" exact="United States." post="AIDS Behav. 2020;1â€�3.30903450 17BlackM. How COVIDâ€�19 Is impacting people"/>
   <result pre="SteifK, KuhnR, ByrneT. Estimated emergency and observational/quarantine capacity need for" exact="the US" post="homeless population related to COVIDâ€�19 exposure by county; projected"/>
   <result pre="Narcan Kits Save Nearly 27,000 Lives: Community Antiâ€�Drug Coalitions of" exact="America" post="(CADCA); 2014 [cited 2020 June 15]. Available from: https://www.cadca.org/resources/cdcâ€�reportâ€�narcanâ€�kitsâ€�saveâ€�nearlyâ€�27000â€�lives"/>
   <result pre="2020;26(5):309â€&quot;13.32196391 24PriestKC, GorfinkelL, KlimasJ, JonesAA, FairbairnN, McCartyD. Comparing Canadian and" exact="United States" post="opioid agonist therapy policies. Int J Drug Policy. 2019;74:257â€&quot;65.30765118"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7300770\results\search\country\results.xml">
   <result pre="Contributions Socialâ€�economic impact of COVIDâ€�19 pandemic on aesthetic centers in" exact="Greece" post="BiskanakiFoteini1fbiskanaki@uniwa.grRallisÎ•fstathios1AndreouÎ•leni1SfiriÎ•leni1TertipiÎ�iki1KefalaVasiliki1[1], Department of Biomedical SciencesUniversity of West AtticaAthensGreece *"/>
   <result pre="Foteini Biskanaki, Academic Scholar Peloponnisou 14 Agioi Anargyroi Athens, 13562" exact="Greece" post="Email: fbiskanaki@uniwa.gr epub: 2020-5-510.1111/jocd.13517(C) , This article is being"/>
   <result pre="One hundred and fifthâ€�eight aesthetic centers from various areas of" exact="Greece" post="were participated in this study, and the questionnaires were"/>
   <result pre="bringâ€� with returning to â€œnormalcyâ€�. aesthetic center COVIDâ€�19 financial impact" exact="Greece" post="pandemic public health fig-count: table-count: page-count: word-count: This article"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7300956\results\search\country\results.xml">
   <result pre="of Nursing and Public Health, University of KwaZuluâ€�Natal, Durban, 4001," exact="South Africa." post="Email: anthonydzina@gmail.com; 219095120@stu.ukzn.ac.za epub: 2020-6-610.1002/jmv.26159(C) , This article is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7301781\results\search\country\results.xml">
   <result pre="doi: 10.1016/j.ajp.2020.102213102213 : Article Lockdown of 1.3 billion people in" exact="India" post="during Covid-19 pandemic: A survey of its impact on"/>
   <result pre="and social restrictions. On March 24, 2020, the Government of" exact="India" post="ordered a nationwide lockdown for 21 days, limiting movement"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7301795\results\search\country\results.xml">
   <result pre="the word, on February 21 the first person-to-person transmission in" exact="Italy" post="was reported (Spina et al., 2020). Here, we report"/>
   <result pre="harm/benefit balance (Wu et al., 2020a). The epidemiological situation in" exact="Italy" post="in February 2020 and the recommendations in use at"/>
   <result pre="Ebola virus infection in survivor and fatal cases occurred in" exact="Sierra Leone" post="during the 2014â€&quot;2016 outbreak in West AfricaViruses112019373Available at: https://www.mdpi.com/1999-4915/11/4/373"/>
   <result pre="coronavirus disease 2019 and influenza A: a report from IranArch" exact="Iran" post="Med23April (4)202023924310.34172/aim.2020.0432271596 KimD.QuinnJ.PinskyB.ShahN.H.BrownI.Rates of co-infection between SARS-CoV-2 and other"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7302922\results\search\country\results.xml">
   <result pre="7302922218 doi: 10.1007/s40495-020-00218-5 : Hot Topic COVID-19 Drug Treatment in" exact="China" post="FanLinzifelicitafan@163.com1JiangShuangjsjiang111@163.com1YangXinrongyangxinrongx@163.com1WangZhibinwzbmailbox@hljucm.net2YangChunjuanchunjuanyang@hrbmu.edu.cn1[1], grid.410736.70000 0001 2204 9268Department of Pharmaceutical Analysis and"/>
   <result pre="of Review An unprecedented outbreak of the novel coronavirus in" exact="China" post="(COVID-19) occurred in December 2019, and then engulfed the"/>
   <result pre="review, we summarize the drugs used for COVID-19 treatment in" exact="China" post="based on the emerging basic and clinical data. It"/>
   <result pre="is highly contagious and has rapidly spread to the entire" exact="China" post="and multiple other countries worldwide since then [4â€&quot;6]. On"/>
   <result pre="first novel coronavirus genome sequence to the National Bank of" exact="the US" post="National Center for Biotechnology Information (Acc. No. MN908947). After"/>
   <result pre="review, we summarized the drugs used for COVID-19 treatment in" exact="China" post="based on the emerging basic and clinical data. It"/>
   <result pre="drug developed by the research center for pharmaceutical chemistry of" exact="the Soviet Union." post="Arbidol exerts an antiviral effect by inhibiting the fusion"/>
   <result pre="developed by the research center for pharmaceutical chemistry of the" exact="Soviet Union." post="Arbidol exerts an antiviral effect by inhibiting the fusion"/>
   <result pre="polymerase (RdRp) inhibitor which was developed by Gilead Sciences in" exact="the USA" post="[60, 61]. Accumulating evidence indicates that remdesivir could inhibit"/>
   <result pre="and treatment process of the first SARS-CoV-2 infected patient in" exact="the USA," post="showing that remdesivir has a certain role in the"/>
   <result pre="[32]. Currently, remdesivirâ€™s clinical trials have been officially launched in" exact="China" post="that a total of 761 patients are planned to"/>
   <result pre="as human immunoglobulin and intestinal microecological regulator. Some researchers in" exact="China" post="have suggested that human immunoglobulins can be selectively used"/>
   <result pre="is still the main direction of treatment. Up to now," exact="China" post="has made a great breakthrough in fighting against COVID-19,"/>
   <result pre="great breakthrough in fighting against COVID-19, but the situation outside" exact="China" post="is not optimistic. The Chinese Health Commission has established"/>
   <result pre="coronavirus epidemic. Conclusions The drugs used for COVID-19 treatment in" exact="China" post="based on the emerging basic and clinical data were"/>
   <result pre="the Scientific Research Project of National Natural Science Foundation of" exact="China" post="(Nos. 81872979 and 81973439). Compliance with Ethical Standards Conflict"/>
   <result pre="Interim Clinical Guidance for the 2019 Novel coronavirus outbreak -" exact="United States," post="December 31, 2019-February 4, 2020MMWR Morb Mortal Wkly Rep202069514014632027631"/>
   <result pre="StatPearls, StatPearls Publishing. Copyright Â© 2020, StatPearls Publishing LLC: Treasure" exact="Island" post="(FL), 2020. 81.ShafiHReddyDVSKhanTRanjanRSrivastavaAVaishyaSSharmaTSiddiquiMIHabibSMisraADehydroascorbate-derivatized chitosan particles for targeting antimalarial agents"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7303642\results\search\country\results.xml">
   <result pre="of a large randomized controlled trial (RCT) conducted in the" exact="United Kingdom" post="revealed reduced 28-day mortality and hospital length of stay"/>
   <result pre="with Covid-19N Engl J Med3822520202411241832379955 29MagagnoliJ.NarendranS.PereiraF.Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covid-19 [preprint]medRxiv202010.1101/2020.04.16.20065920 30TangW.CaoZ.HanM.Hydroxychloroquine in patients mainly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7303804\results\search\country\results.xml">
   <result pre="Ten years later, in 2012, the MERS coronavirus appeared in" exact="Saudi Arabia." post="It was passed on to humans from the camels"/>
   <result pre="the media and the public. But then the President of" exact="the USA," post="Mr Donald Trump, also made a public statement saying"/>
   <result pre="the report of an international panel of experts who visited" exact="China" post="[12]. They looked at the cases across China that"/>
   <result pre="who visited China [12]. They looked at the cases across" exact="China" post="that were reported after February the 1st. At this"/>
   <result pre="ie, 0.5%-1%. Because of all of the above, President of" exact="the USA" post="Donald Trump was most likely right to say that"/>
   <result pre="newly infected people will increase from 100â€‰000 to 800â€‰000. When" exact="China" post="realised that the COVID-19 epidemic was out of control"/>
   <result pre="Everything stopped [12]. However, this measure produced excellent results and" exact="China" post="could keep its death toll below 5000, although the"/>
   <result pre="Health Organisationâ€™s commission made up of 25 international experts visiting" exact="China" post="concluded the following: â€œChinaâ€™s bold approach to contain the"/>
   <result pre="The reason why the death toll among infected people in" exact="Italy" post="appears to be very high is because the disease"/>
   <result pre="of COVID-19 rather than its epidemiology. For now, clinicians in" exact="China" post="have reported that registered infected people report to the"/>
   <result pre="The author is scientific advisor to the Government of the" exact="Republic of Croatia" post="for COVID-19 response and co-Editor-in-Chief of the â€œJournal of"/>
   <result pre="is scientific advisor to the Government of the Republic of" exact="Croatia" post="for COVID-19 response and co-Editor-in-Chief of the â€œJournal of"/>
   <result pre="bat origin.Nature. 2020;579:270-3. 10.1038/s41586-020-2012-732015507 5Cyranoski D. Did pangolins spread the" exact="China" post="coronavirus to people? Nature. 2020. Available: https://www.nature.com/articles/d41586-020-00364-2. Accessed: 7"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7305479\results\search\country\results.xml">
   <result pre="in 2008, 68% of influenza A (H1N1) virus isolates in" exact="Norway" post="were resistant to oseltamivir [6]. The third group of"/>
   <result pre="363, eaar6221. 8AndronovaV.L.SkorobogatyiM.V.ManasovaE.V.BerlinY.A.KorshunV.A.GalegovG.A.Russ. J. Bioorg. Chem20032926226610.1023/A:1023936516589 9VincentM.R.ColpittsC.C.UstinovA.V.MuqadasM.JoyceM.A.BarsbyN.L.EpandR.F.EpandR.M.KhramyshevS.A.ValuevaO.A.KorshunV.A.TyrrellD.L.J.SchangL.M.Proc. Natl. Acad. Sci." exact="U. S." post="A.2010107173391734410.1073/pnas.101002610720823220 10ColpittsC.C.UstinovA.V.EpandR.F.EpandR.M.KorshunV.A.SchangL.M.J. Virol2013873640365410.1128/JVI.02882-1223283943 11SpeerstraS.ChistovA.A.ProskurinG.V.AralovA.V.UlashchikE.A.StreshnevP.P.ShmanaiV.V.KorshunV.A.ShangL.M.Antivir. Res201814916417310.1016/j.antiviral.2017.11.01829191427 12OrlovA.A.ChistovA.A.KozlovskayaL.I.UstinovA.V.KorshunV.A.KarganovaG.G.OsolodkinD.I.Med. Chem. Commun2016749549910.1039/C5MD00538H 13HakobyanA.GalindoI.NanezA.ArabyanE.KaralyanZ.ChistovA.A.StreshnevP.P.KorshunV.A.AlonsoC.ZakaryanH.J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7305759\results\search\country\results.xml">
   <result pre="illness in Wuhan, the capital of Hubei Province in the" exact="People's Republic of China." post="Soon afterward, authorities reported a novel coronavirus as the"/>
   <result pre="in Wuhan, the capital of Hubei Province in the People's" exact="Republic of" post="China. Soon afterward, authorities reported a novel coronavirus as"/>
   <result pre="2020). A population genetic analysis of 103 SARS-CoV-2 genomes from" exact="China" post="revealed that the causative agent of COVID-19 consists of"/>
   <result pre="for males was significantly more than that for females in" exact="China" post="and Italy) (Liang etÂ al., 2020; Onder et al.,"/>
   <result pre="still ongoing. No specific therapy for COVID-19 is approved by" exact="the US" post="Food and Drug Administration (FDA) so far, but many"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7305919\results\search\country\results.xml">
   <result pre="pulmonary emboli. Despite routine thromboprophylaxis, studies from France, Italy, and" exact="the Netherlands" post="report VTE in 35â€&quot;47% of ICU-treated patients.16 The British"/>
   <result pre="emboli. Despite routine thromboprophylaxis, studies from France, Italy, and the" exact="Netherlands" post="report VTE in 35â€&quot;47% of ICU-treated patients.16 The British"/>
   <result pre="agents are required to facilitate mechanical ventilation. Early reports from" exact="China" post="indicated a high incidence of other neurological complications in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306310\results\search\country\results.xml">
   <result pre="(NCT04338360). Various countries have been implicated in these studies, including" exact="the USA," post="China, Colombia, Iran, Italy, Mexico, and the Netherlands. If"/>
   <result pre="studies, including the USA, China, Colombia, Iran, Italy, Mexico, and" exact="the Netherlands." post="If completed, these studies would examine a minimum total"/>
   <result pre="is warranted.29 In accordance to the Infectious Diseases Society of" exact="America" post="Guidelines on the treatment and management of patients with"/>
   <result pre="disease. For instance, there is anecdotal evidence that in Northern" exact="Italy" post="among 60 volunteer blood donors in the town of"/>
   <result pre="30.ChengYWongRSooYOet al.Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur J Clin Microbiol Infect Dis.2005;24:44â€&quot;46.15616839 31.ChenLXiongJBaoLet al.Convalescent plasma"/>
   <result pre="serious infections. Crit Care Med.2010;38(4 Suppl):e66â€&quot;e73.20154602 39.The Globe and Mail." exact="Canada" post="begins clinical trial of experimental COVID-19 treatment using plasma"/>
   <result pre="Morgan RL, Shumaker AH, et al. Infectious Diseases Society of" exact="America" post="Guidelines on the Treatment and Management of Patients with"/>
   <result pre="08, 2020. 50.FelberBKPavlakisGNHIV vaccine: better to start together?Lancet HIV.2019;6:e724â€&quot;e725.31601543 51.Xinhuanet." exact="China" post="puts 245 COVID-19 patients on convalescent plasma therapy. 2020;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306893\results\search\country\results.xml">
   <result pre="Medicine0924-64791878-6847 0924-6479 IOS PressNieuwe Hemweg 6B, 1013 BG Amsterdam, The" exact="Netherlands" post="JRS201017 doi: 10.3233/JRS-201017 : Article Commentary Coronavirus drugs: Using"/>
   <result pre="illness cases with unknown etiology has been reported in Wuhan," exact="China" post="[9]. On January 7, 2020, Chinese authorities confirmed that"/>
   <result pre="the Ebola virus (EBO) outbreak in 1995 in Kikwit, the" exact="Democratic Republic of Congo." post="Eight patients were transfused with blood donated by five"/>
   <result pre="Ebola virus (EBO) outbreak in 1995 in Kikwit, the Democratic" exact="Republic of" post="Congo. Eight patients were transfused with blood donated by"/>
   <result pre="reemerged arbovirus responsible for a massive outbreak of infections in" exact="India" post="and has a vast potential to spread globally because"/>
   <result pre="other CoVs epidemics: SARS-CoV in Guandong, China, and MERS-CoV in" exact="Saudi Arabia." post="Since these CoVs have a zoonotic origin and host"/>
   <result pre="who were given CP at the Prince of Wales Hospital," exact="Hong Kong" post="in 2003, where the higher discharge rate was observed"/>
   <result pre="ChengG. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="European Journal of Clinical Microbiology and Infectious Diseases. 2005."/>
   <result pre="relative of human middle east respiratory syndrome coronavirus in bat," exact="South Africa." post="Emerging Infectious Diseases. 2013. doi:10.3201/eid1910.130946. [11]KoJH, HyeriS, ChoSY, HaYE,"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospital. Journal of Antimicrobial Chemotherapy. 2005. doi:10.1093/jac/dki346."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306998\results\search\country\results.xml">
   <result pre="clinical trials. A consistent finding in early case series in" exact="China" post="and New York City is an association between elevations"/>
   <result pre="thrombosis. Supporting this enthusiasm was a recent retrospective study in" exact="China" post="in which VTE prophylaxic dose heparin was associated with"/>
   <result pre="therapeutic anticoagulation in patients with significantly elevated D-dimer both in" exact="Italy" post="and in the US. While heparin offers both anti-inflammatory"/>
   <result pre="patients with significantly elevated D-dimer both in Italy and in" exact="the US." post="While heparin offers both anti-inflammatory and anticoagulant effects, the"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N Engl J Med2012; 367: 1814â€&quot;1820.23075143 14collab: World Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307057\results\search\country\results.xml">
   <result pre="coronavirus outbreaks have occurred: 1. SARS starting in 2002 in" exact="China" post="due to SARSâ€�CoV; 2. MERS starting in 2012 in"/>
   <result pre="China due to SARSâ€�CoV; 2. MERS starting in 2012 in" exact="Saudi Arabia" post="due to MERSâ€�CoV; 3. Covidâ€�19 due to SARSâ€�CoVâ€�2 starting"/>
   <result pre="3. Covidâ€�19 due to SARSâ€�CoVâ€�2 starting in 2019 in Wuhan," exact="China" post="(1).Â Both betaâ€�coronaviruses, SARSâ€�CoV and MERSâ€�CoV caused a severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307799\results\search\country\results.xml">
   <result pre="of Global Health jogh-10-010372 doi: 10.7189/jogh.10.010372 : Viewpoints COVID-19: Could" exact="India" post="still escape? RammohanAshwinRelaMohamed[], Correspondence to: Dr. Ashwin Rammohan The Institute of"/>
   <result pre="addressed previously, and our manuscript critically analyzes the reasons why" exact="India" post="could still come out of the COVID-19 pandemic relatively"/>
   <result pre="to be a reporting bias, with many more cases in" exact="India" post="that have not been detected [1-3]. Although it is"/>
   <result pre="it is indeed notable that notwithstanding an initial sluggish approach," exact="India" post="has been testing over 100â€‰000 samples a day [4]."/>
   <result pre="numbers close to those of the western countries, given that" exact="India" post="has 20% of the worldâ€™s population, it may not"/>
   <result pre="mortality rate as a surrogate yardstick for numbers, rates in" exact="India" post="are among the lowest in the world (India 3.1%"/>
   <result pre="are among the lowest in the world (India 3.1% vs" exact="China" post="5.6%, USA 6% and global average 6.5%) [2,5,6]. It"/>
   <result pre="the COVID-19 lockdown measures [2,6]. Certain other countries like Singapore," exact="Germany" post="and South Korea too have shown low mortality rates,"/>
   <result pre="lockdown measures [2,6]. Certain other countries like Singapore, Germany and" exact="South Korea" post="too have shown low mortality rates, however their deaths/million"/>
   <result pre="returned from Italian ski-trips and were naturally healthier and younger." exact="Germany" post="also has successfully been able to insulate their vulnerable"/>
   <result pre="of sufficient ICU beds and respirators [7]. The scenario in" exact="India" post="could not be more distinct from that of Germany."/>
   <result pre="consists of an explosive increase numbers, as observed in Italy," exact="Iran" post="and Spain has been conspicuous by its absence in"/>
   <result pre="an explosive increase numbers, as observed in Italy, Iran and" exact="Spain" post="has been conspicuous by its absence in India. Consequent"/>
   <result pre="of quick and strict efforts right from the start, has" exact="India" post="indeed managed to so far escape the worst? Complacency"/>
   <result pre="has not caused the same degree of damage so far." exact="India" post="has a decent track record with epidemics, it has"/>
   <result pre="in 2016, mass community health drives are not new to" exact="India" post="[8]. Malaria is endemic and antimalarials like Chloroquine are"/>
   <result pre="could have played a role in serendipitously controlling the disease." exact="India" post="is one of the worldâ€™s largest producers of generic"/>
   <result pre="that if, in fact the above hypotheses are wrong, then" exact="India" post="with its archaic public health system, one of the"/>
   <result pre="It will be an economic and social disaster, from which" exact="India" post="might take decades to come out of. India has"/>
   <result pre="from which India might take decades to come out of." exact="India" post="has also been proactive in announcing preventive measures. It"/>
   <result pre="being mandatory. Indians stranded across the world from Wuhan to" exact="Maldives" post="have been evacuated, quarantined, tested and discharged when negative."/>
   <result pre="the civic, health and other essential services; completely shutting down" exact="India" post="Inc. Religious places, schools and universities have closed, so"/>
   <result pre="burning issues, to drive the pathways of discovery and recovery." exact="India" post="appears to have taken bold pre-emptive steps in this"/>
   <result pre="control.Lancet Infect Dis. 2020;20:544. 10.1016/S1473-3099(20)30300-532311328 12Smith E. Jim Oâ€™Neill praises" exact="China" post="governmentâ€™s virus response: â€˜Thank God this didnâ€™t start in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307801\results\search\country\results.xml">
   <result pre="individuals already affected by other pathologies. Epidemiological data collected in" exact="Italy" post="at the time of this article shows that 95%"/>
   <result pre="[21]. A recent meta-analysis of thirteen retrospective studies conducted in" exact="China" post="(on a total of 3027 patients) has shown that"/>
   <result pre="disease (ORâ€‰=â€‰5.15) [22]. Another meta-analysis of six studies conducted in" exact="China" post="(on a total of 1558 patients) confirmed that the"/>
   <result pre="al.The epidemiology of severe acute respiratory syndrome in the 2003" exact="Hong Kong" post="epidemic: an analysis of all 1755 patients.Ann Intern Med."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307812\results\search\country\results.xml">
   <result pre="Stancioiu, Bio-Forum Foundation, Splai Unirii Nr 8, Parter, 030121 Bucharest," exact="Romania" post="E-mail: felicians@bio-forum.net ppub: 2020-8epub: 2020-6-6pmc-release: 2020-6-6462489508received: 2020-5-15accepted: 2020-6-09(C) ,"/>
   <result pre="49.0%. Similar data were published by other authors on the" exact="China" post="epidemic (2,3); another analysis (4) identified 3 biological markers"/>
   <result pre="Europe there was a higher rate of severe cases in" exact="Italy" post="(5,6) where 12% of positive patients were admitted to"/>
   <result pre="proportion of elderly and increased social contact (7,8). Data from" exact="Germany" post="(9) showed that ~1/3 of admitted patients had leucopenia"/>
   <result pre="in a small number of patients, with unclear significance. In" exact="the USA," post="a recent publication showed that a majority (71%) of"/>
   <result pre="There is already an extensive clinical experience with ARDS in" exact="the USA," post="where &amp;gt;180,000 patients annually are admitted with this pathology"/>
   <result pre="Agents Chemother5848754884201410.1128/AAC.03011-1424841269 18CascellaMRajnikMCuomoADulebohnSCDi NapoliRFeatures, evaluation and treatment coronavirus (COVID-19)StatPearls [Internet]Treasure" exact="Island" post="(FL)StatPearls Publishing20201https://www.ncbi.nlm.nih.gov/books/NBK554776 19NeaguMBostanMConstantinCProtein microarray technology: Assisting personalized medicine in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307834\results\search\country\results.xml">
   <result pre="Correspondence to: Dr Ronald N. Kostoff, School of Public Policy," exact="Georgia" post="Institute of Technology, Gainesville, VA 20155, USA E-mail: rkostoff@gmail.com"/>
   <result pre="Laboratory of Toxicology, Medical School, University of Crete, 70013 Heraklion," exact="Greece" post="E-mail: tsatsaka@uoc.gr ppub: 2020-8epub: 2020-6-6pmc-release: 2020-6-6462463466received: 2020-5-28accepted: 2020-6-11(C) ,"/>
   <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci" exact="China" post="Life Sci63364374202010.1007/s11427-020-1643-832048163 3MoPXingYXiaoYDengLZhaoQWangHXiongYChengZGaoSLiangKet al.Clinical characteristics of refractory COVID-19 pneumonia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309195\results\search\country\results.xml">
   <result pre="The drugs were unregulated and sold to the public in" exact="the USA" post="and many parts of the world. To protect the"/>
   <result pre="the sale of misbranded, mislabeled and/or adulterated foods and drugs," exact="the US" post="in 1906 enacted [1] the â€œPure Food and Drug"/>
   <result pre="of life; and (vi) the patient can be treated in" exact="the USA" post="with valuable family time, more comfort and fewer risks"/>
   <result pre="between US$ 1.9â€&quot;2.5 billion [7, 8]. On the other hand," exact="China" post="for almost two decades approved a number of experimental"/>
   <result pre="in oncology through strategic partnerships [33]. Examples of programs in" exact="the USA" post="include: the National Center for Advancing Translational Sciences (NCATS)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309305\results\search\country\results.xml">
   <result pre="in Molecular Cell Science, University of Science and Technology of" exact="China" post="(USTC), Collaborative Innovation Center of Genetics and DevelopmentChina[f], State"/>
   <result pre="and Biotechnology, Shanghai Jiao Tong UniversityP.R. China[g], Peng Cheng LaboratoryP.R." exact="China" post="CONTACT Dong-Qing Wei dqwei@sjtu.edu.cnState Key Lab of Microbial Metabolism,"/>
   <result pre="Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240," exact="China" post="collection: 2020epub: 2020-6-6112received: 2020-4-14accepted: 2020-6-03(C) Informa UK Limited, trading"/>
   <result pre="binding free energy Funding Ministry of Science and Technology of" exact="China" post="National Natural Science Foundation of China Joint Research Funds"/>
   <result pre="Science and Technology of China National Natural Science Foundation of" exact="China" post="Joint Research Funds for Medical and Engineering Scientific Research"/>
   <result pre="and Technology of China, the National Natural Science Foundation of" exact="China" post="(Contract no. 61832019, 61503244), the Natural Science Foundation of"/>
   <result pre="horseshoe bats. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 102(39), 14040â€&quot;14045. 10.1073/pnas.050673510216169905 LeeN., HuiD., WuA., ChanP.,"/>
   <result pre="bats. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="102(39), 14040â€&quot;14045. 10.1073/pnas.050673510216169905 LeeN., HuiD., WuA., ChanP., CameronP., JoyntG."/>
   <result pre="(2003). A major outbreak of severe acute respiratory syndrome in" exact="Hong Kong." post="The New England Journal of Medicine, 348(20), 1986â€&quot;1994. 10.1056/NEJMoa03068512682352"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="The New England Journal of Medicine, 367(19), 1814â€&quot;1820. 10.1056/NEJMoa121172123075143"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309518\results\search\country\results.xml">
   <result pre="with viral epidemics or pandemics, including H1N1, swine flu A/New" exact="Jersey" post="influenza strain, arthropod-borne flaviviruses, such as the West Nile"/>
   <result pre="and 6 nurses treating her GBS were put on isolation." exact="Italy" post="has just reported 6 patients with GBS,8 1 in"/>
   <result pre="1 died. The third series refers to 2 men from" exact="Spain" post="who, 3â€&quot;5 days after experiencing low-grade fever, malaise, anosmia,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309685\results\search\country\results.xml">
   <result pre="the SARS epidemic, a research team from the University of" exact="Hong Kong" post="warned the scientific community that â€œthe presence of a"/>
   <result pre="little do with Frank Fennerâ€™s classic study of myxomatosis in" exact="Australia" post="in the 1950s, but, as Honigsbaum and Anderson show,"/>
   <result pre="The result was that by the time Fenner returned to" exact="Australia" post="in 1950 and renewed his association with Burnet he"/>
   <result pre="transmission of the myxoma virus, which had been introduced to" exact="Australia" post="a few years earlier in an effort to curb"/>
   <result pre="Nicolle in Tunis, and even visited the Pasteur Institute in" exact="Tunisia" post="on the eve of the First World War (see"/>
   <result pre="the History of Biology201750235739110.1007/s10739-016-9441-z27098776 JonesSAmraminaAEntangled histories of plague ecology in" exact="Russia" post="under the USSRHistory and Philosophy of the Life Sciences201810.1007/s40656-018-0220-3"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7310596\results\search\country\results.xml">
   <result pre="of 29 May 2020, the total number of cases in" exact="the US" post="was 1,719,827, including 101,711 deaths [3]. The first case"/>
   <result pre="deaths [3]. The first case of COVID-19 was reported in" exact="the US" post="on 30 January 2020, and, since then, more than"/>
   <result pre="infection) First reported case to the WHO Country Office in" exact="China" post="on 31 December 2019 On 20 January 2020, the"/>
   <result pre="positive test for 2019-nCoV, by rRT-PCR, in an individual in" exact="the US" post="In a meeting on 30 January 2020, per the"/>
   <result pre="[22, 23] are also less common. The initial experience from" exact="China" post="suggests that approximately 81% of infected patients experience mild"/>
   <result pre="CVD/CAD % of other cardiac diseasesa Chen et al. [30]" exact="China" post="January 2020 99 55.1 68 32 NA 12 40"/>
   <result pre="68 32 NA 12 40 NA Huang et al. [13]" exact="China" post="January 2020 41 49 73 27 15 20 15"/>
   <result pre="73 27 15 20 15 NA Zhang et al. [31]" exact="China" post="February 2020 140 57 50.7 49.3 30 12.1 5"/>
   <result pre="50.7 49.3 30 12.1 5 3.6 Wang et al. [32]" exact="China" post="March 2020 339 69 49 51 40.8 16 15.7"/>
   <result pre="49 51 40.8 16 15.7 NA Wu et al. [33]" exact="China" post="March 2020 280 43.1 53.93 46.07 NA 12.14d 20.4"/>
   <result pre="53.93 46.07 NA 12.14d 20.4 NA Zhou et al. [17]" exact="China" post="March 2020 191 56 62 38 30 19 8"/>
   <result pre="62 38 30 19 8 NA Chen et al. [34]" exact="China" post="March 2020 274 62 62.4 37.6 34 17 8"/>
   <result pre="62.4 37.6 34 17 8 NA Liang et al. [35]" exact="China" post="March 2020 1590 48.9 57.3 42.7 16.9 8.2 3.7"/>
   <result pre="31.7 68.3 67.3 31.7 60.4 NA Cao et al. [37]" exact="China" post="April 2020 102 54 52 48 27.5 10.8 4.9"/>
   <result pre="48 27.5 10.8 4.9 14.7b; 17.6c Shao et al. [38]" exact="China" post="April 2020 136 69 66.2 33.8 30.2 20 11"/>
   <result pre="60.6 39.4 50.1 25.2 13.7 7.4 Grasselli et al. [41]" exact="Italy" post="April 2020 1591 63 82 18 49 17 21"/>
   <result pre="week before demise [49]. A meta-analysis of 341 patients in" exact="China" post="confirmed the findings of these studies, reinforcing the importance"/>
   <result pre="the QTc interval, dose adjustments may be necessary [65]. Recently," exact="the US" post="FDA has mentioned the risk of this combination therapy"/>
   <result pre="(HTN) [16]. Indeed, a meta-analysis (nâ€‰=â€‰46,248) including eight studies from" exact="China" post="demonstrated that the most common cardiac comorbidity was HTN"/>
   <result pre="recent analysis showed a 38% decrease in primary PCI in" exact="the US" post="during the COVID-19 pandemic, which is partly attributable to"/>
   <result pre="Similarly, a significant decrease in ACS-related hospitalization rates across northern" exact="Italy" post="has been noted [108]. Interestingly, the incidence of out-of-hospital"/>
   <result pre="powerful chartsNature2020579780048248332203366 3.Centers for Disease Control and Prevention. Cases in" exact="the US." post="https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcases-in-us.html. Accessed 29 May 2020 4.ZhangHPenningerJMLiYZhongNSlutskyASAngiotensin-converting enzyme 2 (ACE2)"/>
   <result pre="on an analysis of data of 150 patients from Wuhan," exact="China" post="[published erratum appears in Intensive Care Med. Epub 6"/>
   <result pre="Setting of COVID-19 InfectionJACC Case Rep.202010.1016/j.jaccas.2020.04.02332363351 58.HarikrishnanSMohananPPChopraVKAmbujRSanjayGManishBet al.Cardiological society of" exact="India" post="position statement on COVID-19 and heart failureIndian Heart J.202010.1016/j.ihj.2020.04.01232405088"/>
   <result pre="disease 2019 (COVID-19) outbreak on ST-Segment-Elevation Myocardial Infarction Care in" exact="Hong Kong," post="ChinaCirc Cardiovasc Qual Outcomes2020134e00663132182131 60.ParkJChoiKHLeeJMKimHKHwangDRheeTMet al.Prognostic implications of door-to-balloon"/>
   <result pre="106.GarciaSAlbaghdadiMSMerajPMSchmidtCGarberichRJafferFAet al.Reduction in ST-segment elevation cardiac catheterization laboratory activations in" exact="the United States" post="during COVID-19 pandemicJ Am Coll Cardiol.202010.1016/j.jacc.2020.04.01132283124 107.ZitelnyENewmanNZhaoDSTEMI during the"/>
   <result pre="al.Reduction in ST-segment elevation cardiac catheterization laboratory activations in the" exact="United States" post="during COVID-19 pandemicJ Am Coll Cardiol.202010.1016/j.jacc.2020.04.01132283124 107.ZitelnyENewmanNZhaoDSTEMI during the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7310912\results\search\country\results.xml">
   <result pre="that was detected as cause of respiratory tract infection in" exact="China" post="by end the December 2019 impelled World Health Organization"/>
   <result pre="December 2019, pneumonia of unknown etiology was reported in Wuhan" exact="China" post="which later named as COVID-19 due to immersion of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7313527\results\search\country\results.xml">
   <result pre="other indications.â€� Use of chloroquine to treat COVID-19 patients in" exact="China" post="also showed clinical and virologic benefit (Gao et al.,"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes Metab. Syndr.14202024124610.1016/j.dsx.2020.03.01132247211 StefanidouM.MaraveliasC.DonaA.SpiliopoulouC.Zinc: a multipurpose"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7313828\results\search\country\results.xml">
   <result pre="on 54 mortality cases of coronavirus disease 2019 in the" exact="Republic of" post="Korea from January 19 to March 10, 2020. J"/>
   <result pre="16.Severe outcomes among patients with coronavirus disease 2019 (COVID-19) â€&quot;" exact="United States," post="February 12â€&quot;March 16, 2020. MMWR Morb Mortal Wkly Rep2020;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7314063\results\search\country\results.xml">
   <result pre="to the reninâ€&quot;angiotensin system http://orcid.org/0000-0003-1332-2466OffringaAnnettep1MontijnRoyp1SinghSandeepp2p3PaulMartinp4http://orcid.org/0000-0002-2836-571XPintoYigal Mp5Pinto-Sietsma*Sara-Joanp2p3[p1], Microbiology and System Biology," exact="Netherlands" post="Organisation for Applied Scientific ResearchNetherlands[p2], Vascular Medicine, Amsterdam UMC,"/>
   <result pre="WangJM, LiuJY, ChenZ, LiG, ZhengZJ, QiuSQ, LuoJ, YeCJ, ZhuSY, ZhongNS;" exact="China" post="Medical Treatment Expert Group for Covid-19. Clinical characteristics of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7314230\results\search\country\results.xml">
   <result pre="(due to the systemic inflammatory state). Overall, existing data from" exact="China" post="suggest that between one-quarter and one-third of the COVID-19"/>
   <result pre="higher due to the likely underreporting of pre-existing conditions in" exact="China" post="[31]. Importantly, the presence of underlying hypertension may be"/>
   <result pre="of Cardiology, American Heart Association and Heart Failure Society of" exact="America" post="posted online on 17 March [45]. This makes sense,"/>
   <result pre="disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in" exact="Hong Kong," post="China. Circ Cardiovasc Qual Outcomes2020: doi: 10.1161/circoutcomes.120.006631 6ZhouF, YuT,"/>
   <result pre="infected patients linked to viral loads and lung injury. Sci" exact="China" post="Life Sci2020; 63: 364â€&quot;37432048163 43KhanA, BenthinC, ZenoBet al.A pilot"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315394\results\search\country\results.xml">
   <result pre="6800 and cobasÂ® 8800 (approved in testing patient samples by" exact="the US" post="FDA), which can process up to 384 results and"/>
   <result pre="screening capacity to help restrain the sudden growing epidemic in" exact="the USA." post="RT-PCR is widely applicable to 2019-nCoV detection in the"/>
   <result pre="bold, novel approach, a team of infectious disease experts in" exact="Singapore" post="utilized an ELISA against 2019-nCoV to ascertain that suspected"/>
   <result pre="efficiency and safety against 2019-nCoV in clinical trials conducted in" exact="China" post="[139]. Currently, chloroquine or hydroxychloroquine has been administered to"/>
   <result pre="2019-nCoV patients on an uncontrolled basis in various countries, including" exact="China" post="and the USA [42]. However, it must be noted"/>
   <result pre="on an uncontrolled basis in various countries, including China and" exact="the USA" post="[42]. However, it must be noted that chloroquine and"/>
   <result pre="and production of viral particles [158]. A clinical study from" exact="Hong Kong" post="has shown that the combination of lopinavir-ritonavir and ribavirin"/>
   <result pre="[229]. To date, the National Health Commission (NHC) of the" exact="People's Republic of China" post="has published seven editions of the guidelines for diagnosis"/>
   <result pre="To date, the National Health Commission (NHC) of the People's" exact="Republic of" post="China has published seven editions of the guidelines for"/>
   <result pre="the National Health Commission (NHC) of the People's Republic of" exact="China" post="has published seven editions of the guidelines for diagnosis"/>
   <result pre="recommended for treatment of COVID-19 by the NHC of the" exact="People's Republic of China," post="because it gave a cure rate of over 90%"/>
   <result pre="for treatment of COVID-19 by the NHC of the People's" exact="Republic of" post="China, because it gave a cure rate of over"/>
   <result pre="COVID-19 patients, because it suppresses severe sepsis, according to the" exact="China" post="Food and Drug Administration. It also promoted significant improvement"/>
   <result pre="The currently adopted procedure in identifying potential COVID-19 cases in" exact="China" post="is summarized in Figure 10. On a community scale"/>
   <result pre="traffic are essential to limiting disease transmission. By establishing lockdowns," exact="China" post="has been able to bring the crisis under control."/>
   <result pre="spread of 2019-nCoV. Acknowledgments This work was supported by the" exact="Singapore" post="Ministry of Education (MOE2017-T2-2-110); Agency for Science, Technology and"/>
   <result pre="programme (Award No. NRF-NRFI05-2019-0003); and National Natural Science Foundation of" exact="China" post="(21771135). Conflicts of Interest The authors declare no conflicts"/>
   <result pre="2020China CDC Weekly20202113122 25collab: National Health Committee of the People's" exact="Republic of" post="ChinaDiagnosis and treatment guidelines for COVID-19April 2020, http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml 26StrobelE."/>
   <result pre="with chain-terminating inhibitorsProceedings of the National Academy of Sciences of" exact="the United States" post="of America197774125463546710.1073/pnas.74.12.5463271968 28WangM.FuA.HuB.et al.Nanopore target sequencing for accurate and"/>
   <result pre="chain-terminating inhibitorsProceedings of the National Academy of Sciences of the" exact="United States" post="of America197774125463546710.1073/pnas.74.12.5463271968 28WangM.FuA.HuB.et al.Nanopore target sequencing for accurate and"/>
   <result pre="64VogelsteinB.KinzlerK. W.Digital PCRProceedings of the National Academy of Sciences of" exact="the United States" post="of America199996169236924110.1073/pnas.96.16.923610430926 65KimD.WeiQ.KongJ. E.OzcanA.Di CarloD.Research highlights: digital assays on"/>
   <result pre="W.Digital PCRProceedings of the National Academy of Sciences of the" exact="United States" post="of America199996169236924110.1073/pnas.96.16.923610430926 65KimD.WeiQ.KongJ. E.OzcanA.Di CarloD.Research highlights: digital assays on"/>
   <result pre="antiviral drug ArbidolProceedings of the National Academy of Sciences of" exact="the United States" post="of America2017114220621410.1073/pnas.161702011428003465 123ShenZ.LouK.WangW.New small-molecule drug design strategies for fighting"/>
   <result pre="drug ArbidolProceedings of the National Academy of Sciences of the" exact="United States" post="of America2017114220621410.1073/pnas.161702011428003465 123ShenZ.LouK.WangW.New small-molecule drug design strategies for fighting"/>
   <result pre="inhibition by darunavirProceedings of the National Academy of Sciences of" exact="the United States" post="of America201411133122341223910.1073/pnas.140002711125092296 164LinS.ShenR.HeJ.LiX.GuoX.Molecular modeling evaluation of the binding effect"/>
   <result pre="by darunavirProceedings of the National Academy of Sciences of the" exact="United States" post="of America201411133122341223910.1073/pnas.140002711125092296 164LinS.ShenR.HeJ.LiX.GuoX.Molecular modeling evaluation of the binding effect"/>
   <result pre="by using ribavirinProceedings of the National Academy of Sciences of" exact="the United States" post="of America200198126895690010.1073/pnas.11108559811371613 173TeH. S.RandallG.JensenD. M.Mechanism of action of ribavirin"/>
   <result pre="using ribavirinProceedings of the National Academy of Sciences of the" exact="United States" post="of America200198126895690010.1073/pnas.11108559811371613 173TeH. S.RandallG.JensenD. M.Mechanism of action of ribavirin"/>
   <result pre="a broad spectrum inhibitor of viral RNA polymeraseProceedings of the" exact="Japan" post="Academy, Series B201793744946310.2183/pjab.93.02728769016 183CaiQ.YangM.LiuD.et al.Experimental treatment with favipiravir for"/>
   <result pre="Traditional and Herbal Drugs202051878882 231collab: Publicity Department of the People's" exact="Republic of" post="ChinaPress conference of the joint prevention and control mechanism"/>
   <result pre="COVID-19 test kits used to screen swab samples collected at" exact="Singapore" post="checkpoints2020https://www.channelnewsasia.com/news/singapore/covid19-new-test-kits-swab-three-hours-12505658 250collab: Beihang UniversityThe development of Beihang University on"/>
   <result pre="of the 2019-nCoV grown in cells at the University of" exact="Hong Kong" post="[97]. Figure 8 Proposed schematic of 2019-nCoV replication and"/>
   <result pre="N/A Compared with favipiravir (see favipiravir) Currently being evaluated in" exact="China" post="Chloroquine, hydroxychloroquine Entry receptor Antiviral drug on malaria; not"/>
   <result pre="on primate cells [135, 138] Ongoing Currently being evaluated in" exact="China" post="and the United States Camostat mesylate Host protease Antiviral"/>
   <result pre="cells [135, 138] Ongoing Currently being evaluated in China and" exact="the United States" post="Camostat mesylate Host protease Antiviral drug on pancreatic diseases;"/>
   <result pre="[135, 138] Ongoing Currently being evaluated in China and the" exact="United States" post="Camostat mesylate Host protease Antiviral drug on pancreatic diseases;"/>
   <result pre="ribavirin for SARS and MERS N/A 199 hospitalized patients, Wuhan," exact="China" post="(99 lopinavir+ritonavir+100 standard care) [161] Currently being evaluated in"/>
   <result pre="China (99 lopinavir+ritonavir+100 standard care) [161] Currently being evaluated in" exact="China" post="and the United States. However, found to be ineffective"/>
   <result pre="lopinavir+ritonavir+100 standard care) [161] Currently being evaluated in China and" exact="the United States." post="However, found to be ineffective based on preliminary findings"/>
   <result pre="standard care) [161] Currently being evaluated in China and the" exact="United States." post="However, found to be ineffective based on preliminary findings"/>
   <result pre="SARS and MERS N/A Not known Currently being evaluated in" exact="China" post="Favipiravir Genome replication Antiviral drug on influenza; not yet"/>
   <result pre="yet tested for coronaviruses N/A 240 patients in Hubei province," exact="China" post="(120 favipiravir+120 arbidol) (preprint) [184] Higher recovery rate compared"/>
   <result pre="boost Janssen Pharmaceutical Companies N/A Protein subunit/S protein EpiVax/Univ. of" exact="Georgia" post="GV-MVA-VLP/vaccine DNA/nonreplicating viral vector GeoVax/BravoVax Protein subunit/S protein (baculovirus"/>
   <result pre="Live attenuated virusâˆ— Deoptimized live attenuated vaccines Codagenix/Serum Institute of" exact="India" post="N/A mRNA vaccine/lipid nanoparticle/S and S-RBD antigen Fudan University/Shanghai"/>
   <result pre="Sinovac BNT162âˆ— mRNA vaccine BioNTech/Fosun Pharma/Pfizer N/A Unknown University of" exact="Hong Kong" post="N/A Self-amplifying RNA vaccine Imperial College London N/A Unknown/IPA's"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315698\results\search\country\results.xml">
   <result pre="to clinical research responses in Africa (nâ€‰=â€‰37), Europe (nâ€‰=â€‰8), North" exact="America" post="(nâ€‰=â€‰5), Latin America and the Caribbean (nâ€‰=â€‰3) and Asia"/>
   <result pre="responses in Africa (nâ€‰=â€‰37), Europe (nâ€‰=â€‰8), North America (nâ€‰=â€‰5), Latin" exact="America" post="and the Caribbean (nâ€‰=â€‰3) and Asia (nâ€‰=â€‰1) and/or globally"/>
   <result pre="responses set in lower-middle-income countries (LMICs) in Africa (nâ€‰=â€‰37), Latin" exact="America" post="and the Caribbean (nâ€‰=â€‰3) and Asia (nâ€‰=â€‰1). Thirteen articles"/>
   <result pre="(1) Europe 1 â€&quot; â€&quot; 7 â€&quot; 8 (9) Latin" exact="America" post="and the Caribbean â€&quot; 2 â€&quot; â€&quot; 1 3"/>
   <result pre="the Caribbean â€&quot; 2 â€&quot; â€&quot; 1 3 (4) North" exact="America" post="â€&quot; â€&quot; â€&quot; 5 â€&quot; 5 (6) Global perspective"/>
   <result pre="action by the national government and an effective partnership between" exact="the USA" post="and Liberia, with strong leadership from both nations [16]."/>
   <result pre="13, 29, 36]. Researchers delivering an Ebola vaccine RCT in" exact="Sierra Leone" post="illustrated reactive solutions implemented to overcome logistic challenges. To"/>
   <result pre="initiate an observational study into severe acute respiratory infections in" exact="Canada" post="[15] Set-up time frames Outbreak Study setting Time frame,"/>
   <result pre="setting Time frame, days, median (IQR) Overall start-up procedures H1N1" exact="Canada" post="335 (128â€&quot;335) Site receipt of the protocol to REB"/>
   <result pre="of corticosteroids in ICU patients with H1N1 influenza pneumonia in" exact="France" post="to start 1â€‰month earlier, before the peak â€˜fluâ€™ wave"/>
   <result pre="for pandemics [70, 74]. An interventional Ebola study set in" exact="Guinea" post="reported patient preference for verbal consent [69]. One article"/>
   <result pre="a candidate Ebola vaccine during the current outbreak in the" exact="Democratic Republic of the Congo" post="(DRC), aiding the containment of the outbreak, illustrating the"/>
   <result pre="candidate Ebola vaccine during the current outbreak in the Democratic" exact="Republic of" post="the Congo (DRC), aiding the containment of the outbreak,"/>
   <result pre="during the current outbreak in the Democratic Republic of the" exact="Congo" post="(DRC), aiding the containment of the outbreak, illustrating the"/>
   <result pre="Africa during the Ebola outbreak or in Europe and Northern" exact="America" post="during the H1N1 pandemic, highlighting the limited information on"/>
   <result pre="viruses ARI Acute respiratory infections CNS Central nervous system DRC" exact="Democratic Republic of the Congo" post="EVD Ebola virus disease GHS Global health security HIC"/>
   <result pre="ARI Acute respiratory infections CNS Central nervous system DRC Democratic" exact="Republic of" post="the Congo EVD Ebola virus disease GHS Global health"/>
   <result pre="infections CNS Central nervous system DRC Democratic Republic of the" exact="Congo" post="EVD Ebola virus disease GHS Global health security HIC"/>
   <result pre="and development SARS Severe acute respiratory syndrome S.E Southeast UK" exact="United Kingdom" post="VHF Viral haemorrhagic fever W West WHO World Health"/>
   <result pre="conducting research in acute epidemics: the Pfizer meningitis study in" exact="Nigeria" post="as an illustrationDev World Bioeth.201010111018665846 6.AnnaneDAntonaMLehmannBKedziaCChevretSInvestigatorsCet al.Designing and conducting"/>
   <result pre="establishment of a phase II/III clinical research trial in resource-poor" exact="Liberia" post="during the largest-ever Ebola outbreakContemp Clin Trials Commun20164687328042619 17.FolayanMOBrownBHaireBYakubuAPetersonKTegliJStakeholdersâ€™"/>
   <result pre="al.Conducting clinical trials in crisis settings, 2012 military coup in" exact="Mali" post="and the Ebola virus outbreak in 2014 in West"/>
   <result pre="health emergenciesLancet2016387100342197219827302027 25.SchieffelinJMosesLMShafferJGobaAGrantDSClinical validation trial of a diagnostic for Ebola" exact="Zaire" post="antigen detection: design rationale and challenges to implementationClin.20161316672 26.KeuschGTMcAdamKPWJClinical"/>
   <result pre="the midst of an Ebola outbreak: lessons learned from the" exact="Sierra Leone" post="Trial to introduce a vaccine against EbolaJ Infect Dis2018217Supplement"/>
   <result pre="challenges in the conduct of an ebola vaccine trial in" exact="Liberia" post="during the international public health emergencyAm J Trop Med"/>
   <result pre="A pandemicCrit Care Med2010384 Supple120e13220101176 56.Lie RK, Wendler D. The" exact="Guinea" post="Phase III Ebola Vaccine Trial: lessons for research ethics"/>
   <result pre="in the control of an Ebola outbreak in the Democratic" exact="Republic of" post="the Congo: an example of integration of research into"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315836\results\search\country\results.xml">
   <result pre="around the world, with 353â€¯373 confirmed deaths (Figure 1).9 The" exact="United States of America" post="and Brazil reporting the majority of the confirmed cases"/>
   <result pre="with 353â€¯373 confirmed deaths (Figure 1).9 The United States of" exact="America" post="and Brazil reporting the majority of the confirmed cases"/>
   <result pre="confirmed deaths (Figure 1).9 The United States of America and" exact="Brazil" post="reporting the majority of the confirmed cases in the"/>
   <result pre="At present, chloroquine is carried out in clinical research in" exact="China" post="for the treatment of SARS-CoV-2 (ChiCTR2000029609).69Hydroxychloroquine (5) is an"/>
   <result pre="(16), a broad-spectrum drug, has been licensed for decades in" exact="Russia" post="and China against influenza by binding to the HA"/>
   <result pre="broad-spectrum drug, has been licensed for decades in Russia and" exact="China" post="against influenza by binding to the HA protein to"/>
   <result pre="he worked at the Instituto de Quimica Medica (CSIC) in" exact="Spain" post="as a senior visiting scholar. He obtained his Ph.D."/>
   <result pre="Acknowledgments Financial support from the National Natural Science Foundation of" exact="China" post="(NSFC nos. 81973181, 81773574), Key Project of NSFC for"/>
   <result pre="furin-mediated activation of the spike protein. Proc. Natl. Acad. Sci." exact="U. S." post="A.2014, 111, 15214â€&quot;15219. 10.1073/pnas.1407087111.25288733 CoutardB.; ValleC.; de LamballerieX.; CanardB.;"/>
   <result pre="coronavirus isolates by human monoclonal antibodies. Proc. Natl. Acad. Sci." exact="U. S." post="A.2007, 104, 12123â€&quot;12128. 10.1073/pnas.0701000104.17620608 LeiC. H.; FuW. Y.; QianK."/>
   <result pre="humanized mouse model of MERS-CoV infection. Proc. Natl. Acad. Sci." exact="U. S." post="A.2015, 112, 8738â€&quot;8743. 10.1073/pnas.1510830112.26124093 de WitE.; FeldmannF.; OkumuraA.; HorneE.;"/>
   <result pre="severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci." exact="U. S." post="A.2005, 102, 11876â€&quot;11881. 10.1073/pnas.0505577102.16081529 BoschB. J.; MartinaB. E. E.;"/>
   <result pre="using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci." exact="U. S." post="A.2004, 101, 8455â€&quot;8460. 10.1073/pnas.0400576101.15150417 DengY.; LiuJ.; ZhengQ.; YongW.; LuM.Structures"/>
   <result pre="gp41 and inhibit HIV envelope-mediated fusion. Proc. Natl. Acad. Sci." exact="U. S." post="A.2006, 103, 13938â€&quot;13943. 10.1073/pnas.0601036103.16963566 YiL.; LiZ.; YuanK.; QuX.; ChenJ.;"/>
   <result pre="inhibition by the antiviral drug Arbidol. Proc. Natl. Acad. Sci." exact="U. S." post="A.2017, 114, 206â€&quot;214. 10.1073/pnas.1617020114.28003465 WangX.; CaoR.; ZhangH.; LiuJ.; XuM.;"/>
   <result pre="attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci." exact="U. S." post="A.2004, 101, 6641â€&quot;6646. 10.1073/pnas.0401939101.15096611 ChenZ.; ZhangL.; QinC.; BaL.; YiC."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315944\results\search\country\results.xml">
   <result pre="date. Since the first Covid-19 (Coronavirus) disease case confirmed in" exact="China" post="December 2019 Wuhan District, the outbreak continues to spread"/>
   <result pre="No Country Contact tracing App Location tracking Launch on 1" exact="Australia" post="COVIDSafe BlueTrace protocol: Bluetooth April 14, 2020 2 Austria"/>
   <result pre="1 Australia COVIDSafe BlueTrace protocol: Bluetooth April 14, 2020 2" exact="Austria" post="Stopp Corona Bluetooth, Google/Apple March, 2020 3 Bahrain BeAware"/>
   <result pre="2020 2 Austria Stopp Corona Bluetooth, Google/Apple March, 2020 3" exact="Bahrain" post="BeAware Bahrain Bluetooth &amp;amp; GSM March 31, 2020 4"/>
   <result pre="Austria Stopp Corona Bluetooth, Google/Apple March, 2020 3 Bahrain BeAware" exact="Bahrain" post="Bluetooth &amp;amp; GSM March 31, 2020 4 Bulgaria ViruSafe"/>
   <result pre="Bahrain BeAware Bahrain Bluetooth &amp;amp; GSM March 31, 2020 4" exact="Bulgaria" post="ViruSafe GSM May, 2020 5 China conjunction with Alipay"/>
   <result pre="March 31, 2020 4 Bulgaria ViruSafe GSM May, 2020 5" exact="China" post="conjunction with Alipay GPS, GSM, credit-card-transaction-history Very little Info"/>
   <result pre="conjunction with Alipay GPS, GSM, credit-card-transaction-history Very little Info 6" exact="Cyprus" post="CovTracer GPS, GSM May, 2020 7 Colombia CoronApp GPS"/>
   <result pre="little Info 6 Cyprus CovTracer GPS, GSM May, 2020 7" exact="Colombia" post="CoronApp GPS April 12, 2020 8 Czech Republic eRouÅ¡ka"/>
   <result pre="May, 2020 7 Colombia CoronApp GPS April 12, 2020 8" exact="Czech Republic" post="eRouÅ¡ka (eFacemask) BlueTrace protocol: Bluetooth April 15, 2020 9"/>
   <result pre="Republic eRouÅ¡ka (eFacemask) BlueTrace protocol: Bluetooth April 15, 2020 9" exact="Estonia" post="Estonia's App Google/Apple, DP-3T, Bluetooth April, 2020 10 Finland"/>
   <result pre="9 Estonia Estonia's App Google/Apple, DP-3T, Bluetooth April, 2020 10" exact="Finland" post="Ketju DP-3T, Bluetooth May, 2020 11 France StopCovid Bluetooth"/>
   <result pre="April, 2020 10 Finland Ketju DP-3T, Bluetooth May, 2020 11" exact="France" post="StopCovid Bluetooth May, 2020 12 Germany CoronaApp Bluetooth, Google/Apple"/>
   <result pre="Bluetooth May, 2020 11 France StopCovid Bluetooth May, 2020 12" exact="Germany" post="CoronaApp Bluetooth, Google/Apple May, 2020 13 Ghana GH Covid-19"/>
   <result pre="May, 2020 12 Germany CoronaApp Bluetooth, Google/Apple May, 2020 13" exact="Ghana" post="GH Covid-19 Tracker App GPS April 12, 2020 14"/>
   <result pre="Ghana GH Covid-19 Tracker App GPS April 12, 2020 14" exact="Hungary" post="VÃ­rusRadar Bluetooth May 13, 2020 15 Iceland Rakning C-19"/>
   <result pre="12, 2020 14 Hungary VÃ­rusRadar Bluetooth May 13, 2020 15" exact="Iceland" post="Rakning C-19 GPS April 2020 16 India Aarogya Setu"/>
   <result pre="13, 2020 15 Iceland Rakning C-19 GPS April 2020 16" exact="India" post="Aarogya Setu Bluetooth &amp;amp; location-generated social graph April 2,"/>
   <result pre="Setu Bluetooth &amp;amp; location-generated social graph April 2, 2020 17" exact="Iran" post="Mask.ir GSM May, 2020 18 Ireland HSE Covid-19 App"/>
   <result pre="April 2, 2020 17 Iran Mask.ir GSM May, 2020 18" exact="Ireland" post="HSE Covid-19 App Bluetooth, Google/Apple May, 2020 19 Israel"/>
   <result pre="18 Ireland HSE Covid-19 App Bluetooth, Google/Apple May, 2020 19" exact="Israel" post="HaMagen Standard location APIs March, 2020 20 Italy Immuni"/>
   <result pre="2020 19 Israel HaMagen Standard location APIs March, 2020 20" exact="Italy" post="Immuni Bluetooth, Google/Apple May, 2020 21 Jordan AMAN App"/>
   <result pre="March, 2020 20 Italy Immuni Bluetooth, Google/Apple May, 2020 21" exact="Jordan" post="AMAN App - Jordan GPS May, 2020 22 Latvia"/>
   <result pre="Immuni Bluetooth, Google/Apple May, 2020 21 Jordan AMAN App -" exact="Jordan" post="GPS May, 2020 22 Latvia Apturi Covid Bluetooth May,"/>
   <result pre="21 Jordan AMAN App - Jordan GPS May, 2020 22" exact="Latvia" post="Apturi Covid Bluetooth May, 29, 2020 23 Malaysia MyTrace"/>
   <result pre="2020 22 Latvia Apturi Covid Bluetooth May, 29, 2020 23" exact="Malaysia" post="MyTrace Bluetooth, Google/Apple May 3, 2020 24 Mexico CovidRadar"/>
   <result pre="2020 23 Malaysia MyTrace Bluetooth, Google/Apple May 3, 2020 24" exact="Mexico" post="CovidRadar Bluetooth May, 2020 25 New Zealand NZ COVID"/>
   <result pre="May 3, 2020 24 Mexico CovidRadar Bluetooth May, 2020 25" exact="New Zealand" post="NZ COVID Tracer Contact details and physical address May"/>
   <result pre="Tracer Contact details and physical address May 20, 2020 26" exact="North Macedonia" post="StopKorona Bluetooth April 13, 2020 27 Norway Smittestopp Bluetooth"/>
   <result pre="Contact details and physical address May 20, 2020 26 North" exact="Macedonia" post="StopKorona Bluetooth April 13, 2020 27 Norway Smittestopp Bluetooth"/>
   <result pre="2020 26 North Macedonia StopKorona Bluetooth April 13, 2020 27" exact="Norway" post="Smittestopp Bluetooth and GSM April 16, 2020 28 Poland"/>
   <result pre="27 Norway Smittestopp Bluetooth and GSM April 16, 2020 28" exact="Poland" post="ProteGO Bluetooth May, 2020 29 Qatar Ehteraz Bluetooth and"/>
   <result pre="April 16, 2020 28 Poland ProteGO Bluetooth May, 2020 29" exact="Qatar" post="Ehteraz Bluetooth and GSM May, 2020 30 Saudi Arabia"/>
   <result pre="2020 29 Qatar Ehteraz Bluetooth and GSM May, 2020 30" exact="Saudi Arabia" post="Corona Map Bluetooth April 3, 2020 31 Singapore TraceTogether"/>
   <result pre="30 Saudi Arabia Corona Map Bluetooth April 3, 2020 31" exact="Singapore" post="TraceTogether BlueTrace protocol, Bluetooth March 20, 2020 32 South"/>
   <result pre="31 Singapore TraceTogether BlueTrace protocol, Bluetooth March 20, 2020 32" exact="South Korea" post="Non-app-based Mobile device tracking data and card transaction data"/>
   <result pre="device tracking data and card transaction data May, 2020 33" exact="Switzerland" post="SwissCovid DP-3T protocol, Bluetooth, Google/Apple May 20, 2020 34"/>
   <result pre="Switzerland SwissCovid DP-3T protocol, Bluetooth, Google/Apple May 20, 2020 34" exact="Turkey" post="Hayat Eve Sigar Bluetooth, GSM April, 2020 35 UAE"/>
   <result pre="Countries are working to overcome the challenges; some countries like" exact="Israel" post="â€œpassed an emergency law to use mobile phone dataâ€�"/>
   <result pre="an ending point estimation of the current SARS-CoV-2 epidemic in" exact="Canada" post="and all over the globe [40]. The suggested model"/>
   <result pre="suggested model forecast ending point of this SARS-CoV-2 outbreak in" exact="Canada" post="will be around June 2020. Based on the data"/>
   <result pre="generating short-term forecasts of the SARS-CoV-2 for various countries (India," exact="United Kingdom," post="Canada, South Korea, and France) to assist healthcare experts"/>
   <result pre="of the SARS-CoV-2 for various countries (India, United Kingdom, Canada," exact="South Korea," post="and France) to assist healthcare experts and policymakers as"/>
   <result pre="31, 2020 Cross-validation Ending point of the pandemic outbreak in" exact="Canada" post="was predicted on June 2020 Chakraborty, T. and Ghosh,"/>
   <result pre="SARS-CoV-2 carrier in a human being is essential. Researchers from" exact="Taiwan" post="are building a new model to augment the development"/>
   <result pre="transformer-drug target interaction model was proposed jointly by researchers from" exact="the US" post="and Korea to tackle the need for an antiviral"/>
   <result pre="medicine of Covid-19 human patients. A group of researchers from" exact="the USA" post="discovered an antiviral drug for treating the Ebola virus."/>
   <result pre="disease epidemics: chronic wasting disease in deer farmsEpidemics232018717510.1016/j.epidem.2017.12.00629329958 37BBC: Coronavirus:" exact="Israel" post="enables emergency spy powers.https://www.bbc.com/news/technology-51930681 (Accessed 3 June 2020). 38RibeiroM.H.D.M.da"/>
   <result pre="patientsNat Mach Intell202010.1038/s42256-020-0180-7 40ChimmulaV.K.R.ZhangL.Time series forecasting of COVID-19 transmission in" exact="Canada" post="using LSTM NetworksChaos, Solitons Fractals202010986410.1016/j.chaos.2020.109864 41ChakrabortyT.GhoshI.Real-time forecasts and risk"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7317074\results\search\country\results.xml">
   <result pre="we know full personal protective equipment (PPE) use in China," exact="Singapore" post="and South Korea to be necessary for staff protection,"/>
   <result pre="full personal protective equipment (PPE) use in China, Singapore and" exact="South Korea" post="to be necessary for staff protection, and there were"/>
   <result pre="was followed. Already, dozens of medical staff have died in" exact="Italy" post="and in many other countries (Iran, Egypt, United Kingdom"/>
   <result pre="died in Italy and in many other countries (Iran, Egypt," exact="United Kingdom" post="and United States, see in memoriam Â atÂ https://www.medscape.com/viewarticle/927976?nlid=134809_3903&amp;amp;src=wnl_exclsv_200402_MSCPEDIT&amp;amp;uac=307247DX&amp;amp;impID=2332449&amp;amp;faf=1)."/>
   <result pre="and in many other countries (Iran, Egypt, United Kingdom and" exact="United States," post="see in memoriam Â atÂ https://www.medscape.com/viewarticle/927976?nlid=134809_3903&amp;amp;src=wnl_exclsv_200402_MSCPEDIT&amp;amp;uac=307247DX&amp;amp;impID=2332449&amp;amp;faf=1). The effects of"/>
   <result pre="see how the death rates vary between a country like" exact="the United States," post="which was so late and others, like Singapore, South"/>
   <result pre="how the death rates vary between a country like the" exact="United States," post="which was so late and others, like Singapore, South"/>
   <result pre="United States, which was so late and others, like Singapore," exact="South Korea" post="and Taiwan, which were early in isolation, testing and"/>
   <result pre="data already present. Planning for previous influenza epidemics in the" exact="United Kingdom," post="including fitting all general practitioners with personal protective masks,"/>
   <result pre="the problems caused by the initial Chinese suppression of information," exact="the USA" post="response of ignoring the threat or â€˜COVID denialâ€™, and"/>
   <result pre="threat or â€˜COVID denialâ€™, and advice continually fluctuating in the" exact="United Kingdom" post="on testing the population or not, testing staff, masks"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7317260\results\search\country\results.xml">
   <result pre="(MERS), which in 2012 affected over 2000 people mainly in" exact="Saudi Arabia" post="[5]. Data on COVID-19 in patients with diabetes are"/>
   <result pre="of 2.3%, which rose to 7.3% in diabetics [7]. In" exact="Italy" post="(15 May 2020), 223.095 cases with 29.884 deaths were"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7318922\results\search\country\results.xml">
   <result pre="China, was identified as the first case of COVID-19 in" exact="the United States" post="(Holshue et al., 2020). The reproduction number of the"/>
   <result pre="was identified as the first case of COVID-19 in the" exact="United States" post="(Holshue et al., 2020). The reproduction number of the"/>
   <result pre="with the identification of four cases in Thailand, Japan, and" exact="South Korea." post="An extended latency phase was postulated to occur, during"/>
   <result pre="later, additional travel bans included travel from Europe and the" exact="United Kingdom." post="The World Health Organization (WHO) declared COVID-19 a pandemic"/>
   <result pre="million with &amp;gt;600,000 deaths across six continents (Fig. 1). The" exact="United States" post="surpassed China in the number of confirmed COVID-19 cases"/>
   <result pre="deaths across six continents (Fig. 1). The United States surpassed" exact="China" post="in the number of confirmed COVID-19 cases and deaths"/>
   <result pre="al., 2020, GalvÃ¡n Casas et al., 2020 Urticaria Cohorts in" exact="Spain" post="and Italy presented with an urticarial rash; many presented"/>
   <result pre="GalvÃ¡n Casas et al., 2020 Urticaria Cohorts in Spain and" exact="Italy" post="presented with an urticarial rash; many presented prior to"/>
   <result pre="2020, Landa et al., 2020 Livedo reticularis Case reports in" exact="the United States" post="of transient Livedo reticularis eruption unilaterally; mechanism may be"/>
   <result pre="Landa et al., 2020 Livedo reticularis Case reports in the" exact="United States" post="of transient Livedo reticularis eruption unilaterally; mechanism may be"/>
   <result pre="relative mortality rate. When comparing mortality across the affected countries," exact="Italy" post="has one of the highest death rates related to"/>
   <result pre="related to COVID-19. The advanced age of the population in" exact="Italy" post="was speculated early on to represent a unique factor"/>
   <result pre="unique factor with regard to susceptibility to severe respiratory illness;" exact="Italy" post="is known to have the oldest European population, with"/>
   <result pre="East and Europe by July. The second wave originated within" exact="France" post="in August 1918 and was known as the fatal"/>
   <result pre="the current global phase of COVID-19, with some regions, including" exact="the US," post="experiencing post-peak transmission rates. The United States Government has"/>
   <result pre="some regions, including the US, experiencing post-peak transmission rates. The" exact="United States" post="Government has placed level 3 travel precautions on multiple"/>
   <result pre="level 3 travel precautions on multiple countries, including China, Iran," exact="South Korea," post="the United Kingdom, and many European nations, and effectively"/>
   <result pre="precautions on multiple countries, including China, Iran, South Korea, the" exact="United Kingdom," post="and many European nations, and effectively banned nonessential travel."/>
   <result pre="safety, health, and security. U.S. citizens looking to return to" exact="the United States" post="are asked to self-quarantine at home for a 14-day"/>
   <result pre="health, and security. U.S. citizens looking to return to the" exact="United States" post="are asked to self-quarantine at home for a 14-day"/>
   <result pre="The government is not allowing foreign nationals who have visited" exact="Iran" post="or China in the last 14â€¯days to enter the"/>
   <result pre="is not allowing foreign nationals who have visited Iran or" exact="China" post="in the last 14â€¯days to enter the country at"/>
   <result pre="Centers for Disease Control and Prevention. Coronavirus and travel in" exact="the United States" post="[Internet]. 2020g [cited 2020 April 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/travelers/travel-in-the-us.html"/>
   <result pre="for Disease Control and Prevention. Coronavirus and travel in the" exact="United States" post="[Internet]. 2020g [cited 2020 April 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/travelers/travel-in-the-us.html"/>
   <result pre="manifestations of COVID-19: a rapid prospective nationwide consensus study in" exact="Spain" post="with 375 casesBr J Dermatol18312020717732348545 GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and azithromycin as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319607\results\search\country\results.xml">
   <result pre="Metaproterenol). EDTA has been added to nebulized bronchodilator solutions in" exact="the United States" post="as both nonsterile and sterile-filled products [22]. Accordingly, Edetate"/>
   <result pre="EDTA has been added to nebulized bronchodilator solutions in the" exact="United States" post="as both nonsterile and sterile-filled products [22]. Accordingly, Edetate"/>
   <result pre="a year. Although surveys for 229E antibodies in adults in" exact="the United States" post="range from 19 to 41%, there are many individuals,"/>
   <result pre="year. Although surveys for 229E antibodies in adults in the" exact="United States" post="range from 19 to 41%, there are many individuals,"/>
   <result pre="antigenicity between laboratory and clinical isolates of HCoV-229E isolated in" exact="Japan" post="in 2004â€&quot;2008 depend on the S1 region sequence of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319644\results\search\country\results.xml">
   <result pre="Newborns 1 Introduction Severe Acute Respiratory Syndrome (SARS) appeared in" exact="China" post="in 2002 as a contagious disease caused by Coronavirus"/>
   <result pre="atypical pneumonia and respiratory failure [[1], [2], [3], [4], [5]]." exact="Saudi Arabia" post="(in 2014), a new respiratory illness called Middle East"/>
   <result pre="[13]. Epidemiological investigations revealed that the spread of SARS-CoV outside" exact="China" post="began on February 21, 2003. When 12 people staying"/>
   <result pre="2003. When 12 people staying at the Metropole Hotel in" exact="Hong Kong" post="were infected with the SARS-CoV from an asymptomatic and"/>
   <result pre="for spreading the infection to Singapore, Vietnam, Canada, Ireland, and" exact="the United States" post="- starting the chain of infection in all these"/>
   <result pre="spreading the infection to Singapore, Vietnam, Canada, Ireland, and the" exact="United States" post="- starting the chain of infection in all these"/>
   <result pre="many countries in a wide geographic range worldwide, including Lebanon," exact="United States," post="Italy and Germany [16]. A comparative study of the"/>
   <result pre="in a wide geographic range worldwide, including Lebanon, United States," exact="Italy" post="and Germany [16]. A comparative study of the MERS-CoV"/>
   <result pre="wide geographic range worldwide, including Lebanon, United States, Italy and" exact="Germany" post="[16]. A comparative study of the MERS-CoV full genome"/>
   <result pre="from bats. Curiously, some studies showed that MERS-CoV patients from" exact="Saudi Arabia" post="who have jobs involving camels have a higher prevalence"/>
   <result pre="is also important to note that both SARS coronaviruses had" exact="China" post="as the epicenter [19,22,23]. Fig. 1 Number of confirmed"/>
   <result pre="growth restriction intra-uterine [87,88]. Assiri et al. [83] demonstrated that" exact="Saudi Arabia" post="accounted for 1308 cases of MERS-CoV between November 2012"/>
   <result pre="confirmed diagnosis for SARS-CoV were analyzed, aged 27â€&quot;44 years in" exact="Hong Kong." post="All patients had a high fever for two to"/>
   <result pre="infections. In two cases of SARS-CoV in pregnant patients in" exact="the United States," post="none had a severe outcome. Both patients had healthy"/>
   <result pre="In two cases of SARS-CoV in pregnant patients in the" exact="United States," post="none had a severe outcome. Both patients had healthy"/>
   <result pre="the remaining cases did not have SARS-CoV infection [2,93]. In" exact="the United States," post="in 2003, a study showed that two out of"/>
   <result pre="remaining cases did not have SARS-CoV infection [2,93]. In the" exact="United States," post="in 2003, a study showed that two out of"/>
   <result pre="laboratory-confirmed case was reported during a MERS outbreak in the" exact="Republic of" post="Korea in a woman in the 35 gestational weeks."/>
   <result pre="of MERS coronavirus infection in a pregnant woman described in" exact="South Korea" post="resulted in maternal recovery. This patient had suspected placental"/>
   <result pre="negative result to MERS-CoV. In addition, a report from the" exact="Kingdom of Saudi Arabia" post="showed a 32-week pregnant woman with MERS-CoV in need"/>
   <result pre="to MERS-CoV. In addition, a report from the Kingdom of" exact="Saudi Arabia" post="showed a 32-week pregnant woman with MERS-CoV in need"/>
   <result pre="to their fetuses. A case of neonatal SARS-CoV-2 infection in" exact="China" post="with pharyngeal swabs was reported with a positive RT-PCR"/>
   <result pre="intrauterine infection by vertical transmission of SARS-CoV-2 [104]. During the" exact="Hong Kong" post="outbreak, a cohort study of five babies born alive"/>
   <result pre="also included in a study for a randomized control in" exact="Saudi Arabia" post="to MERS patients [114]. Lopinavir combined with ribavirin also"/>
   <result pre="by a novel coronavirus, in a patient transferred to the" exact="United Kingdom" post="from the Middle East, September 2012Eurosurveillance1740201220290PMID: 2307880023078800 27ZakiA.M.BoheemenS.BestebroerT.M.AdmeOsterhaysFouchierR.A.M.Isolation of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319650\results\search\country\results.xml">
   <result pre="beginning of February 2020, a novel coronavirus SARSCoV-2 spreads from" exact="China" post="all over the world. SARS-CoV-2 induced a disease called"/>
   <result pre="at 3.7 %, according to the national official statistics in" exact="China" post="[7]. Preliminary reports in the United States indicate that"/>
   <result pre="the national official statistics in China [7]. Preliminary reports in" exact="the United States" post="indicate that the highest mortality is found in people"/>
   <result pre="national official statistics in China [7]. Preliminary reports in the" exact="United States" post="indicate that the highest mortality is found in people"/>
   <result pre="TeamSevere Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -" exact="United States," post="February 12-March 16, 2020MMWR Morb. Mortal. Wkly. Rep.69March 27"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7320698\results\search\country\results.xml">
   <result pre="with acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan," exact="China" post="[1]. The SARS-CoV-2 infection spread rapidly all over the"/>
   <result pre="interest to CP from recovered Covid-19 patients as treatment. The" exact="United States" post="Food and Drug Administration (U.S. FDA) has published guidelines"/>
   <result pre="our center for the first time in the world after" exact="China" post="in the treatment of Covid-19 disease. The purpose of"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospitalJ Antimicrob Chemother565200591992216183666 11DuanK.Effectiveness of convalescent plasma therapy in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7320718\results\search\country\results.xml">
   <result pre="of a health system without a powerful prevention pillar: in" exact="Italy" post="as in most countries. The emergency population solution to"/>
   <result pre="generalised across the world, with very few â€˜felicitousâ€™ exceptions like" exact="South Korea" post="or Taiwan: short of becoming the forerunner of major"/>
   <result pre="for Disease Control and PreventionCoronavirus Disease 2019 (COVID-19) Forecasting in" exact="the US." post="Updated May 21Availablehttp://www.cdc.gov(accessed 27 May 2020) 5collab: Robert Koch"/>
   <result pre="May 2020) 6RiccardoF, AjelliM, AndrianouXDEpidemiological characteristics of COVID-19 cases in" exact="Italy" post="and estimates of the reproductive numbers one month into"/>
   <result pre="and the stiff upper lip- the pandemic response in the" exact="United Kingdom." post="N Engl J Med2020382:e3110.1056/NEJMp200575532197002 9GieseckeJ, The invisible pandemic. LancetPublished"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7320840\results\search\country\results.xml">
   <result pre="respiratory syndrome outbreaks in 2002 and 2003 in Guangdong Province," exact="China" post="[14â€&quot;17]. Although so far there are controversies about the"/>
   <result pre="with 2,286,560 positive cases and 184,120 deaths and regions of" exact="America" post="with 3,311,387 positive cases and 181,804 deaths are the"/>
   <result pre="40,542 deaths to date, followed by Italy, Spain, France, and" exact="Germany" post="[24, 25]. Genetics and Molecular Structure of nCoV and"/>
   <result pre="COVID-19 patients with pneumonia in a recent clinical trial in" exact="China" post="[52]. Recently, hydroxychloroquine and chloroquine had been reported to"/>
   <result pre="higher potency against SARS-CoV-2 [51, 53, 54]. A study in" exact="China" post="reported that chloroquine treatment of COVID-19 patients had the"/>
   <result pre="as an antiviral drug or the treatment of COVID-19 in" exact="China" post="[55]. In the USA, several clinical trials of hydroxychloroquine"/>
   <result pre="drug or the treatment of COVID-19 in China [55]. In" exact="the USA," post="several clinical trials of hydroxychloroquine for prophylaxis or treatment"/>
   <result pre="13.CuiJLiFShiZLOrigin and evolution of pathogenic coronavirusesNat Rev Microbiol20191718119230531947 14.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWcollab: Investigating" exact="China" post="Novel Coronavirus, and Team ResearchA novel coronavirus from patients"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003Lancet20033621353135814585636 18.Li X, Zai J, Zhao"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7321236\results\search\country\results.xml">
   <result pre="by the novel coronavirus SARS-CoV-2, which first emerged in Wuhan," exact="China" post="and was made known to the World in December"/>
   <result pre="Generally well tolerated, increased ALT/AST [42] Danoprevir ChEMBL2311191 Approved in" exact="China" post="2018 Ascletis by Roche - Faldaprevir ChEMBL1241348 Phase III"/>
   <result pre="Johnson &amp;amp; Johnson Rash, anemia, leukopenia/neutropenia [44] Vaniprevir ChEMBL599872 Approved" exact="Japan" post="2014 Merck &amp;amp; Co. Diarrhea, nausea [45] DPP-4 inhibitors"/>
   <result pre="Increased risk of heart failure [46] Anagliptin - Approved in" exact="Japan" post="2012 Sanwa Kagaku Kenkyusho - Dutogliptin - Phase III"/>
   <result pre="LG Life Sciences Generally well tolerated Gosogliptin - Approved in" exact="Russia" post="2016 Pfizer Hypoglycemia [48] Linagliptin ChEMBL237500 Approved 2011 Eli"/>
   <result pre="and Merck KGaA Not known yet Omarigliptin ChEMBL2105762 Approved in" exact="Japan" post="2012 Merck &amp;amp; Co. Generally well tolerated Saxagliptin ChEMBL385517"/>
   <result pre="legs, upper respiratory tract infection [51] Teneligliptin - Approved in" exact="Japan" post="2012 Mitsubishi Tanabe Pharma Generally well tolerated Trelagliptin -"/>
   <result pre="Mitsubishi Tanabe Pharma Generally well tolerated Trelagliptin - Approved in" exact="Japan" post="2015 Takeda Generally well tolerated Vildagliptin ChEMBL142703 Approved 2007"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323073\results\search\country\results.xml">
   <result pre="for pregnant women infected with the virus.4 A study in" exact="Iran" post="details the deaths of seven out of nine women"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323156\results\search\country\results.xml">
   <result pre="murine sepsis. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 111, 18685â€&quot;18690. 10.1073/pnas.141093811125512512 Gustinetti, G., &amp;amp; Mikulska,"/>
   <result pre="sepsis. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="111, 18685â€&quot;18690. 10.1073/pnas.141093811125512512 Gustinetti, G., &amp;amp; Mikulska, M. (2016)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323229\results\search\country\results.xml">
   <result pre="2019 (COVIDâ€�19). This disease started as an outbreak in Wuhan," exact="China" post="in December 2019 and at May 23, 2020, the"/>
   <result pre="higher rates and suffer higher degrees of morbidity and mortality." exact="United States" post="data from the COVIDâ€�19 net dataset (May 9, 2020)"/>
   <result pre="of developing severe COVIDâ€�19 disease. Data from the CDC in" exact="the United States" post="reveal that patients with COVIDâ€�19 disease less than 19â€‰years"/>
   <result pre="developing severe COVIDâ€�19 disease. Data from the CDC in the" exact="United States" post="reveal that patients with COVIDâ€�19 disease less than 19â€‰years"/>
   <result pre="A trend was noted for increasing mortality with age in" exact="the United States" post="with case fatality rates of 0.1% to 0.2% in"/>
   <result pre="trend was noted for increasing mortality with age in the" exact="United States" post="with case fatality rates of 0.1% to 0.2% in"/>
   <result pre="of disease as the number of coâ€�morbidities increase. Studies in" exact="the United States" post="have suggested that obesity may also be a risk"/>
   <result pre="disease as the number of coâ€�morbidities increase. Studies in the" exact="United States" post="have suggested that obesity may also be a risk"/>
   <result pre="risk factor for severe COVIDâ€�19 disease.7 2.4 Race/ethnicity Experience from" exact="the United States" post="and UK have suggested that race/ethnicity may play a"/>
   <result pre="factor for severe COVIDâ€�19 disease.7 2.4 Race/ethnicity Experience from the" exact="United States" post="and UK have suggested that race/ethnicity may play a"/>
   <result pre="noted to be at increased risk from COVIDâ€�19 Disease. In" exact="the United States," post="the rates of COVIDâ€�19 cases have been documented to"/>
   <result pre="to be at increased risk from COVIDâ€�19 Disease. In the" exact="United States," post="the rates of COVIDâ€�19 cases have been documented to"/>
   <result pre="Severe outcomes among patients with coronavirus disease 2019 (COVIDâ€�19) â€�" exact="United States." post="Morb Mortal Wkly Rep. 2020;69(12):343â€�346. 10VerdoniL, MazzaA, GervasoniA, et"/>
   <result pre="Disease 2019 (COVIDâ€�19) outbreak on STâ€�segmentâ€&quot;elevation myocardial infarction care in" exact="Hong Kong," post="China. Circ Cardiovasc Qual Outcomes. 2020;13(4):e006631.32182131 26BarlowA, LandolfKM, BarlowB,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323438\results\search\country\results.xml">
   <result pre="pmcid: 7323438 doi: 10.1002/pa.2157PA2157 : Practitioner Paper: Practitioner Papers Can" exact="India" post="stay immune enough to combat COVIDâ€�19 pandemic? An economic"/>
   <result pre="how does the pandemic affect the bilateral trade relation between" exact="India" post="and China? Third, we question the role of the"/>
   <result pre="the Indian economy. fig-count: table-count: page-count: word-count: RakshitB, BasishthaD. Can" exact="India" post="stay immune enough to combat COVIDâ€�19 pandemic? An economic"/>
   <result pre="The top most affected economies out of the outbreak are" exact="United States," post="Italy, China, Spain, France, United Kingdom, and Germany. These"/>
   <result pre="of the outbreak are United States, Italy, China, Spain, France," exact="United Kingdom," post="and Germany. These economies accidentally happen to be the"/>
   <result pre="likely to affect the advanced economies, most, emerging economies like" exact="India" post="cannot stand unaffected. Governments in many countries have expressed"/>
   <result pre="concern and imposed lockdown to mitigate the rapid spread. Since" exact="India" post="has imposed 21â€�day lockdown nationwide with anticipation of extending"/>
   <result pre="with plummeting economic growth has pushed the developing countries like" exact="India" post="into a volatile market condition. Among all South Asian"/>
   <result pre="into a volatile market condition. Among all South Asian countries," exact="India" post="has recorded the maximum number of active coronavirus cases."/>
   <result pre="there has been total 9,241 number of COVIDâ€�19 cases in" exact="India" post="with 331 deaths. Figure 2 explains the total number"/>
   <result pre="public health perspective, the ability to contain the outbreak in" exact="India" post="will primarily depend upon the strength of the public"/>
   <result pre="system in India. As the number of confirmed cases in" exact="India" post="is on the rise, the capacity of the public"/>
   <result pre="the world. According to the National Health Profile in 2019," exact="India" post="spends only 1.28% of its GDP as public health"/>
   <result pre="its GDP as public health expenditure.2 World Health Organization ranks" exact="India" post="145 among 195 countries in terms of health care"/>
   <result pre="195 countries in terms of health care access and quality." exact="India" post="ranks much below than China (48), Sri Lanka (71),"/>
   <result pre="health care access and quality. India ranks much below than" exact="China" post="(48), Sri Lanka (71), Bangladesh (133), and Bhutan (134)"/>
   <result pre="access and quality. India ranks much below than China (48)," exact="Sri Lanka" post="(71), Bangladesh (133), and Bhutan (134) in South Asia."/>
   <result pre="and quality. India ranks much below than China (48), Sri" exact="Lanka" post="(71), Bangladesh (133), and Bhutan (134) in South Asia."/>
   <result pre="India ranks much below than China (48), Sri Lanka (71)," exact="Bangladesh" post="(133), and Bhutan (134) in South Asia. The human"/>
   <result pre="below than China (48), Sri Lanka (71), Bangladesh (133), and" exact="Bhutan" post="(134) in South Asia. The human resources and physical"/>
   <result pre="resources and physical infrastructures of the public health system in" exact="India" post="stand at an inferior stage. While the private health"/>
   <result pre="spread of infection from the infected at the community level." exact="India" post="has very less number of hospitals and testing centers."/>
   <result pre="essential part to fight the crisis and contain the spread," exact="India" post="does not have enough kits to test most of"/>
   <result pre="its population for the new coronavirus. As of April 9," exact="India" post="has conducted a total of 1,44,920 tests recording lowest"/>
   <result pre="test rates per capita in the world. Some states in" exact="India" post="have reported no tests so far.4 Given the background,"/>
   <result pre="Second, we will highlight how the bilateral trade relation between" exact="India" post="and China has been affected due to the outbreak."/>
   <result pre="will highlight how the bilateral trade relation between India and" exact="China" post="has been affected due to the outbreak. Third, we"/>
   <result pre="we conclude the article by highlighting the growth projections about" exact="India" post="and recommending some policy implications. 2 THREE IMPORTANT CHANNELS"/>
   <result pre="chains. The monetary loss occurred to the agricultural sector in" exact="India" post="amidst the outbreak of COVIDâ€�19 has been tremendous. The"/>
   <result pre="the fastest growing sector in the Indian agriculture ecosystem. Apparently," exact="India" post="ranks third in terms of egg production and fifth"/>
   <result pre="to the outbreak. However, the continuing outbreak of COVIDâ€�19 in" exact="India" post="has made the possibility of revival difficult as several"/>
   <result pre="of raw materials of drugs has been affected immensely. Though" exact="India" post="is considered to be the top exporters of drugs"/>
   <result pre="the import of bulk drugs. In the financial year 2018â€&quot;2019," exact="India" post="had imported around 24,900 crores of bulk drugs and"/>
   <result pre="constitutes approximately 40% of the domestic consumption.6 India's dependence on" exact="China" post="for the import of many critical antibiotics and antipyretics"/>
   <result pre="the disruptions in the supply chain, the automobile industry in" exact="India" post="has also seen a severe impact. The coronavirus outbreak"/>
   <result pre="industry but also hit the automotive components and forging industries." exact="China" post="accounts for 27% of exports of auto components in"/>
   <result pre="China accounts for 27% of exports of auto components in" exact="India" post="and considers to be the leading supplier in India."/>
   <result pre="the leading supplier in India. As the manufacturing industries in" exact="China" post="were shut down in the wake of the coronavirus"/>
   <result pre="Mahindra and Mahindra (M&amp;amp;M), Tata Motors, and MG Motors in" exact="India" post="have announced that they are facings constraints in the"/>
   <result pre="the chemical industries are considered, the local dyestuff companies in" exact="India" post="relies on China and imports several raw materials such"/>
   <result pre="are considered, the local dyestuff companies in India relies on" exact="China" post="and imports several raw materials such as chemicals and"/>
   <result pre="COVIDâ€�19 can also affect the electronic industries located in India." exact="China" post="being the largest supplier of both final and raw"/>
   <result pre="and raw material of electronic products, the electronics industry in" exact="India" post="fears supply disruptions. 3.3 The impact of COVIDâ€�19 on"/>
   <result pre="on the financial markets in India. The banking sector in" exact="India" post="was already going through a crucial time even before"/>
   <result pre="with a decline of 20 and 14% in European and" exact="United States" post="markets.9 3.4 Impact of COVIDâ€�19 on international trade In"/>
   <result pre="COVIDâ€�19 pandemic has significantly impacted the bilateral trade relation between" exact="India" post="and China. China has been the major importers of"/>
   <result pre="significantly impacted the bilateral trade relation between India and China." exact="China" post="has been the major importers of Indian products that"/>
   <result pre="as the total exports of diamond and pharmaceuticals are considered," exact="India" post="exports 36% of diamond and 34% of pharmaceuticals to"/>
   <result pre="As the outbreak has primarily disrupted the manufacturing activities in" exact="China" post="and other parts of the world (United States and"/>
   <result pre="the exports and imports in both countries. China's exports to" exact="India" post="stood at 67.1 billion yuan, dropped by 12.6% on"/>
   <result pre="12.6% on year on year basis. Whereas, the imports from" exact="India" post="was declined by 11.6% to 18 billion yuan.10 According"/>
   <result pre="a result of COVIDâ€�19 pandemic would stand around US$348 million." exact="India" post="is among those 15 countries that have been affected"/>
   <result pre="been affected severely as the outbreak disrupted manufacturing industries in" exact="China" post="and destroyed world trade. In case of India, the"/>
   <result pre="its fall in exports to China. The bilateral trade between" exact="India" post="and China is also tied by the agricultural products,"/>
   <result pre="in exports to China. The bilateral trade between India and" exact="China" post="is also tied by the agricultural products, as the"/>
   <result pre="on reducing the spread of epidemics. 1918 Spanish flu in" exact="the United States" post="(Bootsma &amp;amp; Ferguson, 2007; Hatchett et al., 2007; Markel"/>
   <result pre="reducing the spread of epidemics. 1918 Spanish flu in the" exact="United States" post="(Bootsma &amp;amp; Ferguson, 2007; Hatchett et al., 2007; Markel"/>
   <result pre="2007; Markel et al., 2007) and seasonal viral infections in" exact="France" post="(Adda, 2016) are the notable examples. It does not"/>
   <result pre="the impact of the complete social and economic lockdown of" exact="India" post="on the supply side of the Indian economy. This"/>
   <result pre="months, under the worstâ€�case scenario, the personal consumption expenditure in" exact="India" post="will fall by $1.2 billion. OECD: As against the"/>
   <result pre="to ensure all the required medical facilities to the people." exact="India" post="has reported a very low number of coronavirus tests."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323526\results\search\country\results.xml">
   <result pre="W Disease, Central Australia, 2017 Outbreak of Meningococcal W Disease," exact="Australia" post="SudburyEva L.Oâ€™SullivanSiobhanListerDavidVargheseDeepaSatharasingheKeshan[], Address for correspondence: Eva L. Sudbury, Department"/>
   <result pre="Torres Strait Islander Neisseria meningitidis bacteria MenACWY vaccine meningitis/encephalitis Central" exact="Australia" post="Invasive meningococcal disease (IMD) remains a major cause of"/>
   <result pre="has also emerged as a cause for endemic disease in" exact="South Africa," post="the United Kingdom, and Chile (17â€&quot;19). In Australia, IMD"/>
   <result pre="as a cause for endemic disease in South Africa, the" exact="United Kingdom," post="and Chile (17â€&quot;19). In Australia, IMD has historically been"/>
   <result pre="for endemic disease in South Africa, the United Kingdom, and" exact="Chile" post="(17â€&quot;19). In Australia, IMD has historically been caused by"/>
   <result pre="MenW; in 2016, it was the predominant meningococcal serogroup in" exact="Australia" post="(3,6). During 2003â€&quot;2015, the case-fatality rate for infection with"/>
   <result pre="During 2003â€&quot;2015, the case-fatality rate for infection with MenW in" exact="Australia" post="was 10.7%, which was more than twice the case-fatality"/>
   <result pre="Until 2017, the Northern Territory was the only state in" exact="Australia" post="that had not experienced an increase in IMD caused"/>
   <result pre="W, Y (MenACWY) conjugate vaccines, are registered for use in" exact="Australia" post="but were not part of the funded program during"/>
   <result pre="Alice Springs Hospital is the regional referral center for Central" exact="Australia" post="and has a catchment area that covers â‰ˆ1.6 million"/>
   <result pre="orange dotsÂ indicate Northern Territory communities; purple dotsÂ indicate Western" exact="Australia" post="communities; gray dotsÂ indicate South Australia communities. Of the"/>
   <result pre="purple dotsÂ indicate Western Australia communities; gray dotsÂ indicate South" exact="Australia" post="communities. Of the 58 communities within the catchment area,"/>
   <result pre="58 communities within the catchment area, 20 are within South" exact="Australia" post="and Western Australia state jurisdictions. Pediatric patients from these"/>
   <result pre="the catchment area, 20 are within South Australia and Western" exact="Australia" post="state jurisdictions. Pediatric patients from these communities are treated"/>
   <result pre="catchment area across the Northern Territory, South Australia, and Western" exact="Australia" post="followed this protocol. Patients from remote communities were retrieved"/>
   <result pre="population &amp;lt;15 years of age (Figure 2). In comparison, in" exact="Australia" post="during 2011â€&quot;2015, there were 0â€&quot;2 cases/year in the ATSI"/>
   <result pre="18 (31) Location of communities Northern Territory 14 (78) South" exact="Australia" post="3 (17) Western Australia 1 (5) Air retrieval to"/>
   <result pre="communities Northern Territory 14 (78) South Australia 3 (17) Western" exact="Australia" post="1 (5) Air retrieval to Alice Springs Hospital 15"/>
   <result pre="The outbreak of MenW among the ATSI population in Central" exact="Australia" post="was unique because it juxtaposed a well-resourced healthcare system"/>
   <result pre="case-fatality rates elsewhere of 10% (2,6,34,35). The ATSI population of" exact="Australia" post="has a higher rate of IMD than the non-Indigenous"/>
   <result pre="than the non-Indigenous population (36,37). During 2016, Indigenous persons in" exact="Australia" post="comprised 3.3% of the total population of this country"/>
   <result pre="reflected previously documented antimicrobial drug susceptibility patterns for MenW in" exact="Australia" post="(22,47). ST1287 isolates have previously been described in sporadic"/>
   <result pre="isolates have previously been described in sporadic cases in Western" exact="Australia" post="and were associated with penicillin resistance (48). Of the"/>
   <result pre="VeitchMG, OwenRL. Rise in invasive serogroup W meningococcal disease in" exact="Australia" post="2013-2015.Commun Dis Intell Q Rep. 2016;40:E451â€&quot;3.28043218 4. LewisLA, RamS."/>
   <result pre="HowdenBP, LahraMM, LambertSB, BeardFH, et al.; collab: Communicable Diseases Network" exact="Australia" post="MenW Working Group. Rise in invasive serogroup W meningococcal"/>
   <result pre="Working Group. Rise in invasive serogroup W meningococcal disease in" exact="Australia" post="2013-2015.Commun Dis Intell Q Rep. 2016;40:E454â€&quot;9.28043219 7. VienneP, Ducos-GalandM,"/>
   <result pre="RoseAMC, LegrosD, TiendrebeogoSRM, BachyC, BjÃ¸rlÃ¸wE, et al.Meningitis serogroup W135 outbreak," exact="Burkina Faso," post="2002.Emerg Infect Dis. 2007;13:920â€&quot;3. 10.3201/eid1306.06094017553237 17. von GottbergA, du"/>
   <result pre="collab: Group for Enteric, Respiratory and Meningeal Disease Surveillance in" exact="South Africa." post="Emergence of endemic serogroup W135 meningococcal disease associated with"/>
   <result pre="single meningococcal group W clone (sequence type 11 clonal complex)," exact="United Kingdom" post="2015.Euro Surveill. 2015;20:21188. 10.2807/1560-7917.ES2015.20.28.2118826212140 20. collab: Australian Government Department"/>
   <result pre="CartterML, DanilaR, et al.The changing epidemiology of meningococcal disease in" exact="the United States," post="1992-1996.J Infect Dis. 1999;180:1894â€&quot;901. 10.1086/31515810558946 35. RosensteinNE, PerkinsBA, StephensDS,"/>
   <result pre="DanilaR, et al.The changing epidemiology of meningococcal disease in the" exact="United States," post="1992-1996.J Infect Dis. 1999;180:1894â€&quot;901. 10.1086/31515810558946 35. RosensteinNE, PerkinsBA, StephensDS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7323662\results\search\country\results.xml">
   <result pre="of a novel coronavirus disease (COVID-19) has spread from Wuhan," exact="China" post="(HuangÂ etÂ al., 2020), and became a pandemic affecting"/>
   <result pre="depression, and anxiety (DouglasÂ etÂ al., 2009). Two studies in" exact="China" post="involving 2091 and 285 adult individuals in the weeks"/>
   <result pre="etÂ al., 1996). There are projections of increased suicidality in" exact="Canada" post="due to indirect impacts of COVID-19 (McIntyreÂ and Lee,Â"/>
   <result pre="intrafamilial violence during the COVID-19 pandemic. Several countries, such as" exact="France" post="and Brazil have reported an increase in reported cases"/>
   <result pre="during the COVID-19 pandemic. Several countries, such as France and" exact="Brazil" post="have reported an increase in reported cases of domestic"/>
   <result pre="be encouraged for these patients in particular. A team from" exact="Singapore" post="reported an increase in health-related anxiety in patients with"/>
   <result pre="development during recovery following the 2003 SARS outbreak in Beijing," exact="China" post="(MihashiÂ etÂ al., 2009). Some authors suggested that during"/>
   <result pre="COVID-19 outbreak. Also, psychiatry and psychotherapy teleconsultations increased enormously in" exact="Germany" post="(FegertÂ and Schulze,Â 2020). In many countries, emergency helplines"/>
   <result pre="ChevanceA.GourionD.HoertelN.LlorcaP.-M.ThomasP.BocherR.MoroM.-R.LaprÃ©voteV.BenyaminaA.FossatiP.MassonM.LeauneE.LeboyerM.GaillardR.Assurer les soins aux patients souffrant de troubles psychiques en" exact="France" post="pendant lâ€™Ã©pidÃ©mie Ã SARS-CoV-2L'EncÃ©phale202010.1016/j.encep.2020.03.001 CobhamV.E.McDermottB.HaslamD.SandersM.R.The Role of Parents, Parenting"/>
   <result pre="adolescents with eating disorders in the current COVID-19 pandemic: A" exact="Singapore" post="perspectiveJournal of Adolescent Health Care: Official Publication of the"/>
   <result pre="Does the Economic Crisis Influence Adolescentsâ€™ Happiness? Population-Based Surveys in" exact="Iceland" post="in 2000â€&quot;2010Journal of Happiness Studies17320161219123410.1007/s10902-015-9639-3 GuichardK.GeoffroyP.A.TaillardJ.Micoulaud-FranchiJ.-A.Royant-ParolaS.PoirotI.BrionA.D'OrthoM.-P.GagnadouxF.SchroderC.PhilipP.BioulacS.StratÃ©gies de gestion de"/>
   <result pre="4(1), 128â€&quot;139. 10.1037/a0022121. KokkeviA.StavrouM.KanavouE.FotiouA.The repercussions of the economic recession in" exact="Greece" post="on adolescents and their families2014UNICEF Office of Research-Innocentihttps://pdfs.semanticscholar.org/a96d/4987576360553e6ada47cc3e5eb51a6435bb.pdf KussD.J.van"/>
   <result pre="Health176202010.3390/ijerph17062032 LiuN.ZhangF.WeiC.JiaY.ShangZ.SunL.WuL.SunZ.ZhouY.WangY.LiuW.Prevalence and predictors of PTSS during COVID-19 outbreak in" exact="China" post="hardest-hit areas: Gender differences matterPsychiatry Research287202011292110.1016/j.psychres.2020.112921 LuthraR.AbramovitzR.GreenbergR.SchoorA.NewcornJ.SchmeidlerJ.LevineP.NomuraY.ChemtobC.M.Relationship between type"/>
   <result pre="health: a 10-year challengeCNS Spectrums20201710.1017/S1092852920000140 McIntyreR.S.LeeY.Projected increases in suicide in" exact="Canada" post="as a consequence of COVID-19Psychiatry Research290202011310410.1016/j.psychres.2020.113104 MelhemN.M.PortaG.ShamseddeenW.Walker PayneM.BrentD.A.Grief in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7325419\results\search\country\results.xml">
   <result pre="Leonel de Matos Guedes, Federal University of Rio de Janeiro," exact="Brazil" post="Reviewed by: Ajay Kumar Sharma, Institute of Nuclear Medicine"/>
   <result pre="(DRDO), India; Devanathan Sukumaran, Defence Research &amp;amp; Development Establishment (DRDE)," exact="India" post="*Correspondence: Rodolfo Cordeiro Giunchetti giunchetti@icb.ufmg.br; giunchetti@gmail.com This article was"/>
   <result pre="control of vectors or the interruption of human-vector contact. In" exact="Brazil" post="the first attempt to control A. aegypti took place"/>
   <result pre="American populations against arboviruses. Aedes aegypti arboviruses vector control Latin" exact="America" post="vaccines Funding FundaÃ§Ã£o de Amparo Ã Pesquisa do Estado"/>
   <result pre="(19) *The Yellow fever virus transmission in urban areas in" exact="Brazil" post="has been interrupted since 1942. The Aedes genus has"/>
   <result pre="The first case of CHIKV on the Caribbean island of" exact="Saint Martin" post="was confirmed in October 2013. Subsequently, CHIKV spread to"/>
   <result pre="that a cryptic ZIKV circulation occurred in the Northeast of" exact="Brazil" post="as early as February 2014, and from the region"/>
   <result pre="with ZIKV. The impact of this number of cases in" exact="Brazil" post="had deeper social and emotional consequences, since 1,434 cases"/>
   <result pre="has been described. This virus was discovered in 1954 in" exact="Trinidad and Tobago," post="but so far only isolated cases are known in"/>
   <result pre="Rocio virus (ROCV) were recorded in the southeastern region of" exact="Brazil" post="during a viral encephalitis epidemic that lasted for about"/>
   <result pre="epidemics (37). La crosse virus (LACV) is present in Latin" exact="America" post="and in some regions of North America and is"/>
   <result pre="present in Latin America and in some regions of North" exact="America" post="and is transmitted by mosquitoes of the genus Aedes."/>
   <result pre="domestic use (53). This scenario is not limited only to" exact="Brazil" post="or South America. Moyes et al. (54) described that"/>
   <result pre="throughout the world. Temephos was the preferred larvicide used in" exact="Brazil" post="from 2003 to 2014. As a result of continuous"/>
   <result pre="studies on this approach have shown promising results, especially in" exact="Australia" post="(27, 92, 94â€&quot;100). McMeniman et al. (101) showed that"/>
   <result pre="Project (World Mosquito Programâ€&quot;WMP). The release of mosquitoes in northern" exact="Australia" post="(2011) showed that Wolbachia had already spread throughout the"/>
   <result pre="12 countries, including Brazil. Currently, it is being used in" exact="Brazil" post="by the World Mosquito Program (formerly â€œEliminate Dengue: Brazil"/>
   <result pre="in Brazil by the World Mosquito Program (formerly â€œEliminate Dengue:" exact="Brazil" post="Challengeâ€�) and has shown results worth of attention (102)."/>
   <result pre="1980, there were about 95 species of arboviruses cataloged in" exact="Brazil" post="alone, but this number has doubled in the last"/>
   <result pre="causing disease in humans (2). The recent epidemics in South" exact="America" post="warn of the possibility of the emergence of new"/>
   <result pre="different susceptibility to Plasmodium falciparum and Plasmodium vivax in northern" exact="Brazil" post="identified by immunoassay. Am J Trop Med Hyg. (1986)"/>
   <result pre="(1996) 112:409â€&quot;28. 10.1017/S00311820000666468935952 15.KomarNClarkGG. West Nile virus activity in Latin" exact="America" post="and the Caribbean. Rev Panam Salud Publica. (2006) 19:112â€&quot;7."/>
   <result pre="JesusJGGiovanettiMet al.. Establishment and cryptic transmission of Zika virus in" exact="Brazil" post="and the Americas. Nature. (2017) 546:406â€&quot;10. 10.1038/nature2240128538727 35.LongKCZieglerSAThangamaniSHausserNLKochelTJHiggsSet al.."/>
   <result pre="JuniorAJ. Resistance to temephos and deltamethrin in Aedes aegypti from" exact="Brazil" post="between 1985 and 2017. Mem Inst Oswaldo Cruz. (2019)"/>
   <result pre="al.. Suppression of a field population of Aedes aegypti in" exact="Brazil" post="by sustained release of transgenic male mosquitoes. PLoS Negl"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7326413\results\search\country\results.xml">
   <result pre="environment interaction at the human IL6 locusProc. Natl. Acad. Sci." exact="U. S." post="A1071220105681568610.1073/pnas.091151510720176930 ColeS.W.CapitanioJ.P.ChunK.ArevaloJ.M.MaJ.CacioppoJ.T.Myeloid differentiation architecture of leukocyte transcriptome dynamics in"/>
   <result pre="leukocyte transcriptome dynamics in perceived social isolationProc. Natl. Acad. Sci." exact="U. S." post="A112492015151421514710.1073/pnas.151424911226598672 ColeS.W.HawkleyL.C.ArevaloJ.M.SungC.Y.RoseR.M.CacioppoJ.T.Social regulation of gene expression in human leukocytesGenome"/>
   <result pre="FredricksonB.L.GrewenK.M.CoffeyK.A.AlgoeS.B.FirestineA.M.ArevaloJ.M.MaJ.ColeS.W.AÂ functional genomic perspective on human well-beingProc. Natl. Acad. Sci." exact="U. S." post="A110332013136841368910.1073/pnas.130541911023898182 GarciaL.P.DuarteE.Nonpharmaceutical interventions for tackling the COVID-19 epidemic in"/>
   <result pre="promote resilience versus susceptibility to social stressProc. Natl. Acad. Sci." exact="U. S." post="A111452014161361614110.1073/pnas.141519111125331895 HolmesL.ChinakaC.ElmiH.DeepikaK.PelaezL.EnwereM.AkinolaO.T.DabneyK.W.Implication of spiritual network support system in epigenomic"/>
   <result pre="age-related increases in the proinflammatory cytokine IL-6Proc. Natl. Acad. Sci." exact="U. S." post="A1001520039090909510.1073/pnas.153190310012840146 KiralyD.D.HornS.R.Van DamN.T.CostiS.SchwartzJ.Kim-SchulzeS.PatelM.HodesG.E.RussoS.J.MeradM.IosifescuD.V.CharneyD.S.MurroughJ.W.Altered peripheral immune profiles in treatment-resistant depression:"/>
   <result pre="of posttraumatic stress in Nepali child soldiersProc. Natl. Acad. Sci." exact="U. S." post="A1132920168156816110.1073/pnas.160130111327402736 KucharskiA.J.RussellT.W.DiamondC.LiuY.EdmundsJ.FunkS.EggoR.M.collab: Centre for Mathematical Modelling of Infectious Diseases"/>
   <result pre="modelling studyLancet Infect. Dis.205202055355810.1016/S1473-3099(20)30144-432171059 LeungK.WuJ.T.LiuD.LeungG.M.First-wave COVID-19 transmissibility and severity in" exact="China" post="outside Hubei after control measures, and second-wave scenario planning:"/>
   <result pre="of latent herpes simplex virus type 1Proc. Natl. Acad. Sci." exact="U. S." post="A951219987231723510.1073/pnas.95.12.72319618568 PerellÃ³M.ChaconF.CardinaliD.P.EsquifinoA.I.SpinediE.Effect of social isolation on 24-h pattern of"/>
   <result pre="leukocyte transcriptome via Î²-adrenergic induction of myelopoiesisProc. Natl. Acad. Sci." exact="U. S." post="A110412013165741657910.1073/pnas.131065511024062448 QuallsN.LevittA.KanadeN.Wright-JegedeN.DopsonS.BiggerstaffM.ReedC.UzicaninA.collab: CDC Community Mitigation Guidelines Work GroupCommunity mitigation"/>
   <result pre="Guidelines Work GroupCommunity mitigation guidelines to prevent pandemic influenza -" exact="United States," post="2017. MMWR. Recommendations and reports : Morbidity and mortality"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7326430\results\search\country\results.xml">
   <result pre="Coronavirus 2 (SARS-CoV-2) epidemic trajectories include China, Korea, Japan, Taiwan," exact="New Zealand" post="and Australia. However, the United States and many hard-hit"/>
   <result pre="include China, Korea, Japan, Taiwan, New Zealand and Australia. However," exact="the United States" post="and many hard-hit European countries, like Ireland, Italy, Spain,"/>
   <result pre="China, Korea, Japan, Taiwan, New Zealand and Australia. However, the" exact="United States" post="and many hard-hit European countries, like Ireland, Italy, Spain,"/>
   <result pre="States and many hard-hit European countries, like Ireland, Italy, Spain," exact="France" post="and the United Kingdom, currently appear content to merely"/>
   <result pre="hard-hit European countries, like Ireland, Italy, Spain, France and the" exact="United Kingdom," post="currently appear content to merely flatten the curve of"/>
   <result pre="SARS-CoV-2 transmission at national level, include China, Korea, Japan, Taiwan," exact="New Zealand" post="and Australia. In stark contrast, the United States and"/>
   <result pre="Korea, Japan, Taiwan, New Zealand and Australia. In stark contrast," exact="the United States" post="and many hard-hit European countries, like Ireland, Italy, Spain,"/>
   <result pre="Japan, Taiwan, New Zealand and Australia. In stark contrast, the" exact="United States" post="and many hard-hit European countries, like Ireland, Italy, Spain,"/>
   <result pre="States and many hard-hit European countries, like Ireland, Italy, Spain," exact="France" post="and the United Kingdom, currently appear content to merely"/>
   <result pre="hard-hit European countries, like Ireland, Italy, Spain, France and the" exact="United Kingdom," post="currently appear content to merely flatten the curve of"/>
   <result pre="reduction of transmission (Fig.Â 1A). Countries like Ireland, France, Spain," exact="Italy" post="and the United Kingdom, where daily incidence rates are"/>
   <result pre="(Fig.Â 1A). Countries like Ireland, France, Spain, Italy and the" exact="United Kingdom," post="where daily incidence rates are now slowly falling (RcÂ"/>
   <result pre="of transmission suppression may sound very high, several countries (notably" exact="China" post="(Tang etÂ al., 2020), which was hit first and"/>
   <result pre="Irish Aid, Deparment of Foreign Affairs and Trade, Government of" exact="Ireland" post="through the Embassy of Ireland in Tanzania (Award number"/>
   <result pre="Affairs and Trade, Government of Ireland through the Embassy of" exact="Ireland" post="in Tanzania (Award number IA-TAN/2020/086). Peer review under responsibility"/>
   <result pre="Trade, Government of Ireland through the Embassy of Ireland in" exact="Tanzania" post="(Award number IA-TAN/2020/086). Peer review under responsibility of KeAi"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7326458\results\search\country\results.xml">
   <result pre="of the first five COVID-19 patients treated with remdesivir in" exact="France" post="DubertMariea1â�ŽVisseauxBenoitbc1IserniaValentinaaBouadmaLilacdDeconinckLaurÃ¨neaPatrierJuliettecdWickyPaul-HenricdLe PluartDianeaKramerLauraeRiouxChristopheaLe HingratQuentinbcHouhou-FidouhNadhirabYazdanpanahYazdanacGhosnJadeac2LescureFrancois-Xavierac2[a], [b], [c], [d], [e], â�ŽCorresponding author"/>
   <result pre="for the coronavirus disease 2019 (COVID-19) outbreak that started in" exact="China" post="(Zhu et al., 2020). Treatment options investigated during previous"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7328712\results\search\country\results.xml">
   <result pre="Lun Ellis Hon, Department of Paediatrics and Adolescent Medicine, The" exact="Hong Kong" post="Childrenâ€™s Hospital, Hong Kong SAR, China. ehon@hotmail.com collection: 2020epub:"/>
   <result pre="of Paediatrics and Adolescent Medicine, The Hong Kong Childrenâ€™s Hospital," exact="Hong Kong" post="SAR, China. ehon@hotmail.com collection: 2020epub: 2020-6-692020-4-15received: 2020-4-20rev-recd: 2020-5-27accepted: 2020-5-28(C)"/>
   <result pre="East respiratory syndrome (MERS) outbreak caused by MERS-CoV occurred in" exact="Saudi Arabia." post="In the winter of 2019, the coronavirus disease 2019"/>
   <result pre="(COVID-19) outbreak caused by a novel coronavirus SARS-CoV-2 occurred in" exact="China" post="which rapidly spread worldwide causing a global pandemic. Up"/>
   <result pre="In the summer of 2012, another SARI broke out in" exact="Saudi Arabia," post="which was found to be caused by a new"/>
   <result pre="host, possibly pangolins.20,21 SARS-CoV-2 first emerged in Wuhan, Hubei Province," exact="China" post="in December 2019, after a cluster of pneumonia cases"/>
   <result pre="on Coronavirus Disease 2019 (COVID-19), out of 55,924 patients in" exact="China" post="with laboratory-confirmed COVID-19, only 13.8% had severe symptoms including"/>
   <result pre="blocking the export of newly constructed virions.45,69 A trial in" exact="China" post="involving more than 100 patients with Covid-19 showed that"/>
   <result pre="in populations at high risk of COVID-19 infections, such as" exact="Italy" post="and New York.75 Other antiviral treatments Other antiviral treatments"/>
   <result pre="requirement.92 According to The Diagnosis and Treatment Protocol from the" exact="China" post="National Health Commission and State Administration of Traditional Chinese"/>
   <result pre="anti-SARS activities in vitro.97â€&quot;99 Over 85% of SARS-CoV-2 patients in" exact="China" post="received TCM, which has been reviewed by Yang and"/>
   <result pre="largely disappeared since 2004 and MERS is primarily confined to" exact="Saudi Arabia" post="and Korea, there is little urgency in developing vaccines"/>
   <result pre="fatal case of middle east respiratory syndrome coronavirus infection in" exact="the United Arab Emirates," post="April 2014Am J Pathol2016186365265810.1016/j.ajpath.2015.10.02426857507 29HonKMERS = SARS?Hong Kong Med"/>
   <result pre="case of middle east respiratory syndrome coronavirus infection in the" exact="United Arab Emirates," post="April 2014Am J Pathol2016186365265810.1016/j.ajpath.2015.10.02426857507 29HonKMERS = SARS?Hong Kong Med"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci202063345746010.1007/s11427-020-1637-532009228 36collab: World Health OrganizationQ&amp;amp;A: similarities and differences"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7331074\results\search\country\results.xml">
   <result pre="rats. However, the underlying mechanisms remain largely unknown. Moreover, the" exact="China" post="Food and Drug Administration (CFDA) has recommended SFJD for"/>
   <result pre="(grant no. 2018YFE0102300), and the National Natural Science Foundation of" exact="China" post="(nos. 81773967 and 81803805). Helpful discussions with Prof. Li-Yang,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7331567\results\search\country\results.xml">
   <result pre="novel coronavirus had first been reported in Hubei province of" exact="China" post="in late 2019, where it caused a major cluster"/>
   <result pre="John SE, Mesecar AD. Broad-spectrum non-covalent coronavirus protease inhibitors. US20170313685" exact="United States" post="of America: Purdue Research Foundation 2017. 99SuH.YaoS.ZhaoW.Discovery of baicalin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332457\results\search\country\results.xml">
   <result pre="disease (now termed coronavirus disease 2019 [COVID-19]) emerged in Wuhan," exact="China" post="(Wang etÂ al., 2020a; Zhu etÂ al., 2020). This"/>
   <result pre="2020a; Zhu etÂ al., 2020). This disease spread rapidly across" exact="China" post="and to other countries. The World Health Organization recently"/>
   <result pre="(8%) (Jin etÂ al., 2020). In other studies performed in" exact="China" post="and Hong Kong, the proportion of COVID-19 patients (n"/>
   <result pre="etÂ al., 2020). In other studies performed in China and" exact="Hong Kong," post="the proportion of COVID-19 patients (n totalÂ = 254,"/>
   <result pre="SARS-CoV-2 infection and virus load in fecal samples from a" exact="Hong Kong" post="cohort: systematic review and meta-analysisGastroenterology202010.1053/j.gastro.2020.03.065Published online April 3, 2020"/>
   <result pre="or H1N1 InfluenzaClin. Infect. Dis.202010.1093/cid/ciaa709Published online June 4, 2020 GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.LiuL.ShanH.LeiC.L.HuiD.S.C.collab:" exact="China" post="Medical Treatment Expert Group for Covid-19Clinical characteristics of Coronavirus"/>
   <result pre="of bat and human intestinal organoids by SARS-CoV-2Nat. Med.2020202013 ZhuN.ZhangD.WangW.LiX.YangB.SongJ.ZhaoX.HuangB.ShiW.LuR.collab:" exact="China" post="Novel Coronavirus Investigating and Research TeamA Novel Coronavirus from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332875\results\search\country\results.xml">
   <result pre="of Biomolecular Structure and Dynamics YadavRohitasha#ImranMohammedb#DhamijaPuneetaSuchalKapilcHanduShailendraa[a], Department of Pharmacology, All" exact="India" post="Institute of Medical SciencesIndia[b], Department of Pharmacology, College of"/>
   <result pre="online at https://doi.org/10.1080/07391102.2020.1778536. CONTACT Rohitash Yadav rohitashyadav1@gmail.comDepartment of Pharmacology, All" exact="India" post="Institute of Medical Sciences, Rishikesh, India collection: 2020epub: 2020-6-6116received:"/>
   <result pre="rohitashyadav1@gmail.comDepartment of Pharmacology, All India Institute of Medical Sciences, Rishikesh," exact="India" post="collection: 2020epub: 2020-6-6116received: 2020-5-08accepted: 2020-5-29(C) Informa UK Limited, trading"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332877\results\search\country\results.xml">
   <result pre="Division, ICMR-National Institute of Nutrition, Jamai-Osmania (Post), Hyderabad 500007, Telangana," exact="India" post="collection: 2020epub: 2020-6-6114received: 2020-5-17accepted: 2020-6-03(C) Informa UK Limited, trading"/>
   <result pre="and effectual vaccine/drug is a crucial requisite. Gilead Sciences, Inc.," exact="United States" post="(US), has started the first clinical trial to investigate"/>
   <result pre="accounted for to treat the first case of 2019-nCOV in" exact="the US" post="effectively (Holshue etÂ al., 2020). Various provinces of China"/>
   <result pre="the US effectively (Holshue etÂ al., 2020). Various provinces of" exact="China" post="and India have initiated trials using Chloroquine or hydroxychloroquine,"/>
   <result pre="effectively (Holshue etÂ al., 2020). Various provinces of China and" exact="India" post="have initiated trials using Chloroquine or hydroxychloroquine, known anti-malarial"/>
   <result pre="of Favipiravir and Baloxavir Marboxil also carried out in Zhejiang," exact="China" post="(http://www.chictr.org.cn/showprojen.aspx?proj=49013). Wang etÂ al. (2020) have evaluated seven antiviral"/>
   <result pre="(Phase 3, clinical) trial to treat the 2019-nCoV Pneumonia in" exact="China" post="and Thailand (https://clinicaltrials.gov/ct2/show/NCT04261270; https://clinicaltrials.gov/ct2/show/NCT04303299). Clinical trials for the various"/>
   <result pre="clinical) trial to treat the 2019-nCoV Pneumonia in China and" exact="Thailand" post="(https://clinicaltrials.gov/ct2/show/NCT04261270; https://clinicaltrials.gov/ct2/show/NCT04303299). Clinical trials for the various antiviral drugs"/>
   <result pre="in treatment against MERS-CoV and EBOV (Siegel etÂ al., 2017;" exact="Jordan" post="etÂ al., 2018; Tchesnokov etÂ al., 2019). In coronaviruses,"/>
   <result pre="PillaiS. K. (2020). First case of 2019 novel coronavirus in" exact="the United States." post="The New England Journal of Medicine, 382(10), 929â€&quot;936. 10.1056/NEJMoa200119132004427"/>
   <result pre="K. (2020). First case of 2019 novel coronavirus in the" exact="United States." post="The New England Journal of Medicine, 382(10), 929â€&quot;936. 10.1056/NEJMoa200119132004427"/>
   <result pre="GerberS. I., &amp;amp; WatsonJ. T. (2018). Human coronavirus circulation in" exact="the United States" post="2014â€&quot;2017. Journal of Clinical Virology, 101, 52â€&quot;56. 10.1016/j.jcv.2018.01.01929427907 KumarB.,"/>
   <result pre="I., &amp;amp; WatsonJ. T. (2018). Human coronavirus circulation in the" exact="United States" post="2014â€&quot;2017. Journal of Clinical Virology, 101, 52â€&quot;56. 10.1016/j.jcv.2018.01.01929427907 KumarB.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332961\results\search\country\results.xml">
   <result pre="JaneiroRio de JaneiroBrazil Edited by: Akio Adachi, Kansai Medical University," exact="Japan" post="Reviewed by: Emi E. Nakayama, Osaka University, Japan; Melinda"/>
   <result pre="Nakayama, Osaka University, Japan; Melinda Ann Brindley, University of Georgia," exact="United States" post="*Correspondence: Luciana J. da Costa, ljcosta@micro.ufrj.br â€ These authors"/>
   <result pre="recent study that detected the virus in non-human primates from" exact="Malaysia" post="and revealed a high similarity between human and non-human"/>
   <result pre="et al., 2010). The recent epidemic that affected La RÃ©union" exact="Island" post="and other islands from Indian Ocean revealed a new"/>
   <result pre="strain derived from the ECSA group, which was named the" exact="India" post="Ocean lineage (IOL) (Njenga et al., 2008). The distribution"/>
   <result pre="each country individually. There is not autochthonous transmission reported in" exact="Chile" post="and Uruguay, only imported cases. The Asian strain first"/>
   <result pre="Uruguay, only imported cases. The Asian strain first reached South" exact="America" post="by French Guyana, but ECSA strain has arrived by"/>
   <result pre="by French Guyana, but ECSA strain has arrived by northeast" exact="Brazil" post="and got predominated in Brazil. The colors represent the"/>
   <result pre="(E2 protein) that arose independently in the IOL strain in" exact="India" post="are associated with a greater increase of CHIKV dissemination"/>
   <result pre="CHIKV and confirmed in sequences from Mexico, Trinidad, and the" exact="Dominican Republic," post="conferred a growth advantage in insect cell cultures to"/>
   <result pre="were restricted to Africa and Southeast Asia, in countries like" exact="South Africa," post="Democratic Republic of Congo, Uganda, Indonesia, Thailand, and India."/>
   <result pre="to Africa and Southeast Asia, in countries like South Africa," exact="Democratic Republic of Congo," post="Uganda, Indonesia, Thailand, and India. However, this scenario started"/>
   <result pre="Africa and Southeast Asia, in countries like South Africa, Democratic" exact="Republic of" post="Congo, Uganda, Indonesia, Thailand, and India. However, this scenario"/>
   <result pre="al., 2008). The disease then spread through Mombasa and the" exact="Comoros" post="islands. Other islands from the Indian Ocean were affected,"/>
   <result pre="for the first time in viruses that circulated during the" exact="La Reunion" post="epidemic (Tsetsarkin and Weaver, 2011). This adaptation of CHIKV"/>
   <result pre="the first time in viruses that circulated during the La" exact="Reunion" post="epidemic (Tsetsarkin and Weaver, 2011). This adaptation of CHIKV"/>
   <result pre="Ae. albopictus allowed that regions of the planet such as" exact="Italy" post="(during July and August 2007) (Fadila and Failloux, 2006;"/>
   <result pre="2007) (Fadila and Failloux, 2006; Rezza et al., 2007) and" exact="France" post="(during 2010 and 2014) (Grandadam et al., 2011; Delisle"/>
   <result pre="cases of autochthonous transmission of CHIKV on the island of" exact="Saint Martin" post="and Martinique Islands. In January 2014, CHIKV transmissions occurred"/>
   <result pre="transmission of CHIKV on the island of Saint Martin and" exact="Martinique" post="Islands. In January 2014, CHIKV transmissions occurred in several"/>
   <result pre="CHIKV transmissions occurred in several Caribbean islands, including Dominica, Anguilla," exact="British Virgin Islands," post="Saint Barthelemy, Guadeloupe, the Federation of St. Kitts and"/>
   <result pre="transmissions occurred in several Caribbean islands, including Dominica, Anguilla, British" exact="Virgin Islands," post="Saint Barthelemy, Guadeloupe, the Federation of St. Kitts and"/>
   <result pre="in several Caribbean islands, including Dominica, Anguilla, British Virgin Islands," exact="Saint Barthelemy," post="Guadeloupe, the Federation of St. Kitts and Nevis, Dominican"/>
   <result pre="Anguilla, British Virgin Islands, Saint Barthelemy, Guadeloupe, the Federation of" exact="St. Kitts and Nevis," post="Dominican Republic; and Saint Vincent and the Grenadines. The"/>
   <result pre="Saint Barthelemy, Guadeloupe, the Federation of St. Kitts and Nevis," exact="Dominican Republic;" post="and Saint Vincent and the Grenadines. The number of"/>
   <result pre="the Federation of St. Kitts and Nevis, Dominican Republic; and" exact="Saint Vincent and the Grenadines." post="The number of infected people overcame 30,000 cases in"/>
   <result pre="indicating that different from the explosion of CHIKV infections in" exact="La Reunion" post="related to viral adaptation to another mosquitoes vector, other"/>
   <result pre="that different from the explosion of CHIKV infections in La" exact="Reunion" post="related to viral adaptation to another mosquitoes vector, other"/>
   <result pre="Asian genotype and is closely related to strains circulating in" exact="Indonesia" post="(2007), China (2012), Yap Islands (2013), and Philippines (2013)"/>
   <result pre="and is closely related to strains circulating in Indonesia (2007)," exact="China" post="(2012), Yap Islands (2013), and Philippines (2013) (Lanciotti and"/>
   <result pre="circulating in Indonesia (2007), China (2012), Yap Islands (2013), and" exact="Philippines" post="(2013) (Lanciotti and Valadere, 2014). In February 2014, CHIKV"/>
   <result pre="already reached continental territory, when autochthonous infections were observed in" exact="French Guiana," post="the first country in South America to declare CHIKV"/>
   <result pre="were observed in French Guiana, the first country in South" exact="America" post="to declare CHIKV infection. At this point, the dispersion"/>
   <result pre="2014 to 2015, more than 16,000 individuals were infected in" exact="French Guiana." post="Importantly, infections presented several atypical cases, such as neurological"/>
   <result pre="(Bonifay et al., 2018; Figure 1B). CHIKV cases arose in" exact="Venezuela" post="in June 2014, from recent travelers from the Dominican"/>
   <result pre="in Venezuela in June 2014, from recent travelers from the" exact="Dominican Republic" post="or Haiti, and in July 2014, autochthonous transmissions were"/>
   <result pre="were reported. Phylogenetic analysis showed that the CHIKV circulating in" exact="Venezuela" post="clustered to the Asian genotype (Caribbean clade) and did"/>
   <result pre="associated with Ae. albopictus viral adaptation (Camacho et al., 2017)." exact="Ecuador" post="was another country that early confirmed community transmission of"/>
   <result pre="Berry et al. (2020) showed that CHIKV was introduced into" exact="Ecuador" post="at multiple time points in 2013â€&quot;2014, and these introductions"/>
   <result pre="the increasing influx of Venezuelan citizens. From 2014 to 2017," exact="Ecuador" post="reported 35,714 CHIKF cases. The transmission for two or"/>
   <result pre="has become endemic in this country. The CHIKF outbreaks in" exact="Ecuador" post="were associated with the Asian strain which harbors the"/>
   <result pre="changes. Since Ae. aegypti is the main mosquito vector in" exact="Ecuador" post="this data indicates that CHIKV had not acquired all"/>
   <result pre="(Berry et al., 2020). CHIKV autochthonous cases were confirmed in" exact="Colombia" post="in September 2014, and during the epidemics (2014â€&quot;2015) more"/>
   <result pre="The rate of new infections is decreasing over time, although" exact="Colombia" post="is the country with the third-highest number of infections,"/>
   <result pre="Asian strain and clustered with three distinct Asian strain branches:" exact="Panama" post="(Caribbean Colombia, Huila); Nicaragua (Cauca and Risaralda); and St."/>
   <result pre="with three distinct Asian strain branches: Panama (Caribbean Colombia, Huila);" exact="Nicaragua" post="(Cauca and Risaralda); and St. Barts (BogotÃ¡, D.C), which"/>
   <result pre="branches: Panama (Caribbean Colombia, Huila); Nicaragua (Cauca and Risaralda); and" exact="St. Barts" post="(BogotÃ¡, D.C), which may be the result of three"/>
   <result pre="al., 2019; Figure 1B). Records of CHIKV infection cases in" exact="Bolivia" post="are extremely scarce. However, CHIKV circulated in this country"/>
   <result pre="diagnosed only) (Escalera-Antezana et al., 2018; Figure 1B). Since 2014," exact="Peru" post="has reported 27 confirmed cases of CHIKV, all of"/>
   <result pre="CHIKV, all of them imported from neighboring countries such as" exact="Venezuela" post="and Colombia (Ministerio de Salud, DirecciÃ³n General de EpidemiologÃ­a,"/>
   <result pre="of them imported from neighboring countries such as Venezuela and" exact="Colombia" post="(Ministerio de Salud, DirecciÃ³n General de EpidemiologÃ­a, 2015). This"/>
   <result pre="confirmed in the country according to PAHO. Different regions of" exact="Peru" post="present divergent rates of CHIKV infection, varying from 4.6"/>
   <result pre="arboviruses is negatively impacted. The first CHIKV imported case in" exact="Chile" post="was described in 2014, from the Dominican Republic. Since"/>
   <result pre="imported case in Chile was described in 2014, from the" exact="Dominican Republic." post="Since then, all cases reported in Chile were imported,"/>
   <result pre="from the Dominican Republic. Since then, all cases reported in" exact="Chile" post="were imported, mainly from travelers returning from the Caribbean"/>
   <result pre="the country. The first local transmission of the CHIKV in" exact="Brazil" post="that occurred in September 2014, at the city of"/>
   <result pre="Oiapoque, state of AmapÃ¡, localized in the Northern region of" exact="Brazil" post="was related to the Asian lineage. Soon after this"/>
   <result pre="ECSA genotypes co-circulate in the North and Northeast regions of" exact="Brazil" post="(Nunes et al., 2015). However, CHIKV ECSA strain spread"/>
   <result pre="Amazon region. Interestingly, while the north and southeast regions of" exact="Brazil" post="had the majority of CHIKV cases in 2016, Roraima,"/>
   <result pre="cases in 2016, Roraima, for instance, the northernmost state of" exact="Brazil" post="located in the Amazon basin, only had its exponential"/>
   <result pre="The moderate disease was observed in mice infected with a" exact="Sri Lanka" post="CHIKV isolate harboring an opal stop codon to arginine"/>
   <result pre="moderate disease was observed in mice infected with a Sri" exact="Lanka" post="CHIKV isolate harboring an opal stop codon to arginine"/>
   <result pre="CHIKV isolate harboring an opal stop codon to arginine change." exact="Sri Lanka" post="isolate shares high similarity with the Caribbean isolate, and"/>
   <result pre="isolate harboring an opal stop codon to arginine change. Sri" exact="Lanka" post="isolate shares high similarity with the Caribbean isolate, and"/>
   <result pre="CHIKV isolates related to the most recent epidemics in Latin" exact="America" post="will allow us to understand the pathogenic potential of"/>
   <result pre="In a study with rhesus macaques comparing the CHIKV strains" exact="La Reunion" post="(CHIKV-LR) and Western Africa 37997 (CHIKV-37997), T-cell and antibody"/>
   <result pre="a study with rhesus macaques comparing the CHIKV strains La" exact="Reunion" post="(CHIKV-LR) and Western Africa 37997 (CHIKV-37997), T-cell and antibody"/>
   <result pre="recognized as a non-lethal infection, however during the outbreak in" exact="Reunion" post="Island in 2005â€&quot;2006, the greater number of patients with"/>
   <result pre="as a non-lethal infection, however during the outbreak in Reunion" exact="Island" post="in 2005â€&quot;2006, the greater number of patients with atypical"/>
   <result pre="reported upon recent reemergence and emergence of CHIKV worldwide. In" exact="La Reunion" post="Island, clinical features that had never been associated with"/>
   <result pre="upon recent reemergence and emergence of CHIKV worldwide. In La" exact="Reunion" post="Island, clinical features that had never been associated with"/>
   <result pre="be associated with the IOL circulating strain of CHIKV. In" exact="French Guiana," post="the introduction of the CHIKV Asian strain was associated"/>
   <result pre="from the first decade of the 21st century in Kenya," exact="La Reunion" post="islands, and the Caribbean. Strikingly, the CHIKV genotype responsible"/>
   <result pre="the first decade of the 21st century in Kenya, La" exact="Reunion" post="islands, and the Caribbean. Strikingly, the CHIKV genotype responsible"/>
   <result pre="In fact, as reviewed here, several studies conducted with the" exact="La Reunion" post="CHIKV isolate CHIKV-LR, demonstrated its higher capacity to induce"/>
   <result pre="fact, as reviewed here, several studies conducted with the La" exact="Reunion" post="CHIKV isolate CHIKV-LR, demonstrated its higher capacity to induce"/>
   <result pre="introduced into the country. While in other regions of South" exact="America" post="and in Central America, the Asian strain was responsible"/>
   <result pre="the CoordenaÃ§Ã£o de AperfeiÃ§oamento de Pessoal de NÃ­vel Superior â€&quot;" exact="Brasil" post="(CAPES) â€&quot; Finance Code 001. This work was also"/>
   <result pre="al. (2020). The origins of dengue and chikungunya viruses in" exact="Ecuador" post="following increased migration from Venezuela and Colombia.BMC Evol. Biol.20:3110.1186/s12862-020-1596-1598"/>
   <result pre="dengue and chikungunya viruses in Ecuador following increased migration from" exact="Venezuela" post="and Colombia.BMC Evol. Biol.20:3110.1186/s12862-020-1596-1598 BonifayT.PrinceC.NeyraC.DemarM.RoussetD.KallelH.et al. (2018). Atypical and"/>
   <result pre="J.63313â€&quot;315.6298956 CamachoD.ReyesJ.NegredoA.HernÃ¡ndezL.SÃ¡nchez-SecoM.ComachG. (2017). Asian genotype of Chikungunya virus circulating in" exact="Venezuela" post="during 2014.Acta Trop.17488â€&quot;90. 10.1016/j.actatropica.2017.06.02628690146 CarbajoA. E.VezzaniD. (2015). Waiting for"/>
   <result pre="Serious acute chikungunya virus infection requiring intensive care during the" exact="Reunion" post="Island outbreak in 2005-2006.Crit. Care Med.362536â€&quot;2541. 10.1097/CCM.0b013e318183f2d218679124 Leparc-GoffartI.NougairedeA.CassadouS.PratC.de LamballerieX."/>
   <result pre="acute chikungunya virus infection requiring intensive care during the Reunion" exact="Island" post="outbreak in 2005-2006.Crit. Care Med.362536â€&quot;2541. 10.1097/CCM.0b013e318183f2d218679124 Leparc-GoffartI.NougairedeA.CassadouS.PratC.de LamballerieX. (2014)."/>
   <result pre="al. (2007). A major epidemic of chikungunya virus infection on" exact="Reunion" post="Island, France, 2005-2006.Am. J. Trop. Med. Hyg.77727â€&quot;731. 10.4269/ajtmh.2007.77.72717978079 RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA."/>
   <result pre="10.1128/jvi.66.12.7049-7058.19921433506 SissokoD.MalvyD.GiryC.DelmasG.PaquetC.GabrieP.et al. (2008). Outbreak of Chikungunya fever in Mayotte," exact="Comoros" post="archipelago, 2005-2006.Trans. R. Soc. Trop. Med. Hyg.102780â€&quot;786. 10.1016/j.trstmh.2008.02.01818400240 SjÃ¶bergM.GaroffH."/>
   <result pre="Emergence of the East-Central-South African genotype of Chikungunya virus in" exact="Brazil" post="and the city of Rio de Janeiro may have"/>
   <result pre="(2009). Neurological manifestations in Chikungunya: about 23 cases collected in" exact="Reunion" post="Island.Rev. Neurol.16548â€&quot;51. 10.1016/j.neurol.2008.06.00918835614 TsetsarkinK. A.ChenR.LealC. (2011). Chikungunya virus emergence"/>
   <result pre="10.4103/0974-777X.8352621887052 Villero-WolfY.MattarS.Puerta-GonzÃ¡lezA.ArrietaG.MuskusC.HoyosR.et al. (2019). Genomic epidemiology of Chikungunya virus in" exact="Colombia" post="reveals genetic variability of strains and multiple geographic introductions"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7333627\results\search\country\results.xml">
   <result pre="treat COVID-19. In the early outbreaks of COVID-19 in Wuhan," exact="China" post="occurred in late 2019, Chen etÂ al. reported that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7334131\results\search\country\results.xml">
   <result pre="coronavirus (2019-nCoV) broke out in December 2019 in Wuhan City," exact="China" post="[1, 2]. Before long spread to Europe, Northern Italy"/>
   <result pre="City, China [1, 2]. Before long spread to Europe, Northern" exact="Italy" post="has become one of the areas of highest incidence,"/>
   <result pre="diagnosed also in five of 206 patients with SARS in" exact="Singapore" post="[8]. Nevertheless, several critically ill Covid-19 patients treated at"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7335243\results\search\country\results.xml">
   <result pre="Organization (WHO) [13]. Although the number of confirmed cases in" exact="China" post="has decreased a lot from late February 2020, and"/>
   <result pre="The grand total case fatality rate of global cases outside" exact="China" post="is 1.31% [26]. The US had also recorded the"/>
   <result pre="laboratories. As for the diagnostic criteria currently formulated by the" exact="China" post="National Health Commission, nasopharyngeal cancer and oropharyngeal swab tests"/>
   <result pre="peripheral lung distribution [45]. Some of the data published from" exact="China" post="showed that in 21 primal chest CT scans, a"/>
   <result pre="guanine analog is favipiravir (T-705), which has been approved in" exact="Japan" post="for the therapy of influenza virus infections and has"/>
   <result pre="vitro antiviral activity compared with lopinavir and ritonavir [90]. In" exact="the United States," post="the first case of SARS-CoV-2 infection was reported, and"/>
   <result pre="antiviral activity compared with lopinavir and ritonavir [90]. In the" exact="United States," post="the first case of SARS-CoV-2 infection was reported, and"/>
   <result pre="of COVID-19 infection in China, the National Health Commission of" exact="China" post="also called on convalescent patients to donate blood for"/>
   <result pre="Academy of Military Sciences of the People's Liberation Army of" exact="China" post="Phase II (ChiCTR2000030906) / Inactivated vaccine Beijing Institute of"/>
   <result pre="is making provision for the first phase of trials in" exact="the United States" post="and China [153]. 6.2 mRNA-based vaccines The mRNA vaccine"/>
   <result pre="making provision for the first phase of trials in the" exact="United States" post="and China [153]. 6.2 mRNA-based vaccines The mRNA vaccine"/>
   <result pre="the first phase of trials in the United States and" exact="China" post="[153]. 6.2 mRNA-based vaccines The mRNA vaccine is a"/>
   <result pre="new coronavirus of probable bat originNature579202027027332015507 7CyranoskiD.Did pangolins spread the" exact="China" post="coronavirus to peopleNature202010.1038/d41586-020-00364-2 8ZhangT.WuQ.ZhangZ.Probable pangolin origin of SARS-CoV-2 associated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7335248\results\search\country\results.xml">
   <result pre="outbreak, caused by a new paramyxovirus (Nipah virus), occurred in" exact="Malaysia" post="and Singapore. During 2002 to 2003, a novel coronavirus"/>
   <result pre="finally the viral pneumonia outbreak, caused by 2019-nCoV, started in" exact="China" post="in December 2019 and officially declared as a pandemic"/>
   <result pre="syndrome. Zidovudine (AZT) was the first anti-HIV drug approved in" exact="the United States" post="in 1986. Since then, many research efforts to treat"/>
   <result pre="Zidovudine (AZT) was the first anti-HIV drug approved in the" exact="United States" post="in 1986. Since then, many research efforts to treat"/>
   <result pre="causing respiratory illnesses, with a 34% mortality, firstly identified in" exact="Saudi Arabia" post="in 2012 [43]. Up to date, there are still"/>
   <result pre="proteinChem. Biol.7200066967610.1016/S1074-5521(00)00012-010980447 83DrakeJ.W.HollandJ.J.Mutation rates among RNA virusProc. Natl. Acad. Sci." exact="U. S." post="A961999139101391310.1073/pnas.96.24.1391010570172 84ClouserC.L.PattersonS.E.ManskyL.M.Exploiting drug repositioning for discovery of a novel"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7336121\results\search\country\results.xml">
   <result pre="Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran," exact="Iran" post="and Department of Biotechnology, School of Advanced Technologies in"/>
   <result pre="Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran," exact="Iran" post="(F. Yarian). f.yarian@sbmu.ac.iralibakhshi@sbmu.ac.ir pmc-release: 2020-7-7ppub: 2020-9epub: 2020-7-786106760106760received: 2020-5-19rev-recd: 2020-6-15accepted:"/>
   <result pre="has been evaluated in a phase II/III clinical trial in" exact="India" post="against rabies G glycoprotein. This product was developed for"/>
   <result pre="SARS-CoV-2. A small clinical trial was performed during SARS-CoV-2 in" exact="China" post="that showed tocilizumab that have a good efficacy in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7337839\results\search\country\results.xml">
   <result pre="LondonUK Correspondence:â€ƒN.P. Somasundaram, Diabetes and Endocrine Unit, National Hospital of" exact="Sri Lanka," post="Colombo 10, 01000. E-mail: noelsomasundaram@gmail.com. collection: 2020-8-8epub: 2020-7-7pmc-release: 2020-7-748bvaa082received:"/>
   <result pre="were seen in the thyroid [87]. A recent report from" exact="Italy" post="on a young female who recovered from SARS-CoV-2 describes"/>
   <result pre="found in ethnic minorities with increased skin melanin in the" exact="United Kingdom" post="and the United States [127]. In a provisional analysis"/>
   <result pre="minorities with increased skin melanin in the United Kingdom and" exact="the United States" post="[127]. In a provisional analysis of COVID-19-related deaths in"/>
   <result pre="with increased skin melanin in the United Kingdom and the" exact="United States" post="[127]. In a provisional analysis of COVID-19-related deaths in"/>
   <result pre="higher COVID 19 mortality seen in these ethnicities in the" exact="United Kingdom" post="[128]. Several assumptions can be made regarding the role"/>
   <result pre="male and 2 female patients who died of SARS in" exact="China" post="revealed that virus RNA material or antigens were not"/>
   <result pre="in the hospital with the highest nosocomial infection rate in" exact="Taiwan" post="in 2003. J Clin Microbiol2006;44(2):359-365.16455884 32.WangSF, ChenKH, ChenM, et"/>
   <result pre="and MRSA bacteraemia in a district general hospital in the" exact="United Kingdom." post="Endocrinol Diabetes Metab Case Rep. 2019;2019. doi:10.1530/EDM-19-0044. 81.YuR, WeiMFalse"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7338124\results\search\country\results.xml">
   <result pre="neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the" exact="Republic of" post="Korea KimHeui ManLeeNamjooKimMi-SeonKangChunhttp://orcid.org/0000-0003-4562-5533ChungYoon-Seokrollstone93@korea.kr[], grid.418967.50000 0004 1763 8617Division of Viral"/>
   <result pre="infection [1], which are stockpiled by some countries, including the" exact="Republic of" post="Korea, against unexpected pandemics. NAIs suppress the action of"/>
   <result pre="commonly used drugs for patients with influenza-like illnesses in the" exact="Republic of" post="Korea, help to relieve clinical symptoms within 2 days"/>
   <result pre="Baloxavir, a cap-dependent endonuclease inhibitor, was also recently licensed in" exact="the United States," post="following Japan [3]. However, since most recently detected type"/>
   <result pre="a cap-dependent endonuclease inhibitor, was also recently licensed in the" exact="United States," post="following Japan [3]. However, since most recently detected type"/>
   <result pre="inhibitor, was also recently licensed in the United States, following" exact="Japan" post="[3]. However, since most recently detected type A influenza"/>
   <result pre="the A(H1N1)pdm09 reference vaccine [13] and other isolates from the" exact="Republic of" post="Korea. NA inhibition assay A fluorescence-based neuraminidase inhibition assay"/>
   <result pre="a virus similar to a 2018â€&quot;2019 season-isolated A(H1N1)pdm09 in the" exact="Republic of" post="Korea. A/Korea/S0002/2019 and A/Korea/S0003/2019 HA sequences best matched with"/>
   <result pre="compared to A/Brisbane/02/2018 and clustered with isolated viruses in 2019â€‰year," exact="Republic of" post="Korea (ROK), whereas A/Korea/S0003/2019 virus belonged to 6B.1A4 harboring"/>
   <result pre="swine influenza viruses collected from April to June 2019 in" exact="the United States." post="The antigenic drift in immunocompromised patients may allow swine"/>
   <result pre="influenza viruses collected from April to June 2019 in the" exact="United States." post="The antigenic drift in immunocompromised patients may allow swine"/>
   <result pre="seasonal a (H3N2) and B viruses to Oseltamivir in Guangdong," exact="China" post="between 2009 and 2014Sci Rep20177848810.1038/s41598-017-08282-628814737 12.HoffmannEStechJGuanYWebsterRGPerezDRUniversal primer set for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7338534\results\search\country\results.xml">
   <result pre="University of California San Francisco, [6], [7], grid.452939.0Permanent Mission of" exact="Bolivia" post="to the United Nations, epub: 2020-7-7pmc-release: 2020-7-7collection: 2020558received: 2020-6-18accepted:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7338588\results\search\country\results.xml">
   <result pre="National de la SantÃ© et de la Recherche MÃ©dicale (INSERM)," exact="France" post="Reviewed by: Sergio Rosenzweig, National Institutes of Health (NIH),"/>
   <result pre="France Reviewed by: Sergio Rosenzweig, National Institutes of Health (NIH)," exact="United States;" post="Carlos RodrÃ­guez Gallego, University Hospital of Gran Canaria Dr."/>
   <result pre="Carlos RodrÃ­guez Gallego, University Hospital of Gran Canaria Dr. Negrin," exact="Spain" post="*Correspondence: Trine H. Mogensen trine.mogensen@biomed.au.dk This article was submitted"/>
   <result pre="ethnicities (150â€&quot;154). Allele typing of 37 probable SARS patients in" exact="Taiwan" post="identified an association between HLA-B*4601 and SARS-CoV infection (155);"/>
   <result pre="in a study of 90 serologically confirmed SARS-CoV patients in" exact="Hong Kong" post="(156, 157). The latter study instead identified an association"/>
   <result pre="in TMPRSS2 as possible disease modulators of SARS-CoV-2 infection in" exact="Italy" post="(168). Although these findings necessitate functional validation, it gives"/>
   <result pre="vivo SARS-CoV model (199). Camostat mesylate is widely used in" exact="Japan" post="for chronic pancreatitis and postoperative reflux esophagitis (200, 201),"/>
   <result pre="reflux esophagitis (200, 201), and currently, a clinical trial in" exact="Denmark" post="investigating the impact of this compound on COVID-19 is"/>
   <result pre="has received funding for COVID-19 research by Independent Research Council" exact="Denmark" post="(0214-00001B) and Grosserer L. F. Foght's foundation. References References"/>
   <result pre="10.1126/scitranslmed.aac422726424569 31.BajemaKLOsterAMMcGovernOLLindstromSStengerMRAndersonTCet al.. Persons evaluated for 2019. novel Coronavirus -" exact="United States," post="January. 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:166â€&quot;70."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7339094\results\search\country\results.xml">
   <result pre="than unvaccinated ones [24]. Differently, a cross-sectional study performed in" exact="the United Arab Emirates" post="showed a seroprevalence in the pediatric population quite similar"/>
   <result pre="unvaccinated ones [24]. Differently, a cross-sectional study performed in the" exact="United Arab Emirates" post="showed a seroprevalence in the pediatric population quite similar"/>
   <result pre="[24]. Differently, a cross-sectional study performed in the United Arab" exact="Emirates" post="showed a seroprevalence in the pediatric population quite similar"/>
   <result pre="[2]. A retrospective study, performed in two cancer centers in" exact="the USA" post="and Mexico on hematological patients hospitalized for influenza symptoms"/>
   <result pre="study, performed in two cancer centers in the USA and" exact="Mexico" post="on hematological patients hospitalized for influenza symptoms between 2009"/>
   <result pre="respiratory viruses. According to the 2013 Infectious Diseases Society of" exact="America" post="Guidelines, an intramuscular influenza vaccine is recommended for all"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7339606\results\search\country\results.xml">
   <result pre="University of Agriculture, [5], grid.43519.3a0000 0001 2193 6666Department of Chemistry," exact="United Arab Emirates" post="University, epub: 2020-7-7pmc-release: 2020-7-7collection: 202018275received: 2020-4-23accepted: 2020-6-25(C) , Open"/>
   <result pre="Agriculture, [5], grid.43519.3a0000 0001 2193 6666Department of Chemistry, United Arab" exact="Emirates" post="University, epub: 2020-7-7pmc-release: 2020-7-7collection: 202018275received: 2020-4-23accepted: 2020-6-25(C) , Open"/>
   <result pre="interspecies viral transmission. In support, it has been reported in" exact="China" post="and other countries that bats are the primary reservoirs"/>
   <result pre="use against SARS-CoV-2 [41, 42]. Soon after the COVID-19 outbreak," exact="China" post="initiated several in vitro studies and clinical trials to"/>
   <result pre="that has been approved by National Medical Products Administration of" exact="China" post="to use against SARS-CoV-2 [43]. A number of drugsâ€&quot;such"/>
   <result pre="relation with all the other isolates of SARS-CoV-2 reported from" exact="Hong Kong" post="and the USA (MN975262.1, MN997409.1, MN994467.1, MN988713.1; Fig.Â 1)."/>
   <result pre="the other isolates of SARS-CoV-2 reported from Hong Kong and" exact="the USA" post="(MN975262.1, MN997409.1, MN994467.1, MN988713.1; Fig.Â 1). Fig.Â 1 Dendrogram"/>
   <result pre="from clade III is closely related to its relatives from" exact="Hong Kong" post="and USA (circled in blue). For accessions, origin and"/>
   <result pre="each other and clustered together. SARS-CoV-2 whole-genome sequences reported from" exact="Hong Kong" post="and USA (MN975262.1, MN997409.1, MN994467.1, MN988713.1) revealed close relation"/>
   <result pre="SARS-CoV-2 RdRp proteins relatively clustered together, which included isolates from" exact="Hong Kong," post="USA and Wuhan (Fig.Â 5). It is suggested that"/>
   <result pre="Research, Innovations and Commercialization (ORIC), University of Agriculture, Faisalabad, Punjab," exact="Pakistan" post="for provision of funds to conduct this research work."/>
   <result pre="strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in" exact="China" post="reveal bats as a reservoir for acute, self-limiting infection"/>
   <result pre="coronavirus (COVID-19) [Updated 2020 Mar 8]. In: StatPearls [Internet]. Treasure" exact="Island" post="(FL): StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK554776/. 10.YinYWunderinkRGMERS, SARS and other"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7340244\results\search\country\results.xml">
   <result pre="KD cases:17 the seasonality of KD, with winter peaks in" exact="Japan" post="and winter-spring predominance in the USA or in many"/>
   <result pre="KD, with winter peaks in Japan and winter-spring predominance in" exact="the USA" post="or in many other temperate areas, is highly suggestive"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7341697\results\search\country\results.xml">
   <result pre="The recent past has already shown dependency on vital drugs." exact="China" post="produces 80% of the heparin used worldwide. African swine"/>
   <result pre="nobody questions the boundless availability of high-tech measures and interventions." exact="Germany" post="and Austria are the countries with the highest per"/>
   <result pre="the boundless availability of high-tech measures and interventions. Germany and" exact="Austria" post="are the countries with the highest per capita number"/>
   <result pre="amount of patients flooding the hospitals in countries like Italy," exact="Spain" post="or France requiring intensive care treatment made us aware"/>
   <result pre="patients flooding the hospitals in countries like Italy, Spain or" exact="France" post="requiring intensive care treatment made us aware that we"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7342332\results\search\country\results.xml">
   <result pre="The recently concluded Lopinavir Trial for Suppression of SARS-Cov-2 in" exact="China" post="(LOTUS China) COVID-19 was conducted based on its in"/>
   <result pre="trials usually include patients who are most severely affected. LOTUS" exact="China" post="trial[1] included adult patients 18 years of age or"/>
   <result pre="a potentially beneficial therapy is available. For example, in LOTUS" exact="China" post="open-label RCT, families of 31 patients (8.6%) did not"/>
   <result pre="of objective endpoint â€&quot; reduction of viral load. The LOTUS" exact="China" post="trial was initiated early in the evolution of COVID-19"/>
   <result pre="in the previous trials of influenza infection.[7] In the LOTUS" exact="China" post="study, gastrointestinal AEs were more common in lopinavirâ€&quot;ritonavir group"/>
   <result pre="outcomes making estimation of sample size difficult. In the LOTUS" exact="China" post="trial, the initial sample size was 160, assuming that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7343578\results\search\country\results.xml">
   <result pre="in hospitalized patients in USA and Spain, but not in" exact="China" post="or Italy In this setting, the series by Petrilli"/>
   <result pre="patients in USA and Spain, but not in China or" exact="Italy" post="In this setting, the series by Petrilli et al."/>
   <result pre="diabetes in the general population in their age range in" exact="the US." post="Thus, confirming what was found with Influenza A (H1N1)"/>
   <result pre="when diabetes was present [3]. Consistent with that, data from" exact="China" post="found that diabetes accounted for 8%â€&quot;16% of hospitalized patients"/>
   <result pre="8%â€&quot;16% of hospitalized patients [10, 11], being diabetes prevalence across" exact="China" post="around 5% [12]. A large report of the Centers"/>
   <result pre="report of the Centers for Disease Control and Prevention of" exact="the United States" post="showed that 78% of COVID-19 patients in ICUs had"/>
   <result pre="of the Centers for Disease Control and Prevention of the" exact="United States" post="showed that 78% of COVID-19 patients in ICUs had"/>
   <result pre="having diabetes it reached 7.3% [1]. An additional report from" exact="China" post="including 1590 hospitalized cases analyzed a composite endpoint including"/>
   <result pre="overestimation of the prevalence of case fatality. As indicated, in" exact="China" post="the overall fatality rate was 2.3% and in people"/>
   <result pre="of developing severe forms of COVID-19, as first studies from" exact="China" post="[1] and Italy [34] did not provide data on"/>
   <result pre="forms of COVID-19, as first studies from China [1] and" exact="Italy" post="[34] did not provide data on body weight and"/>
   <result pre="[36]. The Intensive Care National Audit &amp;amp; Research Centre in" exact="United Kingdom" post="observed that 72.1% of patients with confirmed COVID-19 were"/>
   <result pre="the American Heart Association and the Heart Failure Society of" exact="America" post="and the American Society of hypertension have released policy"/>
   <result pre="138 Hospitalized Patients With 2019 Novel coronavirus-infected pneumonia in Wuhan," exact="China" post="JAMA 2020; 7.Remuzzi A, Remuzzi G. COVID-19 and Italy:"/>
   <result pre="Httpswwwcdcgovcoronavirus2019-Ncovhcpclinical-Guid.-Manag.-Patientshtml. 2020 [cited 2020 Apr 3]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html 14.GuanWLiangWZhaoYLiangHChenZLiYLiuXQChenRCTangCLWangTOuCQLiLChenPYSangLWangWLiJFLiCCOuLMChengBXiongSNiZYXiangJHuYLiuLShanHLeiCLPengYXWeiLLiuYHuYHPengPWangJMLiuJYChenZLiGZhengZJQiuSQLuoJYeCJZhuSYChengLLYeFLiSYZhengJPZhangNFZhongNSHeJXcollab:" exact="China" post="Medical Treatment Expert Group for COVID-19Comorbidity and its impact"/>
   <result pre="Toronto areaJAMA.20032892801280912734147 86.UyekiTMMehtaAKDaveyRTLiddellAMWolfTVetterPet al.Clinical Management of Ebola Virus Disease in" exact="the United States" post="and EuropeN Engl J Med201637463664626886522 87.Bossoni S, Chiesa L,"/>
   <result pre="areaJAMA.20032892801280912734147 86.UyekiTMMehtaAKDaveyRTLiddellAMWolfTVetterPet al.Clinical Management of Ebola Virus Disease in the" exact="United States" post="and EuropeN Engl J Med201637463664626886522 87.Bossoni S, Chiesa L,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7343716\results\search\country\results.xml">
   <result pre="of TechnologyVelloreIndia Edited by: Noor Ahmad Shaik, King Abdulaziz University," exact="Saudi Arabia" post="Reviewed by: Jees Sebastian, The State University of New"/>
   <result pre="Reviewed by: Jees Sebastian, The State University of New Jersey," exact="United States;" post="Priya Chandran, Calicut Medical College, India *Correspondence: C. George"/>
   <result pre="of New Jersey, United States; Priya Chandran, Calicut Medical College," exact="India" post="*Correspondence: C. George Priya Doss georgepriyadoss@vit.ac.in This article was"/>
   <result pre="equation-count: ref-count: page-count: word-count: The 21st Century Epidemic Outbreaks in" exact="India" post="Since the beginning of the 21st century, Asian countries"/>
   <result pre="prone to endemic diseases. This has been particularly true in" exact="India" post="due to its increasing population, with the country having"/>
   <result pre="last two decades. A detailed timeline of the outbreaks in" exact="India" post="since 21st century is provided in Figure 1. At"/>
   <result pre="and is threatening humankind. SARS did not spread much in" exact="India" post="(1). As per the WHO-Epidemic and Pandemic Alert and"/>
   <result pre="antibodies to ZIKV have been detected in healthy people in" exact="India" post="(3). This might have occured as a result of"/>
   <result pre="other flaviviruses cannot be denied. The most recent outbreak that" exact="India" post="faced was that of NiV disease during mid-2018. As"/>
   <result pre="contained in Kerala. Figure 1 Timeline of epidemic outbreak in" exact="India" post="in 21st century. Data Source from WHO website (https://www.who.int/csr/don/archive/country/ind/en/)."/>
   <result pre="in 21st century. Data Source from WHO website (https://www.who.int/csr/don/archive/country/ind/en/). Kerala," exact="India" post="Is Vulnerable to Viral and Non-Viral Outbreaks The state"/>
   <result pre="faced several epidemics. Although the first outbreak of Chikungunya in" exact="India" post="was reported in 1963 in Kolkata, after 32 years,"/>
   <result pre="(accessed February 3, 2020). 3.KhaiboullinaSUppalTMartynovaERizvanovABaranwalMVermaSC. History of ZIKV infections in" exact="India" post="and management of disease outbreaks. Front Microbiol. (2018) 9:2126."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344048\results\search\country\results.xml">
   <result pre="on Sharing Avian Influenza Data (GISAID) is headquartered in Munich," exact="Germany" post="and is a publicâ€&quot;private partnership project between German government"/>
   <result pre="our dataset into 6 different geographic areas: Europe (20.31%), North" exact="America" post="(21.13%), Asia (35.37%), Oceania (20.86%), South America (16.63%) and"/>
   <result pre="Europe (20.31%), North America (21.13%), Asia (35.37%), Oceania (20.86%), South" exact="America" post="(16.63%) and Africa (10.35%). The European group comprises of"/>
   <result pre="SARS-CoV-2 infected patient data from the following countries: Austria, Belgium," exact="Czech Republic," post="Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland,"/>
   <result pre="Luxembourg, Netherlands, Poland, Portugal,, Slovakia, Slovenia, Spain, Sweden, Switzerland, and" exact="United Kingdom." post="The North American group contains genomes from the United"/>
   <result pre="and United Kingdom. The North American group contains genomes from" exact="the United States" post="and Canada. The Asian group comprises genomes obtained from"/>
   <result pre="United Kingdom. The North American group contains genomes from the" exact="United States" post="and Canada. The Asian group comprises genomes obtained from"/>
   <result pre="located in China, Indonesia, Pakistan, Philippines, Taiwan, Turkey, Kuwait, Georgia," exact="South Korea," post="Japan, Iran, India, Thailand, Hong Kong, Malaysia, Singapore, and"/>
   <result pre="Taiwan, Turkey, Kuwait, Georgia, South Korea, Japan, Iran, India, Thailand," exact="Hong Kong," post="Malaysia, Singapore, and Vietnam. The Oceanian group comprises genomes"/>
   <result pre="Malaysia, Singapore, and Vietnam. The Oceanian group comprises genomes from" exact="Australia" post="and New Zealand. South America includes Brazil, Peru, Chile,"/>
   <result pre="and Vietnam. The Oceanian group comprises genomes from Australia and" exact="New Zealand." post="South America includes Brazil, Peru, Chile, Colombia, Argentina, and"/>
   <result pre="Oceanian group comprises genomes from Australia and New Zealand. South" exact="America" post="includes Brazil, Peru, Chile, Colombia, Argentina, and Ecuador (Fig.Â"/>
   <result pre="Zealand. South America includes Brazil, Peru, Chile, Colombia, Argentina, and" exact="Ecuador" post="(Fig.Â 2aâ€&quot;c). Fig.Â 2 (a, b) Phylogenetic evolutionary relationships"/>
   <result pre="six different regions; Asia (orange, 35.37%), Oceania (purple, 20.86%), North" exact="America" post="(brown, 21.13%), Europe (blue, 20.31%), Africa (red, 10.35%) and"/>
   <result pre="(brown, 21.13%), Europe (blue, 20.31%), Africa (red, 10.35%) and South" exact="America" post="(black, 16.63%). (d) Phylogenetic relationship of CoVs based on"/>
   <result pre="28,882 and 28,883) were subdivided into 2 geographical areas: South" exact="America" post="(nâ€‰=â€‰307) and Africa (nâ€‰=â€‰191). Previously confirmed mutations at positions"/>
   <result pre="alignment between SARS-CoV and SARS-CoV-2 3CLproÂ from Wuhan (Wu) and" exact="United States of America" post="(US) patients sharing more than 90% sequence identity. c"/>
   <result pre="and SARS-CoV-2 3CLproÂ from Wuhan (Wu) and United States of" exact="America" post="(US) patients sharing more than 90% sequence identity. c"/>
   <result pre="the SARS-Cov-2, and our study corroborates these mutations in South" exact="America" post="and Africa regions [43]. Drug discovery and vaccine development"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344049\results\search\country\results.xml">
   <result pre="8945 4455State Key Laboratory of Quality Research in Chinese Medicine," exact="Macau" post="Institute for Applied Research in Medicine and Health, Macau"/>
   <result pre="Medicine, Macau Institute for Applied Research in Medicine and Health," exact="Macau" post="University of Science and Technology, [2], [3], epub: 2020-7-7pmc-release:"/>
   <result pre="resulting in fatal diseases in humans [3]. In December 2019," exact="China" post="faced another destructing SARS-CoV-2 outbreak leading to major health"/>
   <result pre="reported at the end of December 2019 from Wuhan Hubei," exact="China" post="[4]. The causative agent was announced by Chinese authority"/>
   <result pre="supported by studies found 500 CoVs identification in bats in" exact="China" post="[8]. Bats are exceptional food available in a few"/>
   <result pre="effective treatment is available for COVID-19, but in this regard," exact="China" post="has approximately two thousand old histories of using traditional"/>
   <result pre="effect on the lethal infection of a Hemagglutinating virus of" exact="Japan" post="(HVJ), as well as has antiviral activity on the"/>
   <result pre="medicine that was approved for the treatment of sepsis in" exact="China" post="[30]. XBJI shows a protective effect in patients with"/>
   <result pre="of 40% infected individuals having acute respiratory distress syndrome in" exact="France" post="while 62.2% H7N9 avian influenza-infected patients were treated with"/>
   <result pre="modulating the expression of pro-inflammatory cytokines and is approved in" exact="Russia" post="and China for their inhibitory effects on SARS-CoV-2 [88]."/>
   <result pre="expression of pro-inflammatory cytokines and is approved in Russia and" exact="China" post="for their inhibitory effects on SARS-CoV-2 [88]. Interestingly in"/>
   <result pre="granules (approval number of State Food and Drug Administration of" exact="China" post="(SFDA) Z20160001), Lianhua Qingwen granules (SFDA approval number Z20100040),"/>
   <result pre="have been approved by the National Medical Products Administration of" exact="China" post="and have proved inclusion for the treatment of the"/>
   <result pre="the current outbreak convalescent plasma therapy in uncontrolled studies in" exact="China" post="indeed indicated a beneficial treatment for patients on mechanical"/>
   <result pre="FDCT grants from the Science and Technology Development Fund of" exact="Macao" post="(Project code: 003/2018/A1 grant to F.X.X). Availability of data"/>
   <result pre="Li X, Yang B, Song J, et al. for the" exact="China" post="Novel Coronavirus Investigating and Research Team (2020) A novel"/>
   <result pre="an epitope-based synthetic long peptide vaccine to counteract the novel" exact="China" post="Coronavirus (2019-nCoV). 2020. 76.SkalickovaSHegerZKrejcovaLPekarikVBastlKJandaJet al.Perspective of use of antiviral"/>
   <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci" exact="China" post="Life Sci.2020111 85.LiuZGuoZWangGZhangDHeHLiGet al.Evaluation of the efficacy and safety"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344768\results\search\country\results.xml">
   <result pre="and then reached humans at a seafood market in Wuhan," exact="China" post="[17,18,19,20]. Though, it cannot be said with full convection"/>
   <result pre="manifestation [21,22]. The earliest cases of COVID-19 were reported from" exact="China" post="in December 2019 [1]. WHO failed to recognize the"/>
   <result pre="through urban sewage is always there [9]. Lockdown employed by" exact="China" post="to mitigate the disease has shown positive results in"/>
   <result pre="growth rate and increasing the doubling time of COVID-19 in" exact="China" post="[31]. Although everyone is equally susceptible to SARS-CoV-2, the"/>
   <result pre="[35]. A research group at the Harbin Veterinary Research Institute," exact="China" post="reported that cats and ferrets were susceptible to SARS-CoV-2"/>
   <result pre="UK, Italy, France, Germany, India, Turkey, Iran, Peru, Chile, Canada," exact="China" post="and Saudi Arabia) are contributing to 80% of the"/>
   <result pre="(USA, Brazil, Russia, Spain, UK, Italy, France, Germany, India, Turkey," exact="Iran" post="and Peru) to total deaths due to corona infection"/>
   <result pre="seven of the above countries (USA, Brazil, Russia, Spain, UK," exact="Italy" post="and France) are contributing to more than 72% of"/>
   <result pre="100,000 is similar on the basis of age and sex." exact="Germany" post="does not have much variation based on sex and"/>
   <result pre="number of infected cases [41]. The daily growth rate excluding" exact="China" post="reflects that the rate of increase is quite stable;"/>
   <result pre="Also, 30.8% of 565 Japanese citizens evacuated out of Wuhan," exact="China" post="were reported to be asymptomatic carriers of the disease"/>
   <result pre="have entered clinical trials in different countries (Figure 2). In" exact="the USA," post="trials have begun for an RNA vaccine, mRNA-1273 developed"/>
   <result pre="trials have begun for an RNA vaccine, mRNA-1273 developed by" exact="the US" post="National Institute of Allergy and Infectious Diseases (NIAID) in"/>
   <result pre="CanSino Biologics (Tianjin, China), has entered clinical trials in Wuhan," exact="China" post="and a DNA based vaccine developed by Inovio Pharmaceuticals"/>
   <result pre="by Inovio Pharmaceuticals has entered Phase I clinical trials in" exact="South Korea" post="[52]. Indian company Serum India Limited is also participating"/>
   <result pre="I clinical trials in South Korea [52]. Indian company Serum" exact="India" post="Limited is also participating in a ChAdOx1-S vaccine development"/>
   <result pre="come forward to develop a vaccine against COVID-19. CureVac, TÃ¼bingen," exact="Germany" post="and Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA/Beijing Advaccine"/>
   <result pre="Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA/Beijing Advaccine Biotechnology Co., Beijing," exact="China" post="with funding from the Coalition for Epidemic Preparedness Innovations"/>
   <result pre="separate nucleic acid vaccines [48]. Janssen (Johnson &amp;amp; Johnson), Beerse," exact="Belgium" post="and Codagenix Inc., Farmingdale NY, USA/Serum Institute of India,"/>
   <result pre="and Codagenix Inc., Farmingdale NY, USA/Serum Institute of India, Pune," exact="India" post="in collaboration with the University of Queensland, are working"/>
   <result pre="USA; Clover Biopharmaceuticals, Chengdu, China; Vaxart Inc, San Francisco, CA," exact="United States" post="and Sanofi Pharmaceuticals, Paris, France are in efforts to"/>
   <result pre="Inc, San Francisco, CA, United States and Sanofi Pharmaceuticals, Paris," exact="France" post="are in efforts to develop vaccines using recombinant proteins"/>
   <result pre="spread to many countries, owing to extensive international connectivity of" exact="China" post="to the world via international trade and tourism [23,24]."/>
   <result pre="Biotechnology, India) for monetary support and Central University of Rajasthan," exact="India" post="for providing infrastructure and facilities that has help in"/>
   <result pre="would like to thank the University Grants Commission, Govt of" exact="India" post="(GoI) for UGC-BSR Research Start up Grant. Conflicts of"/>
   <result pre="Vector ChAdOx1-S University of Oxford/AstraZeneca, Cambridge, U.K. /Serum Institute of" exact="India" post="Phase2b/3 2020-001228-32 Phase 1/2 2020-001072-15 Non Replicating Viral Vector"/>
   <result pre="Type 5 Vector CanSino Biological Inc., China/Beijing Institute of Biotechnology," exact="China" post="Phase 2 ChiCTR2000031781 Phase 1 ChiCTR2000030906 RNA Lipid nanoparticles"/>
   <result pre="Inactivated Wuhan Institute of Biological Products, China/Sinopharm Group Co., Ltd.," exact="China" post="Phase 1/2 ChiCTR2000031809 Inactivated Inactivated Beijing Institute of Biological"/>
   <result pre="Inactivated Beijing Institute of Biological Products/ Sinopharm Group Co., Ltd.," exact="China" post="Phase 1/2 ChiCTR2000032459 Inactivated Inactivated + Alum Sinovac Biotech"/>
   <result pre="Phase 1/2 ChiCTR2000032459 Inactivated Inactivated + Alum Sinovac Biotech Ltd.," exact="China" post="Phase 1/2 NCT04383574 NCT04352608 Protein Subunit Full length recombinant"/>
   <result pre="NCT04368988 RNA 3 LNP-mRNAs BioNTech, Germany/Shanghai Fosun Pharmaceutical Co. Ltd.," exact="China" post="/Pfizer, USA Phase 1/2 2020-001038-36 NCT04368728 Inactivated Inactivated Institute"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344800\results\search\country\results.xml">
   <result pre="from a febrile rhesus macaque in the Zika forest of" exact="Uganda" post="through a yellow fever surveillance network in the area"/>
   <result pre="The first human case of infection with ZIKV occurred in" exact="Uganda" post="in 1962â€&quot;3 [3]. Recently, the virus has become more"/>
   <result pre="widely known due to a series of epidemics starting in" exact="Micronesia" post="in 2007 and the eventual emergence of ZIKV in"/>
   <result pre="Micronesia in 2007 and the eventual emergence of ZIKV in" exact="Brazil" post="in 2014 [4]. Since then, the ZIKV has spread"/>
   <result pre="IgG assay. Samples from prevalent areas included patients from Latin" exact="America" post="with suspected Zika infection (N = 396) and patients"/>
   <result pre="Samples from non-endemic countries included presumed negative samples from Latin" exact="America" post="(collected prior to Zika epidemics; N = 94), samples"/>
   <result pre="Specificity(95% CI) ElecsysÂ® Zika IgG Suspected Zika infection from Latin" exact="America" post="396 284 55 36 21 93.11 (89.67â€&quot;95.69) 100 (93.51â€&quot;100)"/>
   <result pre="(97.59â€&quot;100) Anti-Zika Virus ELISA IgG Suspected Zika infection from Latin" exact="America" post="396 305 21 36 34 100.00 (98.80â€&quot;100) 38.18 (25.41â€&quot;52.27)"/>
   <result pre="Discrepant Samples after Resolution Specificity (95% CI) Samples from Latin" exact="America" post="before Zika epidemics 94 2 92 0 100 (96.07â€&quot;100)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344926\results\search\country\results.xml">
   <result pre="respiratory syndrome coronavirus-2 (SARS-CoV-2), outbreak from Wuhan City, Hubei province," exact="China" post="in 2019 has become an ongoing global health emergency."/>
   <result pre="Coronaviruses On 23 February 2020, the lockdown of Wuhan in" exact="China" post="finally caught peopleâ€™s attention and alarmed the public all"/>
   <result pre="8000 people, with a fatality rate of 10% in southern" exact="China" post="in 2003. Horseshoe bats are the natural reservoir for"/>
   <result pre="East respiratory syndrome coronavirus (MERS-CoV), which was first reported by" exact="Saudi Arabia" post="in 2012 [6]. MERS coronaviruses can cause both human"/>
   <result pre="against the influenza virus, and was approved and stockpiled in" exact="Japan" post="against novel influence pandemics [18,19,20]. This drug was recently"/>
   <result pre="Ebola and the novel coronavirus (SARS-CoV-2) [21]. Clinical trials in" exact="China" post="have led the effort in testing the efficacy of"/>
   <result pre="Favipiravir. Even though the drug was not initially approved in" exact="the USA" post="for the treatment of influenza, several clinical trials have"/>
   <result pre="the disease in central healthcare infrastructures. One study in Wuhan," exact="China" post="focused on the progression of COVID-19 in the lungs"/>
   <result pre="that was verified by the Ministry of Health in the" exact="Czech Republic" post="for use in clinical settings (Figure 3i) [66]. Prusa"/>
   <result pre="in the community, with over 250,000 downloads. Researchers at the" exact="Georgia" post="Institute of Technology (Georgia Tech) and Emory University worked"/>
   <result pre="that can be mass-produced using injection molding (Figure 3j). The" exact="Georgia" post="Tech team produced up to 2000 rigid frames per"/>
   <result pre="developed a $1500.00 device, which was donated to hospitals in" exact="Peru" post="[77]. MIT developed a prototype based on a design"/>
   <result pre="3000 devices to the New York City hospitals [79]. A" exact="Georgia" post="Tech team, led by Dr. Shannon Yee, partnered with"/>
   <result pre="Bennett 560. The company plans on introducing the device in" exact="the USA" post="under the EUA, and to ramp up production to"/>
   <result pre="come from the WHO, National Health Commission of the Peopleâ€™s" exact="Republic of" post="China (NHC), the COVID Tracking Project, European Centre for"/>
   <result pre="the WHO, National Health Commission of the Peopleâ€™s Republic of" exact="China" post="(NHC), the COVID Tracking Project, European Centre for Disease"/>
   <result pre="healthcare resources, such as the number of beds available in" exact="the US," post="can be circumvented by taking appropriate social distance measures."/>
   <result pre="the prevalence of COVID-19 in a few countries, including the" exact="United Kingdom," post="the United States of America (USA), Australia, Canada, and"/>
   <result pre="of COVID-19 in a few countries, including the United Kingdom," exact="the United States" post="of America (USA), Australia, Canada, and Italy. This research"/>
   <result pre="COVID-19 in a few countries, including the United Kingdom, the" exact="United States of America" post="(USA), Australia, Canada, and Italy. This research can help"/>
   <result pre="few countries, including the United Kingdom, the United States of" exact="America" post="(USA), Australia, Canada, and Italy. This research can help"/>
   <result pre="Wellcome Fund. A.F.C. was supported by start-up funds from the" exact="Georgia" post="Institute of Technology and Emory University. Conflicts of Interest"/>
   <result pre="with Enhanced Hepatitis in FerretsJ. Virol.200478126721267610.1128/JVI.78.22.12672-12676.200415507655 37.HouserK.V.BroadbentA.J.GretebeckL.VogelL.LamirandeE.W.SuttonT.BockK.W.MinaiM.OrandleM.MooreI.N.et al.Enhanced inflammation in" exact="New Zealand" post="white rabbits when MERS-CoV reinfection occurs in the absence"/>
   <result pre="snorkel-inspired Pneumask. The Pneumask has deployed 2600 units all across" exact="the United States" post="(US), with concentrations in New York, Massachusetts, and California;"/>
   <result pre="Pneumask. The Pneumask has deployed 2600 units all across the" exact="United States" post="(US), with concentrations in New York, Massachusetts, and California;"/>
   <result pre="personnel when no FDA-approved face shields are available; (j) The" exact="Georgia" post="Tech 3D-printed rigid frame and a disposable face shield"/>
   <result pre="shield design; (k) The MIT origami disposable face shield. The" exact="Georgia" post="Tech and MIT labs have collaborated to produce almost"/>
   <result pre="one million face shields to be used by hospitals around" exact="the US;" post="(l) An illustration of the transparent acrylic barrier concept"/>
   <result pre="quarantine rules. The model predicted the infected case count of" exact="the US" post="with quarantine control and the exponential increase of cases"/>
   <result pre="under various quarantine measures, as implemented in Wuhan, Italy, and" exact="South Korea." post="All of them led to a plateau of cases"/>
   <result pre="of them led to a plateau of cases sooner than" exact="the US" post="model; (e) COVID Scholar website for scientific article search."/>
   <result pre="social distancing, for the months of March to January in" exact="the US;" post="(e) Projection of the number of active cases, those"/>
   <result pre="from COVID-19, simulated between May 3 to May 31 in" exact="the US;" post="(f) A rendition of the billiards balls model by"/>
   <result pre="of mortality cases related to COVID-19, influenza, and pneumonia in" exact="the US," post="as visualized by the CDC; (i) A rendition of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7345039\results\search\country\results.xml">
   <result pre="countries. The use of Artemisia annua was also boosted by" exact="Madagascar" post="in the form of an herbal drink, widely known"/>
   <result pre="possible reason for a higher mortality rate for CoVID-19 in" exact="Italy" post="compared to China could be the fact that there"/>
   <result pre="a higher mortality rate for CoVID-19 in Italy compared to" exact="China" post="could be the fact that there is a higher"/>
   <result pre="facilities is still an issue in rural areas, particularly in" exact="the United States." post="Although there has been a trend of an increasing"/>
   <result pre="is still an issue in rural areas, particularly in the" exact="United States." post="Although there has been a trend of an increasing"/>
   <result pre="Besides a lack of ICU availability, the healthcare in rural" exact="America" post="has noted a significant disparity in terms of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7345143\results\search\country\results.xml">
   <result pre="2009 implicated Blacks with survival disadvantage relative to Whites in" exact="the United States," post="COVID-19 currently indicates comparable disparities. We aimed to: (a)"/>
   <result pre="implicated Blacks with survival disadvantage relative to Whites in the" exact="United States," post="COVID-19 currently indicates comparable disparities. We aimed to: (a)"/>
   <result pre="CmI indicated Blacks/AA with 34% of the total mortality in" exact="the United States," post="albeit their 13% population size. The COVID-19 CF was"/>
   <result pre="indicated Blacks/AA with 34% of the total mortality in the" exact="United States," post="albeit their 13% population size. The COVID-19 CF was"/>
   <result pre="in COVID-19 CF and mortality with Blacks/AA disproportionately affected across" exact="the United States." post="COVID-19 (SARS-COV2) race/ethnicity case fatality mortality health disparities United"/>
   <result pre="COVID-19 CF and mortality with Blacks/AA disproportionately affected across the" exact="United States." post="COVID-19 (SARS-COV2) race/ethnicity case fatality mortality health disparities United"/>
   <result pre="United States. COVID-19 (SARS-COV2) race/ethnicity case fatality mortality health disparities" exact="United States" post="1. Introduction The understanding of the social gradient, implying"/>
   <result pre="residing in poor neighborhoods as well as racial/ethnic minorities in" exact="the US" post="[13]. Observed in the 1918â€&quot;1920 flu pandemic mortality was"/>
   <result pre="racial minorities are disproportionately affected by almost all pathologies in" exact="the US" post="except tuberculosis (TB), cystic fibrosis, suicide, alcoholism and unintentional"/>
   <result pre="A recent review of race and 1918 influenza pandemic in" exact="the USA" post="observed lower transmission (13% vs. 25%) among Blacks but"/>
   <result pre="in Blacks/AA residing in apartment complexes and crowded neighborhoods in" exact="the US." post="The higher case fatality among Blacks/AA reflects the poorer"/>
   <result pre="urgent equitable preparedness in addressing mortality and case fatality in" exact="the United States." post="With structural or organized racism as the main predisposition"/>
   <result pre="equitable preparedness in addressing mortality and case fatality in the" exact="United States." post="With structural or organized racism as the main predisposition"/>
   <result pre="sought to: (a) examine the frequency of confirmed cases in" exact="the United States" post="and, by region and states, namely Illinois, Michigan, Louisiana,"/>
   <result pre="to: (a) examine the frequency of confirmed cases in the" exact="United States" post="and, by region and states, namely Illinois, Michigan, Louisiana,"/>
   <result pre="case fatality mitigation remains the norm in a pandemic in" exact="the USA." post="2.1. Study Design Data simulation and cross-sectional ecologic design"/>
   <result pre="case fatality of SARS-COV2, the causative pathogen in COVID-19 in" exact="the United States" post="as per 04/14/20 was 4.11%, with New York, California,"/>
   <result pre="fatality of SARS-COV2, the causative pathogen in COVID-19 in the" exact="United States" post="as per 04/14/20 was 4.11%, with New York, California,"/>
   <result pre="the case fatality was 6.70% globally, the case fatality in" exact="the US" post="was 4.94%. The cumulative Incidence (CmI) of COVID-19 mortality"/>
   <result pre="(Milwaukee County). While Blacks/AA represent 13% of the population of" exact="the US" post="as per US Census projection (2020), overall mortality was"/>
   <result pre="Jersey, with New York as the number one epicenter in" exact="the US." post="The case fatality in MI as per 15 April"/>
   <result pre="of Blacks/AA was 6.85%. With the case of fatality in" exact="the US," post="estimated at 4.93% during the same period, COVID-19 mortality"/>
   <result pre="CI, 1.35â€&quot;3.88. 4. Discussion With the current COVID-19 pandemic, and" exact="the USA" post="with the highest confirmed cases and mortality globally as"/>
   <result pre="race information, Blacks/AA despite the population size of 13% in" exact="the US," post="represented 34% of all deaths in the referenced states"/>
   <result pre="has demonstrated that, despite the 13% population of Blacks/AA in" exact="the US," post="this population represented an estimated 34% of all deaths"/>
   <result pre="flu or influenza pandemic of the 1918 through 1919 in" exact="the US" post="observed a lower cumulative incidence of the disease among"/>
   <result pre="cases or morbidity among Blacks, due to decreased effort by" exact="the US" post="public health system, local and county health departments and"/>
   <result pre="identification of COVID-19 burden and engagement with this subpopulation of" exact="the US" post="society via national public health initiative, will enhance a"/>
   <result pre="of the geographic locations with the highest case fatality in" exact="the US," post="7.90% as per mid-April 2020. The long-term exposure to"/>
   <result pre="the outcome of morbidity and mortality in Black/AA populations in" exact="the US" post="[33]. Since chronic health conditions render the biologic system"/>
   <result pre="employment opportunity and the departure from structural racism, will render" exact="the US" post="population more vulnerable to public health and healthcare crises"/>
   <result pre="authors would like to thank the department of health in" exact="the US" post="with available data on demographics such as race/ethnicity for"/>
   <result pre="Natl. Acad. Sci. USA2016113138391384410.1073/pnas.161283811327872284 16.collab: National Center for Health StatisticsHealth," exact="United States," post="2018Hyattsville, MD2019Available online: https://www.cdc.gov/nchs/data/hus18.pdf?(accessed on 20 April 2020) 17.collab:"/>
   <result pre="of Health and Human ServicesCDC Health Disparities and Inequalities Report:" exact="United States," post="2013MMWR201362184 29.PennerL.A.IreneV.BlairI.V.AlbrechtT.DovidioJ.F.Reducing Racial Health Care Disparities: A Social Psychological"/>
   <result pre="differentials in COVID-19 mortality in selected states and regions in" exact="the United States," post="April 2020. Notes: The solid line indicates the risk"/>
   <result pre="in COVID-19 mortality in selected states and regions in the" exact="United States," post="April 2020. Notes: The solid line indicates the risk"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7345211\results\search\country\results.xml">
   <result pre="Syndrome Coronavirus 2 (SARS-CoV-2, formerly known as 2019-nCoV), appeared in" exact="China" post="for the first time, and subsequently spread worldwide [1,2]."/>
   <result pre="Health (HK) Real-time fluorescent RT-PCR kit 2019-nCoV USA EUA; CE-IVD;" exact="Canada" post="CerTest Biotec, S.L VIASURE SARS-CoV-2 Real Time PCR Kit"/>
   <result pre="DAAN Gene Co Detection Kit for 2019 Novel Coronavirus CE-IVD;" exact="China" post="Edinburgh Genetics COVID-19 Real-time PCR Testing Kit CE-IVD; China"/>
   <result pre="CE-IVD; China Edinburgh Genetics COVID-19 Real-time PCR Testing Kit CE-IVD;" exact="China" post="FDA Gencurix Inc. GenePro COVID-19 Detection Test CE-IVD Genomictree,"/>
   <result pre="Inc. STANDARD M nCoV Real-Time Detection Kit CE-IVD; USA EUA;" exact="Brazil" post="TIB/Roche Diagn. LightMix Modular SARS-CoV-2 (COVID19) RUO TIB/Roche Diagn"/>
   <result pre="BIOSENSOR STANDARD M nCoV Real-Time Detection kit USA EUA; CE-IVD;" exact="Brazil" post="Seegene, Inc. Allplex 2019-nCoV assay USA EUA; CE-IVD; Canada"/>
   <result pre="CE-IVD; Brazil Seegene, Inc. Allplex 2019-nCoV assay USA EUA; CE-IVD;" exact="Canada" post="Sansure Biotech Inc Novel Coronavirus (2019-nCoV) Nucleic Acid USA"/>
   <result pre="Biotech Inc Novel Coronavirus (2019-nCoV) Nucleic Acid USA EUA; CE-IVD;" exact="China" post="Sente Biolab Sentelig COVID-19 qRT PCR Detection Kit CE-IVD"/>
   <result pre="CE-IVD Shanghai ZJ Bio-Tech Liferiver Novel Coronavirus Multiplex RT-PCR CE-IVD," exact="China" post="FDA Thermo Fisher TaqPathâ&quot;¢ COVID-19 CE-IVD RT-PCR Kit CE-IVD"/>
   <result pre="CE-IVD BioMedomics, Inc COVID-19 IgM-IgG Dual Antibody Rapid Test CE-IVD;" exact="India" post="Cellex Inc. Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test CE-IVD;"/>
   <result pre="Inc. Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test CE-IVD; USA; Australia;" exact="Brazil" post="Changsha Sinocare Inc. SARS-CoV-2 Antibody Test Strip (Colloidal Gold"/>
   <result pre="Biological Technology 2019-nCoV Ab Test (Colloidal Gold) IgM/IgG CE-IVD; China," exact="Brazil" post="InTec Products, Inc. Rapid SARS-CoV-2 Antibody Test IgG or"/>
   <result pre="CE-IVD SD BIOSENSOR, Inc. STANDARD Q COVID-19 Ag Test CE-IVD," exact="Brasil" post="ELISA DRG International, Inc. COVID-19 lgG, EIA-6146 IgG Serum"/>
   <result pre="ELISA Kit CE-IVD EUROIMMUN AG Anti-SARS-CoV-2 ELISA (IgA) IgA CE-IVD;" exact="Brazil" post="immunofluorescent SD BIOSENSOR, Inc. STANDARD F COVID-19 Ag FIA"/>
   <result pre="Inc. STANDARD F COVID-19 Ag FIA Antigen Nasopharyngeal swab CE-IVD," exact="Brasil" post="Shenzhen Bioeasy Biotechnology Co., Ltd. Bioeasy 2019-nCoV Ag Fluorescence"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7346995\results\search\country\results.xml">
   <result pre="in Asia https://orcid.org/0000-0002-0760-0071LeeJae-Hyun1https://orcid.org/0000-0001-8918-9353LeeYoungsoo2https://orcid.org/0000-0001-7276-8519LeeSuh-Young3https://orcid.org/0000-0002-6308-2045Van BeverHugo4https://orcid.org/0000-0002-8553-812XLouHongfei56https://orcid.org/0000-0002-0910-9884ZhangLuo567https://orcid.org/0000-0003-2614-0303ParkHae-Sim2[1], Korea[2], Korea[3], Korea[4], Singapore[5], China[6], China[7]," exact="China" post="Correspondence to Hae-Sim Park, MD, PhD. Department of Allergy"/>
   <result pre="coronavirus disease 2019 (COVID-19) outbreak has started from Wuhan in" exact="China" post="in late December 2019; the World Health Organization (WHO)"/>
   <result pre="our region: 5.5% in China, 2.2% in Korea, 2.5% in" exact="Japan" post="and 0.1% in Singapore, which is lower than in"/>
   <result pre="Japan and 0.1% in Singapore, which is lower than in" exact="the US" post="and European countries.2 Higher mortality rates (8%â€&quot;15%) were reported"/>
   <result pre="patients who were hospitalized due to confirmed COVID-19 in Wuhan," exact="China" post="had asthma or other allergic diseases such as AR,"/>
   <result pre="Institute (KHIDI), funded by the Ministry of Health &amp;amp; Welfare," exact="Republic of" post="Korea (HI16C0992). Disclosure: There are no financial or other"/>
   <result pre="epidemiological feature of coronavirus disease 2019 (COVID-19) Outbreak in the" exact="Republic of" post="Korea from January 19 to March 2, 2020J Korean"/>
   <result pre="36collab: CDC COVID-19 Response TeamCoronavirus disease 2019 in Children â€&quot;" exact="United States," post="February 12â€&quot;April 2, 2020MMWR Recomm Rep202069422426 37BousquetJAkdisCJutelMBachertCKlimekLAgacheIet al.Intranasal corticosteroids"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7347348\results\search\country\results.xml">
   <result pre="reported to the World Health Organization (WHO) Country Office in" exact="China" post="(The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020)."/>
   <result pre="of a pandemic. The widest report on COVID-19 diffusion in" exact="China" post="revealed a 0.9 % incidence of cancer among 1099"/>
   <result pre="recent report from the National Health Commission of the Peopleâ€™s" exact="Republic of" post="China, which collected 1590 cases of laboratory-confirmed COVID-19 admitted"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7348116\results\search\country\results.xml">
   <result pre="by traditional Chinese medicine in preventing and treating COVID-19 in" exact="China" post="LiQingwei1WangHan12LiXiuyang1ZhengYujiao13WeiYu13ZhangPei1DingQiyou13LinJiaran14TangShuang14ZhaoYikun5ZhaoLinhuamelonzhao@163.com1TongXiaolintongxiaolin@vip.163.com1[1], grid.410318.f0000 0004 0632 3409Department of Endocrinology, Guangâ€™anmen Hospital,"/>
   <result pre="China LiQingwei1WangHan12LiXiuyang1ZhengYujiao13WeiYu13ZhangPei1DingQiyou13LinJiaran14TangShuang14ZhaoYikun5ZhaoLinhuamelonzhao@163.com1TongXiaolintongxiaolin@vip.163.com1[1], grid.410318.f0000 0004 0632 3409Department of Endocrinology, Guangâ€™anmen Hospital," exact="China" post="Academy of Chinese Medical Sciences, [2], grid.411863.90000 0001 0067"/>
   <result pre="(accessed May 28, 2020) 2.National Health Commission of the Peopleâ€™s" exact="Republic of" post="China. The latest situation of the COVID-19 situation as"/>
   <result pre="2020; 153242 18.The State Council Information Office of the Peopleâ€™s" exact="Republic of" post="China. The State Council Information Office held a conference"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7349555\results\search\country\results.xml">
   <result pre="difficult to calculate. Recent estimates based on aggregate data from" exact="China" post="adjusted for demography and under-ascertainment bias suggest that the"/>
   <result pre="the most significant risk factors among patients with COVID-19 in" exact="China" post="and Europe [7,8,9]. In the United States disproportionately higher"/>
   <result pre="among patients with COVID-19 in China and Europe [7,8,9]. In" exact="the United States" post="disproportionately higher rates of hospitalization and death have been"/>
   <result pre="patients with COVID-19 in China and Europe [7,8,9]. In the" exact="United States" post="disproportionately higher rates of hospitalization and death have been"/>
   <result pre="placebo-controlled, multicenter trial that included 237 patients with Covid-19 from" exact="China" post="admitted to hospital with an interval from symptom onset"/>
   <result pre="analysis from another randomized, controlled trial involving 1063 patients in" exact="the United States" post="have also been recently made available. Preliminary results indicate"/>
   <result pre="from another randomized, controlled trial involving 1063 patients in the" exact="United States" post="have also been recently made available. Preliminary results indicate"/>
   <result pre="is approved for the treatment of influenza virus infections in" exact="Japan" post="and China. The results of a small open-label non-randomized"/>
   <result pre="results of a small open-label non-randomized control study conducted in" exact="China" post="in Covid-19 have been published recently [147]. In the"/>
   <result pre="analysis of data from 368 hospitalized patients with Covid-19 across" exact="the United States" post="investigated the risk of death and the need for"/>
   <result pre="of data from 368 hospitalized patients with Covid-19 across the" exact="United States" post="investigated the risk of death and the need for"/>
   <result pre="far, the use of inhalatory INF-Î±1b has been used in" exact="China" post="but no clinical data are available regarding its efficacy."/>
   <result pre="and epidemiological survey of the largest dengue outbreak in Southern" exact="Taiwan" post="in 2015Int. J. Infect. Dis.201988889910.1016/j.ijid.2019.09.00731521850 76.OliveiraR.A.de Oliveira-FilhoE.F.FernandesA.I.BritoC.A.MarquesE.T.TenorioM.C.GilL.H.Previous dengue or"/>
   <result pre="of a randomized clinical trialmedRxiv202010.1101/2020.03.22.20040758 155.MagagnoliJ.NarendranS.PereiraF.CummingsT.HardinJ.W.SuttonS.S.AmbatiJ.Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covid-19medRxiv202010.1101/2020.04.16.20065920 156.MahevasM.TranV.-T.RoumierM.ChabrolA.PauleR.GuillaudC.GallienS.LepeuleR.SzwebelT.-A.LescureX.et al.No evidence of clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7350360\results\search\country\results.xml">
   <result pre="A novel strain of coronoviridae (SARS-CoV-2) was reported in Wuhan" exact="China" post="in December 2019. Initially, infection presented with a broad"/>
   <result pre="coronaviridae (SARS-CoV-2) was first reported in the Wuhan province of" exact="China" post="in December 2019. As of 8 May 2020, it"/>
   <result pre="with liver failure, without other apparent cause, recently described in" exact="Germany" post="[31]. However, direct viral damage has been contested by"/>
   <result pre="al. reported on 10 SARS-CoV-2-positive renal transplant recipients in Wuhan," exact="China" post="[51]. All were admitted to hospital with significant progressive"/>
   <result pre="53.PereiraM.R.MohanS.CohenD.J.HusainS.A.DubeG.K.RatnerL.E.ArcasoyS.AversaM.M.BenvenutoL.J.DadhaniaD.M.et al.COVID-19 in solid organ transplant recipients: Initial report from" exact="the US" post="epicenterArab. Archaeol. Epigr.202010.1111/ajt.15941 54.LippiG.PlebaniM.Procalcitonin in patients with severe coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7351052\results\search\country\results.xml">
   <result pre="2020). In a recent guideline, the Infectious Diseases Society of" exact="America" post="(IDSA) recommended against the use of corticosteroids in COVID-19"/>
   <result pre="syndromeAm. J. Respir. Crit. Care Med.197201875776729161116 BhimrajA.MorganL.R.LShumakerA.H.LavergneV.BadenL.ChengV.C.EdwardsK.M.GandhiR.MullerW.J.Oâ€™HoroJ.O.ShohamS.MuradM.H.MustafaR.A.SultanS.Falck-YtterY.Infectious Diseases Society of" exact="America" post="Guidelines on the Treatment and Management of Patients With"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7351566\results\search\country\results.xml">
   <result pre="America. Recent Findings However, recent (2016) large outbreaks in Angola," exact="Democratic Republic of Congo" post="(DRC), and South-Eastern Brazil, where previously had been demarcated"/>
   <result pre="Recent Findings However, recent (2016) large outbreaks in Angola, Democratic" exact="Republic of" post="Congo (DRC), and South-Eastern Brazil, where previously had been"/>
   <result pre="However, recent (2016) large outbreaks in Angola, Democratic Republic of" exact="Congo" post="(DRC), and South-Eastern Brazil, where previously had been demarcated"/>
   <result pre="patterns of YFV are highly divergent between Africa and South" exact="America" post="[2]. In South America, YFV strains circulate in two"/>
   <result pre="compared with NHP species from Africa, NHP species in South" exact="America" post="are far more susceptible to YFV infection with high"/>
   <result pre="(3) East and Central African, (4) East African, and (5)" exact="Angola" post="[1, 13]. The South American genotypes I and II"/>
   <result pre="epidemic rapidly spread from Luanda to other urban populations in" exact="Angola" post="and crossed into the neighboring country, Democratic Republic of"/>
   <result pre="urban populations in Angola and crossed into the neighboring country," exact="Democratic Republic of Congo" post="(DRC) [27]. Modeling studies predict that YFV transmission was"/>
   <result pre="populations in Angola and crossed into the neighboring country, Democratic" exact="Republic of" post="Congo (DRC) [27]. Modeling studies predict that YFV transmission"/>
   <result pre="Angola and crossed into the neighboring country, Democratic Republic of" exact="Congo" post="(DRC) [27]. Modeling studies predict that YFV transmission was"/>
   <result pre="cases and 393 deaths related to this YFV outbreak. Since" exact="Angola" post="and DRC were previously classified as low-risk for YFV"/>
   <result pre="low YF vaccination coverage facilitated the large 2016 outbreak in" exact="Angola" post="and DRC. As a response, the WHO revised its"/>
   <result pre="outbreaks of 100 or more cases reported to WHO from" exact="Mali" post="and Chad (2018) and Nigeria (2019). As a step"/>
   <result pre="100 or more cases reported to WHO from Mali and" exact="Chad" post="(2018) and Nigeria (2019). As a step towards eliminating"/>
   <result pre="cases reported to WHO from Mali and Chad (2018) and" exact="Nigeria" post="(2019). As a step towards eliminating future YF outbreaks,"/>
   <result pre="in 2016 a large YF outbreak occurred in regions of" exact="Brazil" post="that had previously had low or no risk of"/>
   <result pre="attributed the 2016 YF epidemic in YF non-endemic regions of" exact="Brazil" post="to increased virulence of the new virus strain [31,"/>
   <result pre="increased movement of individuals between Asia and Africa and/or South" exact="America" post="pose a real fear that YFV might spread to"/>
   <result pre="spread to Asia [39]. In 2016, 11 Chinese working in" exact="Angola" post="returned to China and imported YFV for the first"/>
   <result pre="[39]. In 2016, 11 Chinese working in Angola returned to" exact="China" post="and imported YFV for the first time into Asia"/>
   <result pre="42] [43]. As links between Asia and Africa and/or South" exact="America" post="increase, the threat of YFV spreading to Asia becomes"/>
   <result pre="only ~â€‰40% retaining long-term sero-protection (~â€‰6Â years post vaccination) in" exact="Brazil" post="[54, 55] and Ghana [52â€¢â€¢]. Surprisingly, a retrospective study"/>
   <result pre="sero-protection (~â€‰6Â years post vaccination) in Brazil [54, 55] and" exact="Ghana" post="[52â€¢â€¢]. Surprisingly, a retrospective study in Brazil between 1973"/>
   <result pre="[54, 55] and Ghana [52â€¢â€¢]. Surprisingly, a retrospective study in" exact="Brazil" post="between 1973 and 2008 noted that the number of"/>
   <result pre="to maximize vaccination coverage and to curtail the epidemics in" exact="Angola" post="and DRC, public health officials proceeded to conduct fractional"/>
   <result pre="by the prediction that during the 2016 YF epidemic in" exact="Angola" post="a lack of fractional dosing would have led to"/>
   <result pre="in the diagnostics laboratoryEmerg Microbes Infect20187112910.1038/s41426-018-0128-830002363 9.IngelbeenBWeregemereNANoelHTshapendaGPMossokoMNsioJRonsseAAhuka-MundekeSCohuetSKebelaBIUrban yellow fever outbreak-Democratic" exact="Republic of" post="the Congo, 2016: towards more rapid case detectionPLoS Negl"/>
   <result pre="SantosCCet al.Yellow fever epizootics in non-human primates, southeast and northeast" exact="Brazil" post="(2017 and 2018)Parasit Vectors20201319010.1186/s13071-020-3966-x32075684 20.DouamFPlossAYellow fever virus: knowledge gaps"/>
   <result pre="Trop Dis2018123e000628410.1371/journal.pntd.000628429543798 27.KraemerMUGFariaNRReinerRCJrGoldingNNikolayBStasseSJohanssonMASaljeHFayeOWintGRWNiedrigMShearerFMHillSCThompsonRNBisanzioDTaveiraNNaxHHPradelskiBSRNsoesieEOMurphyNRBogochIIKhanKBrownsteinJSTatemAJde OliveiraTSmithDLSallAAPybusOGHaySICauchemezSSpread of yellow fever virus outbreak in" exact="Angola" post="and the Democratic Republic of the Congo 2015-16: a"/>
   <result pre="OliveiraTSmithDLSallAAPybusOGHaySICauchemezSSpread of yellow fever virus outbreak in Angola and the" exact="Democratic Republic of the Congo" post="2015-16: a modelling studyLancet Infect Dis201717333033810.1016/S1473-3099(16)30513-828017559 28.ZhaoSStoneLGaoDHeDModelling the large-scale"/>
   <result pre="of yellow fever virus outbreak in Angola and the Democratic" exact="Republic of" post="the Congo 2015-16: a modelling studyLancet Infect Dis201717333033810.1016/S1473-3099(16)30513-828017559 28.ZhaoSStoneLGaoDHeDModelling"/>
   <result pre="virus outbreak in Angola and the Democratic Republic of the" exact="Congo" post="2015-16: a modelling studyLancet Infect Dis201717333033810.1016/S1473-3099(16)30513-828017559 28.ZhaoSStoneLGaoDHeDModelling the large-scale"/>
   <result pre="of re-emergence of urban transmission of yellow fever virus in" exact="Brazil" post="facilitated by competent Aedes populationsSci Rep201771484810.1038/s41598-017-05186-328687779 36.NavaAShimabukuroJSChmuraAALuzSLBThe impact of"/>
   <result pre="lack of vaccination linked to importation of yellow fever from" exact="Angola" post="to ChinaEmerg Infect Dis20182471383138610.3201/eid2407.171868 43.Wilder-SmithALeongWYImportation of yellow fever into"/>
   <result pre="cell responses to smallpox and yellow fever vaccinesImmunity.200828571072210.1016/j.immuni.2008.02.02018468462 78.VeitONiedrigMChapuis-TaillardCCavassiniMMossdorfESchmidPBaeHGLitzbaNStaubTHatzCFurrerHcollab: the" exact="Swiss" post="HIV Cohort StudyImmunogenicity and safety of yellow fever vaccination"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7352498\results\search\country\results.xml">
   <result pre="positive cases and at least over 286,353 deaths, transmitted from" exact="China" post="to over 212 countries/regions. Now, various antiviral agents and"/>
   <result pre="which a radioimmunoassay was utilized towards the detection of the" exact="Australia" post="antigen, which was later labeled, the HBs Ag (hepatitis"/>
   <result pre="functionalized Te/BSA nanostars against arterivirus and coronavirusRSC Adv.202010141611416910.1039/D0RA01387K 63.WalshJ.H.YalowR.S.BersonS.A.Radioimmunoassay of" exact="Australia" post="antigenVoxSanguinis197019217224 64.BoschA.Diagnostic Virology ProtocolsJohnR.StephensonA.W.SpringerBerlin/Heidelberg, Germany1999Volume 256 65.ZehbeI.HackerG.W.SuH.Hauser-KronbergerC.HainfeldJ.F.TubbsR.Sensitive in situ"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7353929\results\search\country\results.xml">
   <result pre="{font-family : courier ; font-style : italic;} Lung IndiaLung IndiaLILung" exact="India" post=": Official Organ of Indian Chest Society0970-21130974-598XWolters Kluwer -"/>
   <result pre="of Allergy and Pulmonary Medicine, SMS Medical College, Jaipur, Rajasthan," exact="India" post="Address for correspondence: Prof. Bharat Bhushan Sharma, Department of"/>
   <result pre="SMS Medical College, Jaipur, Rajasthan, India Address for correspondence: Prof." exact="Bharat" post="Bhushan Sharma, Department of Medicine, Division of Allergy and"/>
   <result pre="notified of a pneumonia of unknown cause in Wuhan city," exact="China" post="on December 31, 2019, in people visiting the Huanan"/>
   <result pre="the novel coronavirus disease 2019 (COVID-19). The disease spreads across" exact="China" post="and subsequently the world. As of March 22, 2020,"/>
   <result pre="per the Centers for Disease Control and Prevention data from" exact="the USA." post="Health-care workers are another susceptible group with longer duty"/>
   <result pre="Quarantine, social isolation, and lockdown have been tried successfully by" exact="China" post="and some other countries, but unless we develop a"/>
   <result pre="is mainly limited to case reports. A controlled trial from" exact="China" post="on 99 patients with COVID-19 has failed to show"/>
   <result pre="Shang Za Zhi202036E00632174095 16collab: ICMRRevised Strategy of COVID19 Testing in" exact="India" post="Version 3Last accessed on 2020 Mar 20Available from: https://icmrnicin/sites/default/files/upload_documents/2020-03-20_Covid19_test_v3pdf"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7354743\results\search\country\results.xml">
   <result pre="to TLR9-CpG ODN interactions. Interestingly, the virus strains sequenced in" exact="China" post="(Wuhan) in February 2020 contained on average one CpG"/>
   <result pre="dinucleotide more in their genome than the later strains from" exact="the USA" post="(New York) sequenced in May 2020. Obviously, during the"/>
   <result pre="to replicate. Interestingly, the genome of virus strains sequenced in" exact="China" post="(Wuhan) on February 11, 2020 contained on average 1"/>
   <result pre="CpG dinucleotide more than was observed in later strains from" exact="the USA" post="sequenced on May 6, 2020 (Table 2). Obviously, at"/>
   <result pre="2 Occurrence of CpG dinucleotides in the SARS-CoV-2 isolates from" exact="China" post="(nâ€‰=â€‰7) and USA (nâ€‰=â€‰36) found in GenBank Virus origin"/>
   <result pre="FZEG-2020-0060 of the Ministry of Science and Higher Education of" exact="Russian Federation." post="References References 1.AndersenKGRambautALipkinWIet al.The proximal origin of SARS-CoV-2Nat Med20202645045232284615"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356537\results\search\country\results.xml">
   <result pre="been reported between the measures employed to treat ACS in" exact="China" post="during the first disease outbreak and what currently represents"/>
   <result pre="outbreak and what currently represents clinical practice across Europe and" exact="the USA." post="This review aims to discuss the pathophysiological links between"/>
   <result pre="province, spreading rapidly first throughout China, and subsequently across Europe," exact="the United States" post="(US), and the rest of the world [1,2,3], reaching"/>
   <result pre="spreading rapidly first throughout China, and subsequently across Europe, the" exact="United States" post="(US), and the rest of the world [1,2,3], reaching"/>
   <result pre="are responsible for more than 1 million hospital admissions in" exact="the US" post="annually, while ischemic heart disease accounts for almost 1.8"/>
   <result pre="2 out of 5 fatal cases [51]. A study from" exact="Singapore" post="reported post-mortem examinations in 8 patients who died suddenly"/>
   <result pre="respiratory syndrome (MERS), which was first reported in 2012 in" exact="Saudi Arabia" post="and has afflicted 2519 patients with 866 associated deaths"/>
   <result pre="evidence of myocardial injury was recognized in early cases in" exact="China" post="(see Table 3). Huang et al. first reported a"/>
   <result pre="of AMI cases. In addition, the National Health Commission of" exact="China" post="reported that among people who died from Covid-19, 11.8%"/>
   <result pre="for ACS were reduced by up to 75% [72]. In" exact="the US" post="and Spain, approximately 38% and 40% reductions in cardiac"/>
   <result pre="catheterization laboratory STEMI activations were experienced [73,74], respectively, while in" exact="Italy" post="a reduction in hospitalizations for STEMI (26.5%; less striking"/>
   <result pre="consecutive patients who were admitted at 15 hospitals in northern" exact="Italy" post="for ACS. They showed that the mean admission rate"/>
   <result pre="Prioritizing and Treating STEMI Patients the Way We Should? In" exact="Hong Kong," post="Tam et al. described a small number of patients"/>
   <result pre="on the management of AMI during the Covid-19 pandemic in" exact="the US" post="[89,90]. These guidelines state that after a first evaluation"/>
   <result pre="73.GarciaS.AlbaghdadiM.S.MerajP.M.SchmidtC.GarberichR.JafferF.A.DixonS.RadeJ.J.TannenbaumM.ChambersJ.et al.Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in" exact="the United States" post="during COVID-19 PandemicJ. Am. Coll. Cardiol.202010.1016/j.jacc.2020.04.01132283124 74.RodrÃ­guez-LeorO.Cid-Ã�lvarezB.OjedaS.MartÃ­n-MoreirasJ.RamÃ³n RumorosoJ.LÃ³pez-PalopR.SerradorA.CequierÃ�.RomagueraR.CruzI.et al.Impacto"/>
   <result pre="al.Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the" exact="United States" post="during COVID-19 PandemicJ. Am. Coll. Cardiol.202010.1016/j.jacc.2020.04.01132283124 74.RodrÃ­guez-LeorO.Cid-Ã�lvarezB.OjedaS.MartÃ­n-MoreirasJ.RamÃ³n RumorosoJ.LÃ³pez-PalopR.SerradorA.CequierÃ�.RomagueraR.CruzI.et al.Impacto"/>
   <result pre="Cardiol.202010.24875/RECIC.M20000120 75.De RosaS.SpaccarotellaC.BassoC.CalabrÃ²M.P.CurcioA.FilardiP.P.ManconeM.MercuroG.MuscoliS.NodariS.et al.Reduction of hospitalizations for myocardial infarction in" exact="Italy" post="in the COVID-19 eraEur. Heart J.202010.1093/eurheartj/ehaa409 76.De FilippoO.Dâ€™AscenzoF.AngeliniF.BocchinoP.P.ConrottoF.SagliettoA.SeccoG.G.CampoG.GalloneG.VerardiR.et al.Reduced"/>
   <result pre="disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in" exact="Hong Kong," post="ChinaCirc. Cardiovasc. Qual. Outcomes202010.1161/CIRCOUTCOMES.120.00663132182131 78.StefaniniG.G.AzzoliniE.CondorelliG.Critical organizational issues for cardiologists"/>
   <result pre="acute respiratory syndrome coronavirus; STEMI: ST-segment elevation myocardial infarction; UK:" exact="United Kingdom." post="jcm-09-01683-t003_Table 3Table 3 Myocardial injury and ACS in patients"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356825\results\search\country\results.xml">
   <result pre="disease burden is contributed by Asia alone, followed by Latin" exact="America" post="and Africa [25]. As the vast majority of cases"/>
   <result pre="Virus (ZIKV) Discovered in 1947 in the Zika forest of" exact="Uganda" post="[46], Aedes mosquitoes are the vectors responsible for ZIKV"/>
   <result pre="and Southeast Asian countries including Indonesia, Thailand, Philippines, Malaysia, and" exact="Vietnam" post="[13]. The first ZIKV outbreak recorded outside of Africa"/>
   <result pre="recorded outside of Africa and Asia occurred in Yap Island," exact="Federated States of Micronesia" post="in 2007 [47]. This was followed by a larger"/>
   <result pre="Africa and Asia occurred in Yap Island, Federated States of" exact="Micronesia" post="in 2007 [47]. This was followed by a larger"/>
   <result pre="[47]. This was followed by a larger epidemic in the" exact="French Polynesia" post="in 2013â€&quot;2014, and ZIKV subsequently spread to other Pacific"/>
   <result pre="the Americas, with a massive outbreak of infections occurring in" exact="Brazil" post="[50,51]. Symptoms of ZIKV infection resembles that of dengue"/>
   <result pre="3.1. Chikungunya Virus (CHIKV) First isolated from an outbreak in" exact="Tanzania" post="in 1952, Chikungunya derives its name from the Tanzanian"/>
   <result pre="countries, including Indonesia, Thailand, Singapore, Cambodia, India, USA, Italy, and" exact="France" post="[66,67,68,69,70]. 3.2. Mayaro Virus Mayaro virus (MAYV) is a"/>
   <result pre="rural communities of South America, including Brazil, Peru, Venezuela, and" exact="Bolivia" post="[71,72,73]. First isolated in 1954 in Trinidad, it is"/>
   <result pre="and China, and is gaining popularity in other countries including" exact="Australia" post="and USA [80]. As the development of antivirals from"/>
   <result pre="Psiloxylon mauritianum Extract An indigenous medicinal plant ubiquitous in the" exact="Reunion" post="and Mauritius Islands, Psiloxylon mauritianum is widely used in"/>
   <result pre="Extract An indigenous medicinal plant ubiquitous in the Reunion and" exact="Mauritius" post="Islands, Psiloxylon mauritianum is widely used in traditional medicine"/>
   <result pre="Island, Federated States of MicronesiaN. Engl. J. Med.20093602536254310.1056/NEJMoa080571519516034 48.Cao-LormeauV.-M.RocheC.TeissierA.RobinE.BerryA.-L.MalletH.-P.SallA.A.MussoD.Zika Virus," exact="French Polynesia," post="South Pacific, 2013Emerg. Infect. Dis.2014201084108610.3201/eid2006.14013824856001 49.Dupont-RouzeyrolM.Oâ€™ConnorO.CalvezE.DaurÃ¨sM.JohnM.GrangeonJ.-P.GourinatA.-C.Co-infection with Zika and"/>
   <result pre="Dis.2014201084108610.3201/eid2006.14013824856001 49.Dupont-RouzeyrolM.Oâ€™ConnorO.CalvezE.DaurÃ¨sM.JohnM.GrangeonJ.-P.GourinatA.-C.Co-infection with Zika and Dengue Viruses in 2 Patients," exact="New Caledonia," post="2014Emerg. Infect. Dis.20152138138210.3201/eid2102.14155325625687 50.MussoD.Zika Virus Transmission from French Polynesia"/>
   <result pre="Patients, New Caledonia, 2014Emerg. Infect. Dis.20152138138210.3201/eid2102.14155325625687 50.MussoD.Zika Virus Transmission from" exact="French Polynesia" post="to BrazilEmerg. Infect. Dis.201521188710.3201/eid2110.151125 51.CamposG.S.BandeiraA.C.SardiS.I.Zika Virus Outbreak, Bahia, BrazilEmerg."/>
   <result pre="An overviewNew Microbiol.20133621123912863 59.HammonW.M.RudnickA.SatherG.E.Viruses Associated with Epidemic Hemorrhagic Fevers of" exact="the Philippines" post="and ThailandScience19601311102110310.1126/science.131.3407.110214399343 60.WeaverS.C.Arrival of Chikungunya Virus in the New"/>
   <result pre="overviewNew Microbiol.20133621123912863 59.HammonW.M.RudnickA.SatherG.E.Viruses Associated with Epidemic Hemorrhagic Fevers of the" exact="Philippines" post="and ThailandScience19601311102110310.1126/science.131.3407.110214399343 60.WeaverS.C.Arrival of Chikungunya Virus in the New"/>
   <result pre="al.Re-emergence of Chikungunya virus in South-east Asia: Virological evidence from" exact="Sri Lanka" post="and SingaporeJ. Gen. Virol.2010911067107610.1099/vir.0.015743-019955565 68.HochedezP.HausfaterP.JaureguiberryS.GayF.DatryA.DanisM.BricaireF.BossiP.Cases of chikungunya fever imported"/>
   <result pre="of Chikungunya virus in South-east Asia: Virological evidence from Sri" exact="Lanka" post="and SingaporeJ. Gen. Virol.2010911067107610.1099/vir.0.015743-019955565 68.HochedezP.HausfaterP.JaureguiberryS.GayF.DatryA.DanisM.BricaireF.BossiP.Cases of chikungunya fever imported"/>
   <result pre="SantosC.N.D.et al.Extract from Aphloia theiformis, an edible indigenous plant from" exact="Reunion" post="Island, impairs Zika virus attachment to the host cell"/>
   <result pre="Polyphenol-Rich Extract from Psiloxylon mauritianum, an Endemic Medicinal Plant from" exact="Reunion" post="Island, Inhibits the Early Stages of Dengue and Zika"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356962\results\search\country\results.xml">
   <result pre="spring 2003 because of an outbreak in South-East Asia and" exact="Canada" post="[4]. At the time, the suspect virus was quickly"/>
   <result pre="This novel MERS-CoV was first observed in different countries including" exact="Saudi Arabia" post="[7]. A novel coronavirus with human-to-human contagion and causing"/>
   <result pre="a Pandemic The coronavirus 2019-nCoV has infected numerous people in" exact="China" post="and spread to other regions in a short period."/>
   <result pre="in Yokohama, Japan, and the cruise ship MS Zaandam from" exact="Holland" post="America [36]. The COVID-19 viral infection resulted in the"/>
   <result pre="Yokohama, Japan, and the cruise ship MS Zaandam from Holland" exact="America" post="[36]. The COVID-19 viral infection resulted in the deaths"/>
   <result pre="tripled, and the number of human cases of COVID-19 outside" exact="China" post="has increased 15-fold. The WHO is profoundly worried, both"/>
   <result pre="COVID-19 are mild to date, a recent investigation [37] from" exact="China" post="indicates that severe illness occurs in 16% of cases."/>
   <result pre="patients with SARS, and one herb shortened the duration hospitalization." exact="China" post="is currently conducting more than 80 preclinical studies on"/>
   <result pre="infections in order to provide support to health agencies in" exact="China" post="for the treatment of COVID-19, SARS, and H1N1 influenza."/>
   <result pre="infected with SARS. Based on those data, 23 territories in" exact="China" post="released COVID-19 prevention strategies using appropriate herbal medicines used"/>
   <result pre="antipyretic and anti-inflammatory properties [32]. It has been reported that" exact="China" post="has widely used traditional Chinese aromatic herbs and medicinal"/>
   <result pre="eventInfect. Genet. Evol.20207910421210.1016/j.meegid.2020.10421232004758 9.RoosaK.LeeY.LuoR.KirpichA.RothenbergR.HymanJ.M.ChowellG.Real-time forecasts of the COVID-19 epidemic in" exact="China" post="from February 5 to 24 February 2020Infect. Dis. Model.2020525626332110742"/>
   <result pre="in vitro antiviral activities of the essential oils of seven" exact="Lebanon" post="speciesChem. Biodiv.2008546147010.1002/cbdv.20089004518357554 50.ZhuangM.JiangH.SuzukiY.LiX.XiaoP.TanakaT.QinC.Procyanidins and butanol extract of Cinnamomi Cortex"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7358098\results\search\country\results.xml">
   <result pre="investigation in patients with COVID-19. Tocilizumab is already approved in" exact="the USA" post="to manage CRS occurring after chimeric antigen receptor T"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7358456\results\search\country\results.xml">
   <result pre="Angeles, CAUnited States Edited by: Rashika El Ridi, Cairo University," exact="Egypt" post="Reviewed by: Shu Yuan, Sichuan Agricultural University, China; Dhiraj"/>
   <result pre="China; Dhiraj Kumar, International Centre for Genetic Engineering and Biotechnology," exact="India" post="*Correspondence: Kenichi Shimada kenichi.shimada@cshs.org This article was submitted to"/>
   <result pre="the clinical practice guidelines by the infectious diseases society of" exact="America" post="on the management of influenza, early treatment with antiviral"/>
   <result pre="(2020) 59:447â€&quot;8. 10.1053/j.jfas.2020.03.01032354499 47.AyitteyFKAyitteyMKChiweroNBKamasahJSDzuvorC. Economic impacts of Wuhan 2019-nCoV on" exact="China" post="and the world. J Med Virol. (2020) 92:473â€&quot;5. 10.1002/jmv.2570632048740"/>
   <result pre="727:138761. 10.1016/j.scitotenv.2020.13876132330703 82.YamanaTSasikiran KandulaSPShamanJProjection of COVID-19 cases and deaths in" exact="the US" post="as individual states re-open May 4, 2020. mdRxiv. (2020)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7358648\results\search\country\results.xml">
   <result pre="Kingdom Edited by: Rodolfo GarcÃ­a-Contreras, National Autonomous University of Mexico," exact="Mexico" post="Reviewed by: Jingmin Gu, Jilin University, China; Zhimin Guo,"/>
   <result pre="University, China; Zhimin Guo, The First Hospital of Jilin University," exact="China" post="*Correspondence: Sebastian Leptihn, Leptihn@intl.zju.edu.cn â€ These authors have contributed"/>
   <result pre="a novel CoV that caused a first major outbreak in" exact="China" post="in 2019 has now infected almost 8 million people"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7359800\results\search\country\results.xml">
   <result pre="urgent use of chloroquine and hydroxychloroquine have been approved by" exact="the United States" post="Food and Drug Administration. The use of an antiviral"/>
   <result pre="use of chloroquine and hydroxychloroquine have been approved by the" exact="United States" post="Food and Drug Administration. The use of an antiviral"/>
   <result pre="as high as 49%, based on a recent epidemiological by" exact="China" post="CDC [20]. In Wuhan, 292 patients with COVID-19 were"/>
   <result pre="different epidemics. Table 2 Country Viral etiology Adverse events References" exact="China" post="COVID-19 None [47] China COVID-19 None [48] China COVID-19"/>
   <result pre="Country Viral etiology Adverse events References China COVID-19 None [47]" exact="China" post="COVID-19 None [48] China COVID-19 Self-limited facial erythema in"/>
   <result pre="events References China COVID-19 None [47] China COVID-19 None [48]" exact="China" post="COVID-19 Self-limited facial erythema in 2/10 patients. No major"/>
   <result pre="facial erythema in 2/10 patients. No major adverse events. [49]" exact="China" post="COVID-19 None [50] South Korea COVID-19 None [51] China"/>
   <result pre="patients. No major adverse events. [49] China COVID-19 None [50]" exact="South Korea" post="COVID-19 None [51] China SARS-CoV None [52] China SARS-CoV"/>
   <result pre="[49] China COVID-19 None [50] South Korea COVID-19 None [51]" exact="China" post="SARS-CoV None [52] China SARS-CoV None [53] China SARS-CoV"/>
   <result pre="[50] South Korea COVID-19 None [51] China SARS-CoV None [52]" exact="China" post="SARS-CoV None [53] China SARS-CoV None [54] Taiwan SARS-CoV"/>
   <result pre="None [51] China SARS-CoV None [52] China SARS-CoV None [53]" exact="China" post="SARS-CoV None [54] Taiwan SARS-CoV None [55] China SARS-CoV"/>
   <result pre="None [52] China SARS-CoV None [53] China SARS-CoV None [54]" exact="Taiwan" post="SARS-CoV None [55] China SARS-CoV None [56] China SARS-CoV"/>
   <result pre="None [53] China SARS-CoV None [54] Taiwan SARS-CoV None [55]" exact="China" post="SARS-CoV None [56] China SARS-CoV None [57] China SARS-CoV"/>
   <result pre="None [54] Taiwan SARS-CoV None [55] China SARS-CoV None [56]" exact="China" post="SARS-CoV None [57] China SARS-CoV None [58] South Korea"/>
   <result pre="None [55] China SARS-CoV None [56] China SARS-CoV None [57]" exact="China" post="SARS-CoV None [58] South Korea MERS-CoV None [59] Guinea"/>
   <result pre="None [56] China SARS-CoV None [57] China SARS-CoV None [58]" exact="South Korea" post="MERS-CoV None [59] Guinea Ebola Nausea, skin erythema, fever."/>
   <result pre="[57] China SARS-CoV None [58] South Korea MERS-CoV None [59]" exact="Guinea" post="Ebola Nausea, skin erythema, fever. No major adverse events."/>
   <result pre="Ebola Nausea, skin erythema, fever. No major adverse events. [60]" exact="China" post="Influenza A (H1N1) None [61] China Influenza A (H1N1)"/>
   <result pre="major adverse events. [60] China Influenza A (H1N1) None [61]" exact="China" post="Influenza A (H1N1) None [62] China Influenza A (H1N1)"/>
   <result pre="A (H1N1) None [61] China Influenza A (H1N1) None [62]" exact="China" post="Influenza A (H1N1) None [63] China Influenza A (H1N1)"/>
   <result pre="A (H1N1) None [62] China Influenza A (H1N1) None [63]" exact="China" post="Influenza A (H1N1) None [64] Because there is no"/>
   <result pre="HIV-1 protease [67]. Another drug, umifenovir, was first developed in" exact="Russia" post="and used in Russia and China for the treatment"/>
   <result pre="drug, umifenovir, was first developed in Russia and used in" exact="Russia" post="and China for the treatment of prophylaxis, infections associated"/>
   <result pre="was first developed in Russia and used in Russia and" exact="China" post="for the treatment of prophylaxis, infections associated with influenza"/>
   <result pre="The highest number of infections was found in seven countries:" exact="the United States" post="(nÂ =Â 2294), France (nÂ =Â 3671), Germany (nÂ"/>
   <result pre="highest number of infections was found in seven countries: the" exact="United States" post="(nÂ =Â 2294), France (nÂ =Â 3671), Germany (nÂ"/>
   <result pre="found in seven countries: the United States (nÂ =Â 2294)," exact="France" post="(nÂ =Â 3671), Germany (nÂ =Â 3675), Spain (nÂ"/>
   <result pre="the United States (nÂ =Â 2294), France (nÂ =Â 3671)," exact="Germany" post="(nÂ =Â 3675), Spain (nÂ =Â 5232), South Korea"/>
   <result pre="=Â 2294), France (nÂ =Â 3671), Germany (nÂ =Â 3675)," exact="Spain" post="(nÂ =Â 5232), South Korea (nÂ =Â 8086), Iran"/>
   <result pre="=Â 3671), Germany (nÂ =Â 3675), Spain (nÂ =Â 5232)," exact="South Korea" post="(nÂ =Â 8086), Iran (nÂ =Â 11,364), and Italy"/>
   <result pre="3675), Spain (nÂ =Â 5232), South Korea (nÂ =Â 8086)," exact="Iran" post="(nÂ =Â 11,364), and Italy (nÂ =Â 17,660). The"/>
   <result pre="South Korea (nÂ =Â 8086), Iran (nÂ =Â 11,364), and" exact="Italy" post="(nÂ =Â 17,660). The number of confirmed cases in"/>
   <result pre="to recover from COVID-19 to confer immunity (Pcrit) Rt &amp;gt;4" exact="Bahrain" post="210 6.64 (5.20, 8.61) 85.0 Slovenia 141 6.38 (4.91,"/>
   <result pre="immunity (Pcrit) Rt &amp;gt;4 Bahrain 210 6.64 (5.20, 8.61) 85.0" exact="Slovenia" post="141 6.38 (4.91, 8.38) 84.3 Qatar 320 5.38 (4.59,"/>
   <result pre="6.64 (5.20, 8.61) 85.0 Slovenia 141 6.38 (4.91, 8.38) 84.3" exact="Qatar" post="320 5.38 (4.59, 6.34) 81.4 Spain 5232 5.17 (4.98,"/>
   <result pre="6.38 (4.91, 8.38) 84.3 Qatar 320 5.38 (4.59, 6.34) 81.4" exact="Spain" post="5232 5.17 (4.98, 5.37) 80.7 Denmark 804 5.08 (4.60,"/>
   <result pre="5.38 (4.59, 6.34) 81.4 Spain 5232 5.17 (4.98, 5.37) 80.7" exact="Denmark" post="804 5.08 (4.60, 5.62) 80.3 Finland 155 4.52 (3.72,"/>
   <result pre="5.17 (4.98, 5.37) 80.7 Denmark 804 5.08 (4.60, 5.62) 80.3" exact="Finland" post="155 4.52 (3.72, 5.56) 77.9    Rt (2â€&quot;4) Austria"/>
   <result pre="80.3 Finland 155 4.52 (3.72, 5.56) 77.9    Rt (2â€&quot;4)" exact="Austria" post="504 3.97 (3.56, 4.42) 74.8 Norway 996 3.74 (3.47,"/>
   <result pre="77.9    Rt (2â€&quot;4) Austria 504 3.97 (3.56, 4.42) 74.8" exact="Norway" post="996 3.74 (3.47, 4.04) 73.3 Portugal 112 3.68 (2.86,"/>
   <result pre="3.97 (3.56, 4.42) 74.8 Norway 996 3.74 (3.47, 4.04) 73.3" exact="Portugal" post="112 3.68 (2.86, 4.75) 72.8 Czech Republic 141 3.57"/>
   <result pre="3.74 (3.47, 4.04) 73.3 Portugal 112 3.68 (2.86, 4.75) 72.8" exact="Czech Republic" post="141 3.57 (2.88, 4.45) 72.0 Sweden 814 3.44 (3.20,"/>
   <result pre="(2.86, 4.75) 72.8 Czech Republic 141 3.57 (2.88, 4.45) 72.0" exact="Sweden" post="814 3.44 (3.20, 3.71) 70.9 United States 2294 3.29"/>
   <result pre="3.57 (2.88, 4.45) 72.0 Sweden 814 3.44 (3.20, 3.71) 70.9" exact="United States" post="2294 3.29 (3.15, 3.43) 69.6 Germany 3675 3.29 (3.18,"/>
   <result pre="(3.20, 3.71) 70.9 United States 2294 3.29 (3.15, 3.43) 69.6" exact="Germany" post="3675 3.29 (3.18, 3.40) 69.6 Switzerland 1139 3.26 (3.05,"/>
   <result pre="3.29 (3.15, 3.43) 69.6 Germany 3675 3.29 (3.18, 3.40) 69.6" exact="Switzerland" post="1139 3.26 (3.05, 4.78) 69.3 Brazil 151 3.26 (2.99,"/>
   <result pre="3.29 (3.18, 3.40) 69.6 Switzerland 1139 3.26 (3.05, 4.78) 69.3" exact="Brazil" post="151 3.26 (2.99, 3.55) 69.3 Netherlands 804 3.25 (3.02,"/>
   <result pre="3.26 (3.05, 4.78) 69.3 Brazil 151 3.26 (2.99, 3.55) 69.3" exact="Netherlands" post="804 3.25 (3.02, 3.51) 69.2 Greece 190 3.12 (2.67,"/>
   <result pre="3.26 (2.99, 3.55) 69.3 Netherlands 804 3.25 (3.02, 3.51) 69.2" exact="Greece" post="190 3.12 (2.67, 3.67) 67.9 France 3661 3.09 (2.99,"/>
   <result pre="3.25 (3.02, 3.51) 69.2 Greece 190 3.12 (2.67, 3.67) 67.9" exact="France" post="3661 3.09 (2.99, 3.19) 67.6 Israel 143 3.02 (2.56,"/>
   <result pre="3.12 (2.67, 3.67) 67.9 France 3661 3.09 (2.99, 3.19) 67.6" exact="Israel" post="143 3.02 (2.56, 3.59) 66.9 United Kingdom 798 2.90"/>
   <result pre="3.09 (2.99, 3.19) 67.6 Israel 143 3.02 (2.56, 3.59) 66.9" exact="United Kingdom" post="798 2.90 (2.72, 3.10) 65.5 Italy 17,660 2.44 (2.41,"/>
   <result pre="(2.56, 3.59) 66.9 United Kingdom 798 2.90 (2.72, 3.10) 65.5" exact="Italy" post="17,660 2.44 (2.41, 2.47) 59.0 Canada 198 2.30 (2.07,"/>
   <result pre="2.90 (2.72, 3.10) 65.5 Italy 17,660 2.44 (2.41, 2.47) 59.0" exact="Canada" post="198 2.30 (2.07, 2.57) 56.5 Iceland 134 2.28 (1.90,"/>
   <result pre="2.44 (2.41, 2.47) 59.0 Canada 198 2.30 (2.07, 2.57) 56.5" exact="Iceland" post="134 2.28 (1.90, 2.75) 56.1    Rt (1â€&quot;2) Iran"/>
   <result pre="56.5 Iceland 134 2.28 (1.90, 2.75) 56.1    Rt (1â€&quot;2)" exact="Iran" post="11,364 2.00 (1.96, 2.03) 50.0 Australia 199 1.86 (1.71,"/>
   <result pre="56.1    Rt (1â€&quot;2) Iran 11,364 2.00 (1.96, 2.03) 50.0" exact="Australia" post="199 1.86 (1.71, 2.03) 46.2 Belgium 559 1.75 (1.55,"/>
   <result pre="2.00 (1.96, 2.03) 50.0 Australia 199 1.86 (1.71, 2.03) 46.2" exact="Belgium" post="559 1.75 (1.55, 1.97) 42.9 Malaysia 197 1.74 (1.61,"/>
   <result pre="1.86 (1.71, 2.03) 46.2 Belgium 559 1.75 (1.55, 1.97) 42.9" exact="Malaysia" post="197 1.74 (1.61, 1.88) 42.5 Iraq 101 1.67 (1.41,1.97)"/>
   <result pre="1.75 (1.55, 1.97) 42.9 Malaysia 197 1.74 (1.61, 1.88) 42.5" exact="Iraq" post="101 1.67 (1.41,1.97) 40.1 Japan 734 1.49 (1.44, 1.54)"/>
   <result pre="197 1.74 (1.61, 1.88) 42.5 Iraq 101 1.67 (1.41,1.97) 40.1" exact="Japan" post="734 1.49 (1.44, 1.54) 32.9 Korea 8086 1.43 (1.42,"/>
   <result pre="1.49 (1.44, 1.54) 32.9 Korea 8086 1.43 (1.42, 1.45) 30.1" exact="Singapore" post="200 1.13 (1.06, 1.19) 11.5 Kuwait 100 1.06 (0.89,"/>
   <result pre="1.43 (1.42, 1.45) 30.1 Singapore 200 1.13 (1.06, 1.19) 11.5" exact="Kuwait" post="100 1.06 (0.89, 1.26) 5.66 Case study-3 Dong et"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospitalJ Antimicrob Chemother56200591992216183666 56ZhouX.ZhaoM.WangF.JiangT.LiY.NieW.Epidemiologic features, clinical diagnosis and therapy"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7360125\results\search\country\results.xml">
   <result pre="in the incidence of Kawasaki disease has been reported from" exact="Italy" post="as a post-SARS-CoV-2 phenomenon. As compared to the classical"/>
   <result pre="30-fold increased incidence as compared to the pre-COVID time in" exact="Italy" post="Higher mean age (7.5Â years) More cardiac involvement, shock"/>
   <result pre="manifestations of COVID-19: a rapid prospective nationwide consensus study in" exact="Spain" post="with 375 cases. Br J Dermatol. 10.1111/bjd.19163 24.OxleyTJMoccoJMajidiSet al.Large-vessel"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7360901\results\search\country\results.xml">
   <result pre="Genome size /GenBank Acc. No Receptor Disease Alphacoronavirus HCoV-229E 4285768â€&quot;1966" exact="United States of America" post="27,317 nts AF304460 ANPEP Endemic common colds Betacoronavirus HCoV-HKU1"/>
   <result pre="Acc. No Receptor Disease Alphacoronavirus HCoV-229E 4285768â€&quot;1966 United States of" exact="America" post="27,317 nts AF304460 ANPEP Endemic common colds Betacoronavirus HCoV-HKU1"/>
   <result pre="27,317 nts AF304460 ANPEP Endemic common colds Betacoronavirus HCoV-HKU1 15613317â€&quot;2005" exact="China" post="29,926 nts AY597011 9-O-acetylated sialic acid Endemic common colds"/>
   <result pre="9-O-acetylated sialic acid Endemic common colds Betacoronavirus HCoV-OC43 5231356, 4298953â€&quot;1967" exact="United States of America" post="30,741 nts AY585228 9-O-acetylated sialic acid Endemic common colds"/>
   <result pre="Endemic common colds Betacoronavirus HCoV-OC43 5231356, 4298953â€&quot;1967 United States of" exact="America" post="30,741 nts AY585228 9-O-acetylated sialic acid Endemic common colds"/>
   <result pre="9-O-acetylated sialic acid Endemic common colds Alphacoronavirus HCoV-NL63 15034574â€&quot;2004 The" exact="Netherlands" post="27,553 nts AY567487 ACE2 Endemic common colds Betacoronavirus SARS-CoV"/>
   <result pre="AY567487 ACE2 Endemic common colds Betacoronavirus SARS-CoV 12690092, 12690091, 12711465â€&quot;2003" exact="China" post="29,751 nts AY274119 ACE2 SARS epidemic 2002â€&quot;2004 Betacoronavirus MERS-CoV"/>
   <result pre="nts AY274119 ACE2 SARS epidemic 2002â€&quot;2004 Betacoronavirus MERS-CoV 23075143, 15073334â€&quot;2012" exact="Saudi Arabia" post="30,119 nts JX869059 DPP4 MERS epidemic 2012-now Betacoronavirus SARS-CoVâ€‘2"/>
   <result pre="DPP4 MERS epidemic 2012-now Betacoronavirus SARS-CoVâ€‘2 31986261, 31978945, 32015508, 332015507â€&quot;2020" exact="China" post="29,903 nts NC_045512 ACE2 COVID-19 pandemic 2020â€&quot;now ntsÂ nucleotides,"/>
   <result pre="Recently, aÂ new human CoV has emerged in Wuhan, Peopleâ€™s" exact="Republic of" post="China, which appears genetically very closely related to several"/>
   <result pre="with SARS-CoVâ€‘2 [29]. Analysis of 44,415 confirmed COVID-19 cases from" exact="China" post="as of 11Â February 2020 indicated that 81% had"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361119\results\search\country\results.xml">
   <result pre="one of the top three leading causes of death in" exact="the USA" post="[1]. Fortunately, science advanced dramatically during the 20th century,"/>
   <result pre="cases over a short period of time would result in" exact="the USA" post="having barely enough masks to last even 2 weeks"/>
   <result pre="data [7], one can see that, on Super Tuesday in" exact="the USA" post="in 2020, the popularity of Google searches for â€˜coronavirusâ€™"/>
   <result pre="better known as AZT, was the first drug approved in" exact="the USA" post="to treat HIV and was tested in clinical trials"/>
   <result pre="within their own countries, let alone, internationally 23, 42. In" exact="the USA" post="in particular, initial measures to predict or surveil disease"/>
   <result pre="it is better to be safe than sorry; for example," exact="the US" post="Government has a stockpile of tecovirimat, a drug used"/>
   <result pre="26ChenX.Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in" exact="Saudi Arabia" post="and South KoreaEmerg. Microbes Infect.62017e51 27MenacheryV.D.A SARS-like cluster of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361333\results\search\country\results.xml">
   <result pre="coronavirus 2 (SARSâ€�CoVâ€�2), the novel human pathogen, first detected in" exact="China" post="quickly became a global health emergency, culminating with the"/>
   <result pre="the early viral mutations observed in Europe and then in" exact="the US" post="after the virus emerged from China radically influenced its"/>
   <result pre="and then in the US after the virus emerged from" exact="China" post="radically influenced its fitness. Moreover, their contribution to lethality"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361338\results\search\country\results.xml">
   <result pre="and stored in blood banks in some countries such as" exact="Turkey" post="and the United States of America in hopes of"/>
   <result pre="in blood banks in some countries such as Turkey and" exact="the United States" post="of America in hopes of reducing mortality rates and"/>
   <result pre="blood banks in some countries such as Turkey and the" exact="United States of America" post="in hopes of reducing mortality rates and reduce the"/>
   <result pre="some countries such as Turkey and the United States of" exact="America" post="in hopes of reducing mortality rates and reduce the"/>
   <result pre="in three patients with Middle East Respiratory Syndrome (MERS) in" exact="South Korea." post="In this study, 3 of 13 MERS patients with"/>
   <result pre="plasma for severeacute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospital. J Antimicrob Chemother. 2005;56:919â€�922.16183666 10ChengY, WongR, SooYO, et"/>
   <result pre="al. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur J Clin Microbiol Infect Dis. 2005;24:44â€�46.15616839 11van GriensvenJ,"/>
   <result pre="al. Feasibility of using convalescent plasma immunotherapy for MERSâ€�CoV infection," exact="Saudi Arabia." post="Emerg Infect Dis. 2016;22:1554â€�1561.27532807 14ShenC, WangZ, ZhaoF, et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361446\results\search\country\results.xml">
   <result pre="Hospital MarburgPhillippsâ€�UniversitÃ¤t MarburgGermany[2], Allergy Clinical UnitHospital Regional Universitario de MÃ¡lagaâ€�UMAâ€�ARADyALMÃ¡lagaSpain[3]," exact="Swiss" post="Institute of Allergy and Asthma Research (SIAF)University of ZurichDavosSwitzerland"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361468\results\search\country\results.xml">
   <result pre="explanations for why so many epidemics seem to arise in" exact="China" post="may not only be cultural, but also a matter"/>
   <result pre="and humans [7]. This is abundantly clear if we compare" exact="China" post="to the United States, or Europe, when the latter"/>
   <result pre="[7]. This is abundantly clear if we compare China to" exact="the United States," post="or Europe, when the latter were hubs of global"/>
   <result pre="This is abundantly clear if we compare China to the" exact="United States," post="or Europe, when the latter were hubs of global"/>
   <result pre="exception in years to come. It is estimated that in" exact="the United States" post="alone, three out of four new infectious diseases have"/>
   <result pre="in years to come. It is estimated that in the" exact="United States" post="alone, three out of four new infectious diseases have"/>
   <result pre="sale of wild meat at a wet market in Wuhan," exact="China" post="[16]. Indeed, bats are believed to be one of"/>
   <result pre="SchloegelLM, DaszakP. Risk of importing zoonotic diseases through wildlife trade," exact="United States." post="Emerg Infect Dis2009; 15: 1721â€&quot;6.19891857 15Kreuder JohnsonC, HitchensPL, Smiley"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361534\results\search\country\results.xml">
   <result pre="of recent outbreak of COVIDâ€�19 was recognized atÂ Wuhan, Hubei," exact="China" post="five months ago. Later, it spread to the whole"/>
   <result pre="Guangdong province of China, in 2002â€�2003, followed by MERS in" exact="Saudi Arabia" post="in 2012. CoVs are pleiomorphic, enveloped, with an average"/>
   <result pre="virus IBV Î³ 36 Pheasant Pheasant coronavirus PhCoV Î³ 37" exact="Turkey" post="Turkey coronavirus TCV Î³ (C) Wileyâ€�VCH Verlag GmbH &amp;amp;"/>
   <result pre="IBV Î³ 36 Pheasant Pheasant coronavirus PhCoV Î³ 37 Turkey" exact="Turkey" post="coronavirus TCV Î³ (C) Wileyâ€�VCH Verlag GmbH &amp;amp; Co."/>
   <result pre="Another epidemic was caused in 2002 emerged from Guangdong Province," exact="China" post="caused by SARSâ€�HCoV. The virus spread in almost 30"/>
   <result pre="71 years old man suffering from pneumonia and bronchiolitis in" exact="Hong Kong." post="The old person was returned from Shenzhen, China. The"/>
   <result pre="asthmatic exacerbation and it was different from common pneumonia.22 In" exact="Saudi Arabia" post="2012, MERSâ€�HCoV (6th HCoV) reported in an old aged"/>
   <result pre="the spread of different HCoVs in the middle east, including" exact="South Korea" post="(2015).30 Several countries such as the United States of"/>
   <result pre="middle east, including South Korea (2015).30 Several countries such as" exact="the United States" post="of America, the United Kingdom, Saudi Arabia, Kenya, France,"/>
   <result pre="east, including South Korea (2015).30 Several countries such as the" exact="United States of America," post="the United Kingdom, Saudi Arabia, Kenya, France, China, and"/>
   <result pre="Several countries such as the United States of America, the" exact="United Kingdom," post="Saudi Arabia, Kenya, France, China, and other countries are"/>
   <result pre="such as the United States of America, the United Kingdom," exact="Saudi Arabia," post="Kenya, France, China, and other countries are profoundly affected"/>
   <result pre="MERS was found in an old aged patient in Jeddah," exact="Saudi Arabia" post="suffered from pneumonia, renal failure, and respiratory infection who"/>
   <result pre="to find and describe HCoV strains spreading all regions of" exact="Kenya" post="and explored the epidemiological significance of human coronaviruses.41a Table"/>
   <result pre="among medical students at the University of Chicago 5a 2" exact="Netherlands" post="HCoVâ€�NL63 2002â€�2003 Replicated faster in monkey kidney cells as"/>
   <result pre="epidemic diarrhea virus and HCoV 229E 42c, 52 3 Frankfurt," exact="Germany" post="SARSâ€�CoV 2003 The patient traveled Singapore, Hong Kong, New"/>
   <result pre="52 3 Frankfurt, Germany SARSâ€�CoV 2003 The patient traveled Singapore," exact="Hong Kong," post="New York and During a stopover in Frankfurt, Germany"/>
   <result pre="Hong Kong, New York and During a stopover in Frankfurt," exact="Germany" post="on day 7 67 4 Hongâ€�Kong MERSâ€�CoV, SARCâ€�CoV 2003"/>
   <result pre="2003 SARSâ€�CoV behind the outbreak of severe respiratory infection in" exact="China" post="in this period 51, 68 5 Shenzhen, China SARSâ€�CoV,"/>
   <result pre="infection in China in this period 51, 68 5 Shenzhen," exact="China" post="SARSâ€�CoV, NL63, HKU1 2003â€�2004 Isolation of SARSâ€�CoV from civet"/>
   <result pre="revealed that it might be originated from animals 69 6" exact="Kenya" post="HCoV 229E, NL63, OC43, HKU1 2009â€&quot;2012 Out of 417"/>
   <result pre="HKU1, 1% 29E. CoVs are spreaded globally 41a 7 Jordan," exact="Saudi Arabia" post="MERSâ€�CoV 2012 Relatives are bat coronaviruses HKU4 and HKU5,"/>
   <result pre="is unknown 2012 Severe respiratory infection, the patient traveled from" exact="Qatar" post="and Saudi Arabia 70 9 France HCoVâ€�OC43 2001â€�2013 Genomic"/>
   <result pre="2012 Severe respiratory infection, the patient traveled from Qatar and" exact="Saudi Arabia" post="70 9 France HCoVâ€�OC43 2001â€�2013 Genomic studies revealed to"/>
   <result pre="the patient traveled from Qatar and Saudi Arabia 70 9" exact="France" post="HCoVâ€�OC43 2001â€�2013 Genomic studies revealed to understand the dynamics"/>
   <result pre="Kumari studied Zoology at Dayalbagh Educational Institute, Agra, Uttar Pradesh," exact="India" post="and did M.Sc. in 2007. She joined the research"/>
   <result pre="joined the research group of Dr. Samim, Jamia Hamdard, Delhi," exact="India" post="and worked in the area of nanoscience. Then, she"/>
   <result pre="Prashant Singh studied Chemistry at Indian Institute of Technology, Delhi," exact="India" post="and did M.Sc. in 2005. He then joined the"/>
   <result pre="W.To, S.Yuan, K. Y.Yuen, Emerg. Microbes Infect.2020, 9, 221â€&quot;236;31987001 55bV.Surveillances," exact="China" post="CDC Weekly2020, 2, 113â€&quot;122. 56G.Kampf, D.Todt, S.Pfaender, E.Steinmann, J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361641\results\search\country\results.xml">
   <result pre="Abdullah Al Mamun Sohag, Department of Biochemistry and Molecular Biology," exact="Bangladesh" post="Agricultural University, Mymensingh 2202, Bangladesh. Email: sohag2010bmb.sust@gmail.com Md Abdul"/>
   <result pre="sohag2010bmb.sust@gmail.com Md Abdul Hannan, Department of Biochemistry and Molecular Biology," exact="Bangladesh" post="Agricultural University, Mymensingh 2202, Bangladesh. Email: hannanbmb@bau.edu.bd epub: 2020-7-710.1002/ddr.21709received:"/>
   <result pre="Number: 2018H1D3A1A01074712 1 INTRODUCTION COVIDâ€�19 that was first surfaced in" exact="China" post="has already emerged as a global pandemic with a"/>
   <result pre="disease. An estimated 70% of the firstâ€�class drugs approved by" exact="the United States" post="Food and Drug Administration in between 1999 to 2013"/>
   <result pre="An estimated 70% of the firstâ€�class drugs approved by the" exact="United States" post="Food and Drug Administration in between 1999 to 2013"/>
   <result pre="are also undergoing at Ruijin Hospital, China, and Tongji Hospital," exact="China" post="(NCT04260594, NCT04255017). Moreover, a recent study has demonstrated that"/>
   <result pre="Ribavirin â€ 3 Interferon Betaâ€�1B Phase 2 The University of" exact="Hong Kong," post="Hospital Authority, Hong Kong NCT04276688 3CLpro, interferon receptor (IFNAR)"/>
   <result pre="Betaâ€�1B Phase 2 The University of Hong Kong, Hospital Authority," exact="Hong Kong" post="NCT04276688 3CLpro, interferon receptor (IFNAR) â€ 1 Xiyanping injection"/>
   <result pre="2 Hydroxychloroquine Phase 4 Chronic Obstructive Pulmonary Disease Trial Network," exact="Denmark" post="NCT04322396 ACE2 and spike binding complex, Endosomal acidification â€"/>
   <result pre="syncytial virus and also been proven effective against influenza in" exact="Japan" post="(Delang, Abdelnabi, &amp;amp; Neyts, 2018; Furuta, Komeno, &amp;amp; Nakamura,"/>
   <result pre="50 COVIDâ€�19 patients with serious respiratory complications is ongoing in" exact="Italy" post="to determine the effectivity of Siltuximab (NCT04322188). Another group"/>
   <result pre="â€ 2 Thymosin + standard treatment Phase 2 Southeast University," exact="China" post="NCT04268537 Prostaglandins Naproxen Phase 3 Assistance Publique â€� HÃƒÂ´pitaux"/>
   <result pre="distinct sites. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 106(14), 5871â€&quot;5876. 10.1073/pnas.080952410619321428 Broer, R., Boson, B.,"/>
   <result pre="sites. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="106(14), 5871â€&quot;5876. 10.1073/pnas.080952410619321428 Broer, R., Boson, B., Spaan, W.,"/>
   <result pre="SARSâ€�CoVâ€�2 genomes. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 117, 9241â€&quot;9243. 10.1073/pnas.200499911732269081 Frazer, I. H. (2014)."/>
   <result pre="genomes. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="117, 9241â€&quot;9243. 10.1073/pnas.200499911732269081 Frazer, I. H. (2014). Development and"/>
   <result pre="broad spectrum inhibitor of viral RNA polymerase. Proceedings of the" exact="Japan" post="Academy. Series B, Physical and Biological Sciences, 93(7), 449â€&quot;463."/>
   <result pre="drug Arbidol. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 114(2), 206â€&quot;214. 10.1073/pnas.161702011428003465 Kam, Y. W., Okumura,"/>
   <result pre="Arbidol. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="114(2), 206â€&quot;214. 10.1073/pnas.161702011428003465 Kam, Y. W., Okumura, Y., Kido,"/>
   <result pre="S., &amp;amp; Ambati, J. (2020). Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covidâ€�19. medRxiv 2020.2004.2016.20065920. doi:10.1101/2020.04.16.20065920%J Marra, M."/>
   <result pre="TMPRSS2â€�expressing cells. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 117(13), 7001â€&quot;7003. 10.1073/pnas.200258911732165541 Mehra, M. R., Desai,"/>
   <result pre="cells. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="117(13), 7001â€&quot;7003. 10.1073/pnas.200258911732165541 Mehra, M. R., Desai, S. S.,"/>
   <result pre="deubiquitinating enzyme. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 103(15), 5717â€&quot;5722. 10.1073/pnas.051085110316581910 Rimanshee, A., Amit, D.,"/>
   <result pre="enzyme. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="103(15), 5717â€&quot;5722. 10.1073/pnas.051085110316581910 Rimanshee, A., Amit, D., Vishal, P.,"/>
   <result pre="viral entry. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 101(12), 4240â€&quot;4245. 10.1073/pnas.030644610115010527 Siu, Y. L., Teoh,"/>
   <result pre="entry. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="101(12), 4240â€&quot;4245. 10.1073/pnas.030644610115010527 Siu, Y. L., Teoh, K. T.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362761\results\search\country\results.xml">
   <result pre="School of MedicineChicago, ILUnited States[], 8Environmental and Atmospheric Chemistry Laboratory," exact="Bangladesh" post="Atomic Energy CommissionDhakaBangladesh[], 9Department of Chemistry, The University of"/>
   <result pre="by: Alexander Rodriguez-Palacios, Case Western Reserve University School of Medicine," exact="United States" post="Reviewed by: Maria Stefanova Kamusheva, Medical University of Sofia,"/>
   <result pre="Medicine and Pharmacy, Romania; Ciprian Vasile Iovan, University of Oradea," exact="Romania" post="*Correspondence: William C. Cho williamcscho@gmail.com Daniela Calina calinadaniela@gmail.com Javad"/>
   <result pre="human coronavirus (SARS-CoV-2) seems emerged in December 2019 in Wuhan," exact="China" post="(1, 2). Later, on January 12, 2020, the World"/>
   <result pre="Antiviral for flu and Ebola RNA polymerase inhibitor Used in" exact="China" post="in patients of childbearing potential only if they had"/>
   <result pre="The camostat molecule, a synthetic serine protease inhibitor approved in" exact="Japan" post="for pancreatic diseases (which also have proteinases as pathogenic"/>
   <result pre="(Interferon beta) used in animal model studies (36, 45). Recently," exact="the US" post="Food and Drug Administration (FDA) has authorized the use"/>
   <result pre="from two studies involving remdesivir: The ACTT study, organized by" exact="the US" post="National Institute of Allergic and Infectious Diseases (NIAID) was"/>
   <result pre="study against the MERS virus, and the first study in" exact="China" post="against SARS-CoV-2 has been started. In addition, a team"/>
   <result pre="for influenza and Ebola infection. It was originally produced in" exact="Japan" post="and used more frequently in China; due to its"/>
   <result pre="more frequently in China; due to its teratogenic effect, in" exact="Japan" post="its use is only allowed during the evolution of"/>
   <result pre="individuals and for immunocompromised patients (65). Several countries, such as" exact="the United States" post="(66) and the United Kingdom (67), have announced initiatives"/>
   <result pre="and for immunocompromised patients (65). Several countries, such as the" exact="United States" post="(66) and the United Kingdom (67), have announced initiatives"/>
   <result pre="Several countries, such as the United States (66) and the" exact="United Kingdom" post="(67), have announced initiatives to treat patients hospitalized with"/>
   <result pre="COVID-19 MIRACLE is the first trial to have begun in" exact="China" post="against SARS-CoV-2. The combination of lopinavir/ritonavir protease inhibitors (marketed"/>
   <result pre="or without interferon beta), and remdesivir and chloroquine (or hydroxychloroquine)." exact="Spain" post="and Norway are the countries that have administered the"/>
   <result pre="interferon beta), and remdesivir and chloroquine (or hydroxychloroquine). Spain and" exact="Norway" post="are the countries that have administered the treatment, out"/>
   <result pre="the progress of the study; the first patients included in" exact="Norway" post="are part of the proposed cohort of 700 patients,"/>
   <result pre="by the National Institutes of Health1 and Medical Research in" exact="France" post="(Inserm), and it will include the same therapeutic molecules"/>
   <result pre="and a total of 3,200 patients from Belgium, Germany, Luxembourg," exact="the Netherlands," post="Spain, Sweden, and the United Kingdom. Several medical centers"/>
   <result pre="from Belgium, Germany, Luxembourg, the Netherlands, Spain, Sweden, and the" exact="United Kingdom." post="Several medical centers will start collecting data as new"/>
   <result pre="acceptable safety against SARS-COV-2 in multicenter clinical trials conducted in" exact="China" post="(74). The use of this drug appears in the"/>
   <result pre="by SARS-CoV-2 issued by the National Health Commission of the" exact="People's Republic of China." post="Another recent study suggested chloroquine phosphate tablet (500 mg"/>
   <result pre="SARS-CoV-2 issued by the National Health Commission of the People's" exact="Republic of" post="China. Another recent study suggested chloroquine phosphate tablet (500"/>
   <result pre="on respiratory viral loads was evaluated using SARS-COV-2 patients from" exact="France" post="(78). Hydroxychloroquine (600 mg daily) was administered to patients"/>
   <result pre="of umifenovir (an active antiviral against influenza, approved only in" exact="China" post="and Russia), its use in COVID-19 is promising; according"/>
   <result pre="having been active during the 2014 Ebola outbreak (93, 94)." exact="China" post="has already announced that it has a vaccine clinical"/>
   <result pre="is realized by the Military Academy of Medical Sciences of" exact="China" post="and Cansino Biologics and is based on a technological"/>
   <result pre="(COVID-19) became available. Janssen research teams, in collaboration with Beth" exact="Israel" post="Deaconess Medical Center, part of Harvard Medical School, have"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362831\results\search\country\results.xml">
   <result pre="company, Zotatifin (also called eFT226, 4, Fig.Â 1) has passed" exact="the US" post="regulatory toxicology requirements necessary to enter a phase 1/2"/>
   <result pre="negative-stranded RNA virus, and Ebola is currently raging in the" exact="Democratic Republic of the Congo" post="in spite of the recent approval of a vaccine"/>
   <result pre="RNA virus, and Ebola is currently raging in the Democratic" exact="Republic of" post="the Congo in spite of the recent approval of"/>
   <result pre="Ebola is currently raging in the Democratic Republic of the" exact="Congo" post="in spite of the recent approval of a vaccine"/>
   <result pre="acute hepatitis in developing countries, but also in Europe and" exact="America" post="[28]. Influenza A viruses (IAV) are negative-sense single-stranded RNA"/>
   <result pre="eiF4A dependent Zika virus translation of two strains originating from" exact="French Polynesia" post="and Uganda [11]. Silvestrol strongly reduced viral replication after"/>
   <result pre="virus translation of two strains originating from French Polynesia and" exact="Uganda" post="[11]. Silvestrol strongly reduced viral replication after 48Â h"/>
   <result pre="traditional medicine. In Southeast Asia, India, South China, Indonesia, Cambodia," exact="Vietnam" post="and Thailand, plants of the genus Aglaia synthesizing flavaglines"/>
   <result pre="during viral infectionsVirus Gene.552019267273 22RohanH.McKayG.The Ebola outbreak in the Democratic" exact="Republic of" post="the Congo: why there is no â€˜silver bulletâ€™Nat. Immunol.212020591594in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362842\results\search\country\results.xml">
   <result pre="targeted therapy and a reported 5.5% case fatality rate in" exact="the United States," post="treatments preventing rapid cardiopulmonary failure are urgently needed. Clinical"/>
   <result pre="therapy and a reported 5.5% case fatality rate in the" exact="United States," post="treatments preventing rapid cardiopulmonary failure are urgently needed. Clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362851\results\search\country\results.xml">
   <result pre="of Medicine, King Saud University, PO Box. 245, Riyadh, 11411," exact="Saudi Arabia." post="Phone: +966-11-4724179-3347 pmc-release: 2020-7-7ppub: 2020-10epub: 2020-7-73604338341received: 2020-4-21accepted: 2020-7-13(C) Southern"/>
   <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci" exact="China" post="Life Sci63202036437410.1007/s11427-020-1643-832048163 16Simone G de.Position Statement of the ESC"/>
   <result pre="and Innovation (MAARIFAH), King Abdulâ€�Aziz City for Science and Technology," exact="Kingdom of Saudi Arabia," post="grant to the Strategic Center for Diabetes Research, the"/>
   <result pre="(MAARIFAH), King Abdulâ€�Aziz City for Science and Technology, Kingdom of" exact="Saudi Arabia," post="grant to the Strategic Center for Diabetes Research, the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362854\results\search\country\results.xml">
   <result pre="Fortunately, after analyzing the complete genome of SARS-CoV-2 from Wuhan," exact="China" post="[13,14], important structural and biochemical details are now available"/>
   <result pre="of RNA or DNA. This antiviral drug was developed in" exact="Japan" post="and approved in 2014 for treating viral strains unresponsive"/>
   <result pre="III clinical trials as a possible treatment for COVID-19 in" exact="the USA" post="(remdesivir) and Japan (favipiravir). Ruxolitinib (10), an anticancer drug"/>
   <result pre="a possible treatment for COVID-19 in the USA (remdesivir) and" exact="Japan" post="(favipiravir). Ruxolitinib (10), an anticancer drug tested for its"/>
   <result pre="inefficient according to the first randomized trial (158 patients) in" exact="China" post="on patients with severe COVID-19 symptoms [130]. In addition,"/>
   <result pre="Res.1002201344645424084488 55FurutaY.KomenoT.NakamuraT.Favipiravir (T-705), a broad-spectrum inhibitor of viral RNA polymeraseProc." exact="Japan" post="Acad., Series B9372017449463 56PiscianzE.CuzzoniE.SharmaR.TesserA.SapraP.TommasiniA.Reappraisal of antimalarials in interferonopathies: new"/>
   <result pre="an open-label control studyEngineering202010.1016/j.eng.2020.03.007 135EkinsS.LaneT.R.MadridP.B.Tilorone: a broad-spectrum antiviral invented in" exact="the USA" post="and commercialized in Russia and beyondPharm. Res. (N. Y.)3720207110.1007/s11095-020-02799-8"/>
   <result pre="a broad-spectrum antiviral invented in the USA and commercialized in" exact="Russia" post="and beyondPharm. Res. (N. Y.)3720207110.1007/s11095-020-02799-8 136SaxenaA.Drug targets for COVID-19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7364167\results\search\country\results.xml">
   <result pre="[c], â�ŽCorresponding author at: School of Pharmacy, Fudan University, Shanghai," exact="China" post="201203. zhudi@fudan.edu.cn pmc-release: 2020-7-7ppub: 2020-9epub: 2020-7-77100056100056received: 2020-6-7rev-recd: 2020-7-5accepted: 2020-7-5(C)"/>
   <result pre="target for coronaviruses [33]. Brunn's team at LMU University in" exact="Germany" post="reported that the N protein of SARS-CoV binds closely"/>
   <result pre="Shanghai (18ZR1403900) (D. Zhu), the National Natural Science Foundation of" exact="China" post="(81872895) (D.Z.). Conflict of interest statement The authors certify"/>
   <result pre="and pathogenesisMethods Mol Biol1282201512325720466 16MunsterV.J.KoopmansM.Van DoremalenN.A Novel Coronavirus Emerging in" exact="China" post="- Key Questions for Impact AssessmentN Engl J Med3828202069269431978293"/>
   <result pre="naming it SARS-CoV-2Nat Microbiol.5202053654432123347 Acknowledgement We thank Hao Zhang from" exact="China" post="State Institute of Pharmaceutical Industry for suggestions in chemical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7366108\results\search\country\results.xml">
   <result pre="baffling pneumonia secondary to an unknown virus emerged in Wuhan," exact="China" post="in December 2019, and later the virus was identified"/>
   <result pre="intensive care [[7], [8], [9]]. A most recent report from" exact="China" post="CDC showed that 25% of patients have pre-existing comorbidities"/>
   <result pre="patients develop neurological symptoms [49]. Recently reports from UK and" exact="China" post="documented that COVID-19 patients showed convulsions, delirium, altered consciousness,"/>
   <result pre="Guillain-Barre syndrome (GBS) associated with COVID-19 was firstly reported in" exact="China" post="with manifestations, including leg weakness, and severe fatigue. It"/>
   <result pre="April 2020, a study from around 25 different hospitals in" exact="China" post="has been published with clinical records of pregnant women"/>
   <result pre="for treatment of influenza A and influenza B flu in" exact="Japan" post="and in the United States Chinese Clinical Trial Registry:(CHiCTR2000029544),"/>
   <result pre="influenza A and influenza B flu in Japan and in" exact="the United States" post="Chinese Clinical Trial Registry:(CHiCTR2000029544), (CHiCTR2000029548) 2. Favipiravir Broad-spectrum antiviral"/>
   <result pre="A and influenza B flu in Japan and in the" exact="United States" post="Chinese Clinical Trial Registry:(CHiCTR2000029544), (CHiCTR2000029548) 2. Favipiravir Broad-spectrum antiviral"/>
   <result pre="including coronaviruses Favipiravir is approved for treatment of influenza in" exact="Japan" post="National Clinical Trial Identifier:(NCT04336904), (NCT04349241), (NCT04336904), (NCT04346628), (NCT04310228), (NCT04319900),"/>
   <result pre="is an antiviral treatment used for influenza infection used in" exact="Russia" post="and China. National Clinical Trial Identifier:(NCT04252885), (NCT04260594)Chinese Clinical Trial"/>
   <result pre="Plasma from Recovered COVID-19 Donors Hackensack Meridian Health, New Jersey," exact="United States" post="Phase II(55) On-going NCT04343755 2. Convalescent Plasma from Recovered"/>
   <result pre="3. Convalescent Plasma from Recovered COVID-19 Donors Cristina AvendaÃ±o SolÃ¡," exact="Spain" post="Phase II(278) On-going NCT04345523 4. Convalescent Plasma from Recovered"/>
   <result pre="from Recovered COVID-19 Donors Centro de HematologÃ­a y Medicina Interna," exact="Mexico" post="Phase II(10) On-going NCT04357106 6. Convalescent Plasma from Recovered"/>
   <result pre="Convalescent Plasma from Recovered COVID-19 Donors University of Chicago, Illinois," exact="United States" post="Phase I(10) On-going NCT04340050 7. Anti-SARS-CoV-2 Inactivated Convalescent Plasma"/>
   <result pre="recovered from COVID-19 Donors Shanghai Public Health Clinical Center, Shanghai," exact="China" post="Observational Study(15) On-going NCT04292340 8. Convalescent Plasma from Recovered"/>
   <result pre="COVID-19 Donors Institute of Liver and Biliary Sciences, New Delhi," exact="India" post="Phase II(20) Completed NCT04346446 9. Convalescent Plasma Therapy on"/>
   <result pre="on Critically ill Novel Coronavirus (COVID-19) Patients Alkarkh Health Directorate-Baghdad." exact="Iraq" post="Interventional study(49) Completed NCT04441424 10. Effectiveness of Convalescent Immune"/>
   <result pre="Convalescent Immune Plasma Therapy Bagcilar Training and Research Hospital, Istanbul," exact="Turkey" post="Interventional study(60) Completed NCT04442958 7 Vaccines currently in clinical"/>
   <result pre="NCT04380701 6. Pathogen-specific aAPC; Subcutaneously Shenzhen Geno-Immune Medical Institute, Guangdong," exact="China" post="Phase I(100) On-going NCT04299724 7. Lentiviral Minigene Vaccine (LV-SMENP)"/>
   <result pre="(LV-SMENP) of Covid-19 Coronavirus; Subcutaneously Shenzhen Geno-Immune Medical Institute, Guangdong," exact="China" post="Phase I &amp;amp;II(100) On-going NCT04276896 8. BCG Vaccine for"/>
   <result pre="NCT04328441 9. SARS-CoV-2 Inactivated Vaccine Sinovac Biotech Co., Ltd., Jiangsu," exact="China" post="Phase I (Medium Dose, 144)Phase II (High Dose, 600)"/>
   <result pre="BCG Vaccine for Covid-19; Intradermally Murdoch Children's Research Institute, Victoria," exact="Australia" post="Phase III(4170) On-going NCT04327206 11. Coronavirus Disease (COVID-19) vaccineChAdOx1"/>
   <result pre="NCT04327206 11. Coronavirus Disease (COVID-19) vaccineChAdOx1 nCoV-19 University of Oxford," exact="United Kingdom" post="Phase I &amp;amp; II(1090) Completed NCT04324606 12. Investigating a"/>
   <result pre="NCT04324606 12. Investigating a Vaccine Against COVID-19 University of Oxford," exact="United Kingdom" post="Phase II &amp;amp; III(10260) On-going NCT04400838 13. Biological: Recombinant"/>
   <result pre="Inc.Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of" exact="China" post="Phase II(508) On-going NCT04341389 15. Evaluation of the Safety"/>
   <result pre="Journal of Pathology: A Journal of the Pathological Society of" exact="Great Britain" post="and Ireland203200463163710.1002/path.1570 14JaimesJ.A.WhittakerG.R.Feline coronavirus: insights into viral pathogenesis based"/>
   <result pre="function injury in 250 patients with severe acute respiratorv syndrome." exact="China" post="Journal of Modern Medicine 14, 121â€&quot;123. 61Jiang, T. J.,"/>
   <result pre="of liver injury in patients with severe acute respiratory syndrome." exact="China" post="Journal of Modern Medicine, 2004, 46. 62FarcasG.A.PoutanenS.M.MazzulliT.WilleyB.M.ButanyJ.AsaS.L.KainK.C.Fatal severe acute"/>
   <result pre="SARS-CoV-2 infection and virus load in fecal samples from the" exact="Hong Kong" post="cohort and systematic review and meta-analysisGastroenterology202010.1053/j.gastro.2020.03.065 71PetrieJ.R.GuzikT.J.TouyzR.M.Diabetes, hypertension, and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7366994\results\search\country\results.xml">
   <result pre="Medicine, Kyung Hee University, 26 Kyung Hee Dae-ro, Dongdaemun-gu, Seoul," exact="South Korea." post="erc633@khu.ac.kr pmc-release: 2020-7-7ppub: 2020-9epub: 2020-7-793100478received: 2020-6-27rev-recd: 2020-7-11accepted: 2020-7-11(C) ,"/>
   <result pre="these are approximately 19% of confirmed cases of COVID-19 in" exact="South Korea." post="This number is particularly crucial because it was based"/>
   <result pre="in traditional medicine, I presented the role of KM in" exact="South Korea," post="particularly that of our KM treatment via teleconsultation. Although"/>
   <result pre="contact some newspapers to introduce the role of KM in" exact="South Korea," post="they remained uninterested. Therefore, I instead wrote an article"/>
   <result pre="instead wrote an article that was published in the South" exact="China" post="Morning Post in Hong Kong on April 9, 2020,"/>
   <result pre="that was published in the South China Morning Post in" exact="Hong Kong" post="on April 9, 2020, where I highlighted the role"/>
   <result pre="constitutes 27% of the total number of medical doctors in" exact="South Korea" post="and this number includes KMDs in South Korea. Approximately"/>
   <result pre="doctors in South Korea and this number includes KMDs in" exact="South Korea." post="Approximately 80% of all patients with COVID-19 in South"/>
   <result pre="South Korea. Approximately 80% of all patients with COVID-19 in" exact="South Korea" post="have been mild-stage patients. How can we treat this"/>
   <result pre="large number of patients? This problem is not specific to" exact="South Korea." post="To prevent the collapse of medical systems worldwide, it"/>
   <result pre="be available later. 2.3 A comparison of COVID-19 guidelines between" exact="China" post="and Korea Choi: The Chinese government has provided guidelines"/>
   <result pre="lie in the integration of WM and TCM or KM." exact="China" post="has promoted the outstanding effect of TCM against COVID-19"/>
   <result pre="treatment led to better outcomes.15 The herbs primarily used in" exact="China" post="are ginseng and milk vetch root (Astragalus membranaceus, Huangqi)"/>
   <result pre="similar settings for active participation in the future. Finally, the" exact="Japan" post="Society for Oriental Medicine is conducting evaluations on the"/>
   <result pre="by primary care doctors can help relieve hospital workloadsThe South" exact="China" post="Morning Post2020(Accessed in June 2020) 5https://www.oecd-ilibrary.org/social-issues-migration-health/data/oecd-health-statistics_health-data-en. OECD Health Statistics."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7367788\results\search\country\results.xml">
   <result pre="has emerged in late December 2019 in Wuhan city of" exact="China" post="and spread rapidly to other parts of the world."/>
   <result pre="inducing metabolic and epigenetic changes. Clinical trials are underway in" exact="Australia" post="and Netherlands for determining the efficacy of BCG vaccines"/>
   <result pre="and epigenetic changes. Clinical trials are underway in Australia and" exact="Netherlands" post="for determining the efficacy of BCG vaccines in healthcare"/>
   <result pre="and inhibits viral RNA synthesis Approved to treat influenza in" exact="Japan" post="Ribavirin (antiviral, guanine nucleotide analog) Phase 1/2 Target RdRp"/>
   <result pre="4 Inhibits fusion between viral and cellular membrane Approved in" exact="Russia" post="and China for the prophylaxis and treatment of influenza"/>
   <result pre="fusion between viral and cellular membrane Approved in Russia and" exact="China" post="for the prophylaxis and treatment of influenza A, B,"/>
   <result pre="action and thereby inhibits viral entry to cells Approved in" exact="Japan" post="for chronic pancreatitis and drug-induced lung injury Clevudine (synthetic"/>
   <result pre="The published report of treatment of first COVID-19 patients in" exact="the USA" post="and remdesivirâ€™s use in a 53-patient case series have"/>
   <result pre="emergency use authorization (EUA) for treating hospitalized COVID-19 patients by" exact="the US" post="Food and Drug Administration (FDA). Promising signals from various"/>
   <result pre="thus ceasing viral replication [27]. It has been approved in" exact="Japan" post="and China for the treatment of novel influenza virus"/>
   <result pre="viral replication [27]. It has been approved in Japan and" exact="China" post="for the treatment of novel influenza virus infections, and"/>
   <result pre="treatment of novel influenza virus infections, and in March 2020," exact="China" post="has approved its use for COVID-19 patients. A study"/>
   <result pre="E6 cells [19]. A study conducted on COVID-19 patients in" exact="China" post="has stated the more potent antiviral action (shorter time"/>
   <result pre="interferon-alpha [28]. Furthermore, a prospective, multicenter, open-label, randomized trial in" exact="China" post="comparing favipiravir with arbidol has shown better recovery profile"/>
   <result pre="group [40]. But, a prospective study of 30 patients in" exact="China" post="stated that there was no difference in clinical outcomes"/>
   <result pre="Recently, the results of a most awaited trial conducted in" exact="the USA" post="on 96,032 COVID-19 patients using HCQ and CQ with"/>
   <result pre="along with standard treatment in a clinical trial conducted in" exact="China" post="(ChiCTR2000029757) [51]. These data support the utility of convalescent"/>
   <result pre="a recent open-label phase 2 trial (NCT04346355) conducted in the" exact="Italy" post="was stopped early because of lack of benefit of"/>
   <result pre="injury and ARDS [64â€&quot;66]. Recently, a pilot study conducted in" exact="China" post="on seven COVID-19 patients, who had received intravenous infusions"/>
   <result pre="patient outcomes on further use. Also, on April 5, 2020," exact="the US" post="FDA has approved mesenchymal stem cell (MSC) treatments for"/>
   <result pre="antiviral effect to prevent SARS-CoV-2 infection [70]. Medical institutions in" exact="China" post="have published many TCM prescriptions, and guideline in China"/>
   <result pre="in China have published many TCM prescriptions, and guideline in" exact="China" post="(The Novel Coronavirus Pneumonia Diagnosis and Treatment Plan, 6th"/>
   <result pre="[69]. On February 17, The National Health Commission (NHC) of" exact="China" post="has reported the beneficial effect of TCM in around"/>
   <result pre="To date, more than 50 clinical trials have registered in" exact="China" post="for the evaluation of TCM in COVID-19. Luo, et"/>
   <result pre="subjects performed by any of the authors. References References 1.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWcollab:" exact="China" post="Novel Coronavirus Investigating and Research TeamA novel coronavirus from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7368942\results\search\country\results.xml">
   <result pre="with 773 thousand (29%) occurring in Brazil, mostly in Northeast" exact="Brazil" post="in the state of Pernambuco, which was the epicenter"/>
   <result pre="found a seroprevalence of 20.0% in Feira de Santana, northeastern" exact="Brazil" post="[20]. Although no statistically significant difference was demonstrated, the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7369569\results\search\country\results.xml">
   <result pre="Intermediary host Pangolin Palm civet Dromedary camel Origin Unknown Guangdong," exact="China" post="Arabian Peninsula Route transmission Airway, contact transmission and aerosol"/>
   <result pre="2019 [25]. There was one SARS vaccine trial conducted by" exact="the US" post="National Institute of Allergy and Infectious Diseases. Both Phase"/>
   <result pre="ranged from 0.15% (95% confidence interval [CI]: 0.12â€&quot;0.18%) in mainland" exact="China" post="excluding Hubei t 1.41% (95% CI: 1.38â€&quot;1.45%) in Hubei"/>
   <result pre="on data from the Wuhan Municipal Health Commission and the" exact="China" post="and National Health Commission of China [28]. Chen et"/>
   <result pre="Health Commission and the China and National Health Commission of" exact="China" post="[28]. Chen et al. systematically described 99 cases of"/>
   <result pre="that can potentially serve as an alternative route of transmission." exact="China" post="and other countries have implemented major prevention and control"/>
   <result pre="of COVID-19 was performed in five different institutions, namely, the" exact="China" post="CDC, Chinese Academy of Medical Science, Wuhan Institute of"/>
   <result pre="to Prashant Pradhan, the first case cured in sevenâ€‰days in" exact="the United States" post="showed that the antiviral medication remdesivir may become one"/>
   <result pre="Prashant Pradhan, the first case cured in sevenâ€‰days in the" exact="United States" post="showed that the antiviral medication remdesivir may become one"/>
   <result pre="funded by the National Key Research and Development Program of" exact="China" post="(2018YFA0108700), the NSFC Projects of International Cooperation and Exchanges"/>
   <result pre="and Exchanges (81720102004), and the National Natural Science Foundation of" exact="China" post="(81974019, 81970248). Availability of data and materials Not applicable."/>
   <result pre="routes of MERS-CoV during the first hospital outbreak in the" exact="Republic of" post="KoreaIndoor Air201828516328960494 23.JinYHCaiLChengZSChengHDengTFanYPFangCHuangDHuangLQHuangQHanYHuBHuFLiBHLiYRLiangKLinLKLuoLSMaJMaLLPengZYPanYBPanZYRenXQSunHMWangYWangYYWengHWeiCJWuDFXiaJXiongYXuHBYaoXMYuanYFYeTSZhangXCZhangYWZhangYGZhangHMZhaoYZhaoMJZiHZengXTWangYYWangXHA rapid advice guideline for the diagnosis"/>
   <result pre="snake to humanJ Med Virol20202218 31.LauSKPWongACPZhangLLukHKHKwokJSLAhmedSSCaiJPZhaoPSHTengJLLTsuiSKWYuenKYWooPCYNovel Bat Alphacoronaviruses in Southern" exact="China" post="Support Chinese Horseshoe Bats as an Important Reservoir for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7369591\results\search\country\results.xml">
   <result pre="multiple case reports and series from Canada, Europe, Japan, and" exact="the United States" post="have provided early promising results of treatment with remdesivir,"/>
   <result pre="case reports and series from Canada, Europe, Japan, and the" exact="United States" post="have provided early promising results of treatment with remdesivir,"/>
   <result pre="clinical data on LPV/RTV therapy in patients with COVID-19 in" exact="China" post="and Singapore have suggested mixed results.30, 31, 32 Two"/>
   <result pre="on LPV/RTV therapy in patients with COVID-19 in China and" exact="Singapore" post="have suggested mixed results.30, 31, 32 Two retrospective studies"/>
   <result pre="is also being explored. A study of 21 patients in" exact="China" post="receiving tocilizumab in addition to standard of care found"/>
   <result pre="P&amp;lt;.05).59 Conversely, a 21-patient retrospective analysis of tocilizumab treatment in" exact="Italy" post="did not find reductions in ICU admission (P=.22) or"/>
   <result pre="of care.65 However, a retrospective study of 14 patients in" exact="Germany" post="with progressive hyperinflammation due to COVID-19 reported a 58%"/>
   <result pre="SARS-CoV-2.77,78 A publication of a 30-patient RCT of HCQ in" exact="China" post="reported no difference in time to viral clearance, body"/>
   <result pre="retrospective analysis of 95 patients receiving CQ for COVID-19 in" exact="the Netherlands," post="23% of patients had a corrected QT interval exceeding"/>
   <result pre="One arm of a double-blind randomized trial of CQ in" exact="Brazil" post="with a dosage of 600 mg twice daily was"/>
   <result pre="sepsis, this approach may improve mortality rates.102 On March 24," exact="the US" post="Food and Drug Administration made CPT available for use"/>
   <result pre="limited, but increasing. Case series in China, Korea, Mexico, and" exact="the United States" post="have reported varying clinical improvement due to CPT, ranging"/>
   <result pre="but increasing. Case series in China, Korea, Mexico, and the" exact="United States" post="have reported varying clinical improvement due to CPT, ranging"/>
   <result pre="An open-label, multicenter, randomized clinical trial of 101 patients in" exact="China" post="reported clinical improvement on a 6-point scale within 28"/>
   <result pre="a study of 5000 patients receiving CPT as part of" exact="the US" post="Food and Drug Administration Expanded Access Program resulted in"/>
   <result pre="(46) Single 3 (12) Multi 11 (42) Low-dose radiation 12" exact="United States," post="Italy, India, Spain, Iran 3 (25) None 11 (92)"/>
   <result pre="11 (42) Low-dose radiation 12 United States, Italy, India, Spain," exact="Iran" post="3 (25) None 11 (92) Single 0 (0) Multi"/>
   <result pre="therapy (RECOVERY) Trial (International Clinical trials Registry Platform identifier: ISRCTN50189673)" exact="United Kingdom" post="(5000) University of Oxford SoCÂ + LPV/RTVSoCÂ + IFN"/>
   <result pre="Patients at Risk for Severe Disease (HYCOVID) (ClinicalTrials.gov identifier: NCT04325893)" exact="France" post="(1300) University Hospital Angers HCQ Placebo Phase III, multicenter,"/>
   <result pre="Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) (ClinicalTrials.gov identifier: NCT04342182) The" exact="Netherlands" post="(426) Erasmus Medical Center COVID-19 convalescent plasma SoC Phase"/>
   <result pre="2Johns Hopkins University &amp;amp; Medicine Coronavirus Resource Center. COVID-19 in" exact="the USA." post="https://coronavirus.jhu.edu. Accessed June 29, 2020 3DengY.LiuW.LiuK.Clinical characteristics of fatal"/>
   <result pre="pneumonia receiving combined Chinese and Western medicine treatmentBiosci Trends1412020646832037389 31YoungB.E.OngS.W.X.KalimuddinS.collab:" exact="Singapore" post="2019 Novel Coronavirus Outbreak Research TeamEpidemiologic features and clinical"/>
   <result pre="Dis7115202076276832161940 48ShiY.TanM.ChenX.Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou," exact="China" post="[published online ahead of print March 16, 2020]medRxivhttps://doi.org/10.1101/2020.03.12.20034736 49RichardsonP.GriffinI.TuckerC.Baricitinib"/>
   <result pre="open label, randomised controlled trialBMJ3692020m184932409561 81MagagnoliJ.NarendranS.PereiraF.Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with COVID-19 [published online ahead of print"/>
   <result pre="of print May 15, 2020] [published correction appears in Sci" exact="China" post="Life Sci. June 18, 2020. doi:10.1007/s11427-020-1751-3]Sci China Life Scihttps://doi.org/10.1007/s11427-020-1732-2"/>
   <result pre="appears in Sci China Life Sci. June 18, 2020. doi:10.1007/s11427-020-1751-3]Sci" exact="China" post="Life Scihttps://doi.org/10.1007/s11427-020-1732-2 94ChenZ.HuJ.ZhangZ.Efficacy of hydroxychloroquine in patients with COVID-19:"/>
   <result pre="infectionChest15812020e9e1332243945 106YeM.FuD.RenY.Treatment with convalescent plasma for COVID-19 patients in Wuhan," exact="China" post="[published online ahead of print April 15, 2020]J Med"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7369612\results\search\country\results.xml">
   <result pre="county levels. â€¢We compare mitigation measures in various counties in" exact="the United States" post="based on the proposed LSTM model. â€¢We can obtain"/>
   <result pre="levels. â€¢We compare mitigation measures in various counties in the" exact="United States" post="based on the proposed LSTM model. â€¢We can obtain"/>
   <result pre="a quantitative comparison of mitigation measures in various counties in" exact="the United States" post="based on the rate of difference of a short"/>
   <result pre="quantitative comparison of mitigation measures in various counties in the" exact="United States" post="based on the rate of difference of a short"/>
   <result pre="Introduction The outbreak of a novel coronavirus which spread from" exact="China" post="in December 2019 led to severe health problems and"/>
   <result pre="based on stacked auto-encoders to forecast cumulative COVID-19 cases in" exact="China" post="till April 2020 based on past cumulative data. They"/>
   <result pre="data [28] as well as to study epidemic trends in" exact="China" post="[29]. All COVID-19 forecast and projection models proposed so"/>
   <result pre="focusing on the values of the RMSE. 4.1.1 Predictions for" exact="the United States" post="and other global locations In this section, we discuss"/>
   <result pre="on the values of the RMSE. 4.1.1 Predictions for the" exact="United States" post="and other global locations In this section, we discuss"/>
   <result pre="we discuss our results on five globally affected locations: (a)" exact="the United States" post="of America, (b) Italy, (c) India, (d) Japan, and"/>
   <result pre="discuss our results on five globally affected locations: (a) the" exact="United States of America," post="(b) Italy, (c) India, (d) Japan, and (e) Hubei,"/>
   <result pre="shows the plot of predictions for COVID-19 confirmed cases in" exact="the United States" post="of America. Fig.Â 3 shows the plot of predictions"/>
   <result pre="the plot of predictions for COVID-19 confirmed cases in the" exact="United States of America." post="Fig.Â 3 shows the plot of predictions for COVID-19"/>
   <result pre="3 shows the plot of predictions for COVID-19 deaths in" exact="United States of America." post="The United States had different lockdown and phased reopening"/>
   <result pre="predictions for COVID-19 deaths in United States of America. The" exact="United States" post="had different lockdown and phased reopening strategies for the"/>
   <result pre="may be needed. Fig. 2 Results on COVID-19 Cases in" exact="the United States" post="of America. Fig. 3 Results on COVID-19 Deaths in"/>
   <result pre="be needed. Fig. 2 Results on COVID-19 Cases in the" exact="United States of America." post="Fig. 3 Results on COVID-19 Deaths in the United"/>
   <result pre="States of America. Fig. 3 Results on COVID-19 Deaths in" exact="the United States" post="of America. Fig.Â 4 shows the plot of predictions"/>
   <result pre="of America. Fig. 3 Results on COVID-19 Deaths in the" exact="United States of America." post="Fig.Â 4 shows the plot of predictions for COVID-19"/>
   <result pre="shows the plot of predictions for COVID-19 deaths in Italy." exact="Italy" post="progressively enforced strict lockdown policies in various regions starting"/>
   <result pre="the flattened curve as achieved by Italy. The deaths in" exact="Italy" post="show a similar trend as that of the cases."/>
   <result pre="shows the plot of predictions for COVID-19 deaths in India." exact="India" post="enforced nationwide lockdowns in several phases following the order"/>
   <result pre="shows the plot of predictions for COVID-19 deaths in Japan." exact="Japan" post="implemented a series of measures in March 2020 to"/>
   <result pre="as the confirmed cases, however, here the COVID-19 deaths in" exact="Japan" post="show a flattening in the curve that is also"/>
   <result pre="predictions for COVID-19 deaths in Hubei, China. Wuhan in Hubei," exact="China" post="was the location where the first cases of COVID-19"/>
   <result pre="location where the first cases of COVID-19 were observed [23]." exact="China" post="enforced mitigation measures in January [44]. Based on both"/>
   <result pre="COVID-19 Deaths in Hubei, China. 4.1.2 Predictions for counties in" exact="the United States" post="In this section, we show predictions of our proposed"/>
   <result pre="Deaths in Hubei, China. 4.1.2 Predictions for counties in the" exact="United States" post="In this section, we show predictions of our proposed"/>
   <result pre="of our proposed LSTM model on eight affected counties within" exact="the United States" post="of America: (a) Los Angeles, California, (b) Dallas, Texas,"/>
   <result pre="our proposed LSTM model on eight affected counties within the" exact="United States" post="of America: (a) Los Angeles, California, (b) Dallas, Texas,"/>
   <result pre="York was one of the most heavily affected areas of" exact="the United States." post="Counties in New York enforced lockdowns in March similar"/>
   <result pre="was one of the most heavily affected areas of the" exact="United States." post="Counties in New York enforced lockdowns in March similar"/>
   <result pre="enforced lockdowns in March similar to most other places of" exact="the United States" post="[40]. The graphs suggest that mitigation measures are working"/>
   <result pre="lockdowns in March similar to most other places of the" exact="United States" post="[40]. The graphs suggest that mitigation measures are working"/>
   <result pre="28 Evaluating effects of mitigation measures in various counties in" exact="the United States." post="In order to quantify and evaluate how well mitigation"/>
   <result pre="Evaluating effects of mitigation measures in various counties in the" exact="United States." post="In order to quantify and evaluate how well mitigation"/>
   <result pre="1 Comparing effects of mitigation measures in various counties in" exact="the United States." post="Table 1 County Mitigation measures for COVID-19 infections Mitigation"/>
   <result pre="Comparing effects of mitigation measures in various counties in the" exact="United States." post="Table 1 County Mitigation measures for COVID-19 infections Mitigation"/>
   <result pre="5.97 King, Washington 1.52 âˆ’1.80 24.73 âˆ’0.00 0.27 2.19 Fulton," exact="Georgia" post="1.94 1.65 44.21 âˆ’0.02 0.25 4.36 Cook, Illinois 10.78"/>
   <result pre="mitigation measures did not work in Hillsborough, Florida and Fulton," exact="Georgia" post="because of the rising infection rates even though the"/>
   <result pre="or nearly stabilized as shown by the eight counties in" exact="the United States." post="This happened due to the rapid increase in testing"/>
   <result pre="nearly stabilized as shown by the eight counties in the" exact="United States." post="This happened due to the rapid increase in testing"/>
   <result pre="Table 2 Evaluation of mitigation measures in various counties in" exact="the United States." post="Table 2 County Success of mitigation measures based on"/>
   <result pre="2 Evaluation of mitigation measures in various counties in the" exact="United States." post="Table 2 County Success of mitigation measures based on"/>
   <result pre="âœ&quot; Maricopa, Arizona âœ&quot; âœ— King, Washington âœ— âœ&quot; Fulton," exact="Georgia" post="âœ— âœ&quot; Cook, Illinois âœ— âœ&quot; New York City,"/>
   <result pre="of mitigation measures have been observed in different parts of" exact="the United States" post="which may require additional measures like rapid testing, contact"/>
   <result pre="mitigation measures have been observed in different parts of the" exact="United States" post="which may require additional measures like rapid testing, contact"/>
   <result pre="Team, ResponseSevere outcomes among patients with coronavirus disease 2019 (COVID-19)" exact="United States," post="February 12â€&quot;March 16, 2020MMWR Morb Mortal Weekly Rep69122020343346 18CruzA.T.ZeichnerS.L.COVID-19"/>
   <result pre="and AI prediction of the epidemics trend of COVID-19 in" exact="China" post="under public health interventionsJ Thorac Dis123202016532274081 30Wang Z, Li"/>
   <result pre="Y. Evaluating the traditional Chinese medicine (TCM) officially recommended in" exact="China" post="for COVID-19 using ontology-based side-effect prediction framework (OSPF) and"/>
   <result pre="work: health, distress and life satisfaction of working adults in" exact="China" post="one month into the COVID-19 outbreakPsychiatry Res288202011295832283450 45US Reopening"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7369980\results\search\country\results.xml">
   <result pre="lead to the syndemic emergence of diseases in PWH in" exact="the United States" post="and in LMICs [2,3]. The Framework of Syndemics (Figure"/>
   <result pre="to the syndemic emergence of diseases in PWH in the" exact="United States" post="and in LMICs [2,3]. The Framework of Syndemics (Figure"/>
   <result pre="cluster with other NCDs [14]. Countries within Central and South" exact="America" post="and the Caribbean, Central and sub-Saharan Africa, and Southeast"/>
   <result pre="is the third leading cause of death by disease in" exact="the US" post="[24]. In comparison to people without HIV, PWH have"/>
   <result pre="rather than becoming blocked by a ruptured plaque [26]. In" exact="the US," post="currently, 11% of HIV-positive veterans also have COPD, and"/>
   <result pre="suffer from emphysema. The management of COPD and emphysema within" exact="the US" post="veteran population is of significance to the US Department"/>
   <result pre="emphysema within the US veteran population is of significance to" exact="the US" post="Department of Veteran Affairs [27,28]. Thus, the importance of"/>
   <result pre="population will be indispensable in addressing this significant problem in" exact="the US" post="and global populations [29]. On a final note, it"/>
   <result pre="that, while most people who receive an HIV diagnosis in" exact="the US" post="live in urban areas, many live in rural areas"/>
   <result pre="all levels of CD4 count [35]. A male living in" exact="Kenya" post="diagnosed at age 20 could expect to pay a"/>
   <result pre="27.SchaferK.R.AlbrechtH.DillinghamR.HoggR.S.JaworskyD.KasperK.LoutfyM.MacKenzieL.J.McManusK.A.OurslerK.A.et al.The Continuum of HIV Care in Rural Communities in" exact="the United States" post="and Canada: What Is Known and Future Research DirectionsJ."/>
   <result pre="al.The Continuum of HIV Care in Rural Communities in the" exact="United States" post="and Canada: What Is Known and Future Research DirectionsJ."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7370876\results\search\country\results.xml">
   <result pre="the SARS pandemic, an outbreak of MERS was detected in" exact="Saudi Arabia," post="caused by MERS-CoV, another highly pathogenic coronavirus29. In the"/>
   <result pre="with COVID-19 have also described similar findings12â€&quot;15. Early reports from" exact="China" post="found that CVD and its risk factors, such as"/>
   <result pre="Ref. Cardiovascular disease (%) Hypertension (%) Diabetes (%) Obesity (%)" exact="China" post="41 15 (23) 15 (15) 20 (8) NR 17"/>
   <result pre="China 41 15 (23) 15 (15) 20 (8) NR 17" exact="China" post="138 14.5 (25.0) 31.2 (58.3) 10.1 (22.2) NR 18"/>
   <result pre="China 138 14.5 (25.0) 31.2 (58.3) 10.1 (22.2) NR 18" exact="China" post="191 8a (24)a,b 30 (48)b 19 (31)b NR 19"/>
   <result pre="China 191 8a (24)a,b 30 (48)b 19 (31)b NR 19" exact="China" post="150 8.7 (19.1)b 34.7 (42.6)b 16.7 (17.6)b NR 22"/>
   <result pre="China 150 8.7 (19.1)b 34.7 (42.6)b 16.7 (17.6)b NR 22" exact="China" post="1,099 2.5a (5.8)a 15.0 (23.7) 7.4 (16.2) NR 20"/>
   <result pre="China 1,099 2.5a (5.8)a 15.0 (23.7) 7.4 (16.2) NR 20" exact="China" post="44,672 4.2 (22.7) 12.8 (39.7) 5.3 (19.7) NR 21"/>
   <result pre="China 44,672 4.2 (22.7) 12.8 (39.7) 5.3 (19.7) NR 21" exact="Italy" post="1,591 NR (21) NR (49) NR (17) NR 46"/>
   <result pre="had not been reported in the studies on patients in" exact="China" post="probably owing to differences in the background prevalence of"/>
   <result pre="owing to differences in the background prevalence of obesity between" exact="the USA" post="and China. Investigators in this study suggest that obesity"/>
   <result pre="infarction required percutaneous coronary intervention66. In a case series from" exact="Italy" post="involving 28 patients with COVID-19 and ST segment elevation"/>
   <result pre="reported cases of ACS during the COVID-19 outbreak in Italy," exact="Spain" post="and the USA was actually significantly lower than during"/>
   <result pre="of ACS during the COVID-19 outbreak in Italy, Spain and" exact="the USA" post="was actually significantly lower than during pre-COVID-19 periods, with"/>
   <result pre="days and 29.1% versus 62.7%, respectively)89. Another retrospective study in" exact="China" post="also showed reduced mortality in patients with COVID-19-associated coagulopathy"/>
   <result pre="Society of Cardiology, ESC and the Heart Failure Society of" exact="America" post="have issued statements recommending continuation of RAAS antagonists for"/>
   <result pre="from clinical studies support this recommendation. In four studies from" exact="Spain" post="(nâ€‰=â€‰1,139)125, Italy (nâ€‰=â€‰6,772)126 and the USA (nâ€‰=â€‰5,894 and 1,735)127,128,"/>
   <result pre="studies support this recommendation. In four studies from Spain (nâ€‰=â€‰1,139)125," exact="Italy" post="(nâ€‰=â€‰6,772)126 and the USA (nâ€‰=â€‰5,894 and 1,735)127,128, the use"/>
   <result pre="recommendation. In four studies from Spain (nâ€‰=â€‰1,139)125, Italy (nâ€‰=â€‰6,772)126 and" exact="the USA" post="(nâ€‰=â€‰5,894 and 1,735)127,128, the use of RAAS inhibitors was"/>
   <result pre="genome GenBank severe acute respiratory syndrome coronavirus 2 sequence: https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/" exact="China" post="National Center for Bioinformation: https://bigd.big.ac.cn/ncov?lang=en Virus protein data ViralZone:"/>
   <result pre="statement on the diagnosis and treatment of adult fulminant myocarditisSci." exact="China" post="Life Sci.20196218720230519877 55.InciardiRMet al.Cardiac involvement in a patient with"/>
   <result pre="70.GarciaSet al.Reduction in ST-segment elevation cardiac catheterization laboratory activations in" exact="the United States" post="during COVID-19 pandemicJ. Am. Coll. Cardiol.2020752871287232283124 71.De FilippoOet al.Reduced"/>
   <result pre="al.Reduction in ST-segment elevation cardiac catheterization laboratory activations in the" exact="United States" post="during COVID-19 pandemicJ. Am. Coll. Cardiol.2020752871287232283124 71.De FilippoOet al.Reduced"/>
   <result pre="Ed.202010.24875/recice.M20000123 73.De RosaSet al.Reduction of hospitalizations for myocardial infarction in" exact="Italy" post="in the COVID-19 eraEur. Heart J.2020412083208832412631 74.BaldiEet al.Out-of-hospital cardiac"/>
   <result pre="of hydroxychloroquine reduces fatality of critically ill patients with COVID-19Sci." exact="China" post="Life. Sci.202010.1007/s11427-020-1732-232676969 149.GelerisJet al.Observational study of hydroxychloroquine in hospitalized"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7371486\results\search\country\results.xml">
   <result pre="al.A harm-reduction model of abortion counseling about misoprostol use in" exact="Peru" post="with telephone and in-person follow-up: a cohort study. PLoS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7371569\results\search\country\results.xml">
   <result pre="requirement. Method Health and Social Care (HSC) Trusts across Northern" exact="Ireland" post="(NI) identified critical care drugs required and an estimation"/>
   <result pre="requirement. Methodology Health and Social Care (HSC) Trusts across Northern" exact="Ireland" post="(NI) identified critical care drugs required in the pandemic"/>
   <result pre="pandemic and subsequently updated for COVID-19 using published data from" exact="China" post="(Borthwick, Barton and Graham-Clarke, 2020), was considered for use"/>
   <result pre="database was clinically reviewed by the Critical Care Network Northern" exact="Ireland" post="and HSC Trusts (ICU pharmacists and pharmacy procurement leads)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7372203\results\search\country\results.xml">
   <result pre="by intravenous infusion [20]. Other noncomparative, open-label studies underway in" exact="Greece" post="(NCT04356366, NCT04339712) and Belgium (NCT04330638) are using the subcutaneous"/>
   <result pre="Other noncomparative, open-label studies underway in Greece (NCT04356366, NCT04339712) and" exact="Belgium" post="(NCT04330638) are using the subcutaneous form. IL-6 Receptor Antagonists"/>
   <result pre="trials planned or initiated using tocilizumab in COVID-19 patients in" exact="the US," post="China, and Europe. Interim results from CORIMUNO-TOCI (NCT04331808), an"/>
   <result pre="III trial is taking place at a global level in" exact="the US," post="Canada, UK, and Europe (NCT04320615). The study will evaluate"/>
   <result pre="been used orally as a treatment for allergic rhinitis in" exact="Japan" post="for the past 20Â years. Hence, clinical trials investigating"/>
   <result pre="3.WuFZhaoSYuBet al.A new coronavirus associated with human respiratory disease in" exact="China" post="[published correction appears in Nature. 2020;580(7803):E7]Nature2020579779826526910.1038/s41586-020-2008-332015508 4.HuangCWangYLiXRenLZhaoJHuYet al.Clinical features"/>
   <result pre="medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia. From" exact="China" post="consulate website. https://busan.china-consulate.org/chn/zt/4/P020200310548447287942.pdf. Accessed 20 Mar 2020. 27.LuoPLiuYQiuLLiuXLiuDLiJTocilizumab treatment"/>
   <result pre="from ChinaClin Immunol202021410839310.1016/j.clim.2020.10839332222466 61.I-Mab seeks approval for Covid-19 trial in" exact="South Korea." post="https://www.clinicaltrialsarena.com/news/i-mab-covid-19-drug-trial/. Accessed 14 May 2020. 62.Izana intiates study assessing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7374000\results\search\country\results.xml">
   <result pre="Western countries, but not in East Asian countries such as" exact="Japan" post="and Korea, where KD is endemic. Children affected by"/>
   <result pre="[43,44]. Between the 2 pandemics, there was the 1968 H2N3" exact="Hong Kong" post="influenza pandemic just 40 years before the 2009 pandemic."/>
   <result pre="Child Health200642423716898879 83LauEHHsiungCACowlingBJChenCHHoLMTsangTet al.A comparative epidemiologic analysis of SARS in" exact="Hong Kong," post="Beijing and TaiwanBMC Infect Dis2010105010.1186/1471-2334-10-5020205928 84FrankCWerberDCramerJPAskarMFaberMHeidenMAet al.collab: the HUS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7375387\results\search\country\results.xml">
   <result pre="Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, Krakow," exact="Poland" post="Sandri-GoldinRozanne M.Editor[], Address correspondence to Krzysztof Pyrc, k.a.pyrc@uj.edu.pl. Aleksandra"/>
   <result pre="bioethical committee of the Medical University of Silesia in Katowice," exact="Poland" post="(approval no KNW/0022/KB1/17/10, dated 16 February 2010). Written consent"/>
   <result pre="ZEN 2012 SP1 black edition software and processed in ImageJ" exact="Fiji" post="(National Institutes of Health, Bethesda, MD). ACKNOWLEDGMENTS This work"/>
   <result pre="LiuJY, ChenZ, LiG, ZhengZJ, QiuSQ, LuoJ, YeCJ, ZhuSY, ZhongNS; collab:" exact="China" post="Medical Treatment Expert Group for COVID-19. 2020Clinical Characteristics of"/>
   <result pre="syndrome coronavirus 2 from patient with 2019 novel coronavirus disease," exact="United States." post="Emerg Infect Dis26:1266â€&quot;1273. doi:10.3201/eid2606.200516.32160149 12.ShiratoK, KawaseM, MatsuyamaS2018Wild-type human coronaviruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7376532\results\search\country\results.xml">
   <result pre="and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)Pharmacol Res202015610476110.1016/j.phrs.2020.10478332205232 12.Cyranoski D." exact="China" post="is promoting coronavirus treatments based on unproven traditional medicines."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7376974\results\search\country\results.xml">
   <result pre="in a Clinical Pilot Device Study. Proc. Natl. Acad. Sci." exact="U. S." post="A.2019, 116, 18590â€&quot;18596. 10.1073/pnas.1906929116.31451630 AlsalehN. B.; BrownJ. M.Engineered Nanomaterials"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7377207\results\search\country\results.xml">
   <result pre="syndrome (MERS) coronavirus (MERS-CoV) emerged, it was in 2012 in" exact="Saudi Arabia" post="[6, 17, 18]. During 2002â€&quot;03, more than 8000 infected"/>
   <result pre="cases of infection and 858 mortalities, including 38 fatalities in" exact="South Korea" post="[19, 20]. In late December 2019, many infected patients"/>
   <result pre="MERS-CoV (about 79 and 52%, respectively). Samples from Wuhan and" exact="China" post="after Sequencing indicated that this virus comes from the"/>
   <result pre="27]. On January 26, 2020, the National Health Commission of" exact="China" post="has determined some guideline documents, starting with the notification"/>
   <result pre="active site [60, 61]. Through the outbreak of SARS in" exact="Hong Kong," post="ribavirin was widely used for patients with or without"/>
   <result pre="is the host receptor for COVID-19 which discovered in Wuhan," exact="China" post="in December 2019. Angiotensin receptor blockers (i.e., AT1R), like"/>
   <result pre="approved in patients with COVID-19 pneumonia and raised IL-6 in" exact="China" post="(ChiCTR2000029765) [80]. Also, disruption of IL-6 signaling with anti-IL-6"/>
   <result pre="the perfect source of convalescent plasma for health care providers." exact="China" post="National Biotec Group Co has claimed that 10 severely"/>
   <result pre="been recovered from coronavirus to inject to COVID19-infected cases in" exact="Iran" post="[104] but the result is not available yet. In"/>
   <result pre="has transmitted 140 convalescent plasma transfusions at its six Long" exact="Island" post="hospitals (https://news.sky.com/story/coronavirus-plasma-treatment-for-covid-19-patients-to-be-trialled-11978522). On Saturday 25 April 2020, Health Secretary"/>
   <result pre="to enter the market next year [107â€&quot;109]. The University of" exact="Hong Kong" post="is working on a live influenza vaccine that expresses"/>
   <result pre="demonstrated to be efficient (https://www.businessinsider.com/india-serum-institute-millions-oxford-university-vaccine-before-approval-2020-4). And The Serum Institute of" exact="India" post="declares it will start producing an experimental COVID-19 vaccine"/>
   <result pre="of Hygiene. These kinds of trials are already underway in" exact="the United States" post="and China and will start at the end of"/>
   <result pre="Hygiene. These kinds of trials are already underway in the" exact="United States" post="and China and will start at the end of"/>
   <result pre="of trials are already underway in the United States and" exact="China" post="and will start at the end of this month"/>
   <result pre="and will start at the end of this month in" exact="Germany" post="(https://www.nytimes.com/2020/04/08/health/coronavirus-vaccines.html). Monoclonal Antibody Passive antibody therapy can be a"/>
   <result pre="National Institute of Genetic Engineering and Biotechnology (NIGEB) of the" exact="Islamic Republic of Iran." post="Availability of data and materials Not applicable for this"/>
   <result pre="Institute of Genetic Engineering and Biotechnology (NIGEB) of the Islamic" exact="Republic of Iran." post="Availability of data and materials Not applicable for this"/>
   <result pre="model for the Middle East respiratory syndrome outbreak in the" exact="Republic of" post="Korea: a retrospective analysis on control interventions and superspreading"/>
   <result pre="features of the first imported case causing MERS-CoV outbreak in" exact="South Korea," post="2015BMC Infect Dis201717149828709419 21.Zhu N, Zhang D, Wang W,"/>
   <result pre="Chen J. The mental health of medical workers in Wuhan," exact="China" post="dealing with the 2019 novel coronavirus. Lancet Psychiatr. 2020;7(3):e14.doi:"/>
   <result pre="Z, Hu S, Zhang B. Online mental health services in" exact="China" post="during the COVID-19 outbreak. Lancet Psychiatr. 2020;7(4):e17â€&quot;e18.doi: 10.1016/S2215-0366(20)30077-8. 29.Clinton,"/>
   <result pre="care workers during the severe acute respiratory syndrome epidemic in" exact="Hong Kong" post="to prevent severe acute respiratory syndrome transmission, relieve influenza-related"/>
   <result pre="43.FurutaYKomenoTNakamuraTFavipiravir (T-705), a broad spectrum inhibitor of viral RNA polymeraseProceed" exact="Japan" post="Acad B2017937449463 44.Cai Q, Yang M, Liu D, Chen"/>
   <result pre="working on coronavirus vaccine 2020; Available from: https://www.thepharmaletter.com/article/j-j-working-on-coronavirus-vaccine. 109.Cheung E." exact="China" post="coronavirus: Hong Kong researchers have already developed vaccine but"/>
   <result pre="coronavirus vaccine 2020; Available from: https://www.thepharmaletter.com/article/j-j-working-on-coronavirus-vaccine. 109.Cheung E. China coronavirus:" exact="Hong Kong" post="researchers have already developed vaccine but need time to"/>
   <result pre="vaccine but need time to test it, expert reveals. South" exact="China" post="Morning Post. 110.Shieber J. Codagenix raises $20 million for"/>
   <result pre="Induce Immune Responses for 2019-nCoV. 2020; Available from: https://www.precisionvaccinations.com/curevac-mrna-platform-specifically-suitable-rapidly-provide-answer-viral-outbreak-situation-novel. 118.Xinhua." exact="China" post="fast-tracks novel coronavirus vaccine development xinhua. 2020; Available from:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7380217\results\search\country\results.xml">
   <result pre="philanthropy serving all aspects of HCT under the laws of" exact="Switzerland" post="and as a nongovernmental organization (NGO) in an official"/>
   <result pre="THERAPIES Currently approved therapies for COVID-19 complications include remdesivir in" exact="the United States" post="(under emergency use authorization) and Japan and tocilizumab in"/>
   <result pre="Currently approved therapies for COVID-19 complications include remdesivir in the" exact="United States" post="(under emergency use authorization) and Japan and tocilizumab in"/>
   <result pre="remdesivir in the United States (under emergency use authorization) and" exact="Japan" post="and tocilizumab in China. Ongoing clinical trials are examining"/>
   <result pre="on anecdotal and limited observational evidence. On June 15, 2020," exact="the US" post="Food and Drug Administration (FDA) revoked chloroquine and hydroxychloroquine's"/>
   <result pre="trial showing moderate/minimal impact on clinical outcomes [35]. Approved in" exact="China" post="for treatment of COVID-19 complications [36]. Used for the"/>
   <result pre="7 patients [56]. Approved treatment for acute GVHD in Canada," exact="New Zealand," post="and Japan Can be used in the context of"/>
   <result pre="Approved treatment for acute GVHD in Canada, New Zealand, and" exact="Japan" post="Can be used in the context of clinical trials"/>
   <result pre="hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia," exact="Italy" post="[e-pub ahead of print]. Estote parati. Bone Marrow Transplant."/>
   <result pre="of severe COVID-19 patients with tocilizumabChinaXiv2020202003.00026v1 36Liu R, Miller J." exact="China" post="approves use of Roche drug in battle against coronavirus"/>
   <result pre="of a randomized clinical trialmedRxiv202003.22.20040758 43MagagnoliJNarendranSPereiraFOutcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with COVID-19medRxiv202004.16.20065920 44GelerisJSunYPlattJObservational study of hydroxychloroquine in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7380759\results\search\country\results.xml">
   <result pre="Kerala, India[10], Department of Emergency Medicine, AIIMS, New Delhi, India[11]," exact="India" post="Unison Medicare and Research Centre, Alibhai Premji Marg, Grant"/>
   <result pre="India[12], Bodhankar Childrens Hospital, Sharhari, Central Bazaar Road, Nagpur, Maharashtra," exact="India" post="Address for correspondence: Dr. Sunil Kumar Raina, Professor and"/>
   <result pre="of OMAG. Currently, the key stakeholder in epidemic preparedness in" exact="India" post="is the National Centre for Disease Control (NCDC). Outbreak"/>
   <result pre="part of the epidemic, the most cases were reported from" exact="China" post="or among individuals with travel history to China.[5] However"/>
   <result pre="the end of March 2020, the number of cases in" exact="China" post="declined while the number of cases from Europe and"/>
   <result pre="China declined while the number of cases from Europe and" exact="the USA" post="has increased and overtaken the total numbers reported by"/>
   <result pre="in the current crisis may be debatable. The Government of" exact="India" post="also runs an Integrated Disease Surveillance Program (IDSP), a"/>
   <result pre="firm policy on epidemics across the globe; reasons mainly economic." exact="India" post="is no exception to this. We have mounted a"/>
   <result pre="Members Dr. Raman Kumar, President, Academy of Family Physicians of" exact="India" post="and founder member OMAG. Dr. Sagar Galvankar, Chief executive"/>
   <result pre="founder member OMAG. Dr. Ishwar Gilada, president, AIDS Society of" exact="India" post="and founder member OMAG Dr. Udhay Bodhankar, president, Commonwealth"/>
   <result pre="can respond as effectively as possible. As per a report," exact="India" post="did not rank favourably in a recent study of"/>
   <result pre="transparency and communication. Policy Strategy Guidelines Invest in public health" exact="China" post="imposed a lockdown for COVID-19 and it has been"/>
   <result pre="other countries should not be taking the wrong lesson from" exact="China" post="by attributing its success to the Government's unprecedented restrictions"/>
   <result pre="mass gatherings. All these efforts needed finances. So what will" exact="India" post="need in terms of finances to prepare for epidemics"/>
   <result pre="vaccines and drugs arrive. CT imaging was rolled out in" exact="China" post="as a frontline diagnostic tool. In a study of"/>
   <result pre="community centres to nursing homes will be required. The â€œAyushman" exact="Bharat" post="PMJAYâ€� program of the Government of India will be"/>
   <result pre="required. The â€œAyushman Bharat PMJAYâ€� program of the Government of" exact="India" post="will be the key in supporting needs.[12] Strengthen surveillance"/>
   <result pre="so. There are important lessons to be learnt from how" exact="China" post="tackled the problem at the original epi-centre of this"/>
   <result pre="COVID-19 has raised unprecedented situations, the responses have been extraordinary." exact="India" post="has made all-out efforts to be on the right"/>
   <result pre="Disease Surveillance Programme (IDSP)Ministry of Health and Family Welfare-Government of" exact="India" post="From idspnicinLast accessed on 2020 Mar 13 7collab: Anupriya"/>
   <result pre="2020 Mar 13Available from: wwwuniindiacom ' news ' anupriya-patel-reviews-activities-of-ncdc 8collab:" exact="India" post="fares poorly on transparency, finds KPMG healthcare reportLast accessed"/>
   <result pre="from: www sciencedailycom ' releases '2020/02 12collab: Home | Ayushman" exact="Bharat" post="| National Health Authority | GoILast accessed on 2020"/>
   <result pre="GoILast accessed on 2020 Mar 13Available from: wwwpmjaygovin 13collab: How" exact="China" post="managed to build an entirely new hospital in 10"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7381894\results\search\country\results.xml">
   <result pre="remains active. Abstract Coronavirus disease-2019 (COVID-19) pandemic started from Wuhan," exact="China" post="has infected more than 6.7 million individuals and killed"/>
   <result pre="(COVID-19) pandemic caused by a novel coronavirus (SARS-CoV-2) in Wuhan," exact="China" post="[1]. In December 2019, various cases of pneumonia with"/>
   <result pre="syndrome (SARS) outbreak caused by SARS-CoV during 2002 in Guangdong," exact="China" post="affected 8098 individuals and killed 774 individuals in 29"/>
   <result pre="trials are underway in different regions of the world, while" exact="China" post="based preliminary data has demonstrated benefits of chloroquine in"/>
   <result pre="lower mortality and higher recovery rate from COVID-19 disease in" exact="China" post="may be linked to the treatment with tradiations Chinese"/>
   <result pre="in combined with Western medicines, as approximately 85% patients in" exact="China" post="received these combinations [42,48]. However, we did not find"/>
   <result pre="by the National Institute of Allergy and Infectious Diseases in" exact="the USA," post="which is currently in phase 1 clinical trial. INO-4800,"/>
   <result pre="by the Inovio pharmaceuticals and put under clinical trials in" exact="the United States" post="(Inovio pharmaceuticals 2020) [42]. Recently, the Centre for Disease"/>
   <result pre="the Inovio pharmaceuticals and put under clinical trials in the" exact="United States" post="(Inovio pharmaceuticals 2020) [42]. Recently, the Centre for Disease"/>
   <result pre="Recently, the Centre for Disease Control and Prevention (CDC) in" exact="China" post="and Stermirna Therapeutics have announced the designing of an"/>
   <result pre="operating grant support from the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(grants no: 81870942, 81471174 and 81520108011), 10.13039/501100012166National Key Research"/>
   <result pre="81471174 and 81520108011), 10.13039/501100012166National Key Research and Development Program of" exact="China" post="(grant no: 2018YFC1312200), and Innovation Scientists and Technicians Troop"/>
   <result pre="Scientists and Technicians Troop Constructions Projects of Henan Province of" exact="China" post="(for M.X)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7383122\results\search\country\results.xml">
   <result pre="patients who die from the infection; a recent study from" exact="China" post="that included 416 patients showed that 19% had signs"/>
   <result pre="associated with significantly higher mortality. Multiple studies from Wuhan in" exact="China" post="reported acute cardiac injury in 17â€&quot;23% of the population,"/>
   <result pre="required in 35% of the patients in a study from" exact="China" post="and up to 67% of the critically ill patients"/>
   <result pre="67% of the critically ill patients in a study from" exact="the USA," post="although most of them did not present with evidence"/>
   <result pre="pathways and delivery Remote monitoring The Heart Failure Society of" exact="America" post="released a statement addressing how the care for HF"/>
   <result pre="of acquiring the novel virus. In a small study from" exact="China" post="[64], Ren et al. observed 87 heart transplant recipients"/>
   <result pre="COVID-19 [34, 66]. The clinical picture in reported cases from" exact="China" post="was accompanied by mild to severe symptoms at presentation,"/>
   <result pre="among the first consecutive 1,096 patients diagnosed with COVID-19: the" exact="Kuwait" post="experience. medRxiv 32.Javanian M, Bayani M, Shokri M, Sadeghi-Haddad-Zavareh"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7384729\results\search\country\results.xml">
   <result pre="JAMA Cardiol. 2020;5:802â€&quot;10. 10.1001/jamacardio.2020.0950. 11.Inciardi RM, Lupi L, Zaccone G," exact="Italia" post="L, Raffo M, Tomasoni D, et al. Cardiac Involvement"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7385132\results\search\country\results.xml">
   <result pre="General HospitalBoston, MAUnited States Edited by: Ying-Yong Zhao, Northwest University," exact="China" post="Reviewed by: Umberto Maggiore, Decision Research, United States; Bassam"/>
   <result pre="Zhao, Northwest University, China Reviewed by: Umberto Maggiore, Decision Research," exact="United States;" post="Bassam G. Abu Jawdeh, University of Cincinnati, United States"/>
   <result pre="Research, United States; Bassam G. Abu Jawdeh, University of Cincinnati," exact="United States" post="*Correspondence: Paolo Cravedi paolo.cravedi@mssm.edu This article was submitted to"/>
   <result pre="(SARS-CoV-2), first described in humans in December 2019 in Wuhan," exact="China" post="(1), is the third coronavirus to have emerged in"/>
   <result pre="protection devices are required. Chinese Society of Nephrology and the" exact="Taiwan" post="Society of Nephrology have recently published detailed guidelines for"/>
   <result pre="is a serin protease inhibitor with anti-inflammatory effects approved in" exact="China" post="and Japan for the treatment of acute pancreatitis and"/>
   <result pre="serin protease inhibitor with anti-inflammatory effects approved in China and" exact="Japan" post="for the treatment of acute pancreatitis and sepsis (123)."/>
   <result pre="10.1056/NEJMoa200541232220208 2.MunsterVJKoopmansMvan DoremalenNvan RielDde WitE. A novel coronavirus emerging in" exact="China" post="â€&quot; Key questions for impact assessment. N Engl J"/>
   <result pre="al.. COVID-19 in solid organ transplant recipients: initial report from" exact="the US" post="epicenter. Am J Transplant. (2020) 20:1800â€&quot;8. 10.1111/ajt.1594132330343 66.AkalinEAzziYBartashRSeethamrajuHParidesMHemmigeVet al.."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7385229\results\search\country\results.xml">
   <result pre="Pathologie, C.H.U. Grenoble-AlpesLa TroncheFrance Edited by: Rudolf Lucas, Augusta University," exact="United States" post="Reviewed by: Oreste Gualillo, Servicio Gallego de Salud, Spain;"/>
   <result pre="Servicio Gallego de Salud, Spain; P. Trayhurn, University of Liverpool," exact="United Kingdom" post="*Correspondence: Audrey Le Gouellec alegouellec@chu-grenoble.fr This article was submitted"/>
   <result pre="(SARS-CoV-1) occurred between November 2002 and July 2003, originating from" exact="China" post="and then spreading worldwide (2). Although the symptoms of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7388682\results\search\country\results.xml">
   <result pre="encoding viral S protein [64â€&quot;66]. In May 2020, Moderna receivedÂ" exact="the US" post="FDA clearance to start a Phase II study on"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N. Engl. J. Med.367(19), 1814â€&quot;1820 (2012).23075143 33.LuR , ZhaoX"/>
   <result pre="DeboltC , LindquistSet al.First case of 2019 novel coronavirus in" exact="the United States." post="N. Engl. J. Med.382(10), 929â€&quot;936 (2020).32004427 92.ReinaJRemdesivir, the antiviral"/>
   <result pre=", LindquistSet al.First case of 2019 novel coronavirus in the" exact="United States." post="N. Engl. J. Med.382(10), 929â€&quot;936 (2020).32004427 92.ReinaJRemdesivir, the antiviral"/>
   <result pre="of its spike protein for risk of human transmission. Sci." exact="China" post="Life Sci.63(3), 457â€&quot;460 (2020).32009228 110.AtluriS , ManchikantiL , HirschJAExpanded"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7391015\results\search\country\results.xml">
   <result pre="118) integrated response to coronavirus disease 2019 in a Northern" exact="Italy" post="centreIntern Emerg Med202010.1007/s11739-020-02390-432507926 11.CogliatiCCerianiEBrambillaAMWhen internal and emergency medicine speak"/>
   <result pre="for non-invasive ventilation support in COVID-19 patients from a northern" exact="Italy" post="emergency departmentIntern Emerg Med202010.1007/s11739-020-02370-832435934 36.SarzaniRGiuliettiFDi PentimaCet al.Antagonizing the reninâ€&quot;angiotensinâ€&quot;aldosterone"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7391235\results\search\country\results.xml">
   <result pre="confusion to mankind. Movements of great masses of soldiers from" exact="the US" post="brought the H1N1 influenza A virus to Europe; disruption"/>
   <result pre="epidemics begun in 19 century. The eminent English doctor, Henry" exact="Holland" post="in 1839 proclaimed that the flu was responsible â€œof"/>
   <result pre="infection with a novel coronavirus that was first identified in" exact="China" post="following an initial outbreak in 20192. This coronavirus, named"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7392152\results\search\country\results.xml">
   <result pre="tilorone and arbidol (umifenovir). Even though tilorone was invented in" exact="the US" post="as an interferon inducing broad spectrum antiviral, additional studies"/>
   <result pre="properties [25]. Tilorone is currently registered and used only in" exact="Russia" post="and some neighbouring countries, where it is approved for"/>
   <result pre="viral hepatitis, viral encephalitis and myelitis. Arbidol is registered in" exact="Russia" post="and China for the treatment of influenza [24]. It"/>
   <result pre="viral encephalitis and myelitis. Arbidol is registered in Russia and" exact="China" post="for the treatment of influenza [24]. It is claimed"/>
   <result pre="to hemifusion by Abl kinase inhibitorsJ. Gen. Virol.99201861963029557770 41Medicine, N." exact="U. S." post="N. L. O. ClinicalTrials.gov [Online]. Available: https://clinicaltrials.gov/ [Accessed]. 42FuD.ZhouJ.ZhuW.S.ManleyP.W.WangY.K.HoodT.WylieA.XieX.S.Imaging"/>
   <result pre="[Online]. Available: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or [Accessed]. 44PubChem [Online]. Available: https://pubchem.ncbi.nlm.nih.gov/ [Accessed]. 45Administration," exact="U. S." post="F. A. D. Drugs@FDA: FDA-Approved Drugs [Online] Available: https://www.accessdata.fda.gov/scripts/cder/daf/"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7392210\results\search\country\results.xml">
   <result pre="respectively [9], [10]). SARS-CoV first emerged in late 2002 in" exact="China" post="and spread rapidly to other parts of the world"/>
   <result pre="and spread rapidly to other parts of the world from" exact="Hong Kong" post="via air travel. The virus was believed to have"/>
   <result pre="(95% CI of 3.8â€&quot;8.9) and SI of 6â€&quot;9Â days in" exact="China" post="during the initial period of the outbreak [27]. In"/>
   <result pre="did not exhibit significant clinical benefits [38]. On April 29," exact="the US" post="NIH reported that in a high powered RCT of"/>
   <result pre="placebo group (15Â days) (pÂ [40] for COVID-19 patients in" exact="the United States." post="It has also been approved for therapeutic use in"/>
   <result pre="group (15Â days) (pÂ [40] for COVID-19 patients in the" exact="United States." post="It has also been approved for therapeutic use in"/>
   <result pre="in COVID-19 patients at the onset of the outbreak in" exact="China" post="before SARS-CoV-2 was identified as the etiologic factor. It"/>
   <result pre="an RNA-dependent RNA polymerase (RdRp) inhibitor. It is used in" exact="China" post="for the treatment of Influenza and is capable of"/>
   <result pre="been approved for experimental use in COVID-19 patients in Italy," exact="China" post="and Russia [54], [55]. In a recent multicenter trial"/>
   <result pre="for experimental use in COVID-19 patients in Italy, China and" exact="Russia" post="[54], [55]. In a recent multicenter trial in Japan,"/>
   <result pre="adverse effects or intolerance of the medication. A study in" exact="Brazil" post="(NCT04323527) was forced to prematurely halt patient recruitment due"/>
   <result pre="factor C5a. One trial (NCT04333420) is currently being held in" exact="the Netherlands" post="to test its efficacy in patients with severe COVID-19,"/>
   <result pre="C5a. One trial (NCT04333420) is currently being held in the" exact="Netherlands" post="to test its efficacy in patients with severe COVID-19,"/>
   <result pre="of the ACE2 is being studied on 200 participants in" exact="Austria" post="to determine if it can prevent viral entry and"/>
   <result pre="will include 3170 patients and will be conducted in the" exact="United Kingdom," post="with a completion date of March 30, 2021. 11"/>
   <result pre="plasma [77]. Another study on ten severely ill patients in" exact="China" post="showed that the clinical symptoms improved significantly within three"/>
   <result pre="Allergy And Infectious Diseases (NIAID) Phase II trial (NCT04405076) 600" exact="United States" post="August 2021 [83], [84] Lentiviral Minigene Vaccines (LV-SMENP-DC) Lentiviral"/>
   <result pre="Label Shenzhen Geno-Immune Medical Institute Phase I (NCT04276896) 100 Shenzen," exact="China" post="December 31, 2024 Bacillus Calmette-Guerin (BCG) live-attenuated vaccine* Live-attenuated"/>
   <result pre="(NCT04327206)ANDPhase III BCG-CORONA trial - (NCT04328441) 4,170 (Australia)AND1500 (Netherlands) AustraliaANDThe" exact="Netherlands" post="March 30, 2022ANDDecember 25, 2020 INO-4800 DNA plasmid vaccine."/>
   <result pre="trial (NCT04313127)ANDRandomized controlled phase II trial (ChiCTR2000031781) 108AND500 Wuhan, Hubei," exact="China" post="December 20, 2022 (Phase 1)ANDJanuary 2021 (Phase 2) AZD1222"/>
   <result pre="Single blinded University Of Oxford Phase II/III trial (NCT04400838) 10,260" exact="United Kingdom" post="August 2021 Pathogen-specific aAPC aAPCs modified with lentiviral vector"/>
   <result pre="Label Shenzhen Geno-Immune Medical Institute Phase I (NCT04299724) 100 Shenzen," exact="China" post="December 31, 2024 CoronaVac (Previously PiCoVacc) Formalin-InactivatedÂ +Â alum"/>
   <result pre="Outcomes Assessor) Sinovac Phase I (NCT04352608)ANDPhase II (NCT04383574). 143AND600 Jiangsu," exact="China" post="December 13, 2020 BNT162 Four mRNA vaccines: 2 nucleoside"/>
   <result pre="Open Label Pfizer and BioNtech Phase I/II (NCT04380701) 200 Berlin," exact="Germany" post="August 2020 Inactivated Vaccine Inactivated Novel Coronavirus Pneumonia vaccine"/>
   <result pre="ProductsANDChina National Pharmaceutical Group (Sinopharm) Phase I/II (ChiCTR2000031809) 1456 Wuhan," exact="China" post="November 2021 BBIBP-CorV Inactivated novel coronavirus (2019-CoV) vaccine (Vero"/>
   <result pre="Biological ProductsANDChina National Pharmaceutical Group (Sinopharm) Phase II (ChiCTR2000032459) 2128" exact="China" post="November 2021 GX-19 COVID-19 Preventive DNA Vaccine Randomized; Double"/>
   <result pre="Vaccine Randomized; Double blind Genexine Phase I/IIa (NCT04445389) 190 Seoul," exact="Republic of" post="Korea March 2021 Gam-COVID-Vac Non-replicating viral vector COVID-19 vaccine"/>
   <result pre="Contract Drug Research and Development Phase I (NCT04436471) 38 Moscow," exact="Russia" post="August 2020 mRNA-based vaccine SCB-2019 Non-chemically modified nucleotides within"/>
   <result pre="TBD** CureVacANDGerman federal government Phase I (Yet to commence) 168" exact="Germany" post="and Belgium TBD** SCB-2019 COVID-19 vaccine candidate that uses"/>
   <result pre="federal government Phase I (Yet to commence) 168 Germany and" exact="Belgium" post="TBD** SCB-2019 COVID-19 vaccine candidate that uses Clover's S-Trimer"/>
   <result pre="Clover Biopharmaceuticals, DynavaxÂ and Xiamen Innovax Phase I (NCT04405908) 150" exact="Australia" post="March 2021 COVAX-19 Monovalent recombinant protein vaccine Randomized; Triple"/>
   <result pre="Triple blind Vaxine Pty Ltd. Phase I (NCT04453852) 40 Adelaide," exact="Australia" post="July 2021 bacTRL-Spike Bifidobacteria monovalent SARS-CoV-2 DNA oral vaccine"/>
   <result pre="vaccine candidate Randomized; Triple blind Symvivo Phase I (NCT04334980) 112" exact="Canada" post="and United States December 2021 Covaxin (BBV152) Inactivated whole-virion"/>
   <result pre="Randomized; Triple blind Symvivo Phase I (NCT04334980) 112 Canada and" exact="United States" post="December 2021 Covaxin (BBV152) Inactivated whole-virion vaccine Randomized; Triple"/>
   <result pre="December 2021 Covaxin (BBV152) Inactivated whole-virion vaccine Randomized; Triple blind" exact="Bharat" post="BiotechANDNational Institute of Virology Phase I/II (NCT04471519) 1125 India"/>
   <result pre="blind Bharat BiotechANDNational Institute of Virology Phase I/II (NCT04471519) 1125" exact="India" post="June 2021 ZyCoV-D DNA-plasmid based vaccine TBD** Zydus Cadila"/>
   <result pre="vaccine TBD** Zydus Cadila Phase I/II (Yet to commence) 1048" exact="India" post="2021 *- Repurposed Vaccine; Original indication: Tuberculosis (TB) pediatric"/>
   <result pre="of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19" exact="Brasil" post="II) Experimental: HydroxychloroquineÂ +Â azithromycinHydroxychloroquine [400Â mg 2Ã—/day, 12/12Â"/>
   <result pre="53FurutaY.KomenoT.NakamuraT.Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymeraseProc." exact="Japan" post="Acad. Ser. B: Phys. Biol. Sci.932017449463 54Russian Ministry of"/>
   <result pre="a recipient of Junior Research Fellowship from University Grants Commission," exact="India" post="(UGC JRF Ref No: 190510369725). The Grant no. [SR/FST/LS-I/2017/05(C)]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7396637\results\search\country\results.xml">
   <result pre="UniversityTuen MunChina Edited by: Neta Regev-Rudzki, Weizmann Institute of Science," exact="Israel" post="Reviewed by: Teneema Kuriakose, St. Jude Children's Research Hospital,"/>
   <result pre="Israel Reviewed by: Teneema Kuriakose, St. Jude Children's Research Hospital," exact="United States;" post="Asuka Nanbo, Nagasaki University, Japan *Correspondence: Wingnang Leung awnleung@gmail.com"/>
   <result pre="Jude Children's Research Hospital, United States; Asuka Nanbo, Nagasaki University," exact="Japan" post="*Correspondence: Wingnang Leung awnleung@gmail.com Chuanshan Xu xcshan@163.com This article"/>
   <result pre="2009; Goeijenbier et al., 2014). Since 2010, 140,000â€&quot;710,000 inpatients of" exact="the United States" post="were infected with influenza viruses, and 12,000â€&quot;56,000 deaths each"/>
   <result pre="Goeijenbier et al., 2014). Since 2010, 140,000â€&quot;710,000 inpatients of the" exact="United States" post="were infected with influenza viruses, and 12,000â€&quot;56,000 deaths each"/>
   <result pre="and older regardless of the state of their health in" exact="United States." post="During the 2018â€&quot;2019 influenza season, in United States, the"/>
   <result pre="health in United States. During the 2018â€&quot;2019 influenza season, in" exact="United States," post="the overall adjusted vaccine effectiveness (VE) against all influenza"/>
   <result pre="is estimated that vaccination could prevent 300â€&quot;4,000 deaths annually in" exact="the United States" post="alone, however, vaccination rates remain low, only 37% of"/>
   <result pre="estimated that vaccination could prevent 300â€&quot;4,000 deaths annually in the" exact="United States" post="alone, however, vaccination rates remain low, only 37% of"/>
   <result pre="from a scientific research project of Sichuan Education Department of" exact="China" post="(no. 18ZB0171), Research Project of Chengdu Medical College (CYZ17-27),"/>
   <result pre="(2019). Interim estimates of 2018-19 seasonal influenza vaccine effectiveness -" exact="United States," post="February 2019. MMWR. Morb. Mortal. Wkly. Rep.68, 135â€&quot;139. 10.15585/mmwr.mm6806a230763298"/>
   <result pre="M.Ben-NunM.BrooksL.et al.. (2019). Collaborative efforts to forecast seasonal influenza in" exact="the United States," post="2015-2016. Sci. Rep.9:683. 10.1038/s41598-018-36361-930679458 McNamaraR. P.DittmerD. P. (2019). Modern"/>
   <result pre="al.. (2019). Collaborative efforts to forecast seasonal influenza in the" exact="United States," post="2015-2016. Sci. Rep.9:683. 10.1038/s41598-018-36361-930679458 McNamaraR. P.DittmerD. P. (2019). Modern"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7396720\results\search\country\results.xml">
   <result pre="its pathogenicity, as observed in the avian influenza outbreak in" exact="Hong Kong" post="in 1997 [45, 46]. In addition, host cell proteases"/>
   <result pre="lopinavirâ€&quot;ritonavir (Aluvia), have been clinically used to treat COVID-19 in" exact="China" post="[84]. Nevertheless, NIAID-VRC scientists are developing a candidate vaccine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7397412\results\search\country\results.xml">
   <result pre="for the Control and Prevention of Major Infectious Diseases of" exact="China" post="(2017ZX10103004) and Beijing Hospital Authority Project (DFL20191802). Abbreviations FilmArray"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7397939\results\search\country\results.xml">
   <result pre="Coping strategies 1 Introduction In 2019 a new coronavirus affected" exact="China" post="and spread all over the world in a short"/>
   <result pre="March 2020. Since February 2020 the pandemic took hold in" exact="Italy" post="producing a state of emergency, especially in the northern"/>
   <result pre="there are approximately two hundred thousand of people infected in" exact="Italy" post="(Protezione Civile, 2020). Facing this dramatic emergency, the Government"/>
   <result pre="292 (48.4) Â No 311 (51.6) Geographical Areas Â Northern" exact="Italy" post="223 (37.5) Â Central Italy 140 (23.5) Â Southern"/>
   <result pre="(51.6) Geographical Areas Â Northern Italy 223 (37.5) Â Central" exact="Italy" post="140 (23.5) Â Southern Italy (including islands) 232 (39.0)"/>
   <result pre="Italy 223 (37.5) Â Central Italy 140 (23.5) Â Southern" exact="Italy" post="(including islands) 232 (39.0) 2.2 Procedures This cross-sectional study"/>
   <result pre="al., 2020) and also with the normative data collected in" exact="Italy" post="(Mondo,Â Sechi, and Cabras, 2019). Furthermore, healthcare workers with"/>
   <result pre="(COPE-NVI)Psicoterapia Cognitiva e Comportamentale14120082753 TamC.W.C.PangE.P.F.LamL.C.W.ChiuH.F.K.Severe acute respiratory syndrome (SARS) in" exact="Hong Kong" post="in, 2003: Stress and psychological impact among frontline healthcare"/>
   <result pre="Acad. Med. Singapore336200474374815608831 VyasKJDelaneyEMWebb-MurphyJAJohnstonSLPsychological impact of deploying in support of" exact="the US" post="response to ebola: a systematic review and meta-analysis of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7398440\results\search\country\results.xml">
   <result pre="pmid: 3228138810.1089/aid.2020.0031 doi: 10.1089/aid.2020.0031 : Epidemiology New Genomes from the" exact="Congo" post="Basin Expand History of CRF01_AE Origin and Dissemination Junqueira"/>
   <result pre="in many Asian countries, it is uncommonly found in the" exact="Congo" post="Basin from where it first originated. To fill the"/>
   <result pre="genomes from HIV samples with subgenomic CRF01_AE regions collected in" exact="Cameroon" post="and the Democratic Republic of the Congo from 2001"/>
   <result pre="samples with subgenomic CRF01_AE regions collected in Cameroon and the" exact="Democratic Republic of the Congo" post="from 2001 to 2006. HIV genomes were generated from"/>
   <result pre="with subgenomic CRF01_AE regions collected in Cameroon and the Democratic" exact="Republic of" post="the Congo from 2001 to 2006. HIV genomes were"/>
   <result pre="regions collected in Cameroon and the Democratic Republic of the" exact="Congo" post="from 2001 to 2006. HIV genomes were generated from"/>
   <result pre="CRF01_AE genomes, placed these samples as a bridge between basal" exact="Central African Republic" post="CRF01_AE strains and all Asian, European, and American CRF01_AE"/>
   <result pre="phylogenetic tree, map, and timeline at (https://nextstrain.org/community/EduanWilkinson/hiv-1_crf01). HIV CRF surveillance" exact="Congo" post="phylogenetics molecular clock analysis fig-count: table-count: ref-count: page-count: Introduction"/>
   <result pre="earliest isolates of CRF01_AE were collected in 1990 in the" exact="Central African Republic" post="(CAR).2â€&quot;4 Molecular characterization of the envelope region from strains"/>
   <result pre="whereas subtype E was absent from studies conducted in Uganda," exact="Zaire" post="(now Democratic Republic of the Congo [DRC]), Malawi, and"/>
   <result pre="E was absent from studies conducted in Uganda, Zaire (now" exact="Democratic Republic of the Congo" post="[DRC]), Malawi, and Tanzania.5â€&quot;8 In contrast, HIV isolates collected"/>
   <result pre="was absent from studies conducted in Uganda, Zaire (now Democratic" exact="Republic of" post="the Congo [DRC]), Malawi, and Tanzania.5â€&quot;8 In contrast, HIV"/>
   <result pre="studies conducted in Uganda, Zaire (now Democratic Republic of the" exact="Congo" post="[DRC]), Malawi, and Tanzania.5â€&quot;8 In contrast, HIV isolates collected"/>
   <result pre="[DRC]), Malawi, and Tanzania.5â€&quot;8 In contrast, HIV isolates collected from" exact="Thailand" post="in the 1990s were dominated by subtype E envelope"/>
   <result pre="the region).10 The spread of CRF01_AE has been tracked from" exact="Thailand" post="to Vietnam, China, and ultimately a global dissemination.11â€&quot;14 However,"/>
   <result pre="Cameroon,15 &amp;lt;4% in DRC,16,17 &amp;lt;3% in Chad,18,19 &amp;lt;1% in the" exact="Republic of" post="the Congo,20â€&quot;22 and 6% in CAR23 in recent studies."/>
   <result pre="near-complete genome sequences were generated from Nâ€‰=â€‰13 specimens collected in" exact="Cameroon" post="and DRC carrying HIV strains identified as CRF01_AE by"/>
   <result pre="2006 from HIV-1-positive individuals participating in viral diversity studies in" exact="Cameroon" post="and the DRC (Table 1). The specimens came from"/>
   <result pre="approved by the University of Missouri-Kansas City Research Board. The" exact="Cameroon" post="study was approved by the Cameroon National Ethical Review"/>
   <result pre="City Research Board. The Cameroon study was approved by the" exact="Cameroon" post="National Ethical Review Board, the Faculty of Medicine and"/>
   <result pre="Alignment Search Tool; CM, Cameroon; CRF, circulating recombinant form; DRC," exact="Democratic Republic of the Congo;" post="jpHMM, jumping profile Hidden Markov Model; NA, not assigned;"/>
   <result pre="Search Tool; CM, Cameroon; CRF, circulating recombinant form; DRC, Democratic" exact="Republic of" post="the Congo; jpHMM, jumping profile Hidden Markov Model; NA,"/>
   <result pre="CRF01 was identified from previous viral diversity studies conducted in" exact="Cameroon" post="and DRC for complete genome sequencing. A range of"/>
   <result pre="samples collected between 2001 and 2006 from HIV-1-positive individuals in" exact="Cameroon" post="and the DRC samples isolated in the Congo Basin,"/>
   <result pre="individuals in Cameroon and the DRC samples isolated in the" exact="Congo" post="Basin, Africa. Viral subtypes were denoted by different colors"/>
   <result pre="portions correspond to unclassifiable regions. CRF, circulating recombinant form; DRC," exact="Democratic Republic of the Congo;" post="jpHMM, jumping profile Hidden Markov Model; LTR, long terminal"/>
   <result pre="correspond to unclassifiable regions. CRF, circulating recombinant form; DRC, Democratic" exact="Republic of" post="the Congo; jpHMM, jumping profile Hidden Markov Model; LTR,"/>
   <result pre="and one from Cameroon) (Fig. 2). This pattern suggests that" exact="Cameroon" post="has a secondary role in the African CRF01_AE epidemic"/>
   <result pre="4). Specifically, Thai sequences seeded the epidemics in China, Myanmar," exact="the Philippines," post="Indonesia, the United States, The United Kingdom, and Sweden"/>
   <result pre="sequences seeded the epidemics in China, Myanmar, the Philippines, Indonesia," exact="the United States," post="The United Kingdom, and Sweden (Fig. 4). The epidemic"/>
   <result pre="seeded the epidemics in China, Myanmar, the Philippines, Indonesia, the" exact="United States," post="The United Kingdom, and Sweden (Fig. 4). The epidemic"/>
   <result pre="in China, Myanmar, the Philippines, Indonesia, the United States, The" exact="United Kingdom," post="and Sweden (Fig. 4). The epidemic in China that"/>
   <result pre="the Philippines, Indonesia, the United States, The United Kingdom, and" exact="Sweden" post="(Fig. 4). The epidemic in China that started in"/>
   <result pre="The United Kingdom, and Sweden (Fig. 4). The epidemic in" exact="China" post="that started in 1984 was driven by multiple independent"/>
   <result pre="China. The Chinese epidemic was also seeded by strains from" exact="Vietnam" post="in the mid-1990s (Fig. 2). In addition, Chinese sequences"/>
   <result pre="appears to have originated in CAR where it spread to" exact="Cameroon" post="and other countries in central Africa, although limited sampling"/>
   <result pre="years of localized transmission in central Africa, CRF01_AE spread to" exact="Thailand" post="and onward to other Asian countries (Fig. 4). These"/>
   <result pre="sex with man related clusters. The four CRF01_AE genomes from" exact="Cameroon" post="were identified among a larger set of Nâ€‰=â€‰13 genomes"/>
   <result pre="from unrecognized recombinant genomes. Although CRF01_AE is rare in the" exact="Congo" post="Basin, it is likely that its prevalence is actually"/>
   <result pre="CRF01_AE has recently been found at dramatically higher rates in" exact="Kenya" post="in 2008 and 2015 (14%â€&quot;25%),47,48 although with subgenomic sequence"/>
   <result pre="size may very well be due to behavioral changes in" exact="Thailand" post="at the outbreak of the epidemic in that country.49"/>
   <result pre="al.: The heterosexual human immunodeficiency virus type 1 epidemic in" exact="Thailand" post="is caused by an intersubtype (A/E) recombinant of African"/>
   <result pre="al.: V3 loops of HIV-1 specimens from pregnant women in" exact="Malawi" post="uniformly lack a potential N-linked glycosylation site. AIDS Res"/>
   <result pre="al.: Greater diversity of the HIV-1 V3 neutralization domain in" exact="Tanzania" post="compared with The Netherlands: Serological and genetic analysis. AIDS1993;7:467â€&quot;4748507412"/>
   <result pre="HeX, HsiJH, et al.: The rapidly expanding CRF01_AE epidemic in" exact="China" post="is driven by multiple lineages of HIV-1 viruses introduced"/>
   <result pre="sequencing method reveals deep genetic diversity of HIV-1 in the" exact="Democratic Republic of the Congo." post="J Virol2017;91:e01841-1628077647 17.VidalN, MulangaC, BazepeoSE, et al.: HIV type"/>
   <result pre="method reveals deep genetic diversity of HIV-1 in the Democratic" exact="Republic of" post="the Congo. J Virol2017;91:e01841-1628077647 17.VidalN, MulangaC, BazepeoSE, et al.:"/>
   <result pre="pol gene diversity and antiretroviral drug resistance mutations in the" exact="Democratic Republic of Congo" post="(DRC). AIDS Res Hum Retroviruses2006;22:202â€&quot;20616478404 18.AdawayeC, FokamJ, KamanguE, et"/>
   <result pre="gene diversity and antiretroviral drug resistance mutations in the Democratic" exact="Republic of" post="Congo (DRC). AIDS Res Hum Retroviruses2006;22:202â€&quot;20616478404 18.AdawayeC, FokamJ, KamanguE,"/>
   <result pre="and antiretroviral drug resistance mutations in the Democratic Republic of" exact="Congo" post="(DRC). AIDS Res Hum Retroviruses2006;22:202â€&quot;20616478404 18.AdawayeC, FokamJ, KamanguE, et"/>
   <result pre="Toure-KaneC, VidalN, et al.: HIV-1 subtypes and recombinants in the" exact="Republic of" post="Congo. Infect Genet Evol2006;6:337â€&quot;34316473564 21.NiamaFR, VidalN, Diop-NdiayeH, et al.:"/>
   <result pre="primary drug resistance mutations before large-scale access to antiretroviral therapy," exact="Republic of" post="Congo. BMC Res Notes2017;10:24328679441 22.PircherM, DiafoukaM, PapuchonJ, et al.:"/>
   <result pre="et al.: Molecular characterization of HIV type 1 in Brazzaville," exact="Republic of" post="Congo, and first data on resistance to antiretroviral drugs."/>
   <result pre="an old complex circulating recombinant form, CRF27_cpx, originating from the" exact="Democratic Republic of Congo" post="(DRC) and circulating in France. AIDS Res Hum Retroviruses2008;24:315â€&quot;32118257687"/>
   <result pre="old complex circulating recombinant form, CRF27_cpx, originating from the Democratic" exact="Republic of" post="Congo (DRC) and circulating in France. AIDS Res Hum"/>
   <result pre="circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of" exact="Congo" post="(DRC) and circulating in France. AIDS Res Hum Retroviruses2008;24:315â€&quot;32118257687"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7399136\results\search\country\results.xml">
   <result pre="coronavirus disease 2019 epidemic at the primary level: perspective from" exact="China" post="https://orcid.org/0000-0002-1815-5188ZhangXiaoyan1https://orcid.org/0000-0002-1613-5140WangYuxuan2[1], Hubei UniversityWuhanChina[2], Huazhong University of Science and TechnologyWuhanChina"/>
   <result pre="consistent with existing copyright protections.S0950268820001636a.pdf After the 2003 SARS epidemic," exact="China" post="started constructing a primary-level emergency response system and focused"/>
   <result pre="health and social development. As the origin of the epidemic," exact="China" post="adopted epidemic prevention and control measures for several months"/>
   <result pre="the epidemic. The WHOâ€&quot;China Joint Mission on COVID-19 found that" exact="China" post="had employed unprecedented public health response measures [1]; it"/>
   <result pre="were made responsible for mobilisation of resources. Regarding operational mechanisms," exact="China" post="launched the Contagious Disease National Direct Reporting System in"/>
   <result pre="their local conditions. Regarding emergency assurance, the Law of the" exact="People's Republic of China" post="on Prevention and Treatment of Infectious Diseases was promulgated"/>
   <result pre="local conditions. Regarding emergency assurance, the Law of the People's" exact="Republic of" post="China on Prevention and Treatment of Infectious Diseases was"/>
   <result pre="Regarding emergency assurance, the Law of the People's Republic of" exact="China" post="on Prevention and Treatment of Infectious Diseases was promulgated"/>
   <result pre="During the 2009 H1N1 outbreak, all districts and counties in" exact="China" post="initiated the emergency response for public health emergencies within"/>
   <result pre="that the primary-level disease prevention and control measures adopted in" exact="China" post="for COVID-19, such as multi-department cooperation, precise prevention and"/>
   <result pre="The closed-off community management policies adopted by primary-level organisations in" exact="China" post="resulted in severe inconvenience to residents, particularly among the"/>
   <result pre="policies, the construction of â€˜hospital alliancesâ€™ and â€˜medical cooperativesâ€™ in" exact="China" post="can be used as a reference [21, 22], the"/>
   <result pre="work is funded by the National Natural Science Foundation of" exact="China" post="(No. 71704048). We acknowledge all healthcare workers involved in"/>
   <result pre="Journal of Surgery76, 71â€&quot;76.32112977 3.collab: Central People's Government of the" exact="People's Republic of China." post="Regulation on the Urgent Handling of Public Health Emergencies."/>
   <result pre="of Surgery76, 71â€&quot;76.32112977 3.collab: Central People's Government of the People's" exact="Republic of" post="China. Regulation on the Urgent Handling of Public Health"/>
   <result pre="2020). 4.collab: General Office of the State Council of the" exact="People's Republic of China." post="Opinions of the General Office of the State Council"/>
   <result pre="4.collab: General Office of the State Council of the People's" exact="Republic of" post="China. Opinions of the General Office of the State"/>
   <result pre="2020). 7.collab: Department of Laws and Regulations. Law of the" exact="People's Republic of China" post="on Prevention and Treatment of Infectious Diseases (Decree No."/>
   <result pre="7.collab: Department of Laws and Regulations. Law of the People's" exact="Republic of" post="China on Prevention and Treatment of Infectious Diseases (Decree"/>
   <result pre="of Laws and Regulations. Law of the People's Republic of" exact="China" post="on Prevention and Treatment of Infectious Diseases (Decree No."/>
   <result pre="Diseases (Decree No. 17 of the President of the People's" exact="Republic of" post="China). Available at http://www.nhc.gov.cn/fzs/pfl/200804/5d63e0e212764588bfe925425b1b19c9.shtml (Accessed 26 April 2020). 8.collab:"/>
   <result pre="(Accessed 26 April 2020). 8.collab: Central People's Government of the" exact="People's Republic of China." post="Several Provisions on the Construction of the Disease Prevention"/>
   <result pre="26 April 2020). 8.collab: Central People's Government of the People's" exact="Republic of" post="China. Several Provisions on the Construction of the Disease"/>
   <result pre="(Accessed 28 April 2020). 9.collab: Central People's Government of the" exact="People's Republic of China." post="Opinions of the General Office of the State Council"/>
   <result pre="28 April 2020). 9.collab: Central People's Government of the People's" exact="Republic of" post="China. Opinions of the General Office of the State"/>
   <result pre="(Accessed 5 May 2020). 15.collab: Ministry of Finance of the" exact="People's Republic of China." post="The Ministry of Finance and National Health Commission allocated"/>
   <result pre="5 May 2020). 15.collab: Ministry of Finance of the People's" exact="Republic of" post="China. The Ministry of Finance and National Health Commission"/>
   <result pre="The Lancet Public Health5, e261â€&quot;e270. doi: 10.1016/S2468-2667(20)30073-6.32220655 23.JiangR (2020) Inside" exact="China" post="and COVID-19: questions and answers. Travel Medicine and Infectious"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7400054\results\search\country\results.xml">
   <result pre="animal market in the Hubei Province of Wuhan in Mainland" exact="China" post="was identified as the first epicenter of the pandemic"/>
   <result pre="of which 1,501,876 confirmed cases and 90,203 deaths were from" exact="the United States" post="of America, followed by Brazil (271,628; 17,971), the United"/>
   <result pre="which 1,501,876 confirmed cases and 90,203 deaths were from the" exact="United States of America," post="followed by Brazil (271,628; 17,971), the United Kingdom (248,297;"/>
   <result pre="deaths were from the United States of America, followed by" exact="Brazil" post="(271,628; 17,971), the United Kingdom (248,297; 35,704), Spain (232,555;"/>
   <result pre="United States of America, followed by Brazil (271,628; 17,971), the" exact="United Kingdom" post="(248,297; 35,704), Spain (232,555; 27,888), Italy (227,364; 32,330), France"/>
   <result pre="followed by Brazil (271,628; 17,971), the United Kingdom (248,297; 35,704)," exact="Spain" post="(232,555; 27,888), Italy (227,364; 32,330), France (141,312; 28,081), and"/>
   <result pre="(271,628; 17,971), the United Kingdom (248,297; 35,704), Spain (232,555; 27,888)," exact="Italy" post="(227,364; 32,330), France (141,312; 28,081), and China (84,507; 4645)"/>
   <result pre="United Kingdom (248,297; 35,704), Spain (232,555; 27,888), Italy (227,364; 32,330)," exact="France" post="(141,312; 28,081), and China (84,507; 4645) [5]. Notably, all"/>
   <result pre="Spain (232,555; 27,888), Italy (227,364; 32,330), France (141,312; 28,081), and" exact="China" post="(84,507; 4645) [5]. Notably, all age groups show susceptibility"/>
   <result pre="reporting a continuous increase in the number of cases, with" exact="the USA" post="reporting the highest increase in daily deaths. The definitive"/>
   <result pre="16 November 2002, in the coastal Guangdong province of southeast" exact="China" post="bordering Hong Kong and Macau. This infection spread across"/>
   <result pre="2002, in the coastal Guangdong province of southeast China bordering" exact="Hong Kong" post="and Macau. This infection spread across 31 countries at"/>
   <result pre="managed. 2.2. MERS-CoV Since the first occurrence of MERS in" exact="Saudi Arabia" post="in June 2012, sporadic cases are still reported, primarily"/>
   <result pre="the deaths of 868 patients. The disease was reported in" exact="Saudi Arabia," post="the UAE and the Republic of Korea, as shown"/>
   <result pre="of 868 patients. The disease was reported in Saudi Arabia," exact="the UAE" post="and the Republic of Korea, as shown in Table"/>
   <result pre="disease was reported in Saudi Arabia, the UAE and the" exact="Republic of" post="Korea, as shown in Table 1. A few travel-related"/>
   <result pre="as shown in Table 3. A pangolin-CoV strain MP789 from" exact="China" post="also had a similarity index of 89.7 and 89.78%"/>
   <result pre="7. Epidemiology of SARS-CoV-2 Infection The Wuhan seafood market in" exact="China" post="was implicated as the epicenter of the COVID-19 pandemic,"/>
   <result pre="was implicated as the epicenter of the COVID-19 pandemic, and" exact="China" post="was marked as the index country. Seven cases of"/>
   <result pre="distribute the COVID-19 disease (Figure 5). Between 13â€&quot;20 January 2020," exact="Thailand" post="(the first country after China to report a case),"/>
   <result pre="5). Between 13â€&quot;20 January 2020, Thailand (the first country after" exact="China" post="to report a case), Japan, and the Republic of"/>
   <result pre="country after China to report a case), Japan, and the" exact="Republic of" post="Korea, reported their respective first cases of COVID-19. On"/>
   <result pre="their respective first cases of COVID-19. On 20 January, the" exact="China" post="CDC identified three different strains of this virus, confirming"/>
   <result pre="had underlying comorbidities [66]. Between 22 and 25 January, Macau," exact="Hong Kong," post="Nepal, France, Australia, Malaysia, and Canada confirmed their first"/>
   <result pre="25 January, Macau, Hong Kong, Nepal, France, Australia, Malaysia, and" exact="Canada" post="confirmed their first cases. As in China, the WHO"/>
   <result pre="virus, detected in Rhinolophus affinis in the Yunnan province of" exact="China" post="[99], leading to speculation that bats might act as"/>
   <result pre="The successful limitation of virus spread in Singapore, Taiwan, and" exact="Hong Kong," post="despite their geographical proximity to China, indicates that widespread"/>
   <result pre="the XpertÂ® Xpress SARS-CoV-2 test (an RT-qPCR test) developed in" exact="the USA" post="and reported as a rapid diagnostic test that provides"/>
   <result pre="vaccine candidate recently commenced at the Tongji Hospital in Wuhan," exact="China" post="[123]. The phase I clinical trials for two other"/>
   <result pre="candidates (BNT-162 and INO-4800) are due in April 2020 in" exact="China" post="and the USA, respectively. The BNT-162, an mRNA vaccine"/>
   <result pre="and INO-4800) are due in April 2020 in China and" exact="the USA," post="respectively. The BNT-162, an mRNA vaccine candidate, expressing codon-optimized"/>
   <result pre="changing the viral genetic code was given by researchers from" exact="China" post="in 2016 while working on influenza A virus. They"/>
   <result pre="[12,124]. However, no specific anti-SARS-CoV-2 treatment has been recommended by" exact="the US" post="FDA, yet owing to the lack of supportive data."/>
   <result pre="against SARS-CoV-2, approved by the National Medical Products Administration of" exact="China" post="in February 2020, is commonly used to treat influenza"/>
   <result pre="February 2020, is commonly used to treat influenza infection in" exact="China" post="and Japan and has shown promising results in shortening"/>
   <result pre="is commonly used to treat influenza infection in China and" exact="Japan" post="and has shown promising results in shortening the course"/>
   <result pre="reported to significantly improve the conditions of COVID-19 patients in" exact="South Korea" post="[126]. Similar to remdisivir, a combination of lopinavir and"/>
   <result pre="the treatment of COVID-19 patients in recent clinical trials in" exact="China" post="[128]. Hydroxychloroquine, an anti-malarial drug, in combination with azithromycin,"/>
   <result pre="and national level [132]. Additionally, the National Health Commission of" exact="China" post="issued protocols for the mitigation of COVID-19 in order"/>
   <result pre="they have been the root cause of spreading SARS-CoV-2 from" exact="China" post="to subsequently more than 200 countries. Measures, such as"/>
   <result pre="infections with COVID-19 screened among close contacts in Nanjing, ChinaSci." exact="China" post="Life Sci.20206370671110.1007/s11427-020-1661-432146694 70.collab: Centers for Disease Control and Prevention"/>
   <result pre="scoping reviewInfect. Dis. Poverty202092910.1186/s40249-020-00646-x32183901 133.collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="China (NHC)Notice on Printing and Distributing the Work Plan"/>
   <result pre="Dis. Poverty202092910.1186/s40249-020-00646-x32183901 133.collab: National Health Commission of Peopleâ€™s Republic of" exact="China" post="(NHC)Notice on Printing and Distributing the Work Plan for"/>
   <result pre="on 11 April 2020) 134.collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="China (NHC)Notice on Prevention and Control of Novel Coronavirus"/>
   <result pre="April 2020) 134.collab: National Health Commission of Peopleâ€™s Republic of" exact="China" post="(NHC)Notice on Prevention and Control of Novel Coronavirus Infection"/>
   <result pre="on 31 January 2020) 135.collab: National Health Commission of Peopleâ€™s" exact="Republic of" post="China (NHC)Notice on Further Prevention and Control of Pneumonia"/>
   <result pre="January 2020) 135.collab: National Health Commission of Peopleâ€™s Republic of" exact="China" post="(NHC)Notice on Further Prevention and Control of Pneumonia Caused"/>
   <result pre="Betacoronaviruses, including SARS-CoV-2. The phyloanalysis included SARS-CoV-2 originating from China," exact="the USA," post="Australia, Japan, and South Korea. Different subgenera of Betacoronaviruses"/>
   <result pre="included SARS-CoV-2 originating from China, the USA, Australia, Japan, and" exact="South Korea." post="Different subgenera of Betacoronaviruses have been labeled with different"/>
   <result pre="Winter (Decâ€&quot;Jan) Summer (Mayâ€&quot;July) Winter (Decâ€&quot;Jan) Place of Origin Guangdong," exact="China" post="Jeddah, Saudi Arabia Wuhan, China First incidence 16 November"/>
   <result pre="Summer (Mayâ€&quot;July) Winter (Decâ€&quot;Jan) Place of Origin Guangdong, China Jeddah," exact="Saudi Arabia" post="Wuhan, China First incidence 16 November 2002 13 June"/>
   <result pre="(Decâ€&quot;Jan) Place of Origin Guangdong, China Jeddah, Saudi Arabia Wuhan," exact="China" post="First incidence 16 November 2002 13 June 2012 7"/>
   <result pre="province of southern China, and later to western pacific countries" exact="Saudi Arabia," post="followed by UAE and Republic of Korea Hubei, especially,"/>
   <result pre="to western pacific countries Saudi Arabia, followed by UAE and" exact="Republic of" post="Korea Hubei, especially, Wuhan in China, followed by worldwide"/>
   <result pre="Sequence Identity % Protein Sequence Identity (a)Whole Genome-Based Comparison (29.9kb)" exact="South Korea" post="SNU01/MT039890 99 99.9 Australia VIC01/MT007544 99 99.9 Nepal 61-TW/MT072688"/>
   <result pre="Identity (a)Whole Genome-Based Comparison (29.9kb) South Korea SNU01/MT039890 99 99.9" exact="Australia" post="VIC01/MT007544 99 99.9 Nepal 61-TW/MT072688 99â€&quot;100 100 Taiwan NTU02/MT066176"/>
   <result pre="(29.9kb) South Korea SNU01/MT039890 99 99.9 Australia VIC01/MT007544 99 99.9" exact="Nepal" post="61-TW/MT072688 99â€&quot;100 100 Taiwan NTU02/MT066176 99â€&quot;100 100 USA USA-CA9/MT118835"/>
   <result pre="99 99.9 Australia VIC01/MT007544 99 99.9 Nepal 61-TW/MT072688 99â€&quot;100 100" exact="Taiwan" post="NTU02/MT066176 99â€&quot;100 100 USA USA-CA9/MT118835 99â€&quot;100 100 Japan WK-501/LC522974"/>
   <result pre="99â€&quot;100 100 Taiwan NTU02/MT066176 99â€&quot;100 100 USA USA-CA9/MT118835 99â€&quot;100 100" exact="Japan" post="WK-501/LC522974 99â€&quot;100 100 (b) Spike Protein-Based Comparison (~3800 bases)"/>
   <result pre="Novel Coronavirus (2019-nCoV) RNA (PCR-Fluorescence Probing) ORF1ab and N gene" exact="China" post="EUA Seegene, Inc. Allplex 2019-nCoV assay E, RdRp and"/>
   <result pre="1(ChiCTR2000030906) Clinical trials recently started at Tongji Hospital in Wuhan," exact="China" post="INO-4800 Inovio Pharmaceuticals Phase I (NCT04336410) DNA plasmid encoding"/>
   <result pre="domains of selected viral proteins Drug candidates Favilavir Hisun Pharmaceutical," exact="China" post="Approved by NMPA, China Inhibition of RNA-dependent RNA polymerase"/>
   <result pre="proteins Drug candidates Favilavir Hisun Pharmaceutical, China Approved by NMPA," exact="China" post="Inhibition of RNA-dependent RNA polymerase of SARS-CoV-2 Hydroxychloroquine and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7400365\results\search\country\results.xml">
   <result pre="to a lack of published studies in Latin and Central" exact="America" post="and the Caribbean. Our Ovid MEDLINE search is shown"/>
   <result pre="studies also used data from partnering high-income countries, including Canada," exact="Australia" post="and the United States. We observed an inverse association"/>
   <result pre="used data from partnering high-income countries, including Canada, Australia and" exact="the United States." post="We observed an inverse association between HCV infection rates"/>
   <result pre="data from partnering high-income countries, including Canada, Australia and the" exact="United States." post="We observed an inverse association between HCV infection rates"/>
   <result pre="who completed DAA treatment; they identified studies conducted in Demark," exact="Spain" post="and the USA with high reinfection rates ranging from"/>
   <result pre="DAA treatment; they identified studies conducted in Demark, Spain and" exact="the USA" post="with high reinfection rates ranging from 8.0 to 18.3"/>
   <result pre="from 1.1 to 1.7 cases per 100 PY in Canada," exact="the USA" post="and Germany [16]. Notably, the USA study results are"/>
   <result pre="1.7 cases per 100 PY in Canada, the USA and" exact="Germany" post="[16]. Notably, the USA study results are in both"/>
   <result pre="100 PY in Canada, the USA and Germany [16]. Notably," exact="the USA" post="study results are in both the low and high"/>
   <result pre="weeks 0.01 2 Huang et al., 2019 [21] Cohort study" exact="Taiwan" post="= $14,273Upper middle-income N = 219Male 100.0%Prevalence = 33.7%"/>
   <result pre="years 0.02 4 Rahman et al., 2019 [23] Prospective cohort" exact="Bangladesh" post="= $1698Lower middle-income N = 200Sex not delineatedPrevalence ="/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402078\results\search\country\results.xml">
   <result pre="reduce the pressure on hospitals to serve those in need." exact="India" post="has learned lessons from the past and the present"/>
   <result pre="and Van Bergen 2014), Asian flu (1956â€&quot;1958), flu pandemic (1968)," exact="Hong Kong" post="flu (1981) (http://content.time.com/time/specials/packages/completelist/025969,2027479.00 acccessed on 15 June 2020), SARS"/>
   <result pre="follow Antonine plague 165Â AD Unknown/5 million Anatolia, Egypt, Greece," exact="Italy" post="Believed to be outbreak of smallpox, appearance of boils"/>
   <result pre="Flu pandemic 1889â€&quot;1890 Influenza A virus/H2N2/H3N3/1 million Central Asia, Canada," exact="Greenland" post="Bed rest; ample fluids; nourishing food; treatment through alcohol"/>
   <result pre="cholera pandemic 1910â€&quot;1911 Cholera/800,000 Middle East, North Africa, Eastern Europe," exact="Russia" post="Transmitted through water contaminated with faeces and food; disinfection"/>
   <result pre="Flu pandemic/Spanish flu 1918â€&quot;1919 Influenza/20â€&quot;50 million Europe, Australia, Africa, North" exact="America" post="Social distancing; wearing masks; avoid public gatherings; care for"/>
   <result pre="quarantine; isolation; economy Asian flu 1956â€&quot;1958 Influenza/H2N2/2 million China, Singapore," exact="Hong Kong," post="USA Infections in children from schools; deadly to pregnant"/>
   <result pre="heart diseases; economy Flu pandemic/Hong Kong flu 1968 Influenza/H2N2/1 million" exact="Hong Kong," post="Singapore, Vietnam/Philippines, India, Australia, Europe, USA Human-to-human transmission Social"/>
   <result pre="of 21/07/2020 China, Europe, USA, South America, Africa, Gulf countries," exact="Russia" post="Characteristics of virus are changing Fast-spreading; symptoms appear after"/>
   <result pre="with it with full precautions Source: WHO Reports (2010, 2020);" exact="Jordan" post="and Robert (2011); Shanks (2015); Gupta et al. (2017);"/>
   <result pre="16 June 2020; http://www.mpholine.org/worst-pandemics-in-history accesed on 25/May 2020 Indian scenario" exact="India" post="has witnessed in the recent past large outbreaks of"/>
   <result pre="high-threat pathogens, and building on the success in eliminating polio," exact="India" post="is now readying itself to address the threat of"/>
   <result pre="and the defence sector to identify and address challenges that" exact="India" post="would face during an influenza pandemic (WHO Report 2014;"/>
   <result pre="al. 2011). There were continuous struggles for HIV/AIDS programs in" exact="India" post="to bring about changes in public attitudes (Satyajeet and"/>
   <result pre="attitudes (Satyajeet and Pramanik 2009). It is not uncommon for" exact="India" post="to experience sudden and rapid outbreaks of epidemics and"/>
   <result pre="and Srinivas 2020). It is also a sad truth that" exact="India" post="will have to be ready to face several more"/>
   <result pre="Post-coronavirus effects The novel coronavirus COVID-19 that originated in Wuhan," exact="China" post="(Zhou et al. 2020; Chowdhury et al. 2020) is"/>
   <result pre="The present COVID-19 pandemic, with its first case reported in" exact="India" post="on 30 January 2020, has a severity in terms"/>
   <result pre="et al. 2015). In Europe, the disease spread through France," exact="Great Britain," post="Italy and Spain, causing havoc with military efforts in"/>
   <result pre="2015). In Europe, the disease spread through France, Great Britain," exact="Italy" post="and Spain, causing havoc with military efforts in the"/>
   <result pre="Bombay, India, in June to China, and in July to" exact="Australia" post="(Radusin 2012a; Krammer et al. 2018). The second wave"/>
   <result pre="Krammer et al. 2018). The second wave spread from North" exact="America" post="to Central and South America, and from Freetown, West"/>
   <result pre="Central and South America, and from Freetown, West Africa to" exact="South Africa" post="and the Horn of Africa in November 2019. The"/>
   <result pre="2019. The flu had spread to almost all of Europe," exact="Poland" post="and Russia, northern Asia, India and China (Radusin 2012b)."/>
   <result pre="to almost all of Europe, Poland and Russia, northern Asia," exact="India" post="and China (Radusin 2012b). The third wave of the"/>
   <result pre="all of Europe, Poland and Russia, northern Asia, India and" exact="China" post="(Radusin 2012b). The third wave of the Spanish flu"/>
   <result pre="(Radusin 2012b). The third wave of the Spanish flu hit" exact="Australia" post="in December 1918, New York in January 1919, Paris"/>
   <result pre="in December 1918, New York in January 1919, Paris and" exact="Japan" post="in December 1919, and ended in January 1920 (Taubenberger"/>
   <result pre="of the pandemic. The steps taken by the government of" exact="India" post="include (1) the â€˜Janata Curfewâ€™ 14 March 2020, (2)"/>
   <result pre="2020). The Ministry of Family Welfare of the Government of" exact="India" post="has set forth guidance for fighting COVID-19. The strategy"/>
   <result pre="Source: Ministry of Health and Family Welfare 2020 Government of" exact="India" post="Plasma technology Plasma technology is now being considered as"/>
   <result pre="and Mc Cullough 2020; Paital et al. 2020; Singhal 2020)." exact="India" post="is known for its millets throughout the world, and"/>
   <result pre="but it is not yet approved for this indication by" exact="the US" post="Food and Drug Administration and is currently being tested"/>
   <result pre="22 May 2020; http://www.thehindubusinessline.com/economy/agri-business/strong-immunity-is-a-key-weapo-in-the-fight-against-Covid-19/article 31453126.ece accessed on 16 May 2020)." exact="Israel" post="is advocating the separation of the elderly and children"/>
   <result pre="Shankland, a research fellow, in his opinion piece â€˜Lessons from" exact="Brazil" post="for the global response to COVID-19â€™ published by the"/>
   <result pre="reduce the pressure on hospitals to serve those in need." exact="India" post="has learned lessons from the past and present pandemic"/>
   <result pre="Yashovarma and Shri Jeevandhaar Kumar for their encouragement during Unnat" exact="Bharat" post="Abhiyan community project works. We thank our Principal Dr."/>
   <result pre="coronaviruses. One Health. 10.1016/j.onehlt.2020.100128 Anonymous (2020) Letter to the editor," exact="Japan" post="ECMOnet for COVID-19. J Intensive Care 8:24. 10.1186/s40560-020-00440-9 BalajiKSravendraRCOVID"/>
   <result pre="JordanWTRobertVTLessons learned during public health response to cholera epidemic in" exact="Haiti" post="and the Dominican RepublicEmerging Infect Dis201117122399 Kalteh EA, Rajabi"/>
   <result pre="(2020) Lack of collaboration slacking Indiaâ€™s corona virus fight. Nat" exact="India" post="10.1038/nindia2020.50 NicklinJGraeme-CookPagetTKillintonRInstant notes in microbiology2002New DelhiVikas Books Pvt Ltd269326"/>
   <result pre="reference to IndiaSci Total Environ202023138914 ParijaSCTextbook of microbiology and immunology2016ChennaiElsevier" exact="India" post="PatelABVermaACOVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers:"/>
   <result pre="10.1007/s10389-020-01293-0 SuriJCSenMKPandemic influenzaâ€&quot;Indian experienceLung India20112812421654977 SwethaGAnantha EashwarVMGopalakrishnanSEpidemics and pandemics in" exact="India" post="throughout history: a review articleIndian J Public Health Res"/>
   <result pre="TsoucalasGKarachaliouFKalogirouVGatosGMavrogiannakiEAntoniouAGatosKThe first announcement about the 1918 â€œSpanish fluâ€� pandemic in" exact="Greece" post="through the writings of the pioneer newspaper â€œThessaliaâ€� almost"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402116\results\search\country\results.xml">
   <result pre="patients [124]. Favipiravir is undergoing phase II clinical trials in" exact="China" post="and Thailand with reports of efficacy when combined with"/>
   <result pre="Favipiravir is undergoing phase II clinical trials in China and" exact="Thailand" post="with reports of efficacy when combined with interferon [125]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402212\results\search\country\results.xml">
   <result pre="rabbits, snakes, birds and frogs) in Wuhan City, Hubei province," exact="China" post="[11]. As of July 12, 2020, this virus has"/>
   <result pre="time of revision), and the most affected continents are the" exact="America" post="and Europe with 6,685,097 and 2,572,406 confirmed cases respectively"/>
   <result pre="world including 564,924 deaths. The most affected continent is the" exact="America" post="with 6,685,097 confirmed cases and 286,796 deaths on this"/>
   <result pre="SARS-CoV-2 Emergency year 2002 2013 2019 Emergency area Guangdong province," exact="China" post="Arabian peninsula Wuhan, China Number of infected countries 29"/>
   <result pre="2013 2019 Emergency area Guangdong province, China Arabian peninsula Wuhan," exact="China" post="Number of infected countries 29 27 213 Animal reservoir"/>
   <result pre="with confirmed COVID-19 cases in the largest clinical hospital in" exact="Iran" post="showed that all air samples were negative [56]. This"/>
   <result pre="is also under development (in phase 1 clinical trial by" exact="the US" post="National Institute of Allergy and Infectious Diseases) [79]. Remdesivir,"/>
   <result pre="(2020) performed a pilot study in three participating hospitals in" exact="China" post="to explore the feasibility of CP treatment in 10"/>
   <result pre="intense case finding measures to stop virus transmission. For example," exact="South Korea" post="dramatically slowed the epidemic by performing more than 300"/>
   <result pre="described. Individuals who tested positive were identified and isolated [96]." exact="Singapore" post="used a broad case deï¬�nition, aggressive contact tracing, and"/>
   <result pre="intensive care, and deaths with a possible infectious disease [97]." exact="Taiwan" post="and Hong Kong used similar strategies [98]. Conclusion The"/>
   <result pre="and deaths with a possible infectious disease [97]. Taiwan and" exact="Hong Kong" post="used similar strategies [98]. Conclusion The international alert about"/>
   <result pre="Microbiol Infect266202072973432234451 7MunsterV.J.KoopmansM.van DoremalenN.van RielD.de WitE.A novel coronavirus emerging in" exact="China" post="- key questions for impact assessmentN Engl J Med382202069269431978293"/>
   <result pre="epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the" exact="Republic of" post="Korea from January 19 to March 2, 2020J Korean"/>
   <result pre="santÃ© durable de lâ€™UQAC and the chair holder of the" exact="Canada" post="Research Chair tier 1 (CRC1) in the Environment and"/>
   <result pre="la COVID-19 (bqc19.ca). Caroline Duchaine is holder of the Tier-1" exact="Canada" post="Research Chair on Bioaerosols. Mbarka Bchetnia is professor under"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402395\results\search\country\results.xml">
   <result pre="[4], grid.411746.10000 0004 4911 7066Department of Biochemistry, Faculty of Medicine," exact="Iran" post="University of Medical Sciences, [5], grid.413021.50000 0004 0612 8240Department"/>
   <result pre="be comparable with the outbreaks of the SARS-CoV (2002â€&quot;2003) in" exact="China" post="and with the Middle East Respiratory Syndrome Coronavirus (2012)"/>
   <result pre="and with the Middle East Respiratory Syndrome Coronavirus (2012) in" exact="Saudi Arabia" post="for their zoonotic transmission and some similarities in clinical"/>
   <result pre="that 15 to 30% of hospitalized patients with COVID-19 in" exact="China" post="and New York need to receive renal treatments or"/>
   <result pre="Chinese have reported that than 85% of COVID-19 patients in" exact="China" post="had received Traditional Chinese Medicine treatments. Due to the"/>
   <result pre="traditionally used for SARS-CoV were also used for 2019-nCoV in" exact="China" post="and Korea. Some of the commonly used herbal medicine"/>
   <result pre="and Korea. Some of the commonly used herbal medicine in" exact="China" post="include Astragalus Membranaceus, Saposhnikoviae Divaricata, Glycyrrhiza Uralensis, Lonicerae Japonicae"/>
   <result pre="Inflamm2009613 48.HanYDuJSuHZhangJZhuGZhangSet al.Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in" exact="China" post="Provides New Insights Into the Evolution and Origin of"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiab Metab Syndr.2020143241246 90.PrajapatiSKumarNSARS-CoV-2 pandemic: an"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402641\results\search\country\results.xml">
   <result pre="State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East" exact="China" post="University of Science and Technology, [3], grid.9227.e0000000119573309State Key Laboratory"/>
   <result pre="developing BSA (Min and Subbarao, 2010; Jordheim et al., 2013;" exact="Jordan" post="et al., 2018). With the former drug class usually"/>
   <result pre="K.X., 2016YFA0502304 to H.L.), the National Natural Science Foundation of" exact="China" post="(Grants 31922004 and 81772202 to K.X., 81825020 to H.L.),"/>
   <result pre="Major Project â€œKey New Drug Creation and Manufacturing Programâ€� of" exact="China" post="(Grant 2018ZX09711002 to H.L.), Application &amp;amp; Frontier Research Program"/>
   <result pre="Infect Dis20152859660226524332 DengCLiuSZhangQXuMZhangHGuDShiLHeJXiaoGZhangBIsolation and characterization of Zika virus imported to" exact="China" post="using C6/36 mosquito cellsVirol Sin20163117617927105638 DiaoYYLuWQJinHTZhuJSHanLXuMHGaoRShenXZhaoZJLiuXFet al.Discovery of diverse"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402643\results\search\country\results.xml">
   <result pre="Internet ResJ. Med. Internet ResJMIRJournal of Medical Internet Research1439-44561438-8871JMIR PublicationsToronto," exact="Canada" post="pmcid: 7402643v22i8e21143 pmid: 32701460 doi: 10.2196/21143 : Original Paper:"/>
   <result pre="led to a surge of sales in herbal remedies in" exact="China" post="and antimalarial drugs worldwide, and timely clarification of rumors"/>
   <result pre="disease (COVID-19) emerged in Wuhan City and spread rapidly across" exact="China" post="[1,2]. On January 23, 2020, the Chinese government placed"/>
   <result pre="declaration stressed the risk the virus posed to countries beyond" exact="China" post="and the need for a more coordinated international response"/>
   <result pre="than 90% of cases were localized in four countries, including" exact="China" post="and South Korea, where local epidemics had significantly declined"/>
   <result pre="of cases were localized in four countries, including China and" exact="South Korea," post="where local epidemics had significantly declined [4]. By the"/>
   <result pre="confirmed cases, leading to at least 208,000 deaths [5]. The" exact="United States" post="reported the highest numbers of confirmed cases and deaths,"/>
   <result pre="of confirmed cases and deaths, followed by Spain, Italy, the" exact="United Kingdom," post="Germany, and France; all these countries reported over 120,000"/>
   <result pre="epidemic is still underexplored [17-19]. Using internet surveillance data from" exact="China" post="and worldwide, this study aimed to assess the public"/>
   <result pre="the first wave of the pandemic were selected, namely Japan," exact="South Korea," post="and Singapore, followed by four European countries (Italy, France,"/>
   <result pre="European countries (Italy, France, Spain, and the United Kingdom) and" exact="the United States." post="Additionally, Brazil, South Africa, and India, where internet surveillance"/>
   <result pre="countries (Italy, France, Spain, and the United Kingdom) and the" exact="United States." post="Additionally, Brazil, South Africa, and India, where internet surveillance"/>
   <result pre="and the United Kingdom) and the United States. Additionally, Brazil," exact="South Africa," post="and India, where internet surveillance data (Google Trends) are"/>
   <result pre="sanitizer (æ´—æ‰‹æ¶²), disinfectant (æ¶ˆæ¯’æ¶²/æ¶ˆæ¯’å‰‚/æ¶ˆæ¯’æ°´), thermometer (ä½&quot;æ¸©è®¡) Rumors Worldwide chloroquine, hydroxychloroquine" exact="China" post="radix isatidis (æ�¿è&quot;�æ ¹), Shuanghuanglian (å�Œé»&quot;è¿ž), garlic (å¤§è’œ) aCOVID-19:"/>
   <result pre="were limited for assessing public purchasing behavior (including Japan, Singapore," exact="South Korea," post="Italy, and Spain), Google web search data were used"/>
   <result pre="to April 11, 2019. Rumors and misinformation circulated widely in" exact="China" post="regarding certain herbal medicines for personal health protection. From"/>
   <result pre="behavioral data during the epidemic. The National Health Commission of" exact="China" post="issued a series of guidelines recommending that residents adopt"/>
   <result pre="the epidemic was assessed using the Baidu daily indices in" exact="China" post="and Google Trends indices worldwide. We assessed the intentions"/>
   <result pre="Starting on January 20, when the National Health Commission of" exact="China" post="confirmed human-to-human transmission, this number increased sharply, and it"/>
   <result pre="followed by 30 provinces (autonomous regions and municipalities) across mainland" exact="China" post="(excluding Tibet). After that, public searches steadily decreased with"/>
   <result pre="awareness and searches related to COVID-19 by Baidu Index in" exact="China" post="and Google Trends worldwide from December 2019 to April"/>
   <result pre="Adopting Recommended Personal Protection Measures The National Health Commission of" exact="China" post="first proposed respiratory protection and hand hygiene as protection"/>
   <result pre="Baidu and Ali indices for recommended personal protection measures in" exact="China" post="from December 2019 to April 2020: A. Face mask."/>
   <result pre="shown in Multimedia Appendix 3. All listed countries, except for" exact="Brazil" post="and South Africa, started to report COVID-19 cases in"/>
   <result pre="Multimedia Appendix 3. All listed countries, except for Brazil and" exact="South Africa," post="started to report COVID-19 cases in late January 2020,"/>
   <result pre="started to report COVID-19 cases in late January 2020, whereas" exact="Brazil" post="and South Africa reported their first cases on February"/>
   <result pre="report COVID-19 cases in late January 2020, whereas Brazil and" exact="South Africa" post="reported their first cases on February 26 and March"/>
   <result pre="cases on February 26 and March 5, respectively. In Japan," exact="South Korea," post="and Singapore, Google Trends indices on mask and hand"/>
   <result pre="mask and hand sanitizer quickly increased after human-to-human transmission in" exact="China" post="and reached a peak around the end of January."/>
   <result pre="peak around the end of January. The Google indices in" exact="Japan" post="and Singapore then decreased and remained steady while the"/>
   <result pre="the end of January. The Google indices in Japan and" exact="Singapore" post="then decreased and remained steady while the number of"/>
   <result pre="with the rapid increase in the number of cases in" exact="South Korea," post="the Google index sharply increased and reached its second"/>
   <result pre="Asian countries were significantly correlated with new COVID-19 cases in" exact="China" post="rather than local cases. In addition, the Google indices"/>
   <result pre="cases. In addition, the Google indices in European countries and" exact="the United States" post="remained low after human-to-human transmission in China and started"/>
   <result pre="In addition, the Google indices in European countries and the" exact="United States" post="remained low after human-to-human transmission in China and started"/>
   <result pre="and the United States remained low after human-to-human transmission in" exact="China" post="and started to increase when the number of COVID-19"/>
   <result pre="number of COVID-19 cases increased from 11 to 123 in" exact="Italy" post="on February 23 (Figure 3). In Italy and Spain,"/>
   <result pre="to 123 in Italy on February 23 (Figure 3). In" exact="Italy" post="and Spain, where the epidemic first spread among European"/>
   <result pre="and Multimedia Appendix 4). The public in India, Brazil, and" exact="South Africa" post="did not respond to the spread of COVID-19 in"/>
   <result pre="Africa did not respond to the spread of COVID-19 in" exact="China" post="and Italy or to the PHEIC, with their Google"/>
   <result pre="not respond to the spread of COVID-19 in China and" exact="Italy" post="or to the PHEIC, with their Google indices remaining"/>
   <result pre="of Baidu indices for rumors related to herbal remedies in" exact="China" post="from December 2019 to April 2020. Figure 5 shows"/>
   <result pre="during this time only in Asian and European countries (Japan," exact="South Korea," post="Singapore, Italy, France, Spain, and the United Kingdom); it"/>
   <result pre="Spain, and the United Kingdom); it was not found in" exact="the United States," post="India, Brazil, or South Africa. Public searches on both"/>
   <result pre="and the United Kingdom); it was not found in the" exact="United States," post="India, Brazil, or South Africa. Public searches on both"/>
   <result pre="was not found in the United States, India, Brazil, or" exact="South Africa." post="Public searches on both drugs increased after mid-March and"/>
   <result pre="for early epidemic control in 12 countries. The epidemic in" exact="China" post="and the PHEIC did not prompt a worldwide public"/>
   <result pre="led to a surge in sales of herbal remedies in" exact="China" post="and antimalarial drugs worldwide. Chinese data showed that the"/>
   <result pre="of mass gatherings and personal protection in China, Europe, and" exact="the United States." post="In China, the government did not provide actionable advice"/>
   <result pre="mass gatherings and personal protection in China, Europe, and the" exact="United States." post="In China, the government did not provide actionable advice"/>
   <result pre="of missed opportunity for early epidemic control in Europe and" exact="the United States" post="between the PHEIC declaration in late January and the"/>
   <result pre="missed opportunity for early epidemic control in Europe and the" exact="United States" post="between the PHEIC declaration in late January and the"/>
   <result pre="declaration in late January and the outbreaks in Europe and" exact="the United States" post="in March. Transmission of COVID-19 appears to be possible"/>
   <result pre="in late January and the outbreaks in Europe and the" exact="United States" post="in March. Transmission of COVID-19 appears to be possible"/>
   <result pre="the spread. However, other than flight cancellations and evacuation from" exact="China" post="in late January, governments in Europe and the United"/>
   <result pre="evacuation from China in late January, governments in Europe and" exact="the United States" post="did not implement epidemic prevention or control measures such"/>
   <result pre="from China in late January, governments in Europe and the" exact="United States" post="did not implement epidemic prevention or control measures such"/>
   <result pre="tracing [23,24]. Despite reports of local transmissions, population movement between" exact="Italy" post="and the rest of the world and public gatherings"/>
   <result pre="largely unchecked even after the number of cases surged in" exact="Italy" post="[25]. Additionally, some political leaders and media outlets repeatedly"/>
   <result pre="shifted public opinion. In April 2020, governments in Europe and" exact="the United States" post="changed their mask-wearing guidelines and mandated universal face mask"/>
   <result pre="public opinion. In April 2020, governments in Europe and the" exact="United States" post="changed their mask-wearing guidelines and mandated universal face mask"/>
   <result pre="effectively control the COVID-19 epidemic [27]. However, the epidemic in" exact="China" post="only caught the public attention of East and Southeast"/>
   <result pre="in the rest of the world. Similarly, the epidemic in" exact="Italy" post="only resulted in public awareness and reaction in Europe"/>
   <result pre="only resulted in public awareness and reaction in Europe and" exact="the United States." post="Due to the dense populations and fragile health systems"/>
   <result pre="resulted in public awareness and reaction in Europe and the" exact="United States." post="Due to the dense populations and fragile health systems"/>
   <result pre="First, Google Trends are not applicable in all countries, including" exact="China" post="and most countries in Africa; therefore, we could only"/>
   <result pre="the volumes of Google Shopping data were low (Japan, Singapore," exact="South Korea," post="Italy, and Spain), we used Google web search data"/>
   <result pre="acknowledges financial support from the National Natural Science Foundation of" exact="China" post="(No. 71874034). The funders had no role in the"/>
   <result pre="search term &quot;mask&quot; and numbers of new COVID-19 cases in" exact="Italy" post="and Spain. LINK Abbreviations COVID-19 coronavirus disease PHEIC public"/>
   <result pre="Wuhan, China: a descriptive studyLancet202023951022350751310.1016/s0140-6736(20)30211-732007143 3National Health Commission of the" exact="People's Republic of China." post="Webpage in Chinese2020-03-02http://www.nhc.gov.cn 4WHO Director-General's opening remarks at the"/>
   <result pre="China: a descriptive studyLancet202023951022350751310.1016/s0140-6736(20)30211-732007143 3National Health Commission of the People's" exact="Republic of" post="China. Webpage in Chinese2020-03-02http://www.nhc.gov.cn 4WHO Director-General's opening remarks at"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402669\results\search\country\results.xml">
   <result pre="73% expected under 90-90-90. Figures reveal great disparities. Successes include" exact="eSwatini" post="and Switzerland, which have achieved 85% viral suppression among"/>
   <result pre="have met the 90-90-90 goals: Australia, Botswana, Cambodia, Ireland, Namibia," exact="the Netherlands," post="Rwanda, Spain, Thailand, Uganda, Zambia, and Zimbabwe. Although some"/>
   <result pre="of the effects of COVID-19. If countries as disparate as" exact="Switzerland" post="and eSwatini can succeed, then targets can be met"/>
   <result pre="effects of COVID-19. If countries as disparate as Switzerland and" exact="eSwatini" post="can succeed, then targets can be met elsewhere. Local"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7403001\results\search\country\results.xml">
   <result pre="than 1,500 papers on COVID-19 available in the PubMed and" exact="China" post="National Knowledge Infrastructure databases from January 1, 2020 to"/>
   <result pre="JAMA, BMJ, Springer Nature, National Medical Journal of China, and" exact="China" post="Biotechnology set up a special hub to support the"/>
   <result pre="prognosis, nursing, prevention, and control, were available in PubMed and" exact="China" post="National Knowledge Infrastructure (CNKI)databases. In this review, the global"/>
   <result pre="February, by more than 2.5 times. This may be because" exact="China" post="was the most severely affected country in the early"/>
   <result pre="is positively correlated with the severity in that particular country." exact="China" post="was one of the most severely affected countries in"/>
   <result pre="therefore, COVID-19-related studies were carried out rapidly. As a result," exact="China" post="(including Hong Kong, Macao, and Taiwan) ranked no. 1"/>
   <result pre="studies were carried out rapidly. As a result, China (including" exact="Hong Kong," post="Macao, and Taiwan) ranked no. 1 with 353 published"/>
   <result pre="recent experience in the prevention and control of seasonal influenza," exact="the US" post="ranked second, with 97 published studies related to COVID-19."/>
   <result pre="to COVID-19. European countries, such as the UK (27 papers)," exact="Germany" post="(15 papers) and Italy (15 papers) were among the"/>
   <result pre="such as the UK (27 papers), Germany (15 papers) and" exact="Italy" post="(15 papers) were among the countries with the highest"/>
   <result pre="focus of COVID-19 studies has varied across different regions worldwide." exact="China" post="has mainly focused on the epidemiology of COVID-19. Patients"/>
   <result pre="characteristics and biochemical markers of COVID-19.6 A research foundation in" exact="Hong Kong," post="with 26 articles on SARS, rapidly initiated studies on"/>
   <result pre="effective control of the spread of COVID-19. Research institutions in" exact="Hong Kong" post="include universities (such as the University of Hong Kong,"/>
   <result pre="in Hong Kong include universities (such as the University of" exact="Hong Kong," post="Hong Kong Polytechnic University) as well as hospitals (such"/>
   <result pre="Kong include universities (such as the University of Hong Kong," exact="Hong Kong" post="Polytechnic University) as well as hospitals (such as the"/>
   <result pre="as preventative and control measures for COVID-19.7,8 The Government of" exact="Macau" post="has placed greater emphasis on studies related to the"/>
   <result pre="against transmission of COVID-19. Furthermore, studies performed by hospitals, in" exact="Taiwan" post="(nine papers) (such as the National Taiwan University College"/>
   <result pre="by hospitals, in Taiwan (nine papers) (such as the National" exact="Taiwan" post="University College of Medicine and regional general hospitals), have"/>
   <result pre="on routes of transmission and clinical characteristics of COVID-19.9 In" exact="the US," post="considerable studies on the epidemiology (30 papers), prevention and"/>
   <result pre="be undertaken at different phases of epidemic development. Research in" exact="Canada" post="has focused on the epidemiology of COVID-19, such as"/>
   <result pre="University of Toronto about the transmission dynamics and risk assessment." exact="Japan" post="has placed significant emphasis on epidemiological studies, with studies"/>
   <result pre="epidemiological studies, with studies published by Hokkaido University and the" exact="Japan" post="Science and Technology Agency describing the incubation period of"/>
   <result pre="describing the incubation period of SARS-CoV-2 and quarantine duration. Similarly," exact="Germany" post="has mainly focused on epidemiological studies; for example, Heidelberg"/>
   <result pre="SARS-CoV-2 and predict its transmission dynamics and impact. Studies in" exact="Italy" post="have placed a relatively higher focus on the epidemiological"/>
   <result pre="research projects for the prevention and control of the epidemic." exact="China" post="has collaborated with 21 countries, including the US, Canada,"/>
   <result pre="of the epidemic. China has collaborated with 21 countries, including" exact="the US," post="Canada, and Japan, and published 80 related articles on"/>
   <result pre="dominating COVID-19 research. Furthermore, collaborative networks have been established among" exact="the US," post="Europe, and Southeast Asia as well as within European"/>
   <result pre="line. Table 1 Number of Publications Resulting from Collaborations between" exact="China" post="and Collaborative Countries, by Research Subdomain Etiology Diagnosis Epidemiology"/>
   <result pre="Nursing Prevention and Control US (9) US (4) US (11)" exact="Japan" post="(3) Canada (1) Canada (2) US (8) Japan (2)"/>
   <result pre="and Control US (9) US (4) US (11) Japan (3)" exact="Canada" post="(1) Canada (2) US (8) Japan (2) UK (1)"/>
   <result pre="US (9) US (4) US (11) Japan (3) Canada (1)" exact="Canada" post="(2) US (8) Japan (2) UK (1) Saudi Arabia"/>
   <result pre="US (11) Japan (3) Canada (1) Canada (2) US (8)" exact="Japan" post="(2) UK (1) Saudi Arabia (2) US (1) Australia"/>
   <result pre="Canada (1) Canada (2) US (8) Japan (2) UK (1)" exact="Saudi Arabia" post="(2) US (1) Australia (1) Australia (2) Australia (1)"/>
   <result pre="(8) Japan (2) UK (1) Saudi Arabia (2) US (1)" exact="Australia" post="(1) Australia (2) Australia (1) Germany (1) Japan (2)"/>
   <result pre="(2) UK (1) Saudi Arabia (2) US (1) Australia (1)" exact="Australia" post="(2) Australia (1) Germany (1) Japan (2) Italy (1)"/>
   <result pre="(1) Saudi Arabia (2) US (1) Australia (1) Australia (2)" exact="Australia" post="(1) Germany (1) Japan (2) Italy (1) Canada (2)"/>
   <result pre="Arabia (2) US (1) Australia (1) Australia (2) Australia (1)" exact="Germany" post="(1) Japan (2) Italy (1) Canada (2) Austria (1)"/>
   <result pre="US (1) Australia (1) Australia (2) Australia (1) Germany (1)" exact="Japan" post="(2) Italy (1) Canada (2) Austria (1) Japan (1)"/>
   <result pre="Australia (1) Australia (2) Australia (1) Germany (1) Japan (2)" exact="Italy" post="(1) Canada (2) Austria (1) Japan (1) Italy (2)"/>
   <result pre="Australia (2) Australia (1) Germany (1) Japan (2) Italy (1)" exact="Canada" post="(2) Austria (1) Japan (1) Italy (2) Bangladesh (1)"/>
   <result pre="Australia (1) Germany (1) Japan (2) Italy (1) Canada (2)" exact="Austria" post="(1) Japan (1) Italy (2) Bangladesh (1) Germany (1)"/>
   <result pre="Germany (1) Japan (2) Italy (1) Canada (2) Austria (1)" exact="Japan" post="(1) Italy (2) Bangladesh (1) Germany (1) Switzerland (1)"/>
   <result pre="Japan (2) Italy (1) Canada (2) Austria (1) Japan (1)" exact="Italy" post="(2) Bangladesh (1) Germany (1) Switzerland (1) Germany (2)"/>
   <result pre="Italy (1) Canada (2) Austria (1) Japan (1) Italy (2)" exact="Bangladesh" post="(1) Germany (1) Switzerland (1) Germany (2) Sweden (1)"/>
   <result pre="Canada (2) Austria (1) Japan (1) Italy (2) Bangladesh (1)" exact="Germany" post="(1) Switzerland (1) Germany (2) Sweden (1) Saudi Arabia"/>
   <result pre="Austria (1) Japan (1) Italy (2) Bangladesh (1) Germany (1)" exact="Switzerland" post="(1) Germany (2) Sweden (1) Saudi Arabia (1) the"/>
   <result pre="Japan (1) Italy (2) Bangladesh (1) Germany (1) Switzerland (1)" exact="Germany" post="(2) Sweden (1) Saudi Arabia (1) the Netherlands (1)"/>
   <result pre="Italy (2) Bangladesh (1) Germany (1) Switzerland (1) Germany (2)" exact="Sweden" post="(1) Saudi Arabia (1) the Netherlands (1) Canada (2)"/>
   <result pre="Bangladesh (1) Germany (1) Switzerland (1) Germany (2) Sweden (1)" exact="Saudi Arabia" post="(1) the Netherlands (1) Canada (2) Denmark (1) Norway"/>
   <result pre="(1) Switzerland (1) Germany (2) Sweden (1) Saudi Arabia (1)" exact="the Netherlands" post="(1) Canada (2) Denmark (1) Norway (1) Thailand (1)"/>
   <result pre="Switzerland (1) Germany (2) Sweden (1) Saudi Arabia (1) the" exact="Netherlands" post="(1) Canada (2) Denmark (1) Norway (1) Thailand (1)"/>
   <result pre="Germany (2) Sweden (1) Saudi Arabia (1) the Netherlands (1)" exact="Canada" post="(2) Denmark (1) Norway (1) Thailand (1) Iran (1)"/>
   <result pre="Sweden (1) Saudi Arabia (1) the Netherlands (1) Canada (2)" exact="Denmark" post="(1) Norway (1) Thailand (1) Iran (1) Sweden (1)"/>
   <result pre="Saudi Arabia (1) the Netherlands (1) Canada (2) Denmark (1)" exact="Norway" post="(1) Thailand (1) Iran (1) Sweden (1) Malaysia (1)"/>
   <result pre="(1) the Netherlands (1) Canada (2) Denmark (1) Norway (1)" exact="Thailand" post="(1) Iran (1) Sweden (1) Malaysia (1) Malaysia (1)"/>
   <result pre="Netherlands (1) Canada (2) Denmark (1) Norway (1) Thailand (1)" exact="Iran" post="(1) Sweden (1) Malaysia (1) Malaysia (1) Norway (1)"/>
   <result pre="Canada (2) Denmark (1) Norway (1) Thailand (1) Iran (1)" exact="Sweden" post="(1) Malaysia (1) Malaysia (1) Norway (1) India (1)"/>
   <result pre="Denmark (1) Norway (1) Thailand (1) Iran (1) Sweden (1)" exact="Malaysia" post="(1) Malaysia (1) Norway (1) India (1) UK (1)"/>
   <result pre="Norway (1) Thailand (1) Iran (1) Sweden (1) Malaysia (1)" exact="Malaysia" post="(1) Norway (1) India (1) UK (1) Egypt (1)"/>
   <result pre="Thailand (1) Iran (1) Sweden (1) Malaysia (1) Malaysia (1)" exact="Norway" post="(1) India (1) UK (1) Egypt (1) Belgium (1)"/>
   <result pre="Iran (1) Sweden (1) Malaysia (1) Malaysia (1) Norway (1)" exact="India" post="(1) UK (1) Egypt (1) Belgium (1) Epidemiological, etiological,"/>
   <result pre="Malaysia (1) Malaysia (1) Norway (1) India (1) UK (1)" exact="Egypt" post="(1) Belgium (1) Epidemiological, etiological, and diagnostic studies (75.6%)"/>
   <result pre="Malaysia (1) Norway (1) India (1) UK (1) Egypt (1)" exact="Belgium" post="(1) Epidemiological, etiological, and diagnostic studies (75.6%) predominate among"/>
   <result pre="diagnostic studies (75.6%) predominate among research arising from collaborations between" exact="China" post="and other countries across a range of research topics"/>
   <result pre="virus, receptors, PCR techniques, and immunological detection methods. In addition," exact="China" post="and Japan have collaborated to conduct clinical studies on"/>
   <result pre="PCR techniques, and immunological detection methods. In addition, China and" exact="Japan" post="have collaborated to conduct clinical studies on extracorporeal membrane"/>
   <result pre="support, potential antiviral therapeutics, and clinical features of patients. Furthermore," exact="China" post="has launched joint research projects with the US, Australia,"/>
   <result pre="of patients. Furthermore, China has launched joint research projects with" exact="the US," post="Australia, and Canada to study protective measures for postpartum"/>
   <result pre="has launched joint research projects with the US, Australia, and" exact="Canada" post="to study protective measures for postpartum women and newborns,"/>
   <result pre="Distribution As of March 8, all 31 provincial-level entities in" exact="China" post="have published COVID-19-related articles in Chinese journals. From the"/>
   <result pre="focus on treatment, prevention, etiology, and prognosis, ranking first in" exact="China" post="in terms of number of publications. In addition to"/>
   <result pre="COVID-19 Resulting from Research Collaborations by Provinces and Cities in" exact="China" post="Province/City No. Chinese Papers No. Inter-provincial Collaborative Papers Ratio"/>
   <result pre="Early epidemiological investigations have found that most COVID-19 patients in" exact="China" post="had a history of travel to Wuhan, as well"/>
   <result pre="24,727 on March 8, 2020. Specifically, the worst-affected countries were" exact="the US," post="Spain, Italy, Germany, and China. The number of the"/>
   <result pre="risk of SARS-CoV-2 transmission were Thailand, Cambodia, Malaysia, Canada, and" exact="the US," post="based on the weekly simulated passengers' end-destination data for"/>
   <result pre="concentrated among West European countries, such as the UK (39%)," exact="France" post="(24%), and Germany (15%) before the implementation of the"/>
   <result pre="European countries, such as the UK (39%), France (24%), and" exact="Germany" post="(15%) before the implementation of the travel ban in"/>
   <result pre="travel of infectious COVID-19 cases from Wuhan to cities throughout" exact="China" post="before the quarantine was expected to result in a"/>
   <result pre="of transmission, and protecting the susceptible population. In addition, Singapore," exact="the US," post="the UK, and other countries have also taken active"/>
   <result pre="affected areas to reduce movement and increase personal protection in" exact="China" post="in the early stages of the COVID-19 outbreak. (5)Global"/>
   <result pre="of COVID-19 transmission have been implemented. In addition to China," exact="the US" post="Health Community has reviewed and updated protocols developed for"/>
   <result pre="quarantine periods and tracing close contacts of confirmed cases. Discussion" exact="China" post="Has Initiated COVID-19-Related Research in Considerable Scope and Depth"/>
   <result pre="China Has Initiated COVID-19-Related Research in Considerable Scope and Depth" exact="China" post="has made great contributions to scientific progress related to"/>
   <result pre="scope and depth. The early stages of the outbreak in" exact="China" post="provided a large number of cases for scientific research"/>
   <result pre="and sequenced the viral genome on January 12, 2020. Furthermore," exact="China" post="shared its diagnosis and treatment strategies worldwide, actively participated"/>
   <result pre="the SARS epidemic in 2003, the scientific research capability of" exact="China" post="has demonstrated great qualitative progress, promoting more virus-related research"/>
   <result pre="been published in English or Chinese. In addition to China," exact="the US," post="Canada, and European countries also carried out scientific research"/>
   <result pre="prevention and control during the recent outbreak. European countries and" exact="Japan" post="carried out epidemiological studies before the outbreak based on"/>
   <result pre="reached a consensus on strategic direction and cultivated scientific cooperation.73" exact="China" post="and the US have established cooperative networks with European"/>
   <result pre="consensus on strategic direction and cultivated scientific cooperation.73 China and" exact="the US" post="have established cooperative networks with European and Southeast Asian"/>
   <result pre="of broad-spectrum drugs for the treatment of coronaviral infections.74 For" exact="China" post="in particular, acceleration of research aimed at the clinical"/>
   <result pre="above general suggestions, there are some other specific efforts that" exact="China" post="must undertake. Regional differences in previous studies reflect the"/>
   <result pre="and the exportation of novel coronavirus (2019-nCoV) cases from Wuhan," exact="China" post="in 2020: a correlational analysisJ.Â Travel Med.27202013 8ChengV.C.C.WongS.C.ChenJ.H.K.YipC.C.Y.ChuangV.W.M.TsangO.T.Y.SridharS.ChanJ.F.W.HoP.L.YuenK.Y.Escalating infection"/>
   <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci." exact="China" post="Life. Sci.502020258269 32RothanH.A.ByrareddyS.N.The epidemiology and pathogenesis of coronavirus disease"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7403098\results\search\country\results.xml">
   <result pre="Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was first reported in Wuhan," exact="China" post="at the end of December 2019. SARS-CoV-2 is a"/>
   <result pre="Coronavirus-2 (SARS-CoV-2) (Khan et al., 2020b). COVID-19 originated in Wuhan," exact="China" post="is considered the continuation of previous outbreaks of coronaviruses"/>
   <result pre="transmission to humans through an unknown intermediate animal in Wuhan," exact="China" post="is still controversial (Khan et al., 2020a; Zaman et"/>
   <result pre="B Chem.22820163642 HanY.DuJ.SuH.ZhangJ.ZhuG.ZhangS.WuZ.JinQ.Identification of diverse bat alphacoronaviruses and betacoronaviruses in" exact="China" post="provides new insights into the evolution and origin of"/>
   <result pre="extraordinarily stringent selective constraints on protein evolutionProc. Natl. Acad. Sci." exact="U. S." post="A1162019190091901831484772 LiuF.LongX.ZouW.FangM.WuW.LiW.ZhangB.ZhangW.ChenX.ZhangZ.Highly ACE2 expression in pancreas may cause pancreas"/>
   <result pre="interim clinical guidance for the 2019 novel coronavirus outbreak -" exact="United States," post="december 31, 2019-february 4, 2020MMWR. Morbidity. Mortality692020140146weekly report QinC.ZhouL.HuZ.ZhangS.YangS.TaoY.XieC.MaK.ShangK.WangW.TianD.S.Dysregulation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404079\results\search\country\results.xml">
   <result pre="[3, 11]. In 2012, MERS-CoV was initially detected in the" exact="Kingdom of Saudi Arabia" post="revealing 2494 confirmed infected cases and 858 mortalities. It"/>
   <result pre="In 2012, MERS-CoV was initially detected in the Kingdom of" exact="Saudi Arabia" post="revealing 2494 confirmed infected cases and 858 mortalities. It"/>
   <result pre="condition. SARS-CoV-2 was identified in late December, 2019 in Wuhan," exact="China" post="[8]. The World Health Organization (WHO) declared that COVID-19"/>
   <result pre="to the significant blockade of the SARS-CoV-2 replication [89]. In" exact="Saudi Arabia," post="a clinical trial discovered that a combination of lopinavir/ritonavir"/>
   <result pre="shown. Since ribavirin treatment did not improve patient outcome health," exact="Canada" post="stopped permitting the use of ribavirin. Additional studies tested"/>
   <result pre="up to 2 weeks. An ongoing randomized clinical trial in" exact="Saudi Arabia" post="is evaluating treatment of MERS patients with IFN-Î²1b conjointly"/>
   <result pre="antigenicity between laboratory and clinical isolates of HCoV-229E isolated in" exact="Japan" post="in 2004-2008 depend on the S1 region sequence of"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes Metab Syndr Clin Res Rev.202014241246"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404132\results\search\country\results.xml">
   <result pre="virus from biological samples of affected patients during the recent" exact="China" post="outbreak and defined its genetic code [4]: GenBank Database"/>
   <result pre="for anti-SARS-CoV2 CP [37]. In another trial, carried out in" exact="China" post="by recruiting patients with severe or life-threatening COVID-19 syndrome"/>
   <result pre="to be administered to critical COVID-19 patients was started in" exact="Italy" post="in March 2020 (NCT04321421), with the limited recruitment of"/>
   <result pre="other day up to 10 days [62]. A trial in" exact="China" post="(ChiCTR2000029308) has been registered for hospitalized COVID-19 patients, estimating"/>
   <result pre="for SARS-CoV [63,70]. A number of clinical trials conducted in" exact="China" post="demonstrated apparent efficacy and acceptable safety of chloroquine or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404376\results\search\country\results.xml">
   <result pre="defence programs. Indeed, in recent decades commercial bioindustrial facilities in" exact="the USA" post="have developed vaccines, laboratories, and other technologies that can"/>
   <result pre="the military use of poison and disease, countries such as" exact="the USA," post="Soviet Union, and Japan have developed and deployed microbes"/>
   <result pre="use of poison and disease, countries such as the USA," exact="Soviet Union," post="and Japan have developed and deployed microbes as part"/>
   <result pre="and disease, countries such as the USA, Soviet Union, and" exact="Japan" post="have developed and deployed microbes as part of national"/>
   <result pre="nutrients, and thus increased the plants' susceptibility to disease. In" exact="the USA" post="in the late 1940s, it â€œcaused an annual average"/>
   <result pre="birth of nationâ€�states; cf. Robinson (1971). Biological warfare programs of" exact="the Soviet Union" post="started in 1928, and involved the production of bacteria"/>
   <result pre="of nationâ€�states; cf. Robinson (1971). Biological warfare programs of the" exact="Soviet Union" post="started in 1928, and involved the production of bacteria"/>
   <result pre="and Company, and these resembled the biological warfare activities of" exact="the Soviet Union;" post="cf. Tucker (2002). 45Butler (2015); Inglesby (2018); Koblentz (2010;"/>
   <result pre="Company, and these resembled the biological warfare activities of the" exact="Soviet Union;" post="cf. Tucker (2002). 45Butler (2015); Inglesby (2018); Koblentz (2010;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404498\results\search\country\results.xml">
   <result pre="Sciences, University of Genoa, Via Antonio Pastore 1, Genova 16132," exact="Italy" post="mail id: antonio.dibiagio@hsanmartino.it epub: 2020-7-7e13358(C) , This article is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404531\results\search\country\results.xml">
   <result pre="Wuhan, China. It was first confirmed in subâ€�Saharan Africa in" exact="Nigeria" post="on 27 February 2020 and has since spread quickly"/>
   <result pre="from West African countries. Clinical Medicine. 15(1): 54â€�7. and the" exact="Democratic Republic of Congo" post="(DRC) 4Ebola Virus Disease: Democratic Republic of the Congo."/>
   <result pre="West African countries. Clinical Medicine. 15(1): 54â€�7. and the Democratic" exact="Republic of" post="Congo (DRC) 4Ebola Virus Disease: Democratic Republic of the"/>
   <result pre="countries. Clinical Medicine. 15(1): 54â€�7. and the Democratic Republic of" exact="Congo" post="(DRC) 4Ebola Virus Disease: Democratic Republic of the Congo."/>
   <result pre="and the Democratic Republic of Congo (DRC) 4Ebola Virus Disease:" exact="Democratic Republic of the Congo." post="(2020). External Situation Report 85. Retrieved March 26, 2020"/>
   <result pre="the Democratic Republic of Congo (DRC) 4Ebola Virus Disease: Democratic" exact="Republic of" post="the Congo. (2020). External Situation Report 85. Retrieved March"/>
   <result pre="from https://apps.who.int/iris/bitstream/handle/10665/204714/ebolasitrep_30mar2016_eng.pdf. and 3,316 infections and 2,279 deaths in the" exact="Democratic Republic of Congo" post="(DRC) as of 28 April 2020. 11Ebola virus disease"/>
   <result pre="https://apps.who.int/iris/bitstream/handle/10665/204714/ebolasitrep_30mar2016_eng.pdf. and 3,316 infections and 2,279 deaths in the Democratic" exact="Republic of" post="Congo (DRC) as of 28 April 2020. 11Ebola virus"/>
   <result pre="3,316 infections and 2,279 deaths in the Democratic Republic of" exact="Congo" post="(DRC) as of 28 April 2020. 11Ebola virus disease"/>
   <result pre="(DRC) as of 28 April 2020. 11Ebola virus disease â€&quot;" exact="Democratic Republic of the Congo" post="(2020). Retrieved May 2, 2020 from https://www.who.int/csr/don/30â€�Aprilâ€�2020â€�ebolaâ€�drc/en/. The delayed"/>
   <result pre="as of 28 April 2020. 11Ebola virus disease â€&quot; Democratic" exact="Republic of" post="the Congo (2020). Retrieved May 2, 2020 from https://www.who.int/csr/don/30â€�Aprilâ€�2020â€�ebolaâ€�drc/en/."/>
   <result pre="April 2020. 11Ebola virus disease â€&quot; Democratic Republic of the" exact="Congo" post="(2020). Retrieved May 2, 2020 from https://www.who.int/csr/don/30â€�Aprilâ€�2020â€�ebolaâ€�drc/en/. The delayed"/>
   <result pre="The first confirmed COVIDâ€�19 case in SSA was reported in" exact="Nigeria" post="on 27 February 2020. 16WHO, op. cit. note 6."/>
   <result pre="soup can cure COVIDâ€�19; and medical face masks imported from" exact="China" post="were infected with SARSâ€�CoVâ€�2. 35COVIDâ€�19: Myths and facts. (2020)."/>
   <result pre="the West African Ebola outbreak and health systems in Guinea," exact="Liberia" post="and Sierra Leone: a systematic review. Global Health.13(1):1â€�1. Laboratory"/>
   <result pre="Socioâ€�cultural Dimensions of Emerging Infectious Diseases in Africa. Springer Nature" exact="Switzerland" post="AG. 3 DISCUSSION Although the number of confirmed COVIDâ€�19"/>
   <result pre="compared to the number of confirmed cases in Europe and" exact="the United States," post="the regionâ€™s weak and poorly resilient health systems, poor"/>
   <result pre="to the number of confirmed cases in Europe and the" exact="United States," post="the regionâ€™s weak and poorly resilient health systems, poor"/>
   <result pre="to global health security. The COVIDâ€�19 related experiences in China," exact="the United States" post="of America, Italy and Spain indicate that a lot"/>
   <result pre="global health security. The COVIDâ€�19 related experiences in China, the" exact="United States of America," post="Italy and Spain indicate that a lot more than"/>
   <result pre="COVIDâ€�19 related experiences in China, the United States of America," exact="Italy" post="and Spain indicate that a lot more than an"/>
   <result pre="experiences in China, the United States of America, Italy and" exact="Spain" post="indicate that a lot more than an efficient health"/>
   <result pre="A practical communityâ€�based response strategy to interrupt Ebola transmission in" exact="Sierra Leone," post="2014â€&quot;2015. Infectious Diseases of Poverty. 5(1): 74. and would"/>
   <result pre="(2014). Support services for survivors of ebola virus disease â€�" exact="Sierra Leone." post="MMWR Morb Mortal Wkly Rep 2014; 63(50): 1205â€�6. COVIDâ€�19"/>
   <result pre="for universal health coverage? The future of â€œfree healthâ€� in" exact="Sri Lanka." post="Globalization and Health. 15(1): 75. This approach would ensure"/>
   <result pre="Syntia Munung is based at the University of Cape Town," exact="South Africa." post="She is interested in questions on the governance of"/>
   <result pre="global genomics research. He was the pioneer Administrator to the" exact="Nigeria" post="National Health Research Ethics Committee. He had postgraduate training"/>
   <result pre="London. He is based at the Medical Research Council Unit" exact="The Gambia" post="at LSHTM where he leads the Viral Hepatitis Research"/>
   <result pre="He is based at the Medical Research Council Unit The" exact="Gambia" post="at LSHTM where he leads the Viral Hepatitis Research"/>
   <result pre="Medical Sociology/Anthropology and Bioethics at the University of Ibadan, Ibadan," exact="Nigeria" post="where he is also the Director, Research Management Office"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404868\results\search\country\results.xml">
   <result pre="Disease Control and PreventionTianjinChina[2], Buckingham Centre for AstrobiologyUniversity of BuckinghamBuckinghamUK[3]," exact="Sri Lanka" post="Centre for AstrobiologyUniversity of RuhunaSri Lanka[4], National Institute of"/>
   <result pre="Control and PreventionTianjinChina[2], Buckingham Centre for AstrobiologyUniversity of BuckinghamBuckinghamUK[3], Sri" exact="Lanka" post="Centre for AstrobiologyUniversity of RuhunaSri Lanka[4], National Institute of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404911\results\search\country\results.xml">
   <result pre="stated in a credit line to the data. Abstract Background" exact="China" post="ranks second in the world in terms of numbers"/>
   <result pre="pyrazinamide), as these drugs are highly associated with hepatotoxicity [4]." exact="China" post="is burdened with the second largest number of TB"/>
   <result pre="the Central Government of China, which is located in southwest" exact="China" post="[8]. With over 30 million residents, Chongqing has a"/>
   <result pre="Chongqing was 75/100,000, ranking tenth among the top 10 in" exact="China" post="[15]. Therefore, TB control in Chongqing faced many challenges,"/>
   <result pre="the Guidelines for implementing the national TB control programme in" exact="China" post="(2008) [18]. Chongqing has also implemented the integrated model"/>
   <result pre="in CPHMC. CPHMC reports all notified TB patients to the" exact="China" post="Information System for Disease Control and Prevention (CIS-DCP). A"/>
   <result pre="which is consistent with the reports in other regions of" exact="China" post="[23, 24]. TB cases are more likely to cluster"/>
   <result pre="regions with the highest TB burden among undergraduate students in" exact="China" post="[28]. Several TB outbreaks among students have been recently"/>
   <result pre="1. Abbreviations CDC Center for Disease Control and Prevention CIS-DCP" exact="China" post="Information System for Disease Control And Prevention CPHMC The"/>
   <result pre="project was funded by the National Natural Science Foundation of" exact="China" post="(81773489), Social Science and Technology Innovation Subject in Chongqing"/>
   <result pre="17.collab: National Health and Family Planning Commission of the people's" exact="Republic of" post="ChinaDiagnosis for pulmonary tuberculosis2017 18.collab: Department of Disease Control"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405170\results\search\country\results.xml">
   <result pre="an infection at this site. The Infectious Diseases Society of" exact="America" post="(IDSA) has defined â€œrespirable particlesâ€� as having a diameter"/>
   <result pre="aspiration of oral fluids, whereas most studies from Europe and" exact="the United States" post="have used high or low volume aspirators. Because the"/>
   <result pre="of oral fluids, whereas most studies from Europe and the" exact="United States" post="have used high or low volume aspirators. Because the"/>
   <result pre="RNA transmitted via aerosol during various human respiratory activitiesâ€&quot;experiments from" exact="Singapore" post="and Hong Kong. PLoS One. 2014;9:e107338.25208000 54MiltonDK, FabianMP, CowlingBJ,"/>
   <result pre="via aerosol during various human respiratory activitiesâ€&quot;experiments from Singapore and" exact="Hong Kong." post="PLoS One. 2014;9:e107338.25208000 54MiltonDK, FabianMP, CowlingBJ, GranthamML, McDevittJJ. Influenza"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405322\results\search\country\results.xml">
   <result pre="Infectious Diseases and Immunology, Wilhelmina Children's HospitalUniversity Medical Center UtrechtUtrechtThe" exact="Netherlands" post="*Correspondence Pierre Goussard, PhD, Department of Paediatrics and Child"/>
   <result pre="Tygerberg Hospital, Stellenbosch University, PO Box 241, Cape Town 8000," exact="South Africa." post="Email: pgouss@sun.ac.za epub: 2020-7-710.1002/ppul.24927received: 2020-4-29accepted: 2020-6-23(C) , This article"/>
   <result pre="2019 (COVIDâ€�19) is now wellâ€�known with the first case in" exact="South Africa" post="on 5 March 2020,1 and since then, the country"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405402\results\search\country\results.xml">
   <result pre="influenza virus (Balgi etÂ al.,Â 2013). The herbal medicine of" exact="Japan" post="called Maoto has also shown inhibitory activity on influenza"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405496\results\search\country\results.xml">
   <result pre="affected by the worldwide outbreak of COVIDâ€�19. Among Western countries," exact="Italy" post="has been particularly hit at the beginning of the"/>
   <result pre="at the beginning of the pandemic, immediately after China. In" exact="Italy" post="and elsewhere, women seem to be less affected than"/>
   <result pre="coronavirus disease 2019 (COVIDâ€�19) is likely to have started in" exact="China" post="(Zhou, Yang, et al.,Â 2020) and rapidly turned into"/>
   <result pre="2020) and rapidly turned into a global pandemic with Europe," exact="the United States," post="and South America being particularly affected (https://coronavirus.jhu.edu/map.html, accessed on"/>
   <result pre="and rapidly turned into a global pandemic with Europe, the" exact="United States," post="and South America being particularly affected (https://coronavirus.jhu.edu/map.html, accessed on"/>
   <result pre="a global pandemic with Europe, the United States, and South" exact="America" post="being particularly affected (https://coronavirus.jhu.edu/map.html, accessed on June 28, 2020)."/>
   <result pre="on May 11, 28,903 COVIDâ€�19 positive patients had died in" exact="Italy" post="(TableÂ 1). Their mean age was 80 years (median,"/>
   <result pre="for death results above 1, and in four countries (Albania," exact="Costa Rica," post="Thailand, and The Netherlands), this ratio is even above"/>
   <result pre="fatality of severe Covid 19 in men and women in" exact="Italy" post="and China Number of patients/Covid+ patients ICU/severe cases Deceased"/>
   <result pre="severe Covid 19 in men and women in Italy and" exact="China" post="Number of patients/Covid+ patients ICU/severe cases Deceased Median age"/>
   <result pre="(Guan et al.,Â 2020). In the largest study available from" exact="China" post="(Guan et al.,Â 2020), quite similar percentages to those"/>
   <result pre="quite similar percentages to those reported for deceased women in" exact="Italy" post="have been observed. Yet, in this latter study, the"/>
   <result pre="distribution between sexes according to age was not reported. For" exact="the United States," post="sex disaggregated data on case fatality are not available,"/>
   <result pre="between sexes according to age was not reported. For the" exact="United States," post="sex disaggregated data on case fatality are not available,"/>
   <result pre="habits in different countries. For example, an outbreak in the" exact="Republic of" post="Korea exhibited a high incidence of cases in women"/>
   <result pre="Epidemiological Features of Coronavirus Disease 2019 [COVIDâ€�19] Outbreak in the" exact="Republic of" post="Korea from January 19 to March 2, 2020). Smoking"/>
   <result pre="W. H., Ou, C. Q., He, J. X., â€¦ collab:" exact="China" post="Medical Treatment Expert Group for Covidâ€�19 . (2020). Clinical"/>
   <result pre="epigenetic landscape. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 115(5), E1012â€&quot;E1021. 10.1073/pnas.170692811529339515 Moccia, F., Gerbino, A.,"/>
   <result pre="landscape. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="115(5), E1012â€&quot;E1021. 10.1073/pnas.170692811529339515 Moccia, F., Gerbino, A., Lionetti, V.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405653\results\search\country\results.xml">
   <result pre="Abstract Abstract Since the emergence of the chikungunya virus in" exact="Brazil" post="in 2014, more than 700,000 cases have been reported"/>
   <result pre="Alphavirus. The first reports of chikungunya outbreaks were described in" exact="Tanzania" post="in 1952, and it did not reach the Americas"/>
   <result pre="Alto CemitÃ©rio, higher than the prevalence reported in the literature9." exact="Brazil" post="is a country of continental dimensions, with 8 million"/>
   <result pre="by a French group14; the second one was published in" exact="Brazil" post="in 2016 by a multidisciplinary team15, and was incorporated"/>
   <result pre="in intensity. In a study by Schilte et al. in" exact="French Polynesia," post="60% of patients experienced chronification, of whom 72 were"/>
   <result pre="Post-Chikungunya Rheumatic Disorders: A Retrospective Study of 159 Cases in" exact="Reunion" post="Island from 2006-2012PLoS Negl Trop Dis20159311810.1371/journal.pntd.0003603 29BletteryMBrunierLPolomatKMoinetFDelignyCArfiSet al.Brief Report:"/>
   <result pre="Rheumatic Disorders: A Retrospective Study of 159 Cases in Reunion" exact="Island" post="from 2006-2012PLoS Negl Trop Dis20159311810.1371/journal.pntd.0003603 29BletteryMBrunierLPolomatKMoinetFDelignyCArfiSet al.Brief Report: Management"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405836\results\search\country\results.xml">
   <result pre="of Medicine, FundaciÃ³n Universitaria AutÃ³noma de las Americas, Pereira, Risaralda," exact="Colombia" post="Address correspondence to Yashpal Singh Malik, malikyps@gmail.com, or Alfonso"/>
   <result pre="patients was found to be connected with the Huanan South" exact="China" post="Seafood Market in Wuhan (2). CoVs belong to the"/>
   <result pre="et al. predicted potential SARS- or MERS-like CoV outbreaks in" exact="China" post="following pathogen transmission from bats (6). COVID-19 emerged in"/>
   <result pre="China following pathogen transmission from bats (6). COVID-19 emerged in" exact="China" post="and spread rapidly throughout the country and, subsequently, to"/>
   <result pre="(17, 279). The recently emerging SARS-CoV-2 has wrought havoc in" exact="China" post="and caused a pandemic situation in the worldwide population,"/>
   <result pre="have been reported in more than 210 countries apart from" exact="China" post="(Fig. 3 and 4) (WHO Situation Report 114) (25,"/>
   <result pre="been reported on all continents except Antarctica. For many weeks," exact="Italy" post="was the focus of concerns regarding the large number"/>
   <result pre="of cases, with 221,216 cases and 30,911 deaths, but now," exact="the United States" post="is the country with the largest number of cases,"/>
   <result pre="cases, with 221,216 cases and 30,911 deaths, but now, the" exact="United States" post="is the country with the largest number of cases,"/>
   <result pre="largest number of cases, 1,322,054, and 79,634 deaths. Now, the" exact="United Kingdom" post="has even more cases (226,4671) and deaths (32,692) than"/>
   <result pre="cases and deaths. Shown are laboratory-confirmed cases and deaths in" exact="China" post="and the rest of the world due to SARS-CoV-2."/>
   <result pre="May 2020. (B) Total numbers of deaths and cases in" exact="China" post="only. (C) Total number of cases worldwide by region."/>
   <result pre="8 December 2019 to 13 May 2020. At the beginning," exact="China" post="experienced the majority of the burden associated with COVID-19"/>
   <result pre="but over time the COVID-19 menace moved to Europe, particularly" exact="Italy" post="and Spain, and now the United States has the"/>
   <result pre="menace moved to Europe, particularly Italy and Spain, and now" exact="the United States" post="has the highest number of confirmed cases and deaths."/>
   <result pre="moved to Europe, particularly Italy and Spain, and now the" exact="United States" post="has the highest number of confirmed cases and deaths."/>
   <result pre="time taken to identify SARS-CoV reported in Foshan, Guangdong Province," exact="China" post="(125â€‰days) (68). Immediately after the confirmation of viral etiology,"/>
   <result pre="common exposure point, a seafood market in Wuhan, Hubei Province," exact="China" post="(Fig. 6). The restaurants of this market are well-known"/>
   <result pre="of wild animals for human consumption (71). The Huanan South" exact="China" post="Seafood Market also sells live animals, such as poultry,"/>
   <result pre="is not the first time where the culinary practices of" exact="China" post="have been blamed for the origin of novel coronavirus"/>
   <result pre="to be the intermediate hosts of the SARS outbreak in" exact="China" post="(78). Several wildlife species were found to harbor potentially"/>
   <result pre="animals and humans at the market (284). In January 2020," exact="China" post="imposed a temporary ban on the sale of live-dead"/>
   <result pre="without optimizing standard food safety and sanitation practices (286). With" exact="China" post="being the most populated country in the world and"/>
   <result pre="whole world is now facing the menace of COVID-19, including" exact="China" post="itself. Wet markets of live-dead animals do not maintain"/>
   <result pre="a rational international campaign against the unhealthy food practices of" exact="China" post="to encourage the sellers to increase hygienic food practices"/>
   <result pre="namely, bat-SL-CoVZC45 and bat-SL-CoVZXC21, which were reported during 2018 in" exact="China" post="(17). It was reported that SARS-CoV-2 had been confirmed"/>
   <result pre="Several countries have provided recommendations to their people traveling to" exact="China" post="(88, 89). Compared to the previous coronavirus outbreaks caused"/>
   <result pre="(90, 91). Almost half of the MERS-CoV cases reported in" exact="Saudi Arabia" post="are of secondary origin that occurred through contact with"/>
   <result pre="animal CoV that originated from the wet markets in southern" exact="China" post="after adapting to the human host, thereby enabling transmission"/>
   <result pre="The outbreak severely affected the Asia Pacific region, especially mainland" exact="China" post="(94). Even though the case fatality rate (CFR) of"/>
   <result pre="MERS is another respiratory disease that was first reported in" exact="Saudi Arabia" post="during the year 2012. The disease was found to"/>
   <result pre="The updates obtained from countries like China, Japan, Thailand, and" exact="South Korea" post="indicated that the COVID-19 patients had relatively mild manifestations"/>
   <result pre="of novel SARS-CoV-2 from COVID-19-infected mothers to their neonates in" exact="China" post="based upon the rise in IgM and IgG antibody"/>
   <result pre="scale mortality of piglets (24,693 deaths) across four farms in" exact="China" post="(134). The virus isolated from the piglets was almost"/>
   <result pre="dogs (Hong Kong) and four pet cats (one each from" exact="Belgium" post="and Hong Kong, two from the United States) have"/>
   <result pre="Kong) and four pet cats (one each from Belgium and" exact="Hong Kong," post="two from the United States) have tested positive for"/>
   <result pre="Fisher Scientific, Inc. TaqPath COVID-19 combo kit Laboratory Corporation of" exact="America" post="(LabCorp) COVID-19 RT-PCR test Hologic, Inc. Panther fusion SARS-CoV-2"/>
   <result pre="having minimum signs and symptoms (82). Another study, conducted in" exact="South Korea," post="related to SARS-CoV-2 viral load, opined that SARS-CoV-2 kinetics"/>
   <result pre="biosafety implications (151). The samples from 18 SARS-CoV-2-positive patients in" exact="Singapore" post="who had traveled from Wuhan to Singapore showed the"/>
   <result pre="SARS-CoV-2-positive patients in Singapore who had traveled from Wuhan to" exact="Singapore" post="showed the presence of viral RNA in stool and"/>
   <result pre="16 March 2020, Jennifer Haller became the first person outside" exact="China" post="to receive an experimental vaccine, developed by Moderna, against"/>
   <result pre="COVID-19 (305). A broad-spectrum antiviral drug that was developed in" exact="the United States," post="tilorone dihydrochloride (tilorone), was previously found to possess potent"/>
   <result pre="(305). A broad-spectrum antiviral drug that was developed in the" exact="United States," post="tilorone dihydrochloride (tilorone), was previously found to possess potent"/>
   <result pre="guidelines issued by the National Health Commission of the Peopleâ€™s" exact="Republic of" post="China. The preliminary clinical trials using hydroxychloroquine, another aminoquinoline"/>
   <result pre="In contrast to their response to the 2002 SARS outbreak," exact="China" post="has shown immense political openness in reporting the COVID-19"/>
   <result pre="of identifying the novel virus (225). The move made by" exact="China" post="opened a new chapter in global health security and"/>
   <result pre="coming days. Studies also report that since air traffic between" exact="China" post="and African countries increased many times over in the"/>
   <result pre="of preventive measures, like controlling the entry of individuals from" exact="China" post="or countries where the disease has flared up, isolating"/>
   <result pre="with human-animal contact. Live-animal markets, such as the Huanan South" exact="China" post="Seafood Market, represent ideal conditions for interspecies contact of"/>
   <result pre="next step following the control of the COVID-19 outbreak in" exact="China" post="should be focused on screening, identification, isolation, and characterization"/>
   <result pre="Canada, and Wuhan Institute of Virology, China. He has represented" exact="India" post="in the scientific arena in more than 12 countries."/>
   <result pre="2019. He worked at the Institute of Animal Health, Pirbright," exact="United Kingdom," post="as a visiting fellow from April to December 1996."/>
   <result pre="1996. He worked at the Institute of Animal Health, Pirbright," exact="United Kingdom," post="as a Postdoctoral Fellow on a Wellcome Trust Fellowship"/>
   <result pre="2004. Further, he worked at the Veterinary Research Centre, Muscat," exact="Sultanate of Oman," post="as an Expert Pathologist from June 2008 to May"/>
   <result pre="and antibody engineering. She is an executive member of the" exact="Thailand" post="Academy of Sciences. She has served as Editor in"/>
   <result pre="LuR, NiuP, ZhanF, MaX, WangD, XuW, WuG, GaoGF, TanW, collab:" exact="China" post="Novel Coronavirus Investigating and Research Team2020A novel coronavirus from"/>
   <result pre="of a new human coronavirus: there and back again. Sci" exact="China" post="Life Sci63:461â€&quot;462. doi:10.1007/s11427-020-1645-7.32048160 48.NeumanBW, KissG, KundingAH, BhellaD, BakshMF, ConnellyS,"/>
   <result pre="66.AyitteyFK, AyitteyMK, ChiweroNB, KamasahJS, DzuvorC2020Economic impacts of Wuhan 2019-nCoV on" exact="China" post="and the world. J Med Virol92:473â€&quot;475. doi:10.1002/jmv.25706.32048740 67.QiuH, TongZ,"/>
   <result pre="Virol92:473â€&quot;475. doi:10.1002/jmv.25706.32048740 67.QiuH, TongZ, MaP, HuM, PengZ, WuW, DuB, collab:" exact="China" post="Critical Care Clinical Trials Group (CCCCTG)2020Intensive care during the"/>
   <result pre="spread of causal agent of severe acute respiratory syndrome in" exact="Hong Kong." post="Lancet361:1761â€&quot;1766. doi:10.1016/S0140-6736(03)13410-1.12781533 95.Millan-OÃ±ateJ, RodrÃ­guez-MoralesAJ, Camacho-MorenoG, Mendoza-RamÃ­rezH, RodrÃ­guez-SabogalIA, Ã�lvarez-MorenoC2020A new"/>
   <result pre="patients linked to viral loads and lung injury. 63:364â€&quot;374. Sci" exact="China" post="Life Sci doi:10.1007/s11427-020-1643-8.32048163 122.QiuHB, LiXY, DuB, KangHYJ, WangYS, WangF,"/>
   <result pre="ShiZL2017Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses. Sci" exact="China" post="Life Sci60:1399â€&quot;1402. doi:10.1007/s11427-017-9189-3.29134417 201.CohenJ2020New coronavirus threat galvanizes scientists. Science367:492â€&quot;493."/>
   <result pre="WangG, MaH, LiuZ2020The mental health of medical workers in Wuhan," exact="China" post="dealing with the 2019 novel coronavirus. Lancet Psychiatry7:e14. doi:10.1016/S2215-0366p(20)30047-X.32035030"/>
   <result pre="ChenMI, ChanM, VasooS, WangLF, TanBH, LinRTP, LeeVJM, LeoYS, LyeDC, collab:" exact="Singapore" post="2019 Novel Coronavirus Outbreak Research Team2020Epidemiologic features and clinical"/>
   <result pre="Sci253:117592. doi:10.1016/j.lfs.2020.117592.32222463 306.EkinsS, LaneTR, MadridPB2020Tilorone: a broad-spectrum antiviral invented in" exact="the USA" post="and commercialized in Russia and beyond. Pharm Res37:71. doi:10.1007/s11095-020-02799-8.32215760"/>
   <result pre="a broad-spectrum antiviral invented in the USA and commercialized in" exact="Russia" post="and beyond. Pharm Res37:71. doi:10.1007/s11095-020-02799-8.32215760 307.MolinaJM, DelaugerreC, GoffJL, Mela-LimaB,"/>
   <result pre="357.EbrahimSH, MemishZA2020COVID-19: preparing for superspreader potential among Umrah pilgrims to" exact="Saudi Arabia." post="Lancet395:e48. doi:10.1016/S0140-6736(20)30466-9.32113506 358.Kamel BoulosMN, GeraghtyEM2020Geographical tracking and mapping of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405927\results\search\country\results.xml">
   <result pre="accompanied by the same load of suspicion and distrust. In" exact="the USA" post="face masks have been resemantized from personal protective equipment"/>
   <result pre="measure introduced for the first time by the Most Serene" exact="Republic of" post="Venice in 1377, during a plague outbreak in Dubrovnik"/>
   <result pre="during the 2005 outbreak of extensively drug-resistant tuberculosis in KwaZulu-Natal," exact="South Africa" post="(Singh et al. 2007), the WHO embraced this approach,"/>
   <result pre="more critical situations in which much worse ethical issues arise." exact="Italy" post="already faced a hard time in this sense: the"/>
   <result pre="long lasting friendship. Funding This work was supported by the" exact="Swiss" post="National Science Foundation (Project Number 31CA30_195905). Compliance with ethical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409030\results\search\country\results.xml">
   <result pre="atypical pneumonia cases (27 cases) recorded in Wuhan, Hubei province," exact="China" post="[2,3]. The infection was declared a pandemic on 11"/>
   <result pre="addition, since 7 May 2020, Remdesivir (VekluryÂ®) was approved in" exact="Japan" post="as a treatment for patients with severe COVID-19 pathology"/>
   <result pre="of the randomized, double-blind, placebo-controlled, multicentre clinical trials developed in" exact="China" post="(NCT04257656) in order to verify RDV efficacy as a"/>
   <result pre="profile of LPV/r and its high potential for drugâ€&quot;drug interactions," exact="China" post="National Center for Adverse Drug Reaction Monitoring collected and"/>
   <result pre="[115]. In the opinion of the Infectious Diseases Society of" exact="America" post="(IDSA), the published clinical data concerning LPV/r efficacy as"/>
   <result pre="an influenza virus inhibitor and is clinically approved only in" exact="Russia" post="and China. Its mechanism of action consists of binding"/>
   <result pre="Favipiravir Favipiravir, (6-fluoro-3-hydroxypyrazine-2-carboxamide), is a prodrug antiviral agent approved in" exact="Japan" post="for the treatment of influenza. The compound is a"/>
   <result pre="free/co-morbidity associated COVID-19 patients [131]. Favipiravir is currently approved in" exact="Russia" post="for COVID-19 treatment, only in hospital settings [132]. 4.5."/>
   <result pre="COVID-19 patients are rather scarce, and only several reports from" exact="China" post="assert the efficacy of this kind of treatment (small"/>
   <result pre="ICTRPAvailable online: https://www.who.int/ictrp/en/(accessed on 30 April 2020) 53.Van IersselS.DaubyN.BottieauE.HuitsR.collab: The" exact="Belgium" post="Task ForceInterim Clinical Guidance for Adults with Suspected or"/>
   <result pre="Clinical Guidance for Adults with Suspected or Confirmed COVID-19 in" exact="Belgium" post="06 May 2020Version 82020 54.Van IersselS.DaubyN.BottieauE.HuitsR.collab: The Belgium Task"/>
   <result pre="COVID-19 in Belgium 06 May 2020Version 82020 54.Van IersselS.DaubyN.BottieauE.HuitsR.collab: The" exact="Belgium" post="Task ForceInterim Clinical Guidance for Adults with Suspected or"/>
   <result pre="Clinical Guidance for Adults with Suspected or Confirmed COVID-19 in" exact="Belgium" post="06 May 2020Version 52020 55.collab: Lombardy Section Italian Society"/>
   <result pre="June 2020) 75.collab: GileadGilead Announces Approval of VekluryÂ® (Remdesivir) in" exact="Japan" post="for Patients with Severe COVID-19Available online: https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gilead-announces-approval-of-veklury-remdesivir-in-japan-for-patients-with-severe-covid19(accessed on 19"/>
   <result pre="Hospital Pharmacovigilance SystemClin. Pharmacol. Ther.202010.1002/cpt.1866 116.collab: IDSAInfectious Diseases Society of" exact="America" post="Guidelines on the Treatment and Management of Patients with"/>
   <result pre="guidelines in different countries dependent on clinical stage. Clinical Status" exact="Belgium" post="Italy(Lombardia Protocol) France Netherlands Switzerland Romania Mild-to-moderateâ€&quot;no risk group"/>
   <result pre="countries dependent on clinical stage. Clinical Status Belgium Italy(Lombardia Protocol)" exact="France" post="Netherlands Switzerland Romania Mild-to-moderateâ€&quot;no risk group Symptomatic care (paracetamol)"/>
   <result pre="dependent on clinical stage. Clinical Status Belgium Italy(Lombardia Protocol) France" exact="Netherlands" post="Switzerland Romania Mild-to-moderateâ€&quot;no risk group Symptomatic care (paracetamol) No"/>
   <result pre="on clinical stage. Clinical Status Belgium Italy(Lombardia Protocol) France Netherlands" exact="Switzerland" post="Romania Mild-to-moderateâ€&quot;no risk group Symptomatic care (paracetamol) No antiviral"/>
   <result pre="clinical stage. Clinical Status Belgium Italy(Lombardia Protocol) France Netherlands Switzerland" exact="Romania" post="Mild-to-moderateâ€&quot;no risk group Symptomatic care (paracetamol) No antiviral treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409380\results\search\country\results.xml">
   <result pre="Police Security, Ministry of Public SecurityChina[#], Shenzhen Customs District Peopleâ€™s" exact="Republic of" post="ChinaChina[Â¶], Rochester Institute of TechnologyUnited States *Email: pwqin@sz.tsinghua.edu.cn. *Email:"/>
   <result pre="125 copies/mL for SARS-CoV-2 detection, and has been approved by" exact="the US" post="FDA for emergency use. The droplet microfluidic LAMP is"/>
   <result pre="has been released,83 demonstrated in clinical scenarios,92 and approved by" exact="the US" post="FDA for emergency use. Cas12a combined with RT-LAMP exhibits"/>
   <result pre="Isolation of SARS-CoV-2 by TMPRSS2-Expressing Cells. Proc. Natl. Acad. Sci." exact="U. S." post="A.117, 7001â€&quot;7003. 10.1073/pnas.2002589117.32165541 WuY.; GuoG.; ZhengJ.; XingD.; ZhangT. (2019)"/>
   <result pre="Capture and Identification from Clinical Samples. Proc. Natl. Acad. Sci." exact="U. S." post="A.117, 895â€&quot;901. 10.1073/pnas.1910113117.31882450 SinghR.; MaD.; KimerlingL.; AgarwalA. M.; AnthonyB."/>
   <result pre="Low-Cost Molecular Diagnostics on A Smartphone. Proc. Natl. Acad. Sci." exact="U. S." post="A.112, 5613â€&quot;8. 10.1073/pnas.1501815112.25870273 XiaY.; ChenY.; TangY.; ChengG.; YuX.; HeH.;"/>
   <result pre="Selectivity by Photonic Resonator Absorption Microscopy. Proc. Natl. Acad. Sci." exact="U. S." post="A.116, 19362â€&quot;19367. 10.1073/pnas.1904770116.31501320 WangL.; ZhangH.; WangC.; XuY.; SuJ.; WangX.;"/>
   <result pre="products approved by the National Medical Products Administration, http://www.nmpa.gov.cn/WS04/CL2056/375802.html. collab:" exact="United States" post="Food and Drug Administration. (accessed on 2020-05-11) Emergency Use"/>
   <result pre="Diagnostics Using a Coronavirus Protein Microarray. Proc. Natl. Acad. Sci." exact="U. S." post="A.103, 4011â€&quot;4016. 10.1073/pnas.0510921103.16537477 YershovG.; BarskyV.; BelgovskiyA.; KirillovE.; KreindlinE.; IvanovI.;"/>
   <result pre="Analysis and Diagnostics on Oligonucleotide Microchips. Proc. Natl. Acad. Sci." exact="U. S." post="A.93, 4913â€&quot;8. 10.1073/pnas.93.10.4913.8643503 JiangS.; DuL.; ShiZ. (2020) An Emerging"/>
   <result pre="Spectrometry Assay for One-Shot Flavivirus Diagnosis. Proc. Natl. Acad. Sci." exact="U. S." post="A.116, 6754â€&quot;6759. 10.1073/pnas.1817867116.30886083 DaiL.; LiY.; WangY.; LuoX.; WeiD.; FengR.;"/>
   <result pre="Immunoassays as Rapid Saliva-Based Clinical Diagnostics. Proc. Natl. Acad. Sci." exact="U. S." post="A.104, 5268â€&quot;5273. 10.1073/pnas.0607254104.17374724 ZhangJ.; LiuJ.; LiN.; LiuY.; YeR.; QinX.;"/>
   <result pre="in Vitro and in Vivo Diagnostics. Proc. Natl. Acad. Sci." exact="U. S." post="A.112, 14429â€&quot;35. 10.1073/pnas.1508521112.26598662 ZhangK.; YueY.; WuS.; LiuW.; ShiJ.; ZhangZ."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409838\results\search\country\results.xml">
   <result pre="work was supported by the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(grant nos. 81602967 and 81803784), the 10.13039/501100002858China Postdoctoral Science"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409942\results\search\country\results.xml">
   <result pre="without treatment we analyzed in this paper were from Germany," exact="South Korea" post="and China. We also studied the viral load data"/>
   <result pre="load data from a SARS-CoV-2 infected adult rhesus macaque in" exact="the US." post="The viral load data of eight patients from Germany"/>
   <result pre="the US. The viral load data of eight patients from" exact="Germany" post="were from a larger cohort of COVID-19 cases in"/>
   <result pre="expressing the spike proteins of SARS-CoV-2Â [14]. The data from" exact="China" post="were collected by RT-PCR from serial samples (throat swabs,"/>
   <result pre="of enough measurements in another. The viral load data from" exact="South Korea" post="were from a 35-year-old Chinese woman traveling from Wuhan,"/>
   <result pre="Korea were from a 35-year-old Chinese woman traveling from Wuhan," exact="China" post="[50]. She was the first case reported in South"/>
   <result pre="Wuhan, China [50]. She was the first case reported in" exact="South Korea." post="The viral load was also measured with RT-PCR every"/>
   <result pre="the viral load data of SARS-CoV-2 infection in patients from" exact="Germany" post="and ChinaÂ [14], [51]. The best fits to the"/>
   <result pre="LRT and URT viral load data of a patient in" exact="South Korea" post="who received lopinavir/ritonavir on day 5 after the onset"/>
   <result pre="the data of a non-human primate and a patient in" exact="South Korea" post="treated with lopinavir/ritonavir. (A) Best fit to long-term viral"/>
   <result pre="interferon pretreatment2020bioRxiv. 2020.03.07.982264. 10.1101/2020.03.07.982264 54BÃ¶hmerM.M.BuchholzU.CormanV.M.HochM.KatzK.MarosevicD.V.Investigation of a COVID-19 outbreak in" exact="Germany" post="resulting from a single travel-associated primary case: a case"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7410019\results\search\country\results.xml">
   <result pre="Byrd JC, Gaidano G, Hallek M, Hillmen P, Mato A," exact="Montserrat" post="E, Ghia P. How we Manage Patients with Chronic"/>
   <result pre="disclose. References References 1.LeungKWuJTLiuDet al.First-wave COVID-19 transmissibility and severity in" exact="China" post="outside Hubei after control measures, and second-wave scenario planning:"/>
   <result pre="in Wuhan, China. JAMA.2020;323:1061â€&quot;1069. 30.collab: National University Cancer Institute of" exact="Singapore" post="Workflow TeamA Segregated-Team Model to Maintain Cancer Care During"/>
   <result pre="SARS-CoV-2 infection and virus load in fecal samples from the" exact="Hong Kong" post="Cohort and systematic review and meta-analysis. Gastroenterology.2020;April 3. [Epub"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7410434\results\search\country\results.xml">
   <result pre="of the Dual COVID-19 and Ebola Epidemics in the Democratic" exact="Republic of" post="Congoâ€&quot;Priorities for Achieving Control NachegaJean B.123*â€ Mbala-KingebeniPlacide4â€ OtshudiemaJohn5â€ MobulaLinda"/>
   <result pre="novel agents for treatment of high-risk outpatient COVID-19 patients in" exact="South Africa" post="supported by the Bill &amp;amp; Melinda Gates Foundation. A."/>
   <result pre="Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town," exact="South Africa," post="Department of Epidemiology and International Health, Johns Hopkins Bloomberg"/>
   <result pre="Mbala-Kingebeni, Department of Microbiology, Institut National de Recherche Biomedicale, Kinshasa," exact="Democratic Republic of the Congo," post="E-mail: mbalaplacide@gmail.com. John Otshudiema, World Health Organization Regional Office"/>
   <result pre="Department of Microbiology, Institut National de Recherche Biomedicale, Kinshasa, Democratic" exact="Republic of" post="the Congo, E-mail: mbalaplacide@gmail.com. John Otshudiema, World Health Organization"/>
   <result pre="Office for Africa, Emergencies Program, COVID-19 Response, Epidemiological Surveillance Team," exact="Democratic Republic of the Congo," post="E-mail: johnotokoye@gmail.com. Linda M. Mobula, International Health, Johns Hopkins"/>
   <result pre="for Africa, Emergencies Program, COVID-19 Response, Epidemiological Surveillance Team, Democratic" exact="Republic of" post="the Congo, E-mail: johnotokoye@gmail.com. Linda M. Mobula, International Health,"/>
   <result pre="Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town," exact="South Africa," post="and National Health Laboratory Service (NHLS), Cape Town, South"/>
   <result pre="South Africa, and National Health Laboratory Service (NHLS), Cape Town," exact="South Africa," post="E-mail: preiser@sun.ac.za. Oscar Kallay, Erasme Hospital, UniversitÃ© Libre de"/>
   <result pre="National Institute of Biomedical Research, COVID-19 Response Task Team, Kinshasa," exact="Democratic Republic of the Congo," post="E-mail: justusnsio@yahoo.fr. Steve Ahuka-Mundeke, National Institute of Biomedical Research,"/>
   <result pre="Institute of Biomedical Research, COVID-19 Response Task Team, Kinshasa, Democratic" exact="Republic of" post="the Congo, E-mail: justusnsio@yahoo.fr. Steve Ahuka-Mundeke, National Institute of"/>
   <result pre="National Institute of Biomedical Research, COVID-19 Response Task Force, Kinshasa," exact="Democratic Republic of the Congo," post="and Department of Medical Virology and Microbiology, University of"/>
   <result pre="Institute of Biomedical Research, COVID-19 Response Task Force, Kinshasa, Democratic" exact="Republic of" post="the Congo, and Department of Medical Virology and Microbiology,"/>
   <result pre="Department of Medical Virology and Microbiology, University of Kinshasa, Kinshasa," exact="Democratic Republic of the Congo," post="E-mail: amstev04@yahoo.fr. Alimuddin Zumla, Division of Infection and Immunity,"/>
   <result pre="of Medical Virology and Microbiology, University of Kinshasa, Kinshasa, Democratic" exact="Republic of" post="the Congo, E-mail: amstev04@yahoo.fr. Alimuddin Zumla, Division of Infection"/>
   <result pre="Biomedical Research (INRB), Faculty of Medicine, University of Kinshasa, Kinshasa," exact="Democratic Republic of the Congo," post="E-mail: jjmuyembet@gmail.com. â€ These authors contributed equally to this"/>
   <result pre="Research (INRB), Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic" exact="Republic of" post="the Congo, E-mail: jjmuyembet@gmail.com. â€ These authors contributed equally"/>
   <result pre="are credited.tpmd200642.pdf Abstract Abstract. As of June 11, 2020, the" exact="Democratic Republic of the Congo" post="(DRC) has reported 4,258 COVID-19 cases with 90 deaths."/>
   <result pre="credited.tpmd200642.pdf Abstract Abstract. As of June 11, 2020, the Democratic" exact="Republic of" post="the Congo (DRC) has reported 4,258 COVID-19 cases with"/>
   <result pre="As of June 11, 2020, the Democratic Republic of the" exact="Congo" post="(DRC) has reported 4,258 COVID-19 cases with 90 deaths."/>
   <result pre="and food insecurity for large sectors of the population.2â€&quot;4 The" exact="Democratic Republic of the Congo" post="(DRC) recently experienced its tenth Ebola virus disease (EVD)"/>
   <result pre="food insecurity for large sectors of the population.2â€&quot;4 The Democratic" exact="Republic of" post="the Congo (DRC) recently experienced its tenth Ebola virus"/>
   <result pre="large sectors of the population.2â€&quot;4 The Democratic Republic of the" exact="Congo" post="(DRC) recently experienced its tenth Ebola virus disease (EVD)"/>
   <result pre="due to air travel of infected individuals from Europe.2,3 The" exact="Democratic Republic of the Congo" post="confirmed its first case of COVID-19 on March 10,"/>
   <result pre="to air travel of infected individuals from Europe.2,3 The Democratic" exact="Republic of" post="the Congo confirmed its first case of COVID-19 on"/>
   <result pre="of infected individuals from Europe.2,3 The Democratic Republic of the" exact="Congo" post="confirmed its first case of COVID-19 on March 10,"/>
   <result pre="poverty line. Figure 1. Epidemiology status of COVID-19 in the" exact="Democratic Republic of the Congo" post="(as of June 14, 2020). Figure 2. COVID-19 daily"/>
   <result pre="line. Figure 1. Epidemiology status of COVID-19 in the Democratic" exact="Republic of" post="the Congo (as of June 14, 2020). Figure 2."/>
   <result pre="Epidemiology status of COVID-19 in the Democratic Republic of the" exact="Congo" post="(as of June 14, 2020). Figure 2. COVID-19 daily"/>
   <result pre="14, 2020). Figure 2. COVID-19 daily case numbers in the" exact="Democratic Republic of the Congo" post="(March 10, 2020â€&quot;June 9, 2020). THE DEMOCRATIC REPUBLIC OF"/>
   <result pre="2020). Figure 2. COVID-19 daily case numbers in the Democratic" exact="Republic of" post="the Congo (March 10, 2020â€&quot;June 9, 2020). THE DEMOCRATIC"/>
   <result pre="COVID-19 daily case numbers in the Democratic Republic of the" exact="Congo" post="(March 10, 2020â€&quot;June 9, 2020). THE DEMOCRATIC REPUBLIC OF"/>
   <result pre="care. Table 1 COVID-19 contact-tracing in affected provinces in the" exact="Democratic Republic of the Congo" post="(March 10, 2020â€&quot;May 27, 2020) Province Total health zones"/>
   <result pre="Table 1 COVID-19 contact-tracing in affected provinces in the Democratic" exact="Republic of" post="the Congo (March 10, 2020â€&quot;May 27, 2020) Province Total"/>
   <result pre="contact-tracing in affected provinces in the Democratic Republic of the" exact="Congo" post="(March 10, 2020â€&quot;May 27, 2020) Province Total health zones"/>
   <result pre="Na Ituri 36 2 6 2 0 0 Na Democratic" exact="Republic of" post="the Congoâ€&quot;nationwide 518 54 10 2,659 6,389 5,882 92"/>
   <result pre="Challenges and priority solutions for optimizing COVID-19 response in the" exact="Democratic Republic of the Congo" post="Early and late challenges Priority solutions 1 Social distancing,"/>
   <result pre="and priority solutions for optimizing COVID-19 response in the Democratic" exact="Republic of" post="the Congo Early and late challenges Priority solutions 1"/>
   <result pre="for optimizing COVID-19 response in the Democratic Republic of the" exact="Congo" post="Early and late challenges Priority solutions 1 Social distancing,"/>
   <result pre="and other comorbidities CHCWs = community healthcare workers; DRC =" exact="Democratic Republic of the Congo;" post="PPE = personal protection equipment; POC = point of"/>
   <result pre="other comorbidities CHCWs = community healthcare workers; DRC = Democratic" exact="Republic of" post="the Congo; PPE = personal protection equipment; POC ="/>
   <result pre="lessons learned from the Ebola virus disease outbreak in the" exact="Democratic Republic of the Congo." post="Am J Trop Med Hyg103: 12â€&quot;17.32431285 7.MulanguSet al.2019A rendomized"/>
   <result pre="learned from the Ebola virus disease outbreak in the Democratic" exact="Republic of" post="the Congo. Am J Trop Med Hyg103: 12â€&quot;17.32431285 7.MulanguSet"/>
   <result pre="J Med381: 2293â€&quot;2303.31774950 8.RohanHMcKayG, 2020The Ebola outbreak in the Democratic" exact="Republic of" post="the Congo: why there is no â€˜silver bulletâ€™. Nat"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7410516\results\search\country\results.xml">
   <result pre="to the rapid and extensive spreading of the infection from" exact="China" post="to Europe and worldwide, the WHO declared COVID-19 a"/>
   <result pre="of encephalitis has been reported in a paediatric patient from" exact="Germany" post="[79]. Psychological burden and associated psychiatric disorders It is"/>
   <result pre="Ethical approval None. Code availability Not applicable. References References 1.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWcollab:" exact="China" post="Novel Coronavirus Investigating and Research TeamA novel coronavirus from"/>
   <result pre="COVID-19 Response Team (2020) Coronavirus Disease 2019 in Children â€&quot;" exact="United States," post="February 12â€&quot;April 2, 2020. MMWR Morb Mortal Wkly Rep"/>
   <result pre="Disord20111301â€&quot;222022521030090 84.LiuNZhangFWeiCJiaYShangZSunLWuLSunZZhouYWangYLiuWPrevalence and predictors of PTSS during COVID-19 outbreak in" exact="China" post="hardest-hit areas: gender differences matterPsychiatry Res202028711292132240896 85.TangWHuTHuBJinCWangGXieCChenSXuJPrevalence and correlates"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7411102\results\search\country\results.xml">
   <result pre="Î²-coronavirus genus, is a novel coronavirus first detected in Wuhan," exact="China" post="in December, 2019.1 The current Corona virus pandemic has"/>
   <result pre="282020(Epub ahead of print]:ciaa198.10.1093/cid/ciaa198 3Coronavirus disease 2019 in children â€&quot;" exact="United States," post="february 12â€&quot;april 2, 2020MMWR Morb Mortal Wkly Rep69202042242610.15585/mmwr.mm6914e432271728 4MadjidM.MillerC.C.ZarubaevV.V.Influenza"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7412427\results\search\country\results.xml">
   <result pre="on infection of polarized broncho-epithelial Calu-3 cells with pdm09 or" exact="Panama" post="influenza A virus strains. We detected significantly stronger antiviral"/>
   <result pre="baloxavir marboxil [16], was recently approved for medical use in" exact="Japan" post="and the United States. While baloxavir marboxil is another"/>
   <result pre="[16], was recently approved for medical use in Japan and" exact="the United States." post="While baloxavir marboxil is another success in the development"/>
   <result pre="was recently approved for medical use in Japan and the" exact="United States." post="While baloxavir marboxil is another success in the development"/>
   <result pre="acquired on an LSM 800 confocal microscope (Carl Zeiss, Jena," exact="Germany" post="equipped with a Plan-Apochromat 63Ã—/1.4 oil immersion objective. Images"/>
   <result pre="monolayers were inoculated with 0.1 MOI of either pdm09 or" exact="Panama" post="isolate, and the drugs were added 2 h p.i."/>
   <result pre="effective in reducing virus titers for both pdm09 and the" exact="Panama" post="IAV variant. Oseltamivir and itraconazole EC50 values indicated that"/>
   <result pre="A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong," exact="China" post="between 2009 and 2014Sci. Rep.20177848810.1038/s41598-017-08282-628814737 15.MukherjeeA.NayakM.K.DuttaS.PandaS.SatpathiB.R.Chawla-SarkarM.Genetic characterization of circulating"/>
   <result pre="titers obtained in cells infected with (a) pdm09 and (b)" exact="Panama" post="are expressed as plaque-forming units (PFU) per mL with"/>
   <result pre="were infected with 0.1 MOI of (a,c) pdm09 or (b,d)" exact="Panama" post="for 24 h. At 2 h p.i. cells were"/>
   <result pre="were infected with 0.1 MOI of (a) pdm09 or (b)" exact="Panama" post="for 24 h. Oseltamivir and itraconazole were added at"/>
   <result pre="were infected with 0.1 MOI of (a) pdm09 or (b)" exact="Panama" post="for 24 h. Oseltamivir and itraconazole were added at"/>
   <result pre="were infected with 0.1 MOI of (a) pdm09 or (b)" exact="Panama" post="for 24 h. Oseltamivir and itraconazole were added at"/>
   <result pre="to assess drug interaction profiles for (a) pdm09 and (b)" exact="Panama" post="virus infections. Bliss independence model, Î&quot;E &amp;lt; 0 indicates"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7413162\results\search\country\results.xml">
   <result pre="caused by the MERS-CoV, was first identified in 2012 in" exact="Saudi Arabia" post="and caused outbreaks in South Korea and Saudi Arabia."/>
   <result pre="identified in 2012 in Saudi Arabia and caused outbreaks in" exact="South Korea" post="and Saudi Arabia. Symptoms varied from none or mild"/>
   <result pre="in Saudi Arabia and caused outbreaks in South Korea and" exact="Saudi Arabia." post="Symptoms varied from none or mild common cold such"/>
   <result pre="NR: Not reported Studies were performed in 25 different countries;" exact="the United States" post="with 46 publications had the highest number of publications"/>
   <result pre="Not reported Studies were performed in 25 different countries; the" exact="United States" post="with 46 publications had the highest number of publications"/>
   <result pre="widely in different studies from 5% in a study from" exact="China" post="[39] to about 88% in an Italian study [56]."/>
   <result pre="of early symptoms for SARS-CoV-2 test positivity among healthcare workers," exact="the Netherlands," post="March 2020Euro Surveill.2520005082020 69VacchianoV.RiguzziP.VolpiL.TappatÃ M.AvoniP.RizzoG.Early neurological manifestations of hospitalized"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7413836\results\search\country\results.xml">
   <result pre="et al. 2020). The novel coronavirus has initially spread from" exact="China" post="and propagated rapidly throughout the globe and has received"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7414693\results\search\country\results.xml">
   <result pre="are important to quell the opioid use disorder epidemic in" exact="the United States." post="This article identifies similar barriers to treatment and care"/>
   <result pre="important to quell the opioid use disorder epidemic in the" exact="United States." post="This article identifies similar barriers to treatment and care"/>
   <result pre="virus, and serious bacterial infections such as infective endocarditis, across" exact="the United States" post="among persons who use drugs. â€¢There are significant parallels"/>
   <result pre="and serious bacterial infections such as infective endocarditis, across the" exact="United States" post="among persons who use drugs. â€¢There are significant parallels"/>
   <result pre="the current opioid epidemic and intertwined infectious disease epidemics in" exact="the United States." post="Introduction When people typically hear the word epidemic these"/>
   <result pre="current opioid epidemic and intertwined infectious disease epidemics in the" exact="United States." post="Introduction When people typically hear the word epidemic these"/>
   <result pre="Organization (WHO).1 When the HIV epidemic was first recognized in" exact="the United States," post="the response was delayed and stigma and discrimination in"/>
   <result pre="(WHO).1 When the HIV epidemic was first recognized in the" exact="United States," post="the response was delayed and stigma and discrimination in"/>
   <result pre="care were prominent. In responding to the early HIV epidemic," exact="the US" post="government funded the AIDS (acquired immunodeficiency syndrome) Service Demonstration"/>
   <result pre="approximately 20% receiving treatment. In October 2017, the President of" exact="the United States" post="declared the opioid epidemic a national public health emergency."/>
   <result pre="20% receiving treatment. In October 2017, the President of the" exact="United States" post="declared the opioid epidemic a national public health emergency."/>
   <result pre="overdoses, which was the leading cause of accidental death in" exact="the United States," post="surpassing motor vehicle accidents and gun deaths.5 According to"/>
   <result pre="which was the leading cause of accidental death in the" exact="United States," post="surpassing motor vehicle accidents and gun deaths.5 According to"/>
   <result pre="The Human Immunodeficiency Virus Epidemic in 1980s to 1990s in" exact="the United States" post="In the early 1980s and 1990s, the United States"/>
   <result pre="Human Immunodeficiency Virus Epidemic in 1980s to 1990s in the" exact="United States" post="In the early 1980s and 1990s, the United States"/>
   <result pre="in the United States In the early 1980s and 1990s," exact="the United States" post="was experiencing one of the worst epidemics in the"/>
   <result pre="the United States In the early 1980s and 1990s, the" exact="United States" post="was experiencing one of the worst epidemics in the"/>
   <result pre="white heroin from Asia, which had low supply levels in" exact="the United States" post="back then and was predominantly affecting urban African Americans.28"/>
   <result pre="heroin from Asia, which had low supply levels in the" exact="United States" post="back then and was predominantly affecting urban African Americans.28"/>
   <result pre="infectious disease outbreaks without any evidence of abating.9,29 The reason" exact="the United States" post="did not have a rapidly expanding opioid epidemic in"/>
   <result pre="disease outbreaks without any evidence of abating.9,29 The reason the" exact="United States" post="did not have a rapidly expanding opioid epidemic in"/>
   <result pre="and easily available black tar heroin that was supplied through" exact="Mexico" post="and now the illicitly manufactured fentanyl.28,30 Although it is"/>
   <result pre="with HIV (PWH) to see more HIV outbreaks occurring in" exact="the United States" post="among PWUD related to these newer opioid epidemics over"/>
   <result pre="HIV (PWH) to see more HIV outbreaks occurring in the" exact="United States" post="among PWUD related to these newer opioid epidemics over"/>
   <result pre="was identified at the height of the AIDS epidemic in" exact="the United States," post="harm reduction services such as clean needle syringe exchange"/>
   <result pre="identified at the height of the AIDS epidemic in the" exact="United States," post="harm reduction services such as clean needle syringe exchange"/>
   <result pre="reduced HIV transmission in PWUD,34,35 but few programs exist in" exact="the United States" post="and, as yet, federal dollars are not provided to"/>
   <result pre="HIV transmission in PWUD,34,35 but few programs exist in the" exact="United States" post="and, as yet, federal dollars are not provided to"/>
   <result pre="provided to purchase syringes. In February 2019, the President of" exact="the United States" post="called for a plan to end HIV in the"/>
   <result pre="to purchase syringes. In February 2019, the President of the" exact="United States" post="called for a plan to end HIV in the"/>
   <result pre="United States called for a plan to end HIV in" exact="the United States," post="with specific goals to reduce new HIV infections by"/>
   <result pre="States called for a plan to end HIV in the" exact="United States," post="with specific goals to reduce new HIV infections by"/>
   <result pre="as well as a reduction in new HIV infections in" exact="the United States." post="In addition to these actions, as well as the"/>
   <result pre="well as a reduction in new HIV infections in the" exact="United States." post="In addition to these actions, as well as the"/>
   <result pre="Epidemic The opioid epidemic parallels the early HIV epidemic in" exact="the United States," post="and clinicians have the tools to combat the epidemic"/>
   <result pre="The opioid epidemic parallels the early HIV epidemic in the" exact="United States," post="and clinicians have the tools to combat the epidemic"/>
   <result pre="and treatment services.48,58 In addition, the Infectious Disease Society of" exact="America" post="(IDSA) and HIV Medicine Association (HIVMA) working groups also"/>
   <result pre="use disorders among adults aged 18 through 64 years in" exact="the United States," post="2003-2013JAMA31420151468147826461997 3Botticelli M. Americaâ€™s Addiction to Opioids: Heroin and"/>
   <result pre="disorders among adults aged 18 through 64 years in the" exact="United States," post="2003-2013JAMA31420151468147826461997 3Botticelli M. Americaâ€™s Addiction to Opioids: Heroin and"/>
   <result pre="at: http://www.samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htm#5.2. 5RuddR.A.SethP.DavidF.Increases in drug and opioid-involved overdose deaths -" exact="United States," post="2010-2015MMWR Morb Mortal Wkly Rep6520161445145228033313 6National Institute of Drug"/>
   <result pre="overdose deaths involving cocaine and psychostimulants with abuse potential -" exact="United States," post="2003-2017MMWR Morb Mortal Wkly Rep68201938839531048676 10RonanM.V.HerzigS.J.Hospitalizations related to opioid"/>
   <result pre="to a growing opioid epidemic and associated injection drug use," exact="United States," post="2004 to 2014Am J Public Health108201817518129267061 17SchranzA.J.FleischauerA.ChuV.H.Trends in drug"/>
   <result pre="history and prospects of a crisis of authorityMillbank Q8342005126 26DeWeerdtS.Tracing" exact="the US" post="opioid crisis to its rootsNature5732019S10S1231511672 27PetersP.J.PontonesP.HooverK.W.HIV infection linked to"/>
   <result pre="Rep63201484985425275328 30CiccaroneD.The triple wave epidemic: Supply and demand drivers of" exact="the US" post="opioid overdose crisisInt J Drug Policy71201918318830718120 31Des JarlaisD.C.FriedmanS.R.NovickD.M.HIV-1 infection"/>
   <result pre="for Disease Control and Prevention (CDC)Diagnoses of HIV infection in" exact="the United States" post="and dependent areas, 20182018(CDC)Atlanta (GA) 43Centers for Disease Control"/>
   <result pre="Disease Control and Prevention (CDC)Diagnoses of HIV infection in the" exact="United States" post="and dependent areas, 20182018(CDC)Atlanta (GA) 43Centers for Disease Control"/>
   <result pre="HIV infection in the United States-2014: a Clinical Practice Guideline2014DHHS)" exact="United States" post="Department of Health and Human Services (DHHS)Bethesda (MD) 44collab:"/>
   <result pre="Urgent Call to Action from the Infectious Disease Society of" exact="America" post="(IDSA) and HIV Medicine Association (HIVMA). Journal Of Infectious"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7414743\results\search\country\results.xml">
   <result pre="among HIV+ men who have sex with men (MSM) in" exact="the Netherlands" post="alongside widespread DAA scale up [15], combined with modeling"/>
   <result pre="HIV+ men who have sex with men (MSM) in the" exact="Netherlands" post="alongside widespread DAA scale up [15], combined with modeling"/>
   <result pre="studies indicating HCV elimination may be achievable among PLWH in" exact="France" post="[16], have fuelled optimism that microelimination among PLWH is"/>
   <result pre="fuelled optimism that microelimination among PLWH is achievable. In 2015," exact="Spain" post="developed a National Strategy for HCV treatment and instituted"/>
   <result pre="with chronic HCV infection from 21 reference centers in Andalusia," exact="Spain" post="was established (HERACLES cohort). From 2015 to 2017, the"/>
   <result pre="among PWID. One study examined elimination among HIV+ individuals in" exact="France" post="[16], but did not incorporate full transmission dynamics from"/>
   <result pre="target of 80% reduction in incidence by 2030, using Andalusia," exact="Spain" post="as a case study. Methods Mathematical model A deterministic"/>
   <result pre="and in care are on HIV antiretroviral therapy (ART) in" exact="Spain" post="[28], and 97% of HIV/HCV coinfected individuals in Andalusia"/>
   <result pre="per year among PWID Î¼ 0.0179 Average life expectancy in" exact="Spain" post="to 80.7 (WHO life table), and average age of"/>
   <result pre="HIV/HCV-diagnosed MSM (per year) Î¼MSM 0.026 Average life expectancy in" exact="Spain" post="of 80.7 [56], and average age at HIV/HCV diagnosis"/>
   <result pre="drug use over the past decade in Andalusia and across" exact="Spain" post="more broadly. First, data from OST admissions in Andalusia"/>
   <result pre="and HIV+ people who inject drugs (b, d) in Andalusia," exact="Spain" post="with various treatment scenarios and 95% Sustained Virologic Response"/>
   <result pre="recent scale-up of HCV treatment to HIV/HCV coinfected individuals in" exact="Spain" post="since 2015 may have had an impact on reducing"/>
   <result pre="PLWH and the broader population. One previous study conducted in" exact="France" post="modeled the HCV epidemic among HIV-positive patients from all"/>
   <result pre="as prevention benefits among PWID. Most incident HCV infections in" exact="Spain" post="are among PWID, and the majority of HIV/HCV coinfected"/>
   <result pre="has been noted among the PWID and MSM populations in" exact="Australia" post="[68]. Further, we used country-level (for Spain) HCV reinfection"/>
   <result pre="a barrier to immediate universal scale-up of HCV treatment. As" exact="Spain" post="has recently relaxed the HCV restrictions regarding therapy and"/>
   <result pre="Conclusions In conclusion, microelimination of HCV among HIV+ PWID in" exact="Spain" post="requires a focus on elimination of HCV transmission among"/>
   <result pre="(A,C) and HIV+ people who inject drugs (B,D) in Andalusia," exact="Spain" post="with observed scaled-up DAA treatment rates from 2015. Black"/>
   <result pre="new HCV infections among HIV+ MSM and PWID in Andalusia," exact="Spain" post="if all coinfected individuals were diagnosed and treated annually"/>
   <result pre="Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in" exact="Spain" post="2004â€&quot;2011: Increasing rates of HCV diagnosis but not of"/>
   <result pre="Epidemic Among Men Who Have Sex With Men in the" exact="United Kingdom?" post="Epidemiological and Modeling Insights. (1537â€&quot;6591 (Electronic)). 25.MacGregor L, Martin"/>
   <result pre="al. Prevalence and distribution of hepatitis C virus genotypes in" exact="Spain" post="during the 2000â€&quot;2015 period (the GEHEP 005 study). (1365â€&quot;2893"/>
   <result pre="of people living with HIV and the undiagnosed fraction in" exact="Spain" post="in 2013. (1473â€&quot;5571 (Electronic)). 54.HaganHJordanAENeurerJClelandCMIncidence of sexually transmitted hepatitis"/>
   <result pre="71.Platt LMS, Reed J, Vickerman P, Hagan H, French C," exact="Jordan" post="A, Degenhardt L, Hope V, Hutchinson S, Maher L,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7414935\results\search\country\results.xml">
   <result pre="Collaborative Innovation Center for Functional Food, Chongqing University of EducationChongqingPeopleâ€™s" exact="Republic of" post="China[2], Chongqing Engineering Research Center of Functional Food, Chongqing"/>
   <result pre="Engineering Research Center of Functional Food, Chongqing University of EducationChongqingPeopleâ€™s" exact="Republic of" post="China[3], Chongqing Engineering Laboratory for Research and Development of"/>
   <result pre="Research and Development of Functional Food, Chongqing University of EducationChongqingPeopleâ€™s" exact="Republic of" post="China[4], Our Lady of Fatima UniversityValenzuelaPhilippines Correspondence: Xin ZhaoNo."/>
   <result pre="Collaborative Innovation Center for Functional FoodChongqing University of EducationChongqing400067, Peopleâ€™s" exact="Republic of" post="ChinaTel +86-23-6265-3650 Email zhaoxin@cque.edu.cn epub: 2020-8-8collection: 202013743751received: 2020-5-29accepted: 2020-7-21(C)"/>
   <result pre="from certain underlying diseases. In 2002, SARS-CoV appeared in southern" exact="China" post="before spreading to the rest of the world. Ultimately,"/>
   <result pre="with a mortality rate of 9.56%.41 MERS-CoV first appeared in" exact="Saudi Arabia" post="in 2012, causing epidemics in the Middle East. Subsequently,"/>
   <result pre="conditions for viral and bacterial outbreaks in human societies. Therefore," exact="China" post="has revised the Wild Animal Conservation Law and adjusted"/>
   <result pre="a number of coronavirus outbreaks in many counties, such as" exact="Germany" post="and America. Processing facilities and equipment need to be"/>
   <result pre="and the role of rapid diagnostic tests: a prospective study." exact="Hong Kong" post="Med J. 2012;18:22â€&quot;24.22311356 6.Pneumonia caused by the novel coronavirus"/>
   <result pre="of infectious disease statutory. National Health Commission of the Peopleâ€™s" exact="Republic of" post="China; 120, 2020Available from:http://www.nhc.gov.cn/jkj/s7915/202001/e4e2d5e6f01147e0a8df3f6701d49f33.shtml. Accessed 724, 2020. 7.LeeP, HsuehP."/>
   <result pre="of three camel coronavirus species and recombination of MERS-CoVs in" exact="Saudi Arabia." post="Science. 2016;351:81â€&quot;84. doi:10.1126/science.aac860826678874 60.Standardization Administration.GB 14881-2013 National Standard for"/>
   <result pre="Standard for Food Safety: General Hygienic Standard for Food Production." exact="China" post="standard press; 2014."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7416109\results\search\country\results.xml">
   <result pre="ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh," exact="India" post="pmc-release: 2020-8-8ppub: 2020epub: 2020-8-837101844101844received: 2020-6-30rev-recd: 2020-7-27accepted: 2020-8-4(C) Elsevier Ltd,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7416802\results\search\country\results.xml">
   <result pre="of pre-existing medical conditions [1]. The SARS outbreak severely affected" exact="China" post="and neighboring countries, with a fatality rate of about"/>
   <result pre="and industries such as the European Innovative Medicines Project [17]," exact="the US" post="Critical Path Program to upgrade advancement of drug development"/>
   <result pre="improve candidate vaccines [11, 22, 38, 39]. The government of" exact="Canada" post="is contributing a grant of CA $192 million for"/>
   <result pre="a patient infected with SARS-CoV-2 with remdesivir was reported in" exact="the US," post="where the drug was administered to the patient a"/>
   <result pre="of three out of twelve COVID-19 patients with remdesivir in" exact="the US" post="was carried out under the protocol for compassionate use"/>
   <result pre="efficacy. At present, there are four ongoing clinical trials in" exact="the US" post="that are enlisting patients for potential treatments. Two clinical"/>
   <result pre="for potential treatments. Two clinical trials have been commenced in" exact="China" post="for the evaluation of remdesivir against COVID-19. The criteria"/>
   <result pre="and cardiovascular toxicity have restricted their use in countries like" exact="the USA." post="As a substitute, another drug called hydroxychloroquine is being"/>
   <result pre="administration of both chloroquine and hydroxychloroquine, initial studies conducted in" exact="China" post="have been hopeful in elucidating the encouraging that both"/>
   <result pre="side effects, but no trials are currently being done in" exact="the United States." post="In the future, there will be more information about"/>
   <result pre="effects, but no trials are currently being done in the" exact="United States." post="In the future, there will be more information about"/>
   <result pre="Treatment Guide from the National Health Commission of the Peopleâ€™s" exact="Republic of" post="China, where the authors state, â€œBased on respiratory distress"/>
   <result pre="storming Not registered yet Umifenovir Antiviral/used against influenza Inhibits fusion" exact="China" post="Baricitinib Treats rheumatoid arthritis A Janus kinase family (JAK)"/>
   <result pre="endothelial growth factor associated with endothelial receptors Flt-1 and KDR" exact="China" post="Brilacidin Antibiotic A host defense peptide mimetic USA Convalescent"/>
   <result pre="monoclonal antibody Anti-IL6R Not registered yet XueBiJing Anti-pneumonia Treats sepsis" exact="China" post="Fig. 3 Therapeutic targets of various pharmacological agents against"/>
   <result pre="Eastern countries, followed by a second wave of infection in" exact="South Korea." post="In both of these viral outbreaks, high mortality and"/>
   <result pre="potential as an effective treatment option. A study conducted in" exact="Hong Kong" post="investigated the effect of treatment with convalescent sera on"/>
   <result pre="convalescent serum therapy for the treatment of infected patients in" exact="China" post="[157], which shed light on its effectivity and safety"/>
   <result pre="Press, London, Waltham 4.LauEHHsiungCACowlingBJChenC-HHoL-MTsangTChangC-WDonnellyCALeungGMA comparative epidemiologic analysis of SARS in" exact="Hong Kong," post="Beijing and TaiwanBMC Infect Dis20101015020205928 5.SextonNRSmithECBlancHVignuzziMPeersenOBDenisonMRHomology-based identification of a"/>
   <result pre="megatrial of the four most promising coronavirus treatmentsScience202010.1126/science.abb849732732400 44.Government of" exact="Canada" post="funds 49 additional COVID-19 research projectsâ€&quot;details of the funded"/>
   <result pre="Dis2017215217117428073857 89.First 12 patients with coronavirus disease 2019 (COVID-19) in" exact="the United States." post="https://www.medrxiv.org/content/10.1101/2020.03.09.20032896v1.full.pdf. Retrieved 14 Mar 2020 90.ColsonPRolainJ-MLagierJ-CBrouquiPRaoultDChloroquine and hydroxychloroquine as"/>
   <result pre="89.First 12 patients with coronavirus disease 2019 (COVID-19) in the" exact="United States." post="https://www.medrxiv.org/content/10.1101/2020.03.09.20032896v1.full.pdf. Retrieved 14 Mar 2020 90.ColsonPRolainJ-MLagierJ-CBrouquiPRaoultDChloroquine and hydroxychloroquine as"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospitalJ Antimicrob Chemother200556591992216183666 152.KoJ-HSeokHChoSYHaYEBaekJYKimSHKimY-JParkJKChungCRKangE-SChallenges of convalescent plasma infusion therapy"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7417167\results\search\country\results.xml">
   <result pre="(COVID-19), was first officially reported in Wuhan, Hubei Province, in" exact="China" post="on December 31, 2019 (1). Spreading rapidly, COVID-19 has"/>
   <result pre="common. One case series of 146 hospitalized COVID-19 patients in" exact="China" post="reported a cardiac injury incidence of 20% and a"/>
   <result pre="with laboratory-confirmed Middle Eastern respiratory syndrome coronavirus in 2014 in" exact="Saudi Arabia," post="cardiac arrhythmias including tachyarrhythmias and severe bradyarrhythmia requiring temporary"/>
   <result pre="patients. The data on arrhythmia characterization in COVID-19 patients in" exact="the United States" post="are now emerging. In a retrospective case series involving"/>
   <result pre="The data on arrhythmia characterization in COVID-19 patients in the" exact="United States" post="are now emerging. In a retrospective case series involving"/>
   <result pre="IHR emergency committee for the COVID-19 outbreakEpidemiology and Health422020e2020013 2COVID-19" exact="United States" post="cases by county. Johns Hopkins Coronavirus Resource CenterAvailable at:https://coronavirus.jhu.edu/us-map"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7418792\results\search\country\results.xml">
   <result pre="Middle East respiratory syndrome coronavirus (MERS-CoV) caused an outbreak in" exact="Saudi Arabia," post="which affected both camels and humans, with a high"/>
   <result pre="links between the majority of COVID-19 cases and Huanan South" exact="China" post="Seafood Market, a live-animal market, have been reported. A"/>
   <result pre="recovered. Notably, 75,447 of the confirmed cases were reported in" exact="China" post="[12]. The size of the ssRNA genome of SARS-CoV-2"/>
   <result pre="selection: viral strategies of immune function impairmentProc. Natl. Acad. Sci." exact="U. S." post="A.9119948062806610.1073/pnas.91.17.80628058757 26DayT.GandonS.LionS.OttoS.P.On the evolutionary epidemiology of SARS-CoV-2Curr. Biol.202010.1016/j.cub.2020.06.031 27HolmesE.C.The"/>
   <result pre="mediate antibody-independent acquired immunity to pneumococcal colonizationProc. Natl. Acad. Sci." exact="U. S." post="A.10220054848485310.1073/pnas.050125410215781870 30LipsitchM.Oâ€™HaganJ.J.Patterns of antigenic diversity and the mechanisms that"/>
   <result pre="Acids Res.362008W7010.1093/nar/gkn18818424795 49KostakiE.-G.KaramitrosT.BobkovaM.OikonomopoulouM.MagiorkinisG.GarciaF.HatzakisA.ParaskevisD.Spatiotemporal characteristics of the HIV-1 CRF02_AG/CRF63_02A1 epidemic in" exact="Russia" post="and Central AsiaAIDS Res. Hum. Retroviruses34201841542029455562 50CooperD.N.GroupN.P.Nature Encyclopedia of"/>
   <result pre="56BalA.DestrasG.GaymardA.Bouscambert-DuchampM.ValetteM.EscuretV.FrobertE.BillaudG.Trouillet-AssantS.CheynetV.Brengel-PesceK.MorfinF.LinaB.JossetL.Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in" exact="France" post="reveals an amino acid deletion in nsp2 (Asp268del)Clin. Microbiol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7419580\results\search\country\results.xml">
   <result pre="Kingdom Edited by: Rodolfo GarcÃ­a-Contreras, National Autonomous University of Mexico," exact="Mexico" post="Reviewed by: Michael Bachman, University of Michigan, United States;"/>
   <result pre="of Mexico, Mexico Reviewed by: Michael Bachman, University of Michigan," exact="United States;" post="Srijon Kaushik Banerjee, University of Arkansas for Medical Sciences,"/>
   <result pre="States; Srijon Kaushik Banerjee, University of Arkansas for Medical Sciences," exact="United States;" post="Yael GonzÃ¡lez Tinoco, Center for Scientific Research and Higher"/>
   <result pre="Center for Scientific Research and Higher Education in Ensenada (CICESE)," exact="Mexico" post="*Correspondence: Sebastian Leptihn Leptihn@intl.zju.edu.cn This article was submitted to"/>
   <result pre="Syndrome-related Coronavirus (SARS) Co-V, was first report in Guangdong Province," exact="China" post="in November 2002. At its initial outbreak (until August"/>
   <result pre="respiratory syndrome (MERS) CoV epidemic occurred in June 2012 in" exact="Saudi Arabia" post="with later outbreaks observed in 2015 and 2018. To"/>
   <result pre="323:1061â€&quot;9. 10.1001/jama.2020.158532031570 29.HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHet al.First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med. (2020) 382:929â€&quot;36. 10.1056/NEJMoa200119132004427 30.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical"/>
   <result pre="10.1001/jama.2020.158532031570 29.HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHet al.First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med. (2020) 382:929â€&quot;36. 10.1056/NEJMoa200119132004427 30.GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical"/>
   <result pre="10.1016/j.ijid.2020.03.07032289565 40.RichardsMJEdwardsJRCulverDHGaynesRP. Nosocomial infections in medical intensive care units in" exact="the United States." post="Crit Care Med. (1999) 27:887â€&quot;92. 10.1097/00003246-199905000-0002010362409 41.collab: World Health"/>
   <result pre="40.RichardsMJEdwardsJRCulverDHGaynesRP. Nosocomial infections in medical intensive care units in the" exact="United States." post="Crit Care Med. (1999) 27:887â€&quot;92. 10.1097/00003246-199905000-0002010362409 41.collab: World Health"/>
   <result pre="al.. A major outbreak of severe acute respiratory syndrome in" exact="Hong Kong." post="N Engl J Med. (2003) 348:1986â€&quot;94. 10.1056/NEJMoa03068512682352 48.TsangKWHoPLOoiGCYeeWKWangTChan-YeungMet al.."/>
   <result pre="A cluster of cases of severe acute respiratory syndrome in" exact="Hong Kong." post="N Engl J Med. (2003) 348:1977â€&quot;85. 10.1056/NEJMoa03066612671062 49.PeirisJSChuCMChengVCChanKSHungIFPoonLLet al.."/>
   <result pre="early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou," exact="PR China." post="J Med Microbiol. (2003) 52:715â€&quot;20. 10.1099/jmm.0.05320-012867568 51.WangJTShengWHFangCTChenYCWangJLYuCJet al.. Clinical"/>
   <result pre="middle east respiratory syndrome coronavirus infection: a single-center experience in" exact="Saudi Arabia." post="Int J Infect Dis. (2014) 29:301â€&quot;6. 10.1016/j.ijid.2014.09.00325303830 58.AssiriAAl-TawfiqJAAl-RabeeahAAAl-RabiahFAAl-HajjarSAl-BarrakAet al.."/>
   <result pre="A (H1N1): pathology and pathogenesis of 100 fatal cases in" exact="the United States." post="Am J Pathol. (2010) 177:166â€&quot;75.20508031 71.NakajimaNSatoYKatanoHHasegawaHKumasakaTHataSet al.. Histopathological and"/>
   <result pre="(H1N1): pathology and pathogenesis of 100 fatal cases in the" exact="United States." post="Am J Pathol. (2010) 177:166â€&quot;75.20508031 71.NakajimaNSatoYKatanoHHasegawaHKumasakaTHataSet al.. Histopathological and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7423503\results\search\country\results.xml">
   <result pre="heart failure [70]. According to the National Health Commission of" exact="China" post="(NHC), 58% of COVID-19 patients with dire symptoms had"/>
   <result pre="a group of hospitalized patients. This percentage was 5% in" exact="China" post="and 3.7% with Dutch COVID-19 patients [75]. The risk"/>
   <result pre="The virus has been associated with 5 GBS cases in" exact="Italy" post="and 2 GBS cases in Wuhan [75]. In addition"/>
   <result pre="Health Officials imposed new safety measures for the citizens of" exact="Spain" post="[78]. These measures included avoiding public gatherings in closed"/>
   <result pre="in an eerily similar fashion. The virus originated in Wuhan," exact="China" post="with the first case documented in December 2019. After"/>
   <result pre="controlling disease outbreaks. This practice was commonly employed in fourteenth-century" exact="Italy" post="when ships coming from a plague-infected port arrived at"/>
   <result pre="coming from a plague-infected port arrived at a port in" exact="Italy" post="[79]. The ships were required to anchor and wait"/>
   <result pre="returned from a country with high COVID-19 rates such as" exact="China" post="were subjected to a mandatory 2-week quarantine. Some countries"/>
   <result pre="exposed, infectious, and recovered state [80]. Preventive measures taken in" exact="China" post="such as travel bans, home quarantine, and extended vacations"/>
   <result pre="pneumonia. In a study of patients using the drug in" exact="the United States," post="70% of patients had improvement in regards to oxygen"/>
   <result pre="In a study of patients using the drug in the" exact="United States," post="70% of patients had improvement in regards to oxygen"/>
   <result pre="mechanical ventilation [89]. Currently, there are four clinical trials in" exact="the United States," post="and two additional trials in China registered on ClinicalTrials.gov"/>
   <result pre="ventilation [89]. Currently, there are four clinical trials in the" exact="United States," post="and two additional trials in China registered on ClinicalTrials.gov"/>
   <result pre="trials in the United States, and two additional trials in" exact="China" post="registered on ClinicalTrials.gov [88]. Remdesivir serves as a promising"/>
   <result pre="of convalescent plasma for COVID-19. Small clinical studies conducted in" exact="the US" post="and East Asian countries have displayed an increase in"/>
   <result pre="of the immune system [102]. In another clinical study in" exact="South Korea," post="two patients received convalescent plasma treatment. Similar to the"/>
   <result pre="are no approved MSC-based treatments or therapies. Preliminary results from" exact="the US" post="and China demonstrate improved immune function without adverse events"/>
   <result pre="MSC-based treatments or therapies. Preliminary results from the US and" exact="China" post="demonstrate improved immune function without adverse events in COVID-19"/>
   <result pre="lives of the vast majority of the human population. Despite" exact="the US" post="leading the world at 2.1Â million confirmed cases and"/>
   <result pre="have begun reopening in response to an economic crisis [1]." exact="Georgia" post="was the first state to begin reopening businesses on"/>
   <result pre="the spike proteinProceedings of the National Academy of Sciences of" exact="the United States" post="of America201411142152141521925288733 19.BelouzardSChuVCWhittakerGRActivation of the SARS coronavirus spike protein"/>
   <result pre="spike proteinProceedings of the National Academy of Sciences of the" exact="United States" post="of America201411142152141521925288733 19.BelouzardSChuVCWhittakerGRActivation of the SARS coronavirus spike protein"/>
   <result pre="two distinct sitesProceedings of the National Academy of Sciences of" exact="the United States" post="of America2009106145871587619321428 20.HeurichAHofmann-WinklerHGiererSLiepoldTJahnOPohlmannSTMPRSS2 and ADAM17 cleave ACE2 differentially and"/>
   <result pre="distinct sitesProceedings of the National Academy of Sciences of the" exact="United States" post="of America2009106145871587619321428 20.HeurichAHofmann-WinklerHGiererSLiepoldTJahnOPohlmannSTMPRSS2 and ADAM17 cleave ACE2 differentially and"/>
   <result pre="Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease," exact="United States." post="Emerging Infectious Disease Journal, 26(9). Advance online publication. 39.Guan,"/>
   <result pre="COVID-19 patients. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 117(17), 9490-6. 103.ShenCWangZZhaoFm YangYLiJYuanJWangFLiDYangMXingLWeiJXiaoHYangYJiuxinQQingLChenLXuZPengLLioYZhengHChenFHuangKJiangYLiuDZhangZLiuYLiuLTreatment of 5 critically"/>
   <result pre="patients. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="117(17), 9490-6. 103.ShenCWangZZhaoFm YangYLiJYuanJWangFLiDYangMXingLWeiJXiaoHYangYJiuxinQQingLChenLXuZPengLLioYZhengHChenFHuangKJiangYLiuDZhangZLiuYLiuLTreatment of 5 critically ill patients"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7423511\results\search\country\results.xml">
   <result pre="should be prioritised. This model has been tested in the" exact="United Kingdom" post="with reported success (GenomicsEngland, 2017). Biomedical research challenges impeding"/>
   <result pre="heterogeneous, with wide differences between most sub-Saharan African countries and" exact="South Africa," post="for example. Moreover, research activities are little coordinated across"/>
   <result pre="deposition in open access repositories: The Medical Research Council Unit," exact="The Gambia" post="at London School of Hygiene and Tropical Medicine (MRCG-LSHTM);"/>
   <result pre="in open access repositories: The Medical Research Council Unit, The" exact="Gambia" post="at London School of Hygiene and Tropical Medicine (MRCG-LSHTM);"/>
   <result pre="a large number of public, private and commercial platforms in" exact="South Africa." post="These institutions, supported by funders, are investing significantly in"/>
   <result pre="09 July 2020] AriasA.WatsonS.J.AsogunD.TobinE.A.LuJ.PhanM.V.T.Rapid outbreak sequencing of Ebola virus in" exact="Sierra Leone" post="identifies transmission chains linked to sporadic casesVirus Evol212016110 DevexStrengthening"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7424135\results\search\country\results.xml">
   <result pre="about 10% case fatality rate (CFR) was initially witnessed from" exact="China" post="in 2002, while Middle East respiratory syndrome coronavirus (MERS-CoV)"/>
   <result pre="(MERS-CoV) infection with about 34.4% CFR was originally detailed from" exact="Saudi Arabia" post="in June 2012 [2]. This third outbreak coronavirus disease"/>
   <result pre="previous epidemics, which has spread from a marketplace in Wuhan," exact="China" post="in December 2019 to more than 213 countries and"/>
   <result pre="including full genome sequencing of strains from China, Japan, USA," exact="Finland" post="and Korea showed more than 99.9% sequence homology [12,"/>
   <result pre="respectively [12]. One study on the sequences of SARS-CoV-2 from" exact="India" post="illustrated high (~â€‰99.98%) identity with Wuhan seafood market pneumonia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7425093\results\search\country\results.xml">
   <result pre="Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran," exact="Iran" post="Tel/Fax +982126109931 Email tayebehfarhadi@yahoo.com epub: 2020-8-8collection: 20201432153222received: 2020-5-05accepted: 2020-7-17(C)"/>
   <result pre="pharmacokinetics of remdesivir have been summarized in documentation published by" exact="the US" post="Food and Drug Administration (FDA). The FDA has issued"/>
   <result pre="Different Viruses Remdesivir (GS-5734) was developed by Gilead Sciences. Gilead," exact="the US" post="Centers for Disease Control and Prevention (CDC) and the"/>
   <result pre="the US Centers for Disease Control and Prevention (CDC) and" exact="the US" post="Army Medical Research Institute of Infectious Diseases (USAMRIID) collaborated"/>
   <result pre="observed.24 In a controlled, randomized clinical trial conducted in the" exact="Democratic Republic of Congo," post="175 patients were randomly treated with remdesivir for Ebola."/>
   <result pre="In a controlled, randomized clinical trial conducted in the Democratic" exact="Republic of" post="Congo, 175 patients were randomly treated with remdesivir for"/>
   <result pre="new medical research on the first 12 COVID-19 patients in" exact="the USA;" post="however, authors indicated that the study has yet to"/>
   <result pre="trial in adult patients with COVID-19 at ten hospitals in" exact="China" post="(ClinicalTrials.gov number: NCT04257656). The 237 patients were randomly divided"/>
   <result pre="A double-blinded, placebo-controlled trial (ClinicalTrials.gov identifier: NCT04280705) is underway in" exact="the USA" post="in which patients are randomly divided into two placebo"/>
   <result pre="discharged by day 11.38 Two double-blinded, placebo-controlled trials recruiting in" exact="China" post="were designed to evaluate the efficacy and safety of"/>
   <result pre="of remdesivir in hospitalized adult patients with severe COVID-19 Terminated" exact="China" post="April 10, 2020 NCT04365725 A multicenter, retrospective study of"/>
   <result pre="of remdesivir in the treatment of severe COVID-19 infections Recruiting" exact="France" post="June 2020 NCT04302766 An intermediate-size patient population expanded access"/>
   <result pre="in hospitalized adult patients with mild and moderate COVID-19 Suspended" exact="China" post="April 27, 2020 NCT04323761 Expanded access treatment protocol: remdesivir"/>
   <result pre="the Public Health Emergency SOLIDARITY Trial (World Health Organization) Recruiting" exact="Canada" post="May 18, 2022 Up Going Steps Initial findings of"/>
   <result pre="(WHO) has welcomed the initial clinical trial results from the" exact="United Kingdom" post="that showed dexamethasone could reduce mortality by one-third in"/>
   <result pre="LindquistS, et al. First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med. 2020;382(10):929â€&quot;936. doi:10.1056/NEJMoa200119132004427 28.collab: The COVID-19"/>
   <result pre="et al. First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med. 2020;382(10):929â€&quot;936. doi:10.1056/NEJMoa200119132004427 28.collab: The COVID-19"/>
   <result pre="Team. First 12 Patients with Coronavirus Disease 2019 (COVID-19) in" exact="the United States." post="Preprint; 2020. 29.GreinJ, OhmagariN, ShinD, et al. Compassionate use"/>
   <result pre="First 12 Patients with Coronavirus Disease 2019 (COVID-19) in the" exact="United States." post="Preprint; 2020. 29.GreinJ, OhmagariN, ShinD, et al. Compassionate use"/>
   <result pre="al. First 12 Patients with Coronavirus Disease 2019 (COVID-19) in" exact="the United States." post="medRxiv; 2020. 31.LescureFX, BouadmaL, NguyenD, et al. Clinical and"/>
   <result pre="First 12 Patients with Coronavirus Disease 2019 (COVID-19) in the" exact="United States." post="medRxiv; 2020. 31.LescureFX, BouadmaL, NguyenD, et al. Clinical and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7425942\results\search\country\results.xml">
   <result pre="infections : People and places : Geographical locations : Asia:" exact="Hong Kong" post=": Biology and Life Sciences : Immunology : Vaccination"/>
   <result pre="acquired infections and treatment interventions on heterosexual HIV transmission in" exact="Hong Kong" post="Heterosexual HIV transmission WongNgai SzeConceptualizationFormal analysisMethodologyWriting â€&quot; original draft123LeeMan"/>
   <result pre="Ho Centre for Emerging Infectious Diseases, The Chinese University of" exact="Hong Kong," post="Shatin, Hong Kong, Peopleâ€™s Republic of China[2], Institute for"/>
   <result pre="Emerging Infectious Diseases, The Chinese University of Hong Kong, Shatin," exact="Hong Kong," post="Peopleâ€™s Republic of China[2], Institute for Global Health &amp;amp;"/>
   <result pre="The Chinese University of Hong Kong, Shatin, Hong Kong, Peopleâ€™s" exact="Republic of" post="China[2], Institute for Global Health &amp;amp; Infectious Diseases, University"/>
   <result pre="University of North Carolina at Chapel Hill, Chapel Hill, NC," exact="United States" post="of America[3], University of North Carolina Project-China, Guangzhou, Guangdong,"/>
   <result pre="Guangzhou, Guangdong, China[4], Department of Medicine, Queen Elizabeth Hospital, Kowloon," exact="Hong Kong," post="Peopleâ€™s Republic of China[5], Special Preventive Programme, Department of"/>
   <result pre="Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong, Peopleâ€™s" exact="Republic of" post="China[5], Special Preventive Programme, Department of Health, Hong Kong"/>
   <result pre="Peopleâ€™s Republic of China[5], Special Preventive Programme, Department of Health," exact="Hong Kong" post="Special Administrative Region Government, Hong Kong, Peopleâ€™s Republic of"/>
   <result pre="Programme, Department of Health, Hong Kong Special Administrative Region Government," exact="Hong Kong," post="Peopleâ€™s Republic of China[6], Department of Medicine and Geriatrics,"/>
   <result pre="Health, Hong Kong Special Administrative Region Government, Hong Kong, Peopleâ€™s" exact="Republic of" post="China[6], Department of Medicine and Geriatrics, Princess Margaret Hospital,"/>
   <result pre="of Medicine and Geriatrics, Princess Margaret Hospital, Lai King, Kowloon," exact="Hong Kong," post="Peopleâ€™s Republic of ChinaDoddPeter J.Editor[], University of Sheffield, UNITED"/>
   <result pre="Geriatrics, Princess Margaret Hospital, Lai King, Kowloon, Hong Kong, Peopleâ€™s" exact="Republic of" post="ChinaDoddPeter J.Editor[], University of Sheffield, UNITED KINGDOM Competing Interests:"/>
   <result pre="HIV transmissions, parameterized by clinical and surveillance data (1984â€&quot;2014) in" exact="Hong Kong." post="HIV sequence data were included for examining genetic linkages"/>
   <result pre="1451 male) diagnosed with HIV between 1984 and 2012 in" exact="Hong Kong" post="were collected for model parameterization. Among 1229 sequences of"/>
   <result pre="grant approved by the Council for the AIDS Trust Fund," exact="Hong Kong" post="Special Administrative Region Government (project code: MSS229R to SSL"/>
   <result pre="the impact of which varied by local context. [14â€&quot;16] In" exact="Hong Kong," post="an international city in Asia, the heterosexual HIV epidemic"/>
   <result pre="all three HIV specialist clinics in the public service in" exact="Hong Kong." post="[18] In addition, HIV-1 genotype resistance testing sequences in"/>
   <result pre="obtained. Data access approval was granted by Department of Health," exact="Hong Kong" post="Special Administrative Region Government in compliance with the Personal"/>
   <result pre="number of HIV-infected heterosexual male and female in 1984â€&quot;2012 in" exact="Hong Kong" post="under negative log likelihood in R (stats4 package) using"/>
   <result pre="defined non-locally acquired infections as HIV transmissions occurring either outside" exact="Hong Kong," post="or from a non-local HIV positive individual within the"/>
   <result pre="acquired HIV infection was assumed to be physically present in" exact="Hong Kong" post="during acute infection, on the premise that he/she was"/>
   <result pre="were infected beyond the period of acute infection before entering" exact="Hong Kong." post="Annual surveillance reports [17] published by the Department of"/>
   <result pre="intervention scenarios. Results Characteristics of heterosexually acquired HIV infections in" exact="Hong Kong" post="Between 1984 and 2012, 2174 (48%) of 4508 patients"/>
   <result pre="heterosexually acquired HIV infections diagnosed between 1984 and 2014 in" exact="Hong Kong" post="(n = 2174). Female Male n % N n"/>
   <result pre="explanation for interpreting the epidemiology of heterosexual HIV infections in" exact="Hong Kong." post="Concurrent partnership aside, non-locally acquired infection was of notable"/>
   <result pre="retention in care has been highlighted in a study in" exact="South Africa" post="[25] and the United States [30]. Our modelling results"/>
   <result pre="been highlighted in a study in South Africa [25] and" exact="the United States" post="[30]. Our modelling results suggested that enhancing retention in"/>
   <result pre="highlighted in a study in South Africa [25] and the" exact="United States" post="[30]. Our modelling results suggested that enhancing retention in"/>
   <result pre="concluded in other studies, [23, 31] a test-and-treat strategy in" exact="Hong Kong" post="is not anticipated to achieve such significant outcome. The"/>
   <result pre="current high treatment coverage and high proportion of SVL in" exact="Hong Kong," post="leaving limited rooms of improvement. [18] In addition, a"/>
   <result pre="5% of MSM [unpublished data]. In places like neighbouring Mainland" exact="China" post="where some 26% of MSM were bisexual, [33] their"/>
   <result pre="not separating overseas infections and those from non-local people in" exact="Hong Kong" post="was constrained by data availability. The transmission hazard for"/>
   <result pre="most beneficial for controlling the heterosexual spread of HIV in" exact="Hong Kong." post="Such approach would also be most feasible for introduction"/>
   <result pre="be most useful. Finally, while our models were designed for" exact="Hong Kong," post="we believe that the methods and results are applicable"/>
   <result pre="Centre for Emerging Infectious Diseases of The Chinese University of" exact="Hong Kong" post="are acknowledged for providing technical support in conducting the"/>
   <result pre="not necessarily reflect those of the Centre for Health Protection," exact="Hong Kong" post="Special Administrative Region Government Department of Health, or other"/>
   <result pre="4Brown T. HIV/AIDS in Hong Kong: Living on the edge." exact="Hong Kong;" post="2006. 5LiuL, LuanR, YangW, ZhangL, ZhangJ, NanL, et al.Projecting"/>
   <result pre="10.1093/infdis/jis40122711905 17Department of Health HKSAR. HIV surveillance reportâ€&quot; 2014 update." exact="Hong Kong" post="December 2015. 18WongNS, WongKH, WongPKH, LeeSS. Incorporation of estimated"/>
   <result pre="men who have sex with men and heterosexual men in" exact="Hong Kong." post="Asia Pac J Public Health. 2015;27:756â€&quot;64. 10.1177/101053951558934026041836 19WongNS, KwanTH,"/>
   <result pre="LurieMN, BÃ¤rnighausenT, BakkerR, BaltussenR, TanserF, et al.Elimination of HIV in" exact="South Africa" post="through expanded access to antiretroviral therapy: a model comparison"/>
   <result pre="virus transmission at each step of the care continuum in" exact="the United States." post="JAMA Intern Med. 2015;175:588â€&quot;96. 10.1001/jamainternmed.2014.818025706928 31GranichRM, GilksCF, DyeC, De"/>
   <result pre="transmission at each step of the care continuum in the" exact="United States." post="JAMA Intern Med. 2015;175:588â€&quot;96. 10.1001/jamainternmed.2014.818025706928 31GranichRM, GilksCF, DyeC, De"/>
   <result pre="WilsonDP, ZhangL. What is the potential for bisexual men in" exact="China" post="to act as a bridge of HIV transmission to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426275\results\search\country\results.xml">
   <result pre="outbreaks of yellow fever frequently occur in Africa and South" exact="America" post="with significant mortality, highlighting the pressing need for antiviral"/>
   <result pre="dissemination. In 2016, there were urban yellow fever outbreaks in" exact="Angola" post="and Democratic Republic of Congo, which resulted in vaccine"/>
   <result pre="2016, there were urban yellow fever outbreaks in Angola and" exact="Democratic Republic of Congo," post="which resulted in vaccine shortage and emergent vaccination campaigns"/>
   <result pre="there were urban yellow fever outbreaks in Angola and Democratic" exact="Republic of" post="Congo, which resulted in vaccine shortage and emergent vaccination"/>
   <result pre="turnover in vivo by using click chemistryProc. Natl. Acad. Sci." exact="U. S." post="A.1052008157791578418840688 JulanderJ.G.Experimental therapies for yellow feverAntivir. Res.97201316917923237991 KlittingR.FischerC.DrexlerJ.F.GouldE.A.RoizD.PaupyC.de LamballerieX.What"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426442\results\search\country\results.xml">
   <result pre="Edited by: Alexis M. Kalergis, Pontificia Universidad CatÃ³lica de Chile," exact="Chile" post="Reviewed by: Nilu Goonetilleke, University of North Carolina at"/>
   <result pre="by: Nilu Goonetilleke, University of North Carolina at Chapel Hill," exact="United States;" post="Perla Mariana Del Rio Estrada, Instituto Nacional de Enfermedades"/>
   <result pre="Mexico; Rachel Graham, University of North Carolina at Chapel Hill," exact="United States" post="*Correspondence: Samit Chattopadhyay samitc@goa.bits-pilani.ac.in; samitchatterji@yahoo.com This article was submitted"/>
   <result pre="3, 2020, revealed that the 48 children were admitted in" exact="the USA" post="whereas no COVID-19 cases were reported in Canadian PICUs."/>
   <result pre="effective in treating the first known patient of COVID-19 in" exact="the USA" post="(152). A randomized double-blinded clinical trial on 1,059 adult"/>
   <result pre="a randomized clinical trial (NCT04308668) involving 821 asymptomatic individuals across" exact="the US" post="and Canada who had come into close contact with"/>
   <result pre="trial (NCT04308668) involving 821 asymptomatic individuals across the US and" exact="Canada" post="who had come into close contact with potential COVID-19"/>
   <result pre="along with drugs and oxygen support (168). A report from" exact="Hong Kong" post="suggested that this therapy had poor outcome in SARS"/>
   <result pre="agent is warranted in plasma transfusion. Recently, the FDA in" exact="the USA" post="has approved trials of convalescent plasma therapy in COVID-19"/>
   <result pre="coronavirus infection and its role in the pathogenesis of SARS." exact="Hong Kong" post="Med J. (2016) 22:25â€&quot;31. 27390007 69.WanYShangJSunSTaiWChenJGengQet al.. Molecular mechanism"/>
   <result pre="in the hospital with the highest nosocomial infection rate in" exact="Taiwan" post="in 2003. J Clin Microbiol. (2006) 44:359â€&quot;65. 10.1128/JCM.44.2.359-365.200616455884 74.WangSFChenKHChenMLiWYChenYJTsaoCHet"/>
   <result pre="fatal case of middle east respiratory syndrome coronavirus infection in" exact="the United Arab Emirates," post="April 2014. Am J Pathol. (2016) 186:652â€&quot;8. 10.1016/j.ajpath.2015.10.02426857507 93.KongSLChuiPLimBSalto-TellezM."/>
   <result pre="case of middle east respiratory syndrome coronavirus infection in the" exact="United Arab Emirates," post="April 2014. Am J Pathol. (2016) 186:652â€&quot;8. 10.1016/j.ajpath.2015.10.02426857507 93.KongSLChuiPLimBSalto-TellezM."/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N Engl J Med. (2012) 367:1814â€&quot;20. 10.1056/NEJMoa121172123075143 106.YangYZhangLGengHDengYHuangBGuoYet al.."/>
   <result pre="11:1â€&quot;7. 10.1126/scitranslmed.aau924231142680 152.HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHet al.First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med. (2020) 382:929â€&quot;36. 10.1056/NEJMoa200119132004427 153.BeigelJHTomashekKMDoddLEMehtaAKZingmanBSKalilACet al.Remdesivir"/>
   <result pre="10.1126/scitranslmed.aau924231142680 152.HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHet al.First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med. (2020) 382:929â€&quot;36. 10.1056/NEJMoa200119132004427 153.BeigelJHTomashekKMDoddLEMehtaAKZingmanBSKalilACet al.Remdesivir"/>
   <result pre="al.. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection," exact="Saudi Arabia." post="Emerg Infect Dis. (2016) 22:1554â€&quot;61. 10.3201/eid2209.15116427532807 165.ZhouBZhongNGuanY. Treatment with"/>
   <result pre="al.. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur J Clin Microbiol Infect Dis. (2005) 24:44â€&quot;6. 10.1007/s10096-004-1271-915616839"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426546\results\search\country\results.xml">
   <result pre="more than 11,000 people in West Africa, and warned that" exact="the USA" post="and other countries were not ready for the future"/>
   <result pre="influenza virus outbreaks, the most recent of which emerged in" exact="Mexico" post="in 2009.2 Little attention was paid to coronaviruses, which"/>
   <result pre="when the severe acute respiratory syndrome (SARS) disease emerged in" exact="China" post="in 2002,3â€&quot;5 and later when the Middle East respiratory"/>
   <result pre="later when the Middle East respiratory syndrome (MERS) appeared in" exact="Saudi Arabia" post="in 2012.6,7 These outbreaks attracted some research interest to"/>
   <result pre="Infect Dis Med Microbiol200617330610.1155/2006/15261218382647 30TaoYShiMChommanardCet al.Surveillance of bat coronaviruses in" exact="Kenya" post="identifies relatives of human coronaviruses NL63 and 229E and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426550\results\search\country\results.xml">
   <result pre="intermediate host. Pangolins are mammals covered by keratin scales. In" exact="China" post="the pangolin is seen as an edible animal mainly,"/>
   <result pre="coronavirus disease 2019; HCoV-229E, human coronavirus 229E; HCoV-NL63, human coronavirus" exact="Netherlands" post="63; HCoV-OC43, human coronavirus OC43; HCoV-HKU1, human coronavirus Hong"/>
   <result pre="coronavirus Netherlands 63; HCoV-OC43, human coronavirus OC43; HCoV-HKU1, human coronavirus" exact="Hong Kong" post="U1; MERS, Middle East respiratory syndrome; MERS-CoV, Middle East"/>
   <result pre="coronavirus disease 2019; HCoV-229E, human coronavirus 229E; HCoV-HKU1, human coronavirus" exact="Hong Kong" post="U1; HCoV-NL63, human coronavirus Netherlands 63; HCoV-OC43, human coronavirus"/>
   <result pre="229E; HCoV-HKU1, human coronavirus Hong Kong U1; HCoV-NL63, human coronavirus" exact="Netherlands" post="63; HCoV-OC43, human coronavirus OC43; MERS-CoV, Middle East respiratory"/>
   <result pre="Influenza H1N1 40â€&quot;50M 1957â€&quot;1958 Asian flu Influenza H2N2 1.1M 1968â€&quot;1970" exact="Hong Kong" post="flu Influenza H3N2 1M 1981â€&quot;present AIDS HIV (RNA virus)"/>
   <result pre="â€ Never used in humans. Two million doses stockpiled in" exact="the US," post="in case of bioterror attack. â€¡Other effective antibiotics available."/>
   <result pre="to smallpox, several well preserved mummies have been found in" exact="Egypt" post="and other countries. Some mummies, such as that of"/>
   <result pre="considering importation of the first COVID-19 cases to the Western" exact="United States," post="the initial investigation based on contact tracing indicated that"/>
   <result pre="placebo is the antiviral remdesivir, which has been approved by" exact="the US" post="Food and Drug Administration and other regulatory institutions.82 The"/>
   <result pre="syndrome SARS-CoV-2 severe acute respiratory syndrome coronavirus-2; spp, species US" exact="United States" post="WHO World Health Organization. References REFERENCES 1Genomic epidemiology of"/>
   <result pre="74SeasCMirandaJGilAIet al.New insights on the emergence of cholera in Latin" exact="America" post="during 1991: the Peruvian experienceAm J Trop Med Hyg2000625131710.4269/ajtmh.2000.62.51311220769"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426727\results\search\country\results.xml">
   <result pre="[f], [g], [h], [i], âˆ—Corresponding author. School of Public Policy," exact="Georgia" post="Institute of Technology, Gainesville, VA, USA. pmc-release: 2020-8-8ppub: 2020-11epub:"/>
   <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci." exact="China" post="Life Sci.633202036437432048163 MarginaD.UngurianuA.PurdelC.TsoukalasD.SarandiE.ThanasoulaM.Chronic inflammation in the context of everyday"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426732\results\search\country\results.xml">
   <result pre="Microbiology and Virology Lab, University Hospital of Bari, 70124 Bari," exact="Italy" post="E-mail: luigi.santacroce@uniba.it collection: 2020-7epub: 2020-7-7113151152received: 2020-3-29accepted: 2020-3-29(C) , 2020"/>
   <result pre="number of people with COVID-19 is now dramatically increasing in" exact="Italy" post="and, to date, it remains a severe urgent public"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7427555\results\search\country\results.xml">
   <result pre="subprime mortgages, which first produced a surge in 2007 in" exact="the United States," post="and then tipped the entire world economy into a"/>
   <result pre="mortgages, which first produced a surge in 2007 in the" exact="United States," post="and then tipped the entire world economy into a"/>
   <result pre="political leaders, who usually think of current economic crises facing" exact="the US" post="as being the consequence of just long-term threats. For"/>
   <result pre="a global alert, warning of an atypical pneumonia spreading from" exact="China" post="and coined the name SARS for the disease. Right"/>
   <result pre="this researchâ€&quot;world GDP growth rates, succession of economic expansionsâ€&quot;contractions in" exact="the US," post="purchasing power of gold and the historical ratio DJIA/gold"/>
   <result pre="China's global economic significance of course increased and in 2010" exact="China" post="became the world's second largest economy, and now more"/>
   <result pre="- Entrepreneurship and Structural Change in the New Digital Landscape2017SpringerHeidelberg," exact="Germany" post="Hoffauer, H. (2020) â€&quot; â€œ12 people who seemingly predicted"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7428724\results\search\country\results.xml">
   <result pre="Europeans 1793â€&quot;1798 â€œThe American plagueâ€� âˆ¼25,000 Yellow fever terrorized colonial" exact="America" post="1832 2nd cholera pandemic (Paris) 18,402 Spread from India"/>
   <result pre="colonial America 1832 2nd cholera pandemic (Paris) 18,402 Spread from" exact="India" post="to Europe/Western Hemisphere 1918 â€œSpanishâ€� influenza âˆ¼50 million Led"/>
   <result pre="the pandemic exploded in Europe and the Americas, particularly in" exact="the United States," post="was blunted in these two regions between March and"/>
   <result pre="pandemic exploded in Europe and the Americas, particularly in the" exact="United States," post="was blunted in these two regions between March and"/>
   <result pre="to re-appear either in new locations (e.g., West Nile in" exact="the United States" post="and Russia in 1999) or in resistant forms (e.g.,"/>
   <result pre="re-appear either in new locations (e.g., West Nile in the" exact="United States" post="and Russia in 1999) or in resistant forms (e.g.,"/>
   <result pre="new locations (e.g., West Nile in the United States and" exact="Russia" post="in 1999) or in resistant forms (e.g., methicillin-resistant Staphylococcus"/>
   <result pre="types, exemplified, for example, by comparing the highly pathogenic Ebola" exact="Zaire" post="strain to the closely related but lowly pathogenic Ebola"/>
   <result pre="(bubonic/pneumonic plague) and the 1832 cholera pandemic (which traveled from" exact="India" post="to Europe and then to the Western Hemisphere) were"/>
   <result pre="North Carolina). In 2002â€&quot;2003, SARS was exported by air from" exact="Hong Kong" post="to the Western Hemisphere and Europe. In 2019â€&quot;2020, SARS-CoV-2"/>
   <result pre="Hemisphere and Europe. In 2019â€&quot;2020, SARS-CoV-2 was spread globally from" exact="China" post="in a similar manner. These many ancient and modern"/>
   <result pre="influenza, in 1997 and 2013, respectively, from wet markets in" exact="China" post="(Morens etÂ al., 2020a; Morens etÂ al., 2020b). These"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7428753\results\search\country\results.xml">
   <result pre="significant Eggerâ€™s test. Third, most of the studies are from" exact="China" post="and may not be generalizable to other populations. Fourth,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7428924\results\search\country\results.xml">
   <result pre="PhD, FWAAS, FIAHSI, FEFMI, FACMI. Academy of Medical Sciences of" exact="Bosnia and Herzegovina." post="izetmasic@gmail.com. ORCID ID: http//www.orcid.org/0000-0002-9080-5456. ppub: 2020-6322158164received: 2020-5-25accepted: 2020-6-13(C) ,"/>
   <result pre="reached in USA with 109.675 died persons, and after USA," exact="Great Britain" post="has been with 39.904, Italy with 33.689 cases, Brasil"/>
   <result pre="persons, and after USA, Great Britain has been with 39.904," exact="Italy" post="with 33.689 cases, Brasil with 33.038 cases, France with"/>
   <result pre="Great Britain has been with 39.904, Italy with 33.689 cases," exact="Brasil" post="with 33.038 cases, France with 29.065 cases and Spain"/>
   <result pre="with 39.904, Italy with 33.689 cases, Brasil with 33.038 cases," exact="France" post="with 29.065 cases and Spain with 27.133 cases (5)."/>
   <result pre="cases, Brasil with 33.038 cases, France with 29.065 cases and" exact="Spain" post="with 27.133 cases (5). 2. THE CARDIOVASCULAR DISEASES (CVD)"/>
   <result pre="have developed. Similar studies with tocilizumab are underway in France," exact="Belgium" post="and Denmark. Other therapeutic options include chloroquine, hydroxychloroquine, lopinavir/ritonavir"/>
   <result pre="want to be vaccinated. Four European governments (of Italy, Germany," exact="France" post="and The Netherlands) for their citizens has signed contract"/>
   <result pre="Inclusive Vaccines Alliance (IVA), a group formed by France, Germany," exact="Italy" post="and the Netherlands to secure vaccine doses for all"/>
   <result pre="Alliance (IVA), a group formed by France, Germany, Italy and" exact="the Netherlands" post="to secure vaccine doses for all member states as"/>
   <result pre="(IVA), a group formed by France, Germany, Italy and the" exact="Netherlands" post="to secure vaccine doses for all member states as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429184\results\search\country\results.xml">
   <result pre="with a novel strain of coronavirus (SARS-CoV-2) that emerged in" exact="China" post="during late 2019 and by the time of this"/>
   <result pre="trends in microbiology publications. They discovered that microbiology research in" exact="the USA" post="had the highest average impact factor, but in terms"/>
   <result pre="to 33) of the number of publications about HIV in" exact="Nigeria" post="and that papers with international collaborations were published in"/>
   <result pre="total were published about infectious diseases in Europe than in" exact="the USA." post="In 2012, Takahashi-Omoe and Omoe [30] surveyed publications of"/>
   <result pre="publications of 100 journals about infectious diseases. They discovered that" exact="the USA" post="and the UK had the highest number of publications,"/>
   <result pre="number of publications, and relative to the countryâ€™s socioeconomic status," exact="the Netherlands," post="India, and China had relatively high productivity. In 2014,"/>
   <result pre="relative to the countryâ€™s socioeconomic status, the Netherlands, India, and" exact="China" post="had relatively high productivity. In 2014, similar to Wislar"/>
   <result pre="and avian influenza research was done by investigators based in" exact="the USA" post="and China (Fig.Â 7). In the case of SARS"/>
   <result pre="research was done by investigators based in the USA and" exact="China" post="(Fig.Â 7). In the case of SARS and MERS,"/>
   <result pre="of SARS and MERS, most of the research stemmed from" exact="China" post="and the USA (Fig.Â 8), with only 17% of"/>
   <result pre="and MERS, most of the research stemmed from China and" exact="the USA" post="(Fig.Â 8), with only 17% of SARS papersâ€™ first"/>
   <result pre="written by researchers in only 6 countries (Fig.Â 7). While" exact="the USA" post="was dominant in the research of all inspected diseases,"/>
   <result pre="USA was dominant in the research of all inspected diseases," exact="China" post="showed an increased output in only these 3 diseases."/>
   <result pre="require further follow-up. Fourth, looking at international collaboration, we observed" exact="the USA" post="to be very dominant in all the disease studies"/>
   <result pre="looking at Ebola, which has not been a threat to" exact="China" post="for the past 2 decades, we observed a relatively"/>
   <result pre="studies the top 3 biggest contributors in MERS studies were" exact="the USA," post="China, and Saudi Arabia. Many of the trends that"/>
   <result pre="biggest contributors in MERS studies were the USA, China, and" exact="Saudi Arabia." post="Many of the trends that we observed are related"/>
   <result pre="BrownsteinJS, HawkinsJB, et al.Forecasting Zika incidence in the 2016 Latin" exact="America" post="outbreak combining traditional disease surveillance with search, social media,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429403\results\search\country\results.xml">
   <result pre="et al http://orcid.org/0000-0002-8753-9599Sadeghi DousariAmin1Taati MoghadamMajid23http://orcid.org/0000-0002-7500-0924SatarzadehNaghmeh45[1], Jiroft University of Medical SciencesJiroftIran[2]," exact="Iran" post="University of Medical SciencesTehranIran[3], Iran University of Medical SciencesTehranIran[4],"/>
   <result pre="Jiroft University of Medical SciencesJiroftIran[2], Iran University of Medical SciencesTehranIran[3]," exact="Iran" post="University of Medical SciencesTehranIran[4], Kerman University of Medical SciencesKermanIran[5],"/>
   <result pre="presented symptoms of acute pneumonia and subsequent renal failure in" exact="Saudi Arabia" post="in 2012.8 In December 2019, a Î²-coronavirus was discovered"/>
   <result pre="genomic analysis of coronavirus 2019 isolates from patients COVID-19 in" exact="China" post="and the USA, Malik et al27 reported that the"/>
   <result pre="of coronavirus 2019 isolates from patients COVID-19 in China and" exact="the USA," post="Malik et al27 reported that the length of the"/>
   <result pre="of the Iranian Society of Radiology COVID-19 Consultant Group (ISRCC)." exact="Iran" post="J Radiol. 2020:e102324; doi:10.5812/iranjradiol.102324 62.KarimiA, RajabnejadSRTM, RahimiZPH, et al."/>
   <result pre="LindquistS, et al. First Case of 2019 Novel Coronavirus in" exact="the United States." post="N Engl J Med. 2020;382(10):929â€&quot;936. doi:10.1056/NEJMoa200119132004427 70.De ClercqE. New"/>
   <result pre="et al. First Case of 2019 Novel Coronavirus in the" exact="United States." post="N Engl J Med. 2020;382(10):929â€&quot;936. doi:10.1056/NEJMoa200119132004427 70.De ClercqE. New"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429942\results\search\country\results.xml">
   <result pre="in Washington State, US [49] and 88% in Lombardy region," exact="Italy" post="[48]. Conversely, ICU patients that could be managed with"/>
   <result pre="showed clinical improvement [66]. However, a randomized study conducted in" exact="China" post="failed to show statistically significant differences between treated and"/>
   <result pre="disorders: World Muscle Society position and advice. https://www.worldmusclesociety.org/news/view/150 9.Muscular Distrophy" exact="Canada" post="(2020) COVID-19 and neuromuscular patients. https://neuromuscularnetwork.ca/news/covid-19-and-neuromuscular-patients-la-covid-19-et-les-patients-neuromusculaires/ 10.ScalcoRSGardinerARPitceathlyRDZanoteliEBeckerJHoltonJLet al.Rhabdomyolysis: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7430223\results\search\country\results.xml">
   <result pre="authority. In this context, the Ministry of AYUSH, Government of" exact="India" post="has recommended â€˜Ayush Kwathâ€™ to improve the immunity and"/>
   <result pre="control of COVID-19 [2]. In this context, the Government of" exact="India" post="has recommended to take â€˜Ayush Kwathâ€™ in order to"/>
   <result pre="is the most common treatment for India, Nepal, Bhutan, and" exact="China" post="for different flu, common cold, fever, GI disorders, etc."/>
   <result pre="common cold, fever, GI disorders, etc. Prevention of smallpox in" exact="China" post="has been an epoch-making effort in the period of"/>
   <result pre="wake of COVID-19 outbreak, the Ministry of AYUSH, Government of" exact="India" post="with the interest of health promotion of the masses,"/>
   <result pre="action: a reviewJDDT [Internet]91-s2019453466Available from:http://jddtonline.info/index.php/jddt/article/view/2339 75Anonymous. The ayurvedic pharmacopoeia of" exact="India" post="part-I and volume-I, II and III. Ministry of Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7431281\results\search\country\results.xml">
   <result pre="federal governments. COVID-19, which initially started in Wuhan City of" exact="China" post="and then spread to the whole world, has been"/>
   <result pre="emerged from an animal market in the Guangdong province of" exact="China" post="and spread to 32 countries through air travel routes,"/>
   <result pre="7]. MERS-CoV was first reported to cause human infection in" exact="Saudi Arabia" post="in 2012, where it remains a major public health"/>
   <result pre="2019 (COVID-19) started in December 2019 in Wuhan City of" exact="China" post="and spread through human-to-human transmission across the world [9â€&quot;11]."/>
   <result pre="infections in humans, posing significant threats to global public health." exact="China" post="initially reported to the World Health Organization (WHO) on"/>
   <result pre="the disease is now better contained in the suspected origin," exact="the USA" post="has witnessed the biggest surge in coronavirus cases over"/>
   <result pre="the total number of infections worldwide. The USA, Brazil, and" exact="India" post="are the most affected countries, contributing about half of"/>
   <result pre="coronavirus-related deaths than any part of the world followed by" exact="the USA." post="However, the actual total death toll may be higher"/>
   <result pre="clinical trials of remdesivir against COVID-19 are ongoing primarily in" exact="the USA" post="and China [43]. Table 1 Current status of clinical"/>
   <result pre="remdesivir against COVID-19 are ongoing primarily in the USA and" exact="China" post="[43]. Table 1 Current status of clinical trial studies"/>
   <result pre="the blood cord, and the placenta â€¢ CHR OrlÃ©ans, OrlÃ©ans," exact="France" post="2 COVID-19 Breastfeeding Guideline for African-Americans Not yet recruiting"/>
   <result pre="COVID-19 infection 4 The Role of a Private Hospital in" exact="Hong Kong" post="Amid COVID-19 Pandemic Active, not recruiting COVID Diagnostic test:"/>
   <result pre="not recruiting COVID Diagnostic test: COVID 19 diagnostic test â€¢" exact="Hong Kong" post="Sanatorium &amp;amp; Hospital, Hong Kong, Hong Kong 5 Lung"/>
   <result pre="COVID 19 diagnostic test â€¢ Hong Kong Sanatorium &amp;amp; Hospital," exact="Hong Kong," post="Hong Kong 5 Lung CT Scan Analysis of SARS-CoV2"/>
   <result pre="diagnostic test â€¢ Hong Kong Sanatorium &amp;amp; Hospital, Hong Kong," exact="Hong Kong" post="5 Lung CT Scan Analysis of SARS-CoV2 Induced Lung"/>
   <result pre="analysis in COVID-19 patients â€¢ Ospedale Papa Giovanni XXIII, Bergamo," exact="Italy" post="â€¢ Policlinico San Marco-San Donato group, Bergamo, Italy â€¢"/>
   <result pre="XXIII, Bergamo, Italy â€¢ Policlinico San Marco-San Donato group, Bergamo," exact="Italy" post="â€¢ Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy â€¢ ASST"/>
   <result pre="Donato group, Bergamo, Italy â€¢ Azienda Ospedaliero-Universitaria di Ferrara, Ferrara," exact="Italy" post="â€¢ ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy"/>
   <result pre="Ferrara, Italy â€¢ ASST di Lecco Ospedale Alessandro Manzoni, Lecco," exact="Italy" post="â€¢ ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo,"/>
   <result pre="Italy â€¢ ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo," exact="Italy" post="â€¢ ASST Monza, Monza, Italy â€¢ AUSL Romagna-Ospedale Infermi"/>
   <result pre="Santa Maria delle Stelle, Melzo, Italy â€¢ ASST Monza, Monza," exact="Italy" post="â€¢ AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy â€¢"/>
   <result pre="Monza, Monza, Italy â€¢ AUSL Romagna-Ospedale Infermi di Rimini, Rimini," exact="Italy" post="â€¢ Istituto per la Sicurezza Sociale-Ospedale della Repubblica di"/>
   <result pre="Italy â€¢ Istituto per la Sicurezza Sociale-Ospedale della Repubblica di" exact="San Marino," post="San Marino, San Marino 6 Study Evaluating the Safety"/>
   <result pre="Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino," exact="San Marino," post="San Marino 6 Study Evaluating the Safety and Efficacy"/>
   <result pre="la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino," exact="San Marino" post="6 Study Evaluating the Safety and Efficacy of Autologous"/>
   <result pre="standard care â€¢ Abu Dhabi Stem Cells Center, Abu Dhabi," exact="United Arab Emirates" post="7 Performance Evaluation of RealDetectâ&quot;¢ COVID-19 RT-PCR Kit for"/>
   <result pre="â€¢ Abu Dhabi Stem Cells Center, Abu Dhabi, United Arab" exact="Emirates" post="7 Performance Evaluation of RealDetectâ&quot;¢ COVID-19 RT-PCR Kit for"/>
   <result pre="Mohakhali, Dhaka (for sample analysis, data collection, data analysis), Dhaka," exact="Bangladesh" post="8 Diagnostic Value of Patient-Reported and Clinically Verified Olfactory"/>
   <result pre="of anosmia, ageusia, and other clinical symptoms â€¢ Uhmontpellier, Montpellier," exact="France" post="9 Smell and Taste Disorders in COVID-19 Patients Recruiting"/>
   <result pre="smell and taste disorders â€¢ ASST Monza-Ospedale San Gerardo, Monza," exact="Italy" post="10 Neonatal Complications of Coronavirus Disease (COVID-19) Recruiting Neonatal"/>
   <result pre="COVID-19 Diagnostic test: nasopharyngeal COVID-19 RT-PCR â€¢ CHU Amiens, Amiens," exact="France" post="12 COVID-19 Prevalence and Cognitive Deficits in Neurological Patients"/>
   <result pre="COVID-19 swap test PCR â€¢ Aalborg University Hospital, Aalborg, DK," exact="Denmark" post="â€¢ Aarhus University Hospital, Aarhus, DK, Denmark â€¢ Regional"/>
   <result pre="Hospital, Aalborg, DK, Denmark â€¢ Aarhus University Hospital, Aarhus, DK," exact="Denmark" post="â€¢ Regional Hospital West Jutland, Hostebro, Holstebro, DK, Denmark"/>
   <result pre="DK, Denmark â€¢ Regional Hospital West Jutland, Hostebro, Holstebro, DK," exact="Denmark" post="â€¢ Regional Hospital Central Jutland, Viborg, Viborg, DK, Denmark"/>
   <result pre="DK, Denmark â€¢ Regional Hospital Central Jutland, Viborg, Viborg, DK," exact="Denmark" post="13 Frailty in Elderly Patients with COVID-19 Recruiting COVID-19"/>
   <result pre="elderly patients with COVID-19 â€¢ ASST Monza-Ospedale San Gerardo, Monza," exact="Italy" post="14 COVID-19 Convalescent Plasma (CCP) Transfusion Recruiting COVID-19 Biological:"/>
   <result pre="antibodies against COVID-19 â€¢ Parc Tauli University Hospital, Sabadell, Barcelona," exact="Spain" post="18 The Assessment of the Prevalence, Clinical Course and"/>
   <result pre="diagnostic panel â€¢ Silesian Centre for Heart Disease, Zabrze, Silesia," exact="Poland" post="19 COVID19-Convalescent Plasma for Treating Patients with Active Symptomatic"/>
   <result pre="from COVID-19 donors â€¢ Fundacion Arturo Lopez Perez, Providencia, Santiago," exact="Chile" post="20 COVID-19 Endoscopy Survey Completed COVID-19 Other: practice details"/>
   <result pre="NY, USA â€¢ Faculty of Medicine, Zagazig University, Zagazig, Sharkia," exact="Egypt" post="â€¢ Al-Azhar Univerisity, Cairo, Egypt â€¢ Ahvaz Imam hospital,"/>
   <result pre="Medicine, Zagazig University, Zagazig, Sharkia, Egypt â€¢ Al-Azhar Univerisity, Cairo," exact="Egypt" post="â€¢ Ahvaz Imam hospital, Ahvaz, Iran, Islamic Republic of"/>
   <result pre="Univerisity, Cairo, Egypt â€¢ Ahvaz Imam hospital, Ahvaz, Iran, Islamic" exact="Republic of" post="21 Survey: COVID-19 Patients Managed in the Operating Theatre"/>
   <result pre="Belgian Hospitals Recruiting COVID-19 â€¢ Cliniques Universitaires Saint Luc, Brussels," exact="Belgium" post="22 COVID-19 Surveillance of Patients and Healthcare Workers in"/>
   <result pre="reaction for SARS-CoV-2 â€¢ Rigshospitalet University Hospital of Copenhagen, Copenhagen," exact="Denmark" post="23 Viral Infection and Respiratory Illness Universal Study [VIRUS]:"/>
   <result pre="in patients with COVID-19 â€¢ ASST Monza-Ospedale San Gerardo, Monza," exact="Italy" post="25 Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19)"/>
   <result pre="25 Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in" exact="Egypt" post="Not yet recruiting Characteristic diseases Outcome, fatal Other: follow-up"/>
   <result pre="anti-COVID-19 antibody level â€¢ Humanitas Rozzano/San Pio X, Rozzano, Lombardia," exact="Italy" post="27 Isotretinoin in Treatment of COVID-19 Not yet recruiting"/>
   <result pre="Coronavirus infection Drug: plasma â€¢ Universidad del Rosario, Bogota, Cundinamarca," exact="Colombia" post="29 Slovenian National COVID-19 Prevalence Study Recruiting COVID-19 SARS-CoV-2"/>
   <result pre="study designâ€&quot;only a diagnostic testing â€¢ University of Ljubljana, Ljubljana," exact="Slovenia" post="30 Incidence of COVID-19 Test Conversion in Post-surgical Patients"/>
   <result pre="â€¢ North Shore University Hospital, Manhasset, NY, USA â€¢ Long" exact="Island" post="Jewish Medical Center, New Hyde Park, NY, USA 31"/>
   <result pre="COVID-19 Other: prevalence of COVID-19 â€¢ Assiut University Hospitals, Assiut," exact="Egypt" post="32 Convalescent Plasma for Patients with COVID-19: a Randomized,"/>
   <result pre="Drug: plasma Drug: hydroxychloroquine â€¢ Universidad del Rosario, Bogota, Cundinamarca," exact="Colombia" post="33 Methodist Health System COVID-19 Patient Registry Not yet"/>
   <result pre="diagnostic test by PCR â€¢ University Hospital of Toulouse, Toulouse," exact="France" post="40 Minimal Invasive Autopsies to Investigate Changes in Deceased"/>
   <result pre="Procedure: CT-scan with minimal invasive autopsy â€¢ Jessa Hospital, Hasselt," exact="Belgium" post="41 Exchange Transfusion Versus Plasma from Convalescent Patients with"/>
   <result pre="Drug: Methylene Blue 5 MG/ML â€¢ Ain Shams University, Cairo," exact="Egypt" post="42 Clinical Characteristics and Outcomes of Pediatric COVID-19 Recruiting"/>
   <result pre="intervention)â€&quot;SARS-CoV-2 infection â€¢ University of Calgary/Alberta Childrenâ€™s Hospital, Calgary, Alberta," exact="Canada" post="43 Relation Between Lab Finding and COVID-19 Severity Not"/>
   <result pre="Setting Up a COVID-19 Care Facility at a Prison in" exact="Pakistan" post="Completed COVID-19 Other: COVID-19 facility â€¢ Camp Jail/COVID-19 care"/>
   <result pre="COVID-19 Other: COVID-19 facility â€¢ Camp Jail/COVID-19 care facility/SIMS, Lahore," exact="Pakistan" post="45 Impact of COVID-19 on Marshallese Communities in the"/>
   <result pre="scan â€¢ Tepecik Training and Research Hospital, Izmir, Izmir, Konak," exact="Turkey" post="47 Antibody Based Tests for SARSCOV-2 COVID-19-Evaluation of Patients"/>
   <result pre="Spartan COVID-19 System â€¢ Humber River Hospital, North York, Ontario," exact="Canada" post="â€¢ The University of Ottawa Heart Institute, Ottawa, Ontario,"/>
   <result pre="Canada â€¢ The University of Ottawa Heart Institute, Ottawa, Ontario," exact="Canada" post="49 Classification of COVID-19 Infection in Posteroanterior Chest X-rays"/>
   <result pre="- Heart Institute - University of Sao Paulo, SÃ£o Paulo," exact="Brazil" post="â€¢ IRCCS San Raffaele, Milano, Italy 54 COVID-19 Surveillance"/>
   <result pre="Sao Paulo, SÃ£o Paulo, Brazil â€¢ IRCCS San Raffaele, Milano," exact="Italy" post="54 COVID-19 Surveillance Based on Smart Wearable Device Not"/>
   <result pre="yet recruiting COVID-19 â€¢ Peking University First Hospital, Beijing, Beijing," exact="China" post="55 Descriptive and Retrospective Analysis of Acute Myocarditis Associated"/>
   <result pre="Children Not yet recruiting COVID-19 â€¢ HÃ´pital BicÃªtre, Le Kremlin-BicÃªtre," exact="France" post="â€¢ HÃ´pital Armand Trousseau, Paris, France â€¢ HÃ´pital Necker-Enfants"/>
   <result pre="HÃ´pital BicÃªtre, Le Kremlin-BicÃªtre, France â€¢ HÃ´pital Armand Trousseau, Paris," exact="France" post="â€¢ HÃ´pital Necker-Enfants Malades, Paris, France â€¢ HÃ´pital Robert"/>
   <result pre="HÃ´pital Armand Trousseau, Paris, France â€¢ HÃ´pital Necker-Enfants Malades, Paris," exact="France" post="â€¢ HÃ´pital Robert DebrÃ©, Paris, France 56 Diagnostic Value"/>
   <result pre="HÃ´pital Necker-Enfants Malades, Paris, France â€¢ HÃ´pital Robert DebrÃ©, Paris," exact="France" post="56 Diagnostic Value of New COVID-19 Antibodies Testing Among"/>
   <result pre="(autoclaved) Mycobacterium w Drug: standard therapy of COVID-19 â€¢ All" exact="India" post="Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India â€¢"/>
   <result pre="â€¢ All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh," exact="India" post="â€¢ All India Institute of Medical Sciences, Bhopal, Bhopal,"/>
   <result pre="Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India â€¢ All" exact="India" post="Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India"/>
   <result pre="All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh," exact="India" post="â€¢ Postgraduate Institute of Medical Education and Research, Chandigarh,"/>
   <result pre="India â€¢ Postgraduate Institute of Medical Education and Research, Chandigarh," exact="India" post="â€¢ All lndia Institute of Medical Science, Delhi, Delhi,"/>
   <result pre="India â€¢ All lndia Institute of Medical Science, Delhi, Delhi," exact="India" post="58 Convalescent Plasma In ICU Patients With COVID-19-Induced Respiratory"/>
   <result pre="COVID-19 Egyptian Patients Recruiting COVID-19 â€¢ Sohag University Hospital, Sohag," exact="Egypt" post="60 Efficacy and Safety of Early COVID-19 Convalescent Plasma"/>
   <result pre="Biological: COVID-19 convalescent plasma â€¢ Hospital ClÃ­nico Universidad CatÃ³lica, Santiago," exact="Chile" post="61 Will Hydroxychloroquine Impede or Prevent COVID-19 Recruiting COVID-19"/>
   <result pre="infections COVID-19 Drug: oral â€¢ Assistant Professor Subsai Kongsaengdao, Bangkok," exact="Thailand" post="63 Predicting the Need for Intubation in Hospitalised COVID-19"/>
   <result pre="of admission for COVID-19 â€¢ Louis Mourier hospital (AP-HP), Colombes," exact="France" post="â€¢ Brabois Hospital (CHRU de Nancy), VandÅ&quot;uvre-lÃ¨s-Nancy, France 64"/>
   <result pre="(AP-HP), Colombes, France â€¢ Brabois Hospital (CHRU de Nancy), VandÅ&quot;uvre-lÃ¨s-Nancy," exact="France" post="64 Effects on the Qt Interval of COVID-19 Coronavirus"/>
   <result pre="â€¢ Servicio de Anestesia, Hospital General Universitario Gregorio MaraÃ±on, Madrid," exact="Spain" post="65 COVID-19 Convalescent Plasma for the Treatment of Hospitalized"/>
   <result pre="Worldwide Organ Procurement Recruiting COVID-19 â€¢ Paris Transplant Group, Paris," exact="France" post="67 Testing the Accuracy of a Digital Test to"/>
   <result pre="test: COVID-19 swab PCR test â€¢ Kingâ€™s College London, London," exact="United Kingdom" post="68 Clinical Trial of Allogeneic Mesenchymal Cells from Umbilical"/>
   <result pre="standard of care â€¢ Hospital Universitario de Getafe, Getafe, Madrid," exact="Spain" post="â€¢ Hospital Universitario de Cruces, Barakaldo, Spain â€¢ Hospital"/>
   <result pre="Getafe, Getafe, Madrid, Spain â€¢ Hospital Universitario de Cruces, Barakaldo," exact="Spain" post="â€¢ Hospital Universitario de La Princesa, Madrid, Spain â€¢"/>
   <result pre="Cruces, Barakaldo, Spain â€¢ Hospital Universitario de La Princesa, Madrid," exact="Spain" post="â€¢ Hospital Infantil Universitario NiÃ±o Jesus, Madrid, Spain â€¢"/>
   <result pre="Princesa, Madrid, Spain â€¢ Hospital Infantil Universitario NiÃ±o Jesus, Madrid," exact="Spain" post="â€¢ Hospital RamÃ³n Y Cajal, Madrid, Spain â€¢ Complejo"/>
   <result pre="NiÃ±o Jesus, Madrid, Spain â€¢ Hospital RamÃ³n Y Cajal, Madrid," exact="Spain" post="â€¢ Complejo Universitario La Paz, Madrid, Spain 69 The"/>
   <result pre="Y Cajal, Madrid, Spain â€¢ Complejo Universitario La Paz, Madrid," exact="Spain" post="69 The Heart Hive COVID-19 Study Not yet recruiting"/>
   <result pre="Completed SARS-CoV-2 COVID-19 Other: observation â€¢ Angers University Hospital, Angers," exact="France" post="71 Seroconversion Among Staff at a Large Acute Care"/>
   <result pre="Seroconversion Among Staff at a Large Acute Care Hospital in" exact="Denmark" post="During the COVID-19 Pandemic Recruiting COVID-19 Health personnel Personnel,"/>
   <result pre="during the COVID-19 pandemic â€¢ NordsjÃ¦llands Hospital, HillerÃ¸d, Capital Region," exact="Denmark" post="â€¢ NykÃ¸bing Falster County Hospital, NykÃ¸bing Falster, Southern Region,"/>
   <result pre="Denmark â€¢ NykÃ¸bing Falster County Hospital, NykÃ¸bing Falster, Southern Region," exact="Denmark" post="72 Clinical Trial of Efficacy and Safety of Sinovac's"/>
   <result pre="(inactivated) vaccine Biological: placebo â€¢ Universidade de BrasÃ­lia, Brasilia, DF," exact="Brazil" post="â€¢ Universidade Federal de Minas Gerais, Belo Horizonte, MG,"/>
   <result pre="Brazil â€¢ Universidade Federal de Minas Gerais, Belo Horizonte, MG," exact="Brazil" post="â€¢ Hospital das ClÃ­nicas da Universidade Federal do ParanÃ¡,"/>
   <result pre="Hospital das ClÃ­nicas da Universidade Federal do ParanÃ¡, Curitiba, PR," exact="Brazil" post="â€¢ Hospital SÃ£o Lucas da Pontificia Universidade Catolica do"/>
   <result pre="Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS," exact="Brazil" post="â€¢ Hospital das ClÃ­nicas da UNICAMP, Campinas, SP, Brazil"/>
   <result pre="RS, Brazil â€¢ Hospital das ClÃ­nicas da UNICAMP, Campinas, SP," exact="Brazil" post="â€¢ Hospital das ClÃ­nicas da Faculdade de Medicina de"/>
   <result pre="RibeirÃ£o Preto da Universidade de SÃ£o Paulo, Ribeirao Preto, SP," exact="Brazil" post="â€¢ Instituto de Infectologia EmÃ­lio Ribas, Sao Paulo, SP,"/>
   <result pre="Brazil â€¢ Instituto de Infectologia EmÃ­lio Ribas, Sao Paulo, SP," exact="Brazil" post="â€¢ Centro de Pesquisas ClÃ­nicas do Instituto Central do"/>
   <result pre="de Medicina da Universidade de SÃ£o Paulo, Sao Paulo, SP," exact="Brazil" post="â€¢ Instituto Israelita de Ensino e Pesquisa Albert Einstein,"/>
   <result pre="Israelita de Ensino e Pesquisa Albert Einstein, Sao Paulo, SP," exact="Brazil" post="â€¢ Universidade Municipal de SÃ£o Caetano do Sul, SÃ£o"/>
   <result pre="de SÃ£o Caetano do Sul, SÃ£o Caetano do Sul, SP," exact="Brazil" post="â€¢ Faculdade de Medicina de SÃ£o JosÃ© do Rio"/>
   <result pre="Preto - FAMERP, SÃ£o JosÃ© Do Rio Preto, SÃ£o Paulo," exact="Brazil" post="â€¢ Instituto de Infectologia Evandro Chagas - Fiocruz, Rio"/>
   <result pre="Instituto de Infectologia Evandro Chagas - Fiocruz, Rio De Janeiro," exact="Brazil" post="73 Gut Microbiota, â€œSpark and Flameâ€� of COVID-19 Disease"/>
   <result pre="COVID-19 Other: exposure â€¢ Hospital CUF Infante Santo, S.A., Lisbon," exact="Portugal" post="â€¢ Hospital de SÃ£o Francisco Xavier, Lisbon, Portugal â€¢"/>
   <result pre="S.A., Lisbon, Portugal â€¢ Hospital de SÃ£o Francisco Xavier, Lisbon," exact="Portugal" post="â€¢ Centro Hospitalar UniversitÃ¡rio SÃ£o JoÃ£o, Oporto, Portugal 74"/>
   <result pre="Xavier, Lisbon, Portugal â€¢ Centro Hospitalar UniversitÃ¡rio SÃ£o JoÃ£o, Oporto," exact="Portugal" post="74 Antioxidant Therapy for COVID-19 Study Not yet recruiting"/>
   <result pre="care â€¢ Abia State Isolation Centre, Amachara, Umuahia, Abia State," exact="Nigeria" post="â€¢ Benue State University Teaching Hospital, Makurdi, Benue State,"/>
   <result pre="Nigeria â€¢ Benue State University Teaching Hospital, Makurdi, Benue State," exact="Nigeria" post="â€¢ Brigadier Abba Kyari Memorial Hospital, Borno, Borno State,"/>
   <result pre="Nigeria â€¢ Brigadier Abba Kyari Memorial Hospital, Borno, Borno State," exact="Nigeria" post="â€¢ University of Maiduguri Teaching Hospital, Maiduguri, Borno State,"/>
   <result pre="Nigeria â€¢ University of Maiduguri Teaching Hospital, Maiduguri, Borno State," exact="Nigeria" post="â€¢ University of Calabar Teaching Hospital, Calabar, Cross River,"/>
   <result pre="Nigeria â€¢ University of Calabar Teaching Hospital, Calabar, Cross River," exact="Nigeria" post="â€¢ Federal Medical Centre Idi-Aba, Abeokuta, Ogun State, Nigeria"/>
   <result pre="River, Nigeria â€¢ Federal Medical Centre Idi-Aba, Abeokuta, Ogun State," exact="Nigeria" post="â€¢ Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State,"/>
   <result pre="Nigeria â€¢ Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State," exact="Nigeria" post="â€¢ Infectious Disease Hospital, Amanawa, Sokoto State, Nigeria â€¢"/>
   <result pre="Ogun State, Nigeria â€¢ Infectious Disease Hospital, Amanawa, Sokoto State," exact="Nigeria" post="â€¢ Murtala Muhammad Speciaist Hospital, Sokoto, Sokoto State, Nigeria"/>
   <result pre="State, Nigeria â€¢ Murtala Muhammad Speciaist Hospital, Sokoto, Sokoto State," exact="Nigeria" post="â€¢ Occupational Therapy Center, Sokoto, Sokoto State, Nigeria â€¢"/>
   <result pre="Sokoto State, Nigeria â€¢ Occupational Therapy Center, Sokoto, Sokoto State," exact="Nigeria" post="â€¢ Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State,"/>
   <result pre="Nigeria â€¢ Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State," exact="Nigeria" post="75 COST (COvid STudio) ACTION: Study for the Evaluation"/>
   <result pre="COVID-19 IgM-IgG Rapid Test â€¢ AO San Paolo, Milan, IT," exact="Italy" post="76 Experience of an Emergency Intensive Care Unit During"/>
   <result pre="Diagnostic test: COVID-19 diagnostic PCR â€¢ Seda Yilmaz Semerci, Istanbul," exact="Turkey" post="77 Inhaled Nitric Oxide for Preventing Progression in COVID-19"/>
   <result pre="GH PitiÃ©-SalpÃªtriÃ¨re / Service dâ€™Accueil des Urgences, Paris, Ile- de-France," exact="France" post="79 Hydrogen-Oxygen Generator with Nebulizer in the Improvement of"/>
   <result pre="â€¢ First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong," exact="China" post="80 Endovascular Thrombectomy in COVID-19 Infected Patients Completed Ischemic"/>
   <result pre="Completed Ischemic stroke COVID-19 Other: mechanical trombectomy â€¢ Uhmontpellier, Montpellier," exact="France" post="81 Pre-exposure Prophylaxis with Hydroxychloroquine for High- Risk Healthcare"/>
   <result pre="Pandemic Suspended COVID-19 Drug: hydroxychloroquine Drug: placebos â€¢ ISGlobal, Barcelona," exact="Spain" post="82 Evaluating Clinical Parameters of COVID-19 in Pregnancy Not"/>
   <result pre="Pandemia Active, not recruiting COVID-19 SARS-CoV-2 â€¢ Uh Montpellier, Montpellier," exact="France" post="85 Implementation of Physiotherapy on COVID-19 Patients in ICU"/>
   <result pre="in ICU Recruiting SARS-CoV-2 COVID-19 Other: physiotherapy â€¢ Uhmontpellier, Montpellier," exact="France" post="86 Tableted COVID-19 Therapeutic Vaccine Active, not recruiting COVID-19"/>
   <result pre="Biological: V-SARS â€¢ Immunitor Inc., Vancouver, BC - British Columbia," exact="Canada" post="â€¢ Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo, Mongolia 87 Effects"/>
   <result pre="- British Columbia, Canada â€¢ Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo," exact="Mongolia" post="87 Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-Associated"/>
   <result pre="oral and nasal spray Other: placebo â€¢ National Hospital of" exact="Iceland" post="(LandspÃ­tali), ReykjavÃ­k, Iceland 89 Anti COVID-19 Convalescent Plasma Therapy"/>
   <result pre="spray Other: placebo â€¢ National Hospital of Iceland (LandspÃ­tali), ReykjavÃ­k," exact="Iceland" post="89 Anti COVID-19 Convalescent Plasma Therapy Not yet recruiting"/>
   <result pre="venous disease diagnostic â€¢ Red de Investigacion Vascular (SEACV), Madrid," exact="Spain" post="91 Elmo Respiratory Support Project - COVID-19 Not yet"/>
   <result pre="patient Drug: human immunoglobulin â€¢ Centenario Hospital Miguel Hidalgo, Aguascalientes," exact="Mexico" post="93 Observational Cohort of COVID-19 Patients at Raymond- Poincare"/>
   <result pre="COVID-19 â€¢ Department of Infectiology, Raymond PoincarÃ© Hospital, APHP, Garches," exact="France" post="94 Longitudinal Energy Expenditure and Metabolic Effects in Patients"/>
   <result pre="Biological: SARS-CoV-2 specific T cells â€¢ Changi General Hospital, Singapore," exact="Singapore" post="â€¢ KK Womenâ€™s and Childrenâ€™s Hospital, Singapore, Singapore â€¢"/>
   <result pre="Hospital, Singapore, Singapore â€¢ KK Womenâ€™s and Childrenâ€™s Hospital, Singapore," exact="Singapore" post="â€¢ National University Hospital, Singapore, Singapore â€¢ Sengkang General"/>
   <result pre="and Childrenâ€™s Hospital, Singapore, Singapore â€¢ National University Hospital, Singapore," exact="Singapore" post="â€¢ Sengkang General Hospital, Singapore, Singapore â€¢ Singapore General"/>
   <result pre="National University Hospital, Singapore, Singapore â€¢ Sengkang General Hospital, Singapore," exact="Singapore" post="â€¢ Singapore General Hospital, Singapore, Singapore 96 A Study"/>
   <result pre="Hospital, Singapore, Singapore â€¢ Sengkang General Hospital, Singapore, Singapore â€¢" exact="Singapore" post="General Hospital, Singapore, Singapore 96 A Study Evaluating the"/>
   <result pre="Sengkang General Hospital, Singapore, Singapore â€¢ Singapore General Hospital, Singapore," exact="Singapore" post="96 A Study Evaluating the Efficacy and Safety of"/>
   <result pre="pneumonia â€¢ IRCCS Policlinico San Donato, San Donato Milanese, MI," exact="Italy" post="98 CORonavirus (COVID-19) Diagnostic Lung UltraSound Study Not yet"/>
   <result pre="therapy for COVID-19 â€¢ LifeFactors Zona Franca SAS, MedellÃ­n, Antioquia," exact="Colombia" post="100 Safety and Efficacy of Tramadol in COVID-19 Egyptian"/>
   <result pre="as a treatment option is explored in India, China, and" exact="the USA." post="Table 1 shows the status of recent clinical trials"/>
   <result pre="2/3 trial in UK, phase 3 trials in SA and" exact="Brazil" post="AZD 1222 Non-replicating virus Bharat Biotech Vaccine Phase 1/2"/>
   <result pre="3 trials in SA and Brazil AZD 1222 Non-replicating virus" exact="Bharat" post="Biotech Vaccine Phase 1/2 COVAXIN inactivated virus Immune Catastrophe"/>
   <result pre="therapies against COVID-19, the Food and Drug Administration (FDA) of" exact="the USA" post="has provided fast-track designation to Mrna Vaccine mRNA-1273 created"/>
   <result pre="the RBM of SARS-CoV-2 virus. Tel Aviv University (TAU) of" exact="Israel" post="is working on the same plan in association with"/>
   <result pre="Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS," exact="China" post="Medical Treatment Expert Group for C (2020) Clinical characteristics"/>
   <result pre="Li SY, Zheng JP, Zhang NF, Zhong NS, He JX," exact="China" post="Medical Treatment Expert Group for C (2020) Comorbidity and"/>
   <result pre="nCo VCIT (2020) First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med 382 (10):929â€&quot;936. 10.1056/NEJMoa2001191 34.AguiarACCMurceECortopassiWAPimentelASAlmeidaMBarrosDCSGuedesJSMeneghettiMRKrettliAUChloroquine analogs"/>
   <result pre="VCIT (2020) First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med 382 (10):929â€&quot;936. 10.1056/NEJMoa2001191 34.AguiarACCMurceECortopassiWAPimentelASAlmeidaMBarrosDCSGuedesJSMeneghettiMRKrettliAUChloroquine analogs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7431560\results\search\country\results.xml">
   <result pre="Edited by: Antonio Russo, Paolo Giaccone University Hospital in Palermo," exact="Italy" post="Reviewed by: Cristian FIori, University of Turin, Italy; Riccardo"/>
   <result pre="Campi, Careggi University Hospital, Italy; Luigi Cavanna, Ospedaliera di Piacenza," exact="Italy" post="*Correspondence: Anna Crispo, a.crispo@istitutotumori.na.it This article was submitted to"/>
   <result pre="is permitted which does not comply with these terms. Abstract" exact="Italy" post="and worldwide are experiencing an outbreak of a new"/>
   <result pre="because of fear of contagion. Moreover, in some regions in" exact="Italy" post="even the very first non-urgent visits have been postponed"/>
   <result pre="telemedicine infections fig-count: table-count: equation-count: ref-count: page-count: word-count: Background Epidemiology" exact="Italy" post="and worldwide are experiencing an outbreak of a new"/>
   <result pre="within a few months, WHO declared COVID-19 a pandemic (3)." exact="Italy" post="currently is the second European country after Spain for"/>
   <result pre="pandemic (3). Italy currently is the second European country after" exact="Spain" post="for confirmed COVID-19 cases (197,675 and 207,634, respectively), and"/>
   <result pre="the second country in the world for COVID-19 death after" exact="United States" post="(26,644 and 47,980, respectively) (4). Of note, although in"/>
   <result pre="States (26,644 and 47,980, respectively) (4). Of note, although in" exact="Italy" post="the outbreak of SARS-CoV-2 infection grew progressively from end"/>
   <result pre="telemedicine was higher in rural areas of northern Ontario in" exact="Canada" post="compared to other parts of the province suggesting that"/>
   <result pre="these patients. The general policy of Cancer Centres (CC) in" exact="Italy" post="has been to remain COVID-19 free to ensure sufficient"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7432271\results\search\country\results.xml">
   <result pre="analysis of COVID-19 patients admitted to a hospital in Wuhan," exact="China" post="reported that patients showed elevated plasma concentrations of other"/>
   <result pre="common comorbidity varied among the seven countries reviewed, as follows:" exact="China" post="(hypertension 39.5%), South Korea (cardiovascular disease 25.6%), Italy (hypertension"/>
   <result pre="among the seven countries reviewed, as follows: China (hypertension 39.5%)," exact="South Korea" post="(cardiovascular disease 25.6%), Italy (hypertension 35.9%), USA (hypertension 38.9%),"/>
   <result pre="as follows: China (hypertension 39.5%), South Korea (cardiovascular disease 25.6%)," exact="Italy" post="(hypertension 35.9%), USA (hypertension 38.9%), Mexico, (other 42.3%), UK"/>
   <result pre="35.9%), USA (hypertension 38.9%), Mexico, (other 42.3%), UK (hypertension 27.8%)," exact="Iran" post="(diabetes 35.0%); diabetes was the second most common comorbidity"/>
   <result pre="in treatment of the first patient diagnosed with COVID-19 in" exact="the United States" post="[102]. In order to further investigate the efficacy and"/>
   <result pre="treatment of the first patient diagnosed with COVID-19 in the" exact="United States" post="[102]. In order to further investigate the efficacy and"/>
   <result pre="trials in severe and mild/moderate respiratory infections by SARS-CoV-2 in" exact="the United States" post="and two in China have been commenced [103]. The"/>
   <result pre="in severe and mild/moderate respiratory infections by SARS-CoV-2 in the" exact="United States" post="and two in China have been commenced [103]. The"/>
   <result pre="infections by SARS-CoV-2 in the United States and two in" exact="China" post="have been commenced [103]. The first randomized controlled clinical"/>
   <result pre="[103]. The first randomized controlled clinical trial of remdesivir in" exact="the United States," post="known as the Adaptive COVID-19 Treatment Trial, enrolled 1063"/>
   <result pre="The first randomized controlled clinical trial of remdesivir in the" exact="United States," post="known as the Adaptive COVID-19 Treatment Trial, enrolled 1063"/>
   <result pre="another cohort of 53 patients hospitalized for severe COVID-19 in" exact="the United States," post="Europe, Canada or Japan a 10-day course of remdesivir"/>
   <result pre="cohort of 53 patients hospitalized for severe COVID-19 in the" exact="United States," post="Europe, Canada or Japan a 10-day course of remdesivir"/>
   <result pre="patients hospitalized for severe COVID-19 in the United States, Europe," exact="Canada" post="or Japan a 10-day course of remdesivir resulted in"/>
   <result pre="for severe COVID-19 in the United States, Europe, Canada or" exact="Japan" post="a 10-day course of remdesivir resulted in clinical improvement"/>
   <result pre="in 237 laboratory-confirmed SARS-CoV-2 infected patients, from ten hospitals in" exact="China" post="(NCT04257656), revealed that time to clinical improvement was not"/>
   <result pre="hospitalized with severe suspected or laboratory-confirmed COVID-19 was approved by" exact="the US" post="FDA [4]. 8.1.2. Lopinavir/Ritonavir Lopinavir/Ritonavir (LPV/r) is a coformulation"/>
   <result pre="of six patients with confirmed COVID-19 infection in Korea and" exact="China" post="showed a significant decrease in SARS-CoV-2 viral load and"/>
   <result pre="caution when interpreting such results [80,110,111]. In another study in" exact="Singapore" post="the efficacy of LPV/r was evaluated on five patients"/>
   <result pre="10 ongoing clinical trials have been registered from China, Korea," exact="Thailand" post="and Hong Kong to evaluate efficacy of LPV/r for"/>
   <result pre="clinical trials have been registered from China, Korea, Thailand and" exact="Hong Kong" post="to evaluate efficacy of LPV/r for the treatment of"/>
   <result pre="been reported from limited clinical experiences. An open-label study in" exact="China" post="compared the effects of favipiravir plus interferon-Î± with LPV/r"/>
   <result pre="results favipiravir was approved as the first anti-COVID-19 drug in" exact="China" post="[121]. Another randomized clinical trial compared the effect of"/>
   <result pre="treatment of COVID-19 is not recommended. An ongoing trial in" exact="China" post="(ChiCTR2000029387) is evaluating the efficacy and safety of ribavirin"/>
   <result pre="various enveloped and non-enveloped viruses and is widely used in" exact="Russia" post="and China [133]. Arbidol displays antiviral activity in vitro"/>
   <result pre="and non-enveloped viruses and is widely used in Russia and" exact="China" post="[133]. Arbidol displays antiviral activity in vitro and/or in"/>
   <result pre="are investigating the efficacy of arbidol on COVID-19 patients in" exact="China" post="and USA (NCT04260594, NCT04255017). Four clinical trials are comparing"/>
   <result pre="exocrine pancreatic enzyme inhibition [138]. Camostat mesylate was developed in" exact="Japan" post="in the 1980s but very little data from outside"/>
   <result pre="Japan in the 1980s but very little data from outside" exact="Japan" post="is available. Some coronaviruses (SARS-CoV, MERS-CoV) and influenza virus"/>
   <result pre="guanidinobenzoate dimethanesulfonate) is a synthetic serine protease inhibitor available in" exact="Japan" post="since 1986 that has been approved for the treatment"/>
   <result pre="administered shortly after the appearance of symptoms [177]. In a" exact="Hong Kong" post="study, 80 SARS patients who were administrated convalescent plasma"/>
   <result pre="patients to three health care workers with SARS infection in" exact="Taiwan" post="resulted in survival of all three patients, a decrease"/>
   <result pre="administration of convalescent plasma to three patients with MERS in" exact="South Korea" post="showed the presence of neutralizing antibodies in only two"/>
   <result pre="demonstrated anti-SARS-CoV-2 activity of convalescent plasma from six patients in" exact="China" post="who had recovered; transfusion of the plasma to a"/>
   <result pre="COVID-19 [182,183,184,185,186,187,188,189], joining other registered trials in China, Columbia, Iran," exact="Mexico" post="and Baylor Research Institute in USA [182,183,184,185,186,187,188,189]. 9.2. Intravenous"/>
   <result pre="cohort study of 325 critically unwell adult COVID-19 patients in" exact="China" post="who were exposed to IVIG, demonstrated that although early"/>
   <result pre="In a study on 20 patients with COVID-19 in Anhui," exact="China" post="more than 75% of patients admitted to ICU who"/>
   <result pre="and favipiravir, a randomized controlled trial has been registered in" exact="China" post="(ChiCTR2000030894) [201]. Sarilumab (Kevzara) is another IL-6 receptor antagonist"/>
   <result pre="(Qletli) for their safety and efficacy in COVID-19 treatment in" exact="China" post="(ChiCTR2000030089, ChiCTR2000030580). However, upper respiratory tract infections and reactivation"/>
   <result pre="registered using camrelizumab for treatment of critical COVID-19 patients in" exact="China" post="[209]. Omalizumab is an IgG1 humanized anti IgE monoclonal"/>
   <result pre="University of Sydney; National Health and Medical Research Council of" exact="Australia" post="(NHMRC) Program Grant (1053206) and Project grants (APP1107178 and"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes Metab. Syndr. Clin. Res. Rev.20201424124610.1016/j.dsx.2020.03.01132247211"/>
   <result pre="Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal" exact="Zaire" post="Ebolavirus Challenge in Rhesus MacaquesJ. Infect. Dis.2018218S658S66110.1093/infdis/jiy43030053153 174.ZhangJ.-S.ChenJ.-T.LiuY.-X.ZhangZ.-S.GaoH.LiuY.WangX.NingY.LiuY.-F.GaoQ.et al.A"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospitalJ. Antimicrob. Chemother.20055691992210.1093/jac/dki34616183666 180.KoJ.-H.SeokH.ChoS.Y.HaY.E.BaekJ.Y.KimS.H.KimY.-J.ParkJ.K.ChungC.R.KangE.-S.et al.Challenges of convalescent plasma infusion"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7432648\results\search\country\results.xml">
   <result pre="control mechanisms in mitigating the virus for selected countries and" exact="the UAE" post="as a special case. Pre-existing conditions defined the needed"/>
   <result pre="D droplets indoor and outdoor climate post-lockdown period recommendations UAE" exact="India" post="1. Introduction A novel coronavirus (CoV) was identified in"/>
   <result pre="In 2003, a virus was identified in Guangdong province in" exact="China" post="causing severe acute respiratory syndrome (SARS). Later, the virus"/>
   <result pre="[9]. The Middle East respiratory syndrome (MERS) coronavirus (2012) in" exact="Saudi Arabia" post="is a beta-coronavirus originating from camels as the primary"/>
   <result pre="an exponential increase of infection on a national basis in" exact="China" post="[12,13]. Similar measurements were implemented by many other countries"/>
   <result pre="studied clinical and demographic characteristics of 44,672 COVID-19 cases in" exact="China" post="and noted that everyone without age limitation is susceptible"/>
   <result pre="2 June. We also investigated the public health strategies in" exact="the UAE," post="which has not been previously represented in the literature."/>
   <result pre="[18]. For the first time, we highlight the situation in" exact="the United Arab Emirates" post="(UAE) by discussing its national strategies and their impact"/>
   <result pre="For the first time, we highlight the situation in the" exact="United Arab Emirates" post="(UAE) by discussing its national strategies and their impact"/>
   <result pre="first time, we highlight the situation in the United Arab" exact="Emirates" post="(UAE) by discussing its national strategies and their impact"/>
   <result pre="mortality. Furthermore, we report the experiences of USA, Italy, and" exact="India" post="as special cases. We compare several countries with similar"/>
   <result pre="and Franceâ€&quot;Spain are compared as examples of European countries. Latin" exact="America" post="is represented by analysis of data from Brazil, Peru,"/>
   <result pre="by analysis of data from Brazil, Peru, Ecuador, and Mexico." exact="South Korea" post="and Japan were chosen as examples of Far Eastern"/>
   <result pre="data from Brazil, Peru, Ecuador, and Mexico. South Korea and" exact="Japan" post="were chosen as examples of Far Eastern countries with"/>
   <result pre="and their impact on COVID-19-related fatalities in Portugal, Sweden, and" exact="Switzerland" post="(Figure 1). Figure 1 shows the highest fatality numbers"/>
   <result pre="1 shows the highest fatality numbers in Sweden, followed by" exact="Switzerland" post="and then Portugal. Sweden is one of the few"/>
   <result pre="fatality numbers in Sweden, followed by Switzerland and then Portugal." exact="Sweden" post="is one of the few European countries refraining from"/>
   <result pre="the mean serum vitamin D levels for the populations in" exact="Portugal" post="(39 nmol/L), Spain (42.5 nmol/L), Switzerland (46 nmol/L), UK"/>
   <result pre="vitamin D levels for the populations in Portugal (39 nmol/L)," exact="Spain" post="(42.5 nmol/L), Switzerland (46 nmol/L), UK (47.4 nmol/L), Italy"/>
   <result pre="for the populations in Portugal (39 nmol/L), Spain (42.5 nmol/L)," exact="Switzerland" post="(46 nmol/L), UK (47.4 nmol/L), Italy (50 nmol/L), Germany"/>
   <result pre="nmol/L), Spain (42.5 nmol/L), Switzerland (46 nmol/L), UK (47.4 nmol/L)," exact="Italy" post="(50 nmol/L), Germany (50.1 nmol/L), Turkey (51.8 nmol/L), France"/>
   <result pre="nmol/L), Switzerland (46 nmol/L), UK (47.4 nmol/L), Italy (50 nmol/L)," exact="Germany" post="(50.1 nmol/L), Turkey (51.8 nmol/L), France (60 nmol/L), Sweden"/>
   <result pre="nmol/L), UK (47.4 nmol/L), Italy (50 nmol/L), Germany (50.1 nmol/L)," exact="Turkey" post="(51.8 nmol/L), France (60 nmol/L), Sweden (73.5 nmol/L), and"/>
   <result pre="nmol/L), Italy (50 nmol/L), Germany (50.1 nmol/L), Turkey (51.8 nmol/L)," exact="France" post="(60 nmol/L), Sweden (73.5 nmol/L), and other countries [27]."/>
   <result pre="nmol/L), Germany (50.1 nmol/L), Turkey (51.8 nmol/L), France (60 nmol/L)," exact="Sweden" post="(73.5 nmol/L), and other countries [27]. Portugal has the"/>
   <result pre="France (60 nmol/L), Sweden (73.5 nmol/L), and other countries [27]." exact="Portugal" post="has the smallest, Switzerland represents the average, and Sweden"/>
   <result pre="(73.5 nmol/L), and other countries [27]. Portugal has the smallest," exact="Switzerland" post="represents the average, and Sweden the highest mean serum"/>
   <result pre="[27]. Portugal has the smallest, Switzerland represents the average, and" exact="Sweden" post="the highest mean serum 25-hydroxyvitamin D (25(OH)D) levels and"/>
   <result pre="that the highest COVID-19-related mortality was in Sweden, followed by" exact="Switzerland" post="and Portugal with median ages of 41.1, 42.7, and"/>
   <result pre="highest COVID-19-related mortality was in Sweden, followed by Switzerland and" exact="Portugal" post="with median ages of 41.1, 42.7, and 44.6, respectively"/>
   <result pre="first confirmed COVID-19 case was reported in Portugal, Switzerland, and" exact="Sweden" post="on 3 March, 26 February, and 1 February 2020,"/>
   <result pre="The average temperature in March 2020 was the highest in" exact="Portugal" post="at 12.4 Â°C, followed by Switzerland with 2.2 Â°C,"/>
   <result pre="was the highest in Portugal at 12.4 Â°C, followed by" exact="Switzerland" post="with 2.2 Â°C, and the lowest was Sweden with"/>
   <result pre="followed by Switzerland with 2.2 Â°C, and the lowest was" exact="Sweden" post="with âˆ’3.3 Â°C [24]. The lowest relative humidity was"/>
   <result pre="âˆ’3.3 Â°C [24]. The lowest relative humidity was recorded in" exact="Portugal" post="with 70%, Switzerlandâ€™s was 73%, and the highest was"/>
   <result pre="with 70%, Switzerlandâ€™s was 73%, and the highest was in" exact="Sweden" post="with 88% [24]. According to these numbers, the spread"/>
   <result pre="it was Sweden. An explanation for the higher fatality in" exact="Sweden" post="is the cold weather itself. The virus cannot survive"/>
   <result pre="in relation to the number of confirmed SARS-CoV-2 cases/fatalities in" exact="Hong Kong," post="Singapore, and other countries [29]. Singapore has the second"/>
   <result pre="SARS-CoV-2 cases/fatalities in Hong Kong, Singapore, and other countries [29]." exact="Singapore" post="has the second highest population density in the world,"/>
   <result pre="second highest population density in the world, directly followed by" exact="Hong Kong" post="[29]. Due to their previous experience with the SARS"/>
   <result pre="SARS virus in 2003, 97% of the studied population in" exact="Hong Kong" post="began using masks when the first COVID-19 confirmed case"/>
   <result pre="from 60 general outpatient clinics and three cross-sectional surveys in" exact="Hong Kong" post="[30]. They findings indicate that rapidly implemented public health"/>
   <result pre="the compliance of the population mitigated the SARS-CoV-2 outbreak in" exact="Hong Kong" post="[30]. The population readily embraced the recommended prevention methods"/>
   <result pre="To validate this thesis, we compared the fatality numbers in" exact="South Korea" post="and Japan during the SARS-CoV-2 pandemic (Figure 2). The"/>
   <result pre="thesis, we compared the fatality numbers in South Korea and" exact="Japan" post="during the SARS-CoV-2 pandemic (Figure 2). The first confirmed"/>
   <result pre="SARS-CoV-2 pandemic (Figure 2). The first confirmed COVID-19 case in" exact="Japan" post="was announced on 15 January 2020, while South Korea"/>
   <result pre="case in Japan was announced on 15 January 2020, while" exact="South Korea" post="had a confirmed case five days later [18]. The"/>
   <result pre="confirmed case five days later [18]. The first fatality in" exact="Japan" post="occurred on 13 February 2020, while South Koreaâ€™s first"/>
   <result pre="on 21 February [18]. The total number of fatalities in" exact="Japan" post="on 2 June 2020 was 894 within a population"/>
   <result pre="to this success should be discussed. The median age in" exact="Japan" post="of 48.6 years is the highest globally, and could"/>
   <result pre="elderly [28]. The number of deaths is low compared to" exact="Mexico" post="with a similarly sized population (&amp;gt;126 million) and 10,167"/>
   <result pre="fatalities until 2 June 2020 [18]. The median age in" exact="South Korea" post="is 43.2 [28]. Both South Korean and Japan adopted"/>
   <result pre="in South Korea is 43.2 [28]. Both South Korean and" exact="Japan" post="adopted early intervention strategies to control the viral spread"/>
   <result pre="habit of wearing masks, which prepared them for this pandemic." exact="South Korea" post="introduced a dynamic and quick response to the needs"/>
   <result pre="with different control mechanisms compared to the experiences of China," exact="South Korea," post="Japan, and Hong Kong [29,30,44,45]. Highly industrialized, European countries"/>
   <result pre="compared to the experiences of China, South Korea, Japan, and" exact="Hong Kong" post="[29,30,44,45]. Highly industrialized, European countries were expected to best"/>
   <result pre="according to their population size and/or number of fatalities [18]." exact="Germany" post="(population 2018: 82,927,922) and Turkey (population 2018: 82,319,724) faced"/>
   <result pre="and/or number of fatalities [18]. Germany (population 2018: 82,927,922) and" exact="Turkey" post="(population 2018: 82,319,724) faced their first reported COVID-19 case"/>
   <result pre="Until 2 June 2020, the number of confirmed cases in" exact="Germany" post="was 182,028, while Turkey had 164,769 cases. Germany had"/>
   <result pre="the number of confirmed cases in Germany was 182,028, while" exact="Turkey" post="had 164,769 cases. Germany had reported a total number"/>
   <result pre="cases in Germany was 182,028, while Turkey had 164,769 cases." exact="Germany" post="had reported a total number of 8522 fatalities, while"/>
   <result pre="Germany had reported a total number of 8522 fatalities, while" exact="Turkey" post="recorded 4563 fatal cases (Figure 3) [18]. The COVID-19"/>
   <result pre="fatal cases (Figure 3) [18]. The COVID-19 fatality numbers in" exact="Germany" post="are almost double the number of fatalities in Turkey."/>
   <result pre="reason may be due to the higher median age in" exact="Germany" post="[24]. The median age of the German population is"/>
   <result pre="age of the German population is the second highest after" exact="Japan" post="[24]. The arrival of the pandemic in Turkey was"/>
   <result pre="highest after Japan [24]. The arrival of the pandemic in" exact="Turkey" post="was more than one month later than in Germany."/>
   <result pre="with widespread testing and followed-up on clusters and asymptomatic cases." exact="Turkey" post="started producing masks, effective personal protection equipment (PPE), and"/>
   <result pre="the needed measures to control the spread of the virus." exact="Italy" post="and Spain have younger populations compared with Germany [24]."/>
   <result pre="measures to control the spread of the virus. Italy and" exact="Spain" post="have younger populations compared with Germany [24]. The median"/>
   <result pre="the virus. Italy and Spain have younger populations compared with" exact="Germany" post="[24]. The median age in Germany is 47.8, while"/>
   <result pre="younger populations compared with Germany [24]. The median age in" exact="Germany" post="is 47.8, while in Italy it is 46.6 and"/>
   <result pre="[24]. The median age in Germany is 47.8, while in" exact="Italy" post="it is 46.6 and in Spain it is 43.9"/>
   <result pre="is 47.8, while in Italy it is 46.6 and in" exact="Spain" post="it is 43.9 [24]. Furthermore, the mean serum vitamin"/>
   <result pre="the mean serum vitamin D levels for the populations in" exact="Italy" post="and Spain are similar to those of Germany [27]."/>
   <result pre="serum vitamin D levels for the populations in Italy and" exact="Spain" post="are similar to those of Germany [27]. These factors"/>
   <result pre="populations in Italy and Spain are similar to those of" exact="Germany" post="[27]. These factors should have resulted in lower SARS-CoV-2"/>
   <result pre="lower SARS-CoV-2 susceptibility and better control of the outbreak. However," exact="Italy" post="and Spain were confronted with a massive outbreak of"/>
   <result pre="susceptibility and better control of the outbreak. However, Italy and" exact="Spain" post="were confronted with a massive outbreak of COVID-19 in"/>
   <result pre="were confronted with a massive outbreak of COVID-19 in 2020." exact="Italy" post="reported the first confirmed case in 31 January 2020"/>
   <result pre="2020 and the first fatality on 23 February 2020 [18]." exact="Spain" post="confirmed the first case on 1 February 2020 and"/>
   <result pre="occurred almost one month later on 5 March 2020 [18]." exact="Spain" post="had recorded 239,638 cases and 27,940 fatal cases with"/>
   <result pre="of approximately 46,723,749 [18]. The number of COVID-19 cases in" exact="Italy" post="was 233,197 with a population size of 60,431,283 and"/>
   <result pre="median age and similar serum vitamin D levels compared to" exact="Germany" post="did not have any positive impact on the COVID-19"/>
   <result pre="disease course and did not reduce fatality numbers in Italy." exact="France" post="and the United Kingdom (UK) were also severely hit"/>
   <result pre="did not reduce fatality numbers in Italy. France and the" exact="United Kingdom" post="(UK) were also severely hit by the COVID-19 pandemic."/>
   <result pre="67 million inhabitants [18]. The total number of fatalities in" exact="France" post="was 28,833 and in the UK 39,045 until 2"/>
   <result pre="the UK 39,045 until 2 June 2020 (Figure 5) [18]." exact="France" post="recorded 152,091 and UK reported 276,332 COVID-19 cases until"/>
   <result pre="date [18]. The highest number of fatalities were counted in" exact="France" post="between 31 March and 20 April 2020. UK registered"/>
   <result pre="American continent. The first confirmed case of SARS-CoV-2 infection in" exact="the United States" post="of America (USA) was reported on 21 January 2020"/>
   <result pre="continent. The first confirmed case of SARS-CoV-2 infection in the" exact="United States of America" post="(USA) was reported on 21 January 2020 one day"/>
   <result pre="confirmed case of SARS-CoV-2 infection in the United States of" exact="America" post="(USA) was reported on 21 January 2020 one day"/>
   <result pre="reported on 21 January 2020 one day after that of" exact="South Korea" post="[18]. The fatality rate on 10 April 2020 was"/>
   <result pre="The fatality rate on 10 April 2020 was 2% for" exact="South Korea" post="and 3.6% in the USA [46]. South Korea, due"/>
   <result pre="April 2020 was 2% for South Korea and 3.6% in" exact="the USA" post="[46]. South Korea, due to its previous SARS experience,"/>
   <result pre="2% for South Korea and 3.6% in the USA [46]." exact="South Korea," post="due to its previous SARS experience, reacted swiftly with"/>
   <result pre="curve may indicate that the worst of the outbreak in" exact="the USA" post="is over and the peak lasted for around one"/>
   <result pre="treatment protocols, or vaccines resulted in a health disaster for" exact="the USA" post="(105,147) (fatalities in USA due to COVID-19 at the"/>
   <result pre="writing), in addition to countries such as the UK (39,045)," exact="Italy" post="(33,475), Brazil (29,937), France (28,833), Spain (27,940), and Mexico"/>
   <result pre="addition to countries such as the UK (39,045), Italy (33,475)," exact="Brazil" post="(29,937), France (28,833), Spain (27,940), and Mexico (10,167), which"/>
   <result pre="countries such as the UK (39,045), Italy (33,475), Brazil (29,937)," exact="France" post="(28,833), Spain (27,940), and Mexico (10,167), which had recorded"/>
   <result pre="as the UK (39,045), Italy (33,475), Brazil (29,937), France (28,833)," exact="Spain" post="(27,940), and Mexico (10,167), which had recorded mortalities in"/>
   <result pre="(39,045), Italy (33,475), Brazil (29,937), France (28,833), Spain (27,940), and" exact="Mexico" post="(10,167), which had recorded mortalities in excess of 10,000"/>
   <result pre="post-quarantine is essential [46]. The first COVID-19 case in Latin" exact="America" post="was reported on 26 February 2020 [47]. Subsequently, SARS-CoV-2"/>
   <result pre="continent. We analyzed the data for selected countries in Latin" exact="America" post="and compared their number of fatalities from the European"/>
   <result pre="Centers for Disease Control and Prevention (EDCD) (Figure 7) [18]." exact="Brazil" post="has reported the highest number of fatalities with 29,937,"/>
   <result pre="reported the highest number of fatalities with 29,937, followed by" exact="Mexico" post="with 10,167, Peru with 4634, and Ecuador with 3394"/>
   <result pre="number of fatalities with 29,937, followed by Mexico with 10,167," exact="Peru" post="with 4634, and Ecuador with 3394 [18]. At the"/>
   <result pre="29,937, followed by Mexico with 10,167, Peru with 4634, and" exact="Ecuador" post="with 3394 [18]. At the present time, it appears"/>
   <result pre="with 3394 [18]. At the present time, it appears that" exact="Brazil" post="and Mexico have reached the peak of the pandemic"/>
   <result pre="[18]. At the present time, it appears that Brazil and" exact="Mexico" post="have reached the peak of the pandemic according to"/>
   <result pre="the peak of the pandemic according to Figure 4, while" exact="Ecuador" post="and Peru may still be in the initial phase"/>
   <result pre="of the pandemic according to Figure 4, while Ecuador and" exact="Peru" post="may still be in the initial phase of the"/>
   <result pre="the curve continues to rise [18]. The COVID-19 pandemic in" exact="Ecuador" post="may also overlap with further viral outbreaks of dengue"/>
   <result pre="burden on the already depleted health care system in Latin" exact="America" post="[47]. The situation in South America is far from"/>
   <result pre="care system in Latin America [47]. The situation in South" exact="America" post="is far from resolved and could develop into the"/>
   <result pre="could develop into the worst COVID-19 outbreak this year. China," exact="South Korea," post="Singapore, Hong Kong, and Taiwan are among the countries"/>
   <result pre="the worst COVID-19 outbreak this year. China, South Korea, Singapore," exact="Hong Kong," post="and Taiwan are among the countries that were able"/>
   <result pre="outbreak this year. China, South Korea, Singapore, Hong Kong, and" exact="Taiwan" post="are among the countries that were able to control"/>
   <result pre="distancing may help to prevent infection. A modeling study from" exact="Singapore" post="investigated the impact of control measures implemented to reduce"/>
   <result pre="Health Strategies During COVID-19 We investigated the SARS-CoV-2 pandemic in" exact="the United Arab Emirates" post="(UAE) as an example of a highly populated, globally"/>
   <result pre="Strategies During COVID-19 We investigated the SARS-CoV-2 pandemic in the" exact="United Arab Emirates" post="(UAE) as an example of a highly populated, globally"/>
   <result pre="COVID-19 We investigated the SARS-CoV-2 pandemic in the United Arab" exact="Emirates" post="(UAE) as an example of a highly populated, globally"/>
   <result pre="level of public health responses and control of SARS-CoV-2 in" exact="the UAE," post="and underline that publications about COVID-19 in the UAE"/>
   <result pre="in the UAE, and underline that publications about COVID-19 in" exact="the UAE" post="are very rare. Figure 8a shows the confirmed cases"/>
   <result pre="shows the confirmed cases and Figure 8b the fatalities in" exact="the UAE." post="The population in the UAE totals around 7 million"/>
   <result pre="Figure 8b the fatalities in the UAE. The population in" exact="the UAE" post="totals around 7 million according to the 2018 census"/>
   <result pre="to SARS-CoV-2 proliferation [24]. Similar climatic conditions also exist in" exact="Hong Kong," post="Singapore, and other Gulf countries [24]. All of these"/>
   <result pre="international airports, and low median age (with the exception of" exact="Hong Kong" post="in the case of the latter) [24]. These countries"/>
   <result pre="mobility and helped to efficiently control the viral outbreak in" exact="the UAE" post="[53]. Via stepwise measures, on 25 March 2020 the"/>
   <result pre="the UAE [53]. Via stepwise measures, on 25 March 2020" exact="the UAE" post="General Civil Aviation Authority suspended all flights into and"/>
   <result pre="Drive-through COVID-19 testing facilities were opened in many locations throughout" exact="the UAE" post="and continue to serve the population together with mobile"/>
   <result pre="by most institutions of the federal and local governments in" exact="the UAE" post="to protect employees and customers. The pre-existing advanced technological"/>
   <result pre="protect employees and customers. The pre-existing advanced technological infrastructure of" exact="the UAE" post="enabled remote working and online meetings throughout the educational"/>
   <result pre="have been supportive factors in controlling the SARS-CoV-2 outbreak in" exact="the UAE." post="The influence of hot weather and increasing humidity in"/>
   <result pre="be followed to prevent viral infections until further research emerges." exact="India" post="implemented strict nationwide lockdowns to address the problem of"/>
   <result pre="from March to June 2020 [56]. The first fatality in" exact="India" post="was recorded on 13 March 2020 (Figure 10) [18]."/>
   <result pre="January 2020 [18]. The total number of confirmed cases for" exact="India" post="was 198,706 within a population of around 1.4 billion"/>
   <result pre="increase in COVID-19 cases and fatalities [56]. The situation in" exact="India" post="is far from over and strict regulations should continue,"/>
   <result pre="and Ms. Fariyal S. Shaikh from New Vision University, Tiblisi," exact="Georgia" post="with her contributions to this paper by preparing the"/>
   <result pre="by the Deanship of Graduate Studies and Research, AU, Ajman," exact="United Arab Emirates." post="Conflicts of Interest The authors declare no conflict of"/>
   <result pre="(Including Drive-Through System) Data at a Single University Hospital in" exact="South Korea" post="from 27 January 2020 to 31 March 2020 during"/>
   <result pre="targetsJ. Biomol. Struct. Dyn.202011310.1080/07391102.2020.176721132397951 46.Sen-CroweB.McKenneyM.ElkbuliA.COVID-19 response and containment strategies in" exact="the US," post="South Korea, and Iceland: Lessons learned and future directionsAm."/>
   <result pre="Struct. Dyn.202011310.1080/07391102.2020.176721132397951 46.Sen-CroweB.McKenneyM.ElkbuliA.COVID-19 response and containment strategies in the US," exact="South Korea," post="and Iceland: Lessons learned and future directionsAm. J. Emerg."/>
   <result pre="impact of uncertainties, mitigation strategies, and underreporting of cases in" exact="South Korea," post="Italy, and BrazilChaos Solitons Fractals202013610988810.1016/j.chaos.2020.109888 52.HsihW.H.ChengM.Y.HoM.W.ChouC.H.LinP.C.ChiC.Y.LiaoW.C.ChenC.Y.LeongL.Y.TienN.et al.Featuring COVID-19 cases"/>
   <result pre="Biosci.20205899810.5281/zenodo.3755267 Figure 1 Fatalities during COVID-19 in Portugal, Switzerland, and" exact="Sweden" post="until 2 June 2020 [18]. First fatality occurred in"/>
   <result pre="Sweden until 2 June 2020 [18]. First fatality occurred in" exact="Portugal" post="on 18 March, Switzerland on 6 March, and Sweden"/>
   <result pre="2020 [18]. First fatality occurred in Portugal on 18 March," exact="Switzerland" post="on 6 March, and Sweden on 12 March 2020."/>
   <result pre="in Portugal on 18 March, Switzerland on 6 March, and" exact="Sweden" post="on 12 March 2020. Figure 2 Fatalities during COVID-19"/>
   <result pre="on 12 March 2020. Figure 2 Fatalities during COVID-19 in" exact="South Korea" post="and Japan until 2 June 2020 [18]. First fatality"/>
   <result pre="2020. Figure 2 Fatalities during COVID-19 in South Korea and" exact="Japan" post="until 2 June 2020 [18]. First fatality in South"/>
   <result pre="and Japan until 2 June 2020 [18]. First fatality in" exact="South Korea" post="on 21 February 2020 and Japan on 13 February"/>
   <result pre="First fatality in South Korea on 21 February 2020 and" exact="Japan" post="on 13 February 2020. Figure 3 Fatalities during COVID-19"/>
   <result pre="on 13 February 2020. Figure 3 Fatalities during COVID-19 in" exact="Germany" post="and Turkey until 2 June 2020 [18]. First fatality"/>
   <result pre="February 2020. Figure 3 Fatalities during COVID-19 in Germany and" exact="Turkey" post="until 2 June 2020 [18]. First fatality in Germany"/>
   <result pre="and Turkey until 2 June 2020 [18]. First fatality in" exact="Germany" post="on 10 March 2020 and Turkey on 19 March"/>
   <result pre="[18]. First fatality in Germany on 10 March 2020 and" exact="Turkey" post="on 19 March 2020. Figure 4 Fatalities during COVID-19"/>
   <result pre="on 19 March 2020. Figure 4 Fatalities during COVID-19 in" exact="Italy" post="until 2 June 2020 [18]. First confirmed case in"/>
   <result pre="Italy until 2 June 2020 [18]. First confirmed case in" exact="Italy" post="on 31 January 2020 and first two fatal cases"/>
   <result pre="on 23 February 2020. Figure 5 Fatalities during COVID-19 in" exact="France" post="and UK until 2 June 2020 [18]. First fatality"/>
   <result pre="and UK until 2 June 2020 [18]. First fatality in" exact="France" post="on 15 February 2020 and in UK on 7"/>
   <result pre="on 7 March 2020. Figure 6 Confirmed COVID-19 cases/fatalities in" exact="the USA" post="until 2 June 2020 [18]. First fatality in US"/>
   <result pre="From left to right: (a) confirmed cases and fatalities in" exact="the USA;" post="(b) fatalities in the USA. Figure 7 Fatalities during"/>
   <result pre="confirmed cases and fatalities in the USA; (b) fatalities in" exact="the USA." post="Figure 7 Fatalities during COVID-19 in Latin America until"/>
   <result pre="in the USA. Figure 7 Fatalities during COVID-19 in Latin" exact="America" post="until 2 June 2020 [18]. First fatality in Brazil"/>
   <result pre="Latin America until 2 June 2020 [18]. First fatality in" exact="Brazil" post="on 18 March, Peru on 20 March, Ecuador on"/>
   <result pre="June 2020 [18]. First fatality in Brazil on 18 March," exact="Peru" post="on 20 March, Ecuador on 14 March, and Mexico"/>
   <result pre="fatality in Brazil on 18 March, Peru on 20 March," exact="Ecuador" post="on 14 March, and Mexico on 24 March 2020."/>
   <result pre="March, Peru on 20 March, Ecuador on 14 March, and" exact="Mexico" post="on 24 March 2020. Figure 8 Confirmed COVID-19 cases"/>
   <result pre="March 2020. Figure 8 Confirmed COVID-19 cases and fatalities in" exact="the UAE" post="until 2 June 2020 [18]. First confirmed case on"/>
   <result pre="in UAE. From left to right: (a) confirmed cases in" exact="the UAE;" post="(b) fatalities in the UAE. Figure 9 Safety recommendations"/>
   <result pre="right: (a) confirmed cases in the UAE; (b) fatalities in" exact="the UAE." post="Figure 9 Safety recommendations and measurements during the COVID-19"/>
   <result pre="on 11 May 2020.). Figure 10 Confirmed COVID-19 fatalities in" exact="India" post="until 2 June 2020 [18]. First fatality on 13"/>
   <result pre="Countries [24] Pre-Existing Conditions [19] Preventive Measures Results [18,24] 1" exact="Taiwan" post="[52], South Korea [43,44,51],Hong Kong [29,30],Singapore [29,49], Japan [43]"/>
   <result pre="Pre-Existing Conditions [19] Preventive Measures Results [18,24] 1 Taiwan [52]," exact="South Korea" post="[43,44,51],Hong Kong [29,30],Singapore [29,49], Japan [43] High population density.Old"/>
   <result pre="[18,24] 1 Taiwan [52], South Korea [43,44,51],Hong Kong [29,30],Singapore [29,49]," exact="Japan" post="[43] High population density.Old age population in Japan.Prepared health"/>
   <result pre="12 years Under Control(Figure 8 and Figure 9) 3 Germany," exact="Turkey" post="Old age population in Germany.High population density in urban"/>
   <result pre="isolation, quarantine, and re-testing during quarantine. Under control(Figure 3) 4" exact="Italy" post="[51], Spain Old age population.Low serum 25-hydroxyvitamin D (25(OH)D)"/>
   <result pre="and re-testing during quarantine. Under control(Figure 3) 4 Italy [51]," exact="Spain" post="Old age population.Low serum 25-hydroxyvitamin D (25(OH)D) concentrations in"/>
   <result pre="quarantine. Hit hard, ongoing outbreak(Figure 5 and Figure 6) 6" exact="Sweden" post="[27] Prepared health care system. No lockdown Ongoing outbreak(Figure"/>
   <result pre="health care system. No lockdown Ongoing outbreak(Figure 1) 7 Latin" exact="America" post="[47,51] Unprepared or poor health care system.Overlap with epidemics"/>
   <result pre="of prevention strategy.Late ban on mobility. Hit hard(Figure 7) 8" exact="India" post="[56] Unprepared health care system.High population density in urban"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7434367\results\search\country\results.xml">
   <result pre="130 out of the total 166 new infections identified in" exact="China" post="on April 1, 2020 had no symptoms whatsoever (Day,"/>
   <result pre="for SARS-CoV-2 and enforced to self-isolate at home were in" exact="Italy" post="about 40% of all positive individuals at the beginning"/>
   <result pre="human interferon alpha (rhIFN-Î±) on 2944 health care workers in" exact="China" post="during SARS-CoV-2 epidemics as follows (Meng et al., 2020):"/>
   <result pre="2020). Sanitizers with at least 60% ethanol are recommended by" exact="the USA" post="Centre for Disease Control and Prevention (CDC) for hand"/>
   <result pre="foam both with a 70% concentration of ethanol) marketed in" exact="the USA" post="achieved the abatement of SARS-CoV-2 in suspension below detectable"/>
   <result pre="are active ingredients in over 200 disinfectants currently recommended by" exact="the USA" post="Environmental Protection Agency (EPA) to inactivate SARS-CoV-2. The amounts"/>
   <result pre="Texas Medical BranchGalveston122 DayM.Covid-19: four fifths of cases are asymptomatic," exact="China" post="figures indicateBMJ3692020 Apr 2m137532241884 DolanJ.HamiltonM.Consider Pulling Residents from Nursing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7435356\results\search\country\results.xml">
   <result pre="School of Biology, The Australian National University, Canberra, ACT 2600," exact="Australia" post="Eâ€�mail: farid.rahimi@anu.edu.au epub: 2020-8-8e13656(C) , This article is being"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7435473\results\search\country\results.xml">
   <result pre="in a city called Wuhan in the Hubei province of" exact="China" post="[1]. COVID-19 is a pneumonia-based disease that is the"/>
   <result pre="masks mandatory on public transport and shops, such as the" exact="Czech Republic" post="[17] and Germany [18], while countries like Spain [19]"/>
   <result pre="transport and shops, such as the Czech Republic [17] and" exact="Germany" post="[18], while countries like Spain [19] have made them"/>
   <result pre="the Czech Republic [17] and Germany [18], while countries like" exact="Spain" post="[19] have made them mandatory to be worn outside"/>
   <result pre="made them mandatory to be worn outside as well. In" exact="the United States" post="of America, the Centre for Disease Control and Prevention"/>
   <result pre="them mandatory to be worn outside as well. In the" exact="United States of America," post="the Centre for Disease Control and Prevention have recommended"/>
   <result pre="the 1980s when Mycobacterium tuberculosis (TB) infections became prevalent in" exact="the United States" post="of America [27]. Respirators were used instead of traditional"/>
   <result pre="1980s when Mycobacterium tuberculosis (TB) infections became prevalent in the" exact="United States of America" post="[27]. Respirators were used instead of traditional face masks"/>
   <result pre="tuberculosis (TB) infections became prevalent in the United States of" exact="America" post="[27]. Respirators were used instead of traditional face masks"/>
   <result pre="to breathe. They are named differently in different countries. In" exact="the USA," post="the National Institute for Occupational Safety and Health (NIOSH),"/>
   <result pre="preventing the transmission and spread of viruses [39]. In the" exact="Republic of" post="Ireland, the Health Safety and Executive (HSE) guidelines and"/>
   <result pre="as Lockdown Eases2020Available online: https://www.bbc.com/news/world-europe-52439926(accessed on 22 May 2020) 19.@BBCWorld," exact="Spain" post="Tightens Mask Rules for All Older Than Five2020Available online:"/>
   <result pre="the COVID-19 Pandemic2020Available online: https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/guidance/infectionpreventionandcontrolguidance/ppe/useofsurgicalmasksinhealthcaresetting/(accessed on 27 July 2020) 46.collab:" exact="Ireland" post="Health Service ExecutiveGuidance on the Use of Personal Protective"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7435512\results\search\country\results.xml">
   <result pre="by the FDA, this broadâ€�spectrum antiviral molecule is used in" exact="China" post="and Russia for influenza treatment, and therefore was rapidly"/>
   <result pre="FDA, this broadâ€�spectrum antiviral molecule is used in China and" exact="Russia" post="for influenza treatment, and therefore was rapidly included in"/>
   <result pre="virus.78, 79, 80 Favipiravir was approved for influenza treatment in" exact="Japan" post="in 2014, and is currently assessed for Covidâ€�19 treatment"/>
   <result pre="of a novel coronavirus from a man with pneumonia in" exact="Saudi Arabia." post="N Engl J Med. 2012;367(19):1814â€�1820.23075143 3WuF, ZhaoS, YuB, et"/>
   <result pre="al. Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur J Clin Microbiol Infect Dis. 2005;24(1):44â€�46.15616839 19Mairâ€�JenkinsJ, Saavedraâ€�CamposM,"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospital. J Antimicrob Chemother. 2005;56(5):919â€�922.16183666 21ChenL, XiongJ, BaoL, ShiY."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7435532\results\search\country\results.xml">
   <result pre="today. The Ministry of Science and Technology in the Peopleâ€™s" exact="Republic of" post="China declared three potential antiâ€�viral medicines suitable for treating"/>
   <result pre="Ministry of Science and Technology in the Peopleâ€™s Republic of" exact="China" post="declared three potential antiâ€�viral medicines suitable for treating COVIDâ€�19."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7436575\results\search\country\results.xml">
   <result pre="Clinico S.Anna Brescia, Istituti Ospedalieri Bresciani, Gruppo San Donato, Brescia," exact="Italy" post="Email: deliotds@yahoo.it epub: 2020-8-810.1002/ccd.29179received: 2020-4-27rev-recd: 2020-5-20accepted: 2020-7-19(C) , This"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438223\results\search\country\results.xml">
   <result pre="December 2019 a new RNA betacoronavirus infection emerged in Wuhan," exact="China" post="[1]. It has been recognized as causative factor of"/>
   <result pre="diabetes among patients with adverse disease course was 2.26 in" exact="China" post="and 1.75 at the University Hospital of Padua (Italy)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438224\results\search\country\results.xml">
   <result pre="Western-based: Africa (nÂ =Â 2, Sierra Leona and Liberia), South" exact="America" post="(nÂ =Â 2, Brazil and Colombia), North America (nÂ"/>
   <result pre="2, Sierra Leona and Liberia), South America (nÂ =Â 2," exact="Brazil" post="and Colombia), North America (nÂ =Â 1, United States"/>
   <result pre="Liberia), South America (nÂ =Â 2, Brazil and Colombia), North" exact="America" post="(nÂ =Â 1, United States of America), Europe (nÂ"/>
   <result pre="=Â 2, Brazil and Colombia), North America (nÂ =Â 1," exact="United States" post="of America), Europe (nÂ =Â 1, Norway), and Asia"/>
   <result pre="Europe (nÂ =Â 1, Norway), and Asia (nÂ =Â 2," exact="Australia" post="and Hong Kong). Five studies (Filgueiras MeirelesÂ etÂ al.,"/>
   <result pre="/ Pandemic Aim Methodology Results Erland etÂ al. 2017 /" exact="Norway" post="(Europe) Ebola virus disease To explore and describe midwivesâ€™"/>
   <result pre="for pregnant women who were admitted to Ebola centers in" exact="Sierra Leone" post="Study design:Qualitative study with descriptive and exploratory approach; individual"/>
   <result pre="learn for the futureâ€� Filgueiras MeirelesÂ etÂ al., 2017 /" exact="Brazil" post="(South America) Zika virus To investigate the psychological adjustments"/>
   <result pre="of external demand regarding preventionâ€� GomezÂ etÂ al., 2020 /" exact="Colombia" post="(South America) Zika virus To explore the perceptions and"/>
   <result pre="for access to healthcare servicesâ€� JonesÂ etÂ al., 2017 /" exact="Sierra Leone" post="(Africa) Ebola virus disease To explore nursesâ€™ and midwivesâ€™"/>
   <result pre="sector recovery after the epidemicâ€� KollieÂ etÂ al., 2017 /" exact="Liberia" post="(Africa) Ebola virus disease To explore the experiences of"/>
   <result pre="decision Outcome category: -Work decision LeeÂ etÂ al., 2006 /" exact="Hongkong" post="(Asia) Severe Acute Respiratory Syndrome (SARS) To examine the"/>
   <result pre="4â€œTime and risk managementâ€� LynchÂ etÂ al., 2012 / North" exact="America" post="Pandemic H1N1/09 To explore pregnant women's perceptions of the"/>
   <result pre="for depressive and anxiety disorders in primary care in Goa," exact="India" post="(MANAS): A cluster randomised controlled trialThe Lancet376975820102086209510.1016/s0140-6736(10)61508-5 PezaroS.The case"/>
   <result pre="Organisation. (2020). Middle East respiratory syndrome coronavirus (MERS-Cov) â€&quot; The" exact="Kingdom of Saudi Arabia." post="Retrieved fromhttps://www.who.int/csr/don/24-february-2020-mers-saudi-arabia/en/ World Health Organisation. (2020). Q&amp;amp;A on coronaviruses"/>
   <result pre="Middle East respiratory syndrome coronavirus (MERS-Cov) â€&quot; The Kingdom of" exact="Saudi Arabia." post="Retrieved fromhttps://www.who.int/csr/don/24-february-2020-mers-saudi-arabia/en/ World Health Organisation. (2020). Q&amp;amp;A on coronaviruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438404\results\search\country\results.xml">
   <result pre="UberlÃ¢ndiaUberlÃ¢ndiaBrazil Edited by: Anna Kramvis, University of the Witwatersrand, Johannesburg," exact="South Africa" post="Reviewed by: Olivier Terrier, UMR 5308 Centre International de"/>
   <result pre="(CIRI), France; Maryam Dadar, Razi Vaccine and Serum Research Institute," exact="Iran" post="*Correspondence: Ana Carolina Gomes Jardim, jardim@ufu.br This article was"/>
   <result pre="in clinical phase 3, being tested in several countries, including" exact="the United States," post="Brazil, and countries in Asia and Africa; (ii) mRNA-1273"/>
   <result pre="clinical phase 3, being tested in several countries, including the" exact="United States," post="Brazil, and countries in Asia and Africa; (ii) mRNA-1273"/>
   <result pre="been assessed by several clinical trials in different countries like" exact="France" post="(NCT04365725), Canada (NCT04330690), and the United States (NCT04292899), which"/>
   <result pre="by several clinical trials in different countries like France (NCT04365725)," exact="Canada" post="(NCT04330690), and the United States (NCT04292899), which have been"/>
   <result pre="trials in different countries like France (NCT04365725), Canada (NCT04330690), and" exact="the United States" post="(NCT04292899), which have been conducted based on the first"/>
   <result pre="in different countries like France (NCT04365725), Canada (NCT04330690), and the" exact="United States" post="(NCT04292899), which have been conducted based on the first"/>
   <result pre="the first reported treatment of COVID-19 with Remdesivir in Washington," exact="United States" post="(Holshue et al., 2020). In the first findings from"/>
   <result pre="Clinical trials have been conducted in different medical centers in" exact="Argentina" post="(NCT04381884), Mexico (NCT04391127), Spain (NCT04390022), and the United States"/>
   <result pre="have been conducted in different medical centers in Argentina (NCT04381884)," exact="Mexico" post="(NCT04391127), Spain (NCT04390022), and the United States (NCT04374279) to"/>
   <result pre="conducted in different medical centers in Argentina (NCT04381884), Mexico (NCT04391127)," exact="Spain" post="(NCT04390022), and the United States (NCT04374279) to assess the"/>
   <result pre="medical centers in Argentina (NCT04381884), Mexico (NCT04391127), Spain (NCT04390022), and" exact="the United States" post="(NCT04374279) to assess the clinical implications of the use"/>
   <result pre="centers in Argentina (NCT04381884), Mexico (NCT04391127), Spain (NCT04390022), and the" exact="United States" post="(NCT04374279) to assess the clinical implications of the use"/>
   <result pre="al., 2020a). Tocilizumab is an IL-6 receptor antagonist approved by" exact="the US" post="FDA for the treatment of severe CRS (Grupp et"/>
   <result pre="Additionally, Toniati and collaborators administered Tocilizumab in 100 patients in" exact="Italy" post="(average age of 62 years old) who had been"/>
   <result pre="the performance of chloroquine in vitro, clinical studies conducted in" exact="China" post="and France showed contradictory clinical data (Chen J. et"/>
   <result pre="of chloroquine in vitro, clinical studies conducted in China and" exact="France" post="showed contradictory clinical data (Chen J. et al., 2020;"/>
   <result pre="treatment of patients with SARS during the SARS-CoV outbreak in" exact="Hong Kong" post="in the early 2000s (Cheng et al., 2005). It"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438974\results\search\country\results.xml">
   <result pre="Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE," exact="United Kingdom." post="Tel.: +44 (0) 7903079149. geretti@liverpool.ac.uk pmc-release: 2020-9-9ppub: 2020-9733523532received: 2019-12-19rev-recd:"/>
   <result pre="positive. Prevalence among HBsAg-positive people was highest in Mongolia, the" exact="Republic of" post="Moldova and countries in Western and Middle Africa, and"/>
   <result pre="among HBsAg-positive people was highest in Mongolia, the Republic of" exact="Moldova" post="and countries in Western and Middle Africa, and was"/>
   <result pre="and are detailed in supplementary appendix 13. Among HBsAg-positive people," exact="Mongolia" post="had the highest national anti-HDV prevalence (36.9%); prevalence rates"/>
   <result pre="prevalence (36.9%); prevalence rates &amp;gt;10% were also estimated for the" exact="Republic of" post="Moldova and countries in Western and Middle Africa. Several"/>
   <result pre="prevalence rates &amp;gt;10% were also estimated for the Republic of" exact="Moldova" post="and countries in Western and Middle Africa. Several isolated"/>
   <result pre="HDV anti-prevalence, including indigenous Amazonian Amerindian tribes in Bolivia, Brazil," exact="Colombia" post="and Venezuela, indigenous tribes in the Uttar Pradesh region"/>
   <result pre="the Uttar Pradesh region of India, and selected populations in" exact="Greenland" post="and Rhodes (Greece) (Fig.Â 3, supplementary appendix 11). Only"/>
   <result pre="11). Only limited data were available for North America, Latin" exact="America" post="and Southern Africa and, particularly in view of the"/>
   <result pre="and in haemodialysis recipients (pooled OR 3.4). Five studies from" exact="China" post="and Vietnam indicated that CSWs also had higher prevalence"/>
   <result pre="haemodialysis recipients (pooled OR 3.4). Five studies from China and" exact="Vietnam" post="indicated that CSWs also had higher prevalence (pooled OR"/>
   <result pre="had higher prevalence (pooled OR 18.7). Three studies from Italy," exact="Burkina Faso" post="and Indonesia investigated anti-HDV prevalence among MSM. No cases"/>
   <result pre="(pooled OR 18.7). Three studies from Italy, Burkina Faso and" exact="Indonesia" post="investigated anti-HDV prevalence among MSM. No cases were reported"/>
   <result pre="anti-HDV prevalence among MSM. No cases were reported in the" exact="Burkina Faso" post="study, whereas data from the other 2 studies indicated"/>
   <result pre="localised, including genotype 2 in Asia, genotype 3 in Latin" exact="America" post="(predominating in the Amazon basin), genotype 4 in Japan"/>
   <result pre="Latin America (predominating in the Amazon basin), genotype 4 in" exact="Japan" post="and China (Taiwan), genotype 5 in Western Africa, and"/>
   <result pre="(predominating in the Amazon basin), genotype 4 in Japan and" exact="China" post="(Taiwan), genotype 5 in Western Africa, and genotypes 6â€&quot;8"/>
   <result pre="is heterogeneous, with particularly high prevalence reported in Mongolia, the" exact="Republic of" post="Moldova, and countries in Western and Middle Africa. We"/>
   <result pre="analysis. There are significant data gaps, most strikingly in North" exact="America" post="and Latin America, Southern Africa and most of Asia,"/>
   <result pre="further details. References References 1collab: World Health OrganizationGlobal Hepatitis Report2017WHOGeneva," exact="Switzerland" post="2collab: Polaris Observatory CollaboratorsGlobal prevalence, treatment, and prevention of"/>
   <result pre="series studies using a modified Delphi technique2012Institute of Health EconomicsAlberta," exact="Canada" post="14MunnZ.MoolaS.LisyK.RiitanoD.TufanaruC.Methodological guidance for systematic reviews of observational epidemiological studies"/>
   <result pre="and country estimates of immunization coverage and chronic HBV infection2017WHOGeneva," exact="Switzerland" post="18collab: World Health OrganizationConsolidated strategic information guidelines for viral"/>
   <result pre="guidelines for viral hepatitis: planning and tracking progress towards elimination2019WHOGeneva," exact="Switzerland" post="19MiettinenO.S.Proportion of disease caused or prevented by a given"/>
   <result pre="World Health OrganizationGlobal health sector strategy on viral hepatitis 2016-20212016WHOGeneva," exact="Switzerland" post="28LutterkortG.L.WrankeA.HengstJ.YurdaydinC.StiftJ.BremerB.Viral dominance patterns in chronic hepatitis delta determine early"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7439087\results\search\country\results.xml">
   <result pre="As of March 13, 2020, new cases of COVID-19 in" exact="China" post="have decreased in number to single digits. TCM's curative"/>
   <result pre="and six qi,â€� the science of disaster prediction in ancient" exact="China" post="can be used to predict the effect of natural"/>
   <result pre="herbal intervention in the control group) and conducted it in" exact="Hong Kong," post="China. The sample size was 16,437 (1063 in the"/>
   <result pre="continuously introduced the achievements of modern scientific development. Now that" exact="China" post="is helping overseas to fight the pandemic, it is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7440033\results\search\country\results.xml">
   <result pre="since confirmation of the continent's first case of COVID-19 in" exact="Egypt" post="on February 14th, 2020, the infection rate remains at"/>
   <result pre="486,925 recoveries as at 31st July, 2020; out of which" exact="Nigeria" post="reported 42,689 cases, 878 deaths and 19,290 recoveries, with"/>
   <result pre="et 486Â 925 rÃ©cupÃ©rations au 31Â juillet 2020Â ; le" exact="Nigeria" post="a fait Ã©tat de 42Â 689 cas, 878 dÃ©cÃ¨s"/>
   <result pre="dâ€™Ebola ont eu un impact significatif sur la rÃ©ponse du" exact="Nigeria" post="Ã la COVID-19. Dans cet article, nous examinons la"/>
   <result pre="Afrique. Keywords Africa Coronavirus disease 2019 (COVID-19) Health system preparedness" exact="Nigeria" post="SARS-CoV-2 Mots clÃ©s Afrique Coronavirus 2019 (COVID-19) PrÃ©paration des"/>
   <result pre="clÃ©s Afrique Coronavirus 2019 (COVID-19) PrÃ©paration des systÃ¨mes de santÃ©" exact="Nigeria" post="SRAS-CoV-2 Introduction The current coronavirus disease 2019 (COVID-19) pandemic"/>
   <result pre="and the next one may stamp its feet firmer in" exact="Nigeria" post="and the rest of Africa with much more catastrophic"/>
   <result pre="especially in countries with dysfunctional or weak health systems; and" exact="Nigeria" post="is not excluded in this class. For instance, does"/>
   <result pre="occupy the minds of public health officials and policy-makers in" exact="Nigeria" post="and other African countries. Moreover, since its first report,"/>
   <result pre="the world, at the time an African country such as" exact="Ghana" post="and the USA issued travel bans on returning travellers"/>
   <result pre="at the time an African country such as Ghana and" exact="the USA" post="issued travel bans on returning travellers from high-risk countries"/>
   <result pre="issued travel bans on returning travellers from high-risk countries including" exact="China" post="and countries in Europe, Nigeria, like many other African"/>
   <result pre="there were unconfirmed reports that some Europe-based returning travellers to" exact="the USA" post="who got caught up in the web of travel"/>
   <result pre="State has conducted more tests than any other state in" exact="Nigeria" post="or both? Health system preparedness The COVID-19 pandemic caught"/>
   <result pre="including developed countries. It is no surprise, therefore, that in" exact="Nigeria" post="and the rest of Africa, the initial reaction was"/>
   <result pre="the monumental challenge posed by the ferocious new coronavirus. However," exact="Nigeria" post="has been through similar health emergencies in the past,"/>
   <result pre="leadership in times of health crises. That institute is the" exact="Nigeria" post="Centre for Disease Control (NCDC), which was copycatted from"/>
   <result pre="settings [11], [12]. Lessons from Ebola epidemic inform COVID-19 response" exact="Nigeria" post="demonstrated strong leadership and well-coordinated response during the Ebola"/>
   <result pre="year. Patrick Sawyer, the index case, was a citizen of" exact="Liberia" post="who lost a sister to Ebola before taking a"/>
   <result pre="is, therefore, obvious that Mr Sawyer's decision to travel to" exact="Nigeria" post="could be a deliberate one in a desperate attempt"/>
   <result pre="a declaration on 20th October, 2014, by the WHO that" exact="Nigeria" post="was free of Ebola transmission [7]. The success story"/>
   <result pre="Ebola transmission [7]. The success story of Ebola response in" exact="Nigeria" post="was possible because public health officials leveraged on the"/>
   <result pre="must require a robust multi-sectoral response for effective containment and" exact="Nigeria" post="realizes this. Consequently, the Nigeria Centre for Disease Control"/>
   <result pre="response for effective containment and Nigeria realizes this. Consequently, the" exact="Nigeria" post="Centre for Disease Control (NCDC) and the Presidential Task"/>
   <result pre="public health advisory to Nigerians, case-definition to guide diagnosis in" exact="Nigeria" post="and answers to frequently asked questions on COVID-19 [13]."/>
   <result pre="effective prevention and control. In addition, the Central Bank of" exact="Nigeria" post="(CBN), Nigeria's apex regulatory bank, announced a 1.15 trillion"/>
   <result pre="cholera pandemicProceedings Nat Acad Sci1132016E7730E7739 7WHOSuccessful Ebola responses in Nigeria," exact="Senegal" post="and Mali2015WHOGeneva 8WHO. World Health Organization, 2015. [Accessed on"/>
   <result pre="AfricaNat Med26202044444832161414 11ChengH.-Y.JianS.-W.LiuD.-P.NgT.-C.HuangW.-T.LinH.-H.Contact tracing assessment of COVID-19 transmission dynamics in" exact="Taiwan" post="and risk at different exposure periods before and after"/>
   <result pre="situation report: situation report 1302020[Available from: https://ncdc.gov.ng/diseases/sitreps/] 15Central Bank of" exact="Nigeria" post="(CBN). Healthcare research and development grant guidelines, 2020. [Available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441012\results\search\country\results.xml">
   <result pre="adults.8 In 1918 and 1919, 99% of influenza death in" exact="the US" post="occurred in those younger than age 65, and nearly"/>
   <result pre="and is believed to have originated from chimpanzees in the" exact="Democratic Republic of Congo" post="around 1920. HIV is most commonly acquired via sexual"/>
   <result pre="is believed to have originated from chimpanzees in the Democratic" exact="Republic of" post="Congo around 1920. HIV is most commonly acquired via"/>
   <result pre="to have originated from chimpanzees in the Democratic Republic of" exact="Congo" post="around 1920. HIV is most commonly acquired via sexual"/>
   <result pre="1981. As of 2016, an estimated 1.2 million people in" exact="the US" post="are living with HIV, of whom 1 in 7"/>
   <result pre="of zoonotic originâ€&quot;perhaps batsâ€&quot;and first infected humans in Guangdong Province," exact="China" post="in 2002.23 Most cases of human-to-human transmission occurred via"/>
   <result pre="existing infection control measures to adapt. Hospitals in Toronto and" exact="Singapore" post="exemplified adaptive infectious control practices. In Toronto, an investigation"/>
   <result pre="remained free of SARS-CoV.29 The first wave of infections in" exact="Singapore" post="was largely from intrahospital transmissions; 42% of initial cases"/>
   <result pre="were healthcare providers. During the epidemic, the designated hospital in" exact="Singapore" post="for treating patients with SARS-CoV performed 41 operations.30 One-hundred"/>
   <result pre="followed, with an outbreak rapidly spreading to Guineaâ€™s bordering countries," exact="Liberia" post="and Sierra Leone. With response efforts hampered by limited"/>
   <result pre="an outbreak rapidly spreading to Guineaâ€™s bordering countries, Liberia and" exact="Sierra Leone." post="With response efforts hampered by limited surveillance systems and"/>
   <result pre="healthcare provider infections and 513 deaths were reported in Guinea," exact="Sierra Leone," post="and Liberia combined.34 Guinea lost 1%, Sierra Leone lost"/>
   <result pre="and 513 deaths were reported in Guinea, Sierra Leone, and" exact="Liberia" post="combined.34 Guinea lost 1%, Sierra Leone lost 7%, and"/>
   <result pre="deaths were reported in Guinea, Sierra Leone, and Liberia combined.34" exact="Guinea" post="lost 1%, Sierra Leone lost 7%, and Liberia lost"/>
   <result pre="in Guinea, Sierra Leone, and Liberia combined.34 Guinea lost 1%," exact="Sierra Leone" post="lost 7%, and Liberia lost 8% of their healthcare"/>
   <result pre="Liberia combined.34 Guinea lost 1%, Sierra Leone lost 7%, and" exact="Liberia" post="lost 8% of their healthcare workforce to EVD.35 Impact"/>
   <result pre="rapidly developed protocols to guide EVD care and management.38 In" exact="the US," post="the American College of Surgeons (ACS) adapted Centers for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441141\results\search\country\results.xml">
   <result pre="resulted in chaos, fraudulent schemes, financial abuse, and fear. In" exact="the United States," post="for example, promoters of misinformation sent text messages in"/>
   <result pre="in chaos, fraudulent schemes, financial abuse, and fear. In the" exact="United States," post="for example, promoters of misinformation sent text messages in"/>
   <result pre="to share health information with specific target groups [13]. The" exact="United States" post="Centers for Disease Control and Prevention (CDC) built a"/>
   <result pre="of the National Institute of Allergy and Infectious Diseases in" exact="the United States," post="has taken a leading role in the White House"/>
   <result pre="the National Institute of Allergy and Infectious Diseases in the" exact="United States," post="has taken a leading role in the White House"/>
   <result pre="of public information officers at local public health departments across" exact="the United States" post="revealed that monitoring social media resulted in higher satisfaction"/>
   <result pre="public information officers at local public health departments across the" exact="United States" post="revealed that monitoring social media resulted in higher satisfaction"/>
   <result pre="populations and people of different classes, races, and ethnicities. In" exact="the United States," post="health professionals estimated that about a third of COVID-19"/>
   <result pre="and people of different classes, races, and ethnicities. In the" exact="United States," post="health professionals estimated that about a third of COVID-19"/>
   <result pre="insights through a 67-country surveyEBioMedicine20161229530110.1016/j.ebiom.2016.08.04227658738 5.LarsonHJHartigan-GoKde FigueiredoAVaccine confidence plummets in" exact="the Philippines" post="following dengue vaccine scare: why it matters to pandemic"/>
   <result pre="through a 67-country surveyEBioMedicine20161229530110.1016/j.ebiom.2016.08.04227658738 5.LarsonHJHartigan-GoKde FigueiredoAVaccine confidence plummets in the" exact="Philippines" post="following dengue vaccine scare: why it matters to pandemic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441224\results\search\country\results.xml">
   <result pre="treatment data. The highest number of papers was published by" exact="the USA" post="(nâ€‰=â€‰25, reporting 2559 treatment courses), followed by China (nâ€‰=â€‰16,"/>
   <result pre="by the USA (nâ€‰=â€‰25, reporting 2559 treatment courses), followed by" exact="China" post="(nâ€‰=â€‰16, reporting 14,680 treatment courses) and Spain (nâ€‰=â€‰16, reporting"/>
   <result pre="courses), followed by China (nâ€‰=â€‰16, reporting 14,680 treatment courses) and" exact="Spain" post="(nâ€‰=â€‰16, reporting 4103 treatment courses). Country-level data describing the"/>
   <result pre="(such as the sudden end to the EVD outbreak in" exact="Liberia" post="that prematurely halted a clinical treatment trial) [25] or"/>
   <result pre="geographic diversity and global epidemiology. In the results reported here," exact="China" post="was heavily represented and reported the majority of treatment"/>
   <result pre="of the epidemiological literature on the 2003 SARS outbreaks in" exact="Hong Kong" post="and Toronto: a time-stratified reviewPLoS Med201075e100027210.1371/journal.pmed.100027220454570 30.IoannidisJPManzoliLDe VitoCD'AddarioMVillariPPublication delay"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441399\results\search\country\results.xml">
   <result pre="high mortality rates, particularly in residential home patients across the" exact="United Kingdom," post="Italy, the United States, and many other countries16,17. Moreover,"/>
   <result pre="particularly in residential home patients across the United Kingdom, Italy," exact="the United States," post="and many other countries16,17. Moreover, other comorbidities and factors"/>
   <result pre="in residential home patients across the United Kingdom, Italy, the" exact="United States," post="and many other countries16,17. Moreover, other comorbidities and factors"/>
   <result pre="series and case reports45,46. A community-based case control study in" exact="Italy" post="of 12 PD COVID-19 cases suggested substantial worsening of"/>
   <result pre="of the next human pandemicArch. Virol. Suppl.1997131051139413531 7.NguyenAMNoymerAInfluenza mortality in" exact="the United States," post="2009 pandemic: burden, timing and age distributionPLoS ONE20138e6419823717567 8.SalamatbakhshMMobarakiKSadeghimohammadiSAhmadzadehJThe"/>
   <result pre="the next human pandemicArch. Virol. Suppl.1997131051139413531 7.NguyenAMNoymerAInfluenza mortality in the" exact="United States," post="2009 pandemic: burden, timing and age distributionPLoS ONE20138e6419823717567 8.SalamatbakhshMMobarakiKSadeghimohammadiSAhmadzadehJThe"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci." exact="China" post="Life Sci.20206345746032009228 59.HoffmannMet al.SARS-CoV-2 cell entry depends on ACE2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441762\results\search\country\results.xml">
   <result pre="druggability of screened molecules were investigated for ADME properties using" exact="Swiss" post="ADME software (Daina etÂ al., 2017). Three pharmacokinetic parameters"/>
   <result pre="project under Nanobiotechnology scheme (BT/PR21972/NNT/28/1280/2017). AS acknowledge the Government of" exact="India" post="for funding under DST-SERB core research grant scheme (EMR/2016/003851)."/>
   <result pre="respiratory syndrome corona virus-2 (SARS-CoV-2) virus that cause COVID-19 disease" exact="Swiss" post="ADME a tool to predict ADME parameters, pharmacokinetic properties,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441776\results\search\country\results.xml">
   <result pre="word-count: 1. Introduction A novel coronavirus was identified in Wuhan," exact="China" post="in December 2019 spreading an infectious pneumonia-like disease (Huang"/>
   <result pre="epidemics of severe acute respiratory syndrome coronavirus (SARS-CoV) in Guangdong," exact="China" post="in 2003 and Middle East respiratory syndrome coronavirus (MERS-CoV)"/>
   <result pre="the ribosome. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, (18), 10037â€&quot;10041. 10.1073/pnas.18134239811517324 BedfordJ., EnriaD., GieseckeJ., HeymannD."/>
   <result pre="ribosome. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="(18), 10037â€&quot;10041. 10.1073/pnas.18134239811517324 BedfordJ., EnriaD., GieseckeJ., HeymannD. L., IhekweazuC.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7442131\results\search\country\results.xml">
   <result pre="and regions affected. Most of the cases occurred in China," exact="Canada" post="and Singapore. Both outbreaks were first reported in China"/>
   <result pre="China, Canada and Singapore. Both outbreaks were first reported in" exact="China" post="and resulted in a large number of infections. However,"/>
   <result pre="RNA detection. The first autopsy report of the COVID-19 in" exact="China" post="indicated that the gross view of the lung had"/>
   <result pre="undergo psychological counseling. Drugs Recently, based on the experiences of" exact="China" post="and other countries worldwide in the fight against COVID-19,"/>
   <result pre="919 &amp;gt;668,073 Geographical distribution Mainly in China, Canada, Singapore, and" exact="Vietnam" post="Global Epidemic prevention Community lockdown only Community, city, even"/>
   <result pre="had spread to 216 countries and regions. Among these countries," exact="the United States" post="has confirmed a total of 4,388,566 cases, both Brazil"/>
   <result pre="spread to 216 countries and regions. Among these countries, the" exact="United States" post="has confirmed a total of 4,388,566 cases, both Brazil"/>
   <result pre="United States has confirmed a total of 4,388,566 cases, both" exact="Brazil" post="and India had more than 1,600,000 confirmed patients and"/>
   <result pre="has confirmed a total of 4,388,566 cases, both Brazil and" exact="India" post="had more than 1,600,000 confirmed patients and the epidemic"/>
   <result pre="cases was lower than 10 everyday now. During the outbreak," exact="China" post="acted quickly; an epidemiological investigation was carried out on"/>
   <result pre="carried out on December 29. On January 1, the South" exact="China" post="seafood market in Wuhan was closed. On January 23,"/>
   <result pre="18, the WHO representative in China, Dr. Colliers, said that" exact="China" post="has shown the world that the trajectory of the"/>
   <result pre="that has not occurred in China. The epidemiological curve in" exact="China" post="is irregular, the epidemic has been snuffed out in"/>
   <result pre="that the international community works together to fight the epidemic." exact="China" post="has taken the lead in building a community of"/>
   <result pre="building a community of shared futures to fight the epidemic:" exact="China" post="has provided anti-epidemic material assistance to 82 other countries"/>
   <result pre="82 other countries and international organizations, including Japan, Korea, Italia," exact="France" post="and Serbia. More importantly, China is willing to share"/>
   <result pre="organizations, including Japan, Korea, Italia, France and Serbia. More importantly," exact="China" post="is willing to share its experience with the rest"/>
   <result pre="to share its experience with the rest of the world." exact="China" post="has recently sent anti-epidemic teams to Iran, Iraq and"/>
   <result pre="the world. China has recently sent anti-epidemic teams to Iran," exact="Iraq" post="and Italy. Although the development of therapeutics and vaccines"/>
   <result pre="immunogenic in healthy adults, and ongoing phase 2 trial in" exact="China" post="(NCT04341389) will provide more information on the safety and"/>
   <result pre="work was supported by the National Natural Scientific Foundation of" exact="China" post="(81870767 &amp;amp; 81570978), the Project of 10.13039/501100013059Jiangsu Provincial Medical"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003Lancet362939320031353135814585636 2HuangC.WangY.LiX.RenL.ZhaoJ.HuY.Clinical features of patients infected"/>
   <result pre="pneumoniaN Engl J Med3821320201199120731995857 18Nation Health Commission of the Peopleâ€™s" exact="Republic of" post="ChinaNotice on the Issuance of COVID-19 Protocol (Trial Seventh"/>
   <result pre="Biotechnol303202031332410.4014/jmb.2003.0301132238757 38LiH.ChenX.HuangH.The novel coronavirus outbreak: what can be learned from" exact="China" post="in public reporting?Glob Health Res Policy52020932166128 39ZhuF.C.LiY.H.GuanX.H.HouL.H.WangW.J.LiJ.X.Safety, tolerability, and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7443229\results\search\country\results.xml">
   <result pre="from coronavirus RNAProceedings of the National Academy of Sciences of" exact="the United States" post="of America20181152E162E17110.1073/pnas.171880611529279395 110MartÃ­nJ. F. B.JimÃ©nezJ. L.MuEÃ³z-FernÃ¡ndezA.Pentoxifylline and severe acute"/>
   <result pre="coronavirus RNAProceedings of the National Academy of Sciences of the" exact="United States" post="of America20181152E162E17110.1073/pnas.171880611529279395 110MartÃ­nJ. F. B.JimÃ©nezJ. L.MuEÃ³z-FernÃ¡ndezA.Pentoxifylline and severe acute"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7443335\results\search\country\results.xml">
   <result pre="spread to many countries including European Union (EU), Southeast Asia," exact="South Africa" post="and North America [1]. Fig. 1 Globally, as of"/>
   <result pre="including European Union (EU), Southeast Asia, South Africa and North" exact="America" post="[1]. Fig. 1 Globally, as of 3:06Â pm CEST,"/>
   <result pre="first approved drug by the national medical products administration of" exact="China" post="for the treatment of COVID-19 [41]. Cai et al."/>
   <result pre="indicated that almost all clinically stable patients with COVID-19 in" exact="China" post="experienced significant severity of post-traumatic stress symptoms [144]. Both"/>
   <result pre="an open-label non-randomized clinical trialMedRxiv.202010.1101/2020.03.16.200371352020.03.16.20037135 50MagagnoliJ.NarendranS.PereiraF.CummingsT.HardinJ.W.SuttonS.S.AmbatiJ.Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covid-19MedRxiv.202010.1101/2020.04.16.200659202020.04.16.20065920 51COVID-19 presenting as stroke, (n.d)."/>
   <result pre="convalescent plasma therapy in severe COVID-19 patientsProc. Natl. Acad. Sci." exact="U. S." post="A.11720209490949610.1073/pnas.200416811732253318 57RajendranK.KrishnasamyN.RangarajanJ.RathinamJ.NatarajanM.RamachandranA.Convalescent plasma transfusion for the treatment of COVID-19:"/>
   <result pre="porous particles of capreomycin for treatment of tuberculosis in a" exact="Guinea" post="pig modelAntimicrob. Agents Chemother.5120072830283610.1128/AAC.01164-0617517845 70Ben-JebriaA.EskewM.L.EdwardsD.A.Inhalation system for pulmonary aerosol"/>
   <result pre="with multiwalled carbon nanotubes and near-infrared radiationProc. Natl. Acad. Sci." exact="U. S." post="A.1062009128971290210.1073/pnas.090519510619620717 90YangJ.Inhibition of SARS-CoV-2 replication by acidizing and RNA"/>
   <result pre="nCoV-19) targeting COVID-19, (n.d). https://www.trialsitenews.com/university-of-oxford-commences-clinical-trial-for-vaccine-candidate-chadox1-ncov-19-targeting-covid-19-2/ (accessed June 18, 2020). 125Update:" exact="China" post="approves three COVID-19 vaccines for clinical trials - Xinhua|English.news.cn,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7444586\results\search\country\results.xml">
   <result pre="Epidemiology : People and Places : Geographical Locations : Asia:" exact="China" post=": People and places : Geographical locations : Europe"/>
   <result pre="and places : Geographical locations : Europe : European Union:" exact="Italy" post=": People and Places : Geographical Locations : Asia:"/>
   <result pre="Italy : People and Places : Geographical Locations : Asia:" exact="Pakistan" post="Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide"/>
   <result pre="â€&quot; review &amp;amp; editing234*[1], Department of Mathematics, Statistics, and Physics," exact="Qatar" post="University, Doha, Qatar[2], Infectious Disease Epidemiology Group, Weill Cornell"/>
   <result pre="Qatar[2], Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University," exact="Qatar" post="Foundation â€&quot; Education City, Doha, Qatar[3], World Health Organization"/>
   <result pre="and Viral Hepatitis, Weill Cornell Medicine â€&quot; Qatar, Cornell University," exact="Qatar" post="Foundation â€&quot; Education City, Doha, Qatar[4], Department of Population"/>
   <result pre="Weill Cornell Medicine, Cornell University, New York City, New York," exact="United States" post="of America[5], Department of Epidemiology and Population Health, American"/>
   <result pre="grant number 9-040-3-008 and NPRP grant number 12S-0216-190094 from the" exact="Qatar" post="National Research Fund (a member of Qatar Foundation). The"/>
   <result pre="12S-0216-190094 from the Qatar National Research Fund (a member of" exact="Qatar" post="Foundation). The authors are also grateful for support provided"/>
   <result pre="manuscript. The publication of this article was funded by the" exact="Qatar" post="National Library. fig-count: table-count: page-count: Data Availability All relevant"/>
   <result pre="apparent [4â€&quot;7]. In a recent study examining SARS-CoV-2 epidemiology in" exact="China" post="[4], we quantified the effect of age on the"/>
   <result pre="developed deterministic mathematical model [4] describing SARS-CoV-2 transmission dynamics in" exact="China" post="(S3 Fig in S1 File), to 159 countries and"/>
   <result pre="observed age-specific distribution of cases across these infection stages in" exact="China" post="[8â€&quot;10]. The duration of infectiousness was assumed to last"/>
   <result pre="mortality, as informed by the age-stratified disease mortality rate in" exact="China" post="[11, 12]. Model parameters were based on current data"/>
   <result pre="natural history and epidemiology, or through model fitting to the" exact="China" post="outbreak data [4] (S1, S2 Tables in S1 File)."/>
   <result pre="the observed case fatality rate) were assumed as those in" exact="China" post="[4]. The population size, demographic structure, and life expectancy"/>
   <result pre="estimated R0 in these select countries, which was highest in" exact="Italy" post="at 2.30, followed by USA and China at 1.95,"/>
   <result pre="was highest in Italy at 2.30, followed by USA and" exact="China" post="at 1.95, Brazil at 1.75, Indonesia at 1.55, India"/>
   <result pre="Italy at 2.30, followed by USA and China at 1.95," exact="Brazil" post="at 1.75, Indonesia at 1.55, India at 1.45, Egypt"/>
   <result pre="followed by USA and China at 1.95, Brazil at 1.75," exact="Indonesia" post="at 1.55, India at 1.45, Egypt at 1.35, Pakistan"/>
   <result pre="and China at 1.95, Brazil at 1.75, Indonesia at 1.55," exact="India" post="at 1.45, Egypt at 1.35, Pakistan at 1.25, and"/>
   <result pre="1.95, Brazil at 1.75, Indonesia at 1.55, India at 1.45," exact="Egypt" post="at 1.35, Pakistan at 1.25, and lowest in Niger"/>
   <result pre="1.75, Indonesia at 1.55, India at 1.45, Egypt at 1.35," exact="Pakistan" post="at 1.25, and lowest in Niger at 0.93. Country-specific"/>
   <result pre="1.45, Egypt at 1.35, Pakistan at 1.25, and lowest in" exact="Niger" post="at 0.93. Country-specific estimates of R0 grouped by World"/>
   <result pre="peak was reached after 122 days (~4 months), whereas in" exact="Pakistan" post="it was reached after 350 days (nearly a year)."/>
   <result pre="epidemic cycle out of the total population, was highest in" exact="Italy" post="at 75.5 and lowest in Pakistan at 33.0 (Fig"/>
   <result pre="population, was highest in Italy at 75.5 and lowest in" exact="Pakistan" post="at 33.0 (Fig 3A). Across world regions, the median"/>
   <result pre="countries followed the same pattern, where it was highest in" exact="Italy" post="at 4.7 and lowest in Pakistan at 0.9 (Fig"/>
   <result pre="it was highest in Italy at 4.7 and lowest in" exact="Pakistan" post="at 0.9 (Fig 3B). Across world regions, the median"/>
   <result pre="100 persons in the nine select countries was highest in" exact="Italy" post="at 60.5 and lowest in Pakistan at 27.0 (Fig"/>
   <result pre="countries was highest in Italy at 60.5 and lowest in" exact="Pakistan" post="at 27.0 (Fig 4A). Across world regions, the median"/>
   <result pre="100 persons in the nine select countries was highest in" exact="Italy" post="at 14.7 and lowest in Pakistan at 5.0 (Fig"/>
   <result pre="countries was highest in Italy at 14.7 and lowest in" exact="Pakistan" post="at 5.0 (Fig 4B). Across world regions, the median"/>
   <result pre="opposed to fast growing epidemics in the European Region and" exact="the USA." post="This study has limitations. Model estimations are contingent on"/>
   <result pre="profile. We used the susceptibility profile as derived from the" exact="China" post="outbreak data [4], but this may not be generalizable"/>
   <result pre="clearance and limited transmission potential. Data on infection clusters from" exact="China" post="and other countries suggested that children do not appear"/>
   <result pre="R0 is higher than assumed here based on fitting the" exact="China" post="epidemic [4, 39, 40], which would increase the R0"/>
   <result pre="of assortativeness in age group mixing based on fitting the" exact="China" post="epidemic [4], however, a sensitivity analysis assuming high assortativeness,"/>
   <result pre="R0. For instance, the most probable value for R0 in" exact="China" post="was 1.95, but the point estimate assuming the baseline"/>
   <result pre="data, was able to reproduce the epidemic as observed in" exact="China" post="[4], and generated results that are valid to a"/>
   <result pre="Del MansoM, FabianiM, et al.Epidemiological characteristics of COVID-19 cases in" exact="Italy" post="and estimates of the reproductive numbers one month into"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7445016\results\search\country\results.xml">
   <result pre="humans [52]. In 2001, samples from the healthy persons of" exact="Hong Kong" post="on molecular assessment showed 2.5% frequency rate of antibodies"/>
   <result pre="detects a large number of new coronaviruses in the South" exact="China" post="seafood market in Wuhan. Available at: https://www.xinhuanet.com/2020-01/27/c_1125504355.htm. Accessed 20"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in FebruaryLancet20033621353135814585636 49.Zi-WeiYShuofengYKit-SanYSin-YeeFChi-PingCDong-YanJZoonotic origins of human coronavirusesInt J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7445120\results\search\country\results.xml">
   <result pre="Program (5th edition) published by the National Health Commission of" exact="China" post="[19]. Patients with diabetes were designated according to the"/>
   <result pre="Special Project for â€œSignificant New Drugs Developmentâ€� (grant number 2017ZX09304022);" exact="China" post="Ying-cai Young Scientific Talent Research Project (grant number 2017-N-07)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7445369\results\search\country\results.xml">
   <result pre="10, P.O. Box Â· Postfach Â· Case postale, CHâ€&quot;4009, Basel," exact="Switzerland" post="Â· Schweiz Â· Suisse, Phone: +41 61 306 11"/>
   <result pre="Box Â· Postfach Â· Case postale, CHâ€&quot;4009, Basel, Switzerland Â·" exact="Schweiz" post="Â· Suisse, Phone: +41 61 306 11 11, Fax:"/>
   <result pre="5 continents, with most cases reported in North and South" exact="America" post="and Europe, and children and young adults being the"/>
   <result pre="young adults being the most susceptible age-groups [18]. In Central" exact="America" post="and the Dominican Republic, H1N1 pandemic was lethal in"/>
   <result pre="the most susceptible age-groups [18]. In Central America and the" exact="Dominican Republic," post="H1N1 pandemic was lethal in young adults, pregnant women,"/>
   <result pre="large outbreak of severe lower respiratory tract disease in North" exact="America" post="[23]. HFMD is associated with acute neurological disease in"/>
   <result pre="significantly increased incidence of GBS after swine flu vaccination in" exact="the USA" post="in 1976 led to a debate on the possible"/>
   <result pre="pandemic influenza A/H1N1 virus. A case-control study was conducted in" exact="Italy" post="between October 2010 and May 2011 to explore the"/>
   <result pre="encephalopathy, myelopathy, and peripheral nerve lesions [37]. These claims led" exact="the US" post="government to ask Leonard T. Kurland, an eminent US"/>
   <result pre="China, where the virus was first discovered, and data from" exact="the US" post="and several European countries. The GBD Collaboration might provide"/>
   <result pre="characteristics of deaths associated with influenza A(H1N1) pdm09 in Central" exact="America" post="and Dominican Republic 2009â€&quot;2010BMC Public Health20151573426227404 20ColtartCELindseyBGhinaiIJohnsonAMHeymannDLThe Ebola outbreak,"/>
   <result pre="deaths associated with influenza A(H1N1) pdm09 in Central America and" exact="Dominican Republic" post="2009â€&quot;2010BMC Public Health20151573426227404 20ColtartCELindseyBGhinaiIJohnsonAMHeymannDLThe Ebola outbreak, 2013â€&quot;2016: old lessons"/>
   <result pre="al.Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program," exact="United States," post="1976â€&quot;1977Am J Epidemiol1979110(2)10523463869 34GaleottiFMassariMD'AlessandroRBeghiEChiÃ²ALogroscinoGet al.Risk of Guillain-BarrÃ© syndrome after"/>
   <result pre="of the COVID-19 pandemic on hospital demand and deaths for" exact="the USA" post="and European Economic Area countriesSubmitted April 21, 2020 as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7446744\results\search\country\results.xml">
   <result pre="there was no thrombosis or death in a study from" exact="Singapore" post="[35]. A study on 24 critically ill patients analyzed"/>
   <result pre="larger study involving 184 patients admitted in three hospitals in" exact="the Netherlands" post="and treated with prophylactic enoxaparin reported an incidence of"/>
   <result pre="study involving 184 patients admitted in three hospitals in the" exact="Netherlands" post="and treated with prophylactic enoxaparin reported an incidence of"/>
   <result pre="from COVID-19 disease, The ANTI-CO Trial Hamad Medical Corporation, Doha," exact="Qatar" post="RCT of anticoagulation with bivalirudin vs. SOC heparin in"/>
   <result pre="of Therapeutic Anticoagulation Versus Standard Care St Michaelâ€™s Hospital, Toronto," exact="Canada" post="RCT of therapeutic heparin anticoagulation vs. SOC in patients"/>
   <result pre="of Anticoagulation therapy on clinical outcomes in COVID-19 27 centers," exact="Germany" post="RCT of rivaroxaban vs. SOC heparin prophylaxis Any thrombosis,"/>
   <result pre="Complications With Low- and High-dose Anticoagulation Geneva University Hospitals, Geneva," exact="Switzerland" post="RCT of therapeutic vs. prophylactic anticoagulation with heparin Any"/>
   <result pre="with COVID-19 Infection, nested in the Corimmuno-19 Cohort Multiple centers," exact="France" post="RCT of therapeutic tinzaparin or unfractionated heparin with SOC"/>
   <result pre="Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial Multiple centers," exact="Brazil" post="RCT of therapeutic anticoagulation with rivaroxaban or enoxaparin vs."/>
   <result pre="to COVID-19 Pandemic Hospital das Clinicas da FMUSP Sao Paolo," exact="Brazil" post="RCT of therapeutic enoxaparin vs. SOC heparin prophylaxis in"/>
   <result pre="Critically Ill COVID-19 Patients South General Hospital, Stockholm, Stockholms LÃ¤n," exact="Sweden" post="Retrospective observational study of conventional, double dose, and therapeutic"/>
   <result pre="Patients in ECMO Multiple (97) centers in Europe, Russia, and" exact="Israel" post="Observational study in ECMO patients Clinical outcome at 6Â"/>
   <result pre="controlled trial of methylprednisolone against standard of care in Beijing," exact="China" post="(NCT04244591) had to be stopped because of lack of"/>
   <result pre="the Randomised Evaluation of COVID-19 Therapy (RECOVERY) conducted in the" exact="United Kingdom" post="provided preliminary data that low-dose dexamethasone reduced deaths by"/>
   <result pre="clinical trial is currently being undertaken (ChiCTR2000029765). Another trial in" exact="Belgium" post="has been designed to observe the efficacy of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7447002\results\search\country\results.xml">
   <result pre="SARS-CoV-2 (COVID-19) Protective Behaviors on People Living With HIV, Atlanta," exact="Georgia" post="KalichmanSeth C.PhDaEatonLisa A.PhDaBermanMarciePhDaKalichmanMoira O.MSWaKatnerHaroldMDbSamSoya S.PhDcCaliendoAngela M.MD, PhDd[a], [b], [c],"/>
   <result pre="the absence of a national COVID-19 strategy, the state of" exact="Georgia" post="was late in response. On March 13, 2020, the"/>
   <result pre="of Georgia was late in response. On March 13, 2020," exact="the US" post="government declared a national state of emergency, and on"/>
   <result pre="with HIV in Atlanta, GA, conducted at the start of" exact="the US" post="COVID-19 epidemic. There were 2397 diagnosed cases and 12"/>
   <result pre="7-day average number of COVID-19 diagnoses in the state of" exact="Georgia" post="was greater than 600, and the average daily deaths"/>
   <result pre="More than 40% of cases and 40% of deaths in" exact="Georgia" post="occurred in the Atlanta metro area. The City of"/>
   <result pre="(AUDIT-C).24,25 To assess food insecurity, we used items adapted from" exact="the US" post="Food Security Scale that have been validated in the"/>
   <result pre="have been validated in the past research and used by" exact="the US" post="Census Bureau.26 History of COVID-19 Severity Risks We constructed"/>
   <result pre="risk for contracting COVID-19. All behaviors assessed were recommended by" exact="the US" post="Federal Government and the state of GA to mitigate"/>
   <result pre="Months in: A Timeline of How COVID-19 Has Unfolded in" exact="the US" post="2020. Available at: https://www.usatoday.com/in-depth/news/nation/2020/04/21/coronavirus-updates-how-covid-19-unfolded-u-s-timeline/2990956001/. Accessed May 1, 2020. 19.RidgwayJSchmittJFriedmanEet"/>
   <result pre="amid the COVID-19 pandemic.AIDS Behav.2020. doi: 10.1007/s10461-020-02904-3. 21.collab: Health GDoP." exact="Georgia" post="Department of Public Health COVID-19 Daily Status Report 2020."/>
   <result pre="AUDIT. Psychol Assess.2000;12:346â€&quot;353.11021159 26.CookJTFrankDAFood security, poverty, and human development in" exact="the United States." post="Ann N Y Acad Sci.2008;1136:193â€&quot;209.17954670 27.MolecularARealTime HIV-1 Assay. Abbott"/>
   <result pre="Psychol Assess.2000;12:346â€&quot;353.11021159 26.CookJTFrankDAFood security, poverty, and human development in the" exact="United States." post="Ann N Y Acad Sci.2008;1136:193â€&quot;209.17954670 27.MolecularARealTime HIV-1 Assay. Abbott"/>
   <result pre="active antiretroviral therapy use in patients with HIV infection in" exact="the United States." post="HCSUS Consortium. HIV Cost and Services Utilization. J Acquir"/>
   <result pre="antiretroviral therapy use in patients with HIV infection in the" exact="United States." post="HCSUS Consortium. HIV Cost and Services Utilization. J Acquir"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7448857\results\search\country\results.xml">
   <result pre="of Virology, Center for Biosafety Mega-Science, Chinese Academy of SciencesWuhanPeopleâ€™s" exact="Republic of" post="China[b], The Joint Center of Translational Precision Medicine, Guangzhou"/>
   <result pre="Guangzhou Institute of Pediatrics, Guangzhou Women and Childrenâ€™s Medical CenterGuangzhouPeopleâ€™s" exact="Republic of" post="China[c], The Joint Center of Translational Precision Medicine, Wuhan"/>
   <result pre="Precision Medicine, Wuhan Institute of Virology, Chinese Academy of SciencesWuhanPeopleâ€™s" exact="Republic of" post="China[d], School of Medicine, Hunan Normal UniversityChangshaPeopleâ€™s Republic of"/>
   <result pre="SciencesWuhanPeopleâ€™s Republic of China[d], School of Medicine, Hunan Normal UniversityChangshaPeopleâ€™s" exact="Republic of" post="China[e], University of Chinese Academy of SciencesBeijingPeopleâ€™s Republic of"/>
   <result pre="UniversityChangshaPeopleâ€™s Republic of China[e], University of Chinese Academy of SciencesBeijingPeopleâ€™s" exact="Republic of" post="China[f], Drug Discovery Center for Infectious Disease, Nankai UniversityTianjinPeopleâ€™s"/>
   <result pre="of China[f], Drug Discovery Center for Infectious Disease, Nankai UniversityTianjinPeopleâ€™s" exact="Republic of" post="China CONTACT Han-Qing Ye yehq@wh.iov.cnWuhan Institute of Virology, Chinese"/>
   <result pre="Drug Discovery Center for Infectious Disease, Nankai UniversityTianjinPeopleâ€™s Republic of" exact="China" post="CONTACT Han-Qing Ye yehq@wh.iov.cnWuhan Institute of Virology, Chinese Academy"/>
   <result pre="yehq@wh.iov.cnWuhan Institute of Virology, Chinese Academy of Sciences, Wuhan430071, Peopleâ€™s" exact="Republic of" post="China Bo Zhang zhangbo@wh.iov.cnWuhan Institute of Virology, Chinese Academy"/>
   <result pre="of Virology, Chinese Academy of Sciences, Wuhan430071, Peopleâ€™s Republic of" exact="China" post="Bo Zhang zhangbo@wh.iov.cnWuhan Institute of Virology, Chinese Academy of"/>
   <result pre="zhangbo@wh.iov.cnWuhan Institute of Virology, Chinese Academy of Sciences, Wuhan430071, Peopleâ€™s" exact="Republic of" post="China *These authors have equal contribution to this study."/>
   <result pre="of Virology, Chinese Academy of Sciences, Wuhan430071, Peopleâ€™s Republic of" exact="China" post="*These authors have equal contribution to this study. :"/>
   <result pre="SARS-CoV-2 infection associated with the outbreak of viral pneumonia in" exact="China" post="is ongoing worldwide. There are no approved antiviral therapies"/>
   <result pre="supported by the National Key Research and Development Program of" exact="China" post="(2018YFA0507201). The experiments related to SARS-CoV-2 are completed at"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449072\results\search\country\results.xml">
   <result pre="First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in" exact="Cameroon" post="following exposure to Raltegravir: lessons and implications in the"/>
   <result pre="Keywords HIV drug resistance Integrase inhibitors Protease inhibitors Viral tropism" exact="Cameroon" post="Funding Chantal Biya International Reference center for research on"/>
   <result pre="essentially) remains sub-optimal [1, 2]. ART program was launched in" exact="Cameroon" post="by May 2003, and genotyping drug resistance testing (GRT)"/>
   <result pre="of DRV/r and DTG efficacies. Of note, previous report from" exact="Cameroon" post="showed a case of successful raltegravir-containing ART for managing"/>
   <result pre="case surveillance should be required even in resource-limited settings like" exact="Cameroon" post="[18]. Conclusion In the era of transition to DTG-based"/>
   <result pre="the care and monitoring of this patient. We thank Michael" exact="Jordan" post="for a thorough review of this manuscript prior to"/>
   <result pre="transcriptase genotyping assay in CameroonArch Virol201115671235124310.1007/s00705-011-0982-321465085 11.Fokam J, Bellocchi MC," exact="Armenia" post="D, et al. Next-generation sequencing provides an added value"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449407\results\search\country\results.xml">
   <result pre="Abuse : People and places : Geographical locations : North" exact="America" post=": United States: Indiana : Medicine and Health Sciences"/>
   <result pre="review &amp;amp; editing1257*[1], Global Health Policy Institute, San Diego, CA," exact="United States" post="of America[2], Department of Healthcare Research and Policy, University"/>
   <result pre="Healthcare Research and Policy, University of California, San Diego, CA," exact="United States" post="of America[3], Department of Computer Science and Engineering, University"/>
   <result pre="Computer Science and Engineering, University of California, San Diego, CA," exact="United States" post="of America[4], Department of Computational Science, Mathematics and Engineering,"/>
   <result pre="Science, Mathematics and Engineering, University of California, San Diego, CA," exact="United States" post="of America[5], Department of Anesthesiology, San Diego School of"/>
   <result pre="Diego School of Medicine, University of California, San Diego, CA," exact="United States" post="of America[6], Max Planck Institute for Human Development, Berlin,"/>
   <result pre="Diego School of Medicine, University of California, San Diego, CA," exact="United States" post="of AmericaLavorgnaLuigiEditor[], Universita degli Studi della Campania Luigi Vanvitelli,"/>
   <result pre="after the outbreak was widely reported, though we note that" exact="the US" post="Centers for Disease Control and Prevention reports that the"/>
   <result pre="dataset consisted of 585,620,471 tweets geocoded for different locations in" exact="the United States;" post="each tweet contained the text content of the tweet"/>
   <result pre="consisted of 585,620,471 tweets geocoded for different locations in the" exact="United States;" post="each tweet contained the text content of the tweet"/>
   <result pre="IDU among people who inject drugs (PWIDs) and HIV in" exact="the USA" post="has been primarily black, male, and urban, whereas the"/>
   <result pre="This epidemiological profile is similar to current heroin users in" exact="the United States," post="potentially indicating that the demographic makeup of the state"/>
   <result pre="epidemiological profile is similar to current heroin users in the" exact="United States," post="potentially indicating that the demographic makeup of the state"/>
   <result pre="JohnsonAS, HallHI. The status of the National HIV Surveillance System," exact="United States," post="2013. Public Health Rep. 20147;129:335â€&quot;41. 10.1177/00333549141290040824982536 9KagasheI, YanZ, SuheryaniI."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449465\results\search\country\results.xml">
   <result pre="2020 ManickamCordelia1http://orcid.org/0000-0002-5187-423XSugawaraSho1http://orcid.org/0000-0003-3157-2557ReevesR. Keith12*[1], Center for Virology and Vaccine Research, Beth" exact="Israel" post="Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United"/>
   <result pre="Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts," exact="United States" post="of America[2], Ragon Institute of Massachusetts General Hospital, MIT,"/>
   <result pre="Institute of Massachusetts General Hospital, MIT, and Harvard, Cambridge, Massachusetts," exact="United States" post="of AmericaHobmanTom C.Editor[], University of Alberta, CANADA The authors"/>
   <result pre="could prove beneficial against COVID-19. Clinical studies are underway in" exact="the Netherlands" post="and Australia (ClinicalTrials.gov Identifier: NCT04327206 and NCT04328441) to test"/>
   <result pre="prove beneficial against COVID-19. Clinical studies are underway in the" exact="Netherlands" post="and Australia (ClinicalTrials.gov Identifier: NCT04327206 and NCT04328441) to test"/>
   <result pre="against COVID-19. Clinical studies are underway in the Netherlands and" exact="Australia" post="(ClinicalTrials.gov Identifier: NCT04327206 and NCT04328441) to test the efficacy"/>
   <result pre="for COVID-19 patients with severe pneumonia is also underway in" exact="China" post="[78] (NCT04264533). Functional exhaustion of NK cells and T"/>
   <result pre="T cells responses [86]. A randomized Phase II trial in" exact="Hong Kong" post="showed viral clearance in patients with mild and moderate"/>
   <result pre="estimates of comorbidities affecting risk for complications from COVID-19 in" exact="the US." post="202010.1101/2020.03.30.20043919 17WanS, YiQ, FanS, LvJ, ZhangX, GuoL, et al.Relationships"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449622\results\search\country\results.xml">
   <result pre="Science Zurich Graduate School, ETH and University of Zurich, Zurich," exact="Switzerland" post="LakdawalaSeemaEditor[], Address correspondence to Silke Stertz, stertz.silke@virology.uzh.ch, or Benjamin"/>
   <result pre="the start of the project and were approved by the" exact="Swiss" post="Federal Office of Public Health (Ecogen number A161912). In"/>
   <result pre="outset of this project. This work was supported by the" exact="Swiss" post="National Science Foundation (grant 31003A_182464 to B.G.H. and grant"/>
   <result pre="Influenza Seasonal Mortality Study Group. 2005Multinational impact of the 1968" exact="Hong Kong" post="influenza pandemic: evidence for a smoldering pandemic. J Infect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7451040\results\search\country\results.xml">
   <result pre="oxygen and, in severe cases, intensive care [4]. In the" exact="Singapore" post="study, SARS-CoV-2 remained detectable for 7 or more days,"/>
   <result pre="of novel coronavirus infection implicated a seafood market in Wuhan," exact="PR China" post="[12]. Subsequent spread out of Wuhan province was then"/>
   <result pre="novel coronavirus infection implicated a seafood market in Wuhan, PR" exact="China" post="[12]. Subsequent spread out of Wuhan province was then"/>
   <result pre="has been presented to justify the control measures taken in" exact="China" post="[21] and a case has been made for wider"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7451056\results\search\country\results.xml">
   <result pre="and oral health, and some of the strategies that allowed" exact="Taiwan" post="to handle the outbreak exceptionally well, including a COVID-19"/>
   <result pre="to develop treatments and vaccines, and crisis management strategies with" exact="Taiwan" post="as an example. Both articles set forth by reminding"/>
   <result pre="possible manipulations [16]. For this reason, Huang and colleagues from" exact="Taiwan" post="advocate here for the multiple advantages of working with"/>
   <result pre="old drugs Researchers from the National Health Research Institutes in" exact="Taiwan" post="combined old and new methods in order to hunt"/>
   <result pre="the COVID-19 outbreak and the significant amount of travel transit," exact="Taiwan" post="has handled the outbreak exceptionally well [30]. To date,"/>
   <result pre="in the emergency department of Linkou Chang Gung Memorial Hospital," exact="Taiwan" post="effectively prevents spread of COVID-19 among healthcare workers of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7451121\results\search\country\results.xml">
   <result pre="criticised by physicians and scientists from many countries, starting in" exact="France" post="because of his unorthodox approach and thinking. Despite this"/>
   <result pre="in national guidelines for the management of COVID-19 patients in" exact="Italy" post="[14], [15], Spain [16], and also the United States"/>
   <result pre="for the management of COVID-19 patients in Italy [14], [15]," exact="Spain" post="[16], and also the United States [17]. Let us"/>
   <result pre="COVID-19 patients in Italy [14], [15], Spain [16], and also" exact="the United States" post="[17]. Let us be clear, the question is not"/>
   <result pre="patients in Italy [14], [15], Spain [16], and also the" exact="United States" post="[17]. Let us be clear, the question is not"/>
   <result pre="the Spanish flu (pandemic of 1918), where many deaths in" exact="the United States" post="(at least 3%) were attributed, not to the direct"/>
   <result pre="Spanish flu (pandemic of 1918), where many deaths in the" exact="United States" post="(at least 3%) were attributed, not to the direct"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7452913\results\search\country\results.xml">
   <result pre="humans were first reported in late December 2019 from Wuhan," exact="China" post="where the clinical symptoms showed resemblance to viral pneumonia"/>
   <result pre="respiratory syndrome coronavirus (SARS-CoV) during 2002â€&quot;2003 in Guangdong province of" exact="China" post="with a mortality rate of 11% (Chan-Yeung and Xu,"/>
   <result pre="East respiratory syndrome coronavirus (MERS-CoV) in 2012 which emerged in" exact="Saudi Arabia" post="with a fatality rate of 34% (Singhal, 2020). It"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7453465\results\search\country\results.xml">
   <result pre="Sciences, University of the Western Cape, Pirvate Bag X17, Bellville," exact="South Africa." post="Email: afadaka@uwc.ac.za epub: 2020-8-8collection: 2020-84880300060520949077received: 2020-5-9accepted: 2020-7-20(C) SAGE Publications,"/>
   <result pre="countries with the highest reported prevalence and mortality such as" exact="the United States," post="Spain, Italy, the United Kingdom, Russia, Germany, Brazil, France,"/>
   <result pre="with the highest reported prevalence and mortality such as the" exact="United States," post="Spain, Italy, the United Kingdom, Russia, Germany, Brazil, France,"/>
   <result pre="and mortality such as the United States, Spain, Italy, the" exact="United Kingdom," post="Russia, Germany, Brazil, France, Turkey, Iran and China, are"/>
   <result pre="Spain, Italy, the United Kingdom, Russia, Germany, Brazil, France, Turkey," exact="Iran" post="and China, are more concerned with flattening the curve"/>
   <result pre="early 2000s.20 A pneumonia-like syndrome (MERS) was first discovered in" exact="Saudi Arabia" post="and then spread to several countries, where it incurred"/>
   <result pre="60 years. In December 2019, SARS-CoV-2, caused an outbreak in" exact="China" post="and then spread worldwide. The resulting disease (COVID-19) is"/>
   <result pre="SARS-CoV-1 infection in humans was first reported in 2002 in" exact="China" post="(Figure 3a). Within 1 year, it affected about 29"/>
   <result pre="first cases of human infection by MERS-CoV were reported in" exact="Saudi Arabia" post="in 2012. Cases were subsequently reported in other countries"/>
   <result pre="subsequently reported in other countries including Qatar, Egypt, and the" exact="Republic of" post="Korea following contact with infected camels (Figure 3b). Cases"/>
   <result pre="countries and territories are affected by the SARS-CoV-2 outbreak, including" exact="the United States," post="Italy, Germany, South Africa, and Nigeria. The distribution of"/>
   <result pre="and territories are affected by the SARS-CoV-2 outbreak, including the" exact="United States," post="Italy, Germany, South Africa, and Nigeria. The distribution of"/>
   <result pre="by the SARS-CoV-2 outbreak, including the United States, Italy, Germany," exact="South Africa," post="and Nigeria. The distribution of SARS-CoV-2 confirmed cases, including"/>
   <result pre="including mortality and recovery, is shown inÂ Figure 4. The" exact="United States," post="China, and some European countries have high case numbers"/>
   <result pre="CFR. The highest CFR was observed in Italy, followed by" exact="Spain" post="and the Netherlands (Figure 5a). In Africa, countries such"/>
   <result pre="highest CFR was observed in Italy, followed by Spain and" exact="the Netherlands" post="(Figure 5a). In Africa, countries such as Egypt, Algeria,"/>
   <result pre="CFR was observed in Italy, followed by Spain and the" exact="Netherlands" post="(Figure 5a). In Africa, countries such as Egypt, Algeria,"/>
   <result pre="Netherlands (Figure 5a). In Africa, countries such as Egypt, Algeria," exact="Burkina Faso," post="and Morocco had CFRs above 5% (Figure 5b). A"/>
   <result pre="In Africa, countries such as Egypt, Algeria, Burkina Faso, and" exact="Morocco" post="had CFRs above 5% (Figure 5b). A major challenge"/>
   <result pre="269â€&quot;271.32020029 90HolshueMLDeBoltCLindquistS, et al.First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med2020; 382: 929â€&quot;936.32004427 91KoWCRolainJMLeeNY, et al.Arguments"/>
   <result pre="90HolshueMLDeBoltCLindquistS, et al.First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med2020; 382: 929â€&quot;936.32004427 91KoWCRolainJMLeeNY, et al.Arguments"/>
   <result pre="modeling of its spike protein for risk of human transmission.Sci" exact="China" post="Life Sci2020; 63: 457â€&quot;460.32009228 108WanYShangJGrahamR, et al.Receptor recognition by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7453598\results\search\country\results.xml">
   <result pre="a young lady from the tormented Italian city of Bergamo." exact="Italy" post="is one the seven largest International Monetary Fund (IMF)-advanced"/>
   <result pre="Furthermore, lamentable news of unclaimed dead people in USA and" exact="Italy" post="reminded the inhumanity of the society. The sense of"/>
   <result pre="the Bundestag president and former finance minister, Wolfgang SchÃ¤uble. While" exact="Germany" post="was mourning the deaths of more than 5,600 people"/>
   <result pre="Sinovac (Beijing), which uses an inactivated virus (PiCoVacc). In the" exact="United Kingdom," post="researchers at the University of Oxford are testing the"/>
   <result pre="includes an adenoviral vector and the spike protein S. In" exact="the United States," post="Inovio Pharmaceuticals is testing a DNA type vaccine. The"/>
   <result pre="an adenoviral vector and the spike protein S. In the" exact="United States," post="Inovio Pharmaceuticals is testing a DNA type vaccine. The"/>
   <result pre="the head of Russia's Federal Biomedical Agency (FMBA), announced that" exact="Russia" post="had created seven novel anti-coronavirus vaccines ready to enter"/>
   <result pre="among the powerful of the world. Some politicians, led by" exact="the US" post="president, have insisted that the virus is a fabrication"/>
   <result pre="solarium and disinfectant injections to treat the coronavirus infection. Respectively," exact="China" post="insists on denying allegations by the US government that"/>
   <result pre="the coronavirus infection. Respectively, China insists on denying allegations by" exact="the US" post="government that it has been negligent in dealing with"/>
   <result pre="early enough (22). More specifically, through the newspaper â€˜People's Dailyâ€™," exact="China" post="poses a series of questions to the US government,"/>
   <result pre="newspaper â€˜People's Dailyâ€™, China poses a series of questions to" exact="the US" post="government, substantiated as follows: they accuse the US government"/>
   <result pre="questions to the US government, substantiated as follows: they accuse" exact="the US" post="government that after â€˜inadequately dealing with the outbreakâ€™, they"/>
   <result pre="now â€˜shifting the responsibilitiesâ€™ to China. In particular, they provoke" exact="the US" post="government to provide answers regarding the sudden closure of"/>
   <result pre="US government to provide answers regarding the sudden closure of" exact="the US" post="Army's biological weapons laboratory in Fort Detrick, Maryland, USA,"/>
   <result pre="By 2050, the E7 countries (Brazil, China, India, Indonesia, Mexico," exact="Russia" post="and Turkey) will produce approximately 50% of the world"/>
   <result pre="class While the pandemic was still in its infancy in" exact="the United States," post="with a reported 400,000 cases and 13,000 deaths from"/>
   <result pre="While the pandemic was still in its infancy in the" exact="United States," post="with a reported 400,000 cases and 13,000 deaths from"/>
   <result pre="the SARS-CoV-2 virus isolated from the city of Wuhan in" exact="China" post="and submitted it to the public database Genbank on"/>
   <result pre="the article published in The Lancet, if only to rebuke" exact="the US" post="President, Mr Donald Trump, who vigorously endorsed hydroxychloroquine as"/>
   <result pre="April 2020, the Swedish Health Minister Lena Hallengren said that" exact="Sweden" post="is planning to ask the European Union to push"/>
   <result pre="spread of the coronavirusâ€™ (36). Accordingly, the UN envoy to" exact="China" post="Chen Xu expressed backing for the WHO but said"/>
   <result pre="The reactions of the economically powerful countries of Europe and" exact="the United States" post="to the upcoming pandemic have seemed rather surprising, and"/>
   <result pre="reactions of the economically powerful countries of Europe and the" exact="United States" post="to the upcoming pandemic have seemed rather surprising, and"/>
   <result pre="the 6th month of the pandemic since its outbreak in" exact="China" post="that it did not help in the preparation of"/>
   <result pre="the announcement of the pandemic, panic spread across Europe and" exact="America" post="(40). The feeling at that point was that the"/>
   <result pre="a shortage of 30,000 doctors and auxiliary nursing staff; ii)" exact="Greece" post="being the third country in the EU with the"/>
   <result pre="in relation to its population (41). According to EU data," exact="Greece" post="has only 6 ICU beds per 100,000 residents! iii)"/>
   <result pre="face of the pandemic than the rest of the world." exact="Hong Kong," post="for example, has slowed down the spreading of SARS-CoV-2"/>
   <result pre="in an effort to control the spreading of COVID-19. However," exact="Hong Kong" post="was based on a program that included extensive testing,"/>
   <result pre="distancing measures such as closing schools. When Peng Wu at" exact="Hong Kong" post="University and her colleagues conducted a residential survey in"/>
   <result pre="compliance with government measures kept viral spreading relatively low in" exact="Hong Kong" post="until the end of March 2020. Despite the fact"/>
   <result pre="surprise of us Molecular Biologists, the whole of Europe and" exact="America" post="seemed unable to respond. Indeed, it has been extremely"/>
   <result pre="Public Health and Animal Husbandry at the Humane Society of" exact="the United States," post="and Professor Rob Wallace, evolutionary biologist and Public Health"/>
   <result pre="Health and Animal Husbandry at the Humane Society of the" exact="United States," post="and Professor Rob Wallace, evolutionary biologist and Public Health"/>
   <result pre="of production is exported to the North, mainly to North" exact="America" post="and Europe. In terms of climate change, the economically"/>
   <result pre="is dangerousVoxNew York, NY2020https://www.vox.com/2020/3/18/21185478/coronavirus-usa-trump-chinese-virus3182020 21SchwabNDonald Trump's national security adviser accuses" exact="China" post="of a two-month cover-up which stopped the world getting"/>
   <result pre="treatment of COVID-19: A multinational registry analysisLancet3951820201010.1016/S0140-6736(20)31324-6 36KupferschmidtKMalakoffDNormileDTravisJPressure grows on" exact="China" post="for independent investigation into pandemic's originsScience News2020https://www.sciencemag.org/news/2020/05/pressure-grows-china-independent-investigation-pandemic-s-origins542020 37KeatenJChinese envoy"/>
   <result pre="PPP Country GDP in PPP Country GDP in PPP 1" exact="China" post="21,269 China 38,008 China 58,499 2 USA 18,562 USA"/>
   <result pre="GDP in PPP Country GDP in PPP 1 China 21,269" exact="China" post="38,008 China 58,499 2 USA 18,562 USA 23,475 India"/>
   <result pre="PPP Country GDP in PPP 1 China 21,269 China 38,008" exact="China" post="58,499 2 USA 18,562 USA 23,475 India 44,128 3"/>
   <result pre="21,269 China 38,008 China 58,499 2 USA 18,562 USA 23,475" exact="India" post="44,128 3 India Â Â 8,721 India 19,511 USA"/>
   <result pre="China 58,499 2 USA 18,562 USA 23,475 India 44,128 3" exact="India" post="Â Â 8,721 India 19,511 USA 34,102 4 Japan"/>
   <result pre="18,562 USA 23,475 India 44,128 3 India Â Â 8,721" exact="India" post="19,511 USA 34,102 4 Japan Â Â 4,932 Japan"/>
   <result pre="3 India Â Â 8,721 India 19,511 USA 34,102 4" exact="Japan" post="Â Â 4,932 Japan Â Â 5,606 Indonesia 10,502"/>
   <result pre="8,721 India 19,511 USA 34,102 4 Japan Â Â 4,932" exact="Japan" post="Â Â 5,606 Indonesia 10,502 5 Germany Â Â"/>
   <result pre="34,102 4 Japan Â Â 4,932 Japan Â Â 5,606" exact="Indonesia" post="10,502 5 Germany Â Â 3,979 Indonesia Â Â"/>
   <result pre="Â Â 4,932 Japan Â Â 5,606 Indonesia 10,502 5" exact="Germany" post="Â Â 3,979 Indonesia Â Â 5,424 Brazil Â"/>
   <result pre="Â Â 5,606 Indonesia 10,502 5 Germany Â Â 3,979" exact="Indonesia" post="Â Â 5,424 Brazil Â Â 7,540 6 Russia"/>
   <result pre="10,502 5 Germany Â Â 3,979 Indonesia Â Â 5,424" exact="Brazil" post="Â Â 7,540 6 Russia Â Â 3,745 Russia"/>
   <result pre="3,979 Indonesia Â Â 5,424 Brazil Â Â 7,540 6" exact="Russia" post="Â Â 3,745 Russia Â Â 4,736 Russia Â"/>
   <result pre="5,424 Brazil Â Â 7,540 6 Russia Â Â 3,745" exact="Russia" post="Â Â 4,736 Russia Â Â 7,131 7 Brazil"/>
   <result pre="7,540 6 Russia Â Â 3,745 Russia Â Â 4,736" exact="Russia" post="Â Â 7,131 7 Brazil Â Â 3,135 Germany"/>
   <result pre="3,745 Russia Â Â 4,736 Russia Â Â 7,131 7" exact="Brazil" post="Â Â 3,135 Germany Â Â 4,707 Mexico Â"/>
   <result pre="4,736 Russia Â Â 7,131 7 Brazil Â Â 3,135" exact="Germany" post="Â Â 4,707 Mexico Â Â 6,863 GDP, gross"/>
   <result pre="7,131 7 Brazil Â Â 3,135 Germany Â Â 4,707" exact="Mexico" post="Â Â 6,863 GDP, gross domestic product; PPP, purchasing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7454523\results\search\country\results.xml">
   <result pre="related virus (COVID-19 virus). MERS CoV was first identified in" exact="Jordan" post="in 2012 (World Health Organization 2019), SARS CoV-1 was"/>
   <result pre="Organization 2019), SARS CoV-1 was first described in Guangdong province," exact="China" post="in 2002, (World Health Organization 2020) and SARS CoV-2"/>
   <result pre="2020) and SARS CoV-2 was first detected in Hubei province," exact="China" post="in 2019 (World Health Organization 2020). SARS CoV-2/COVID-19 is"/>
   <result pre="the range of 2.0â€&quot;2.8 during its initial outbreak in Riyadh," exact="Saudi Arabia," post="versus an R0 in the range of 3.5â€&quot;6.7 during"/>
   <result pre="during a second outbreak occurring 11 days later in Jeddah," exact="Saudi Arabia" post="(Majumder etÂ al. 2014). In addition to exhibiting some"/>
   <result pre="all 12 members of a cohort of MERS patients in" exact="Saudi Arabia" post="who developed ARDS suffered from comorbidities (asthma, diabetes mellitus,"/>
   <result pre="80 patients (22.50%) of a cohort from Jiangsu province in" exact="China" post="(Wu etÂ al. 2020). One study found that levels"/>
   <result pre="syndrome coronavirus disease is rare in children: an update from" exact="Saudi Arabia." post="World Journal of Clinical Pediatrics. 2016;5:391â€&quot;6.27872828 ArabiYM, ArifiAA, BalkhyHHet"/>
   <result pre="reproductive number and case fatality rate for the Spring 2014" exact="Saudi Arabia" post="outbreak: insights from publicly available data. PLoS Curr. 2014;6."/>
   <result pre="(MERS) death during the course of the outbreak in the" exact="Republic of" post="Korea, 2015. Int J Infect Dis. 2015;39:7â€&quot;9.26275845 MolinaJ, DelaugerreC,"/>
   <result pre="KelvinDet al.Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in" exact="Italy" post="and China. J Infect Dev Ctries. 2020;14:125â€&quot;8.32146445 QinC, ZhouL,"/>
   <result pre="Middle East respiratory syndrome coronavirus infection: a single-center experience in" exact="Saudi Arabia." post="J Glob Infect Dis. 2014;29:301â€&quot;6. SampathkumarP, TemesgenZ, SmithTFet al.SARS:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7454939\results\search\country\results.xml">
   <result pre="HIV-1 : People and Places : Geographical Locations : Asia:" exact="Pakistan" post=": Earth Sciences : Geography : Human Geography :"/>
   <result pre="Size : People and Places : Geographical Locations : Asia:" exact="Afghanistan" post=": Medicine and Health Sciences : Pharmacology : Behavioral"/>
   <result pre="Heroin HIV-1 phylodynamic analysis among people who inject drugs in" exact="Pakistan" post="correlates with trends in illicit opioid trade HIV-1 phylodynamic"/>
   <result pre="phylodynamic analysis correlates with trends in illicit opioid trade in" exact="Pakistan" post="http://orcid.org/0000-0001-8706-8128CholetteFranÃ§oisConceptualizationFormal analysisInvestigationMethodologyProject administrationSupervisionVisualizationWriting â€&quot; original draft12JoyJeffreyFormal analysisMethodologySupervisionWriting â€&quot; review"/>
   <result pre="medium, provided the original author and source are credited.pone.0237560.pdf Abstract" exact="Pakistan" post="is considered by the World Health Organization to currently"/>
   <result pre="1,453 PWID as part of a cross-sectional survey conducted in" exact="Pakistan" post="during 2014/2015. Overall, subtype A1 strains were dominant (75.2%)"/>
   <result pre="Larkana at the center of the PWID HIV-1 epidemic in" exact="Pakistan" post="which is consistent with previous epidemiological data. Funding The"/>
   <result pre="be found in the supporting information file, S1 Table. Introduction" exact="Pakistan" post="is considered to have transitioned from a â€œlow prevalence,"/>
   <result pre="important drug trafficking routes, connecting opioid production areas in eastern" exact="Afghanistan" post="with southern and central Pakistan, ultimately providing the cityâ€™s"/>
   <result pre="PWID or associated at risk populations in other regions of" exact="Pakistan" post="remains unclear. In particular, a better understanding of the"/>
   <result pre="seeded by migrant contract workers who had been deported to" exact="Pakistan" post="in the early 1990s after supposedly contracting HIV-1 through"/>
   <result pre="to examine HIV-1 transmission clusters within and among cities in" exact="Pakistan" post="and test hypotheses concerning the association between rates of"/>
   <result pre="from unique HIV-1 circulating recombinant forms (CRFs) recently reported in" exact="Pakistan" post="[10]. HIV-1 subtype distribution Each viral sequence from our"/>
   <result pre="background sequences consisting of all available HIV-1 pol sequences from" exact="Pakistan" post="in the Los Alamos HIV database as well as"/>
   <result pre="PWID sequences from our study were nested among sequences from" exact="Afghanistan" post="and the Islamic Republic of Iran (Fig 2b), supported"/>
   <result pre="our study were nested among sequences from Afghanistan and the" exact="Islamic Republic of Iran" post="(Fig 2b), supported by a high bootstrap value, suggesting"/>
   <result pre="study were nested among sequences from Afghanistan and the Islamic" exact="Republic of Iran" post="(Fig 2b), supported by a high bootstrap value, suggesting"/>
   <result pre="nested among sequences from Afghanistan and the Islamic Republic of" exact="Iran" post="(Fig 2b), supported by a high bootstrap value, suggesting"/>
   <result pre="A) Viral strain sequences from people who inject drugs in" exact="Pakistan" post="are annotated according to city of origin: Karachi (blue,"/>
   <result pre="n = 1 [2.9%]), Quetta (red, n = 1 [2.9%])," exact="Afghanistan" post="(black, n = 10 [28.6%]), and grey (Iran, n"/>
   <result pre="trees. Viral strain sequences from people who inject drugs in" exact="Pakistan" post="are annotated according to city of origin: Karachi (blue),"/>
   <result pre="of 1994 to 2013 suggests that HIV-1 among PWID in" exact="Pakistan" post="experienced an initial phase of exponential growth sometime around"/>
   <result pre="â†’ Larkana 5.62 5.15 Quetta â†’ Peshawar 1.16 1.33 Discussion" exact="Pakistan" post="is currently facing a concentrated HIV-1 epidemic among PWID"/>
   <result pre="sex workers (MSW) as well as Afghan refugees residing in" exact="Pakistan" post="[14, 15]. Phylogenetic analysis of HIV-1 gag gene sequences"/>
   <result pre="the use of professional injectors are common among PWID in" exact="Pakistan" post="[5]. Therefore, it is not surprising that nearly three"/>
   <result pre="or were unwilling to admit participation in such behaviors. Currently," exact="Afghanistan" post="produces approximately 80% of the worldâ€™s heroin supply [30]."/>
   <result pre="heroin supply [30]. Most of the heroin is trafficked through" exact="Pakistan" post="before reaching its final destination in Europe, the Russian"/>
   <result pre="through Pakistan before reaching its final destination in Europe, the" exact="Russian Federation" post="and Asia [4]. As such, local consumption markets have"/>
   <result pre="chemical for the synthesis of opium into heroinâ€&quot;is trafficked into" exact="Afghanistan" post="allegedly along the same trafficking routes, albeit in the"/>
   <result pre="the northward direction [16]. Acetic anhydride importation is prohibited in" exact="Afghanistan" post="therefore the precursor needs to be smuggled into the"/>
   <result pre="migration patterns. Initially, high quality powder heroin was abundant in" exact="Pakistan" post="with smoking being the primary means of consumption [20]."/>
   <result pre="primary means of consumption [20]. However, recent conflict in neighboring" exact="Afghanistan" post="may have directly or indirectly facilitated transitions to injection"/>
   <result pre="or indirectly facilitated transitions to injection drug use [20] in" exact="Pakistan" post="by causing fluctuations in prices, purity and availability of"/>
   <result pre="changes in HIV-1 effective population size estimates among PWID in" exact="Pakistan" post="correspond with fluctuations in opium cultivation in Afghanistan [12]."/>
   <result pre="PWID in Pakistan correspond with fluctuations in opium cultivation in" exact="Afghanistan" post="[12]. More specifically, both spikes in estimates of HIV-1"/>
   <result pre="observation suggests that the transmission of HIV-1 among PWID in" exact="Pakistan" post="is associated with local trends in opium traffickingâ€&quot;influenced by"/>
   <result pre="Health Research Ethics Board at the University of Manitoba [HS15691(H2012:294)]," exact="Canada" post="and BRIDGE Consultants Foundation, Pakistan. Informed consent was obtained"/>
   <result pre="for each city based on mapping exercises carried out in" exact="Pakistan" post="[1]. Convergence of each run was assessed using Tracer"/>
   <result pre="to provide a contemporary snapshot of HIV-1 migration. PWID in" exact="Pakistan" post="are a highly mobile population [1] therefore, including older"/>
   <result pre="2009;6:1310.1186/1477-7517-6-1319558668 6KhanAA, KhanA. The HIV Epidemic in Pakistan. Journal of" exact="Pakistan" post="Medical Association. 2010;60(4):300â€&quot;7. 7RaiMA, NerurkarVR, KhojaS, KhanS, YanagiharaR, RehmanA,"/>
   <result pre="Journal of Molecular Biology. 1990;215:403â€&quot;10. 10.1016/S0022-2836(05)80360-22231712 12Crime UNOoDa, Narcotics IRoAMoC." exact="Afghanistan" post="opium survey: Cultivation and production. 2016. 13ArchibaldCP, ShawSY, EmmanuelF,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7456638\results\search\country\results.xml">
   <result pre="of poly (ADP-ribose) polymerase prevents allergen-induced asthma-like reaction in sensitized" exact="Guinea" post="pigsJ Pharmacol Exp Ther200431131241124810.1124/jpet.104.07254615254147 30.LiuLKeYJiangXHeFPanLXuLZengXBaXLipopolysaccharide activates ERK-PARP-1-RelA pathway and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7456910\results\search\country\results.xml">
   <result pre="Edited by: Andres M. Perez, University of Minnesota Twin Cities," exact="United States" post="Reviewed by: Susan Catherine Cork, University of Calgary, Canada;"/>
   <result pre="of Calgary, Canada; Mary M. Christopher, University of California, Davis," exact="United States" post="*Correspondence: Ali Mobasheri ali.mobasheri@oulu.fi; ali.mobasheri@imcentras.lt; a.mobasheri@umcutrecht.nl This article was"/>
   <result pre="December, 2019, an outbreak of COVID-19 was reported in Wuhan," exact="China" post="(3). Despite early warning about its contagious nature, SARS-CoV-2"/>
   <result pre="the infection. The team at Harbin Veterinary Research Institute in" exact="China" post="has proposed that chickens, pigs, and ducks are not"/>
   <result pre="predicted this pandemic (37). The authors from the University of" exact="Hong Kong" post="did not possess a crystal ball. Instead, they had"/>
   <result pre="26.OreshkovaNMolenaarRJVremanSHardersFOude MunninkBBHakze-van der HoningRWet al.. SARS-CoV-2 infection in farmed minks," exact="the Netherlands," post="April and May 2020. Euro Surveill. (2020) 25:5. 10.2807/1560-7917.ES.2020.25.23.200100532553059"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7457578\results\search\country\results.xml">
   <result pre="coronavirus disease 19 (COVID-19), which was first identified in Wuhan," exact="China" post="in December 2019.1,2 According to a recent World Health"/>
   <result pre="this effect.4 After the first report of SARS-CoV-2 infection from" exact="Nepal" post="in a student who returned from Wuhan,5 there has"/>
   <result pre="knowledge, attitudes, and practices of rheumatic patients regarding COVID-19 in" exact="Nepal" post="during the first week of April 2020. Study Population"/>
   <result pre="majority (96.9%), however, denied changing their behavior regarding vaccination practice." exact="Nepal" post="being in stage 3 of the COVID-19 epidemic, this"/>
   <result pre="6.PiryaniRM, PiryaniS, ShahJN. Nepalâ€™s response to contain COVID-19 infection. J" exact="Nepal" post="Health Res Counc. 2020;18(1):128â€&quot;134. doi:10.33314/jnhrc.v18i1.260832335608 7.ZhongBL, LuoW, LiHM, et"/>
   <result pre="MekkodathilA, SubramanyaSH, SimkhadaP. COVID-19 pandemic: public health implications in Nepal." exact="Nepal" post="J Epidemiol. 2020;10(1):817â€&quot;820. doi:10.3126/nje.v10i1.2826932257511 10.collab: Nepal telecommunications authority. MIS"/>
   <result pre="health implications in Nepal. Nepal J Epidemiol. 2020;10(1):817â€&quot;820. doi:10.3126/nje.v10i1.2826932257511 10.collab:" exact="Nepal" post="telecommunications authority. MIS report [Internet]. Kathmandu; 2019Available from: https://nta.gov.np/en/mis-reports/."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7457942\results\search\country\results.xml">
   <result pre="from the marine sponge-derived Streptomyces sp. CMN-62 collected from Naozhou" exact="Island" post="of the Guangdong Province, China [39]. This compound exhibited"/>
   <result pre="sp. CMN-62 collected from Naozhou Island of the Guangdong Province," exact="China" post="[39]. This compound exhibited inhibitory activity against H1N1 with"/>
   <result pre="gathered from a marine worm, Sipunculus nudus, from Haikou Bay," exact="China" post="[40]. Compounds 20, 21, and 22 exhibited inhibitory activity"/>
   <result pre="Aspergillus sp. OUCMDZ-1583, and collected from the Xisha Islands of" exact="China" post="[42]. Compounds 25 and 26 showed anti-H1N1 activity with"/>
   <result pre="of the gorgonian Echinogorgia aurantiaca collected from Sanya, Hainan Province," exact="China" post="[44]. Asperterrestide A (36, Fig.Â 7), a new alkaloid"/>
   <result pre="collected from the sea area near Xuwen County, Guangdong Province," exact="China" post="[45]. Compound 37 showed weak anti-H3N2 activity with IC50"/>
   <result pre="a marine algae Coelarthrum sp. collected in Paracel Islands, South" exact="China" post="Sea, which produced a new nitrobenzoyl sesquiterpenoid, 6Î²,9Î±-dihydroxy-14-p-nitrobenzoylcinnamolide (38,"/>
   <result pre="Streptomyces koyangensis SCSIO 5802, which was isolated from the South" exact="China" post="Sea at a depth of 3536Â m, resulted in"/>
   <result pre="sample at a depth of 2326Â m from the South" exact="China" post="Sea [55]. These compounds displayed significant antiviral activity towards"/>
   <result pre="isolated from the deep sea sediment collected from the South" exact="China" post="Sea, resulted in the isolation of three new tetramic"/>
   <result pre="isolated from a marine sediment sample collected in the South" exact="China" post="Sea [57]. These compounds inÂ vitro exhibited moderate antiviral"/>
   <result pre="Î¼M, respectively [57]. A gorgonian sample collected from the South" exact="China" post="Sea, Sanya, Hainan Province, resulted in the isolation of"/>
   <result pre="SCSGAF0162 under rice solid-state fermentation, which was gathered from South" exact="China" post="Sea gorgonian coral Echinogorgia aurantiaca [59]. All the isolated"/>
   <result pre="collected from the coast of the Greifswalder Bodden, Baltic Sea," exact="Germany" post="[60]. This compound exhibited antiviral activity against HSV-1 with"/>
   <result pre="nucleoside/nucleotide reverse transcriptase inhibitors, and entry inhibitors [64]. However, in" exact="the United States," post="the annual cost of the drugs per individual can"/>
   <result pre="reverse transcriptase inhibitors, and entry inhibitors [64]. However, in the" exact="United States," post="the annual cost of the drugs per individual can"/>
   <result pre="a marine algae Sargassum sp. collected in Yongxing Island, South" exact="China" post="Sea, in July 2012, and produced a novel 2-benzylpyridin-4-one"/>
   <result pre="isolated from the gorgonian Dichotella gemmacea collected at the Weizhou" exact="Island" post="coral reef, in the South China Sea, in September"/>
   <result pre="collected at the Weizhou Island coral reef, in the South" exact="China" post="Sea, in September 2008 [70]. Compound 70 was tested"/>
   <result pre="gemmacea, collected from the Weizhou coral reef in the South" exact="China" post="Sea, Guangxi Province, China in 2008 [71]. The isolated"/>
   <result pre="Weizhou coral reef in the South China Sea, Guangxi Province," exact="China" post="in 2008 [71]. The isolated secondary metabolites were evaluated"/>
   <result pre="which was acquired from Hainan Sanya National Coral Reef Reserve," exact="China" post="[77]. Compound 75 exerted obvious antivirus activity with 50%"/>
   <result pre="extracts of Trichodesmium erythraeum (TLT/PSK/001), collected from Pulau Seringat Kias," exact="Singapore" post="[79]. Compounds 76, 77 and 78 exhibited significant dose-dependent"/>
   <result pre="Streptomyces kaviengensis (F7E2f) collected from the coast of New Ireland," exact="Papua New Guinea," post="resulted in the isolation of antimycin A10a (79, Fig.Â"/>
   <result pre="IMB17-046Molecules2420192821 67ZhouX.FangW.TanS.LinX.XunT.LiuY.Aspernigrins with anti-HIV-1 activities from the marine-derived fungus Aspergillus" exact="Niger" post="SCSIO Jcsw6F30Bioorg. Med. Chem. Lett26201636136526711143 68Boyoglu-BarnumS.ChirkovaT.AndersonL.J.Biology of infection and"/>
   <result pre="research was funded by the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(41706167), 10.13039/501100013314National 111 Project of China (D16013), and Li"/>
   <result pre="Natural Science Foundation of China (41706167), 10.13039/501100013314National 111 Project of" exact="China" post="(D16013), and Li Dak Sum Yip Yio Chin Kenneth"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7458227\results\search\country\results.xml">
   <result pre="No. 39 Shi-er-qiao Road, Chengdu, 610072, Sichuan Province, P. R." exact="China" post="(e-mail: huangju0777@126.com). collection: 2020-8-8epub: 2020-8-8pmc-release: 2020-8-89935e21774received: 2020-7-13accepted: 2020-7-15(C) ,"/>
   <result pre="Central Register of Controlled Trials, PubMed, Web of Science, EMBASE," exact="China" post="National Knowledge Infrastructure, Traditional Chinese Medicine, Chinese Biomedical Literature"/>
   <result pre="Chinese herbs have been used to treat human diseases in" exact="China" post="for thousands of years.[11] The awarding of part of"/>
   <result pre="CM in the treatment of SARS.[19] The sixth version of" exact="China" post="national clinical guideline on COVID-19 associated pneumonia was published"/>
   <result pre="Register of Controlled Trials (CENTRAL), PubMed, EMBASE, Web of Science," exact="China" post="National Knowledge Infrastructure, Chinese Biomedical Literature Database, and Wan-Fang"/>
   <result pre="Med Infect Dis2020;33:101567.32006657 [5]MunsterVJKoopmansMvan DoremalenNet al.A novel coronavirus emerging in" exact="China" post="- key questions for impact assessment. N Engl J"/>
   <result pre="Chinese Medicine, WangWConcept and Methods of Epidemic Prevention in Ancient" exact="China" post="and their Modern Applications Research[Z]. 2011. [14]HuWWuQReview of historical"/>
   <result pre="care workers during the severe acute respiratory syndrome epidemic in" exact="Hong Kong" post="to prevent severe acute respiratory syndrome transmission, relieve influenza-related"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7458341\results\search\country\results.xml">
   <result pre="Virus : People and places : Geographical locations : North" exact="America" post=": Central America: Guatemala : People and Places :"/>
   <result pre="places : Geographical locations : North America : Central America:" exact="Guatemala" post=": People and Places : Population Groupings: Age Groups"/>
   <result pre="Techniques : Immunoassays: Enzyme-Linked Immunoassays Epidemiology of dengue fever in" exact="Guatemala" post="Dengue in Guatemala Castillo SignorLeticia del CarmenConceptualizationData curationFunding acquisitionInvestigationProject"/>
   <result pre="Enzyme-Linked Immunoassays Epidemiology of dengue fever in Guatemala Dengue in" exact="Guatemala" post="Castillo SignorLeticia del CarmenConceptualizationData curationFunding acquisitionInvestigationProject administrationValidationWriting â€&quot; review"/>
   <result pre="editing24*[1], Ministerio de Salud Publica y Asistencia Social de Guatemala," exact="Guatemala" post="City, Guatemala[2], Centre for Drugs and Diagnostics Research, Liverpool"/>
   <result pre="Department of Fish and Wildlife Conservation, Virginia Tech, Blacksburg, VA," exact="United States" post="of America[4], Tropical Clinical Trials Unit. Liverpool School of"/>
   <result pre="progress to severe haemorrhage and shock. Dengue is endemic in" exact="Guatemala" post="and its surveillance system could document long term trends."/>
   <result pre="We analysed 17 years of country-wide dengue surveillance data in" exact="Guatemala" post="to describe epidemiological trends from 2000 to 2016.Data from"/>
   <result pre="lead to severe dengue. We also report that adults in" exact="Guatemala" post="have a lower likelihood of infection the year after"/>
   <result pre="incidence and was not considered a public health problem in" exact="Guatemala" post="during most of the twentieth century, possibly as a"/>
   <result pre="prior to analysis. National surveillance Surveillance of arboviral infections in" exact="Guatemala" post="is conducted by the National Epidemiology Centre and the"/>
   <result pre="and 4. Fig 2 Monthly distribution of dengue cases in" exact="Guatemala" post="(2000â€&quot;2016). The mean annual number of cases is shown"/>
   <result pre="included Guatemala, Santa Rosa, Quetzaltenango, and Zacapa. The Department of" exact="Guatemala" post="received most imported patients from Jutiapa, Escuintla, El Progreso,"/>
   <result pre="samples from El Progreso and Chiquimula. Overall, the Department of" exact="Guatemala" post="reported the highest number of cases followed by the"/>
   <result pre="dengue-positive (Fig 5). Fig 5 Geographic distribution of dengue in" exact="Guatemala" post="(2000â€&quot;2016). A. Number of dengue cases by Department (incidence"/>
   <result pre="from Wikipedia: Departments of Guatemala, 2011 population estimate). Discussion Central" exact="America" post="has a considerable burden of dengue, with an estimated"/>
   <result pre="the Caribbean, and 586.3 cases per 100,000 inhabitants in South" exact="America" post="[22]. Dengue is hyperendemic, and seasonal in Guatemala with"/>
   <result pre="in South America [22]. Dengue is hyperendemic, and seasonal in" exact="Guatemala" post="with simultaneous circulation of all DENV serotypes [23]. In"/>
   <result pre="which have been shown to increase dengue transmission in Central" exact="America" post="[28]. The understanding of the seasonality of dengue is"/>
   <result pre="2010 and 2016 [30]. The large 2010 DENV2 epidemic in" exact="Guatemala" post="coincided with simultaneous DENV2 outbreaks across other Central and"/>
   <result pre="years had been reported during DENV1 and DENV2 outbreaks in" exact="Singapore" post="[31]. The reduced incidence in older age groups immediately"/>
   <result pre="and limited vaccine uptake. Passive surveillance for dengue in Latin" exact="America" post="has underestimated the number of cases by a factor"/>
   <result pre="management and to Guadalupe GuzmÃ¡n, Pedro Kouri Institute in Havana," exact="Cuba" post="for her support in interpreting the information. References References"/>
   <result pre="2017;7(317). 31RajarethinamJ, AngL-W, OngJ, YcasasJ, HapuarachchiHC, YapG, et al.Dengue in" exact="Singapore" post="from 2004 to 2016: cyclical epidemic patterns dominated by"/>
   <result pre="BaqueroL, CastaÃ±eda-CardonaC, RosselliD. Economic impact of dengue fever in Latin" exact="America" post="and the Caribbean: a systematic review. Rev Panam Salud"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7459861\results\search\country\results.xml">
   <result pre="Rhinolophus bat coronavirus HKU2 isolated in Guangdong Province, in southern" exact="China" post="[61,62]. This suggests that coronaviruses of bat origin may"/>
   <result pre="main type of transmission worldwide [5,19]. On January 13, 2020," exact="Thailand" post="announced the first non-Chinese case of infection that spread"/>
   <result pre="This case was a Chinese tourist who has traveled to" exact="Thailand" post="and did not have any epidemiological link to the"/>
   <result pre="humans until the outbreak of SARS in Guangdong state of" exact="China" post="in 2002 and 2003. SARS-CoV infected more than 8000"/>
   <result pre="10% [86]. Ten years later in 2012, MERS-CoV emerged in" exact="Saudi Arabia" post="and infected over 2494 people with 858 deaths, accounting"/>
   <result pre="for a mortality rate approximately of 35% [9,24,87]. Starting in" exact="China" post="in December 2019, there were reports of patients presenting"/>
   <result pre="allowed viral spreading primarily in other Asian countries such as" exact="South Korea" post="and Iran followed by many countries such as Italy,"/>
   <result pre="primarily in other Asian countries such as South Korea and" exact="Iran" post="followed by many countries such as Italy, Spain, Germany,"/>
   <result pre="followed by many countries such as Italy, Spain, Germany, France," exact="Brazil" post="and USA [24,60]. It is very intriguing to note"/>
   <result pre="very intriguing to note that the SARS epidemic in southern" exact="China" post="in 2002 and the current outbreak of COVID-19 had"/>
   <result pre="in daily new deaths [101]. A recent study conducted in" exact="Italy" post="showed a positive correlation of SARS-CoV-2 spreading and weather"/>
   <result pre="been added to the National Health Commission of the Peopleâ€™s" exact="Republic of" post="China (NHC) guidelines for COVID-19 treatment (Figure 8I) (http://www.nhc.gov.cn)."/>
   <result pre="to the National Health Commission of the Peopleâ€™s Republic of" exact="China" post="(NHC) guidelines for COVID-19 treatment (Figure 8I) (http://www.nhc.gov.cn). In"/>
   <result pre="Among these, Remdesivir was recently approved for medical use in" exact="America" post="and European Union and seems to be the most"/>
   <result pre="of clinical trials regarding cell-based therapies have been started in" exact="China" post="during COVID-19 outbreak. Among these, mesenchymal stromal cells (MSCs)-based"/>
   <result pre="mRNA vaccine against SARS-CoV-2 ready for phase I study in" exact="the United States." post="Available online: https://investors.modernatx.com/news-releases/news-release-details/moderna-ships-mrna-vaccine-against-novel-coronavirus-mrna-1273 (accessed on 24 February 2020). More"/>
   <result pre="vaccine against SARS-CoV-2 ready for phase I study in the" exact="United States." post="Available online: https://investors.modernatx.com/news-releases/news-release-details/moderna-ships-mrna-vaccine-against-novel-coronavirus-mrna-1273 (accessed on 24 February 2020). More"/>
   <result pre="was previously done during the 2018 Ebola epidemic in the" exact="Democratic Republic of the Congo." post="Overall, a joint effort headed to apply both already"/>
   <result pre="previously done during the 2018 Ebola epidemic in the Democratic" exact="Republic of" post="the Congo. Overall, a joint effort headed to apply"/>
   <result pre="antibodies (mAbs); naso-pharyngeal (NP); National Health Commission of the Peopleâ€™s" exact="Republic of" post="China (NHC); nonstructural protein 14 (nsp14); Northern Hemisphere (NH);"/>
   <result pre="naso-pharyngeal (NP); National Health Commission of the Peopleâ€™s Republic of" exact="China" post="(NHC); nonstructural protein 14 (nsp14); Northern Hemisphere (NH); nucleocapsid"/>
   <result pre="coronavirusNat. Rev. Microbiol.20201812310.1038/s41579-020-0332-031988490 89.collab: National Health Commission of the Peopleâ€™s" exact="Republic of" post="ChinaPneumonia Epidemic Situation of New Coronavirus Infection on 23"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7460442\results\search\country\results.xml">
   <result pre="of COVID-19 was reported from Wuhanâ€™s Huanan seafood market in" exact="China" post="late December 2019. Bats, pangolins, and snakes have been"/>
   <result pre="from birds and pigs [11]. SARS-CoV and MERS-CoV originated from" exact="China" post="in 2003 [12] and Saudi Arabia [13] in 2012,"/>
   <result pre="SARS-CoV and MERS-CoV originated from China in 2003 [12] and" exact="Saudi Arabia" post="[13] in 2012, respectively, while the outbreak of COVID-19"/>
   <result pre="(WHO) confirmed that the COVID-19 triggered by the Huanan South" exact="China" post="seafood marketplace in Wuhan. However, no substantial evidence to"/>
   <result pre="China, France, England, Germany, Taiwan, Japan, Belgium, USA, and Vietnam." exact="China" post="was used as a reference to evaluate the sequence"/>
   <result pre="examination identified three deletions in the genomes collected from Australia," exact="the USA," post="and Japan. Out of three deletions, two deletions were"/>
   <result pre="2 January 2020. The diagnosis of these patients confirmed COVID-19." exact="Thailand" post="was the first country that was infected after China,"/>
   <result pre="infected after China, and the first case was reported in" exact="Thailand" post="on 13 January 2020, in a patient who traveled"/>
   <result pre="were reported by 22 January 2020, in 25 provinces of" exact="China" post="[39]. National Health Commission of China (NHC) confirmed the"/>
   <result pre="in 25 provinces of China [39]. National Health Commission of" exact="China" post="(NHC) confirmed the first 17 deaths due to COVID-19"/>
   <result pre="90 cases were confirmed from other countries including Vietnam, Nepal," exact="Sri Lanka," post="Japan, Thailand, Republic of Korea, United States, United Arab"/>
   <result pre="from other countries including Vietnam, Nepal, Sri Lanka, Japan, Thailand," exact="Republic of" post="Korea, United States, United Arab Emirates, Malaysia, The Philippines,"/>
   <result pre="including Vietnam, Nepal, Sri Lanka, Japan, Thailand, Republic of Korea," exact="United States," post="United Arab Emirates, Malaysia, The Philippines, India, Australia, Canada,"/>
   <result pre="Nepal, Sri Lanka, Japan, Thailand, Republic of Korea, United States," exact="United Arab Emirates," post="Malaysia, The Philippines, India, Australia, Canada, Cambodia, Finland, Singapore,"/>
   <result pre="Philippines, India, Australia, Canada, Cambodia, Finland, Singapore, France, Germany, and" exact="Taiwan" post="[41]. The Chinese Center for Disease Control and Prevention"/>
   <result pre="as compared with the rest of the world. In Europe," exact="Italy" post="was the largest outbreak territory. The United States President"/>
   <result pre="world. In Europe, Italy was the largest outbreak territory. The" exact="United States" post="President declared the national emergency in the United States"/>
   <result pre="territory. The United States President declared the national emergency in" exact="the United States" post="on 13 March 2020. By 27 March 2020, the"/>
   <result pre="The United States President declared the national emergency in the" exact="United States" post="on 13 March 2020. By 27 March 2020, the"/>
   <result pre="were 2 million cases worldwide on 15 April 2020, with" exact="the United States" post="being on the top of the list, followed by"/>
   <result pre="2 million cases worldwide on 15 April 2020, with the" exact="United States" post="being on the top of the list, followed by"/>
   <result pre="States being on the top of the list, followed by" exact="Italy" post="and Spain [44]. Currently, there are almost 21 million"/>
   <result pre="on the top of the list, followed by Italy and" exact="Spain" post="[44]. Currently, there are almost 21 million cases with"/>
   <result pre="and treatment program for COVID-19 was formulated by NHC of" exact="China" post="[69,74] and was previously suggested by WHO for SARS"/>
   <result pre="have a swab collected for molecular testing. The experience in" exact="China" post="has shown that the use of a serological antibody"/>
   <result pre="1 May 2020, the Food and Drug Administration (FDA) of" exact="the USA" post="authorized the emergency use of remdesivir for the treatment"/>
   <result pre="critical patients [110]. Another drug, oseltamivir, is being used in" exact="China" post="by the medical personnel for suspected patients, but there"/>
   <result pre="medical officers and by the National Institutes of Health in" exact="the United States" post="have already been updated to recommend the use of"/>
   <result pre="officers and by the National Institutes of Health in the" exact="United States" post="have already been updated to recommend the use of"/>
   <result pre="options and development of other vaccines [133]. University of Oxford," exact="United Kingdom," post="conducted a randomized clinical trial of the COVID-19 vaccine"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003Lancet20033621353135810.1016/S0140-6736(03)14630-214585636 18.De WitE.Van DoremalenN.FalzaranoD.MunsterV.J.SARS and MERS:"/>
   <result pre="case fatality ratio. Territory Total Confirmed Cases Total Deaths CFR" exact="France" post="167,456 30,060 17.95 Belgium 296,381 45,501 15.35 Italy 64,534"/>
   <result pre="Total Confirmed Cases Total Deaths CFR France 167,456 30,060 17.95" exact="Belgium" post="296,381 45,501 15.35 Italy 64,534 9808 15.19 United Kingdom"/>
   <result pre="Deaths CFR France 167,456 30,060 17.95 Belgium 296,381 45,501 15.35" exact="Italy" post="64,534 9808 15.19 United Kingdom 245,032 35,082 14.32 Netherlands"/>
   <result pre="30,060 17.95 Belgium 296,381 45,501 15.35 Italy 64,534 9808 15.19" exact="United Kingdom" post="245,032 35,082 14.32 Netherlands 52,241 6139 11.75 Spain 267,551"/>
   <result pre="15.35 Italy 64,534 9808 15.19 United Kingdom 245,032 35,082 14.32" exact="Netherlands" post="52,241 6139 11.75 Spain 267,551 28,426 10.62 Sweden 111,697"/>
   <result pre="15.19 United Kingdom 245,032 35,082 14.32 Netherlands 52,241 6139 11.75" exact="Spain" post="267,551 28,426 10.62 Sweden 111,697 8862 7.93 Canada 78,504"/>
   <result pre="35,082 14.32 Netherlands 52,241 6139 11.75 Spain 267,551 28,426 10.62" exact="Sweden" post="111,697 8862 7.93 Canada 78,504 5667 7.21 Ireland 25,819"/>
   <result pre="6139 11.75 Spain 267,551 28,426 10.62 Sweden 111,697 8862 7.93" exact="Canada" post="78,504 5667 7.21 Ireland 25,819 1754 6.79 Brazil 86,361"/>
   <result pre="28,426 10.62 Sweden 111,697 8862 7.93 Canada 78,504 5667 7.21" exact="Ireland" post="25,819 1754 6.79 Brazil 86,361 4655 5.39 United States"/>
   <result pre="8862 7.93 Canada 78,504 5667 7.21 Ireland 25,819 1754 6.79" exact="Brazil" post="86,361 4655 5.39 United States of America 281,413 14,853"/>
   <result pre="5667 7.21 Ireland 25,819 1754 6.79 Brazil 86,361 4655 5.39" exact="United States of America" post="281,413 14,853 5.28 China 33,796 1692 5.01 Switzerland 203,368"/>
   <result pre="25,819 1754 6.79 Brazil 86,361 4655 5.39 United States of" exact="America" post="281,413 14,853 5.28 China 33,796 1692 5.01 Switzerland 203,368"/>
   <result pre="86,361 4655 5.39 United States of America 281,413 14,853 5.28" exact="China" post="33,796 1692 5.01 Switzerland 203,368 9101 4.47 Japan 2,159,654"/>
   <result pre="States of America 281,413 14,853 5.28 China 33,796 1692 5.01" exact="Switzerland" post="203,368 9101 4.47 Japan 2,159,654 81,487 3.77 Iran 27,029"/>
   <result pre="14,853 5.28 China 33,796 1692 5.01 Switzerland 203,368 9101 4.47" exact="Japan" post="2,159,654 81,487 3.77 Iran 27,029 990 3.66 Germany 3,868,453"/>
   <result pre="1692 5.01 Switzerland 203,368 9101 4.47 Japan 2,159,654 81,487 3.77" exact="Iran" post="27,029 990 3.66 Germany 3,868,453 141,479 3.65 Austria 20,038"/>
   <result pre="9101 4.47 Japan 2,159,654 81,487 3.77 Iran 27,029 990 3.66" exact="Germany" post="3,868,453 141,479 3.65 Austria 20,038 711 3.55 Turkey 222,402"/>
   <result pre="81,487 3.77 Iran 27,029 990 3.66 Germany 3,868,453 141,479 3.65" exact="Austria" post="20,038 711 3.55 Turkey 222,402 5545 2.49 Australia 12,896"/>
   <result pre="990 3.66 Germany 3,868,453 141,479 3.65 Austria 20,038 711 3.55" exact="Turkey" post="222,402 5545 2.49 Australia 12,896 128 0.99 Saudi Arabia"/>
   <result pre="141,479 3.65 Austria 20,038 711 3.55 Turkey 222,402 5545 2.49" exact="Australia" post="12,896 128 0.99 Saudi Arabia 258,156 2601 1.00 Grand"/>
   <result pre="711 3.55 Turkey 222,402 5545 2.49 Australia 12,896 128 0.99" exact="Saudi Arabia" post="258,156 2601 1.00 Grand total 8,482,781 434,541 5.12 *"/>
   <result pre="Antivirals included in the treatment guidelines issued by NHC of" exact="China" post="for COVID-19, version 6 [107,109]. NHC, National Health Commission;"/>
   <result pre="in Covid-19 Pandemic Through BCG Vaccine (BCG-CORONA) Multiple sites in" exact="the Netherlands" post="NCT04328441 SARS-CoV-2 inactivated vaccine Randomized A Randomized, Double-Blinded, Placebo-Controlled,"/>
   <result pre="Covid-19 Pandemic Through BCG Vaccine (BCG-CORONA) Multiple sites in the" exact="Netherlands" post="NCT04328441 SARS-CoV-2 inactivated vaccine Randomized A Randomized, Double-Blinded, Placebo-Controlled,"/>
   <result pre="Adults Suining County Center for Disease Control and Prevention in" exact="China" post="NCT04352608 mRNA-1273 Non-Randomized Safety and Immunogenicity Study of 2019-nCoV"/>
   <result pre="(mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) Multiple sites in" exact="America" post="NCT04283461 LV-SMENP-DC vaccine and antigen-specific CTLs NA Phase I/II"/>
   <result pre="(LV-SMENP) of Covid-19 Coronavirus Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong," exact="China" post="NCT04276896 bacTRL-Spike vaccine Randomized A Phase 1, Randomized, Observer-Blind,"/>
   <result pre="Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 vaccine Multiple sites in" exact="United Kingdom" post="NCT04400838 Inactivated SARS-CoV-2 Vaccine Randomized A Randomized, Double-blind, Placebo-controlled,"/>
   <result pre="Healthy People Aged 18 to 59 Years Multiple sites in" exact="China" post="NCT04412538 BCG, Bacillus Calmetteâ€&quot;GuÃ©rin; a clinical trials not yet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7460939\results\search\country\results.xml">
   <result pre="Boshra A. Arnout, Department of Psychology, King Khalid University, Abha," exact="Saudi Arabia." post="Email: prof.arnout74@gmail.com; beahmad@kku.edu.sa epub: 2020-8-8e2332received: 2020-6-25rev-recd: 2020-7-24accepted: 2020-7-25(C) ,"/>
   <result pre="human specializations at Princess Nourah Bint Abdul Rahman University in" exact="Saudi Arabia." post="The researchers designed a questionnaire to collect the data"/>
   <result pre="to Europe, America, and the Arab Gulf countries, including the" exact="Kingdom of Saudi Arabia," post="it was necessary for the responsible government sectors take"/>
   <result pre="America, and the Arab Gulf countries, including the Kingdom of" exact="Saudi Arabia," post="it was necessary for the responsible government sectors take"/>
   <result pre="over the internet. About the role of educational institutions in" exact="the United States" post="of America in coping COVIDâ€�19 pandemic crisis, the Oklahoma"/>
   <result pre="the internet. About the role of educational institutions in the" exact="United States of America" post="in coping COVIDâ€�19 pandemic crisis, the Oklahoma (2020) conducted"/>
   <result pre="the role of educational institutions in the United States of" exact="America" post="in coping COVIDâ€�19 pandemic crisis, the Oklahoma (2020) conducted"/>
   <result pre="syndrome in the Middle East, and the situation in the" exact="Kingdom of Saudi Arabia." post="This epidemic could put a great stress on students'"/>
   <result pre="the Middle East, and the situation in the Kingdom of" exact="Saudi Arabia." post="This epidemic could put a great stress on students'"/>
   <result pre="by Asaad, Elâ€�Sokkary, Aedh, Alzamanan, and Khalil (2019) in the" exact="Kingdom of Saudi Arabia" post="aimed to study knowledge and attitude toward Corona Virus"/>
   <result pre="Elâ€�Sokkary, Aedh, Alzamanan, and Khalil (2019) in the Kingdom of" exact="Saudi Arabia" post="aimed to study knowledge and attitude toward Corona Virus"/>
   <result pre="to overcome those crises without stopping the educational system. In" exact="Saudi Arabia," post="the Ministry of Education has succeeded in interacting with"/>
   <result pre="members at Princess Nora Bint Abdul Rahman University in the" exact="Kingdom of Saudi Arabia" post="during the academic year (2019â€&quot;2020). A random sample was"/>
   <result pre="Princess Nora Bint Abdul Rahman University in the Kingdom of" exact="Saudi Arabia" post="during the academic year (2019â€&quot;2020). A random sample was"/>
   <result pre="members at Princess Nora Bint Abdul Rahman University in the" exact="Kingdom of Saudi Arabia" post="during the academic year (2019â€&quot;2020) have responded to the"/>
   <result pre="Princess Nora Bint Abdul Rahman University in the Kingdom of" exact="Saudi Arabia" post="during the academic year (2019â€&quot;2020) have responded to the"/>
   <result pre="members at Princess Nora Bint Abdul Rahman University in the" exact="Kingdom of Saudi Arabia" post="about their responsibilities to raise the skill, health, moral"/>
   <result pre="Princess Nora Bint Abdul Rahman University in the Kingdom of" exact="Saudi Arabia" post="about their responsibilities to raise the skill, health, moral"/>
   <result pre="to increase the awareness of officials and decisionâ€�makers in the" exact="Kingdom of Saudi Arabia" post="about the importance of educational institutions and their contribution"/>
   <result pre="the awareness of officials and decisionâ€�makers in the Kingdom of" exact="Saudi Arabia" post="about the importance of educational institutions and their contribution"/>
   <result pre="al. (2020) study showed that the death rate in the" exact="Kingdom of Saudi Arabia" post="is the lowest compared to neighboring countries. The findings"/>
   <result pre="study showed that the death rate in the Kingdom of" exact="Saudi Arabia" post="is the lowest compared to neighboring countries. The findings"/>
   <result pre="Egypt, Umm Al Qura University and King Khalid University in" exact="Saudi Arabia." post="DATA AVAILABILITY STATEMENT All data underpin this study found"/>
   <result pre="stress among medical students at a university teaching hospital in" exact="Saudi Arabia." post="Journal of Infection and Public Health, 13(5), 687â€&quot;691. 10.1016/j.jiph.2020.01.00532001194"/>
   <result pre="to raise awareness of nonâ€�communicable diseases in secondary schools in" exact="Brunei" post="Darussalam. Proceeding of the 3rd International Conference on Education,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7461160\results\search\country\results.xml">
   <result pre="acute respiratory syndrome (SARS)-CoV spread into the human population in" exact="China" post="[4, 5]. Then, two new coronaviruses, CoV NL63 in"/>
   <result pre="and partial neuronal degeneration were observed in brain tissues in" exact="China" post="and many cases of viral encephalitis in different countries"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7461537\results\search\country\results.xml">
   <result pre="COVIDâ€�19 Coâ€�Infection; A Threat to Public Health for Coâ€�epidemic in" exact="Pakistan" post="BUTT et al. ButtMuhammad Hammadhttp://orcid.org/0000-0003-4387-13511AhmadAbrar1MisbahShahzadi1MallhiTauqeer Hussain2tauqeer.hussain.mallhi@hotmail.comKhanYusra Habib2[1], Faculty of"/>
   <result pre="Clinical PharmacyCollege of Pharmacy, Jouf University, Sakaka, Alâ€�Jouf ProvinceKingdom of" exact="Saudi Arabia" post="* Correspondence Tauqeer Hussain Mallhi, Department of Clinical Pharmacy,"/>
   <result pre="Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Alâ€�Jouf Province," exact="Kingdom of Saudi Arabia." post="Email: tauqeer.hussain.mallhi@hotmail.com epub: 2020-8-810.1002/jmv.26464(C) , This article is being"/>
   <result pre="College of Pharmacy, Jouf University, Sakaka, Alâ€�Jouf Province, Kingdom of" exact="Saudi Arabia." post="Email: tauqeer.hussain.mallhi@hotmail.com epub: 2020-8-810.1002/jmv.26464(C) , This article is being"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462115\results\search\country\results.xml">
   <result pre="respiratory syndrome (MERS) coronavirus (MERS-CoV) emerged, was in 2012 in" exact="Saudi Arabia" post="[7, 23, 24]. During 2002â€&quot;03, more than 8000 infected"/>
   <result pre="cases of infection and 858 mortalities, including 38 fatalities in" exact="South Korea" post="[25, 26]. In late December 2019, many infected patients"/>
   <result pre="named the 2019 novel coronavirus (2019-nCoV). From Mar 21, 2020," exact="China" post="has reported 80,967 confirmed cases across the country, with"/>
   <result pre="other areas, causing more than 44,000 cases of COVID-19 in" exact="China" post="until Feb 12, 2020, based on statistical data. Besides,"/>
   <result pre="until Feb 12, 2020, based on statistical data. Besides, outside" exact="China" post="including Hong Kong, Macao, and Taiwan, more than 400"/>
   <result pre="12, 2020, based on statistical data. Besides, outside China including" exact="Hong Kong," post="Macao, and Taiwan, more than 400 cases were reported"/>
   <result pre="reported in Thailand, Japan, Turkey, Italy, Singapore, France, Australia, and" exact="Canada" post="[31]. The number of reported cases was growing appreciably."/>
   <result pre="MERS-CoV (about 79 and 52%, respectively). Sequencing of samples from" exact="China" post="especially Wuhan indicated that this virus comes from the"/>
   <result pre="viruses and new ones, which had never been described in" exact="Hungary" post="before. Electron Microscopy (EM) Electron microscopy (EM) is one"/>
   <result pre="distant member within the SARS-related bat CoV clade, detected in" exact="Bulgaria" post="(GenBank Acc. No. NC_014470). Dots represent identical nucleotides compared"/>
   <result pre="National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, The" exact="Islamic Republic of Iran." post="Availability of Data and Materials Not applicable for this"/>
   <result pre="Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, The Islamic" exact="Republic of Iran." post="Availability of Data and Materials Not applicable for this"/>
   <result pre="coronavirusesTrends Microbiol201624649050227012512 19.CavanaghDCoronavirus avian infectious bronchitis virusVet Res200738228129717296157 20.IsmailMMTangAYSaifYMPathogenicity of" exact="Turkey" post="coronavirus in turkeys and chickensAvian Dis200347351552214562877 21.ZhouPet al.Fatal swine"/>
   <result pre="model for the Middle East respiratory syndrome outbreak in the" exact="Republic of" post="Korea: a retrospective analysis on control interventions and superspreading"/>
   <result pre="features of the first imported case causing MERS-CoV outbreak in" exact="South Korea," post="2015BMC Infect Dis201717149828709419 27.ZhuNet al.A novel coronavirus from patients"/>
   <result pre="of suspected Middle East respiratory syndrome coronavirus patients in Jakarta," exact="Indonesia" post="2015â€&quot;2016Int J Infect Dis20198610210731238156 72.CormanVet al.Diagnostic detection of Wuhan"/>
   <result pre="characterization of aptamer-based enzyme-linked apta-sorbent assay for the detection of" exact="Singapore" post="grouper iridovirus infectionJ Appl Microbiol2016121363464327124762 94.ChengAKSenDYuH-ZDesign and testing of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462603\results\search\country\results.xml">
   <result pre="which also blocks viral replication is approved for influenza in" exact="Japan" post="[67] and it is currently in clinical trials for"/>
   <result pre="In 2018, Albuvirtide, a peptide fusion inhibitor, was approved in" exact="China" post="[222]. Within the past decade, the development of peptide-based"/>
   <result pre="(B/E), failed to show sufficient efficacy for approval by the" exact="Thailand" post="Ministry of Health [174]. In 2019, the National Institutes"/>
   <result pre="[49]. The first known case of SARS occurred in southern" exact="China" post="in November 2002 [49]. The disease spread to more"/>
   <result pre="and tested for safety in Phase I clinical trials in" exact="China" post="[123]. Despite the promising safety results, these candidate vaccines"/>
   <result pre="A series of COVID-19 cases were first detected in Wuhan" exact="China" post="in December 2019, WHO declared a global health emergency"/>
   <result pre="2004-20192020CDC 30Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths in" exact="the United States" post="â€&quot; 2018â€&quot;2019 Influenza Season2020CDC 31Influenza A Subtypes and the"/>
   <result pre="30Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths in the" exact="United States" post="â€&quot; 2018â€&quot;2019 Influenza Season2020CDC 31Influenza A Subtypes and the"/>
   <result pre="HIV fusion inhibitors against enfuvirtide-resistant HIV-1 strainsProc. Natl. Acad. Sci." exact="U. S." post="A.105422008163321633718852475 86HeY.XiaoY.SongH.LiangQ.JuD.ChenX.Design and evaluation of sifuvirtide, a novel HIV-1"/>
   <result pre="silico design to preclinical proof of conceptProc. Natl. Acad. Sci." exact="U. S." post="A.106332009137971380119666568 114KshatriyaR.CachafeiroA.A.KerrR.J.NelsonJ.A.FiscusS.A.Comparison of two rapid human immunodeficiency virus (HIV)"/>
   <result pre="proteins are potent inhibitors of viral fusionProc. Natl. Acad. Sci." exact="U. S." post="A.9351996218621918700906 117LeistnerC.M.Gruen-BernhardS.GlebeD.Role of glycosaminoglycans for binding and infection of"/>
   <result pre="diamond electrode terminated with sialic acid-mimic peptideProc. Natl. Acad. Sci." exact="U. S." post="A.1133220168981898427457924 139McGregorD.P.Discovering and improving novel peptide therapeuticsCurr. Opin. Pharmacol.85200861661918602024"/>
   <result pre="correlation between solution structure and viral inhibitionProc. Natl. Acad. Sci." exact="U. S." post="A.8921199210537105411438243 212WinckelmannA.MorcillaV.ShaoW.SchleimannM.H.HojenJ.F.SchlubT.E.Genetic characterization of the HIV-1 reservoir after Vacc-4x"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462898\results\search\country\results.xml">
   <result pre="of fundamental basic science discoveries on developing an effective vaccine," exact="the US" post="Department of Health and Human Services has launched the"/>
   <result pre="from Houston, Texas, and review of autopsy findings from other" exact="United States" post="citiesCardiovasc Pathol482020107233 35BarthRFBujaLMParwaniAVThe spectrum of pathological findings in coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7463036\results\search\country\results.xml">
   <result pre="has once again become a hot topic. A study from" exact="Thailand" post="reported that a 71-year-old patient with severe COVID-19 on"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci." exact="China" post="Life Sci.633202045746032009228 8FehrA.R.PerlmanS.Coronaviruses: An Overview of their Replication and"/>
   <result pre="This work was supported by Novel coronavirus pneumonia emergency project," exact="China" post="(no. 2020YFC084430), 10.13039/501100013076National Major Science and Technology Projects of"/>
   <result pre="China (no. 2020YFC084430), 10.13039/501100013076National Major Science and Technology Projects of" exact="China" post="(CN):2019ZX09301001, 10.13039/501100002855Ministry of Science and Technology of the People's"/>
   <result pre="of China (CN):2019ZX09301001, 10.13039/501100002855Ministry of Science and Technology of the" exact="People's Republic of China" post="(CN):2020YFC0844300, and the 10.13039/501100012226Fundamental Research Funds for the Central"/>
   <result pre="China (CN):2019ZX09301001, 10.13039/501100002855Ministry of Science and Technology of the People's" exact="Republic of" post="China (CN):2020YFC0844300, and the 10.13039/501100012226Fundamental Research Funds for the"/>
   <result pre="10.13039/501100002855Ministry of Science and Technology of the People's Republic of" exact="China" post="(CN):2020YFC0844300, and the 10.13039/501100012226Fundamental Research Funds for the Central"/>
   <result pre="Universities , HUST: 2020kfyXGYJ011, 10.13039/501100011198State Key Laboratory of Drug Research," exact="China" post="(no. 2019ZX09301001) and the 10.13039/501100001809National Natural Science Foundation of"/>
   <result pre="China (no. 2019ZX09301001) and the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(no. 82041018, no. 81770096 and no. 81700091)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7463108\results\search\country\results.xml">
   <result pre="DA045596R01 DA044939FittingSylviaMcRaeMaryPeaceHauserKurt F. Overview The Opioid Crisis Opioid abuse in" exact="the United States" post="(U.S.) has reached catastrophic levels. According to the latest"/>
   <result pre="DA044939FittingSylviaMcRaeMaryPeaceHauserKurt F. Overview The Opioid Crisis Opioid abuse in the" exact="United States" post="(U.S.) has reached catastrophic levels. According to the latest"/>
   <result pre="56% higher than in the previous year (UNODC 2019a). North" exact="America" post="remains the region with the highest non-medical use of"/>
   <result pre="Int AIDS Soc2014171884424388495 MeijerinkHIndratiARSoedarmoSUtamiFde JongCAAlisjahbanaBvan CrevelRWisaksanaRVan der VenAJHeroin use in" exact="Indonesia" post="is associated with higher expression of CCR5 on CD4+"/>
   <result pre="Reed J, Minozzi S, Vickerman P, Hagan H, French C," exact="Jordan" post="A, Degenhardt L, Hope V, Hutchinson S, Maher L,"/>
   <result pre="and their effects on sleep. The medical clinics of North" exact="America" post="88:751â€&quot;766 RadjaFKayDGAlbrechtSJolicoeurPOligodendrocyte-specific expression of human immunodeficiency virus type 1"/>
   <result pre="consequence, or correlate?Biol Psychiatry20198673473531648680 SchollLSethPKariisaMWilsonNBaldwinGDrug and opioid-involved overdose deaths -" exact="United States," post="2013-2017MMWR Morb Mortal Wkly Rep2018671419142730605448 SchwartzLMajorEONeural progenitors and HIV-1-associated"/>
   <result pre="neural progenitors in archival pediatric brain tissueJ Neuro-Oncol200713274283 Secretary â€&quot;" exact="United States" post="Department of Health and Human Services (2017) Determination that"/>
   <result pre="JAM-A, and ALCAM in diapedesisPLoS One20138e6927023922698 Williams JT, Ingram SL," exact="Henderson" post="G, Chavkin C, von Zastrow M, Schulz S, Koch"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464065\results\search\country\results.xml">
   <result pre="has taken a catastrophic turn with high toll rates in" exact="China" post="and subsequently spreading across the globe. The rapid spread"/>
   <result pre="[5]. After severely affecting few countries particularly such as China," exact="Italy" post="and Iran, the vast majority of confirmed cases, and"/>
   <result pre="cases, and fatalities presently fall within USA, Brazil, India, Russia," exact="South Africa," post="Peru, Mexico, Colombia, Chile, Spain, UK, France, Germany [6,"/>
   <result pre="Russia, South Africa, Peru, Mexico, Colombia, Chile, Spain, UK, France," exact="Germany" post="[6, 7], and multiple countries in the globe. COVID-19"/>
   <result pre="has been stated that most of the affected patients in" exact="China" post="worked at or lived in the Huanan seafood wholesale"/>
   <result pre="reported from December 31, 2019, with unknown aetiology in Wuhan," exact="China" post="[18], which was thought to be SARS-CoV (an epidemic"/>
   <result pre="was thought to be SARS-CoV (an epidemic which originated in" exact="China" post="as well in 2002). Finally, it was confirmed that"/>
   <result pre="revealed that the new virus which commenced its spreading from" exact="China" post="is a version of SARS-CoV[37, 38]. There are two"/>
   <result pre="internationally to 37 different countries. Noteworthy outbreak sites included China," exact="Hong Kong," post="Taiwan, Singapore, and Vietnam. However, outside the Southeast Asia"/>
   <result pre="Taiwan, Singapore, and Vietnam. However, outside the Southeast Asia area," exact="Canada" post="was also significantly affected. The WHO reported 8,437 SARS"/>
   <result pre="been discussed earlier. MERS-CoV MERS-CoV was first identified in the" exact="Kingdom of Saudi Arabia" post="in 2012. Cases have been geographically restricted to the"/>
   <result pre="earlier. MERS-CoV MERS-CoV was first identified in the Kingdom of" exact="Saudi Arabia" post="in 2012. Cases have been geographically restricted to the"/>
   <result pre="In early March 2020, the pandemic started to subside in" exact="China" post="[66] but began to haunt Europe and the United"/>
   <result pre="subside in China [66] but began to haunt Europe and" exact="the United States," post="becoming Italy the epicentre of Europe and later New"/>
   <result pre="in China [66] but began to haunt Europe and the" exact="United States," post="becoming Italy the epicentre of Europe and later New"/>
   <result pre="but began to haunt Europe and the United States, becoming" exact="Italy" post="the epicentre of Europe and later New York city"/>
   <result pre="the increasing of cases and mortality was later higher in" exact="the US," post="where now there is the highest number of cases"/>
   <result pre="the significant increase in Russia, or the exponential growth in" exact="Brazil" post="and other countries in Latin America, as well in"/>
   <result pre="Brazil and other countries in Latin America, as well in" exact="India" post="could not be overlooked [67]. Few countries are left"/>
   <result pre="C-reactive protein and lactate dehydrogenase levels among people in Wuhan," exact="China" post="[40, 75]. As per reports, mild COVID-19 cases revealed"/>
   <result pre="found associated with rhabdomyolysis in a COVID-19 patient in Wuhan," exact="China" post="suggesting the need for rapid clinical diagnosis followed by"/>
   <result pre="(NASDAQ-GILD) pharmaceutical company (https://www.fool.com/investing/2020/03/04/is-gilead-sciences-the-best-buy-in-the-coronavirus.aspx). National Health Commission of the Peopleâ€™s" exact="Republic of" post="China has advocated the inclusion of chloroquine phosphate for"/>
   <result pre="company (https://www.fool.com/investing/2020/03/04/is-gilead-sciences-the-best-buy-in-the-coronavirus.aspx). National Health Commission of the Peopleâ€™s Republic of" exact="China" post="has advocated the inclusion of chloroquine phosphate for the"/>
   <result pre="2b in COVID-19 patients [191, 192]. National Health Commission of" exact="China" post="recommended a combination of ribavirin and interferon-Î± as a"/>
   <result pre="provide an avian infectious bronchitis virus natural mutant, kept in" exact="China" post="General Microbiological Culture Collection Center, named infectious bronchitis virus,"/>
   <result pre="evaluated in clinical trials (https://ttconsultants.com/blog/potential-covid-19-drugs-and-their-patents-in-major-jurisdictions/). Wuhan Institute of Virology in" exact="China" post="has filed a patent for the application of remdesivir"/>
   <result pre="taken a disastrous turn with high toll rates alone in" exact="China" post="itself, most likely. The infection is spreading across the"/>
   <result pre="Hepatol.20201892142214332387226 29.Rodriguez-MoralesAJRodriguez-MoralesAGMendezCAHernandez-BoteroSTracing new clinical manifestations in patients with COVID-19 in" exact="Chile" post="and its potential relationship with the SARS-CoV-2 divergenceCurr Trop"/>
   <result pre="January 2020. Geneva: World Health Organization; 2020. vol. WHO/nCoV/Clinical/2020.3]. 66.FlahaultAHas" exact="China" post="faced only a herald wave of SARS-CoV-2?Lancet20203951022894732145187 67.CimermanSChebaboACunhaCAdRodrÃ­guez-MoralesAJDeep impact"/>
   <result pre="of the basic reproduction number of Zika virus infection during" exact="Colombia" post="epidemic, 2015-2016Travel Med Infect Dis201614327427627060613 105.Rodriguez-MoralesAJZika and microcephaly in"/>
   <result pre="2020. 114.Millan-OnateJMillanWMendozaLASanchezCGFernandez-SuarezHBonilla-AldanaDKRodriguez-MoralesAJSuccessful recovery of COVID-19 pneumonia in a patient from" exact="Colombia" post="after receiving chloroquine and clarithromycinAnn Clin Microbiol Antimicrob20201911632331519 115.SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic"/>
   <result pre="Gene Delivery SystemsKona201633638527081214 131.ThiEPLeeACHGeisbertJBUrsic-BedoyaRAgansKNRobbinsMDeerDJFentonKAKondratowiczASMacLachlanIet al.Rescue of non-human primates from advanced" exact="Sudan" post="ebolavirus infection with lipid encapsulated siRNANat Microbiol2016110161421614227670117 132.ThiEPMireCELeeACHGeisbertJBZhouJZAgansKNSneadNMDeerDJBarnardTRFentonKAet al.Lipid"/>
   <result pre="severe covid-19 lung disease: the pulmonology perspective from the first" exact="United States" post="epicenter. Int J Infect Dis. 2020. 191.CaoBWangYWenDLiuWWangJFanGRuanLSongBCaiYWeiMet al.A trial"/>
   <result pre="randomised controlled trial. Lancet 2020. 212.First coronavirus vaccine trial in" exact="the US" post="is recruiting volunteers. https://www.livescience.com/us-coronavirus-vaccine-trial-recruiting.html. 213.HeYZhouYLiuSKouZLiWFarzanMJiangSReceptor-binding domain of SARS-CoV spike"/>
   <result pre="H-T, Wang CJ. Managing medication supply chains: lessons learned from" exact="Taiwan" post="during the COVID-19 pandemic and preparedness planning for the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464173\results\search\country\results.xml">
   <result pre="(â€œnâ€� denoting â€œnovelâ€�), which emerged during an outbreak in Wuhan," exact="China" post="[14]. Research is currently underway on the use of"/>
   <result pre="of CA-CTD-SP1 protein were restored with the SWISS-MODEL Workspace (https://swissmodel.expasy.org/;" exact="Swiss" post="Institute of Bioinformatics, Basel, Switzerland) [24]. Geometry optimization of"/>
   <result pre="BVM. Betulin 1 obtained from birch bark harvested in southern" exact="Poland" post="by extraction with dichloromethane was used as the starting"/>
   <result pre="the diagnosis and treatment of the first SARS-CoV-2 patient in" exact="the United States" post="[58], and remdesivir exhibited some potential in the treatment"/>
   <result pre="diagnosis and treatment of the first SARS-CoV-2 patient in the" exact="United States" post="[58], and remdesivir exhibited some potential in the treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464234\results\search\country\results.xml">
   <result pre="hosts as demonstrated by their finding in fecal specimens from" exact="Ghana" post="[6]. Bats are consumed throughout Africa as wild meat"/>
   <result pre="Middle Eastern Respiratory Syndrome (MERS) CoV (MERS-CoV), first identified in" exact="Saudi Arabia" post="in June 2012 [15], and (iii) SARS-CoV-2, formerly named"/>
   <result pre="of respiratory clinical samples from patients in Wuhan, Hubei province," exact="China" post="[16]. The disease caused by SARS-CoV-2 is now called"/>
   <result pre="[26]. MERS (Middle East Respiratory Syndrome) originated in 2012 in" exact="Saudi Arabia" post="and then spread to other countries in the Middle"/>
   <result pre="[29]. Even in January 2020, sporadic cases were reported in" exact="the United Arab Emirates." post="The total cumulative number of cases is 2499, with"/>
   <result pre="Even in January 2020, sporadic cases were reported in the" exact="United Arab Emirates." post="The total cumulative number of cases is 2499, with"/>
   <result pre="The number of infected cases is steadily increasing especially in" exact="the USA," post="South America (Brazil), South East Asia, and Africa [16]."/>
   <result pre="infected cases is steadily increasing especially in the USA, South" exact="America" post="(Brazil), South East Asia, and Africa [16]. Its origin"/>
   <result pre="the initial cases have been associated with the Huanan South" exact="China" post="Seafood Market. However, there is no absolute evidence so"/>
   <result pre="In Europe, the first few cases have been reported in" exact="France" post="and Germany and then in Italy and Spain. In"/>
   <result pre="the first few cases have been reported in France and" exact="Germany" post="and then in Italy and Spain. In France, the"/>
   <result pre="have been reported in France and Germany and then in" exact="Italy" post="and Spain. In France, the COVID-19 epidemic is believed"/>
   <result pre="in Italy. Furthermore, the Chinese touristâ€™s viral strains isolated in" exact="Italy" post="clustered with other European strains from France and Germany,"/>
   <result pre="strains isolated in Italy clustered with other European strains from" exact="France" post="and Germany, intermixing with other Chinese sequences, thus suggesting"/>
   <result pre="suggesting that strains introduced in Europe to date came from" exact="China" post="[18]. The results are consistent with several introductions of"/>
   <result pre="chain reaction (RT-PCR) assay for viral RNA detection, according to" exact="the US" post="Centers for Disease Control and Prevention instructions. Although this"/>
   <result pre="diagnostic tools [87]. 9. The Fight Against COVID-19 in Northern" exact="Italy" post="The reactions of health systems to COVID-19 in the"/>
   <result pre="guanine analog approved for treatment against influenza virus infection in" exact="Japan" post="and also can effectively inhibit replication of Ebola, yellow"/>
   <result pre="peptidase-4 expression in some MERS-CoV naturally infected dromedary camels in" exact="Saudi Arabia" post="2018â€&quot;2019Virus Dis.202061410.1007/s13337-020-00586-y 29.RamadanN.ShaibH.Middle East respiratory syndrome coronavirus (MERS-CoV)Germs20199354210.18683/germs.2019.115531119115 30.IslamA.EpsteinJ.H.RostalM.K.IslamS.RahmanM.Z.HossainM.E.UzzamanM.S.MunsterV.J.PeirisM.FloraM.S.et"/>
   <result pre="novel coronavirus in Wuhan, ChinaLancet202039549750610.1016/S0140-6736(20)30183-531986264 32.DeslandesA.BertiV.Tandjaoui-LambotteY.AllouiC.CarbonnelleE.ZaharJ.R.BrichlerS.CohenY.SARS-CoV-2 was already spreading in" exact="France" post="in late December 2019Int. J. Antimicrob. Agents20205510600610.1016/j.ijantimicag.2020.10600632371096 33.CapobianchiM.R.RuecaM.MessinaF.GiombiniE.CarlettiF.ColavitaF.CastillettiC.LalleE.BordiL.VairoF.et al.Molecular"/>
   <result pre="coronavirus, and human interaction. SARS-CoV-1 MERS-CoV SARS-CoV-2 Origin Guangdong Province," exact="China" post="Saudi Arabia Wuhan, China Rome, Italy Paris, France Potential"/>
   <result pre="and human interaction. SARS-CoV-1 MERS-CoV SARS-CoV-2 Origin Guangdong Province, China" exact="Saudi Arabia" post="Wuhan, China Rome, Italy Paris, France Potential reservoir Bat"/>
   <result pre="SARS-CoV-1 MERS-CoV SARS-CoV-2 Origin Guangdong Province, China Saudi Arabia Wuhan," exact="China" post="Rome, Italy Paris, France Potential reservoir Bat * Bat"/>
   <result pre="SARS-CoV-2 Origin Guangdong Province, China Saudi Arabia Wuhan, China Rome," exact="Italy" post="Paris, France Potential reservoir Bat * Bat * Bat"/>
   <result pre="Guangdong Province, China Saudi Arabia Wuhan, China Rome, Italy Paris," exact="France" post="Potential reservoir Bat * Bat * Bat * Intermediate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464724\results\search\country\results.xml">
   <result pre="of Everglades virus, which is only found in Florida in" exact="the United States" post="[22]. Tonate virus, Everglades virus and VEEV have been"/>
   <result pre="Everglades virus, which is only found in Florida in the" exact="United States" post="[22]. Tonate virus, Everglades virus and VEEV have been"/>
   <result pre="America, while VEEV is the only species described in Central" exact="America" post="as well [22]. While VEEV has been shown to"/>
   <result pre="Central America; and IE is located in Central and North" exact="America" post="[22]. VEEV preferentially utilizes mosquitoes in the subgenus Culex"/>
   <result pre="first isolated from the brain of an infected equine from" exact="Venezuela" post="in 1938 [5]. It is possible that VEEV outbreaks"/>
   <result pre="of human infection with 176 fatalities [16]. Cases continued in" exact="Colombia" post="between 1967 and 1968. Closely thereafter in 1969, Ecuador"/>
   <result pre="in Colombia between 1967 and 1968. Closely thereafter in 1969," exact="Ecuador" post="would report approximately 20,000 equine deaths and 31,000 human"/>
   <result pre="deaths [16]. The virus spread northward during that year to" exact="El Salvador," post="Guatemala and Mexico [57]. The disease burden in these"/>
   <result pre="The virus spread northward during that year to El Salvador," exact="Guatemala" post="and Mexico [57]. The disease burden in these countries"/>
   <result pre="spread northward during that year to El Salvador, Guatemala and" exact="Mexico" post="[57]. The disease burden in these countries exceeded 50,000"/>
   <result pre="to spread northward and by 1970â€&quot;1971, the outbreak crossed into" exact="the United States." post="Texas would report more than 1500 horse deaths, 110"/>
   <result pre="spread northward and by 1970â€&quot;1971, the outbreak crossed into the" exact="United States." post="Texas would report more than 1500 horse deaths, 110"/>
   <result pre="a decade later, a large outbreak occurred in 1979 in" exact="Mexico" post="and Texas [42], during which tens of thousands of"/>
   <result pre="1995, however, the largest recognized human outbreak was observed in" exact="Venezuela" post="and Colombia in 1995 [50,61] in which approximately 100,000"/>
   <result pre="the largest recognized human outbreak was observed in Venezuela and" exact="Colombia" post="in 1995 [50,61] in which approximately 100,000 people and"/>
   <result pre="infected. More recent outbreaks occurred in 2005 and 2006 in" exact="Peru" post="[52]. Over 20% of the people of Iquitos, Peru,"/>
   <result pre="distinct lineages, one of which is found circulating in North" exact="America" post="and the Caribbean, with the remaining three circulating in"/>
   <result pre="Caribbean, with the remaining three circulating in South and Central" exact="America" post="[64,65]. Until 2013, the entire EEEV antigenic complex was"/>
   <result pre="equine pathogen [64,72,81]. Indeed, until an outbreak taking place in" exact="Panama" post="in 2010, MADV has been associated with only two"/>
   <result pre="two cases of fatal human disease, one taking place in" exact="Brazil" post="in 1956, and the other in Trinidad in 1972"/>
   <result pre="human patients were characterized over the course of the 2010" exact="Panama" post="outbreak, with only one reported fatality, which was not"/>
   <result pre="lesions previously reported [79,85]. Serosurveys conducted in endemic regions of" exact="Peru" post="and Panama have demonstrated that 2 to 5% of"/>
   <result pre="reported [79,85]. Serosurveys conducted in endemic regions of Peru and" exact="Panama" post="have demonstrated that 2 to 5% of the human"/>
   <result pre="climate and season. In the temperate climates of the Northeastern" exact="United States," post="transmission is seasonal, with detection of viremic birds taking"/>
   <result pre="November or December [64,91]. However, in the Southeastern regions of" exact="the United States," post="such as Florida, enzootic transmission of EEEV is maintained"/>
   <result pre="or December [64,91]. However, in the Southeastern regions of the" exact="United States," post="such as Florida, enzootic transmission of EEEV is maintained"/>
   <result pre="is maintained year-round [64,92,93]. Likewise, MADV in South and Central" exact="America" post="is transmitted continuously throughout the year [64,91]. It is"/>
   <result pre="[64,91]. Both enzootic and epizootic cycles for EEEV in North" exact="America" post="are well-characterized. The definitive mosquito vector for EEEV is"/>
   <result pre="(Peru) [64,91]. Experimentally, a field population of Cx. pedroi from" exact="Peru" post="has been demonstrated to be efficiently infected when exposed"/>
   <result pre="reservoirs for MADV [120]. Strikingly, during a MADV epizootic in" exact="Panama" post="in 2010, a small subset of both human and"/>
   <result pre="Outbreaks Evidence indicates that EEEV has caused outbreaks in North" exact="America" post="in equines as early as 1831 [90,121]. The causative"/>
   <result pre="isolated from the brain of an infected horse in New" exact="Jersey" post="during a large scale (&amp;gt;1000 horses), multistate (Maryland, Delaware,"/>
   <result pre="in Boston [64,121,125]. Since then, multiple outbreaks in the eastern" exact="United States" post="have occurred, with 112 human cases identified between the"/>
   <result pre="in 1938 (34 human cases, 248 equine cases) [64,75,80], New" exact="Jersey" post="in 1959 (32 human cases, 66 equine cases) [64,70,73],"/>
   <result pre="as 1908. Although the virus was isolated in horses in" exact="Argentina" post="in 1930, it not identified as South American EEEV/MADV"/>
   <result pre="[83,85]. Of the 19 hospitalized patients diagnosed with encephalitis in" exact="Panama" post="in 2010, seven of these patients were confirmed to"/>
   <result pre="were reported in a cohort of young school children in" exact="Haiti" post="[130,131]. Similarly, in 2016, a single adolescent patient in"/>
   <result pre="Haiti [130,131]. Similarly, in 2016, a single adolescent patient in" exact="Venezuela" post="was diagnosed with MADV after demonstrating signs of a"/>
   <result pre="[139]. The primary summer transmission cycle of WEEV in North" exact="America" post="is well understood with Cx. tarsalis acting as the"/>
   <result pre="from viremic horses, the large number of horses in North" exact="America" post="in the early 20th century, for agricultural use, could"/>
   <result pre="reduction in incidence does correlate with a drastic decline in" exact="the US" post="horse population and increased vaccination coverage of horses [139]."/>
   <result pre="the years of 1931 through 1934, reaching the grasslands of" exact="Canada" post="in 1935 [139]. Further, several severe outbreaks occurred during"/>
   <result pre="that occurred in 1941 resulted in 3336 human deaths in" exact="the United States" post="(mostly in the Dakotas, Minnesota, and Nebraska) and Canada"/>
   <result pre="occurred in 1941 resulted in 3336 human deaths in the" exact="United States" post="(mostly in the Dakotas, Minnesota, and Nebraska) and Canada"/>
   <result pre="United States (mostly in the Dakotas, Minnesota, and Nebraska) and" exact="Canada" post="(Manitoba and Saskatchewan) [175,176]. After the 1930s and 1940s,"/>
   <result pre="of the most severe epizootic events occurred in Midwestern North" exact="America" post="and southern Manitoba, for example, in 1941. Additionally, several"/>
   <result pre="and 1990s with the last reported human case in North" exact="America" post="occurring in 1998. One fatal case of WEE arose"/>
   <result pre="occurring in 1998. One fatal case of WEE arose in" exact="Uruguay" post="during April of 2009 in an otherwise healthy 14-year-old"/>
   <result pre="dalzeili, Ae. africanus, Ae. neoafricanus and Ae. cordellieri in Senegal," exact="Ivory Coast," post="Uganda, Central African Republic and South Africa [204,205,206,207,208]. Nonhuman"/>
   <result pre="Ae. neoafricanus and Ae. cordellieri in Senegal, Ivory Coast, Uganda," exact="Central African Republic" post="and South Africa [204,205,206,207,208]. Nonhuman primates have been implicated"/>
   <result pre="cordellieri in Senegal, Ivory Coast, Uganda, Central African Republic and" exact="South Africa" post="[204,205,206,207,208]. Nonhuman primates have been implicated as the principal"/>
   <result pre="can be initiated. Asian and IOL lineage viruses in Asia," exact="India" post="and the Americas are primarily associated with this urban"/>
   <result pre="[209]. Throughout the 1960s and 1970s, infections were observed in" exact="South Africa," post="the Democratic Republic of Congo, Senegal, Uganda, Nigeria, Angola,"/>
   <result pre="1960s and 1970s, infections were observed in South Africa, the" exact="Democratic Republic of Congo," post="Senegal, Uganda, Nigeria, Angola, Central African Republic, Ivory Coast"/>
   <result pre="and 1970s, infections were observed in South Africa, the Democratic" exact="Republic of" post="Congo, Senegal, Uganda, Nigeria, Angola, Central African Republic, Ivory"/>
   <result pre="Africa, the Democratic Republic of Congo, Senegal, Uganda, Nigeria, Angola," exact="Central African Republic," post="Ivory Coast and Cameroon [209,210]. The first large urban"/>
   <result pre="Republic of Congo, Senegal, Uganda, Nigeria, Angola, Central African Republic," exact="Ivory Coast" post="and Cameroon [209,210]. The first large urban outbreak of"/>
   <result pre="Senegal, Uganda, Nigeria, Angola, Central African Republic, Ivory Coast and" exact="Cameroon" post="[209,210]. The first large urban outbreak of CHIKV was"/>
   <result pre="The first large urban outbreak of CHIKV was observed in" exact="Thailand" post="starting in 1960; this outbreak also incriminated the Ae."/>
   <result pre="WAf, ECSA and Asian lineages. In 2004, CHIKV spread from" exact="Kenya" post="to Comoros and ultimately to the island of La"/>
   <result pre="and Asian lineages. In 2004, CHIKV spread from Kenya to" exact="Comoros" post="and ultimately to the island of La RÃ©union off"/>
   <result pre="to the island of La RÃ©union off the coast of" exact="Madagascar" post="in the Indian Ocean in 2015. Here, a unique"/>
   <result pre="to other islands in the Indian Ocean including Madagascar, India," exact="Sri Lanka," post="Cameroon, Gabon and Congo. Travel-associated infections were identified in"/>
   <result pre="in the Indian Ocean including Madagascar, India, Sri Lanka, Cameroon," exact="Gabon" post="and Congo. Travel-associated infections were identified in multiple European"/>
   <result pre="multiple European countries [210] and local transmission was observed in" exact="Italy" post="in 2007 [215]. By 2008, CHIKV outbreaks were observed"/>
   <result pre="in 2007 [215]. By 2008, CHIKV outbreaks were observed in" exact="Malaysia" post="[216], Singapore [217], Thailand [218] and China [219]. Considering"/>
   <result pre="[215]. By 2008, CHIKV outbreaks were observed in Malaysia [216]," exact="Singapore" post="[217], Thailand [218] and China [219]. Considering the outbreaks"/>
   <result pre="2008, CHIKV outbreaks were observed in Malaysia [216], Singapore [217]," exact="Thailand" post="[218] and China [219]. Considering the outbreaks of Africa"/>
   <result pre="were observed in Malaysia [216], Singapore [217], Thailand [218] and" exact="China" post="[219]. Considering the outbreaks of Africa and Asia, experts"/>
   <result pre="virus quickly spread to neighboring islands and into South America." exact="Brazil" post="noted its first case in 2014. More than one"/>
   <result pre="another introduction of an ECSA lineage virus was noted in" exact="Brazil" post="with sustained autochthonous transmission, proving that ECSA stains were"/>
   <result pre="this initial introduction, CHIKV spread across the South and Central" exact="America" post="spreading as far north as Mexico. The majority of"/>
   <result pre="as far north as Mexico. The majority of cases in" exact="the United States" post="were travel related though some might have been locally"/>
   <result pre="far north as Mexico. The majority of cases in the" exact="United States" post="were travel related though some might have been locally"/>
   <result pre="found to transmit MAYV during its largest outbreak in Belterra," exact="Brazil" post="[237]. Although mosquitoes of the genus Aedes can also"/>
   <result pre="reported only in the Americas, mainly in Brazil, Peru, and" exact="Bolivia" post="[241]. Additionally, reports of infections are based on serological"/>
   <result pre="MAYV was first isolated in the Mayaro county, southwest of" exact="Trinidad and Tobago," post="in 1954 [242], the first registered outbreak occurred in"/>
   <result pre="outbreak was also registered in the Portuguesa state, west of" exact="Venezuela" post="in 2010. Nineteen of 77 cases reported were confirmed"/>
   <result pre="six MAYV strains were isolated [247]. Other outbreaks occurred in" exact="Brazil" post="in 1981, 1991 and 2015 with no detailed information"/>
   <result pre="mosquitoes causing large urban outbreaks. MAYV is present in South" exact="America" post="[231,247,251,252] and it may also be present to a"/>
   <result pre="present to a lesser extent in Central [130,253] and North" exact="America" post="[130,254], and it is known to cause small outbreaks"/>
   <result pre="wide distribution of the SINV, the most affected regions are" exact="South Africa" post="and countries in Northern Europe [257,260]. The SINV infection"/>
   <result pre="or subclinical and, therefore, largely undiagnosed [261,262,263,264]. Serological surveys in" exact="Finland" post="[264] and Sweden [261] indicate that as much as"/>
   <result pre="therefore, largely undiagnosed [261,262,263,264]. Serological surveys in Finland [264] and" exact="Sweden" post="[261] indicate that as much as 95% of all"/>
   <result pre="Kurkela et al. [268] investigated a cohort of patients in" exact="Finland" post="and found that 24.5% of the patients experienced joint"/>
   <result pre="hooded crow (Corvus corone sardonius) during an epidemic in Cairo," exact="Egypt" post="[271]. SINV replicates within mosquitoes, birds, and humans, however,"/>
   <result pre="been isolated from Cs. morsitans and Aedes (Ae.) cinereus in" exact="Sweden" post="[275,276], Ochlerotatus spp. in Finland [277], and Aedes spp."/>
   <result pre="and Aedes (Ae.) cinereus in Sweden [275,276], Ochlerotatus spp. in" exact="Finland" post="[277], and Aedes spp. in Russia [278]. Evidence of"/>
   <result pre="[275,276], Ochlerotatus spp. in Finland [277], and Aedes spp. in" exact="Russia" post="[278]. Evidence of transmission from birds to humans implicates"/>
   <result pre="and Central Europe, might be the main amplification hosts in" exact="Sweden" post="[283,284]. A study in Finland detected antibodies anti-SINV mainly"/>
   <result pre="the main amplification hosts in Sweden [283,284]. A study in" exact="Finland" post="detected antibodies anti-SINV mainly in two Tetrao spp., black"/>
   <result pre="an epidemic in the village of Sindbis, close to Cairo," exact="Egypt" post="in 1952 [271]. Later, the virus was also isolated"/>
   <result pre="isolated from skin lesion samples from a woman infected in" exact="South Africa" post="[286]. Noticeably, SINV outbreaks in the African continent have"/>
   <result pre="SINV outbreaks in the African continent have been reported by" exact="South Africa" post="only [257]. Later in 1963, an outbreak of similar"/>
   <result pre="as the women whom the virus was isolated occurred in" exact="South Africa" post="and 14 out of 21 (66.6%) patients were serologically"/>
   <result pre="seropositive rate [288]. SINV neutralizing antibodies were also found in" exact="Egypt" post="in 1967 [289]. Serological testing following the febrile illness"/>
   <result pre="Serological testing following the febrile illness of a child in" exact="Australia" post="in 1969 also showed evidence of SINV infection [290]."/>
   <result pre="Northern Europe emerged as a focus of SINV infection in" exact="Sweden" post="in 1967 [293] and Finland in 1974 [264]. SINV"/>
   <result pre="focus of SINV infection in Sweden in 1967 [293] and" exact="Finland" post="in 1974 [264]. SINV infections have been recorded yearly"/>
   <result pre="yearly since in this region [257]. Since 1974, outbreaks in" exact="Finland" post="occur in approximate seven-year cycles without a directly implicated"/>
   <result pre="larger study revealed a seroprevalence of 9âˆ’17% in regions of" exact="Finland" post="in the early 2000s [296]. Additionally, Kurkela and collaborators"/>
   <result pre="number (40%) seen in 1988 [261]. The 1995 outbreak in" exact="Finland" post="was also identified in Sweden but with fewer cases"/>
   <result pre="[261]. The 1995 outbreak in Finland was also identified in" exact="Sweden" post="but with fewer cases [260]. The last reported outbreak"/>
   <result pre="but with fewer cases [260]. The last reported outbreak in" exact="Sweden" post="occurred in 2013 in a previously non-endemic area in"/>
   <result pre="non-endemic area in the northern region of the country [275]." exact="South Africa" post="is another country significantly affected by SINV; however, epidemiological"/>
   <result pre="by SINV; however, epidemiological data and public health burden in" exact="South Africa" post="are still quite vague [262]. The simultaneous outbreak of"/>
   <result pre="IgM positive in 2010 [262]. 2.6.4. Potential for Future Outbreaks" exact="Finland" post="has reported more SINV cases than other areas but"/>
   <result pre="1995 [298]. Since this year, the number of cases in" exact="Finland" post="increased dramatically in comparison to Sweden, for example, which"/>
   <result pre="not adopt this measure. Notably, the number of cases in" exact="Finland" post="was 33 times higher than Swedenâ€²s from 1995 to"/>
   <result pre="Since 1974, SINV outbreaks have occurred every seven years in" exact="Finland" post="without a firm underlying reason [264]. One hypothesis is"/>
   <result pre="of Sindbis disease. SINV has been isolated from mosquitoes in" exact="Kenya" post="[302]. South Africa has reported infections but underreporting is"/>
   <result pre="disease. SINV has been isolated from mosquitoes in Kenya [302]." exact="South Africa" post="has reported infections but underreporting is highly likely as"/>
   <result pre="illnesses with similar symptoms [259]. SINV has been circulating within" exact="Australia" post="for at least 33 years in different locations of"/>
   <result pre="linked to Swedish strains and related to human cases in" exact="Sweden" post="[306]. In addition, IgG anti-SINV was detected in four"/>
   <result pre="that SINV outbreaks may occur in the analyzed area in" exact="Germany" post="when these findings are considered along with the lack"/>
   <result pre="about the risk of human SINV infection, not only in" exact="Germany" post="but also in other regions where mosquitoes infected with"/>
   <result pre="Ross River virus causes Ross River virus disease (RRVD) in" exact="Papua New Guinea" post="and is the most common arboviral disease in Australia"/>
   <result pre="virus causes Ross River virus disease (RRVD) in Papua New" exact="Guinea" post="and is the most common arboviral disease in Australia"/>
   <result pre="New Guinea and is the most common arboviral disease in" exact="Australia" post="[308,309,310,311]. Patients experience a variety of symptoms ranging from"/>
   <result pre="1959 [321], but reports of RRV outbreaks have occurred in" exact="Australia" post="since 1928. Several outbreaks were also registered in Australia"/>
   <result pre="in Australia since 1928. Several outbreaks were also registered in" exact="Australia" post="and Papua New Guinea during the Second World War"/>
   <result pre="since 1928. Several outbreaks were also registered in Australia and" exact="Papua New Guinea" post="during the Second World War and in 1956 [309]."/>
   <result pre="Several outbreaks were also registered in Australia and Papua New" exact="Guinea" post="during the Second World War and in 1956 [309]."/>
   <result pre="samples was done in 1971, from an aboriginal child in" exact="Australia" post="[325]. RRV spread to the South Pacific in 1979,"/>
   <result pre="the South Pacific in 1979, subsequently causing important outbreaks in" exact="Fiji" post="[326], Cook Islands [327], and American Samoa [319]. There"/>
   <result pre="Pacific in 1979, subsequently causing important outbreaks in Fiji [326]," exact="Cook Islands" post="[327], and American Samoa [319]. There have been no"/>
   <result pre="causing important outbreaks in Fiji [326], Cook Islands [327], and" exact="American Samoa" post="[319]. There have been no registered outbreaks in the"/>
   <result pre="important outbreaks in Fiji [326], Cook Islands [327], and American" exact="Samoa" post="[319]. There have been no registered outbreaks in the"/>
   <result pre="[319]. There have been no registered outbreaks in the Pacific" exact="Island" post="Countries and Territories since these events, however serological studies"/>
   <result pre="Therefore, new outbreaks of RRVD are a continuous threat in" exact="Australia" post="[318], and the virus may also pose a threat"/>
   <result pre="Dogs, FloridaEmerg. Infect. Dis.2006121873187910.3201/eid1212.06044617326938 26.GalindoP.GraysonM.A.Culex (Melanoconion) aikenii: Natural vector in" exact="Panama" post="of endemic Venezuelan encephalitisScience197117259459510.1126/science.172.3983.5945555082 27.SmithD.R.AdamsA.P.KenneyJ.L.WangE.WeaverS.C.Venezuelan equine encephalitis virus in"/>
   <result pre="southern TexasJ. Wildl. Dis.19751119520010.7589/0090-3558-11.2.195238050 44.SudiaW.D.McLeanR.G.NewhouseV.F.JohnstonJ.G.MillerD.L.TrevinoH.BowenG.S.SatherG.Epidemic Venezuelan equine encephalitis in North" exact="America" post="in 1971: Vertebrate field studiesAm. J. Epidemiol.1975101365010.1093/oxfordjournals.aje.a1120691119481 45.SudiaW.D.NewhouseV.F.HendersonB.E.Experimental infection"/>
   <result pre="Encephalomyelitis in VenezuelaScience193990202110.1126/science.90.2323.2017818578 49.DickermanR.W.CuppE.W.GrootH.AlarconA.M.CuraE.DickermanA.W.IbagosA.L.Ricco-HesseR.TaylorC.A.WeaverS.C.Venezuelan equine encephalitis virus activity in northern" exact="Colombia" post="during April and May 1983Bull. Pan Am. Health Organ.1986202762832879583"/>
   <result pre="RosaA.P.WangE.BeltranD.GundakerN.D.ArmienB.ArroyoG.SosaN.PascaleJ.M.et al.Human and Equine Infection with Alphaviruses and Flaviviruses in" exact="Panama" post="during 2010: A Cross-Sectional Study of Household Contacts during"/>
   <result pre="Med. Hyg.2018981798180410.4269/ajtmh.17-067929737271 55.CardozoF.KonigheimB.Albrieu-LlinasG.RivarolaM.E.AguilarJ.RojasA.QuagliaA.I.PaezM.GuillenY.DiazA.et al.Alphaviruses: Serological Evidence of Human Infection in" exact="Paraguay" post="(2012â€&quot;2013)Vector Borne Zoonotic Dis.20181826627210.1089/vbz.2017.217829652644 56.SudiaW.D.LordR.D.NewhouseV.F.MillerD.L.KisslingR.E.Vector-host studies of an epizootic"/>
   <result pre="Equine Encephalomyelitis: Surveys of Human Illness During an Epizootic in" exact="Guatemala" post="and El SalvadorAm. J. Epidemiol.19719313013610.1093/oxfordjournals.aje.a1212335101138 58.SudiaW.D.NewhouseV.F.BeadleL.D.MillerD.L.JohnstonJ.G.YoungR.CalisherC.H.ManessK.Epidemic Venezuelan Equine Encephalitis"/>
   <result pre="El SalvadorAm. J. Epidemiol.19719313013610.1093/oxfordjournals.aje.a1212335101138 58.SudiaW.D.NewhouseV.F.BeadleL.D.MillerD.L.JohnstonJ.G.YoungR.CalisherC.H.ManessK.Epidemic Venezuelan Equine Encephalitis in North" exact="America" post="in 1971: Vector StudiesAm. J. Epidemiol.1975101173510.1093/oxfordjournals.aje.a112068235212 59.BergeT.O.BanksI.S.TigerttW.D.Attenuation of Venezuelan"/>
   <result pre="patterns of eastern equine encephalitis virus in North versus South" exact="America" post="suggest ecological differences and taxonomic revisionJ. Virol.2010841014102510.1128/JVI.01586-0919889755 66.ArrigoN.C.WeaverS.C.Proposal 2012.007aV."/>
   <result pre="and Animal HealthOpen Virol. J.201812809810.2174/187435790181201008030288197 68.LindseyN.P.StaplesJ.E.FischerM.Eastern Equine Encephalitis Virus in" exact="the United States," post="2003â€&quot;2016Am. J. Trop. Med. Hyg.2018981472147710.4269/ajtmh.17-092729557336 69.MorensD.M.FolkersG.K.FauciA.S.Eastern Equine Encephalitis Virus-Another"/>
   <result pre="Animal HealthOpen Virol. J.201812809810.2174/187435790181201008030288197 68.LindseyN.P.StaplesJ.E.FischerM.Eastern Equine Encephalitis Virus in the" exact="United States," post="2003â€&quot;2016Am. J. Trop. Med. Hyg.2018981472147710.4269/ajtmh.17-092729557336 69.MorensD.M.FolkersG.K.FauciA.S.Eastern Equine Encephalitis Virus-Another"/>
   <result pre="J. Med.20193811989199210.1056/NEJMp191432831747726 70.GoldfieldM.WelshJ.N.TaylorB.F.The 1959 Outbreak of Eastern Encephalitis in New" exact="Jersey" post="5. The Inapparent Infection: Disease RatioAm. J. Epidemiol.196887323810.1093/oxfordjournals.aje.a1208075637876 71.DavisL.E.BeckhamJ.D.TylerK.L.North"/>
   <result pre="emergenceAntivir. Res.20129424225710.1016/j.antiviral.2012.04.00222522323 73.GoldfieldM.SussmanO.The 1959 Outbreak of Eastern Encephalitis in New" exact="Jersey" post="1. Introduction and Description of OutbreakAm. J. Epidemiol.19688711010.1093/oxfordjournals.aje.a1207895637871 74.AyresJ.C.FeemsterR.F.The"/>
   <result pre="Eastern Equine Encephalitis Virus in the Amazon Basin Region of" exact="Peru" post="using Reverse Transcription-Polymerase Chain Reaction adapted for field identification"/>
   <result pre="equine encephalomyelitis in infantsJ. Pediatr.19432230831810.1016/S0022-3476(43)80169-4 143.McGowanJ.E.BryanJ.S.GreggM.B.Surveillance of arboviral encephalitis in" exact="the United States," post="1955â€&quot;1971Am. J. Epidemiol.19739719920710.1093/oxfordjournals.aje.a1215004692993 144.EarnestM.P.GoolishianH.A.CalverleyJ.R.HayesR.O.HillH.R.Neurologic, intellectual, and psychologic sequelae following"/>
   <result pre="encephalomyelitis in infantsJ. Pediatr.19432230831810.1016/S0022-3476(43)80169-4 143.McGowanJ.E.BryanJ.S.GreggM.B.Surveillance of arboviral encephalitis in the" exact="United States," post="1955â€&quot;1971Am. J. Epidemiol.19739719920710.1093/oxfordjournals.aje.a1215004692993 144.EarnestM.P.GoolishianH.A.CalverleyJ.R.HayesR.O.HillH.R.Neurologic, intellectual, and psychologic sequelae following"/>
   <result pre="risk of Chikungunya viremic blood donation during an epidemic on" exact="Reunion" post="Island in the Indian Ocean, 2005 to 2007Transfusion2008481333134110.1111/j.1537-2995.2008.01646.x18298600 190.SuhrbierA.Jaffar-BandjeeM.C.GasqueP.Arthritogenic"/>
   <result pre="of Chikungunya viremic blood donation during an epidemic on Reunion" exact="Island" post="in the Indian Ocean, 2005 to 2007Transfusion2008481333134110.1111/j.1537-2995.2008.01646.x18298600 190.SuhrbierA.Jaffar-BandjeeM.C.GasqueP.Arthritogenic alphaviruses-an"/>
   <result pre="arbovirusJ. Gen. Virol.2007882363237710.1099/vir.0.82858-017698645 211.HammonW.D.RundnickA.SatherG.E.Viruses Associated with Epidemic Hemorrhagic Fevers of" exact="the Philippines" post="and ThailandScience19601311102110310.1126/science.131.3407.110214399343 212.NimmannityaS.HalsteadS.B.CohenS.N.MargiottaM.R.Dengue and Chikungunya Virus Infection in Man"/>
   <result pre="Gen. Virol.2007882363237710.1099/vir.0.82858-017698645 211.HammonW.D.RundnickA.SatherG.E.Viruses Associated with Epidemic Hemorrhagic Fevers of the" exact="Philippines" post="and ThailandScience19601311102110310.1126/science.131.3407.110214399343 212.NimmannityaS.HalsteadS.B.CohenS.N.MargiottaM.R.Dengue and Chikungunya Virus Infection in Man"/>
   <result pre="220.SouzaT.M.L.VieiraY.R.DelatorreE.Barbosa-LimaG.LuizR.L.F.VizzoniA.JainK.MirandaM.M.BhuvaN.GogartenJ.F.et al.Emergence of the East-Central-South-African genotype of Chikungunya virus in" exact="Brazil" post="and the city of Rio de Janeiro may have"/>
   <result pre="EpidemiolÃ³gica 35, 2017Bol. Epidemiol.201748113 224.collab: CDCFirst Chikungunya Case Acquired in" exact="the United States" post="Reported in FloridaAvailable online: https://www.cdc.gov/media/releases/2014/p0717-chikungunya.html(accessed on 23 June 2020)"/>
   <result pre="35, 2017Bol. Epidemiol.201748113 224.collab: CDCFirst Chikungunya Case Acquired in the" exact="United States" post="Reported in FloridaAvailable online: https://www.cdc.gov/media/releases/2014/p0717-chikungunya.html(accessed on 23 June 2020)"/>
   <result pre="BrazilTrans. R. Soc. Trop. Med. Hyg.202010.1093/trstmh/traa016 253.GanjianN.Riviere-CinnamondA.Mayaro virus in Latin" exact="America" post="and the CaribbeanRev. Panam. Salud Publica202044e1410.26633/RPSP.2020.1432051685 254.Navarrete-EspinosaJ.GÃ³mez-DantÃ©sH.[Arbovirus causing hemorrhagic"/>
   <result pre="disease in SwedenEpidemiol. Infect.199110656757410.1017/S09502688000676371646735 262.StormN.WeyerJ.MarkotterW.KempA.LemanP.A.Dermaux-MsimangV.NelL.H.PaweskaJ.T.Human cases of Sindbis fever in" exact="South Africa," post="2006-2010Epidemiol. Infect.201414223423810.1017/S095026881300096423611492 263.LaineM.LuukkainenR.ToivanenA.Sindbis Viruses and Other Alphaviruses as a"/>
   <result pre="Arthritic DiseaseJ. Intern. Med.200425645747110.1111/j.1365-2796.2004.01413.x15554947 264.Brummer-KorvenkontioM.VapalahtiO.KuusistoP.SaikkuP.ManniT.KoskelaP.NygrenT.Brummer-KorvenkontioH.VaheriA.Epidemiology of Sindbis virus infections in" exact="Finland" post="1981-96: Possible factors explaining a peculiar disease patternEpidemiol. Infect.200212933534510.1017/S095026880200740912403109"/>
   <result pre="of Mosquitoes and Birds as Hosts of Ockelbo Virus in" exact="Sweden" post="and Isolation of Inkoo and Batai Viruses From MosquitoesAm."/>
   <result pre="J. Trop. Med. Hyg.19671621121510.4269/ajtmh.1967.16.2116067094 293.SkoghM.EspmarkA.Ockelbo Disease: Epidemic Arthritis-Exanthema Syndrome in" exact="Sweden" post="Caused by a Sindbis-virus Like AgentLancet198231979579610.1016/S0140-6736(82)91834-7 294.TurunenM.KuusistoP.UggeldahlP.-E.ToivanenA.Pogosta Disease: Clinical"/>
   <result pre="Hyg.1984331203121110.4269/ajtmh.1984.33.12036150654 300.McIntoshB.M.JuppP.G.Dos SantosI.MeenehanG.M.Epidemics of West Nile and Sindbis viruses in" exact="South Africa" post="with Culex (Culex) univittatus Theobald as vectorS. Afr. J."/>
   <result pre="329.RussellR.C.KayB.H.Medical entomology: Changes in the spectrum of mosquito-borne disease in" exact="Australia" post="and other vector threats and risks, 1972â€&quot;2004Aust. J. Entomol.20044327128210.1111/j.1326-6756.2004.00436.x"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7466376\results\search\country\results.xml">
   <result pre="virus started in Hubei, in the city of Wuhan, in" exact="China" post="and rapidly spread throughout this country and the world."/>
   <result pre="7. Arbidol Arbidol has been used for many years in" exact="Russia" post="and is also known as umifenovir. It was approved"/>
   <result pre="It was approved to treat the influenza viral infections in" exact="Russia" post="and China. It has little side effects and is"/>
   <result pre="joint consortium of Russian scientists arbidol has been employed in" exact="China" post="since 2006 for the treatment and prophylaxis of human"/>
   <result pre="China. Its clinical efficacy was first reported and published in" exact="Russia" post="in the 1990s [71,72]. It is cost-effective in prophylactic"/>
   <result pre="([74] ClinicalTrials.gov, Identifier NCT04295551). 8. Danoprevir Danoprevir was approved in" exact="China" post="as an HCV NS3 protease inhibitor. It may be"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7466926\results\search\country\results.xml">
   <result pre="Microbiology, School of Environment and Life Sciences (SELS), Independent University," exact="Bangladesh" post="(IUB), epub: 2020-9-919received: 2020-5-30accepted: 2020-8-21(C) , This article is"/>
   <result pre="Spanish influenza H1N1 (causing around 50 million people in 1918â€&quot;1920)," exact="Hong Kong" post="influenza H3N2, causing approximately 1 million people in 1968,"/>
   <result pre="originate in Spain; rather it originated in the Midwest of" exact="the United States" post="of America and then France, from where the viral"/>
   <result pre="in Spain; rather it originated in the Midwest of the" exact="United States of America" post="and then France, from where the viral transmission spread"/>
   <result pre="it originated in the Midwest of the United States of" exact="America" post="and then France, from where the viral transmission spread"/>
   <result pre="developed to cure the children suffering from seasonal influenza in" exact="the US" post="[25]. In healthy adults, such DNA influenza vaccines against"/>
   <result pre="known as Asian Flu [11]. The first reported case was" exact="Singapore" post="in February 1957, Hong Kong in April 1957 and"/>
   <result pre="[11]. The first reported case was Singapore in February 1957," exact="Hong Kong" post="in April 1957 and in the coastal cities of"/>
   <result pre="Kong in April 1957 and in the coastal cities of" exact="the USA" post="in summer 1957, with the final fatality exerted by"/>
   <result pre="clleagues (in 2017), the first local outbreak originated in continental" exact="China" post="during Februaryâ€�March 1957, and then the virus reached Hong"/>
   <result pre="continental China during Februaryâ€�March 1957, and then the virus reached" exact="Hong Kong" post="and other parts of Asia within a few weeks;"/>
   <result pre="reached Europe and South American countries of the Pacific coast," exact="New Zealand," post="and South Africa. In the USA, the sporadic outbreaks"/>
   <result pre="South American countries of the Pacific coast, New Zealand, and" exact="South Africa." post="In the USA, the sporadic outbreaks were reported during"/>
   <result pre="of the Pacific coast, New Zealand, and South Africa. In" exact="the USA," post="the sporadic outbreaks were reported during Juneâ€�August 1957 [26]."/>
   <result pre="may draw sufficient attention for the development of vaccines [29]." exact="Hong Kong" post="influenza H3N2 in 1968 The H1N1 subtype influenza A"/>
   <result pre="highly infectious and lethal atypical form of pneumonia, originating in" exact="China" post="too; and spreading from Southeast-Asia to over all five"/>
   <result pre="is the ongoing pandemics around the world which originated in" exact="China" post="[38]. COVID-19 has already caused more than 3,500,000 deaths"/>
   <result pre="in more than 200 countries with its utmost severity in" exact="the USA," post="Italy, Spain, Germany, France, UK and Iran [39, 40]."/>
   <result pre="severity in the USA, Italy, Spain, Germany, France, UK and" exact="Iran" post="[39, 40]. A significant genomic similarity with Severe Acute"/>
   <result pre="Together with an array of published articles on coronaviruses, the" exact="China" post="CDC (Centers for Disease Control and Prevention) published a"/>
   <result pre="model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan," exact="China" post="with individual reaction and governmental actionInt J Infect Dis20209321121610.1016/j.ijid.2020.02.05832145465"/>
   <result pre="1918â€&quot;19: based on surveys of families in certain localities in" exact="the United States" post="following the epidemicsPublic Health Rep1931461909193710.2307/458013919315308 18.BarryJMViboudCSimonsenLCross-protection between successive waves"/>
   <result pre="based on surveys of families in certain localities in the" exact="United States" post="following the epidemicsPublic Health Rep1931461909193710.2307/458013919315308 18.BarryJMViboudCSimonsenLCross-protection between successive waves"/>
   <result pre="31.BabuTMPereraRAPMWuJTFitzgeraldTNolanCCowlingBJKraussSTreanorJJPeirisMPopulation serologic immunity to human and avian H2N2 viruses in" exact="the United States" post="and Hong Kong for pandemic risk assessmentJ Infect Dis201821871054106010.1093/infdis/jiy29129762672"/>
   <result pre="serologic immunity to human and avian H2N2 viruses in the" exact="United States" post="and Hong Kong for pandemic risk assessmentJ Infect Dis201821871054106010.1093/infdis/jiy29129762672"/>
   <result pre="human and avian H2N2 viruses in the United States and" exact="Hong Kong" post="for pandemic risk assessmentJ Infect Dis201821871054106010.1093/infdis/jiy29129762672 32.FehrARPerlmanSCoronaviruses: an overview"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7467230\results\search\country\results.xml">
   <result pre="A1BarocasJoshua A2WurcelAlysse3NijhawanAnk4ThakararKinna56LynfieldRuth7HurleyHermione8SnowdenJessica9ThorntonAlice10del RioCarlos11on behalf of the Infectious Diseases Society of" exact="America" post="and HIV Medicine Associationâ€™s Infectious Diseases and Opioid Use"/>
   <result pre="EPIDEMIC MATTERS TO INFECTIOUS DISEASES /HIV CLINICIANS The epidemiology of" exact="the US" post="opioid epidemic continues to evolve and presents new challenges."/>
   <result pre="for a plan to end HIV as an epidemic in" exact="the United States." post="This plan seeks to reduce new infections by 75%"/>
   <result pre="a plan to end HIV as an epidemic in the" exact="United States." post="This plan seeks to reduce new infections by 75%"/>
   <result pre="be addressed to end the opioid and HIV epidemics in" exact="the United States" post="as well as reduce the other infectious disease health"/>
   <result pre="addressed to end the opioid and HIV epidemics in the" exact="United States" post="as well as reduce the other infectious disease health"/>
   <result pre="a working group created by the Infectious Diseases Society of" exact="America" post="(IDSA) and the HIV Medicine Association (HIVMA) in 2017"/>
   <result pre="supervised injection facilities to implement and evaluate the intervention in" exact="the United States." post="4.â€ƒUrge all states to expand Medicaid. 5.â€ƒFund demonstration projects"/>
   <result pre="injection facilities to implement and evaluate the intervention in the" exact="United States." post="4.â€ƒUrge all states to expand Medicaid. 5.â€ƒFund demonstration projects"/>
   <result pre="sites have been legally established successfully in areas outside of" exact="the United States." post="Review of the processes and experience could facilitate implementation"/>
   <result pre="have been legally established successfully in areas outside of the" exact="United States." post="Review of the processes and experience could facilitate implementation"/>
   <result pre="should be allowed to implement and evaluate the intervention in" exact="the United States." post="Improving the Care Continuum for Individuals With Infectious Diseases"/>
   <result pre="be allowed to implement and evaluate the intervention in the" exact="United States." post="Improving the Care Continuum for Individuals With Infectious Diseases"/>
   <result pre="emphasis in order to end the epidemic. In August 2019," exact="the US" post="Preventive Services Task Force issued a draft recommendation for"/>
   <result pre="prevent new infectious disease epidemics related to substance use in" exact="the United States." post="In addition, the majority of federal funding has been"/>
   <result pre="new infectious disease epidemics related to substance use in the" exact="United States." post="In addition, the majority of federal funding has been"/>
   <result pre="are at a pivotal moment in the opioid epidemic in" exact="the United States." post="As we desperately attempt to decrease the staggering number"/>
   <result pre="at a pivotal moment in the opioid epidemic in the" exact="United States." post="As we desperately attempt to decrease the staggering number"/>
   <result pre="to a growing opioid epidemic and associated injection drug use," exact="United States," post="2004 to 2014. Am J Public Health2018; 108:175â€&quot;81.29267061 6.SchranzAJ,"/>
   <result pre="Service. Opioid treatment programs and related federal regulations. Washington, DC:" exact="United States" post="Congress, 2018. 19.SUPPORT for Patients and Communities Act 1."/>
   <result pre="and Energy and Water Development Appropriations Act, 2020. Passed by" exact="the US" post="House of Representatives 19 June 2019. 21.HR 1865 -"/>
   <result pre="to a growing opioid epidemic and associated injection drug use," exact="United States," post="2004 to 2014. Am J Public Health2018; 108:175â€&quot;81.29267061 55.LyKN,"/>
   <result pre="HolmbergSDHepatitis C virus infection among reproductive-aged women and children in" exact="the United States," post="2006 to 2014. Ann Intern Med2017; 166:775â€&quot;82.28492929 56.CottrellEB, ChouR,"/>
   <result pre="C virus infection among reproductive-aged women and children in the" exact="United States," post="2006 to 2014. Ann Intern Med2017; 166:775â€&quot;82.28492929 56.CottrellEB, ChouR,"/>
   <result pre="jails: a case for viral hepatitis prevention in jails in" exact="the United States." post="J Urban Health2009; 86:93â€&quot;105. 64.ZallerN, Brinkley-RubinsteinLIncarceration, drug use, and"/>
   <result pre="a case for viral hepatitis prevention in jails in the" exact="United States." post="J Urban Health2009; 86:93â€&quot;105. 64.ZallerN, Brinkley-RubinsteinLIncarceration, drug use, and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7471937\results\search\country\results.xml">
   <result pre="COVID-19 spreading based on analysis of epidemiological data in mainland" exact="China" post="and other countries [9], [10], [11], [12], [13], [14],"/>
   <result pre="eradication of infection by following quarantine and treatment policies in" exact="China" post="and Spain for different types of disease (COVID-19, Ebola,"/>
   <result pre="infection by following quarantine and treatment policies in China and" exact="Spain" post="for different types of disease (COVID-19, Ebola, and Influenza)."/>
   <result pre="Soc. India952020637639 15FanelliD.PiazzaF.Analysis and forecast of COVID-19 spreading in China," exact="Italy" post="and FranceChaos Solitons Fractals1342020109761 16LiuJ.WangL.ZhangQ.YauS.T.The dynamical model for COVID-19"/>
   <result pre="evolution of the COVID-19 epidemic with the A-SIR model: Lombardy," exact="Italy" post="and Sao Paulo state, BrazilPhysica D2020132693 19WeinsteinS.J.HollandM.S.RogersK.E.BarlowN.S.Analytic solution of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7472103\results\search\country\results.xml">
   <result pre="the insect cell line, which were authorized for use in" exact="the United States." post="These influenza vaccines, administered subcutaneously or intramuscularly, can elevate"/>
   <result pre="insect cell line, which were authorized for use in the" exact="United States." post="These influenza vaccines, administered subcutaneously or intramuscularly, can elevate"/>
   <result pre="in poultry [84]. LAIVs have been administered to adults in" exact="Russia" post="since the 1950s. Starting from 1987, LAIV administration in"/>
   <result pre="Russia since the 1950s. Starting from 1987, LAIV administration in" exact="Russia" post="has been implemented throughout various age groups [85,86]. LAIVs"/>
   <result pre="implemented throughout various age groups [85,86]. LAIVs were licensed in" exact="the US" post="in 2003 for use in healthy individuals aged 2â€&quot;49"/>
   <result pre="This work was supported by National Natural Science Foundation of" exact="China" post="(31761133003 and 31961130381). Conflicts of Interest Tong Wang, Fanhua"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7472125\results\search\country\results.xml">
   <result pre="of Arboviruses in Patients Suffering from Acute Fever in RondÃ´nia," exact="Brazil" post="QueirozJackson Alves da Silva123https://orcid.org/0000-0002-3522-3306Botelho-SouzaLuan Felipo134Nogueira-LimaFelipe Souza123https://orcid.org/0000-0002-8367-999XRampazzoRita de CÃ¡ssia Pontello5KriegerMarco"/>
   <result pre="aegypti and Aedes albopictus [9,10,11,12,13]. With a predominantly tropical climate," exact="Brazil" post="is a country of high territorial dimensions, encompassing several"/>
   <result pre="report of Zika virus transmission using vectors was observed in" exact="France" post="in 2019. A few months after the ecological identification,"/>
   <result pre="the introduction of the CHIKV ECSA (East/Central/South African) genotype in" exact="Brazil" post="occurred separately in several locations, as opposed to a"/>
   <result pre="case. Until 2016, the prevalence of dengue serotype 1 in" exact="Brazil" post="was higher than serotype 2, being 97.24% and 0.69%,"/>
   <result pre="illnesses, since in the last 20 years DENV-2 activity in" exact="Brazil" post="has contributed significantly to changes in disease morbidity [27],"/>
   <result pre="epidemic outbreaks of the disease. DENV-4 was first identified in" exact="Brazil" post="in 1982, in the state of Roraima [58]. In"/>
   <result pre="between 2005 and 2007, being the first case reported in" exact="Brazil" post="after 25 years [59]. In 2012 and 2013, the"/>
   <result pre="most severe epidemic observed in the state of Minas Gerais," exact="Brazil" post="[29]. In 2014, the same situation was observed in"/>
   <result pre="resulted from two independent introductions of the V genotype from" exact="India" post="around the early 1970s and 1980s [60]. The two"/>
   <result pre="their known hosts, and their pathology for manAn Overview Arbovirology" exact="Brazil" post="Neighbouring CtriesBelÃ©m Instituto Evandro ChagasBelÃ©m, Brazil19981931 16.CiccozziM.LaiA.ZehenderG.BorsettiA.CellaE.CiottiM.SagnelliE.SagnelliC.AngelettiS.The phylogenetic approach"/>
   <result pre="of all four dengue serotypes in Manaus, State of Amazonas," exact="Brazil" post="in 2011Rev. Soc. Bras. Med. Trop.20124539339410.1590/S0037-8682201200030002222760143 27.RodriguesN.MariaR.NogueiraR.MariaA.de FilippisB.NogueiraF.D.B.QueirozR.BarretoF.Twenty years"/>
   <result pre="Cacipacore virus in a human in the State of RondÃ´nia," exact="Brazil" post="NotificaÃ§Ã£o do primeiro isolamento do vÃ­rus CacipacorÃ© em um"/>
   <result pre="a novel clade of DENV-4 (genotype I) virus in Pune," exact="India" post="during 2016 seasonPLoS ONE201813e019267210.1371/journal.pone.019267229470509 42.TouretF.BarontiC.GoethalsO.Van LoockM.de LamballerieX.QueratG.Phylogenetically based establishment"/>
   <result pre="dengue hemorrhagic fever: An analysis of data collected in Bangkok," exact="Thailand" post="from 1994 to 2006PLoS Negl. Trop. Dis.201041610.1371/journal.pntd.0000617 55.FrancoL.PalaciosG.MartinezJ.A.VÃ¡zquezA.SavjiN.de OryF.Sanchez-SecoM.P.MartÃ­nD.LipkinW.I.TenorioA.First"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7472261\results\search\country\results.xml">
   <result pre="Article Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in" exact="Russia" post="and Predicted Susceptibility to INSTIs https://orcid.org/0000-0002-7116-0138KirichenkoAlina1*https://orcid.org/0000-0002-6328-1415LapovokIlya1BaryshevPavel1van de VijverDavid A."/>
   <result pre="A6 integrase INSTI L74I polymorphisms genetic barrier founder effect phylogenetics" exact="Russia" post="1. Introduction It was estimated that more than 1"/>
   <result pre="than 1 million individuals were living with HIV-1 in the" exact="Russian Federation" post="at the end of 2019, which is 0.7% of"/>
   <result pre="INSTI drug approved for the treatment of HIV-infected patients in" exact="Russia" post="in 2008, followed by DTG and EVG in 2014"/>
   <result pre="participants experienced virological failure. Interestingly, these patients were all from" exact="Russia" post="and had an HIV infection with subtype A and"/>
   <result pre="2 treatment experience participants with the L74I mutation from the" exact="Russian Federation" post="with virological failure after therapy containing CAB [16]. The"/>
   <result pre="subtype A sequences [17]; however, according to previous studies in" exact="Russia" post="and the former Soviet Union (FSU) countries, the prevalence"/>
   <result pre="however, according to previous studies in Russia and the former" exact="Soviet Union" post="(FSU) countries, the prevalence of this mutation varied from"/>
   <result pre="which may have important implications for INSTI therapy [13,22,34,35,36,37,38,39,40]. In" exact="Russia" post="and FSU countries, the HIV-1 epidemic is dominated by"/>
   <result pre="viral clade [18,19,20,21]. Therefore, the expanded use of INSTIs in" exact="Russia" post="makes it urgent to analyze the HIV-1 integrase gene."/>
   <result pre="with L74M, including 7 samples from Uzbekistan, one sample from" exact="Russia" post="(Tomsk), and one sample from Kuwait. However, analysis of"/>
   <result pre="distance between these samples showed that only 7 sequences from" exact="Uzbekistan" post="differ by less than 1% (0.2â€&quot;1.0%), which suggests an"/>
   <result pre="epidemiological link between the samples. Notably, two outlier sequences from" exact="Italy" post="(A6.IT.2002.60000. EU861977) and Russia (A6.RU.2000.RU00051. EF545108) with L74L were"/>
   <result pre="samples. Notably, two outlier sequences from Italy (A6.IT.2002.60000. EU861977) and" exact="Russia" post="(A6.RU.2000.RU00051. EF545108) with L74L were placed close to the"/>
   <result pre="at the early stage of the epidemic among injectors in" exact="Russia" post="and subsequently spread as a founder effect in Russia"/>
   <result pre="in Russia and subsequently spread as a founder effect in" exact="Russia" post="and other regions. The phylodynamic analysis revealed that the"/>
   <result pre="the most recent common ancestor (tMRCA) for sub-subtype A6 in" exact="Russia" post="was 1998 (95% HPD: 1989â€&quot;2003). tMRCA is considered the"/>
   <result pre="the genetic features of HIV-1 integrase sub-subtype A6, which dominated" exact="Russia" post="and spread successfully across FSU countries and evolved into"/>
   <result pre="2015. Because the use of INSTIs was introduced recently in" exact="Russia" post="[6], we found a low level of INSTI DR."/>
   <result pre="for the treatment of HIV-infected ARV-naÃ¯ve and ARV-experienced patients in" exact="Russia" post="will be successful. However, not only DRMs can affect"/>
   <result pre="A1 viruses. Taking into account that the A6 virus dominating" exact="Russia" post="may be misclassified as A1, these gene features allow"/>
   <result pre="of virological failures in patients with the L74I mutation from" exact="Russia" post="in the ATLAS and FLAIR studies [15,16]. In vitro"/>
   <result pre="to HIV integrase strand transfer inhibitors among clinical specimens in" exact="the United States," post="2009â€&quot;2012Clin. Infect. Dis.20135842343110.1093/cid/cit69724145878 10.DelelisO.CarayonK.SaÃ¯bA.DeprezE.MouscadetJ.-F.Integrase and integration: Biochemical activities of"/>
   <result pre="HIV integrase strand transfer inhibitors among clinical specimens in the" exact="United States," post="2009â€&quot;2012Clin. Infect. Dis.20135842343110.1093/cid/cit69724145878 10.DelelisO.CarayonK.SaÃ¯bA.DeprezE.MouscadetJ.-F.Integrase and integration: Biochemical activities of"/>
   <result pre="pol gene region coding for HIV-1 integrase in patients from" exact="Russia" post="and UkraineHIV Infect. Immunosuppressive Disord.201247381 21.KazennovaE.V.LapovokI.A.LagaV.Y.VasilyevA.V.BobkovaM.R.Natural polymorphisms of HIV-1"/>
   <result pre="HIV-1 CRF01_AE integrase coding region in ARV-naÃ¯ve individuals in Cambodia," exact="Thailand" post="and Vietnam: An ANRS AC12 working group studyInfect. Genet."/>
   <result pre="54.AcharyaA.TagnyC.T.MbanyaD.FonsahJ.Y.NchindapE.KenmogneL.MaJ.NjamnshiA.KanmogneG.D.Variability in HIV-1 Integrase Gene and 3â€²-Polypurine Tract Sequences in" exact="Cameroon" post="Clinical Isolates, and Implications for Integrase Inhibitors EfficacyInt. J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7472297\results\search\country\results.xml">
   <result pre="Health Research (CIHR) (NHC-142832) and the Public Health Agency of" exact="Canada" post="(PHAC). This study is funded by the Ministry of"/>
   <result pre="is funded by the Ministry of Science and Technology of" exact="Taiwan" post="(MOST107-2320-B-038-034-MY3 to L.-T.L.) and the MOST-CNR (National Research Council"/>
   <result pre="LeeuwenM.T.VajdicC.M.MiddletonM.G.McDonaldA.M.LawM.KaldorJ.M.GrulichA.E.Continuing declines in some but not all HIV-associated cancers in" exact="Australia" post="after widespread use of antiretroviral therapyAIDS2009232183219010.1097/QAD.0b013e328331d38419734774 20.YanikE.L.NapravnikS.ColeS.R.AchenbachC.J.GopalS.OlshanA.DittmerD.P.KitahataM.M.MugaveroM.J.SaagM.et al.Incidence and"/>
   <result pre="AIDSJ. Acquir. Immune Defic. Syndr.20105537537910.1097/QAI.0b013e3181eef4f720736841 29.CliffordG.M.LiseM.FranceschiS.EggerM.BouchardyC.KorolD.LeviF.EssS.JundtG.WandelerG.et al.Lung cancer in the" exact="Swiss" post="HIV Cohort Study: Role of smoking, immunodeficiency and pulmonary"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7474329\results\search\country\results.xml">
   <result pre="high sterilization capacity [85] Development of nanomaterials for PPE According" exact="the United States" post="Centers for Disease Control and Prevention (CDC), the main"/>
   <result pre="sterilization capacity [85] Development of nanomaterials for PPE According the" exact="United States" post="Centers for Disease Control and Prevention (CDC), the main"/>
   <result pre="and the active compounds thiabendazole and zinc pyrithione Mapa Spontex-" exact="United Kingdom" post="PADYCAREÂ® Product coated with silver nanoparticles with antibacterial effect"/>
   <result pre="chemical exposures and temporal associations with COVID-19â€&quot;National Poison Data System," exact="United States," post="January 1, 2020â€&quot;March 31, 2020MMWR Morb Mortal Wkly Rep20206949649832324720"/>
   <result pre="acid)) compounded shell-core structure nanoparticles. CN109568180A. 2019. https://worldwide.espacenet.com/patent/search/family/065924361/publication/CN109568180A?q=CN109568180A&amp;amp;queryLang=en%3Ade%3Afr. 78.Chiattello ML," exact="Oman" post="M. Polymer-based antimicrobial compositions and methods of use thereof."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7476354\results\search\country\results.xml">
   <result pre="half-cytotoxic concentration (CC50) for COVID-19.5 A preliminary study conducted in" exact="China" post="showed benefits in pneumonia image, shortening of disease course,"/>
   <result pre="were predictive of a high mortality rate according to a" exact="China" post="retrospective study.17 Baricitinib inhibits cytokines including IL-2, IL-6, IL-10,"/>
   <result pre="plus stavudine, with and without hydroxyurea, for HIV infection. The" exact="Swiss" post="HIV cohort study. AIDS1998; 12: F71â€&quot;F77.9631134 67LafeuilladeAHittingerGChadapaudS, et al.The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7476961\results\search\country\results.xml">
   <result pre="been first identified in the city of Wuhan, Hubei province" exact="China" post="in December 2019, and was declared as a pandemic"/>
   <result pre="infusion-related and anaphylaxis and elevation in liver transaminases [94]. In" exact="the USA," post="the Food and Drug Administration (FDA) has granted remdesivir"/>
   <result pre="conducted clinical trial, Lopinavir Trial for Suppression of SARS-Cov-2 in" exact="China" post="(LOTUS China), revealed that the combination of lopinavir/ritonavir offered"/>
   <result pre="). Umifenovir is used for the treatment of influenza in" exact="Russia" post="and China. Umifenovir exhibits its action by preventing the"/>
   <result pre="Camostat, a serine protease inhibitor that has been approved in" exact="Japan" post="for the treatment of pancreatitis, was shown to block"/>
   <result pre="of COVID-19 [151]. National Health Commission (NHC) of the Peopleâ€™s" exact="Republic of" post="China has recommended the use of TCM for Covid-19"/>
   <result pre="[151]. National Health Commission (NHC) of the Peopleâ€™s Republic of" exact="China" post="has recommended the use of TCM for Covid-19 since"/>
   <result pre="in liver transaminases Phase 3 clinical trial (NCT04292899), EAU in" exact="the USA" post="[62], [94] Lopinavir Antiviral 26.63 Mpro inhibitor Serious cardiotoxicity,"/>
   <result pre="Zhang, A new coronavirus associated with human respiratory disease in" exact="China" post="Supplementary information, (n.d.). doi:10.1038/s41586-020-2008-3. 12ZumlaA.ChanJ.F.W.AzharE.I.HuiD.S.C.YuenK.Y.Coronaviruses-drug discovery and therapeutic optionsNat."/>
   <result pre="(CAH B) with chloroquine: a preliminary report, Ann. Acad. Med." exact="Singapore" post="15 (1986) 149â€&quot;152. http://www.ncbi.nlm.nih.gov/pubmed/3752892 (accessed March 31, 2020). 123KoyamaA.H.UchidaT.Inhibition"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes Metab. Syndr. Clin. Res. Rev.202010.1016/j.dsx.2020.03.011"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7478670\results\search\country\results.xml">
   <result pre="Chinese Medicine, No. 39 Shi-er-qiao Road, Chengdu, 610072, Sichuan Province," exact="China" post="(e-mail: xcg899@163.com). collection: 2020-9-9epub: 2020-9-9pmc-release: 2020-9-99936e22040received: 2020-7-31accepted: 2020-8-4(C) ,"/>
   <result pre="of the coronavirus disease, the National Health Commission of the" exact="People's Republic of China" post="formulated and issued theâ€œDiagnosis and Treatment Protocol for Novel"/>
   <result pre="the coronavirus disease, the National Health Commission of the People's" exact="Republic of" post="China formulated and issued theâ€œDiagnosis and Treatment Protocol for"/>
   <result pre="disease, the National Health Commission of the People's Republic of" exact="China" post="formulated and issued theâ€œDiagnosis and Treatment Protocol for Novel"/>
   <result pre="of print.32205204 [9]HolshueMLDeBoltCLindquistSet al.First case of 2019 novel Coronavirus in" exact="the United States." post="N Engl J Med2020;382:92936.32004427 [10]SandersJMMonogueMLJodlowskiTZet al.Pharmacologic treatments for coronavirus"/>
   <result pre="print.32205204 [9]HolshueMLDeBoltCLindquistSet al.First case of 2019 novel Coronavirus in the" exact="United States." post="N Engl J Med2020;382:92936.32004427 [10]SandersJMMonogueMLJodlowskiTZet al.Pharmacologic treatments for coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7479232\results\search\country\results.xml">
   <result pre="Emergency University HospitalBucharestRomania Edited by: Brian Godman, Karolinska Institutet (KI)," exact="Sweden" post="Reviewed by: Suyash Prasad, Independent Researcher, San Francisco, CA,"/>
   <result pre="Sweden Reviewed by: Suyash Prasad, Independent Researcher, San Francisco, CA," exact="United States;" post="Kurt Neumann, Independent Researcher, KerÃ©kteleki, Hungary *Correspondence: Diana Gabriela"/>
   <result pre="San Francisco, CA, United States; Kurt Neumann, Independent Researcher, KerÃ©kteleki," exact="Hungary" post="*Correspondence: Diana Gabriela Iacob, dianagiacob@gmail.com This article was submitted"/>
   <result pre="use in hospitalized patients with severe forms of COVID-19 in" exact="the United States" post="and Europe, while dexamethasone is also recommended in specific"/>
   <result pre="in hospitalized patients with severe forms of COVID-19 in the" exact="United States" post="and Europe, while dexamethasone is also recommended in specific"/>
   <result pre="the Guidelines for the Diagnosis and Treatment of COVID-19 in" exact="China" post="(Youyao and Yizhen Chen, 2020). The article provides a"/>
   <result pre="ISRCTN83971151,WHO) was stopped and other similar trials were withdrawn (NCT04347512," exact="France" post="and NCT04371926, United States). Finally, on July 1st the"/>
   <result pre="death. On a similar note, two completed studies carried in" exact="China" post="(NCT04261517, ChiCTR2000029868) and the preliminary data from other trials"/>
   <result pre="across China, Russia, as well as in studies performed in" exact="Iran" post="or India (IRCT20151227025726N15), with controversial efficiency (Deng et al.,"/>
   <result pre="Russia, as well as in studies performed in Iran or" exact="India" post="(IRCT20151227025726N15), with controversial efficiency (Deng et al., 2020; Lian"/>
   <result pre="a wide antiviral spectrum, approved for manufacture and sale in" exact="Japan" post="and used against influenza viruses. Favipiravir displays an in"/>
   <result pre="SARS-CoV-2 and has currently entered numerous studies against SARS-CoV-2 in" exact="China" post="and Japan, (ChiCTR2000030254, ChiCTR2000029544 and ChiCTR2000029600) (Coomes and Haghbayan,"/>
   <result pre="trial prompted an emergency use authorization (EUA) for remdesivir in" exact="the US." post="At the same time, the ACTT trial also enabled"/>
   <result pre="treatment Study identifier number, locations IFN-beta, cholchicine, rivaroxaban, aspirin NCT04331899," exact="Canada" post="IFN-beta, remdesivir, chloroquine, hydroxychloroquine, lopinavir/ritonavir ISRCTN83971151 (Solidarity), WHO, multi-country"/>
   <result pre="(Europe) IFN-beta1a NCT04385095, UK IFN-beta1a, lopinavir, ritonavir, hydroxychloroquine NCT04350671 (IB1aIC)," exact="Iran" post="IFN-beta1a, lopinavir, ritonavir, hydroxychloroquine NCT04350684 (UAIIC), Iran IFN-beta1b, hydroxychloroquine"/>
   <result pre="hydroxychloroquine NCT04350671 (IB1aIC), Iran IFN-beta1a, lopinavir, ritonavir, hydroxychloroquine NCT04350684 (UAIIC)," exact="Iran" post="IFN-beta1b, hydroxychloroquine NCT04350281, Hong Kong IFN-alfa (aerosols), lopinavir/ritonavir, traditional"/>
   <result pre="IFN-beta1a, lopinavir, ritonavir, hydroxychloroquine NCT04350684 (UAIIC), Iran IFN-beta1b, hydroxychloroquine NCT04350281," exact="Hong Kong" post="IFN-alfa (aerosols), lopinavir/ritonavir, traditional Chinese medicines NCT04251871, China Recombinant"/>
   <result pre="NCT04350281, Hong Kong IFN-alfa (aerosols), lopinavir/ritonavir, traditional Chinese medicines NCT04251871," exact="China" post="Recombinant human IFN-alpha1b ChiCTR2000030480, ChinaÂ IFN-alpha aerosol inhalation, lopinavir"/>
   <result pre="Recombinant human IFN-alpha1b ChiCTR2000030480, ChinaÂ IFN-alpha aerosol inhalation, lopinavir ChiCTR2000030535,Â" exact="China" post="IFN-alpha, ribavirin, lopinavir/ritonavir ChiCTR2000029387, China IFN-alpha atomization, lopinavir/ritonavir, favipiravir"/>
   <result pre="IFN-alpha aerosol inhalation, lopinavir ChiCTR2000030535,Â China IFN-alpha, ribavirin, lopinavir/ritonavir ChiCTR2000029387," exact="China" post="IFN-alpha atomization, lopinavir/ritonavir, favipiravir ChiCTR2000029600, China IFN-alpha, traditional Chinese"/>
   <result pre="IFN-alpha, ribavirin, lopinavir/ritonavir ChiCTR2000029387, China IFN-alpha atomization, lopinavir/ritonavir, favipiravir ChiCTR2000029600," exact="China" post="IFN-alpha, traditional Chinese medicine ChiCTR2000029756, China IFN-alpha aerosol/lopinavir/ritonavir ChiCTR2000031196,"/>
   <result pre="atomization, lopinavir/ritonavir, favipiravir ChiCTR2000029600, China IFN-alpha, traditional Chinese medicine ChiCTR2000029756," exact="China" post="IFN-alpha aerosol/lopinavir/ritonavir ChiCTR2000031196, China IFN-alpha2b, tocilizumab, losartan, remdesivir, hydroxychloroquine"/>
   <result pre="China IFN-alpha, traditional Chinese medicine ChiCTR2000029756, China IFN-alpha aerosol/lopinavir/ritonavir ChiCTR2000031196," exact="China" post="IFN-alpha2b, tocilizumab, losartan, remdesivir, hydroxychloroquine + combinations, methylprednisolone, convalescent"/>
   <result pre="ChiCTR2000030922, ChinaÂ Recombinant human IFN-alpha-1b (nasal drops)/thymosin alpha 1 NCT04320238," exact="China" post="PegIFN-Î±2b atomization, arbidol hydrochloride NCT04254874, China Long-acting IFN-alpha2a plus"/>
   <result pre="drops)/thymosin alpha 1 NCT04320238, China PegIFN-Î±2b atomization, arbidol hydrochloride NCT04254874," exact="China" post="Long-acting IFN-alpha2a plus ribavirin ChiCTR2000030922, China PegIFN-lambda-1a NCT04331899, SUA"/>
   <result pre="atomization, arbidol hydrochloride NCT04254874, China Long-acting IFN-alpha2a plus ribavirin ChiCTR2000030922," exact="China" post="PegIFN-lambda-1a NCT04331899, SUA PegIFN-lambda1a NCT04354259 (ILIAD), Canada PegIFN-lambda1a NCT04344600,"/>
   <result pre="plus ribavirin ChiCTR2000030922, China PegIFN-lambda-1a NCT04331899, SUA PegIFN-lambda1a NCT04354259 (ILIAD)," exact="Canada" post="PegIFN-lambda1a NCT04344600, (PROTECT), SUA HeberFERON (recombinant IFN-Î±2b and IFN-Î³,"/>
   <result pre="SUA HeberFERON (recombinant IFN-Î±2b and IFN-Î³, Heberon alfa (IFN-alfa2b) RPCEC00000307," exact="Cuba" post="Resources: U.S. National Library of Medicine https://clinicaltrials.gov, International Clinical"/>
   <result pre="for the treatment of COVID-19 and will be assessed through" exact="the US" post="BREATH clinical trial for the ARDS induced by SARS-CoV2"/>
   <result pre="number, country Allogeneic adult MSC of expanded adipose tissue NCT04366323," exact="Spain" post="Allogenic and expanded adipose tissue-derived MSC NCT04416139, Mexico Adipose-derived"/>
   <result pre="tissue NCT04366323, Spain Allogenic and expanded adipose tissue-derived MSC NCT04416139," exact="Mexico" post="Adipose-derived MSC (HB-adMSCs) NCT04348435, SUA Autologous adipose-derived MSC (HB-adMSCs)"/>
   <result pre="MSC (HB-adMSCs) NCT04349631, SUA Allogenic pooled olfactory mucosa-derived MSC NCT04382547," exact="Belarus" post="Placental MSC exosomes ISRCTN33578935, Germany Umbilical cord-derived MSC NCT04333368,"/>
   <result pre="pooled olfactory mucosa-derived MSC NCT04382547, Belarus Placental MSC exosomes ISRCTN33578935," exact="Germany" post="Umbilical cord-derived MSC NCT04333368, France Umbilical cord-derived MSC NCT04366271,"/>
   <result pre="Belarus Placental MSC exosomes ISRCTN33578935, Germany Umbilical cord-derived MSC NCT04333368," exact="France" post="Umbilical cord-derived MSC NCT04366271, Spain Umbilical cord-derived MSC (hucMSCs)"/>
   <result pre="Germany Umbilical cord-derived MSC NCT04333368, France Umbilical cord-derived MSC NCT04366271," exact="Spain" post="Umbilical cord-derived MSC (hucMSCs) ChiCTR2000030300, China Umbilical cord-derived MSC"/>
   <result pre="Umbilical cord-derived MSC NCT04366271, Spain Umbilical cord-derived MSC (hucMSCs) ChiCTR2000030300," exact="China" post="Umbilical cord-derived MSC (UC-MSC) NCT04355728, SUA Human umbilical cord-derived"/>
   <result pre="cord-derived MSC ChiCTR2000030116, ChinaÂ Human umbilical cord-derived MSC (UC-MSCs) NCT04269525," exact="China" post="Umbilical cord blood mononuclear cells ChiCTR2000029572, ChinaÂ Human embryonic-stem"/>
   <result pre="ChiCTR2000029572, ChinaÂ Human embryonic-stem cells derived M cells (CAStem) NCT04331613," exact="China" post="Human embryonic- stem cells derived M cells (CAStem) ChiCTR2000031139,"/>
   <result pre="China Human embryonic- stem cells derived M cells (CAStem) ChiCTR2000031139," exact="China" post="Whartonâ€™s Jelly MSC (derived from cord tissue of newborns)"/>
   <result pre="Whartonâ€™s Jelly MSC (derived from cord tissue of newborns) NCT04313322," exact="Jordan" post="Human amniotic fluid NCT04319731, SUA MSC (remestemcel-L) NCT04371393, SUA"/>
   <result pre="amniotic fluid NCT04319731, SUA MSC (remestemcel-L) NCT04371393, SUA MSC NCT04366063," exact="Iran" post="MSC NCT04361942, COVID_MSV, Spain MSC ChiCTR2000030020, China MSC NCT04252118,"/>
   <result pre="MSC (remestemcel-L) NCT04371393, SUA MSC NCT04366063, Iran MSC NCT04361942, COVID_MSV," exact="Spain" post="MSC ChiCTR2000030020, China MSC NCT04252118, China MSC NCT04339660 (iunie),"/>
   <result pre="SUA MSC NCT04366063, Iran MSC NCT04361942, COVID_MSV, Spain MSC ChiCTR2000030020," exact="China" post="MSC NCT04252118, China MSC NCT04339660 (iunie), China MultiStemÂ® Therapy"/>
   <result pre="Iran MSC NCT04361942, COVID_MSV, Spain MSC ChiCTR2000030020, China MSC NCT04252118," exact="China" post="MSC NCT04339660 (iunie), China MultiStemÂ® Therapy NCT04367077, MACoVIA, SUA"/>
   <result pre="Spain MSC ChiCTR2000030020, China MSC NCT04252118, China MSC NCT04339660 (iunie)," exact="China" post="MultiStemÂ® Therapy NCT04367077, MACoVIA, SUA MSC (called PLX-PAD) NCT04389450"/>
   <result pre="ruxolitinib ChiCTR2000029580, ChinaÂ Allogeneic human dental pulp derived-stem cells NCT04336254," exact="China" post="Natural Killer Cells NCT04280224, China FT516 (pluripotent stem cell"/>
   <result pre="dental pulp derived-stem cells NCT04336254, China Natural Killer Cells NCT04280224," exact="China" post="FT516 (pluripotent stem cell derived NK cells) NCT04363346, SUA"/>
   <result pre="cells) NCT04365101, SUA M1 (type I macrophage) inhibition therapy ChiCTR2000029431," exact="China" post="Mesenchymal stem cells, MSC. Resources: U.S. National Library of"/>
   <result pre="Vaccine Institute, CEPI, Inovio Pharmaceuticals)/19 to 64 Year NCT04447781 (ph1-2," exact="Republic of" post="Korea)/February 2022 GX-19 (Genexine,Inc); DNA vaccine expressing SARS-CoV-2 S-protein"/>
   <result pre="vaccine expressing SARS-CoV-2 S-protein antigen/18 to 50 Years NCT04445389 (ph1-2," exact="Republic of" post="Korea/March, 2021 Resources: U.S. National Library of Medicine https://clinicaltrials.gov"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7479474\results\search\country\results.xml">
   <result pre="in the EU [4]. The incidence of TB increased in" exact="Romania" post="after 1990, peaking in 2002 (142.2%), with a downward"/>
   <result pre="HIV coinfection, and (TB-related) mortality in children. TB mortality in" exact="Romania" post="has followed the same course as the incidence, with"/>
   <result pre="worldwide [3, 6, 12] and the TB endemic situation in" exact="Romania" post="[4], we sought to explore the possible outcomes of"/>
   <result pre="[22, 23]. Also, inappropriate implementation of infection control strategies in" exact="Singapore" post="led to massive healthcare personnel infection (half of the"/>
   <result pre="studies from TB endemic countries such as Singapore, China, or" exact="Taiwan" post="[24, 25], all with known TB patients that acquired"/>
   <result pre="However, overcrowding hospitals are prone to mistakes. Known-TB patients from" exact="China" post="supposedly acquired SARS due to exposure to SARS patients"/>
   <result pre="respiratory syndrome in SARS-CoV-2 coinfection, considering the cases described in" exact="China" post="and India [34]. A recent meta-analysis [35] concluded that"/>
   <result pre="in SARS-CoV-2 coinfection, considering the cases described in China and" exact="India" post="[34]. A recent meta-analysis [35] concluded that patients with"/>
   <result pre="might argue that the lack of widespread BCG vaccination in" exact="the United States" post="may be influencing the course of their pandemic compared"/>
   <result pre="argue that the lack of widespread BCG vaccination in the" exact="United States" post="may be influencing the course of their pandemic compared"/>
   <result pre="broad spread vaccination, one should also keep in mind that" exact="the United States" post="delayed the implementation of infection control strategies (that could"/>
   <result pre="spread vaccination, one should also keep in mind that the" exact="United States" post="delayed the implementation of infection control strategies (that could"/>
   <result pre="against respiratory viruses [48]. Moreover, Muldron Children's Research Institute from" exact="Australia" post="already announced a phase III randomized controlled trial, which"/>
   <result pre="Lung Disease201923222623110.5588/ijtld.18.027030808456 5NiÅ¢uF. M.OlteanuM.StrebaC. Tet al.Tuberculosis and its particularities in" exact="Romania" post="and worldwideRomanian journal of morphology and embryology=Revue roumaine de"/>
   <result pre="L.McAnerneyJ.von MollendorfC.Excess mortality associated with influenza among tuberculosis deaths in" exact="South Africa," post="1999â€&quot;2009PLoS One201510610.1371/journal.pone.0129173 11RedfordP. S.Mayer-BarberK. D.McNabF. W.et al.Influenza A virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7480504\results\search\country\results.xml">
   <result pre="Center, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala," exact="Sweden" post=": 2020-7-7: 20201011792620(C) The Author(s), 2020This is an Open"/>
   <result pre="temperature inÂ Januaryâ€&quot;February 2020. The attack rate was highest in" exact="Luxembourg" post="followed by Italy and Switzerland. There was a significant"/>
   <result pre="2020. The attack rate was highest in Luxembourg followed by" exact="Italy" post="and Switzerland. There was a significant (p = 0.02)"/>
   <result pre="increased environmental temperature. The case fatality rate was highest in" exact="Italy" post="followed by Iran and Spain. There was no significant"/>
   <result pre="The case fatality rate was highest in Italy followed by" exact="Iran" post="and Spain. There was no significant correlation between the"/>
   <result pre="significant threat in the Middle East since its emergence in" exact="Saudi Arabia" post="in 2012. SARS-CoV-2 is aÂ zoonoticÂ Betacoronavirus, which likely"/>
   <result pre="humans. It emerged in late DecemberÂ 2019 in Wuhan in" exact="China" post="and causes COVID-19 pandemic which is the first coronavirusÂ"/>
   <result pre="period. This recent emergence of a previously unknown coronavirus in" exact="China" post="has led to huge impacts on humans globally. SARS-CoV-2"/>
   <result pre="the globe, with more than three million reported cases in" exact="the USA" post="as of 9 July 2020 [6,7]. Despite recent efforts"/>
   <result pre="large movement of people in the Asian region and between" exact="China" post="and globally due to the lunar new year celebrated"/>
   <result pre="and globally due to the lunar new year celebrated in" exact="China" post="likely increased the rapid geographical dispersal of infection during"/>
   <result pre="far formed key pieces of successful control efforts, e.g. in" exact="Singapore" post="and Hong Kong [14]. Many other countries are adopting"/>
   <result pre="key pieces of successful control efforts, e.g. in Singapore and" exact="Hong Kong" post="[14]. Many other countries are adopting measures termed â€˜social"/>
   <result pre="the case number doubled on average every 7.4Â days [15]." exact="China" post="was able to reduce the cases more than 90%"/>
   <result pre="strict containment measures. Other affected countries like Italy, Spain, and" exact="Iran" post="have not been able to successfully replicate this containment"/>
   <result pre="Asian countries and most of the European countries and North" exact="America" post="experienced low environmental temperatures during the study period. The"/>
   <result pre="period. The attack rate (in 100,000 population) of COVID-19 in" exact="China" post="was 5.67. However, outside of China, there were countries"/>
   <result pre="there were countries with markedly higher attack rates: 78.60 in" exact="Luxembourg" post="followed by 77.65 in Italy, 56.33 in Switzerland, 42.75"/>
   <result pre="in Denmark, 19.55 in Belgium, 19.36 in France, 17.51 in" exact="the Netherlands," post="and 17.17 in South Korea. It was found that"/>
   <result pre="19.36 in France, 17.51 in the Netherlands, and 17.17 in" exact="South Korea." post="It was found that the attack rate decreased significantly"/>
   <result pre="in Table 1. The case fatality rate was highest in" exact="Italy" post="(8.57%) followed by Indonesia (8.09%), Iran (7.29%), Iraq (7.25%),"/>
   <result pre="case fatality rate was highest in Italy (8.57%) followed by" exact="Indonesia" post="(8.09%), Iran (7.29%), Iraq (7.25%), Spain (5.01%), the UK"/>
   <result pre="rate was highest in Italy (8.57%) followed by Indonesia (8.09%)," exact="Iran" post="(7.29%), Iraq (7.25%), Spain (5.01%), the UK (4.44%), China"/>
   <result pre="highest in Italy (8.57%) followed by Indonesia (8.09%), Iran (7.29%)," exact="Iraq" post="(7.25%), Spain (5.01%), the UK (4.44%), China (4.00%), France"/>
   <result pre="Italy (8.57%) followed by Indonesia (8.09%), Iran (7.29%), Iraq (7.25%)," exact="Spain" post="(5.01%), the UK (4.44%), China (4.00%), France (3.56%), and"/>
   <result pre="(8.09%), Iran (7.29%), Iraq (7.25%), Spain (5.01%), the UK (4.44%)," exact="China" post="(4.00%), France (3.56%), and the Netherlands (3.54%) (Table 1)."/>
   <result pre="(7.29%), Iraq (7.25%), Spain (5.01%), the UK (4.44%), China (4.00%)," exact="France" post="(3.56%), and the Netherlands (3.54%) (Table 1). Figure 1."/>
   <result pre="Spain (5.01%), the UK (4.44%), China (4.00%), France (3.56%), and" exact="the Netherlands" post="(3.54%) (Table 1). Figure 1. The correlation between environmental"/>
   <result pre="(5.01%), the UK (4.44%), China (4.00%), France (3.56%), and the" exact="Netherlands" post="(3.54%) (Table 1). Figure 1. The correlation between environmental"/>
   <result pre="2020 Populationin 2019 Total cases Total deaths AR CFR Asia" exact="China" post="âˆ’2.285 1,433,783,686 81,416 3261 5.678 4.006 India 20.485 1,366,417,754"/>
   <result pre="AR CFR Asia China âˆ’2.285 1,433,783,686 81,416 3261 5.678 4.006" exact="India" post="20.485 1,366,417,754 231 4 0.017 1.732 Indonesia 26.48 270,625,568"/>
   <result pre="3261 5.678 4.006 India 20.485 1,366,417,754 231 4 0.017 1.732" exact="Indonesia" post="26.48 270,625,568 309 25 0.114 8.091 Iran 9.205 82,913,906"/>
   <result pre="4 0.017 1.732 Indonesia 26.48 270,625,568 309 25 0.114 8.091" exact="Iran" post="9.205 82,913,906 19,644 1433 23.692 7.295 Iraq 12.565 39,309,783"/>
   <result pre="25 0.114 8.091 Iran 9.205 82,913,906 19,644 1433 23.692 7.295" exact="Iraq" post="12.565 39,309,783 193 14 0.491 7.254 Japan 6.67 126,860,301"/>
   <result pre="1433 23.692 7.295 Iraq 12.565 39,309,783 193 14 0.491 7.254" exact="Japan" post="6.67 126,860,301 1007 35 0.794 3.476 Lebanon 10.815 6,855,713"/>
   <result pre="14 0.491 7.254 Japan 6.67 126,860,301 1007 35 0.794 3.476" exact="Lebanon" post="10.815 6,855,713 163 4 2.378 2.454 Malaysia 25.885 31,949,777"/>
   <result pre="35 0.794 3.476 Lebanon 10.815 6,855,713 163 4 2.378 2.454" exact="Malaysia" post="25.885 31,949,777 1030 2 3.224 0.194 Pakistan 13.46 216,565,318"/>
   <result pre="4 2.378 2.454 Malaysia 25.885 31,949,777 1030 2 3.224 0.194" exact="Pakistan" post="13.46 216,565,318 495 3 0.229 0.606 Philippines 26.025 108,116,615"/>
   <result pre="2 3.224 0.194 Pakistan 13.46 216,565,318 495 3 0.229 0.606" exact="Philippines" post="26.025 108,116,615 230 18 0.213 7.826 South Korea 4.8"/>
   <result pre="3 0.229 0.606 Philippines 26.025 108,116,615 230 18 0.213 7.826" exact="South Korea" post="4.8 51,225,308 8799 103 17.177 1.171 Australia Australia 27.505"/>
   <result pre="0.213 7.826 South Korea 4.8 51,225,308 8799 103 17.177 1.171" exact="Australia" post="Australia 27.505 25,203,198 874 7 3.468 0.801 Eurasia Turkey"/>
   <result pre="7.826 South Korea 4.8 51,225,308 8799 103 17.177 1.171 Australia" exact="Australia" post="27.505 25,203,198 874 7 3.468 0.801 Eurasia Turkey 4.71"/>
   <result pre="1.171 Australia Australia 27.505 25,203,198 874 7 3.468 0.801 Eurasia" exact="Turkey" post="4.71 83,429,615 670 9 0.803 1.343 Europe Austria 3.15"/>
   <result pre="0.801 Eurasia Turkey 4.71 83,429,615 670 9 0.803 1.343 Europe" exact="Austria" post="3.15 8,955,102 2649 6 29.581 0.227 Belgium 9.04 390,353"/>
   <result pre="0.803 1.343 Europe Austria 3.15 8,955,102 2649 6 29.581 0.227" exact="Belgium" post="9.04 390,353 2257 37 19.559 1.639 Bulgaria 5.31 7,000,119"/>
   <result pre="6 29.581 0.227 Belgium 9.04 390,353 2257 37 19.559 1.639" exact="Bulgaria" post="5.31 7,000,119 127 3 1.814 2.362 Denmark âˆ’2.34 5,771,876"/>
   <result pre="37 19.559 1.639 Bulgaria 5.31 7,000,119 127 3 1.814 2.362" exact="Denmark" post="âˆ’2.34 5,771,876 1255 9 21.743 0.717 France 8.675 65,129,728"/>
   <result pre="3 1.814 2.362 Denmark âˆ’2.34 5,771,876 1255 9 21.743 0.717" exact="France" post="8.675 65,129,728 12,612 450 19.364 3.568 Germany 7.245 83,517,045"/>
   <result pre="9 21.743 0.717 France 8.675 65,129,728 12,612 450 19.364 3.568" exact="Germany" post="7.245 83,517,045 18,323 45 21.939 0.246 Greece 8.895 10,473,455"/>
   <result pre="450 19.364 3.568 Germany 7.245 83,517,045 18,323 45 21.939 0.246" exact="Greece" post="8.895 10,473,455 495 8 4.726 1.616 Ireland 8.11 4,882,495"/>
   <result pre="45 21.939 0.246 Greece 8.895 10,473,455 495 8 4.726 1.616" exact="Ireland" post="8.11 4,882,495 683 3 13.989 0.439 Italy 8.295 60,550,075"/>
   <result pre="8 4.726 1.616 Ireland 8.11 4,882,495 683 3 13.989 0.439" exact="Italy" post="8.295 60,550,075 47,021 4032 77.656 8.575 Luxembourg 1.25 615,729"/>
   <result pre="3 13.989 0.439 Italy 8.295 60,550,075 47,021 4032 77.656 8.575" exact="Luxembourg" post="1.25 615,729 484 5 78.606 1.033 Netherlands 2.45 17,097,130"/>
   <result pre="4032 77.656 8.575 Luxembourg 1.25 615,729 484 5 78.606 1.033" exact="Netherlands" post="2.45 17,097,130 2994 106 17.512 3.540 Norway âˆ’1.89 5,378,857"/>
   <result pre="5 78.606 1.033 Netherlands 2.45 17,097,130 2994 106 17.512 3.540" exact="Norway" post="âˆ’1.89 5,378,857 1742 7 32.386 0.402 Poland 4.895 37,887,768"/>
   <result pre="106 17.512 3.540 Norway âˆ’1.89 5,378,857 1742 7 32.386 0.402" exact="Poland" post="4.895 37,887,768 425 5 1.123 1.176 Portugal 11.9 10,226,187"/>
   <result pre="7 32.386 0.402 Poland 4.895 37,887,768 425 5 1.123 1.176" exact="Portugal" post="11.9 10,226,187 1020 6 9.974 0.588 Spain 9.79 46,736,776"/>
   <result pre="5 1.123 1.176 Portugal 11.9 10,226,187 1020 6 9.974 0.588" exact="Spain" post="9.79 46,736,776 19,980 1002 42.750 5.015 Sweden âˆ’1.845 10,036,379"/>
   <result pre="6 9.974 0.588 Spain 9.79 46,736,776 19,980 1002 42.750 5.015" exact="Sweden" post="âˆ’1.845 10,036,379 1623 16 16.171 0.986 Switzerland 3.23 8,591,365"/>
   <result pre="1002 42.750 5.015 Sweden âˆ’1.845 10,036,379 1623 16 16.171 0.986" exact="Switzerland" post="3.23 8,591,365 4840 43 56.336 0.888 UK 7.565 67,530,172"/>
   <result pre="56.336 0.888 UK 7.565 67,530,172 3983 177 5.898 4.444 North" exact="America" post="Canada âˆ’15.08 37,411,047 971 12 2.595 1.236 Costa Rica"/>
   <result pre="0.888 UK 7.565 67,530,172 3983 177 5.898 4.444 North America" exact="Canada" post="âˆ’15.08 37,411,047 971 12 2.595 1.236 Costa Rica 24.865"/>
   <result pre="4.444 North America Canada âˆ’15.08 37,411,047 971 12 2.595 1.236" exact="Costa Rica" post="24.865 5,047,561 113 2 2.239 1.770 Mexico 18.095 127,575,529"/>
   <result pre="2.595 1.236 Costa Rica 24.865 5,047,561 113 2 2.239 1.770" exact="Mexico" post="18.095 127,575,529 203 2 0.159 0.985 USA 0.515 329,064,917"/>
   <result pre="0.159 0.985 USA 0.515 329,064,917 19,624 260 5.964 1.325 South" exact="America" post="Argentina 18.79 44,780,677 158 3 0.353 1.899 Brazil 24.47"/>
   <result pre="0.985 USA 0.515 329,064,917 19,624 260 5.964 1.325 South America" exact="Argentina" post="18.79 44,780,677 158 3 0.353 1.899 Brazil 24.47 211,049,527"/>
   <result pre="1.325 South America Argentina 18.79 44,780,677 158 3 0.353 1.899" exact="Brazil" post="24.47 211,049,527 904 11 0.428 1.217 Ecuador 21.375 17,373,662"/>
   <result pre="3 0.353 1.899 Brazil 24.47 211,049,527 904 11 0.428 1.217" exact="Ecuador" post="21.375 17,373,662 426 7 2.452 1.643 Peru 20.925 32,510,453"/>
   <result pre="11 0.428 1.217 Ecuador 21.375 17,373,662 426 7 2.452 1.643" exact="Peru" post="20.925 32,510,453 263 3 0.809 1.141 Total populations and"/>
   <result pre="countries with relatively high environmental temperature (Taiwan, Thailand, Myanmar, Nepal," exact="Sri Lanka," post="and Bangladesh) were relatively less affected than the neighboring"/>
   <result pre="COVID-19 outbreak, Asian countries with relatively lower environmental temperature (e.g." exact="South Korea," post="Japan, Indonesia, and Iran) had more severe outbreaks than"/>
   <result pre="severely affected in Europe (including Luxembourg, Italy, Spain, Germany, Belgium," exact="the Netherlands," post="and the UK). Our study demonstrated a significant correlation"/>
   <result pre="epidemiologist and disease ecologist, working as a senior scientist in" exact="Bangladesh" post="field program in EcoHealth Alliance. His research focuses on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7480628\results\search\country\results.xml">
   <result pre="Muna Heart Centre, Department of General Surgery, Faculty of Medicine," exact="Jordan" post="University of Science and Technology and King Abdullah University"/>
   <result pre="wet market, the Huanan Seafood Wholesale Market, in Wuhan, Hubei," exact="China" post="[4, 5]. The underlying causative agent of this outbreak"/>
   <result pre="fluid, the Center for Disease Control and Prevention (CDC) in" exact="the United States" post="recommends collecting only the upper respiratory nasopharyngeal swab to"/>
   <result pre="the Center for Disease Control and Prevention (CDC) in the" exact="United States" post="recommends collecting only the upper respiratory nasopharyngeal swab to"/>
   <result pre="monitoring of persons exposed to patients with confirmed COVID-19 â€&quot;" exact="United States," post="Januaryâ€&quot;February 2020MMWR Morb Mortal Wkly Rep20206924524610.15585/mmwr.mm6909e132134909 17.Colavita F, Lapa"/>
   <result pre="Isolation from ocular secretions of a patient with COVID-19 in" exact="Italy" post="with prolonged viral RNA detection. Ann Intern Med. 2020;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7481143\results\search\country\results.xml">
   <result pre="September 2012, the second highly pathogenic human coronavirus arose in" exact="Saudi Arabia" post="and spread across Middle Eastern countries.14 The virus was"/>
   <result pre="RDV for humans infected with EBOV was evaluated in the" exact="Democratic Republic of Congo." post="Results confirmed its safety but did not point RDV"/>
   <result pre="for humans infected with EBOV was evaluated in the Democratic" exact="Republic of" post="Congo. Results confirmed its safety but did not point"/>
   <result pre="acid.163 This investigation allowed the National Medical Products Administration in" exact="China" post="to approve, in March 2020, FPV as the first"/>
   <result pre="COVID-19 patients. A randomized clinical assay in six hospitals in" exact="Hong Kong" post="conducted by Hung et al.173 investigated whether the administration"/>
   <result pre="and combine therapy130, 176 because the outbreak of COVID-19 in" exact="China" post="happened at the same time the flu reached its"/>
   <result pre="involving 1.099 patients infected with SARS-CoV-2 from different hospitals in" exact="China" post="identified that 35,8% of patients were treated with oseltamivir."/>
   <result pre="oseltamivir.46 According to Yan et al.141, a 71-year-old woman in" exact="China" post="presented positive results for combined treatment with oseltamivir and"/>
   <result pre="classified as antiviral and has been used for 25â€¯years in" exact="Russia" post="and for 14â€¯years in China as prophylaxis and treatment"/>
   <result pre="been used for 25â€¯years in Russia and for 14â€¯years in" exact="China" post="as prophylaxis and treatment of influenzas A and B."/>
   <result pre="Res2015123701237710.1016/j.antiviral.2015.08.015 162FurutaY.KomenoT.NakamuraT.Favipiravir (T-705), a broad-spectrum inhibitor of viral RNA polymeraseProc" exact="Japan" post="Acad Ser B93201744946310.2183/pjab.93.02728769016 163Chen C, Huang J, Cheng Z,"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes Metab Syndr Clin Res Rev142020241246"/>
   <result pre="the CoordenaÃ§Ã£o de AperfeiÃ§oamento de Pessoal de NÃ­vel Superior -" exact="Brasil" post="( 10.13039/501100002322CAPES ) - Finance Code 001. The authors"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7482434\results\search\country\results.xml">
   <result pre="with HIV run by the Human Sciences Research Council in" exact="South Africa" post="via a social media platform found that 13% of"/>
   <result pre="patients were collecting their medication.7 A rapid survey assessment in" exact="Zimbabwe" post="in April, 2020, found 19% of people with HIV"/>
   <result pre="to get a partial refill,8 while a telephone-based survey in" exact="Kenya" post="and Nigeria run by the Finmark Trust in April,"/>
   <result pre="a partial refill,8 while a telephone-based survey in Kenya and" exact="Nigeria" post="run by the Finmark Trust in April, 2020, found"/>
   <result pre="mortality, VMMC coverage, and health-seeking and sexual behaviour; data from" exact="South Africa" post="on age-specific and sex-specific HIV prevalence, ART coverage, population"/>
   <result pre="Africa (Botswana, Cameroon, CÃ´te d'Ivoire, eSwatini, Kenya, Malawi, Mozambique, Nigeria," exact="South Africa," post="Tanzania, Uganda, and Zimbabwe). Numbers of circumcisions are held"/>
   <result pre="are an average of three countries in sub-Saharan Africa (Malawi," exact="South Africa," post="and Zimbabwe) and are for adult mortality and new"/>
   <result pre="include results for 12 countries in sub-Saharan Africa (Botswana, Cameroon," exact="Cote d'Ivoire," post="eSwatini, Kenya, Malawi, Mozambique, Nigeria, South Africa, Tanzania, Uganda,"/>
   <result pre="Africa (Botswana, Cameroon, Cote d'Ivoire, eSwatini, Kenya, Malawi, Mozambique, Nigeria," exact="South Africa," post="Tanzania, Uganda, and Zimbabwe). Regional values are sums of"/>
   <result pre="Goals Optima HIV HIV Synthesis Imperial College London Modelâ€ EMOD" exact="South Africa" post="71â€ˆ000 (52â€ˆ000â€&quot;91â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre="230â€ˆ000 (170â€ˆ000â€&quot;280â€ˆ000) 84â€ˆ000 (66â€ˆ000â€&quot;107â€ˆ000) 112â€ˆ000 (74â€ˆ600â€&quot;190â€ˆ000) 80â€ˆ400 (25â€ˆ000â€&quot;160â€ˆ300) 138â€ˆ126 (135â€ˆ400â€&quot;140â€ˆ900)" exact="Malawi" post="13â€ˆ000 (11â€ˆ000â€&quot;16â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre="32â€ˆ000 (25â€ˆ000â€&quot;38â€ˆ000) 18â€ˆ000 (17â€ˆ000â€&quot;19â€ˆ000) 29â€ˆ200 (12â€ˆ900â€&quot;46â€ˆ700) 13â€ˆ200 (4300â€&quot;25â€ˆ900) 22â€ˆ921 (19â€ˆ400â€&quot;27â€ˆ400)â€¡" exact="Mozambique" post="54â€ˆ000 (39â€ˆ000â€&quot;73â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre=".. 69â€ˆ000 (40â€ˆ000â€&quot;98â€ˆ000) 54â€ˆ000 (44â€ˆ000â€&quot;69â€ˆ000) 72â€ˆ000 (39â€ˆ200â€&quot;94â€ˆ000) 68â€ˆ600 (23â€ˆ800â€&quot;126â€ˆ900)â€¡ .." exact="Zimbabwe" post="22â€ˆ000 (17â€ˆ000â€&quot;27â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre="29â€ˆ000 (21â€ˆ000â€&quot;37â€ˆ000) 21â€ˆ000 (18â€ˆ000â€&quot;24â€ˆ000) 42â€ˆ300 (18â€ˆ100â€&quot;70â€ˆ300) 21â€ˆ100 (6800â€&quot;41â€ˆ600) 25â€ˆ738 (21â€ˆ000â€&quot;30â€ˆ800)â€¡" exact="eSwatini" post="2400 (2000â€&quot;2900) .. .. .. .. .. 20% disruption"/>
   <result pre="3600 (2800â€&quot;4400) 4700 (2600â€&quot;7000) 8270 (4670â€&quot;12â€ˆ670) 3000 (1100â€&quot;5600)â€¡ 5651 (4800â€&quot;6500)â€¡" exact="Lesotho" post="6100 (5000â€&quot;7500) .. .. .. .. .. 20% disruption"/>
   <result pre=".. 13â€ˆ000 (11â€ˆ000â€&quot;16â€ˆ000) .. 9900 (3700â€&quot;15â€ˆ400) 7600 (2600â€&quot;14â€ˆ100)â€¡ 6438 (5600â€&quot;7200)â€¡" exact="Uganda" post="23â€ˆ000 (19â€ˆ000â€&quot;31â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre="52â€ˆ000 (37â€ˆ000â€&quot;66â€ˆ000) 43â€ˆ000 (36â€ˆ000â€&quot;53â€ˆ000) 43â€ˆ700 (14â€ˆ800â€&quot;64â€ˆ600) 29â€ˆ200 (10â€ˆ100â€&quot;54â€ˆ100)â€¡ 29â€ˆ765 (25â€ˆ900â€&quot;34â€ˆ400)â€¡" exact="Kenya" post="25â€ˆ000 (18â€ˆ000â€&quot;38â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre="66â€ˆ000 (34â€ˆ000â€&quot;99â€ˆ000) 38â€ˆ000 (26â€ˆ000â€&quot;55â€ˆ000) 55â€ˆ900 (24â€ˆ700â€&quot;89â€ˆ400) 31â€ˆ800 (11â€ˆ000â€&quot;58â€ˆ800)â€¡ 38â€ˆ056 (29â€ˆ700â€&quot;47â€ˆ000)â€¡" exact="Botswana" post="4800 (4100â€&quot;5700) .. .. .. .. .. 20% disruption"/>
   <result pre="6100 (4700â€&quot;7600) 9500 (7900â€&quot;12â€ˆ000) 17â€ˆ400 (9800â€&quot;26â€ˆ800) 6100 (2100â€&quot;11â€ˆ300)â€¡ 9956 (8000â€&quot;11â€ˆ700)â€¡" exact="Tanzania" post="24â€ˆ000 (20â€ˆ000â€&quot;29â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre="54â€ˆ000 (44â€ˆ000â€&quot;65â€ˆ000) 24â€ˆ000 (16â€ˆ000â€&quot;35â€ˆ000) 45â€ˆ200 (15â€ˆ300â€&quot;66â€ˆ800) 31â€ˆ800 (11â€ˆ000â€&quot;58â€ˆ800)â€¡ 32â€ˆ954 (26â€ˆ000â€&quot;38â€ˆ400)â€¡" exact="Cameroon" post="18â€ˆ000 (15â€ˆ000â€&quot;21â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre="12â€ˆ000 (6500â€&quot;17â€ˆ000) 12â€ˆ000 (9200â€&quot;16â€ˆ000) 21â€ˆ900 (11â€ˆ900â€&quot;28â€ˆ600) 20â€ˆ300 (7000â€&quot;37â€ˆ600)â€¡ 6265 (3900â€&quot;10â€ˆ000)â€¡" exact="Nigeria" post="53â€ˆ000 (31â€ˆ000â€&quot;89â€ˆ000) .. .. .. .. .. 20% disruption"/>
   <result pre="in Mozambique, 1Â·70 times in Uganda, and 1Â·53 times in" exact="Zimbabwe" post="because PMTCT coverage is quite high in most countries."/>
   <result pre="for antiretrovirals are delayed because most manufacturers are based in" exact="India" post="(which has been under lockdown in response to COVID-19)"/>
   <result pre="response to COVID-19) and transport challenges. Incoming raw materials from" exact="China" post="to India have also been reported to be affected"/>
   <result pre="COVID-19) and transport challenges. Incoming raw materials from China to" exact="India" post="have also been reported to be affected by logistical"/>
   <result pre="reported to be affected by logistical constraints. Anecdotal evidence from" exact="Malawi" post="shows relaxation of eligibility criteria for multi-month dispensing of"/>
   <result pre="in other crisis situations such as the post-election unrest in" exact="Kenya" post="in 2007,22, 23 during the Ebola epidemic in Guinea"/>
   <result pre="in Kenya in 2007,22, 23 during the Ebola epidemic in" exact="Guinea" post="in 2014,24 in acute conflict areas in the Central"/>
   <result pre="in Guinea in 2014,24 in acute conflict areas in the" exact="Central African Republic" post="and Yemen,25 and as a consequence of food insecurity.26"/>
   <result pre="AIDS Societyhttp://www.differentiatedcare.org/Resources/Resource-Library/COVID-19-DSD-Resources-Community-responses 9collab: Finmark TrustLivelihood impacts of COVID-19 in Kenya," exact="Nigeria" post="and South AfricaApril 28, 2020Tech Centralhttps://techcentral.co.za/livelihood-impacts-of-covid-19-in-kenya-nigeria-and-south-africa/97669/ 10StoverJBollingerLIzazolaJALouresLDeLayPGhysPDWhat is required"/>
   <result pre="Dec 18.10.1093/infdis/jiz667 13BeacroftLSmithJAHallettTBWhat impact could DMPA use have had in" exact="South Africa" post="and how might its continued use affect the future"/>
   <result pre="virological failureJ Acquir Immune Defic Syndr64201322022424047971 23YoderRBNyandikoWMVreemanRCLong-term impact of the" exact="Kenya" post="postelection crisis on clinic attendance and medication adherence for"/>
   <result pre="antiretroviral therapy during acute conflict: the experience of MSF in" exact="Central African Republic" post="and YemenConfl Health1220183029988565 26YoungSWheelerACMcCoySIWesierSDA review of the role of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7484576\results\search\country\results.xml">
   <result pre="Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian223003," exact="China" post="Hafiz M. N. Iqbal hafiz.iqbal@tec.mx School of Engineering and"/>
   <result pre="Monterrey, Ave. Eugenio Garza Sada 2501, Monterrey, N.L. CP 64849," exact="Mexico" post=": 2020-8-8: 202019(C) Taylor &amp;amp; Francis, 2020This article is"/>
   <result pre="high selectivity index.22 Moreover, the first patient of COVID-19 in" exact="the United States" post="was successfully treated by the intravenous administration of remdesivir.29"/>
   <result pre="selectivity index.22 Moreover, the first patient of COVID-19 in the" exact="United States" post="was successfully treated by the intravenous administration of remdesivir.29"/>
   <result pre="Generex Company contracted an agreement with a Chinese consortium involving" exact="China" post="Technology Exchange, Biology Institute of Shandong Academy of Sciences,"/>
   <result pre="LofyKH, WiesmanJ, BruceH, DiazGFirst case of 2019 novel coronavirus in" exact="the United States." post="New Engl J Med. 2020;382:929â€&quot;36. doi:10.1056/NEJMoa2001191.32004427 30.LiH, LiuSM, YuXH,"/>
   <result pre="WiesmanJ, BruceH, DiazGFirst case of 2019 novel coronavirus in the" exact="United States." post="New Engl J Med. 2020;382:929â€&quot;36. doi:10.1056/NEJMoa2001191.32004427 30.LiH, LiuSM, YuXH,"/>
   <result pre="NgMHL, ChengGUse of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur J Clin Microbiol Infect Dis. 2005;24(1):44â€&quot;46. doi:10.1007/s10096-004-1271-9.15616839 74.NgOW,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7485819\results\search\country\results.xml">
   <result pre="editing1*[1], Department of Laboratory Medicine, Korea University Guro Hospital, Seoul," exact="Republic of" post="Korea[2], Department of Diagnostic Immunology, Seegene Medical Foundation, Seoul,"/>
   <result pre="of Korea[2], Department of Diagnostic Immunology, Seegene Medical Foundation, Seoul," exact="Republic of" post="Korea[3], Department of Veterinary Microbiology, College of Veterinary Medicine,"/>
   <result pre="Veterinary Microbiology, College of Veterinary Medicine, Kangwon National University, Chuncheon," exact="Republic of" post="KoreaTrippRalph A.Editor[], University of Georgia, UNITED STATES Competing Interests:"/>
   <result pre="disease research (HG18C0012) and National Research Foundation of Korea (NRF-2016R1A5A1010148)," exact="Republic of" post="Korea. We also received a grant from the Korea"/>
   <result pre="Institute (KHIDI), funded by the Ministry of Health &amp;amp; Welfare," exact="Republic of" post="Korea (grant number: HR20C0021). fig-count: table-count: page-count: Data Availability"/>
   <result pre="LAMP primers and probes were synthesized by Macrogen, Inc. (Seoul," exact="South Korea;" post="Table 1). 10.1371/journal.pone.0238615.t001Table 1 Loop-mediated isothermal amplification (LAMP) and"/>
   <result pre="2PutriW, MuscatelloDJ, StockwellMS, NewallAT. Economic burden of seasonal influenza in" exact="the United States." post="Vaccine. 2018;36(27):3960â€&quot;6. Epub 2018/05/29. 10.1016/j.vaccine.2018.05.057 .29801998 3IulianoAD, RoguskiKM, ChangHH,"/>
   <result pre="MuscatelloDJ, StockwellMS, NewallAT. Economic burden of seasonal influenza in the" exact="United States." post="Vaccine. 2018;36(27):3960â€&quot;6. Epub 2018/05/29. 10.1016/j.vaccine.2018.05.057 .29801998 3IulianoAD, RoguskiKM, ChangHH,"/>
   <result pre="world of diagnosis of animal and human pathogens: a review." exact="Pakistan" post="journal of biological sciences: PJBS. 2014;17(2):151â€&quot;66. Epub 2014/05/03. 10.3923/pjbs.2014.151.166"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7485949\results\search\country\results.xml">
   <result pre="currently in clinical trials via an expanded access program in" exact="the United States," post="managed by the COVIDâ€�19 Convalescent Plasma Project (CCPP19.org). In"/>
   <result pre="in clinical trials via an expanded access program in the" exact="United States," post="managed by the COVIDâ€�19 Convalescent Plasma Project (CCPP19.org). In"/>
   <result pre="and commercial supply of Hâ€�IG depends on plasma collection. In" exact="the United States," post="Europe, Japan, and China, there is established and highly"/>
   <result pre="commercial supply of Hâ€�IG depends on plasma collection. In the" exact="United States," post="Europe, Japan, and China, there is established and highly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7486771\results\search\country\results.xml">
   <result pre="Acad. Sci. U.S.ApnaspnasPNASProceedings of the National Academy of Sciences of" exact="the United States" post="of America0027-84241091-6490National Academy of Sciences pmcid: 7486771 pmid: 32820077202006392"/>
   <result pre="Sci. U.S.ApnaspnasPNASProceedings of the National Academy of Sciences of the" exact="United States" post="of America0027-84241091-6490National Academy of Sciences pmcid: 7486771 pmid: 32820077202006392"/>
   <result pre="suggest there would have been about 3 million deaths in" exact="the US" post="population of 330 million, giving a crude death rate"/>
   <result pre="We use compiled age-specific death data from the following countries:" exact="China" post="(3), South Korea, Italy, Spain, France, Germany, England and"/>
   <result pre="compiled age-specific death data from the following countries: China (3)," exact="South Korea," post="Italy, Spain, France, Germany, England and Wales, and the"/>
   <result pre="South Korea, Italy, Spain, France, Germany, England and Wales, and" exact="the United States" post="(4).â€ Our approach does not require that the counts"/>
   <result pre="Korea, Italy, Spain, France, Germany, England and Wales, and the" exact="United States" post="(4).â€ Our approach does not require that the counts"/>
   <result pre="age after age 30 y. Fig. 1B shows that in" exact="South Korea," post="Italy, France, Germany, England and Wales, and Spain, virus-attributed"/>
   <result pre="and Spain, virus-attributed mortality rates rise by about 12%/y, while" exact="the United States" post="and Wuhan, China show a slower rate of increase"/>
   <result pre="Spain, virus-attributed mortality rates rise by about 12%/y, while the" exact="United States" post="and Wuhan, China show a slower rate of increase"/>
   <result pre="rise by about 12%/y, while the United States and Wuhan," exact="China" post="show a slower rate of increase (about 9.5%/y of"/>
   <result pre="central value of about 0.10, higher than the 0.086 for" exact="the United States." post="The smaller rate of increase in the United States"/>
   <result pre="value of about 0.10, higher than the 0.086 for the" exact="United States." post="The smaller rate of increase in the United States"/>
   <result pre="for the United States. The smaller rate of increase in" exact="the United States" post="is due to unusually high mortality at younger ages,"/>
   <result pre="the United States. The smaller rate of increase in the" exact="United States" post="is due to unusually high mortality at younger ages,"/>
   <result pre="an aside, however, analysis of COVID-19 mortality by sex in" exact="the United States" post="finds a steeper rate of increase for females above"/>
   <result pre="aside, however, analysis of COVID-19 mortality by sex in the" exact="United States" post="finds a steeper rate of increase for females above"/>
   <result pre="is actually lower for COVID-19 than for all-cause mortality in" exact="the United States" post="in 2017 (7). Epidemic Mortality Risk as Temporary Aging"/>
   <result pre="actually lower for COVID-19 than for all-cause mortality in the" exact="United States" post="in 2017 (7). Epidemic Mortality Risk as Temporary Aging"/>
   <result pre="Table 1 shows such calculations for different epidemiological forecasts for" exact="the United States" post="in terms of temporary aging, assuming a 3-mo window"/>
   <result pre="1 shows such calculations for different epidemiological forecasts for the" exact="United States" post="in terms of temporary aging, assuming a 3-mo window"/>
   <result pre="y in life expectancy. Fig. 3. Estimated age-specific mortality in" exact="the United States" post="in 2020 for the scenario of 1 million additional"/>
   <result pre="in life expectancy. Fig. 3. Estimated age-specific mortality in the" exact="United States" post="in 2020 for the scenario of 1 million additional"/>
   <result pre="average rates to result in 1 million additional deaths using" exact="the US" post="population age structure for 2020. This decline in life"/>
   <result pre="instead of 45.8 y). Our above calculation is specific to" exact="the United States" post="and to our estimated age pattern of COVID-19, but"/>
   <result pre="of 45.8 y). Our above calculation is specific to the" exact="United States" post="and to our estimated age pattern of COVID-19, but"/>
   <result pre="the cohort life expectancy forecast, or the particular features of" exact="the US" post="age distribution. Nonetheless, such stylized calculations arrive at a"/>
   <result pre="by a substantial literature in this area. Current estimates for" exact="the United States" post="by Viscusi (11, 12) give a single value of"/>
   <result pre="a substantial literature in this area. Current estimates for the" exact="United States" post="by Viscusi (11, 12) give a single value of"/>
   <result pre="x ) â€‰ d x e ( 0 ) .In" exact="the United States," post="H is about 0.15 and A is about 40."/>
   <result pre=") â€‰ d x e ( 0 ) .In the" exact="United States," post="H is about 0.15 and A is about 40."/>
   <result pre="indirect standardization, we used the 2017 period both-sex mortality from" exact="the United States" post="as the standard mortality schedule M x s by"/>
   <result pre="standardization, we used the 2017 period both-sex mortality from the" exact="United States" post="as the standard mortality schedule M x s by"/>
   <result pre="99 c x , k , letting the shares for" exact="the United States" post="age structure be the reference age structure, c x"/>
   <result pre="c x , k , letting the shares for the" exact="United States" post="age structure be the reference age structure, c x"/>
   <result pre="y. Table 2. Adjustment factors used for open age interval" exact="France" post="United States England Spain Italy Germany Korea Wuhan 0.997"/>
   <result pre="Table 2. Adjustment factors used for open age interval France" exact="United States" post="England Spain Italy Germany Korea Wuhan 0.997 1.000 1.036"/>
   <result pre="factors used for open age interval France United States England" exact="Spain" post="Italy Germany Korea Wuhan 0.997 1.000 1.036 1.051 1.067"/>
   <result pre="used for open age interval France United States England Spain" exact="Italy" post="Germany Korea Wuhan 0.997 1.000 1.036 1.051 1.067 1.098"/>
   <result pre="for open age interval France United States England Spain Italy" exact="Germany" post="Korea Wuhan 0.997 1.000 1.036 1.051 1.067 1.098 1.160"/>
   <result pre="with the Chinese data. Peter Choi sent us data for" exact="South Korea." post="Sam Preston, John Wilmoth, Barry Schwartz, and two anonymous"/>
   <result pre="were in Hubei. We thank Yi Zhou, Peking University, Beijing," exact="China" post="for these calculations. Data Availability. Data and computer code"/>
   <result pre="characteristics of an outbreak of 2019 novel coronavirus diseases (covid-19)â€&quot;China." exact="China" post="CDC Weekly2, 113â€&quot;122 (2020). 4collab: Institut National dâ€™Etudes DÃ©mographiques,"/>
   <result pre="Projections for 2020 and 2021â€� (Tech. Rep. 56351, Congress of" exact="the United States," post="Washington, DC, 2020). 17collab: Centers for Disease Control, Todayâ€™s"/>
   <result pre="for 2020 and 2021â€� (Tech. Rep. 56351, Congress of the" exact="United States," post="Washington, DC, 2020). 17collab: Centers for Disease Control, Todayâ€™s"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7486822\results\search\country\results.xml">
   <result pre="of comedications and effect of potential drug-drug interactions in the" exact="Swiss" post="HIV Cohort StudyAntivir Ther.15201041342310.3851/IMP154020516560 12TsengA.FoisyM.Important drug-drug interactions in HIV-infected"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7488313\results\search\country\results.xml">
   <result pre="evaluate the pathobiology of a recent H5N8 HPAIV isolated in" exact="Spain" post="(Gs/GD lineage, clade 2.3.4.4, Group B) in comparison with"/>
   <result pre="HPAIV in different local, commercial and experimental chicken lines from" exact="Spain" post="with diverse genetic backgrounds; and (2) determine the role"/>
   <result pre="chickens (Gallus gallus domestica) of six different local breeds from" exact="Spain" post="(Empordanesa, Penedesenca, Catalana del Prat, Flor dâ€™Ametller, Castellana negra,"/>
   <result pre="their pathobiology in a broad spectrum of chicken breeds from" exact="Spain" post="(local and commercial breeds). Both HPAIVs used in this"/>
   <result pre="in comparison with its detections in waterfowl holdings, including in" exact="Spain" post="[5]. However, different genotypes of H5N8 HPAIV circulated in"/>
   <result pre="in backyards in the absence or few biosecurity measures and" exact="Spain" post="is located within natural migratory routes between Eurasia and"/>
   <result pre="Indian native chicken breeds [54], a native chicken breed from" exact="Indonesia" post="[55] and 2 chicken breeds and 7 strains from"/>
   <result pre="Indonesia [55] and 2 chicken breeds and 7 strains from" exact="Egypt" post="[56]. The statistical analyses showed that the different genotypes"/>
   <result pre="highly pathogenic avian influenza virus in three chicken breeds from" exact="South Korea" post="in 2016/2017J Vet Sci.201920e2731161745 10.SubaSNagarajanSSaxenaVKKumarMVanamayyaPRRajukumarKGowthamanVJainRSinghDPDubeySCPathology of a H5N1, highly"/>
   <result pre="Microbiol2002403256326012202562 22.BusquetsNAlbaANappSSanchezASerranoERivasRNÃºÃ±ezJIMajÃ³NInfluenza A virus subtypes in wild birds in North-Eastern" exact="Spain" post="(Catalonia)Virus Res2010149101820045439 23.SironiLRamelliPWilliamsJLMarianiPPCR-RFLP genotyping protocol for chicken Mx gene"/>
   <result pre="from chickens during an outbreak of severe avian influenza in" exact="Japan" post="in April 2014Arch Virol20151601629164325902725 28.BertranKSwayneDEPantin-jackwoodMJKapczynskiDRSpackmanESuarezDLLack of chicken adaptation of"/>
   <result pre="highly pathogenic avian influenza H5N8 and H5N5 viruses detected in" exact="Poland" post="in 2016-2017Transbound Emerg Dis2018651664167029920971 31.collab: The Global Consortium for"/>
   <result pre="avian influenza viruses in chickensArch Virol200915496997919475480 36.CapuaIMutinelliFMarangonSAlexanderDJH7N1 avian influenza in" exact="Italy" post="(1999 to 2000) in intensively reared chickens and turkeysAvian"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7489051\results\search\country\results.xml">
   <result pre="Syndrome Coronavirus 2 (SARS-CoV-2) ChoudhryNamrtaâ€ #ZhaoXinâ€¡#XuDanâ€ ZaninMarkÂ§âŠ¥ChenWeisan*âˆ¥YangZifeng*Â§ChenJianxin*â€ [â€ ], South" exact="China" post="Agricultural UniversityChina[â€¡], Guangdong Institute of Analysis (China National Analytical"/>
   <result pre="East respiratory syndrome (MERS), caused by MERS-CoV, emerged in the" exact="Kingdom of Saudi Arabia" post="and subsequently spread to 27 countries.7 MERS presented as"/>
   <result pre="syndrome (MERS), caused by MERS-CoV, emerged in the Kingdom of" exact="Saudi Arabia" post="and subsequently spread to 27 countries.7 MERS presented as"/>
   <result pre="COVID-19. In 2002â€&quot;2003, the SARS outbreak first started in South" exact="China" post="and subsequently spread to 31 countries worldwide. Patients in"/>
   <result pre="and subsequently spread to 31 countries worldwide. Patients in mainland" exact="China" post="accounted for over 60% of the total cases. Interestingly,"/>
   <result pre="the total cases. Interestingly, the average death rate in mainland" exact="China" post="(approximately 6.5%) was lower than the worldwide average death"/>
   <result pre="worldwide average death rate (9.3%). The higher cure rate in" exact="China" post="for SARS infections was attributed to combining traditional Chinese"/>
   <result pre="On January 20, 2020, the National Health Commission (NHC) of" exact="China" post="issued the first edition of the Guidelines for the"/>
   <result pre="to 15 clinical trials of CQ or hydroxychloroquine (HCQ) in" exact="China" post="to test their efficacy and safety for COVID-19 patients."/>
   <result pre="Western medicine.24 A total of 92% of COVID-19 patients in" exact="China" post="received TCM treatment, with a total effective rate of"/>
   <result pre="patients from 12 hospitals in Guangdong and Hubei Provinces in" exact="China" post="were treated with CQ, and 176 patients were included"/>
   <result pre="a therapeutic evaluation of HCQ in 36 COVID-19 patients in" exact="France" post="and suggested that 600 mg/day HCQ significantly reduced viral"/>
   <result pre="(T-705, 3), a guanine analog approved for influenza treatment in" exact="Japan" post="in 2014, can effectively inhibit the RNA-dependent RNA polymerase"/>
   <result pre="medicines have been extensively used to treat COVID-19 patients in" exact="China" post="and have achieved positive effects. However, the major challenges"/>
   <result pre="with the Council of Scientific and Industrial Research- NBRI, Lucknow" exact="India" post="in 2015, later she joined a project entitled â€˜World"/>
   <result pre="IAV and CoVs at the College of Veterinary Medicine, South" exact="China" post="Agricultural University in Guangzhou, China. Xin Zhao received his"/>
   <result pre="has been working at the College of Veterinary Medicine, South" exact="China" post="Agriculture University, in Guangzhou, China. Her main research interests"/>
   <result pre="Guangzhou, and the School of Public Health, The University of" exact="Hong Kong." post="He earned a Ph.D. from Monash University, Australia, in"/>
   <result pre="discovered the 11th IAV gene product PB1-F2. He returned to" exact="Australia" post="in 2001 and established his independent T Cell Laboratory"/>
   <result pre="Chen is a professor at College of Veterinary Medicine, South" exact="China" post="Agricultural University in Guangzhou, China. He earned a B.S."/>
   <result pre="We also acknowledge Prof. Jing Zhao from the University of" exact="Macau" post="and Prof. Geng Li from Guangzhou University of Chinese"/>
   <result pre="funded by the National Key Research and Development Program of" exact="China" post="(Grant 2017YFD0501404), Guangdong Special Support Program Innovation Team (Grant"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003. Lancet2003, 362, 1353â€&quot;1358. 10.1016/S0140-6736(03)14630-2.14585636 KsiazekT."/>
   <result pre="UyekiT. M.; PillaiS. K.First case of 2019 novel coronavirus in" exact="the United States." post="N. Engl. J. Med.2020, 382, 929â€&quot;936. 10.1056/NEJMoa2001191.32004427 GreinJ.; OhmagariN.;"/>
   <result pre="M.; PillaiS. K.First case of 2019 novel coronavirus in the" exact="United States." post="N. Engl. J. Med.2020, 382, 929â€&quot;936. 10.1056/NEJMoa2001191.32004427 GreinJ.; OhmagariN.;"/>
   <result pre="severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci." exact="U. S." post="A.2004, 101, 10012â€&quot;10017. 10.1073/pnas.0403596101.15226499 ChandwaniA.; ShuterJ.Lopinavir/ritonavir in the treatment"/>
   <result pre="structure of a viral deubiquitinating enzyme. Proc. Natl. Acad. Sci." exact="U. S." post="A.2006, 103, 5717â€&quot;5722. 10.1073/pnas.0510851103.16581910 DevarajS. G.; WangN.; ChenZ.; ChenZ.;"/>
   <result pre="S1 protein that blocks receptor association. Proc. Natl. Acad. Sci." exact="U. S." post="A.2004, 101, 2536â€&quot;2541. 10.1073/pnas.0307140101.14983044 YuanB.; YangR.; MaY.; ZhouS.; ZhangX.;"/>
   <result pre="and their derivatives are widely implicated in liver cancers in" exact="Taiwan" post="and throughout Asia. Sci. Transl. Med.2017, 9, eaan644610.1126/scitranslmed.aan6446.29046434 ZengZ."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7491483\results\search\country\results.xml">
   <result pre="of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in" exact="Turkey" post="(A-HIT 1 registry)Atherosclerosis2702018424829407887 4DuffyE.Y.Cainzos-AchiricaM.MichosE.D.Primary and secondary prevention of cardiovascular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7493771\results\search\country\results.xml">
   <result pre="Moreover, other general factors may be over-represented in PLWH. In" exact="Spain" post="more than three quarters of PLWH are men [15],"/>
   <result pre="de la cronicidad mÃ¡s allÃ¡ del control virolÃ³gico [HIV in" exact="Spain" post="2017: policies for a new management of chronicity beyond"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7493775\results\search\country\results.xml">
   <result pre="genome replication. Recently, the first experience of remdesivir usage in" exact="the United States" post="for the COVID-19-infected patient was reported.19 The in vitro/in"/>
   <result pre="replication. Recently, the first experience of remdesivir usage in the" exact="United States" post="for the COVID-19-infected patient was reported.19 The in vitro/in"/>
   <result pre="under clinical trial (open-label trial ChiCTR2000029609). The preliminary study in" exact="France" post="evaluated the efficacy of hydroxychloroquine in SARS-CoV-2 patients. The"/>
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospital.J Antimicrob Chemother2005;56:919â€&quot;22.16183666 56.LukeTCKilbaneEMJacksonJLHoffmanSLMeta-analysis: convalescent blood products for Spanish"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7493780\results\search\country\results.xml">
   <result pre="of 53 patients (68%).34 Gilead has initiated several trials in" exact="United States" post="and China to evaluate the effect of remdesivir in"/>
   <result pre="(68%).34 Gilead has initiated several trials in United States and" exact="China" post="to evaluate the effect of remdesivir in COVID-19 patients"/>
   <result pre="elimination in present observation.42 Different trials were soon performed in" exact="China" post="and the results showed acceptable safety against COVID-19-associated pneumonia.43"/>
   <result pre="Wuhan, China, of novel coronavirus-infected pneumonia.N Engl J Med2020;382:1199â€&quot;207.31995857 12.FlahaultAHas" exact="China" post="faced only a herald wave of SARS-CoV-2?Lancet2020;395:947. 13.BackerJAKlinkenbergDWallingaJIncubation period"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7494453\results\search\country\results.xml">
   <result pre="Acute Respiratory Syndrome (SARS) in China, parts of Asia and" exact="Canada" post="in 2003, Ebola in West Africa in 2014 and"/>
   <result pre="year Measures An etÂ al. (2020) (An etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 1,103 nurses 6 days, March 2020 PHQ-9"/>
   <result pre="and WHO-QOL-BREF Babore etÂ al. (2020) (Babore etÂ al., 2020)" exact="Italy" post="Cross-sectional COVID-19 595 health care workers 6 days, April"/>
   <result pre="and COPE-NVI-25 Bai etÂ al. (2004) (Bai etÂ al., 2004)" exact="Taiwan" post="Cross-sectional SARS 338 staff members (218 health care workers"/>
   <result pre="the DSM-IV Cai etÂ al. (2020) (Cai etÂ al., 2020a)" exact="China" post="Cross-sectional COVID-19 1,521 health care workers (comprising doctors, nurses,"/>
   <result pre="SSRS Cai Q etÂ al. (2020) (Cai etÂ al., 2020b)" exact="China" post="Case-control COVID-19 1,173 frontline and 1,173 age- and sex-matched"/>
   <result pre="and PHQ-9 Chan and Huak (2004) (Chan and Huak, 2004)" exact="Singapore" post="Cross-sectional SARS 661 hospital workers (113 doctors and 548"/>
   <result pre="and coping Chan etÂ al. (2005) (Chan etÂ al., 2005)" exact="Hong Kong" post="Cross-sectional SARS 1470 nurses May 2003 SARS NSQ Chew"/>
   <result pre="SARS NSQ Chew etÂ al. (2020) (Chew etÂ al., 2020)" exact="Singapore" post="and India Cross-sectional COVID-19 906 health care workers (268"/>
   <result pre="Chew etÂ al. (2020) (Chew etÂ al., 2020) Singapore and" exact="India" post="Cross-sectional COVID-19 906 health care workers (268 physicians, 355"/>
   <result pre="and IES-R Chua etÂ al. (2004) (Chua etÂ al., 2004)" exact="Hong Kong" post="Case-control SARS 271 health care workers (roles unknown) and"/>
   <result pre="Di Tella etÂ al. (2020) (Di Tella etÂ al., 2020)" exact="Italy" post="Cross-sectional COVID-19 145 health care workers (72 doctors and"/>
   <result pre="and PCL-5 Du etÂ al. (2020) (Du etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 134 health care workers (60 from Wuhan"/>
   <result pre="and BDI-II Elbay etÂ al. (2020) (Elbay etÂ al., 2020)" exact="Turkey" post="Cross-sectional COVID-19 442 physicians 5 days, March 2020 DAS-21"/>
   <result pre="days, March 2020 DAS-21 Garcia-Fernandez (2020) (GarcÃ­a-FernÃ¡ndez etÂ al., 2020)" exact="Spain" post="Cross-sectional COVID-19 781 health care workers (385 physicians, 233"/>
   <result pre="and ASDI Hong etÂ al. (2020) (Hong etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 4,692 nurses 7 days, February 2020 PHQ-9,"/>
   <result pre="and PHQ-15 Hu etÂ al. (2020) (Hu etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 2,014 nurses February 2020 MBI-HSS, SAS, SDS,"/>
   <result pre="and MSPSS Ji etÂ al. (2017) (Ji etÂ al., 2017)" exact="Sierra Leone" post="Cross-sectional EVD 161 participants: local medical staff (59), logistic"/>
   <result pre="2015 SCL-90-R Juan etÂ al. (2020) (Juan etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 456 health care workers (doctors and nurses)"/>
   <result pre="and PHQ-15 Kang etÂ al. (2020) (Kang etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 944 hospital workers (811 nurses and 183"/>
   <result pre="and IES-R Khalid etÂ al. (2016) (Khalid etÂ al., 2016)" exact="Saudi Arabia" post="Cross-sectional MERS 117 health care workers (89 nurses, 16"/>
   <result pre="coping strategies Khee etÂ al. (2004) (Khee etÂ al., 2004)" exact="Singapore" post="Qualitative SARS 188 health care workers (mainly nurses, composition"/>
   <result pre="care providers Koh etÂ al. (2005) (Koh etÂ al., 2005)" exact="Singapore" post="Cross-sectional SARS 10,511 health care workers (comprising doctors, nurses,"/>
   <result pre="life3. IES Korkmaz etÂ al. (2020) (Korkmaz etÂ al., 2020)" exact="Turkey" post="Cross-sectional COVID-19 140 health care workers Unknown, 2020 PSQI,"/>
   <result pre="and BAI Lai etÂ al. (2020) (Lai etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 1,257 health care workers (493 physicians and"/>
   <result pre="ISI, IES-R Lancee etÂ al. (2008) (Lancee etÂ al., 2008)" exact="Canada" post="Cross-sectional SARS 139 health care workers (103 nurses, 15"/>
   <result pre="problem activities Lee etÂ al. (2018) (Lee etÂ al., 2018)" exact="South Korea" post="Longitudinal MERS 359 hospital workers (doctors, nurses, pharmacists and"/>
   <result pre="2015 IES-R Li etÂ al. (2020) (Li etÂ al., 2020b)" exact="China" post="Cross-sectional COVID-19 4,369 female frontline HCWs 8 days, February"/>
   <result pre="IES-R X. Li etÂ al. (2020) (Li etÂ al., 2020a)" exact="China" post="Cross-sectional COVID-19 948 medical staff 8 days, February 2020"/>
   <result pre="SRQ-20 Z. Li etÂ al. (2020) (Li etÂ al., 2020c)" exact="China" post="Case-control COVID-19 234 frontline nurses and 292 non-frontline nurses"/>
   <result pre="and VTS) Lin etÂ al. (2020) (Lin etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 2,316 nurses and physicians (885 frontline health"/>
   <result pre="and IES-R Liu etÂ al. (2020) (Liu etÂ al., 2020a)" exact="China" post="Cross-sectional COVID-19 512 healthcare staff working in a clinical"/>
   <result pre="SAS Y. Liu etÂ al. (2020) (Liu etÂ al., 2020b)" exact="China" post="Cross-sectional COVID-19 2,073 doctors and nurses 7 days, February"/>
   <result pre="2020 DASS-21 Lu etÂ al. (2020) (Lu etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 2,042 medical staff and 257 administrative staff,"/>
   <result pre="and HAMD Lung etÂ al. (2009) (Lung etÂ al., 2009)" exact="Taiwan" post="Longitudinal SARS 127 (49 nurses, 24 physicians and 54"/>
   <result pre="and CHQ Maunder etÂ al. (2005) (Maunder etÂ al., 2004)" exact="Canada" post="Cross-sectional SARS 1,557, majority were nurses (430). Also allied"/>
   <result pre="attitudes toward SARS Mo etÂ al. (2020) (Mo etÂ al.)" exact="China" post="Cross-sectional COVID-19 180 nurses Unknown, 2020 SOS and SAS"/>
   <result pre="and SAS Park etÂ al. (2018) (Park etÂ al., 2018)" exact="South Korea" post="Cross-sectional MERS 187 nurses 1 month, 2015 SF-36, PSS-10,"/>
   <result pre="of nurses Pouralizadeh etÂ al. (2020) (Pouralizadeh etÂ al., 2020)" exact="Iran" post="Cross-sectional COVID-19 441 nurses 6 days, April 2020 GAD-7"/>
   <result pre="and PHQ-9 Romero etÂ al. (2020) (Romero etÂ al., 2020)" exact="Spain" post="Cross-sectional COVID-19 3,109 health care workers 10 days, April"/>
   <result pre="Meta-Mood Scale Rossi etÂ al. (2020) (Rossi etÂ al., 2020)" exact="Italy" post="Cross-sectional COVID-19 1,378 health care workers (472 nurses, 433"/>
   <result pre="and PSS Sandesh etÂ al. (2020) (Sandesh etÂ al., 2020)" exact="Pakistan" post="Cross-sectional COVID-19 112 health care workers May 2020 DASS-21"/>
   <result pre="2020 DASS-21 Schechter etÂ al. (2020) (Shechter etÂ al., 2020)" exact="United States of America" post="Cross-sectional COVID-19 657 health care workers, including physicians, advanced"/>
   <result pre="etÂ al. (2020) (Shechter etÂ al., 2020) United States of" exact="America" post="Cross-sectional COVID-19 657 health care workers, including physicians, advanced"/>
   <result pre="and ISI Shih etÂ al. (2007) (Shih etÂ al., 2007)" exact="Taiwan" post="Qualitative SARS 200 nurses Unknown, after SARS outbreak in"/>
   <result pre="open-ended responses Tam etÂ al. (2004) (Tam etÂ al., 2004)" exact="Hong Kong" post="Cross-sectional SARS 652 (62% nurses, 24% health care assistants"/>
   <result pre="the outbreak Tian etÂ al. (2020) (Tian etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 845 health care workers 5 days, April"/>
   <result pre="and ISI-7 Wang etÂ al. (2020) (Wang etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 274 health care workers 6 days, February"/>
   <result pre="and PSQI Wankowicz etÂ al. (2020) (WaÅ&quot;kowicz etÂ al., 2020)" exact="Poland" post="Cross-sectional COVID-19 441 health care workers 14 days, May"/>
   <result pre="and ISI Wasim etÂ al. (2020) (Wasim etÂ al., 2020)" exact="Pakistan" post="Cross-sectional COVID-19 356 health care workers 14 days, May"/>
   <result pre="and IS Wilson etÂ al. (2020) (Wilson etÂ al., 2020)" exact="India" post="Cross-sectional COVID-19 350 health care workers April 2020 PHQ-9"/>
   <result pre="and GAD-7 Wong etÂ al. (2005) (Wong etÂ al., 2005)" exact="Hong Kong" post="Cross-sectional SARS 466 health care workers (123 doctors, 257"/>
   <result pre="18-item questionnaire Wu etÂ al. (2009) (Wu etÂ al., 2009)" exact="China" post="Retrospective cross-sectional SARS 549 hospital employees in 3 categories"/>
   <result pre="Risks questionnaires Xiao etÂ al. (2020) (Xiao etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 180 medical staff 1 month, January to"/>
   <result pre="and SSRS Xiaoming etÂ al. (2020) (Xiaoming etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 8,817 hospital workers 9 days, February 2020"/>
   <result pre="Zhang and Wang etÂ al. (2020) (Zhang etÂ al., 2020b)" exact="China" post="Cross-sectional COVID-19 2,182 Chinese medical (927) and non-medical (125)"/>
   <result pre="Zhang and Yang etÂ al. (2020) (Zhang etÂ al., 2020a)" exact="China" post="Cross-sectional COVID-19 1,563 medical workers (984 nurses 454 doctors,"/>
   <result pre="and IES-R Zhou etÂ al. (2020) (Zhou etÂ al., 2020)" exact="China" post="Cross-sectional COVID-19 1,001 health care workers (doctors and nurses)"/>
   <result pre="HCWs had PTSD two months after the SARS outbreak in" exact="Singapore" post="(Chan and Huak, 2004). While 5% (17 of 338)"/>
   <result pre="of 338) of staff members at a hospital in East" exact="Taiwan" post="met criteria for an Acute Stress Disorder (ASD) during"/>
   <result pre="studies (Tam etÂ al., 2004; Wong etÂ al., 2005) from" exact="Hong Kong," post="the overall distress level for nurses was significantly higher"/>
   <result pre="spread of the virus. The psychological morbidity of HCWs in" exact="Hong Kong" post="was associated with perceptions of personal vulnerability, stress and"/>
   <result pre="outbreakBrain Behav. Immun.88202055956532330593 ChuaS.E.Psychological effects of the SARS outbreak in" exact="Hong Kong" post="on high-risk health care workersCan. J. Psychiatr.4962004391393 Di TellaM.Mental"/>
   <result pre="(SARS) on work and personal lives of healthcare workers in" exact="Singapore" post="what can we learn?Med. Care200567668215970782 KorkmazS.The anxiety levels, quality"/>
   <result pre="surveyEpidemiol. Infect.1482020e98-e LiuY.Mental health status of paediatric medical workers in" exact="China" post="during the COVID-19 outbreakFront. Psychiatr.112020702 LuW.Psychological status of medical"/>
   <result pre="respiratory syndromeAppl. Nurs. Res.204200717118017996803 TamC.W.Severe acute respiratory syndrome (SARS) in" exact="Hong Kong" post="in 2003: stress and psychological impact among frontline healthcare"/>
   <result pre="of frontline health professionals treating imported patients with COVID-19 in" exact="China" post="during the pandemicPsychol. Med.202012 Unprecedented Number of Medical Staff"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7496561\results\search\country\results.xml">
   <result pre="outbreak that was presumably first detected in a province in" exact="China" post="in late December has found its way into almost"/>
   <result pre="transfusion-transmissible infections, the incidence of which is very low in" exact="the US." post="Other noninfectious risks include allergic transfusion reactions, transfusion-associated circulatory"/>
   <result pre="2020â€&quot; March 2021 Phase 4 National University of Ireland, Galway," exact="Ireland" post="Drug: lopinavir/ritonavir; drug: hydroxychloroquine sulfate; drug: losartan; drug: placebos"/>
   <result pre="Institut National de la SantÃ© Et de la Recherche MÃ©dicale," exact="France" post="Drug: lopinavir/ritonavir; drug: hydroxychloroquine; drug: remdesivir NCT04330690 2900 March"/>
   <result pre="NCT04411433 1000 May 2020â€&quot;July 2020 Phase 3 Ministry of Health," exact="Turkey" post="Drug: hydroxychloroquine - daily dosing; drug: hydroxychloroquine - weekly"/>
   <result pre="effects. Early reports from the first 99 patients hospitalized in" exact="China" post="showed that 5% had elevated prothrombin time (PT), 6%"/>
   <result pre="Arbidol Arbidol is an antiviral that has been approved in" exact="China" post="and Russia for treating influenza, SARS, and Lassa viruses."/>
   <result pre="is an antiviral that has been approved in China and" exact="Russia" post="for treating influenza, SARS, and Lassa viruses. It blocks"/>
   <result pre="an antiviral drug approved for the treatment of influenza in" exact="Japan" post="due to its activity against a wide spectrum of"/>
   <result pre="search and a narrative review with a special reference to" exact="India" post="and other developing countriesDiabetes Metab SyndrSinghAKSinghAShaikhASinghRMisraA24124614202032247211 29Finding the dose"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7498210\results\search\country\results.xml">
   <result pre="Respiratory Syndrome) in 2013 and 2018, respectively in China, and" exact="Saudi Arabia" post="(2). COVID-19 was first recognized as intense pneumonia in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7498411\results\search\country\results.xml">
   <result pre="supported by grants from the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(21922611, 21707161, 21637004, and 21920102007), the Youth Innovation Promotion"/>
   <result pre="She has received her bachelorâ€™s degree in 2011 from South" exact="China" post="University of Technology and Ph.D. in 2015 from the"/>
   <result pre="Excellent Young Scholarsâ€� by the National Natural Science Foundation of" exact="China" post="(NSFC) in 2019. He has also been a member"/>
   <result pre="Young Scientistâ€� award from the National Natural Science Foundation of" exact="China" post="(NSFC). He had served as the Chief Scientist for"/>
   <result pre="of Engineered Nanomaterials under the â€œNational Basic Research Program of" exact="China" post="(973 Program)â€� from 2014 to 2018."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7498997\results\search\country\results.xml">
   <result pre="originate from a live animal market in the Hubei province," exact="China" post="[1]. This is the third coronavirus outbreak in the"/>
   <result pre="past few years. In 2002â€&quot;2003, a coronavirus (SARS-CoV) emerged in" exact="China" post="and it resulted in 774 deaths. In 2012, Middle"/>
   <result pre="2012, Middle East respiratory syndrome (MERS) which first emerged in" exact="Saudi Arabia" post="resulted in 858 deaths [4]. The SARS-CoV-2 is mainly"/>
   <result pre="The data for Peru, Italy, Spain, England, France, USA, and" exact="Mexico" post="was obtained from Global Health 50/50 which was updated"/>
   <result pre="July 12. The mortality data as of July 24 for" exact="Sweden" post="was taken from the Swedish Public Health Agency Coronavirus"/>
   <result pre="sex-biased mortality from COVID-19. For instance, the male mortality in" exact="Italy" post="was reported to be high compared to China and"/>
   <result pre="mortality in Italy was reported to be high compared to" exact="China" post="and this is suggested to be due to a"/>
   <result pre="in harsh climate including famine [46]. The 1772â€&quot;1773 famine in" exact="Sweden" post="dropped the life expectancy of males to 17.15â€‰years while"/>
   <result pre="males and 2.23â€‰years for females [46]. The measles outbreak in" exact="Iceland" post="(1845â€&quot;1849) also showed sex-specific mortality. The average life expectancy"/>
   <result pre="Research Council (2019-04455)â€&quot;data analysis and manuscript writing; the Knowledge Foundation" exact="Sweden" post="(20170231)â€&quot;data analysis and manuscript writing; O.E and Edla Johannsonâ€™s"/>
   <result pre="New York CityHum Reprod2006213127313116936298 50.GrechVThe great recession of 2007 in" exact="the United States" post="and the male: female ratio at birthJ Turk Ger"/>
   <result pre="York CityHum Reprod2006213127313116936298 50.GrechVThe great recession of 2007 in the" exact="United States" post="and the male: female ratio at birthJ Turk Ger"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7499567\results\search\country\results.xml">
   <result pre="Spanish flu 1918â€&quot;1920 H1N1 40â€&quot;50 Asian flu 1957â€&quot;1958 H2N2 1â€&quot;2" exact="Hong Kong" post="flu 1968â€&quot;1970 H3N2 0.5â€&quot;2 Swine flu 2009â€&quot;2010 H1N1 0.5"/>
   <result pre="have an active corrective site (Steinhauer, de la Torre and" exact="Holland" post="1989; Cheung etÂ al. 2014), which results in a"/>
   <result pre="chloroquine has also been identified by several groups (in China," exact="South Korea" post="and the United States) (Jeon etÂ al. 2020; Jin"/>
   <result pre="DonchenkoEAet al.Agent for the treatment of iron overload and hemochromatosis." exact="Russian Federation" post="patent RU 2557959C12014. AskwithCC, deÂ SilvaD, KaplanJMolecular biology of"/>
   <result pre="J Clin Invest. 1984;73:1576â€&quot;9.6327764 BisnoAL, GriffinJP, VanÂ EppsKAet al.Pneumonia and" exact="Hong Kong" post="influenza: a prospective study of the 1968â€&quot;1969 epidemic. Am"/>
   <result pre="Cardiol. 1996;91:418â€&quot;24.8996626 EkinsS, LaneTR, MadridPBTilorone: a broad-spectrum antiviral invented in" exact="the USA" post="and commercialized in Russia and beyond. Pharm Res. 2020;37:71.32215760"/>
   <result pre="a broad-spectrum antiviral invented in the USA and commercialized in" exact="Russia" post="and beyond. Pharm Res. 2020;37:71.32215760 EkinsS, MadridPBTilorone: a broad-spectrum"/>
   <result pre="IlyashenkoKK, LuzhnikovEA, AbakumovMMet al.Sklifosovsky Research Institute for Emergency Medicine, assignees." exact="Russian Federation" post="patent RU 2205641C22001. IshiguroT, KagiyamaN, UozumiRet al.Clinical characteristics of"/>
   <result pre="1989;109:2721â€&quot;9.2556405 KastanMB, SemenkovichCF, SchneiderJUse of chloroquine to treat metabolic syndrome." exact="United States" post="patent US 20080319010A12008. KearneyJChloroquine as a potential treatment and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7500907\results\search\country\results.xml">
   <result pre="new coronavirus (COVID-19) was first detected in Wuhan city of" exact="China" post="in December 2019. Most patients infected with COVID-19 had"/>
   <result pre="of these drugs could overweigh their potential benefits and efficacy," exact="United States" post="Food and Drug Administration (FDA) no longer recommended these"/>
   <result pre="hepatitis C virus (HCV), etc. Umifenovir was first developed in" exact="Russia" post="and now its usage is more common in Russia"/>
   <result pre="in Russia and now its usage is more common in" exact="Russia" post="and China and is less common in western countries."/>
   <result pre="and now its usage is more common in Russia and" exact="China" post="and is less common in western countries. Its possible"/>
   <result pre="during the concomitant administration. An open-label non-randomized clinical trial in" exact="France" post="revealed that co-administration of azithromycin with hydroxychloroquine in COVID-19"/>
   <result pre="in the inhibition of COVID-19 infection.49 On 1st May 2020," exact="the US" post="Food and Drug Administration (FDA) approved the emergency use"/>
   <result pre="shorter recovery time and clinical benefit.73 Also results of a" exact="United States" post="clinical trial on remdesivir have not been published till"/>
   <result pre="new coronavirus (COVID-19) was first detected in Wuhan city of" exact="China" post="in December 2019. Soon this coronavirus disease 2019 (COVID-19)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501082\results\search\country\results.xml">
   <result pre="Notably, epidemiological studies, carried out in several countries (i.e., China," exact="Italy" post="and the United States), suggest that the incidence and"/>
   <result pre="triazavirin was docked against SARS-CoV-2 Mpro and tested clinically in" exact="China" post="for COVID-19 treatment [147]. Viomycin, a nonribosomal peptide with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501538\results\search\country\results.xml">
   <result pre="critical review on earlier drafts of this manuscript. We acknowledge" exact="the US" post="Drug Testing Laboratories as the laboratory that conducted all"/>
   <result pre="(PWH).1 In a large multisite clinical cohort of PWH in" exact="the United States," post="27% reported hazardous alcohol use and 34% reported binge"/>
   <result pre="In a large multisite clinical cohort of PWH in the" exact="United States," post="27% reported hazardous alcohol use and 34% reported binge"/>
   <result pre="was conducted in Thai Nguyen, a semi-urban province in North" exact="Vietnam" post="located 75 kilometers north of Hanoi with a population"/>
   <result pre="treatment has rarely been incorporated into HIV care settings. In" exact="the United States," post="a stepped alcohol treatment intervention for patients with HIV"/>
   <result pre="has rarely been incorporated into HIV care settings. In the" exact="United States," post="a stepped alcohol treatment intervention for patients with HIV"/>
   <result pre="are men36 and most individuals with alcohol use disorder in" exact="Vietnam" post="are men.36 Therefore, we anticipate that our findings will"/>
   <result pre="with hazardous alcohol use among persons living with HIV across" exact="the US" post="in the current era of antiretroviral treatment. AIDS Behav."/>
   <result pre="in the Study From Each ART Clinic, Thai Nguyen Province," exact="Vietnam" post="eTable 2. Descriptions of Each Alcohol Reduction Intervention Evaluated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501552\results\search\country\results.xml">
   <result pre="Krasnoyarsk Krai: Area with High Levels of HIV-1 Recombination in" exact="Russia" post="MaksimenkoLada V.1TotmeninAleksey V.1GashnikovaMariya P.1AstakhovaEkaterina M.1SkudarnovSergey E.2OstapovaTatyana S.2YaschenkoSvetlana V.2MeshkovIvan O.3BocharovEvgeniy"/>
   <result pre="Abstract More than a quarter of HIV-infected individuals registered in" exact="Russia" post="live in Siberia. Unlike Central Russia where HIV-1 subtype"/>
   <result pre="HIV-infected individuals registered in Russia live in Siberia. Unlike Central" exact="Russia" post="where HIV-1 subtype A6 is predominant, in most Siberian"/>
   <result pre="and Development Program 2-16 1. Introduction HIV infection epidemic in" exact="Russia" post="continues to evolve [1], and HIV infection cases have"/>
   <result pre="cases have been registered in all territorial entities of the" exact="Russian Federation." post="The number of Russian regions with a high prevalence"/>
   <result pre="development, where more than a quarter of HIV-infected population of" exact="Russia" post="is registered. Five SFD regions make the list of"/>
   <result pre="HIV infection rates. In 2018, Krasnoyarsk Krai ranks 8th in" exact="Russia" post="and 5th in SFD according to this index [2,"/>
   <result pre="from the beginning of large volume of opioids delivery to" exact="Russian Federation" post="from Afghanistan through Central Asia countries (so-called North Route)."/>
   <result pre="of large volume of opioids delivery to Russian Federation from" exact="Afghanistan" post="through Central Asia countries (so-called North Route). At the"/>
   <result pre="Far East with currently predominant HIV-1 subtype A specific to" exact="Russia" post="[14â€&quot;20], after 2010â€&quot;2014 in Novosibirsk Oblast, Tomsk Oblast, Kemerovo"/>
   <result pre="3). Among the studied HIV-1, A (A6) subtype specific to" exact="Russia" post="was detected in 57.2% and CRF63_02A1 in 12.6%; CRF02_AGÐ¡Ð�"/>
   <result pre="among subtype A viruses in the countries of the former" exact="Soviet Union" post="[30]. Among other mutations impacting the development of anti-HIV"/>
   <result pre="of HIV subtype A, in the countries of the former" exact="Soviet Union." post="In the studied sample, A62V was registered in 69.1%"/>
   <result pre="Russian federationPLoS Medicine2017141110.1371/journal.pmed.1002462 3collab: Central Research Institute of EpidemiologyHIV-Infection in" exact="Russian Federation" post="in the First Half of 20182018Moscow, RussiaCentral Research Institute"/>
   <result pre="Y.DelgadoE.et al.Rapid spread of the HIV-1 circular recombinant CRF02-AG in" exact="Russia" post="and neighboring countriesVoprosy Virusologii20156061419 45KolomeetsA. N.VargheseV.LemeyP.BobkovaM. R.ShaferR. W.A uniquely"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501848\results\search\country\results.xml">
   <result pre="The coronavirus disease 2019 (COVID-19), the pandemic that originated in" exact="China" post="has already spread into more than 190 countries, resulting"/>
   <result pre="acute respiratory syndrome coronavirus (SARS-CoV) epidemic in 2002â€&quot;2003 originated in" exact="China" post="[1], Influenza A pandemic in 2009, first reported in"/>
   <result pre="China [1], Influenza A pandemic in 2009, first reported in" exact="Spain" post="[2], Middle East respiratory syndrome (MERS) pandemic in 2012,"/>
   <result pre="East respiratory syndrome (MERS) pandemic in 2012, first identified in" exact="Saudi Arabia" post="and the current [3], Severe acute respiratory syndrome coronavirus"/>
   <result pre="SARS-CoV siRNA S,N,M,E gene, Replicase A1 US20050004063 The University of" exact="Hongkong" post="SARS-CoV siRNA orf3a CN101085986 Shanghai Institutes for Biological Sciences,"/>
   <result pre="DNAzymesTheranostics7420171010102528382172 109SantoroS.W.JoyceG.F.AÂ general purpose RNA-cleaving DNA enzymeProc. Natl. Acad. Sci." exact="U. S." post="A.9491997426242669113977 110AkhtarS.AgrawalS.In vivo studies with antisense oligonucleotidesTrends Pharmacol. Sci.181199712189114724"/>
   <result pre="and cytopathic effects of human immunodeficiency virusProc. Natl. Acad. Sci." exact="U. S." post="A.84211987770677103499613 117BennettC.F.Pharmacology of antisense drugsAnnu. Rev. Pharmacol. Toxicol.5720178110527732800 118SasakiS.GuoS.Nucleic"/>
   <result pre="structure of a D-lysine-based chiral PNA-DNA duplexProc. Natl. Acad. Sci." exact="U. S." post="A.100212003120211202614512516 123PellestorF.PaulasovaP.The peptide nucleic acids (PNAs), powerful tools for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7502134\results\search\country\results.xml">
   <result pre="ViralesANRS 12353 National Institute on Drug AbuseRO1 DA041978 1. Introduction" exact="Vietnam" post="is particularly concerned with illicit drug use since the"/>
   <result pre="approximately 200,000 people who inject drugs (PWID) in 2012 in" exact="Vietnam" post="[3]. Since 1993, the political response to drug use"/>
   <result pre="early 2000s. In 2002, needle/syringe exchange programs were expanded throughout" exact="Vietnam" post="for HIV control, reducing new HIV infections by 23%"/>
   <result pre="HCV prevalence in 2014 was approximately 74% among PWID in" exact="Vietnam" post="[6] and approximately 67% in Haiphong [7]. We recently"/>
   <result pre="the SD Bioline HCV rapid test (Standard Diagnostics Inc., Gyeonggi-do," exact="Republic of" post="Korea) and HIV serology testing with the Determineâ&quot;¢ HIV-1/2"/>
   <result pre="the Bioline HIV1/2 3.0 rapid test (Standard Diagnostics Inc., Gyeonggi-do," exact="Republic of" post="Korea) plus the VIKIAÂ® HIV1/2 test (Marcy-l'Etoile, Lyon, France)"/>
   <result pre="1GiangL. M.NgocL. B.HoangV. H.MulveyK.RawsonR. A.Substance use disorders and HIV in" exact="Vietnam" post="since Doi Moi (renovation): an overviewJournal of Food and"/>
   <result pre="drug users: eight years of cross-border HIV prevention interventions in" exact="Vietnam" post="and ChinaPLoS One201278, article e4314110.1371/journal.pone.004314122952640 4VuongT.AliR.BaldwinS.MillsS.Drug policy in Vietnam:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7503980\results\search\country\results.xml">
   <result pre="the Ministry of Education, Science and Technological Development of the" exact="Republic of" post="Serbia. Supplementary Materials The following are available online: Figure"/>
   <result pre="the Ministry of Education, Science and Technological Development of the" exact="Republic of" post="Serbia. Conflicts of Interest The authors declare no conflict"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505219\results\search\country\results.xml">
   <result pre="viral strain of the twenty-first century was first documented in" exact="Mexico" post="in April 2009; the virus has spread rapidly to"/>
   <result pre="Spanish flu (H1N1) in 1918, the Asian flu (H2N2) in" exact="China" post="in 1957, and the Hong Kong flu (H3N2) in"/>
   <result pre="the Asian flu (H2N2) in China in 1957, and the" exact="Hong Kong" post="flu (H3N2) in 1968 [14]. It is believed that"/>
   <result pre="from various parts of the country have been reported in" exact="India" post="[17]. The highest incidence of H1N1 2009 was reported"/>
   <result pre="deaths) are higher due to the 2009 H1N1 pandemic in" exact="India" post="[20]. At the beginning of 2015, H1N1 2009 re-emerged"/>
   <result pre="3100 Fatality/1 lakh â€‰ 1â€&quot;4 5â€&quot;14 30 27 11 [23]" exact="Germany" post="2009 (Aprâ€&quot;Aug) 9950 3630 NR up to 2 15â€&quot;19"/>
   <result pre="0 0â€&quot;4 5â€&quot;9 10â€&quot;14 15â€&quot;19 4% 22% 16% 12% [25]" exact="Australia" post="(Queensland) 2009 (Aprâ€&quot;Jun) 593 16 0 0â€&quot;4 5â€&quot;9 10â€&quot;14"/>
   <result pre="Fatality 0â€&quot;4 5â€&quot;14 0â€&quot;4 5â€&quot;14 113 147 25 11 [27]" exact="France" post="2009 (Aprâ€&quot;Jun) 4867 all patients 358 confirmed NR 0â€&quot;9"/>
   <result pre="all patients 358 confirmed NR 0â€&quot;9 10â€&quot;19 26 35 [28]" exact="New Zealand" post="2009 (Aprâ€&quot;Aug) 3179 972 16 Cumulative Incidence /1 lakh"/>
   <result pre="Incidence /1 lakh â€‰ 219 Fatality/1 lakh â€‰ 150 [29]" exact="Australia" post="2009 (Aprâ€&quot;Jul) 223 NR NR 0â€&quot;4 15â€&quot;19 3% 37%"/>
   <result pre="2009 (Aprâ€&quot;Jul) 223 NR NR 0â€&quot;4 15â€&quot;19 3% 37% [30]" exact="Australia" post="2009 (Mayâ€&quot;Aug) 5106 1214 hospitalization, all ages 1 0â€&quot;4"/>
   <result pre="2009 ending NR 725 NR â€‰ 5â€&quot;17 325 500 [32]" exact="Ireland" post="2009 (Aprâ€&quot;Oct) NR 205 4 0â€&quot;4 5â€&quot;9 10â€&quot;14 15â€&quot;19"/>
   <result pre="19 0â€&quot;2 2â€&quot;4 5â€&quot;9 10â€&quot;17 8% 7% 11% 18% [34]" exact="Japan" post="2009 (Aprâ€&quot;Dec) NR 10,487 85 0â€&quot;4 5â€&quot;9 10â€&quot;14 15â€&quot;19"/>
   <result pre="2009 (Aprâ€&quot;Aug) NA NR 36 0â€&quot;4 5â€&quot;17 7 29 [36]" exact="Cyprus" post="2009 (Junâ€&quot;Aug) 45 5 0 â€‰ 1â€&quot;5 4 10"/>
   <result pre="2009 (Junâ€&quot;Aug) 45 5 0 â€‰ 1â€&quot;5 4 10 [37]" exact="Australia" post="2009 (Mayâ€&quot;Sep) NR 977 24 0â€&quot;18 3 [38] US"/>
   <result pre="0â€&quot;4 5â€&quot;17 2.45% 0.61% 0.026% 0.010% Fatality 0â€&quot;4 5â€&quot;17 [39]" exact="France" post="2009 (Julâ€&quot;Nov) NA 514 Incidence /1 lakh â€‰ 2.03"/>
   <result pre="lakh â€‰ 2.03 3 2 37 fatality â€‰ 1â€&quot;14 [40]" exact="Canada" post="2009 (Mayâ€&quot;Aug) 324 235 2 â€‰ 3â€&quot;5Â months 6â€&quot;23Â"/>
   <result pre="0â€&quot;4 5â€&quot;14 565 350 5 9 Fatality 0â€&quot;4 5â€&quot;14 [42]" exact="New Zealand" post="2009 (Mayâ€&quot;Oct) 3254 1008 Cumulative incidence /1 lakh â€‰"/>
   <result pre="â€‰ 1â€&quot;4 5â€&quot;15 42 49 125 Fatality 0â€&quot;15 3.5% [44]" exact="Canada" post="2009 (Aprâ€&quot;Jun) 3152 140 7 â€‰ 1â€&quot;11 12â€&quot;18 48"/>
   <result pre="of influenza attack during the 2009 H1N1 pandemic [59]. In" exact="the US," post="during annual epidemics between 1977â€&quot;1978 and 1980â€&quot;1981, children aged"/>
   <result pre="in children aged 40Â days to 15Â years in the" exact="Cyprus" post="region; 5 of them were hospitalized (average time of"/>
   <result pre="in 4% of patients [66]. A serum-based diagnostic study from" exact="the USA" post="has shown that most people are likely to be"/>
   <result pre="from 34 to 43%. Although the results were inconsistent, the" exact="Hong Kong" post="study found higher rates of infection in older children,"/>
   <result pre="more than two years of age [70]. One study from" exact="India" post="reported that 85 children were positive for 2009 H1N1"/>
   <result pre="been reported from various studies. A cross-sectional study in the" exact="United Kingdom" post="reported that 18% of children with oseltamivir treated with"/>
   <result pre="use is limited to a few countries, including Japan, China," exact="South Korea" post="and the USA [84, 85]. Vaccination Vaccination is a"/>
   <result pre="to a few countries, including Japan, China, South Korea and" exact="the USA" post="[84, 85]. Vaccination Vaccination is a very effective strategy"/>
   <result pre="but are not allowed to be transported and distributed in" exact="India" post="[87]. Currently available TIV vaccines are not approved for"/>
   <result pre="A vaccines have been licensed by the Drug Controller General" exact="India" post="(DCGI) and have been available since September 2010 [90]."/>
   <result pre="September 2010 [90]. In the preliminary phase, the Government of" exact="India" post="offeredâ€‰&amp;gt;â€‰2.5 million doses of pandemic influenza to immunize high-risk"/>
   <result pre="effect than Oseltamivir but is only authorized for use in" exact="Japan" post="and the USA [96]. Therefore, the researchers also need"/>
   <result pre="Oseltamivir but is only authorized for use in Japan and" exact="the USA" post="[96]. Therefore, the researchers also need to emphasize these"/>
   <result pre="characterization of swine origin influenza viruses isolated from humans in" exact="the United States," post="1990â€&quot;2010Virology2012422115116010.1016/j.virol.2011.10.01622078166 5.ChastagnerABoninEFabletCQuÃ©guinerSHirchaudEet al.Virus persistence in pig herds led to"/>
   <result pre="of swine origin influenza viruses isolated from humans in the" exact="United States," post="1990â€&quot;2010Virology2012422115116010.1016/j.virol.2011.10.01622078166 5.ChastagnerABoninEFabletCQuÃ©guinerSHirchaudEet al.Virus persistence in pig herds led to"/>
   <result pre="Res2014139345445824820841 21.ChadhaMSPotdarVASahaSKoulPABroorSet al.Dynamics of influenza seasonality at sub-regional levels in" exact="India" post="and implications for vaccination timingPLoS ONE2015105e012412210.1371/journal.pone.012412225938466 22.DonaldsonLJRutterPDEllisBMGreavesFEMyttonOTet al.Mortality from"/>
   <result pre="31.ReedCKatzJMHancockKBalishAFryAMet al.Prevalence of seropositivity to pandemic influenza A/H1N1 virus in" exact="the United States" post="following the 2009 pandemicPLoS ONE2012710e4818710.1371/journal.pone.004818723118949 32.Cullen G, Martin J,"/>
   <result pre="al.Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the" exact="United States" post="following the 2009 pandemicPLoS ONE2012710e4818710.1371/journal.pone.004818723118949 32.Cullen G, Martin J,"/>
   <result pre="Surveill 14(44) 33.JainSKamimotoLBramleyAMSchmitzAMBenoitSRet al.Hospitalized patients with 2009 H1N1 influenza in" exact="the United States," post="April-June 2009N Engl J Med2009361201935194410.1056/NEJMoa090669519815859 34.Kamigaki T, Oshitani H"/>
   <result pre="14(44) 33.JainSKamimotoLBramleyAMSchmitzAMBenoitSRet al.Hospitalized patients with 2009 H1N1 influenza in the" exact="United States," post="April-June 2009N Engl J Med2009361201935194410.1056/NEJMoa090669519815859 34.Kamigaki T, Oshitani H"/>
   <result pre="et al. (2009) The severity of pandemic H1N1 influenza in" exact="the United States," post="April - July 2009. PLoS Curr 1:RRN1042. 10.1371/currents.RRN1042 39.FuhrmanCBonmarinIPatyACDuportNChironEet"/>
   <result pre="al. (2009) The severity of pandemic H1N1 influenza in the" exact="United States," post="April - July 2009. PLoS Curr 1:RRN1042. 10.1371/currents.RRN1042 39.FuhrmanCBonmarinIPatyACDuportNChironEet"/>
   <result pre="KloosterTMWieldersCCDonkerTIskenLMeijerAet al.Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in" exact="the Netherlands," post="5 June - 31 December 2009Euro Surveill201010.2807/ese.15.02.19461-en 42.Paine S,"/>
   <result pre="factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza:" exact="United Kingdom" post="first wave (May-September 2009)Thorax201065764565110.1136/thx.2010.13521020627925 44.TuiteARGreerALWhelanMWinterALLeeBet al.Estimated epidemiologic parameters and"/>
   <result pre="with acute respiratory infection in a community-based cohort of healthy" exact="New Zealand" post="childrenJ Med Virol201910.1002/jmv.2549331017663 61.BenderJMAmpofoKGestelandPShengXKorgenskiKet al.Influenza virus infection in infants"/>
   <result pre="effectiveness of influenza vaccination against influenza-associated hospitalization in children in" exact="Hong Kong," post="2015â€&quot;16Influenza Other Respir Viruses2017111616510.1111/irv.1239927313064 63.ChiuSSLoJYChanKHChanELSoLYet al.Population-based hospitalization burden of"/>
   <result pre="a virus subtypes and antigenic drift variants in children in" exact="Hong Kong" post="(2004â€&quot;2011)PLoS ONE201494e9291410.1371/journal.pone.009291424786780 64.KrogJSHjulsagerCKLarsenMALarsenLETriple-reassortant influenza A virus with H3 of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505229\results\search\country\results.xml">
   <result pre="Middle Eastern Respiratory Syndrome (MERS) disease was discovered in Jeddah," exact="Saudi Arabia." post="These two constituted the two most major coronavirus outbreaks,"/>
   <result pre="MERS literature, it appears that authors affiliated with institutes in" exact="Saudi Arabia" post="have been exceptionally overrepresented in the publications. This is"/>
   <result pre="This is also, to a lesser extent, the case with" exact="Egypt" post="being markedly presented on the MERS map of the"/>
   <result pre="Chinese authors have most strongly collaborated with authors residing in" exact="the United States," post="followed by authors from Germany, Taiwan, Singapore, Japan, France,"/>
   <result pre="authors have most strongly collaborated with authors residing in the" exact="United States," post="followed by authors from Germany, Taiwan, Singapore, Japan, France,"/>
   <result pre="followed by authors from Germany, Taiwan, Singapore, Japan, France, Australia," exact="United Kingdom" post="and Canada. The SARS network of collaborations for the"/>
   <result pre="network of collaborations for the authors affiliated with Institutes in" exact="the United States" post="has been, by and large, similar to that of"/>
   <result pre="of collaborations for the authors affiliated with Institutes in the" exact="United States" post="has been, by and large, similar to that of"/>
   <result pre="been, by and large, similar to that of China. Except," exact="South Korea," post="The Netherlands, Italy and Spain are also strongly represented"/>
   <result pre="similar to that of China. Except, South Korea, The Netherlands," exact="Italy" post="and Spain are also strongly represented in the collaborations"/>
   <result pre="that of China. Except, South Korea, The Netherlands, Italy and" exact="Spain" post="are also strongly represented in the collaborations with the"/>
   <result pre="and Spain are also strongly represented in the collaborations with" exact="the United States." post="The map of co-authorships associated with the MERS literature"/>
   <result pre="Spain are also strongly represented in the collaborations with the" exact="United States." post="The map of co-authorships associated with the MERS literature"/>
   <result pre="literature presents the names of many Middle Eastern countries including" exact="Saudi Arabia," post="Egypt, Lebanon, Iran, Tunisia, Qatar, Oman, Jordan, and United"/>
   <result pre="Saudi Arabia, Egypt, Lebanon, Iran, Tunisia, Qatar, Oman, Jordan, and" exact="United Arab Emirates" post="which is a clear indication into the exceptionally strong"/>
   <result pre="Egypt, Lebanon, Iran, Tunisia, Qatar, Oman, Jordan, and United Arab" exact="Emirates" post="which is a clear indication into the exceptionally strong"/>
   <result pre="of co-authorships on this topic are observed between authors from" exact="the United States" post="and those of Saudi Arabia, followed by China, United"/>
   <result pre="co-authorships on this topic are observed between authors from the" exact="United States" post="and those of Saudi Arabia, followed by China, United"/>
   <result pre="observed between authors from the United States and those of" exact="Saudi Arabia," post="followed by China, United Kingdom, Egypt, South Korea, Canada"/>
   <result pre="United States and those of Saudi Arabia, followed by China," exact="United Kingdom," post="Egypt, South Korea, Canada and the Netherlands. The closest"/>
   <result pre="those of Saudi Arabia, followed by China, United Kingdom, Egypt," exact="South Korea," post="Canada and the Netherlands. The closest collaborators of Chinese"/>
   <result pre="Saudi Arabia, followed by China, United Kingdom, Egypt, South Korea," exact="Canada" post="and the Netherlands. The closest collaborators of Chinese authors"/>
   <result pre="followed by China, United Kingdom, Egypt, South Korea, Canada and" exact="the Netherlands." post="The closest collaborators of Chinese authors on this topic,"/>
   <result pre="on this topic, after the United states, have been from" exact="Saudi Arabia," post="United Kingdom and Egypt. The closest collaborators of Saudi"/>
   <result pre="topic, after the United states, have been from Saudi Arabia," exact="United Kingdom" post="and Egypt. The closest collaborators of Saudi Arabia, after"/>
   <result pre="Saudi Arabia, United Kingdom and Egypt. The closest collaborators of" exact="Saudi Arabia," post="after the United States, have been Egypt, China and"/>
   <result pre="Kingdom and Egypt. The closest collaborators of Saudi Arabia, after" exact="the United States," post="have been Egypt, China and United Kingdom. The Covid-19"/>
   <result pre="and Egypt. The closest collaborators of Saudi Arabia, after the" exact="United States," post="have been Egypt, China and United Kingdom. The Covid-19"/>
   <result pre="of Saudi Arabia, after the United States, have been Egypt," exact="China" post="and United Kingdom. The Covid-19 map presents a considerably"/>
   <result pre="Arabia, after the United States, have been Egypt, China and" exact="United Kingdom." post="The Covid-19 map presents a considerably higher number of"/>
   <result pre="SARS and MERS. While its strongest collaboration has been with" exact="the United States," post="the names of many other countries appear on its"/>
   <result pre="and MERS. While its strongest collaboration has been with the" exact="United States," post="the names of many other countries appear on its"/>
   <result pre="this map with a very strong link of collaboration with" exact="the United States," post="followed by United Kingdom at a smaller scale. This"/>
   <result pre="map with a very strong link of collaboration with the" exact="United States," post="followed by United Kingdom at a smaller scale. This"/>
   <result pre="strong link of collaboration with the United States, followed by" exact="United Kingdom" post="at a smaller scale. This pattern of exceptional representation"/>
   <result pre="maps has to a lesser extent extended to Iran, Spain," exact="France" post="and Brazil as countries severely affected by the Covid-19"/>
   <result pre="to a lesser extent extended to Iran, Spain, France and" exact="Brazil" post="as countries severely affected by the Covid-19 outbreak at"/>
   <result pre="SARS studies in which authors affiliated with the institutes in" exact="the Netherlands" post="were involved have, on average, received the highest number"/>
   <result pre="studies in which authors affiliated with the institutes in the" exact="Netherlands" post="were involved have, on average, received the highest number"/>
   <result pre="repeated in relation to the MERS literature, with studies from" exact="the Netherlands," post="Germany and United Kingdom having received, on average, the"/>
   <result pre="relation to the MERS literature, with studies from the Netherlands," exact="Germany" post="and United Kingdom having received, on average, the highest"/>
   <result pre="the MERS literature, with studies from the Netherlands, Germany and" exact="United Kingdom" post="having received, on average, the highest number of citations."/>
   <result pre="number of citations. For studies published on Covid-19, publications from" exact="China" post="have so far stood out in terms of both"/>
   <result pre="of global scientific research on coronavirus (covid-19)Medical Journal of The" exact="Islamic Republic of Iran" post="(MJIRI)2020341354362 GolinelliDNuzzoleseAGBoettoERalloFGrecoMToscanoFFantiniMPThe impact of early scientific literature in response"/>
   <result pre="global scientific research on coronavirus (covid-19)Medical Journal of The Islamic" exact="Republic of Iran" post="(MJIRI)2020341354362 GolinelliDNuzzoleseAGBoettoERalloFGrecoMToscanoFFantiniMPThe impact of early scientific literature in response"/>
   <result pre="research on coronavirus (covid-19)Medical Journal of The Islamic Republic of" exact="Iran" post="(MJIRI)2020341354362 GolinelliDNuzzoleseAGBoettoERalloFGrecoMToscanoFFantiniMPThe impact of early scientific literature in response"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505701\results\search\country\results.xml">
   <result pre="of chloroquine and hydroxychloroquine in the treatment of COVID-19.13 The" exact="United States" post="Food and Drug Administration (FDA) also struggles to play"/>
   <result pre="trial that tested chloroquine and hydroxychloroquine in Brazil, Spain, and" exact="Mozambique" post="also concluded that these drugs are not safe when"/>
   <result pre="as East Africa, North Africa, West Africa, Central Africa, and" exact="South Africa." post="Study Design The study aimed to include all published"/>
   <result pre="the continentâ€™s step for treatment and prevention of the COVID-19." exact="Egypt" post="has 13 trials ongoing which specifically focus on COVID-19"/>
   <result pre="doing nutritional support especially with honey and some immunotherapy trials." exact="Zambia" post="has one trial ongoing with hydroxychloroquine, an anti-malarial drug,"/>
   <result pre="anti-malarial drug, which advertised as a potent remedy for coronavirus." exact="South Africa" post="is also looking at the efficacy of chloroquine, interferon,"/>
   <result pre="chloroquine, interferon, and remdesivir. Like in the case of Egypt," exact="Nigeria" post="has a trial in progress for different therapeutic agents."/>
   <result pre="extensive shortages of these drugs on the continent. For instance," exact="Nigeria" post="records several chloroquine poisonings cases after using it for"/>
   <result pre="using it for COVID-19 treatment. As CNN reported from Lagos," exact="Nigeria" post="showed that three Nigerians in the country are critically"/>
   <result pre="discovered between March 31, 2020, and April 4, 2020, in" exact="Cameroon" post="and the Democratic Republic of Congo by liquid chromatographic"/>
   <result pre="31, 2020, and April 4, 2020, in Cameroon and the" exact="Democratic Republic of Congo" post="by liquid chromatographic and mass spectrometric analysis. Such products"/>
   <result pre="2020, and April 4, 2020, in Cameroon and the Democratic" exact="Republic of" post="Congo by liquid chromatographic and mass spectrometric analysis. Such"/>
   <result pre="April 4, 2020, in Cameroon and the Democratic Republic of" exact="Congo" post="by liquid chromatographic and mass spectrometric analysis. Such products"/>
   <result pre="are around 3305 confirmed COVID-19 cases and 96 Deaths in" exact="Kenya" post="until June 13, 2020. South African Broadcasting Corporation (SABC)"/>
   <result pre="June 13, 2020. South African Broadcasting Corporation (SABC) reported that" exact="Kenya" post="approved the use of chloroquine to treat critical cases"/>
   <result pre="clinical study and might not be the cure of COVID-19.22,31" exact="Djibouti" post="is one of the African countries which is extremely"/>
   <result pre="ignoring WHO caution. Ahmed Zouiten, the WHO representative for the" exact="Djibouti" post="country office, told via VOA that while the WHO"/>
   <result pre="COVID-19 treatment.33 The Global Times report also showed that both" exact="Ethiopia" post="and Djibouti use an anti-malarial drug, chloroquine, and an"/>
   <result pre="The Global Times report also showed that both Ethiopia and" exact="Djibouti" post="use an anti-malarial drug, chloroquine, and an antibiotic, azithromycin,"/>
   <result pre="an antibiotic, azithromycin, to treat COVID-19 patients against WHO recommendations.34" exact="Uganda" post="recorded good results by treating COVID-19 patients with hydroxychloroquine"/>
   <result pre="results by treating COVID-19 patients with hydroxychloroquine or chloroquine. The" exact="Uganda" post="Ministry of Health told The Independent that they got"/>
   <result pre="patients even though the drugs did not treat the disease." exact="Uganda" post="has used either of the two drugs in combination"/>
   <result pre="the Ministry of Health, said that despite the recent findings," exact="Uganda" post="has scored good results from using these drugs. He"/>
   <result pre="the side effects.35 Off-Label Use of Chloroquine/Hydroxychloroquine in North Africa" exact="Egypt" post="is the leading African country with COVID cases as"/>
   <result pre="COVID cases as well as deaths. Like many African countries," exact="Egypt" post="uses chloroquine in treating COVID-19 patients. As Egypt Today"/>
   <result pre="African countries, Egypt uses chloroquine in treating COVID-19 patients. As" exact="Egypt" post="Today report by mentioning the Egyptian Minister of Health,"/>
   <result pre="mentioning the Egyptian Minister of Health, Hala Zayed, showed that" exact="Egypt" post="is using anti-malarial and HIV drugs in the treatment"/>
   <result pre="Hala Zayed, the Health Ministry spokesman, Khaled Megahed, told to" exact="Egypt" post="Today that the country denies producing chloroquine to treat"/>
   <result pre="of chloroquine by last May.37 According to the AFP report," exact="Algeria" post="is also one of the North African countries which"/>
   <result pre="undesirable reactions. The Health Minister, Abderrahmane Benbouzid, also said that" exact="Algeria" post="had great success in using hydroxychloroquine in combination with"/>
   <result pre="Algerian doctors have also claimed the treatment is very effective.24" exact="Morocco" post="also continues the use of chloroquine for COVID-19 treatment"/>
   <result pre="WHO has decided to momentarily suspend clinical trials with hydroxychloroquine," exact="Morocco" post="maintains its use. He was explaining and defending the"/>
   <result pre="4841 COVID-19 patients out of the 7584 cases recorded in" exact="Morocco" post="have recovered from the virus after following chloroquine treatment."/>
   <result pre="initially excited to and even started manufacturing its hydroxychloroquine. However," exact="Tunisia" post="declared that the treatment with hydroxychloroquine has been stopped"/>
   <result pre="admission.22 The Ghanaian Times also reported that the government of" exact="Ghana" post="decided to use hydroxychloroquine for COVID-19 case management. However,"/>
   <result pre="as a possible treatment for coronavirus. The Director-General of the" exact="Ghana" post="Health Service (GHS), Dr. Patrick Aboagye, said to Accra"/>
   <result pre="Aboagye, said to Accra that the case management team of" exact="Ghana" post="has decided to stop using hydroxychloroquine for the treatment"/>
   <result pre="to stop using hydroxychloroquine for the treatment of COVID-19.40 The" exact="Ghana" post="News Agency reported that Ghana denies chloroquine phosphate to"/>
   <result pre="the treatment of COVID-19.40 The Ghana News Agency reported that" exact="Ghana" post="denies chloroquine phosphate to cure coronavirus. The Director-General said"/>
   <result pre="the use of the drug to treat the virus.41 The" exact="Ghana" post="Medical Association (GMA) is also cautioning Ghanaians against the"/>
   <result pre="with COVID-19.44 The report of the Anadolu Agency showed that" exact="Nigeria" post="goes into clinical trials with hydroxychloroquine. The director of"/>
   <result pre="related symptoms or prevent infection.29,45 African news reported that the" exact="Senegal" post="government also continues treating COVID-19 patients with hydroxychloroquine despite"/>
   <result pre="cardiogram by the medical staff.46 The senior health official of" exact="Senegal" post="also told the Jakarta Post that Senegal is continuing"/>
   <result pre="health official of Senegal also told the Jakarta Post that" exact="Senegal" post="is continuing to administer hydroxychloroquine to COVID-19 patients. The"/>
   <result pre="with Covid-19 has taken very seriously for Cameron. AFP and" exact="France" post="24 report showed the countryâ€™s scientific council and Cameroonâ€™s"/>
   <result pre="worse. The black market for drugs in normal times in" exact="Cameroon" post="is rising with the Covid-19 crisis. Several fake chloroquine"/>
   <result pre="Covid-19 crisis. Several fake chloroquine products are circulated within the" exact="Cameroon" post="health network.49 Off-Label Use of Chloroquine/Hydroxychloroquine in South Africa"/>
   <result pre="within the Cameroon health network.49 Off-Label Use of Chloroquine/Hydroxychloroquine in" exact="South Africa" post="South Africa is one of the highly infected African"/>
   <result pre="Cameroon health network.49 Off-Label Use of Chloroquine/Hydroxychloroquine in South Africa" exact="South Africa" post="is one of the highly infected African countries by"/>
   <result pre="chloroquine is made available and affordable for every corner of" exact="South Africa." post="However, science still does not know enough to back"/>
   <result pre="against the new coronavirus. A local pharmaceutical company in Johannesburg," exact="South Africa," post="has received permission from the medical regulator of the"/>
   <result pre="for state use in a week.51 The health minister of" exact="Mozambique" post="is also considering the possibility of using chloroquine to"/>
   <result pre="public health programs in Zimbabwe. World Health Organization said that" exact="Zimbabwe" post="reported that mosquito-borne diseases are significantly spiked in the"/>
   <result pre="Against WHO Recommendation References East Africa Djibouti, Kenya, Uganda, and" exact="Ethiopia" post="22,31-35 North Africa Egypt, Morocco, and Algeria 24,36-39 West"/>
   <result pre="Kenya, Uganda, and Ethiopia 22,31-35 North Africa Egypt, Morocco, and" exact="Algeria" post="24,36-39 West Africa Ghana, Nigeria, and Senegal 22,29,40-47 Central"/>
   <result pre="Egypt, Morocco, and Algeria 24,36-39 West Africa Ghana, Nigeria, and" exact="Senegal" post="22,29,40-47 Central Africa Cameroon 48,49 South Africa South Africa,"/>
   <result pre="24,36-39 West Africa Ghana, Nigeria, and Senegal 22,29,40-47 Central Africa" exact="Cameroon" post="48,49 South Africa South Africa, Mozambique, and Zimbabwe 50â€&quot;52,54"/>
   <result pre="Africa Ghana, Nigeria, and Senegal 22,29,40-47 Central Africa Cameroon 48,49" exact="South Africa" post="South Africa, Mozambique, and Zimbabwe 50â€&quot;52,54 Conclusion and Recommendations"/>
   <result pre="Nigeria, and Senegal 22,29,40-47 Central Africa Cameroon 48,49 South Africa" exact="South Africa," post="Mozambique, and Zimbabwe 50â€&quot;52,54 Conclusion and Recommendations According to"/>
   <result pre="Central Africa Cameroon 48,49 South Africa South Africa, Mozambique, and" exact="Zimbabwe" post="50â€&quot;52,54 Conclusion and Recommendations According to this review, many"/>
   <result pre="Health Policy Update. 2020Available fromhttps://africacdc.org/download/covid-19-scientific-and-public-health-policy-update-28-aprilâ€&quot;2020/. Accessed 819, 2020. 22.IsaacK. Ghana," exact="Kenya" post="approve the use of Chloroquine to treat COVID-19 patients."/>
   <result pre="healthcare settings. Am J Trop Med Hyg. 2020;102(6):1184â€&quot;1188. doi:10.4269/ajtmh.20-029032323646 24.RyadK." exact="Algeria" post="backs the use of the malaria drug despite WHO"/>
   <result pre="coronavirus trials. Africanews. 2020Available fromhttps://www.africanews.com/2020/05/01/fiveafricancountries-with-ongoing-coronavirus-trials//. Accessed 819, 2020. 29.StephanieB, BukolaA." exact="Nigeria" post="records chloroquine poisoning after Trump endorses it for coronavirus"/>
   <result pre="2020Available fromhttps://face2faceafrica.com/article/djibouti-others-warned-about-chloroquine-despite-big-covid-19-recoveries. Accessed 819, 2020. 34.LiQChinese medical expert decorated by" exact="Djibouti" post="for COVID-19 prevention. Global Times. 2020Available from:https://www.globaltimes.cn/content/1189839.shtml. Accessed 819,"/>
   <result pre="819, 2020. 36.MohhamadDEgypt uses chloroquine in treating COVID-19 patients: minister." exact="Egypt" post="Today. 2020Available fromhttps://www.egypttoday.com/Article/1/83104/Egypt-uses-chloroquine-in-treating-COVID-19-patients-Minister. Accessed 819, 2020. 37.AlexB. Egypt uses"/>
   <result pre="patients: minister. Egypt Today. 2020Available fromhttps://www.egypttoday.com/Article/1/83104/Egypt-uses-chloroquine-in-treating-COVID-19-patients-Minister. Accessed 819, 2020. 37.AlexB." exact="Egypt" post="uses chloroquine in treating COVID-19 patients: minister. Egypt Today."/>
   <result pre="2020. 37.AlexB. Egypt uses chloroquine in treating COVID-19 patients: minister." exact="Egypt" post="Today. 2020Available fromhttps://www.egypttoday.com/Article/1/84462/Health-Ministry-denies-producing-chloroquine-to-treat-COVID-19-patients. Accessed 819, 2020. 38.MussaK. Morocco continues"/>
   <result pre="patients: minister. Egypt Today. 2020Available fromhttps://www.egypttoday.com/Article/1/84462/Health-Ministry-denies-producing-chloroquine-to-treat-COVID-19-patients. Accessed 819, 2020. 38.MussaK." exact="Morocco" post="continues the use of Chloroquine despite controversy. The North"/>
   <result pre="Post. 2020Available fromhttps://northafricapost.com/41247-morocco-continues-use-of-chloroquine-despite-controversy.html. Accessed 819, 2020. 39.BrianW. Covid-19: algeria and" exact="Morocco" post="continue using chloroquine despite concerns. al-bab.com. 2020Available fromhttps://al-bab.com/blog/2020/05/covid-19-algeria-and-morocco-continue-using-chloroquine-despite-concerns. Accessed"/>
   <result pre="management. all African news. 2020Available fromhttps://allafrica.com/stories/202005270578.html. Accessed 819, 2020. 41.AlfonsonL." exact="Ghana" post="denies Chloroquine Phosphate can cure coronavirus. African Press Agency."/>
   <result pre="coronavirus. African Press Agency. 2020Available fromhttp://apanews.net/en/news/ghana-denies-chloroquine-phosphate-can-cure-coronavirus. Accessed 819, 2020. 42.FeliciaO." exact="Ghana" post="Medical Association cautions against the use of Chloroquine, others"/>
   <result pre="treatment of Covid-19. Health. 2020Available fromhttps://www.myjoyonline.com/news/health/ghana-medical-association-cautions-against-use-of-chloroquine-others-in-the-treatment-of-COVIDâ€&quot;19/. Accessed 819, 2020. 43.FelixT." exact="Nigeria" post="goes on with hydroxychloroquine clinical trials. Anadolu Agency. 2020Available"/>
   <result pre="programs, new guidance from the World Health Organisation says, as" exact="Zimbabwe" post="reported its significant spike in the mosquito-borne disease. APA."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505804\results\search\country\results.xml">
   <result pre="perform and validating our approach on both real-life data from" exact="Italy" post="and synthetic instances. Our results show that increased inter-regional"/>
   <result pre="used by the United Kingdomâ€™s National Health Service. Fig. 1" exact="United Kingdom" post="National Health Serviceâ€™s protocol for rRT-PCR analysis of samples"/>
   <result pre="increasing the number of tests in much of Europe, North" exact="America" post="and Asia [1], [13], [27], [43]. Therefore, health authorities"/>
   <result pre="performed. The problem is motivated by the practice employed in" exact="Italy" post="during the early period of the epidemic, of double-checking"/>
   <result pre="based on data sources relative to the COVID-19 pandemic in" exact="Italy" post="[12], [25], [28], [32], [38]. We use data for"/>
   <result pre="a shows the distribution of laboratories and reagent factories in" exact="Italy" post="[25]: dots represents labs which are officially authorised to"/>
   <result pre="testing. Fig.Â 4b reports the number of swabs analysed in" exact="Italy" post="during the period 01â€&quot;13 April, 2020, on a regional"/>
   <result pre="models, compared to the number of swabs actually tested in" exact="Italy" post="in the described period. The last row gives aggregate"/>
   <result pre="the hypotheses explained above. In particular, assuming that tests in" exact="Italy" post="were largely limited by the unavailability of reagent due"/>
   <result pre="two computational studies: the first based on real-life data from" exact="Italy" post="and the second on synthetic instances. Under the assumptions"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505852\results\search\country\results.xml">
   <result pre="with SARS-CoV, was transferred to humans from dromedary camels in" exact="Saudi Arabia" post="(Azhar et al., 2014). The new SARS-CoV2 was identified"/>
   <result pre="in monitoring the NP safety on the market, supported by" exact="the US" post="Food and Drug Administration ( FDA) and the European"/>
   <result pre="syndrome human coronavirusProceedings of the National Academy of Sciences of" exact="the United States" post="of America101272004100121001710.1073/pnas.040359610115226499 WuC.LiuY.YangY.ZhangP.ZhongW.WangY. â€¦LiH.Analysis of therapeutic targets for SARS-CoV-2"/>
   <result pre="human coronavirusProceedings of the National Academy of Sciences of the" exact="United States" post="of America101272004100121001710.1073/pnas.040359610115226499 WuC.LiuY.YangY.ZhangP.ZhongW.WangY. â€¦LiH.Analysis of therapeutic targets for SARS-CoV-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505936\results\search\country\results.xml">
   <result pre="health Prognosis Treatment Depression Funding http://dx.doi.org/10.13039/501100001809National Natural Science Foundation of" exact="China" post="81560397 Background Nearly 8â€‰months have passed since the first"/>
   <result pre="des jarlais PhD proposed a positive and effective strategy for" exact="the United States" post="to remove the stigma of Acquired Immune Deficiency Syndrome"/>
   <result pre="jarlais PhD proposed a positive and effective strategy for the" exact="United States" post="to remove the stigma of Acquired Immune Deficiency Syndrome"/>
   <result pre="protect people suffering from AIDS, such as the President of" exact="the United States" post="posing with AIDS patients, and the promulgation of the"/>
   <result pre="people suffering from AIDS, such as the President of the" exact="United States" post="posing with AIDS patients, and the promulgation of the"/>
   <result pre="work was supported by the National Natural Science Foundation of" exact="China" post="(81560397) which provided the funds for the research project"/>
   <result pre="adult hippocampusJ Neurosci200424231932814724230 40.ChenRChouKRHuangYJWangTSLiuSYHoLYEffects of a SARS prevention programme in" exact="Taiwan" post="on nursing staff's anxiety, depression and sleep quality: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7506176\results\search\country\results.xml">
   <result pre="such as comorbidities, climatic conditions and demography on the pandemic." exact="Burkina Faso" post="is used as a case study to better describe"/>
   <result pre="From 13 January, the epidemic began to spread outside of" exact="China" post="[7] and on 30 January 2020, the World Health"/>
   <result pre="case of COVID-19 on the African continent was registered in" exact="Egypt" post="[10]. Since then, the disease has spread to several"/>
   <result pre="has spread to several other African countries. In sub-Saharan Africa," exact="Nigeria" post="was the first country to report a case of"/>
   <result pre="been affected by the pandemic. As of 29 July 2020," exact="Nigeria" post="is the most affected country by the coronavirus pandemic"/>
   <result pre="country by the coronavirus pandemic in West Africa followed by" exact="Ghana" post="[12]. Previous studies have shown the circulation of MERS-CoV"/>
   <result pre="of MERS-CoV in camels in some West African countries (Nigeria," exact="Burkina Faso" post="and Mali) [13, 14]. However, no case of HCoVs"/>
   <result pre="and demography on the pandemic. We focused our attention on" exact="Burkina Faso" post="as it is one of the countries of West"/>
   <result pre="1 were plotted using SitRep 115 data on COVID in" exact="Burkina Faso." post="Figure 1a and b were generated by datawrapper, and"/>
   <result pre="Fig. 3. Distribution by age group of COVID-19 cases in" exact="Burkina Faso" post="from 9 March to 21 June 2020 (NÂ =Â"/>
   <result pre="June 2020 (NÂ =Â 845). Source: MinistÃ¨re de la santÃ©" exact="Burkina Faso," post="Sitrep 115. https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/sitrep_covid-19_ndeg_115.pdf. Table 1. Mortality rate of SARS"/>
   <result pre="1. Mortality rate of SARS CoV-2 by age group in" exact="Burkina Faso" post="as of 21 June 2020 (nÂ =Â 907) Age"/>
   <result pre="3.6 Total 53 (100) 5.7 Source: MinistÃ¨re de la santÃ©" exact="Burkina Faso," post="Sitrep 115. https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/sitrep_covid-19_ndeg_115.pdf. Clinical manifestations and mode of disease"/>
   <result pre="chain reaction (PCR), 88Â 305 recoveries and 2102 deaths [12]." exact="Nigeria" post="is the most affected country in terms of registered"/>
   <result pre="with 41Â 804 confirmed cases and 868 deaths followed by" exact="Ghana" post="(34Â 406 confirmed cases and 168 deaths) and Cote"/>
   <result pre="by Ghana (34Â 406 confirmed cases and 168 deaths) and" exact="Cote d'Ivoire" post="(15Â 713 confirmed cases and 98 deaths). Among the"/>
   <result pre="98 deaths). Among the least affected countries we can cite" exact="Gambia" post="(326 confirmed cases and 8 deaths), Togo (896 confirmed"/>
   <result pre="we can cite Gambia (326 confirmed cases and 8 deaths)," exact="Togo" post="(896 confirmed cases and 18 deaths) and Chad (926"/>
   <result pre="8 deaths), Togo (896 confirmed cases and 18 deaths) and" exact="Chad" post="(926 confirmed cases and 75 deaths) (Fig. 2a and"/>
   <result pre="[12]. If we analyse in more detail the situation in" exact="Burkina Faso," post="the first two cases were highlighted on 9 March"/>
   <result pre="shows the death rate of SARS-CoV-2 by age group in" exact="Burkina Faso" post="as of 21 June 2020. If we take the"/>
   <result pre="limit the spread of COVID-19. Indeed, with the exception of" exact="Nigeria" post="(220 people/km2), the population density of West African countries"/>
   <result pre="United Kingdom: 267 people/km2) and Asians countries (China: 144 people/km2," exact="Republic of" post="Korea: 516 people/km2, Hong Kong: 6510 people/km2) [34â€&quot;36]. Nevertheless,"/>
   <result pre="disease. This is, for example, the case of Lagos in" exact="Nigeria" post="with around 6871 people/km2 [37]. Preventive measures against SARS-CoV-2"/>
   <result pre="and to respect barrier measures [38]. Also, the experiences of" exact="China" post="and South Korea teach us that rapid and systematic"/>
   <result pre="respect barrier measures [38]. Also, the experiences of China and" exact="South Korea" post="teach us that rapid and systematic detection of suspected"/>
   <result pre="(iv) introduction of a curfew in certain countries (Burkina Faso," exact="Cote d'Ivoire," post="Mali, Senegal, Niger and Guinea) and (v) closure of"/>
   <result pre="curfew in certain countries (Burkina Faso, Cote d'Ivoire, Mali, Senegal," exact="Niger" post="and Guinea) and (v) closure of markets and places"/>
   <result pre="have basic handwashing facilities available at home. Only Ghana, Mali," exact="Mauritania" post="and Nigeria were above the global average of 60%"/>
   <result pre="handwashing facilities available at home. Only Ghana, Mali, Mauritania and" exact="Nigeria" post="were above the global average of 60% of people"/>
   <result pre="particularly bad in small countries such as Benin, Gambia, Guinea-Bissau," exact="Liberia" post="and Togo where at least three-quarters of the population"/>
   <result pre="in small countries such as Benin, Gambia, Guinea-Bissau, Liberia and" exact="Togo" post="where at least three-quarters of the population had no"/>
   <result pre="are not always accessible to the population. Some countries (Senegal," exact="Nigeria" post="and Mali) have invested in the production and local"/>
   <result pre="quality of these masks is often lacking. For example, in" exact="Benin" post="buying a quality mask in pharmacies subsidised at 30"/>
   <result pre="health events in affected countries [47]. In a country like" exact="Burkina Faso" post="we have six university hospitals for around 20Â 244Â"/>
   <result pre="available. For instance, there are only 15 resuscitation beds in" exact="Burkina Faso," post="40 in Mali and 80 in Senegal. There are"/>
   <result pre="are only 15 resuscitation beds in Burkina Faso, 40 in" exact="Mali" post="and 80 in Senegal. There are only 4 respirators"/>
   <result pre="only 4 respirators in Togo, 5 in Niger, 11 in" exact="Burkina Faso," post="20 in CÃ´te d'Ivoire, 56 in Mali, 80 in"/>
   <result pre="Faso, 20 in CÃ´te d'Ivoire, 56 in Mali, 80 in" exact="Senegal" post="and around 400 in Nigeria [49]. The hospital's capacity"/>
   <result pre="56 in Mali, 80 in Senegal and around 400 in" exact="Nigeria" post="[49]. The hospital's capacity could quickly be exceeded. So,"/>
   <result pre="from quarantine without being tested as is the case of" exact="Burkina Faso." post="Among these asymptomatic people out of quarantine, there could"/>
   <result pre="Reference Laboratory) for confirmation of the cases for all the" exact="Burkina Faso," post="located in Bobo-Dioulasso, the second city in the country,"/>
   <result pre="thereby improving diagnostic capacities. SARS-CoV-2 and co-morbidities Several studies in" exact="China" post="and Italy tend to confirm that co-morbidities increase the"/>
   <result pre="diagnostic capacities. SARS-CoV-2 and co-morbidities Several studies in China and" exact="Italy" post="tend to confirm that co-morbidities increase the risk of"/>
   <result pre="rate being 3% in Benin; in 6% Mauritania, 5% in" exact="Ivory Coast" post="and 4.2% in Burkina Faso [57â€&quot;59]. High blood pressure"/>
   <result pre="in 6% Mauritania, 5% in Ivory Coast and 4.2% in" exact="Burkina Faso" post="[57â€&quot;59]. High blood pressure High blood pressure is defined"/>
   <result pre="contract COVID-19 and develop severe forms. With the exception of" exact="Niger" post="(0.3%), Burkina Faso has one of the lowest rates"/>
   <result pre="and develop severe forms. With the exception of Niger (0.3%)," exact="Burkina Faso" post="has one of the lowest rates of people living"/>
   <result pre="living with HIV in the West African sub region (0.7%)." exact="Ivory Coast" post="has the highest rate with 2.6% followed by Togo"/>
   <result pre="Ivory Coast has the highest rate with 2.6% followed by" exact="Togo" post="with 2.3%, Ghana with 1.7%, Mali with 1.4% and"/>
   <result pre="the highest rate with 2.6% followed by Togo with 2.3%," exact="Ghana" post="with 1.7%, Mali with 1.4% and Benin with 1%"/>
   <result pre="with 2.6% followed by Togo with 2.3%, Ghana with 1.7%," exact="Mali" post="with 1.4% and Benin with 1% [65]. SARS-CoV-2 and"/>
   <result pre="Togo with 2.3%, Ghana with 1.7%, Mali with 1.4% and" exact="Benin" post="with 1% [65]. SARS-CoV-2 and climatic factors SARS-CoV appeared"/>
   <result pre="with 1% [65]. SARS-CoV-2 and climatic factors SARS-CoV appeared in" exact="China" post="in Foshan, Guangdong province, in November 2002, while SARS-CoV-2"/>
   <result pre="SARS CoV-2 [73]. With the exception of the Mediterranean and" exact="South Africa," post="most countries on the African continent have a tropical"/>
   <result pre="45Â Â°C in some areas; this is the case in" exact="Burkina Faso," post="Niger and Mali [76â€&quot;78]. These high heats could be"/>
   <result pre="in some areas; this is the case in Burkina Faso," exact="Niger" post="and Mali [76â€&quot;78]. These high heats could be a"/>
   <result pre="areas; this is the case in Burkina Faso, Niger and" exact="Mali" post="[76â€&quot;78]. These high heats could be a factor contributing"/>
   <result pre="marks the climate of the countries of the Gulf of" exact="Guinea" post="[74]. These periods are also marked by an increase"/>
   <result pre="SARS-CoV-2 infection. Indeed, the epidemiological situation of COVID-19 infection in" exact="China" post="and Italy supports the hypothesis that the age factor"/>
   <result pre="Indeed, the epidemiological situation of COVID-19 infection in China and" exact="Italy" post="supports the hypothesis that the age factor plays an"/>
   <result pre="forms of the disease [22]. The fatality rate higher in" exact="Italy" post="than in China could be explained in particular by"/>
   <result pre="disease [22]. The fatality rate higher in Italy than in" exact="China" post="could be explained in particular by the fact that"/>
   <result pre="better prepared to face the COVID-19 pandemic. For example, in" exact="Burkina Faso," post="the epidemic of Ebola virus disease has led to"/>
   <result pre="We also used data from the ministry of health of" exact="Burkina Faso" post="available in free access at https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/sitrep_covid-19_ndeg_115.pdf. References References 1.WuF,"/>
   <result pre="genetic diversity. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America115, 3144â€&quot;3149.29507189 14.FalzaranoDet al. (2017) Dromedary camels in"/>
   <result pre="diversity. Proceedings of the National Academy of Sciences of the" exact="United States" post="of America115, 3144â€&quot;3149.29507189 14.FalzaranoDet al. (2017) Dromedary camels in"/>
   <result pre="of America115, 3144â€&quot;3149.29507189 14.FalzaranoDet al. (2017) Dromedary camels in northern" exact="Mali" post="have high seropositivity to MERS-CoV. One Health (Amsterdam, Netherlands)3,"/>
   <result pre="Urbanization and humidity shape the intensity of influenza epidemics in" exact="U. S." post="cities. Science362, 75â€&quot;79.30287659 18.DongE, DuH and GardnerL (2020) An"/>
   <result pre="(Accessed 3 May 2020). 48.Annuaire statistique ministÃ¨re de la santÃ©" exact="Burkina Faso" post="2018 â€&quot; Recherche Google. https://www.google.com/search?q=annuaire+statistique+ministÃ¨re+de+la+santÃ©+burkina+faso+2018&amp;amp;oq=annuaire+statistique+&amp;amp;aqs=chrome.1.69i57j0l7.15132j0j7&amp;amp;sourceid=chrome&amp;amp;ie=UTF-8 (Accessed 3 May 2020)."/>
   <result pre="artÃ©rielle chez les personnes Ã¢gÃ©es: Ã©tude transversale menÃ©e Ã Bobo-Dioulasso," exact="Burkina Faso" post="Prevalence and knowledge of arterial hypertension in the elderly:"/>
   <result pre="arterial hypertension in the elderly: cross-sectional study conducted in Bobo-Dioulasso," exact="Burkina Faso" post="Case series Open Access. Pan African Medical Journal-ISSN30, 1937â€&quot;8688."/>
   <result pre="influenza infection. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America166, 10905â€&quot;10910. 73.WangJet al. (2020) High temperature and"/>
   <result pre="infection. Proceedings of the National Academy of Sciences of the" exact="United States" post="of America166, 10905â€&quot;10910. 73.WangJet al. (2020) High temperature and"/>
   <result pre="Niamey. 2014; 7 pages. 77.BambaraDCH (2018) Ã‰volution des tempÃ©ratures au" exact="Burkina Faso" post="entre 1956 et 2015: cas de Ouagadougou et de"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7506210\results\search\country\results.xml">
   <result pre="discovery Microbiology Drug discovery Funding https://doi.org/10.13039/501100001809National Natural Science Foundation of" exact="China" post="(National Science Foundation of China) 8204102581630090JiangShibo Funding a starting"/>
   <result pre="rate 9.6% ~3.1%a Epidemic area Asia, Europe, North, and South" exact="America" post="Globally Epidemic time ~8 months Unknown High-risk for severe"/>
   <result pre="and H4, were isolated from a convalescent COVID-19 patient in" exact="China" post="and were recently reported to have antiviral activity against"/>
   <result pre="supported by grants from the National Natural Science Foundation of" exact="China" post="(81974302, 82041025, and 81630090), a starting grant from Hebei"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7506363\results\search\country\results.xml">
   <result pre="in the SARS epidemic (Fig.Â 1a,b). The initial reaction from" exact="China" post="was represented by two remdesivir trials in early February,"/>
   <result pre="from the international trial of remdesivir from the NIH [7]," exact="the US" post="Food and Drug Administration issued authorization for its emergency"/>
   <result pre="References References 1CallawayE.CyranoskiD.MallapatyS.StoyeE.TollefsonJ.The coronavirus pandemic in five powerful chartsNature579202048248332203366 2collab:" exact="China" post="National Health CommissionChinese clinical guidance for COVID-19 pneumonia diagnosis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7507004\results\search\country\results.xml">
   <result pre="antiretroviral therapy versus standard of care among HIVâ€�positive participants in" exact="Eswatini" post="in the public health sector: the MaxART steppedâ€�wedge randomized"/>
   <result pre="Chan School of Public HealthBostonMAUSA[4], Clinton Health Access Initiative (CHAI)BostonMAUSA[5]," exact="Eswatini" post="National ART program (SNAP)Ministry of HealthMbabaneSwaziland[6], Department of NutritionHarvard"/>
   <result pre="of Global HealthFaculty of Medicine and Health SciencesStellenbosch UniversityStellenboschSouth Africa[15]," exact="Eswatini" post="National Network of People Living with HIV (SWANNEPHA)MbabaneSwaziland[16], SAfAIDSManziniSwaziland[17],"/>
   <result pre="steppedâ€�wedge randomized controlled trial, 14 public sector health facilities in" exact="Eswatini" post="were paired and randomly assigned to stepwise transition from"/>
   <result pre="this â€œreal worldâ€� health systems trial strongly support EAAA for" exact="Eswatini" post="and countries with similar HIV epidemics and health systems."/>
   <result pre="for appropriate care management. universal treatment HIV retention viral suppression" exact="Eswatini" post="Subâ€�Saharan Africa antiretroviral therapy Funding Dutch Postcode Lottery, Netherlands"/>
   <result pre="suppression Eswatini Subâ€�Saharan Africa antiretroviral therapy Funding Dutch Postcode Lottery," exact="Netherlands" post="Clinton Health Access Initiative National Institute of Child Health"/>
   <result pre="Child Health and Human Development 10.13039/100000071 R01â€�HD084233 Embassy of the" exact="Kingdom of the Netherlands" post="in Mozambique Alexander von Humboldtâ€�Stiftung 10.13039/100005156 National Institute of"/>
   <result pre="and Human Development 10.13039/100000071 R01â€�HD084233 Embassy of the Kingdom of" exact="the Netherlands" post="in Mozambique Alexander von Humboldtâ€�Stiftung 10.13039/100005156 National Institute of"/>
   <result pre="Human Development 10.13039/100000071 R01â€�HD084233 Embassy of the Kingdom of the" exact="Netherlands" post="in Mozambique Alexander von Humboldtâ€�Stiftung 10.13039/100005156 National Institute of"/>
   <result pre="10.13039/100000071 R01â€�HD084233 Embassy of the Kingdom of the Netherlands in" exact="Mozambique" post="Alexander von Humboldtâ€�Stiftung 10.13039/100005156 National Institute of Aging, NIHP01â€�AG041710"/>
   <result pre="antiretroviral therapy versus standard of care among HIVâ€�positive participants in" exact="Eswatini" post="in the public health sector: the MaxART steppedâ€�wedge randomized"/>
   <result pre="reducing HIV incidence in highâ€�prevalence resourceâ€�limited settings. In 2014, the" exact="Eswatini" post="Ministry of Health launched the MaxART steppedâ€�wedge randomized controlled"/>
   <result pre="controlled trial to implement EAAA through the governmentâ€�managed health system." exact="Eswatini" post="has one of the highest HIV prevalence rates in"/>
   <result pre="estimated annual incidence of 1.36% in adults [9]. While the" exact="Eswatini" post="Ministry of Health had made substantial progress in addressing"/>
   <result pre="this reduction, the number of people needing HIV treatment in" exact="Eswatini" post="will likely expand along with the treatment costs. In"/>
   <result pre="and conducted by the MaxART Consortium â€&quot; led by the" exact="Eswatini" post="Ministry of Health â€&quot; from September 2014 to August"/>
   <result pre="instead of 1 January 2017, because on the former date," exact="Eswatini" post="changed its SoC from CD4Â â‰¤Â 500 to EAAA."/>
   <result pre="Safety Monitoring Board, Advisory Board, Primary Research Team and the" exact="Eswatini" post="Ministry of Health. The health workers, trial participants and"/>
   <result pre="WHO Stage 3 or 4, and on 1 October 2016," exact="Eswatini" post="adopted EAAA as SoC. 2.3 Early access to ART"/>
   <result pre="suppression, were established according to the definitions outlined by the" exact="Eswatini" post="Ministry of Health Integrated HIV Management Guidelines 2015 (TableÂ"/>
   <result pre="percentage. 2.7 Ethical approval The trial was approved by the" exact="Eswatini" post="National Health Research Review Board on 17 July 2014"/>
   <result pre="is still so high in, for example, Kwa Zulu Natal," exact="South Africa," post="bordering Eswatini [30]. Calendar time was controlled for in"/>
   <result pre="high in, for example, Kwa Zulu Natal, South Africa, bordering" exact="Eswatini" post="[30]. Calendar time was controlled for in all analyses,"/>
   <result pre="be successfully implemented in a public sector health system, supporting" exact="Eswatini" post="and other countries' decisions to roll out this policy"/>
   <result pre="32, 33, 34, 35]. This trial had several limitations. The" exact="Eswatini" post="national ART guidelines evolved during the trial from recommending"/>
   <result pre="and for those who became newly eligible under EAAA. Thus," exact="Eswatini" post="and other countries with similar HIV epidemics and health"/>
   <result pre="Data Safety Monitoring Board Sten Vermund, USA (chair); Nhlanhla Nhlabatsi," exact="Eswatini" post="(coâ€�chair); Rhinos Chekenyere, Eswatini; Shaffiq Essajee, USA; Nomsa Mulima,"/>
   <result pre="file. Acknowledgements The members of the MaxART Consortium included the" exact="Eswatini" post="Ministry of Health, Aidsfonds, Clinton Health Access Initiative (CHAI),"/>
   <result pre="Ministry of Health, Aidsfonds, Clinton Health Access Initiative (CHAI), the" exact="Eswatini" post="National Network of People Living with HIV/AIDS (SWANNEPHA), the"/>
   <result pre="This trial was funded by the Dutch Postcode Lottery in" exact="the Netherlands," post="and the Embassy of the Kingdom of the Netherlands"/>
   <result pre="Postcode Lottery in the Netherlands, and the Embassy of the" exact="Kingdom of the Netherlands" post="in Mozambique, and supported by Mylan Laboratories Limited, which"/>
   <result pre="in the Netherlands, and the Embassy of the Kingdom of" exact="the Netherlands" post="in Mozambique, and supported by Mylan Laboratories Limited, which"/>
   <result pre="the Netherlands, and the Embassy of the Kingdom of the" exact="Netherlands" post="in Mozambique, and supported by Mylan Laboratories Limited, which"/>
   <result pre="Test and Treat: the ANRS 12249 TasP trial in rural" exact="South Africa." post="J Int AIDS Soc. 2019;22:e2540231637821 8TanserF, KimHâ€�Y, VandormaelA, IwujiC,"/>
   <result pre="trial and associated population cohort. Curr HIV/AIDS Rep. 2020;17:97â€&quot;108.32072468 9collab:" exact="Kingdom of Eswatini" post=". Preliminary findings â€� Swaziland HIV incidence measurement survey"/>
   <result pre="associated population cohort. Curr HIV/AIDS Rep. 2020;17:97â€&quot;108.32072468 9collab: Kingdom of" exact="Eswatini" post=". Preliminary findings â€� Swaziland HIV incidence measurement survey"/>
   <result pre="Rep. 2020;17:97â€&quot;108.32072468 9collab: Kingdom of Eswatini . Preliminary findings â€�" exact="Swaziland" post="HIV incidence measurement survey 2: a populationâ€�based HIV impact"/>
   <result pre="needed for multiple comparisons. Epidemiology. 1990;1(1):43â€&quot;6.2081237 25collab: ICAP and the" exact="Swaziland" post="Ministry of Health . PHIA Project. Swaziland HIV incidence"/>
   <result pre="ICAP and the Swaziland Ministry of Health . PHIA Project." exact="Swaziland" post="HIV incidence measurement survey 2: a Populationâ€�based HIV impact"/>
   <result pre="therapeutic response: a populationâ€�based longitudinal HIV cascadeâ€�ofâ€�care study in KwaZuluâ€�Natalm," exact="South Africa." post="Lancet HIV. 2017;4(5):e223â€&quot;30. 28BorJ, FoxMP, RosenS, VenkataramaniA, TanserF, PillayD,"/>
   <result pre="retention in clinical HIV care: a regression discontinuity study in" exact="South Africa." post="PLoS Medicine. 2017;14:e1002463.29182641 29LessellsRJ, MutevedziPC, CookeGS, NewellML. Retention in"/>
   <result pre="for individuals not yet eligible for antiretroviral therapy: rural KwaZuluâ€�Natal," exact="South Africa." post="J Acquir Immune Defic Syndr. 2011;56(3):e79â€&quot;86. 30RamjeeG, SartoriusB, MorrisN,"/>
   <result pre="sustained geographic spread of HIV infections among women in Durban," exact="South Africa." post="BMC Infect Dis. 2019;19(1):500.31174475 31MolemansM, VernooijE, DlaminiN, ShabalalaFS, KhanS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7508045\results\search\country\results.xml">
   <result pre="is ongoing with a particular hotspot in southern Europe and" exact="America" post="in spring 2020. Many studies predicted an epidemic in"/>
   <result pre="in Africa similar to that currently seen in Europe and" exact="the USA." post="However, reported data do not confirm these predictions. Several"/>
   <result pre="infected individuals with SARS-CoV-2 included in a nationwide cohort in" exact="South Korea" post="(24 January to 9 April 2020), 6350 individuals (62%)"/>
   <result pre="were asymptomatic [4]. In another study on 1096 individuals in" exact="Kuwait" post="(24 February to 20 April 2020), 46.3% of the"/>
   <result pre="other Asian countries and western European countries and then to" exact="the USA" post="in Spring 2020 (Fig.Â 1). COVID-19 later spread to"/>
   <result pre="1). COVID-19 later spread to Central and South America, Africa," exact="India" post="and Southeastern Asia. Cities most affected by COVID-19 are"/>
   <result pre="are either those with intensive international economic exchanges, such as" exact="Hong Kong," post="Milan, London, Paris, Madrid, and more recently New York,"/>
   <result pre="the ranking of countries that faced the most severe outbreaks," exact="Italy" post="was the first to be very strongly impacted in"/>
   <result pre="reported deaths [12]. The five most affected African countries are" exact="South Africa" post="with 37Â 525 cases and 792 deaths, Nigeria with"/>
   <result pre="are South Africa with 37Â 525 cases and 792 deaths," exact="Nigeria" post="with 11Â 166 cases and 315 deaths, Algeria with"/>
   <result pre="792 deaths, Nigeria with 11Â 166 cases and 315 deaths," exact="Algeria" post="with 9733 cases and 673 deaths, Ghana with 8548"/>
   <result pre="and 315 deaths, Algeria with 9733 cases and 673 deaths," exact="Ghana" post="with 8548 cases and 38 deaths, and Cameroon with"/>
   <result pre="673 deaths, Ghana with 8548 cases and 38 deaths, and" exact="Cameroon" post="with 6789 cases and 203 deaths, on June 4,"/>
   <result pre="cases of SARS-CoV-2 were reported on 14 February 2020 in" exact="Egypt" post="for north Africa [13] and on 27 February 2020"/>
   <result pre="for north Africa [13] and on 27 February 2020 in" exact="Nigeria" post="for Sub-Saharan Africa [14]. Gilbert etÂ al. estimated the"/>
   <result pre="Africa according to air travel flows from infected provinces of" exact="China" post="to Africa and taking into account the African countries'"/>
   <result pre="detect COVID-19 [15]. The countries at highest importation risk from" exact="China" post="were Egypt, Algeria, South Africa, Nigeria and Ethiopia. Three"/>
   <result pre="countries at highest importation risk from China were Egypt, Algeria," exact="South Africa," post="Nigeria and Ethiopia. Three of these countries (South Africa,"/>
   <result pre="highest importation risk from China were Egypt, Algeria, South Africa," exact="Nigeria" post="and Ethiopia. Three of these countries (South Africa, Algeria"/>
   <result pre="Africa, Nigeria and Ethiopia. Three of these countries (South Africa," exact="Algeria" post="and Nigeria) are the three most affected countries and"/>
   <result pre="Algeria and Nigeria) are the three most affected countries and" exact="Egypt" post="has recorded 28Â 615 cases and 1088 deaths. Another"/>
   <result pre="high risk of exposure in countries of small size like" exact="Mauritius" post="(1Â 097Â 013 estimated cases for 1Â 265Â 303"/>
   <result pre="303 inhabitants; 335 confirmed cases on 4 June 2020) or" exact="Equatorial Guinea" post="(819Â 289 estimated cases for 1Â 308Â 974 inhabitants;"/>
   <result pre="inhabitants; 335 confirmed cases on 4 June 2020) or Equatorial" exact="Guinea" post="(819Â 289 estimated cases for 1Â 308Â 974 inhabitants;"/>
   <result pre="to 21 May (86 cases on 4 June 2020) in" exact="Angola" post="and 23 April and 3 May (1486 cases on"/>
   <result pre="two to 34 countries [19]. However, on 1 April 2020," exact="South Africa" post="had tested more than 47Â 000 people, but Zimbabwe"/>
   <result pre="South Africa had tested more than 47Â 000 people, but" exact="Zimbabwe" post="had tested only 316 people and Namibia only 306"/>
   <result pre="000 people, but Zimbabwe had tested only 316 people and" exact="Namibia" post="only 306 [20]. The lack of health-care infrastructure capable"/>
   <result pre="confirmed cases in Africa [21]. The most affected country is" exact="South Africa" post="with 37Â 525 cases and 792 deaths (4 June"/>
   <result pre="instance, COVID-19 has been reported in the same areas in" exact="Brazil" post="where cases of dengue fever, with similar clinical and"/>
   <result pre="to handwashing in 2019 [31]. In three African countries (Nigeria," exact="Ethiopia" post="and Democratic Republic of the Congo), more than 50"/>
   <result pre="2019 [31]. In three African countries (Nigeria, Ethiopia and Democratic" exact="Republic of" post="the Congo), more than 50 million people were estimated"/>
   <result pre="Ebola virus disease became pillars in the COVID-19 response in" exact="Uganda" post="[35] and Ebola standard operating procedures were updated for"/>
   <result pre="Ebola standard operating procedures were updated for COVID-19 in the" exact="Democratic Republic of Congo" post="[36]. Delay in the dynamic of the COVID-19 epidemic"/>
   <result pre="standard operating procedures were updated for COVID-19 in the Democratic" exact="Republic of" post="Congo [36]. Delay in the dynamic of the COVID-19"/>
   <result pre="procedures were updated for COVID-19 in the Democratic Republic of" exact="Congo" post="[36]. Delay in the dynamic of the COVID-19 epidemic"/>
   <result pre="in Africa could be linked to less frequent exchanges between" exact="China" post="and Africa (a mono-directional exchanges model where it is"/>
   <result pre="is especially the Chinese who travel to Africa) than between" exact="China" post="and Europe or China and the USA (a bi-directional"/>
   <result pre="who travel to Africa) than between China and Europe or" exact="China" post="and the USA (a bi-directional exchange model). According to"/>
   <result pre="to Africa) than between China and Europe or China and" exact="the USA" post="(a bi-directional exchange model). According to air travel flows"/>
   <result pre="model). According to air travel flows from infected provinces in" exact="China" post="to Africa and the African country's capacity to detect"/>
   <result pre="to detect COVID-19, Gilbert etÂ al. estimated that Egypt, Algeria," exact="South Africa," post="Nigeria and Ethiopia presented the highest risk of importation"/>
   <result pre="COVID-19, Gilbert etÂ al. estimated that Egypt, Algeria, South Africa," exact="Nigeria" post="and Ethiopia presented the highest risk of importation of"/>
   <result pre="etÂ al. estimated that Egypt, Algeria, South Africa, Nigeria and" exact="Ethiopia" post="presented the highest risk of importation of cases of"/>
   <result pre="the highest risk of importation of cases of COVID-19 from" exact="China" post="[15]. Another study, based on the analysis of 388Â"/>
   <result pre="The only African countries identified as at high risk were" exact="Ethiopia" post="(28th) and South Africa (40th). Egypt, Algeria and Nigeria"/>
   <result pre="countries identified as at high risk were Ethiopia (28th) and" exact="South Africa" post="(40th). Egypt, Algeria and Nigeria were estimated as at"/>
   <result pre="high risk were Ethiopia (28th) and South Africa (40th). Egypt," exact="Algeria" post="and Nigeria were estimated as at low risk (59th,"/>
   <result pre="were Ethiopia (28th) and South Africa (40th). Egypt, Algeria and" exact="Nigeria" post="were estimated as at low risk (59th, 88th and"/>
   <result pre="compared with 2005 (31 million)) [38], while according to the" exact="China" post="Tourism Academy, about six million Chinese visitors were recorded"/>
   <result pre="million visitors [42]. The Chinese workers typically fly back to" exact="China" post="once or twice a year, and especially for Chinese"/>
   <result pre="for Chinese New Year. In contrast, many Chinese tourists leave" exact="China" post="for Europe on vacation days before the Chinese New"/>
   <result pre="have been linked to Chinese tourists or people returning from" exact="China" post="[43,44]: on 29 January 2020, two Chinese tourists from"/>
   <result pre="January 2020, two Chinese tourists from Hubei province coming to" exact="Italy" post="[45]; on 27 January 2020, a Chinese individual working"/>
   <result pre="been in contact with their parents from Wuhan before visiting" exact="Germany" post="[46]; on 4 February 2020, a Belgian individual returning"/>
   <result pre="travel rather than China. The first case of SARS-CoV-2 in" exact="Nigeria" post="was identified in an Italian citizen on 27 February"/>
   <result pre="2020 [14], in Italian people on 1 March 2020 in" exact="South Africa" post="[50], in an Italian citizen on 17 February 2020"/>
   <result pre="[50], in an Italian citizen on 17 February 2020 in" exact="Algeria" post="[51], in a French citizen on 24 February 2020"/>
   <result pre="[51], in a French citizen on 24 February 2020 in" exact="Cameroon" post="[52], in a French resident in Dakar returning from"/>
   <result pre="Cameroon [52], in a French resident in Dakar returning from" exact="France" post="on 26 February 2020 in Senegal [53], in two"/>
   <result pre="in Dakar returning from France on 26 February 2020 in" exact="Senegal" post="[53], in two citizens arrived in Ghana from Norway"/>
   <result pre="February 2020 in Senegal [53], in two citizens arrived in" exact="Ghana" post="from Norway and Turkey on 12 March 2020 [54],"/>
   <result pre="in Senegal [53], in two citizens arrived in Ghana from" exact="Norway" post="and Turkey on 12 March 2020 [54], in a"/>
   <result pre="[53], in two citizens arrived in Ghana from Norway and" exact="Turkey" post="on 12 March 2020 [54], in a Kenyan citizen"/>
   <result pre="12 March 2020 [54], in a Kenyan citizen returning to" exact="Kenya" post="from the USA via London on 5 March 2020"/>
   <result pre="2020 [54], in a Kenyan citizen returning to Kenya from" exact="the USA" post="via London on 5 March 2020 [55] and in"/>
   <result pre="2020 [55] and in a Japanese man who travelled from" exact="Japan" post="to Burkina Faso before coming to Ethiopia on 13"/>
   <result pre="and in a Japanese man who travelled from Japan to" exact="Burkina Faso" post="before coming to Ethiopia on 13 March 2020 [56]."/>
   <result pre="who travelled from Japan to Burkina Faso before coming to" exact="Ethiopia" post="on 13 March 2020 [56]. Among the countries most"/>
   <result pre="countries most affected by COVID-19, only the first case in" exact="Egypt" post="came from Wuhan [57]. First cases of SARS-CoV-2 were"/>
   <result pre="SARS-CoV-2 were identified preferably in Januaryâ€&quot;February 2020 in Europe and" exact="the USA," post="and in Februaryâ€&quot;March in Africa and Brazil. The dynamic"/>
   <result pre="the number of deaths evolved in a similar way in" exact="South Africa" post="and Algeria during the first 30 days to what"/>
   <result pre="deaths evolved in a similar way in South Africa and" exact="Algeria" post="during the first 30 days to what was observed"/>
   <result pre="during the first 30 days to what was observed in" exact="the USA," post="Brazil or Europe. The dynamic was slower in Nigeria,"/>
   <result pre="first 30 days to what was observed in the USA," exact="Brazil" post="or Europe. The dynamic was slower in Nigeria, Cameroon,"/>
   <result pre="Europe. The dynamic was slower in Nigeria, Cameroon, Senegal, Ghana," exact="Kenya" post="and Ethiopia than in South Africa or Algeria (Fig.Â"/>
   <result pre="dynamic was slower in Nigeria, Cameroon, Senegal, Ghana, Kenya and" exact="Ethiopia" post="than in South Africa or Algeria (Fig.Â 2d). Fig.Â"/>
   <result pre="in Nigeria, Cameroon, Senegal, Ghana, Kenya and Ethiopia than in" exact="South Africa" post="or Algeria (Fig.Â 2d). Fig.Â 2 Comparison of the"/>
   <result pre="Senegal, Ghana, Kenya and Ethiopia than in South Africa or" exact="Algeria" post="(Fig.Â 2d). Fig.Â 2 Comparison of the cumulative total"/>
   <result pre="reported in the first 200 days of the pandemic in" exact="the USA," post="Brazil, France, Italy and the most affected countries in"/>
   <result pre="200 days of the pandemic in the USA, Brazil, France," exact="Italy" post="and the most affected countries in Africa (South Africa,"/>
   <result pre="countries in Africa (South Africa, Algeria, Nigeria, Cameroon, Senegal, Ghana," exact="Kenya" post="and Ethiopia). (a) Cumulative deaths for the 12 selected"/>
   <result pre="in 2019 was higher in Southeastern Asia (7%), in Central" exact="America" post="(7%) and South America (9%) but remained much lower"/>
   <result pre="in Southeastern Asia (7%), in Central America (7%) and South" exact="America" post="(9%) but remained much lower than in Europe (21%)"/>
   <result pre="temperatures above 20Â°C [68]. However, a study carried out in" exact="Australia" post="suggested that even with high temperature, COVID-19 could persist"/>
   <result pre="countries most affected by COVID-19 on 4 June 2020 are" exact="South Africa" post="(37Â 525 cases and 792 deaths), Algeria (9733 cases"/>
   <result pre="2020 are South Africa (37Â 525 cases and 792 deaths)," exact="Algeria" post="(9733 cases and 673 deaths) and Egypt (28Â 615"/>
   <result pre="and 792 deaths), Algeria (9733 cases and 673 deaths) and" exact="Egypt" post="(28Â 615 cases and 1088 deaths), which belong to"/>
   <result pre="Agents55202010592432081636 9Accessedhttps://www.euro.who.int/en/health-topics/health-emergencies/international-health-regulations/news/news/2020/2/2019-ncov-outbreak-is-an-emergency-of-international-concern 10Accessedhttps://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 11ChirumboloS.Might the many positive COVID19 subjects in" exact="Italy" post="have been caused by resident bat-derived zoonotic Î²-coronaviruses instead"/>
   <result pre="of the dual COVID-19 and Ebola epidemics in the Democratic" exact="Republic of" post="Congoâ€&quot;priorities for achieving controlAm J Trop Med Hyg103202059760232563272 37HaiderN.YavlinskyA.SimonsD.OsmanA.Y.NtoumiF.ZumlaA.Passengersâ€™"/>
   <result pre="in ItalyClin Microbiol Infect26202095495632229288 46BohmerM.M.BuchholzU.CormanV.M.HochM.KatzK.MarosevicD.V.Investigation of a COVID-19 outbreak in" exact="Germany" post="resulting from a single travel-asspciated primary case: a case"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7508070\results\search\country\results.xml">
   <result pre="in patients with COVID-19 infection. However, a recent study from" exact="China" post="reports that almost 31.6% of patients with COVID-19 had"/>
   <result pre="disease 2019 control measures for ophthalmology clinics based on a" exact="Singapore" post="center experienceJAMA Ophthalmology2020doi: 101001/jamaophthalmol 20201288 4RomanowskiEGYatesKAShanksRMQKowalskiRPIs Benzalkonium chloride (BAK)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7508551\results\search\country\results.xml">
   <result pre="â€˜bush meatâ€™ is a primary food source, in places like" exact="Congo" post="basin. Several species such as chiropteran flying foxes, carnivores,"/>
   <result pre="like SARS, Ebola, SARS-CoV-2 etc [45]. Ebola outbreak in the" exact="Congo" post="Basin and Gabon in 1990s was linked to humans"/>
   <result pre="SARS-CoV-2 etc [45]. Ebola outbreak in the Congo Basin and" exact="Gabon" post="in 1990s was linked to humans being exposed to"/>
   <result pre="example, in 2003, the monkeypox disease was introduced in to" exact="United States," post="when African Gambian giant rats were shipped along with"/>
   <result pre="acute viral disease found endemic in West African countries of" exact="Sierra Leone," post="Nigeria, Liberia, and Guinea, was transmitted to humans because"/>
   <result pre="and emerging infections, as was documented in SARS in Southern" exact="China" post="and the H1N1 flu in Mexico. Other examples include"/>
   <result pre="been reported. By then, the disease had heavily affected Guinea," exact="Liberia" post="and Sierra Leone. It infected more than 28,000 people"/>
   <result pre="By then, the disease had heavily affected Guinea, Liberia and" exact="Sierra Leone." post="It infected more than 28,000 people and killed 11,300."/>
   <result pre="the rise of zoonoses as happened in the reforested north-eastern" exact="United States" post="and in virgin forests of agro-ecosystems in the Central"/>
   <result pre="in virgin forests of agro-ecosystems in the Central Valley of" exact="Costa Rica" post="[91,92] when deforestation and hunting reduced the number of"/>
   <result pre="of global warming and climate change [93,94] According to reports," exact="China" post="is the worldâ€™s largest CO2 emitter contributing about 25%"/>
   <result pre="two centuries spreading from Asia to Europe, Africa, and North" exact="America" post="[98]. 2.13 Illegal wildlife trade Illegal wildlife trade is"/>
   <result pre="they are spreading to new geographic zones. For example, in" exact="the USA" post="and Europe, the changes in distribution patterns observed in"/>
   <result pre="and competition [[111], [112], [113], [114], [115]]. For example, in" exact="the United States," post="the incidence of West Nile encephalitis was supposed to"/>
   <result pre="competition [[111], [112], [113], [114], [115]]. For example, in the" exact="United States," post="the incidence of West Nile encephalitis was supposed to"/>
   <result pre="outbreaks in Africa of, for example the Ebola in the" exact="Congo" post="basin and SARS in east Asian countries weredue changes"/>
   <result pre="of Lyme disease and other Ixodes tick-borne infections in North" exact="America" post="and EuropeBr. Med. Bull.543199864765810326291 36KovatsR.S.Campbell-LendrumD.H.McMichelA.J.WoodwardA.CoxJ.S.H.Early effects of climate change:"/>
   <result pre="evolution of pathogenic coronavirusesNat. Rev. Microbiol.173201918119230531947 50WilkieD.S.CarpenterJ.F.Bushmeat hunting in the" exact="Congo" post="Basin: an assessment of impacts and options for mitigationBiodivers."/>
   <result pre="World: Workshop Summary2010National Academies Press(US)Washington (DC) 102CyranoskiD.Did pangolins spread the" exact="China" post="coronavirus to peopleNature.NEWS202007 February 2020https://www.nature.com/articles/d41586-020-00364-2 103SosnowskiM.C.PetrossianG.A.Luxury fashion wildlife contraband"/>
   <result pre="PhD in Biochemistry from Rajiv Gandhi Centre for Biotechnology, Kerala," exact="India" post="and post-doctoral research in viral immunology from Emory Vaccine"/>
   <result pre="PhD in Project Management from Indian Institute of Technology, Bombay," exact="India" post="and Masterâ€™s in Industrial Engineering from PSG College of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7509820\results\search\country\results.xml">
   <result pre="that similar to SARS and MERS appeared in Wuhan, Hubei," exact="China" post="and has been confirmed that has the ability of"/>
   <result pre="with Type A are from outside East Asia, mainly in" exact="the United States" post="and Australia, and two-thirds of American samples are infected"/>
   <result pre="Type A are from outside East Asia, mainly in the" exact="United States" post="and Australia, and two-thirds of American samples are infected"/>
   <result pre="there are about 234,030 new cases with lung cancer in" exact="the United States" post="in 2018 [19]. There are a large number of"/>
   <result pre="are about 234,030 new cases with lung cancer in the" exact="United States" post="in 2018 [19]. There are a large number of"/>
   <result pre="N Engl J Med. 2020;382(13):1199â€&quot;207. 10.1056/NEJMoa2001316. 8.CohenJNormileDNew SARS-like virus in" exact="China" post="triggers alarmScience (New York, NY)2020367647523423510.1126/science.367.6475.234 9.ZhuNet al.A novel coronavirus"/>
   <result pre="health concernLancet (London, England)20203951022347047310.1016/S0140-6736(20)30185-9 12.MunsterVJet al.A novel coronavirus emerging in" exact="China" post="- key questions for impact assessmentN Engl J Med2020382869210.1056/NEJMp200092931978293"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life Sci202063345746010.1007/s11427-020-1637-532009228 33.WrappDet al.Cryo-EM structure of the 2019-nCoV spike"/>
   <result pre="patientsEur J Cancer Care200716646247410.1111/j.1365-2354.2006.00739.x 87.LiuSet al.Online mental health services in" exact="China" post="during the COVID-19 outbreakLancet Psychiatry202074e17e1810.1016/S2215-0366(20)30077-832085841 88.FujitaKet al.Impact of COVID-19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7510719\results\search\country\results.xml">
   <result pre="Spread in 6 Metropolitan Regions, Germany, 2001â€&quot;20181 Drug Resistance Spread," exact="Germany" post="StecherMelanie2ChaillonAntoine2StephanChristophKnopsElenaKohmerNikoLehmannClaraEberleJosefBognerJohannesSpinnerChristoph D.Eis-HÃ¼bingerAnna MariaWasmuthJan-ChristianSchÃ¤ferGuidoBehrensGeorgMehtaSanjay R.VehreschildJÃ¶rg JanneHoeniglMartin[], [], [], [], [],"/>
   <result pre="antimicrobial resistance ART antiretroviral therapy mutations phylogenetic analysis public health" exact="Germany" post="The use of antiretroviral therapy (ART) has shown markedly"/>
   <result pre="prevalence of drug resistance mutations (DRMs) are not available in" exact="Germany" post="(6); the reported prevalence of transmitted HIV-1 DRMs differ"/>
   <result pre="participants were included. Most were male (82.9%; 1,158/1,397), originated from" exact="Germany" post="(69.6%; 972/1,397), and infected with HIV-1 subtype B (72.8%;"/>
   <result pre="146 (10.5) 36 (24.7) 1 (0.7) Country of origin 0.104" exact="Germany" post="972 (69.6) 181 (18.6) 17 (1.7) Other 373 (26.7)"/>
   <result pre="GlassTR, SterneJA, SchneiderMP, De GeestS, NiccaD, FurrerH, et al.; collab:" exact="Swiss" post="HIV Cohort Study. Self-reported nonadherence to antiretroviral therapy as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7511040\results\search\country\results.xml">
   <result pre="AlShoaibi âˆ™ Department of Medicine, King Abdulaziz University, Jeddah 21441," exact="Saudi Arabia" post="âˆ™ naeem.alshoaibi@gmail.com ppub: 2020-9epub: 2020-10-10405365372365-372received: 2020-4-20accepted: 2020-7-04(C) , 2020This"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7511596\results\search\country\results.xml">
   <result pre="Rm207, 2/F, Postgraduate Education Centre, Prince of Wales Hospital, Shatin," exact="Hong Kong." post="Tel: (852) 2252â€�8812. (sslee@cuhk.edu.hk) epub: 2020-9-9collection: 2020-923910.1002/jia2.v23.9e25618received: 2020-1-30rev-recd: 2020-7-29accepted:"/>
   <result pre="infected cases occurred in HIVâ€�positive MSM. In some places, notably" exact="Hong Kong," post="India and Indonesia, the predominant subtype in sexually acquired"/>
   <result pre="occurred in HIVâ€�positive MSM. In some places, notably Hong Kong," exact="India" post="and Indonesia, the predominant subtype in sexually acquired HCV"/>
   <result pre="people who inject drugs (PWID) and MSM were shown in" exact="Australia" post="and New Zealand, whereas overlapping risk elicited from a"/>
   <result pre="inject drugs (PWID) and MSM were shown in Australia and" exact="New Zealand," post="whereas overlapping risk elicited from a small number of"/>
   <result pre="in Tokyo, Taipei and Guangxi. MSMâ€�specific clusters were identified in" exact="Hong Kong," post="Taipei and Hubei. Conclusions The distribution of sexually acquired"/>
   <result pre="2009 within HIVâ€�infected MSM in the Western countries, including the" exact="United Kingdom," post="the Netherlands and Germany [9]. The infection risks brought"/>
   <result pre="HIVâ€�infected MSM in the Western countries, including the United Kingdom," exact="the Netherlands" post="and Germany [9]. The infection risks brought on by"/>
   <result pre="MSM in the Western countries, including the United Kingdom, the" exact="Netherlands" post="and Germany [9]. The infection risks brought on by"/>
   <result pre="the Western countries, including the United Kingdom, the Netherlands and" exact="Germany" post="[9]. The infection risks brought on by the complex"/>
   <result pre="of 1994 to 2016, originated from nine countries/cities, namely Australia," exact="New Zealand," post="China, Hong Kong, India, Indonesia, Japan, Pakistan and Taiwan."/>
   <result pre="2016, originated from nine countries/cities, namely Australia, New Zealand, China," exact="Hong Kong," post="India, Indonesia, Japan, Pakistan and Taiwan. Of 3211 HCVâ€�viraemic"/>
   <result pre="namely Australia, New Zealand, China, Hong Kong, India, Indonesia, Japan," exact="Pakistan" post="and Taiwan. Of 3211 HCVâ€�viraemic subjects in these 13"/>
   <result pre="sequencing N, HCVâ€�viraemica N, eligible b , c %, HIV+" exact="Australia" post="&amp;amp; New Zealand 237 111 (18) 100 Bartlett et"/>
   <result pre="HCVâ€�viraemica N, eligible b , c %, HIV+ Australia &amp;amp;" exact="New Zealand" post="237 111 (18) 100 Bartlett et al. [13] Crossâ€�sectional"/>
   <result pre="Clinic/hospital HCVâ€�mono &amp;amp; HIV/HCVâ€�coinfected individuals C/E2 237 111 (18)d 100" exact="China" post="1209 86 (3) â‰¥60.5 Jiao et al. [14] Crossâ€�sectional"/>
   <result pre="Clinic/hospital HCVâ€�mono &amp;amp; HIV/HCVâ€�coinfected individuals C/E1, NS5B 99 11 NA" exact="Hong Kong" post="58 40 100 Sun et al. [20] Crossâ€�sectional study"/>
   <result pre="Kong 58 40 100 Sun et al. [20] Crossâ€�sectional study" exact="Hong Kong" post="2010 to 2016 Clinic/hospital HIV/HCVâ€�coinfected individuals NS5B 58 40"/>
   <result pre="2010 to 2016 Clinic/hospital HIV/HCVâ€�coinfected individuals NS5B 58 40 100" exact="India" post="70 15 NA Medhi et al. [21] Crossâ€�sectional study"/>
   <result pre="2008 Clinic/hospital Individuals with liver diseases NS5B 70 15 NA" exact="Indonesia" post="7 6 0 Hadikusumo et al. [22] Crossâ€�sectional study"/>
   <result pre="study Surabaya 2012 Screening Transgender individuals NS5B 7 6 0" exact="Japan" post="98 64 100 Ishida et al. [23] Crossâ€�sectional study"/>
   <result pre="to 2015 Clinic/hospital HIVâ€�positive individuals Full genome 98 64 100" exact="Pakistan" post="1364 78 NA Ahmad et al. [24] Crossâ€�sectional study"/>
   <result pre="2007 to 2009 Clinic/hospital HCVâ€�infected individuals 5â€™NC 1364 78 NA" exact="Taiwan" post="168 149 100 Sun et al. [25] Cohort study"/>
   <result pre="history of injection drug use in parentheses deighteen samples from" exact="Australia" post="who acquired HCV by injection drug use (as determined"/>
   <result pre="HCV were similar to those in the general population in" exact="Australia" post="and New Zealand [13], China [14, 15, 16, 17,"/>
   <result pre="similar to those in the general population in Australia and" exact="New Zealand" post="[13], China [14, 15, 16, 17, 18, 19], Japan"/>
   <result pre="in the general population in Australia and New Zealand [13]," exact="China" post="[14, 15, 16, 17, 18, 19], Japan [23], Pakistan"/>
   <result pre="New Zealand [13], China [14, 15, 16, 17, 18, 19]," exact="Japan" post="[23], Pakistan [24] and Taiwan [20, 25, 26] (TableÂ"/>
   <result pre="[13], China [14, 15, 16, 17, 18, 19], Japan [23]," exact="Pakistan" post="[24] and Taiwan [20, 25, 26] (TableÂ 3). Table"/>
   <result pre="15, 16, 17, 18, 19], Japan [23], Pakistan [24] and" exact="Taiwan" post="[20, 25, 26] (TableÂ 3). Table 2 Genotype distribution"/>
   <result pre="% 6a, % 6n, % Other, % Phylogenetic analysis Reference" exact="Australia" post="&amp;amp; New Zealand 111 31.5 55.9 1b/2/4/6: 12.6 Multiâ€�centre"/>
   <result pre="% 6n, % Other, % Phylogenetic analysis Reference Australia &amp;amp;" exact="New Zealand" post="111 31.5 55.9 1b/2/4/6: 12.6 Multiâ€�centre 2004 to 2015"/>
   <result pre="(18)b 31.5 55.9 1b/2/4/6: 12.6 Yes Bartlett et al. [13]" exact="China" post="86 3.5 39.5 18.6 9.3 14.0 11.6 2.3 6u:"/>
   <result pre="11 18.2 36.4 27.3 9.1 9.1 Yang et al. [19]" exact="Hong Kong" post="40 7.5 2.5 87.5 2.5 2010 to 2016 40"/>
   <result pre="40 7.5 2.5 87.5 2.5 Yes Sun et al. [20]" exact="India" post="15 40.0 6.7 33.3 1c: 20.0 Multiâ€�centre 2005 to"/>
   <result pre="15 40.0 6.7 33.3 1c: 20.0 Medhi et al. [21]" exact="Indonesia" post="6 33.3 66.7 Surabaya 2012 6 33.3 66.7 Hadikusumo"/>
   <result pre="66.7 Surabaya 2012 6 33.3 66.7 Hadikusumo et al. [22]" exact="Japan" post="64 76.6 10.9 7.8 3.1 1.6 Tokyo 1997 to"/>
   <result pre="76.6 10.9 7.8 3.1 1.6 Yes Ishida et al. [23]" exact="Pakistan" post="78 17.9 67.9 12.8 4b: 1.3 Lahore 2007 to"/>
   <result pre="78 17.9 67.9 12.8 4b: 1.3 Ahmad et al. [24]" exact="Taiwan" post="149 4.0 27.5 54.4 2.7 10.7 0.7 Taipei 1994"/>
   <result pre="history of injection drug use in parentheses beighteen samples from" exact="Australia" post="who acquired HCV by injection drug use (as determined"/>
   <result pre="(95% CI) Genotype (%) N Genotype (%) N Genotype (%)" exact="Australia" post="1.0 (0.7â€&quot;1.0) 230 (178â€&quot;244) 3 (42.2%), 1a (18.5%) 111"/>
   <result pre="1a (64.2%), 3a (35.8%) [13] 134 3 (36.2%), 1a (29.0%)" exact="New Zealand" post="1.0 (0.6â€&quot;1.3) 48 (30â€&quot;62) 1a (44.0%), 3 (35.0%) /"/>
   <result pre="48 (30â€&quot;62) 1a (44.0%), 3 (35.0%) / Data not available" exact="China" post="0.7 (0.5â€&quot;0.8) 9795 (6675â€&quot;10832) 1b (56.8%), 2 (15.4%) 86"/>
   <result pre="15, 16, 17, 18, 19] 126 6 (42.1%), 3 (38.1%)" exact="Hong Kong" post="0.2 (0.1â€&quot;0.3) 15 (6â€&quot;22) 1b (62.4%), 6 (27.4%) 40"/>
   <result pre="(79.5%), 1a (11.4%) [20] 273 6a (52.4%), 1b (38.5%) [28]" exact="India" post="0.5 (0.4â€&quot;0.8) 6245 (4748â€&quot;10957) 3 (64.1%), 1b (16.1%) 15"/>
   <result pre="(40.0%), 4a (33.3%) [21] 73 3 (54.7%), 1a (15.1%)/1b (15.1%)" exact="Indonesia" post="0.5 (0.2â€&quot;0.8) 1289 (443â€&quot;2046) 1b (39.0%), 1a (25.6%) 6"/>
   <result pre="3k (66.7%), 1b (33.3%) [22] 30 1a (46.6%), 3 (26.6%)" exact="Japan" post="0.7 (0.3â€&quot;0.8) 857 (364â€&quot;1024) 1b (64.8%), 2 (34.2%) 64"/>
   <result pre="(34.2%) 64 1b (76.6%), 2a (10.9%) [23] 9 2 (100%)" exact="Pakistan" post="3.8 (2.8â€&quot;3.9) 7172 (5363â€&quot;7487) 3 (79.0%), 1a (4.8%) 78"/>
   <result pre="3a (67.9%), 1a (17.9%) [24] 28 2 (35.7%), 3 (28.6%)" exact="Taiwan" post="2.1 (1.3â€&quot;3.7) 489 (310â€&quot;877) 1b (45.5%), 2 (39.5%) 149"/>
   <result pre="in the following paragraphs. In a multiâ€�centre study conducted in" exact="Australia" post="and New Zealand during 2004 to 2015 on 237"/>
   <result pre="following paragraphs. In a multiâ€�centre study conducted in Australia and" exact="New Zealand" post="during 2004 to 2015 on 237 subjects, some 41%"/>
   <result pre="between MSM and PWID that had facilitated HCV transmission in" exact="Australia" post="[13]. In a study conducted in Tokyo during 1997"/>
   <result pre="the infection sexually, the same subtypes were only identified in" exact="Australia" post="[13, 27]. Some similarities were also noted in India"/>
   <result pre="in Australia [13, 27]. Some similarities were also noted in" exact="India" post="(subtype 1a) [21], Indonesia (genotype 3) [22], Japan (genotype"/>
   <result pre="Some similarities were also noted in India (subtype 1a) [21]," exact="Indonesia" post="(genotype 3) [22], Japan (genotype 2) [23] and Pakistan"/>
   <result pre="noted in India (subtype 1a) [21], Indonesia (genotype 3) [22]," exact="Japan" post="(genotype 2) [23] and Pakistan (genotype 3) [24, 27]"/>
   <result pre="[21], Indonesia (genotype 3) [22], Japan (genotype 2) [23] and" exact="Pakistan" post="(genotype 3) [24, 27] (TableÂ 3). In the remaining"/>
   <result pre="indicating the absence of a shared network with PWID. In" exact="Hong Kong," post="a large monophyletic cluster of subtype 3a (nÂ =Â"/>
   <result pre="to be a unique variant for sexually acquired HCV in" exact="Indonesia" post="[22]. 3.4 Intercity and crossâ€�border transmission of sexually acquired"/>
   <result pre="small number of samples. Five intercity clusters were described in" exact="Australia" post="(4 and 1 of subtype 1a and 3a respectively),"/>
   <result pre="within a large cluster of subtype 3a among MSM in" exact="Hong Kong" post="[20]. 4 DISCUSSION This is the first review that"/>
   <result pre="locations. A unique dominant subtype circulating among MSM existed in" exact="Hong Kong" post="(subtype 3a) [20], India (subtype 1a) [21] and Indonesia"/>
   <result pre="circulating among MSM existed in Hong Kong (subtype 3a) [20]," exact="India" post="(subtype 1a) [21] and Indonesia (subtype 3k among transgender"/>
   <result pre="Hong Kong (subtype 3a) [20], India (subtype 1a) [21] and" exact="Indonesia" post="(subtype 3k among transgender women) [22, 26]. Probably due"/>
   <result pre="in the Asiaâ€�Pacific region, two different patterns were observed. In" exact="Australia" post="and New Zealand, the extensive coâ€�clustering of HCV between"/>
   <result pre="Asiaâ€�Pacific region, two different patterns were observed. In Australia and" exact="New Zealand," post="the extensive coâ€�clustering of HCV between MSM and PWID"/>
   <result pre="identified two intergroup clusters within the domestic transmission network in" exact="Australia" post="[9, 13]. Considering the substantial overlap between the two"/>
   <result pre="similar set of prevalent genotypes among MSM and PWID in" exact="Australia" post="and New Zealand [13, 27]. On the other hand,"/>
   <result pre="of prevalent genotypes among MSM and PWID in Australia and" exact="New Zealand" post="[13, 27]. On the other hand, limited coâ€�clustering of"/>
   <result pre="definitively the occurrence of any intergroup spread in countries/cities outside" exact="Australia" post="and New Zealand. Similar to Europe where there were"/>
   <result pre="occurrence of any intergroup spread in countries/cities outside Australia and" exact="New Zealand." post="Similar to Europe where there were dissimilar subsets of"/>
   <result pre="networks were also seen in locations in the Asiaâ€�Pacific like" exact="China" post="[14, 15, 16, 17, 18, 19] and Hong Kong"/>
   <result pre="Asiaâ€�Pacific like China [14, 15, 16, 17, 18, 19] and" exact="Hong Kong" post="[20, 28]. In perspective, evidence suggests the existence of"/>
   <result pre="the existence of the widespread overlapping risk of HCV in" exact="Australia" post="and New Zealand but not in Asian countries. Interpretation"/>
   <result pre="of the widespread overlapping risk of HCV in Australia and" exact="New Zealand" post="but not in Asian countries. Interpretation of HCV molecular"/>
   <result pre="[13, 17, 20]. The identification of a related sequence between" exact="Taiwan" post="and Hong Kong could have been driven by occasional"/>
   <result pre="20]. The identification of a related sequence between Taiwan and" exact="Hong Kong" post="could have been driven by occasional travels without the"/>
   <result pre="transmission event, since the founding subtypes in different regions of" exact="Australia" post="were largely identical [13, 40]. Demonstration of HCV spread"/>
   <result pre="HIVâ€�positive MSM, based on ten included studies in Australia, China," exact="Japan" post="and Taiwan, averaged 9.42% (range: 1.2% to 24.3%), which"/>
   <result pre="21, 7.7%, 2.6% to 18%) but slightly lower than North" exact="America" post="(nÂ =Â 9, 10.7%, 4.3% to 17.9%) [8]. In"/>
   <result pre="considerably higher estimates were also recorded in some Asian countries:" exact="Myanmar" post="(1.0%), Laos (1.1%), Indonesia (2.1%), Cambodia (2.3%), Thailand (2.7%)"/>
   <result pre="estimates were also recorded in some Asian countries: Myanmar (1.0%)," exact="Laos" post="(1.1%), Indonesia (2.1%), Cambodia (2.3%), Thailand (2.7%) and Vietnam"/>
   <result pre="also recorded in some Asian countries: Myanmar (1.0%), Laos (1.1%)," exact="Indonesia" post="(2.1%), Cambodia (2.3%), Thailand (2.7%) and Vietnam (6.1%) [3,"/>
   <result pre="in some Asian countries: Myanmar (1.0%), Laos (1.1%), Indonesia (2.1%)," exact="Cambodia" post="(2.3%), Thailand (2.7%) and Vietnam (6.1%) [3, 42]. Furthermore,"/>
   <result pre="Asian countries: Myanmar (1.0%), Laos (1.1%), Indonesia (2.1%), Cambodia (2.3%)," exact="Thailand" post="(2.7%) and Vietnam (6.1%) [3, 42]. Furthermore, the high"/>
   <result pre="(1.0%), Laos (1.1%), Indonesia (2.1%), Cambodia (2.3%), Thailand (2.7%) and" exact="Vietnam" post="(6.1%) [3, 42]. Furthermore, the high prevalence of HIV"/>
   <result pre="transmission network between MSM and PWID was noted only in" exact="Australia" post="and New Zealand, while overlapping risk elicited from a"/>
   <result pre="between MSM and PWID was noted only in Australia and" exact="New Zealand," post="while overlapping risk elicited from a small number of"/>
   <result pre="Ka Shing Institute of Health Sciences, The Chinese University of" exact="Hong Kong," post="for rendering technical support throughout the conduction of this"/>
   <result pre="for the AIDS Trust Fund (project code: MSS302R) of the" exact="Hong Kong" post="Government. References REFERENCES 1RosenHR. Chronic hepatitis C infection. N"/>
   <result pre="with phylogenetic clustering of recent hepatitis C virus infection in" exact="Australia" post="and New Zealand from 2004 to 2015. J Int"/>
   <result pre="clustering of recent hepatitis C virus infection in Australia and" exact="New Zealand" post="from 2004 to 2015. J Int AIDS Soc. 2019;22(2):e25222.30746864"/>
   <result pre="Molecular epidemiology of acute HCV infection in HIVâ€�positive patients from" exact="Hong Kong," post="Taipei, Tokyo. Liver Int. 2019;39(6):1044â€&quot;51.30770636 21MedhiS, GoswamiB, DasAK, SinghTB,"/>
   <result pre="of hepatitis C virus infection among injecting drug users in" exact="Hong Kong." post="J Med Virol. 2011;83:1187â€&quot;94.21567422 29VogelM, van de LaarT, KupferB,"/>
   <result pre="reveals a still active outbreak and a strong link to" exact="the Netherlands." post="Clin Microbiol Infect. 2020266:785.e1â€&quot;785.e4.32035235 32ProvineWB. Ernst Mayr: genetics and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7512176\results\search\country\results.xml">
   <result pre="Infectious Disease, Imperial College London, Imperial College NIHR BRC, London," exact="United Kingdom" post="CaliendoAngela M.Editor[], Address correspondence to David Bonsall, david.bonsall@bdi.ox.ac.uk. David"/>
   <result pre="samples collected from individuals attending 10 large urban clinics in" exact="Zambia" post="as part of the HPTN 071-2 study (PopART Phylogenetics)."/>
   <result pre="been approved by the ethics committees of the University of" exact="Zambia" post="(c/o the Zambian ministry of health) and of the"/>
   <result pre="transported to a central research laboratory (ZAMBART facility) in Lusaka," exact="Zambia" post="using a mobile âˆ’20Â°C freezer, and then shipped to"/>
   <result pre="freezer, and then shipped to the sequencing laboratory in the" exact="United Kingdom." post="Samples were processed approximately in order of collection and"/>
   <result pre="viral genotype. Specificity for all known HIV subtypes circulating in" exact="Zambia" post="was achieved using a probe-based, rather than a primer-based,"/>
   <result pre="epidemiology. The method has proven robust to field conditions in" exact="Zambia" post="and carries no additional testing burden for patients. Sequencing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7513902\results\search\country\results.xml">
   <result pre="7793Department of Pharmacy, School of Basic Medicine and Clinical Pharmacy," exact="China" post="Pharmaceutical University, [2], grid.268191.50000 0001 0490 2480Department of Pharmacy"/>
   <result pre="In the absence of specific vaccines and antiviral drugs, the" exact="China" post="National Health Commission has released a series of COVID-19"/>
   <result pre="a literature search to synthesize the extracted data. Results The" exact="China" post="National Health Commission guidelines recommend 15 oral and injectable"/>
   <result pre="2]. To guide the diagnosis and treatment of COVID-19, the" exact="China" post="National Health Commission (NHC) has successively released and updated"/>
   <result pre="were identified through searching in PubMed, Embase, the Cochrane Library," exact="China" post="National Knowledge Infrastructure (CNKI), and the China Wanfang database."/>
   <result pre="the Cochrane Library, China National Knowledge Infrastructure (CNKI), and the" exact="China" post="Wanfang database. Both CNKI and China Wanfang are the"/>
   <result pre="Infrastructure (CNKI), and the China Wanfang database. Both CNKI and" exact="China" post="Wanfang are the two most authoritative, comprehensive, and the"/>
   <result pre="either English or Chinese. We also searched websites of the" exact="China" post="NHC, and the China Food and Drug Administration (CFDA)"/>
   <result pre="We also searched websites of the China NHC, and the" exact="China" post="Food and Drug Administration (CFDA) to identify relevant information."/>
   <result pre="â€œrandomized controlled trialâ€�). Our research team includes members practicing in" exact="the US" post="and China and are fluent in English and Chinese."/>
   <result pre="Our research team includes members practicing in the US and" exact="China" post="and are fluent in English and Chinese. Relevant information"/>
   <result pre="Table 3. Table 2 Traditional Chinese medicine recommended by the" exact="China" post="National Health Commission treatment guidelines Compounds Recommended scope of"/>
   <result pre="The active constituents of traditional Chinese medicine recommended by the" exact="China" post="National Health Commission treatment guidelines Compounds Active constituents of"/>
   <result pre="organ dysfunction syndromes (MODS) [30]. Xuebijing is widely used in" exact="China" post="for treating severe pneumonia, chronic obstructive pulmonary disease, acute"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7514029\results\search\country\results.xml">
   <result pre="Epidemiology and Control, School of Public Health, The University of" exact="Hong Kong," post="Hong Kong Special Administrative Region, ChinaHobmanTom C.Editor[], University of"/>
   <result pre="Control, School of Public Health, The University of Hong Kong," exact="Hong Kong" post="Special Administrative Region, ChinaHobmanTom C.Editor[], University of Alberta, CANADA"/>
   <result pre="careful monitoring of safety signals in these vulnerable populations. In" exact="the United States," post="it is recommended that infants be immunized at six"/>
   <result pre="monitoring of safety signals in these vulnerable populations. In the" exact="United States," post="it is recommended that infants be immunized at six"/>
   <result pre="were anecdotally more widely used than in Europe and North" exact="America" post="[82, 83]. The global dissemination of the resistant viruses"/>
   <result pre="large-scale pediatric vaccination program initiated 5 years ago in the" exact="United Kingdom" post="generated much enthusiasm but has reported mixed-effects on disease"/>
   <result pre="do not necessarily represent the views of the NIH or" exact="the US" post="government. References References 1ErbeldingEJ, et al. (2018) A Universal"/>
   <result pre="LafontBA, MillerMA, &amp;amp; SimonsenL (2005) Multinational impact of the 1968" exact="Hong Kong" post="influenza pandemic: evidence for a smoldering pandemic. J Infect"/>
   <result pre="Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in" exact="the United States." post="J Infect Dis218(2):189â€&quot;196. 10.1093/infdis/jix63429361005 51GagnonA, et al. (2018) Pandemic"/>
   <result pre="Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the" exact="United States." post="J Infect Dis218(2):189â€&quot;196. 10.1093/infdis/jix63429361005 51GagnonA, et al. (2018) Pandemic"/>
   <result pre="al. (2005) Impact of influenza vaccination on seasonal mortality in" exact="the US" post="elderly population. Arch Intern Med165(3):265â€&quot;72. 10.1001/archinte.165.3.26515710788 78ArinaminpathyN, et al."/>
   <result pre="Estimating Direct and Indirect Protective Effect of Influenza Vaccination in" exact="the United States." post="Am J Epidemiol186(1):92â€&quot;100. 10.1093/aje/kwx03728369163 79ReadAF, et al. (2015) Imperfect"/>
   <result pre="Direct and Indirect Protective Effect of Influenza Vaccination in the" exact="United States." post="Am J Epidemiol186(1):92â€&quot;100. 10.1093/aje/kwx03728369163 79ReadAF, et al. (2015) Imperfect"/>
   <result pre="Elife4: e0796910.7554/eLife.0796926329460 104ChowellG, MillerMA, &amp;amp; ViboudC (2007) Seasonal influenza in" exact="the United States," post="France, and Australia: transmission and prospects for control. Epidemiol"/>
   <result pre="e0796910.7554/eLife.0796926329460 104ChowellG, MillerMA, &amp;amp; ViboudC (2007) Seasonal influenza in the" exact="United States," post="France, and Australia: transmission and prospects for control. Epidemiol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7517057\results\search\country\results.xml">
   <result pre="worldwide. Key words Humans Factors (Re)emerging infectious disease Coronavirus Funding" exact="Japan" post="Society for the Promotion of ScienceJP19H05737YamamotoTaro Funding http://dx.doi.org/10.13039/501100001691Japan Society"/>
   <result pre="virus in 1999 [12], the outbreak of chikungunya fever in" exact="Italy" post="in 2007 [13], the epidemic of Q fever in"/>
   <result pre="Italy in 2007 [13], the epidemic of Q fever in" exact="the Netherlands" post="[14, 15], the outbreak of severe acute respiratory syndrome"/>
   <result pre="in 2007 [13], the epidemic of Q fever in the" exact="Netherlands" post="[14, 15], the outbreak of severe acute respiratory syndrome"/>
   <result pre="A/H1N1 in 1997 in Hong-Kong [20], A/H7N7 in 2004 in" exact="the US" post="[21], A/H7N2 in 2007 in the UK [22], and"/>
   <result pre="A/H7N2 in 2007 in the UK [22], and A/H7N9 in" exact="China" post="[20, 23]. Recently, major outbreaks of Ebola virus disease"/>
   <result pre="with 28,603 cases and 11,310 deaths [24], and in the" exact="Democratic Republic of Congo" post="(DRC) from 2018 to 2020, with 3444 cases and"/>
   <result pre="28,603 cases and 11,310 deaths [24], and in the Democratic" exact="Republic of" post="Congo (DRC) from 2018 to 2020, with 3444 cases"/>
   <result pre="and 11,310 deaths [24], and in the Democratic Republic of" exact="Congo" post="(DRC) from 2018 to 2020, with 3444 cases and"/>
   <result pre="or tourists in Europe, such as chikungunya and dengue in" exact="France" post="and Italy as well as COVID-19 in France from"/>
   <result pre="in Europe, such as chikungunya and dengue in France and" exact="Italy" post="as well as COVID-19 in France from China [35â€&quot;37]."/>
   <result pre="dengue in France and Italy as well as COVID-19 in" exact="France" post="from China [35â€&quot;37]. Cross-border movements of people, as well"/>
   <result pre="France and Italy as well as COVID-19 in France from" exact="China" post="[35â€&quot;37]. Cross-border movements of people, as well as trade"/>
   <result pre="from two mountain hawk eagles that were illegally imported from" exact="Thailand" post="in an airline cabin carry-on baggage to Belgium [38]."/>
   <result pre="imported from Thailand in an airline cabin carry-on baggage to" exact="Belgium" post="[38]. The risk of infectious diseases rises with the"/>
   <result pre="were resistant to penicillin and beta-lactam antibiotics in hospitals in" exact="the United States" post="(US) and were responsible for approximately 19,000 deaths in"/>
   <result pre="resistant to penicillin and beta-lactam antibiotics in hospitals in the" exact="United States" post="(US) and were responsible for approximately 19,000 deaths in"/>
   <result pre="and 1993, the incidence of vancomycin-resistant enterococci increased 20-fold in" exact="the US," post="and in 1997, the susceptibility of Staphylococcus aureus to"/>
   <result pre="the susceptibility of Staphylococcus aureus to vancomycin decreased in both" exact="the US" post="and Japan [99]. In the European Union (EU), approximately"/>
   <result pre="Staphylococcus aureus to vancomycin decreased in both the US and" exact="Japan" post="[99]. In the European Union (EU), approximately 15â€&quot;50% of"/>
   <result pre="that started in December 2019 in Wuhan, Hubei Province of" exact="China" post="[159â€&quot;161]. The disease rapidly spread from Wuhan to the"/>
   <result pre="disease rapidly spread from Wuhan to the rest of Mainland" exact="China" post="and other parts of the world, affecting at least"/>
   <result pre="177]. In some countries, such as Japan, Singapore, China, and" exact="South Korea," post="cultural habitsâ€&quot;such as the culture of mask-wearing, minimal personal"/>
   <result pre="the other hand, in Western countries such as Italy, Spain," exact="the United States," post="the United Kingdom, France, and many other countries where"/>
   <result pre="other hand, in Western countries such as Italy, Spain, the" exact="United States," post="the United Kingdom, France, and many other countries where"/>
   <result pre="Western countries such as Italy, Spain, the United States, the" exact="United Kingdom," post="France, and many other countries where the culture of"/>
   <result pre="overcrowded cities in countries such as China, Japan, India, and" exact="the United States." post="Additionally, countries with a high proportion of elderly populations,"/>
   <result pre="cities in countries such as China, Japan, India, and the" exact="United States." post="Additionally, countries with a high proportion of elderly populations,"/>
   <result pre="countries with a high proportion of elderly populations, such as" exact="Italy" post="and Spain, have a higher risk of severity [181],"/>
   <result pre="in controlling the outbreak by adopting an effective mitigating strategy." exact="South Korea" post="and other countries, such as Singapore, Hong Kong, Japan,"/>
   <result pre="mitigating strategy. South Korea and other countries, such as Singapore," exact="Hong Kong," post="Japan, and Germany, quickly responded after the first case"/>
   <result pre="Additionally, countries that have experienced SARS-like epidemics such as Taiwan," exact="Hong Kong," post="and South Korea have successfully prevented the spread of"/>
   <result pre="have experienced SARS-like epidemics such as Taiwan, Hong Kong, and" exact="South Korea" post="have successfully prevented the spread of COVID-19 from China"/>
   <result pre="South Korea have successfully prevented the spread of COVID-19 from" exact="China" post="by adopting preventive measures such as travel bans, closing"/>
   <result pre="and Prevention COVID-19 Coronavirus disease 2019 CTX-M Cefotaxime-M DRC The" exact="Democratic Republic of the Congo" post="EIDs Emerging infectious diseases EVD Ebola virus disease FWBDs"/>
   <result pre="Prevention COVID-19 Coronavirus disease 2019 CTX-M Cefotaxime-M DRC The Democratic" exact="Republic of" post="the Congo EIDs Emerging infectious diseases EVD Ebola virus"/>
   <result pre="disease 2019 CTX-M Cefotaxime-M DRC The Democratic Republic of the" exact="Congo" post="EIDs Emerging infectious diseases EVD Ebola virus disease FWBDs"/>
   <result pre="SDGs Sustainable Development Goals TB Tuberculosis EU European Union UK" exact="United Kingdom" post="of Great Britain and Northern Ireland UNHCR The Office"/>
   <result pre="Goals TB Tuberculosis EU European Union UK United Kingdom of" exact="Great Britain" post="and Northern Ireland UNHCR The Office of the United"/>
   <result pre="European Union UK United Kingdom of Great Britain and Northern" exact="Ireland" post="UNHCR The Office of the United Nations High Commissioner"/>
   <result pre="of the United Nations High Commissioner for Refugees US The" exact="United States" post="VBDs Vector-borne diseases WHO World Health Organization Publisherâ€™s Note"/>
   <result pre="by Grants-in-Aid for Scientific Research (KAKENHI No. JP19K24679) from the" exact="Japan" post="Society for the Promotion of Science. Availability of data"/>
   <result pre="may 19971998Washington, DCNational Academies Press 11.MarwickCInvestigators present latest findings on" exact="Hong Kong" post="'bird flu' to the FDAJAMA.19982796436449496966 12.collab: Centers for Disease"/>
   <result pre="Sci U S A20041011356136114745020 22.Avian influenza A/(H7N2) outbreak in the" exact="United Kingdom." post="Euro Surveill. 2007;12:E070531.2. 23.GaoRCaoBHuYFengZWangDHuWet al.Human infection with a novel"/>
   <result pre="corona virus disease 2019 epidemicWorld J Clin Cases2020865265732149049 178.Grace H." exact="Japan" post="may have beaten coronavirus without lockdowns or mass testing."/>
   <result pre="27 Jul 2020. 181.Sara B. 5 reasons the coronavirus hit" exact="Italy" post="so hard. 2020. https://theconversation.com/5-reasons-the-coronavirus-hit-italy-so-hard-134636. Accessed 27 Jul 2020. 182.RaghupathiVAn"/>
   <result pre="JohnRKKingAde JongDBodie-CollinsMSquiresSGTamTWBorder screening for SARSEmerg Infect Dis20051161015705315 199.Jason B. How" exact="South Korea" post="reined in the outbreak without shutting everything down. 2020."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7517806\results\search\country\results.xml">
   <result pre="Keywords People who inject drugs PWID HCV Respondent-driven sampling RDS" exact="Thailand" post="Background Seventy-one million people, or 1% of the world"/>
   <result pre="to the â€˜Golden Triangleâ€™,â€‰the area where the borders of Thailand," exact="Myanmar" post="and Laos meet. It isâ€‰known as one of the"/>
   <result pre="â€˜Golden Triangleâ€™,â€‰the area where the borders of Thailand, Myanmar and" exact="Laos" post="meet. It isâ€‰known as one of the worldâ€™s largest"/>
   <result pre="safety measures and on encouraging PWID to seek addiction treatment." exact="Thailand" post="has recently received a voluntary licence for generic DAAs"/>
   <result pre="to information and screening. The complex HCV care pathway in" exact="Thailand" post="makes it difficult for PWID to access diagnosis and"/>
   <result pre="diseases. The prevalence of HCV in the general population in" exact="Thailand" post="is estimated, based on scant data, at 1â€&quot;3% [15â€&quot;17],"/>
   <result pre="number of PWID ranges from 40,300 to 160,500 individuals in" exact="Thailand" post="[21â€&quot;23] and from 3000 to 4000 individuals in Chiang"/>
   <result pre="The few studies estimating HCV screening uptake among PWID in" exact="Thailand" post="found low rates coupled with low awareness of the"/>
   <result pre="reliant on international donors [40]. Most studies among PWID in" exact="Thailand" post="have used convenience-based sampling methods, recruiting participants from harm"/>
   <result pre="centres should be provided. As with other studies conducted in" exact="Thailand" post="[29, 30, 57], we found very low HCV awareness"/>
   <result pre="in PWID [57]. One study among male PWID in Southern" exact="Thailand" post="has evaluated the uptake of HCV testing at 39.5%"/>
   <result pre="of their answers. Our study, along with others conducted in" exact="Thailand" post="[8, 48], shows that it is possible to conduct"/>
   <result pre="virus infectionJ Hepatol2014611S45S5710.1016/j.jhep.2014.07.02725086286 17.WasitthankasemRet al.Decreasing hepatitis C virus infection in" exact="Thailand" post="in the past decade: evidence from the 2014 National"/>
   <result pre="C infection in high risk people who inject drugs in" exact="China" post="and ThailandHepat Res Treat2014201429695810.1155/2014/29695824860664 27.MartinMet al.Hepatitis C virus infection"/>
   <result pre="Minozzi S, Reed J, Vickerman P, Hagan H, French C," exact="Jordan" post="A, Degenhardt L, Hope V, Hutchinson S, Maher L,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7518803\results\search\country\results.xml">
   <result pre="trials. Previously, the Ministry of Science and Technology of the" exact="People's Republic of China" post="officially announced that both favipiravir and remdesivir were scheduled"/>
   <result pre="Previously, the Ministry of Science and Technology of the People's" exact="Republic of" post="China officially announced that both favipiravir and remdesivir were"/>
   <result pre="Ministry of Science and Technology of the People's Republic of" exact="China" post="officially announced that both favipiravir and remdesivir were scheduled"/>
   <result pre="the major cause of the rapid spread of SARS-CoV-2 in" exact="China" post="[76]. Therefore, increasing the identification and isolation of asymptomatic"/>
   <result pre="work was supported by the 10.13039/501100001809National Natural Science Foundation of" exact="China" post="(No. 81800338). Declaration of competing interest The authors declare"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci." exact="China" post="Life Sci.63202045746032009228 3ZhouP.YangX..WangX.HuB.ZhangL.A pneumonia outbreak associated with a new"/>
   <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci." exact="China" post="Life Sci.63202036437432048163 29DonoghueM.HsiehF.BaronasE.GodboutK.GosselinM.StaglianoN.A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7518973\results\search\country\results.xml">
   <result pre="socially, politically, and economically [8]. In mid-2012, MERS emerged in" exact="Saudi Arabia" post="due to human exposure to MERS-CoV-infected dromedary camels [9]."/>
   <result pre="in the countries of the Gulf Cooperation [56], and in" exact="Oman" post="[41], based on human-animal health committees, enhancement of capacities"/>
   <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003Lancet.36220031353135810.1016/S0140-6736(03)14630-214585636 4BaileyE.S.FieldhouseJ.K.ChoiJ.Y.GrayG.C.A mini review of the"/>
   <result pre="Sci. Int. Rep.2202010009010.1016/j.fsir.2020.100090 72RoosaK.LeeY.LuoR.KirpichA.RothenbergR.HymanJ.M.Real-time forecasts of the COVID-19 epidemic in" exact="China" post="from February 5th to February 24th, 2020Infect. Dis. Model5202025626310.1016/j.idm.2020.02.00232110742"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7520644\results\search\country\results.xml">
   <result pre="of COVID-19 varies widely between countries ranging from 0.2% in" exact="Germany" post="to 7.7 % in Italy[25]. The differences in the"/>
   <result pre="or bradykinin-associated angioedema is not controlled[60]. Although various clinics in" exact="China" post="have proclaimed the use of mesenchymal stromal/stem cells (MSCs)"/>
   <result pre="2020 Specialty type: Biochemistry and molecular biology Country/Territory of origin:" exact="Bulgaria" post="Peer-review reportâ€™s scientific quality classification Grade A (Excellent): 0"/>
   <result pre="disease 2019 (COVID-19) situation report-48. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsnÂ¼16f7ccef_4 2ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWcollab:" exact="China" post="Novel Coronavirus Investigating and Research TeamA Novel Coronavirus from"/>
   <result pre="J (Engl)20201331025103132044814 12MunsterVJKoopmansMvan DoremalenNvan RielDde WitEA Novel Coronavirus Emerging in" exact="China" post="- Key Questions for Impact AssessmentN Engl J Med202038269269431978293"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7524442\results\search\country\results.xml">
   <result pre="COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation (CYCOV) R NCT04324528 Freiburg," exact="Germany" post="Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring"/>
   <result pre="COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation (CYCOV-II) IP NCT04385771 Freiburg," exact="Germany" post="Early Haemadsorption in Major Burns IP NCT04195126 Pecs, Hungary"/>
   <result pre="Freiburg, Germany Early Haemadsorption in Major Burns IP NCT04195126 Pecs," exact="Hungary" post="Adsorbtion of Cytokines Early in Septic Shock: the ACESS"/>
   <result pre="Early in Septic Shock: the ACESS Study C NCT02288975 Szeged," exact="Hungary" post="Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring"/>
   <result pre="in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation (CYTER) R NCT03685383 Freiburg," exact="Germany" post="Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated"/>
   <result pre="CAR-T Associated Cytokine Release Syndrome (CRS) (CYTORELEASE) IP NCT04048434 Hannover," exact="Germany" post="Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on"/>
   <result pre="Cytokine Removal Hemofilter on Severe Septic Shock R NCT03974386 Taipei," exact="Taiwan" post="Safety and Efficacy of Hyperbaric Oxygen for ARDS in"/>
   <result pre="Patients With COVID-19 (COVID-19-HBO) R NCT04327505 Gelsenkirchen, Regensburg, Germany*** Blekinge," exact="Sweden" post="Phase 2/3 Efficacy and Safety of Tocilizumab in the"/>
   <result pre="the Treatment of SARS-Cov-2 Related Pneumonia (TOSCA) R NCT04332913 L'Aquila," exact="Italy" post="Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation"/>
   <result pre="Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation R NCT03533101 Monterrey," exact="Mexico" post="** Study of the Tocilizumab Optimization Timing for CART19"/>
   <result pre="Syndrome in Patients With COVID-19 Infection (RESPIRE) IP NCT04361903 Pisa," exact="Italy" post="Treatment of SARS Caused by COVID-19 With Ruxolitinib R"/>
   <result pre="of SARS Caused by COVID-19 With Ruxolitinib R NCT04334044 Huixquilucan," exact="Mexico" post="Phase 1/2 Baricitinib in Symptomatic Patients Infected by COVID-19:"/>
   <result pre="by COVID-19: an Open-label, Pilot Study. (BARI-COVID) IP NCT04320277 Prato," exact="Italy" post="Phase 2/3 Baricitinib Therapy in COVID-19 C NCT04358614 Prato,"/>
   <result pre="Italy Phase 2/3 Baricitinib Therapy in COVID-19 C NCT04358614 Prato," exact="Italy" post="Phase 2/3 Effects of Free Fatty Acids and 3-hydroxybutyrate"/>
   <result pre="Glucose, Lipid Metabolism and Intracellular Signals C NCT01752348 Aarhus C," exact="Denmark" post="Prevention and Treatment With Calcifediol of COVID-19 Induced Acute"/>
   <result pre="of COVID-19 Induced Acute Respiratory Syndrome (COVIDIOL) IP NCT04366908 CÃ³rdoba," exact="Spain" post="Phase 2 The Effect of D3 on Selected Cytokines"/>
   <result pre="Storm in the Covid-19 Uninfected Jordanian People IP NCT04476745 Amman," exact="Jordan" post="A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7525249\results\search\country\results.xml">
   <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan city of" exact="China" post="in late December 2019 and identified as a novel"/>
   <result pre="diagnosis of SARS-CoV-2 infection [6]. As of 19 April 2020," exact="the US" post="Food and Drug Administration had approved more than 37"/>
   <result pre="[47]. According to the report, an individual with COVID-19 in" exact="the USA" post="exhibited substantial improvement when treated with remdesivir intravenously [48],"/>
   <result pre="remdesivir treatment. At present, four clinical trials recruiting patients in" exact="the USA" post="and two other trials enrolled only in China have"/>
   <result pre="in the USA and two other trials enrolled only in" exact="China" post="have been registered on ClinicalTrials.gov: NCT04257656 (serious disease) and"/>
   <result pre="[55]. Ivermectin Ivermectin is a broad-spectrum antiparasitic drug approved by" exact="the US" post="Food and Drug Administration. In recent years, it has"/>
   <result pre="spread of viruses among populations. Molecular based laboratory testing Currently," exact="the US" post="CDC recommended strategy for identifying individuals with COVID-19 is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7527651\results\search\country\results.xml">
   <result pre="[56]. Countries without universal policies of BCG vaccination (e.g. Italy," exact="the Netherlands" post="and the USA) seem more severely affected by COVID-19"/>
   <result pre="Countries without universal policies of BCG vaccination (e.g. Italy, the" exact="Netherlands" post="and the USA) seem more severely affected by COVID-19"/>
   <result pre="against COVID-19 in thousands of healthcare workers and elderly, in" exact="the Netherlands," post="Australia and other countries, will provide evidence to support"/>
   <result pre="in thousands of healthcare workers and elderly, in the Netherlands," exact="Australia" post="and other countries, will provide evidence to support or"/>
   <result pre="32 million cases of influenza resulting in 32â€Š000 deaths in" exact="the USA" post="[61]. H1N1, the virus behind the 1918 and 2009"/>
   <result pre="associated with influenza has been described among TB patients in" exact="South Africa" post="[107]. TB patients have a similar prevalence of viral"/>
   <result pre="TB during the influenza pandemics of 1889 and 1918 in" exact="Switzerland" post="[112]. It has also been reported that summer influenza"/>
   <result pre="increase in reported TB cases [113]. Conversely, a report from" exact="Thailand" post="did not demonstrate a worse outcome for patients with"/>
   <result pre="with concurrent influenza and TB [114], and another report from" exact="Indonesia" post="did not demonstrate a correlation between antibodies against influenza"/>
   <result pre="be a protective factor against TB in elderly persons in" exact="Taiwan" post="[116]. The exact impact of concurrent influenza and TB"/>
   <result pre="the responses to the 1918 influenza pandemic showed that in" exact="the USA," post="cities that introduced early social isolation measures experienced a"/>
   <result pre="education and secondary school Primary school Day care or nursery" exact="Austria" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Belgium âœ&quot;"/>
   <result pre="or nursery Austria âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Belgium" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Bulgaria âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Belgium âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Bulgaria" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Croatia âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; Bulgaria âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Croatia" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Cyprus âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Croatia âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Cyprus" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Czech Republic âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; Cyprus âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Czech Republic" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Denmark âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; Czech Republic âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Denmark" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Estonia âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; Denmark âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Estonia" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Finland âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Estonia âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Finland" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; France âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Finland âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="France" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Germany âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; France âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Germany" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Greece âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; Germany âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Greece" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Hungary âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; Greece âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Hungary" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Iceland âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Hungary âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Iceland" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Ireland âœ&quot; âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Iceland âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Ireland" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Italy"/>
   <result pre="âœ&quot; Ireland âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Italy" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Latvia âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; Italy âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Latvia" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Liechtenstein âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Latvia âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Liechtenstein" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Lithuania âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; Liechtenstein âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Lithuania" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Luxembourg âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Lithuania âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Luxembourg" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Malta âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; Luxembourg âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Malta" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Netherlands âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; Malta âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Netherlands" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Norway âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; Netherlands âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Norway" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Poland âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; Norway âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Poland" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Portugal âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; Poland âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Portugal" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Romania âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; Portugal âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Romania" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Slovakia âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; Romania âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Slovakia" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Slovenia âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; âœ&quot; Slovakia âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Slovenia" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Spain âœ&quot; âœ&quot;"/>
   <result pre="âœ&quot; âœ&quot; âœ&quot; Slovenia âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Spain" post="âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; Sweden"/>
   <result pre="âœ&quot; Spain âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;" exact="Sweden" post="âœ&quot; âœ&quot; âœ&quot; UK âœ&quot; âœ&quot; âœ&quot; âœ&quot; âœ&quot;"/>
   <result pre="Health Research senior investigator award. C.W.M. Ong is funded by" exact="Singapore" post="National Medical Research Council (NMRC/TA/0042/2015, CSAINV17nov014); National University Health"/>
   <result pre="National Medical Research Council (NMRC/TA/0042/2015, CSAINV17nov014); National University Health System," exact="Singapore" post="(NUHS/RO/2017/092/SU/01, CFGFY18P11, NUHS/RO/2020/042/RO5+5/ad-hoc/1); National Centre for Infectious Diseases, Singapore"/>
   <result pre="System, Singapore (NUHS/RO/2017/092/SU/01, CFGFY18P11, NUHS/RO/2020/042/RO5+5/ad-hoc/1); National Centre for Infectious Diseases," exact="Singapore" post="(STPRG-FY19-003); and is recipient of the Young Investigator Award,"/>
   <result pre="SahaS, et al.Dynamics of influenza seasonality at sub-regional levels in" exact="India" post="and implications for vaccination timing. PLoS One2015; 10: e0124122."/>
   <result pre="Prevention. Estimated influenza illnesses, medical visits, hospitalizations, and deaths in" exact="the United States" post="â€&quot; 2018â€&quot;2019 influenza season2020www.cdc.gov/flu/about/burden/2018-2019.htmlDate last accessed: April 6, 2020."/>
   <result pre="Estimated influenza illnesses, medical visits, hospitalizations, and deaths in the" exact="United States" post="â€&quot; 2018â€&quot;2019 influenza season2020www.cdc.gov/flu/about/burden/2018-2019.htmlDate last accessed: April 6, 2020."/>
   <result pre="from 2009 pandemic influenza A virus and bacterial coinfection in" exact="the United States." post="Crit Care Med2012; 40: 1487â€&quot;1498. doi:10.1097/CCM.0b013e3182416f2322511131 63EspositoS, MolteniCG, DalenoC,"/>
   <result pre="2009 pandemic influenza A virus and bacterial coinfection in the" exact="United States." post="Crit Care Med2012; 40: 1487â€&quot;1498. doi:10.1097/CCM.0b013e3182416f2322511131 63EspositoS, MolteniCG, DalenoC,"/>
   <result pre="Middle East respiratory syndrome coronavirus infection: a single-center experience in" exact="Saudi Arabia." post="Int J Infect Dis2014; 29: 301â€&quot;306. doi:10.1016/j.ijid.2014.09.00325303830 73Al-TawfiqJA, HinediK,"/>
   <result pre="individuals aged â‰¥â€‰15 years hospitalized with severe respiratory illness in" exact="South Africa," post="2010â€&quot;2016. Open Forum Infect Dis2019; 6: ofz020. doi:10.1093/ofid/ofz02030906797 107WalazaS,"/>
   <result pre="et al.Excess mortality associated with influenza among tuberculosis deaths in" exact="South Africa," post="1999â€&quot;2009. PLoS One2015; 10: e0129173. doi:10.1371/journal.pone.012917326076197 108MhimbiraF, HizaH, MbubaE,"/>
   <result pre="RasmussenSA, et al.H1N1 2009 influenza virus infection during pregnancy in" exact="the USA." post="Lancet2009; 374: 451â€&quot;458. doi:10.1016/S0140-6736(09)61304-019643469 143CorderoE, AydilloT, FarinasMC, et al.Immunosuppressed"/>
   <result pre="linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg," exact="South Africa." post="BMC Health Serv Res2018; 18: 973. doi:10.1186/s12913-018-3762-x30558670 160GolettiD, SanduzziA,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7533207\results\search\country\results.xml">
   <result pre="East respiratory syndrome (MERS). A study from a hospital in" exact="Hong Kong" post="evaluated the efficacy of convalescent plasma therapy in the"/>
   <result pre="the time of plasma infusion. During the MERS epidemic in" exact="South Korea," post="convalescent plasma therapy was performed for several MERS patients,"/>
   <result pre="of convalescent plasma therapy for COVID-19 patients was conducted in" exact="China" post="[28]. To evaluate the efficacy and adverse effects of"/>
   <result pre="used in the study. However, because the COVID-19 epidemic in" exact="China" post="was contained while enrolment was in progress, the trial"/>
   <result pre="events Reference Cases Controls Cases Controls Abolghasemi et al., 2020" exact="Iran" post="Nonrandomized, controlled study 115 74 14.8% died 24.3% died"/>
   <result pre="study 2 100% improved None [23] Duan et al., 2020" exact="China" post="Nonrandomized, non-controlled study 10 100% improved within 3 days"/>
   <result pre="1 evanescent facial red spot [20] Li et al., 2020" exact="China" post="Randomized, controlled study 53 51 51.9% improved within 28"/>
   <result pre="events within hours after transfusion [28] Perotti et al., 2020" exact="Italy" post="Nonrandomized, non-controlled study 46 6.5% died within 7 days"/>
   <result pre="improved within 14 days None [25] Shen et al., 2020" exact="China" post="Nonrandomized, non-controlled study 5 100% improved None [21] Zeng"/>
   <result pre="study 5 100% improved None [21] Zeng et al., 2020" exact="China" post="Nonrandomized, non-controlled study 6 15 83% died 93% died"/>
   <result pre="83% died 93% died None [24] Zhang et al., 2020" exact="China" post="Nonrandomized, non-controlled study 4 100% improved None [22] COVID-19,"/>
   <result pre="in reported cases and clinical trials on coronaviruses [72021222328]. A" exact="United States" post="(US) study of 5,000 hospitalized adults with severe or"/>
   <result pre="conducted in patients with severe or life-threatening disease. According to" exact="the US" post="Food and Drug Administration (FDA) guidelines, investigators in the"/>
   <result pre="the US Food and Drug Administration (FDA) guidelines, investigators in" exact="the US" post="wishing to study the use of convalescent plasma in"/>
   <result pre="if available (when measurement of neutralizing antibody titers is available," exact="the US" post="FDA recommends neutralizing antibody titers of at least 1:160."/>
   <result pre="(WHO)Coronavirus disease (COVID-19) pandemicAccessed 3 August 2020Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 2GuanWJNiZYHuYLiangWHOuCQHeJXLiuLShanHLeiCLHuiDSCDuBLiLJZengGYuenKYChenRCTangCLWangTChenPYXiangJLiSYWangJLLiangZJPengYXWeiLLiuYHuYHPengPWangJMLiuJYChenZLiGZhengZJQiuSQLuoJYeCJZhuSYZhongNScollab:" exact="China" post="Medical Treatment Expert Group for Covid-19Clinical characteristics of coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7533477\results\search\country\results.xml">
   <result pre="Previous Epidemics Rare instances of neurological manifestations from patients in" exact="Taiwan" post="were reported by Tsai etÂ al.45, which included five"/>
   <result pre="cerebrovascular events following COVID-19 infection.54 Outside China, a study from" exact="France" post="by Helms etÂ al.55 found neurologic manifestations in 14%"/>
   <result pre="closely by headache (13.1%). In a large study conducted across" exact="China" post="throughout January 2020, which included 1099 patients, headache was"/>
   <result pre="associations are seen in more than one study from China," exact="South Korea," post="France, Italy, Iran, UK and USA, and it is"/>
   <result pre="succumbed subsequently to respiratory failure.4 In divergent studies conducted across" exact="China" post="during this pandemic, cerebrovascular events have been reported in"/>
   <result pre="number of stroke patients undergoing imaging at a centre in" exact="the United States" post="compared to the pre-pandemic times.129 Patients will be unable"/>
   <result pre="of stroke patients undergoing imaging at a centre in the" exact="United States" post="compared to the pre-pandemic times.129 Patients will be unable"/>
   <result pre="needed to avert a mental health crisisâ€�.141 A study from" exact="Ethiopia" post="showed a threefold increase in the prevalence of depression"/>
   <result pre="in the prevalence of depression in April 2020.141 Surveys across" exact="China" post="have reported soaring rates of depression (50%), anxiety (45%)"/>
   <result pre="(45%) and insomnia (34%) among healthcare personnel.153 Similar studies from" exact="Canada" post="recorded a mighty 47% of healthcare workers in need"/>
   <result pre="accountable for this psychological upheaval.154â€&quot;156 Within a week of lockdowns," exact="India" post="registered a 20% increase in overall mental health issues.154"/>
   <result pre="addressed are the rising incidences of addiction and substance abuse." exact="Canada" post="has reported an increase in alcohol intake in about"/>
   <result pre="exception. On 27 January 2020, the central health authority of" exact="China" post="issued the â€œPrinciples for Emergency Psychological Crisis Intervention for"/>
   <result pre="expert consensus were made available to frontline healthcare professionals in" exact="China" post="at the end of February 2020.166 Extensive adoption of"/>
   <result pre="psychological support.153,167 Considering these recent events, it is imperative that" exact="China" post="shares its protocol of emergency mental health services with"/>
   <result pre="Middle East respiratory syndrome coronavirus infection: a single-center experience in" exact="Saudi Arabia." post="Int J Infect Dis.2014;29:301â€&quot;6.25303830 54.LiY, WangM, ZhouY, et al.Acute"/>
   <result pre="intensive care with COVID-19 at a teaching hospital in the" exact="United Kingdom." post="Thromb Res.2020;191:76â€&quot;7.32402996 89.LodigianiC, IapichinoG, CarenzoL, et al.Venous and arterial"/>
   <result pre="GoyalMS, HamiltonS, AlbersGW.Collateral effect of Covid-19 on stroke evaluation in" exact="the United States." post="N Engl J Med. 2020;NEJMc2014816. 130.SasannejadC, ElyEW, LahiriS.Long-term cognitive"/>
   <result pre="HamiltonS, AlbersGW.Collateral effect of Covid-19 on stroke evaluation in the" exact="United States." post="N Engl J Med. 2020;NEJMc2014816. 130.SasannejadC, ElyEW, LahiriS.Long-term cognitive"/>
   <result pre="2019. JAMA Netw Open. 2020;3(3):e203976.32202646 154.Mental illness, suicides rise in" exact="India" post="during Covid-19 crisis [Internet]. RFI. 2020. Available from: http://www.rfi.fr/en/international/20200514-mental-illness-suicides-on-the-rise-in-india-during-covid-19-lockdown;"/>
   <result pre="2003;168(10):1245â€&quot;51.12743065 158.TamCW, PangEP, LamLC, ChiuHF.Severe acute respiratory syndrome (SARS) in" exact="Hong Kong" post="in 2003: stress and psychological impact among frontline healthcare"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7534958\results\search\country\results.xml">
   <result pre="of COVID-19 outbreak during the peak of influenza season in" exact="China" post="when the etiologic agent of this disease was yet"/>
   <result pre="COVID-19, no published results NCT04252664 (suspended by epidemic control in" exact="China" post="with no eligible patients) 237 patients Adult patients with"/>
   <result pre="still requires confirmation 215; NCT04257656 (terminated by epidemic control in" exact="China" post="with no eligible patients) 1063 patients Remdesivir (8) treated"/>
   <result pre="was used compassionately in the first COVID-19 patient diagnosed in" exact="the United States" post="by intravenous treatment and improved patient clinical condition.222 Grein"/>
   <result pre="used compassionately in the first COVID-19 patient diagnosed in the" exact="United States" post="by intravenous treatment and improved patient clinical condition.222 Grein"/>
   <result pre="drug manufacturers rely on low-cost suppliers of raw materials in" exact="India" post="and China, which might be scarce during a pandemic."/>
   <result pre="O'Brien JWFirst confirmed detection of SARS-CoV-2 in untreated wastewater in" exact="Australia" post="a proof of concept for the wastewater surveillance of"/>
   <result pre="Med20202176e2020065232302401 31PorchedduRSerraCKelvinDKelvinNRubinoSSimilarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in" exact="Italy" post="and ChinaJ Infect Dev Ctries2020140212512832146445 32CookTMThe importance of hypertension"/>
   <result pre="fatal and recovered cases of coronavirus disease 2019 in Wuhan," exact="China" post="a retrospective studyChin Med J (Engl)2020133111261126732209890 34GuoWLiMDongYZhouHZhangZTianCDiabetes is a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7536086\results\search\country\results.xml">
   <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospital. J. Antimicrob. Chemother.56, 919â€&quot;922. (10.1093/jac/dki346)16183666 50WongSS, YuenK-Y2008The management"/>
   <result pre="extracorporeal membrane oxygenation for the treatment of influenza A (H1N1)." exact="Hong Kong" post="Med. J.16, 447â€&quot;454.21135421 52ZhangH, ZengY, LinZ, ChenW, LiangJ, ZhangH,"/>
   <result pre="56ChengYet al.2005Use of convalescent plasma therapy in SARS patients in" exact="Hong Kong." post="Eur. J. Clin. Microbiol. Infect. Dis.24, 44â€&quot;46. (10.1007/s10096-004-1271-9)15616839 57ZhouB,"/>
   <result pre="WuA, SungJJ2003Treatment of severe acute respiratory syndrome with convalescent plasma." exact="Hong Kong" post="Med. J.9, 199â€&quot;201.12777656 89KongLJT2003Severe acute respiratory syndrome (SARS). Transfus."/>
   <result pre="91ArabiYMet al.2016Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection," exact="Saudi Arabia." post="Emerg. Infect. Dis.22, 1554 (10.3201/eid2209.151164)27532807 92ChunS, ChungCR, HaYE, HanTH,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7536932\results\search\country\results.xml">
   <result pre="retrospective cohort analysis of 349 patients across 14 sites in" exact="Saudi Arabia" post="found no significant reduction in 90â€�day mortality (odds ratio"/>
   <result pre="that increasing rates of macrolide resistance in Streptococcus pneumoniae in" exact="the United States" post="correlated closely with global sales of AZM, while in"/>
   <result pre="increasing rates of macrolide resistance in Streptococcus pneumoniae in the" exact="United States" post="correlated closely with global sales of AZM, while in"/>
   <result pre="global sales of AZM, while in some regions such as" exact="China" post="resistance rates approach 90% for Mycoplasma pneumoniae and nearly"/>
   <result pre="symptoms and complication of pneumonia in children with influenza. J" exact="Nippon" post="Med Sch. 2002;69(1):53â€�57.11847511 23McCallumGB, MorrisPS, ChatfieldMD, et al. A"/>
   <result pre="on an analysis of data of 150 patients from Wuhan." exact="China" post="Intens Care Med. 2020;46(5):846â€�848doi:10.1007/s00134-020-05991-x. 130LiaoM, LiuY, YuanJ, et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7536958\results\search\country\results.xml">
   <result pre="the International Standardised Randomised Controlled Trial Number6 (www.isrctn.com); and the" exact="Australia" post="New Zealand Clinical Trials Register7 (www.anzctr.org.au). The available registries"/>
   <result pre="International Standardised Randomised Controlled Trial Number6 (www.isrctn.com); and the Australia" exact="New Zealand" post="Clinical Trials Register7 (www.anzctr.org.au). The available registries were searched"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7540197\results\search\country\results.xml">
   <result pre="herbaceous plant that grows only in humid soils in northern" exact="Chile" post="(IV Region) [11]. Studies on Schizanthus have shown that"/>
   <result pre="bronchodilators [18] and antivirals [19]. Species Schizanthus porrigens, native to" exact="Chile" post="and Argentina [20], was chosen as source of potential"/>
   <result pre="and antivirals [19]. Species Schizanthus porrigens, native to Chile and" exact="Argentina" post="[20], was chosen as source of potential inhibitors for"/>
   <result pre="shrub plant Schizanthus porrigens that grows in soils in northern" exact="Chile" post="(IV Region) [11] and perform molecular docking of these"/>
   <result pre="spectrometry investigation of tropane alkaloids in Hyoscyamus albus L. from" exact="Morocco" post="AhmedZeitschrift fÃ¼r Naturforsch. C679â€&quot;102012461465 18Kohnen-johannsenK.L.KayserO.Tropane alkaloids: chemistry, pharmacology, biosynthesis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7544963\results\search\country\results.xml">
   <result pre="Biological Standardization, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh," exact="India" post="ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India Kuldeep"/>
   <result pre="Uttar Pradesh, India ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh," exact="India" post="Kuldeep Dhama, PhD kdhama@rediffmail.com Division of Pathology, ICAR-Indian Veterinary"/>
   <result pre="PhD kdhama@rediffmail.com Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly," exact="India" post=": 2020-9-9: 202019(C) Taylor &amp;amp; Francis, 2020This article is"/>
   <result pre="respiratory syndrome Coronavirus (MERS-CoV), have caused epidemics that originated in" exact="China" post="(2002) and Saudi Arabia (2012), respectively, and spread over"/>
   <result pre="(MERS-CoV), have caused epidemics that originated in China (2002) and" exact="Saudi Arabia" post="(2012), respectively, and spread over to several countries with"/>
   <result pre="human CoV disease, SARS, that originated in Guangdong region of" exact="China" post="in 2002 and spread over 27 countries before its"/>
   <result pre="case was confirmed in Wuhan city of Hubei province in" exact="China" post="on December 7, 2019, COVID-19 has gripped essentially all"/>
   <result pre="generated strong immune responses in all the participants in the" exact="United Kingdom." post="The vaccine has entred in its final trial in"/>
   <result pre="Kingdom. The vaccine has entred in its final trial in" exact="Brazil" post="along with studies going on in the United Kingdom"/>
   <result pre="trial in Brazil along with studies going on in the" exact="United Kingdom" post="and South Africa. Similarly Pfizer also trigerred strong T-cell"/>
   <result pre="along with studies going on in the United Kingdom and" exact="South Africa." post="Similarly Pfizer also trigerred strong T-cell response in phase"/>
   <result pre="Johnson and Janssen Pharmaceutical research teams, in collaboration with Beth" exact="Israel" post="Deaconess Medical Center, part of Harvard Medical School, have"/>
   <result pre="provide vaccination only to â€œat-riskâ€� groups. Some countries, like the" exact="United Kingdom," post="run programs for universal BCG vaccination. In contrast, others,"/>
   <result pre="run programs for universal BCG vaccination. In contrast, others, like" exact="the United States" post="and Canada, either recommend BCG for high-risk groups or"/>
   <result pre="programs for universal BCG vaccination. In contrast, others, like the" exact="United States" post="and Canada, either recommend BCG for high-risk groups or"/>
   <result pre="program of BCG vaccination; however, a few nations, such as," exact="Romania" post="and Uzbekistan, had started vaccination much earlier in 1928"/>
   <result pre="1928 and 1937, respectively, while few African countries, for example," exact="Nigeria" post="and Sierra Leone, began to provide BCG vaccination as"/>
   <result pre="1937, respectively, while few African countries, for example, Nigeria and" exact="Sierra Leone," post="began to provide BCG vaccination as late as in"/>
   <result pre="nine countries have stopped the program of universal BCG vaccination." exact="Spain" post="and Denmark were among the first countries to stop"/>
   <result pre="have stopped the program of universal BCG vaccination. Spain and" exact="Denmark" post="were among the first countries to stop in 1981â€&quot;1986,"/>
   <result pre="were among the first countries to stop in 1981â€&quot;1986, while" exact="Austria" post="and Germany halted the vaccination in 1990 and 1998,"/>
   <result pre="the first countries to stop in 1981â€&quot;1986, while Austria and" exact="Germany" post="halted the vaccination in 1990 and 1998, respectively. The"/>
   <result pre="vaccination in 1990 and 1998, respectively. The remaining nations, including" exact="the Isle of Man," post="Slovenia, the United Kingdom, Finland, and France, stopped their"/>
   <result pre="in 1990 and 1998, respectively. The remaining nations, including the" exact="Isle of Man," post="Slovenia, the United Kingdom, Finland, and France, stopped their"/>
   <result pre="The remaining nations, including the Isle of Man, Slovenia, the" exact="United Kingdom," post="Finland, and France, stopped their respective BCG vaccination programs"/>
   <result pre="respiratory virus infections. A study on BCG vaccination done in" exact="South Africa" post="and in Guinea-Bissau reported up to 70% reduction in"/>
   <result pre="study on BCG vaccination done in South Africa and in" exact="Guinea-Bissau" post="reported up to 70% reduction in the incidence of"/>
   <result pre="or do not provide universal BCG vaccination to children, including" exact="the United States," post="Italy, Spain, and France, have more COVID-19 cases and"/>
   <result pre="do not provide universal BCG vaccination to children, including the" exact="United States," post="Italy, Spain, and France, have more COVID-19 cases and"/>
   <result pre="16.39Â Â±Â 7.33 deaths per million people. Moreover countries like" exact="Japan" post="and Russia where the vaccine composition includes the original"/>
   <result pre="7.33 deaths per million people. Moreover countries like Japan and" exact="Russia" post="where the vaccine composition includes the original BCG strain"/>
   <result pre="countries where modified BCG strain is used for vaccination.74 But" exact="Brazil" post="is the exception with having second highest number of"/>
   <result pre="on BCG vaccination from 81 countries, including Canada, Italy, and" exact="the United States." post="The results of the study revealed that there is"/>
   <result pre="BCG vaccination from 81 countries, including Canada, Italy, and the" exact="United States." post="The results of the study revealed that there is"/>
   <result pre="number of confirmed cases and deaths due to COVID-19 in" exact="the United States," post="Italy, and Spain has outnumbered that of China, which"/>
   <result pre="of confirmed cases and deaths due to COVID-19 in the" exact="United States," post="Italy, and Spain has outnumbered that of China, which"/>
   <result pre="deaths due to COVID-19 in the United States, Italy, and" exact="Spain" post="has outnumbered that of China, which was the epicenter"/>
   <result pre="role in spread of COVID-19 transmission. Currently, the condition in" exact="China" post="appears to be improving promisingly.4 In India, childhood BCG"/>
   <result pre="at present, around 97% of 26 million children born in" exact="India" post="are administered free BCG vaccine during their first week"/>
   <result pre="43,000 deaths in the following 191Â days (WHO Situation Report-201," exact="India" post="as on August 8, 2020).5 The question before medical"/>
   <result pre="is that will BCG vaccination, which had been started in" exact="India" post="long ago, help in preventing COVID-19 cases and reducing"/>
   <result pre="conclusion is reached, the statistical figures on BCG vaccination in" exact="India" post="during the early 1950s with target coverage of 80%"/>
   <result pre="adopted a universal BCG policy later than other countries, like" exact="Iran" post="in 1984, have exhibited a high death rate, which"/>
   <result pre="protects the vaccinated population against COVID-19. The current population of" exact="India" post="is 1339.2 million, and to date, India has reported"/>
   <result pre="current population of India is 1339.2 million, and to date," exact="India" post="has reported 0.42 deaths per million, which is in"/>
   <result pre="of BCG while other two trails have been planned in" exact="Australia" post="and Netherland. However, some group also suggest that COVID-19"/>
   <result pre="and they are currently classified under community transmission phase viz." exact="the United States," post="and European countries, while the United States is leading"/>
   <result pre="they are currently classified under community transmission phase viz. the" exact="United States," post="and European countries, while the United States is leading"/>
   <result pre="transmission phase viz. the United States, and European countries, while" exact="the United States" post="is leading the count with more than 4.8 million"/>
   <result pre="phase viz. the United States, and European countries, while the" exact="United States" post="is leading the count with more than 4.8 million"/>
   <result pre="of deaths due to COVID-19 among the developed nations viz." exact="the United States," post="about 160,000 deaths followed by the Brazil, Mexico, the"/>
   <result pre="deaths due to COVID-19 among the developed nations viz. the" exact="United States," post="about 160,000 deaths followed by the Brazil, Mexico, the"/>
   <result pre="States, about 160,000 deaths followed by the Brazil, Mexico, the" exact="United Kingdom," post="Italy, France, Spain, etc. The mortality rate among the"/>
   <result pre="trials on BCG vaccination among health-care workers against COVID-19 In" exact="the United States," post="a group of researchers from the academic and research"/>
   <result pre="on BCG vaccination among health-care workers against COVID-19 In the" exact="United States," post="a group of researchers from the academic and research"/>
   <result pre="underway in many countries including Murdoch Childrenâ€™s Research Institute in" exact="Australia" post="(MCRI), and India. Since the studies are ongoing, we"/>
   <result pre="have stopped and do not provide childhood BCG vaccination, including" exact="the United States," post="Italy, Spain, and France, revealed that these countries are"/>
   <result pre="stopped and do not provide childhood BCG vaccination, including the" exact="United States," post="Italy, Spain, and France, revealed that these countries are"/>
   <result pre="emergence and transmission, scholars at Murdoch Childrenâ€™s Research Institute in" exact="Australia" post="(MCRI) are underway to explore the use of BCG"/>
   <result pre="COVID-19: an epidemiological study. medRxiv. 2020. doi:10.1101/2020.03.24.20042937. 74.IwasakiA, rubauNDWhy does" exact="Japan" post="have so few cases of COVID-19?EMBO Mol Med. 2020;12(5):e12481."/>
   <result pre="of BCG immunotherapy. Trials Vaccinol. 2014;3:143â€&quot;49. doi:10.1016/j.trivac.2014.08.002. 77.UdaniPMBCG vaccination in" exact="India" post="and tuberculosis in children: newer facets. Indian J Pediat."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7545115\results\search\country\results.xml">
   <result pre="Americaâ€� aims to reduce human immunodeficiency virus (HIV) incidence in" exact="the United States" post="by at least 90% by 2030, using diagnosis, treatment,"/>
   <result pre="aims to reduce human immunodeficiency virus (HIV) incidence in the" exact="United States" post="by at least 90% by 2030, using diagnosis, treatment,"/>
   <result pre="Texas page-count: A SNAPSHOT OF THE NATIONAL HIV EPIDEMIC The" exact="United States" post="embarked on a landmark initiative on February 5, 2019,"/>
   <result pre="states and half of jurisdictions are located in the Southern" exact="United States," post="including 5 counties in Texas. Figure 1. Forty-eight highest"/>
   <result pre="1. Forty-eight highest burden counties, Washington DC, and San Juan," exact="Puerto Rico," post="that accounted for more than 50% of new human"/>
   <result pre="against HIV, the annual number of new HIV diagnoses in" exact="the United States" post="has remained steady for over a decade, and since"/>
   <result pre="HIV, the annual number of new HIV diagnoses in the" exact="United States" post="has remained steady for over a decade, and since"/>
   <result pre="to 34-year-olds. This brings the total number of PWH in" exact="the United States" post="to an estimated 1.2 million, 14% of whom are"/>
   <result pre="34-year-olds. This brings the total number of PWH in the" exact="United States" post="to an estimated 1.2 million, 14% of whom are"/>
   <result pre="has shifted from the coastal urban centers to the Southern" exact="United States" post="[5]: home to approximately 50% of persons who are"/>
   <result pre="Dugas in Toronto in 1978, a flight attendant for Air" exact="Canada" post="(erroneously termed â€œPatient 0â€�) [13], Rodger Frasier, Paul Gustafson,"/>
   <result pre="Research) [28]. Furthermore, the Annual Houston Conference on AIDS in" exact="America" post="was launched to keep Houstonâ€™s AIDS community engaged and"/>
   <result pre="until December 1995, and AIDS deaths continued to rise in" exact="the United States" post="including Texas (Figure 3). Figure 3. New human immunodeficiency"/>
   <result pre="December 1995, and AIDS deaths continued to rise in the" exact="United States" post="including Texas (Figure 3). Figure 3. New human immunodeficiency"/>
   <result pre="and similar disparities were observed. These and other data prompted" exact="the US" post="Congressional Black Caucus to create the Minority AIDS Initiative"/>
   <result pre="in the 2003 landmark civil rights case, Lawrence v. Texas," exact="the US" post="Supreme Court struck down the sodomy law in Texas"/>
   <result pre="56]. THE EVOLVING HIV EPIDEMIC IN TEXAS Texas is among" exact="the US" post="states most severely affected by HIV. In 2018, it"/>
   <result pre="[3â€&quot;5, 48, 49, 55, 59]. The EHE initiative, launched by" exact="the US" post="Department of Health and Human Services, provides a once-in-a-generation"/>
   <result pre="gateway for both prevention and treatment. However, only 38.9% of" exact="the US" post="population in 2016â€&quot;2017 had ever been tested, including 46.9%"/>
   <result pre="high rural burden states [59]. Although 86% of PWH across" exact="the United States" post="were diagnosed, the biggest gaps in the prevalence-based HIV"/>
   <result pre="rural burden states [59]. Although 86% of PWH across the" exact="United States" post="were diagnosed, the biggest gaps in the prevalence-based HIV"/>
   <result pre="and provides support to more than half of PWH in" exact="the United States," post="63% of whom have incomes below the poverty line"/>
   <result pre="provides support to more than half of PWH in the" exact="United States," post="63% of whom have incomes below the poverty line"/>
   <result pre="health interventions [70]. Rapidly growing clusters have been detected across" exact="the United States," post="including Texas [71]. Of the 76 confirmed and other"/>
   <result pre="interventions [70]. Rapidly growing clusters have been detected across the" exact="United States," post="including Texas [71]. Of the 76 confirmed and other"/>
   <result pre="Although federally qualified health centers (FQHCs) have greatly expanded in" exact="the United States" post="and can serve as a critical source of prevention"/>
   <result pre="federally qualified health centers (FQHCs) have greatly expanded in the" exact="United States" post="and can serve as a critical source of prevention"/>
   <result pre="et al. Â Ending the HIV Epidemic: A Plan for" exact="the United States." post="JAMA Â 2019; 321:844â€&quot;5.30730529 2.collab: Centers for Disease Control"/>
   <result pre="al. Â Ending the HIV Epidemic: A Plan for the" exact="United States." post="JAMA Â 2019; 321:844â€&quot;5.30730529 2.collab: Centers for Disease Control"/>
   <result pre="Centers for Disease Control and Prevention. HIV in the Southen" exact="United States." post="Â 2019 Available at: https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf. Accessed 17 July 2020."/>
   <result pre="October 2002 Available at: https://www.chron.com/news/houston-deaths/article/Deaths-Dr-Robert-Awe-longtime-AIDS-activist-2113874.php. Accessed 17 July 2020. 26.collab:" exact="United States." post="Congress. House. Committee on Energy and Commerce. Subcommittee on"/>
   <result pre="al. Â Results of the expanded HIV testing initiative--25 jurisdictions," exact="United States," post="2007â€&quot;2010. MMWR Morb Mortal Wkly Rep Â 2011; 60:805â€&quot;10.21697804"/>
   <result pre="Â 2011; 58:S79â€&quot;84.21684414 38.The White House. National HIV/AIDS Strategy for" exact="the United States." post="Available at: https://www.hivlawandpolicy.org/sites/default/files/NHAS%20strategy.pdf. Accessed 17 July 2020. 39.collab: UNAIDS."/>
   <result pre="2011; 58:S79â€&quot;84.21684414 38.The White House. National HIV/AIDS Strategy for the" exact="United States." post="Available at: https://www.hivlawandpolicy.org/sites/default/files/NHAS%20strategy.pdf. Accessed 17 July 2020. 39.collab: UNAIDS."/>
   <result pre="2015; 40:642â€&quot;51.25524210 55.ColasantiJA, ArmstrongWSChallenges of reaching 90-90-90 in the Southern" exact="United States." post="Curr Opin HIV AIDS Â 2019; 14:471â€&quot;80.31425179 56.KatesJ, MillettG,"/>
   <result pre="58.ReifS, SafleyD, McAllasterC, et al. Â State of HIV in" exact="the US" post="Deep South. J Community Health Â 2017; 42:844â€&quot;53.28247067 59.PitasiMA,"/>
   <result pre="cost-effectiveness of genotype testing at human immunodeficiency virus diagnosis in" exact="the United States." post="Clin Infect Dis Â 2020; 70:1353â€&quot;63.31055599 70.OsterAM, FranceAM, PanneerN,"/>
   <result pre="of genotype testing at human immunodeficiency virus diagnosis in the" exact="United States." post="Clin Infect Dis Â 2020; 70:1353â€&quot;63.31055599 70.OsterAM, FranceAM, PanneerN,"/>
   <result pre="82.NosykB, ZangX, KrebsE, et al. Â Ending the Epidemic in" exact="America" post="will not happen if the status quo continues: modeled"/>
   <result pre="economic impact of attaining National HIV/AIDS Strategy Treatment Targets in" exact="the United States." post="J Infect Dis Â 2017; 216:798â€&quot;807.29029344 84.NosykB, KrebsE, ZangX,"/>
   <result pre="impact of attaining National HIV/AIDS Strategy Treatment Targets in the" exact="United States." post="J Infect Dis Â 2017; 216:798â€&quot;807.29029344 84.NosykB, KrebsE, ZangX,"/>
   <result pre="the Epidemicâ€™ will not happen without addressing racial/ethnic disparities in" exact="the US" post="HIV epidemic. Clin Infect Dis Â 2020. doi:10.1093/cid/ciaa566 85.Del"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7545798\results\search\country\results.xml">
   <result pre="expect an increased number of TB during or post COVID-19:" exact="South Africa," post="Nigeria, Cameroon, Kenya, Tanzania, Mozambique, Zambia, Zimbabwe and Uganda."/>
   <result pre="post COVID-19: South Africa, Nigeria, Cameroon, Kenya, Tanzania, Mozambique, Zambia," exact="Zimbabwe" post="and Uganda. The distribution of estimated new HIV cases"/>
   <result pre="N Author/Country Population/Study design Reasons for exclusion 1 Shalhoub 2015" exact="Saudi Arabia" post="A patient with MERS-CoV/HIV co-infection/case study TB status was"/>
   <result pre="co-infection/case study TB status was not reported 2 Bogorodckaya 2020" exact="Russia" post="three TB patients co-infected with COVID-19/ case study Cases"/>
   <result pre="COVID-19/ case study Cases were incompletely reported. 3 Wang 2020" exact="China" post="[26] A patient with COVID-19/HIV co-infection/case report TB status"/>
   <result pre="co-infection/case report TB status was not reported 4 Zhu 2020" exact="China" post="A patient with COVID-19/HIV co-infection/case report TB status was"/>
   <result pre="co-infection/case report TB status was not reported 5 Zhao 2020" exact="China" post="A patient with COVID-19/HIV/HCV co-infection/ case report TB status"/>
   <result pre="case report TB status was not reported 6 Baluku 2020" exact="Uganda" post="A patient with COVID-19/HIV co-infection /case report TB status"/>
   <result pre="/case report TB status was not reported 7 Blanco 2020" exact="Spain" post="Five cases of COVID-19/HIV co-infection/ clinical case series None"/>
   <result pre="clinical case series None reported TB status 8 Riva 2020" exact="Italy" post="Three cases with COVID-19/HIV co-infection / case series None"/>
   <result pre="/ case series None reported TB status 9 Aydin 2020" exact="Turkey" post="Three patients with COVID-19/HIV co-infection /case series Outcomes of"/>
   <result pre="co-infection/Case report TB screening was not reported 12 Gervasoni 2020" exact="Italy" post="47 COVID-19/HIV co-infected patients Retrospective study Outcomes of interest"/>
   <result pre="study Outcomes of interest were not reported 13 Wang 2020" exact="China" post="[26] A patient with COVID-19/HIV Co-infection/Case report TB status"/>
   <result pre="Co-infection/Case report TB status was not reported 14 HÃ¤rter 2020" exact="Germany" post="33 COVID-19/HIV co-infected patients Retrospective study Outcomes of interest"/>
   <result pre="study Outcomes of interest were not reported 15 Wu 2020" exact="China" post="Two patients with COVID-19/HIV co-infection/Case series TB screening was"/>
   <result pre="co-infection/Case series TB screening was not reported 16 Del 2020" exact="Spain" post="[27] 77,590 COVID/HIV co-infected cases Outcomes of interest were"/>
   <result pre="cases Outcomes of interest were not reported 17 Bulled 2020" exact="South Africa" post="Comment on COVID-19/HIV/TB co-infection This was a commentary 18"/>
   <result pre="on COVID-19/HIV/TB co-infection This was a commentary 18 Tadolini 2020" exact="Italy" post="49 patients with COVID-19/TB co-infection Duplicate report from the"/>
   <result pre="co-infection Duplicate report from the same cohort 19 Chen 2020" exact="China" post="[28] COVID-19/TB burden Letter to the editor without case"/>
   <result pre="of COVID-19/HIV/TB report No primary data reported 22 Pang 2020" exact="China" post="Included COVID-19/TB cases A correspondence 23 Wang 2020 China"/>
   <result pre="2020 China Included COVID-19/TB cases A correspondence 23 Wang 2020" exact="China" post="[26] A case of COVID-19/HIV co-infection The outcomes of"/>
   <result pre="co-infection The interest outcome was not reported 28 Guo 2020" exact="China" post="A survey among COVID-19/HIV co-infected cases The interest outcome"/>
   <result pre="The outcomes of interest were not reported 31 Toombs 2020" exact="United Kingdom" post="Three Cases with COVID-19/HIV co-infection Do not contain the"/>
   <result pre="Do not contain the outcome of interest 32 Ruan 2020" exact="China" post="Three cases with COVID-19/HIV co-infection Had no outcome of"/>
   <result pre="co-infection Had no outcome of interest reported 33 Sun 2020" exact="Singapore" post="A case of SARS-2/HIV co-infection Had no outcome of"/>
   <result pre="The outcomes of interest were not reported 36 Su 2020" exact="China" post="Two cases with SARS-2/AIDS co-infection The outcomes of interest"/>
   <result pre="co-infection The outcomes of interest were not reported 37 Kumar" exact="India" post="A case of COVID-19/HIV co-infection Had no outcome of"/>
   <result pre="SARS-CoV/MERS/COVID-19 Severity rate/Time SARS-CoV/MERS-CoV/COVID-19 Recovery rate/Time Mortality rate Liu 2006" exact="China" post="[29] -Three males of 48(case 1), 18 (case 2)"/>
   <result pre="recovered form SARS-CoV and continue anti-TB drugs N/A Low 2004" exact="Singapore" post="[30] -Two males of 54 and 39â€‰years old with"/>
   <result pre="Both of the cases recovered from SARS-CoV N/A Wong 2004" exact="Hong Kong" post="[31] -30â€‰years old male with confirmed SARS-CoV and HIV"/>
   <result pre="course SARS The case recovered from SARS-CoV N/A Alfaraj 2017" exact="Kingdom of Saudi Arabia" post="[32] âˆ’13-year-old girl and A 30-year-old female with confirmed"/>
   <result pre="The case recovered from SARS-CoV N/A Alfaraj 2017 Kingdom of" exact="Saudi Arabia" post="[32] âˆ’13-year-old girl and A 30-year-old female with confirmed"/>
   <result pre="Both of the cases recovered from MERS-CoV N/A Singh 2020" exact="India" post="[33] 76-year- old female with confirmed COVID-19 Case study"/>
   <result pre="moderate COVID-19 The patient recovered from COVID-19 N/A He 2020" exact="China" post="[34] All three patients were males with 26, 67"/>
   <result pre="hospitalization Critical COVID-19 stage Recovered for COVID-19 N/A Ã‡Ä±nar 2020" exact="Turkey" post="[36] 55-year-old male with a history of myelodysplastic Syndrome,"/>
   <result pre="hospitalization Critical COVID-19 stage Recovered for COVID-19 N/A Faqihi 2020" exact="Saudi Arabia" post="[37] 60â€‰year-old male, hypertensive and diabetic, with confirmed COVID-19"/>
   <result pre="COVID-19 stage Recovered for COVID-19 after 20â€‰days N/A Liu 2020a" exact="China" post="[38] 48â€‰year-old, 26-year-old and 46-year-old males with confirmed COVID-19/TB"/>
   <result pre="with the range of 9 to 14â€‰days N/A Tham 2020" exact="Singapore" post="[39] 32-year-old, 33-year-old, 22-year old and 40-year old males"/>
   <result pre="drugs N/A N/A All of them recovered. N/A Stochino 2020" exact="Italy" post="[40] 20 confirmed cases of COVID-19/TB co-infection. Among them,"/>
   <result pre="out of 20 patients recovered. 1 patient died. Chen 2020" exact="China" post="[28] Only four cases of COVID-19/TB co-infection were included"/>
   <result pre="N/A N/A 1 case out of 4 died. Du 2020" exact="China" post="[41] 8 confirmed cases of COVID-19/TB prospective cohort study"/>
   <result pre="N/A N/A N/A N/A COVID-19/TB: 0/8 COVID-19: 21/171 Davies 2020" exact="South Africa" post="[42] 3978 COVID-19/HIV co-infected patients 18,330 COVID-19 infected patients,"/>
   <result pre="COVID-19/TB Died: 25 /106 COVID-19 Died: 46/ 424 Liu 2020" exact="China" post="[38] âˆ’36 confirmed COVID-19 cases Among which 13 were"/>
   <result pre="COVID-19: 3.4â€‰days after initial symptom development. N/A N/A Li 2020" exact="China" post="[2] A total of 549 patients with COVID-19 were"/>
   <result pre="Severe: 4/269 Not severe: 5/ 279 N/A N/A Zhang 2020" exact="China" post="[44] âˆ’140 confirmed COVID-19 cases, 2 of whom had"/>
   <result pre="COVID-19/TB Severe: 2/58 Not severe: 0/82 N/A N/A Zhang 2020b" exact="China" post="[44] 1350 confirmed cases of COVID-19 among which 8"/>
   <result pre="N/A Motta 2020 Italy, Belgium, Brazil, France, Russia, Singapore, Spain," exact="Switzerland" post="[47] - 49 confirmed TB and COVID-19 cases, median"/>
   <result pre="[32] and one case control study [37] were undertaken in" exact="Saudi Arabia," post="a case series [40] was conducted in Italy, one"/>
   <result pre="was conducted in Italy, one cohort study was done in" exact="South Africa" post="[42] and another in the Philippines [43], one case"/>
   <result pre="study was done in South Africa [42] and another in" exact="the Philippines" post="[43], one case study was conducted in the United"/>
   <result pre="was done in South Africa [42] and another in the" exact="Philippines" post="[43], one case study was conducted in the United"/>
   <result pre="one case study was conducted in the United State of" exact="America" post="[35], other three case studies were found in Turkey"/>
   <result pre="of America [35], other three case studies were found in" exact="Turkey" post="[36], Hong Kong [31] and India [33] respectively. Lastly,"/>
   <result pre="[35], other three case studies were found in Turkey [36]," exact="Hong Kong" post="[31] and India [33] respectively. Lastly, a retrospective cohort"/>
   <result pre="studies were found in Turkey [36], Hong Kong [31] and" exact="India" post="[33] respectively. Lastly, a retrospective cohort was undertaken in"/>
   <result pre="A case control and four cohort studies were conducted in" exact="China" post="[38, 41, 44, 45, 48] and two other cohort"/>
   <result pre="45, 48] and two other cohort studies were undertaken in" exact="South Africa" post="[42] and the Philippines [43] (see Table 2). One"/>
   <result pre="other cohort studies were undertaken in South Africa [42] and" exact="the Philippines" post="[43] (see Table 2). One cohort included COVID-19/HIV/TB and"/>
   <result pre="cohort studies were undertaken in South Africa [42] and the" exact="Philippines" post="[43] (see Table 2). One cohort included COVID-19/HIV/TB and"/>
   <result pre="evidence is supported by two large cohort studies conducted in" exact="Spain" post="and South Africa, showing that the risks for PCR-confirmed"/>
   <result pre="supported by two large cohort studies conducted in Spain and" exact="South Africa," post="showing that the risks for PCR-confirmed COVID-19 diagnosis, hospitalization,"/>
   <result pre="of older patients with coronavirus disease 2019 (COVID-19) in Wuhan," exact="China" post="(2019): a single-centered, retrospective studyJ Gerontol A Biol Sci"/>
   <result pre="RSevere Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -" exact="United States," post="February 12-march 16, 2020MMWR Morb Mortal Wkly Rep2020691234334610.15585/mmwr.mm6912e232214079 51.ShiauSKrauseKDValeraPSwaminathanSHalkitisPNThe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7546461\results\search\country\results.xml">
   <result pre="Diseases, University of Bern, Bern, Switzerland[7], Biology Division, Spiez Laboratory," exact="Swiss" post="Federal Office for Civil Protection, Spiez, Switzerland[8], Graduate School"/>
   <result pre="which recently had its emergency use authorisation (EUA) revoked by" exact="the United States" post="Food and Drug Administration (FDA) [49]. Clinical trials of"/>
   <result pre="recently had its emergency use authorisation (EUA) revoked by the" exact="United States" post="Food and Drug Administration (FDA) [49]. Clinical trials of"/>
   <result pre="novel coronavirus genome identified in a cluster of pneumonia casesâ€&quot;Wuhan," exact="China" post="2019âˆ’2020.China CDC Wkly.2020;2:61â€&quot;62. 8ZhuN, ZhangD, WangW, LiX, YangB, SongJ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7546524\results\search\country\results.xml">
   <result pre="Restricted Prevalence Rates of COVID-19â€™s Infectivity, Hospitalization, Recovery, Mortality in" exact="the USA" post="and Their Implications https://orcid.org/0000-0002-3388-1014ShanmugamRamalingamShanmugam@txstate.edu[], grid.264772.20000 0001 0682 245XInternational Studies,"/>
   <result pre="the eastern, central, mountain, and pacific time zone states in" exact="the USA." post="We add additional new properties for the incidence rate"/>
   <result pre="Aziz-Alaoui [1] took into consideration the daily fluxes between New" exact="Jersey" post="(NJ) and New York (NY) states to notice a"/>
   <result pre="January 2020, in Wuhan city (capital of the Hubei province)," exact="China" post="[5]. The name coronavirus is derived from the Latin"/>
   <result pre="from the Latin word â€œcoronaâ€� meaning â€œcrown.â€� The government of" exact="China" post="reported that there were 1287 coronavirus cases, causing 41"/>
   <result pre="inflicted by the coronavirus again, according to Japanâ€™s Broadcasting Corporation" exact="Nippon" post="HÅ�sÅ� KyÅ�kai (NHK). This dampens the hope of the"/>
   <result pre="to recommend quarantine the potential coronavirus cases. Despite this pandemonium," exact="China" post="discovered that on 25 March 2020, an estimated 81,285"/>
   <result pre="30 January 2020, the Center for Disease Control (CDC) in" exact="the USA" post="came to know the first COVID-19 case in Chicago"/>
   <result pre="city in China. Subsequently, five more COVID-19 cases occurred in" exact="the USA." post="On 31 January 2020, the President of the USA"/>
   <result pre="in the USA. On 31 January 2020, the President of" exact="the USA" post="signed an executive order to deny entry to anyone"/>
   <result pre="cases and others imposed a severe curfew. Many nations, including" exact="the USA," post="adapted social distancing of people from each other first"/>
   <result pre="sectors, travels, parks, schools, and universities were locked down in" exact="the USA" post="and in almost 198 nations around the world. As"/>
   <result pre="research findings (not thorough or complete in any sense) for" exact="the US" post="regions will form a basis to come forward with"/>
   <result pre="District of Columbia 4323 224 660 Florida 33,690 1268 5589" exact="Georgia" post="26,237 1131 5186 Indiana 17,835 1007 Kentucky 4708 240"/>
   <result pre="Michigan 41,379 3789 New Hampshire 2054 66 980 259 New" exact="Jersey" post="118,652 7228 New York 304,372 18,321 North Carolina 10,509"/>
   <result pre="10,509 378 Ohio 18,027 975 3533 Pennsylvania 45,763 2292 Rhode" exact="Island" post="8621 266 South Carolina 6095 244 Tennessee 10,735 199"/>
   <result pre="1984 60 1121 175 Montana 453 16 392 61 New" exact="Mexico" post="3411 123 Utah 4672 46 1939 390 Wyoming 559"/>
   <result pre="confirm what we heard in the media about COVID-19 in" exact="the USA." post="Fig. 4 Impact, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy}"/>
   <result pre="and the administrators of such policies. One would anticipate that" exact="the USA" post="is one nation, ought to have the same health"/>
   <result pre="are missing data in recovery information across the zones in" exact="the USA." post="The results, based on the available data information, point"/>
   <result pre="up the reality of hospitalization to treat COVID-19 infections in" exact="the USA." post="In hospitalization, there is missing information for some states"/>
   <result pre="analyze and interpret the COVID-19 data across the zones in" exact="the USA." post="One would have thought that the USA as a"/>
   <result pre="the zones in the USA. One would have thought that" exact="the USA" post="as a nation comprising of homogeneous people and practices,"/>
   <result pre="no matter in which zone we live and practice in" exact="the USA." post="Conclusion and Thoughts for Future Work Many of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7547437\results\search\country\results.xml">
   <result pre="(IRR, 1.281; Pâ€‰=â€‰0.003), a higher proportion of men from Latin" exact="America" post="(IRR, 1.260; Pâ€‰=â€‰0.003), and a higher number of gay"/>
   <result pre="other men who have sex with men (GBMSM) from Latin" exact="America" post="and Western Europe, are also highly vulnerable to HIV"/>
   <result pre="drugs to enhance sexual experiences [11, 13]. Studies performed in" exact="the United States" post="of America have reported that increased poverty and inequality"/>
   <result pre="to enhance sexual experiences [11, 13]. Studies performed in the" exact="United States of America" post="have reported that increased poverty and inequality are associated"/>
   <result pre="experiences [11, 13]. Studies performed in the United States of" exact="America" post="have reported that increased poverty and inequality are associated"/>
   <result pre="transmitted infections [14â€&quot;16]. In contrast, a study performed in the" exact="United Kingdom" post="showed an increased incidence of viral hepatitis and sexually"/>
   <result pre="associated with socioeconomic indicators [18]. Catalonia, in the northeast of" exact="Spain" post="has one of the highest rates of new HIV"/>
   <result pre="and the percentage of men from Western Europe and Latin" exact="America" post="(year 2014) at the ABS level were calculated to"/>
   <result pre="6.93 (5.75â€&quot;8.11) Female 410 12.73 1.04 (0.90â€&quot;1.18) Country of birth" exact="Spain" post="1890 58.69 4.76 (4.23â€&quot;5.29) Other 1330 41.30 3.2 (2.42â€&quot;3.98)"/>
   <result pre="Western Europe (%) 5.01 5.49 5.71 15.64 0.491*** Men, Latin" exact="America" post="(%) 3.90 4.74 6.70 16.52 0.318*** Gay references (count)a"/>
   <result pre="from Western Europe (IRR, 1.281; Pâ€‰=â€‰0.003) and men from Latin" exact="America" post="(IRR: 1.260 Pâ€‰=â€‰0.003), and those with a higher number"/>
   <result pre="1.281 (1.085â€&quot;1.513) 0,003 ** 1.29 (1.098â€&quot;1.516) 0,002 ** â€ƒMen, Latin" exact="America" post="(%)a â€ƒâ€ƒ[0.45â€&quot;5.35] Ref. â€ƒâ€ƒ[5.35â€&quot;22.2] 1.26 (1.077â€&quot;1.473) 0,003 ** 1.246"/>
   <result pre="transmission among migrants from Western Europe (65%) and from Latin" exact="America" post="(60.4%), who account for 19.8 and 70.5%, respectively, of"/>
   <result pre="the high rates of HIV infection among GBMSM from Latin" exact="America" post="may reflect selective migration of GBMSM from this region"/>
   <result pre="Oct 2020. 2.PatelDTaylor-AidooNMarandetAHeitgerdJMaciakBAssessing Differences in CDC-Funded HIV Testing by Urbanicity," exact="United States," post="2016J Community Health20194419510230069826 3.SchaferKRAlbrechtHDillinghamRHoggRSJaworskyDKasperKet al.The Continuum of HIV Care"/>
   <result pre="3.SchaferKRAlbrechtHDillinghamRHoggRSJaworskyDKasperKet al.The Continuum of HIV Care in Rural Communities in" exact="the United States" post="and CanadaJAIDS J Acquir Immune Defic Syndr2017751354428225437 4.OhlMEPerencevichEFrequency of"/>
   <result pre="al.The Continuum of HIV Care in Rural Communities in the" exact="United States" post="and CanadaJAIDS J Acquir Immune Defic Syndr2017751354428225437 4.OhlMEPerencevichEFrequency of"/>
   <result pre="STDS201428418819724660767 27.HallHITangTEspinozaLLate Diagnosis of HIV Infection in Metropolitan Areas of" exact="the United States" post="and Puerto RicoAIDS Behav201620596797226542730 28.Kurtz SP. In: Cohler B,"/>
   <result pre="27.HallHITangTEspinozaLLate Diagnosis of HIV Infection in Metropolitan Areas of the" exact="United States" post="and Puerto RicoAIDS Behav201620596797226542730 28.Kurtz SP. In: Cohler B,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7547609\results\search\country\results.xml">
   <result pre="health care system (Table 4 ). A study conducted in" exact="Italy" post="reported severe decompensations of underlying diseases and even deaths"/>
   <result pre="Esp202010.1016/j.rce.2020.05.010 3CDC COVID-19 Response TeamCoronavirus Disease 2019 in Children -" exact="United States," post="February 12-April 2, 2020MMWR Morb Mortal Wkly Rep69202042242632271728 4MuÃ±oz-QuilesC.LÃ³pez-LacortM.Ãšbeda-SansanoI.AlemÃ¡n-SÃ¡nchezSPÃ©rez-VilarSPuig-BarberÃ"/>
   <result pre="AEPAn Pediatr (Barc)92202024132173188 33LazzeriniM.BarbiE.ApicellaA.MarchettiF.CardinaleF.TrobiaG.Delayed access or provision of care in" exact="Italy" post="resulting from fear of COVID-19Lancet Child Adolesc Health42020e10e1132278365 34AhmedH.AllafM.ElghazalyH.COVID-19"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7548526\results\search\country\results.xml">
   <result pre="Chen LJ, Suo XC. Let all diagnosed patients use TCM." exact="China" post="Traditional Chinese Medicine Network, Feb 14, 2020. Available at"/>
   <result pre="cured and discharged after integrated Chinese and Western medicine treatment." exact="China" post="News Network, Feb 12, 2020. Available at https://m.chinanews.com/wap/detail/zw/sh/2020/02-12/9089028.shtml 6.Guangdong"/>
   <result pre="rescue and treatment of patients with COVID-19 pneumonia is promising." exact="China" post="Youth Daily, Mar 3, 2020. Available at http://www.xinhuanet.com/2020-03/03/c_1125657175.htm 11.YuanBDawn"/>
   <result pre="Ebola strikes, it is both a challenge and an opportunity." exact="China" post="Traditional Chinese Medicine News, Oct 20, 2014. 3rd Edition,"/>
   <result pre="important regulatory mechanism of cell â€œDoor Godâ€� against viral infection." exact="China" post="News Network, Feb 23, 2019. Available at https://tech.huanqiu.com/article/9CaKrnKilTz 26.Yuan"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7549853\results\search\country\results.xml">
   <result pre="world. On January 20, the first case was reported in" exact="the United States," post="and on March 11, 2020, the World Health Organization"/>
   <result pre="On January 20, the first case was reported in the" exact="United States," post="and on March 11, 2020, the World Health Organization"/>
   <result pre="then, the virus has affected over 5.7 million patients in" exact="the United States" post="and over 23.6 million patients worldwideÂ [8]. Since the"/>
   <result pre="the virus has affected over 5.7 million patients in the" exact="United States" post="and over 23.6 million patients worldwideÂ [8]. Since the"/>
   <result pre="outcomes, pediatrics, complications, and treatment. In addition, official webpages from" exact="the United States," post="CDC (Centers for Disease Control and Prevention), NIH (National"/>
   <result pre="pediatrics, complications, and treatment. In addition, official webpages from the" exact="United States," post="CDC (Centers for Disease Control and Prevention), NIH (National"/>
   <result pre="pneumoniaÂ [35]. WhileÂ a retrospective review of critically-ill patients from" exact="China" post="revealed that patients treated with methylprednisolone (median dosage of"/>
   <result pre="modeling of its spike protein for risk of human transmissionSci" exact="China" post="Life SciXuXChenPWangJet al.45746063202032009228 6A pneumonia outbreak associated with a"/>
   <result pre="in New York StateJAMARosenbergESDufortEMUdoTet al.24932502323202032392282 45Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with COVID-19 [Online ahead of print]Med (NY)MagagnoliJNarendranSPereiraFet"/>
   <result pre="al.2020 46Treatment with convalescent plasma for COVID-19 patients in Wuhan," exact="China" post="[Online ahead of print]J Med VirolYeMFuDRenYet al.2020 47Effectiveness of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7550130\results\search\country\results.xml">
   <result pre="12â€&quot;35 millions of animals are harvested every year from the" exact="Congo" post="and the Amazon basin respectively (Karesh et al., 2007)."/>
   <result pre="bushmeat are reported to be imported every year on Air" exact="France" post="routes from Central and West Africa and 7% of"/>
   <result pre="also reported in countries such as USA, Spain, UK and" exact="Italy" post="(Mann et al., 2015). The emergence of the severe"/>
   <result pre="in up to 10% of cases (WHO, 2016), occurred in" exact="the USA" post="because of the importation of naturally-infected wild African rodents"/>
   <result pre="because of the importation of naturally-infected wild African rodents from" exact="Ghana" post="to supply the wildlife pet trade (Karesh et al.,"/>
   <result pre="al., 2007). In 2004, two crested hawk-eagles illegally smuggled from" exact="Thailand" post="to Belgium that were seized at the airport, turned"/>
   <result pre="In 2004, two crested hawk-eagles illegally smuggled from Thailand to" exact="Belgium" post="that were seized at the airport, turned out to"/>
   <result pre="2019â€&quot;2020 originated probably from pangolin sold on wet markets in" exact="China" post="(Zhang et al., 2020). About 10Â months following the"/>
   <result pre="on Africaâ€™s economic developmentBritish Medical Journal3247331200223223410.1136/bmj.324.7331.23211809650 DudleyJ.P.Bird flu outbreak in" exact="United Kingdom" post="reveals global vulnerabilitiesBioscience56200618218310.1641/0006-3568(2006)056[0182:BFOIUK]2.0.CO;2 EatonM.MeyersG.KolokotronisS.O.LeslieM.MartinA.AmatoG.Barcoding bushmeat: molecular identification of central"/>
   <result pre="Bruford, M.W.DNA identification of primate bushmeat from urban markets in" exact="Guinea-Bissau" post="and its implications for conservationBiol. Conserv.1672013434910.1016/j.biocon.2013.07.018 MinIONPortable RNA/DNA sequencerhttps://nanoporetech.com/products/minion2017"/>
   <result pre="30 years after smallpox vaccination campaigns cease in the Democratic" exact="Republic of" post="CongoProceedings of the National Academy of Sciences of the"/>
   <result pre="Republic of CongoProceedings of the National Academy of Sciences of" exact="the United States" post="of America107372010162621626710.1073/pnas.100576910720805472 RippleW.J.AbernethyK.BettsM.G.ChapronG.DirzoR.GalettiM.LeviT.LindseyP.A.MacdonalD.W.MachovinaB.Bushmeat hunting and extinction risk to the"/>
   <result pre="of CongoProceedings of the National Academy of Sciences of the" exact="United States" post="of America107372010162621626710.1073/pnas.100576910720805472 RippleW.J.AbernethyK.BettsM.G.ChapronG.DirzoR.GalettiM.LeviT.LindseyP.A.MacdonalD.W.MachovinaB.Bushmeat hunting and extinction risk to the"/>
   <result pre="African bushmeat huntersProceedings of the National Academy of Sciences of" exact="the United States" post="of America1022220057994799910.1073/pnas.050173410215911757 WolfeN.D.SwitzerW.M.CarrJ.K.BhullarV.B.ShanmugamV.TamoufeU.ProsserA.T.TorimiroJ.N.WrightA.Mpoudi-NgoleE.Naturally acquired simian retrovirus infections in central"/>
   <result pre="bushmeat huntersProceedings of the National Academy of Sciences of the" exact="United States" post="of America1022220057994799910.1073/pnas.050173410215911757 WolfeN.D.SwitzerW.M.CarrJ.K.BhullarV.B.ShanmugamV.TamoufeU.ProsserA.T.TorimiroJ.N.WrightA.Mpoudi-NgoleE.Naturally acquired simian retrovirus infections in central"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551028\results\search\country\results.xml">
   <result pre="For instance, the Thalidomide tragedy which became widespread across Europe," exact="Australia" post="and Japan reported more than 10,000 children with an"/>
   <result pre="the Thalidomide tragedy which became widespread across Europe, Australia and" exact="Japan" post="reported more than 10,000 children with an inborn defect"/>
   <result pre="syndrome. In 2018, The Washington Post had interviewed a 40-year-old" exact="Georgia" post="resident who suffered from Cushingâ€™s syndrome. The drug Korlym"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551260\results\search\country\results.xml">
   <result pre="from pigs, one of which, porcine Deltacoronavirus (PDCoV), emerged in" exact="the USA," post="Korea, and China, resulting in huge economic losses in"/>
   <result pre="This work was supported by the National Science Foundation of" exact="China" post="(U1805231), the National Key Research and Development Program of"/>
   <result pre="China (U1805231), the National Key Research and Development Program of" exact="China" post="(2016YFD0500205), and the National Science Foundation of China (U1305212)."/>
   <result pre="Program of China (2016YFD0500205), and the National Science Foundation of" exact="China" post="(U1305212). Conflicts of Interest The authors declare no conflict"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551450\results\search\country\results.xml">
   <result pre="future health security threats. Beyond technical solutions, the government of" exact="South Korea" post="needs to establish a timely strategic investment in coronavirus-related"/>
   <result pre="perspective. National funded projects stemmed from leading nations such as" exact="the United States," post="countries of the European Union, and Japan between 2012"/>
   <result pre="National funded projects stemmed from leading nations such as the" exact="United States," post="countries of the European Union, and Japan between 2012"/>
   <result pre="as the United States, countries of the European Union, and" exact="Japan" post="between 2012 and 2018. Six research fields were derived"/>
   <result pre="and an expert-based approach, and then matched to those of" exact="South Korea." post="The comparative analysis among them allowed for the identification"/>
   <result pre="with a cluster of patients with connections to Huanan South" exact="China" post="Seafood Market in Wuhan, Hubei Province, China [1,2]. The"/>
   <result pre="to Huanan South China Seafood Market in Wuhan, Hubei Province," exact="China" post="[1,2]. The cases of those infected in China had"/>
   <result pre="Hubei Province, China [1,2]. The cases of those infected in" exact="China" post="had spread to the US, Thailand, Japan, and South"/>
   <result pre="The cases of those infected in China had spread to" exact="the US," post="Thailand, Japan, and South Korea (hereafter Korea) on a"/>
   <result pre="in China had spread to the US, Thailand, Japan, and" exact="South Korea" post="(hereafter Korea) on a smaller scale by early February."/>
   <result pre="been confirmed outside China, 6284 of which were confined to" exact="South Korea" post="(42 deaths). Italy (3858 confirmed cases and 148 deaths)"/>
   <result pre="6284 of which were confined to South Korea (42 deaths)." exact="Italy" post="(3858 confirmed cases and 148 deaths) and Iran (3513"/>
   <result pre="(42 deaths). Italy (3858 confirmed cases and 148 deaths) and" exact="Iran" post="(3513 confirmed cases and 107 deaths) were ranked next"/>
   <result pre="to plan further scientific research. Many studies have indicated that" exact="the US," post="EU, and Japan have critical roles in the scientific"/>
   <result pre="research. Many studies have indicated that the US, EU, and" exact="Japan" post="have critical roles in the scientific and technological advancements"/>
   <result pre="in the world, the National Institutes of Health (NIH) of" exact="the US;" post="the framework programs for research and innovation (i.e., Horizon"/>
   <result pre="apply machine learning methodologies and network analysis to understand how" exact="the US," post="EU, and Japan have invested their funding to determine"/>
   <result pre="and network analysis to understand how the US, EU, and" exact="Japan" post="have invested their funding to determine what coronavirus disease-related"/>
   <result pre="from the global R&amp;amp;D database provided by STAR METRICS of" exact="the US," post="CORDIS of the EU, and KAKEN of Japan. The"/>
   <result pre="approach to classify the different R&amp;amp;D projects that stemmed from" exact="the US," post="the EU, and Japan [15]. The number of data"/>
   <result pre="R&amp;amp;D projects that stemmed from the US, the EU, and" exact="Japan" post="[15]. The number of data utilized by Korea, which"/>
   <result pre="the centralized database, was as high as that used by" exact="the US." post="It may cause a â€œhome advantageâ€� bias [26,27]. Thus,"/>
   <result pre="prevents us from comparing the amount of R&amp;amp;D funding among" exact="the US," post="the EU, Japan, and Korea. Thus, all of the"/>
   <result pre="Research and Development Fields of Coronavirus-Related National Funded Projects of" exact="the US," post="the EU, and Japan As shown in Figure 2,"/>
   <result pre="Coronavirus-Related National Funded Projects of the US, the EU, and" exact="Japan" post="As shown in Figure 2, the scientific research fields"/>
   <result pre="scientific research fields of the coronavirus-related national funded projects in" exact="the US," post="the EU, and Japan may be divided into three"/>
   <result pre="coronavirus-related national funded projects in the US, the EU, and" exact="Japan" post="may be divided into three clusters (categories). After reviewing"/>
   <result pre="81 projects worth 186,810,747 USD. The University of Maryland in" exact="the US" post="recently completed a project called â€œHost, pathogen, and the"/>
   <result pre="Medisch Centrum Rotterdam of the EU and Yamaguchi University of" exact="Japan" post="conducted a project entitled â€œEuropean management platform for emerging"/>
   <result pre="146,167,160 USD. The University of North Carolina Chapel Hill in" exact="the US" post="is projected to have spent 24 million USD on"/>
   <result pre="and 2023. Meanwhile, The National Institute of Infectious Diseases of" exact="Japan" post="finished a vaccine project costing 144,300 USD between 2016"/>
   <result pre="comprised of 16 projects, which are worth 34,526,645 USD. In" exact="the US," post="Columbia University Health Sciences completed a 5 million USD"/>
   <result pre="with a budget of 205,891 USD. Between 2015 and 2018," exact="Nihon" post="University of Japan completed its study â€œEstablishment of gene"/>
   <result pre="of 205,891 USD. Between 2015 and 2018, Nihon University of" exact="Japan" post="completed its study â€œEstablishment of gene diagnosis of feline"/>
   <result pre="modulation (Sub-Cluster 2-1) included six projects totaling 6,911,261 USD. In" exact="the US," post="The Blood Systems Research Institute joined a 2 million"/>
   <result pre="metagenomic sequencingâ€�, between 2015 and 2018. Meanwhile, Osaka University of" exact="Japan" post="studied the same research area with expenditures of 144,300"/>
   <result pre="proteins (Sub-Cluster 2-2) included 31 projects totaling 76,626,049 USD. In" exact="the US," post="The University of North Carolina Chapel Hill and Kansas"/>
   <result pre="inhibitors against MERS-CoVâ€� between 2018 and 2023. In Japan, the" exact="Nippon" post="Veterinary and Life Science University finished â€œThe development of"/>
   <result pre="projects worth 152,373,487 USD. In 2018, George Washington University in" exact="the US" post="began executing a project worth 9.9 million USD titled"/>
   <result pre="funding scale for coronavirus-related R&amp;amp;D areas in the EU and" exact="Japan" post="is smaller than that of the United States, the"/>
   <result pre="in the EU and Japan is smaller than that of" exact="the United States," post="the directions for the R&amp;amp;D areas are considerably analogous"/>
   <result pre="the EU and Japan is smaller than that of the" exact="United States," post="the directions for the R&amp;amp;D areas are considerably analogous"/>
   <result pre="for the R&amp;amp;D areas are considerably analogous to those in" exact="the US." post="These trends in coronavirus-related R&amp;amp;D funding show that the"/>
   <result pre="in the host, and immune responses, which are dominated by" exact="the US" post="and EUâ€™s technological edge. However, some coronavirus-related R&amp;amp;D areas"/>
   <result pre="areas were heavily supported by the Korean government compared to" exact="the US." post="These R&amp;amp;D areas covered research related to the platform"/>
   <result pre="additionally extrapolated based on expertsâ€™ reviews. According to the results," exact="the US," post="the EU, and Japan have invested in coronavirus-related research"/>
   <result pre="reviews. According to the results, the US, the EU, and" exact="Japan" post="have invested in coronavirus-related research areas through 160 projects"/>
   <result pre="for a global response to infectious disease threats. As aforementioned," exact="the US," post="the EU, and Japanâ€™s data sources did not include"/>
   <result pre="References 1.GralinskiL.E.MenacheryV.D.Return of the coronavirus: 2019-NCoVViruses20201213510.3390/v1202013531991541 2.HerM.How is COVID-19 affecting" exact="South Korea?" post="What is our current strategy?Disaster Med. Public Health Prep.202010.1017/dmp.2020.6932241325"/>
   <result pre="for interdisciplinary research: A comparison study of infectious diseases in" exact="the US" post="and EUSustain. Switz.201911412010.3390/su11154120 16.ParkS.-C.ParkY.C.Mental health care measures in response"/>
   <result pre="perspective of diversity and persistence: A cross-sector comparative analysis between" exact="the United States" post="and South KoreaPLoS ONE201611e015924910.1371/journal.pone.015924927416495 28.van EckN.J.WaltmanL.Software survey: VOSviewer, a"/>
   <result pre="of diversity and persistence: A cross-sector comparative analysis between the" exact="United States" post="and South KoreaPLoS ONE201611e015924910.1371/journal.pone.015924927416495 28.van EckN.J.WaltmanL.Software survey: VOSviewer, a"/>
   <result pre="The workflow of the comparison of coronavirus-related R&amp;amp;D areas among" exact="the US," post="the EU, Japan, and South Korea. Search terms marked"/>
   <result pre="coronavirus-related R&amp;amp;D areas among the US, the EU, Japan, and" exact="South Korea." post="Search terms marked with an asterisk (*) are root"/>
   <result pre="2 Clusters of R&amp;amp;D fields on coronavirus-related national-funded projects of" exact="the US," post="the EU, and Japan. Figure 3 Comparative ratio analysis"/>
   <result pre="3 Comparative ratio analysis for three coronavirus-related R&amp;amp;D areas among" exact="the US," post="the EU, Japan, and Korea. Figure 4 Comparative ratio"/>
   <result pre="4 Comparative ratio analysis for six coronavirus-related R&amp;amp;D areas for" exact="the US" post="and Korea. healthcare-08-00204-t001_Table 1Table 1 The source of global"/>
   <result pre="102,946 205,891 1 July 2014 30 June 2016 EU 5" exact="Nihon" post="University Establishment of gene diagnosis of feline infectious peritonitis"/>
   <result pre="1,222,700 3,668,100 30 September 2015 29 September 2018 US 5" exact="Nippon" post="Veterinary and Life Science University The development of specific"/>
   <result pre="University Ecology of MERS-CoV in camels, humans, and wildlife in" exact="Ethiopia" post="2,487,071 9,948,284 1 September 2018 31 August 2022 US"/>
   <result pre="of middle east respiratory syndrome coronavirus of the dromedary in" exact="Ethiopia" post="137,800 413,400 1 April 2017 31 March 2020 JP"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551807\results\search\country\results.xml">
   <result pre="local communities. We discuss this question broadly, with examples from" exact="the US," post="as it is globally relevant for all health authorities"/>
   <result pre="multiple times, to help guide clinical/therapeutic decisions. For example, many" exact="United States" post="(US) state health departments collect HIV sequence data from"/>
   <result pre="ranging from dispersed rural communities to large urban centers in" exact="the US" post="and worldwide. Nevertheless, using these databases for public health"/>
   <result pre="We discuss this sensitive question primarily in the context of" exact="the US" post="HIV epidemic, but the issues, benefits, and risks associated"/>
   <result pre="social threats. For example, an HIV-positive, undocumented person living in" exact="the US" post="could be charged with a crime, forming the grounds"/>
   <result pre="populations that need public health services [20]. The reality in" exact="the US" post="is that 35 of 50 states have laws criminalizing"/>
   <result pre="a local issue that requires adaptation to local populations. In" exact="the US," post="HIV transmission is highly heterogenous, including major demographic, geographic,"/>
   <result pre="diagnosis rates at both the state and county levels in" exact="the US" post="controlling for the relevant population sizes. HIV diagnosis rates"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551931\results\search\country\results.xml">
   <result pre="Microscopy GmbH, Jena, Germany) and processed using ImageJ (ver. 1.52b)" exact="Fiji" post="software (Madison, WI, USA) [38]. The number of viral"/>
   <result pre="virions for each focal plane was assessed using the ImageJ" exact="Fiji" post="software (National Institutes of Health, Bethesda, MD, USA). 2.9."/>
   <result pre="virus replication. 4. Discussion Since the epidemic outbreak on Yap" exact="Island" post="in 2007 and subsequent epidemics in Polynesia and Brazil,"/>
   <result pre="particles and the number of cells was assessed using ImageJ" exact="Fiji" post="3D Objects Counter tool. Each set shows data from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7553131\results\search\country\results.xml">
   <result pre="of hospital stay, and resolution of symptoms. A trial in" exact="China" post="(Identifier: NCT04323514) is mirroring the study taking place in"/>
   <result pre="who are testing the same treatment. While a study in" exact="Turkey" post="(Identifier: NCT04326725) is testing the effects of vitamin C"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7557800\results\search\country\results.xml">
   <result pre="disease that emerged from Wuhan in the Hubei province of" exact="China" post="in December 2019. It has spread to 210 countries"/>
   <result pre="in the H1N1 influenza epidemic in the Shaanxi province of" exact="China" post="in 2009. In a study published in 2016, Yan"/>
   <result pre="the MERS epidemic in 2012 and the H7N9 epidemic in" exact="China" post="was studied, showing a stronger reaction in the H7N9"/>
   <result pre="December 2019, the reports of patients with viral pneumoniaÂ in" exact="China" post="surfaced. The origin was related to the Huanan Seafoodâ€™s"/>
   <result pre="service has remained under-utilized. In 2017, a survey study in" exact="the USA" post="showed that 82% of people do not use this"/>
   <result pre="a small non-randomized clinical trial of just 36 patients from" exact="France" post="[25]. However, a subsequent randomized clinical trial using high"/>
   <result pre="Virusâ€™ label, ignoring growing criticism320202020https://www.nytimes.com/2020/03/18/us/politics/china-virus.html 9'Wolf Warrior' strives to make" exact="China" post="first with coronavirus vaccine. The Washington Post32020FifieldFifieldA.(2020March 22).'Wolf2020https://www.washingtonpost.com/world/asia_pacific/chinas-wolf-warrior-strives-to-be-first-with-coronavirus-vaccine/2020/03/19/d6705cba-699c-11ea-b199-3a9799c54512_story.html 10Coronavirus:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7558548\results\search\country\results.xml">
   <result pre="with the SARS-CoV-2 virus in Wuhan and other parts of" exact="China" post="showed preliminary evidence of benefit against pneumonia and the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7561179\results\search\country\results.xml">
   <result pre="account for 37,000 deaths in Europe and 99,000 deaths in" exact="the United States" post="of America annually and are associated with a financial"/>
   <result pre="for 37,000 deaths in Europe and 99,000 deaths in the" exact="United States of America" post="annually and are associated with a financial loss of"/>
   <result pre="in Europe and 99,000 deaths in the United States of" exact="America" post="annually and are associated with a financial loss of"/>
   <result pre="â‚¬7 billion in the EU and US$ 6.5 billion in" exact="the US" post="[2]. Many of these deaths are attributed to multiple"/>
   <result pre="The recent emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)," exact="Zaire" post="ebolavirus, and Zika virus led many experts to believe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7567346\results\search\country\results.xml">
   <result pre="perpetration: A longitudinal analysis among men with HIV in northern" exact="Vietnam" post="Alcohol use, depressive symptoms, and intimate partner violence perpetration"/>
   <result pre="of North Carolina at Chapel Hill, Chapel Hill, North Carolina," exact="United States" post="of America[2], Yen Hoa Health Clinic, University of North"/>
   <result pre="of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland," exact="United States" post="of America[4], Department of Epidemiology, Johns Hopkins University Bloomberg"/>
   <result pre="Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland," exact="United States" post="of America[5], Department of Biostatistics, Johns Hopkins University Bloomberg"/>
   <result pre="Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland," exact="United States" post="of America[6], Department of Health, Behavior and Society, Johns"/>
   <result pre="Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland," exact="United States" post="of America[7], Department of Psychiatry and Behavioral Sciences, Johns"/>
   <result pre="Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland," exact="United States" post="of America[8], Department of Epidemiology, Gillings School of Global"/>
   <result pre="of North Carolina at Chapel Hill, Chapel Hill, North Carolina," exact="United States" post="of AmericaWithersMellissa H.Editor[], USC Keck School of Medicine, Institute"/>
   <result pre="competing interests exist. Â¤Current address: Vinmec Health Care System, Hanoi," exact="Vietnam" post="* E-mail: rhershow@live.unc.edu epub: 2020-10-10collection: 20201510e0240674received: 2020-5-28accepted: 2020-9-30(C) Hershow"/>
   <result pre="[13â€&quot;17]. Alcohol use and IPV perpetration are highly prevalent in" exact="Vietnam" post="and largely shaped by sociocultural norms that stem from"/>
   <result pre="that the annual per capita consumption of pure alcohol in" exact="Vietnam" post="was 5.1 liters [14], which is greater than the"/>
   <result pre="perpetration [32â€&quot;36]. However, there is a dearth of research in" exact="Vietnam" post="and other global settings examining how depressive symptoms and"/>
   <result pre="mental health exacerbates violence outcomes. A nationally representative study in" exact="the United States" post="found that reporting a severe mental illness did not"/>
   <result pre="health exacerbates violence outcomes. A nationally representative study in the" exact="United States" post="found that reporting a severe mental illness did not"/>
   <result pre="a severe mental illness and substance abuse did [40]. Another" exact="United States" post="study found that alcohol use strengthened the relationship between"/>
   <result pre="[32]. In addition to these quantitative studies, qualitative research in" exact="India" post="has suggested that depressive symptoms interact with alcohol use"/>
   <result pre="= 440) in Thai Nguyen, a semi-urban province in northern" exact="Vietnam" post="[42]. Thai Nguyen has the highest HIV prevalence among"/>
   <result pre="HIV prevalence among people who inject drugs (PWID; 34%) in" exact="Vietnam" post="[44]. Participant recruitment and data collection Recruitment of study"/>
   <result pre="= 0.83) [53], a tool that has been validated in" exact="Vietnam" post="[54]. A composite PHQ-9 score was calculated for each"/>
   <result pre="a previous study conducted among men with HIV in northern" exact="Vietnam" post="demonstrated that the alcohol-IPV relationship operates differently for men"/>
   <result pre="uncommon [23, 24]. Instead, drinking centers around social interactions in" exact="Vietnam" post="[23, 24, 74]. Those experiencing the co-occurrence of heightened"/>
   <result pre="and depressive symptoms among men with HIV globally and in" exact="Vietnam" post="[71, 74], intervening on alcohol use and depression may"/>
   <result pre="currently or previously injected drugs because the HIV epidemic in" exact="Vietnam" post="is largely driven by injection drug use [44, 77]."/>
   <result pre="to compare IPV prevalence estimates from our study to other" exact="Vietnam" post="studies as the IPV measures and recall periods often"/>
   <result pre="alcohol misuse, and HIV risk among peri-urban, heterosexual men in" exact="South Africa." post="Soc Sci Med. 2019:11263710.1016/j.socscimed.2019.11263731708236 17OkaforCN, ChristodoulouJ, BantjesJ, QondelaT, StewartJ,"/>
   <result pre="Behav. 2018;22(12):3962â€&quot;70. 10.1007/s10461-018-2227-x30003507 18ZhangHX, LockeC. Contextualising Reproductive Rights Challenges: The" exact="Vietnam" post="Situation. Womenâ€™s Studies International Forum. 2002;25(4):443â€&quot;53. 19HortonP, RydstromH. Heterosexual"/>
   <result pre="a depressive symptom severity measure for sexual minority women in" exact="Viet Nam." post="J Gay Lesbian Ment Health. 2016;20(2):173â€&quot;91. 10.1080/19359705.2015.108020427642381 55KroenkeK, SpitzerRL,"/>
   <result pre="intimate partner violence by men receiving substance use treatment in" exact="Brazil" post="and England: A cross-cultural comparison. Drug Alcohol Rev. 2017;36(1):34â€&quot;51."/>
   <result pre="Namâ€™s HIV Response: An Investment Case. Ministry of Health of" exact="Viet Nam;" post="2014. 78MayMT, JusticeAC, BirnieK, Schwarze-ZanderC, MorenoS, GuestJL, et al.Injection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7567380\results\search\country\results.xml">
   <result pre=": People and places : Geographical locations : North America:" exact="United States" post=": Medicine and health sciences : Public and occupational"/>
   <result pre="HIV upon estimated HIV incidence between 2010 and 2015 in" exact="the United States" post="Impact of viral suppression among persons with HIV on"/>
   <result pre="upon estimated HIV incidence between 2010 and 2015 in the" exact="United States" post="Impact of viral suppression among persons with HIV on"/>
   <result pre="suppression among persons with HIV on HIV incidence 2010-2015 in" exact="the United States" post="https://orcid.org/0000-0003-4830-6108SamandariTarazConceptualizationInvestigationMethodologyProject administrationWriting â€&quot; original draftWriting â€&quot; review &amp;amp; editing*WienerJeffreyFormal"/>
   <result pre="among persons with HIV on HIV incidence 2010-2015 in the" exact="United States" post="https://orcid.org/0000-0003-4830-6108SamandariTarazConceptualizationInvestigationMethodologyProject administrationWriting â€&quot; original draftWriting â€&quot; review &amp;amp; editing*WienerJeffreyFormal"/>
   <result pre="HIV/AIDS Prevention, Centers for Disease Control &amp;amp; Prevention, Atlanta, Georgia," exact="United States" post="of AmericaHearpsAnna C.Editor[], Burnet Institute, AUSTRALIA Competing Interests: The"/>
   <result pre="the impact of state level viral suppression among PWH in" exact="the United States" post="on estimated HIV incidence between 2010 and 2015. Methods"/>
   <result pre="impact of state level viral suppression among PWH in the" exact="United States" post="on estimated HIV incidence between 2010 and 2015. Methods"/>
   <result pre="2010 to 2015 was associated with increasing viral suppression in" exact="the United States." post="Race and sexual orientation were important HIV acquisition risk"/>
   <result pre="to 2015 was associated with increasing viral suppression in the" exact="United States." post="Race and sexual orientation were important HIV acquisition risk"/>
   <result pre="antiretroviral therapyâ€&quot;subsequently referred to as antiretroviral therapy (ART)â€&quot;was introduced in" exact="the United States" post="in 1996. Shortly thereafter the United States Centers for"/>
   <result pre="therapyâ€&quot;subsequently referred to as antiretroviral therapy (ART)â€&quot;was introduced in the" exact="United States" post="in 1996. Shortly thereafter the United States Centers for"/>
   <result pre="(ART)â€&quot;was introduced in the United States in 1996. Shortly thereafter" exact="the United States" post="Centers for Disease Control and Prevention (CDC) reported the"/>
   <result pre="introduced in the United States in 1996. Shortly thereafter the" exact="United States" post="Centers for Disease Control and Prevention (CDC) reported the"/>
   <result pre="at least three million life years had been saved in" exact="the United States" post="as a direct result of ART [2]. Treatment of"/>
   <result pre="least three million life years had been saved in the" exact="United States" post="as a direct result of ART [2]. Treatment of"/>
   <result pre="persons has been the recommendation of public health officials in" exact="the United States" post="since 2012. Viewed from the perspective of public health"/>
   <result pre="has been the recommendation of public health officials in the" exact="United States" post="since 2012. Viewed from the perspective of public health"/>
   <result pre="has contributed to the announcement of a new initiative by" exact="the United States" post="government namely â€˜Ending the HIV Epidemicâ€™ [3]. A treatment"/>
   <result pre="contributed to the announcement of a new initiative by the" exact="United States" post="government namely â€˜Ending the HIV Epidemicâ€™ [3]. A treatment"/>
   <result pre="by PWH would have to increase by 19.5% [8]. In" exact="the United States," post="a Poisson model using â€œcommunity viral loadâ€� in the"/>
   <result pre="PWH would have to increase by 19.5% [8]. In the" exact="United States," post="a Poisson model using â€œcommunity viral loadâ€� in the"/>
   <result pre="suppression on incident HIV has not been previously reported for" exact="the United States" post="at the state, regional or national levels. Over the"/>
   <result pre="on incident HIV has not been previously reported for the" exact="United States" post="at the state, regional or national levels. Over the"/>
   <result pre="Current Population Survey [14, 15]. Approximately 60% of PWH in" exact="the United States" post="are gay, bisexual, or other MSM. We included published"/>
   <result pre="Population Survey [14, 15]. Approximately 60% of PWH in the" exact="United States" post="are gay, bisexual, or other MSM. We included published"/>
   <result pre="each state [16]. Recent increases in injection drug use in" exact="the United States" post="has resulted in growing hepatitis C (HCV) and HIV"/>
   <result pre="state [16]. Recent increases in injection drug use in the" exact="United States" post="has resulted in growing hepatitis C (HCV) and HIV"/>
   <result pre="version 9.4 and R version 3.5.0. Results Of the 30" exact="United States" post="jurisdictions included in the analysis, one third were located"/>
   <result pre="99.6 87.0 75.9 -12.69 (-15.05, -10.27) Â Â Â Â" exact="Georgia" post="30.9 30.0 29.0 28.1 27.3 26.4 -3.11 (-4.44, -1.77)"/>
   <result pre="a mixed effects Poisson regression model showed that all four" exact="United States" post="regions experienced declines in HIV incidence from 2010 to"/>
   <result pre="by 2015. Fig 1 Fitted HIV incidence rate by region," exact="United States" post="2010â€&quot;2015. Fitted HIV incidence rate determined using a mixed-effects"/>
   <result pre="with HIV and estimated HIV incidence in 2010 and 2015," exact="United States." post="The subset includes 30 jurisdictions (29 states and the"/>
   <result pre="the populations of these 30 jurisdictions amount to 64.5% of" exact="the United States" post="population in 2010, and are not only diverse in"/>
   <result pre="populations of these 30 jurisdictions amount to 64.5% of the" exact="United States" post="population in 2010, and are not only diverse in"/>
   <result pre="contexts. By virtue of having the highest incidence of any" exact="United States" post="region, Southern states also have the opportunity to make"/>
   <result pre="estimated 44% percent of all PWH (diagnosed and undiagnosed) in" exact="the United States" post="despite being populated by only a third (37%) of"/>
   <result pre="44% percent of all PWH (diagnosed and undiagnosed) in the" exact="United States" post="despite being populated by only a third (37%) of"/>
   <result pre="high school education, an 11.5% decline in the proportion of" exact="the United States" post="population below the poverty level and a 36.0% decline"/>
   <result pre="school education, an 11.5% decline in the proportion of the" exact="United States" post="population below the poverty level and a 36.0% decline"/>
   <result pre="the United States: in 2017, they accounted for 13% of" exact="the United States" post="population but 43% of new HIV diagnoses. This racial"/>
   <result pre="United States: in 2017, they accounted for 13% of the" exact="United States" post="population but 43% of new HIV diagnoses. This racial"/>
   <result pre="all HIV diagnoses in 2016 despite being approximately 4% of" exact="the United States" post="male population [16] and, of these new diagnoses in"/>
   <result pre="HIV diagnoses in 2016 despite being approximately 4% of the" exact="United States" post="male population [16] and, of these new diagnoses in"/>
   <result pre="overall increases in viral suppression and decreased HIV incidence across" exact="the United States." post="In 2014, the major provisions of the Affordable Care"/>
   <result pre="increases in viral suppression and decreased HIV incidence across the" exact="United States." post="In 2014, the major provisions of the Affordable Care"/>
   <result pre="for low-income PWH [24]. By 2016, the uninsured share of" exact="the United States" post="population had roughly halved, with estimates ranging from 20"/>
   <result pre="low-income PWH [24]. By 2016, the uninsured share of the" exact="United States" post="population had roughly halved, with estimates ranging from 20"/>
   <result pre="lack of insurance. Indeed, nearly half of all PWH in" exact="the United States" post="have a household income at or below the federal"/>
   <result pre="of insurance. Indeed, nearly half of all PWH in the" exact="United States" post="have a household income at or below the federal"/>
   <result pre="jurisdictions included in this analysis represent almost two thirds of" exact="the United States" post="population. Another limitation is that we used a single"/>
   <result pre="included in this analysis represent almost two thirds of the" exact="United States" post="population. Another limitation is that we used a single"/>
   <result pre="to successfully prosecuting the â€˜Ending the HIV Epidemicâ€™ campaign in" exact="the United States." post="In conclusion, our ecologic analysis suggests that between 2010"/>
   <result pre="successfully prosecuting the â€˜Ending the HIV Epidemicâ€™ campaign in the" exact="United States." post="In conclusion, our ecologic analysis suggests that between 2010"/>
   <result pre="already have made a contribution towards reducing incident HIV in" exact="the United States" post="[37]. Our analysis appears to underscore the importance of"/>
   <result pre="have made a contribution towards reducing incident HIV in the" exact="United States" post="[37]. Our analysis appears to underscore the importance of"/>
   <result pre="PaltielAD, LosinaE, et al.The survival benefits of AIDS treatment in" exact="the United States." post="J Infect Dis2006; 194: 11â€&quot;19. 10.1086/50514716741877 3FauciAS, RedfieldRR, SigounasG,"/>
   <result pre="LosinaE, et al.The survival benefits of AIDS treatment in the" exact="United States." post="J Infect Dis2006; 194: 11â€&quot;19. 10.1086/50514716741877 3FauciAS, RedfieldRR, SigounasG,"/>
   <result pre="RedfieldRR, SigounasG, et al.Ending the HIV epidemic: a plan for" exact="the United States." post="JAMA 2019; 20192710.1001/jama.2019.1343 [Epub ahead of print] 30730529 4FangC-T,"/>
   <result pre="SigounasG, et al.Ending the HIV epidemic: a plan for the" exact="United States." post="JAMA 2019; 20192710.1001/jama.2019.1343 [Epub ahead of print] 30730529 4FangC-T,"/>
   <result pre="estimate HIV incidence, prevalence, and percent of undiagnosed infections in" exact="the United States." post="J Acquir Immune Defic Syndr. 2017;74:3â€&quot;9. 10.1097/QAI.000000000000115127509244 12collab: Centers"/>
   <result pre="HIV incidence, prevalence, and percent of undiagnosed infections in the" exact="United States." post="J Acquir Immune Defic Syndr. 2017;74:3â€&quot;9. 10.1097/QAI.000000000000115127509244 12collab: Centers"/>
   <result pre="Disease Control and Prevention. Estimated HIV incidence and prevalence in" exact="the United States," post="2010â€&quot;2016. HIV Surveillance Supplemental Report2019;24(No. 1). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published February"/>
   <result pre="Control and Prevention. Estimated HIV incidence and prevalence in the" exact="United States," post="2010â€&quot;2016. HIV Surveillance Supplemental Report2019;24(No. 1). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published February"/>
   <result pre="HIV infection in 20 states, the District of Columbia, and" exact="Puerto Rico," post="2010. HIV Surveillance Supplemental Report2014;19(No. 2). Revised edition. http://www.cdc.gov/hiv/library/reports/surveillance/."/>
   <result pre="HIV among black men who have sex with men in" exact="the United States." post="J Acquir Immune Defic Syndr. 201465(2):218â€&quot;25. 10.1097/01.qai.0000434953.65620.3d24091691 24MandsagerP, MarierA,"/>
   <result pre="among black men who have sex with men in the" exact="United States." post="J Acquir Immune Defic Syndr. 201465(2):218â€&quot;25. 10.1097/01.qai.0000434953.65620.3d24091691 24MandsagerP, MarierA,"/>
   <result pre="of HIV or HCV infections among persons who inject drugs," exact="United States." post="J Acquir Immune Defic Syndr2016;73:323â€&quot;331. 10.1097/QAI.000000000000109827763996 29CrepazN, TangT, MarksG,"/>
   <result pre="29CrepazN, TangT, MarksG, et al.Viral suppression patterns among persons in" exact="the United States" post="with diagnosed HIV infection in 2014Ann Intern Med2017; 167:"/>
   <result pre="TangT, MarksG, et al.Viral suppression patterns among persons in the" exact="United States" post="with diagnosed HIV infection in 2014Ann Intern Med2017; 167:"/>
   <result pre="HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity," exact="United States," post="2015. Ann Epidem2018; 28:850â€&quot;857. 36LiZ, PurcellDW, SansomSL, et al.Vital"/>
   <result pre="Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in" exact="the United States," post="2012â€&quot;2016Clin Infect Dis2020"/>
   <result pre="With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the" exact="United States," post="2012â€&quot;2016Clin Infect Dis2020"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7568023\results\search\country\results.xml">
   <result pre="In December 2019, COVID-19 emerged for the first time in" exact="China" post="and has quickly-transmitted in the world (Angel-Korman et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7569636\results\search\country\results.xml">
   <result pre="length of the Medieval quarantine established for plague in the" exact="Republic of" post="Venice (Italy) in the course of the fourteenth century"/>
   <result pre="days (16). From the coining of the term â€œquarantineâ€� onwards," exact="Italy" post="has always played a major role in defining and"/>
   <result pre="materially performed, comes from Italy; in the fourteenth century the" exact="Republic of" post="Venice again disposed that the quarantine of clearly infected"/>
   <result pre="of the health of entire communities, thus giving rise in" exact="Italy" post="to public health interventions and initial sanitary administration (17,"/>
   <result pre="of the ever-lasting measure of quarantine (21). On that occasion" exact="the US" post="Centers for Disease Control and Prevention explicitly stated that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7570423\results\search\country\results.xml">
   <result pre="T cell response associated with severe COVID-19, a study from" exact="the USA" post="documented the presence of circulating SARS-CoV-2-specific CD4+ and CD8+"/>
   <result pre="Italy. A retrospective study of 35 children with MIS-C in" exact="France" post="described acute heart failure as a result of the"/>
   <result pre="early small, uncontrolled studies showing the opposite183,184, a report from" exact="Japan" post="showed substantially higher mortality among patients on maintenance haemodialysis"/>
   <result pre="patients on haemodialysis185. Two further studies from the UK and" exact="Italy" post="also reported significantly higher mortality among patients on haemodialysis"/>
   <result pre="COVID-19 failed to demonstrate a beneficial effect of remdesivir191. However," exact="the US" post="FDA granted emergency use authorization for remdesivir when review"/>
   <result pre="long-term complications and prolonged virus shedding207. However, early reports from" exact="China" post="indicated that treatment with methylprednisolone decreased the risk of"/>
   <result pre="preventing the development of venous thromboembolisms. In a report from" exact="China" post="published in preprint form, administration of LMWH to patients"/>
   <result pre="support of this proposal, a small clinical trial conducted in" exact="China" post="and published in preprint form showed that prophylactic anti-coagulation"/>
   <result pre="L.F.P.N. and L.R. are supported by core funds at the" exact="Singapore" post="Immunology Network (SIgN) through the Biomedical Medical Research Council"/>
   <result pre="Covid-19N. Engl. J. Med.202038351752510.1056/NEJMoa201663832492293 203.MagagnoliJet al.Outcomes of hydroxychloroquine usage in" exact="United States" post="veterans hospitalized with Covid-19Med202010.1016/j.medj.2020.06.00132838355 204.BorbaMGSet al.Effect of high vs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7574529\results\search\country\results.xml">
   <result pre="review and initial findings from a qualitative study in Barcelona," exact="Spain" post="http://orcid.org/0000-0001-7427-6796Shirley-BeavanSamsam.shirleybeavan@hri.global1RoigAura2Burke-ShyneNaomi1DanielsColleen1CsakRobert1[1], [2], epub: 2020-10-10pmc-release: 2020-10-10collection: 20201778received: 2020-8-5accepted: 2020-10-12(C) ,"/>
   <result pre="who use drugs. Keywords Harm reduction Women Prison Europe Barcelona" exact="Spain" post="Gender-based violence Funding Robert Carr Fund Funding MAC AIDS"/>
   <result pre="programmes and integrated psychosocial services for people who use drugs." exact="Spain" post="is one of just ten countries worldwide that provide"/>
   <result pre="harm reduction services for women. Qualitative studies in Georgia, Indonesia," exact="South Africa" post="and Tanzania have consistently found that women face greater"/>
   <result pre="for women. Qualitative studies in Georgia, Indonesia, South Africa and" exact="Tanzania" post="have consistently found that women face greater stigma based"/>
   <result pre="spend on education in some countries [53]. A study in" exact="Spain" post="found that a high proportion of women who use"/>
   <result pre="equipped to meet those needs. A study among staff in" exact="Canada" post="found that when accessing health and harm reduction services,"/>
   <result pre="on womenâ€™s access to harm reduction services: for example, in" exact="Denmark" post="pregnant women are the only group explicitly excluded from"/>
   <result pre="drug use is disclosed, or in some jurisdictions including in" exact="Russia" post="and Ukraine, the risk of prosecution for child abuse"/>
   <result pre="has been documented in prison NSPs elsewhere (such as in" exact="Canada" post="[83]), a lack of anonymity can result in punitive"/>
   <result pre="greater vulnerability to the harms of drug use. For example," exact="Switzerland" post="has been successful in substantially reducing the number of"/>
   <result pre="this include an NSP for women who inject drugs in" exact="Malta" post="[92] and a syringe dispensing machine in a womenâ€™s"/>
   <result pre="and a syringe dispensing machine in a womenâ€™s prison in" exact="Germany" post="(a syringe-dispensing machine in one out of 181 prisonsâ€&quot;a"/>
   <result pre="two formally established networks for women who use drugs in" exact="Italy" post="(the Chemical Sisters) and in Spain (XADUDâ€&quot;Xarxa de Dones"/>
   <result pre="who use drugs in Italy (the Chemical Sisters) and in" exact="Spain" post="(XADUDâ€&quot;Xarxa de Dones que Usen Drogues, Network of Woman"/>
   <result pre="can get holistic support across these issues [42]. Women in" exact="Georgia" post="report that the lack of services for people with"/>
   <result pre="women who use drugs than in men in studies in" exact="Spain" post="and globally [60, 102â€&quot;105]. Where services addressing these issues"/>
   <result pre="Policy201630525810.1016/j.drugpo.2015.12.01926797188 43.OtiashviliDKirtadzeIOâ€™GradyKEZuleWKrupitskyEWechsbergWMet al.Access to treatment for substance-using women in the" exact="Republic of" post="Georgia: socio-cultural and structural barriersInt J Drug Policy20132456657210.1016/j.drugpo.2013.05.00423756037 44.SpoonerCSaktiawatiAMILazuardiEWorthHSubrontoYWPadmawatiRSImpacts"/>
   <result pre="harm reduction, and HIV: key findings from Azerbaijan, Georgia, Kyrgyzstan," exact="Russia" post="and Ukraine2009New YorkOpen Society Foundations 77.van der MeulenEShalitADChuSKHA legacy"/>
   <result pre="for hepatitis C (TraP Hep C)â€&quot;a nationwide elimination programme in" exact="Iceland" post="using direct-acting antiviral agentsJ Intern Med201828350050710.1111/joim.1274029512219 99.OlsenABanwellCDancePMaherLPositive health beliefs"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
